<SEC-DOCUMENT>0001206774-16-006893.txt : 20160816
<SEC-HEADER>0001206774-16-006893.hdr.sgml : 20160816
<ACCEPTANCE-DATETIME>20160816164109
ACCESSION NUMBER:		0001206774-16-006893
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		136
CONFORMED PERIOD OF REPORT:	20160630
FILED AS OF DATE:		20160816
DATE AS OF CHANGE:		20160816

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLOROX CO /DE/
		CENTRAL INDEX KEY:			0000021076
		STANDARD INDUSTRIAL CLASSIFICATION:	SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
		IRS NUMBER:				310595760
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07151
		FILM NUMBER:		161836503

	BUSINESS ADDRESS:	
		STREET 1:		THE CLOROX COMPANY
		STREET 2:		1221 BROADWAY
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1888
		BUSINESS PHONE:		5102717000

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 24305
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1305
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>clorox3118951_1-10k.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<p align=left><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<HR style="MARGIN-TOP: -2px" color=black SIZE=1>

<HR style="MARGIN-TOP: -10px" color=black SIZE=1>

<P align=center><B><FONT face="Times New Roman" size=4>UNITED STATES
<BR></FONT></B><B><FONT face="Times New Roman" size=4>SECURITIES AND EXCHANGE
COMMISSION<BR></FONT></B><B><FONT face="Times New Roman">Washington, D.C. 20549
<BR></FONT></B><FONT face="Times New Roman">__________________</FONT></P>
<P align=center><B><FONT face="Times New Roman" size=5>FORM
10-K<BR></FONT></B><FONT face="Times New Roman">__________________</FONT></P>
<TABLE style="FONT-SIZE: 10pt; LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom style="line-height: 12pt">
    <TD NOWRAP STYLE="width: 1%; text-align: left; vertical-align: top"><FONT face="Times New Roman" size=2>&#9745;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 98%; text-align: left; vertical-align: top"><B><FONT face="Times New Roman" size=2>Annual report pursuant to Section 13 or 15(d) of the
      Securities Exchange Act of 1934</FONT></B></TD></TR>
  <TR style="line-height: 8pt">
    <TD NOWRAP STYLE="width: 1%; text-align: left; vertical-align: top"></TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 98%"><FONT face="Times New Roman" size=2>&nbsp;</font></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center; width: 99%"><FONT face="Times New Roman" size=2>for the fiscal year ended June 30,
      2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center; width: 99%"><FONT face="Times New Roman" size=2>OR</FONT></TD></TR>
    <TR STYLE="vertical-align: bottom"  style="line-height: 8pt">
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=2>&nbsp;</font></TD></TR>
<TR vAlign=bottom   style="line-height: 12pt">
    <TD NOWRAP STYLE="width: 1%; text-align: left; vertical-align: top"><FONT face="Times New Roman" size=2>&#9744;</FONT></TD>
    <TD STYLE="width: 98%; text-align: left; vertical-align: top"><B><FONT face="Times New Roman" size=2>Transition report pursuant to Section 13 or 15(d) of the
      Securities Exchange Act of 1934</FONT></B></TD></TR>
    <TR STYLE="vertical-align: bottom"   style="line-height: 8pt">
    <TD NOWRAP STYLE="vertical-align: top; text-align: left"><FONT face="Times New Roman" size=2>&nbsp;</font></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=2>&nbsp;</font></TD></TR>
<TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center; width: 99%"><FONT face="Times New Roman" size=2>for the transition period
      from__________to__________.</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="width: 1%; text-align: left; vertical-align: top"></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center; width: 98%"><FONT face="Times New Roman" size=2>Commission file number:
1-07151</FONT></TD></TR></TABLE><BR>
<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="font-size: 10pt; line-height: normal; border-collapse: collapse; width: 100%">

  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><B><FONT face="Times New Roman" size=6>THE CLOROX
      COMPANY</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=2>(Exact name of registrant as
      specified in its charter)</FONT></TD></TR>
  <TR style="line-height: 8pt">
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp; </TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center; width: 50%"><B><FONT face="Times New Roman" size=2>Delaware</FONT></B></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center; width: 50%"><B><FONT face="Times New Roman" size=2>31-0595760</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=1>(State or other jurisdiction of</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=1>(I.R.S. Employer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=1>incorporation or organization)</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=1>Identification Number)</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><B><FONT face="Times New Roman" size=2>1221 Broadway,
      Oakland, California 94612-1888</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=1>(Address of principal executive
      offices) (ZIP code)</FONT></TD></TR>
  <TR style="line-height: 8pt">
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><B><FONT face="Times New Roman" size=2>(510)
      271-7000</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=1>(Registrant&#146;s telephone number,
      including area code)</FONT></TD></TR>
  <TR style="line-height: 8pt">
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><B><FONT face="Times New Roman" size=2>Securities registered
      pursuant to Section 12(b) of the Act:</FONT></B></TD></TR>
  <TR style="line-height: 8pt">
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"><B><U><FONT face="Times New Roman" size=1>Title of each class</FONT></U></B></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"><B><U><FONT face="Times New Roman" size=1>Name of each exchange on which
    registered</FONT></U></B></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=2>Common Stock&#150;$1.00 par value</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"><FONT face="Times New Roman" size=2>New
      York Stock Exchange</FONT></TD></TR>
  <TR style="line-height: 8pt">
    <TD NOWRAP STYLE="vertical-align: top; text-align: center"></TD>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><B><FONT face="Times New Roman" size=2>Securities registered
      pursuant to Section 12(g) of the Act:</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><B><FONT face="Times New Roman" size=2>None</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP COLSPAN="2" STYLE="vertical-align: top; text-align: center"><B><FONT face="Times New Roman" size=1>(Title of
      class)</FONT></B></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Indicate by check mark if the
registrant is a well-known seasoned issuer, as defined in Rule 405 of the
Securities Act. Yes </FONT><FONT face="Times New Roman" size=2>&#9745;. </FONT><FONT face="Times New Roman" size=2>No &#9744;</FONT><FONT face="Times New Roman" size=2>.</FONT><FONT face="Times New Roman"> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Indicate by check mark if the
registrant is not required to file reports pursuant to Section 13 or Section
15(d) of the Act. Yes &#9744;<FONT face="Times New Roman" size=2>.</FONT> </FONT><FONT face="Times New Roman" size=2>No &#9745;.</FONT><FONT face="Times New Roman">&nbsp;</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Indicate by check mark whether
the registrant (1) has filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes
<FONT face="Times New Roman" size=2>&#9745;.</FONT></FONT><FONT face="Times New Roman" size=2> No </FONT><FONT face="Times New Roman" size=2>&#9744;.</FONT><FONT face="Times New Roman"> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Indicate by check mark whether
the registrant has submitted electronically and posted on its corporate Web
site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required
to submit and post such files). Yes <FONT face="Times New Roman" size=2>&#9745;.
</FONT><FONT face="Times New Roman" size=2>No &#9744;</FONT><FONT face="Times New Roman" size=2>.</FONT></FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=left><FONT face="Times New Roman" size=2>Indicate by check mark if
disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (&#167;229.405
of this chapter) is not contained herein, and will not be contained, to the best
of registrant&#146;s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. </FONT><FONT face="Times New Roman" size=2>&#9745;</FONT><FONT face="Times New Roman" size=2>.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of
&#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148;
in Rule 12b-2 of the Exchange Act. (Check one): </FONT></P>
<div style="padding-left: 15pt">
<TABLE style="FONT-SIZE: 10pt; LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="24%"><FONT face="Times New Roman" size=2>Large accelerated filer </FONT><FONT face="Times New Roman" size=2>&#9745;</FONT></TD>
    <TD noWrap align=left width="25%"><FONT face="Times New Roman" size=2>Accelerated filer </FONT><FONT face="Times New Roman" size=2>&#9744;</FONT></TD>
    <TD noWrap align=left width="25%"><FONT face="Times New Roman" size=2>Non-accelerated filer </FONT><FONT face="Times New Roman" size=2>&#9744;</FONT></TD>
    <TD noWrap align=left width="25%"><FONT face="Times New Roman" size=2>Smaller reporting company </FONT><FONT face="Times New Roman" size=2>&#9744;</FONT></TD></TR></TABLE></div><BR>
<P align=left><FONT face="Times New Roman" size=2>Indicate by check mark whether
the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
</FONT><FONT face="Times New Roman" size=2>&#9744; </FONT><FONT face="Times New Roman" size=2>No </FONT><FONT face="Times New Roman" size=2>&#9745;</FONT><FONT face="Times New Roman" size=2>.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The aggregate market value of
the registrant&#146;s common stock held by non-affiliates as of December 31, 2015
(the last business day of the registrant&#146;s most recently completed second fiscal
quarter) was approximately $16.4 billion.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of July 29, 2016, there
were 129,469,454 shares of the registrant&#146;s common stock outstanding.</FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>Documents Incorporated by
Reference: </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Portions of the registrant&#146;s
definitive proxy statement for the 2016 Annual Meeting of Stockholders (the
&#147;Proxy Statement&#148;), to be filed within 120 days after June 30, 2016, are
incorporated by reference into Part III, Items 10 through 14 of this Annual
Report on Form 10-K.</FONT></P>
<HR style="MARGIN-TOP: -2px" color=black SIZE=1>

<HR style="MARGIN-TOP: -10px" color=black SIZE=1>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=center><B><FONT face="Times New Roman" size=2><A NAME="toc"></A>THE CLOROX
COMPANY<BR>ANNUAL REPORT ON FORM 10-K <BR></FONT></B><B><FONT face="Times New Roman" size=2>FOR THE FISCAL YEAR ENDED JUNE 30, 2016<BR>TABLE
OF CONTENTS</FONT></B><B></B></P>
<TABLE style="FONT-SIZE: 10pt; LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="5%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="86%"></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" vAlign=top noWrap align=center width="2%"><B><FONT face="Times New Roman" size=2>Page</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2><A HREF="#part1">Part I</A></FONT></B></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item1">Item 1.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item1">Business</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item1">1</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2><A HREF="#item1a">Item 1.A.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="86%"><FONT face="Times New Roman" size=2><A HREF="#item1a">Risk
      Factors</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="2%"><FONT face="Times New Roman" size=2><A HREF="#item1a">5</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item1b">Item 1.B.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item1b">Unresolved Staff Comments</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item1b">18</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2><A HREF="#item2">Item 2.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="86%"><FONT face="Times New Roman" size=2><A HREF="#item2">Properties</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="2%"><FONT face="Times New Roman" size=2><A HREF="#item2">18</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item3">Item 3.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item3">Legal Proceedings</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item3">19</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2><A HREF="#item4">Item 4.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="86%"><FONT face="Times New Roman" size=2><A HREF="#item4">Mine
      Safety Disclosures</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="2%"><FONT face="Times New Roman" size=2><A HREF="#item4">19</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2><A HREF="#Part2">Part II</A></FONT></B></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item5">Item 5.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item5">Market for Registrant&#146;s Common Equity, Related
      Stockholder Matters and</a></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <A HREF="#item5">Issuer
      Purchases of Equity Securities</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item5">22</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2><A HREF="#item6">Item 6.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="86%"><FONT face="Times New Roman" size=2><A HREF="#item6">Selected Financial Data</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="2%"><FONT face="Times New Roman" size=2><A HREF="#item6">23</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item7">Item 7.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item7">Management&#146;s Discussion and Analysis of
      Financial Condition and Results of Operations</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item7">23</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2><A HREF="#item7a">Item 7.A.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="86%"><FONT face="Times New Roman" size=2><A HREF="#item7a">Quantitative and Qualitative Disclosures About
      Market Risk</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="2%"><FONT face="Times New Roman" size=2><A HREF="#item7a">23</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item8">Item 8.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item8">Financial Statements and Supplementary
      Data</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item8">23</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2><A HREF="#item9">Item 9.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%">&nbsp;</TD>
    <TD vAlign=top align=left width="86%"><FONT face="Times New Roman" size=2><A HREF="#item9">Changes in and Disagreements with Accountants
      on Accounting and Financial Disclosure</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="2%"><FONT face="Times New Roman" size=2><A HREF="#item9">23</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item9a">Item 9.A.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item9a">Controls and Procedures</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item9a">23</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="2%">&nbsp;</TD>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2><A HREF="#item9b">Item 9.B.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="86%"><FONT face="Times New Roman" size=2><A HREF="#item9b">Other Information</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="2%"><FONT face="Times New Roman" size=2><A HREF="#item9b">23</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2><A HREF="#part3">Part III</A></FONT></B></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item10">Item 10.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item10">Directors, Executive Officers and Corporate
      Governance</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item10">24</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2><A HREF="#item11">Item 11.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="86%"><FONT face="Times New Roman" size=2><A HREF="#item11">Executive Compensation</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="2%"><FONT face="Times New Roman" size=2><A HREF="#item11">24</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item12">Item 12.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item12">Security Ownership of Certain Beneficial Owners
      and Management and Related</a></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      <A HREF="#item12">Stockholder Matters</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item12">24</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2><A HREF="#item13">Item 13.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="86%"><FONT face="Times New Roman" size=2><A HREF="#item13">Certain Relationships and Related Transactions,
      and Director Independence</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="2%"><FONT face="Times New Roman" size=2><A HREF="#item13">24</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item14">Item 14.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item14">Principal Accounting Fees and
Services</a></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#item14">24</a></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="2%"><B><FONT face="Times New Roman" size=2><A HREF="#part4">Part IV</A></FONT></B></TD>
    <TD vAlign=top noWrap align=left width="2%"></TD>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2><A HREF="#item15">Item 15.</A></FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="86%"><FONT face="Times New Roman" size=2><A HREF="#item15">Exhibits and Financial Statement Schedules</A></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="2%"><FONT face="Times New Roman" size=2><A HREF="#item15">25</a></FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap align=left width="4%" bgColor=#c0c0c0 colSpan=2><STRONG><FONT face="Times New Roman" size=2><STRONG><A HREF="#sign">Signatures</A></STRONG></FONT></STRONG></TD>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="86%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><A HREF="#sign">30</a></FONT></TD></TR></TABLE><BR>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left   style="margin-top: -2pt"><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=center   style="margin-top: -2pt"><B><FONT face="Times New Roman" size=2><A NAME="part1"></A>PART I</FONT></B></P>
<P align=left   style="margin-top: -2pt"><FONT face="Times New Roman" size=2>This Annual Report on Form
10-K for the fiscal year ended June 30, 2016 (this Report), including the
exhibits hereto and the information incorporated by reference herein, contains
&#147;forward-looking statements&#148; within the meaning of Section 27A of the Securities
Act of 1933, as amended (the Securities Act), and Section 21E of the Securities
Exchange Act of 1934, as amended (the Exchange Act), and such forward-looking
statements involve risks and uncertainties. Except for historical information,
statements about future volume, sales, foreign currencies, costs, cost savings,
margin, earnings, earnings per share, diluted earnings per share, foreign
currency exchange rates, cash flows, plans, objectives, expectations, growth or
profitability, are forward-looking statements based on management&#146;s estimates,
assumptions and projections. Words such as &#147;could,&#148; &#147;may,&#148; &#147;expects,&#148;
&#147;anticipates,&#148; &#147;targets,&#148; &#147;goals,&#148; &#147;projects,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;believes,&#148;
&#147;seeks,&#148; &#147;estimates,&#148; &#147;predicts&#148; and variations on such words, and similar
expressions that reflect our current views with respect to future events and
operational and financial performance, are intended to identify such
forward-looking statements. These forward-looking statements are only
predictions, subject to risks and uncertainties, and actual results could differ
materially from those discussed below. Important factors that could affect
performance and cause results to differ materially from management&#146;s
expectations are described in the sections entitled &#147;Risk Factors&#148; and
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations&#148; in this Report, as updated from time to time in the Company&#146;s U.S.
Securities and Exchange Commission (SEC) filings.</FONT></P>
<P align=left   style="margin-top: -2pt"><FONT face="Times New Roman" size=2>The Company&#146;s forward-looking
statements in this Report are based on management&#146;s current views and
assumptions regarding future events and speak only as of their dates. The
Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise, except as required by the federal securities laws.</FONT>
</P>
<P align=left   style="margin-top: -2pt"><FONT face="Times New Roman" size=2>In this Report, unless the
context requires otherwise, the terms &#147;the Company&#148; and &#147;Clorox&#148; refer to The
Clorox Company and its subsidiaries.</FONT></P>
<P align=left   style="margin-top: -2pt"><B><FONT face="Times New Roman" size=2><A NAME="item1"></A>ITEM 1.
BUSINESS</FONT></B></P>
<P align=left   style="margin-top: -2pt"><B><FONT face="Times New Roman" size=2>Overview of
Business</FONT></B></P>
<P align=left   style="margin-top: -2pt"><FONT face="Times New Roman" size=2>The Clorox Company is a
leading multinational manufacturer and marketer of consumer and professional
products with fiscal year 2016 net sales of $5.8 billion and approximately 8,000
employees worldwide as of June 30, 2016. Clorox sells its products primarily
through grocery and mass retail outlets, e-commerce channels, wholesale
distributors and medical supply distributors. Clorox markets some of the most
trusted and recognized consumer brand names, including its namesake bleach and
cleaning products, Pine-Sol<SUP>&#174;</SUP> cleaners, Liquid-Plumr<SUP>&#174;</SUP> clog
removers, Poett<SUP>&#174;</SUP> home care products, Fresh Step<SUP>&#174;</SUP> cat
litter, Glad<SUP>&#174;</SUP> bags, wraps and container products,
Kingsford<SUP>&#174;</SUP> charcoal, Renew Life<SUP>&#174;</SUP> digestive health
products, Hidden Valley<SUP>&#174;</SUP> dressings and sauces, Brita<SUP>&#174;</SUP>
water-filtration products, and Burt&#146;s Bees<SUP>&#174;</SUP></FONT> <FONT face="Times New Roman" size=2>natural personal care products. The Company also
markets brands through professional services channels, including infection
control products for the healthcare industry under Clorox
Healthcare<SUP>&#174;</SUP></FONT> <FONT face="Times New Roman" size=2>and Clorox
Commercial Solutions<SUP>&#174;</SUP>. More than 80% of the Company&#146;s sales are
generated from brands that hold the No. 1 or No. 2 market share positions in
their categories. The Company was founded in Oakland, California in 1913 and is
incorporated in Delaware.</FONT></P>
<P align=left   style="margin-top: -2pt"><FONT face="Times New Roman" size=2>The Company&#146;s 2020 strategy
focuses on delivering long-term, profitable growth and total shareholder return.
The Company&#146;s long-term financial goals include annual net sales growth of 3-5%,
annual EBIT margin growth of 25-50 basis points and annual free cash flow of
10-12% of net sales.</FONT></P>
<P align=left   style="margin-top: -2pt"><FONT face="Times New Roman" size=2>On May 2, 2016, the Company
acquired 100 percent of the digestive health company Renew Life for $290
million. The purchase of the Renew Life business aligns with the Company&#146;s
acquisition strategy to target leading brands with attractive margins in
high-growth categories, particularly in health and wellness. Results for Renew
Life&#146;s domestic business are reflected in the Household reportable segment and
results for Renew Life&#146;s international business are reflected in the
International reportable segment. Included in the Company&#146;s results for fiscal
year 2016 was $21 million of Renew Life&#146;s global net sales.</FONT></P>
<P align=left   style="margin-top: -2pt"><FONT face="Times New Roman" size=2>In fiscal year 2016, the
Company delivered strong results including 2% net sales growth and an 8%
increase in diluted earnings per share (EPS) from continuing operations, despite
a highly competitive environment in the U.S. and a difficult macro-environment,
including unfavorable foreign exchange rates and challenging economies in
International markets.</FONT></P>


<P align=center  style="margin-top: -2pt"><FONT size=2 face="Times New Roman">1</FONT></P>
<HR align=center width="100%" noShade SIZE=2 style="margin-top: -2pt">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left  style="margin-top: -2pt"><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=left  style="margin-top: -2pt"><FONT face="Times New Roman" size=2>The Company focused on driving
sales growth in its U.S. business, leveraging incremental demand building
investments and innovation, to drive category growth and market share
improvements. In particular, the Company launched new products in many
categories in fiscal year 2016, including the Brita<SUP>&#174;</SUP> Infinity
pitcher, Burt's Bees<SUP>&#174;</SUP> lipsticks, Clorox Healthcare<SUP>&#174;</SUP> nasal
antiseptic swabs, Clorox Healthcare<SUP>&#174;</SUP> Optimum-UV Enlight, Fresh
Step<SUP>&#174;</SUP> with Febreze<SUP>&#153;</SUP>, Glad<SUP>&#174;</SUP>
DualDefense<SUP>&#153;</SUP> trash bags, Hidden Valley<SUP>&#174;</SUP> Greek yogurt
dressing.</FONT></P>
<P align=left  style="margin-top: -2pt"><FONT face="Times New Roman" size=2>In international markets, the
Company focused on a number of measures to address economic challenges
experienced in fiscal year 2016. Significant currency declines across the
majority of countries and high inflation in several markets were partially
offset by price increases and cost savings initiatives. Despite these
challenges, the Company&#146;s international business continued to play an important
strategic role, with No. 1 and No. 2 brands in multiple countries and strong
growth of the Burt&#146;s Bees<SUP>&#174;</SUP> brand internationally.</FONT></P>
<P align=left  style="margin-top: -2pt"><FONT face="Times New Roman" size=2>In fiscal year 2016, the
Company repurchased approximately 2 million shares of its common stock for $254
million, paid $398 million in dividends to stockholders and announced a 4%
increase in its quarterly dividend from prior year, payable in August
2016.</FONT></P>
<P align=left  style="margin-top: -2pt"><FONT face="Times New Roman" size=2>Finally, the Company continued
its commitment to corporate responsibility by maintaining strong and transparent
environmental, social and governance practices. The Company remained committed
to lowering water and energy use, solid waste to landfill and greenhouse gas
emissions as part of its 2020 operational footprint reduction goals. The Company
was recognized as one of the top corporate citizens by Corporate Responsibility
magazine and named as one of the greenest companies in the 2016 Newsweek Green
Rankings. In fiscal year 2016, together The Clorox Company Foundation and The
Burt&#146;s Bees Greater Good Foundation awarded approximately $5 million in cash
grants, and the Company made product donations with a fair market value of
approximately $8 million and contributed more than $1 million to deserving
nonprofits through cause marketing programs for social and charitable
causes.</FONT></P>
<P align=left  style="margin-top: -2pt"><FONT face="Times New Roman" size=2>In fiscal year 2017, Clorox
anticipates ongoing challenges that may impact its sales and margins, including
unfavorable foreign currency exchange rates, particularly in Argentina, and a
continuation of challenging international economies. In addition, the Company is
monitoring anticipated slower U.S. category growth, driven primarily by expected
competitive activity and changes to commodity costs and manufacturing and
logistics costs.</FONT></P>
<P align=left  style="margin-top: -2pt"><FONT face="Times New Roman" size=2>For additional information on
recent business developments, see &#147;Management&#146;s Discussion and Analysis of
Financial Condition and Results of Operations,&#148; in Exhibit 99.1, incorporated
herein by reference.</FONT></P>
<P align=left  style="margin-top: -2pt"><B><FONT face="Times New Roman" size=2>Financial Information About
Operating Segments and Principal Products</FONT></B></P>
<P align=left  style="margin-top: -2pt"><FONT face="Times New Roman" size=2>The Company operates through
strategic business units that are aggregated into four reportable segments:
Cleaning, Household, Lifestyle and International. The four reportable segments
consist of the following:</FONT></P>
<TABLE style="FONT-SIZE: 10pt; line-height: 12pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%">
      <P align=left><I><FONT face="Times New Roman" size=2>Cleaning</FONT></I>
      <FONT face="Times New Roman" size=2>consists of laundry, home care and
      professional products marketed and sold in the United States. Products
      within this segment include laundry additives, including bleach products
      under the Clorox<SUP>&#174;</SUP> brand and Clorox 2<SUP>&#174;</SUP> stain fighter
      and color booster; home care products, primarily under the
      Clorox<SUP>&#174;</SUP>, Formula 409<SUP>&#174;</SUP>, Liquid-Plumr<SUP>&#174;</SUP>,
      Pine-Sol<SUP>&#174;</SUP>, S.O.S<SUP>&#174;</SUP> and Tilex<SUP>&#174;</SUP> brands;
      naturally derived products under the Green Works<SUP>&#174;</SUP> brand; and
      professional cleaning and disinfecting products under the
      Clorox<SUP>&#174;</SUP>, Dispatch<SUP>&#174;</SUP>, Aplicare<SUP>&#174;</SUP>,
      HealthLink<SUP>&#174;</SUP> and Clorox Healthcare<SUP>&#174;</SUP>
    brands.</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%">
      <P align=left><I><FONT face="Times New Roman" size=2>Household</FONT></I>
      <FONT face="Times New Roman" size=2>consists of charcoal, cat litter,
      digestive health products and bags, wraps and container products marketed
      and sold in the United States. Products within this segment include
      charcoal products under the Kingsford<SUP>&#174;</SUP> and Match
      Light<SUP>&#174;</SUP> brands; cat litter products under the Fresh
      Step<SUP>&#174;</SUP>, Scoop Away<SUP>&#174;</SUP> and Ever Clean<SUP>&#174;</SUP>
      brands; digestive health products under the Renew Life<SUP>&#174;</SUP> brand;
      and bags, wraps and containers under the Glad<SUP>&#174;</SUP>
    brand.</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%"><EM>Lifestyle</EM> <FONT face="Times New Roman" size=2>consists of food products, water-filtration systems and filters and
      natural personal care products marketed and sold in the United States.
      Products within this segment include dressings and sauces, primarily under
      the Hidden Valley<SUP>&#174;</SUP>, KC Masterpiece<SUP>&#174;</SUP> and Soy
      Vay<SUP>&#174;</SUP> brands; water-filtration systems and filters under the
      Brita<SUP>&#174;</SUP> brand; and natural personal care products under the
      Burt&#146;s Bees<SUP>&#174;</SUP> brand.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%">
      <P align=left><I><FONT face="Times New Roman" size=2>International</FONT></I> <FONT face="Times New Roman" size=2>consists of products sold outside the United States. Products
      within this segment include laundry, home care, water-filtration,
      digestive health products, charcoal and cat litter products, dressings and
      sauces, bags, wraps and containers and natural personal care products,
      primarily under the Clorox<SUP>&#174;</SUP>, Glad<SUP>&#174;</SUP>,
      PinoLuz<SUP>&#174;</SUP>, Ayudin<SUP>&#174;</SUP>, Limpido<SUP>&#174;</SUP>,
      Clorinda<SUP>&#174;</SUP>, Poett<SUP>&#174;</SUP>, Mistolin<SUP>&#174;</SUP>,
      Lestoil<SUP>&#174;</SUP>, Bon Bril<SUP>&#174;</SUP>, Brita<SUP>&#174;</SUP>, Green
      Works<SUP>&#174;</SUP>, Pine-Sol<SUP>&#174;</SUP>, Agua Jane<SUP>&#174;</SUP>,
      Chux<SUP>&#174;</SUP>, Renew Life<SUP>&#174;</SUP>, Kingsford<SUP>&#174;</SUP>, Fresh
      Step<SUP>&#174;</SUP>, Scoop Away<SUP>&#174;</SUP>, Ever Clean<SUP>&#174;</SUP>, KC
      Masterpiece<SUP>&#174;</SUP>, Hidden Valley<SUP>&#174;</SUP> and Burt&#146;s
      Bees<SUP>&#174;</SUP> brands.</FONT></P></TD></TR></TABLE>

<P align=center><FONT size=2 face="Times New Roman">2</FONT></P>
<HR align=center width="100%" noShade SIZE=2 style="margin-top: -2pt">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left  style="margin-top: -3pt"><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=left  style="margin-top: -3pt"><FONT face="Times New Roman" size=2>Three of the Company&#146;s product
lines have accounted for 10% or more of consolidated net sales during each of
the past three fiscal years. In fiscal years 2016, 2015 and 2014, sales of
liquid bleach represented approximately 13%, 14% and 13% of the Company&#146;s
consolidated net sales, respectively, approximately 25%, 26%, and 26% of net
sales in the Cleaning segment for each such years, respectively, and
approximately 27%, 27% and 28% of net sales in the International segment,
respectively. Sales of trash bags represented approximately 13%, 14% and 13% of
the Company&#146;s consolidated net sales in each of the fiscal years 2016, 2015 and
2014, respectively, and approximately 37%, 38% and 36% of net sales in the
Household segment, respectively, for each such years. Sales of charcoal
represented approximately 11% of the Company&#146;s consolidated net sales and
approximately 34% of net sales in the Household segment in fiscal years 2016,
2015 and 2014.</FONT></P>
<P align=left  style="margin-top: -3pt"><FONT face="Times New Roman" size=2>Information about the results
of each of the Company&#146;s reportable segments for the last three fiscal years and
total assets as of the end of the last three fiscal years, reconciled to the
consolidated amounts, is set forth below. Certain non-allocated administrative
costs, interest income, interest expense and various other non-operating income
and expenses are reflected in Corporate. For additional information, refer to
the information set forth under the caption &#147;Segment Results from Continuing
Operations&#148; in &#147;Management&#146;s Discussion and Analysis of Financial Condition and
Results of Operations,&#148; in Exhibit 99.1.</FONT></P>
<TABLE style="FONT-SIZE: 10pt; LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 71%; padding-bottom: 2pt"><FONT face="Times New Roman" size=1>(Dollars in millions)</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 2%; padding-bottom: 2pt"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 2%; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Fiscal<BR>Year</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-bottom: 2pt"></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 4%; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Cleaning</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-bottom: 2pt"></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 3%; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Household</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-bottom: 2pt"></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 2%; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Lifestyle</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-bottom: 2pt"></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 3%; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>International</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-bottom: 2pt"></TD>
    <TD NOWRAP COLSPAN="3" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 4%; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Corporate</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-bottom: 2pt"></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 3%; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Total<BR>Company</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net
      Sales</FONT></TD>
    <TD noWrap style="text-align: center" width="2%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap style="text-align: center" width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,912</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,862</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>990</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>997</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5,761</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap style="text-align: center" width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap style="text-align: center" width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,824</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,794</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>950</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,087</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5,655</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0></TD>
    <TD noWrap style="text-align: center" width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap style="text-align: center" width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2014</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,776</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,709</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>936</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,093</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5,514</FONT></TD></TR>
  <TR  style="line-height: 6pt">
    <TD width="100%" bgColor=#c0c0c0 colSpan=22>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%"><FONT face="Times New Roman" size=2>Earnings (losses) from</FONT></TD>
    <TD noWrap style="text-align: center" width="2%"></TD>
    <TD noWrap style="text-align: center" width="2%"><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>511</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>428</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>251</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>66</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(273</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>983</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%"><FONT face="Times New Roman" size=2>continuing operations before</FONT></TD>
    <TD noWrap style="text-align: center" width="2%"></TD>
    <TD noWrap style="text-align: center" width="2%"><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>445</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>375</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>257</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>79</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(235</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>921</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%"><FONT face="Times New Roman" size=2>Income taxes</FONT></TD>
    <TD noWrap style="text-align: center" width="2%"></TD>
    <TD noWrap style="text-align: center" width="2%"><FONT face="Times New Roman" size=2>2014</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>428</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>326</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>258</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>99</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(227</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>884</FONT></TD></TR>
  <TR style="line-height: 6pt">
    <TD width="100%" colSpan=22>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total assets</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap style="text-align: center" width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>883</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,092</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>880</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,057</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>606</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,518</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap style="text-align: center" width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>876</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>725</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>860</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,057</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>646</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,164</FONT></TD></TR></TABLE><BR>
<P align=left  style="margin-top: -3pt"><B><FONT face="Times New Roman" size=2>Principal Markets and
Methods of Distribution</FONT></B></P>
<P align=left  style="margin-top: -3pt"><FONT face="Times New Roman" size=2>In the United States, most of
the Company&#146;s products are nationally advertised and sold to mass
retail-outlets, warehouse clubs, and dollar, military and other types of retail
stores primarily through a direct sales force, and to grocery stores and grocery
wholesalers primarily through a combination of direct sales teams and a network
of brokers. The Company sells institutional, janitorial, and food-service
versions of many of its products through distributors using a network of
brokers, and sells healthcare products through a direct sales force and medical
supply distributors. Outside the United States, the Company sells products to
the retail trade through subsidiaries, licensees, distributors and joint-venture
arrangements with local partners. Additionally, the Company sells many of its
products through online retailers.</FONT></P>
<P align=left  style="margin-top: -3pt"><B><FONT face="Times New Roman" size=2>Financial Information About
Foreign and Domestic Operations</FONT></B></P>
<P align=left  style="margin-top: -3pt"><FONT face="Times New Roman" size=2>For detailed financial
information about the Company&#146;s foreign and domestic operations, including net
sales and property, plant and equipment, net, by geographic area, see the Notes
to Consolidated Financial Statements in Exhibit 99.1.</FONT></P>
<P align=left  style="margin-top: -3pt"><B><FONT face="Times New Roman" size=2>Sources and Availability of
Raw Materials</FONT></B><FONT face="Times New Roman" size=2></FONT> </P>
<P align=left style="margin-top: -3pt"><FONT face="Times New Roman" size=2>The Company purchases raw
materials from numerous unaffiliated domestic and international suppliers, some
of which are sole-source or single-source suppliers. Interruptions in the
delivery of these materials could adversely impact the Company. Key raw
materials used by the Company include resin, diesel, sodium hypochlorite,
corrugated cardboard and agricultural commodities. Sufficient raw materials were
available during fiscal year 2016. Costs for resin and diesel decreased in
fiscal year 2016. </FONT><FONT face="Times New Roman" size=2>However, costs for many
materials continued to increase amid volatility and inflation in some key
geographic and commodity markets, which the Company expects to continue in
fiscal year 2017. The Company generally utilizes supply and forward-purchase
contracts to help ensure availability and help manage the volatility of the
pricing of raw materials needed in its operations. However, the Company is
nonetheless highly exposed to changes in the prices of commodities used as raw
materials in the manufacturing of its products. For further information
regarding the impact of changes in commodity prices, see &#147;Management&#146;s
Discussion and Analysis of Financial Condition and Results of Operations&#148; in
Exhibit 99.1 and &#147;Risk Factors &#150; Volatility and increases in the costs of raw
materials, energy, transportation, labor and other necessary supplies or
services have harmed, and in the future may harm, the Company&#146;s net earnings and
cash flow&#148; in Item 1.A.</FONT></P>


<P align=center style="margin-top: -3pt"><FONT face="Times New Roman" size=2>3</FONT></P>
<HR align=center width="100%" noShade SIZE=2 style="margin-top: -2pt">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>

<P align=left><B><FONT face="Times New Roman" size=2>Patents and
Trademarks</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Most of the Company&#146;s brand
name consumer products are protected by registered trademarks. The Company&#146;s
brand names and trademarks are highly important to its business, and the Company
vigorously protects its trademarks from apparent infringements. Maintenance of
brand equity value is critical to the Company&#146;s success. The Company&#146;s patent
rights are also material to its business and are asserted, where appropriate,
against apparent infringements.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Seasonality</FONT></B>
</P>
<P align=left><FONT face="Times New Roman" size=2>Most sales of the Company&#146;s
charcoal products occur in the first six months of each calendar year. A
moderate seasonality trend also occurs in the net sales of the Company&#146;s Burt&#146;s
Bees<SUP>&#174;</SUP> natural personal care products, with slightly more than half of
the annual net sales occurring during the months of October through March.
Short-term borrowings may be used to fund inventories of those products in the
off season.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Customers</FONT></B> </P>
<P align=left><FONT face="Times New Roman" size=2>Net sales to the Company&#146;s
largest customer, Walmart Stores, Inc. and its affiliates, were 27%, 26% and 27%
of consolidated net sales for each of the fiscal years ended June 30, 2016, 2015
and 2014, respectively, and occurred in each of the Company&#146;s reportable
segments. No other customers accounted for more than 10% of consolidated net
sales in any of these fiscal years. During fiscal years 2016, 2015 and 2014, the
Company&#146;s five largest customers accounted for 46%, 45%, and 45% of its
consolidated net sales for each of the three fiscal years,
respectively.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Competition</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The markets for consumer
products are highly competitive. The Company&#146;s products compete with other
nationally advertised brands and with &#147;private label&#148; brands within each
category. Competition comes from similar and alternative products, some of which
are produced and marketed by major multinational or national companies having
financial resources greater than those of the Company. The Company&#146;s products <FONT STYLE="BACKGROUND-COLOR: Transparent">generally</FONT>
compete on <FONT STYLE="BACKGROUND-COLOR: Transparent">the basis of</FONT> product performance, brand recognition, and price. A newly introduced
consumer product (whether improved or newly developed) usually encounters
intense competition requiring substantial expenditures for advertising, sales
promotion and trade merchandising support. If a product gains consumer
acceptance, it typically requires continued advertising and promotional support
and ongoing product improvements to maintain its relative market position. For
further information regarding the intense competition the Company faces, see
&#147;Risk Factors &#150; The Company faces intense competition in its markets, which
could lead to reduced net sales, net earnings and cash flow&#148; in Item
1.A.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Research and
Development</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company conducts research
and development primarily at its facility located in Pleasanton, CA, which the
Company has leased since 2011. The Pleasanton facility consists of approximately
357,000 square feet of leased space, utilizing state-of-the-art labs and open
work spaces to encourage creativity, collaboration and innovation. In addition
to the leased facility in Pleasanton, CA, the Company conducts research and
development activities in Meriden, CT; Willowbrook, IL; Durham, NC; Cincinnati,
OH; and Buenos Aires, Argentina.</FONT></P>



<P align=center><FONT face="Times New Roman" size=2>4</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=left><FONT face="Times New Roman" size=2>The Company devotes
significant resources and attention to product development, process technology
and consumer insight research to develop commercially viable consumer-preferred
products with innovative and distinctive features. The Company incurred expenses
of $141 million, $136 million and $125 million in fiscal years 2016, 2015 and
2014, respectively, on direct research activities relating to the development of
new products and/or the improvement of existing products. In addition, the
Company obtains technologies from third parties for use in its products.
Royalties relating to such technologies are reflected in the Company&#146;s Cost of
products sold. For further information regarding the Company&#146;s research and
development costs, see &#147;Management&#146;s Discussion and Analysis of Financial
Condition and Results of Operations&#148; in Exhibit 99.1.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Environmental
Matters</FONT></B><FONT face="Times New Roman" size=2></FONT> </P>
<P align=left><FONT face="Times New Roman" size=2>For information regarding
noncapital expenditures related to environmental matters, see the discussions
below under &#147;Risk Factors &#150; Environmental matters create potential liabilities
that could adversely affect the Company&#146;s results of operations or financial
condition&#148; in Item 1.A. No material capital expenditures relating to
environmental compliance are presently anticipated.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Number of Persons
Employed</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016, the
Company employed approximately 8,000 people.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Available
Information</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s Annual Report on
Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K and
amendments to those reports filed or furnished pursuant to Sections 13(a) or
15(d) of the Exchange Act are available on the Company&#146;s website, free of
charge, as soon as reasonably practicable after the reports are electronically
filed with or furnished to the SEC. These reports are available at
TheCloroxCompany.com under Investors/Financial Reporting/SEC Filings.
Information relating to corporate governance at Clorox, including the Company&#146;s
Code of Conduct, the Clorox Company Board of Directors Governance Guidelines and
Board Committee charters for the Management Development and Compensation
Committee, the Audit Committee, and the Nominating and Governance Committee, is
available at TheCloroxCompany.com under Corporate Responsibility/Performance/Corporate Governance or http://www.thecloroxcompany.com/corporate-responsibility/performance/corporate-governance.
The Company will provide any of the foregoing information without charge upon
written request to Corporate Communications, The Clorox Company, 1221 Broadway,
Oakland, CA 94612-1888. The information contained on the Company&#146;s website is
not included as a part of, or incorporated by reference into, this
Report.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item1a"></A>ITEM 1.A. RISK
FACTORS</FONT></B><FONT face="Times New Roman"> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The risks and uncertainties
set forth below, as well as other factors described elsewhere in this Report or
in other filings by the Company with the SEC, could adversely affect the
Company&#146;s business, financial condition and results of operations. Additional
risks and uncertainties that are not currently known to the Company or that are
not currently believed by the Company to be material may also harm the Company&#146;s
business operations and financial results.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>The Company faces intense
competition in its markets, which could lead to reduced net sales, net earnings
and cash flow.</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company faces intense
competition from consumer product companies both in the United States and in its
international markets. Most of the Company&#146;s products compete with other widely
advertised brands within each product category. The Company also faces
competition from retailers, including club stores, grocery, dollar stores, mass
merchandisers and internet-based retailers, which are increasingly offering
&#147;private label&#148; brands that are typically sold at lower prices and compete with
the Company&#146;s products in certain categories. During times of economic
uncertainty, consumers tend to purchase more &#147;private label&#148; or other economy
brands. Increased purchases of &#147;private label&#148; products could reduce net sales
of the Company&#146;s higher-margin products or there could be a shift in product mix
to lower-margin offerings.</FONT></P>

<P align=center><FONT face="Times New Roman" size=2>5</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s products
generally compete on the basis of product performance, brand recognition, and
price. Advertising, promotion, merchandising and packaging also have significant
impacts on consumer purchasing decisions, and the Company is increasingly using
digital media marketing and promotional programs to reach consumers. A newly
introduced consumer product (whether improved or newly developed) usually
encounters intense competition requiring substantial expenditures for
advertising, sales promotion and trade merchandising. If a product gains
consumer acceptance, it typically requires continued advertising, promotional
support and product improvements to maintain its relative market position. If
the Company&#146;s advertising, marketing and promotional programs, including its use
of digital media to reach consumers, are not effective or adequate, the
Company&#146;s net sales may be negatively impacted.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Some of the Company&#146;s
competitors are larger than the Company and have greater financial resources.
These competitors may be able to spend more aggressively on advertising and
promotional activities, introduce competing products more quickly and respond
more effectively to changing business and economic conditions than the Company
can. In addition, the Company&#146;s competitors may attempt to gain market share by
offering products at prices at or below those typically offered by the Company.
Competitive activity may require the Company to increase its spending on
advertising and promotions and/or reduce prices, which could lead to reduced net
earnings and adversely affect growth.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Uncertain worldwide,
regional and local economic conditions and financial market volatility may
negatively impact the Company and consumers of its products, which would
negatively affect the Company&#146;s financial performance and
liquidity.</FONT></B><FONT face="Times New Roman"> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Although the Company continues
to devote significant resources to support its brands, uncertain economic
conditions may continue to negatively affect consumer demand for the Company&#146;s
products. Consumers may also be sensitive to economic uncertainty or unfavorable
economic conditions and reduce discretionary spending, which may lead to reduced
net sales or cause a shift in the Company&#146;s product mix from higher-margin to
lower-margin products. Consumers may increase purchases of lower-priced or
&#147;private label&#148; products, and the Company&#146;s competitors may increase levels of
advertising and promotional activity for lower-priced products as they seek to
maintain sales volumes during uncertain economic times, which may negatively
impact the Company&#146;s net sales.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Global markets continued to
experience significant disruptions during fiscal year 2016, and continuing
volatility could continue to harm the Company&#146;s business. In addition, financial
market volatility could adversely affect the Company&#146;s liquidity and capital
resources. Uncertain economic conditions and financial market volatility may
also adversely affect the financial condition of the Company&#146;s customers,
suppliers and other business partners. If customers&#146; financial conditions are
severely affected, customers may reduce their purchases of the Company&#146;s
products or the Company may not be able to collect accounts receivable, each of
which could have a material adverse impact on the Company&#146;s business operations
or financial results.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Sales growth objectives may
be difficult to achieve, and price increases, market and category declines and
changes to the Company&#146;s product and geographic mix may adversely impact the
Company&#146;s financial results.</FONT></B><FONT face="Times New Roman"> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>A large percentage of the
Company&#146;s revenues comes from mature markets that are subject to high levels of
competition. During fiscal year 2016, approximately 83% of the Company&#146;s net
sales were generated in U.S. markets. The Company&#146;s ability to achieve sales
growth depends on its ability to drive growth through innovation, expansion into
new product categories, channels and countries, investment in its established
brands and enhanced merchandising and its ability to capture market share from
competitors. If the Company is unable to increase market share in existing
product lines, develop product improvements, undertake sales, marketing and
advertising initiatives that grow its product categories and/or develop, acquire
or successfully launch new products or brands, it may not achieve its sales
growth objectives. Even when the Company is successful in increasing market
share within particular product categories, a decline in the markets for such
product categories has had and can continue to have a negative impact on the
Company&#146;s financial results.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In addition, changes to the
mix of products the Company sells, as well as the mix of countries in which its
products are sold, can adversely impact the Company&#146;s net sales, profitability
and cash flow. The Company&#146;s financial outlook assumes a certain volume and
product mix, and if actual results vary from this projected volume and product
mix, the Company&#146;s business operations and financial results could be negatively
affected. </FONT></P>

<P align=center><FONT face="Times New Roman" size=2>6 </FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=left><B><FONT face="Times New Roman" size=2>Volatility and increases in
the costs of raw materials, energy, transportation, labor and other necessary
supplies or services have harmed, and in the future may harm, the Company&#146;s net
earnings and cash flow. </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Volatility and increases in
the costs of raw materials, including resin, sodium hypochlorite, linerboard,
soybean oil, solvent, corrugated cardboard and other chemicals and agricultural
commodities, or increases in the cost of energy, transportation, labor and other
necessary supplies or services have harmed, and in the future may harm, the
Company&#146;s profits and operating results. We distribute our products and receive
raw materials primarily by rail and truck. Reduced availability of rail or
trucking could cause us to incur unanticipated expenses and impair our ability
to distribute our products or receive our raw materials in a timely
manner.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company believes commodity
and other cost increases are possible in the future. If such increases occur or
exceed the Company&#146;s estimates and the Company is not able to increase the
prices of its products or achieve cost savings to offset such cost increases,
its profits and operating results will be harmed. In addition, if the Company
increases the prices of its products in response to increases in the cost of
commodities, and commodity costs decline, the Company may not be able to sustain
its price increases. Sustained price increases may lead to declines in volume as
competitors may not adjust their prices or customers may decide not to pay the
higher prices, which could lead to sales declines and loss of market share.
While the Company seeks to project tradeoffs between price increases and volume,
its projections may not accurately predict the volume impact of price increases,
which could adversely affect its financial condition and results of
operations.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>To reduce the cost volatility
associated with anticipated commodity purchases, the Company uses derivative
instruments, including commodity futures and swaps. The extent of the Company&#146;s
derivative position at any given time depends on the Company&#146;s assessment of the
markets for these commodities, the cost volatility in the markets and the cost
of the derivative instruments. Many of the commodities used by the Company in
its products do not have actively traded derivative instruments. If the Company
does not or is unable to take a derivative position and costs subsequently
increase, or if it institutes a position and costs subsequently decrease, the
Company&#146;s costs may be greater than anticipated or higher than its competitors&#146;
costs and the Company&#146;s financial results could be adversely affected. For
further information regarding the Company&#146;s use of derivative instruments, see
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations&#148; in Exhibit 99.1.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Dependence on key customers
could adversely affect the Company&#146;s business, financial condition and results
of operations. </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>A limited number of customers
account for a large percentage of the Company&#146;s net sales. Net sales to the
Company&#146;s largest customer, Walmart Stores, Inc. and its affiliates, were 27%,
26% and 27% of consolidated net sales for each of the fiscal years ended June
30, 2016, 2015 and 2014, respectively, and occurred in each of the Company&#146;s
reportable segments. No other individual customer accounted for more than 10% of
consolidated net sales in any of these fiscal years. During fiscal years 2016,
2015 and 2014, the Company&#146;s five largest customers accounted for 46%, 45%, and
45% of its consolidated net sales for each of the three fiscal years,
respectively. The Company expects that a significant portion of its revenues
will continue to be derived from a small number of customers. As a result,
changes in the strategies of the Company&#146;s largest customers, including a
reduction in the number of brands they carry or a shift of shelf space to
&#147;private label&#148; or competitors&#146; products, may harm the Company&#146;s net sales and
reduce the ability of the Company to offer new innovative and improved products
to consumers. In addition, any loss of a key customer or a significant reduction
in net sales to a key customer, even if such loss or reduction relates to a key
customer of a business unit of the Company, could have a material adverse effect
on the Company&#146;s business, financial condition and results of
operations.</FONT></P>
<P align=left><FONT STYLE="font-family: Times New Roman; font-size: 10pt">In addition, the Company&#146;s business is
based primarily upon individual sales orders, and the Company typically does not enter into long-term contracts with its
customers. Accordingly, customers could reduce their purchasing levels or cease buying products from the Company at any time
and for any reason. If the Company does not effectively respond to the demands of its customers, they could decrease their
purchases from the Company, causing the Company&#146;s net sales and net earnings to decline. Furthermore, unfavorable market
conditions or competitive pressures may cause the Company&#146;s customers to reevaluate the number and mix of brands they
sell, resulting in lower purchases of the Company&#146;s products by these customers.</FONT></P>

<P align=center><FONT face="Times New Roman" size=2>7</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=left><FONT face="Times New Roman" size=2>The Company continues to see
retailer consolidation both in the United States and internationally. This trend
has resulted in the increased size and influence of large consolidated
retailers, who have in the past changed, and may in the future change, their
business strategies, demand lower pricing or special packaging or impose other
burdensome requirements on product suppliers. These business demands may relate
to inventory practices, logistics, a shift in focus away from branded products
toward &#147;private label&#148; or other aspects of the customer-supplier relationship.
These large consolidated companies could also exert additional competitive
pressure on the Company&#146;s other customers, which could in turn lead to such
customers demanding lower pricing or special packaging or imposing other onerous
requirements on the Company. If the Company ceases doing business with a
significant customer or if sales of its products to a significant customer
materially decrease due to customer inventory reductions or otherwise, the
Company&#146;s business, financial condition and results of operations may be
harmed.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Cyber-attacks, privacy
breaches, data breaches or a failure of key information technology systems could
adversely impact the Company&#146;s ability to conduct business.</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company relies extensively
on information technology systems, many of which are managed by third-party
service providers, in order to conduct its business. These systems include, but
are not limited to, programs and processes relating to communicating within the
Company and with customers, consumers and other parties, ordering and managing
materials from suppliers, converting materials to finished products, shipping
products to customers, processing transactions, summarizing and reporting
results of operations, complying with regulatory, legal and tax requirements and
implementing other processes involved in managing the business. Although the
Company has made progress with its implementation of enterprise-wide upgrades to
its hardware, software and operating systems, legacy systems still remain. If
the Company&#146;s existing and/or future technology systems, third-party service
providers and processes do not adequately support the future growth of the
Company&#146;s business, the Company&#146;s business may be adversely impacted.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Although the Company has  network security measures in place, the systems
may be vulnerable to computer  viruses or other malicious codes, security breaches and other disruptions from  unauthorized
users or system failures, including Internet outages. While the  Company has business continuity plans in place, if the
systems are damaged or  cease to function properly due to any number of causes, including catastrophic  events, power
outages, security breaches or other similar events, and if the  business continuity plans do not effectively resolve such
issues on a timely  basis, the Company may suffer interruptions in its ability to manage or conduct  business, which may
adversely impact the Company&#146;s business. Furthermore, the  Company sells its Burt&#146;s Bees<SUP>&#174;</SUP> natural
personal care products, Renew  Life<SUP>&#174;</SUP> digestive health products and other products directly to  consumers
online, provides websites, mobile apps and connected devices, and  offers promotions, rebates, customer loyalty and other
programs through which it  may receive personal information, and it or its vendors could experience  cyber-attacks, privacy
breaches, data breaches or other incidents that result in  unauthorized disclosure of consumer, customer, employee or Company
information.  In August 2015, the federal government brought an </FONT><FONT face="Times New Roman" size=2>indictment against
brokers and hackers for stealing advanced, nonpublic  press releases of various public companies from news wires and trading
on  securities using the information from such press releases. If the Company  suffers a loss as a result of a breach or
other breakdown in its technology,  including such cyber-attack, privacy breaches, data breaches or other incident  involving
one of the Company&#146;s vendors, that result in unauthorized disclosure  or significant unavailability of business,
financial, personal or stakeholder  information, the Company may suffer reputational, competitive and/or business  harm and
may be exposed to legal liability, which may adversely affect the  Company&#146;s results of operations and/or financial
condition. In addition, if the  Company&#146;s service providers, suppliers or customers experience such a breach or
unauthorized disclosure or system failure, their businesses could be disrupted  or otherwise negatively affected, which may
result in a disruption in the  Company&#146;s supply chain or reduced customer orders, which would adversely affect  the
Company&#146;s business operations.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Government regulations
could impose material costs.</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Generally, the manufacture,
packaging, labeling, storage, distribution and advertising of the Company&#146;s
products and the conduct of its business operations must all comply with
extensive federal, state and foreign laws and regulations. For example, in the
United States, many of the Company&#146;s products are regulated by the Environmental
Protection Agency, the Food and Drug Administration and the Consumer Product
Safety Commission, and the Company&#146;s product claims and advertising are
regulated by the Federal Trade Commission, among other regulatory agencies. Most
states have agencies that regulate in parallel to these federal agencies. The
Company&#146;s international operations are also subject to regulation in each of the
foreign jurisdictions in which it manufactures or distributes its products.
There is also a risk of potentially higher incidence of fraud or corruption in
certain foreign jurisdictions and related difficulties in maintaining effective
internal controls. Additionally, the Company could be subject to inquiries or
investigations by governmental and other regulatory bodies. Any determination
that the Company&#146;s operations or activities are not in compliance with
applicable law could expose the Company to significant fines, penalties or other
sanctions that may harm the business and reputation of the Company.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>8 </FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=left><FONT face="Times New Roman" size=2>In particular, because of the
Company&#146;s extensive international operations, we could be adversely affected by
violations of the Foreign Corrupt Practices Act and similar worldwide
anti-bribery laws. The Foreign Corrupt Practices Act and similar worldwide
anti-bribery laws generally prohibit companies and their intermediaries from
making improper payments to government officials or other third parties for the
purpose of obtaining or retaining business. While our policies mandate
compliance with these anti-bribery laws, we cannot provide assurance that our
internal control policies and procedures will always protect us from reckless or
criminal acts committed by our employees, joint-venture partners or agents.
Violations of these laws, or allegations of such violations, could disrupt our
business and adversely affect our reputation and our business, results of
operations, cash flows and financial condition.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>It is expected that federal,
state and foreign governments will continue to introduce new and expanded
legislation affecting the Company&#146;s operations, which may require the Company to
increase its resources, capabilities and expertise in such areas. For example,
the Company is subject to regulations regarding the transportation, storage or
use of certain chemicals to protect the environment, including as a result of
evolving climate change standards, and new and increased regulation in other
areas, such as with respect to &#147;conflict minerals.&#148; Such regulation could
negatively impact the Company&#146;s ability to obtain raw materials or could
increase its acquisition and compliance costs. In addition, pending legislative
initiatives and adopted legislation in the areas of healthcare reform and other
areas, such as the Patient Protection and Affordable Care Act and the Health
Care and Education Reconciliation Act of 2010, the Dodd-Frank Wall Street Reform
and Consumer Protection</FONT><B><FONT face="Times New Roman" size=2>
</FONT></B><FONT face="Times New Roman" size=2>Act, the Foreign Account Tax
Compliance Act and legislation in the area of taxation of domestic and foreign
profits, executive compensation and corporate governance, could also increase
the Company&#146;s costs. These risks may be increased by the Company&#146;s recent
acquisition of Renew Life, which manufactures products subject to additional
regulations. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>If the Company is found to be
noncompliant with applicable laws and regulations in these or other areas, it
could be subject to civil remedies, including fines, import detentions,
injunctions, product withdrawals or recalls or asset seizures, as well as
potential criminal sanctions, any of which could have a material adverse effect
on its business. Loss of or failure to obtain necessary permits and
registrations, particularly with respect to its charcoal business, could delay
or prevent the Company from meeting current product demand, introducing new
products, building new facilities or acquiring new businesses and could
adversely affect operating results. As the Company expands its natural personal
care and healthcare businesses such as through Burt&#146;s Bees<SUP>&#174;</SUP>,
HealthLink<SUP>&#174;</SUP>, Aplicare<SUP>&#174;</SUP> and Caltech Industries, an
increasing number of its products have and will become subject to regulations
and laws relating to drugs and medical devices. In addition, as the Company
enters the digestive health space through its acquisition of Renew Life<SUP>
&#174;</SUP>, its products are subject to regulations relating to dietary
supplements. In order to comply with these laws and regulations, the Company may
be required to make changes to product formulation, labeling or marketing
claims, perform additional testing to substantiate its product claims, make
costly changes in its manufacturing processes or supply chain or stop selling
certain products until corrective actions have been taken.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>9</font></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<p align=left><A HREF="#toc"><B><FONT face="Times New Roman" size=2>Table of Contents</font></B></A></p>
<P align=left><B><FONT face="Times New Roman" size=2>The Company is subject to
risks related to its international operations.</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>In fiscal year 2016,
approximately 17% of the Company&#146;s net sales were generated in international
markets, including approximately 3% of the Company&#146;s net sales in Argentina. The
Company faces and will continue to face substantial risks associated with its
foreign operations, including the following:</FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">economic or political instability, particularly
      in Argentina;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">price controls and related government
    actions;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">foreign currency fluctuations, currency
      controls and inflation, particularly in Argentina, which may adversely
      affect the Company&#146;s ability to do business in certain markets and reduce
      the U.S. dollar value of revenues, profits or cash flows it generates in
      non-U.S. markets;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">difficulty in obtaining non-local currency
      (e.g., U.S. dollars) to pay for the raw materials needed to manufacture
      the Company&#146;s products and contract-manufactured products;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">restrictions on or costs related to the
      repatriation of foreign profits to the United States, including possible
      taxes or withholding obligations on any repatriations;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">the imposition of tariffs, trade restrictions,
      import and export laws or other government actions generating a negative
      impact on the Company&#146;s business;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">difficulties in hiring and retaining qualified
      employees;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">civil unrest, work stoppages and labor
    disputes;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">employment litigation related to employees,
      contractors and suppliers, particularly in Argentina;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">difficulties in obtaining or unavailability of
      raw materials;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">potential loss of distribution channels as a
      result of retailer consolidation;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">increased credit risk of customers, suppliers
      and distributors;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">potential harm to third parties, the Company&#146;s
      employees and/or surrounding communities, and related liabilities and
      damages to the Company&#146;s reputation, from the use, storage and
      transportation of chlorine in certain international markets where chlorine
      is used in the production of bleach, whether such actions are undertaken
      by the Company or by the Company&#146;s business partners;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">difficulties in enforcing intellectual property
      and contractual rights;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">lack of well-established or reliable, and
      impartial legal systems in certain countries where the Company
  operates;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">challenges relating to enforcement of or
      compliance with local laws and regulations and with U.S. laws affecting
      operations outside of the United States, including without limitation, the
      Foreign Corrupt Practices Act;</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">the possibility of nationalization,
      expropriation of assets or other similar government actions; and</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">risks related to the Company&#146;s discontinued
      operations in Venezuela.</TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>The risks described above
could have a significant adverse impact on the Company&#146;s ability to
commercialize its products on a competitive basis in international markets and
may have a material adverse effect on its results of operations or financial
condition. The Company&#146;s small sales volume in some countries, relative to some
multinational and local competitors, could exacerbate such risks.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In addition, the Company is
exposed to foreign currency exchange rate risks with respect to its net sales,
net earnings and cash flow driven by movements of the U.S. dollar relative to
other currencies. A weakening of the currencies in which sales are generated
relative to the currencies in which costs are denominated would decrease net
earnings and cash flow. Although the Company uses instruments to hedge certain
foreign currency risks, these hedges only offset a small portion of the
Company&#146;s exposure to foreign currency
fluctuations and, therefore, the Company&#146;s reported net earnings may be
negatively affected by changes in foreign exchange rates.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>10</font></P>
<HR align=center width="100%" noShade SIZE=2>
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>


<!--part 02-->
<P align=left><B><FONT face="Times New Roman" size=2><A href="#toc">Table of
Contents</A></FONT></B></P>

<P align=left><FONT face="Times New Roman" size=2>Inflation is another risk
associated with the Company&#146;s international operations. For example, Argentina
could in the future be designated as a highly inflationary economy. Gains and
losses resulting from the remeasurement of non-U.S. dollar monetary assets and
liabilities of subsidiaries operating in highly inflationary economies are
recorded in net earnings. Other countries in which the Company operates may also
become highly inflationary or such countries&#146; currencies may be devalued, or
both, which may negatively impact the Company&#146;s business operations and
financial results. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>For further information
regarding Argentina, see &#147;Management&#146;s Discussion and Analysis of Financial
Condition and Results of Operations&#148; in Exhibit 99.1. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Acquisitions, new venture
investments and divestitures may not be successful, which could impact the
Company&#146;s business operations and financial results.</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>In connection with the
Company&#146;s strategy, the Company expects to continue to seek acquisition
opportunities, such as the recent acquisition of Renew Life, which competes in
the digestive health category. However, the Company may not be able to identify
and successfully negotiate suitable strategic acquisitions at attractive prices.
In addition, all acquisitions and investments entail numerous risks, including
risks relating to the Company&#146;s ability to: </FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>successfully integrate acquired companies, products, systems or
      personnel into the Company&#146;s existing business, especially with respect to
      businesses or operations that are outside of the United States;
    </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>minimize any potential interruption to the
      ongoing business of the Company or the acquired company; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>successfully enter categories and markets in
      which the Company may have limited or no prior experience, such as the
      digestive health category; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>achieve expected synergies and obtain the
      desired financial or strategic benefits from acquisitions;
  </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>achieve distribution expansion related to
      products, categories and markets from acquisitions;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>retain key relationships with employees,
      customers, partners and suppliers of acquired companies; </FONT><FONT face="Times New Roman" size=2>and </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>maintain uniform standards, controls,
      procedures and policies throughout acquired companies.</FONT></P></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Acquired companies or
operations or joint ventures may not be profitable or may not achieve sales
levels and profitability and cash flow expectations. Future acquisitions or
ventures could also result in potentially dilutive issuances of equity
securities, the incurrence of debt, the assumption of contingent liabilities,
including litigation, an increase in expenses related to certain assets and
increased operating expenses, all of which could adversely affect the Company&#146;s
results of operations and financial condition. Future acquisitions of foreign
companies or new foreign ventures would subject the Company to local regulations
and could potentially lead to risks related to, among other things, increased
exposure to foreign exchange rate changes, government price control,
repatriation of profits and liabilities relating to the Foreign Corrupt
Practices Act. In addition, to the extent that the economic benefits associated
with any of the Company&#146;s acquisitions diminish in the future, the Company may
be required to record impairment charges related to goodwill, intangible assets
or other assets associated with such acquisitions, which could adversely affect
its operating results and/or net earnings per share. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company may also divest
certain assets, businesses or brands that do not meet the Company&#146;s strategic
objectives or growth targets. With respect to any divestiture, the Company may
encounter difficulty finding potential acquirers or other divestiture options on
favorable terms. Any divestiture could affect the profitability of the Company
as a result of the gains or losses on such sale of a business or brand, the loss
of the operating income resulting from such sale or the costs or liabilities
that are not assumed by the acquirer (i.e., stranded costs) that may negatively
impact profitability and cash flow subsequent to any divestiture. The Company
may also be required to recognize impairment charges as a result of a divesture.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In addition, any potential
future acquisitions, new ventures or divestitures may divert the attention of
management and resources from matters that are core or critical to the Company&#146;s
business.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>11</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A href="#toc"><STRONG>Table
of Contents</STRONG></A></FONT></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2>The Company may not
successfully develop and introduce new products and line extensions or
successfully expand into adjacent categories and countries, which could
adversely impact its financial results. </FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s future
performance and growth depends on innovation and its ability to successfully
develop or license capabilities to introduce new products, brands, line
extensions and product improvements or enter into or expand into adjacent
product categories, sales channels or countries. The Company cannot be certain
that it will successfully achieve its innovation goals. The development and
introduction of new products require substantial and effective research and
development and marketing expenditures, which the Company may be unable to
recoup if the new products do not gain widespread market acceptance. In
addition, effective and integrated systems are required for the Company to
gather and use consumer data and information to successfully market its
products. New product development and marketing efforts, including efforts to
enter markets or product categories in which the Company has limited or no prior
experience, have inherent risks. These risks include product development or
launch delays, which could result in the Company not being first to market and
the failure of new products, brands and line extensions to achieve anticipated
levels of market acceptance. If product introductions or new or expanded
adjacencies are not successful, costs associated with these efforts may not be
fully recouped and the Company&#146;s net earnings could be adversely affected. In addition, if sales generated by
new products cause a decline in sales of the Company&#146;s existing products, the
Company&#146;s financial condition and results of operations could be materially
adversely affected<FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">.</FONT></FONT></P>
<P align=left><FONT face="Times New Roman" size=2><STRONG>Reliance on a limited base of suppliers may result in
disruptions to the Company&#146;s business. </STRONG></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company relies on a
limited number of suppliers for certain commodities and raw material inputs,
including sole-source and single-source suppliers for certain of its raw
materials, packaging, product components, finished products and other necessary
supplies. New suppliers have to be qualified under Company standards and may
also have to be qualified under governmental and industry standards, which can
require additional investment and time. The Company could experience disruptions
in production and its financial results and relationships with customers could
be adversely affected if the Company is unable to qualify any needed new
suppliers or maintain supplier arrangements and relationships, if it is unable
to contract with suppliers at the quantity, quality and price levels needed for
its business or if any of the Company&#146;s key suppliers becomes insolvent,
experiences financial distress or environmental, economic or other outside
factors impact its operations. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Product liability,
commercial claims or other legal proceedings could adversely affect the
Company&#146;s net sales and operating results, including cash flow. </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company has in the past
paid, and may be required in the future to pay, for losses or injuries
purportedly caused by its products. Such claims may be based on allegations
that, among other things, the Company&#146;s products contain contaminants or provide
inadequate instructions or warnings regarding their use, have defective
packaging, fail to perform as advertised, or damage property or persons. Product
liability claims could result in negative publicity that could harm the
Company&#146;s reputation, sales and operating results. In addition, if any of the
Company&#146;s products is found to be defective, the Company may recall it, which
could result in adverse publicity and significant expenses. In July 2016, the
Company voluntarily recalled three of the Liquid-Plumr<SUP>&#174;</SUP> products,
which recall affects products manufactured prior to March 22, 2016. Although the
Company maintains product liability insurance coverage, potential product
liability claims may be subject to a retention, exceed the amount of insurance
coverage or be excluded under the terms of the policies. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In addition, the Company is,
and may in the future become, the subject of, or party to, various pending or
threatened legal actions, government investigations and proceedings from time to
time, including advertising disputes with competitors, consumer class actions,
including those related to advertising claims, labor claims, breach of contract
claims, antitrust litigation, securities litigation, premises liability claims
and litigation in foreign jurisdictions. In general, claims made by or against
the Company in litigation, investigations, disputes or other proceedings have
been and can in the future be expensive and time-consuming to bring or defend
against and could result in settlements, injunctions or damages that could
significantly affect its business or financial results or condition. It is not
possible to predict the final resolution of the litigation, investigations,
disputes or proceedings with which the Company currently is or may in the future
become involved. The impact of these matters on the Company&#146;s business, results
of operations and financial condition could be material. See &#147;Management&#146;s
Discussion and Analysis of Financial Condition and Results of Operations&#148; and
the Notes to Consolidated Financial Statements in Exhibit 99.1 for additional
information related to these matters.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>12</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A href="#toc"><STRONG>Table
of Contents</STRONG></A></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Profitability and cash flow
could suffer if the Company is unable to successfully implement its strategies,
generate anticipated cost savings and efficiencies or efficiently manage supply
chain and manufacturing processes. </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company continues to implement plans to improve its competitive
position by setting aggressive annual cost savings targets, and it expects
ongoing cost savings from its continuous improvement activities. The Company
anticipates these continuing cost savings will result from reducing material
costs and manufacturing inefficiencies and realizing productivity gains,
distribution efficiencies and overhead reductions. If the Company cannot
successfully implement its cost savings plans or the cost of making these
changes increases, the Company may not realize all anticipated benefits, which
could adversely affect its financial results or its long-term strategies, such
as the 2020 Strategy, which includes financial goals such as annual net sales
growth of 3-5%, annual EBIT margin growth between 25-50 basis points and annual
free cash flow as a percentage of net sales of about 10-12%. The Company also
continues to seek to penetrate new markets and introduce new products and
product improvements. These goals and strategies may not be implemented or may
fail to achieve desired results, and the Company may fail to achieve one or more
of the financial goals for one or more of the relevant fiscal years. In
addition, the Company expects to continue to restructure its operations as
necessary to improve operational efficiency, including occasionally closing
facilities or plants. Gaining additional efficiencies may become increasingly
difficult over time, there may be one-time costs relating to facility closures
or other restructurings and anticipated cost savings and the Company&#146;s
strategies may not be implemented or may fail to achieve desired results. If the
Company is unable to implement its strategies or if its strategies do not
achieve the intended effects, if it does not realize cost savings and other
efficiencies or if it is unable to efficiently manage its supply chain and
manufacturing processes, the Company&#146;s financial results could suffer. These
plans and strategies could also have a negative impact on the Company&#146;s
relationships with employees or customers, which could also adversely affect the
Company&#146;s financial results.</FONT><B><FONT face="Times New Roman" size=2>
</FONT></B></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2>Loss of, or inability
to attract, key personnel could adversely impact the Company&#146;s business. </FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s success depends,
in part, on its ability to retain its key personnel, including its executive
officers and senior management team. The unexpected loss of one or more of the
Company&#146;s key employees could disrupt its business. The Company&#146;s success also
depends, in part, on its continuing ability to identify, hire, train and retain
other highly qualified personnel. Competition for these employees can be
intense, especially in the San Francisco Bay Area, where the Company&#146;s
headquarters and largest research facility are located. As the Company expands
into new categories or markets, including more regulated businesses, it will also require personnel with relevant
training and experience in such categories or markets. The Company may not be
able to attract, assimilate or retain qualified personnel in the future, and its
failure to do so could adversely affect its business. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2><STRONG>Harm to the Company&#146;s reputation or the reputation of one
or more of its leading brands could have an adverse effect on the business.
</STRONG></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Maintaining a strong
reputation with consumers, customers and trade partners is critical to the
success of the Company&#146;s business. The Company devotes significant time and
resources to programs designed to protect and preserve the Company&#146;s reputation
and the reputation of its brands. These programs include ethics and compliance,
sustainability and product safety and quality initiatives. Despite these
efforts, negative publicity about the Company, including product safety,
quality, efficacy or similar concerns, whether real or perceived, could occur,
and the Company&#146;s products could face withdrawal, recall or other quality
issues. The Company also licenses certain of its brands to third parties, which
creates additional exposure for those brands to product safety, quality and
other concerns. In addition, widespread use of social media and networking sites
by consumers has greatly increased the speed and accessibility of information
dissemination. Negative publicity, posts or comments on social media or network
sites about the Company or its brands, whether accurate or inaccurate, or
disclosure of non-public sensitive information about the Company, could be
widely disseminated through the use of social media. Such events, if they were
to occur, could harm the Company&#146;s image and adversely affect its business, as
well as require resources to rebuild the Company&#146;s reputation.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>13</FONT></P>
<HR align=center width="100%" noShade SIZE=2>
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A href="#toc"><STRONG>Table
of Contents</STRONG></A></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Environmental matters
create potential liabilities that could adversely affect the Company&#146;s results
of operations or financial condition. </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company must comply with
various environmental laws and regulations in the jurisdictions in which it
operates, including those relating to air emissions, water discharges, handling
and disposal of solid and hazardous wastes, remediation of contamination
associated with the use and disposal of hazardous substances and climate change.
The Company has incurred, and will continue to incur, significant expenditures
and other costs in complying with environmental laws and regulations and in
providing physical security for its worldwide operations, and such expenditures
reduce the cash flow available to the Company for other purposes. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is currently
involved in or has potential liability with respect to the remediation of past
contamination in the operation of some of its current and former facilities. In
addition, some of its present and former facilities have or had been in
operation for many years and, over that time, some of those facilities may have
used substances or generated and disposed of wastes that are or may be
considered hazardous. It is possible that those sites, as well as disposal sites
owned by third parties to whom the Company has sent waste, may be identified and
become the subject of remediation. The Company could also become subject to
additional environmental liabilities in the future that could result in a
material adverse effect on its results of operations or financial condition.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company had a recorded
liability of $14 million and $12 million as of June 30, 2016 and 2015,
respectively, for its share of aggregate future remediation costs related to
certain environmental matters, including response actions at various locations.
One matter in Dickinson County, Michigan, for which the Company is jointly and
severally liable, accounts for a substantial majority of the recorded liability
as of both June 30, 2016 and 2015. See &#147;Management&#146;s Discussion and Analysis of
Financial Condition and Results of Operations&#148; and the Notes to Consolidated
Financial Statements in Exhibit 99.1 for additional information related to these
liabilities.</FONT><I></I></P>
<P align=left><FONT face="Times New Roman" size=2>The Company also handles
and/or transports hazardous substances, including but not limited to chlorine,
at some of its international plant sites. A release of such chemicals, whether
in transit or at the Company&#146;s facilities, due to accident or an intentional
act, could result in substantial liability and business disruptions.
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>The facilities of the
Company and its suppliers are subject to disruption by events beyond the
Company&#146;s control. </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Operations at facilities of the Company, its suppliers, service providers
and retail customers are subject to disruption for a variety of reasons,
including work stoppages, demonstrations, disease outbreaks or pandemics, acts
of war, terrorism, fire, earthquakes, flooding or other natural disasters. The
Company&#146;s corporate headquarters and primary research and development facility
are located near major earthquake fault lines in California. If a major
disruption were to occur, it could result in harm to people or the natural
environment, temporary loss of access to critical data, delays in shipments of
products to customers or suspension of operations. Any such disruption could
have a material adverse impact on the Company&#146;s business. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Failure to maximize,
successfully assert or successfully defend the Company&#146;s intellectual property
rights could impact its competitiveness. </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company relies on
intellectual property rights based on trademark, trade secret, patent and
copyright laws to protect its brands, products and packaging for its products.
The Company cannot be certain that these intellectual property rights will be
maximized or that they can be successfully asserted. There is a risk that the
Company will not be able to obtain and perfect its own intellectual property
rights or, where appropriate, license intellectual property rights necessary to
support new product introductions. The Company cannot be certain that these
rights, if obtained, will not later be invalidated, circumvented or challenged,
and the Company could incur significant costs in connection with legal actions
to assert its intellectual property rights or to defend those rights from assertions of invalidity. In addition,
even if such rights are obtained in the United States, the laws of some of the
other countries in which the Company&#146;s products are or may be sold may not
protect intellectual property rights to the same extent as the laws of the
United States. If other parties infringe the Company&#146;s intellectual property
rights, they may dilute or diminish the value of the Company&#146;s brands and
products in the marketplace, which could diminish the value that consumers
associate with the Company&#146;s brands and harm its net sales. The failure to
perfect and protect its intellectual property rights could make the Company less
competitive and could have a material adverse effect on its business, operating
results, and financial condition. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>14</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2><A href="#toc">Table of
Contents</A></FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>If the Company is found to have infringed the intellectual
property rights of others or cannot obtain necessary intellectual property
rights from others, its competitiveness could be negatively
impacted.</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>If the Company is found to
have violated the trademark, trade secret, copyright, patent or other
intellectual property rights of others, directly or indirectly, through the use
of third-party marks, ideas or technologies, such a finding could result in the
need to cease use of such trademark, trade secret, copyrighted work or patented
invention in the Company&#146;s business and the obligation to pay for past
infringement. If holders are willing to permit the Company to continue to use
such intellectual property rights, they could require a payment of a substantial
amount for continued use of those rights. Either ceasing use or paying such
amounts could cause the Company to become less competitive and could have a
material adverse impact on the Company&#146;s business, operating results and
financial condition.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Even if the Company is not
found to infringe a third party&#146;s intellectual property rights, claims of
infringement could adversely affect the Company&#146;s business. For example, if the
Company seeks proposals from multiple vendors for a new product or innovation
and chooses to partner with a particular vendor, another vendor may claim the
Company infringed its intellectual property rights by using information gathered
from the vendor proposals. The Company could incur material legal costs and
related expenses to defend against such claims and the Company could incur
significant costs associated with discontinuing to use, provide or manufacture
certain products, services or trademarks even if it is ultimately found not to
have infringed such rights. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>An increase in the value of
the Company&#146;s Glad</FONT></B><B><FONT face="Times New Roman" size=2><SUP>&#174;</SUP></FONT></B><B><FONT face="Times New Roman" size=2> business
would result in an increase in the Company&#146;s purchase obligation for The Procter
&amp; Gamble Company&#146;s, P&amp;G&#146;s, 20% interest in that business, which may
adversely affect the Company&#146;s net earnings and cash flow. Additionally, it is
uncertain whether the Company&#146;s net earnings and cash flow would be adversely
affected more by an extension or a termination of the agreement related to the
Glad<SUP>&#174;</SUP></FONT></B><B><FONT face="Times New Roman" size=2>
business.</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>In January 2003, the Company
entered into a venture agreement with P&amp;G related to the Company&#146;s
Glad<SUP>&#174;</SUP> bags, wraps and containers business. In connection with this
agreement, P&amp;G provides research and development support to the
Glad<SUP>&#174;</SUP> business. The agreement with P&amp;G will expire in January
2023 unless the parties decide, on or prior to January 2018, to extend the term
of the agreement for another 10 years.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Unless extended, the agreement
will require the Company to purchase P&amp;G&#146;s 20% interest in January 2023 for
cash at fair value. As of June 30, 2016, the estimated fair value of P&amp;G&#146;s
interest was $448 million, of which $302 million has been recognized by the
Company and is reflected in Other liabilities in the Company&#146;s June 30, 2016
Consolidated Balance Sheet. The difference between the estimated fair value and
the amount recognized, and any future changes in the fair value of P&amp;G&#146;s
interest, is charged to Cost of products sold on a straight line basis over the
remaining life of the agreement. The estimated fair value of P&amp;G&#146;s interest
increased significantly in 2016 and may continue to change up until any such
purchase by the Company of P&amp;G&#146;s interest. Any additional significant
increases in the fair value of such interest may adversely affect the Company&#146;s
net earnings and cash flow.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>If the Company and P&amp;G
decide not to extend the term of the agreement, this decision may harm the terms
on which the Company has access to innovation from P&amp;G. Alternatively, if
the Company and P&amp;G decide to extend the term of the agreement, there can be
no assurance that any future innovation will result. In either case, net
earnings and cash flow may be negatively impacted. For additional information,
see &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations&#148; and Note 10 to the Consolidated Financial Statements in Exhibit
99.1. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>15</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2><A href="#toc">Table of
Contents</A></FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>The Company&#146;s substantial
indebtedness could adversely affect its business operations and financial
results and prevent the Company from fulfilling its obligations, and the Company
may incur substantially more debt in the future, which could exacerbate these
risks. </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016, the
Company had over $2 billion of debt. The Company&#146;s substantial indebtedness
could have important consequences. For example, it could:</FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>require the Company to
      dedicate a substantial portion of its cash flow from operations to
      payments on its indebtedness, which would reduce the availability of its
      cash flow to fund working capital requirements, capital expenditures,
      future acquisitions and other general corporate purposes;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>limit the Company&#146;s
      flexibility in planning for or reacting to general adverse economic
      conditions or changes in its business and the industries in which it
      operates;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>place the Company at a competitive
      disadvantage compared to its competitors that have less debt;
      and</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>limit, along with the financial and other
      restrictive covenants in the Company&#146;s debt documents, its ability to
      borrow additional funds.</FONT><FONT face="Times New Roman">
  </FONT></P></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Additionally, failure by the Company to comply with the financial
and other restrictive covenants in its debt documents could result in an event
of default that, if not cured or waived, could have a significant adverse effect
on the Company. Further, certain terms of the agreements governing the Company&#146;s
over-the-counter derivative instruments contain provisions that require the
Company&#146;s credit ratings, as assigned by Standard &amp; Poor&#146;s and Moody&#146;s to
the Company and its counterparties, to remain at a level equal to or better than
the minimum of an investment grade credit rating. As of June 30, 2016, the
Company and each of its counterparties had been assigned investment-grade
ratings with both Standard &amp; Poor&#146;s and Moody&#146;s. However, if the Company&#146;s
credit rating were to fall below investment grade, the counterparties to the
derivative instruments in net liability positions could request full
collateralization.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company may incur
substantial additional indebtedness in the future to fund acquisitions,
repurchase shares or fund other activities for general business purposes,
subject to compliance with the Company&#146;s existing restrictive debt covenants. As
of June 30, 2016, the Company could add approximately $2 billion in incremental
debt and remain in compliance with restrictive debt covenants, although the
actual amount that the Company may be able to borrow in the future may not equal
this amount. If new debt is added to the current debt levels, the related risks
that the Company now faces could intensify. In addition, the cost of incurring
additional debt could increase due to possible downgrades in the Company&#146;s
credit rating, economic conditions or otherwise. In this regard, failure to
maintain the Company's credit ratings could adversely affect the interest rate
in future financings, liquidity, competitive position and access to capital
markets. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>The Company is subject to
risks related to its discontinued operations in Venezuela. </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>On September 22, 2014, the
Company&#146;s Venezuela subsidiary announced that it was discontinuing its
operations, effective immediately, and seeking to sell its assets. On September
26, 2014, the Company reported that Venezuelan Vice President Jorge Arreaza
announced, with endorsement by President Nicol&#225;s Maduro, that the Venezuelan
government had occupied the production facilities of the Company&#146;s Venezuela
subsidiary. On November 6, 2014, the Company reported that the Venezuelan
government had published a resolution granting a government-sponsored Special
Administrative Board full authority to restart and operate the business formerly
operated by the Company&#146;s Venezuela subsidiary, thereby reaffirming the
government&#146;s expropriation of its assets. Further, President Nicol&#225;s Maduro
announced the government&#146;s intention to facilitate the resumed production of
bleach and other cleaning products at the Venezuela plants. The Venezuelan
government&#146;s actions raise grave concerns, as the production of cleaning
products, in particular bleach, is a highly specialized and technical process.
Any restarting of operations in Venezuela is or would be without the consent or
involvement of the Company and its affiliates, and any resumed production
processes would be outside the Company&#146;s control. The Company has advised
repeatedly that it and its affiliates cannot be responsible for the safety of
any workers and the surrounding communities or for the safety, quality or
effectiveness of any product that may be produced under the Venezuelan
government&#146;s takeover or any use of the names and trademarks of the Company and
its affiliates. Nevertheless, the Company may face liabilities or costs
associated with any such unauthorized resumption of operations by the Venezuelan
government or others. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>16</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A href="#toc"><STRONG>Table
of Contents</STRONG></A></FONT></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2>The Company may not
continue to pay dividends or repurchase its stock. </FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2>Although the Company has
historically declared and paid quarterly cash dividends on its common stock and
has been authorized to repurchase its shares subject to certain limitations
under its share repurchase programs, any determinations by the board of
directors to continue to declare and pay cash dividends on the Company&#146;s common
stock or to repurchase the Company&#146;s common stock will be based primarily upon
the Company&#146;s financial condition, results of operations and business
requirements, the price of its common stock in the case of the repurchase
program and the board of directors&#146; continuing determination that the repurchase
programs and the declaration and payment of dividends are in the best interests
of the Company&#146;s stockholders and are in compliance with all laws and agreements
applicable to the repurchase and dividend programs. The Company&#146;s ability to
continue to declare and pay cash dividends will depend upon, among other things,
its cash balances and future cash requirements, results of operations, financial
condition and net earnings, all of which are subject to general economic,
financial, competitive, legislative, regulatory and other factors beyond the
Company&#146;s control. In the event the Company does not declare and pay a quarterly
dividend or discontinues its share repurchases, the Company&#146;s stock price could
be adversely affected.</FONT></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2>The Company&#146;s
continued growth and expansion and reliance on third-party service providers
could adversely affect its internal control over financial reporting, which
could harm its business and financial results.</FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2>Clorox management is
responsible for establishing and maintaining adequate internal control over
financial reporting. Internal control over financial reporting is a process
designed to provide reasonable assurance regarding the reliability of financial
reporting for external purposes in accordance with accounting principles
generally accepted in the United States. Because of its inherent limitations,
internal control over financial reporting cannot provide absolute assurance that
a misstatement of the Company&#146;s financial statements would be prevented or
detected. The Company&#146;s continuing growth and expansion in domestic and globally
dispersed markets, such as its recent acquisition of Renew Life, may place
significant additional pressure on the Company&#146;s system of internal control over
financial reporting. Moreover, the Company engages the services of third parties
to assist with business operations and financial reporting processes, which
injects additional monitoring obligations and risk into the system of internal
control. Any failure to maintain an effective system of internal control over
financial reporting could limit the Company&#146;s ability to report its financial results accurately and on a
timely basis, or to detect and prevent fraud and could expose it to regulatory
enforcement action and shareholder claims.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><STRONG>The Company&#146;s judgments regarding the accounting for tax
positions and the resolution of tax disputes may impact the Company&#146;s net
earnings and cash flow. </STRONG></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Significant judgment is
required to determine the Company&#146;s effective tax rate and evaluate its tax
positions. The Company provides for uncertain tax positions when such tax
positions do not meet the recognition thresholds or measurement criteria
prescribed by applicable accounting standards. Fluctuations in federal, state,
local and foreign taxes or a change to uncertain tax positions, including
related interest and penalties, may impact the Company&#146;s effective tax rate and
the Company&#146;s financial results. When particular tax matters arise, a number of
years may elapse before such matters are audited and finally resolved.
Unfavorable resolution of any tax matter could increase the effective tax rate,
which would have an adverse effect on the Company&#146;s operating results. Any
resolution of a tax issue may require the use of cash in the year of resolution.
For additional information, see the information set forth in the Notes to
Consolidated Financial Statements in Exhibit 99.1. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>The estimates and
assumptions on which the Company&#146;s financial projections are based may prove to
be inaccurate, which may cause its actual results to materially differ from such
projections, which may adversely affect the Company&#146;s future profitability, cash
flows and stock price. </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s financial
projections are dependent on certain estimates and assumptions related to, among
other things, category growth, market share projections, product pricing,
foreign exchange rates, commodity prices, cost savings, accruals for estimated
liabilities, including litigation reserves, goodwill, measurement of benefit
obligations for pension and other postretirement benefit plans and the Company&#146;s
ability to generate sufficient cash flow to reinvest in its existing business,
fund internal growth, repurchase its shares, make acquisitions, pay dividends
and meet debt obligations. While the Company&#146;s financial projections are based
on historical experience and on various other assumptions that the Company
believes to be reasonable under the circumstances and at the time they are made,
the Company&#146;s actual results may differ materially from its financial
projections. Any material variation between the Company&#146;s financial projections
and its actual results may adversely affect the Company&#146;s future profitability,
cash flows and stock price. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>17</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A href="#toc"><STRONG>Table
of Contents</STRONG></A></FONT></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2>The Company&#146;s business
could be negatively impacted as a result of stockholder activism or an
unsolicited takeover proposal or a proxy contest. </FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2>In recent years, proxy
contests and other forms of stockholder activism have been directed against
numerous public companies, including the Company. During fiscal years 2012 and
2011, the Company was the target of an unsolicited takeover proposal from a
stockholder activist, which resulted in significant costs to the Company. If
such a proposal were to be made again, the Company would incur significant
costs, which would have an adverse effect on the Company&#146;s financial results.
Stockholder activists may also seek to involve themselves in the governance,
strategic direction and operations of the Company. Such proposals may disrupt
the Company&#146;s business and divert the attention of the Company&#146;s management and
employees, and any perceived uncertainties as to the Company&#146;s future direction
resulting from such a situation could result in the loss of potential business
opportunities, the perception that the Company needs a change in the direction
of its business, or the perception that the Company is unstable or lacks
continuity, which may be exploited by our competitors, cause concern to our
current or potential customers, and may make it more difficult for the Company
to attract and retain qualified personnel and business partners, which could
adversely affect the Company&#146;s business. In addition, actions of activist
stockholders may cause significant fluctuations in our stock price based on
temporary or speculative market perceptions or other factors that do not
necessarily reflect the underlying fundamentals and prospects of our
business.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><STRONG><A NAME="item1b"></A>ITEM 1.B. UNRESOLVED
STAFF COMMENTS</STRONG></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>None. </FONT></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2><A NAME="item2"></A>ITEM 2.
PROPERTIES</FONT></STRONG></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2>Production and
Distribution Facilities </FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2>The Company owns or leases and
operates 23 manufacturing facilities in North America and owns or leases and
operates 13 manufacturing facilities outside North America. The Company also
leases 6 regional distribution centers in North America and several other
warehouse facilities in the U.S. and international markets. Management believes
the Company&#146;s owned and leased production and distribution facilities are
adequate to support the business efficiently, and that the Company&#146;s properties
and equipment have generally been well maintained. The Company is continually
performing a supply-chain efficiency analysis, which may lead to closures of
domestic and international manufacturing facilities and the redistribution of
production between its remaining facilities and contract manufacturers to
optimize availability and capacity and to seek to reduce operating costs.
</FONT></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2>Offices and Research
and Development Facilities </FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2>Since 2011, the Company has
leased a facility located in Pleasanton, CA, which houses the Company&#146;s research
and development group as well as other administrative and operational support
personnel. The facility features state-of-the-art labs and open work spaces to
encourage creativity, collaboration and innovation. The Company leases office
space in Oakland, CA for its corporate headquarters. The Company owns a research
and development facility located at its plant in Buenos Aires, Argentina. The
<FONT face="Times New Roman" size=2>Company also conducts research and
development activities and engineering research in leased facilities in Meriden,
CT; Willowbrook, IL; Cincinnati, OH; and Durham, NC. Leased sales offices and
other facilities are located at a number of other locations.</FONT></FONT></P>
<P align=left><FONT face="Times New Roman" size=2><STRONG>Encumbrances </STRONG></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>None of the Company&#146;s owned
facilities are encumbered to secure debt owed by the Company. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>18</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A href="#toc"><STRONG>Table
of Contents</STRONG></A></FONT></P>
<P align=left><B><A NAME="item3"></A><FONT face="Times New Roman" size=2>ITEM 3. LEGAL PROCEEDINGS
</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is subject to
routine litigation incidental to its business in the United States and in
international locations, including various lawsuits and claims relating to
issues such as contract disputes, product liability, patents and trademarks,
advertising, commercial, administrative, employment antitrust, securities,
consumer class actions and other matters. Although the results of claims and
litigation cannot be predicted with certainty, based on management&#146;s analysis,
it is the opinion of management that the ultimate disposition of these matters,
to the extent not previously provided for or disclosed in the Company&#146;s
consolidated financial statements in Exhibit 99.1, will not have a material
adverse effect, individually or in the aggregate, on the Company&#146;s consolidated
financial statements taken as a whole. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item4"></A>ITEM 4. MINE SAFETY
DISCLOSURES</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Not applicable. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>EXECUTIVE OFFICERS OF THE
REGISTRANT</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The names, ages, year first
elected and current titles of each of the executive officers of the Company as
of August 15, 2016, are set forth below:</FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom style="line-height: normal">
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: left; width: 25%; padding-top: 2pt; padding-bottom: 2pt"><FONT face="Times New Roman" size=1>Name</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: left; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: left; width: 3%; padding-top: 2pt; padding-bottom: 2pt"><FONT face="Times New Roman" size=1>Age</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: left; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: left; width: 3%; padding-top: 2pt; padding-bottom: 2pt"><FONT face="Times New Roman" size=1>Year
      First<BR>Elected<BR>Executive<BR>Officer</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: right; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: center; width: 66%; padding-top: 2pt; padding-bottom: 2pt"><FONT face="Times New Roman" size=1>Title</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Benno Dorer</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>52</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2009</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="66%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Chairman and Chief Executive
      Officer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%"><FONT face="Times New Roman" size=2>James Foster</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>53</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>2009</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%"></TD>
    <TD vAlign=top align=left width="66%"><FONT face="Times New Roman" size=2>Executive Vice President &#150; Product Supply, Enterprise
      Performance and IT</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Stephen M. Robb</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>51</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2011</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="66%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Executive Vice President &#150; Chief
      Financial Officer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%"><FONT face="Times New Roman" size=2>Laura Stein</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>54</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>2005</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%"></TD>
    <TD vAlign=top align=left width="66%"><FONT face="Times New Roman" size=2>Executive Vice President &#150; General Counsel and Corporate
      Affairs</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Nikolaos Vlahos</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>48</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2013</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="66%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Executive Vice President &#150; Chief
      Operating Officer<FONT STYLE="BACKGROUND-COLOR: Transparent">,</FONT> Household, Lifestyle <BR>and Core Global
      Functions</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%"><FONT face="Times New Roman" size=2>Dawn
      Willoughby</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>47</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>2013</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%"></TD>
    <TD vAlign=top align=left width="66%"><FONT face="Times New Roman" size=2>Executive Vice President &#150; Chief Operating Officer, Cleaning,
      <BR>International <FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">and</FONT> Corporate
  Strategy</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>William S. Bailey</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>50</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="66%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Senior Vice President &#150; Corporate
      Business Development</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%"><FONT face="Times New Roman" size=2>Jon
      Balousek</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>47</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>2013</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%"></TD>
    <TD vAlign=top align=left width="66%"><FONT face="Times New Roman" size=2>Senior Vice President &#150; General Manager, Specialty
      Division</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Michael R. Costello</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: transparent">50</FONT></FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2011</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="66%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Senior Vice President &#150;
      International</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%"><FONT face="Times New Roman" size=2>Denise Garner</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>53</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%"></TD>
    <TD vAlign=top align=left width="66%"><FONT face="Times New Roman" size=2>Senior Vice President &#150; Chief Innovation Officer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Matthew Laszlo</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>46</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="66%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Senior Vice President &#150; Chief
      Customer Officer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%"><FONT face="Times New Roman" size=2>Kirsten Marriner</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>43</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%"></TD>
    <TD vAlign=top align=left width="66%"><FONT face="Times New Roman" size=2>Senior Vice President &#150; Chief People Officer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Linda Rendle</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>38</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="66%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Senior Vice President &#150; Cleaning
      Division</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%"><FONT face="Times New Roman" size=2>Eric
      Reynolds</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>46</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%"></TD>
    <TD vAlign=top noWrap align=center width="3%"><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%"></TD>
    <TD vAlign=top align=left width="66%"><FONT face="Times New Roman" size=2>Senior Vice President &#150; Chief Marketing Officer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="25%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Manjit Singh</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>47</FONT></TD>
    <TD vAlign=top noWrap align=center width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=center width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD vAlign=top noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="66%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Senior Vice President &#150; Chief
      Information Officer</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>There is no family
relationship between any of the above-named persons, or between any of such
persons and any of the directors of the Company. See Item 10 of Part III of this
Report for additional information. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Benno Dorer is the chairman
and chief executive officer of the Company, a position he has held since August
2016. Prior to this role, he served as chief executive officer of the Company
from November 2014 until August 2016. From January 2013 until November 2014, he
served as executive vice president &#150; chief operating officer, cleaning,
international and corporate strategy. From March 2011 to December 2012, he
served as senior vice president &#150; cleaning division and Canada. He served as
senior vice president &#150; general manager, cleaning division from June 2009 to
March 2011. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>19</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2><A href="#toc">Table of
Contents</A></FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>James Foster is the executive
vice president &#150; product supply, enterprise performance and IT of the Company, a
position he has held since November 2014. Prior to this role, he served as
senior vice president &#150; chief product supply officer from June 2009 to November
2014.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Stephen M. Robb is the executive vice president &#150; chief financial
officer of the Company, a position he has held since November 2014. Prior to
this role, he served as senior vice president &#150; chief financial officer from
November 2011 to November 2014. From January 2011 until November 2011, he
served as vice president &#150; global finance. He served as vice president &#150;
financial planning &amp; analysis from October 2004 to January 2011. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Laura Stein is the executive
vice president &#150; general counsel and corporate affairs of the Company, a
position she has held since February 2016. Prior to this role, she served as
executive vice president &#150; general counsel from February 2015 to February 2016.
She served as senior vice president &#150; general counsel from January 2005 to
February 2015.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Nikolaos Vlahos is the
executive vice president &#150; chief operating officer, household, lifestyle, and
core global functions of the Company, a position he has held since September
2014. Prior to this role, he served as senior vice president &#150; chief customer
officer from March 2013 to September 2014. From March 2011 to February 2013, he
served as vice president &#150; general manager, Burt&#146;s Bees<SUP>&#174;</SUP>. He served
as vice president &#150; general manager, laundry, Brita<SUP>&#174;</SUP> and Green
Works<SUP>&#174;</SUP>, from March 2009 to February 2011.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Dawn Willoughby is the
executive vice president &#150; chief operating officer, cleaning, international <FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">and</FONT> corporate strategy of the Company, having taken on
responsibility for corporate strategy in August 2016; and cleaning and
international in September 2014 and for professional products in November 2014.
Prior to this role, she served as senior vice president &#150; general manager,
cleaning division from January 2013 to September 2014. She served as vice
president &#150; general manager, Home Care, from October 2012 to January 2013, and
vice president &#150; general manager, Glad<SUP>&#174;</SUP> Products from January 2010 to
October 2012.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>William S. Bailey is the
senior vice president &#150; corporate business development of the Company, a
position he has held since January 2016. Prior to joining the Company, he served
as vice president &#150; corporate and business development at TripAdvisor, from June
2012 to January 2016. He served as vice president - corporate development at
Ancestry.com, from June 2011 to June 2012. From August 2009 to June 2011, he
served as vice president &#150; corporate and business development at Check Point
Software Technologies Inc. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Jon Balousek is senior vice
president &#150; general manager, specialty division of the Company, a position he
has held since January 2013. Prior to this role, he served as vice president &#150;
general manager, litter, food and charcoal from October 2011 to December 2012,
and vice president &#150; marketing, cleaning division from October 2008 to September
2011.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Michael R. Costello is the
senior vice president &#150; international of the Company, a position he has held
since September 2013. Prior to this role, he served as vice president &#150; general
manager, international, from March 2011 to August 2013. From July 2009 through
March 2011, he served as vice president &#150; general manager, Latin America and
Europe. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Denise Garner is the senior
vice president - chief innovation officer of the Company, a position she has
held since January 2015. Prior to this role, she served as vice president,
R&amp;D &#150; global cleaning &amp; international, from January 2010 to December
2014. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Matthew Laszlo is the senior
vice president &#150; chief customer officer of the Company, a position he has held
since October 2014. Prior to this role, he served as vice president &#150; general
manager, professional products division, from October 2013 to October 2014. From
January 2012 to October 2013 he served as vice president &#150; sales, professional
products division. From January 2010 to January 2012 he served as director &#150;
field sales, professional products division. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Kirsten Marriner is the senior
vice president &#150; chief people officer of the Company, a position she has held
since March 2016. Prior to joining the Company, she served as senior vice
president and chief human resources officer at Omnicare, from March 2013 to
August 2015. She served in various leadership roles, including as senior vice
president, director of talent management and development at Fifth Third Bank,
from October 2004 to March 2013. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>20</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A href="#toc"><STRONG>Table
of Contents</STRONG></A></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Linda Rendle is senior vice
president &#150; cleaning division of the Company, a position she has held since
August 2016. Prior to this role, she served as vice president &#150; general manager,
homecare from October 2014 to August 2016. From April 2012 to October 2014, she
served as vice president &#150; sales, cleaning division. From August 2011 to April
2012, she served as director of sales planning &#150; litter, food &amp; charcoal.
From January 2010 to August 2011, she served as director of sales &#150; supply
chain. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Eric Reynolds is the senior
vice president &#150; chief marketing officer of the Company, a position he has held
since January 2015. Prior to this role, he served as vice president &#150; general
manager, Europe, Middle East, Africa and Asia from May 2012 to January 2015.
From May 2011 to April 2012 he was director, International business development.
From June 2008 to April 2011 he was general manager, Caribbean. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Manjit Singh is the senior
vice president &#150; chief information officer of the Company, a position he has
held since December 2014. In August 2016, he joined the Company&#146;s executive
committee. Prior to joining the Company, he served as head of vertical
consulting at Box, Inc., from February 2014 to November 2014. From September
2010 to January 2013, he served as Global Chief Information Officer at Las Vegas
Sands Corp.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>21</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A href="#toc"><STRONG>Table
of Contents</STRONG></A></FONT></P>
<P STYLE="text-align: left"><FONT face="Times New Roman" size=2><STRONG><A NAME="Part2"></A>PART II</STRONG></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item5"></A>ITEM 5. MARKET FOR
REGISTRANT&#146;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF
EQUITY SECURITIES</FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Market Information
</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s common stock is
listed on the New York Stock Exchange. The high and low sales prices quoted for
the New York Stock Exchange-Composite Transactions Report for each quarterly
period during the past two fiscal years appear in the Notes to Consolidated
Financial Statements in Exhibit 99.1, incorporated herein by reference.
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Holders </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The number of record holders
of the Company&#146;s common stock as of July 29, 2016, was 10,995 based on
information provided by the Company&#146;s transfer agent. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Dividends</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The amount of quarterly
dividends declared with respect to the Company&#146;s common stock during the past
two fiscal years appears in the Notes to Consolidated Financial Statements in
Exhibit 99.1, incorporated herein by reference. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Equity Compensation Plan
Information</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>See Part III, Item 12 hereof.
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Issuer Purchases of Equity
Securities</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The following table sets forth
the purchases of the Company&#146;s securities by the Company and any affiliated
purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3))
during the fourth quarter of fiscal year 2016. </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0
cellPadding=0 width="100%" border=0>

    <TR STYLE="line-height: normal; font-size: 8pt; vertical-align: bottom">
    <TD NOWRAP STYLE="border-bottom: Black 1pt none; text-align: center; padding-top: 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt none; text-align: center; padding-top: 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt none; text-align: center; padding-top: 2pt; vertical-align: bottom"><FONT face="Times New Roman" size=1><b>[a]</b></font></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt none; text-align: center; padding-top: 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: Black 1pt none; text-align: center; padding-top: 2pt; vertical-align: bottom"><FONT face="Times New Roman" size=1><b>[b]</b></font></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt none; text-align: center; padding-top: 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt none; text-align: center; padding-top: 2pt; vertical-align: bottom"><FONT face="Times New Roman" size=1><b>[c]</b></font></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt none; text-align: center; padding-top: 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: Black 1pt none; text-align: center; padding-top: 2pt; vertical-align: bottom"><FONT face="Times New Roman" size=1><b>[d]</b></font></TD></TR>
<TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 86%; padding-top: 0in; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Period</FONT></B></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 1%; padding-top: 0in; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 3%; padding-top: 0in; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1><BR>Total Number
      of<BR>Shares (or Units)<BR>Purchased </FONT></B><B><FONT
      face="Times New Roman" size=1><SUP>(1)</SUP></FONT></B></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 1%; padding-top: 0in; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 2%; padding-top: 0in; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1><BR>Average Price
      Paid<BR>per Share (or Unit)</FONT></B></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 1%; padding-top: 0in; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 2%; padding-top: 0in; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Total Number
      of<BR>Shares (or Units)<BR>Purchased as Part of<BR>Publicly
      Announced<BR>Plans or Programs</FONT></B></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 1%; padding-top: 0in; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 3%; padding-top: 0in; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Maximum Number
      (or<BR>Approximate Dollar<BR>Value) that May Yet<BR>Be Purchased Under
      the<BR>Plans or Programs</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT
      face="Times New Roman" size=2>April 1 to 30, 2016</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 3%; PADDING-TOP: 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="3%"><FONT face="Times New Roman" size=2>257,617</FONT></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="1%"><FONT face="Times New Roman"
      size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      &nbsp;</FONT></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="1%"><FONT face="Times New Roman" size=2>124.35</FONT></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 2%; PADDING-TOP: 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="2%"><FONT face="Times New Roman" size=2>257,617</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD
    style="PADDING-BOTTOM: 2pt; VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="2%"><FONT face="Times New Roman"
      size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<SUP>(2</SUP></FONT></TD>
    <TD
    style="PADDING-BOTTOM: 2pt; VERTICAL-ALIGN: top; WIDTH: 1%; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left"
    noWrap width="1%"><FONT face="Times New Roman"
    size=1><SUP>)</SUP></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>May
      1 to 31, 2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 3%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="3%"><FONT face="Times New Roman" size=2>30,315</FONT></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="1%"><FONT face="Times New Roman" size=2>126.69</FONT></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 2%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="2%"><FONT face="Times New Roman" size=2>30,315</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD
    style="PADDING-BOTTOM: 2pt; VERTICAL-ALIGN: top; WIDTH: 2%; TEXT-ALIGN: right"
    noWrap width="2%"><FONT face="Times New Roman"
    size=1><SUP>(2</SUP></FONT></TD>
    <TD
    style="PADDING-BOTTOM: 2pt; VERTICAL-ALIGN: top; WIDTH: 1%; TEXT-ALIGN: left"
    noWrap width="1%"><FONT face="Times New Roman"
    size=1><SUP>)</SUP></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT
      face="Times New Roman" size=2>June 1 to 30, 2016</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD
    style="PADDING-BOTTOM: 2pt; VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right"
    noWrap width="2%"><FONT face="Times New Roman"
    size=1><SUP>(2</SUP></FONT></TD>
    <TD
    style="PADDING-BOTTOM: 2pt; VERTICAL-ALIGN: top; WIDTH: 1%; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left"
    noWrap width="1%"><FONT face="Times New Roman"
    size=1><SUP>)</SUP></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 3%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="3%"><FONT face="Times New Roman" size=2>287,932</FONT></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: top; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: left"
    noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="1%"><FONT face="Times New Roman" size=2>124.59</FONT></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="1%"></TD>
    <TD
    style="VERTICAL-ALIGN: bottom; WIDTH: 2%; PADDING-TOP: 2pt; TEXT-ALIGN: right"
    noWrap width="2%"><FONT face="Times New Roman" size=2>287,932</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD></TR></TABLE><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=1><SUP>(1)</SUP>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 100%; padding-top: 1.5pt"><FONT face="Times New Roman" size=2>Shares purchased in
      April 2016 and May 2016 were acquired pursuant to the Company&#146;s share
      repurchase program to offset the impact of share dilution related to
      share-based awards (the Evergreen Program).</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=1><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="width: 100%; padding-top: 1.5pt"><FONT face="Times New Roman" size=2>The Company has two
      share repurchase programs: an open-market purchase program with an
      authorized aggregate purchase amount of up to $750 million, all of which
      was available for share repurchases as of June 30, 2016, and the Evergreen
      Program, the purpose of which is to offset the impact of anticipated share
      dilution related to share-based awards and which has no specified
      cap.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>22</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A href="#toc"><STRONG>Table
of Contents</STRONG></A></FONT></P>
<P align=left><FONT face="Times New Roman" size=2><A NAME="item6"></A><STRONG>ITEM 6. SELECTED
FINANCIAL DATA </STRONG></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>This information appears under
&#147;Five-Year Financial Summary&#148; in Exhibit 99.1, incorporated herein by reference.
</FONT></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2><A NAME="item7"></A>ITEM 7. MANAGEMENT&#146;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS</FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2>This information appears under
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations,&#148; in Exhibit 99.1, incorporated herein by reference. </FONT></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2><A NAME="item7a"></A>ITEM 7.A. QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2>This information appears under
&#147;Quantitative and Qualitative Disclosures about Market Risk&#148; in &#147;Management&#146;s
Discussion and Analysis of Financial Condition and Results of Operations,&#148; in
Exhibit 99.1, incorporated herein by reference. </FONT></P>
<P align=left><STRONG><FONT face="Times New Roman" size=2><A NAME="item8"></A>ITEM 8. FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA</FONT><FONT face="Times New Roman" size=2>
</FONT></STRONG></P>
<P align=left><FONT face="Times New Roman" size=2>These statements and data appear in Exhibit 99.1, incorporated herein by
reference.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><B><A NAME="item9"></A>
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE</B></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>None. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item9a"></A>ITEM 9.A. CONTROLS AND
PROCEDURES</FONT></B></p>

<P align=left><B><FONT face="Times New Roman" size=2>Disclosure Controls and Procedures</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s management, with
the participation of the Company&#146;s chief executive officer and chief financial
officer, evaluated the effectiveness of the Company&#146;s disclosure controls and
procedures as of the end of the period covered by this Report. Based on that
evaluation, the chief executive officer and chief financial officer concluded
that the Company&#146;s disclosure controls and procedures, as of the end of the
period covered by this Report, were effective such that the information required
to be disclosed by the Company in reports filed under the Exchange Act is (i)
recorded, processed, summarized and reported within the time periods specified
in the SEC&#146;s rules and forms and (ii) accumulated and communicated to
management, including the chief executive officer and chief financial officer,
as appropriate to allow timely decisions regarding disclosure.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Management&#146;s Report on
Internal Control Over Financial Reporting</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Management&#146;s report on
internal control over financial reporting is set forth in Exhibit 99.1, and is
incorporated herein by reference. The Company&#146;s independent registered public
accounting firm, Ernst &amp; Young, LLP, has audited the effectiveness of the
Company&#146;s internal control over financial reporting as of June 30, 2016. See
&#147;Report of Independent Registered Public Accounting Firm,&#148; which appears in
Exhibit 99.1. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Change in Internal Control
Over Financial Reporting</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>No change in the Company&#146;s
internal control over financial reporting occurred during the fourth fiscal
quarter of the fiscal year ended June 30, 2016, that has materially affected, or
is reasonably likely to materially affect, the Company&#146;s internal control over
financial reporting. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item9b"></A>ITEM 9.B. OTHER
INFORMATION</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Not applicable.</FONT></P>
<P align=center style= "margin-bottom: 6pt; margin-top: 6pt"><FONT face="Times New Roman" size=2>23</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2><A href="#toc">Table
of Contents</A></FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2><A NAME="part3"></A>PART III</FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item10"></A>ITEM 10. DIRECTORS,
EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Pursuant to Instruction 3 to
Item 401(b) of Regulation S-K, information regarding the executive officers of
the registrant is reported in Part I of this Report. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company has adopted a Code
of Conduct that applies to its principal executive officer, principal financial
officer and principal accounting officer, among others. The Code of Conduct is
located on the Company&#146;s website at TheCloroxCompany.com under Corporate
Responsibility/Performance/Corporate Governance or
http://www.thecloroxcompany.com/corporate-responsibility/performance/corporate-governance.
The Company intends to satisfy the requirement under Item 5.05 of Form 8-K
regarding disclosure of amendments to, or waivers from, provisions of its Code
of Conduct by posting such information on the Company&#146;s website. The Company&#146;s
website also contains its corporate governance guidelines and the charters of
its principal board committees. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Information regarding the
Company&#146;s directors, compliance with Section 16(a) of the Exchange Act and
corporate governance set forth in the Proxy Statement is incorporated herein by
reference. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item11"></A>ITEM 11. EXECUTIVE
COMPENSATION</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Information regarding
executive and director compensation, Management Development and Compensation
Committee interlocks and insider participation and the report of the Management
Development and Compensation Committee of the Company&#146;s board of directors set
forth in the Proxy Statement is incorporated herein by reference. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item12"></A>ITEM 12. SECURITY OWNERSHIP
OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
MATTERS</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Information regarding security
ownership of certain beneficial owners, management and directors and securities
authorized for issuance under equity compensation plans set forth in the Proxy
Statement is incorporated herein by reference.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item13"></A>ITEM 13. CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Information regarding certain
relationships and related transactions and director independence set forth in
the Proxy Statement is incorporated herein by reference.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item14"></A>ITEM 14. PRINCIPAL
ACCOUNTING FEES AND SERVICES</FONT></B><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Information regarding
principal accounting fees and services set forth in the Proxy Statement is
incorporated herein by reference.</FONT><FONT face="Times New Roman">
</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>24</FONT></P>
<HR align=center width="100%" noShade SIZE=2>





<!--part 03-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2><A NAME="part4"></A>PART IV</FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2><A NAME="item15"></A>ITEM 15. EXHIBITS AND
FINANCIAL STATEMENT SCHEDULES</FONT></B><FONT face="Times New Roman" size=2>
</FONT><FONT face="Times New Roman"></FONT></P>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Financial Statements
      and Schedules:</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Consolidated
      Financial Statements and Reports of Independent Registered Public
      Accounting Firm included in Exhibit 99.1, incorporated herein by
      reference.</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Reports of
      Independent Registered Public Accounting Firm.</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Consolidated
      Statements of Earnings for the fiscal years ended June 30, 2016, 2015 and
      2014.</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Consolidated
      Statements of Comprehensive Income for the fiscal years ended June 30,
      2016, 2015 and 2014.</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Consolidated Balance
      Sheets as of June 30, 2016 and 2015.</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Consolidated
      Statements of Stockholders&#146; Equity for the fiscal years ended June 30,
      2016, 2015 and 2014.</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Consolidated
      Statements of Cash Flows for the fiscal years ended June 30, 2016, 2015
      and 2014.</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Notes to Consolidated
      Financial Statements.</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Valuation and
      Qualifying Accounts and Reserves included in Exhibit 99.2, incorporated
      herein by reference.</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(b)</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Exhibits:</FONT></TD></TR></TABLE><BR>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: 14pt" vAlign=bottom>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="43%" colSpan=7><B><FONT face="Times New Roman" size=1>Incorporated by
      Reference</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 5%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit<BR>Number</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 50%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit
      Description</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Form</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>File No.</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Filing
    Date</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3.1</FONT></TD>
    <TD vAlign=top align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Restated Certificate of
    Incorporation.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3(iii)</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>February 14, 2000</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>3.2</FONT></TD>
    <TD vAlign=top align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Bylaws (amended and restated).</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>8-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%">&nbsp;</TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%">&nbsp;</TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>3.2</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 28, 2015</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3.3</FONT></TD>
    <TD vAlign=top align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Certificate of Designations for The Clorox
      Company Series A Junior Participating Preferred Stock.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>July 19, 2011</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>4.1</FONT></TD>
    <TD vAlign=top align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Indenture, dated as of December 3, 2004, between the Company and
      The Bank of New York Trust Company N.A., as trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>8-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>4.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>December 3, 2004</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.2</FONT></TD>
    <TD vAlign=top align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Indenture, dated as of October 9, 2007,
      between the Company and The Bank of New York Trust Company N.A., as
      trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>S-3ASR</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>333-200722</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>December 4,
2014</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>25</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: 14pt" vAlign=bottom>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="43%" colSpan=7><B><FONT face="Times New Roman" size=1>Incorporated by Reference</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 5%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit<BR>Number</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 50%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit Description</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Form</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>File No.</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Filing Date</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.3</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>First
      Supplemental Indenture, dated as of November 9, 2009, among the Company,
      The Bank of New York Trust Company N.A., and Wells Fargo Bank, National
      Association, as trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>S-3ASR</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>333-200722</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.2</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>December 4, 2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>4.4</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Second Supplemental
      Indenture, dated as of November 9, 2009, between the Company and Wells
      Fargo Bank, National Association, as trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>S-3ASR</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>333-200722</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>4.3</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>December 4,
      2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.5</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Third
      Supplemental Indenture, dated as of November 17, 2011, between the company
      and Wells Fargo Bank, National Association, as trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>S-3ASR</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>333-200722</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.4</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>December 4, 2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>4.6</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Fourth Supplemental
      Indenture, dated as of September 13, 2012, between the Company and Wells
      Fargo Bank, National Association, as trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>S-3ASR</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>333-200722</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>4.5</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>December 4,
      2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.7</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Fifth
      Supplemental Indenture, dated as of December 9, 2014, between the Company
      and Wells Fargo Bank, National Association, as trustee</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>December 9, 2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.1*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>The Clorox Company
      Amended and Restated Independent Directors&#146; Deferred Compensation Plan,
      effective as of November 16, 2005, and amended and restated as of February
      7, 2008.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.55</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>May 2,
  2008</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.2*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company Non-Qualified Deferred Compensation Plan, adopted as of
      January 1, 1996, and amended and restated as of July 20, 2004.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10(x)</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>August 27, 2004</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.3*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Amendment No.1 to The
      Clorox Company Non-Qualified Deferred Compensation Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.4*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company Annual Incentive Plan, amended and restated as of September
      17, 2013.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.8</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>August 25, 2014</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>26</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: 14pt" vAlign=bottom>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="43%" colSpan=7><B><FONT face="Times New Roman" size=1>Incorporated by Reference</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 5%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit<BR>Number</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 50%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit Description</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Form</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>File No.</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Filing Date</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.5*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company 2005 Stock Incentive Plan, amended and restated as of
      November 14, 2012.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>February 5, 2013</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.6*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Form of Performance
      Share Award Agreement under the Company&#146;s 2005 Stock Incentive Plan for
      awards made in 2013.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.12</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 25,
    2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.7*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Form
      of Performance Share Award Agreement under the Company&#146;s 2005 Stock
      Incentive Plan for awards made in 2014.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.9</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>August 21, 2015</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.8*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Form of Performance
      Share Award Agreement under the Company&#146;s 2005 Stock Incentive Plan for
      awards made in 2015.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>November 2,
      2015</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.9*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Form
      of Restricted Stock Unit Award Agreement under the Company&#146;s 2005 Stock
      Incentive Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.13</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>August 23, 2013</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.10*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Form of Nonqualified
      Stock Option Award Agreement under the Company&#146;s 2005 Stock Incentive
      Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.14</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 25,
    2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.11*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company Amended and Restated 2005 Nonqualified Deferred
      Compensation Plan, effective January 1, 2008.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.18</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>August 19, 2008</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.12*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Amendment No. 1 to
      The Clorox Company Amended and Restated 2005 Nonqualified Deferred
      Compensation Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.18</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 26,
    2011</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.13*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Amendment No. 2 to The Clorox Company Amended and Restated 2005
      Nonqualified Deferred Compensation Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.14*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>The Clorox Company
      Supplemental Executive Retirement Plan, as restated effective January 5,
      2005, as revised August 13, 2009.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.17</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>November 3,
      2009</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.15*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Amendment No. 1 to The Clorox Company Supplemental Executive
      Retirement Plan, effective as of July 29, 2011.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.21</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>November 3, 2011</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.16*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Amendment No. 2 to
      The Clorox Company Supplemental Executive Retirement Plan, effective as of
      September 11, 2012.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.2</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>November 2,
      2012</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.17*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company Executive Incentive Compensation Plan, amended and restated
      as of February 7, 2008.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.58</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>May
      2, 2008</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.18*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Form of
      Indemnification Agreement.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.27</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>May 4,
  2010</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>27</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: 14pt" vAlign=bottom>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD align=left width="50%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="43%" colSpan=7><B><FONT face="Times New Roman" size=1>Incorporated by Reference</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 5%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit<BR>Number</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 50%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit Description</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Form</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>File No.</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Filing Date</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.19*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>First
      Amended and Restated Executive Change in Control Severance Plan, effective
      November 20, 2014.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>February 5, 2015</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.20*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Severance Plan for
      Clorox Executive Committee Members, amended and restated effective
      November 20, 2014.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.2</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>February 5,
      2015</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.21*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company Executive Retirement Plan, effective as of July 1,
      2011.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.27</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>May
      4, 2011</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.22*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Amendment No. 1 to
      The Clorox Company Executive Retirement Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.23*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company 2011 Nonqualified Deferred Compensation Plan, effective as
      of July 1, 2011.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.29</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>August 26, 2011</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.24*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Amendment No. 1 to
      The Clorox Company 2011 Nonqualified Deferred Compensation Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.25</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Credit Agreement, dated as of October 1, 2014 among The Clorox
      Company, the lenders listed therein, Citibank, N.A., JPMorgan Chase Bank,
      N.A.and Wells Fargo Bank, National Association, as Administrative Agents,
      and Citibank, N.A. as Servicing Agent.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>October 7, 2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.26(+)</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Amended and Restated
      Joint Venture Agreement dated as of January 31, 2003, between The Glad
      Products Company and certain affiliates and The Procter and Gamble Company
      and certain affiliates.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>21</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Subsidiaries.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>23</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Consent of
      Independent Registered Public Accounting Firm.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>31.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Certification of the Chief Executive Officer of The Clorox Company
      pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>31.2</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Certification of the
      Chief Financial Officer of The Clorox Company pursuant to Section 302 of
      the Sarbanes-Oxley Act of 2002.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Certification of the Chief Executive Officer and Chief Financial
      Officer of The Clorox Company pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>28</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: 14pt" vAlign=bottom>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="43%" colSpan=7><B><FONT face="Times New Roman" size=1>Incorporated by Reference</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 5%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit<BR>Number</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 50%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit Description</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Form</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>File No.</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Filing Date</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>99.1</FONT></TD>
    <TD vAlign=top align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Management&#146;s Discussion and Analysis of Financial Condition and
      Results of Operations, Consolidated Financial Statements, Management&#146;s
      Report on Internal Control over Financial Reporting and Reports of
      Independent Registered Public Accounting Firm.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>99.2</FONT></TD>
    <TD vAlign=top align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Valuation and
      Qualifying Accounts and Reserves.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>99.3</FONT></TD>
    <TD vAlign=top align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Reconciliation of Economic Profit (Unaudited).</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>101</FONT></TD>
    <TD vAlign=top align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>The following
      materials from The Clorox Company&#146;s Annual Report on Form 10-K for the
      year ended June 30, 2016 are formatted in extensible Business Reporting
      Language (XBRL): (i) the Consolidated Statements of Earnings, (ii) the
      Consolidated Statements of Comprehensive Income, (iii) the Consolidated
      Balance Sheets, (iv) the Consolidated Statements of Stockholders&#146; Equity,
      (v) the Consolidated Statements of Cash Flows and (vi) Notes to
      Consolidated Financial Statements.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD></TR></TABLE>
<DIV>____________________</DIV><BR>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>(*)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="99%"><FONT face="Times New Roman" size=2>Indicates a management
      or director contract or compensatory plan or arrangement required to be
      filed as an exhibit to this report.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>(+)</FONT></TD>
    <TD width="99%"><FONT face="Times New Roman" size=2>Confidential treatment
      has been requested for certain information contained in this document.
      Such information has been omitted and filed separately with the Securities
      and Exchange Commission.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>29</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2><A NAME="sign"></A>SIGNATURES</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman"></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Pursuant to the requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </FONT><FONT face="Times New Roman"></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="51%"></TD>
    <TD noWrap align=left width="48%" colSpan=2><FONT face="Times New Roman" size=2>THE CLOROX COMPANY</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=3>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="51%"><FONT face="Times New Roman" size=2>Date: August 16, 2016</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>By:&nbsp;&nbsp; </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="47%"><FONT face="Times New Roman" size=2>/s/ Benno
  Dorer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="51%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="47%"><FONT face="Times New Roman" size=2>B.
      Dorer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="51%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="47%"><FONT face="Times New Roman" size=2>Chief Executive Officer</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Pursuant to the requirements
of the Securities Exchange Act of 1934, this report has been signed below by the
following persons on behalf of the registrant and in the capacities and on the
dates indicated. </FONT><FONT face="Times New Roman"></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="20%"><B><FONT face="Times New Roman" size=2>Signature</FONT></B></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="58%"><STRONG><FONT size=2 face="Times New Roman">Title</FONT></STRONG></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="20%"><B><FONT face="Times New Roman" size=2>Date</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ R. H.
Carmona</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>R.
      H. Carmona</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ S. C.
    Fleischer</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>S.
      C. Fleischer</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ G. J. Harad</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>G.
      J. Harad</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ E. Lee</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>E.
      Lee</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ R. W.
      Matschullat</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>R.
      W. Matschullat</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ J. Noddle</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>J.
      Noddle</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ R. M.
    Rebolledo</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>R.
      M. Rebolledo</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ P.
    Thomas-Graham</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>P.
      Thomas-Graham</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ C. M.
Ticknor</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>C.
      M. Ticknor</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ C. J.
    Williams</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>C.
      J. Williams</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR></table>
    <P align=center><FONT face="Times New Roman" size=2>30</FONT></P>
    <HR align=center width="100%" noShade SIZE=2>
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ A.D.D.
MacKay</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Director</FONT></TD>
    <TD noWrap align=right width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>A.D.D. MacKay</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ B. Dorer</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Chairman and Chief Executive Officer</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>B.
      Dorer</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>(Principal Executive Officer)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ S. M. Robb</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Executive Vice President &#151; Chief Financial Officer</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>S.
      M. Robb</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>(Principal Financial Officer)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ T. Johnson</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>Vice
      President &#151; Global Business Services and Chief Accounting
Officer</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap style="text-align: center" width="20%"><FONT face="Times New Roman" size=2>August 16, 2016</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>T.
      Johnson</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="58%"><FONT face="Times New Roman" size=2>(Principal Accounting Officer)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="20%"></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>31</FONT></P>
<HR align=center width="100%" noShade SIZE=2>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>INDEX OF
EXHIBITS</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman"></FONT></P>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: 14pt" vAlign=bottom>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="43%" colSpan=7><B><FONT face="Times New Roman" size=1>Incorporated by Reference</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 5%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit<BR>Number</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 50%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit Description</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Form</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>File No.</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Filing Date</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Restated Certificate of Incorporation.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3(iii)</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>February 14, 2000</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>3.2</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Bylaws (amended and
      restated).</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>8-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>3.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 28,
    2015</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3.3</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Certificate of Designations for The Clorox Company Series A Junior
      Participating Preferred Stock.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>July
      19, 2011</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>4.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Indenture, dated as
      of December 3, 2004, between the Company and The Bank of New York Trust
      Company N.A., as trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>8-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>4.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>December 3,
      2004</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.2</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Indenture, dated as of October 9, 2007, between the Company and The
      Bank of New York Trust Company N.A., as trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>S-3ASR</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>333-200722</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>December 4, 2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>4.3</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>First Supplemental
      Indenture, dated as of November 9, 2009, among the Company, The Bank of
      New York Trust Company N.A., and Wells Fargo Bank, National Association,
      as trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>S-3ASR</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>333-200722</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>4.2</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>December 4,
      2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.4</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Second Supplemental Indenture, dated as of November 9, 2009,
      between the Company and Wells Fargo Bank, National Association, as
      trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>S-3ASR</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>333-200722</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.3</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>December 4, 2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>4.5</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Third Supplemental
      Indenture, dated as of November 17, 2011, between the company and Wells
      Fargo Bank, National Association, as trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>S-3ASR</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>333-200722</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>4.4</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>December 4,
      2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.6</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Fourth Supplemental Indenture, dated as of September 13, 2012,
      between the Company and Wells Fargo Bank, National Association, as
      trustee.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>S-3ASR</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>333-200722</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.5</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>December 4, 2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>4.7</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Fifth Supplemental
      Indenture, dated as of December 9, 2014, between the Company and Wells
      Fargo Bank, National Association, as trustee</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>8-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>4.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>December 9,
      2014</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>32</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: 14pt" vAlign=bottom>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="43%" colSpan=7><B><FONT face="Times New Roman" size=1>Incorporated by Reference</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 5%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit<BR>Number</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 50%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit Description</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Form</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>File No.</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Filing Date</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.1*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company Amended and Restated Independent Directors&#146; Deferred
      Compensation Plan, effective as of November 16, 2005, and amended and
      restated as of February 7, 2008.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.55</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>May
      2, 2008</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.2*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>The Clorox Company
      Non-Qualified Deferred Compensation Plan, adopted as of January 1, 1996,
      and amended and restated as of July 20, 2004.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10(x)</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 27,
    2004</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.3*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Amendment No. 1 to The Clorox Company Non-Qualified Deferred
      Compensation Plan</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.4*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>The Clorox Company
      Annual Incentive Plan, amended and restated as of September 17,
      2013.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.8</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 25,
    2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.5*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company 2005 Stock Incentive Plan, amended and restated as of
      November 14, 2012.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>February 5, 2013</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.6*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Form of Performance
      Share Award Agreement under the Company&#146;s 2005 Stock Incentive Plan for
      awards made in 2013.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.12</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 25,
    2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.7*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Form
      of Performance Share Award Agreement under the Company&#146;s 2005 Stock
      Incentive Plan for awards made in 2014.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.9</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>August 21, 2015</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.8</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Form of Performance
      Share Award Agreement under the Company&#146;s 2005 Stock Incentive Plan for
      awards made in 2015.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>November 2,
      2015</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.9*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Form
      of Restricted Stock Unit Award Agreement under the Company&#146;s 2005 Stock
      Incentive Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.13</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>August 23, 2013</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.10*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Form of Nonqualified
      Stock Option Award Agreement under the Company&#146;s 2005 Stock Incentive
      Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.14</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 25,
    2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.11*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company Amended and Restated 2005 Nonqualified Deferred
      Compensation Plan, effective January 1, 2008.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.18</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>August 19, 2008</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.12*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Amendment No. 1 to
      The Clorox Company Amended and Restated 2005 Nonqualified Deferred
      Compensation Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.18</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 26,
    2011</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.13*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Amendment No. 2 to The Clorox Company Amended and Restated 2005
      Nonqualified Deferred Compensation Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>33</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: 14pt" vAlign=bottom>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="43%" colSpan=7><B><FONT face="Times New Roman" size=1>Incorporated by Reference</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 5%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit<BR>Number</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 50%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit Description</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Form</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>File No.</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Filing Date</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.14*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company Supplemental Executive Retirement Plan, as restated
      effective January 5, 2005, as revised August 13, 2009.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.17</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>November 3, 2009</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.15*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Amendment No. 1 to
      The Clorox Company Supplemental Executive Retirement Plan, effective as of
      July 29, 2011.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.21</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>November 3,
      2011</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.16*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Amendment No. 2 to The Clorox Company Supplemental Executive
      Retirement Plan, effective as of September 11, 2012.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.2</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>November 2, 2012</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.17*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>The Clorox Company
      Executive Incentive Compensation Plan, amended and restated as of February
      7, 2008.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.58</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>May 2,
  2008</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.18*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Form
      of Indemnification Agreement.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.27</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>May
      4, 2010</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.19*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>First Amended and
      Restated Executive Change in Control Severance Plan, effective November
      20, 2014.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>February 5,
      2015</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.20*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Severance Plan for Clorox Executive Committee Members, amended and
      restated effective November 20, 2014.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.2</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>February 5, 2015</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.21*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>The Clorox Company
      Executive Retirement Plan, effective as of July 1, 2011.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-Q</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.27</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>May 4,
  2011</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.22*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Amendment No. 1 to The Clorox Company Executive Retirement
      Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.23*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>The Clorox Company
      2011 Nonqualified Deferred Compensation Plan, effective as of July 1,
      2011.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.29</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>August 26,
    2011</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.24*</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Amendment No. 1 to The Clorox Company 2011 Nonqualified Deferred
      Compensation Plan.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>10.25</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Credit Agreement,
      dated as of October 1, 2014 among The Clorox Company, the lenders listed
      therein, Citibank, N.A., JPMorgan Chase Bank, N.A.and Wells Fargo Bank,
      National Association, as Administrative Agents, and Citibank, N.A. as
      Servicing Agent.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>8-K</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>001-07151</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>10.1</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="10%"><FONT face="Times New Roman" size=2>October 7,
    2014</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10.26(+)</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Amended and Restated Joint Venture Agreement dated as of January
      31, 2003, between The Glad Products Company and certain affiliates and The
      Procter and Gamble Company and certain affiliates.</FONT></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>34</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><A HREF="#toc"><B>Table of Contents</B></A></FONT></P>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: 14pt" vAlign=bottom>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="43%" colSpan=7><B><FONT face="Times New Roman" size=1>Incorporated by Reference</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 5%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit<BR>Number</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 50%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit Description</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Form</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>File No.</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Exhibit</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 10%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Filing Date</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>21</FONT></TD>
    <TD vAlign=top align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Subsidiaries.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>23</FONT></TD>
    <TD vAlign=top align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Consent of
      Independent Registered Public Accounting Firm.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>31.1</FONT></TD>
    <TD vAlign=top align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Certification of the Chief Executive Officer of The Clorox Company
      pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>31.2</FONT></TD>
    <TD vAlign=top align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Certification of the
      Chief Financial Officer of The Clorox Company pursuant to Section 302 of
      the Sarbanes-Oxley Act of 2002.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD vAlign=top align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Certification of the Chief Executive Officer and Chief Financial
      Officer of The Clorox Company pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>99.1</FONT></TD>
    <TD vAlign=top align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Management&#146;s
      Discussion and Analysis of Financial Condition and Results of Operations,
      Consolidated Financial Statements, Management&#146;s Report on Internal Control
      over Financial Reporting and Reports of Independent Registered Public
      Accounting Firm.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>99.2</FONT></TD>
    <TD vAlign=top align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Valuation and Qualifying Accounts and Reserves.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%"><FONT face="Times New Roman" size=2>99.3</FONT></TD>
    <TD vAlign=top align=left width="1%"></TD>
    <TD vAlign=top align=left width="50%"><FONT face="Times New Roman" size=2>Reconciliation of
      Economic Profit (Unaudited).</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="10%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="5%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>101</FONT></TD>
    <TD vAlign=top align=left width="1%" bgColor=#c0c0c0></TD>
    <TD vAlign=top align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      following materials from The Clorox Company&#146;s Annual Report on Form 10-K
      for the year ended June 30, 2015 are formatted in extensible Business
      Reporting Language (XBRL): (i) the Consolidated Statements of Earnings,
      (ii) the Consolidated Statements of Comprehensive Income, (iii) the
      Consolidated Balance Sheets, (iv) the Consolidated Statements of
      Stockholders&#146; Equity, (v) the Consolidated Statements of Cash Flows and
      (vi) Notes to Consolidated Financial Statements.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="10%" bgColor=#c0c0c0></TD></TR></TABLE>
<DIV>____________________</DIV><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(*)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Indicates a
      management or director contract or compensatory plan or arrangement
      required to be filed as an exhibit to this report.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(+)</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Confidential
      treatment has been requested for certain information contained in this
      document. Such information has been omitted and filed separately with the
      Securities and Exchange Commission.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>35</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

</BODY>


</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>clorox3118951_1-ex103.htm
<DESCRIPTION>AMENDMENT NO. 1 TO THE CLOROX COMPANY
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit 10.3
</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>THE CLOROX
COMPANY<BR></FONT></B><B><FONT face="Times New Roman" size=2>NONQUALIFIED
DEFERRED COMPENSATION PLAN<BR>AMENDMENT NO. 1 </FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Pursuant to Section 6.06 of
The Clorox Company Nonqualified Deferred Compensation Plan (the &#147;Plan&#148;), the
Plan is hereby amended as follows, effective as of July 1, 2016: </FONT></P>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>3.</FONT></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%" colSpan=2><FONT face="Times New Roman" size=2>Section
      5.01(b) of the Plan is hereby deleted in its entirety and replaced with
      the following:</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap>&nbsp;</TD>
    <TD vAlign=top noWrap>&nbsp;</TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%">
      <P align=left><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;(b) </FONT><U><FONT face="Times New Roman" size=2>Subsequent Elections</FONT></U><FONT face="Times New Roman" size=2>. A Participant may change the form of a
      distribution election with respect to his or her entire vested Account by
      submitting the change to the Committee in writing, at least two calendar
      years before the Participant has a Termination of Employment. Unless
      otherwise approved by the Administrator in its sole discretion, only one
      change election under this paragraph (b) can be made for the Participant&#146;s
      entire vested Account. A change election made under this paragraph (b)
      shall be irrevocable as of December 31 of the calendar year that is at
      least the second calendar year prior to the calendar year in which the
      Participant has a Termination of Employment. If such a subsequent election
      is not valid because, for example, it is not made in a timely manner, the
      Participant&#146;s most recent effective distribution election under this
      Section 5.01 will govern payment of the Participant&#146;s entire vested
      Account upon the Participant&#146;s Termination of Employment.&#148;
  </FONT></P></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Except as modified by this
Amendment No. 1, the Plan shall remain unchanged and shall remain in full force
and effect. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>IN WITNESS WHEREOF, The Clorox
Company has caused this Amendment No. 1 to be duly executed as of the day and
year first written above. </FONT></P>
<DIV align=right>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=2><FONT face="Times New Roman" size=2>The Clorox
      Company</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="100%" colSpan=2>&nbsp;<BR>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>By:&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="97%"><FONT size=2 face="Times New Roman">/s/ Kirsten
  Marriner</FONT></TD></TR></TABLE></DIV><BR>
<HR align=center width="100%" noShade size="2">

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>3
<FILENAME>clorox3118951_1-ex1013.htm
<DESCRIPTION>AMENDMENT NO. 2 TO THE CLOROX COMPANY
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit 10.13
</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>THE CLOROX
COMPANY<BR>AMENDED AND RESTATED <BR></FONT></B><B><FONT face="Times New Roman" size=2>2005 NONQUALIFIED DEFERRED COMPENSATION PLAN<BR>AMENDMENT NO. 2
</FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Pursuant to Section 6.07 of
The Clorox Company 2005 Nonqualified Deferred </FONT><FONT face="Times New Roman" size=2>Compensation Plan, as amended (the &#147;Plan&#148;), the
Plan is hereby amended as follows, effective as of July 1, 2016: </FONT></P>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>2.</FONT></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%" colSpan=2><FONT face="Times New Roman" size=2>Section 5.01(b) of the
      Plan is hereby deleted in its entirety and replaced with the
      following:</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap>&nbsp;</TD>
    <TD vAlign=top noWrap>&nbsp;</TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%">
      <P align=left><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;(b) </FONT><U><FONT face="Times New Roman" size=2>Subsequent Elections for Elective
      Deferrals</FONT></U><FONT face="Times New Roman" size=2>. A Participant
      may change the form of a distribution election (whether payable in-service
      or upon or following Separation From Service) with respect to all or a
      portion of his or her Account by submitting the change to the Committee,
      in writing, at least one calendar year before the originally scheduled
      distribution date. Unless otherwise approved by the Administrator in its
      sole discretion, only one change election under this paragraph (b) can be
      made for amounts credited to a Participant&#146;s Account for any specific Plan
      Year. Any such change election will defer the timing of commencement of
      the distribution for five years after the originally scheduled
      distribution date. A change election made under this paragraph (b) shall
      be irrevocable as of the date that is one year prior to the originally
      scheduled distribution date. If such a subsequent election is not valid
      because, for example, it is not made in a timely manner, the Participant&#146;s
      most recent effective distribution election will govern the payment of the
      Participant&#146;s Account.&#148; </FONT></P></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Except as modified by this
Amendment No. 2, the Plan shall remain unchanged and shall remain in full force
and effect. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>IN WITNESS WHEREOF, The Clorox
Company has caused this Amendment No. 2 to be duly executed as of the day and
year first written above. </FONT></P>
<DIV align=right>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=2><FONT face="Times New Roman" size=2>The Clorox
      Company</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="100%" colSpan=2>&nbsp;<BR>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>By:&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="97%"><FONT size=2 face="Times New Roman">/s/ Kirsten
  Marriner</FONT></TD></TR></TABLE></DIV><BR>
<HR align=center width="100%" noShade size="2">


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>4
<FILENAME>clorox3118951_1-ex1022.htm
<DESCRIPTION>AMENDMENT NO. 1 TO THE CLOROX COMPANY EXECUTIVE RETIREMENT PLAN
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit 10.22
</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>THE CLOROX
COMPANY<BR>EXECUTIVE RETIREMENT PLAN <BR></FONT></B><B><FONT face="Times New Roman" size=2>AMENDMENT NO. 1 </FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Pursuant to Section 6.07 of
The Clorox Company Executive Retirement Plan (the &#147;Plan&#148;), the Plan is hereby
amended as follows, effective as of July 1, 2016: </FONT></P>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>4.</FONT></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%" colSpan=2><FONT face="Times New Roman" size=2>Section 5.01(b) of
      the Plan is hereby deleted in its entirety and replaced with the
      following:</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap>&nbsp;</TD>
    <TD vAlign=top noWrap>&nbsp;</TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%">
      <P align=left><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;(b) </FONT><U><FONT face="Times New Roman" size=2>Subsequent Election</FONT></U><FONT face="Times New Roman" size=2>. A Participant may change the form of a
      distribution election with respect to all or a portion of his or her
      Account by submitting the change to the Committee, in writing, at least
      one calendar year before the originally scheduled distribution date.
      Unless otherwise approved by the Administrator in its sole discretion,
      only one change election under this paragraph (b) can be made for amounts
      credited to a Participant&#146;s Account for any specific Plan Year. Any such
      change election will defer the timing of commencement of the distribution
      for five years after the originally scheduled distribution date. A change
      election made under this paragraph (b) shall be irrevocable as of the date
      that is one year prior to the originally scheduled distribution date. If
      such a subsequent election is not valid because, for example, it is not
      made in a timely manner, the Participant&#146;s most recent effective
      distribution election will govern the payment of the Participant&#146;s
      Account.&#148; </FONT></P></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Except as modified by this
Amendment No. 1, the Plan shall remain unchanged and shall remain in full force
and effect. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>IN WITNESS WHEREOF, The Clorox
Company has caused this Amendment No. 1 to be duly executed as of the day and
year first written above. </FONT></P>
<DIV align=right>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=2><FONT face="Times New Roman" size=2>The Clorox
      Company</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="100%" colSpan=2>&nbsp;<BR>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>By:&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="97%"><FONT size=2 face="Times New Roman">/s/ Kirsten
  Marriner</FONT></TD></TR></TABLE></DIV><BR>
<HR align=center width="100%" noShade size="2">


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.24
<SEQUENCE>5
<FILENAME>clorox3118951_1-ex1024.htm
<DESCRIPTION>AMENDMENT NO. 1 TO THE CLOROX COMPANY 2011
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit 10.24
</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>THE CLOROX COMPANY
<BR></FONT></B><B><FONT face="Times New Roman" size=2>2011 NONQUALIFIED DEFERRED
COMPENSATION PLAN<BR>AMENDMENT NO. 1 </FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Pursuant to Section 6.07 of
The Clorox Company 2011 Nonqualified Deferred Compensation Plan (the &#147;Plan&#148;),
the Plan is hereby amended as follows, effective as of July 1, 2016: </FONT></P>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>1.</FONT></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%" colSpan=2><FONT face="Times New Roman" size=2>Section 5.01(c) of
      the Plan is hereby deleted in its entirety and replaced with the
      following:</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap>&nbsp;</TD>
    <TD vAlign=top noWrap>&nbsp;</TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%">
      <P align=left><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;(c) </FONT><U><FONT face="Times New Roman" size=2>Subsequent Elections for Elective
      Deferrals</FONT></U><FONT face="Times New Roman" size=2>. A Participant
      may change the form of a distribution election (whether payable in-service
      or upon or following Separation From Service) with respect to all or a
      portion of his or her Account by submitting the change to the Committee,
      in writing, at least one calendar year before the originally scheduled
      distribution date. Unless otherwise approved by the Administrator in its
      sole discretion, only one change election under this paragraph (c) can be
      made for amounts credited to a Participant&#146;s Account for any specific Plan
      Year. Any such change election will defer the timing of commencement of
      the distribution for five years after the originally scheduled
      distribution date. A change election made under this paragraph (c) shall
      be irrevocable as of the date that is one year prior to the originally
      scheduled distribution date. If such a subsequent election is not valid
      because, for example, it is not made in a timely manner, the Participant&#146;s
      most recent effective distribution election will govern the payment of the
      Participant&#146;s Account.&#148; </FONT></P></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Except as modified by this
Amendment No. 1, the Plan shall remain unchanged and shall remain in full force
and effect. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>IN WITNESS WHEREOF, The Clorox
Company has caused this Amendment No. 1 to be duly executed as of the day and
year first written above. </FONT></P>
<DIV align=right>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=2><FONT face="Times New Roman" size=2>The Clorox
      Company</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="100%" colSpan=2>&nbsp;<BR>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>By:&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="97%"><FONT size=2 face="Times New Roman">/s/ Kirsten
  Marriner</FONT></TD></TR></TABLE></DIV><BR>
<HR align=center width="100%" noShade size="2">

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.26
<SEQUENCE>6
<FILENAME>clorox3118951_1-ex10261.htm
<DESCRIPTION>AMENDED AND RESTATED JOINT VENTURE AGREEMENT DATED AS OF JANUARY 31, 2003
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><U><FONT face="Times New Roman" size=2>Exhibit
10.26</FONT></U></B><B><FONT face="Times New Roman" size=2></FONT></B></P>
<P align=right><B><FONT face="Times New Roman" size=2>EXECUTION
COPY</FONT></B></P>
<P align=right><STRONG><FONT size=2 face="Times New Roman"></FONT></STRONG>&nbsp;</P>
<P align=right><STRONG><FONT size=2 face="Times New Roman"></FONT></STRONG>&nbsp;</P>
<P align=right><STRONG><FONT size=2 face="Times New Roman"></FONT></STRONG>&nbsp;</P>
<P align=right><STRONG><FONT size=2 face="Times New Roman"></FONT></STRONG>&nbsp;</P>
<P align=center><B><FONT face="Times New Roman" size=2>AMENDED AND RESTATED
JOINT VENTURE AGREEMENT</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>DATED AS OF JANUARY 31,
2003</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>BETWEEN</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>THE GLAD PRODUCTS COMPANY
AND ITS AFFILIATES IDENTIFIED HEREIN</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>AND</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>THE PROCTER &amp; GAMBLE
COMPANY AND ITS AFFILIATE IDENTIFIED HEREIN</FONT></B></P>
<P align=center><STRONG><FONT size=2 face="Times New Roman"></FONT></STRONG>&nbsp;</P>
<P align=center><STRONG><FONT size=2 face="Times New Roman"></FONT></STRONG>&nbsp;</P>
<P align=center><STRONG><FONT size=2 face="Times New Roman"></FONT></STRONG>&nbsp;</P>
<P align=center><STRONG><FONT size=2 face="Times New Roman"></FONT></STRONG>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST.</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>TABLE OF
CONTENTS</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"></TD>
    <TD noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>Page</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>ARTICLE
    I</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>DEFINITIONS</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 1.1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Defined Terms</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    1.2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Other
      Definitions</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>14</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 1.3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Other Definitional Provisions;
      Interpretation</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>16</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>ARTICLE
    II</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>CONTRIBUTIONS AND
      ALLOCATIONS OF INTEREST</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>16</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 2.1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Closing of Joint Venture</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>16</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    2.2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox
      Contribution and Related Matters</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>16</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 2.3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Contribution by P&amp;G and Related
      Matters</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>19</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    2.4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Nature of JV
      Interest</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>20</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 2.5</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Initial Allocations of Interest and Capital
      Accounts</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>20</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    2.6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Additional
      Capital Calls and Parent Loans</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>21</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 2.7</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>P&amp;G Option</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>23</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    2.8</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Rights with
      Respect to Capital</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>24</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 2.9</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Capital Accounts</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>24</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>ARTICLE
    III</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>ALLOCATIONS AND
      DISTRIBUTIONS</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>26</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 3.1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Allocation of Net Profits and Losses</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>26</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    3.2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Special
      Allocations</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>27</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 3.3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Section 704(c) Allocation</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>29</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    3.4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Distributions of
      Available Cash Flow</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>29</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 3.5</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Distributions of IP Related Amounts</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>32</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>ARTICLE
    IV</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>REPRESENTATIONS
      AND WARRANTIES</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>33</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 4.1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Representations and Warranties of all the
      Parties</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>33</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    4.2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Representations
      and Warranties of the Clorox Parties</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>34</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 4.3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Representations and Warranties of
    P&amp;G</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>39</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    4.4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Survival of
      Representations and Warranties</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>40</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%" colSpan=2><FONT face="Times New Roman" size=2>ARTICLE
    V</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>GOVERNANCE</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>40</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    5.1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Board of
      Managers</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>40</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 5.2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Meetings of the Board</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>42</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    5.3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>P&amp;G Veto
      Rights</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>44</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 5.4</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Business Plan, Budget and Reports to the
      Board</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>45</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>-i-</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>TABLE OF
CONTENTS</FONT></B> <FONT face="Times New Roman" size=2><BR>(continued)</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"></TD>
    <TD noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>Page</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    5.5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Additional Items
      for Board Approval</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>46</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%" colSpan=2><FONT face="Times New Roman" size=2>ARTICLE
    VI</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>TRANSFERS OF INTEREST; TERM AND
      TERMINATION</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>47</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    6.1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>General;
      Restrictions on Transfers</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>47</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 6.2</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Effect of Transfers on Distributions among JV
      Partners</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>47</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    6.3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Term of Joint
      Venture</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>48</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 6.4</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>P&amp;G Put Rights</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>48</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    6.5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Purchase
      of P&amp;G JV Interest</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>50</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 6.6</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Tag-Along Rights</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>52</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    6.7</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Drag Along
      Rights</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>52</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 6.8</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Services Termination Amount</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>53</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>ARTICLE
    VII</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>CERTAIN
      AGREEMENTS</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>54</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 7.1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Personnel; Provision of Services</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>54</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    7.2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Non-Competition</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>55</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 7.3</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Confidentiality; Non-Disclosure</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>56</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    7.4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Non-Solicitation</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>58</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 7.5</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Agreement to Cooperate; Further Assurances;
      Other Matters</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>59</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    7.6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Public
      Statements</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>60</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 7.7</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Conduct of Business</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>60</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    7.8</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>International
      Relationships</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>62</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 7.9</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Sublicenses of P&amp;G Intellectual
      Property</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>62</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>ARTICLE
      VIII</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>CONDITIONS
      PRECEDENT TO CLOSING</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>63</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section&nbsp;8.1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Conditions to Each Party&#146;s
Obligations</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>63</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    8.2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Conditions to the
      Closing Obligations of the Clorox Parties</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>63</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 8.3</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Conditions to the Closing Obligations of the
      P&amp;G Parties</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>64</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>ARTICLE
    IX</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>ACCOUNTING; TAX
      MATTERS</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>65</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 9.1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Accounting</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>65</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
    9.2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Tax
    Matters</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>66</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%" colSpan=2><FONT face="Times New Roman" size=2>ARTICLE
    X</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>INDEMNIFICATION</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>67</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
      10.1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Indemnification
      by Clorox Partners</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>67</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section 10.2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Indemnification by P&amp;G Partners</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>67</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>-ii-</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>TABLE OF
CONTENTS</FONT></B> <FONT face="Times New Roman" size=2><BR>(continued)</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="96%"></TD>
    <TD noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>Page</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
      10.3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Third-Party
      Claims</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>68</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section
      10.4</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Limitation on
      Losses and Expenses</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>69</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=3><FONT face="Times New Roman" size=2>ARTICLE XI</FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>MISCELLANEOUS</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>69</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section
      11.1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Amendments and
      Waivers</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>69</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
      11.2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Successors,
      Assigns and Transferees</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>69</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section
      11.3</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Notices</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>69</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
      11.4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Integration</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>70</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section
      11.5</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Severability</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>70</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
      11.6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Counterparts</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>71</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section
      11.7</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Governing
      Law</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>71</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
      11.8</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Arbitration</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>71</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section
      11.9</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Injunctive
      Relief</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>72</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
      11.10</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Expenses</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>72</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section
      11.11</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>No Third Party
      Beneficiaries</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>72</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Section
      11.12</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Guarantees by
      Clorox and P&amp;G</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>73</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Section
      11.13</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Effectiveness of
      Amendment and Restatement, Representations,</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="96%" bgColor=#ffffff><FONT face="Times New Roman" size=2>Warranties and
      Agreements</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff><FONT face="Times New Roman" size=2>74</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>-iii-</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>TABLE OF
CONTENTS</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="100%"></TD>
    <TD noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>Page</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>EXHIBITS</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Exhibit A</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>P&amp;G License Agreement
[SUPERSEDED]</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%">&nbsp;</TD>
    <TD noWrap align=right width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Exhibit B</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>P&amp;G Services Agreement
    [SUPERSEDED]</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%">&nbsp;</TD>
    <TD noWrap align=right width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Exhibit C</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Description of P&amp;G Equipment</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%">&nbsp;</TD>
    <TD noWrap align=right width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Exhibit D</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Preliminary Business Plan</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%">&nbsp;</TD>
    <TD noWrap align=right width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Exhibit E</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Preliminary Budget</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%">&nbsp;</TD>
    <TD noWrap align=right width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Exhibit F</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Clorox Services</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%">&nbsp;</TD>
    <TD noWrap align=right width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Exhibit G</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Terms of International Relationships</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%">&nbsp;</TD>
    <TD noWrap align=right width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Exhibit H</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>JV Accounting Principles</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%">&nbsp;</TD>
    <TD noWrap align=right width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Exhibit I</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Form of JV Sublicense Agreement</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%">&nbsp;</TD>
    <TD noWrap align=right width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Exhibit J</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Form of Amended Glad License
Agreement</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman"></FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>-iv-</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>AMENDED AND RESTATED
JOINT VENTURE AGREEMENT</FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Amended and Restated
Joint Venture Agreement (this &#147;</FONT><U><FONT face="Times New Roman" size=2>Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148;) is made as of
the 31st day of January, 2003 by and between The Glad Products Company, a
Delaware corporation, Glad Manufacturing Company, a Delaware corporation, Clorox
Services Company, a Delaware corporation, The Clorox Sales Company, a Delaware
corporation, Clorox International Company, a Delaware corporation (collectively
the &#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox
Parties</FONT></U><FONT face="Times New Roman" size=2>&#148;), and The Clorox
Company, a Delaware corporation (&#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox</FONT></U><FONT face="Times New Roman" size=2>&#148;), and The Procter
&amp; Gamble Company, an Ohio corporation (&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G</FONT></U><FONT face="Times New Roman" size=2>&#148;) and Procter &amp; Gamble RHD Inc., an Ohio corporation
(&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Sub</FONT></U><FONT face="Times New Roman" size=2>&#148; and collectively with P&amp;G, the
&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Parties</FONT></U><FONT face="Times New Roman" size=2>&#148;) (each, a &#147;</FONT><U><FONT face="Times New Roman" size=2>Party</FONT></U><FONT face="Times New Roman" size=2>&#148; and collectively, the &#147;</FONT><U><FONT face="Times New Roman" size=2>Parties</FONT></U><FONT face="Times New Roman" size=2>&#148;).</FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>BACKGROUND</FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, the Clorox Parties
currently operate the Glad Business (as defined below);</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, the P&amp;G Parties
have certain intellectual property and proprietary technologies that the P&amp;G
Parties and the Clorox Parties wish to use in the Glad Business;</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, the Clorox Parties
and the P&amp;G Parties desire that P&amp;G Sub acquire an undivided
participation interest in the Glad Business and participate in the management of
such business, as provided for herein;</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, the Clorox Parties
and the P&amp;G Parties have previously entered into a Joint Venture Agreement,
dated as of November 15, 2002 (the &#147;Original Date&#148;) with respect to the Glad
Business (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Original
Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148;);</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, the Clorox Parties
and the P&amp;G Parties wish to amend and restate in its entirety the Original
Agreement in accordance with the further provisions of this
Agreement;</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, the Parties intend
for their contractual relationship established by this Agreement with respect to
the Glad Business to be treated as a partnership for U.S. federal, state and
local income tax purposes; and</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, the Clorox Parties
and the P&amp;G Parties wish to set forth, and be bound by their mutual
agreement as to certain significant terms and conditions regarding the foregoing
and related matters;</FONT></P>


<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>NOW, THEREFORE, in
consideration of the mutual covenants and agreements set forth in this
Agreement, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Parties agree as
follows:</FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE I</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>DEFINITIONS</FONT></U><FONT face="Times New Roman" size=2></FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>For purposes of this
Agreement, the following terms have the meanings specified or referred to in
this Section 1:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 1.1</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Defined Terms</FONT></U><FONT face="Times New Roman" size=2>.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>As used in this
Agreement:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Adjustment Amount</FONT></U><FONT face="Times New Roman" size=2>&#148; means an amount equal to (a) ten percent (10%)
of the aggregate Capital Contributions made or deemed made by all JV Partners
after the Closing Date and on or prior to the closing of the exercise of the
P&amp;G Option, </FONT><U><FONT face="Times New Roman" size=2>minus
</FONT></U><FONT face="Times New Roman" size=2>(b) ten percent (10%) of the
aggregate distributions to the JV Partners with respect to distributions of
Available Cash Flow (other than distributions made under Section 3.4(c)(ii)
hereof) consisting of the net cash proceeds of any sale, transfer or other
disposition of any business or assets of the Glad Business outside the ordinary
course of business of the Glad Business after the Closing Date and on or prior
to the closing of the P&amp;G Option, <U>minus</U> (c) the aggregate
distributions under Section 3.4(c)(ii) and Section 3.5(b)(ii) made prior to the
closing of the P&amp;G Option (which for the avoidance of doubt will not include
any amounts included in the following clause (d)), </FONT><U><FONT face="Times New Roman" size=2>minus </FONT></U><FONT face="Times New Roman" size=2>(d) the cumulative amount of Distribution Shortfalls owed or previously
paid to the holder of the Class A JV Interest under Section 3.4(c)(v)
hereof.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Affiliate</FONT></U><FONT face="Times New Roman" size=2>&#148; means with respect to a specified Person, any Person that directly or
indirectly, through one or more intermediaries, controls, is controlled by, or
is under common control with, the specified Person. As used in this definition,
the term &#147;control&#148; means the possession, directly or indirectly, or as trustee
or executor, of the power to direct or cause the direction of the management and
policies of a Person, whether through ownership of voting securities, as trustee
or executor, by contract or credit arrangement or otherwise. For purposes of
clarification, the Parties agree that Henkel KGaA, an entity organized under the
laws of Germany, will not be deemed to be an Affiliate of any Clorox
Party.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Affiliate Loans</FONT></U><FONT face="Times New Roman" size=2>&#148; with respect to any International Licensee shall
have the meaning set forth in the JV Sublicense Agreement to which such
International Licensee is a party.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;Available Cash Flow&#148; means,
with respect to any Fiscal Quarter or other period, the sum of all cash receipts
during such Fiscal Quarter or other period attributed to the Joint Venture from
any and all sources other than the cash proceeds of any Indebtedness, plus all
Reserves as of the close of business on the last day of the preceding Fiscal
Quarter or other period, plus interest on such Reserves at Clorox&#146;s 30-day
commercial paper borrowing rate (or, if Clorox is unable to obtain commercial
paper, Clorox&#146;s short term cost of borrowing) minus all cash disbursements
attributed to the Joint Venture for any and all purposes during such Fiscal
Quarter or other period (including loan repayments (other than Parent Loans),
interest payments (other than in respect of Parent Loans), capital improvements
and replacements but excluding (x) disbursements funded by the cash proceeds of
any Indebtedness (other than Parent Loans)), (y) guaranteed payments made under
Section 3.5(a) and 3.5(b) for such Fiscal Quarter, and (z) a reasonable
allowance as of the last day of such Fiscal Quarter or other period for
Reserves, contingencies and anticipated obligations as determined by the Board,
determined in accordance with the JV Accounting Principles, minus distributions
made pursuant to Section 3.5 hereof for such Fiscal Quarter (other than the
guaranteed payments described in Sections 3.5(a) and 3.5(b) hereof).</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>2</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Business Day</FONT></U><FONT face="Times New Roman" size=2>&#148; means a day other than a Saturday, Sunday,
federal or New York holiday or other day on which commercial banks in New York,
New York are authorized or required by law to close.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Capital Call</FONT></U><FONT face="Times New Roman" size=2>&#148; means a call by the Board pursuant to Section
2.6 hereof to the JV Partners for additional contributions of capital to be
attributed to the Joint Venture.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Capital Contribution</FONT></U><FONT face="Times New Roman" size=2>&#148; means the total amount of cash and the [* * *]
fair market value </FONT><FONT face="Times New Roman" size=2>[* * *] of all of
the assets to be attributed to the Joint Venture as contributed by a JV Partner,
including the Clorox Contribution and the P&amp;G Contribution.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Carrying Value</FONT></U><FONT face="Times New Roman" size=2>&#148; means, with respect to any Property, the
Property&#146;s [* * *] except that the Carrying Value of all Properties may be
adjusted to equal their [* * *] in accordance with the [* * *] immediately prior
to: (i) the date of the acquisition of any additional interest in the Joint
Venture by any new or existing JV Partner in exchange for more than a de minimis
capital contribution; or (ii) the date of the distribution of more than a de
minimis amount of Property (other than a pro rata distribution) to a JV Partner.
The Carrying Value of any Property distributed to any JV Partner will be
adjusted immediately prior to such distribution to equal its fair market value.
The Carrying Value of any Property contributed by any JV Partner will be
adjusted immediately prior to such contribution to equal its fair market value.
In the case of any asset that has a Carrying Value that differs from its [* * *]
Carrying Value will be adjusted by the amount of depreciation calculated for
purposes of the definition of &#147;Net Profits and Net Loss&#148; rather than the amount
of depreciation calculated for [* * *]. For purposes of clarification, Clorox
and P&amp;G have agreed on the initial contributions and the [* * *] as
reflected in the initial Capital Accounts.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Change of Control</FONT></U><FONT face="Times New Roman" size=2>&#148; of any Person (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Relevant Person</FONT></U><FONT face="Times New Roman" size=2>&#148;) means the occurrence of either (i) the
acquisition by any Person or group of Persons acting in concert (other than a JV
Partner or its Affiliates) of direct or indirect (through the ownership of a
majority of the voting power of a parent corporation of otherwise) beneficial
ownership (as defined under Section 13(d) of the Securities and Exchange Act of
1934, as amended) of securities of the Relevant Person such that following such
acquisition such Person or group of Persons acting in concert beneficially own a
majority of the voting power of all outstanding voting securities of such
Relevant Person or (ii) any merger, consolidation or share exchange of the
Relevant Person with or into any other Person, unless the equity holders of the
Relevant Person immediately prior to any such transaction are holders of a
majority of the voting power of the surviving entity or its parent company
immediately thereafter.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Class A Interest</FONT></U><FONT face="Times New Roman" size=2>&#148; means the undivided Class A participation
interest in the Joint Venture, which shall entitle the JV Partner holding such
Class A interest to receive allocations and distributions from time to time as
provided in this Agreement.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Class A Royalty Amount</FONT></U><FONT face="Times New Roman" size=2>&#148; means, with respect to any Fiscal Quarter,
royalty payments attributable to the Joint Venture received under the Glad
License Agreements in an amount equal to [* * *] percent ([* * *]%) of the
aggregate Distributable Local Cash Flow for the International Licensees for such
Fiscal Quarter, less Deemed Withholding Taxes on such royalty
payments.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>3</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Class B Interest</FONT></U><FONT face="Times New Roman" size=2>&#148; means the undivided Class B participation
interest in the Joint Venture, which shall entitle the JV Partner holding such
Class B interest to receive allocations and distributions from time to time as
provided in this Agreement.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Class C Interest</FONT></U><FONT face="Times New Roman" size=2>&#148; means the undivided Class C participation
interest in the Joint Venture, which shall entitle the JV Partner holding such
Class C interest to receive allocations and distributions from time to time as
provided in this Agreement.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox Disclosure Schedule</FONT></U><FONT face="Times New Roman" size=2>&#148; means a schedule dated as of the Original Date
delivered by Clorox to P&amp;G, which identifies exceptions and other matters
with respect to the representations and warranties of the Clorox Parties
contained in Sections 4.1 and 4.2.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox Partners</FONT></U><FONT face="Times New Roman" size=2>&#148; means the Clorox Parties and any Permitted
Transferees of any Clorox Parties that have been Transferred all or any part of
the JV Interest held by such Clorox Parties.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Code</FONT></U><FONT face="Times New Roman" size=2>&#148; means the Internal Revenue Code of 1986, as amended (or any
corresponding provision or provisions of any succeeding law).</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Contribution Allocation Statement</FONT></U><FONT face="Times New Roman" size=2>&#148; means the allocation of the Clorox Contribution
among the Clorox Parties to be prepared by Clorox in good faith.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Deemed Withholding Taxes</FONT></U><FONT face="Times New Roman" size=2>&#148; means an amount of withholding taxes deemed to
have been imposed under the definition of &#147;Class A Royalty Amount.&#148; The amount
of withholding taxes deemed to have been imposed will be determined based on the
aggregate amount of withholding taxes that would have been imposed on payments
made under the Glad License Agreements had royalty payments in an aggregate
amount equal to the Class A Royalty Amount been paid in such Fiscal Quarter by
the International Licensees pro rata in accordance with the total royalty
payments actually made by the International Licensees under the Glad License
Agreements for such Fiscal Quarter.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Distributable Cash Flow</FONT></U><FONT face="Times New Roman" size=2>&#148; means, with respect to any Fiscal Quarter or
other period, Available Cash Flow for such Fiscal Quarter or other Period minus
any payments required to be made pursuant to Section 3.4(d) hereof.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Distributable Local Cash Flow</FONT></U><FONT face="Times New Roman" size=2>&#148; for any International Licensee has the meaning
set forth in the JV Sublicense Agreement to which such International Licensee is
a party.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Environmental Laws</FONT></U><FONT face="Times New Roman" size=2>&#148; means any and all laws, rules, orders,
regulations, statutes, ordinances, guidelines, codes, decrees, or other legally
enforceable requirement (including common law) of any foreign government, the
United States, or any state, local, municipal or other Governmental Authority,
regulating, relating to or imposing liability or standards of conduct concerning
protection of the environment or of human health, or employee health and
safety.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Exclusive Field</FONT></U><FONT face="Times New Roman" size=2>&#148; means the [* * *] of bags, wraps, straws and
covered containers primarily [* * *].</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>4</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Fair Market Value</FONT></U><FONT face="Times New Roman" size=2>&#148; means, except to the extent otherwise expressly
provided herein:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(i) with respect to a Party&#146;s
Ordinary JV Interest, &#147;Fair Market Value&#148; will be calculated as the product of
(x) the Ordinary JV Interest held by such Party and (y) &#147;Fair Market Value&#148; for
all outstanding Ordinary JV Interests as if all Ordinary JV Interests were to be
sold to a single buyer who would acquire sole control over the business and
affairs of the Glad Business. &#147;Fair Market Value&#148; for all outstanding Ordinary
JV Interests will be determined by agreement of the Parties or, if the Parties
are unable to so agree within [* * *] through good faith negotiation, then the
Parties will agree upon [* * *] to determine such valuation, provided that if
the Parties are unable to so agree [* * *]. Notwithstanding the foregoing, to
the extent &#147;Fair Market Value&#148; is being determined for purposes of Section 6.6
or 6.7 hereof, &#147;Fair Market Value&#148; for purposes of the foregoing clause (y) will
be determined by reference to the [* * *] as applicable. For example, [* * *].
If, in either of the examples provided in the two immediately preceding
sentences, there were $[* * *] outstanding, the Fair Market Value of all
outstanding Ordinary JV Interests would have equaled $[* * *] rather than $[* *
*] (i.e. the value of all of the Ordinary JV Interests would equal the value of
the[* * *]). The [* * *] in any such transaction will include the [* * *] are
not attributable to the Joint Venture. The intent of the immediately preceding
four sentences is to make it clear that Fair Market Value under those
circumstances will be derived solely from the [* * *].</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii) with respect to a Glad
Local Business, &#147;Fair Market Value&#148; will be equal to [* * *]. &#147;Fair Market
Value&#148; of the Glad Local Business will be determined by agreement of the Parties
or, if the Parties are unable to so agree within [* * *] through good faith
negotiation, then the [* * *] will determine such valuation. Notwithstanding the
foregoing, to the extent &#147;Fair Market Value&#148; is being determined [* * *] &#147;Fair
Market Value&#148; will be determined by reference to the [* * *]. For example, if [*
* *]. If, in the example provided in the immediately preceding sentence, there
were $[* * *] of Affiliate Loans outstanding, the Fair Market Value of all
outstanding Ordinary JV Interests would have equaled $[* * *] rather than $[* *
*] (i.e. the value would equal the value of [* * *]). The [* * *] in any such
transaction will include the [* * *]. The intent of the immediately preceding
three sentences is to make it clear that Fair Market Value under those
circumstances will be derived solely from [* </FONT><FONT face="Times New Roman" size=2>* *]. In the event of any transaction involving the [* * *], to the
extent the P&amp;G Partners believe in good faith that the [* * *] in such
transaction [* * *] represents, the Parties will negotiate in good faith to
agree upon the appropriate allocation and, if the Parties are unable to so agree
within [* * *] through good faith negotiation, then the [* * *] will determine
such allocation;</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii) with respect to each of
the Class A Interest and the Class C Interest, individually, &#147;Fair Market Value&#148;
will be deemed to be an amount equal to [* * *] of the aggregate Fair Market
Value of the [* * *];</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv) with respect to the
P&amp;G Option, (A) during the Option Exercise Period, if the P&amp;G Option is
not yet exercised, the greater of [* * *] with respect to the Ordinary JV
Interest and [* * *] the then-applicable Option Price; and (B) after the Option
Exercise Period, </FONT><FONT face="Times New Roman" size=2>[* * *];
and</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>5</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(v) in the event &#147;Fair Market
Value&#148; is being determined in connection with a Clorox Change of Control, the [*
* *] will determine the Fair Market Values of the Ordinary JV Interests held by
the Clorox Partners (taking into account the existence of the P&amp;G Option if
such option has not been previously exercised or terminated) and the Glad Local
Businesses [* </FONT><FONT face="Times New Roman" size=2>* *]. Once the [* * *]
has determined the Fair Market Values of the Ordinary JV Interests held by the
Clorox Partners and the Glad Local Businesses, it will then determine the &#147;Fair
Market Values&#148; of [* * *]. For example, assuming the P&amp;G Option has been
exercised, if a third party buyer acquires [* * *]. If, in the example provided
in the immediately preceding sentence, there were [* * *] the Ordinary JV
Interests would have equaled [* * *] (i.e. the value of all of the Ordinary JV
Interests would equal [* * *] the Glad Local Businesses would have equaled $[* *
*]. The [* * *]. This determination in connection with a Clorox Change of
Control will be made by the [* * *] based on the [* * *], and for avoidance of
doubt it is expected in determining such relative values that [* * *] as the
case may be). The [* * *] will be directed to determine Fair Market Value based
on [* * *].</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>With respect to any
determination of &#147;Fair Market Value&#148; hereunder, the [* * *] by the Clorox
Partners (collectively), and each of the Clorox Partners (collectively) and the
P&amp;G Partners (collectively) will have the right to make a presentation with
respect to the calculation of Fair Market Value to the [* * *] making the
determination.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Field</FONT></U><FONT face="Times New Roman" size=2>&#148; means, collectively, the Exclusive Field and the Non-Exclusive
Field.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Fiscal Quarter</FONT></U><FONT face="Times New Roman" size=2>&#148; means each three (3) calendar month period
ending on March 31, June 30, September 30 and December 31, or in the case of the
first Fiscal Quarter of the Joint Venture, the period from the Closing Date
through March 31, 2003.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Fiscal Year</FONT></U><FONT face="Times New Roman" size=2>&#148; means (i) each 12-month period ending on June 30, or in the case of the
first Fiscal Year of the Joint Venture, the period from the Closing Date through
June 30, 2003, or (ii) if after the date of this Agreement the taxable year is
required by the Code to be a period other than the period described in clause
(i), then each 12-month period that is the taxable year of the Joint Venture
determined in accordance with the requirements of the Code; (iii) the period
from the day after the end of the most recently ended Fiscal Year until the date
the Term ends, and (iv) for purposes of making allocations of Net Profits and
Net Loss, Fiscal Year means any portion of a taxable year of the Joint Venture
to the extent required to comply with Section 706 of the Code.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>GAAP</FONT></U><FONT face="Times New Roman" size=2>&#148; means generally accepted accounting principles as in effect in the
United States (or such other jurisdiction as may be specified herein)
consistently applied.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>General Technology</FONT></U><FONT face="Times New Roman" size=2>&#148; means any technology of general utility not
specific [* * *], including but not limited to technology that can be used [* *
*] and/or [* * *] or [* * *] or [* * *]. Any technology that is not General
Technology is Specific Technology.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Balance Sheet</FONT></U><FONT face="Times New Roman" size=2>&#148; means the balance sheet of the Glad Business as
of June 30, 2002, attached to Section 1.1 to the Clorox Disclosure
Schedule.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>6</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Business</FONT></U><FONT face="Times New Roman" size=2>&#148; means the business conducted by Clorox and its
Subsidiaries within the Field and any other business that the Board determines
to enter into without violating Section 5.3(a), including any expansion of such
business into a New Country that is structured in the manner set forth in
Section 7.8(b) hereof, provided that such business will not include (i) any
business, operations, properties, assets or Liabilities of the Glad Licensed
Business or (ii) any equity interest in any Subsidiary of Clorox conducting the
Glad Licensed Business.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Existing International
Business</FONT></U><FONT face="Times New Roman" size=2>&#148; means the business in
the Field conducted by Clorox and its Subsidiaries in Canada, Australia, New
Zealand, the People&#146;s Republic of China, the Philippines, Hong Kong, Costa Rica,
South Korea and South Africa.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Financial Statements</FONT></U><FONT face="Times New Roman" size=2>&#148; means the Glad Balance Sheet and the related
statements of earnings and cash flows of the Glad Business previously delivered
to P&amp;G.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Global Business</FONT></U><FONT face="Times New Roman" size=2>&#148; means the Glad Business and the Glad Licensed
Business as conducted during the Term.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad License Agreements</FONT></U><FONT face="Times New Roman" size=2>&#148; means the license agreements between The Glad
Products Company and each of the International Licensees, entered into as of the
Closing Date substantially in the form set forth on </FONT><U><FONT face="Times New Roman" size=2>Exhibit J</FONT></U><FONT face="Times New Roman" size=2> hereto, which license agreements provide for a royalty payment calculated
based on the net sales of such International Licensee, and such other comparable
new or amended license agreements that may be entered into during the Term with
respect to intellectual property of Clorox Affiliates for the Glad Business,
which license agreements are between The Glad Products Company (or another
Affiliate on behalf of Clorox) and an International Licensee with respect to New
Countries in connection with an expansion structured in the manner set forth in
Section 7.8(a).</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad License Termination Amount</FONT></U><FONT face="Times New Roman" size=2>&#148; means, under any Glad License Agreement, an
amount equal to [* * *] percent ([* * *]%) of the Fair Market Value of the Glad
Local Business for the Territory (as defined in such Glad License
Agreement).</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Licensed Business</FONT></U><FONT face="Times New Roman" size=2>&#148; means (x) the Glad Existing International
Business and (y) any expansion of the business conducted by Clorox and its
Subsidiaries in the Field into a New Country that is structured in the manner
set forth in Section 7.8(a) hereof.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Local Business</FONT></U><FONT face="Times New Roman" size=2>&#148;, with respect to any International Licensee,
shall have the meaning set forth in the JV Sublicense Agreement to which such
International Licensee is a party.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Parties</FONT></U><FONT face="Times New Roman" size=2>&#148; means, collectively, the Clorox Parties and the
International Licensees and &#147;Glad Party&#148; means any one such Person.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Governmental Authority</FONT></U><FONT face="Times New Roman" size=2>&#148; means any nation or government, any state or
other political subdivision thereof, and any entity exercising executive,
legislative, judicial, regulatory or administrative functions of or pertaining
to government.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>7</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Improvements</FONT></U><FONT face="Times New Roman" size=2>&#148; means any and all Intellectual Property rights
in and to any update, modification, customization, translation, upgrade,
improvement, enhancement and/or derivative work.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Indebtedness</FONT></U><FONT face="Times New Roman" size=2>&#148; means all obligations for borrowed money,
including guarantees, and all reimbursement obligations in respect of
outstanding letters of credit (measured assuming such letters of credit are
drawn in full).</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>[* * *] shall have the meaning
set forth in the definition of [* * *].</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Industrial Packaging</FONT></U><FONT face="Times New Roman" size=2>&#148; means [* * *] used as packaging for products,
which packaging is (i) [* * *], (ii) sold to [* * *] for their use as the
packaging for their products, and (iii) [* </FONT><FONT face="Times New Roman" size=2>* *]. For the avoidance of doubt, Industrial Packaging shall exclude any
[* * *] and used as packaging [* * *], and which packaging is (A) [* * *] and
(B) sold to [* * *] for their use as the packaging for their
products.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Infringe</FONT></U><FONT face="Times New Roman" size=2>&#148; means to infringe, misappropriate, dilute, impair or otherwise
violate.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Institutional Channel</FONT></U><FONT face="Times New Roman" size=2>&#148; means sales of products to commercial,
educational and/or governmental institutions and organizations including,
without limitation, hospitals, restaurants, janitorial service providers,
universities, schools, hotels and caterers (collectively, &#147;</FONT><U><FONT face="Times New Roman" size=2>Institutions</FONT></U><FONT face="Times New Roman" size=2>&#148;), as well as sales of products to [* *
*].</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Intellectual Property</FONT></U><FONT face="Times New Roman" size=2>&#148; means any and all intellectual property,
including, without limitation, patents, copyrights, trademarks, service marks,
trade names, software, trade secrets, technology, inventions, specifications,
know-how, processes, formulae, product descriptions and specifications and other
technical or proprietary information, and all registrations and applications
therefor.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>International Acquisition</FONT></U><FONT face="Times New Roman" size=2>&#148; means, with respect to any International
Licensee, the sale, disposition or other transfer to a Third Party of all or
substantially all of the equity interests of such International Licensee or of
all or substantially all the business, assets and properties of such
International Licensee used in the Glad Local Business of such International
Licensee, but excluding any transaction in which the JV Interests of the P&amp;G
Partners are purchased pursuant to the provisions of Sections 6.4, 6.5, 6.6 or
6.7.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>International Licensee</FONT></U><FONT face="Times New Roman" size=2>&#148; means each of Clorox Australia Pty. Ltd., The
Clorox Company of Canada Ltd., Clorox de Centro America, S.A., Clorox China
(Guangzhou) Ltd., Clorox Hong Kong Limited, Clorox New Zealand Limited, Clorox
International Philippines, Inc., Clorox Africa (Pty) Ltd. and Clorox Korea
Limited and any other Person that becomes a party to a JV Sublicense Agreement
as a licensee thereunder.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>IP Acquisition</FONT></U><FONT face="Times New Roman" size=2>&#148; means, in connection with an International
Acquisition, a grant of a [* </FONT><FONT face="Times New Roman" size=2>* *] the
Related Local Intellectual Property (or other disposition of all substantial
rights to all such Related Local Intellectual Property) of the applicable
International Licensee, which license is granted to a Third Party licensee on
behalf of the Joint Venture in exchange for a [* * *] to the Joint Venture from
the new licensee of such Related Local Intellectual Property.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>8</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>IP Allocation Amount</FONT></U><FONT face="Times New Roman" size=2>&#148; means, in the case of any International
Acquisition in which there is an IP Acquisition, an amount equal to [* * *]
percent ([* * *]%) of the Fair Market Value of the relevant Glad Local
Business.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>IP Acquisition Price</FONT></U><FONT face="Times New Roman" size=2>&#148; means, in the case of any International
Acquisition in which there is a related IP Acquisition, the amount paid to
acquire the license of or rights to the Related Local Intellectual Property by
the new licensee of such Related Local Intellectual Property.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Joint Venture</FONT></U><FONT face="Times New Roman" size=2>&#148; means the contractual relationship between the
JV Partners created by this Agreement, which will be treated as a partnership
for U.S. federal, state and local income tax purposes, and will include all
interests attributed to such Joint Venture in accordance with the terms of this
Agreement with respect to any business, asset, right, property or Liability,
including without limitation the Clorox Contribution and the P&amp;G
Contribution.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>JV Interest</FONT></U><FONT face="Times New Roman" size=2>&#148; means an Ordinary JV Interest, Class A Interest, Class B Interest or
Class C Interest.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>JV Sublicense Agreements</FONT></U><FONT face="Times New Roman" size=2>&#148; means (i) the sublicense agreements to be dated
and executed as of the Closing Date in the form attached hereto as Exhibit I
between The Glad Products Company and each International Licensee, providing for
the sublicense to the International Licensee of certain Intellectual Property
rights licensed under the P&amp;G License Agreement, pursuant to the terms
thereof, and (ii) such other license agreements which may be entered into on
behalf of the Joint Venture during the Term with respect to New Countries
pursuant to Section 7.8(a).</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>JV Sublicense Termination Amount</FONT></U><FONT face="Times New Roman" size=2>&#148; means, under any JV Sublicense Agreement, an
amount equal to [* * *] percent ([* * *]%) of the Fair Market Value of the Glad
Local Business to which such JV Sublicense Agreement relates.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>JV Partners</FONT></U><FONT face="Times New Roman" size=2>&#148; means any Person that holds a JV Interest in accordance with the terms
of this Agreement. As of the Closing Date, the JV Partners will consist of each
of the Clorox Parties and P&amp;G Sub.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Know How</FONT></U><FONT face="Times New Roman" size=2>&#148; means any and all proprietary information, knowledge or expertise known
to P&amp;G [* * *]; and may include, without limitation, any know how,
copyrights, software, trade secrets, technology, inventions, specifications,
processes, formulae, product descriptions and specifications and other technical
or proprietary information, if any, owned or held by P&amp;G </FONT><FONT face="Times New Roman" size=2>[* * *] (as defined in the P&amp;G License
Agreement).</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Liabilities</FONT></U><FONT face="Times New Roman" size=2>&#148; means, as to any Person, all debts, liabilities and obligations,
direct, indirect, absolute or contingent of such Person, whether accrued, vested
or otherwise, whether known or unknown and whether or not actually reflected, or
required by GAAP to be reflected, in such Person&#146;s balance sheet.</FONT></P>

<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>9</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Knowledge</FONT></U><FONT face="Times New Roman" size=2>&#148; or &#147;</FONT><U><FONT face="Times New Roman" size=2>knowledge</FONT></U><FONT face="Times New Roman" size=2>&#148; of a Party
means to the actual knowledge after reasonable inquiry (i) of those employees of
such Party and its Affiliates who prior to the execution of the Original
Agreement participated in the preparation or negotiation of the Original
Agreement or </FONT><FONT face="Times New Roman" size=2>any of the Related Agreements
or the due diligence investigations relating to the PWC Report or the
transactions contemplated by the Original Agreement and the Related Agreements
or (ii) of those employees of such Party and its Affiliates who have been
consulted prior to the execution of the Original Agreement by the employees
specified in clause (i) with respect to the Original Agreement or any of the
Related Agreements or any of the transactions contemplated hereby or
thereby.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Liens</FONT></U><FONT face="Times New Roman" size=2>&#148; means any adverse claims, liens, security interests, charges, leases,
licenses or sublicenses and other encumbrances of any kind and
nature.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Material Adverse Effect</FONT></U><FONT face="Times New Roman" size=2>&#148; means (i) with respect to the Clorox Parties, a
material adverse effect upon the business, properties, financial condition or
results of operations of the Glad Business and the Glad Existing International
Business, taken as a whole (provided that for avoidance of doubt the Parties
acknowledge that it is not a precondition that an adverse effect impact more
than one country or market before it is possible for this standard to be
satisfied) or on the ability of the Clorox Parties to perform their obligations
under this Agreement or any of the Related Agreements and (ii) with respect to
the P&amp;G Parties, a material adverse effect on the ability of the P&amp;G
Parties to perform their obligations under this Agreement or any of the Related
Agreements.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Materials of Environmental Concern</FONT></U><FONT face="Times New Roman" size=2>&#148; means any gasoline or petroleum (including crude
oil or any fraction thereof) or petroleum products, polychlorinated biphenyls,
urea-formaldehyde insulation, asbestos, pollutants, contaminants, radioactivity,
and any other substances of any kind, whether or not any such substance is
defined as hazardous or toxic under any Environmental Law, that is regulated
pursuant to or could give rise to liability under any Environmental
Law.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Net Income (Loss)</FONT></U><FONT face="Times New Roman" size=2>&#148; means, for any period, the net income (loss)
attributed to the Joint Venture in accordance with the JV Accounting Principles,
excluding (a) any gains or loss resulting from the sale or other disposition of
any property, plant or equipment attributed to the Joint Venture which is not
sold or otherwise disposed of in the ordinary course of business; (b) any gains
or loss resulting from the sale or other disposition of any equity interest in
any Person; (c) any extraordinary gain or loss; (d) any one-time charges or
expenses associated with the acquisition of any business or Person; and (e) any
cumulative effect of a change in accounting principles.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Net Profits</FONT></U><FONT face="Times New Roman" size=2>&#148; and &#147;</FONT><U><FONT face="Times New Roman" size=2>Net
Loss</FONT></U><FONT face="Times New Roman" size=2>&#148; mean, for each Fiscal Year
or other period, an amount equal to the taxable income or loss attributed to the
Joint Venture for such year or period, determined in accordance with Code
Section 703(a) (for this purpose, all items of income, gain, loss or deduction
required to be stated separately pursuant to Code Section 703(a)(1) will be
included in taxable income or loss) and with the accounting method used by the
Joint Venture for federal income tax purposes, with the following
adjustments:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(i) any income attributed to
the Joint Venture that is exempt from U.S. federal income tax and not otherwise
taken into account in computing Net Profits or Net Loss will be added to such
taxable income or loss;</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>10</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii) any expenditures
attributed to the Joint Venture described in Code Section 705(a)(2)(B) or
treated as Code Section 705(a)(2)(B) expenditures pursuant to Treasury
Regulation Section 1.704-1(b)(2)(iv)(i) and not otherwise taken into account in
computing Net Profits or Net Loss will be subtracted from such taxable income or
loss;</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii) if the Carrying Value of
any Property differs from its adjusted tax basis for federal income tax
purposes, any gain or loss resulting from a disposition of such asset will be
calculated with reference to such Carrying Value;</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv) upon an adjustment to the
Carrying Value of any Property (other than an adjustment in respect of
depreciation) pursuant to the definition of Carrying Value, the amount of the
adjustment will be included as gain or loss in computing such taxable income or
loss;</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(v) if the Carrying Value of
any Property differs from its adjusted tax basis for federal income tax purposes
the amount of depreciation, amortization or cost recovery deductions with
respect to such Property will for purposes of determining Net Profits and Net
Loss be an amount which bears the same ratio to such Carrying Value as the
federal income tax depreciation, amortization or other cost recovery deductions
bears to such adjusted tax basis;</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(vi) notwithstanding any other
provision of this definition, any items of income, gain, loss or deduction that
are specially allocated pursuant to Section 3.2 will not be taken into account
in computing Net Profits or Net Loss.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Non-Exclusive Field</FONT></U><FONT face="Times New Roman" size=2>&#148; means (i) [* * *] outside of the Exclusive Field
of [* * *] products of the Glad Global Business in the Exclusive Field as of the
Closing Date, including [* </FONT><FONT face="Times New Roman" size=2>* *] of
the Glad Global Business and/or the [* * *] and (ii) [* * *] branded with a Glad
Global Business trademark sold to [* * *] Glad Global Business products [* *
*].</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Ordinary JV Interest</FONT></U><FONT face="Times New Roman" size=2>&#148; means, with respect to any JV Partner, its
undivided participation interest in the Joint Venture (other than any
participation interest represented by the Class A Interest, Class B Interest or
Class C Interest, as applicable). The Ordinary JV Interest of each JV Partner
will be expressed as a percentage of the aggregate Ordinary JV Interests of all
JV Partners. The Ordinary JV Interests of the JV Partners may be adjusted from
time to time as provided in this Agreement. The initial Ordinary JV Interest of
each JV Partner as of the Closing will be as set forth in Section 2.5
hereof.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Disclosure Schedule</FONT></U><FONT face="Times New Roman" size=2>&#148; means a schedule dated as of the Original Date
delivered by P&amp;G to Clorox, which identifies exceptions and other matters
with respect to the representations and warranties of the P&amp;G Parties
contained in Sections 4.1 and 4.3.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Equipment</FONT></U><FONT face="Times New Roman" size=2>&#148; means the equipment described on </FONT><U><FONT face="Times New Roman" size=2>Exhibit C</FONT></U> <FONT face="Times New Roman" size=2>hereto.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Equipment Transfer
Documents</FONT></U><FONT face="Times New Roman" size=2>&#148; means such instruments
of transfer, with appropriate instruments of title, in form and substance
reasonably satisfactory to Clorox, to effectively transfer the P&amp;G Equipment
as provided in Section 2.3 hereof.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>11</FONT></P>
<HR align=center width="100%" noShade size="2">
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G License Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148; means the Intellectual Property License
Agreement to be dated and executed as of the Closing Date in the form attached
hereto as </FONT><U><FONT face="Times New Roman" size=2>Exhibit
A</FONT></U><FONT face="Times New Roman" size=2>, providing for the license of
certain Intellectual Property by P&amp;G Sub. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Partners</FONT></U><FONT face="Times New Roman" size=2>&#148; means P&amp;G Sub and any Permitted Transferee
of P&amp;G Sub that has been Transferred all or any part of the JV Interest held
by P&amp;G. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Services Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148; means the Product Development and Services
Agreement to be dated and executed as of the Closing Date in the form attached
hereto as </FONT><U><FONT face="Times New Roman" size=2>Exhibit
B</FONT></U><FONT face="Times New Roman" size=2>, providing for certain services
to be provided by P&amp;G. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Permitted Liens</FONT></U><FONT face="Times New Roman" size=2>&#148; means (i) Liens for Taxes that (x) are not yet
due or delinquent or (y) are being contested in good faith by appropriate
proceedings; (ii) statutory Liens or landlords&#146;, carriers&#146;, warehousemen&#146;s,
mechanics&#146;, suppliers&#146;, materialmen&#146;s, repairmen&#146;s or other like Liens arising
in the ordinary course of business; (iii) Liens incurred or deposits made in
connection with workers&#146; compensation, unemployment insurance and other types of
social security or similar benefits; (iv) Liens incurred or deposits made to
secure the performance of tenders, bids, leases, statutory obligations, surety
and appeal bonds, government contracts, performance bonds and other obligations
of like nature; (v) as to any real property leases with respect to which the
relevant entity is a lessee, any Lien effecting the interest of the landlord
thereunder and (vi) Liens the existence of which do not and will not have,
individually or in the aggregate, a Material Adverse Effect. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Permitted Transfer</FONT></U><FONT face="Times New Roman" size=2>&#148; means a Transfer of all or part of any JV
Interest to a Permitted Transferee. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Permitted Transferee</FONT></U><FONT face="Times New Roman" size=2>&#148; means: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(i) in the case of the Clorox
Parties and any Permitted Transferee of any Clorox Party: (A) Clorox, (B) any
Subsidiary of Clorox, (C) any Person that, together with its Affiliates, has
acquired all or substantially all of the Glad Global Business from the Clorox
Parties or their Permitted Transferees, and (D) any other Person to the extent
P&amp;G has given its prior written consent to such Transfer; and </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii) in the case of P&amp;G
Sub and any Permitted Transferee of P&amp;G Sub, (A) P&amp;G, (B) any Subsidiary
of P&amp;G and (C) any other Person to the extent Clorox has given its prior
written consent to such Transfer. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Person</FONT></U><FONT face="Times New Roman" size=2>&#148; means any individual, corporation, limited liability company,
partnership, trust, joint stock company, business trust, unincorporated
association, joint venture or other form of business or legal entity or
Governmental Authority. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Prime Rate</FONT></U><FONT face="Times New Roman" size=2>&#148; means the rate of interest per annum publicly announced from time to
time by Citibank, N.A. as its prime rate in effect at its principal office in
New York, New York; each change in the Prime Rate will be effective from and
including the date such change is publicly announced as being effective.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>12</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Property</FONT></U><FONT face="Times New Roman" size=2>&#148; means the assets attributed to the Joint Venture, both tangible and
intangible. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>PWC Report</FONT></U><FONT face="Times New Roman" size=2>&#148; means the report of PriceWaterhouse Coopers dated October 4, 2002 with
respect to the Glad Business and the Glad Existing International Business
previously provided by Clorox to P&amp;G. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Raw Material Technology</FONT></U><FONT face="Times New Roman" size=2>&#148; means technology used in the production of [* *
*] that can be used in the production of products [* * *]. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Regulations</FONT></U><FONT face="Times New Roman" size=2>&#148; means the federal income tax regulations promulgated by the Treasury
Department under the Code, as such regulations may be amended from time to time.
All references herein to a specific section of the Regulations will be deemed
also to refer to any corresponding provisions of succeeding Regulations.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Related Agreements</FONT></U><FONT face="Times New Roman" size=2>&#148; means, collectively, (i) the P&amp;G License
Agreement, (ii) the P&amp;G Services Agreement, (iii) the P&amp;G Equipment
Transfer Documents, (iv) the JV Sublicense Agreements and (v) the Glad License
Agreements. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Related Local Intellectual
Property</FONT></U><FONT face="Times New Roman" size=2>&#148; means, for any
International Licensee, the Intellectual Property licensed to such International
Licensee under the applicable Glad License Agreement and JV Sublicense
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Reserves</FONT></U><FONT face="Times New Roman" size=2>&#148; means cash funds set aside from Capital Contributions or gross cash
revenues as reserves. Such &#147;Reserves&#148; will be maintained in amounts and upon
such timing as is reasonably deemed necessary by the Board to finance any
working capital requirements and/or to pay taxes, insurance, debt service,
repairs, replacements, renewals, capital expenditures or other costs or expenses
to be attributed to the Joint Venture in accordance with the JV Accounting
Principles in the four Fiscal Quarters following the date such Reserves are
being established that will not be funded from Available Cash Flow based on the
then-current financial forecasts of the Joint Venture. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Significant Contracts</FONT></U><FONT face="Times New Roman" size=2>&#148; means any contract that would be required to be
submitted to the board of directors of Clorox in accordance with the policies of
Clorox for authorization and approval of contracts to which Clorox or its
Subsidiaries are a party as such policies are in effect as of the Original Date.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Specific Technology</FONT></U><FONT face="Times New Roman" size=2>&#148; means any technology (as it may be modified with
[* * *] for specific application [* * *]) that has specific application [* * *],
including but not limited to technology that has a [* * *] or otherwise is of
specific utility [* * *]. Any technology that is not Specific Technology is
General Technology. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Subsidiary</FONT></U><FONT face="Times New Roman" size=2>&#148; of any Person means any corporation, partnership, limited liability
company, joint venture or other legal entity of which such Person (either alone
or through or together with any other Subsidiary) owns or has the right to
acquire, directly or indirectly, 50% or more of the stock or other equity
interests the holder of which is generally entitled to vote for the election of
the board of directors or other governing body of such corporation or other
legal entity. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>13</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Taxes</FONT></U><FONT face="Times New Roman" size=2>&#148; means all forms of taxation, duties, levies and imposts, whether of the
United States or elsewhere including income, chargeable gains, alternative or
add-on minimum, gross receipts, sales, use, ad valorem, value added, franchise,
capital, paid-up capital, profits, greenmail, license, environmental (including
taxes under Section 59A of the Internal Revenue Code of 1986, as amended),
withholding, payroll, employment, excise, severance, stamp, occupation, premium,
real or personal property, windfall profit, custom, duty or other tax,
(including national insurance contributions) together with any interest or any
penalty or addition to tax. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Third Party</FONT></U><FONT face="Times New Roman" size=2>&#148; means a Person other than the Clorox Parties, the P&amp;G Parties or
their respective Affiliates. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Transfer</FONT></U><FONT face="Times New Roman" size=2>&#148; means to transfer, sell, hypothecate, encumber or assign, directly or
indirectly, provided that a Change of Control of Clorox will not be considered a
Transfer of any JV Interest held by any Clorox Partner for purposes hereof, and
a Change of Control of P&amp;G will not be considered a Transfer of any JV
Interest held by any P&amp;G Partner for purposes hereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 1.2</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Other
Definitions</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The following terms are
defined in the Sections indicated: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><B><FONT face="Times New Roman" size=2>Term</FONT></B></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="50%"><B><FONT face="Times New Roman" size=2>Section</FONT></B></TD></TR>
  <TR>
    <TD width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD width="99%" colSpan=3></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Additional
      Amount</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.6(e)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Additional
      Contribution</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.6(f)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Agreement</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Arm&#146;s Length
      Terms</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>5.3(a)(v)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Authorized
      Persons</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.3(b)(iii)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Board</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>5.1(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Call
    Right</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>6.5(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Capital
      Account</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.9(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Change of Control
      Notice</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>6.4(a)(i)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Class A Special
      Amount</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>3.4(c)(ii)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Class C Special
      Amount</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>3.4(c)(i)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Clorox</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Clorox
      Contribution</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.2(a)(i)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Clorox Benefit
      Plans</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>4.2(o)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Clorox Excluded
      Assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.2(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Clorox
      Indemnified Parties</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>10.2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Clorox
      Parties</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Clorox Retained
      Liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.2(c)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Clorox
      Services</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.1(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Closing</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.1</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Closing
      Date</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.1</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Competing
      Business</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.2(c)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Confidential
      Information</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.3(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Deadlock
      Notice</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>6.5(b)(i)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Defined Benefit
      Plans</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.5(d)</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>14</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><B><FONT face="Times New Roman" size=2>Term</FONT></B></TD>
    <TD noWrap align=right width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=left width="50%"><B><FONT face="Times New Roman" size=2>Section</FONT></B></TD></TR>
  <TR>
    <TD width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </TD>
    <TD width="99%" colSpan=3>&nbsp;</TD></TR>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Distribution
      Shortfall</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>3.4(c)(v)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Escalation</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>5.3(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Existing
      International Balance Sheets</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>4.2(a)(vii)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Existing
      Product</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.2(b)(vii)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>FDA</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>4.2(h)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Glad Leadership
      Team</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>5.1(e)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>HSR Act</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.5(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Indemnified
      Parties</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>10.2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Indemnifying
      Party</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>10.3</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Initial
      Term</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>6.3(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>IP
      Transferees</FONT></TD>
    <TD noWrap align=right width="1%">&nbsp;</TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>11.12(c)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>JV Accounting
      Principles</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>9.1(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Leased Real
      Property</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>4.2(e)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Losses and
      Expenses</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>10.1</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Negative Cash
      Flow</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.6(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>New
    Country</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.8</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Option Exercise
      Period</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.7(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Option
      Price</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.7(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Original
      Agreement</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Recitals</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Original
      Date</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Recitals</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Owned Real
      Property</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>4.2(e)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>P&amp;G</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>P&amp;G
    Sub</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>P&amp;G
      Contribution</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.3(a)(ii)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>P&amp;G
      Indemnified Parties</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>10.1</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>P&amp;G
      Observers</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>5.1(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>P&amp;G
      Option</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.7(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>P&amp;G
      True-Up</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.6(c)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>P&amp;G
      Parties</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>P&amp;G
      Veto</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>5.3(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Parent
      Loans</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.6(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Party</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Pro Rata
      Portion</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.5(d)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Prohibited
      License Amounts</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>3.4(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Purchaser
      Plan</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.5(d)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Put
    Right</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>6.4(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Resolution
      Period</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>5.3(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Revised
      Valuation</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>6.8(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Quarterly
      Financials</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>2.6(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>SEC</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>4.2(a)(v)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>SEC
      Documents</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>4.2(a)(v)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Supplemental
      Schedule</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>7.5(e)</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>15</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </TD>
    <TD noWrap align=left width="48%"><B><FONT face="Times New Roman" size=2>Term</FONT></B></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=left width="50%"><B><FONT face="Times New Roman" size=2>Section</FONT></B></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=3>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Tag-Along
      Right</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>6.6(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Tax Matters
      Partner</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>9.2(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Third-Party
      Sale</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>6.7(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Term</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>6.3(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="48%"><FONT face="Times New Roman" size=2>Working
      Capital</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>4.2(a)(ii)</FONT></TD></TR></TABLE><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 1.3</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Other
Definitional Provisions; Interpretation</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The words &#147;hereof,&#148; &#147;herein&#148;
and &#147;hereunder&#148; and words of similar import when used in this Agreement will
refer to this Agreement as a whole and not to any particular provision of this
Agreement, and section and subsection references are to this Agreement unless
otherwise specified. The headings in this Agreement are included for convenience
of reference only and will not limit or otherwise affect the meaning or
interpretation of this Agreement. Whenever the words &#147;include,&#148; &#147;includes&#148; or
&#147;including&#148; are used in this Agreement, they will be deemed to be followed by
the words &#147;without limitation.&#148; The phrases &#147;the date of this Agreement,&#148; &#147;the
date hereof&#148; and terms of similar import, unless the context otherwise requires,
will be deemed to refer to the date set forth in the first paragraph of this
Agreement. The meanings given to terms defined herein will be equally applicable
to both the singular and plural forms of such terms. All matters to be agreed to
by any Party hereunder must be agreed to in writing by such Party unless
otherwise indicated herein. </FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE
II</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>CONTRIBUTIONS AND
ALLOCATIONS OF INTEREST</FONT></U><FONT face="Times New Roman" size=2>
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 2.1</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Closing of
Joint Venture</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Subject to the satisfaction or
waiver of the conditions set forth in Article VIII, the closing of the
transactions contemplated by Sections 2.2 and 2.3 (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Closing</FONT></U><FONT face="Times New Roman" size=2>&#148;) will take place as of the close of business Pacific Time on January
31, 2003 at the offices of Clorox in Oakland, California, or at such other time
and place as may be mutually agreed to by the Parties (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Closing Date</FONT></U><FONT face="Times New Roman" size=2>&#148;). The Parties agree that the actual exchange of
any documents, certificates assets or any other object required to be delivered
at Closing will take place at such other time and place either before or after
the close of business Pacific Time on January 31, 2003, as the Parties
reasonably determine. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 2.2</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Clorox
Contribution and Related Matters</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>From and after the Closing,
the following interests and Liabilities of the Clorox Parties and their
Subsidiaries will be attributed to, and for income Tax purposes will be deemed
owned or assumed by, the Joint Venture, except as provided in Section 2.2(b)
below with respect to Clorox Excluded Assets and Section 2.2(c) below with
respect to Clorox Retained Liabilities: </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>16</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the interest of the Clorox
Parties and their respective Subsidiaries on the Closing Date in all of the
businesses, assets, rights and properties (w) reflected in the Glad Balance
Sheet except as set forth in Schedule 2.2(a)(i) hereto, (x) set forth in Section
2.2(a)(iii)(C) of the Clorox Disclosure Schedule (to the extent an asset), (y)
subject to the JV Accounting Principles, to the extent and only to the extent
utilized in or related to the Glad Business, not reflected in the Glad Balance
Sheet, </FONT><U><FONT face="Times New Roman" size=2>provided</FONT></U><FONT face="Times New Roman" size=2> that the Joint Venture and the Glad Business
shall continue to have the right to use (in the same manner, to the same extent
and on the same terms) any businesses, assets, rights and properties of the
Clorox Parties and their Subsidiaries that would have been included in this
clause (y) but for the application of the JV Accounting Principles or (z)
subject to the JV Accounting Principles, to the extent and only to the extent
utilized in or related to the Glad Business, acquired after the date of such
Glad Financial Statements and prior to the Closing and including, for the
avoidance of doubt, the rights of the Clorox Parties under the Glad License
Agreements as of the Closing and in the Intellectual Property licensed
thereunder (collectively, the &#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox Contribution</FONT></U><FONT face="Times New Roman" size=2>&#148;), and
which Clorox Contribution will be allocated among the Clorox Parties as set
forth in the Contribution Allocation Statement and for income Tax purposes will
be deemed contributed to the Joint Venture; </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>subject to the JV Accounting
Principles, the interest of the Clorox Parties and their Subsidiaries in any
business, asset, right or property acquired during the Term by the Clorox
Parties to the extent and only to the extent utilized in or related to the Glad
Business (for the avoidance of doubt, for income Tax purposes, such interests
shall be deemed to be acquired by the Joint Venture rather than contributed by
the Clorox Parties); </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all Liabilities of the Clorox
Parties and their Subsidiaries to the extent and only to the extent (A)
reflected in the Glad Balance Sheet except as set forth in Schedule 2.2(a)(iii)
hereto, (B) incurred or assumed by the Glad Business in the ordinary course of
business after the date of such Glad Balance Sheet and prior to the Closing that
would be reflected as current Liabilities on a balance sheet of the Glad
Business as of the Closing prepared in accordance with the JV Accounting
Principles, but excluding any current Liabilities arising from third party
litigation claims, (C) set forth in Section 2.2(a)(iii)(C) of the Clorox
Disclosure Schedule (to the extent a Liability), (D) arising out of the conduct
of the Glad Business or the ownership or possession of any business, assets,
rights or property of the Glad Business during the Term or (E) assumed or
incurred during the Term by the Clorox Parties or their Subsidiaries in
accordance with the terms hereof with respect to the Glad Business,
</FONT><U><FONT face="Times New Roman" size=2>provided</FONT></U><FONT face="Times New Roman" size=2> that Indebtedness will be attributed to the Joint
Venture only to the extent that the provisions of Article V hereof with respect
to approvals are complied with and the proceeds of such Indebtedness are
utilized in the Glad Business to finance expenditures that cannot be financed by
Distributable Cash Flow; and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all Net Income and Net Loss
and Available Cash Flow arising in respect of the foregoing and proceeds of any
disposition thereof. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>17</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>For avoidance of doubt, the
interests in clauses (i) through (iv) above will not include any interests in
the Glad Licensed Business other than the interests represented by the Glad
License Agreements and no foreign Subsidiary of Clorox that conducts the Glad
Licensed Business will be a JV Partner hereunder. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The following interests of
the Clorox Parties and their Subsidiaries will be excluded from the Joint
Venture and will not be attributed to the Joint Venture (collectively, the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox Excluded
Assets</FONT></U><FONT face="Times New Roman" size=2>&#148;), and from and after the
Closing the Joint Venture will not include any interest in any of the following:
</FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all rights of the Clorox
Parties and their Subsidiaries under this Agreement; </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all interests in any
business, asset, right or property sold, transferred or otherwise disposed of
after the date of the Glad Financial Statements and prior to the Closing in the
ordinary course of the Glad Business and not in violation of Section 7.7 hereof;
</FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all cash and cash equivalents
as of the Closing other than petty cash with respect to the Glad Business;
</FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all refunds or credits with
respect to any Taxes paid or incurred by Clorox or its Subsidiaries prior to the
Closing Date, except to the extent reflected on the Glad Balance Sheet;
</FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(v)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all refunds or credits with
respect to any income Taxes of Clorox or its Subsidiaries other than refunds of
non-U.S. income Taxes that were attributed to the Joint Venture pursuant to
Section 2.2(c)(ii); </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(vi)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all capital stock or other
equity interests of Clorox and its Subsidiaries; and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(vii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all rights of the Clorox
Parties arising out of or in connection with any Retained Liabilities, including
without limitation any cause of action, right of recovery, right of set-off or
counterclaim. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>From and after the Closing,
none of the following Liabilities will be attributed to the Joint Venture
(&#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox Retained
Liabilities</FONT></U><FONT face="Times New Roman" size=2>&#148;): </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>any Liability (A) arising out
of or relating to the conduct of the Glad Business or the ownership or
possession of any business, assets, rights or property of the Glad Business
prior to the Closing Date or (B) assumed or incurred prior to the Closing Date
by the Clorox Parties or their Subsidiaries, except for any Liabilities
described in clause (A), (B) or (C) of Section 2.2(a)(iii); </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>(A) any Liability with
respect to income Taxes of the Clorox Parties and their Subsidiaries, except for
income Taxes imposed by a Tax authority of a <FONT face="Times New Roman" size=2>foreign jurisdiction in which the Joint Venture is conducting (or causing
to be conducted) the Glad Business, and (B) any Liability of the Clorox Parties
and their Subsidiaries with respect to Taxes resulting from effecting the Clorox
Contribution at Closing; </FONT></FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>18</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>any Liability arising out of
or relating to the Clorox Excluded Assets; </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>any Liability with respect to
the matters set forth in Section 2.2(c)(iv) of the Clorox Disclosure Schedule;
</FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(v)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>any Liability of the Clorox
Parties to the P&amp;G Parties arising out of or related to any breach of this
Agreement or any Related Agreement by the Clorox Parties or their Subsidiaries,
even if arising out of or related to conduct of the Glad Business or the
ownership or possession of any business, asset, right or property of the Glad
Business during the Term; and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(vi)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>any Liability for which the
Clorox Parties or their Subsidiaries have otherwise agreed to be liable and not
have attributed to the Glad Business pursuant to this Agreement or any Related
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 2.3</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Contribution by
P&amp;G and Related Matters</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>As of the Closing, the
following interests of the P&amp;G Parties will be attributed to, and for Tax
purposes, will be deemed contributed to the Joint Venture: </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>a license to certain
Intellectual Property rights licensed to the Clorox Parties as set forth in the
P&amp;G License Agreement; and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all title, right and interest
to the P&amp;G Equipment, the title to which P&amp;G Equipment will be conveyed
to one or more Clorox Parties at the Closing, free and clear of all Liens,
except for Permitted Liens (collectively clauses (i) and (ii), the
&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G
Contribution</FONT></U><FONT face="Times New Roman" size=2>&#148;). </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>From and after the Closing:
</FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the rights of the Clorox
Parties under the P&amp;G License Agreement and the JV Sublicense Agreements
will be attributed to the Joint Venture; </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the right, title and interest
of the Clorox Parties to the P&amp;G Equipment will be attributed to the Joint
Venture; and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all Net Income and Net Loss
and Available Cash Flow arising in respect of the foregoing and proceeds of any
disposition thereof will also be attributed to the Joint Venture. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>19</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The P&amp;G Parties will make
the following deliveries on the Closing Date and during the Term in connection
with the rights granted under the P&amp;G License Agreement: </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Within a reasonable time after the Closing Date,
the P&amp;G Parties will deliver to Clorox for use in the Glad Business all Know
How included in the [* * *] medium on the Closing Date; </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>On and after the Closing
Date, the P&amp;G Parties will deliver to Clorox for use in the Glad Business
(A) all Know How [* * *], as promptly as commercially practicable after any such
Know How [* * *]; and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In the event that any Know
How is necessary for the Clorox Parties&#146; use or practice of any P&amp;G
Technology, but does not, as of the Closing Date or any later date, [* * *] then
the P&amp;G Parties, at Clorox&#146;s request, will promptly (x) provide the Clorox
Parties with [* * *] to Clorox. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 2.4</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Nature of JV
Interest</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>An Ordinary JV Interest
represents an undivided participation interest in the Glad Business and each JV
Interest represents a right to receive income and losses, cash flow and proceeds
with respect thereto, as described herein. A JV Interest does not represent, and
will not be deemed to convey, a direct ownership interest in any of the
properties, assets or other rights of the Glad Business, title to which will be
held by the Clorox Parties, nor will it result in the assumption by the P&amp;G
Parties of any Liabilities of the Glad Business. For income Tax purposes only, a
JV Interest represents a capital and profits interest in the Joint Venture.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 2.5</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Initial
Allocations of Interest and Capital Accounts</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In consideration for the
Clorox Contribution, at the Closing the Clorox Parties will have an aggregate
initial Ordinary JV Interest of ninety percent (90%), the Class A Interest and
the Class B Interest and an aggregate Capital Account balance as will be
mutually agreed by the Parties prior to Closing. The JV Interests and Capital
Account balance of each individual Clorox Party as of the Closing will be
determined by Clorox in accordance with the Contribution Allocation Statement,
but in no event will the aggregate JV Interests and Capital Accounts balances of
the Clorox Parties as of the Closing exceed those provided in the first sentence
of this Section 2.5(a). </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In consideration for the
P&amp;G Contribution, at the Closing P&amp;G Sub will have an initial Ordinary
JV Interest of ten percent (10%), the Class C Interest and an aggregate Capital
Account balance as will be mutually agreed by the Parties prior to Closing. All
JV Interests and Capital Account balances of the P&amp;G Parties as of the
Closing will be deemed to be owned solely and exclusively by P&amp;G Sub.
P&amp;G is a party to this Agreement for purposes of guaranteeing the
performance of all obligations of P&amp;G Sub and to perform directly certain
obligations pursuant to this Agreement. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>20</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 2.6</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Additional
Capital Calls and Parent Loans</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>All additional capital
contributions that will be attributed to the Joint Venture will be made in
accordance with this Section 2.6. In the event additional funds are required to
finance specific capital, acquisition or extraordinary expenditures of the Glad
Business, such funds may be provided by the JV Partners as loans
attributed to the Joint Venture </FONT><FONT face="Times New Roman" size=2>(&#147;</FONT><U><FONT face="Times New Roman" size=2>Parent
Loans</FONT></U><FONT face="Times New Roman" size=2>&#148;) or as additional
contributions of capital, in each case as provided in this Section 2.6. The
Board may, from time to time, issue Capital Calls, requesting the JV Partners to
make additional contributions of capital in proportion to their respective
Ordinary JV Interests in order to finance expenditures of the Glad Business if
based on the then-current financial forecasts of the Joint Venture (i) such
expenditures cannot be funded entirely out of Distributable Cash Flow for such
Fiscal Quarter and (ii) if Parent Loans are used to finance such expenditures,
the Available Cash Flow during the next [* * *] will be insufficient to repay in
full all Parent Loans that would be outstanding immediately after such new
Parent Loans are incurred. Each JV Partner agrees that Capital Calls issued to
any JV Partner will be paid by the JV Partner at its election. The remedy for
non-payment of any Capital Calls will be limited to the remedy set forth in this
Section 2.6 and such non-payment will not be a breach of this Agreement pursuant
to this Section 2.6(a). Except as otherwise required by law, no JV Partner will
be required to make any additional contributions to the capital attributed to
the Joint Venture. All capital contributions to be attributed to the Joint
Venture will be paid by the JV Partners to the account of the Clorox Partner
designated by Clorox to receive such capital contributions. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In the event that additional
funds are required to finance specific capital, acquisition or extraordinary
expenditures of the Glad Business, and the then-current financial forecasts of
the Joint Venture indicate that (i) such expenditures can be funded entirely out
of Distributable Cash Flow for that Fiscal Quarter or (ii) if Parent Loans are
used to finance such expenditures, the Available Cash Flow during the next [* *
*] will be sufficient to repay in full all Parent Loans that would be
outstanding immediately after such new Parent Loans are incurred, the Clorox
Partners will provide such additional funds as a Parent Loan having a term of [*
* *]. In the event that Available Cash Flow for any Fiscal Quarter as set forth
in the quarterly financial statements of the Joint Venture for such Fiscal
Quarter to be delivered pursuant to Section 9.1(c) (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Quarterly Financials</FONT></U><FONT face="Times New Roman" size=2>&#148;) is a negative number (such number, the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Negative Cash
Flow</FONT></U><FONT face="Times New Roman" size=2>&#148;) (x) less than $[* * *] and
the aggregate outstanding Parent Loans by the Clorox Partners would not exceed
$[* * *] if the amount of such Negative Cash Flow were treated as a Parent Loan
or (y) if Parent Loans are used to fund the Negative Cash Flow, the Available
Cash Flow during the next [* * *] will be sufficient to repay in full all Parent
Loans that would be outstanding immediately after such new Parent Loans are
incurred, then the amount of the Negative Cash Flow will be treated as a Parent
Loan by the Clorox Partners, which Parent Loan will be deemed to have been made
as of the last day of the Fiscal Quarter to which the Negative Cash Flow
relates. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In the event that there is
Negative Cash Flow for any Fiscal Quarter that will not be treated as a Parent
Loan in accordance with Section 2.6(b), then within three (3) Business Days of
delivery of the Quarterly Financials pursuant to Section 9.1(c), the Board will
issue a Capital Call to P&amp;G Sub in an amount (the &#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G True-Up</FONT></U><FONT face="Times New Roman" size=2>&#148;) equal to: (i) the aggregate amount of the
Ordinary JV Interests held by the P&amp;G Partners [* * *] (ii) the Negative
Cash Flow. In the event the P&amp;G Partners pay such Capital Call, (A) the
proceeds thereof will be paid to the Clorox Partner designated by Clorox, (B)
the P&amp;G Partners will be deemed to have made a capital contribution to the
Joint Venture in the amount of the P&amp;G True-Up, (C) each of the Clorox
Partners will be deemed to have made a capital contribution to the Joint Venture
in the amount of (x) the amount of the Ordinary JV Interest held by such Clorox
Partner [* * *] (y) <FONT face="Times New Roman" size=2>the Negative Cash Flow
and (D) the respective Ordinary JV Interests of the Parties will not be adjusted
with respect to such capital contributions or such Capital Call paid by P&amp;G
Sub or deemed paid by the Clorox Partners. In the event the P&amp;G Partners
decline to pay such Capital Call, the Clorox Partners will be deemed to have
advanced the amount of the Negative Cash Flow, which may be treated as a loan or
a contribution by the Clorox Partners at their election as provided in Section
2.6(e) below. </FONT></FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>21</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>All Parent Loans will bear
interest calculated on the outstanding principal amount thereof for each day
from the date such Parent Loan is made until it is paid in full at [* * *] plus [* * *] percent ([*
* *]%) per annum payable on a quarterly basis, and payments with respect to any
Parent Loans will be credited first to accrued interest. Subject to the
provisions of Section 3.4(b)(iv), each Parent Loan will have a maturity date of
the last day of the Term. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(e)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Subject to the provisions of
Section 2.6(c) hereof, in the event of the failure of any P&amp;G Partner to
make full and timely payment of any additional capital contribution required by
any Capital Call pursuant to this Section 2.6, the Clorox Partners will be
deemed to have advanced to the Joint Venture the entire unpaid amount. Subject
to the provisions of Section 2.6(c) hereof, such advance as well as any other
amounts that would have been deemed paid by the Clorox Partner on its own behalf
with respect to such Capital Call if the P&amp;G Partners had paid such Capital
Call in full (together with such advance, the &#147;</FONT><U><FONT face="Times New Roman" size=2>Additional Amount</FONT></U><FONT face="Times New Roman" size=2>&#148;) will, at the election of the advancing Clorox
Partner, be treated in either of the following manners: </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the Additional Amount may be
treated as a Parent Loan; or </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the Additional Amount may be
treated as a contribution by the Clorox Partner paying such Additional Amount
attributed to the Joint Venture of all or any portion of such unpaid Capital
Call. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(f)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Effective upon the making of
an additional capital contribution by a Clorox Partner pursuant to Section
2.6(e)(ii) (an &#147;</FONT><U><FONT face="Times New Roman" size=2>Additional
Contribution</FONT></U><FONT face="Times New Roman" size=2>&#148;), the Ordinary JV
Interest of each JV Partner will be recalculated as that percentage equal to a
fraction: </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>[* * *] of which is equal to
the sum of (A) (x) the Ordinary JV Interest of such JV Partner prior to the
Additional Contribution [* * *] by (y) the aggregate Fair Market Value of all
Ordinary JV Interests prior to the Additional Contribution plus (B) the amount,
if any, of the Additional Contribution made by such JV Partner, and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>[* * *] of which is equal to
the sum of (A) the aggregate Fair Market Value of all Ordinary JV Interests
prior to the Additional Contribution [* * *] (B) the aggregate amount of all
Additional Contributions by all the JV Partners made at the same time as such
Additional Contribution. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>For purposes of this Section
2.6(f), prior to the three-year anniversary of the Closing Date, the Fair Market
Value of all the Ordinary JV Interests will be no less than $[* * *] plus the
<FONT face="Times New Roman" size=2>aggregate amount of Additional Contributions
made or deemed made prior to the date as of which such Fair Market Value is
being determined. </FONT></FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>22</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>By way of illustration, in the
event the Ordinary JV Interests held by the JV Partners remain unchanged from
the Closing Date and the P&amp;G Option has not been exercised, and an
Additional Contribution is made by a Clorox Partner in the amount of $[* * *]
and the Fair Market Value for all Ordinary JV Interests prior to such Additional
Contribution is equal to $[* * *] the Ordinary JV Interests held by the P&amp;G
Partners would be an aggregate of [* * *]% and the Ordinary JV Interests held by
the Clorox Partners would be an aggregate of [* * *]%, calculated as follows:
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>[* * *]% = [* * *] </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>[* * *]% = [* * *] </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 2.7</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>P&amp;G
Option</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>During the period commencing
on the Closing Date and ending on January 1, 2008 (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Option Exercise Period</FONT></U><FONT face="Times New Roman" size=2>&#148;), the P&amp;G Partners will have the option (the
&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Option</FONT></U><FONT face="Times New Roman" size=2>&#148;) to acquire from the Clorox Partners all (but
not less than all) of (x) a portion of the Clorox Partners&#146; Ordinary JV
Interests equal to ten percent (10%) of the total Ordinary JV Interests as of
the date of the closing of the exercise of the P&amp;G Option and (y) the Class
A Interest. The [* * *] price to be paid by P&amp;G Sub to the Clorox Partners
(the &#147;</FONT><U><FONT face="Times New Roman" size=2>Option Price</FONT></U><FONT face="Times New Roman" size=2>&#148;) will be determined as follows: </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>$[* * *] plus the Adjustment
Amount, if any, in the event the P&amp;G Option is exercised on or before
January 1, 2004; </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>$133 million plus the
Adjustment Amount, if any, if the P&amp;G Option is exercised after January 1,
2004 and on or before January 1, 2005; </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>$[* * *] plus the Adjustment
Amount, if any, if the P&amp;G Option is exercised after January 1, 2005 and on
or before January 1, 2006; </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>$[* * *] plus the Adjustment
Amount, if any, if the P&amp;G Option is exercised after January 1, 2006 and on
or before January 1, 2007; and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(v)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>$[* * *] plus the Adjustment
Amount, if any, if the P&amp;G Option is exercised after January 1, 2007 and on
or before January 1, 2008. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>If the P&amp;G Partners wish
to exercise the P&amp;G Option, P&amp;G will provide ten (10) Business Days
prior written notice to Clorox. The closing with respect to any exercise of the
P&amp;G Option will take place on the tenth Business Day after exercise by the
P&amp;G Partners of the P&amp;G Option, provided that if all orders, consents
and approvals of Governmental Authorities legally required for the closing of
such sale will not have been obtained or will not be in effect, or if any
waiting period under the HSR Act will not have expired or been terminated, such
closing will be delayed until the tenth Business Day after such orders, consents
and approvals <FONT face="Times New Roman" size=2>will be obtained and in effect
and such waiting period, if any, will have expired or been terminated. Payment
of the Option Price will be by immediately available funds to the accounts
designated by Clorox. </FONT></FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>23</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 2.8</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Rights with
Respect to Capital</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>No JV Partner will have the
right to withdraw, or receive any return of, its Capital Contribution, and no
Capital Contribution may be returned in the form of property other than cash
except as specifically provided herein. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Except as expressly provided
in this Agreement, no Capital Contribution of any JV Partner will bear any
interest or otherwise entitle the contributing JV Partner to any compensation
for use of the contributed capital. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 2.9</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Capital
Accounts</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>There will be established for
each JV Partner on the books of the Joint Venture a capital account
(&#147;</FONT><U><FONT face="Times New Roman" size=2>Capital Account</FONT></U><FONT face="Times New Roman" size=2>&#148;) that will be maintained in accordance with this
Section 2.9. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In the event a JV Partner
transfers a JV Interest in accordance with the terms of this Agreement, the
transferee will succeed to the Capital Account of the transferor to the extent
it relates to the transferred JV Interest. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The Capital Account of each
JV Partner will be increased by: </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>such JV Partner&#146;s cash
contributions attributed to and deemed contributed to the Joint Venture
(including deemed cash contributions equal to the amount of organizational
expenses incurred by such JV Partner on behalf of the Joint Venture);
</FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the Carrying Value of
property attributed to and deemed contributed by such JV Partner (net of
Liabilities secured by such contributed property that the Joint Venture is
considered to have attributed to it or such property is subject to under Code
Section 752); </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all items of Net Profits
allocated to such JV Partner pursuant to Article III or other provisions of this
Agreement, and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all items of income and gain
specially allocated to such JV Partner pursuant to Section 3.2. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The Capital Account of each
JV Partner will be decreased by: </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the amount of cash
distributed to such JV Partner as a distribution with respect to the Joint
Venture; </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>24</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the Carrying Value of all
actual and deemed distributions of Property made to such JV Partner as a
distribution with respect to the Joint Venture pursuant to this Agreement (net
of Liabilities secured by such distributed Property that the JV Partner is
considered to assume or take subject to under Code Section 752); </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all items of Net Loss
allocated to such JV Partner pursuant to Article III or other provisions of this
Agreement; and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all items of deduction,
expense or loss specially allocated to such JV Partners pursuant to Section 3.2.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(e)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The provisions of this
Agreement relating to the maintenance of Capital Accounts are intended to comply
with Regulations Section 1.704-1(b)(2)(iv), and will be interpreted and applied
in a manner consistent with such Regulations Section. To the extent such
provisions are inconsistent with such Regulations Section or are incomplete with
respect thereto, Capital Accounts will be maintained and adjustments thereto
will be made in accordance with such Regulations Section; provided, however,
that no such adjustment will have any effect on the amount distributable
hereunder to any JV Partner. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>25</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE
III</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>ALLOCATIONS AND
DISTRIBUTIONS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 3.1</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Allocation of
Net Profits and Losses</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Except as otherwise provided
in this Article III, Net Profits and Net Loss of the Joint Venture in each
Fiscal Year will be allocated among the JV Partners in accordance with their
respective Ordinary JV Interests. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Notwithstanding Section
3.1(a) above, Net Profits with respect to each of the first eight Fiscal
Quarters of the Joint Venture will be allocated among the JV Partners as
follows: </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>with respect to the first
four Fiscal Quarters of the Joint Venture, Net Profits will be allocated one
hundred percent (100%) to the Clorox Partners (pro rata in accordance with their
respective Ordinary JV Interests); provided that, if P&amp;G Sub exercises the
P&amp;G Option on or prior to the first day of any such Fiscal Quarter, Net
Profits for such Fiscal Quarter will be allocated (subject to adjustment
pursuant to Section 2.6(f)) ninety percent (90%) to the Clorox Partners (pro
rata in accordance with their respective JV Interests) and ten percent (10%) to
the P&amp;G Partners (pro rata in accordance with their respective Ordinary JV
Interests); </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>with respect to the fifth
through eighth Fiscal Quarters of the Joint Venture, Net Profits will be
allocated (subject to adjustment pursuant to Section 2.6(f)) ninety-five percent
(95%) to the Clorox Partners (pro rata in accordance with their respective
Ordinary JV Interests) and five percent (5%) to the P&amp;G Partners (pro rata
in accordance with their respective Ordinary JV Interests); provided that, if
P&amp;G Sub exercises the P&amp;G Option on or prior to the first day of any
such Fiscal Quarter, Net Profits for such Fiscal Quarter will be allocated
(subject to adjustment pursuant to Section 2.6(f)) eighty-five percent (85%) to
the Clorox Partners (pro rata in accordance with their respective Ordinary JV
Interests) and fifteen percent (15%) to the P&amp;G Partners (pro rata in
accordance with their respective Ordinary JV Interests); and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>notwithstanding the
provisions of Section 3.1(b)(i) and (ii) above, Net Profits with respect to any
sale, transfer or other disposition of any business or assets of the Glad
Business outside the ordinary course of the Glad Business during the first eight
Fiscal Quarters will be allocated among the JV Partners pro rata in accordance
with their respective Ordinary JV Interests. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>26</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 3.2</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Special
Allocations</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>For purposes of the following
provisions of this Section 3.2, the Clorox Partners will be regarded as a single
JV Partner with a single Capital Account. Notwithstanding anything contained
herein to the contrary: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>If a JV Partner would at any time receive, but for
this Section 3.2(a), an allocation of deduction, loss, or expenditure that would
cause or increase a deficit balance in such JV Partner&#146;s Capital Account in
excess of any amount of such deficit balance that the JV Partner is obligated to
restore or deemed obligated to restore (as determined in accordance with
Treasury Regulation Section 1.704-1(b)(2)(ii)(c)), then the portion of such
allocation that would cause or increase such deficit Capital Account balance
will be specially allocated to the other JV Partners, if any, with positive
Capital Account balances in proportion to such balances. The loss limitation
under this Section 3.2(a) is intended to comply with Treasury Regulation Section
1.704-1(b)(2)(ii)(d), including the reductions described in subparagraphs (4),
(5) and (6) therein. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>If in any Fiscal Year a JV
Partner receives an adjustment, allocation or distribution described in Treasury
Regulation Section 1.704-1(b)(2)(ii)(d)(4), (5) or (6), items of Joint Venture
income and gain will be specially allocated to each such JV Partner in an amount
and manner sufficient to eliminate, to the extent required by the Treasury
Regulations, the Capital Account deficit of such JV Partner as quickly as
possible provided that an allocation pursuant to this Section 3.2(b) will be
made only if and to the extent that such JV Partner would have a Capital Account
deficit after all other allocations provided for in this Article III have been
tentatively made as if this Section 3.2(b) were not in the Agreement. This
Section 3.2(b) is intended to qualify and be construed as a &#147;qualified income
offset&#148; within the meaning of Treasury Regulation Section 1.704-1(b)(2)(ii)(d)
and will be interpreted consistently therewith. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>If there is a net decrease in
minimum gain attributed to the Joint Venture or JV Partner nonrecourse debt
minimum gain (determined in accordance with the principles of Treasury
Regulation Sections 1.704-2(d) and 1.704-2(i)) during any Joint Venture
taxable year, the JV Partners will be allocated items of income and gain
attributed to the Joint Venture for such year (and, if necessary, subsequent
years) in an amount equal to their respective shares of such net decrease during
such year, determined pursuant to Treasury Regulation Sections 1.704-2(g) and
1.704-2(i)(5). The items to be so allocated will be determined in accordance
with Treasury Regulation Section 1.704-2(f). This Section 3.2(c) is intended to
comply with the minimum gain chargeback requirements in such Treasury
Regulations and will be interpreted consistently therewith, including that no
chargeback will be required to the extent of the exceptions provided in Treasury
Regulation Sections 1.704-2(f) and 1.704-2(i)(4). </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The allocation provisions set
forth in this Article III and the other provisions of this Agreement relating to
the maintenance of Capital Accounts are intended to comply with Treasury
Regulation Section 1.704-1(b) and will be interpreted and applied in a manner
consistent with such Regulations; </FONT><U><FONT face="Times New Roman" size=2>provided however</FONT></U><FONT face="Times New Roman" size=2> that such
provisions will not affect the economic rights of any JV Partner, including
rights to distributions with respect to the Joint Venture. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(e)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Any special allocations of
items of income, gain, loss or deductions pursuant to Sections 3.2(a), (b) and
(c) will be taken into account in computing subsequent allocations pursuant to
Section 3.1 and this Section 3.2, so that the net amount of any items so
allocated will, to the extent possible, be equal to the net amount that would
have been allocated to each such JV Partner pursuant to the provisions of this
Article III if such special allocations had not occurred. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>27</FONT></P>
<HR align=center width="100%" noShade size="2">

<!--Part03-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(f)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>In the
event that any fees, interest, or other amounts paid to any JV Partner or any
Affiliate thereof pursuant to this Agreement or any other agreement attributed
to the Joint Venture with any JV Partner or Affiliate thereof providing for the
payment of such amount, and deducted by the Joint Venture in reliance on Section
707(a) and/or 707(c) of the Code, are disallowed as deductions to the Joint
Venture on its federal income tax return and are treated as Joint Venture
distributions, then:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>the
Net Profits or Net Loss, as the case may be, for the Fiscal Year in which such
fees, interest, or other amounts were paid will be increased or decreased, as
the case may be, by the amount of such fees, interest, or other amounts that are
treated as Joint Venture distributions; and</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>there
will be allocated to the JV Partner to which (or to whose Affiliate) such fees,
interest, or other amounts were paid, prior to the allocations pursuant to
Section 3.1, an amount of gross income for the Fiscal Year equal to the amount
of such fees, interest, or other amounts that are treated as Joint Venture
distributions.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(g)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Prior
to the allocation of Net Profits and Net Losses pursuant to Section 3.1, the
following allocations shall be made for each Fiscal Year:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
holder of the Class A Interest will be specially allocated royalty income
attributable to royalty payments made under the Glad License Agreements for such
Fiscal Year in an amount of royalty payments [* * *] to the aggregate amounts
distributable to the holder of the Class A Interest under Section 3.5(b)(i)
hereof (without regard to distributions treated as guaranteed payments under
such Section) in each Fiscal Quarter in such Fiscal Year. Royalty income
allocated to the Class A Interest hereunder will be allocated among the various
sources of such royalty income in the same manner as withholding taxes are
calculated under the definition of &#147;Deemed Withholding Taxes&#148;. The holder of the
Class A Interest will also be specially allocated income for such Fiscal Year in
an [* * *] of the IP Allocation Amounts with respect to IP Acquisitions for such
Fiscal Year and will be specially allocated all income attributable to Glad
License Termination Amounts paid for such Fiscal Year;</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>After
the allocations pursuant to Section 3.2(g)(i) are made, the holder of the Class
B Interest will be specially allocated royalty income attributable to royalty
payments made under the Glad License Agreements for such Fiscal Year in an
amount [* * *] royalty payments received under the Glad License Agreements for
such Fiscal Year, [* * *] the amount of royalty income allocated to the Class A
Interest under Section 3.2(g)(i) for such Fiscal Year. The holder of the Class B
Interest will also be specially allocated income for such Fiscal Year [* * *] IP
Acquisition Prices with respect to IP Acquisitions, if any, for such Fiscal Year
in excess of the aggregate IP Allocation Amounts included in the calculation of
the Class A Special Amount and the Class C Special Amount for each Fiscal
Quarter in such Fiscal Year;</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>28</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii) The holder of the Class
C Interest will be specially allocated royalty income attributable to royalty
payments made under the JV Sublicense Agreements in such Fiscal Year in an
amount of royalty payments [* * *] royalty payments received under the JV
Sublicense Agreements for such Fiscal Year. The holder of the Class C Interest
will also be specially allocated income for such Fiscal Year in an amount [* *
*] of the IP Allocation Amounts with respect to IP Acquisitions for such Fiscal
Year and will be specially allocated [* * *] attributable to JV Sublicense
Termination Amounts paid for such Fiscal Year;</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
Clorox Partners will be specially allocated all deductions arising from the
payment of guaranteed payments pursuant to Section 3.5(a) and Section 3.5(b)
hereof in such Fiscal Year and shall be specially allocated [* * *] attributable
to Prohibited License Amounts received on behalf of the Joint Venture in such
Fiscal Year; and</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(v)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Each
JV Partner will be specially allocated all deductions arising from the
amortization of organizational expenses (within the meaning of Section 709(b) of
the Code) incurred by such JV Partner on behalf of the Joint Venture.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 3.3</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Section 704(c) Allocation</FONT></U><FONT face="Times New Roman" size=2>.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>For
income tax purposes only, each item of income, gain, loss, and deduction with
respect to any Property, the Carrying Value of which differs from its adjusted
tax basis for federal income tax purposes, will be allocated in accordance with
the principles of Section 704(c) of the Code so as to take into account the
variation between the adjusted tax basis of such Property and its Carrying
Value. For purposes of applying the principles of Section 704(c) of the Code,
the Joint Venture will use the traditional method described in Treasury
Regulation Section 1.704-3(b) or such other methods as the JV Partners
unanimously agree.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Subject to the provisions of Section 3.3(a), items of income, gain, loss,
deduction and credit to be allocated for income tax purposes will be allocated
for each Fiscal Year among the JV Partners in the same manner and on the same
basis as Net Profits and Net Loss are allocated, taking into account special
allocations made pursuant to Section 3.2.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 3.4</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Distributions of Available Cash Flow</FONT></U><FONT face="Times New Roman" size=2>.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>After
making distributions of Distributable Cash Flow pursuant to Section 3.4(c) for
any Fiscal Quarter, all remaining Distributable Cash Flow attributed to the
Joint Venture for such Fiscal Quarter will be distributed by the Clorox Partners
in accordance with this Section 3.4(a). If Available Cash Flow as shown in the
Quarterly Financials for any Fiscal Quarter results in the Distributable Cash
Flow for that Fiscal Quarter being a positive number, a distribution with
respect to such Fiscal Quarter will be made by the Clorox Partners to the
P&amp;G Partners within three (3) Business Days after delivery of such Quarterly
Financials and each Clorox Partner will be deemed to have received a
distribution on that same date. All distributions made by the Clorox Partners
pursuant to this Section 3.4 will be in [* * *] to the account designated by the
P&amp;G Partners to Clorox in writing. Except as otherwise provided in this
Section 3.4 or Article VI, all distributions of Distributable Cash Flow from any
Fiscal Quarter will be made to the JV Partners pro rata in accordance with their
respective Ordinary JV Interests as of the last day of such Fiscal Quarter so
that the amount distributed to the P&amp;G Partners will equal its Ordinary JV
Interest as of such day multiplied by the aggregate amount of Distributable Cash
Flow. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>29</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Notwithstanding the provisions of Section 3.4(a), after making
distributions of Distributable Cash Flow pursuant to Section 3.4(c),</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>with
respect to the first four Fiscal Quarters of the Joint Venture, the remaining
Distributable Cash Flow will be distributed one hundred percent (100%) to the
Clorox Partners (pro rata in accordance with their respective Ordinary JV
Interests); provided that if the P&amp;G Partners exercise the P&amp;G Option on
or prior to the first day of any such Fiscal Quarter, such Distributable Cash
Flow for such Fiscal Quarter will be distributed (subject to adjustment pursuant
to Section 2.6(f)) ninety percent (90%) to the Clorox Partners (pro rata in
accordance with their respective Ordinary JV Interests) and ten percent (10%) to
the P&amp;G Partners;</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>with
respect to the fifth through eighth Fiscal Quarters of the Joint Venture, the
remaining Distributable Cash Flow will be distributed (subject to adjustment
pursuant to Section 2.6(f)) ninety-five percent (95%) to the Clorox Partners
(pro rata in accordance with their respective Ordinary JV Interests) and five
percent (5%) to the P&amp;G Partners; provided that if the P&amp;G Partners
exercises the P&amp;G Option on or prior to the first day of any such Fiscal
Quarter, such Distributable Cash Flow for such Fiscal Quarter will be
distributed (subject to adjustment pursuant to Section 2.6(f)) eighty-five
percent (85%) to the Clorox Partners (pro rata in accordance with their
respective Ordinary JV Interests) and fifteen percent (15%) to P&amp;G Partners;
and</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>notwithstanding the provisions of Section 3.4(b)(i) and (ii) above,
distributions of Distributable Cash Flow consisting of the net cash proceeds of
any sale, transfer or other disposition of any business or assets of the Glad
Business outside the ordinary course of the Glad Business during the first eight
Fiscal Quarters will be made to the JV Partners pro rata in accordance with
their respective Ordinary JV Interests as of the last day of such Fiscal
Quarter.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Prior
to any distributions of Distributable Cash Flow under Sections 3.4(a) or 3.4(b),
Distributable Cash Flow for any Fiscal Quarter will be distributed in accordance
with this Section 3.4(c) in the following order of priority:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>In the
event of one or more International Acquisitions that have related IP
Acquisitions in a Fiscal Quarter, the holder of the Class C Interest will be
entitled to a distribution with respect to such Fiscal Quarter of Distributable
Cash Flow in an amount equal to the sum of the aggregate IP Allocation Amounts
with respect to all such International Acquisitions in such Fiscal Year (the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Class C Special
Amount</FONT></U><FONT face="Times New Roman" size=2>&#148;);</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>In the
event of one or more International Acquisitions that have related IP
Acquisitions in a Fiscal Quarter, the holder of the Class A Interest will also
be entitled to a distribution with respect to such Fiscal Quarter of
Distributable Cash Flow equal to the sum of the aggregate IP Allocation Amounts
with respect to all such International Acquisitions in such Fiscal Quarter (the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Class A Special
Amount</FONT></U><FONT face="Times New Roman" size=2>&#148;);</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>30</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
holder of the Class B Interest will be entitled to a distribution with respect
to each Fiscal Quarter of Distributable Cash Flow in an amount equal to the
aggregate royalty payments received under the Glad License Agreements (net of
withholding taxes imposed on such royalty payments) for such Fiscal Quarter,
minus the amount distributable to the holder of the Class A Interest under
Section 3.5(b)(i) for such Fiscal Quarter;</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
holder of the Class B Interest will be entitled to a special distribution with
respect to each Fiscal Quarter of Distributable Cash Flow equal to the aggregate
IP Acquisition Prices, if any, for such Fiscal Quarter, less the sum of the
Class A Special Amount and the Class C Special Amount for such Fiscal Quarter;
and</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(v)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>In the
event there is insufficient Distributable Cash Flow in any Fiscal Quarter to pay
the amounts otherwise distributable under this Section 3.4(c) (a
&#147;</FONT><U><FONT face="Times New Roman" size=2>Distribution
Shortfall</FONT></U><FONT face="Times New Roman" size=2>&#148;), there shall be a
priority distribution of Distributable Cash Flow in the next succeeding Fiscal
Quarter in the amount of such Distribution Shortfall (and all prior Distribution
Shortfalls to the extent a distribution has not been made with respect to any
such Distribution Shortfall under this Section 3.4(c)(v)) in the order of
priority set forth in this Section 3.4(c) to the Parties who were the holders of
the Class A Interest, Class B Interest and Class C Interest at the time of such
Distribution Shortfall. </FONT><FONT face="Times New Roman" size=2>Notwithstanding anything set forth in this Section 3.4 to the contrary,
distributions under this Section 3.4(c)(v) shall be made before any
distributions are made under Sections 3.4(c)(i) through (iv), inclusive, for a
Fiscal Quarter.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Any distributions of
Distributable Cash Flow pursuant to this Section 3.4(c) will reduce the amount
of Distributable Cash Flow available for distribution pursuant to Section 3.4(a)
and 3.4(b) hereof.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>To the
extent there are any outstanding Parent Loans, and there is Available Cash Flow
in any Fiscal Quarter, then all Available Cash Flow will be immediately applied
towards outstanding Parent Loans and accrued and unpaid interest thereon until
all Parent Loans and accrued interest thereon will have been repaid in full. As
long as any Parent Loans remain outstanding, no distributions will be made
pursuant to this Section 3.4 in respect of the JV Interests.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(e)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
Parties acknowledge that it is expected that the Glad Global Business will
participate in Clorox&#146;s centralized cash management system and that any cash
generated by the Glad Global Business may be used by Clorox in its discretion,
subject to the other provisions of this Agreement and the Related
Agreements.</FONT></P>

<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>31</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 3.5</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Distributions of IP Related Amounts</FONT></U><FONT face="Times New Roman" size=2>.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The holders of the Class C
Interest and the Class A Interest shall be entitled to distributions of the
following amounts received under the JV Sublicense Agreements and the Glad
License Agreements, which amounts shall be distributed or paid, as the case may
be, by the Clorox Partners on behalf of the Joint Venture in the order and
priority set forth below for any Fiscal Quarter:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
holder of the Class C Interest will be entitled to distributions of (i) all
royalties paid under the JV Sublicense Agreements for such Fiscal Quarter (net
of withholding taxes imposed on such royalty payments), and (ii) all JV
Sublicense Termination Amounts paid under the JV Sublicense Agreements for such
Fiscal Quarter (net of withholding taxes imposed on such JV Sublicense
Termination Amounts). In the event the foregoing amounts payable under any JV
Sublicense Agreement are not permitted to be paid as a result of legal
restrictions in a local jurisdiction of an International Licensee, the holder of
the Class C Interest shall be entitled to receive, and the Clorox Partners on
behalf of the Joint Venture shall cause to be paid, an amount equal to the
shortfall (reduced by any withholding taxes that would have been imposed had the
full amounts due actually been paid by the International Licensee). The amount
of such payment shall be treated as a guaranteed payment under Section 707(c) of
the Code. For the avoidance of doubt, no P&amp;G Partner shall be required to
contribute or otherwise fund, directly or indirectly, such guaranteed payments.
If the International Licensee is later permitted by the local jurisdiction to
make royalty payments that were previously prohibited, the amount of such
payments received shall be distributed to the Clorox Partners.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
holder of the Class A Interest will be entitled to distributions of (i)
royalties paid under the Glad License Agreements for such Fiscal Quarter in an
amount equal to the Class A Royalty Amount (or, in the event the aggregate
royalty payments paid under the Glad License Agreements for such Fiscal Quarter
(net of withholding taxes imposed on such royalty payments) are less than the
Class A Royalty Amount, such lesser amount of royalty payments) and (ii) all
Glad License Termination Amounts paid under the Glad License Agreements for such
Fiscal Quarter (net of withholding taxes imposed on such amounts). In the event
the P&amp;G Option has been exercised, to the extent (x) the aggregate royalty
payments under the Glad License Agreements for a Fiscal Quarter are less than
the Class A Royalty Amount for such Fiscal Quarter or (y) Glad License
Termination Amounts are not permitted to be paid as a result of legal
restrictions in a local jurisdiction of an International Licensee, the holder of
the Class A Interest will be entitled to receive, and the Clorox Partners on
behalf of the Joint Venture shall cause to be paid an amount equal to such
shortfall (in the case of clause (y), reduced by any withholding taxes that
would have been imposed had the full amounts due actually been paid by the
International Licensee). The amount of such payment shall be regarded as a
guaranteed payment under Section 707(c) of the Code. For the avoidance of doubt,
no P&amp;G Partner shall be required to contribute or otherwise fund, directly
or indirectly, such guaranteed payments. If the International Licensee is later
permitted by the local jurisdiction to make royalty payments that were
previously prohibited, the amount of such payments received shall be distributed
to the Clorox Partners (such amounts, together with the amounts described in the
last sentence of Section 3.5(a) hereof, shall be referred to as &#147;Prohibited
License Amounts&#148;).</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>32</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE
IV</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>REPRESENTATIONS AND
WARRANTIES</FONT></U><FONT face="Times New Roman" size=2></FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 4.1 <U>Representations
and Warranties of all the Parties</U>.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Each of the Clorox Parties
hereby jointly and severally represents and warrants to the P&amp;G Parties with
respect to each Glad Party, and each of the P&amp;G Parties hereby jointly
and severally represents and warrants
to each of the Clorox Parties with respect to each of the P&amp;G Parties, as
follows, in each case subject to the exceptions set forth on the Clorox
Disclosure Schedule, or the P&amp;G Disclosure Schedule, as
applicable:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Organization and Authority</FONT></U><FONT face="Times New Roman" size=2>. Such Party is duly organized, validly existing and in good standing
under the laws of its jurisdiction of organization, and has the requisite power
and authority to own, lease and operate its properties and to conduct its
business as now conducted by it. Such Party has all requisite power and
authority to enter into this Agreement and the Related Agreements to which it is
a party and to perform its obligations hereunder and thereunder. Such Party is
qualified to do business and is in good standing as a foreign corporation,
partnership or other entity, as applicable, in all jurisdictions in which it
conducts its business, except where the failure to be so qualified does not and
will not, individually or in the aggregate, have a Material Adverse
Effect.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Authorization</FONT></U><FONT face="Times New Roman" size=2>. The
execution, delivery and performance by such Party of this Agreement and the
Related Agreements, in each case to which it is a party, and the consummation by
such Party of the transactions contemplated hereby and thereby have been duly
authorized by all necessary corporate action on the part of such Party. This
Agreement has been, and each of the Related Agreements will on the Closing Date
be, in each case to which it is a party, duly executed and delivered by such
Party and constitutes or, in the case of the Related Agreements, upon execution
thereof by all other appropriate parties will constitute, a valid and legally
binding obligation of such Party, enforceable against it in accordance with its
terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium and other similar laws relating to or affecting
creditors&#146; rights generally, general equitable principles (whether considered in
a proceeding at equity or at law) and an implied covenant of good faith and fair
dealing.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Consents and Approvals; No Conflicts</FONT></U><FONT face="Times New Roman" size=2>. The execution, delivery and performance by such
Party of this Agreement and the Related Agreements, in each case to which it is
a party, and the consummation by such Party of the transactions contemplated
hereby and thereby will not (i) conflict with or result in a breach of any
provision of the charter or bylaws (or equivalent governing documents) of such
Party, (ii) require any consent, approval, authorization or permit of, or filing
with or notification to, any Governmental Authority, (iii) require the consent
or approval of any Person (other than a Governmental Authority) or violate or
conflict with, or result in a breach of any provision of, constitute a default
(or an event which with notice or lapse of time or both would become a default)
or give to any third party any right of termination, cancellation, amendment or
acceleration under, or result in the creation of a Lien on any of the assets
attributed to the Joint Venture under, any of the terms, conditions or
provisions of any contract or license to which such Party is a party or by which
it or its assets or property are bound, or (iv) violate or conflict with any
order, writ, injunction, decree, statute, rule or regulation applicable to such
Party; other than any matters described in clauses (ii), (iii) and (iv) above
which, individually or in the aggregate, do not and will not have a Material
Adverse Effect.</FONT></P>

<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>33</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d) <U>Certain Fees</U>. Neither such
Party nor any of its officers, directors or employees, on behalf of such Party,
has employed any broker or finder or incurred any other Liability for any brokerage fees, commissions or
finders&#146; fees in connection with transactions contemplated hereby.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 4.2</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Representations and Warranties of the Clorox Parties</FONT></U><FONT face="Times New Roman" size=2>.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Each of the Clorox Parties
hereby jointly and severally represents and warrants to the P&amp;G Parties as
follows, in each case subject to the exceptions set forth on the Clorox
Disclosure Schedule:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Financial Statements</FONT></U><FONT face="Times New Roman" size=2>.</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
Glad Financial Statements were derived from the books and records of the Glad
Business. The Glad Balance Sheet has been prepared in accordance with the
methodologies set forth in the PWC Report consistently applied. The income
statement included in the Glad Financial Statements has been prepared in
accordance with the JV Accounting Principles. The application of the JV
Accounting Principles will not affect the statement of results of operations
included in the Glad Financial Statements. The Glad Financial Statements fairly
and truly present in accordance with the JV Accounting Principles the financial
position of the Glad Business as at June 30, 2002 and the results of its
operations for the year then ended, before deductions for any income Taxes and
after certain internal adjustments indicated in the notes thereto.</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>As of
the Closing, the Glad Business will have sufficient Working Capital to operate
the Glad Business after the Closing in the ordinary course consistent with past
practice. For purposes hereof, &#147;Working Capital&#148; is calculated as (i) the
current assets of the Glad Business attributed to the Joint Venture minus (ii)
the current Liabilities of the Glad Business attributed to the Joint Venture,
prepared and calculated as provided in the immediately preceding
sentence.</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Except
as and to the extent disclosed in the Glad Balance Sheet and, except for
Liabilities incurred in connection with the transactions contemplated by this
Agreement and the Related Agreements, there are no Liabilities of the Glad
Business, that would be required to be reflected on, or reserved against, in a
consolidated balance sheet of the Glad Business in accordance with the JV
Accounting Principles, except for (x) Liabilities which, singly or in the
aggregate, do not and will not have a Material Adverse Effect, and (y)
Liabilities incurred subsequent to the date of such balance sheet by the Glad
Business in the ordinary course of business consistent with past
practice.</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Any
hedge arrangements included in the Liabilities to be attributed to the Glad
Global Business pursuant to Section 2.2(a)(iii)(c) relate to the underlying
business operations of the Glad Global Business and are not held for speculative
purposes.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>34</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(v) Clorox has filed on a
timely basis all forms, reports and documents required to be filed with the
United States Securities and Exchange Commission (the &#147;<u>SEC</u>&#148;) since July 1, 2001
(all forms, reports and documents filed by Clorox with the SEC since July 1,
2001 are referred to herein as the &#147;</FONT><U><FONT face="Times New Roman" size=2>SEC Documents</FONT></U><FONT face="Times New Roman" size=2>&#148;). The SEC
Documents (A) complied as to form in all material respects with the requirements
of the Securities Act of 1933, as amended, or the Exchange Act of 1934, as
amended, as the case may be, and the rules and regulations thereunder, each as
in effect on the date so filed or amended, and (B) did not at the time they were
filed (or if amended or superseded by a filing prior to the date of this
Agreement, then on the date of such filing) contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading.</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(vi)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
most recent audited annual financial statements and unaudited quarterly
financial statements included in the SEC Documents were prepared in accordance
with GAAP applied on a consistent basis throughout the periods involved (except
as may be indicated in the notes thereto or in the SEC Documents), and each
fairly presents the consolidated financial position of Clorox and its
Subsidiaries at the respective dates thereof and the consolidated results of
their operations and cash flows for the periods indicated, except that the
unaudited interim financial statements were or are subject to normal and
recurring year-end adjustments and do not contain all of the footnote
disclosures required by GAAP.</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(vii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Each
of the balance sheets set forth in the PWC Report with respect to the Glad
Existing International Business in Canada, Australia and New Zealand (the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Existing International Balance
Sheets</FONT></U><FONT face="Times New Roman" size=2>&#148;) has been prepared in
accordance with the methodologies set forth in the PWC Report consistently
applied, and is accurate based on such methodologies. The application of the JV
Accounting Principles to the Existing International Balance Sheets will not
affect the statement of results of operations included in the PWC Report with
respect to the Glad Existing International Business in Canada, Australia and New
Zealand. The income statements included in the PWC Report with respect to the
Glad Existing International Business in Canada, Australia and New Zealand fairly
and truly present in accordance with the JV Accounting Principles the results of
operations of the Glad Existing International Business in such countries in
accordance with the JV Accounting Principles, excluding costs included therein
that would be charged through the Clorox Services in accordance with Exhibit
F.</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(viii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>There
are no Liabilities of the Glad Existing International Business in South Africa,
Costa Rica, Hong Kong, Philippines and Korea, singly or in the aggregate, which,
in light of the business, properties, assets and cash flow of the Glad Existing
International Business in such countries, do or will have a material adverse
effect upon the business, properties, financial condition or results of
operations of the Glad Existing International Business or a Material Adverse
Effect.</FONT></P>

<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>35</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b) <U>Absence of Certain Changes or Events</U>. Since June 30, 2002, the Glad Parties have
conducted the Glad Global Business in all material respects only in the ordinary
course, consistent with past practice and except as reflected in the Glad
Financial Statements, since such date there has not been, prior to the date
hereof, (i) any material adverse change in the business, properties, financial
condition or results of operations of the Glad Global Business, except as may arise from or relate to changes in
general economic conditions in the geographic regions in which the Glad Global
Business operates or (ii) any damage, destruction, loss, conversion,
condemnation or taking by eminent domain related to any material property or
assets of the Glad Global Business except for such matters that, individually or
in the aggregate, do not and will not have a Material Adverse Effect related to
the Glad Global Business.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c) <U>Sufficiency of and Title to Properties; Absence of Liens and Encumbrances</U>. The Clorox Parties and their Subsidiaries have
good title to all properties, assets and other rights reflected as owned by the
Clorox Parties on the Glad Balance Sheet or acquired after the date of such Glad
Balance Sheet and prior to the Closing Date, as well as all other properties,
assets and other rights included in the Clorox Contribution, free and clear of
all Liens (other than Permitted Liens), except for any such properties, assets
or other rights sold, transferred or otherwise disposed of after the date of the
Glad Balance Sheet and prior to the Closing in the ordinary course of the Glad
Business and not in violation of Section 7.7 hereof. The Glad Parties and their
Subsidiaries will own or have the right to use all properties, assets and other
rights used to generate the income reflected in the income statements included
in the PWC Report with respect to the Glad Existing International Business
except for any such properties, assets or other rights sold, transferred or
otherwise disposed of after the date of such income statements and prior to the
Closing in the ordinary course of the Glad Existing International Business and
not in violation of Section 7.7 hereof.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Properties, Contracts, Permits and Other Data</FONT></U><FONT face="Times New Roman" size=2>. All rights, licenses, leases, registrations,
applications, contracts, commitments and other agreements of the Glad Global
Business or by which the assets used in the Glad Global Business are bound are
in full force and effect and are valid and enforceable in accordance with their
respective terms except for such failures to be in full force and effect and
valid and enforceable that do not and will not, individually or in the
aggregate, have a Material Adverse Effect. The Glad Parties are not in breach or
default in the performance of their obligations thereunder with respect to the
Glad Global Business and no event has occurred or has failed to occur whereby
any of the other parties thereto have been or will be released therefrom or will
be entitled to refuse to perform thereunder, except for such matters which do
not and will not individually or in the aggregate, a Material Adverse
Effect.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(e)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Real Property</FONT></U><FONT face="Times New Roman" size=2>. With
respect to any real property owned by the Glad Parties and used in the Glad
Global Business (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Owned Real
Property</FONT></U><FONT face="Times New Roman" size=2>&#148;), the Glad Parties have
good title to such parcel, free and clear of all Liens, except for Permitted
Liens, and (i) there are no leases, subleases, licenses or agreements granting
to any party or parties the right of use or occupancy of any portion of such
Owned Real Property; and there are no outstanding options or rights of first
refusal to purchase such parcel, or any portion thereof or interest therein, in
each case except as, individually or in the aggregate, do not and will not have
a Material Adverse Effect. With respect to any real property leased by the Glad
Parties and used in the Glad Global Business (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Leased Real Property</FONT></U><FONT face="Times New Roman" size=2>&#148;), none of the Glad Parties has assigned,
transferred, conveyed, mortgaged, deeded in trust or encumbered any interest in
the leasehold or subleasehold under any Leased Real Property and there are no
leases, subleases, licenses or agreements granting to any third party or parties
the right of use or occupancy of any portion of any Leased Real Property, in
each case except as do not and will not have a Material Adverse Effect.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>36</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(f)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Legal Proceedings</FONT></U><FONT face="Times New Roman" size=2>. As of
the date of this Agreement, there is no material litigation, proceeding or
governmental investigation to which any Glad Party is a party pending or, to the
knowledge of the Clorox Parties, threatened against the Glad Parties or their
respective Subsidiaries arising out of or related to the Glad Global Business or
assets used in the Glad Global Business or the transactions contemplated by this
Agreement or which seeks to restrain or enjoin the consummation of any of the
transactions contemplated hereby. The Glad Parties are not a party to with
respect to the Glad Global Business, nor are the assets used in the Glad Global
Business subject to, any material judgment, writ, decree, injunction or order
entered by any court or Governmental Authority (domestic or foreign).</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(g)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Labor Controversies</FONT></U><FONT face="Times New Roman" size=2>. (i)
There have been no labor strikes, slow-downs, work stoppages or lock-outs during
the past three years, nor is any such strike, slow-down, work stoppage or
lock-out pending or, to the knowledge of the Clorox Parties, threatened with
respect to the current or former employees of the Glad Parties performing
services with respect to the Glad Global Business and (ii) the Glad Parties are
not party with respect to the Glad Global Business to any collective bargaining
agreement, contract, letter of understanding or, to the knowledge of the Clorox
Parties, any other agreement, formal or informal with any labor union or
organization.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(h)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Intellectual Property and Technology</FONT></U><FONT face="Times New Roman" size=2>. The Glad Parties own, or are licensed to use,
all Intellectual Property used in the Glad Global Business as of the date hereof
and as used during the [* * *]. The patents and trademarks used in the Glad
Global Business are unexpired and have not been abandoned other than pursuant to
a reasonable business decision made in the ordinary course of business. The
patents and trademarks of the Glad Global Business are valid and enforceable. To
the knowledge of the Clorox Parties, the Intellectual Property used in the Glad
Global Business is not being Infringed by any third party. The conduct of the
Glad Global Business, including the use or practice of the patents in the Glad
Global Business and the use of the trademarks in the Glad Global Business,
consistent with past practice during the [* * *] does not Infringe upon or
misappropriate the Intellectual Property of any third party. Except as expressly
provided in the [* * *] none of the rights of Clorox or its Affiliates to any
Intellectual Property used in the Glad Global Business will be impaired by the
transactions provided for herein. There are no currently pending claims (whether
private or governmental) against any of the Glad Parties, or to their knowledge
threatened, that seek to limit their right to use any of the Intellectual
Property used by the Glad Parties in conducting the Glad Global Business or
alleging that the use of any Intellectual Property by the Glad Parties does not
comply with any governmental regulation, or that seek to cancel or question the
validity, enforceability, ownership or use of any Intellectual Property used in
the Glad Global Business. The Glad Parties have taken all reasonable steps to
protect, maintain and safeguard the Intellectual Property used in the Glad
Global Business. The food storage, bags, wraps and container products of the
Glad Business contain only substances that are food-contact safe as determined
by the United States Food and Drug Administration (&#147;FDA&#148;) and do not contain any
other substances that require approval of the FDA or any other Governmental
Authority.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>37</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Government Licenses, Permits, Etc</FONT></U><FONT face="Times New Roman" size=2>. The Glad Parties have all licenses, permits, consents, approvals,
authorizations, qualifications and orders of Governmental Authorities required
for the conduct of the Glad Global Business as presently conducted by the Glad
Parties consistent with past practice, except where failure does not and will
not, individually or in the aggregate, have a Material Adverse
Effect.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(j)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Conduct of Business in Compliance with Regulatory and
Contractual</FONT></U><FONT face="Times New Roman" size=2></FONT><U><FONT face="Times New Roman" size=2> Requirements</FONT></U><FONT face="Times New Roman" size=2>. The Glad Parties have complied in conducting the
Glad Global Business with all applicable laws, ordinances, regulations or orders
or other requirements of any Governmental Authority, including all rules,
regulations and administrative orders relating to anti-competitive practices,
discrimination, employment, health and safety, except for such matters which do
not and will not have, individually or in the aggregate, a Material Adverse
Effect.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(k)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Environmental Matters</FONT></U><FONT face="Times New Roman" size=2>.
Except for matters that, individually or in the aggregate, do not and will not
have a Material Adverse Effect, (i) there are no Materials of Environmental
Concern at any property owned or leased by the Glad Parties and used in the
conduct of the Glad Global Business that have or will give rise to any Liability
under any Environmental Law; and (ii) no judicial, administrative, or arbitral
proceeding (including any notice of violation or alleged violation) under any
Environmental Law to which any Glad Party is, or to the knowledge of the Clorox
Parties will be, named as a party is pending or, to the knowledge of the Clorox
Parties, threatened with respect to the Glad Global Business.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(l)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Tax
Matters</FONT></U><FONT face="Times New Roman" size=2>.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Except for matters that,
individually or in the aggregate, do not and will not, have a Material Adverse
Effect:</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>(x)
the Glad Parties have (A) duly and timely filed with the appropriate tax
authority all Tax returns required to be filed by or with respect to the Glad
Global Business, and (B) paid in full all Taxes due by or in respect of the Glad
Global Business for all periods; and (y) the Glad Parties have, in respect of
the Glad Global Business, properly withheld amounts for Taxes from its employees
and has made all remittances of amounts required to be withheld and, with
respect to such employees, has filed all Tax returns and reports required to be
filed with any tax authority;</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>there
is no existing Tax audit or proceeding between any Glad Party and any Tax
authority with respect to, or which may have an effect on, the Glad Global
Business; there are no claims for Taxes that have been asserted or proposed in
writing against any Glad Party with respect to, or which may have an effect on,
the Glad Global Business; and</FONT></P>
<P ALIGN="LEFT" STYLE="margin-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>there
are no Liens for Taxes, nor any pending or threatened Liens for Taxes, upon any
property or assets of the Glad Global Business, except for Liens for current
Taxes not yet due.</FONT></P>

<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>38</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(m) <U>Entire Business</U>. Except
for (i) the Clorox Excluded Assets, (ii) the properties, assets and other rights
used by Clorox and its Subsidiaries to conduct the Clorox Services and (iii) the properties, assets and
other rights used by the Glad Parties to conduct the Glad Existing International
Business, the Clorox Contribution constitutes all of the properties, assets,
contracts and other rights necessary for the conduct of the Glad Global Business
as currently conducted by the Glad Parties consistent with past
practice.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(n)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Affiliate Transactions</FONT></U><FONT face="Times New Roman" size=2>.
Except for transactions and other matters subject to the JV Accounting
Principles or the Related Agreements and for the Clorox Services, there are no
agreements, arrangements, undertakings or other transactions between the Glad
Global Business and any other business or division of Clorox, except for
transactions in the ordinary course of business on terms comparable in all
material respects to those that it would obtain in a comparable arm&#146;s length
transaction with a third party that is not an Affiliate.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(o)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Employee Benefit Matters</FONT></U><FONT face="Times New Roman" size=2>.
Each employee benefit plan, severance, change-in-control or employment plan,
program or agreement, stock option, bonus plan, or incentive plan or program of
the Glad Parties with respect to employees engaged in conducting the Glad Global
Business (such plans, the &#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox
Benefit Plans</FONT></U><FONT face="Times New Roman" size=2>&#148;) has been
administered and is in compliance with the terms of such Clorox Benefit Plan and
all applicable laws, rules and regulations except where the failure thereof does
not and will not, individually or in the aggregate, result in Liability that has
or will have a Material Adverse Effect. No litigation or administrative or other
proceeding involving any Clorox Benefit Plan has occurred or, to the knowledge
of the Clorox Parties, is threatened where an adverse determination would result
in Liability that has or will have a Material Adverse Effect.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(p)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Insurance</FONT></U><FONT face="Times New Roman" size=2>. The Glad
Parties have insurance policies with respect to the assets and Liabilities
attributed to the Glad Global Business that are of the type and in amounts that
are adequate to protect and conduct the Glad Global Business. There is no
material claim by Clorox or any of its Subsidiaries pending under any of such
insurance policies.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 4.3</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Representations and Warranties of P&amp;G</FONT></U><FONT face="Times New Roman" size=2>.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Each of the P&amp;G Parties
hereby jointly and severally represents and warrants to the Clorox Parties as
follows, subject to the exceptions set forth on the P&amp;G Disclosure
Schedule:</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>P&amp;G Equipment</FONT></U><FONT face="Times New Roman" size=2>. The
P&amp;G Parties or their Affiliates have, and at the Closing the Clorox Parties
will receive, good and marketable title to the P&amp;G Equipment, free and clear
of all Liens except for Permitted Liens. The P&amp;G Equipment is in good
condition and, to the extent installed, has been reasonably maintained
consistent with standards generally followed in the industry, and is suitable
for use as it is currently used and as currently expected to be used in
connection with the Glad Global Business after the Closing.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Legal Proceedings</FONT></U><FONT face="Times New Roman" size=2>. As of
the date of this Agreement, there is no material litigation, proceeding or
governmental investigation to which the P&amp;G Parties or their Affiliates is a
party pending or, to the knowledge of the P&amp;G Parties, threatened against
P&amp;G or its Subsidiaries or relating to the P&amp;G Equipment or the
transactions contemplated by this Agreement or which seeks to restrain or enjoin
the consummation of any of the transactions contemplated hereby. None of the
P&amp;G Parties is a party to, nor is the P&amp;G Equipment subject to, any
material judgment, writ, decree, injunction or order entered by any court or
Governmental Authority (domestic or foreign). </FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>39</FONT></p>
<HR align=center width="100%" noShade size="2">


<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 4.4</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Survival of Representations and Warranties</FONT></U><FONT face="Times New Roman" size=2></FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The representations and
warranties given by the Parties in this Article IV and contained in the
certificates delivered pursuant to Article VIII will survive until the eighteen
(18) month anniversary of the Closing Date, at which time such representations
and warranties will terminate and have no further force or effect except for any
claim of breach that has been made in writing to Clorox (in the case of any
breach of representation or warranty by the Clorox Parties) or the P&amp;G
Parties (in the case of any breach of representation or warranty by the P&amp;G
Parties) prior to such termination.</FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE V</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>GOVERNANCE</FONT></U><FONT face="Times New Roman" size=2></FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 5.1</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Board of Managers</FONT></U><FONT face="Times New Roman" size=2>.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a) The
day-to-day business of the Joint Venture will be managed by the Clorox Partners,
under the direction and control of the board of managers of the Joint Venture
(the &#147;<U>Board</U>&#148;). The Board will consist of five (5) managers or
such other number (but in no event fewer than three (3)) as may be established
from time to time by the Board. The Clorox Partners and the P&amp;G Partners
will be entitled to representation on the Board in proportion to their
respective JV Interests, provided that the number of managers that each of the
Clorox Partners (together) and the P&amp;G Partners (together) may appoint will
be rounded to the nearest whole number. Notwithstanding the foregoing, during
the Term, the P&amp;G Partners (together) will have the right to appoint at
least one member of the Board. The remaining members of the Board will be
appointed by the Clorox Partners, <U>provided</U> that, in the
event the total number of members is adjusted, the Clorox Partners will in all
cases have the right to appoint a majority of the Board. In the event the
P&amp;G Partners exercise the P&amp;G Option, the P&amp;G Partners&#146;
representation on the Board will be adjusted, if necessary, so as to comply with
this Section 5.1(a). Each JV Partner will have the right to remove and
designate replacements of those members of the Board appointed by it, and each
JV Partner agrees to take any actions necessary to cause such designations or
removals in accordance with this Section 5.1 to be given immediate effect, and
to give effect to decisions of the Board validly taken in accordance with the
terms hereof. The initial Board will consist of Warwick Every-Burns, Wayne
Delker, Greg Frank and Larry Peiros as the Clorox Partners&#146; appointees and
Robert McDonald as the P&amp;G Partners&#146; appointee. Replacement Board members
designated by the P&amp;G Partners will be reasonably acceptable to Clorox. The
Board will appoint by majority vote one of its members appointed by the Clorox
Partners to preside at meetings of the Board.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
P&amp;G Partners will also be entitled to designate in writing to Clorox up to
two (2) representatives reasonably satisfactory to Clorox to attend all meetings
of the Board in a nonvoting observer capacity (the &#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Observers</FONT></U><FONT face="Times New Roman" size=2>&#148;). Such representatives will receive copies of
all notices, minutes, consents, and other materials as and when provided to the
members of the Board, <U>provided</U> that all such representatives must agree
to be bound by the same policies and agreements relating to confidentiality with
respect to information concerning the Joint Venture as apply to the members of
the Board appointed by the P&amp;G Partners. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>40</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Notwithstanding the foregoing, the provisions of this Article V will not
entitle any Person to receive any information from any Clorox Partner in the
event and to the extent that: (i) such information would be subject to
attorney-client or other legally-recognized privilege except for its being
provided to such Person and (A) based on the reasonable advice of its counsel
the Clorox Partner determines that such privilege would no longer be available
in the event the information was disclosed to such Person and (B) the Clorox
Partner desires to retain the availability of such privilege with respect to
such information, (ii) such information is subject to confidentiality
obligations of the Clorox Partners to third parties, which obligations existed
prior to the date of this Agreement and would be breached by the disclosure to
such Person or (iii) such information is determined by Clorox reasonably and in
good faith as being information that could be used by the P&amp;G Partners to
the competitive disadvantage of any business of operations of Clorox and its
Subsidiaries other than the Glad Global Business. Notwithstanding the foregoing,
the Parties acknowledge and agree that they intend to minimize the amount of
information not shared by the Clorox Partners with the P&amp;G Partners with
respect to the Glad Global Business. Accordingly, the Clorox Partners agree to
use their [* * *] efforts to identify and implement appropriate means to share
such information while at the same time protecting the interests of the Joint
Venture and the Clorox Partners.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
Board has, subject to the control of the JV Partners, general supervision,
direction and control of the business of the Joint Venture. The Board will have
the general powers and duties typically vested in the board of directors of a
corporation and all other powers and duties over the Joint Venture and its
business except as expressly provided elsewhere in this Agreement, provided that
the power of the Board will be no greater than the powers of the board of
directors or equivalent governing body of any other business unit of Clorox, and
the operations of the Glad Business will remain subject to in all respects, and
the provisions of this Section 5.1 will in no way affect, any requirements for
approval of the board of directors of Clorox with respect to any matter. Certain
specific items that will be subject to Board-level authorization are identified
in Sections 5.3, 5.4 and 5.5 hereof.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(e) The
Joint Venture will be managed in the United States on a day-to-day basis by a
Glad Leadership Team (&#147;<U>Glad
Leadership Team</U>&#148;) that will
consist of the executive management team for the Glad Business and will report
to the Board. The composition of the Glad Leadership Team will consist primarily
of representatives of [* * *]. The P&amp;G Partners [* * *] Glad Leadership Team [* * *] position to
be determined by the Board, and subject to the [* * *]. The representatives [* *
*] on the Glad Leadership Team will [* * *] will be attributed to the [* *
*].</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(f)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
persons designated by the P&amp;G Partners as Board members, P&amp;G Observers
and [* * *] will all be employees of P&amp;G or its Subsidiaries who have
sufficient seniority, knowledge and experience to contribute to the success of
the Glad Business.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>41</FONT></p>
<HR align=center width="100%" noShade size="2">
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(g)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>No
member of the Board or P&amp;G Observer will receive any compensation for
serving as Board member or non-voting observer on the Board, other than
reimbursement for reasonable out-of-pocket expenses for travel to and from
meetings of the Board, which reimbursement will be paid by the Party appointing
such Board member or non-voting observer.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(h) Notwithstanding anything to the contrary contained herein, but subject to
the provisions of Section 7.1 hereof, all matters relating to the pricing of
intercompany transfers and charges between or among any of the Clorox Partners
will be decided by the Clorox Partners, in their sole discretion, and the Board
will have no control whatsoever over such matters, <U>provided</U> that such intercompany transfers and charges are consistent with the JV
Accounting Principles, this Agreement and the Related Agreements and the effects
of all such intercompany transfers and charges on the calculation of Net Profits
and Net Loss of the Joint Venture are eliminated therefrom in accordance with
the JV Accounting Principles.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
Board will have the right to form one or more committees of the Board and to
delegate authority to such committees in its discretion, provided that the
formation of any committee, its size, the identity of its members, and the scope
of authority to be delegated to it will all subject to the unanimous approval of
the Board.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 5.2</FONT><FONT face="Times New Roman" size=2></FONT> <U><FONT face="Times New Roman" size=2>Meetings of the Board</FONT></U><FONT face="Times New Roman" size=2>.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>The
Board will meet at least six (6) times a year for the first two Fiscal Years of
the Joint Venture and four (4) times annually thereafter. Regular meetings of
the Board will be scheduled with at least five (5) Business Days notice. Special
meetings of the Board for any purpose may be called at any time by the person
selected to preside at meetings of the Board, upon at least two (2) Business
Days notice unless waived by each member of the Board. Notice of the time and
place of any meeting of the Board will be given to each Board member (i)
personally communicated to them by telephone, and confirmed in writing by
facsimile or electronic mail, or (ii) communicated by Federal Express or other
comparable overnight courier service (receipt requested).</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Meetings of the Board will be held at the Joint Venture&#146;s offices in
Oakland, California, unless some other place is designated in the notice of the
meeting. Any member of the Board may participate in a meeting by conference
telephone or similar medium so long as all members of the Board participating in
such meeting can hear one another and any such member will count towards the
determination of the presence of a quorum. Accurate minutes of any meeting of
the Board will be maintained by the person designated by the Board for that
purpose.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>42</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c) A quorum for any meeting
of the Board will require the presence of (x) a majority of the total number of
incumbent members of the Board and (y) at least one member appointed by the
P&amp;G Partners, which member must be a voting member. Any Board member may
appoint another individual to act in his or her stead for a particular Board
meeting by executing a written proxy that is delivered to the Board at the
meeting and filed with the records of the Board with respect to such meeting.
Any Board member making such an appointment will seek in good faith to provide
that the person appointed will be of comparable seniority and/or experience with
respect to the Joint Venture to such Board member. Except as otherwise set
forth in this Agreement, an action or decision of the Board will require the
consent or vote of a majority of its members. Except as otherwise provided in
this Agreement or by applicable law, the action of a majority of the members of
the Board present at any meeting at which there is a quorum, when duly
assembled, is valid. A meeting at which a quorum is initially present may
continue to transact business, notwithstanding the withdrawal of members of the
Board, if any action taken is approved by a majority of the required quorum for
such meeting. If at any meeting of the Board that has been duly called or
noticed, no Board member(s) appointed by the P&amp;G Partners are present, such
meeting will be adjourned and reconvened in two (2) Business Days, unless such
adjournment has been waived by each of the members of the Board. Notice of the
revised meeting date will be given to each Board member pursuant to the
foregoing provisions excluding the number of days of advance notice.
Notwithstanding the other provisions of this Section 5.2(c), in the event that
no Board member(s) appointed by the P&amp;G Partners are present at such
reconvened meeting, such meeting will be deemed to have a quorum if a majority
of the total number of Board members is present. Meetings of the Board will be
delayed only once for lack of participation of the Board member(s) appointed by
the P&amp;G Partners. For purposes of clarification, all references to member(s)
appointed by P&amp;G Partners are to P&amp;G Partners&#146; voting member(s) not
Board Observers.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>With
respect to a meeting which has not been duly called or noticed pursuant to the
foregoing provisions, all transactions carried out at the meeting are as valid
as if they had been carried out at a meeting regularly called and noticed if:
(i) all members of the Board are present at the meeting, and sign a written
consent to the holding of such meeting, (ii) a majority of the members of the
Board are present and if those not present sign a waiver of notice of such
meeting or a consent to holding the meeting or an approval of the minutes
thereof, whether prior to or after the holding of such meeting, which waiver,
consent or approval will be filed with the other records of the Joint Venture or
(iii) all members of the Board attend a meeting without notice and do not
protest prior to the meeting or at its commencement that notice was not given to
them.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(e)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>Any
action required or permitted to be taken by the Board may be taken without a
meeting and will have the same force and effect as if taken by a vote of Board
at a meeting properly called and notice, if authorized by a writing signed
individually or collectively by all, but not less than all, the members of the
Board. Such consent will be filed with the records of the Joint
Venture.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(f)</FONT><FONT face="Times New Roman" size=2></FONT> <FONT face="Times New Roman" size=2>A
reasonably detailed agenda for any meeting of the Board will be supplied to each
member of the Board at the same time notice of the meeting is given, together
with other appropriate documentation relating to items on such agenda. Any
member of the Board wishing to place a matter on the agenda of any meeting may
do so by communicating with the person selected to preside at meetings of the
Board.</FONT></P>

<P align=left><FONT face="Times New Roman" size=2><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE
BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.</FONT></FONT></P>
<P STYLE="text-align: center"><FONT face="Times New Roman" size=2>43</FONT></P>
<HR align=center width="100%" noShade size="2">
<!--Part04-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 5.3 <U>P&amp;G Veto
Rights</U>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a) Notwithstanding anything
in this Agreement to the contrary, during the Term, none of the following
actions will be taken by the Clorox Partners or their Subsidiaries, regardless
of whether such actions will have been approved by the board of directors of
Clorox or any Clorox Partner, without either (x) the prior written consent of
the P&amp;G Partners or (y) the approval of a majority of the Board members
appointed by the P&amp;G Partners: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>any
issuance of any JV Interest to any Person other than as expressly provided in
this Agreement; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>the
incurrence or assumption of any Indebtedness to be attributed to the Joint
Venture (other than Parent Loans attributed to the Joint Venture pursuant to
Section 2.6) that would result in the aggregate outstanding Indebtedness
attributed to the Joint Venture and the Glad Licensed Business at the time such
Indebtedness is incurred or assumed (other than Parent Loans attributed to the
Joint Venture pursuant to Section 2.6 and Affiliate Loans attributed to the Glad
Licensed Business) to be in excess of [* * *] $[* * *] percent ([* * *]%) of the
annual net sales attributed to the Joint Venture and the Glad Licensed Business
for the prior four Fiscal Quarters; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>any
purchase or other acquisition of any business, division or Person that will be
attributed to the Joint Venture for consideration (which will include the
purchase price, plus the aggregate of (A) any Indebtedness assumed and (B) any
Liabilities assumed that in the good faith estimation of the Board at the time
the relevant acquisition agreement is executed will not be satisfied from cash
flow of the acquired business or assets) in excess of [* * *] $[* * *] percent
([* * *]%) of the annual net sales attributed to the Joint Venture and the Glad
Licensed Business during the prior four Fiscal Quarters; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>subject to the provisions of Section 7.5(c), any sale, transfer or other
disposition in any single transaction or series of related transactions (A) of
any business, division or Person attributed to the Joint Venture, or (B) other
than in the ordinary course of the conduct of the Glad Business of any assets
attributed to the Joint Venture, which assets (x) are not obsolete, (y) are
utilized in a material manner in the Glad Business at the time of such sale, and
(z) are not being replaced with assets of comparable utility or value to the
Glad Business, provided that in each case such business, division, Person or
assets have a value in excess of [* * *] $ [* * *] percent ([* * *]%) of the
annual net sales attributed to the Joint Venture and the Glad Licensed Business
during the prior four Fiscal Quarters, and provided further that this Section
5.3(a)(iv) will not apply with respect to any sale of all or substantially all
the business, assets and properties attributed to the Joint Venture; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(v)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>except
as provided in this Agreement or the Related Agreements, any transaction with
respect to the Glad Business between Clorox and any Affiliate of Clorox unless
(x) (A) such transaction is [* * *] or is less than $[* * *] and (B) the terms
of such transaction to be attributed to the Joint Venture are no less favorable
than those that would be obtained in a comparable arm&#146;s length transaction with
a third party that is not Clorox or an Affiliate of Clorox (&#147;</FONT><U><FONT face="Times New Roman" size=2>Arm&#146;s Length Terms</FONT></U><FONT face="Times New Roman" size=2>&#148;), (y) any effects of such transaction that would
be attributed to the Joint Venture will be eliminated pursuant to the JV
Accounting Principles or (z) such transaction is otherwise provided for pursuant
to the JV Accounting Principles; </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT size=2 face="Times New Roman">44</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(vi)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>any
distributions made to the JV Partners with respect to the JV Interests other
than from Distributable Cash Flow; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(vii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>any
internal restructuring of the method by which Clorox&#146;s legal ownership of the
Glad Business is held by Clorox and its Subsidiaries that, based on the facts
and circumstances known at the time such restructuring is approved, has or will
have a material adverse effect on the business, properties, financial condition,
results of operations or prospects of the Glad Business; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(viii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>any
changes in the accounting policies of the Joint Venture so as to differ from the
JV Accounting Principles, except as required by Governmental Authorities or
except as required to conform to a general change being made by Clorox to its
accounting policies as in effect throughout its businesses that, based on the
facts and circumstances known at the time such change is approved, do not and
will not adversely affect the relative economic interests hereunder of the
P&amp;G Partners, on the one hand, and the Clorox Partners, on the other hand;
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(ix)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>the
Glad Business [* * *]; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(x)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>any
termination of any [* * *], any failure to renew the term of any [* * *] or any
change to the [* * *] terms of any [* * *] in each case prior to the earlier of
(A) termination of [* * *] and (B) any [* * *]; and </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(xi)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>any
termination of any [* * *], any failure to renew the term of any [* * *] or any
change to the [* * *] terms of any [* * *], in each case prior to the earlier of
(A) termination of the [* * *] and (B) any [* * *]. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In the
event that the Board designees of the P&amp;G Partners fail to approve any
action approved by a majority of the Board and the Joint Venture is prohibited
from taking such action (a &#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Veto</FONT></U><FONT face="Times New Roman" size=2>&#148;), the
P&amp;G Partners and Clorox will attempt to resolve such dispute by immediately
submitting it for resolution to the respective chief executive officers of
Clorox and P&amp;G. The chief executive officers will negotiate in good faith to
resolve the dispute in at least one face-to-face meeting to occur within thirty
(30) days (the process of such submission and negotiation is referred to herein
as &#147;</FONT><U><FONT face="Times New Roman" size=2>Escalation</FONT></U><FONT face="Times New Roman" size=2>&#148;). If the chief executive officers of Clorox and
P&amp;G are unable to resolve the dispute within thirty (30) days, the Joint
Venture will be prohibited from taking such action and Clorox will have the
ability to exercise its Call Right pursuant to Section 6.5(b)(i), if and only to
the extent applicable (such thirty (30) day period, the &#147;</FONT><U><FONT face="Times New Roman" size=2>Resolution Period</FONT></U><FONT face="Times New Roman" size=2>&#148;). </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 5.4</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Business Plan, Budget and Reports to the Board</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>The
preliminary business plan for the Joint Venture has been presented to the
P&amp;G Parties and agreed upon by the Parties. The preliminary business plan
with respect to the use of the P&amp;G Parties&#146; proprietary Forceflex and
Impress technologies, which technologies are the subject of licenses under the
P&amp;G License Agreement, is attached as Exhibit D. All subsequent business
plans as well as the long-term strategic plan for the Joint Venture will be
submitted for approval to the Board, in a process that will be consistent with
the submission and approval process of Clorox for the board of directors of
Clorox. The business plan and the long-term strategic plan will be regularly
reviewed by management, and material proposed revisions to the then-current
business plan and long-term strategic plan will be submitted to the Board for
approval.</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>45</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>The
preliminary budget for the Joint Venture is attached as Exhibit E. All
subsequent budgets for the Joint Venture will be submitted for approval to the
Board, in a process that will be consistent with the submission and approval
process of Clorox for the board of directors of Clorox. The budget will be
regularly reviewed by management, and material proposed revisions to the
then-current budget will be submitted to the Board for approval. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>The
Board will determine the additional reports and other information about the
Joint Venture that is to be provided to the members of the Board on a scheduled,
periodic basis. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Additional information about
the Joint Venture will be provided to individual members of the Board upon
reasonable request, provided that it is understood that such requests should not
be unduly burdensome or otherwise of such a nature as to interfere with the
customary operations of the Glad Business or cause the Glad Business to operate
other than in the ordinary course. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 5.5</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Additional Items for Board Approval</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Any
candidate to become a member of the Glad Leadership Team must be submitted to
and approved by the Board prior to becoming a member of such Glad Leadership
Team. The Board will have the right to meet with any such candidate prior to
acting with respect to him or her, and if the Board declines to do so then the
P&amp;G Partners will have an opportunity to meet with such candidate prior to
the Board acting with respect to such candidate. The Board may also designate
other key employee positions in the Glad Business with respect to which it must
approve the candidates, and which the Board will have the right to interview
prior to their appointment (and which the P&amp;G Partners will have an
opportunity to meet with if the Board declines). </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>All
new Significant Contracts to be attributed to the Joint Venture in whole, and
the portions of any Significant Contracts to be attributed to the Joint Venture
in part, will be submitted to and subject to the approval of the Board, in a
process that will be consistent with the submission and approval process of
Clorox for the board of directors of Clorox. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>The
establishment of a direct presence or exclusive distributorship arrangement in
any country where Clorox and its Affiliates do not conduct business directly or
through an exclusive distributor with respect to the Glad Global Business brands
as of the Closing will be submitted to and subject to the approval of the Board,
in a process that will be consistent with the submission and approval process of
Clorox for the board of directors of Clorox. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Any
(i) assumption or incurrence of Indebtedness (other than Parent Loans) in excess
of $[* * *] or (ii) purchase or other acquisition and any sale, transfer or
other disposition of any business, division or Person that will be attributed to
the Glad Business that will not be subject to the prior consent of P&amp;G
pursuant to Sections 5.3(a)(ii), 5.3(a)(iii) or 5.3(a)(iv) hereof will be
submitted to and subject to the approval of the Board.&nbsp;</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>46</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE
VI</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>TRANSFERS OF INTEREST;
TERM AND TERMINATION</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 6.1</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>General; Restrictions on Transfers</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>No JV
Partner may Transfer all or any part of its JV Interests except to a Permitted
Transferee, or pursuant to Section 2.7 hereof. For purposes of clarification, in
the event Clorox engages in any Third-Party Sale, Clorox will assign to the
transferee, and the transferee will assume, this Agreement as part of such
Third-Party Sale as well as all Related Agreements other than those Related
Agreements that by their terms will terminate in connection with such
Third-Party Sale. All Transfers of JV Interests will be effected by written
notice of such Transfer to the Joint Venture. Upon receipt of such notice, the
JV Interests of the JV Partners will be modified to reflect any Transfer
effected in accordance with this Agreement. Notwithstanding the foregoing, any
sale, transfer or assignment of a JV Interest or this Agreement to a Subsidiary
of the transferring Party will not relieve the transferring Party of its
obligations hereunder </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>No JV
Partner will Transfer all or any part of its JV Interest to any Person
(including any Permitted Transferee that is not already bound by the terms of
this Agreement) without such transferee executing and the transferring Party
delivering to the Board and any non-transferring Party a written agreement to be
bound by the terms of this Agreement and all Related Agreements in form and
substance reasonably satisfactory to the Board and the non-transferring Parties.
Any Transfer by a JV Partner of all or any part of its JV Interest must be in
compliance with all applicable federal and state securities laws, and the
provisions of this Section 6.1(b) and the other provisions of this Article VI.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Any
Transfer or attempted Transfer by a JV Partner in violation of this Section 6.1
will be null and void and of no force or effect whatever. Each JV Partner who is
a transferring Party hereby further agrees to hold the Joint Venture and every
other JV Partner and its Affiliates wholly and completely harmless from any
cost, Liability, or damage (including Liabilities for income taxes and costs of
enforcing this indemnity) incurred by any of such indemnified Persons as a
result of a Transfer or an attempted Transfer in violation of this Agreement.
For the avoidance of doubt, the provisions of this Section 6.1 do not limit in
any respect any Transfer by any Clorox Partner of any business, assets or
properties of the Glad Business, including without limitation a Third Party Sale
pursuant to Section 6.7 hereof; provided, such Clorox Partner has assigned to
the transferee and the transferee has assumed this Agreement and all Related
Agreements to the extent required by the terms of Section 6.1. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 6.2</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Effect of Transfers on Distributions among JV Partners</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Upon the occurrence of a
Permitted Transfer of a JV Interest during any Fiscal Year, Net Profits, Net
Losses, each item thereof, and all other items attributed to such JV Interest
for such Fiscal Year will be divided and allocated between the transferor and
the transferee by taking into account their varying interests during the Fiscal
Year in accordance with Code Section 706(d), using any conventions permitted by
law and selected by the Board. Except as otherwise provided in Section
3.4(c)(v), all distributions on or before the date of a Permitted Transfer will
be made to the transferor, and all distributions thereafter will be made to the
transferee. Solely for purposes of making such allocations and distributions, a
Permitted Transfer will be recognized upon the Board&#146;s receipt of (i) written
notice stating the date such Interest was transferred and such other information
as the Board may reasonably require and (ii) the written agreement to be
executed by the Permitted Transferee agreeing to be bound by the terms of this
Agreement pursuant to the requirements of Section 6.1 hereof. The Board will
incur no Liability for making allocations and distributions in accordance with
the provisions of this Section 6.2 whether or not the Board has knowledge of any
Transfer of ownership of any JV Interest.</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>47</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 6.3</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Term of Joint Venture</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>The
term of the Joint Venture (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Term</FONT></U><FONT face="Times New Roman" size=2>&#148;) will commence at
the Closing and will expire on the twenty-year anniversary of the Closing Date
(the &#147;</FONT><U><FONT face="Times New Roman" size=2>Initial Term</FONT></U><FONT face="Times New Roman" size=2>&#148;), unless earlier terminated pursuant to the
provisions of Sections 6.4, 6.5, 6.6 or 6.7 hereof. Either the P&amp;G Partners
or Clorox may deliver written notice to the other not less than five (5) years
prior to the end of the Initial Term requesting that the Term be extended for an
additional ten (10) years after the end of the Initial Term. If the Party
receiving the notice agrees to such extension, the Term will terminate on the
thirty-year anniversary of the Closing Date, unless earlier terminated pursuant
to the provisions of Sections 6.4, 6.5, 6.6 or 6.7 hereof. If the Party
receiving the notice does not agree to such extension, the Term will
automatically terminate at the end of the Initial Term. The expiration of the
Term will not relieve any Party from any liability it may have to any other
Party arising out of or relating to acts or omissions prior to such expiration.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>The
provisions of Section 6.3, 7.2, 7.3, 7.4, 9.1(b) and 9.2, and Articles X and XI
shall survive any termination or expiration, in whole or in part, of this
Agreement. The termination or expiration of this Agreement will not relieve
either Party of any liability it may have to the other Party arising out of or
relating to acts or omissions occurring prior to expiration or termination.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 6.4</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>P&amp;G Put Rights</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>The
P&amp;G Partners will have the right to sell to Clorox, and upon exercise of
such right Clorox (or the Clorox Partner designated by Clorox) will be required
to purchase, all (but not less than all) of the P&amp;G Partners&#146; JV Interests,
including the P&amp;G Option (if the sale is to occur during the Option Exercise
Period and the P&amp;G Option is not yet exercised) (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Put Right</FONT></U><FONT face="Times New Roman" size=2>&#148;) in the event of (x) any Change of Control of
Clorox as set forth in Section 6.4(a)(i) below or (y) the failure to cure
certain breaches by Clorox Partners as set forth in Section 6.4(a)(ii) below.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>48</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(i) In the event a Clorox
Change of Control occurs during the Term, Clorox will provide the P&amp;G
Partners with written notice of the Clorox Change of Control (a &#147;<u>Change of
Control Notice</u>&#148;) within [* * *] after the closing of the transaction resulting
in the Clorox Change of Control. The P&amp;G Partners may irrevocably exercise
their Put Right in connection with such Clorox Change of Control by delivering
written notice of such irrevocable exercise to Clorox within [* * *] days after
the receipt of the Change of Control Notice. The purchase price payable by
Clorox to the P&amp;G Partners for such JV Interests and the P&amp;G Option (if
unexercised but exercisable) will be paid to the P&amp;G Partners and will be
cash equal to the Fair Market Value of their respective JV Interests and the
P&amp;G Option (if unexercised, but exercisable) as of the date of closing of
such Clorox Change of Control, but will be reduced by the applicable Services
Termination Amount, if any, pursuant to Section 6.8 hereof. If the P&amp;G
Partners do not deliver a written exercise notice to Clorox within the
</FONT><FONT face="Times New Roman" size=2>[* * *] period referred to above, the
Put Right will terminate and Clorox will have no further obligation with respect
to the Put Right with respect to such Clorox Change of Control, provided that
such termination will not in any way affect and the P&amp;G Partners will retain
all rights pursuant to this Section 6.4 with respect to any future Clorox Change
of Control. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In the
event a Clorox Partner knowingly breaches in any material respect a material
obligation of a Clorox Partner under the provisions of this Agreement or any
Related Agreement during the Term, the P&amp;G Partners will have the right to
provide Clorox with written notice of such breach. The Clorox Partners will then
have a period of [* * *] to attempt to cure such breach (which period will be
suspended to the extent Clorox is contesting the breach in good faith). If the
Clorox Partners do not cure such breach in all material respects within such [*
* *] period, the P&amp;G Partners and Clorox will attempt to resolve such
dispute by Escalation. If the chief executive officers of Clorox and P&amp;G are
unable to resolve the dispute within thirty (30) days, P&amp;G Partners may
exercise its Put Right in connection with such material breach within [* * *]
after the end of such thirty-day period. The purchase price payable by Clorox to
the P&amp;G Partners for such JV Interests and the P&amp;G Option (if
unexercised, but exercisable) will be cash equal to Fair Market Value of the
P&amp;G Partners&#146; JV Interests and the P&amp;G Option (if unexercised, but
exercisable) as of the date of [* * *] with respect to such breach, provided
that for purposes of this Section 6.4(a)(ii), the Fair Market Value of P&amp;G
Partners&#146; initial Ordinary JV Interest of ten percent (10%) and Class C Interest
during the period commencing on the Closing Date and ending on the [* * *]
anniversary of the Closing Date will be an aggregate of no less than $140
million. If the P&amp;G Partners do not deliver an exercise notice to Clorox
within the [* * *] period referred to above, their Put Right will terminate and
Clorox will have no further obligation with respect to the Put Right with
respect to such Clorox Partner breach and any related matters of which the
P&amp;G Partners have actual knowledge, provided that such termination will not
in any way affect and the P&amp;G Partners will retain all rights pursuant to
this Section 6.4 with respect to any future Clorox Partner breach. In addition,
the P&amp;G Partners will have the right, but not the obligation, to terminate
the P&amp;G Services Agreement at the time of exercise of its Put Right pursuant
to this Section 6.4(a)(ii).</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT size=2 face="Times New Roman">49</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)<FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>The
closing of any sale of a JV Interest pursuant to exercise by P&amp;G Sub of a
Put Right pursuant to this Section 6.4 will take place at the principal office
of Clorox on the </FONT>[* * *] after final determination of Fair Market Value
of the JV Interest being sold, provided that all material orders, consents and
approvals of Governmental Authorities legally required for the closing of such
sale will have been obtained and be in effect. At such closing, Clorox (or the
Clorox Partner designated by Clorox) will deliver the purchase price in
immediately available funds in the appropriate amount (unless other
consideration has been mutually agreed upon by the P&amp;G Partners and Clorox).
The P&amp;G Partners will deliver their JV Interests to Clorox (or the Clorox
Partner designated by Clorox) free and clear of all Liens, and the Term of the
Joint Venture will terminate as of such closing. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 6.5</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Clorox Purchase of P&amp;G JV Interest</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In the
event of any termination or expiration of the Term in accordance with Section
6.3, Clorox (or the Clorox Partner designated by Clorox) will purchase, and the
P&amp;G Partners will be required to sell to Clorox or such Clorox Partner, all
of the JV Interests held by the P&amp;G Partners. In the event of a purchase by
Clorox pursuant to this Section 6.5(a) due to a termination of the Term, the
purchase price for the JV Interests of the P&amp;G Partners will be the Fair
Market Value of such JV Interests, which Fair Market Value will be calculated as
of the date on which the Term is to terminate. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Clorox
will also have the right, but not the obligation, to purchase, and upon exercise
of Clorox&#146;s right the P&amp;G Partners will be required to sell to Clorox (or
the Clorox Partner designated by Clorox), all of the P&amp;G Partners&#146; JV
Interests, including the P&amp;G Option if such exercise by Clorox is within the
Option Exercise Period and the P&amp;G Option is not yet exercised, (the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Call Right</FONT></U><FONT face="Times New Roman" size=2>&#148;) for a cash purchase price of Fair Market Value
in the event of (x) the failure to resolve certain P&amp;G Vetoes within the
Resolution Period as set forth in Section 6.5(b)(i) below or (y) the failure to
cure certain breaches by P&amp;G Partners as set forth in Section 6.5(b)(ii)
below. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In the
event Clorox and the P&amp;G Partners fail pursuant to Section 5.3(b) to resolve
a dispute with respect to a P&amp;G Veto pursuant to (A) Section 5.3(a)(iii),
(B) Section 5.3(a)(iv) or (C) Section 5.3(a)(v) with respect to a transaction
that is on Arm&#146;s Length Terms, Clorox will have the right to exercise its Call
Right by providing written notice to the P&amp;G Partners of such exercise (a
&#147;</FONT><U><FONT face="Times New Roman" size=2>Deadlock Notice</FONT></U><FONT face="Times New Roman" size=2>&#148;) within [* * *] of the end of the Resolution
Period, and if Clorox does not provide the P&amp;G Partners with a Deadlock
Notice in a timely manner in accordance with this Section 6.5(b)(i), all rights
of Clorox to exercise its Call Right with respect to such P&amp;G Veto will
terminate, provided that such termination will not in any way affect and Clorox
will retain all rights pursuant to this Section 6.5 with respect to any future
P&amp;G Veto. Fair Market Value of the P&amp;G Partners&#146; JV Interests and the
P&amp;G Option (if exercisable but unexercised) for purposes of a purchase
pursuant to this Section 6.5(b)(i) will be determined as of the date of the [* *
*], provided that for purposes of this Section 6.5(b)(i), the Fair Market Value
of the P&amp;G Partners initial Ordinary JV Interest of ten percent (10%) and
Class C Interest during the period commencing on the Closing Date and ending on
the [* * *] anniversary of the Closing Date will be an aggregate of no less than
$140 million. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>50</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(ii)<FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In the
event a P&amp;G Partner knowingly breaches in any material respect a material
obligation of a P&amp;G Partner under the provisions of this Agreement or any
Related Agreement during the Term, Clorox will have the right to provide the
P&amp;G Partners with written notice of such breach. The P&amp;G Partners will
then have a period of </FONT>[* * *] to attempt to cure such breach (which
period will be suspended to the extent the P&amp;G Partners are contesting the
breach in good faith). If the P&amp;G Partners do not cure such breach in all
material respects within such [* * *] period, the P&amp;G Partners and Clorox
will attempt to resolve such dispute by Escalation. If the chief executive
officers of Clorox and the P&amp;G Partners are unable to resolve the dispute
within thirty (30) days, Clorox may exercise its Call Right in connection with
such material breach within [* * *] after the end of such thirty-day period. The
purchase price payable by Clorox to the P&amp;G Partners for such JV Interests
and the P&amp;G Option (if unexercised but exercisable) will be cash equal to
Fair Market Value [* * *] with respect to such breach. If Clorox does not
deliver an exercise notice to the P&amp;G Partners within the [* * *] period
referred to above, its Call Right will terminate and the P&amp;G Partners will
have no further obligation with respect to the Call Right with respect to such
P&amp;G Partner breach and any related matters of which Clorox has actual
knowledge, provided that such termination will not in any way affect and Clorox
will retain all rights pursuant to this Section 6.4 with respect to any future
P&amp;G Partner breach. In addition, Clorox will have the right, but not the
obligation, to terminate the P&amp;G Services Agreement at the time of exercise
of its Call Right pursuant to this Section 6.5(b)(ii). </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>The
closing of any sale of a JV Interest and the P&amp;G Option pursuant to an
exercise by Clorox of a Call Right pursuant to this Section 6.5 will take place
at the principal office of Clorox on the [* * *] after final determination of
Fair Market Value of the JV Interest being sold, provided that all material
orders, consents and approvals of Governmental Authorities legally required for
the closing of such sale will have been obtained and be in effect. At such
closing, Clorox (or the Clorox Partner designated by Clorox) will deliver the
purchase price in immediately available funds in the appropriate amount (unless
other consideration has been mutually agreed upon by the P&amp;G Partners and
Clorox). The P&amp;G Partners will deliver their JV Interests to Clorox (or the
Clorox Partner designated by Clorox) free and clear of all Liens, and the Term
of the Joint Venture will terminate as of such closing. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>51</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 6.6</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Tag-Along Rights</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>With
respect to any proposed direct or indirect sale, transfer or assignment (which
will not include a bona fide pledge of assets) by any Clorox Partner of all or
substantially all of the Glad Global Business (other than such a sale, transfer
or assignment to a Clorox Affiliate), Clorox will have the obligation, and each
P&amp;G Partner will have the right (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Tag-Along Right</FONT></U><FONT face="Times New Roman" size=2>&#148;), to
require the proposed transferee to purchase from each P&amp;G Partner all, but
not less than all, its JV Interests, and the P&amp;G Option if the Tag-Along
Right is exercised during the Option Exercise Period and the P&amp;G Option is
not yet exercised, at a price equal to Fair Market Value, and upon the same
other terms and conditions as to be given to the Clorox Partners, provided that
in order to be entitled to exercise their Tag-Along Right, the P&amp;G Partners
must agree to give the same indemnities as the Clorox Partners agree to make in
connection with the proposed sale, transfer or assignment, which obligations
will be borne by the P&amp;G Partners on a pro rata basis based on the relative
Ordinary JV Interests of all the JV Partners but in the case of each P&amp;G
Partner will in no event exceed ten percent (10%) of the sale proceeds received
by such P&amp;G Partner. In addition, the purchase price payable to the P&amp;G
Partners will be reduced by the applicable Services Termination Amount, if any,
pursuant to Section 6.8 hereof. With respect to the P&amp;G
Option if the P&amp;G Option is unexercised but exercisable, the P&amp;G
Partners will receive from the proceeds otherwise payable to the Clorox Partners
the amount by which the Fair Market Value of the Ordinary JV Interest and Class
A Interest subject to the P&amp;G Option exceeds the Option Price. The purchase
price payable to the P&amp;G Partners for the P&amp;G Option (if the P&amp;G
Option is unexercised, but exercisable) will therefore be the greater of (i)
zero and (ii) an amount equal to (x) the Fair Market Value of the Ordinary JV
Interest and Class A Interest to be acquired by the P&amp;G Partners upon
exercise of the P&amp;G Option </FONT><U><FONT face="Times New Roman" size=2>minus</FONT></U><FONT face="Times New Roman" size=2> (y) the
then-applicable Option Price (and the amount of the purchase price payable to
the Clorox Parties will be reduced by an equal amount). Upon completion of such
sale the P&amp;G Option will terminate. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Clorox
must give notice to the P&amp;G Partners of each proposed sale, transfer or
assignment (which will not include a bona fide pledge of assets) giving rise to
a Tag-Along Right at least [* * *] prior to the proposed consummation of such
sale, transfer or assignment, setting forth the JV Interest proposed to be so
sold, transferred or assigned, the name and address of the proposed transferee,
the proposed amount of consideration therefor and terms and conditions agreed to
by the proposed transferee. The Tag-Along Right must be exercised by a P&amp;G
Partner within [* * *] days following receipt of the Clorox notice, by delivery
of a written irrevocable notice to Clorox indicating exercise of the Tag-Along
Right. If the proposed transferee fails to complete its purchase from any
P&amp;G Partner that has properly exercised its tag-along rights, then Clorox
will not be permitted to make the proposed Transfer, and any such attempted
sale, transfer or assignment will be void and of no effect. If a P&amp;G Partner
exercises its Tag-Along Rights, the closing of the purchase will take place
concurrently with and as part of the closing of the sale of the Glad Global
Business, and the Term of the Joint Venture will terminate as of such closing.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 6.7</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Drag Along Rights</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>If at
any time during the Term, any Clorox Partner enters into an agreement to
consummate a transaction constituting a direct or indirect sale of all or
substantially all of the Glad Global Business (other than a Clorox Change of
Control) (a &#147;Third-Party Sale&#148;), then upon the written demand of Clorox, each
P&amp;G Partner will agree to sell all its JV Interests, and the P&amp;G Option
if the Third-Party Sale is during the Option Exercise Period and the P&amp;G
Option is not yet exercised, and at a price equal to the Fair Market Value for
such JV Interests, and upon the same other terms and conditions as to be given
to the Clorox Partners, provided that in order to be entitled to exercise their
rights in connection with a Third Party Sale, the P&amp;G Partners must agree to
give the same indemnities as the Clorox Partners agree to make in connection
with the proposed sale, transfer or assignment, which obligations will be borne
by the P&amp;G Partners on a pro rata basis based on the relative Ordinary JV
Interests of all JV Partners but in the case of each P&amp;G Partner will in no
event exceed ten percent (10%) of the sale proceeds received by such P&amp;G
Partner. Notwithstanding the foregoing, with respect to any a Third-Party Sale
that occurs prior to [* * *] anniversary of the Closing Date, the purchase price
to be paid to the P&amp;G Partners in such Third-Party Sale for P&amp;G&#146;s
initial Ordinary JV Interest of ten percent (10%) and Class C Interest will be
an aggregate of no less than $140 million. With respect to the P&amp;G Option if
the P&amp;G Option is unexercised but exercisable, the P&amp;G Partners will
receive from the proceeds otherwise payable to the Clorox Partners the amount by
which the Fair Market Value of the Ordinary JV Interest and Class A Interest
subject to the P&amp;G Option exceeds the Option Price. The purchase price
payable to the P&amp;G Partners for the P&amp;G Option (if the P&amp;G Option is
unexercised, but exercisable) will therefore be the greater of (i) zero and (ii)
an amount equal to (x) the Fair Market Value of the Ordinary JV Interest and
Class A Interest to be acquired by P&amp;G upon exercise of the P&amp;G Option
minus (y) the then-applicable Option Price (and the amount of the purchase price
payable to the Clorox Parties will be reduced by an equal amount). Upon
completion of such sale the P&amp;G Option will terminate. Clorox agrees it will
not enter into a Third-Party Sale, unless otherwise agreed by the P&amp;G
Partners, without obtaining an opinion from a nationally-recognized investment
banking firm selected by Clorox, which investment banking firm is not otherwise
entitled to any financial advisor&#146;s or similar fee in connection with the
Third-Party Sale, [* * *].</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>52</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Clorox
may exercise its rights in connection with a Third-Party Sale at any time during
the Term upon written notice to the P&amp;G Partners, setting forth the name and
address of the proposed transferee, the proposed amount of consideration
therefor and terms and conditions agreed to by the proposed transferee, provided
that Clorox will use [* * *] efforts to give notice to the P&amp;G Partners at
least [* * *] prior to the proposed consummation of any such Third-Party Sale.
Each P&amp;G Partner will consent to and raise no objections to the proposed
transaction and will take all other actions necessary or desirable to cause the
consummation of such Third-Party Sale on the terms proposed by Clorox. If Clorox
exercises its rights to cause a sale pursuant to this Section 6.7, the closing
of the purchase will take place concurrently with and as part of the closing of
the sale of the Glad Global Business, and the Term of the Joint Venture will
terminate as of such closing. If the proposed transferee fails to complete its
purchase from any P&amp;G Partner at the closing of any Third-Party Sale, then
Clorox will not be permitted to make the proposed Third-Party Sale, and any such
attempted sale, transfer or assignment will be void and of no effect.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Clorox
further agrees that in the event that it [* * *] Third Party Sale, it will
notify the P&amp;G Partners and if the P&amp;G Partners notifies Clorox in
writing within [* * *] of receipt of such notice that P&amp;G has made a good
faith determination to pursue [* * *], Clorox and P&amp;G will negotiate [* * *]
days with respect to [* * *] by P&amp;G of the [* * *] on terms satisfactory to
each of Clorox and P&amp;G, provided that the provisions of this Section 6.7(c)
will in no way obligate Clorox to notify or negotiate with P&amp;G in the event
Clorox receives a [* * *] for a Third Party Sale, and provided further that it
is understood that in the event P&amp;G and Clorox do not enter into a binding
agreement with respect to such a purchase on terms and conditions satisfactory
to each Party in its sole discretion within such [* * *] day period, Clorox will
have the right thereafter to [* * *] into a Third Party Sale with any other
Person. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 6.8</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Services Termination Amount</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In the
event the P&amp;G Services Agreement is terminated by P&amp;G pursuant to
Section 8.2(b) of the P&amp;G Services Agreement in connection with an exercise
by P&amp;G Partners of their Put Right pursuant to Section 6.4(a)(i) hereof or
their Tag-Along Right pursuant to Section 6.6 hereof, the aggregate purchase
price payable to the P&amp;G Partners with respect to their JV Interests
pursuant to such Sections 6.4(a) and 6.6, as applicable, will be reduced as
follows: </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT size=2 face="Times New Roman">53</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%"><FONT face="Times New Roman" size=2>Date of P&amp;G Notice of Termination</FONT></TD>
    <TD noWrap align=left width="90%">&nbsp;</TD>
    <TD noWrap align=left width="2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="6%"><FONT face="Times New Roman" size=2>Purchase Price Reduction</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>On the Closing Date</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="6%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>On the one-year
      anniversary of the Closing Date</FONT></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="6%"><FONT face="Times New Roman" size=2>$[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>On the two-year anniversary of the Closing
      Date</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="6%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>On the three-year
      anniversary of the Closing Date</FONT></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="6%"><FONT face="Times New Roman" size=2>$[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>On the four-year anniversary of the Closing
      Date</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="6%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>On the five-year
      anniversary of the Closing Date</FONT></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="6%"><FONT face="Times New Roman" size=2>$[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>On the six-year anniversary of the Closing
      Date</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="6%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>On the seven-year
      anniversary of the Closing Date</FONT></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="6%"><FONT face="Times New Roman" size=2>$[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>On the eight-year anniversary of the Closing
      Date</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="6%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>On the nine-year
      anniversary of the Closing Date</FONT></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="6%"><FONT face="Times New Roman" size=2>$[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>On and after the ten-year anniversary of the
      Closing Date</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="6%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>[*&nbsp;&nbsp;
      *&nbsp;&nbsp; *]</FONT></TD></TR></TABLE></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>To the extent that the date of
the P&amp;G notice of termination is delivered other than on one of the
anniversary date referenced above, the purchase price reduction will equal the
sum of the purchase price reduction on the immediately succeeding anniversary
date referenced above plus the product of (i) the number of days until the
immediately succeeding anniversary date divided by 365 and (ii) the purchase
price reduction amount on the immediately preceding anniversary date minus the
purchase price reduction amount on the immediately succeeding anniversary date.
</FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE
VII</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>CERTAIN
AGREEMENTS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 7.1</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Personnel; Provision of Services</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>During
the Term, the Clorox Parties will make certain corporate services and employees
available to provide services to the Glad Business and the Glad Licensed
Business on terms and conditions as detailed on </FONT><U><FONT face="Times New Roman" size=2>Exhibit F</FONT></U><FONT face="Times New Roman" size=2> (such services, the &#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox Services</FONT></U><FONT face="Times New Roman" size=2>&#148;). The
cost of the Clorox Services with respect to the Glad Business and the Glad
Licensed Business will be attributed to the Joint Venture as set forth on such
</FONT><U><FONT face="Times New Roman" size=2>Exhibit F</FONT></U><FONT face="Times New Roman" size=2>, which </FONT><U><FONT face="Times New Roman" size=2>Exhibit F</FONT></U><FONT face="Times New Roman" size=2> will be
consistent with the JV Accounting Principles. </FONT><U><FONT face="Times New Roman" size=2>Exhibit F</FONT></U><FONT face="Times New Roman" size=2> also sets forth provisions providing for the modification or termination
of the Clorox Services. All costs and expenses that will otherwise be attributed
to the Joint Venture or the Glad Licensed Business with respect to employees of
Clorox or the Clorox Parties will be attributed solely in accordance with the JV
Accounting Principles. Under no circumstances will the Clorox Services be
considered for tax purposes to be given in exchange for any portion of the
Clorox Parties&#146; JV Interest.</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>54</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>During
the Term, P&amp;G will make certain services and employees available to provide
services to the Glad Business and the Glad Licensed Business on terms and
conditions as provided in the P&amp;G Services Agreement attached as
</FONT><U><FONT face="Times New Roman" size=2>Exhibit B</FONT></U><FONT face="Times New Roman" size=2> hereto. In addition, P&amp;G will have the right
to propose that additional employees provide services to the Glad Business and
the Glad Licensed Business from time to time in business functions in which
P&amp;G thinks such employees would be of benefit to the Glad Business or the
Glad Licensed Business, as the case may be. Any such proposals by P&amp;G with
respect to the Glad Business will be reviewed by the Glad Leadership Team and
the Board, and must be approved by the Board prior to being implemented.
Any such proposals by P&amp;G with respect to the Glad Licensed Business will be
reviewed by The Glad Products Company and the International Affiliate conducting
the relevant Glad Local Business. Any such employees will be provided to the
Glad Business or the Glad Licensed Business, as the case may be, at their actual
cost to P&amp;G and its Subsidiaries, which cost will be attributed to the Joint
Venture in a manner consistent with the JV Accounting Principles. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 7.2</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Non-Competition</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In
order to further the business of the Joint Venture and to protect the
Intellectual Property and other contributions of the Parties to the Joint
Venture, each of Clorox and P&amp;G agrees that during the Term, and P&amp;G
agrees that for [* * *] thereafter (unless otherwise provided herein), it will
not, and it will cause its Subsidiaries not to, directly or indirectly conduct,
engage in, manage, own, operate, invest in or license the right to use any
trademark, tradename or Specific Technology for use in connection with, any
Competing Business anywhere in the world other than through the Joint Venture
and the Glad Global Business. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Notwithstanding the foregoing, the provisions of this Section 7.2 will
not prohibit, restrict or prevent Clorox, P&amp;G or their respective
Subsidiaries from: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>engaging in a [* * *] so long as the aggregate revenues to Clorox and its
Subsidiaries or P&amp;G and its Subsidiaries, as applicable, from all such [*
</FONT><FONT face="Times New Roman" size=2>* *], </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>acquiring not more than [* * *] percent ([* * *]%) of any class of
publicly traded equity securities of any Person, </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>acquiring [* * *] percent ([* * *]%) or more of any class of capital
stock of any Person that directly or indirectly through one or more Subsidiaries
or otherwise has a [* * *] operations as long as (x) such [* * *] percent ([* *
*]%) of such acquired Person&#146;s [* * *] acquisition and (y) the portion of such
Person&#146;s business that engages in the [* * *] is sold or disposed of no later
than [* * *] after the [* * *] by Clorox, P&amp;G or their respective
Subsidiaries (as applicable), </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>investing in any Person [* * *] operations as long as (w) such [*
</FONT><FONT face="Times New Roman" size=2>* *] percent ([* * *]%) of such
acquired Person&#146;s [* * *] acquisition, (x) such investment [* * *] percent ([* *
*]%) of any [* * *] interests of such Person, (y) the investor does not,
directly or indirectly, direct or cause the direction of, or participate in, the
[* * *] of such Person, and (z) the Person that directly or indirectly [* * *]
and its Subsidiaries will [* * *] (A) any trademark or tradename of the investor
or any of the investor&#146;s Affiliates [* * *] or (B) any [* * *] owned, licensed
or otherwise held by the investor or any of the investor&#146;s Affiliates,
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(v)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>with
respect to [* * *] with respect to which (A) the license of any P&amp;G
Technology has terminated pursuant to Section 7.1 of the P&amp;G License
Agreement and (B) the Glad Global Business does not conduct any business in such
country or license any third party to conduct such business,</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>55</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(vi)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>[* *
*] if (A) the license of any P&amp;G Technology for use [* * *] has terminated
pursuant to Section 7.1 of the P&amp;G License Agreement and (B) the Joint
Venture [* * *] any business in the [* * *] or license any third party [* * *]
such business, </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(vii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>[* *
*] directly or indirectly [* * *] or [* * *] any product currently [* * *] or [*
* *] by [* * *] (&#147;Existing Product&#148;) which Existing Product would be deemed [* *
*], or </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(viii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>[* *
*], co-marketing products of P&amp;G or its Subsidiaries that are [* * *] with
products of a third party Competing Business that are [* * *]. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>As
used in this Section 7.2, &#147;</FONT><U><FONT face="Times New Roman" size=2>Competing Business</FONT></U><FONT face="Times New Roman" size=2>&#148; means
the [* * *] bags, wraps, straws or covered containers [* * *] but excluding [* *
*]. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>The
restrictions contained in this Section 7.2 will terminate with respect to
P&amp;G and its Subsidiaries in the event of an exercise by P&amp;G of its Put
Right pursuant to Section 6.4(a)(ii) hereof. The expiration or termination of
this Section 7.2 will not affect any of the Parties&#146; rights under the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(e)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In
order to further the business of the Joint Venture and to protect the
Intellectual Property and other contributions of the Parties to the Joint
Venture, during the Term of this Agreement and for [* * *], P&amp;G [* * *]. For
purposes of clarification, P&amp;G will not be deemed to be in breach hereof if
any products based on [* * *] by a customer or broker (or a subsequent customer
or broker) [* * *], so long as P&amp;G and its Subsidiaries [* * *]. Nothing
herein will prevent P&amp;G or its Subsidiaries from selling to any third party
[* * *] (except as set forth in the immediately preceding two sentences).
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 7.3</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Confidentiality; Non-Disclosure</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Each
of Clorox and P&amp;G will, and will cause their respective Subsidiaries,
directors, officers, employees and any other Person to whom such Party discloses
information with respect to the Joint Venture, to hold in confidence all
documents furnished to it, by or on behalf of the other Party in connection with
the transactions contemplated by this Agreement. For purposes of this Section
7.3, references to information of a Party or to disclosure of information by or
to a Party shall in each case include information of, disclosure by and
disclosure to Affiliates of such Party. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>56</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>During
the Term, Clorox and P&amp;G and their respective Subsidiaries, directors,
officers, employees and other representatives will be given access to
non-public, proprietary information that relates to the other&#146;s past, present,
and future research, development, business activities, products, services, and
technical knowledge, as well as non-public information relating to the Glad
Global Business and the Joint Venture, including without limitation the
information provided with respect to the Glad Global Business and the Joint
Venture to the Board, the members of the Glad Leadership Team, and the
P&amp;G Observers and the financial and other information made available to the
Parties pursuant to Sections 7.9 and 9.1 hereof (collectively, &#147;</FONT><U><FONT face="Times New Roman" size=2>Confidential Information</FONT></U><FONT face="Times New Roman" size=2>&#148;). The Parties acknowledge that certain of the
Confidential Information could be used by one Party to the competitive
disadvantage of the business or operations of the other Party unrelated to the
Joint Venture or the Glad Global Business, and therefore agree as follows with
respect to all the Confidential Information: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>the
Confidential Information of the disclosing Party may be used by the receiving
Party only in connection with the Joint Venture and the Glad Global Business;
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>each
Party agrees to protect, and to cause their respective Subsidiaries, directors,
officers, employees and any other Person to whom such Party discloses
Confidential Information of the other Party, to protect the confidentiality of
the Confidential Information of the other in the same manner that it protects
the confidentiality of its own proprietary and confidential information of like
kind, but in no event will either Party exercise less than reasonable care in
protecting such Confidential Information; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>access
to any Confidential Information of the other Party will be restricted to (A) the
members of the Board and (B) the P&amp;G Observers, members of the Glad
Leadership Team, and those other employees and other personnel of the Parties
that (x) are made available to perform services with respect to the Joint
Venture or the Glad Licensed Business pursuant to Section 7.1 as provided
therein, or (y) otherwise need to know such Confidential Information for
purposes of conducting the business of the Joint Venture or the Glad Licensed
Business or implementing this Agreement or any Related Agreement (collectively,
&#147;</FONT><U><FONT face="Times New Roman" size=2>Authorized
Persons</FONT></U><FONT face="Times New Roman" size=2>&#148;). Each Party will cause
the Authorized Persons of such Party not to disclose any Confidential
Information to any other Person who is not an Authorized Person. Each Party will
establish internal ethical walls and other policies and procedures reasonably
satisfactory to the other Party to prevent the disclosure of Confidential
Information of the other Party other than to Authorized Persons and other than
for the purposes of providing services to or otherwise conducting the business
of the Joint Venture or implementing this Agreement or any Related Agreement;
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>all
Confidential Information made available hereunder, including copies thereof,
will be returned or destroyed upon the first to occur of (A) the termination of
the Joint Venture or (B) any request by the disclosing Party, unless the
receiving Party is otherwise allowed to retain such Confidential Information.
Either Party may retain, subject to the terms of this Section 7.3, copies of the
other&#146;s Confidential Information required for compliance with record keeping or
quality assurance requirements or other applicable legal requirements;
and</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>57</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt; margin-left: 15pt"><FONT face="Times New Roman" size=2>(v)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>nothing in this Agreement will prohibit or limit Clorox&#146;s or P&amp;G&#146;s
(or their Subsidiaries&#146;) use of information (including, but not limited to,
ideas, concepts, know-how, techniques, and methodologies) (A) previously known
to it without an obligation of confidence, (B) independently developed by
or for it, (C) acquired by it from a third party which is not, to its knowledge,
under an obligation of confidence with respect to such information, or (D) which
is or becomes publicly available through no breach of this Agreement. For
avoidance of doubt, this Section 7.3 does not limit the disclosure by the Clorox
Parties of information with respect to the Glad Global Business to Clorox and
its Subsidiaries in the event such information does not include any Confidential
Information disclosed by the P&amp;G Parties. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Each
Party further acknowledge and agree that it is possible that certain uses of its
own Confidential Information could be detrimental to the Joint Venture or the
Glad Global Business, and each Party will use [* * *] efforts to avoid any such
detrimental use. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Notwithstanding the provisions of this Section 7.3, the Parties agree
that each of the other Parties may disclose Confidential Information to one or
more third parties in a due diligence investigation being conducted by such
third party in connection with a Third Party Sale or a transaction that would
result in a Clorox Change of Control, in the case of the Clorox Partners, or a
transaction that would result in a P&amp;G Change of Control, in the case of the
P&amp;G Partners. Prior to any disclosure of Confidential Information pursuant
to this Section 7.3(d), the third party to whom such information is to be
disclosed must have agreed to keep in confidence all Confidential Information to
be disclosed to such third party, and the Party hereto disclosing such
Confidential Information will be responsible for any disclosure of the
Confidential Information by such third party. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 7.4</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Non-Solicitation</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Each of Clorox and P&amp;G
agrees that the solicitation for employment by it or its Subsidiaries of
employees of the other Party whom the soliciting Party becomes aware of as a
result of the Joint Venture or the Glad Licensed Business would have an adverse
impact on the Parties. Each of Clorox and P&amp;G agrees that during the Term
and for [* * *] thereafter it will, and it will cause its Subsidiaries to, take
[* * *] steps to prevent its employees from making such solicitations; to use [*
* *] efforts to cause itself and its Subsidiaries to enforce such prohibition;
and, to the extent that it becomes aware of any such solicitation occurring
within itself or any of its Subsidiaries, to take [* * *] action to cause such
solicitation to immediately cease. In the event of any breach of these
non-solicitation obligations, the Parties agree to conduct good faith
discussions and negotiations to determine a mutually acceptable means of
addressing such breach, provided that in no event will there be any penalty for
any inadvertent breach of this provision by any Party. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>58</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 7.5</FONT><FONT face="Times New Roman" size=2> </FONT><U><FONT face="Times New Roman" size=2>Agreement to Cooperate; Further Assurances; Other Matters</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>Subject to the terms and conditions of this Agreement, each of the
Parties will use all reasonable efforts to take, or cause to be taken, all
actions and to do, or cause to be done, all things necessary, proper or
advisable under applicable laws and regulations to consummate and make effective
the transactions contemplated by this Agreement, including providing information
and using reasonable efforts to obtain all necessary or appropriate waivers,
consents and approvals, and effecting all necessary registrations and filings,
and will actively take all reasonable steps to pursue such waivers,
consents and approvals for a period not to exceed three (3) months, after which
period either Clorox or P&amp;G will have the right to terminate this Agreement
if such waivers, consents and approvals have not been received such that the
condition to closing set forth in Section 8.1(b) has not been satisfied or if
the Closing has not otherwise occurred. The Parties will timely and promptly
make all filings which may be required by each of them in connection with the
consummation of the transactions contemplated hereby under the Hart-Scott-Rodino
Antitrust Improvements act of 1976, as amended, and the rules and regulations
thereunder (the &#147;</FONT><U><FONT face="Times New Roman" size=2>HSR
Act</FONT></U><FONT face="Times New Roman" size=2>&#148;) and any similar foreign
legislation. Each Party will furnish to the other such necessary information and
assistance as such Party may reasonably request in connection with the
preparation of any necessary filings or submissions by it to any U.S. or foreign
governmental agency, including any filings necessary under the provisions of the
HSR Act. Notwithstanding anything to the contrary in this Agreement, no Party
nor any of their Affiliates will be required to make any disposition, including
any disposition of, or any agreement to hold separate, any Subsidiary, asset or
business, and no Party nor any of their Affiliates will be required to comply
with any condition or undertaking or take any action which, individually or in
the aggregate, would materially adversely affect the economic benefits to such
Party of the transactions contemplated hereby and by the Related Agreements,
taken as a whole or adversely affect any other business of such Party or its
Affiliates. In case at any time after the Closing Date any further action is
necessary or desirable to carry out the purposes of this Agreement, the proper
officers and directors of the Parties and their respective Affiliates will
execute such further documents (including assignments, acknowledgments and
consents and other instruments of transfer) and will take such further action as
will be necessary or desirable to effect such transfer and to otherwise carry
out the purposes of this Agreement, in each case to the extent not inconsistent
with applicable law. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>P&amp;G will have the right [* * *] year, upon reasonable notice to
Clorox to have an independent public accounting firm review and audit that
portion of the books, records and accounts of the Glad Business with respect to
those transactions attributed to the Glad Business that are between Clorox and
any Affiliate of Clorox for which the consent of P&amp;G is not sought pursuant
to Section 5.3(a)(v) by reason of such transactions being within the scope of
Section 5.3(a)(v)(x). P&amp;G agrees to cause any review conducted pursuant to
this Section 7.5(b) to be conducted in a manner so as not to unreasonably
interfere with the normal business operations of the Glad Business. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In the
event the Clorox Partners or any of their Subsidiaries wish to [* * *] of any
business, division, Person or asset for which transaction the consent of the
P&amp;G Partners is required pursuant to [* * *], Clorox will notify the P&amp;G
Partners and if the P&amp;G Partners notifies Clorox in writing within [* * *]
of receipt of such notice that the P&amp;G Partners has made a [* * *] to pursue
a [* * *] business, division, Person or asset, Clorox and the P&amp;G Partners
will negotiate [* * *] for a period not to exceed [* * *] with respect to
</FONT><FONT face="Times New Roman" size=2>[* * *] by the P&amp;G Partners of
such business, division, Person or asset, on terms [* * *] Clorox and the
P&amp;G Partners, provided that it is understood that in the event the P&amp;G
Partners and Clorox do not enter into a binding agreement with respect to [* *
*] to each Party in [* * *] within such [* * *] day period, Clorox will have the
right thereafter to [* * *] and enter into a [* * *] of such business, division,
Person or asset with any other Person. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT size=2 face="Times New Roman">59</FONT></P>
<HR align=center width="100%" noShade size="2">

<!--Part05-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In the event of a Third-Party
Sale by Clorox, Clorox will determine the actuarial liabilities with respect to
the pensions of any defined benefit pension plans maintained by Clorox or any
Affiliate which are subject to the funding requirements of Section 412 of the
Code in which personnel engaged in the Glad Global Business at the time of the
proposed sale are participating (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Defined Benefit Plans</FONT></U><FONT face="Times New Roman" size=2>&#148;),
based on the same actuarial assumptions that Clorox uses to fund the Defined
Benefit Plans over time. Clorox will determine the pro rata portion of those
actuarial liabilities attributable to Glad Global Business personnel who will
become employees of the purchaser in connection with the proposed sale (the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Pro Rata Portion</FONT></U><FONT face="Times New Roman" size=2>&#148;) assumed as
compared to the total actuarial liabilities for the Defined Benefit Plans.
Clorox will propose that the purchaser accept a spin-off of the Pro Rata Portion
to a tax-qualified defined benefit pension plan maintained by the purchaser for
its own employees (a &#147;</FONT><U><FONT face="Times New Roman" size=2>Purchaser Plan</FONT></U><FONT face="Times New Roman" size=2>&#148;) to such assets for the benefit of the Glad Global Business personnel
who become employees of the purchaser in connection with the proposed sale. To
the extent the purchaser negotiates a transaction in which an amount different
from the Pro Rata Portion is spun off from the Defined Benefit Plans to the
Purchaser Plan then (i) if the purchaser accepts an amount less than the Pro
Rata Portion, P&amp;G Sub will receive an amount equal to (A) its Ordinary JV
Interest percentage multiplied by (B) the difference between the Pro Rata
Portion and the actual amount accepted by the purchaser and (ii) if the
purchaser acquires more than the Pro Rata Portion, P&amp;G Sub&#146;s purchase price
received for its interest in the Joint Venture will be decreased by an amount
equal to (A) its Ordinary JV Interest percentage multiplied by (B) the
difference between the amount proposed by Clorox in accordance with the
immediately preceding sentence and the actual amount accepted by the purchaser.
With respect to any post-retiree healthcare benefits not assumed by the third
party purchaser, the JV Partners will divide that expense between them, based on
their proportionate share of the actuarial liabilities with respect to such
benefit programs calculated on the basis of their relative Ordinary JV
Interests. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(e)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Prior to the Closing, the
Clorox Parties will deliver to the P&amp;G Parties a supplement to Schedules
2.2(a)(i) and 2.2(a)(iii) setting forth the amounts of the eliminations and
additions referenced therein (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Supplemental Schedule</FONT></U><FONT face="Times New Roman" size=2>&#148;).
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 7.6</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Public
Statements</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Before any Party or any
Affiliate of such Party will release any information concerning this Agreement
or the matters contemplated hereby which is intended for or may result in public
dissemination thereof, they will cooperate with the other Parties, will furnish
drafts of all documents or proposed oral statements to the other Parties,
provide the other Parties the opportunity to review and comment upon any such
documents or statements and will not release or permit release of any such
information without the consent of the other Parties, except to the extent
required by applicable law or the rules of any securities exchange or automated
quotation system on which its securities or those of any of its Affiliates are
traded. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 7.7</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Conduct of
Business</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The Clorox Parties agree that
prior to the Closing Date, without the prior written consent of the P&amp;G
Partners, which consent will not be unreasonably withheld, as may be expressly
permitted or contemplated by this Agreement or as may be set forth in Section
7.7 of the Clorox Disclosure Schedule
hereto, the Clorox Parties will cause the Glad Global Business:
</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>60</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>to be conducted in the usual, regular and ordinary course of business
consistent with past practice, and will use [* * *] efforts to preserve intact
the Glad Global Business, keep available the services of their employees and
preserve their relationships with customers, suppliers, licensees, licensors,
distributors, agents and others having business dealings with the Glad Global
Business; </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>to (A) maintain its inventory of supplies, parts and other materials and
keep its books of account, records and files, in each case in the ordinary
course of business consistent with past practice, (B) maintain its promotional
activities and expenditures in the ordinary course of business consistent with
past practice and (C) maintain in full force and effect property damage,
liability and other insurance with respect to the Glad Global Business and its
assets and properties providing coverage against such risks and in at least the
amounts as provided by the insurance policies currently maintained by the Clorox
Parties with respect to the Glad Global Business to the extent reasonably
available; </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>not to sell, transfer or otherwise dispose of any business, assets,
rights or properties of the Glad Global Business other than (A) sales of
obsolete or worn-out equipment or other assets no longer used in the Glad Global
Business not exceeding a value in excess of $[* * *] individually or $[* * *] in
the aggregate, (B) sales of inventory in the ordinary course of business, (C)
sales, transfers or other dispositions of assets or properties that will be
replaced prior to the Closing with assets or properties of a comparable value or
utility that will be attributed to the Glad Global Business or (D) sales,
transfers or dispositions in the ordinary course of the Glad Global Business
consistent with past practice and not exceeding a value in excess of $[* * *]
individually or $[* * *] in the aggregate not otherwise included in the
foregoing clauses (A) through (C); and </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>not to take any action for which the consent of the P&amp;G Partners
would be required after the Closing Date pursuant to Section 5.3(a) hereof.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Notwithstanding the
provisions of Section 7.7(a), the Parties agree that cash and cash equivalents
(excluding petty cash) of the Glad Global Business prior to Closing will be a
Clorox Excluded Asset pursuant to the provisions of Section 2.2(b) hereof. The
Clorox Parties will have the right to remove any such cash or cash equivalents
(excluding petty cash) from the Glad Global Business prior to the Closing,
subject to the representation and warranty contained in Section 4.2(a)(ii)
hereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The P&amp;G Parties agree
that prior to the Closing Date, without the prior written consent of Clorox, the
P&amp;G Parties will not sell, transfer or otherwise dispose of (i) any P&amp;G
Equipment or (ii) the Forceflex Technology or Impress Technology (in each case
as such terms are defined in the P&amp;G License Agreement) to be licensed to
the Clorox Parties pursuant to the P&amp;G License Agreement. The P&amp;G
Parties agree that they will comply with the <FONT face="Times New Roman" size=2>provisions of Section 7.4 of the form of License Agreement attached as
Exhibit A, which provisions are incorporated by reference herein.
</FONT></FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>61</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 7.8</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>International
Relationships</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The Parties have agreed that
to the extent the Glad Global Business expands to establish operations in any
country other than the United States, Canada, Australia New Zealand, China,
Philippines, Hong Kong, Costa Rica, Korea and South Africa (a &#147;</FONT><U><FONT face="Times New Roman" size=2>New Country</FONT></U><FONT face="Times New Roman" size=2>&#148;), the Parties will enter a relationship in such New Country, which
relationship will, at the election of the Clorox Partners, either (a) have a
structure and be on terms substantially similar to those under the JV Sublicense
Agreements and the Glad License Agreements for the International Licensees or
(b) have the structure and be on the terms set forth on </FONT><U><FONT face="Times New Roman" size=2>Exhibit G</FONT></U><FONT face="Times New Roman" size=2> hereto, in each case unless the Parties mutually determine that such
structure would result in material adverse tax consequences to P&amp;G or
Clorox, in which case P&amp;G and Clorox will negotiate in good faith to modify
the structure as necessary to avoid such adverse tax consequences. The Parties
do not intend for the provisions of this Section 7.8 to specify any particular
operational structure to be used in any New Country or to set in advance
compensation to be received by P&amp;G or its Affiliates in connection with any
services that may be provided by P&amp;G or its Affiliates as a service provider
to the operations in such New Country. The Parties agree to use all [* * *]
efforts and to negotiate in good faith to complete the documentation necessary
to implement any such relationship. For the avoidance of doubt, in the event
that notwithstanding the provisions of this Section 7.8, the Parties are unable
to agree upon the implementation of any such relationship in any country, such
failure will not prevent the Glad Global Business from entering into operation
in the country in question. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 7.9</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Sublicenses of
P&amp;G Intellectual Property</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>To the extent The Glad
Products Company or its Affiliates, on behalf of the Joint Venture, sublicenses
any of the Intellectual Property licensed to it by P&amp;G Sub under the P&amp;G
License Agreement to any Affiliate of Clorox, each of The Glad Products Company
and the other Clorox Parties agree as follows during the term of any such
sublicense: </FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(i)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>to [* * *] with respect to [* * *] relating to the licensees under any
such sublicenses and the [* * *] conducted by such licensees. For purposes of
this Section 7.9(a), materiality will be judged based on the Glad Licensed
Business taken as a whole, </FONT><U><FONT face="Times New Roman" size=2>provided</FONT></U><FONT face="Times New Roman" size=2> that (i) [* * *]
Glad Local Business, (ii) any [* * *] in excess of $[* </FONT><FONT face="Times New Roman" size=2>* *] and (iii) any [* * *] that will be attributed
to any Glad Local Business that [* * *] will be deemed to be material;
</FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>to provide P&amp;G Sub with copies of the information and reports such
Party receives from the licensees under any such sublicenses, and upon the
reasonable request of P&amp;G Sub, obtain from the licensees under such
sublicenses, additional information concerning the Glad Licensed Business;
</FONT></P>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>not to [* * *], to the extent such Party has the right under any such
sublicense to [* * *] with respect to the Joint Venture and the Glad Business;
and </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>62</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="padding-left: 15pt; text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>to use [* * *] efforts to cause the licensees under any such sublicenses
to conduct the Glad Local Businesses conducted by such licensees in a manner not
inconsistent with the overall strategic direction of the Glad Business, but
subject to local market conditions and other circumstances of the jurisdictions
in which such Glad Local Businesses are conducted. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>P&amp;G will have the right
[* * *] year, upon reasonable notice to The Glad Products Company, to have an
independent public accounting firm review and audit the books, records and
accounts of the Glad Licensed Business, at P&amp;G&#146;s expense. P&amp;G agrees to
cause any review conducted pursuant to this Section 7.9(b) to be conducted in a
manner so as not to unreasonably interfere with the normal business operations
of the Glad Licensed Business. </FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE
VIII</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>CONDITIONS PRECEDENT TO
CLOSING</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 8.1</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Conditions to
Each Party&#146;s Obligations</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The respective obligations of
each Party to consummate the transactions contemplated by this Agreement to
occur at the Closing will be subject to the fulfillment of the following
conditions on or prior to the Closing Date: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>no statute, rule, regulation,
executive order, decree, or preliminary or permanent injunction will have been
enacted, entered, promulgated or enforced by any state, federal or foreign court
of competent jurisdiction or Governmental Authority which prohibits consummation
of the transactions contemplated by this Agreement and the Related Agreements,
whether temporary, preliminary or permanent; </FONT><U><FONT face="Times New Roman" size=2>provided</FONT></U><FONT face="Times New Roman" size=2>, </FONT><U><FONT face="Times New Roman" size=2>however</FONT></U><FONT face="Times New Roman" size=2>, that subject to the terms of this Agreement the
Parties will use their [* * *] efforts to have such order, decree or injunction
vacated; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the waiting period applicable
to the consummation of the transactions contemplated by this Agreement under the
HSR Act will have expired or been earlier terminated; and </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>all orders, consents and
approvals of Governmental Authorities legally required for the consummation of
the transactions contemplated by this Agreement will have been obtained and be
in effect at the Closing Date, except those for which failure to obtain such
consents and approvals would not, individually or in the aggregate, have a
material adverse effect upon the Company or its future business or results of
operations. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 8.2</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Conditions to
the Closing Obligations of the Clorox Parties</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The obligations of the Clorox
Parties to consummate the transactions contemplated by this Agreement to occur
at the Closing will be subject to the fulfillment of the following additional
conditions: </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>63</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The P&amp;G Parties will have
performed in all material respects their obligations under this Agreement and
any Related Agreement required to be performed by them at or prior to the
Closing Date, and the representations and warranties of the P&amp;G Parties set
forth in this Agreement (i) that are qualified as to Material Adverse Effect
will be true and correct in all respects and (ii) that are not so qualified will
be true and correct in all material respects at and as of the Closing Date as if
made at and as of such time, except to the extent that any such representation
or warranty specifically speaks to a specified date, in which case such
representation or warranty will have been true and correct as of such date, and
the Clorox Parties will have received a certificate to such effect dated the
Closing Date signed on behalf of the P&amp;G Parties by an executive officer
thereof; and </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The P&amp;G Parties will have
duly authorized, executed and delivered to the Clorox Parties at or prior to the
Closing Date each of the Related Agreements to which it is a party, and each
such Related Agreements will be in full force and effect. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 8.3</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Conditions to
the Closing Obligations of the P&amp;G Parties</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The obligations of the P&amp;G
Parties to consummate the transactions contemplated by this Agreement to occur
at the Closing will be subject to the fulfillment of the following additional
conditions: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the Clorox Parties will have
performed in all material respects their obligations under this Agreement and
any Related Agreement required to be performed by them at or prior to the
Closing Date, and the representations and warranties of the Clorox Parties set
forth in this Agreement (i) that are qualified as to Material Adverse Effect
will be true and correct in all respects and (ii) that are not so qualified will
be true and correct in all material respects at and as of the Closing Date as if
made at and as of such time, except to the extent that any such representation
or warranty specifically speaks to a specified date, in which case such
representation or warranty will have been true and correct as of such date, and
in the case of each of the representations and warranties to the extent relating
to the Glad Existing International Business will not be subject to any
exceptions other than as set forth in the Clorox Disclosure Schedule that would
reasonably be expected to have a Material Adverse Effect, and the P&amp;G
Parties will have received a certificate to such effect dated the Closing Date
signed on behalf of the Clorox Parties by an executive officer of Clorox;
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>each Clorox Party will have
duly authorized, executed and delivered to the P&amp;G Parties at or prior to
the Closing Date each of the Related Agreements to which it is a party, and each
such Related Agreement will be in full force and effect; and </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>the Clorox Parties shall have
delivered the Supplemental Schedule to the P&amp;G Parties. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>64</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE
IX</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>ACCOUNTING; TAX
MATTERS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 9.1</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Accounting</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The accounting principles and
policies adopted with respect to the Joint Venture are set forth on Exhibit H
hereto (the &#147;</FONT><U><FONT face="Times New Roman" size=2>JV Accounting
Principles</FONT></U><FONT face="Times New Roman" size=2>&#148;). The JV Accounting
Principles shall also apply to the conduct of the Glad Licensed Business.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Each JV Partner will be
supplied with estimates of income and other information necessary to enable such
JV Partner to prepare in a timely manner its U.S. federal, state and local
income estimated tax returns (and extension payments, if any) and such other
financial or other statements and reports that the Board deems appropriate;
provided that each JV Partner will be provided with copies of Schedule K-1 for
the Joint Venture for such Fiscal Year no later than seven (7) calendar months
after the end of the first two Fiscal Years of the Joint Venture and no later
than six (6) calendar months after the end of any Fiscal Year thereafter.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Within (i) sixty (60) days
after the end of each of the first eight Fiscal Quarters, and after the end of
any Fiscal Quarter thereafter, (A) forty-five (45) days with respect to the Glad
Business and (B) sixty (60) days with respect to each Glad Local Business and
(ii) 120 days after the close of each of the first two Fiscal Years of the Joint
Venture and within ninety (90) days after the end of any Fiscal Year thereafter,
the Board will cause to be prepared in accordance with the JV Accounting
Principles and submitted to each JV Partner the balance sheet of the Glad
Business and each Glad Local Business as of the end of such period and a
statement of income or loss and a statement of cash flows of the Glad Business
and each Glad Local Business for such period. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The Clorox Partners will keep
or cause to be kept books and records pertaining to the business attributed to
the Joint Venture showing all of its assets and Liabilities, receipts and
disbursements, realized profits and losses, JV Partner&#146;s Capital Accounts and
all transactions attributed to the Joint Venture. Such books and records of the
Joint Venture will be kept at the Glad Business headquarters in Oakland,
California and the JV Partners and their representatives will at all reasonable
times have free access thereto for the purpose of inspecting or copying the
same. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(e)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In case of a Transfer of all
or part of the JV Interest of any JV Partner, the Board may cause the Joint
Venture to elect, pursuant to Section 734, 743 and 754 of the Code to adjust the
basis of the assets attributed to the Joint Venture; provided, however, the
election under Section 754 will [* * *] to the Board&#146;s discretion and such
election will be made timely if [* * *] in connection with [* * *]. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(f)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The Parties acknowledge and
agree that from time to time during the Term, as the Glad Business changes,
adjustments may become necessary to the JV Accounting Principles or the
provisions of this Agreement to maintain the intended relative economic
interests of the Parties hereunder as well as the intended economic benefits to
the Parties of this Joint Venture as effected by this Agreement as of the
Closing. The Parties agree to negotiate in good faith to amend the JV Accounting
Principles and this Agreement as may be necessary to maintain such relative
economic interests and intended economic benefits, and any such adjustment or
amendment pursuant to this Section 9.1(f) must be mutually agreed upon by all
the JV Partners. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>65</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(g)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Clorox&#146;s internal audit group
will perform a review at least once every 24 months of the financial statements
and processes and procedures of the Glad Business, which review will be
conducted in a manner consistent with that used for scheduled periodic reviews
by such internal audit group of other Clorox businesses. The report with respect
to such review will be provided to the Board. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(h)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>P&amp;G will have the right
[* * *] year, upon reasonable notice to Clorox to have an independent public
accounting firm review and audit the books, records and accounts of the Glad
Business, at P&amp;G&#146;s expense. P&amp;G agrees to cause any review conducted
pursuant to this Section 9.1(h) to be conducted in a manner so as not to
unreasonably interfere with the normal business operations of the Glad Business.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 9.2</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Tax
Matters</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The taxable year of the Joint
Venture will be the same as its Fiscal Year. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The JV Partners agree and
acknowledge that the Joint Venture will not be subject to the provisions of
Sections 6221, </FONT><I><FONT face="Times New Roman" size=2>et.
seq</FONT></I><FONT face="Times New Roman" size=2>., of the Code. The JV
Partners further agree that the Joint Venture will not elect, nor will any JV
Partner, the Board, or any other Person, elect on behalf of the Joint Venture,
to cause the Joint Venture to be subject to said unified Tax Proceedings.
Accordingly, no JV Partner will have any authority to represent the Joint
Venture before the Internal Revenue Service or other Tax authority in a unified
Tax proceeding, nor will any JV Partner have authority to sign any consent,
enter into any settlement agreement, extend the statute of limitations,
compromise any Tax dispute, or take any other action regarding a Tax audit
proceeding on behalf of any other JV Partner (except that Clorox Parties may
take such actions on behalf of other Clorox Parties). Each of Clorox and P&amp;G
Sub agree to keep the other informed as to the progress of Tax audits,
examinations and proceedings of such Parties or their Affiliates that relate to
Tax items attributable to the Joint Venture. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The Board will cause to be
prepared all federal, state and local tax returns of the Joint Venture for each
year for which such returns are required to be filed and will cause such returns
to be timely filed. The Board will determine the appropriate treatment of each
item of income, gain, loss, deduction and credit attributed to the Joint Venture
and the accounting methods and conventions under the tax laws of the United
States, the several States and other relevant jurisdictions as to the treatment
of any such item or any other method or procedure related to the preparation of
such tax returns. Each JV Partner agrees that it will take no position on its
tax returns inconsistent with the position taken on the Joint Venture&#146;s tax
returns. The Board on behalf of the Joint Venture may make all elections for
federal income tax purposes; provided that, if such election would have a
material adverse effect on P&amp;G, the Board will provide notice to and consult
P&amp;G regarding such election. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The JV Partners intend for
the Joint Venture to be treated as a partnership for U.S. federal, state and
local income tax purposes, and no JV Partner (nor any Person acting on behalf of
the Joint Venture) will take any action inconsistent with such treatment.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>66</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE X</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>INDEMNIFICATION</FONT></U><FONT face="Times New Roman" size=2>
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 10.1</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Indemnification
by Clorox Partners</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>From and after the Closing
Date, the Clorox Partners will jointly and severally indemnify and hold harmless
the P&amp;G Parties and their respective Affiliates, and the respective
directors, officers, employees and agents of any of the foregoing and any of the
heirs, executors, successors and assigns of any of the foregoing (collectively,
the &#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Indemnified
Parties</FONT></U><FONT face="Times New Roman" size=2>&#148;) from and against any
and all damages, claims, losses, expenses, costs, obligations and Liabilities
including, without limiting the generality of the foregoing, Liabilities for all
reasonable attorneys&#146; fees and expenses (including attorney and expert fees and
expenses incurred to enforce successfully the terms of this Agreement)
(collectively, &#147;</FONT><U><FONT face="Times New Roman" size=2>Losses and
Expenses</FONT></U><FONT face="Times New Roman" size=2>&#148;) suffered or incurred
by any such P&amp;G Indemnified Party arising from, relating to or otherwise in
respect of, (a) any breach of, or inaccuracy in, any representation or warranty
of the Clorox Parties contained in this Agreement or in the certificate
delivered by the Clorox Parties pursuant to Section 8.3(a) of this Agreement,
(b) any breach of any covenant or other agreement of the Clorox Parties
contained in this Agreement, and (c) any Clorox Retained Liabilities. The
aggregate indemnification obligations of the Clorox Partners pursuant to the
foregoing clause (a), together with the indemnification obligations of such
Persons with respect to breaches of representations and warranties under the
P&amp;G License Agreement, will be limited to a maximum of $28,000,000, and the
Clorox Partners will have no indemnification obligations with respect to such
clause (a) unless the aggregate of all Losses and Expenses relating thereto and
with respect to breaches of representations and warranties under the P&amp;G
License Agreement for which the Clorox Partners would, but for this provision,
be liable exceeds on a cumulative basis an amount equal to $3,000,000 , and then
only to the extent of any such excess. Any claims for indemnification pursuant
to such clause (a) must be made prior to the date that is eighteen (18) months
after the Closing Date. From and after the Closing Date, the Clorox Partners
will further jointly and severally indemnify and hold harmless the P&amp;G
Indemnified Parties from and against any and all Losses and Expenses arising out
of or related to any third party claim that any P&amp;G Indemnified Party has
any Liability or obligation with respect to any Liability attributed to the
Joint Venture or arising out of or related to the Glad Business or the Glad
Licensed Business, provided that such indemnification will not apply to any
Liability or obligation for which any P&amp;G Indemnified Party has agreed to
provide indemnification or is otherwise expressly liable for pursuant to the
terms of the Related Agreements. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 10.2</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Indemnification
by P&amp;G Partners</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>From and after the Closing
Date, the P&amp;G Partners will indemnify and hold harmless each of the Clorox
Partners and their respective Affiliates, and the respective directors,
officers, employees and agents of any of the foregoing, and any of the heirs,
executors, successors and assigns of any of the foregoing (collectively, the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox Indemnified
Parties</FONT></U><FONT face="Times New Roman" size=2>&#148; and together with the
P&amp;G Indemnified Parties, the &#147;</FONT><U><FONT face="Times New Roman" size=2>Indemnified Parties</FONT></U><FONT face="Times New Roman" size=2>&#148;) from
and against any and all Losses and Expenses suffered or incurred by any such
Clorox Indemnified Party arising from, relating to or otherwise in respect of,
(a) any breach of, or inaccuracy in, any representation or warranty of the <FONT face="Times New Roman" size=2>P&amp;G Parties contained in this Agreement or in
the certificate delivered by the P&amp;G Parties pursuant to Section 8.2(a) of
this Agreement, (b) any breach of any covenant or other agreement of the P&amp;G
Parties contained in this Agreement and (c) any Permitted Liens existing as of
the Closing with respect to the P&amp;G Equipment. The aggregate indemnification
obligations of the P&amp;G Partners pursuant to the foregoing clause (a),
together with the indemnification obligations of such Persons with respect to
breaches of representations and warranties under the P&amp;G License Agreement,
will be limited to a maximum of $28,000,000, and the P&amp;G Partners will have
no indemnification obligations with respect to such clause (a) or with respect
to breaches of representations and warranties under the P&amp;G License
Agreement, unless the aggregate of all Losses and Expenses relating thereto for
which the P&amp;G Partners would, but for this provision, be liable exceeds on a
cumulative basis an amount equal to $3,000,000, and then only to the extent of
any such excess. Any claims for indemnification pursuant to such clause (a) must
be made prior to the date that is eighteen (18) months after the Closing Date.
</FONT></FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>67</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 10.3</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Third-Party
Claims</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>If a claim by a third party is
made against an Indemnified Party hereunder, and if such Indemnified Party
intends to seek indemnity with respect thereto under this Article X, such
Indemnified Party will promptly notify Clorox, in the case of a P&amp;G
Indemnified Party, or P&amp;G, in the case of a Clorox Indemnified Party (such
person to be notified, the &#147;</FONT><U><FONT face="Times New Roman" size=2>Indemnifying Party</FONT></U><FONT face="Times New Roman" size=2>&#148;) in
writing of such claims setting forth such claims in reasonable detail, provided
that failure of such Indemnified Party to give prompt notice as provided herein
will not relieve the Indemnifying Party of any of its obligations hereunder,
except to the extent that the Indemnifying Party is materially prejudiced by
such failure. The Indemnifying Party will have twenty (20) days after receipt of
such notice to undertake, through counsel of its own choosing, subject to the
reasonable approval of such Indemnified Party, and at its own expense, the
settlement or defense thereof, and the Indemnified Party will cooperate with it
in connection therewith; provided, however, that the Indemnified Party may
participate in such settlement or defense through counsel chosen by such
Indemnified Party, provided that the fees and expenses of such counsel will be
borne by such Indemnified Party. If the Indemnifying Party will assume the
defense of a claim, it will not settle such claim without the prior written
consent of the Indemnified Party, (a) unless such settlement includes as an
unconditional term thereof the giving by the claimant of a release of the
Indemnified Party from all Liability with respect to such claim or (b) if such
settlement involves the imposition of equitable remedies or the imposition of
any material obligations on such Indemnified Party other than financial
obligations for which such Indemnified Party will be indemnified hereunder. If
the Indemnifying Party will assume the defense of a claim, the fees of any
separate counsel retained by the Indemnified Party will be borne by such
Indemnified Party unless there exists a conflict between them as to their
respective legal defenses (other than one that is of a monetary nature), in
which case the Indemnified Party will be entitled to retain separate counsel,
the reasonable fees and expenses of which will be reimbursed by the Indemnifying
Party. If the Indemnifying Party does not notify the Indemnified Party within
twenty (20) days after the receipt of the Indemnified Party&#146;s notice of a claim
of indemnity hereunder that it elects to undertake the defense thereof, the
Indemnified Party will have the right to contest, settle or compromise the claim
but will not thereby waive any right to indemnity therefor pursuant to this
Agreement. The indemnification provisions set <FONT face="Times New Roman" size=2>forth in this Article X are the sole and exclusive means of recovery of
money damages with respect to the matters covered herein, except for fraud.
</FONT></FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>68</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 10.4</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Limitation on
Losses and Expenses</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Notwithstanding anything to
the contrary contained herein, no Indemnifying Party will be liable for any
punitive damages pursuant to this Agreement or any of the Related Agreements (it
being understood that any punitive damages paid by any Indemnified Party to any
third party will be considered direct damages not subject to this Section 10.4). </FONT></P>
<P align=center><B><FONT face="Times New Roman" size=2>ARTICLE
XI</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>MISCELLANEOUS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.1</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Amendments and
Waivers</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement may be amended
only by a written instrument executed by Clorox and the P&amp;G Partners. Any
amendment effected in accordance with the immediately preceding sentence will be
binding on all of the Parties to this Agreement. No failure or delay by any
Party in exercising any right, power or privilege hereunder will operate as a
waiver thereof nor will any single or partial exercise thereof preclude any
other or further exercise thereof or the exercise of any other right, power or
privilege. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.2</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Successors,
Assigns and Transferees</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The provisions of this
Agreement will be binding upon and will inure to the benefit of the Parties and
their respective successors and Permitted Transferees, each of which will agree
in a writing reasonably satisfactory in form and substance to Clorox and the
P&amp;G Partners to become a Party hereto and be bound to the same extent hereby
as the transferor that has transferred the JV Interest. No Party to this
Agreement may assign any of its rights or obligations under this Agreement to
any person other than a Permitted Transferee without the prior written consent
of the other Parties. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.3</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Notices</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Any notices or other
communications required or permitted hereunder will be sufficiently given if (a)
delivered personally, (b) transmitted by facsimile (with written transmission
confirmation), (c) mailed by certified or registered mail (return receipt
requested) (in which case such notice will be deemed given on the third day
after such mailing) or (d) sent by overnight Federal Express or other overnight
courier (with written delivery confirmation), addressed as follows or to such
other address of which the Parties may have given notice: </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>69</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><U><FONT face="Times New Roman" size=2>To the Clorox
Partners</FONT></U><FONT face="Times New Roman" size=2>: </FONT></P>
<div ALIGN="LEFT" STYLE="padding-left: 30pt"><FONT face="Times New Roman" size=2>The Clorox Company<BR>1221
Broadway<BR>Oakland, CA 94612 <BR>Attention: General
Counsel<BR>Facsimile: (510) 271-1696<BR>Telephone: (510) 271-4737<BR>E-mail:
pete.bewley@clorox.com </FONT></Div>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><U><FONT face="Times New Roman" size=2>To the P&amp;G
Partners</FONT></U><FONT face="Times New Roman" size=2>: </FONT></P>
<div ALIGN="LEFT" STYLE="padding-left: 30pt"><FONT face="Times New Roman" size=2>The Procter &amp; Gamble
Company<BR>One P&amp;G Plaza<BR>Cincinnati, OH 45202 <BR></FONT><FONT face="Times New Roman" size=2>Attention: Jeffrey D. Weedman, Vice
President<BR>Facsimile: (513) 983-0911<BR>Telephone: (513) 983-1921<BR>E-mail:
weedman.jd@pg.com </FONT></div>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><U><FONT face="Times New Roman" size=2>With copies
to</FONT></U><FONT face="Times New Roman" size=2>: </FONT></P>
<div ALIGN="LEFT" STYLE="padding-left: 30pt"><FONT face="Times New Roman" size=2>The Procter &amp; Gamble
Company<BR>One P&amp;G Plaza<BR>Cincinnati, OH 45202<BR>Attention: Chris
Walther<BR>Telecopy: (513) 983-2611<BR>Telephone: (513) 983-8469<BR>E-mail:
walther.cb@pg.com </FONT></div>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.4</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Integration</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement, the Related
Agreements and the documents referred to herein or therein, or delivered
pursuant hereto or thereto, contain the entire understanding of the Parties with
respect to the subject matter hereof and thereof. There are no agreements,
representations, warranties, covenants or undertakings with respect to the
subject matter hereof and thereof other than those expressly set forth herein
and therein. This Agreement supersedes all other prior agreements and
understandings between the Parties with respect to such subject matter.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.5</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Severability</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>If one or more of the
provisions, paragraphs, words, clauses, phrases or sentences contained herein,
or the application thereof in any circumstances, is held invalid, illegal or
unenforceable in any respect for any reason, the validity, legality and
enforceability of any such provision, paragraph, word, clause, phrase or
sentence in every other respect and of the remaining provisions, paragraphs,
words, clauses, phrases or sentences hereof will not be in any way impaired, it
being intended that all rights, powers and privileges of the Parties will be
enforceable to the fullest extent permitted by law. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>70</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.6</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Counterparts</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement may be executed
in two or more counterparts, and by different Parties on separate counterparts
each of which will be deemed an original, but all of which will constitute one
and the same instrument. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.7</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Governing
Law</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement will be
construed in accordance with, and the rights of the Parties will be governed by,
the laws of the State of New York. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.8</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Arbitration</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The Parties will attempt in
good faith to resolve through negotiation any dispute, claim or controversy
arising out of or relating to this Agreement. Either Clorox or the P&amp;G
Partners may initiate negotiations on behalf of the Clorox Partners or the
P&amp;G Partners, as the case may be, by providing written notice in letter form
to the other Party, setting forth the subject of the dispute and the relief
requested. The recipient of such notice will respond in writing within five days
with a statement of its position on and recommended solution to the dispute. If
the dispute is not resolved by this exchange of correspondence, then
representatives of each of Clorox and the P&amp;G Partners with full settlement
authority will meet at a mutually agreeable time and place within ten (10) days
of the date of the initial notice in order to exchange relevant information and
perspectives, and to attempt to resolve the dispute. If the dispute is not
resolved by these negotiations, the matter will be submitted to JAMS, or its
successor, for mediation. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Either Clorox or the P&amp;G
Partners may commence mediation on behalf of the Clorox Partners or the P&amp;G
Partners, as the case may be, by providing to JAMS and the other Party a written
request for mediation, setting forth the subject of the dispute and the relief
requested. The Parties will cooperate with JAMS and with one another in
selecting a mediator from JAMS&#146; panel of neutrals, and in scheduling the
mediation proceedings. The Parties covenant that they will participate in the
mediation in good faith, and that Clorox, on the one hand, and the P&amp;G
Partners, on the other hand, will share equally in its costs. All offers,
promises, conduct and statements, whether oral or written, made in the course of
the mediation by any of the Parties, their agents, employees, experts and
attorneys, and by the mediator or any JAMS employees, are confidential,
privileged and inadmissible for any purpose, including impeachment, in any
arbitration or other proceeding involving the Parties, provided that evidence
that is otherwise admissible or discoverable will not be rendered inadmissible
or non-discoverable as a result of its use in the mediation. Either Clorox or
the P&amp;G Partners may initiate arbitration on behalf of the Clorox Partners
or the P&amp;G Partners, as the case may be, with respect to the matters
submitted to mediation by filing a written demand for arbitration at any time
following the initial mediation session or 45 days after the date of filing the
written request for mediation, whichever occurs first. The mediation may
continue after the commencement of arbitration if the Parties so desire. Unless
otherwise agreed by the Parties, the mediator will be disqualified from serving
as arbitrator in the case. The provisions of this Section 11.8 may be enforced
by any court of competent jurisdiction, and the Party seeking enforcement will
be <FONT face="Times New Roman" size=2>entitled to an award of all costs, fees
and expenses, including attorneys&#146; fees, to be paid by the Party against whom
enforcement is ordered. </FONT></FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>71</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>Any dispute, claim or
controversy arising out of or relating to this Agreement or the breach,
termination, enforcement, interpretation or validity thereof, including the
determination of the scope or applicability of this Agreement to arbitrate,
which is not resolved through negotiation or mediation, will be determined by
arbitration conducted in Oakland, CA, before a sole arbitrator based in the
state of New York, in accordance with the laws of the State of New York for
agreements made in and to be performed in that State. The arbitration will be
administered by JAMS pursuant to its Comprehensive Arbitration Rules and
Procedures unless Clorox and the P&amp;G Partners agree to use its Streamlined
Arbitration Rules and Procedures. The arbitrator&#146;s decision and award with
respect to the dispute referred to will be final and binding on the Parties and
may be entered in any court with jurisdiction, and the Parties will abide by
such decision and award. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>The arbitrator will, in its
award, allocate all of the costs of the arbitration (and the mediation, if
applicable), including the fees of the arbitrator and the reasonable attorneys&#146;
fees of the prevailing Party, against the Party who did not prevail, if any.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.9</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Injunctive
Relief</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Each of the Parties
acknowledges and agrees that pending the outcome of any arbitration proceeding
pursuant to Section 11.8, each of the Parties will be entitled to an injunction,
restraining order or other equitable relief to prevent breaches of the
provisions of this Agreement and the Related Agreements in any court of
competent jurisdiction solely for the purpose of maintaining the status quo, in
addition to any other remedy to which they may be entitled pursuant to the terms
hereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.10</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Expenses</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Except as set forth in this
Agreement and the Related Agreements, whether or not the transactions
contemplated by this Agreement are consummated, all legal and other costs and
expenses incurred in connection with this Agreement and the Related Agreements
and the transactions contemplated hereby will be paid by the Party incurring
such costs. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.11</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>No Third Party
Beneficiaries</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Except for the rights of the
Indemnified Parties pursuant to Article X, nothing in this Agreement, express or
implied, is intended to confer upon any Person, other than the Parties or their
respective successors and permitted assigns, any rights, remedies, benefits,
obligations or Liabilities of any nature whatsoever under or by reason of this
Agreement. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>72</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.12</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Guarantees by
Clorox and P&amp;G</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In consideration of the
P&amp;G Parties entering into this Agreement, Clorox hereby fully and
unconditionally guarantees that each of the Clorox Parties will fully perform
and discharge when due all of its obligations and Liabilities under this
Agreement and each of the Related Agreements, including but not limited
to full and punctual payment and discharge when due of all of the Clorox
Parties&#146; indemnification obligations to the P&amp;G Indemnified Parties under
this Agreement and each of the Related Agreements. The guarantee of Clorox
pursuant to this Section 11.12(a) is an absolute, unconditional and continuing
guarantee of the full and punctual payment and performance by the Clorox Parties
of such obligations and Liabilities when due and not of their collectibility
only and is in no way conditioned upon any requirement that the P&amp;G Parties
first attempt to collect any of the obligations or Liabilities from the Clorox
Parties, or upon any other contingency whatsoever. The obligations of Clorox
hereunder are absolute and unconditional regardless of the validity or
enforceability of this Agreement or any of the Related Agreements against any
Clorox Partner. Clorox hereby waives any legal or equitable defense to the
enforceability of the provisions of this Section 11.12(a). </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In consideration of the
Clorox Parties entering into this Agreement, P&amp;G hereby fully and
unconditionally guarantees that each of the P&amp;G Parties will fully perform
and discharge when due all of its obligations and Liabilities under this
Agreement and each of the Related Agreements, including but not limited to full
and punctual payment and discharge when due of all of the P&amp;G Parties&#146;
indemnification obligations to the P&amp;G Indemnified Parties under this
Agreement and each of the Related Agreements. The guarantee of P&amp;G pursuant
to this Section 11.12(b) is an absolute, unconditional and continuing guarantee
of the full and punctual payment and performance by the P&amp;G Parties of such
obligations and Liabilities when due and not of their collectibility only and is
in no way conditioned upon any requirement that the Clorox Parties first attempt
to collect any of the obligations or Liabilities from the P&amp;G Parties, or
upon any other contingency whatsoever. The obligations of P&amp;G hereunder are
absolute and unconditioned regardless of the validity or enforceability of this
Agreement or any of the Related Agreements against any P&amp;G Partner. P&amp;G
hereby waives any legal or equitable defense to the enforceability of the
provisions of this Section 11.12(b). </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c)</FONT><FONT face=Arial size=2> </FONT><FONT face="Times New Roman" size=2>In consideration of the
Clorox Parties entering into this Agreement and the License Agreement, P&amp;G
hereby fully and unconditionally guarantees that any Person to whom any
Intellectual Property subject to the P&amp;G License Agreement is transferred in
accordance with Section 7.3 of the P&amp;G License Agreement and any subsequent
Persons to whom such Intellectual Property may be transferred (collectively,
&#147;</FONT><U><FONT face="Times New Roman" size=2>IP Transferees</FONT></U><FONT face="Times New Roman" size=2>&#148;) will fully perform and discharge when due all
of their obligations and Liabilities under the P&amp;G License Agreement,
including but not limited to any licenses granted pursuant to Article 2, Article
3 or Article 6 of the P&amp;G License Agreement. The guarantee of P&amp;G
pursuant to this Section 11.12(b) is an absolute, unconditional and continuing
guarantee of the full and punctual payment and performance by the IP Transferees
of such obligations and Liabilities when due and not of their collectibility
only and is in no way conditioned upon any requirement that the Clorox Parties
first attempt to collect any of the obligations or Liabilities from the IP
Transferees, or upon any other contingency whatsoever. The obligations of
P&amp;G hereunder are absolute and unconditional regardless of the validity or
enforceability of the License Agreement against any IP Transferee. P&amp;G
hereby waives any legal or equitable defense to the enforceability of the
provisions of this Section 11.12(c). </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>73</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Section 11.13</FONT><FONT face=Arial size=2> </FONT><U><FONT face="Times New Roman" size=2>Effectiveness
of Amendment and Restatement, Representations, </FONT></U><FONT face="Times New Roman" size=2></FONT><U><FONT face="Times New Roman" size=2>Warranties and Agreements</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement amends and
restates certain provisions of the Original Agreement and restates the terms of
the Original Agreement in their entirety. All amendments to the Original
Agreement effected by this Agreement, and all other covenants, agreements, terms
and provisions of this Agreement shall have effect as of the Original Date
unless expressly stated otherwise. This Agreement shall be effective as of the
date that copies hereof have been executed and delivered by each of the Parties.
Each of the representatives and warranties made in this Agreement shall be
deemed to be made on and as of the Original Date and not made as of the date
hereof. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>[REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK.] </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>74</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>IN WITNESS WHEREOF, each of
the undersigned has executed this Agreement or caused this Agreement to be
executed on its behalf as of the date first written above. </FONT></P>
<DIV align=right>
<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="line-height: 14pt; border-collapse: collapse; width: 50%">

  <TR>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: left"><P align=left><FONT face="Times New Roman" size=2>THE
      CLOROX COMPANY </FONT></P></TD></TR>
  <TR>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2>By:&nbsp;
    </FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: left; width: 65%"><FONT size=2 face="Times New Roman">/s/ Larry Peiros</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 34%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left"></TD>
    <TD NOWRAP STYLE="text-align: left"><FONT size=2 face="Times New Roman">Name: Larry Peiros</FONT></TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD NOWRAP STYLE="text-align: left"><FONT size=2 face="Times New Roman">Title: Group Vice President</FONT></TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR></TABLE></DIV><BR>
<DIV align=right>
<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="line-height: 14pt; border-collapse: collapse; width: 50%">

  <TR>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: left">
      <P align=left><FONT face="Times New Roman" size=2>THE GLAD PRODUCTS
      COMPANY </FONT></P></TD></TR>
  <TR>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2>By:&nbsp;
    </FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: left; width: 50%"><FONT size=2 face="Times New Roman">/s/ Larry Peiros</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 49%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left"></TD>
    <TD NOWRAP STYLE="text-align: left"><FONT size=2 face="Times New Roman">Name: Larry Peiros</FONT></TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD NOWRAP STYLE="text-align: left"><FONT size=2 face="Times New Roman">Title: Vice President</FONT></TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR></TABLE></DIV><BR>
<DIV align=right>
<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="line-height: 14pt; border-collapse: collapse; width: 50%">

  <TR>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: left">
      <P align=left><FONT face="Times New Roman" size=2>GLAD MANUFACTURING
      COMPANY </FONT></P></TD></TR>
  <TR>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2>By:&nbsp;
    </FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: left; width: 50%"><FONT size=2 face="Times New Roman">/s/ Larry Peiros</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 49%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left"></TD>
    <TD NOWRAP STYLE="text-align: left"><FONT size=2 face="Times New Roman">Name: Larry Peiros</FONT></TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD NOWRAP STYLE="text-align: left"><FONT size=2 face="Times New Roman">Title: Vice President</FONT></TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR></TABLE></DIV>
<DIV align=right>&nbsp;</DIV>
<DIV align=right>
<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="line-height: 14pt; border-collapse: collapse; width: 50%">

  <TR>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: left">
      <P align=left><FONT face="Times New Roman" size=2>CLOROX SERVICES COMPANY
      </FONT></P></TD></TR>
  <TR>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2>By:&nbsp; </FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: left; width: 50%"><FONT size=2 face="Times New Roman">/s/ Larry Peiros</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 49%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left"></TD>
    <TD NOWRAP STYLE="text-align: left"><FONT size=2 face="Times New Roman">Name: Larry
      Peiros</FONT></TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left"><FONT face="Times New Roman" size=2></FONT></TD>
    <TD NOWRAP STYLE="text-align: left"><FONT size=2 face="Times New Roman">Title: Vice
      President</FONT></TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR></TABLE></DIV><BR>
<P align=center><FONT face="Times New Roman" size=2>[Signature Page to Amended
and Restated Joint Venture Agreement] </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>75</FONT></P>
<HR align=center width="100%" noShade size="2">
<!--Part06-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<DIV align=right>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=3><FONT face="Times New Roman" size=2>THE CLOROX SALES COMPANY</FONT></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT size=2>By:
      &nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%"><FONT face="Times New Roman" size=2>/s/ Larry Peiros</FONT></TD>
    <TD noWrap align=left width="49%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>Name: Larry Peiros</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>Title: Vice President</FONT></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=3><FONT face="Times New Roman" size=2>CLOROX INTERNATIONAL COMPANY</FONT></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT size=2>By: </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%"><FONT face="Times New Roman" size=2>/s/ Larry Peiros</FONT></TD>
    <TD noWrap align=left width="49%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>Name: Larry Peiros</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>Title: Vice President</FONT></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=3><FONT face="Times New Roman" size=2>THE PROCTER &amp; GAMBLE
COMPANY</FONT></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT size=2>By: </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%"><FONT face="Times New Roman" size=2>/s/ Jeffrey D.
      Weedman</FONT></TD>
    <TD noWrap align=left width="49%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>Name: Jeffrey D. Weedman</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>Title: Vice President, External Business</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>Development &amp; Global Licensing</FONT></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=3><FONT face="Times New Roman" size=2>PROCTER &amp; GAMBLE RHD, INC.</FONT></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%" colSpan=2>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT size=2>By: </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%"><FONT face="Times New Roman" size=2>/s/ Jeffrey D.
      Weedman</FONT></TD>
    <TD noWrap align=left width="49%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>Name: Jeffrey D. Weedman</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>Title: Attorney-in-fact</FONT></TD></TR></TABLE></DIV><BR>
<P align=center><FONT face="Times New Roman" size=2>[Signature Page to Amended
and Restated Joint Venture Agreement]</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>76</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>Exhibit
C<BR></FONT></B><B><FONT face="Times New Roman" size=2>Description of P&amp;G
Equipment </FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2></FONT></B>&nbsp;</P>
<P align=center><B><FONT face="Times New Roman" size=2>[* * *]</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>Exhibit D<BR>Preliminary
Business Plan</FONT></B><B><FONT face="Times New Roman" size=2></FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2></FONT></B>&nbsp;</P>
<P align=center><B><FONT face="Times New Roman" size=2>[* * *]</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>Exhibit
E<BR></FONT></B><B><FONT face="Times New Roman" size=2>Preliminary Budget
</FONT></B></P>
<P align=center><FONT face="Times New Roman" size=2></FONT>&nbsp;</P>
<P align=center><FONT face="Times New Roman" size=2>[* * *]</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>EXHIBIT
F<BR></FONT></B><B><FONT face="Times New Roman" size=2>CLOROX CORPORATE SERVICES
</FONT></B></P>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">1.</FONT></TD>
    <TD vAlign=top width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top width="98%" colSpan=2>
      <P align=left><U><FONT face="Times New Roman" size=2>Clorox Services and
      Personnel</FONT></U><FONT face="Times New Roman" size=2>. Clorox will
      provide to the Glad Global Business payroll, product supply, project
      management, human resource services, information systems services,
      facilities services, treasury, tax, financial system and accounting
      services, legal services and other corporate services currently provided
      by Clorox, which are referred to as &#147;Clorox Services&#148; for purposes of this
      Agreement. Clorox will provide or will cause to be provided to the Glad
      Global Business the Clorox Services at such levels as the Glad Global
      Business may require from time to time. The Board will review on an annual
      basis the costs and quality of the Clorox Services and determine whether
      it continues to be in the best interest of the Glad Global Business for
      Clorox to continue to provide all such services. The Glad Leadership Team
      will monitor the Clorox Services on an ongoing basis and will report to
      the Board on an annual basis as to the results of its review of the Clorox
      Services and will provide the Board with any recommendations for changes
      in the Clorox Services. The Board will promptly act on any such
      recommendation by the Glad Leadership Team. </FONT></P></TD></TR>
  <TR>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="98%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">2.</FONT></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="98%" colSpan=2>
      <P align=left><U><FONT face="Times New Roman" size=2>Fees for Clorox
      Services</FONT></U><FONT face="Times New Roman" size=2>. The fees Clorox
      will allocate to the Glad Global Business for the Clorox Services (the
      &#147;</FONT><U><FONT face="Times New Roman" size=2>Service
      Fees</FONT></U><FONT face="Times New Roman" size=2>&#148;) shall be consistent
      with the JV Accounting Principles and will include apportioned amounts for
      facilities leases and supplies, salaries, bonuses and benefits (including
      pension plan costs) of Clorox employees who perform the Clorox Services,
      operating supplies, utilities, telephone, computers and/or other expenses
      as appropriate. Clorox and the Glad Global Business will use [* * *]
      efforts to identify Clorox Services that can be assumed by the Glad Global
      Business and no longer provided by Clorox corporate (&#147;</FONT><U><FONT face="Times New Roman" size=2>Assumed Services</FONT></U><FONT face="Times New Roman" size=2>&#148;). In addition, if the Glad Global Business
      can obtain any Clorox Service from a third party at [* * *] than the
      allocated cost of Clorox providing such Clorox Service, it is contemplated
      that the Glad Global Business will outsource such service and it will no
      longer be provided by Clorox corporate (&#147;</FONT><U><FONT face="Times New Roman" size=2>Outsourced Services</FONT></U><FONT face="Times New Roman" size=2>&#148; and, together with the Assumed Services,
      the &#147;</FONT><U><FONT face="Times New Roman" size=2>Push Down Services</FONT></U><FONT face="Times New Roman" size=2>&#148;). To
      the extent a Clorox Service becomes a Push Down Service in any calendar
      year, the Service Fee for such year will be reduced by an amount (the
      &#147;Push Down Credit&#148;) equal to what the cost of providing such Clorox
      Service for that remainder of the calendar year (i.e. after the push down
      occurs) would have been based on the cost of providing such Clorox Service
      during the same period of the prior calendar year (determined in
      accordance with the JV Accounting Principles). To the extent that the
      Board of the Joint Venture unanimously determines to obtain any additional
      corporate services from Clorox (&#147;</FONT><U><FONT face="Times New Roman" size=2>Incremental Services</FONT></U><FONT face="Times New Roman" size=2>&#148;) in any calendar year, the Service Fee for such year will be
      increased by an amount (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Supplemental Amount</FONT></U><FONT face="Times New Roman" size=2>&#148;) equal to the cost of providing such Incremental Services (which
      will thereafter be deemed Clorox Services) for the remainder of that
      calendar year. </FONT></P></TD></TR>
  <TR>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="97%">&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top width="97%">
      <P align=left><FONT face="Times New Roman" size=2>The Base Service Fee
      allocated to the Glad Global Business for calendar year 2003 (the
      &#147;</FONT><U><FONT face="Times New Roman" size=2>2003 Base Service
      Fee</FONT></U><FONT face="Times New Roman" size=2>&#148;) will equal [* * *]%
      of the aggregate net sales of the Glad Global Business for calendar year
      2002, as adjusted for the change in the Consumer Price Index during
      calendar year 2002 (i.e. if net sales in 2002 were $[* * *] million and
      the Consumer Price Index increased by [* * *]%, the 2003 Base Service Fee
      would equal $[* * *]). The actual Service Fee payable for 2003 will equal
      the 2003 Base Services Fee [* * *] the Push Down Credit for 2003 [* * *]
      the Supplemental Amount for 2003, if
any</FONT></P></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top width="2%" colSpan=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top width="97%">
      <P align=left><FONT face="Times New Roman" size=2>The base Service Fee
      (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Base Service
      Fee</FONT></U><FONT face="Times New Roman" size=2>&#148;) allocated to the Glad
      Global Business for each calendar year (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Relevant Year</FONT></U><FONT face="Times New Roman" size=2>&#148;) commencing in 2004 will equal the Service
      Fee actually paid in the immediately preceding calendar year [*
      </FONT><FONT face="Times New Roman" size=2>* *] the Push Down Adjustment
      for the immediate preceding calendar year [* * *] the Incremental Services
      Adjustment for the immediately preceding calendar year, as adjusted for
      the change in the Consumer Price Index during the immediately preceding
      calendar year (i.e. if the 2003 Service Fee was $[* * *], the Push Down
      Adjustment for 2003 was $[* * *], the Incremental Services Adjustment was
      zero and the Consumer Price Index increased by [* * *]% the Base Service
      Fee would equal $[* * *]). The actual Service Fee payable for the Relevant
      Year will equal the Base Service Fee for the Relevant Year [* * *] the
      Push Down Credit for the Relevant Year [* * *] the Supplemental Amount for
      the Relevant Year, subject to the Cap and Floor described below.
      </FONT></P></TD></TR></TABLE><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The &#147;</FONT><U><FONT face="Times New Roman" size=2>Push Down Adjustment</FONT></U><FONT face="Times New Roman" size=2>&#148; for any calendar year will equal the sum of (x)
the amount that the Push Down Credit would have been in such year had all Clorox
Services that became Push Down Services in that calendar year become Push Down
Services on the first day of that calendar year [* * *] (y) the actual Push Down
Credit for that calendar year. The &#147;</FONT><U><FONT face="Times New Roman" size=2>Incremental Services
Adjustment</FONT></U><FONT face="Times New Roman" size=2>&#148; for any calendar year
will equal the sum of (A) the amount that the Supplemental Amount would have
been in such year had all services that became Incremental Services in that
calendar year become Incremental Services on the first day of that calendar year
</FONT><FONT face="Times New Roman" size=2>[* * *] (B) the actual Supplemental
Amount for that calendar year. </FONT></P>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top width="2%" colSpan=2>&nbsp;</TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top width="97%" colSpan=2>
      <P align=left><FONT face="Times New Roman" size=2>In each calendar year
      beginning in 2004, the Services Fee will not be less than the Floor Amount
      (as defined below) for that calendar year of the aggregate net sales of
      the Clorox Global Business the immediately preceding calendar year nor
      greater than the Cap Amount (as defined below) for that calendar year of
      the aggregate net sales of the Clorox Global Business the immediately
      preceding calendar year. The Floor Amount will initially equal [* * *]%
      and the Cap Amount will initially equal [* * *]%. Beginning in 2004 the
      Floor Amount and the Cap Amount will be subject to adjustment annually as
      follows: </FONT></P></TD></TR>
  <TR>
    <TD vAlign=top width="2%" colSpan=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="97%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top width="2%" colSpan=2>&nbsp;</TD>
    <TD vAlign=top width="1%">&nbsp;</TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top width="96%">
      <P align=left><FONT face="Times New Roman" size=2>At such time as the sum
      of all Push Down Credits [* * *] all Push Down Adjustments [* * *] all
      Supplemental Amounts [* * *] all Incremental Services Adjustments
      occurring in or prior to a specific calendar year (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Base Year</FONT></U><FONT face="Times New Roman" size=2>&#148;) exceeds [* * *]% of the aggregate net
      sales of the Glad Global Business in the Base Year (the percentage amount
      by which they exceed [* * *]% is referred to as the &#147;</FONT><U><FONT face="Times New Roman" size=2>Initial Adjustment Amount</FONT></U><FONT face="Times New Roman" size=2>&#148;), the Floor
      Amount and the Cap Amount for the immediately succeeding calendar year
      will be reduced by the Initial Adjustment Amount. The Floor Amount and the
      Cap Amount will remain at such lower levels unless and until further
      adjusted pursuant to this paragraph (c). </FONT></P></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>2</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top width="97%">
      <P align=left><FONT face="Times New Roman" size=2>To the extent that any
      additional Push Down Services are implemented after the Base Year (each
      year in which any such additional Push Down Service is implemented is
      referred to herein as an &#147;</FONT><U><FONT face="Times New Roman" size=2>Adjustment Year</FONT></U><FONT face="Times New Roman" size=2>&#148;),
      then the Floor Amount and the Cap Amount for the immediately succeeding
      year will be reduced by the percent of the aggregate net sales of the Glad
      Global Business in the Adjustment Year represented by the sum of the Push
      Down Credit for such Adjustment Year plus the Push Down Adjustment for
      such Adjustment Year, </FONT><U><FONT face="Times New Roman" size=2>provided</FONT></U><FONT face="Times New Roman" size=2> that the
      Floor Amount and the Cap Amount shall in no event be less than [* * *].
      The Floor Amount and the Cap Amount will remain at such lower levels
      unless and until further adjusted pursuant to this paragraph
      (c).</FONT></P></TD></TR>
  <TR>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="97%">&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">(iii)</FONT></TD>
    <TD vAlign=top width="97%">
      <P align=left><FONT face="Times New Roman" size=2>To the extent that the
      Board of the Joint Venture unanimously determines to obtain any
      Incremental Services after the Base Year (each year in which any such
      additional Incremental Services are first obtained is referred to herein
      as a &#147;</FONT><U><FONT face="Times New Roman" size=2>Supplemental
      Adjustment Year</FONT></U><FONT face="Times New Roman" size=2>&#148;), then the
      Floor Amount and the Cap Amount for the immediately succeeding year will
      be increased by the percent of the aggregate net sales of the Glad Global
      Business in the Supplemental Adjustment Year represented by the sum of the
      Supplemental Amount for such Supplemental Adjustment Year plus the
      Incremental Services Adjustment for such Adjustment Year. The Floor Amount
      and the Cap Amount will remain at such increased levels unless and until
      further adjusted pursuant to this paragraph (c).</FONT></P></TD></TR>
  <TR>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="97%">&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top width="98%" colSpan=2>
      <P align=left><FONT face="Times New Roman" size=2>The aggregate Push Down
      Credits for 2003 and 2004 plus the aggregate Push Down Adjustments for
      2003 and 2004 will equal at least $[* * *]. </FONT></P></TD></TR>
  <TR>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="98%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top width="1%">&nbsp;</TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">(e)</FONT></TD>
    <TD vAlign=top width="98%" colSpan=2>
      <P align=left><FONT face="Times New Roman" size=2>The &#147;Consumer Price
      Index&#148; means the Consumer Price Index of Urban Consumers, West Region All
      Items (base period 1982-1984=100), as published by the Bureau of Labor
      Statistics of the United States Department of Labor or, if such index is
      no longer published or the method of computation thereof is substantially
      modified, an alternative index of similar weighting and geographic focus
      selected by the Board. </FONT></P></TD></TR>
  <TR>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD vAlign=top width="98%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">3.</FONT></TD>
    <TD vAlign=top width="99%" colSpan=3>
      <P align=left><U><FONT face="Times New Roman" size=2>Payments</FONT></U><FONT face="Times New Roman" size=2>. All
      Service Fees allocated to the Joint Venture pursuant to this Exhibit F
      shall be settled quarterly in arrears by the appropriate accounting
      entries. All Service Fees allocated to the Joint Venture hereunder will be
      expenses attributable to the Joint Venture in accordance with the Joint
      Venture Accounting Principles. </FONT></P></TD></TR>
  </TABLE><BR>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>3</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">4.</FONT></TD>
    <TD vAlign=top width="99%" colSpan=3>
      <P align=left><U><FONT face="Times New Roman" size=2>Outsourcing</FONT></U><FONT face="Times New Roman" size=2>. Any of
      the Clorox Services may be terminated by the Board at any time during the
      Term of the Joint Venture and thereby become Outsourced Services, upon 180
      days prior written notice to Clorox specifying the Clorox Services to be
      terminated and the date of such termination, in the event the Board
      determines (i) that the Glad Global Business can obtain such services from
      a third party at a lower cost to the Glad Global Business or (ii) that it
      is otherwise in the best interest of the Glad Business to discontinue such
      Clorox Services. Clorox&#146;s actual direct costs incurred in connection with
      the termination of any Clorox Services that become Outsourced Services
      will be attributed to the Glad Global Business.</FONT></P></TD></TR>
  <TR>
    <TD vAlign=top width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top width="99%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">5.</FONT></TD>
    <TD vAlign=top width="99%" colSpan=3>
      <P align=left><U><FONT face="Times New Roman" size=2>Relationship of the
      Parties</FONT></U><FONT face="Times New Roman" size=2>. All persons
      employed by Clorox or its affiliates in the performance of the Clorox
      Services shall be the sole responsibility of Clorox and its affiliates and
      P&amp;G shall have no obligation or responsibility with respect thereto
      except as expressly provided herein. The persons assigned by Clorox to
      provide the Clorox Services shall at all times remain employees of Clorox
      or its Affiliates, as applicable, and shall not, for any purposes, be or
      be deemed to be employees of any of P&amp;G and P&amp;G shall have no
      obligation or responsibility with respect thereto, including
      responsibility for payment of compensation, benefits, insurance and taxes
      related to such persons except as expressly provided herein.
  </FONT></P></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>4</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>EXHIBIT
G<BR></FONT></B><B><FONT face="Times New Roman" size=2>TERMS OF INTERNATIONAL
RELATIONSHIPS </FONT></B></P>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top noWrap width="15%">
      <P align=left><B><FONT face="Times New Roman" size=2>Structure</FONT></B></P></TD>
    <TD vAlign=top width="84%">
      <P align=left><I><U><FONT face="Times New Roman" size=2>New Entity Through
      US Joint Venture</FONT></U></I><FONT face="Times New Roman" size=2>. In
      those countries in which the Glad business does not currently operate, the
      Clorox Parties will form an entity in the local country, which may be
      either a corporation or pass-through entity for United States tax
      purposes. The newly formed entity will be an asset deemed attributed to
      the United States Joint Venture. If the local entity is treated as a
      corporation for United States tax purposes, P&amp;G will be directly
      issued one share of special voting stock equal to 10% of the vote in such
      entity, provided that such share shall not carry any dissenter&#146;s appraisal
      or similar rights, and that with respect to any matter that requires a
      vote or consent of the shareholders of such corporation, P&amp;G shall
      agree to vote such shares in the same manner that Clorox votes with
      respect to all matters other than those matters with respect to which
      P&amp;G has a veto right as described below under &#147;Governance &#150; P&amp;G
      Veto&#148;.</FONT></P>
      <P align=left><I><U><FONT face="Times New Roman" size=2>Contribution</FONT></U></I><FONT face="Times New Roman" size=2>.
      The Clorox Parties, on behalf of the joint venture, will contribute or
      license Intellectual Property rights associated with the Glad business to
      the newly formed entity and will contribute cash attributable to the joint
      venture to fund start-up costs. Cash distributions from the foreign entity
      to the Clorox Parties and proceeds from the sale of an interest in such
      entity received by the Clorox Parties will be distributed to the parties
      under the terms of the JV Agreement. </FONT></P>
      <P align=left><I><U><FONT face="Times New Roman" size=2>Distributions</FONT></U></I><FONT face="Times New Roman" size=2>.
      The foreign entity will distribute or pay Distributable Cash Flow (either
      by distributions or royalty payments) of such entity to the Clorox Parties
      on an annual basis or, in the event the net profits of the business in the
      applicable jurisdiction exceed $[* * *] per annum, on a quarterly basis.
      For the avoidance of doubt, Distributable Cash Flow will be reduced by
      applicable foreign income and other taxes. Also, for the avoidance of
      doubt, P&amp;G will be entitled to its share of Section 902 (income)
      and/or Section 901 (withholding) tax credits with respect to such
      Distributable Cash Flow. </FONT></P></TD></TR>
    <TR>
    <TD NOWRAP STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD vAlign=top noWrap width="15%">
      <P align=left><B><FONT face="Times New Roman" size=2>Governance</FONT></B></P></TD>
    <TD vAlign=top width="84%">
      <P align=left><I><U><FONT face="Times New Roman" size=2>International
      Board</FONT></U></I><FONT face="Times New Roman" size=2>. The
      international operations of the joint venture will be governed by a board
      of managers (the &#147;International Board&#148;) that will have authority to make
      decisions with respect to the operations in all countries other than the
      United States in the same manner as the Board with respect to the United
      States operations. </FONT></P></TD></TR></TABLE><BR>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top width="15%">&nbsp;</TD>
    <TD style="PADDING-RIGHT: 8pt; padding-left: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="84%">
      <P align=left><I><U><FONT face="Times New Roman" size=2>Composition</FONT></U></I><FONT face="Times New Roman" size=2>. The
      International Board will consist of the same members as the Board for the
      United States business, with the same board observers being appointed by
      P&amp;G.</FONT></P></TD></TR>
  </TABLE>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top width="15%"></TD>
    <TD style="PADDING-RIGHT: 8pt;  padding-left: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="84%">
      <P align=left><I><U><FONT face="Times New Roman" size=2>Meeting and
      Procedures</FONT></U></I><FONT face="Times New Roman" size=2>. Regular
      meetings of the International Board will be scheduled to occur immediately
      before or after the United States Board meetings. The terms with respect
      to the governance of the international operation will be substantially
      identical to the Joint Venture agreement for the United States, including
      with respect to meeting notice, voting, quorum, proxies and other similar
      procedural requirements, disclosure of information, expense reimbursement
      and other matters addressed in Sections 5.1 and 5.2 of the JV Agreement
      with respect to the Board in the United States.</FONT></P></TD></TR>
    <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding-right: 8pt; padding-left: 8pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD vAlign=top width="15%"></TD>
    <TD style="PADDING-RIGHT: 8pt;  padding-left: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="84%">
      <P align=left><I><U><FONT face="Times New Roman" size=2>Other Board
      Approvals</FONT></U></I><FONT face="Times New Roman" size=2>. The Board
      shall review and approve the budget, business plan and other actions to be
      taken by the international business in the same manner as detailed in
      Section 5.4 and 5.5 of the JV Agreement with respect to the United States
      operations.</FONT></P></TD></TR></TABLE><BR>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top noWrap width="15%"></TD>
    <TD vAlign=top width="84%">
      <P align=left><I><U><FONT face="Times New Roman" size=2>P&amp;G
      Veto</FONT></U></I><FONT face="Times New Roman" size=2>. P&amp;G will have
      the same veto rights with respect to international operations as it does
      in the United States (subject to the same dollar and other thresholds).
      Vetoes will be subject to the same resolution procedure as provided in
      Section 5.3 of the JV Agreement. </FONT></P>
      <P align=left><I><U><FONT face="Times New Roman" size=2>Local
      Governance</FONT></U></I><FONT face="Times New Roman" size=2>. The general
      managers of the Glad business in each country outside of the United States
      will report to the International Board. To the extent required by local
      law, local partnership entities may have a board or directors or other
      similar governing body in addition to the International Board, but no such
      local board or governing body shall have the authority to take any action
      for which approval of the International Board or P&amp;G is required prior
      to such approval being obtained. </FONT></P></TD></TR>
    <TR>
    <TD NOWRAP STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD vAlign=top noWrap width="15%">
      <P align=left><B><FONT face="Times New Roman" size=2>Transfer</FONT></B></P></TD>
    <TD vAlign=top width="84%">
      <P align=left><I><U><FONT face="Times New Roman" size=2>Transfer
      Restrictions</FONT></U></I><FONT face="Times New Roman" size=2>. The
      interests of the parties in the local partnership and license agreements
      described above will be subject to the same restrictions on transfer as
      set forth in the JV Agreement. </FONT></P>
      <P align=left><I><U><FONT face="Times New Roman" size=2>Tag-Along and
      Drag-Along</FONT></U></I><FONT face="Times New Roman" size=2>.
      Internationally, the P&amp;G affiliate will have the same tag-along rights
      in each country on equivalent terms as it has with respect to the Joint
      Venture in the United States. The Clorox affiliate will also have
      equivalent drag-along rights in each country, including with respect to
      any sale of the Glad business in the relevant country that is not part of
      the sale of the entire Glad business. </FONT></P></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>2</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>EXHIBIT
H<BR></FONT></B><B><FONT face="Times New Roman" size=2>Joint Venture Accounting
Principles </FONT></B></P>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD width="100%" colSpan=3>
      <P align=left><FONT face="Times New Roman" size=2>General Approach
      </FONT></P></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>1.</FONT></TD>
    <TD width="99%" colSpan=2><FONT face="Times New Roman" size=2>Create an accounting
      framework that to the extent possible is simple, sustainable and
      accurate.</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>2.</FONT></TD>
    <TD width="99%" colSpan=2><FONT face="Times New Roman" size=2>Start with Clorox&#146;s
      GAAP financial statements for each of Clorox and the relevant subsidiaries
      as a basis for preparing the pro-forma financial statements for the Glad
      Global Business in each country.</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>3.&nbsp;</FONT></TD>
    <TD width="99%" colSpan=2><FONT face="Times New Roman" size=2>Consistent
      application of Clorox and Glad Global Business accounting policies,
      principles, and processes.</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 1%; padding-left: 15pt">&nbsp;</TD>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>a.</FONT></TD>
    <TD width="98%"><FONT face="Times New Roman" size=2>Accounting Principles. The accounting
      principles of Clorox and the Glad Global Business will be the same in many
      respects, but to the extent they differ these Joint Venture Accounting
      Principles will govern. Any changes to the accounting principles of the
      Glad Global Business will be subject to P&amp;G&#146;s consent rights pursuant
      to Sections 5.3(a) and 9.1(f) of this Agreement, and any other provisions
      of this Agreement (or this Exhibit) requiring the consent of P&amp;G. The
      initial accounting principles of the Glad Global Business will be the same
      as those of Clorox and its subsidiaries, except with respect to Clorox
      corporate overhead allocations and as provided in this Exhibit
  H.</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 1%; padding-left: 15pt"></TD>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>b.</FONT></TD>
    <TD width="98%"><FONT face="Times New Roman" size=2>Accounting Policies. The accounting policies
      for the Glad Global Business can be changed as required by GAAP, the rules
      and regulations of the Securities and Exchange Commission or statements of
      the Financial Standards Accounting Board. The accounting policies can also
      be changed in connection with changes to Clorox&#146;s overall accounting
      policies, but in all cases subject to P&amp;G&#146;s consent rights pursuant to
      Sections 5.3(a) and 9.1(f) of this Agreement and any other provisions of
      this Agreement (or this Exhibit) requiring the consent of
    P&amp;G.</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 1%; padding-left: 15pt"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top noWrap width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="98%">&nbsp;</TD></TR>
  <TR>
    <TD width="100%" colSpan=3>
      <P align=left><FONT face="Times New Roman" size=2>Direct Costs and
      Allocated Costs </FONT></P></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>4.</FONT></TD>
    <TD vAlign=top noWrap width="1%"></TD>
    <TD width="98%"><FONT face="Times New Roman" size=2>The PWC report, the source documents
      referenced in the PWC report and the other materials underlying the PWC
      Report provide the basis for how indirect costs were allocated and direct
      costs were identified as of June 30, 2002. These allocations and
      identifications will be used during the Term, and changes to those
      allocations and identifications may only be made consistent with this
      Exhibit and with Exhibit F (Clorox Services).</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>5.</FONT></TD>
    <TD vAlign=top noWrap width="1%"></TD>
    <TD width="98%"><FONT face="Times New Roman" size=2>To the extent any costs that are
      attributable to the Glad Global Business on an allocated basis under
      Exhibit F are subsequently identified as direct costs attributable to the
      Glad Global Business, if they can be charged 100% to the Glad Global
      Business, Clorox will cause them to be directly charged to the Glad Global
      Business to the extent reasonably practicable.</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>6.</FONT></TD>
    <TD vAlign=top noWrap width="1%"></TD>
    <TD width="98%"><FONT face="Times New Roman" size=2>To the extent costs attributable to the Glad
      Global Business cannot be directly identified for the Glad Global Business
      they will be allocated on mutually agreed upon basis and in accordance
      with this Exhibit and with Exhibit F, where
  applicable.</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>7.</FONT></TD>
    <TD width="99%" colSpan=2><FONT face="Times New Roman" size=2>The Glad Global
      Business will continuously work to improve the accuracy of any allocated
      costs attributed to the Glad Global Business on an on-going
    basis.</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>8.</FONT></TD>
    <TD width="99%" colSpan=2><FONT face="Times New Roman" size=2>Capital spending on
      direct property, plant and equipment (e.g. used 100% by the Glad Global
      Business) will be direct costs of the Glad Global Business. Capital
      spending on shared manufacturing, distribution and product development
      assets used in the Glad Global Business will be shared pro rata based upon
      an allocation process to be mutually agreed to by Clorox and P&amp;G. If
      the Parties can not agree on such process the matter will be subject to
      Escalation and, if not resolved by Escalation, by arbitration as to the
      appropriate pro rata allocation.</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="98%">&nbsp;</TD></TR>
  <TR>
    <TD width="100%" colSpan=3>
      <P align=left><FONT face="Times New Roman" size=2>Reviews and Audits
      </FONT></P></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>9.</FONT></TD>
    <TD width="99%" colSpan=2><FONT face="Times New Roman" size=2>All allocations in
      all geographies for all allocated costs (i.e. those costs that cannot be
      solely attributed to the Glad Global Business) will be reviewed and
      documented annually to facilitate consistency and disclosure.</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>10.</FONT></TD>
    <TD width="99%" colSpan=2><FONT face="Times New Roman" size=2>Clorox&#146;s internal
      audit function will review the Glad Global Business&#146; financials and
      processes in a manner and frequency consistent with Clorox internal audit
      procedures. For the United States Glad Business and for each country where
      there is a Glad Global Business with annual revenues in excess of the
      greater of (x) U.S. $[* * *] or (y) [* * *]% of the Glad Global Business&#146;s
      aggregate annual revenue (initially, Canada and Australia), these audits
      will be performed at least once every 24 months, and these reports will be
      shared with the Board.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD width="100%" colSpan=3>
      <P align=left><FONT face="Times New Roman" size=2>Cash Funding Preferences
      </FONT></P></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>11.</FONT></TD>
    <TD width="99%" colSpan=2><FONT face="Times New Roman" size=2>The Glad Global
      Business may fund its own global cash requirements internally (which may
      require loans between Glad businesses in different countries) before
      seeking a Parent Loan, and the Parties expect that it will generally seek
      to fund such amounts internally rather than seeking a Parent
    Loan.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD width="100%" colSpan=3>
      <P align=left><FONT face="Times New Roman" size=2>Balance Sheet
      Preparation </FONT></P></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT face="Times New Roman" size=2>12.</FONT></TD>
    <TD width="99%" colSpan=2><FONT face="Times New Roman" size=2>For each country,
      assets and liabilities directly attributable to the Glad Global Business
      will be included on the pro-forma balance sheet of the Glad Global
      Business.</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 1%; padding-left: 15pt"></TD>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>a.</FONT></TD>
    <TD width="98%"><FONT face="Times New Roman" size=2>Shared Assets and Liabilities other than
      Fixed Assets. Where assets and liabilities other than Fixed Assets are not
      solely attributable to the Glad Global Business but are shared with other
      Clorox businesses in the country, they will be allocated on a fair share
      basis to the Glad Global Business.</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 1%; padding-left: 15pt"></TD>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>b.</FONT></TD>
    <TD width="98%"><FONT face="Times New Roman" size=2>Shared Fixed Assets. Any fixed asset shared
      with a Clorox business other than the Glad Global Business will not be
      allocated to the Glad Global Business unless otherwise mutually agreed. It
      is the intention of the Parties that any significant capital investments
      shared with a business other than the Glad Global Business will be shared
      on a pro rata basis based upon an allocation process to be mutually agreed
      to by Clorox and P&amp;G. If the Parties can not agree on such process the
      matter will be subject to Escalation and, if not resolved by Escalation,
      as to the appropriate pro rata allocation.</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>2</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top width="98%">
      <P align=left><FONT face="Times New Roman" size=2>Allocation Methodology
      Changes. Any change in allocation methodology must be approved by the
      P&amp;G Board member. </FONT></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT size=2 face="Times New Roman">13.</FONT></TD>
    <TD vAlign=top width="99%" colSpan=2>
      <P align=left><FONT face="Times New Roman" size=2>To the extent possible
      and practical all assets and liabilities held by Clorox corporate but
      attributable 100% to the Glad Global Business will be pushed down to the
      pro-forma balance sheet. To the extent this is not possible, an
      appropriate disclosure will be provided. </FONT></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 1%; padding-left: 15pt"><FONT size=2 face="Times New Roman">14.</FONT></TD>
    <TD vAlign=top width="99%" colSpan=2>
      <P align=left><FONT face="Times New Roman" size=2>To the extent either
      Clorox or P&amp;G adopts the accounting position of expensing its stock
      options, it will be able to attribute the option expense with respect to
      the personnel engaged in the Glad business to the Glad Global Business to
      the extent such expense is a direct cost.
</FONT></P></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>3</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>EXHIBIT I
<BR></FONT></B><B><FONT face="Times New Roman" size=2>SUBLICENSE AGREEMENT
</FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Sublicense Agreement
(this &#147;</FONT><U><FONT face="Times New Roman" size=2>Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148;), dated as of January 31, 2003 (the &#147;Effective
Date&#148;), by and between The Glad Products Company, a Delaware corporation
</FONT><FONT face="Times New Roman" size=2>(&#147;</FONT><U><FONT face="Times New Roman" size=2>Licensor</FONT></U><FONT face="Times New Roman" size=2>&#148;), and _________, a __________<SUP>1</SUP> (&#147;</FONT><U><FONT face="Times New Roman" size=2>Licensee</FONT></U><FONT face="Times New Roman" size=2>&#148;) (each, a &#147;</FONT><U><FONT face="Times New Roman" size=2>Party</FONT></U><FONT face="Times New Roman" size=2>&#148; and collectively,
the &#147;</FONT><U><FONT face="Times New Roman" size=2>Parties</FONT></U><FONT face="Times New Roman" size=2>&#148;). </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>WITNESSETH</FONT></U><FONT face="Times New Roman" size=2>: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, Licensor, Procter
&amp; Gamble RHD Inc., an Ohio corporation (&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Sub</FONT></U><FONT face="Times New Roman" size=2>&#148;), and certain Affiliates of Licensor and P&amp;G Sub, respectively,
have entered into an Amended and Restated Joint Venture Agreement with respect
to the Glad Global Business, dated as of January 31, 2003 (as such agreement may
be amended, supplemented or otherwise modified in accordance with the terms
thereof, the &#147;</FONT><U><FONT face="Times New Roman" size=2>JV
Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148;); </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, Licensor and P&amp;G
Sub have entered into a License Agreement, dated as of January 31, 2003 (as such
agreement may be amended, supplemented or otherwise modified in accordance with
the terms thereof, the &#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G
License Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148;) providing,
among other things, for the license by P&amp;G Sub to Licensor of certain
Intellectual Property (as defined below) for use in the Glad Global Business,
subject to the terms and conditions thereof; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, Licensor and Licensee
have agreed to enter into this Agreement providing, subject to the terms and
conditions contained herein, for the sublicense by Licensor to Licensee of
certain Intellectual Property licensed to Licensor by P&amp;G Sub under the
P&amp;G License Agreement, subject to the terms and conditions hereof and
thereof; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, Licensor and Licensee
have entered into a Technology and Trademark License Agreement, dated as of
January 31, 2003 (as such agreement may be amended, supplemented or otherwise
modified in accordance with the terms thereof, the &#147;</FONT><U><FONT face="Times New Roman" size=2>Glad License </FONT></U><FONT face="Times New Roman" size=2></FONT><U><FONT face="Times New Roman" size=2>Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148;) providing,
among other things, for the license by Licensor to Licensee of certain
Intellectual Property (as defined below) for use in the Glad Global Business,
subject to the terms and conditions thereof; and </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>WHEREAS, capitalized terms
used but not defined herein shall, as the context requires, have the meaning set
forth in either the JV Agreement or the P&amp;G License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>NOW, THEREFORE, for good and
valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the Parties agree as follows: </FONT></P>
<p>____________________</p>
<P align=left><FONT face="Times New Roman" size=1><SUP>1</SUP> License
Agreements will be entered into with the Clorox affiliates operating the Glad
business in each of Australia, Canada, New Zealand, South Africa, Costa Rica,
China, Hong Kong, Philippines and Korea. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Article 1.
</FONT></B><B><U><FONT face="Times New Roman" size=2>Definitions</FONT></U></B><B><FONT face="Times New Roman" size=2>.
</FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 1.1 </FONT><U><FONT face="Times New Roman" size=2>Definitions</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Action</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G License Agreement.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Additional P&amp;G Improvements</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Additional P&amp;G Technology</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Affiliate Loans</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean funds provided by Clorox or its
Affiliates as loans attributed to the Glad Local Business pursuant to Section
9.3 hereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Available Local Cash Flow</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean, with respect to any Fiscal Quarter
or other period, without regard to any Royalty payable hereunder, the sum of all
cash receipts during such Fiscal Quarter or other period attributed to the Glad
Local Business from any and all sources other than the cash proceeds of any
Indebtedness, </FONT><U><FONT face="Times New Roman" size=2>plus</FONT></U><FONT face="Times New Roman" size=2> all Reserves of the Glad Local Business as of the
close of business on the last day of the preceding Fiscal Quarter or other
period, </FONT><U><FONT face="Times New Roman" size=2>plus</FONT></U><FONT face="Times New Roman" size=2> interest on such Reserves at Clorox&#146;s 30-day
commercial paper borrowing rate (or, if Clorox is unable to obtain commercial
paper, Clorox&#146;s short term cost of borrowing), </FONT><U><FONT face="Times New Roman" size=2>plus</FONT></U><FONT face="Times New Roman" size=2> the sum of all royalty payments made by Licensee under the Glad License
Agreement during such period, </FONT><U><FONT face="Times New Roman" size=2>minus</FONT></U><FONT face="Times New Roman" size=2> all proceeds
attributed to the Glad Local Business from any International Acquisition,
</FONT><U><FONT face="Times New Roman" size=2>minus</FONT></U><FONT face="Times New Roman" size=2> all cash disbursements attributed to the Glad
Local Business for any and all purposes during such Fiscal Quarter or other
period ((x) including loan repayments (other than Affiliate Loans), interest
payments (other than in respect of Affiliate Loans), capital improvements and
replacements but (y) excluding disbursements funded by the cash proceeds of any
Indebtedness attributed to the Glad Local Business (other than Affiliate Loans)
and (z) excluding any cash dividends to Clorox or its Affiliates and any
Royalties paid under this Agreement) and a reasonable allowance as of the last
day of such Fiscal Quarter or other period for Reserves, contingencies and
anticipated obligations as determined by the Licensee, determined in accordance
with the JV Accounting Principles. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Call Right</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean The Clorox Company, a Delaware corporation. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Collaborative Improvements</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Collaborative Inventions</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Collaborative Inventions Prosecuting
Party</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set
forth in the P&amp;G License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Core P&amp;G Improvements</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>2</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Core P&amp;G Technology</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Distributable Local Cash Flow</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean, with respect to any Fiscal Quarter
or other period, Available Local Cash Flow for such Fiscal Quarter or other
period [* * *] the amount of Available Local Cash Flow required to be applied to
the repayment of Affiliate Loans and accrued interest thereon in accordance with
the immediately succeeding sentence. To the extent there are any outstanding
Affiliate Loans with respect to the Glad Local Business and there is Available
Local Cash Flow in any Fiscal Quarter, then all Available Local Cash Flow will
be immediately applied towards such outstanding Affiliate Loans and accrued and
unpaid interest thereon until all Affiliate Loans and accrued interest thereon
will have been repaid in full. As long as any Affiliate Loans remain
outstanding, Distributable Local Cash Flow will be [* * *]. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Exclusive Field</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Existing International Balance
Sheet</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set
forth in the JV Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Fair Market Value</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Field</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G License Agreement.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Fiscal Quarter</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean each three (3) calendar month period
ending on March 31, June 30, September 30 and December 31 or, in the case of the
first Fiscal Quarter hereunder, the period from the date hereof through March
31, 2003. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>GAAP</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean generally accepted accounting principles as in effect in the
United States (or such other jurisdiction as may be specified herein)
consistently applied. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Local Business</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean the Glad Global Business conducted by
the Licensee in the Territory. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad R&amp;D Team</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Governmental Authority</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean any nation or government, any state
or other political subdivision thereof, and any entity exercising executive,
legislative, judicial, regulatory or administrative functions of or pertaining
to government. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Improvements</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Indebtedness</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean all obligations for borrowed money,
including guarantees, and all reimbursement obligations in respect of
outstanding letters of credit (measured assuming such letters of credit are
drawn in full). </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Infringe</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G License Agreement.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Intellectual Property</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>3</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>International Acquisition</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean the sale, disposition or other
transfer to a Third Party of all or substantially all of the equity interests of
Licensee or of all or substantially all the business, assets and properties of
Licensee used in the Glad Local Business, but excluding (i) any transaction in
connection with which the Put Right or the Call Right is exercised, (ii) any
Third-Party Sale in connection with which Clorox exercises its right to cause a
sale and (iii) any transaction in connection with which the Tag-Along Right is
exercised. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>IP Acquisition</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>JV Accounting Principles</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Know How</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G License Agreement.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Liabilities</FONT></U><FONT face="Times New Roman" size=2>&#148; means, as to any Person, all debts, liabilities and obligations,
direct, indirect, absolute or contingent of such Person, whether accrued, vested
or otherwise, whether known or unknown and whether or not actually reflected, or
required by GAAP to be reflected, in such Person&#146;s balance sheet. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Non&#150;Exclusive Field</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Competitive Business Line</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Technology</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean the Core P&amp;G Technology and the
Additional P&amp;G Technology. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Patents</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G License Agreement.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Person</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean any individual, corporation, limited liability company,
partnership, trust, joint stock company, business trust, unincorporated
association, joint venture or other form of business or legal entity or
Governmental Authority. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Prime Rate</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean the rate of interest per annum publicly announced from time
to time by Citibank, N.A. as its prime rate in effect at its principal office in
New York, New York; each change in the Prime Rate will be effective from and
including the date such change is publicly announced as being effective.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Prosecuting Party</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G
License Agreement.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Put Right</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV Agreement.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Related Agreements</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Reserves</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean cash funds set aside from gross cash revenues as reserves.
Such &#147;Reserves&#148; will be maintained in amounts and upon such timing as is
reasonably deemed necessary by the Licensee to finance any working capital
requirements and/or to pay taxes, insurance, debt service, repairs,
replacements, renewals, capital expenditures or other costs or expenses to be
attributed to the Glad Local Business in accordance with the JV Accounting Principles in the four Fiscal Quarters following the date such Reserves are being established that
will not be funded from Available Local Cash Flow based on the then-current financial forecasts
of the Glad Local Business.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>4</FONT></P>
<HR align=center width="100%" noShade size="2">
<!--Part07-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Services Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the P&amp;G License
Agreement.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Tag-Along Right</FONT></U><FONT face="Times New Roman" size=2>&#148;
shall have the meaning set forth in the JV Agreement.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Team Inventions</FONT></U><FONT face="Times New Roman" size=2>&#148;
shall have the meaning set forth in the P&amp;G License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Territory</FONT></U><FONT face="Times New Roman" size=2>&#148; shall
mean [the Commonwealth of Australia][Canada][New Zealand] [the Republic of South
Africa][the Republic of Costa Rica] [the People&#146;s Republic of China][Hong
Kong][the Republic of the Philippines][the Republic of Korea]. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Third Party</FONT></U><FONT face="Times New Roman" size=2>&#148;
shall have the meaning set forth in the JV Agreement.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Third-Party Sale</FONT></U><FONT face="Times New Roman" size=2>&#148;
shall have the meaning set forth in the JV Agreement.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Trademarks</FONT></U><FONT face="Times New Roman" size=2>&#148; shall
have the meaning set forth in the P&amp;G License Agreement.</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 1.2
</FONT><U><FONT face="Times New Roman" size=2>Other Definitions</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The following terms are defined in
the Sections indicated: </FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: black 1pt dashed" noWrap align=left width="2%"><B><FONT face="Times New Roman" size=2>Term</FONT></B></TD>
    <TD noWrap align=left width="94%"></TD>
    <TD noWrap align=right width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt dashed" noWrap align=left width="3%"><B><FONT face="Times New Roman" size=2>Section</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Effective Date</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" colSpan=2><FONT face="Times New Roman" size=2>Excluded Local
      Assets</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>9.2(b)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Glad License Agreement</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Recitals</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" colSpan=2><FONT face="Times New Roman" size=2>International
      Acquisition</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>7.2(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>JV Agreement</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Recitals</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" colSpan=2><FONT face="Times New Roman" size=2>Licensee</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Licensor</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" colSpan=2><FONT face="Times New Roman" size=2>Negative Cash
    Flow</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>9.3(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>P&amp;G License Agreement</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Recitals</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" colSpan=2><FONT face="Times New Roman" size=2>P&amp;G Sub</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>Recitals</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Party</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Preamble</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" colSpan=2><FONT face="Times New Roman" size=2>Retained Local
      Liabilities</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>9.2(c)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Royalty</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>9.1(a)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" colSpan=2><FONT face="Times New Roman" size=2>Termination
Fee</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>7.2(a)</FONT></TD></TR></TABLE></DIV>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>5</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Article 2. </FONT></B><B><U><FONT face="Times New Roman" size=2>Core P&amp;G Technology</FONT></U></B><B><FONT face="Times New Roman" size=2>. </FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 2.1 </FONT><U><FONT face="Times New Roman" size=2>Licensee&#146;s License in the Field</FONT></U><FONT face="Times New Roman" size=2>. Subject to the terms and conditions of this Agreement,
Licensor hereby grants to Licensee a right and license to use the Core P&amp;G
Technology (including any and all Core P&amp;G Improvements deemed to be Core
P&amp;G Technology pursuant to the provisions of Section 2.3(b) of the P&amp;G
License Agreement) in the Field throughout the Territory,
including without limitation the right and license, in the Field throughout the
Territory, to (i) practice and use the Patents and Know How included in the Core
P&amp;G Technology, (ii) market, make, have made, sell and distribute products
by or on behalf of Licensee in connection with the Glad Local Business, (iii)
make Core P&amp;G Improvements and (iv) sublicense such rights to the Core
P&amp;G Technology. The licenses granted in the Territory pursuant to this
Section 2.1 are exclusive in the Exclusive Field and non-exclusive in the
Non&#150;Exclusive Field. In no event shall the license granted to Licensee pursuant
to this Section 2.1 be interpreted as being broader in any respect than the
license granted to Licensor pursuant to Section 2.1 of the P&amp;G License
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 2.2 </FONT><U><FONT face="Times New Roman" size=2>Core P&amp;G Improvements</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(a) </FONT><U><FONT face="Times New Roman" size=2>Ownership</FONT></U><FONT face="Times New Roman" size=2>. The
Parties acknowledge and agree that, as between P&amp;G (or its Subsidiaries) and
Licensee (on behalf of itself and its Affiliates), P&amp;G (or its Subsidiaries)
is and shall be the sole and exclusive owner of all right, title and interest,
including any and all Intellectual Property rights, in and to any and all Core
P&amp;G Improvements, whether developed by or on behalf of P&amp;G (or its
Subsidiaries), Licensor or Licensee (on behalf of itself and its Affiliates).
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(b)&nbsp;</FONT><U><FONT face="Times New Roman" size=2>Licensee&#146;s
Non&#150;Exclusive License to Certain Core P&amp;G Improvements Outside the
Field</FONT></U><FONT face="Times New Roman" size=2>. In the event that, during the
Term of the Services Agreement the [* * *] (or, after the termination or
expiration of the Services Agreement [* * *]) participates in the development of
any Core P&amp;G Improvements, then, to the extent such Core P&amp;G
Improvements are [* * *] Collaborative Improvements pursuant to the P&amp;G
License Agreement, Licensor hereby grants to Licensee a non-exclusive right and
license to use such Core P&amp;G Improvements throughout the Territory in
connection with [* * *] that is [* * *], including without limitation the right
and license, solely for the foregoing purposes, to (i) practice and use the
Patents and Know How included in such Core P&amp;G Improvements, (ii) market,
make, have made, sell and distribute products by or on behalf of Licensee,
Clorox or its Subsidiaries, (iii) make Improvements based upon or derived from
such Core P&amp;G Improvements and (iv) sublicense such rights solely to
manufacturers of products of Licensee, Clorox or its Subsidiaries and to Clorox
and Subsidiaries of Clorox. In no event shall the license granted to Licensee
pursuant to this Section 2.2(b) be interpreted as being broader in any respect
than the license granted to Licensor pursuant to Section 2.3(c) of the P&amp;G
License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(c) </FONT><U><FONT face="Times New Roman" size=2>Clarification of
Licensee&#146;s Rights</FONT></U><FONT face="Times New Roman" size=2>. For the avoidance of
doubt, (i) any and all Core P&amp;G Improvements developed by P&amp;G or its
Subsidiaries without the participation of the [* * *] or [* * *] ([* * *]) and
(ii) any and all Core P&amp;G Improvements that constitute </FONT><FONT face="Times New Roman" size=2>[* * *] shall not be subject to the licenses set forth in
Section 2.2(b), but shall be subject to the licenses set forth in Section 2.1.
The license granted pursuant to Section 2.2(b) shall only apply to that portion
of the Core P&amp;G Improvements that is incremental to the Core P&amp;G
Technology. Except for the Core P&amp;G Improvements that do not [* * *]
Collaborative Improvements, Licensee (on behalf of itself and its Affiliates)
shall not have the right to use any Core P&amp;G Technology outside of the
Field, irrespective of whether any Core P&amp;G Improvements licensed pursuant
to Section 2.2(b) are based upon or derived from such Core P&amp;G Technology.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>6</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(d) </FONT><U><FONT face="Times New Roman" size=2>Notice of
Improvements</FONT></U><FONT face="Times New Roman" size=2>. In the event Licensee (on
behalf of itself or its Affiliates) develops any Core P&amp;G Improvements,
Licensee shall promptly provide Licensor with written notice thereof.
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Article 3. </FONT></B><B><U><FONT face="Times New Roman" size=2>Additional
P&amp;G Technology.</FONT></U></B><B><FONT face="Times New Roman" size=2>
</FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 3.1 </FONT><U><FONT face="Times New Roman" size=2>Licensee&#146;s License in the Field</FONT></U><FONT face="Times New Roman" size=2>. Subject to the terms and conditions of this Agreement,
Licensor hereby grants to Licensee a right and license to use the Additional
P&amp;G Technology (including any and all P&amp;G Improvements deemed to be
Additional P&amp;G Technology pursuant to the provisions of the P&amp;G License
Agreement), and all Intellectual Property rights therein, in the Field
throughout the Territory, including without limitation the right and license, in
the Field throughout the Territory, to (i) practice the Patents and Know How
included in the Additional P&amp;G Technology, (ii) market, make, have made,
sell and distribute products by or on behalf of Licensee in connection with the
Glad Local Business, (iii) make Additional P&amp;G Improvements and (iv)
sublicense such rights to the Additional P&amp;G Technology. The licenses
granted in the Territory pursuant to this Section 3.1 are exclusive in the
Exclusive Field and non-exclusive in the Non&#150;Exclusive Field. In no event shall
the license granted to Licensee pursuant to this Section 3.1 be interpreted as
being broader in any respect than the license granted to Licensor pursuant to
Section 3.1 of the P&amp;G License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 3.2 </FONT><U><FONT face="Times New Roman" size=2>Additional P&amp;G Improvements</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) </FONT><U><FONT face="Times New Roman" size=2>Ownership</FONT></U><FONT face="Times New Roman" size=2>. The
Parties acknowledge and agree that, as between P&amp;G (or its Subsidiaries) and
Licensee (on behalf of itself and its Affiliates), P&amp;G (or its Subsidiaries)
is and shall be the sole and exclusive owner of all right, title and interest,
including all Intellectual Property rights, in and to any and all Additional
P&amp;G Improvements, whether developed by or on behalf of P&amp;G (or its
Subsidiaries), Licensor or Licensee (on behalf of itself and its Affiliates).
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) </FONT><U><FONT face="Times New Roman" size=2>Licensee&#146;s Non&#150;Exclusive License Outside the
Field</FONT></U><FONT face="Times New Roman" size=2>. In the event that, during the
Term of the Services Agreement the [* * *] (or, after the termination or
expiration of the Services Agreement [* * *]) participates in the development of
any Additional P&amp;G Improvements, then, to the extent such Additional P&amp;G
Improvements are [* * *] Collaborative Improvements pursuant to the P&amp;G
License Agreement, Licensor hereby grants to Licensee a non-exclusive right and
license to use such Additional P&amp;G Improvements throughout the Territory in
connection [* * *] that is [* * *], including without limitation the right and
license, solely for the foregoing purposes, to (i) practice and use the Patents
and Know How included in such Additional P&amp;G Improvements, (ii) market,
make, have made, sell and distribute products by or on behalf of Licensee,
Clorox or its Subsidiaries, (iii) make Improvements based upon or derived from
such Additional P&amp;G Improvements and (iv) sublicense such rights solely to
manufacturers of products of Licensee, Clorox or its Subsidiaries and to Clorox
and Subsidiaries of Clorox. In no event shall the license granted to Licensee
pursuant to this Section 3.1(b) be interpreted as being broader in any respect
than the license granted to Licensor pursuant to Section 3.1(c) of the P&amp;G
License Agreement. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>7</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) </FONT><U><FONT face="Times New Roman" size=2>Clarification of Licensee&#146;s Rights</FONT></U><FONT face="Times New Roman" size=2>. For the avoidance of doubt, (i) any and all Additional
P&amp;G Improvements developed by P&amp;G or its Subsidiaries without the
participation of the [* * *] or [* * *] and (ii) any and all Additional P&amp;G
Improvements that constitute [*&nbsp;</FONT><FONT face="Times New Roman" size=2>* *]
shall not be subject to the licenses set forth in Section 3.2(b), but shall be
subject to the licenses set forth in Section 3.1. The license granted pursuant
to Section 3.2(b) shall only apply to that portion of the Additional P&amp;G
Improvements that is incremental to the Additional P&amp;G Technology. Except
for the Additional P&amp;G Improvements that do not [* * *] Collaborative
Improvements, Licensee (on behalf of itself and its Affiliates) shall not have
the right to use any Additional P&amp;G Technology outside of the Field,
irrespective of whether any Additional P&amp;G Improvements licensed pursuant to
Section 3.2(b) are based upon or derived from such Additional P&amp;G
Technology. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(d) </FONT><U><FONT face="Times New Roman" size=2>Notice of Improvements</FONT></U><FONT face="Times New Roman" size=2>. In the event Licensee (on behalf of itself or its
Affiliates) develops any Additional P&amp;G Improvements, Licensee shall
promptly provide Licensor with written notice thereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 3.3 </FONT><U><FONT face="Times New Roman" size=2>Effect of Expiration or Termination of the JV Agreement
on Section 3.1 and Section 3.2</FONT></U><FONT face="Times New Roman" size=2>. In the event of any expiration or termination of the
Term under the JV Agreement, the licenses granted to Licensee in Section 3.1
and, if applicable, Section 3.2 shall automatically terminate to the extent the
license to Licensor terminates under the P&amp;G License Agreement. This Section
3.3 shall have no effect on any Additional P&amp;G Improvements developed by or
on behalf of Licensor or Licensee after the termination or expiration of the
Term of the JV Agreement, which shall continue to remain subject to the licenses
granted to Licensee in Section 3.1 and Section 3.2. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Article 4. </FONT></B><B><U><FONT face="Times New Roman" size=2>Trademarks and Other Intellectual
Property</FONT></U></B><B><FONT face="Times New Roman" size=2>. </FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 4.1 </FONT><U><FONT face="Times New Roman" size=2>License Grant</FONT></U><FONT face="Times New Roman" size=2>.
Subject to the terms and conditions of this Agreement, Licensor hereby grants to
Licensee an exclusive (as set forth in Section 4.2) right and license to use the
Trademarks in the Field throughout the Territory, including without limitation,
the right and license to sublicense such rights in the Field throughout the
Territory. In no event shall the license granted to Licensee pursuant to this
Section 4.1 be interpreted as being broader in any respect than the license
granted to Licensor pursuant to Section 6.1 of the P&amp;G License Agreement.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 4.2 </FONT><U><FONT face="Times New Roman" size=2>Exclusivity</FONT></U><FONT face="Times New Roman" size=2>. The
licenses granted to Licensee pursuant to Section 4.1 are exclusive with respect
to use of the Trademarks in the Field in the Territory. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 4.3 </FONT><U><FONT face="Times New Roman" size=2>Trademark Use</FONT></U><FONT face="Times New Roman" size=2>.
Licensee agrees to maintain and preserve the quality of the Trademarks and to
use the Trademarks in good faith and in a dignified manner, consistent with
P&amp;G Sub&#146;s and Licensor&#146;s high standards of and reputation for quality, and
in accordance with good trademark practice wherever the Trademarks are used.
Both Parties agree to use the Trademarks only in connection with goods and
services that possess a character and quality consistent with the reputation and
high standards associated with Licensor, P&amp;G Sub and/or the Trademarks.
Licensees agree that any and all goodwill arising from Licensee&#146;s use of the
Trademarks shall inure solely to the benefit of P&amp;G Sub, as licensor to
Licensor under the P&amp;G License Agreement. Upon the
request of Licensor, Licensee shall, to the extent reasonable, provide Licensor
with a representative sample of Licensee&#146;s use of the Trademarks.</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>8</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 4.4 </FONT><U><FONT face="Times New Roman" size=2>Glad Base IP and Glad Improvements</FONT></U><FONT face="Times New Roman" size=2>. The Parties acknowledge and agree that, as between
Licensor and Licensee, Licensor shall be the sole and exclusive owner of all
right, title and interest, including all Intellectual Property rights, in and to
any and all Glad Base IP and any and all Glad Improvements. Licensee hereby
acknowledges and agrees that it is bound by, and its rights hereunder are in all
respects subject to, the license grants of Licensor contained in Article 4 of
the P&amp;G License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 4.5 </FONT><U><FONT face="Times New Roman" size=2>New Inventions</FONT></U><FONT face="Times New Roman" size=2>.
The Parties acknowledge and agree that, as between Licensor and Licensee,
Licensor shall be the sole and exclusive owner of all right, title and interest,
including all Intellectual Property rights, in and to any and all New
Inventions. Licensee hereby acknowledges and agrees that it is bound by, and its
rights hereunder are in all respects subject to, the license grants of Licensor
contained in Article 5 of the P&amp;G License Agreement. Licensee shall not, and
shall not authorize third parties to, (a) use any Team Inventions outside of the
Field in the Territory in connection with a [* * *] that is a [* * *] or (b) use
the Collaborative Inventions in the Territory outside of the Field or to
manufacture a product inside the Field for use, sale or distribution outside of
the Field or provide any information or assistance to any third party related
thereto. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Article 5. </FONT></B><B><U><FONT face="Times New Roman" size=2>Other Agreements</FONT></U></B><B><FONT face="Times New Roman" size=2>. </FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 5.1 </FONT><U><FONT face="Times New Roman" size=2>Transfers and Encumbrances of Intellectual
Property</FONT></U><FONT face="Times New Roman" size=2>. Nothing in this Agreement
shall prevent Licensor from transferring any Intellectual Property rights that
are, in whole or in part, subject to a license or obligation under this
Agreement. Nothing in this Agreement shall prevent Licensor from encumbering any
Intellectual Property rights that are, in whole or in part, subject to a license
or obligation under this Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 5.2 </FONT><U><FONT face="Times New Roman" size=2>Intellectual Property Protection</FONT></U><FONT face="Times New Roman" size=2>. Licensee agrees to notify Licensor immediately after it
becomes aware of any actual or threatened Infringement of the P&amp;G Technology
or the Trademarks or any Collaborative Inventions. Licensee agrees to cooperate
fully with the Prosecuting Party or the Collaborative Invention Prosecuting
Party, as the case may be, during the course of any such Action and to fulfill
all reasonable requests for assistance by the Prosecuting Party or the
Collaborative Invention Prosecuting Party, including without limitation agreeing
to be joined as a party to such Action. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 5.3 </FONT><U><FONT face="Times New Roman" size=2>Information with Respect to Glad Local
Business</FONT></U><FONT face="Times New Roman" size=2>. During the term of this
Agreement, Licensee will provide Licensor with copies of [* * *] of its [* * *]
and [*&nbsp;</FONT><FONT face="Times New Roman" size=2>* *] for its [* * *] prior to
finalizing such [* * *], and [* * *] to the then-current versions </FONT><FONT face="Times New Roman" size=2>[* * *], and [* * *] with respect to such [* * *].
Licensee will also provide Licensor with additional reports and other
information about the Glad Local Business as is provided to the members of its
board of directors or other equivalent governing body on a scheduled, periodic
basis, as well as any additional information upon the reasonable request of
Licensor. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>9 </FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 5.4 </FONT><U><FONT face="Times New Roman" size=2>Consent Rights</FONT></U><FONT face="Times New Roman" size=2>.
Licensee agrees that during the term of this Agreement, without the prior
consent of Licensor, it will not, and will cause its Subsidiaries not to, take
any of the following actions: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) the incurrence or assumption of
any Indebtedness to be attributed to the Glad Local Business pursuant to Section
9.2 (other than Affiliate Loans pursuant to Section 9.3) that would result in
the aggregate outstanding Indebtedness attributed to the Glad Local Business at
the time such Indebtedness is incurred or assumed (other than Affiliate Loans)
to be in excess [*&nbsp;</FONT><FONT face="Times New Roman" size=2>* *] percent ([* *
*]%) of Available Local Cash Flow for the prior four Fiscal Quarters;
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) any purchase or other acquisition
of any business, division or Person that will be attributed to the Glad Local
Business pursuant to Section 9.2; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) any sale, transfer or other
disposition in any single transaction or series of related transactions of any
business, division or Person attributed to the Glad Local Business pursuant to
Section 9.2, </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(d) any sale, transfer or other
disposition in any single transaction or series of related transactions, other
than in the ordinary course of the conduct of the Glad Local Business of any
assets attributed to it, which assets (x) are not obsolete, (y) are utilized in
a material manner in the Glad Local Business at the time of such sale, and (z)
are not being replaced with assets of comparable utility or value to the Glad
Local Business, provided that in each case such business, division, Person or
assets have a value in [* * *] of [* * *] ([* * *]%) of Available Local Cash
Flow for the prior four Fiscal Quarters; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(e) except as provided in the JV
Agreement or the Related Agreements, any transaction with respect to the Glad
Local Business between Licensee or any of its Subsidiaries, on the one hand, and
Clorox or any Affiliate of Clorox, on the other hand, unless (x) (A) such
transaction is [* * *] or is less than $[* * *] and (B) the terms of such
transaction to be attributed to the Glad Local Business are no less favorable
than those that would be obtained in a comparable arm&#146;s length transaction with
a third party that is not Clorox or an Affiliate of Clorox or (y) such
transaction is provided for pursuant to the JV Accounting Principles;
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(f) any internal restructuring of the
method by which the legal ownership of the Glad Local Business is held by
Licensee and its Subsidiaries that, based on the facts and circumstances known
at the time such restructuring is approved, has or will have a material adverse
effect on the business, properties, financial condition, results of operations
or prospects of the Glad Local Business; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(g) any changes in the accounting
policies of the Licensee so as to differ from the JV Accounting Principles,
except as required by Governmental Authorities; and </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(h) the Glad Local Business [* * *].
</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>10</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Article 6. </FONT></B><B><U><FONT face="Times New Roman" size=2>Other Intellectual Property
Matters</FONT></U></B><B><FONT face="Times New Roman" size=2>. </FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 6.1 </FONT><U><FONT face="Times New Roman" size=2>Notices and Legends</FONT></U><FONT face="Times New Roman" size=2>. Licensee shall apply or use all notices and legends,
including patent markings, required by applicable law or regulations to preserve
and protect the value and validity of any Intellectual Property licensed
pursuant to this Agreement, including applying or using any notices or legends
reasonably requested by Licensor. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 6.2 </FONT><U><FONT face="Times New Roman" size=2>No Contest</FONT></U><FONT face="Times New Roman" size=2>.
Licensee agrees not to directly or indirectly question, attack, contest or in
any other manner impugn any Intellectual Property licensed to it pursuant to the
terms of this Agreement, or the enforceability of this Agreement, including
without limitation, in any Action in which enforcement of a provision of this
Agreement is sought; nor shall Licensee willingly become a party adverse to
Licensor or P&amp;G Sub in an Action in which a third party contests the same.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 6.3 </FONT><U><FONT face="Times New Roman" size=2>Assignment and Further Assurances</FONT></U><FONT face="Times New Roman" size=2>. Notwithstanding any other provision of this Agreement,
in the event that Licensee is held to, or becomes the owner of any Intellectual
Property that is intended to be owned by Licensor or P&amp;G Sub pursuant to the
terms of this Agreement or the P&amp;G License Agreement, Licensee hereby
assigns permanently the entirety of such rights to Licensor or P&amp;G Sub, as
the case may be, and shall, during the term of this Agreement and after any
expiration or termination hereof, execute such documents as Licensor and P&amp;G
Sub reasonably may request from time to time to ensure that all such
Intellectual Property rights reside in the proper party. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 6.4 </FONT><U><FONT face="Times New Roman" size=2>Reservation of Rights</FONT></U><FONT face="Times New Roman" size=2>. All Intellectual Property rights not expressly granted
pursuant to this Agreement are reserved to the owner of such Intellectual
Property. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Article 7. </FONT></B><B><U><FONT face="Times New Roman" size=2>Term and Termination.</FONT></U></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 7.1 </FONT><U><FONT face="Times New Roman" size=2>Termination by Licensor</FONT></U><FONT face="Times New Roman" size=2>. The initial term of this Agreement shall be five (5)
years, which term shall be renewable for successive five (5) year periods
thereafter at the option of the Licensor upon written notice. The term of this
Agreement may be terminated by Licensor at any time upon [* * *] notice to
Licensee. The term of this Agreement may be terminated by Licensee only as
provided in Section 7.2(a) hereof. No further Royalty shall accrue hereunder
after the termination (or deemed termination pursuant to Section 7.2) of this
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 7.2 </FONT><U><FONT face="Times New Roman" size=2>International Acquisition Transaction.</FONT></U></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) In the event of an International
Acquisition in which there is no IP Acquisition, Licensee will be deemed to have
terminated this Agreement. Upon such deemed termination, Licensee will be
required to pay Licensor a termination fee (the &#147;<u>Termination Fee</u>&#148;) in an amount
equal to [* * *] ([* * *]%) of the Fair Market Value of the Glad Local Business.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) In the event of an International
Acquisition in which there is an IP Acquisition, Licensor will be deemed to have
terminated this Agreement and no Termination Fee shall be due or payable.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>11</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Article 8. </FONT></B><B><U><FONT face="Times New Roman" size=2>Representations and Warranties.</FONT></U></B><B><FONT face="Times New Roman" size=2> </FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 8.1 </FONT><U><FONT face="Times New Roman" size=2>Of Both Parties</FONT></U><FONT face="Times New Roman" size=2>.
Licensor and Licensee each represents and warrants to the other Party that, as
of the Effective Date: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) The warranting Party is duly
organized and validly existing under the laws of the jurisdiction of its
organization, and has full power, authority and legal right to execute, deliver
and perform this Agreement, and has taken all necessary action to authorize the
execution, delivery and performance of this Agreement; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) This Agreement has been duly
executed and delivered by the warranting Party. This Agreement is a legal, valid
and binding obligation of the warranting Party, enforceable against such Party
in accordance with its terms, subject to the effect of any applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
creditors&#146; rights and remedies generally, and subject, as to enforceability, to
the effect of general principles of equity (regardless of whether enforcement is
considered in a proceeding at law or in equity); and </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) The warranting Party is not
subject to any judgment, order, injunction, decree or award of any court,
administrative agency or governmental body that would or might interfere with
its performance of any of its material obligations hereunder. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 8.2 </FONT><U><FONT face="Times New Roman" size=2>No Other Representations or Warranties</FONT></U><FONT face="Times New Roman" size=2>. Neither Party makes any representations or warranties
other than as expressly set forth in this Article. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Article 9. </FONT></B><B><U><FONT face="Times New Roman" size=2>Royalties and Cash Flow.</FONT></U></B><B><FONT face="Times New Roman" size=2> </FONT></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 9.1 </FONT><U><FONT face="Times New Roman" size=2>Royalties</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) As consideration for the rights
granted in Articles 2, 3 and 4, Licensee shall pay Licensor a royalty (the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Royalty</FONT></U><FONT face="Times New Roman" size=2>&#148;) on a quarterly basis in arrears as set forth below:
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(i) With respect to the first four
Fiscal Quarters of the Joint Venture, the Royalty shall be [* * *]; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii) With respect to the fifth
through eighth Fiscal Quarters of the Joint Venture, the Royalty shall be an
amount [* * *] to [* * *] percent ([* * *]%) of Distributable Local Cash Flow;
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii) With respect to the ninth and
all succeeding Fiscal Quarters of the Joint Venture during the term of this
Agreement, the Royalty shall be an amount [* * *] to [* * *] percent ([* * *]%)
of Distributable Local Cash Flow. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) The Royalty with respect to any
Fiscal Quarter will be paid by Licensee to Licensor within three (3) Business
Days after delivery of the financial statements with respect to the Glad Local
Business for such Fiscal Quarter pursuant to the JV Agreement in immediately
available funds to the account designated by Licensor to Licensee in writing.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>12</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 9.2 </FONT><U><FONT face="Times New Roman" size=2>Determining Available Local Cash Flow</FONT></U><FONT face="Times New Roman" size=2>. For the purposes of determining Available Local Cash
Flow: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) From and after the date hereof,
subject to the JV Accounting Principles, the following interests and Liabilities
of Licensee and other relevant subsidiaries of Clorox will be attributed to the
Glad Local Business for purposes of determining Available Local Cash Flow,
except as provided in Section 9.2(b) below with respect to Excluded Local Assets
and Section 9.2(c) below with respect to Retained Local Liabilities: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(i) the interest of Licensee and
its Subsidiaries on the date hereof in all of the businesses, assets, rights and
properties of Licensee to the extent and only to the extent utilized in or
related to the Glad Local Business; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii) subject to the JV Accounting
Principles, the interest of Licensee and its Subsidiaries in any business,
asset, right or property acquired during the Term by Licensee or its
Subsidiaries to the extent and only to the extent utilized in or related to the
Glad Local Business; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii) all Liabilities of Licensee and
its Subsidiaries to the extent and only to the extent [(A) reflected in the
Existing International Balance Sheet with respect to the Glad Local Business,
(B) incurred or assumed by the Glad Business in the ordinary course of business
after the date of such Glad Balance Sheet and prior to the date hereof that
would be reflected as current Liabilities on a balance sheet of the Glad Local
Business as of the date hereof, but excluding any current Liabilities arising
from third party litigation claims, (C)]<SUP>2</SUP> [(A) incurred or assumed by
the Glad Local Business in the ordinary course of business prior to the date
hereof that would be reflected as current Liabilities on a balance sheet of the
Glad Local Business, but excluding any current Liabilities arising from third
party litigation claims, (B)]<SUP>3</SUP> arising out of the conduct of the Glad
Local Business or the ownership or possession of any business, assets, rights or
property used in the Glad Local Business after the date hereof or [(D)][(C)]
assumed or incurred after the date hereof by the Licensee and other Subsidiaries
of Clorox in accordance with the terms hereof with respect to the Glad Local
Business, </FONT><U><FONT face="Times New Roman" size=2>provided</FONT></U><FONT face="Times New Roman" size=2> that Indebtedness will be attributed to the Glad Local
Business only to the extent permitted to be incurred pursuant to the provisions
of Section 5.4(a); and </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv) net income and net losses and
Available Local Cash Flow arising in respect of the foregoing and proceeds of
any disposition thereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) The following interests of
Licensee and its Subsidiaries will be excluded from the Glad Local Business and
will not be attributed to the Glad Local Business (collectively, the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Excluded Local Assets</FONT></U><FONT face="Times New Roman" size=2>&#148;), and from and after the date hereof the Glad Local
Business will not include any interest in any of the following for purposes of
determining Available Local Cash Flow: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(i) all rights of Licensee under
this Agreement; </FONT></P>

<p>____________________</p>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 1%; text-align: left"><FONT face="Times New Roman" size=2><sup>2</sup></FONT></TD>
    <TD STYLE="width: 99%"><FONT face="Times New Roman" size=2>Use this version only for Australia, Canada and New Zealand.</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: left"><FONT face="Times New Roman" size=2><sup>3</sup></FONT></TD>
    <TD><FONT face="Times New Roman" size=2>Use this version only for South Africa, Costa Rica, China, Hong Kong, Philippines and Korea.</FONT></TD></TR>
</TABLE>

<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>13</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii) [all interests in any business,
asset, right or property sold, transferred or otherwise disposed of prior to the
date hereof in the ordinary course of the Glad Local Business and not in
violation of the terms of the JV Agreement;]<SUP>4</SUP> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii) all cash and cash equivalents
as of the date hereof other than petty cash with respect to the Glad Local
Business; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv) all refunds or credits with
respect to any Taxes paid or incurred by Licensee; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(v) all capital stock or other equity
interests of Licensee, Clorox and any other Subsidiaries of Clorox; and
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(vi) all rights of the Licensee and
other Subsidiaries of Clorox arising out of or in connection with any Retained
Liabilities, including without limitation any cause of action, right of
recovery, right of set-off or counterclaim. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) From and after the date hereof,
none of the following Liabilities will be attributed to the Glad Local Business
(&#147;</FONT><U><FONT face="Times New Roman" size=2>Retained Local
Liabilities</FONT></U><FONT face="Times New Roman" size=2>&#148;) for purposes of
determining Available Local Cash Flow: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(i) any Liability (A) arising out of
or relating to the conduct of the Glad Local Business or the ownership or
possession of any business, assets, rights or property used in the Glad Local
Business prior to the date hereof or (B) assumed or incurred prior to the date
hereof by Licensee and/or other Subsidiaries of Clorox, except for any
Liabilities described in [clause (A) or (B)]<SUP>5</SUP> [clause
(A)]<SUP>6</SUP> of Section 9.2(a)(iii); </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(ii) any Liability with respect to
income Taxes of Licensee and other Subsidiaries of Clorox; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iii) any Liability arising out of or
relating to the Excluded Assets; </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(iv) any Liability of the Licensee,
Clorox and other Subsidiaries of Clorox to the Licensor arising out of or
related to any breach of this Agreement or any Related Agreement by Licensee,
Clorox and other Subsidiaries of Clorox, even if arising out of or related to
conduct of the Glad Local Business or the ownership or possession of any
business, asset, right or property used in the Glad Local Business after the
date hereof; and </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>(v) any Liability for which Licensee
and/or other Clorox Subsidiaries have otherwise agreed to be liable and not have
attributed to the Glad Local Business pursuant to this Agreement or any Related
Agreement. </FONT></P>
<p>____________________</p>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 1%; text-align: left"><FONT face="Times New Roman" size=2><sup>4</sup></FONT></TD>
    <TD STYLE="width: 99%"><FONT face="Times New Roman" size=2>Include only for Australia, Canada and New Zealand.</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: left"><FONT face="Times New Roman" size=2><sup>5</sup></FONT></TD>
    <TD><FONT face="Times New Roman" size=2>Use only for Australia, Canada and New Zealand.</FONT></TD></TR>
    <TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: left"><FONT face="Times New Roman" size=2><sup>6</sup></FONT></TD>
    <TD><FONT face="Times New Roman" size=2>Use only for South Africa, Costa Rica, China, Hong Kong, Philippines and Korea.</FONT></TD></TR>
</TABLE>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>14</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 9.3 </FONT><U><FONT face="Times New Roman" size=2>Affiliate Loans</FONT></U><FONT face="Times New Roman" size=2>.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) In the event that Available Cash
Flow for any Fiscal Quarter as set forth in the quarterly financial statements
of the Glad Business in the Territory for such Fiscal Quarter is a negative
number (such number, the &#147;Negative Cash Flow&#148;) then the amount of the Negative
Cash Flow will be treated as an Affiliate Loan, which Affiliate Loan will be
deemed to have been made as of the last day of the Fiscal Quarter to which the
Negative Cash Flow relates. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) All Affiliate Loans will bear
interest calculated on the outstanding principal amount thereof for each day
from the date such Affiliate Loan is made until it is paid in full at Prime Rate
plus [* * *] percent ([* * *]%) per annum payable on a quarterly basis, and
payments with respect to any Affiliate Loans will be credited first to accrued
interest. Each Affiliate Loan will have a maturity date of the date on which
this Agreement is terminated. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 9.4 </FONT><U><FONT face="Times New Roman" size=2>Foreign Currency Exchange</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>In determining the amount of
royalties and other amounts payable hereunder, such amounts shall first be
determined in the national currency in which sold and then converted into its
equivalent in United States Dollars at: (i) the rate of United States Dollars to
the national currency of the Territory applicable to the transfer of funds
arising from this type of transaction as established by the exchange control
authorities of the Territory for the last business day of the calendar quarter
for which payment is made; or (ii) if there is no applicable rate so
established, at the selling rate for United States Dollars to the applicable
national currency as published by leading commercial banks in the Territory, for
the last business day of such calendar quarter; or (iii) if there is no rate so
published, at the buying rate for the applicable national currency to United
States Dollars as published by leading New York, New York banks for the last
business day of such calendar quarter. Licensee shall bear responsibility for
all expenses of currency conversion and transmission. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Article 10. </FONT></B><B><U><FONT face="Times New Roman" size=2>Miscellaneous Provisions.</FONT></U></B></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.1 </FONT><U><FONT face="Times New Roman" size=2>Assignment</FONT></U><FONT face="Times New Roman" size=2>.
Licensor may assign, transfer or otherwise sublicense its rights under this
Agreement, in whole or in part, to any other party without the prior written
consent of the Licensee. Licensee may not assign, transfer or otherwise
sublicense its rights under this Agreement, in whole or in part, to any other
party without the prior written consent of Licensor. Any purported transfer,
assignment or sublicense of this Agreement or the rights granted hereunder that
is not expressly permitted by this Agreement shall be null and void
</FONT><I><FONT face="Times New Roman" size=2>ab initio</FONT></I><FONT face="Times New Roman" size=2> and of no force or effect. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.2 </FONT><U><FONT face="Times New Roman" size=2>Arbitration</FONT></U><FONT face="Times New Roman" size=2>. Any
dispute, claim or controversy arising out of or relating to this Agreement shall
be subject to the dispute resolution proceedings set forth in Section 11.8 of
the JV Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.3 </FONT><U><FONT face="Times New Roman" size=2>Force Majeure</FONT></U><FONT face="Times New Roman" size=2>.
Should either Party be prevented from performing its obligations under this
Agreement by an event of force majeure, such as an earthquake, typhoon, flood,
fire, act of war, act of the public enemy, act of terrorism, act of God or any
other unforeseen event the happening and consequences of which are unpreventable
and unavoidable, the prevented Party shall notify the other Party by the most
expedient means available (fax, telex or express mail being acceptable in any
event) without any delay, and within fifteen (15) days thereafter provide detailed
information of the events and, if applicable and available, a valid document for
evidence issued by the relevant public notary organization explaining the reason
for its inability to perform or delay in the performance of all or part of this
Agreement. The Parties shall discuss in good faith, taking into account the
effects of the force majeure and other unforeseen events on the performance of
the obligations under this Agreement, whether to (a) exempt the prevented Party
from performing part or all of its obligations under this Agreement or (b) delay
the performance of the affected obligations under this Agreement. In the absence
of any such agreement, no Party shall be excused from its performance hereunder
once the event of force majeure has subsided.</FONT></P>

<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>15</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.4 </FONT><U><FONT face="Times New Roman" size=2>Further Assurances</FONT></U><FONT face="Times New Roman" size=2>. The Parties agree to execute such further documentation
and perform such further actions, including the recordation of such
documentation with appropriate authorities, as may be reasonably requested by
the other Party hereto to evidence, effectuate and further the purposes and
intents set forth in this Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.5 </FONT><U><FONT face="Times New Roman" size=2>Amendments and Waivers</FONT></U><FONT face="Times New Roman" size=2>. This Agreement may be amended only by a written
instrument executed by both Parties. Any amendment effected in accordance with
the immediately preceding sentence will be binding on all of the Parties to this
Agreement. No failure or delay by any Party in exercising any right, power or
privilege hereunder will operate as a waiver thereof nor will any single or
partial exercise thereof preclude any other or further exercise thereof or the
exercise of any other right, power or privilege. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.6 </FONT><U><FONT face="Times New Roman" size=2>Notices</FONT></U><FONT face="Times New Roman" size=2>. Any
notices or other communications required or permitted hereunder will be given in
accordance with the provisions set forth in Section 11.3 of the JV Agreement.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.7 </FONT><U><FONT face="Times New Roman" size=2>Integration</FONT></U><FONT face="Times New Roman" size=2>. This
Agreement, the JV Agreement, the other Related Agreements and the documents
referred to herein or therein, or delivered pursuant hereto or thereto, contain
the entire understanding of the Parties with respect to the subject matter
hereof and thereof. There are no agreements, representations, warranties,
covenants or undertakings with respect to the subject matter hereof and thereof
other than those expressly set forth herein and therein. This Agreement
supersedes all other prior agreements and understandings between the parties
with respect to the subject matter hereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.8 </FONT><U><FONT face="Times New Roman" size=2>Severability</FONT></U><FONT face="Times New Roman" size=2>. If
one or more of the provisions, paragraphs, words, clauses, phrases or sentences
contained herein, or the application thereof in any circumstances, is held
invalid, illegal or unenforceable in any respect for any reason, the validity,
legality and enforceability of any such provision, paragraph, word, clause,
phrase or sentence in every other respect and of the remaining provisions,
paragraphs, words, clauses, phrases or sentences hereof will not be in any way
impaired, it being intended that all rights, powers and privileges of the
parties hereto will be enforceable to the fullest extent permitted by law.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.9 </FONT><U><FONT face="Times New Roman" size=2>Counterparts</FONT></U><FONT face="Times New Roman" size=2>.
This Agreement may be executed in two or more counterparts, and by different
Parties on separate counterparts each of which will be deemed an original, but
all of which will constitute one and the same instrument. </FONT></P>


<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>16</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.10 </FONT><U><FONT face="Times New Roman" size=2>Governing Law</FONT></U><FONT face="Times New Roman" size=2>.
This Agreement will be construed in accordance with, and the rights of the
Parties will be governed by, the laws of the State of New York. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.11 </FONT><U><FONT face="Times New Roman" size=2>Injunctive Relief</FONT></U><FONT face="Times New Roman" size=2>. Each of the Parties acknowledges and agrees that
pending the outcome of any arbitration proceeding pursuant to Section 11.8 of
the JV Agreement, each of the Parties hereto will be entitled to an injunction,
restraining order or other equitable relief to prevent breaches of the
provisions of this Agreement, the JV Agreement or the other Related Agreements
in any court of competent jurisdiction solely for the purpose of maintaining the
status quo, in addition to any other remedy to which they may be entitled
pursuant to the terms hereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.12 </FONT><U><FONT face="Times New Roman" size=2>Third Party Beneficiaries</FONT></U><FONT face="Times New Roman" size=2>. P&amp;G Sub shall be a third party beneficiary of this
Agreement and shall have the right to enforce the rights of Licensor hereunder
solely to the extent that Licensee breaches this Agreement and Licensor fails to
enforce such rights within thirty (30) days being requested by P&amp;G to do so
.. Except as expressly provided in this Section 10.12, nothing in this Agreement,
express or implied, is intended to confer upon any Person, other than the
Parties hereto or their respective successors and permitted assigns, any rights,
remedies, benefits, obligations or liabilities of any nature whatsoever under or
by reason of this Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 30pt"><FONT face="Times New Roman" size=2>Section 10.13 </FONT><U><FONT face="Times New Roman" size=2>No Agency</FONT></U><FONT face="Times New Roman" size=2>.
Nothing herein contained shall be construed to constitute either party hereto as
partner or joint venturer or as agent or other representative of the other.
Licensee is not granted any right, power or authority to assume or create any
obligation, express or implied, on behalf of Licensor or in Licensor&#146;s name, or
to make any purchase for Licensor&#146;s account, or to bind Licensor in any manner
or thing whatsoever. Licensee shall have no right, power or authority to accept
summons or legal process for Licensor. In their operations hereunder, Licensor
and Licensee shall be independent contractors retaining complete control over
and bearing sole liability for each of their own operations and employees.
</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>[The remainder of this page has
been intentionally left blank] </FONT></P>

<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>17</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>IN WITNESS WHEREOF, the Parties
hereto have executed this Agreement, effective as of the date first above
written. </FONT></P>
<DIV align=right>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=2><FONT face="Times New Roman" size=2>THE GLAD PRODUCTS
      COMPANY</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="99%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>By:&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="99%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%"><FONT face="Times New Roman" size=2>Name:</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%"><FONT face="Times New Roman" size=2>Title:</FONT></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%">&nbsp;</TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="99%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=2><FONT face="Times New Roman" size=2>[NAME OF CLOROX
      AFFILIATE]</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>By:</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="99%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%"><FONT face="Times New Roman" size=2>Name:</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="99%"><FONT face="Times New Roman" size=2>Title:</FONT></TD></TR></TABLE></DIV>
<BR>
<BR>
<BR>

<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>18</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=right><B><FONT face="Times New Roman" size=2>EXHIBIT J</FONT></B></P>
<P align=center><FONT face="Times New Roman" size=2>TECHNOLOGY AND TRADEMARK LICENSE
AGREEMENT </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>BETWEEN </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>THE GLAD PRODUCTS COMPANY, AS
LICENSOR </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>AND </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>______________________, AS LICENSEE
</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>DATED: JANUARY 31, 2003 </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>TECHNOLOGY AND TRADEMARK LICENSE
AGREEMENT </FONT></P><BR><BR>
<BR>


<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P STYLE="text-align: center"><FONT face="Times New Roman" size=2>This Agreement is dated as of January
31, 2003 between: </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>(PARTIES) </FONT></P>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><FONT face="Times New Roman" size=2>Name, Address,</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="80%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><U><FONT face="Times New Roman" size=2>Telephone and Facsimile</FONT></U></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="80%"><U><FONT face="Times New Roman" size=2>Identified Herein As</FONT></U></TD></TR>
  <TR>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><FONT face="Times New Roman" size=2>The Glad Products
      Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"><FONT face="Times New Roman" size=2>&#147;Licensor&#148;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><FONT face="Times New Roman" size=2>1221 Broadway</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><FONT face="Times New Roman" size=2>Oakland, California
      94612</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><FONT face="Times New Roman" size=2>United States of
      America</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"></TD></TR>
  <TR>
    <TD width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD width="98%" colSpan=3></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="98%" colSpan=3><FONT face="Times New Roman" size=2>Attention: Corporate
      Secretary</FONT></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="98%" colSpan=3>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><FONT face="Times New Roman" size=2>Telephone:
      510-271-7000</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><FONT face="Times New Roman" size=2>Facsimile:
      510-271-1652</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"><FONT face="Times New Roman" size=2>&#147;Licensee&#148;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><FONT face="Times New Roman" size=2>Attention:
      Director</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"></TD></TR>
  <TR>
    <TD width="1%"></TD>
    <TD width="98%" colSpan=3>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><FONT face="Times New Roman" size=2>Telephone:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="17%"><FONT face="Times New Roman" size=2>Facsimile:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="80%"></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>Parties to Agreement</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>(RECITALS)</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Clorox and Clorox&#146;s affiliates,
including Licensor, are engaged in the business of manufacturing (or causing to
have manufactured), distributing and selling the premium quality consumer
products set forth in </FONT><U><FONT face="Times New Roman" size=2>Exhibit
A</FONT></U><FONT face="Times New Roman" size=2> (the &#147;</FONT><U><FONT face="Times New Roman" size=2>Products</FONT></U><FONT face="Times New Roman" size=2>&#148;).
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensor is the owner of the common
law rights and other rights in the Trademarks in the Territory and the owner of
the Technology in the Territory. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensee desires to use the
Technology to manufacture, produce and package the Products, and to distribute
and sell the Products under the Trademarks in the Territory. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Subject to the terms and conditions
contained herein, Licensor desires to grant Licensee the licenses set forth
herein so that Licensee can manufacture, produce, package, distribute and sell
the Products in the Territories bearing the Trademarks. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensor and Licensee are
simultaneously in connection herewith entering into a Sublicense Agreement
providing, subject to the terms and conditions contained therein, for the
sublicense by Licensor to Licensee of certain Intellectual Property licensed to
Licensor by P&amp;G Sub under the P&amp;G License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Certain capitalized terms shall have
the meaning set forth in Article 30 hereof. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>2</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>(EXHIBITS) </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The following exhibits are attached
to this Agreement and are incorporated herein and made a part hereof:
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>Exhibit</FONT></TD>
    <TD noWrap align=left width="5%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap style="text-align: center" width="10%"><FONT face="Times New Roman" size=2>Content</FONT></TD>
    <TD noWrap style="text-align: center" width="80%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>A</FONT></TD>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="10%"><FONT face="Times New Roman" size=2>Description of
      Products</FONT></TD>
    <TD noWrap align=left width="80%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>B</FONT></TD>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="10%"><FONT face="Times New Roman" size=2>Description of
      Territory</FONT></TD>
    <TD noWrap align=left width="80%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>C</FONT></TD>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="10%"><FONT face="Times New Roman" size=2>Description of
      Royalty</FONT></TD>
    <TD noWrap align=left width="80%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman" size=2>D</FONT></TD>
    <TD noWrap align=left width="5%"></TD>
    <TD noWrap align=left width="10%"><FONT face="Times New Roman" size=2>Superseded
      Agreement(s)</FONT></TD>
    <TD noWrap align=left width="80%"></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>(AGREEMENT)</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The parties hereto agree as follows:
</FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE I. GRANT</FONT></U></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) Licensor grants to Licensee,
subject to the provisions of this Agreement, a right and license to use the
Trademarks in the Territory, in the manufacture, packaging, production,
distribution, sale, offer for sale, advertisement, promotion or any other manner
of use whatsoever on or in relation to the Products, which right shall be
exclusive in the Territory, and Licensee herewith accepts such grant under such
terms and conditions. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) Licensor grants to Licensee,
subject to the provisions of this Agreement, a right and license to use the
Technology in the Territory, in connection with the manufacture, packaging,
production, distribution, sale, offer for sale, advertisement, promotion of or
in relation to the Products, which right shall be exclusive in the Territory,
and Licensee herewith accepts such grant under such terms and conditions.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) Notwithstanding the foregoing,
the rights and licenses granted to Licensee pursuant to this Article 1 shall be
non-exclusive with respect to any Intellectual Property to which Licensor has
granted a license to P&amp;G Sub pursuant to the P&amp;G License Agreement.
</FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 2. AMENDMENTS TO EXHIBIT
A</FONT></U></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) Licensor may, from time to time
by written notices to Licensee, amend </FONT><U><FONT face="Times New Roman" size=2>Exhibit A</FONT></U><FONT face="Times New Roman" size=2>
attached hereto by adding to, revising and/or updating, deleting from or
limiting the Products covered by this Agreement to reflect changes, additions,
or revisions in its Product line, the trademarks associated with such Products
or its practices or policies with respect to the conduct of its business.
</FONT></P>

<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>3</FONT></P>
<HR align=center width="100%" noShade SIZE=2>
<!--Part08-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2><U>ARTICLE 3.
ROYALTIES</U></FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) In consideration of the
rights granted under this Agreement, Licensee agrees to pay Licensor royalties
as set forth on </FONT><U><FONT face="Times New Roman" size=2>Exhibit
C</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) Royalties shall be based
on Licensee&#146;s billing price (set in accordance with Licensee&#146;s and Licensor&#146;s
mutual agreement) on all Products sold by Licensee after the effective date of
this Agreement, whether sold to a distributor appointed hereunder or to other
customers of Licensee. Any Products given away free by Licensee shall for the
purposes of this Article be treated as products sold at said billing price in
effect at the date of shipment by Licensee. The Products sold by Licensee
hereunder shall be considered as &#147;sold&#148; when invoiced whether or not the amount
invoiced is collected from Licensee&#146;s distributor, or if not invoiced, when
shipped or delivered. In the event that any of the Products on which a royalty
has been paid hereunder by Licensee are returned and accepted for credit,
Licensee shall be credited with the royalty already paid by Licensee on account
of said Products against the amount of the royalties subsequently accruing
hereunder. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) The royalties payable
hereunder shall be paid quarterly within thirty (30) days following the end of
each calendar quarter on an estimated basis, with an adjustment within ninety
(90) days after the close of Licensee&#146;s fiscal year. Royalties shall be
transferred in United States Dollars to Licensor at its address set forth above
or as instructed by Licensor. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(d) In determining the amount
of royalties and other amounts payable, the Net Sales of the Products shall
first be determined in the national currency in which sold and then converted
into its equivalent in United States Dollars at: (i) the rate of United States
Dollars to the national currency of the Territory applicable to the transfer of
funds arising from this type of transaction as established by the exchange
control authorities of the Territory for the last business day of the calendar
quarter for which payment is made; or (ii) if there is no applicable rate so
established, at the selling rate for United States Dollars to the applicable
national currency as published by leading commercial banks in the Territory, for
the last business day of such calendar quarter; or (iii) if there is no rate so
published, at the buying rate for the applicable national currency to United
States Dollars as published by leading New York, New York banks for the last
business day of such calendar quarter. Licensee shall bear responsibility for
all expenses of currency conversion and transmission. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(e) Royalties due but not paid
to Licensor, for any reason whatsoever, shall be segregated and not commingled
with monies of Licensee and shall be handled in accordance with written
instructions from Licensor. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(f) Licensee from time to time
shall prepare all applications, reports and other documents which may be
required by the government in the Territory in order that remittances may be
made in accordance with this Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(g) Notwithstanding the above,
no royalties shall be payable on any Products purchased by Licensee from
Licensor or Licensor&#146;s affiliated companies and resold by Licensee, but this
exception shall not apply if Licensee chooses to purchase components of Products
from Licensor. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>4</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(h) Licensee agrees to keep
accurate books of account of its sales of the Products and to provide Licensor
with quarterly royalty statements within ten (10) days following the end of each
calendar quarter in such form as Licensor may prescribe setting forth, at a
minimum, the following information for the preceding calendar quarter: (i) the
Net Sales value and units of Licensee&#146;s sales of the Products, (ii) the amount
of any royalty payment due Licensor, and (iii) all other information necessary
to show the basis or bases on which such payment has been computed. In case no
payment is due for any calendar quarter, Licensee shall so report to Licensor
within ten (10) days following the end of such calendar quarter. Licensee agrees
to permit its books and records to be examined at reasonable times during
business hours to the extent necessary to verify the royalties to be paid
hereunder, and to permit copies of or extracts from any books, accounts,
receipts, papers or other documents in the possession or under the control of
Licensee and relating in whole or in part to the Products manufactured and sold
by Licensee, such examination and copying to be made by Licensor&#146;s agents at
Licensor&#146;s expense. Licensee agrees to maintain said documents for a minimum
period of three (3) years. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 4. QUALITY
CONTROL</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) Standards of Quality
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensee shall use the
Trademarks only on Products that meet Licensor&#146;s specifications and high
standards of quality and workmanship for such Products. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensee undertakes to
implement in full Licensor&#146;s established procedures for the inspection and
quality control of finished Products covered by this Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensee shall generally
ensure that all Products are free from any defects or other faults in design,
workmanship, and materials and conform with any pre-production samples approved
pursuant to Article 4(b) herein below, and no Products that fail to meet the
quality standards of Licensor shall be introduced to the market. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>All labels and labeling used
for the Products shall have the prior written approval of Licensor. Licensee
agrees to follow any instructions of Licensor with respect to the labels for the
Products, and to maintain Licensor&#146;s high standards with respect to the quality
of labels for the Products. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensor and Licensee agree
that the Products manufactured by Licensee as of the date of this Agreement meet
the quality standards required by Licensor pursuant to this Agreement.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) Product Samples
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Representative samples of the
Products (including their packaging) initially and thereafter at Licensor&#146;s
request, shall be furnished by Licensee to Licensor at a place designated by
Licensor in sufficient quantity so as to enable Licensor to determine the
quality of such Products. Licensor shall run such tests on the Products as it
may deem expedient, and shall advise Licensee in writing whether the quality
standards maintained by Licensor are met. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>5</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>In the event any of the
Products do not comply with the product standards maintained by Licensor,
Licensee shall at Licensee&#146;s own expense undertake a diligent inquiry to
determine the reason for such non-conforming Products, the extent of such
non-conforming Products, and correct all such non-conforming Products, or, if
this cannot be done, destroy such Products and bear the loss suffered in this
connection. Licensee shall report to Licensor the cause of such problems, the
extent of the non-conforming Products found, and Licensee&#146;s correction or
destruction of such Products. Licensee shall implement immediately any
instructions received from Licensor regarding changes or modifications in the
products and/or their manufacture or packaging. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) Access to Premises
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensor shall have the right
to have Licensor&#146;s representatives visit Licensee&#146;s facilities from time to time
to inspect the Products to insure that they comply with Licensor&#146;s
specifications and standards of quality, and Licensee shall cooperate with such
representative and comply with any directions issued by the representative.
</FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 5. SALES
EFFORTS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensee represents that it is
fully able to quantitatively meet the demands of, and is able to supply, the
national markets for the Products in the Territory. Licensee shall use its [* *
*] at all times during the term of this Agreement to promote and expand the
sales of the Products. The size of the sales organization, the competence of the
staff and the quality of the sales efforts shall be satisfactory to Licensor and
shall measure up in all respects to Licensor&#146;s standards of excellence. Licensee
and Licensor shall, from time to time, mutually consult with one another
concerning Licensee&#146;s sales efforts. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Within ten (10) days of the
end of each calendar quarter, Licensee shall submit to Licensor, in such detail
as Licensor may request, a statement with respect to the sales made by Licensee
during the sales quarter. Each such statement shall be certified as correct by
an officer of Licensee. During the term of this Agreement a marketing plan shall
be mutually agreed upon for each year. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensee also agrees to:
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) Carry and maintain stocks
of the Products that, in Licensor&#146;s opinion, are sufficient to satisfy market
requirements. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) Keep and maintain true and
accurate records of all transactions involving the Products, including
inventory, purchases and sales and promotional expenditures, which shall be
available to Licensor for inspection. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) Comply with all
governmental laws, regulations and practices with respect to the conduct of
Licensee&#146;s business. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(d) Obey and comply with
reasonable directions and instructions given by Licensor. </FONT></P>

<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>6</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(e) Not make any
representation or give any warranty relating to or in connection with the
Products, except as specifically authorized by Licensor. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(f) Maintain a customer
complaint reporting system that will be made available to Licensor. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(g) Set billing prices and any
discounts for the Products at levels mutually agreed upon in advance by Licensee
and Licensor. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(h) Not appoint a distributor
without Licensor&#146;s previous written authorization. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 6. PRODUCT
REGISTRATIONS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensee shall make every
reasonable effort to investigate and advise Licensor of all required permits or
registrations of the Products with governmental authorities in the Territory;
and, at Licensor&#146;s request, apply for, obtain and maintain, on Licensor&#146;s
behalf, all such necessary product registrations and permits. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Upon termination of this
Agreement for any reason, Licensee shall take such action, execute such
assignments or consents and otherwise do such things as may be reasonably
necessary to transfer all product registrations and permits to Licensor or its
designee(s), and/or to otherwise permit or facilitate the manufacture or
importation and sale of the Products in the Territory by Licensor or any party
Licensor may designate. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 7. TECHNOLOGY AND
TRADEMARKS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) Licensee recognizes and
acknowledges that Licensor, or Licensor&#146;s affiliated companies, are the owners,
assignees or licensees in the Territory of the Technology and the Trademarks,
including all common law rights related to Licensee&#146;s use of the Trademarks, and
the good will and reputation related to the Trademarks generated through such
use, and various proprietary and ancillary rights related to the Trademarks and
the Products including trade names, trade dress, package designs, emblems,
designs, copyrights and any registrations thereof (hereinafter referred to as
the &#147;</FONT><U><FONT face="Times New Roman" size=2>Properties</FONT></U><FONT face="Times New Roman" size=2>&#148;) used on various Products and/or in related
advertising literature. Licensee acknowledges the validity of the Technology,
Trademarks and Properties and Licensor&#146;s, and/or Licensor&#146;s affiliated
companies&#146; title to and rights in the Technology, Trademarks and the Properties
and recognizes the high value of such rights to the business and goodwill of
Licensor. Licensee acknowledges that any goodwill created through the use of the
Trademarks by Licensee belongs to Licensor exclusively. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) Licensee shall not dispute
the validity of or title to the Technology, Trademarks or Properties or oppose
any application by Licensor, or Licensor&#146;s affiliated companies, to register or
protect the Technology, Trademarks or the Properties and shall not, directly or
indirectly, take any action which might impair these proprietary rights or the
business and goodwill of Licensor. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) Licensee will not,
directly or indirectly, seek to register any imitation or translation of the
Trademarks or the Properties. </FONT></P>

<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>7</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(d) Licensee shall not use any
of the Technology, Trademarks or the Properties except as approved by Licensor.
Licensee shall in no way modify, add to or omit any of the Trademarks or the
Properties applied to the Products, advertising or promotional material pursuant
to this Agreement, without the written consent of Licensor. Licensee shall not
use in connection with the sale of or any commercial dealing with any of the
Products any other trademark, or other matter which is confusingly or
deceptively similar to any of the Trademarks or Properties. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(e) Licensee, without the
written consent of Licensor, shall not use any of Licensee&#146;s own trade marks or
trade names in marketing the Products. This provision shall not restrict
Licensee in the normal use of Licensee&#146;s regular business name. Licensee shall
not use the Trademarks or variations thereof in Licensee&#146;s registered trade or
corporate name. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(f) Should Licensee become
aware of any trade practices or actions or threatened actions by third parties
that may injure the business which Licensee conducts pursuant to this Agreement
or the business or goodwill of Licensor including infringement,
misappropriation, impairment, dilution, violation and/or passing off
(&#147;Infringement&#148;) of the Technology, Trademarks or the Properties, full details
of the same shall be promptly supplied to Licensor. Licensee shall in no event
take any action to prevent or remedy such Infringement or trade practices
without Licensor&#146;s written authorization. Licensor or any parties authorized by
Licensor shall have the sole right to take or direct such action as Licensor may
deem proper against such parties. Licensee shall join with Licensor in taking
action against such parties if Licensor so requests. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(g) Licensor and/or Licensor&#146;s
affiliated companies will police and protect the Technology and Trademarks in
the Territory to the best of Licensor&#146;s ability and assume the costs of
prosecuting infringers in those cases, which in the opinion of Licensor&#146;s legal
counsel, merit legal action. Licensor shall renew and maintain the Technology
and Trademarks according to the legal requirements of the Territory. Licensee
shall assist Licensor in policing, protecting, renewing and maintaining the
Technology and Trademarks by (i) providing samples of Products, (ii) providing
evidence of use, (iii) providing Licensor with guidance and assistance as to the
legal requirements of the Territory and (iv) executing documents and taking such
other actions as may be required to renew and maintain or otherwise effect
Licensor&#146;s ownership of the Technology and Trademarks. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(h) Upon expiration or
termination of this Agreement for any reason, Licensee, at Licensee&#146;s own
expense, shall forthwith remove all references to Licensor or any of the
Trademarks or Properties or any work, design, marking, slogan or legend
associated therewith from the business premises, plant, products, materials,
supplies and equipment of Licensee, and from all business paper, stationery and
advertising used or maintained by Licensee (including telephone and business
listings), and Licensee shall not thereafter hold forth in any manner that
Licensee has a connection with Licensor, the Trademarks, Properties or the
Products. Licensee thereafter shall not use the Trademarks or any terms or
devices similar to the Trademarks. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(i) Licensee shall apply or
use all notices and legends, including patent markings, required by applicable
law or regulations to preserve and protect the value and validity of the
Technology and Trademarks licensed pursuant to this Agreement, including
applying or using any notices or legends reasonably requested by Licensor.
</FONT></P>

<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>8</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(j) In the event Licensee
develops any improvements to the Technology, Licensee shall promptly provide
Licensor with written notice thereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(k) Licensee agrees that
Licensor is the sole and exclusive owner of the Technology and the Trademarks
and that nothing in this Agreement or otherwise shall confer on Licensee any
right, title or interest in or to the Technology or Trademarks other than as
expressly set forth in this Agreement. In the event that Licensee is held to, or
becomes the owner of any </FONT><FONT face="Times New Roman" size=2>Technology, Trademarks or
Properties that is intended to be owned by Licensor pursuant to the terms of
this Agreement, Licensee hereby assigns permanently the entirety of such rights
to Licensor and shall, during the term of this Agreement and after any
expiration or termination hereof, execute such documents as Licensor reasonably
may request from time to time to ensure that all such rights reside in Licensor.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(l) Nothing in this Agreement
shall prevent Licensor from transferring or encumbering the Technology or
Trademarks that are subject to a license or obligation under this Agreement.
</FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 8. WARRANTIES AND
DISCLAIMERS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Neither party warrants to the
other that the Products that Licensee may manufacture or sell pursuant to this
Agreement will not Infringe any Intellectual Property or trademark right
possessed by any third parties. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 9.
COMPETITION</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>In order to ensure Licensee&#146;s
undivided attention and maximum efforts on behalf of the Products, Licensee
agrees not to manufacture, market, sell or distribute products which would
compete with the Products during the term of this Agreement. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 10. EFFECTIVENESS
AND TERM OF AGREEMENT</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement shall be
effective as of the date first written above. The initial term of this Agreement
shall be five (5) years, which term shall be renewable for successive five (5)
year periods thereafter at the option of the Licensor upon written notice. The
term of this Agreement may be terminated by Licensor at any time upon [* * *]
notice to Licensee. The term of this Agreement may be terminated by Licensee
only as provided in Article 11(a) hereof. No further Royalty shall accrue
hereunder after the termination (or deemed termination pursuant to Article 11)
of this Agreement. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 11. INTERNATIONAL
ACQUISITION TRANSACTION</FONT></U><FONT face="Times New Roman" size=2>
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(e)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In the
event of an International Acquisition in which there is no IP Acquisition,
Licensee will be deemed to have terminated this Agreement. Upon such deemed
termination, Licensee will be required to pay Licensor a termination fee (the
&#147;</FONT><U><FONT face="Times New Roman" size=2>Termination Fee</FONT></U><FONT face="Times New Roman" size=2>&#148;) in an amount [* * *] to [* * *] percent ([* *
*]%) of the Fair Market Value of the Glad Local Business </FONT></P>

<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>9</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(f)</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2>In the
event of an International Acquisition in which there is an IP Acquisition,
Licensor will be deemed to have terminated this Agreement and no Termination Fee
shall be due or payable. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 12. OBLIGATIONS
UPON TERMINATION</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>In the event of any expiration
or termination of this Agreement: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) Licensee will return to
Licensor, labels, packaging and advertising or other promotional materials
relating to any of the Products. Licensor at Licensor&#146;s sole option shall have
the right to take back at the lower of market price or incremental cost, any
such labels, prints and literature, and Licensee shall be obliged to return to
Licensor without charge all materials received without cost. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) Licensee shall have the
obligation to complete the manufacture of all goods in process. Licensor or
Licensor&#146;s designee, at Licensor&#146;s sole option, shall have the right to purchase
all raw materials, packaging materials and finished goods still in stock after
filling outstanding orders to the date of termination. The price payable to
Licensee with respect to such materials and finished goods shall be the lower of
market price or Licensee&#146;s incremental cost. Licensor in Licensor&#146;s sole
discretion may allow Licensee to sell finished goods still in stock after the
filling of outstanding orders, according to the distribution and pricing
schedule that was in effect for the quarter prior to termination. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) Licensee agrees that from
the date of expiration or termination of this Agreement, none of the Technology
or Trademarks or any terms or devices similar thereto, or to the Properties
shall be used by Licensee. Licensee shall as soon as it is practical, ensure
that any reference to any Trademarks on its products, premises, vehicles or
documents are removed. Upon termination or expiration of this Agreement Licensee
shall immediately cease all use of the Technology and, at Licensor&#146; option,
promptly, return, delete or destroy all tangible embodiments of the Technology
in Licensee&#146;s possession or control. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(d) All royalties, fees and
other amounts payable by Licensee to Licensor through the date of such
expiration or termination shall become immediately due. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 13.
INDEMNITY</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) Licensee agrees to
indemnify and hold Licensor harmless from and against any loss, claim,
liability, action, cause of action or damages (including all costs and
attorneys&#146; fees) for any injury or damages occurring to third parties, or their
property, in connection with the Products manufactured or sold by Licensee and
for such purpose to maintain insurance, if such is available within the
Territory, for the benefit of Licensee and Licensor with such company or
companies and containing such limits as are satisfactory to Licensor.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>10</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) Licensee shall also
indemnify and hold Licensor harmless from any liability, loss, damage or
expense, including reasonable attorneys&#146; fees and expenses, arising out of any
claim or suit involving the manufacture, labeling, sale, distribution or
advertisement of the Products by Licensee in violation of any law or regulation
of the Territory or country of export. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(c) Licensor shall notify
Licensee of any such claim or suit, and Licensee shall have the right to defend
itself and, if Licensor consents, also defend Licensor through counsel of
Licensee&#146;s choice provided such counsel is acceptable to Licensor. Licensor
shall also be free to retain Licensor&#146;s own counsel, in which case Licensor&#146;s
reasonable attorneys&#146; fees and expenses shall be covered by the indemnity set
forth in this Article 13. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 14.
TAXES</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensee agrees to procure at
Licensee&#146;s sole cost any required registrations or governmental approval of this
Agreement and to pay any and all stamp, registration and import taxes and all
other taxes and duties which may be levied on Licensor and/or Licensee by
governmental entities within the Territory. Any taxes, fees or other charges
imposed by any government or any state in the Territory upon this Agreement or
upon the payments to be made to Licensor shall be paid by Licensee, both at
minimum rates and final computations, for and on behalf of Licensor and such
costs may not be deducted by Licensee from royalties as they become due. Except,
however, Licensee may withhold from amounts payable under this Agreement the
nonresident income tax of Licensor, if required by law. Licensee shall furnish
to Licensor all original tax receipts or other documentation necessary for
Licensor to verify payment of any tax, fee, or charge and to receive a foreign
tax credit or tax deduction. If such nonresident income taxes are withheld,
Licensee will supply Licensor with official government receipts which indicate
the amount of tax and date the tax was paid. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 15. FORCE
MAJEURE</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The failure by either party to
perform any term of this Agreement when caused by or resulting from fire,
floods, embargoes, government regulations, war, acts of war (whether war be
declared or not), insurrections, riots, civil commotions, strikes, lockouts, job
actions, Acts of God or any other cause beyond the control of such party, and
which is a result thereof, shall not constitute a default or breach under any
term of this Agreement unless the said party fails to resume normal operations
within one hundred eighty (180) days, in which case the other party may declare
a default. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 16. ASSIGNMENT AND SUBLICENSES</FONT></u></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Licensee may not assign,
pledge, hypothecate, give a security interest in, encumber, or otherwise
transfer any interest in this Agreement or its obligations, rights, claims,
interests or monies due or to become due hereunder, or any materials bearing any
of the Trademarks, without the prior written consent of Licensor. This Agreement
shall be binding upon and inure to the benefit of the parties hereto and their
successors and permitted assigns. Notwithstanding the foregoing, subject to the
terms and conditions of this Agreement, Licensee may sublicense the Technology
and Trademarks to only those persons or entities that agree to abide by and
uphold the terms and conditions of this Agreement (including payment of all
royalties and other fees related to the use of the Technology and the Trademarks
hereunder). </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>11</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 17. NO
AGENCY</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Nothing herein contained shall
be construed to constitute either party hereto as partner or joint venturer or
as agent or other representative of the other. Licensee is not granted any
right, power or authority to assume or create any obligation, express or
implied, on behalf of Licensor or in Licensor&#146;s name, or to make any purchase
for Licensor&#146;s account, or to bind Licensor in any manner or thing whatsoever.
Licensee shall have no right, power or authority to accept summons or legal
process for Licensor. In their operations hereunder, Licensor and Licensee shall
be independent contractors retaining complete control over and bearing sole
liability for each of their own operations and employees. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 18.
AMENDMENTS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement shall not be
changed, modified, abrogated or superseded unless by a writing signed by both
parties. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 19.
SEVERABILITY</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Should any part or provision
of this Agreement be held unenforceable or in conflict with the law of any
jurisdiction, the validity of the remaining parts or provisions shall not be
affected by such holding unless the part or provision which is held to be
unenforceable or in conflict with the law of the jurisdiction is an essential
term of the contract in which event the contract shall be deemed terminated.
</FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 20.
CAPTIONS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The titles of the Articles of
this Agreement are intended only to facilitate reference and shall not be used
in interpreting the meaning of this Agreement. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 21.
TRANSLATION</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Should this Agreement be
translated into any other language but English, the English version shall remain
controlling and prevail on any question of interpretation or otherwise.
</FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 22. NO
WAIVER</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>None of the terms of this
Agreement may be waived except by a writing signed by the waiving party. The
failure of either party hereto to enforce, or the delay by either party in
enforcing, any of its rights under this Agreement shall not be deemed a
continuing waiver or a modification thereof and either party may, within the
time provided by applicable law, commence appropriate legal action to enforce
any or all of such rights. </FONT></P>

<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>12</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 23. GOVERNING
LAW</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement shall be
governed and construed in accordance with the laws of the State of California,
United States of America and the laws of the United States of America as applied
therein, in both cases without regard to the conflict of law principles thereof.
The acts or laws of a foreign government shall not be considered force majeure
or otherwise excuse a departure from this Agreement. It is the intent of the
parties that their relations under this Agreement be governed exclusively as
specified herein. Any controversy or claim arising out of or relating to this
Agreement, or the breach thereof, shall be settled by binding arbitration in
Oakland/San Francisco, California in accordance with the Commercial Arbitration
Rules of the American Arbitration Association, and judgment upon the award may
be entered in any court having jurisdiction thereof. The parties hereby waive
any claim whatsoever that any such controversy or claim is nonarbitrable on the
grounds of public policy. The arbitrator(s) shall have the power to: (1) order
such discovery as, in the arbitrator(s) discretion, shall contribute to a just
and speedy resolution of the controversy or claim and to impose sanctions for
breaches of such orders; (2) award attorneys&#146; fees and costs to a party
prevailing on a controversy or claim or part thereof; and (3) award preliminary
and final injunctions and awards of specific performance, it being the intent of
the parties that such relief be granted liberally. Any arbitrator shall be
fluent in the English language and familiar with the consumer products industry.
The arbitration proceeding will be held in the English language and all opinions
and awards will be issued in English. The costs of the arbitration and
enforcement of the award shall be an issue determined by the arbitrator(s). Each
of the parties hereto will be entitled to an injunction, restraining order or
other equitable relief to prevent breaches of the provisions of this Agreement.
</FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 24. LOCAL LAWS AND
STANDARDS OF BUSINESS CONDUCT</FONT></U><FONT face="Times New Roman" size=2>
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(a) Licensee acknowledges
Licensee&#146;s responsibilities under the local laws and regulations applicable to
Licensee&#146;s operation under this Agreement and will always conduct Licensee&#146;s
business under this Agreement in a manner meeting the highest ethical standards.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>(b) Any failure of Licensee to
abide by this Article that brings harm or injury to the name, good will, or
reputation of Licensor or Licensor&#146;s affiliated companies, the Trademarks, or
the Products shall be grounds for termination of this Agreement by Licensor.
</FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 25. RECORDATION OF
AGREEMENT</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement, or an extract
hereof, may be recorded at the discretion of Licensor in the proper offices and
registries in the Territory and Licensee shall execute any documents considered
by Licensor to be necessary to effect such recordation. In the event of the
termination of this Agreement, Licensee shall execute any documents considered
by Licensor necessary to effect cancellation of the recordation of this
Agreement, and Licensor may cancel such recordation without the consent of
Licensee. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 26.
NOTICES</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>Any notice, offer or demand
desired or required to be given hereunder shall be in writing and deemed given
when personally delivered or sent by first class registered or certified airmail
or by facsimile addressed as respectively set forth above under &#147;PARTIES&#148;, or to
such other address as any party shall have previously designated by such a
notice. Any notice so delivered personally shall be deemed to be received on the
date of receipted delivery, any notice given by registered airmail shall be
deemed to have been received 5 days after the same has been posted, and any
facsimile shall be deemed to be received on the business day following the date
of the facsimile. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>13</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 27.
INTEGRATION</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement contains the
entire understanding of the parties with respect to the subject matter hereof.
There are no agreements, representations, warranties, covenants or undertakings
with respect to the subject matter hereof and thereof other than those expressly
set forth herein. This Agreement supersedes all other prior agreements and
understandings between the parties with respect to the subject matter hereof,
including the agreements, if any, set forth on Exhibit D, which shall, upon the
execution of this Agreement, terminate and be of no further force or effect.
</FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 28. THIRD PARTY
BENEFICIARIES</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>P&amp;G Sub shall be a third
party beneficiary of this Agreement and shall have the right to enforce the
rights of Licensor hereunder solely to the extent that Licensee breaches this
Agreement and Licensor fails to enforce such rights within thirty (30) days
being requested by P&amp;G to do so. Except as expressly provided in this
Article 28, nothing in this Agreement, express or implied, is intended to confer
upon any person, other than the parties hereto or their respective successors
and permitted assigns, any rights, remedies, benefits, obligations or
liabilities of any nature whatsoever under or by reason of this Agreement.
</FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 29.
COUNTERPARTS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>This Agreement may be executed
in any number of counterparts, and by the different parties on separate
counterparts each of which will be deemed an original, but all of which will
constitute one and the same instrument. </FONT></P>
<P align=left><U><FONT face="Times New Roman" size=2>ARTICLE 30.
DEFINITIONS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>The following terms, as used
in this Agreement, shall have the definitions set forth in this Article 30 and
constitute part of the terms and conditions of this Agreement: </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Affiliate</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean any entity that is a direct or indirect subsidiary of a
party, including any entity that is at least [* * *]% owned, directly or
indirectly, by a party, or any entity that owns, directly or indirectly, at
least [* * *]% of a party, or otherwise controls or is controlled by a party, or
which is a joint venture which is at least [* * *]% owned by a party or another
affiliate of a party. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Call Right</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Clorox</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean The Clorox Company, a Delaware corporation. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Fair Market Value</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV
Agreement. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>14</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Global Business</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Glad Local Business</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean the Glad Global Business conducted by
the Licensee in the Territory. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Infringement</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in Article 7(f)
hereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Intellectual Property</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean any and all intellectual property,
including, without limitation, patents, copyrights, software, trade secrets,
technology, inventions, specifications, know-how, processes, formulae, product
descriptions and other technical or proprietary information. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>International Acquisition</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean the sale, disposition or other
transfer to a Third Party of all or substantially all of the equity interests of
Licensee or of all or substantially all the business, assets and properties of
Licensee used in the Glad Local Business, but excluding (i) any transaction in
connection with which the Put Right or the Call Right is exercised, (ii) any
Third-Party Sale in connection with which Clorox exercises its right to cause a
sale and (iii) any transaction in connection with which the Tag-Along Right is
exercised. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>IP Acquisition</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>JV Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean the Amended and Restated Joint
Venture Agreement, dated as of January 31, 2003, between Licensor, P&amp;G Sub
and certain of their respective Affiliates, as such agreement may be amended,
supplemented or otherwise modified in accordance with the terms thereof.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G License Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean the License Agreement, dated as of
January 31, 2003, between P&amp;G Sub and Licensor, as such agreement may be
amended, supplemented or otherwise modified in accordance with the terms
thereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>P&amp;G Sub</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean Procter &amp; Gamble RHD Inc., an Ohio corporation.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Prior Agreement</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in Article 27
hereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Products</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean the products set forth in </FONT><U><FONT face="Times New Roman" size=2>Exhibit A</FONT></U><FONT face="Times New Roman" size=2>, as may be amended from time to time pursuant to Article 2 herein.
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Properties</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in Article 7(a) hereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Put Right</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Tag-Along Right</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Technology</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean any and all Intellectual Property owned or held by Licensor,
from time to time, which Licensor has the right to license or sublicense to
Licensee, that is used or useful in connection with the manufacture, packaging,
production, distribution, sale, offer for sale, advertisement, promotion of or
in relation to the Products, expressly excluding the Intellectual Property
licensed to Licensor under the P&amp;G License Agreement. </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>15</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Termination Fee</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in Article
11(a) hereof. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Territory</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean the territories set forth in </FONT><U><FONT face="Times New Roman" size=2>Exhibit B</FONT></U><FONT face="Times New Roman" size=2>. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Third-Party Sale</FONT></U><FONT face="Times New Roman" size=2>&#148; shall have the meaning set forth in the JV
Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Trademarks</FONT></U><FONT face="Times New Roman" size=2>&#148; shall mean any and all trademarks, service marks, trade names, brand
names, corporate names, domain names, URLs, logos and trade dress, together with
the goodwill symbolized by any of the foregoing and all common law rights
relating to any of the foregoing, owned or held by Licensor, from time to time,
which Licensor has the right to license or sublicense to Licensee, that is used
or useful in the manufacture, packaging, production, distribution, sale, offer
for sale, advertisement, promotion or any other manner of use whatsoever on or
in relation to the Products, expressly excluding any trademarks, service marks,
trade names, brand names, corporate names, domain names, URLs, logos or trade
dress licensed to Licensor under the P&amp;G License Agreement. </FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>IN WITNESS WHEREOF, this
Agreement has been executed as of the date first above written. </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0
cellPadding=0 width="100%" border=0>

  <TR>
    <TD noWrap align=left width="49%" colSpan=2>
      <P align=left><FONT face="Times New Roman" size=2>(&#147;Licensor&#148;)
    </FONT></P></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="46%"><FONT
      size=2>(&#147;Licensee&#148;)</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="47%">&nbsp;</TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="46%">&nbsp;</TD></TR>
  <TR>
    <TD noWrap align=left width="49%" colSpan=2>
      <P align=left><FONT face="Times New Roman" size=2>THE GLAD PRODUCTS
      COMPANY </FONT></P></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="46%"></TD></TR>
  <TR>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="47%">&nbsp; </TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="46%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%"><FONT face="Times New Roman"
      size=2>By:</FONT></TD>
    <TD noWrap align=left width="47%">&nbsp;</TD>
    <TD noWrap align=left
      width="2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman"
      size=2>By:</FONT></TD>
    <TD noWrap align=left width="46%">&nbsp;</TD></TR>
  <TR>
    <TD noWrap align=left width="2%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left
    width="47%">&nbsp;</TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left
    width="46%"></TD></TR>
  <TR>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="47%">&nbsp;</TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="46%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%"><FONT face="Times New Roman"
      size=2>Name:&nbsp;</FONT></TD>
    <TD noWrap align=left width="47%">&nbsp;</TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman"
      size=2>Name&nbsp;</FONT></TD>
    <TD noWrap align=left width="46%">&nbsp;</TD></TR>
  <TR>
    <TD noWrap align=left width="2%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left
    width="47%">&nbsp;</TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left
    width="46%"></TD></TR>
  <TR>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="47%">&nbsp;</TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="46%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="2%"><FONT face="Times New Roman"
      size=2>Title:</FONT></TD>
    <TD noWrap align=left width="47%">&nbsp;</TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"><FONT face="Times New Roman"
      size=2>Title</FONT></TD>
    <TD noWrap align=left width="46%">&nbsp;</TD></TR>
  <TR>
    <TD noWrap align=left width="2%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left
    width="47%">&nbsp;</TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left
    width="46%"></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>Signature Page </FONT></P>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>16</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><U><FONT face="Times New Roman" size=2>EXHIBIT A</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>DESCRIPTION OF
PRODUCTS</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>

<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><FONT face="Times New Roman" size=2><u>EXHIBIT B</u></FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>DESCRIPTION OF
TERRITORY</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>

<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><U><FONT face="Times New Roman" size=2>EXHIBIT C</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>DESCRIPTION OF
ROYALTY</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P ALIGN="LEFT"><FONT face="Times New Roman" size=2>Licensee agrees to pay
Licensor royalties as follows:</FONT></P>

<P STYLE="text-align: left; text-indent: 15pt"><FONT face="Times New Roman" size=2>For Products sold bearing the Trademarks:
</FONT></P>
<P ALIGN="LEFT" STYLE="text-indent: 15pt"><FONT face="Times New Roman" size=2>&#147;Net Sales&#148; shall be defined
as the gross amount billed for the Products less trade or quantity discounts,
credits or allowances. </FONT></P>

<br><br><br><br><br><br><br><br><br><br><br><br><br>
<P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><U><FONT face="Times New Roman" size=2>EXHIBIT D</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><U><FONT face="Times New Roman" size=2>SUPERSEDED
AGREEMENT(S)</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>


<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><P align=left><FONT face="Times New Roman" size=1>THE PORTIONS OF THIS AGREEMENT
IDENTIFIED BY THE SYMBOL &#147;[* * *]&#148; HAVE BEEN OMITTED AND FILED SEPARATELY WITH
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST. </FONT></P>

<HR align=center width="100%" noShade size="2">




</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>7
<FILENAME>clorox3118951_1-ex21.htm
<DESCRIPTION>SUBSIDIARIES
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit 21 </FONT></B></P>
<TABLE style="LINE-HEIGHT: 12.5pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="49%"><B><FONT face="Times New Roman" size=1>Name of Company</FONT></B></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="49%"><B><FONT face="Times New Roman" size=1>Jurisdiction of Incorporation</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1221
      Olux, LLC</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>6570 Donlon Group, LLC</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>A
      &amp; M Products Manufacturing Company</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Andover Properties, Inc.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Aplicare, Inc.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Connecticut</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Bees International
      Corporation</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Japan</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Brita Canada Corporation</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Nova
      Scotia</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Brita Canada Holdings
      Corporation</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Nova Scotia</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Brita GP</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Ontario</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Brita LP</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Ontario</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Brita Manufacturing Company</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The Brita Products
    Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>BGP
      (Switzerland) S. a. r. l.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Switzerland</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Burt&#146;s Bees, Inc.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Burt's Bees Australia Pty Ltd.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Australia</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Burt&#146;s Bees International
      Holdings</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Burt&#146;s Bees Licensing, LLC</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The Burt&#146;s Bees Products
      Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Caltech Industries, Inc.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Michigan</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>CBee (Europe) Limited</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>United Kingdom</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Chesapeake Assurance Limited</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Hawaii</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Africa (Proprietary)
      Ltd.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>South Africa</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Africa Holdings (Proprietary) Ltd.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>South Africa</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Argentina S.A.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Argentina</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Australia Pty. Ltd.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Australia</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Brazil Holdings
    LLC</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox (Cayman Islands) Ltd.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Cayman Islands</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Chile S.A.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Chile</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox China (Guangzhou) Ltd.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Guangzhou, P.R.C.</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Commercial
Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Clorox Company of Canada Ltd.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Canada (Federal)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox de Centro America,
      S.A.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Costa Rica</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox de Colombia S.A.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Colombia</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox de Mexico, S.A. de
      C.V.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Mexico</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox de Panama S.A.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Panama</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox del Ecuador S.A.
      Ecuaclorox</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Ecuador</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Diamond Production Company</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Dominicana S.R.L.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Dominican Republic</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox (Europe) Financing S.a.r.l.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Luxembourg</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Healthcare Holdings,
      LLC</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Holdings Pty. Limited</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Australia</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Hong Kong Limited</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Hong Kong</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Hungary Liquidity Management Kft</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Hungary</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The Clorox International
      Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox International Holdings, LLC</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox International Philippines,
      Inc.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The Philippines</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Luxembourg S.a.r.l.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Luxembourg</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox (Malaysia) Sdn.
    Bhd.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Malaysia</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Manufacturing Company</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Manufacturing Company of
      Puerto Rico, Inc.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Puerto Rico</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Mexicana S. de R.L. de C.V.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Mexico</FONT></TD></TR></TABLE><BR>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="LINE-HEIGHT: 12.5pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="49%"><B><FONT face="Times New Roman" size=1>Name of
      Company</FONT></B></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%"><B><FONT face="Times New Roman" size=1>Jurisdiction of
      Incorporation</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox New Zealand Limited</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>New
      Zealand</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The
      Clorox Outdoor Products Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Peru S.A.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Peru</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The
      Clorox Pet Products Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Texas</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Professional Products Company</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The
      Clorox Sales Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Services Company</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Servicios Corporativos S. de R.L. de C.V.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Mexico</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Spain, S.L.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Spain</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox Spain Holdings, S.L.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Spain</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Sub-Sahara Africa Limited</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Kenya</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Clorox (Switzerland) S.a.r.l.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Switzerland</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Clorox Uruguay S.A.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Uruguay</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The
      Consumer Learning Center, Inc.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Corporacion Clorox de Venezuela, S.A.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Venezuela</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>CLX
      Realty Co.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Evolution Sociedad S.A.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Uruguay</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Fabricante de Productos Plasticos, S.A. de C.V.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Mexico</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>First Brands (Bermuda) Limited</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Bermuda</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>First Brands Corporation</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>First Brands do Brasil Ltda.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Brazil</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>First Brands Mexicana, S.A. de C.V.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Mexico</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Fully Will Limited</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Hong
      Kong</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Gazoontite, LLC</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Glad
      Manufacturing Company</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The
      Glad Products Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>The
      Household Cleaning Products Company of Egypt Ltd.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Egypt</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The
      HV Food Products Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>HV
      Manufacturing Company</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Invermark S.A.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Argentina</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Jingles LLC</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Kaflex S.A.</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Argentina</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Kingsford Manufacturing Company</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The
      Kingsford Products Company, LLC</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Lerwood Holdings Limited</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>British Virgin Islands</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2>The
      Mexco Company</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Mohamed Ali Abudawood for Industry and Partners for
      Industry</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company
    Ltd.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Saudi Arabia</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#ffffff><FONT face="Times New Roman" size=2>National Cleaning Products Company Limited</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="50%" bgColor=#ffffff><FONT face="Times New Roman" size=2>Saudi Arabia</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Paulsboro Packaging Inc.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>New
      Jersey</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#ffffff><FONT face="Times New Roman" size=2>Petroplus Productos Automotivos S.A.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="50%" bgColor=#ffffff><FONT face="Times New Roman" size=2>Brazil</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Petroplus Sul Comercio Exterior S.A.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Brazil</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#ffffff><FONT face="Times New Roman" size=2>ReNew Life Acquisition Corporation</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="50%" bgColor=#ffffff><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>ReNew Life Canada Inc.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Ontario</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#ffffff><FONT face="Times New Roman" size=2>ReNew Life Formulas, Inc.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="50%" bgColor=#ffffff><FONT face="Times New Roman" size=2>Florida</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>ReNew Life Holdings Corporation</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#ffffff><FONT face="Times New Roman" size=2>Round Ridge Production Company</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="50%" bgColor=#ffffff><FONT face="Times New Roman" size=2>Delaware</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Soy
      Vay Enterprises, Inc.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>California</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#ffffff><FONT face="Times New Roman" size=2>STP
      do Brasil Ltda.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="50%" bgColor=#ffffff><FONT face="Times New Roman" size=2>Brazil</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="49%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Yuhan-Clorox Co., Ltd.</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="50%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Korea</FONT></TD></TR></TABLE><BR>
<HR align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>8
<FILENAME>clorox3118951_1-ex23.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit 23 </FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>We consent to the
incorporation by reference in the following Registration Statements: </FONT></P>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Registration
      Statement (Form S-3 No. 333-200722) and in the related Prospectuses of The
      Clorox Company, and</FONT></TD></TR>
  <TR>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(2)</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Registration
      Statements (Form S-8 Nos. 33-41131, including post effective amendments
      No. 1 and No. 2, 33-56565, 33-56563, 333-29375, 333-16969, 333-44675,
      333-86783, 333-131487, 333-69455, including post effective amendment No.
      1, 333-90386, including the post effective amendment No. 1, and
      333-193913) of The Clorox Company;</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>of our reports dated August
16, 2016, with respect to the consolidated financial statements and schedule of
The Clorox Company and the effectiveness of internal control over financial
reporting of The Clorox Company included in this Annual Report (Form 10-K) of
the Clorox Company for the year ended June 30, 2016. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>/s/ Ernst &amp; Young LLP
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>San Francisco, CA<BR>August
16, 2016 </FONT></P>
<HR align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>9
<FILENAME>clorox3118951_1-ex311.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER OF THE CLOROX COMPANY
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit
31.1</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>CERTIFICATION
</FONT></B></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

        <TR>
    <TD NOWRAP STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><P align=justify><FONT face="Times New Roman" size=2>I, Benno
Dorer,</FONT><B><FONT face="Times New Roman" size=2> </FONT></B><FONT face="Times New Roman" size=2>certify that: </FONT></P></TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>1.</FONT></TD>
    <TD></TD>
    <TD width="100%" colSpan=3><FONT face="Times New Roman" size=2>I have
      reviewed this annual report on Form 10-K of The Clorox
  Company;</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD></TD>
    <TD width="100%" colSpan=3><FONT face="Times New Roman" size=2>Based on my
      knowledge, this report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statements
      made, in light of the circumstances under which such statements were made,
      not misleading with respect to the period covered by this
  report;</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>3.</FONT></TD>
    <TD></TD>
    <TD width="100%" colSpan=3><FONT face="Times New Roman" size=2>Based on my
      knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the
      financial condition, results of operations and cash flows of the
      registrant as of, and for, the periods presented in this
  report;</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>4.</FONT></TD>
    <TD></TD>
    <TD width="100%" colSpan=3><FONT face="Times New Roman" size=2>The
      registrant&#146;s other certifying officer and I are responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
      control over financial reporting (as defined in Exchange Act Rules
      13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top noWrap></TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD width="100%"></TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>a)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>designed such
      disclosure controls and procedures, or caused such disclosure controls and
      procedures to be designed under our supervision, to ensure that material
      information relating to the registrant, including its consolidated
      subsidiaries, is made known to us by others within those entities,
      particularly during the period in which this report is being
      prepared;</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>b)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>designed such
      internal control over financial reporting, or caused such internal control
      over financial reporting to be designed under our supervision, to provide
      reasonable assurance regarding the reliability of financial reporting and
      the preparation of financial statements for external purposes in
      accordance with U.S. generally accepted accounting
principles;</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>c)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>evaluated the
      effectiveness of the registrant&#146;s disclosure controls and procedures and
      presented in this report our conclusions about the effectiveness of the
      disclosure controls and procedures, as of the end of the period covered by
      this report based on such evaluation; and</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>d)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>disclosed in this
      report any change in the registrant&#146;s internal control over financial
      reporting that occurred during the registrant&#146;s most recent fiscal quarter
      (the registrant&#146;s fourth fiscal quarter in the case of an annual report)
      that has materially affected, or is reasonably likely to materially
      affect, the registrant&#146;s internal control over financial
    reporting.</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>5.</FONT></TD>
    <TD></TD>
    <TD width="100%" colSpan=3><FONT face="Times New Roman" size=2>The
      registrant&#146;s other certifying officer and I have disclosed, based on our
      most recent evaluation of internal control over financial reporting, to
      the registrant&#146;s auditors and the audit committee of the registrant&#146;s
      board of directors (or persons performing the equivalent
    functions):</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>a)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>all significant
      deficiencies and material weaknesses in the design or operation of
      internal control over financial reporting which are reasonably likely to
      adversely affect the registrant&#146;s ability to record, process, summarize
      and report financial information; and</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>b)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>any fraud, whether or
      not material, that involves management or other employees who have a
      significant role in the registrant&#146;s internal control over financial
      reporting.</FONT></TD></TR></TABLE>
<P align=justify><FONT face="Times New Roman" size=2>Date: August 16, 2016
</FONT></P><BR>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="40%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="100%"><FONT face="Times New Roman" size=2>/s/ Benno Dorer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Benno Dorer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Chairman and Chief Executive
  Officer</FONT></TD></TR></TABLE><BR>
<HR align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>10
<FILENAME>clorox3118951_1-ex312.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF FINANCIAL OFFICER OF THE CLOROX COMPANY
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit
31.2</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>CERTIFICATION
</FONT></B></P>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap></TD>
    <TD></TD>
    <TD width="100%" colSpan=3>
      <P align=justify><FONT face="Times New Roman" size=2>I, Stephen M.
      Robb,</FONT><B><FONT face="Times New Roman" size=2> </FONT></B><FONT face="Times New Roman" size=2>certify that: </FONT></P></TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD></TD>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>1.</FONT></TD>
    <TD></TD>
    <TD width="100%" colSpan=3><FONT face="Times New Roman" size=2>I have
      reviewed this annual report on Form 10-K of The Clorox
  Company;</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>2.</FONT></TD>
    <TD></TD>
    <TD width="100%" colSpan=3><FONT face="Times New Roman" size=2>Based on my
      knowledge, this report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statements
      made, in light of the circumstances under which such statements were made,
      not misleading with respect to the period covered by this
  report;</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>3.</FONT></TD>
    <TD></TD>
    <TD width="100%" colSpan=3><FONT face="Times New Roman" size=2>Based on my
      knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the
      financial condition, results of operations and cash flows of the
      registrant as of, and for, the periods presented in this
  report;</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>4.</FONT></TD>
    <TD></TD>
    <TD width="100%" colSpan=3><FONT face="Times New Roman" size=2>The
      registrant&#146;s other certifying officer and I are responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
      control over financial reporting (as defined in Exchange Act Rules
      13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>a)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>designed such
      disclosure controls and procedures, or caused such disclosure controls and
      procedures to be designed under our supervision, to ensure that material
      information relating to the registrant, including its consolidated
      subsidiaries, is made known to us by others within those entities,
      particularly during the period in which this report is being
      prepared;</FONT></TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top noWrap></TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD width="100%"></TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>b)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>designed such
      internal control over financial reporting, or caused such internal control
      over financial reporting to be designed under our supervision, to provide
      reasonable assurance regarding the reliability of financial reporting and
      the preparation of financial statements for external purposes in
      accordance with U.S. generally accepted accounting
principles;</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>c)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>evaluated the
      effectiveness of the registrant&#146;s disclosure controls and procedures and
      presented in this report our conclusions about the effectiveness of the
      disclosure controls and procedures, as of the end of the period covered by
      this report based on such evaluation; and</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>d)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>disclosed in this
      report any change in the registrant&#146;s internal control over financial
      reporting that occurred during the registrant&#146;s most recent fiscal quarter
      (the registrant&#146;s fourth fiscal quarter in the case of an annual report)
      that has materially affected, or is reasonably likely to materially
      affect, the registrant&#146;s internal control over financial
    reporting.</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>5.</FONT></TD>
    <TD></TD>
    <TD width="100%" colSpan=3><FONT face="Times New Roman" size=2>The
      registrant&#146;s other certifying officer and I have disclosed, based on our
      most recent evaluation of internal control over financial reporting, to
      the registrant&#146;s auditors and the audit committee of the registrant&#146;s
      board of directors (or persons performing the equivalent
    functions):</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>a)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>all significant
      deficiencies and material weaknesses in the design or operation of
      internal control over financial reporting which are reasonably likely to
      adversely affect the registrant&#146;s ability to record, process, summarize
      and report financial information; and</FONT></TD></TR>
  <TR>
    <TD colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>b)</FONT></TD>
    <TD></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>any fraud, whether or
      not material, that involves management or other employees who have a
      significant role in the registrant&#146;s internal control over financial
      reporting.</FONT></TD></TR></TABLE>
<P align=justify><FONT face="Times New Roman" size=2>Date: August 16, 2016
</FONT></P><BR>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="40%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="100%"><FONT face="Times New Roman" size=2>/s/ Stephen M. Robb</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Stephen M. Robb</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Executive Vice President - Chief Financial
  Officer</FONT></TD></TR></TABLE><BR>
<HR align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>11
<FILENAME>clorox3118951_1-ex32.htm
<DESCRIPTION>CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit 32 </FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>CERTIFICATION
</FONT></B></P>
<P align=justify><FONT face="Times New Roman" size=2>In connection with the
periodic report of The Clorox Company (the "Company") on Form 10-K for the
period ended June 30, 2016, as filed with the Securities and Exchange Commission
(the "Report"), we, Benno Dorer, Chairman and Chief Executive Officer of the
Company, and Stephen M. Robb, Chief Financial Officer of the Company, hereby
certify as of the date hereof, solely for purposes of Title 18, Chapter 63,
Section 1350 of the United States Code, that to our knowledge: </FONT></P>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD></TD>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>the Report fully
      complies with the requirements of Section 13(a) or 15(d), as applicable,
      of the Securities Exchange Act of 1934, and</FONT></TD></TR>
  <TR>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(2)</FONT></TD>
    <TD><FONT face="Times New Roman" size=2>the information
      contained in the Report fairly presents, in all material respects, the
      financial condition and results of operations of the Company at the dates
      and for the periods indicated.</FONT></TD></TR></TABLE>
<P align=justify><FONT face="Times New Roman" size=2>This Certification has not
been, and shall not be deemed, &#147;filed&#148; with the Securities and Exchange
Commission. </FONT></P>
<P align=justify><FONT face="Times New Roman" size=2>Date: August 16, 2016
</FONT></P><BR>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ Benno Dorer</FONT></TD>
    <TD noWrap align=left width="80%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=2><FONT face="Times New Roman" size=2>Benno Dorer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=2><FONT face="Times New Roman" size=2>Chairman and Chief Executive Officer</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="100%" colSpan=2>&nbsp; </TD></TR>
    <TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: left">&nbsp;</TD></TR>
<TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="20%"><FONT face="Times New Roman" size=2>/s/ Stephen M. Robb</FONT></TD>
    <TD noWrap align=left width="80%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=2><FONT face="Times New Roman" size=2>Stephen M. Robb</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" colSpan=2><FONT face="Times New Roman" size=2>Executive Vice President &#150; Chief Financial
  Officer</FONT></TD></TR></TABLE><BR>
<HR align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>12
<FILENAME>clorox3118951_1-ex991.htm
<DESCRIPTION>MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit 99.1
</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>MANAGEMENT&#146;S DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND<BR>RESULTS OF OPERATIONS</FONT></B><FONT face="Times New Roman" size=2> <BR></FONT><B><FONT face="Times New Roman" size=2>The Clorox Company <BR></FONT></B><B><FONT face="Times New Roman" size=2>(Dollars in millions, except share and per share data)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Management&#146;s Discussion and
Analysis of Financial Condition and Results of Operations (MD&amp;A) is designed
to provide a reader of The Clorox Company&#146;s (the Company or Clorox) financial
statements with a narrative from the perspective of management on the Company&#146;s
financial condition, results of operations, liquidity and certain other factors
that may affect future results. In certain instances, parenthetical references
are made to relevant sections of the Notes to Consolidated Financial Statements
to direct the reader to a further detailed discussion. This section should be
read in conjunction with the Consolidated Financial Statements and Supplementary
Data included in this Annual Report on Form 10-K.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The following sections are
included herein:</FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: left" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">Executive Overview</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">Results of Operations</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">Financial Position and Liquidity</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">Contingencies</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">Quantitative and Qualitative Disclosures about
      Market Risk</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">Recently Issued Accounting Standards</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%"><FONT face="Times New Roman" size=2>Critical
      Accounting Policies and Estimates</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">Summary of Non-GAAP Financial
  Measures</TD></TR></TABLE>
<P align=left><B><FONT face="Times New Roman" size=2>EXECUTIVE
OVERVIEW</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Clorox is a leading
multinational manufacturer and marketer of consumer and professional products
with approximately 8,000 employees worldwide as of June 30, 2016 and fiscal year
2016 net sales of $5,761. Clorox sells its products primarily through grocery
and mass retail outlets, e-commerce channels, wholesale distributors and medical
supply distributors. Clorox markets some of the most trusted and recognized
consumer brand names, including its namesake bleach and cleaning products,
Pine-Sol<SUP>&#174;</SUP> cleaners, Liquid-Plumr<SUP>&#174;</SUP> clog removers,
Poett<SUP>&#174;</SUP> home care products, Fresh Step<SUP>&#174;</SUP> cat litter,
Glad<SUP>&#174;</SUP> bags, wraps and container products, Kingsford<SUP>&#174;</SUP>
charcoal, Renew Life<SUP>&#174;</SUP> digestive health products, Hidden
Valley<SUP>&#174;</SUP> dressings and sauces, Brita<SUP>&#174;</SUP> water-filtration
products and Burt&#146;s Bees<SUP>&#174;</SUP> natural personal care products. The Company
also markets brands through professional services channels, including infection
control products for the healthcare industry under Clorox
Healthcare<SUP>&#174;</SUP>, HealthLink<SUP>&#174;</SUP>, Aplicare<SUP>&#174;</SUP> and
Dispatch<SUP>&#174;</SUP> brands. The Company manufactures products in more than a
dozen countries and sells them in more than 100 markets. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company primarily markets
its leading brands in midsized categories considered to be financially
attractive. Most of the Company&#146;s products compete with other nationally
advertised brands within each category and with &#147;private label&#148; brands.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company operates through
strategic business units that are aggregated into the following four reportable
segments based on the economics and nature of the products sold: </FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: left" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD style="TEXT-ALIGN: left" vAlign=top width="99%"><EM>Cleaning</EM><FONT face="Times New Roman" size=2> consists of laundry, home care and
      professional products marketed and sold in the United States. Products
      within this segment include laundry additives, including bleach products
      under the Clorox<SUP>&#174;</SUP> brand and Clorox 2<SUP>&#174;</SUP> stain fighter
      and color booster; home care products, primarily under the
      Clorox<SUP>&#174;</SUP>, Formula 409<SUP>&#174;</SUP>, Liquid-Plumr<SUP>&#174;</SUP>,
      Pine-Sol<SUP>&#174;</SUP>, S.O.S<SUP>&#174;</SUP> and Tilex<SUP>&#174;</SUP> brands;
      naturally derived products under the Green Works<SUP>&#174;</SUP> brand; and
      professional cleaning and disinfecting products under the
      Clorox<SUP>&#174;</SUP>, Dispatch<SUP>&#174;</SUP>, Aplicare<SUP>&#174;</SUP>,
      HealthLink<SUP>&#174;</SUP> and Clorox Healthcare<SUP>&#174;</SUP>
  brands.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD style="TEXT-ALIGN: left" vAlign=top width="99%"><EM>Household</EM><FONT face="Times New Roman" size=2>
      consists of charcoal, cat litter, digestive health products and bags,
      wraps and container products marketed and sold in the United States.
      Products within this segment include charcoal products under the
      Kingsford<SUP>&#174;</SUP> and Match Light<SUP>&#174;</SUP> brands; cat litter
      products under the Fresh Step<SUP>&#174;</SUP>, Scoop Away<SUP>&#174;</SUP> and Ever
      Clean<SUP>&#174;</SUP> brands; digestive health products under the Renew
      Life<SUP>&#174;</SUP> brand; and bags, wraps and containers under the
      Glad<SUP>&#174;</SUP> brand.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>1</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: left" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD style="TEXT-ALIGN: left" vAlign=top width="99%"><EM>Lifestyle</EM>
      <FONT face="Times New Roman" size=2>consists of food products,
      water-filtration systems and filters and natural personal care products
      marketed and sold in the United States. Products within this segment
      include dressings and sauces, primarily under the Hidden
      Valley<SUP>&#174;</SUP>, KC Masterpiece<SUP>&#174;</SUP> and Soy Vay<SUP>&#174;</SUP>
      brands; water-filtration systems and filters under the Brita<SUP>&#174;</SUP>
      brand; and natural personal care products under the Burt&#146;s
      Bees<SUP>&#174;</SUP> brand.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD style="TEXT-ALIGN: left" vAlign=top width="99%"><EM>International</EM>
      <FONT face="Times New Roman" size=2>consists of products sold outside the
      United States. Products within this segment include laundry, home care,
      water-filtration, digestive health products, charcoal and cat litter
      products, dressings and sauces, bags, wraps and containers and natural
      personal care products, primarily under the Clorox<SUP>&#174;</SUP>,
      Glad<SUP>&#174;</SUP>, PinoLuz<SUP>&#174;</SUP>, Ayudin<SUP>&#174;</SUP>,
      Limpido<SUP>&#174;</SUP>, Clorinda<SUP>&#174;</SUP>, Poett<SUP>&#174;</SUP>,
      Mistolin<SUP>&#174;</SUP>, Lestoil<SUP>&#174;</SUP>, Bon Bril<SUP>&#174;</SUP>,
      Brita<SUP>&#174;</SUP>, Green Works<SUP>&#174;</SUP>, Pine-Sol<SUP>&#174;</SUP>, Agua
      Jane<SUP>&#174;</SUP>, Chux<SUP>&#174;</SUP>, Renew Life<SUP>&#174;</SUP>,
      Kingsford<SUP>&#174;</SUP>, Fresh Step<SUP>&#174;</SUP>, Scoop Away<SUP>&#174;</SUP>,
      Ever Clean<SUP>&#174;</SUP>, KC Masterpiece<SUP>&#174;</SUP>, Hidden
      Valley<SUP>&#174;</SUP> and Burt&#146;s Bees<SUP>&#174;</SUP>
brands.</FONT></TD></TR></TABLE>
<P align=left><B><FONT face="Times New Roman" size=2>Non-GAAP Financial
Measures</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>This Executive Overview, the
succeeding sections of MD&amp;A and Exhibit 99.3 include certain financial
measures that are not defined by accounting principles generally accepted in the
United States of America (U.S. GAAP). These measures, which are referred to as
non-GAAP measures, are listed below.</FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: left" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%"><EM>Currency-neutral net sales growth</EM>
      <FONT face="Times New Roman" size=2>represents U.S. GAAP net sales growth
      excluding the impact of the change in foreign currency exchange
      rates.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%"><EM>Economic profit (EP)</EM> <FONT face="Times New Roman" size=2>is defined by the Company as earnings from
      continuing operations before income taxes, excluding noncash U.S. GAAP
      restructuring and intangible asset impairment costs, and interest expense;
      less an amount of tax based on the effective tax rate and less a charge
      equal to average capital employed multiplied by a cost of capital
      rate.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%"><EM>Free cash flow and free cash flow as a
      percentage of net sales.</EM> <FONT face="Times New Roman" size=2>Free
      cash flow</FONT><I><FONT face="Times New Roman" size=2></FONT></I> <FONT face="Times New Roman" size=2>is calculated as net cash provided by
      continuing operations less capital expenditures related to continuing
      operations.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%"><EM>Earnings from continuing operations before
      interest and taxes (EBIT) margin (the ratio of EBIT to net
  sales)</EM></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%"><EM>Debt to earnings from continuing operations
      before interest, taxes, depreciation and amortization, and noncash
      intangible asset impairment charges ratio (Consolidated Leverage
      ratio)</EM></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>For a discussion of these
measures and the reasons management believes they are useful to investors, refer
to &#147;</FONT><I><FONT face="Times New Roman" size=2>Summary of Non-GAAP Financial
Measures</FONT></I><FONT face="Times New Roman" size=2>&#148; below. For a discussion
of the Consolidated Leverage ratio, please refer to &#147;</FONT><I><FONT face="Times New Roman" size=2>Credit Arrangements</FONT></I><FONT face="Times New Roman" size=2>&#148; below. This MD&amp;A and Exhibit 99.3 include
reconciliations of these non-GAAP measures to the most directly comparable
financial measures calculated and presented in accordance with U.S.
GAAP.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal Year 2016 Financial
Highlights</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>A detailed discussion of
strategic goals, key initiatives and results of operations is included below.
Key fiscal year 2016 financial results are summarized as follows:</FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: left" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%">The Company&#146;s fiscal year 2016 net sales
      increased by 2%, from $5,655 in fiscal year 2015 to $5,761 in fiscal year
      2016, reflecting higher volume and the benefit of price increases,
      partially offset by unfavorable foreign currency exchange rates and higher
      trade promotion spending. On a currency-neutral basis, net sales increased
      5%.</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%">Gross margin increased 150 basis points to
      45.1% in fiscal year 2016 from 43.6% in fiscal year 2015, reflecting the
      benefits of favorable commodity costs, cost savings and price increases,
      partially offset by higher manufacturing and logistics costs, increased
      trade promotion spending, and the impact of unfavorable foreign currency
      exchange rates.</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%">The Company reported earnings from continuing
      operations of $648 in fiscal year 2016 compared to $606 in fiscal year
      2015. The Company reported earnings from continuing operations before
      income taxes of $983 in fiscal year 2016, compared to $921 in fiscal year
      2015.</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%">The Company delivered diluted net EPS from
      continuing operations in fiscal year 2016 of $4.92, an increase of
      approximately 8% from fiscal year 2015 diluted net EPS of $4.57.</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%">EP increased to $490 in fiscal year 2016
      compared to $458 in fiscal year 2015 (refer to the reconciliation of EP to
      earnings from continuing operations before income taxes in Exhibit
    99.3).</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%">&#9679;</TD>
    <TD vAlign=top width="99%">The Company&#146;s net cash flows provided by
      continuing operations were $768 in fiscal year 2016, compared to $858 in
      fiscal year 2015<FONT face="Times New Roman"></FONT> <FONT face="Times New Roman" size=2>reflecting higher tax payments and higher
      performance-based incentive compensation payments in fiscal year 2016
      related to the Company&#146;s strong fiscal year 2015 financial results. Free
      cash flow was $596 or 10% of net sales in fiscal year 2016, a decrease
      from $733 or 13% of net sales in fiscal year
2015.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>2</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: left" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">The Company paid $398 in cash dividends to
      stockholders in fiscal year 2016 compared to $385 in cash dividends in
      fiscal year 2015. In May 2016, the Company announced an increase of 4% in
      the quarterly cash dividend from prior year. In fiscal year 2016, the
      Company repurchased approximately 2 million shares of its common stock at
      a cost of $254.</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">On May 2, 2016, the Company acquired Renew
      Life, a leading brand in digestive health for $290. Results for Renew
      Life&#146;s domestic business are reflected in the Household reportable segment
      and results for Renew Life&#146;s international business are reflected in the
      International reportable segment. Included in the Company&#146;s results for
      fiscal year 2016 was $21 of Renew Life&#146;s global net
sales.</TD></TR></TABLE>
<P align=left><B><FONT face="Times New Roman" size=2>Strategic Goals and
Initiatives </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Clorox Company&#146;s 2020
Strategy serves as its strategic growth plan, directing the Company to the
highest value opportunities for long-term, profitable growth and total
shareholder return. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The long-term financial goals
reflected in the Company&#146;s 2020 Strategy include annual net sales growth of
3-5%, annual EBIT margin growth of 25-50 basis points and annual free cash flow
of 10-12% of net sales. Clorox anticipates using free cash flow to invest in the
business, maintain appropriate debt levels and return excess cash to
stockholders.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In fiscal year 2017, Clorox
anticipates ongoing macroeconomic challenges that may impact its sales and
margins, including unfavorable foreign currency exchange rates, particularly in
Argentina, and a continuation of challenging international economies. The
Company is monitoring anticipated slower U.S. category growth, driven primarily
by expected competitive activity and changes to commodity costs and
manufacturing and logistics costs. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s priority in
fiscal year 2017 remains investing strongly in its U.S. businesses, particularly
in its &#147;3D&#148; demand-creation model of Desire, Decide and Delight, including
advertising and trade promotion spending. The Company is also focused on product
innovation to delight and deliver superior value to consumers. Importantly, the
Company will work to continue to improve its margins by driving cost savings
initiatives and slowing the growth of selling and administrative expenses by
driving out low-value activity.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As the Company executes its
2020 Strategy, a particular focus on &#147;Strategy Accelerators,&#148; will help drive
investment decisions with the goal to deliver profitable long-term growth:
</FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: left" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%"><STRONG>Accelerating portfolio
      momentum</STRONG><FONT face="Times New Roman" size=2> reallocates
      resources to faster-growing countries, categories and brands in the
      portfolio or focuses investment in new categories with growth tailwinds
      like the Company&#146;s recent acquisition of Renew Life digestive health
      products.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%"><STRONG>Accelerating</STRONG><FONT face="Times New Roman" size=2> </FONT><B><FONT face="Times New Roman" size=2>3D technology transformation</FONT></B><FONT face="Times New Roman" size=2> reflects an emphasis in digital communications that can deliver
      more targeted messages based on how consumers research, shop and buy their
      products. The Company continues to invest in digital marketing and social
      media and is focused on driving its e-commerce business.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%"><STRONG>Accelerating innovation </STRONG><FONT face="Times New Roman" size=2>across the Company&#146;s 3D demand-creation
      model of Desire, Decide and Delight will continue to support category
      growth and market share improvement.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B><FONT face="Times New Roman" size=2>The Company is
      focused on delivering superior value to consumers through the introduction
      of new products and product improvements.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%"><STRONG>Accelerating the Company&#146;s growth
      culture </STRONG><FONT face="Times New Roman" size=2>involves fostering a
      work environment where employees directly support the Company&#146;s effort to
      drive profitable growth. The growth culture vision provides a framework to
      deliver on that goal through five calls to action: put the consumer first,
      be curious, think boldly, embrace change and act like an
  owner.</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Looking forward, the Company
will continue to execute against its 2020 Strategy and seek to achieve its goals
to deliver long-term profitable growth.</FONT><B><I><FONT face="Times New Roman" size=2> </FONT></I></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>RESULTS OF
OPERATIONS</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Unless otherwise noted,
management&#146;s discussion and analysis compares results of continuing operations
from fiscal year 2016 to fiscal year 2015, and fiscal year 2015 to fiscal year
2014, with percentage and basis point calculations based on rounded numbers,
except for per share data and the effective tax rate.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>3</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>CONSOLIDATED
RESULTS</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Continuing operations
</FONT></B></P><IMG src="clorox3118951_1-ex9911x4x1.jpg" border=0><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Net
sales</FONT></I></B><FONT face="Times New Roman" size=2> in fiscal year 2016
increased 2%. Volume increased 4% reflecting higher shipments in all reportable
segments and most significantly in Cleaning, Household and Lifestyle. Higher
shipments in the Cleaning segment were driven by Home Care and Professional
Products, partially offset by Laundry; higher shipments in the Household segment
were primarily due to the acquisition of the Renew Life business, Charcoal, and
Bags and Wraps, partially offset by Cat Litter; and higher shipments in the
Lifestyle segment primarily were due to Natural Personal Care and Dressing and
Sauces. Volume outpaced net sales primarily due to unfavorable foreign currency
exchange rates and higher trade promotion spending, partially offset by the
benefit of price increases. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Net sales in fiscal year 2015
increased 3%. Volume increased 2%, reflecting higher product shipments in the
International segment, primarily due to growth in Latin America, Canada, Europe
and Asia; higher shipments of Burt&#146;s Bees<SUP>&#174;</SUP> natural personal care
products, largely due to innovation in lip and face care products combined with
distribution gains; higher shipments of cleaning and healthcare products in the
professional products business; </FONT><FONT face="Times New Roman"></FONT><FONT face="Times New Roman" size=2>higher shipments of Clorox<SUP>&#174;</SUP> toilet bowl
cleaner due to increased merchandising activities and distribution gains; and
higher shipments of Kingsford<SUP>&#174;</SUP> charcoal products behind increased
merchandising support to launch the start of the grilling season. Volume results
also reflected lower shipments of Clorox<SUP>&#174;</SUP> liquid bleach due to the
February 2015 price increase, category softness and increased competition; and
lower shipments of Brita<SUP>&#174;</SUP> water-filtration products, primarily due to
continuing category softness and increased competition. The variance between
volume and net sales was primarily due to the benefit of price increases,
partially offset by unfavorable foreign currency exchange rates. On a
currency-neutral basis, net sales increased about 5%. </FONT></P><IMG src="clorox3118951_1-ex9911x4x2.jpg" border=0><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Gross
margin</FONT></I></B><FONT face="Times New Roman" size=2>, defined as gross
profit as a percentage of net sales, in fiscal year 2016 increased 150 basis
points from 43.6% to 45.1%. Gross margin expansion in fiscal year 2016 was
driven by the benefits of favorable commodity costs, strong cost savings and
price increases, partially offset by higher manufacturing and logistics costs,
increased trade promotion spending and the impact of unfavorable foreign
currency exchange rates. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Gross margin, defined as gross
profit as a percentage of net sales, in fiscal year 2015 increased 90 basis
points from 42.7% to 43.6%. Gross margin expansion in fiscal year 2015 was
driven by the benefits of cost savings and price increases, partially offset by
the impact of higher manufacturing and logistics costs.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>4</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Expenses</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="68%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=5><B><FONT face="Times New Roman" size=1>% Change</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="11%" colSpan=8><B><FONT face="Times New Roman" size=1>% of Net
    sales</FONT></B></TD></TR>
  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="68%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2016<BR>to<BR>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2015<BR>to<BR>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="68%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Selling and administrative
expenses</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    806</FONT></B></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG>798</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG>751</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    1</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>%</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG>6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>14.0</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>%</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>14.1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>13.6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="68%"><FONT face="Times New Roman" size=2>Advertising costs</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><B><FONT face="Times New Roman" size=2>587</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>523</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>503</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="2%"><B><FONT face="Times New Roman" size=2>12</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><B><FONT face="Times New Roman" size=2>10.2</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>9.2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>9.1</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="68%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Research and development costs</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>141</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>136</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>125</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>4</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>9</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>2.4</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2.4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2.3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Selling and
administrative expenses</FONT></I></B><FONT face="Times New Roman" size=2> were
relatively flat in fiscal year 2016. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Selling and administrative
expenses increased 6% in fiscal year 2015, primarily from higher
performance-based incentive costs as a result of fiscal year financial
performance exceeding financial targets. Expenses in the prior year reflected
lower performance-based incentive costs when the Company&#146;s results fell below
financial targets. In addition, the Company continued to experience inflationary
pressures in international markets. These increases were partially offset by the
benefit of cost savings, one-time costs in fiscal year 2014 related to the
change in information technology (IT) service providers and a one-time impact
related to a change in the Company&#146;s long-term disability plan in fiscal year
2015 to bring it more in line with the marketplace. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Advertising
costs</FONT></I></B><FONT face="Times New Roman" size=2> as a percentage of net
sales increased during fiscal year 2016 mainly to drive awareness and trial
behind innovation and maintain the health of the Company&#146;s core business. The
Company&#146;s U.S. retail advertising spend was approximately 11% of net sales
during the year. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Advertising costs as a
percentage of net sales increased slightly during fiscal year 2015, reflecting
continued support behind the Company&#146;s brands, including driving the trial of
new products. The Company&#146;s U.S. retail advertising spend was approximately 10%
of net sales during the year. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Research and development
costs</FONT></I></B><FONT face="Times New Roman" size=2> as a percentage of net
sales was flat in fiscal year 2016. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Research and development costs
increased slightly as a percentage of net sales in fiscal year 2015, driven by
higher performance-based incentive costs. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>5</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Interest expense, Other
(income) expense, net, and the effective tax rate on
earnings</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Interest expense</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>88</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG>100</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG>103</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Other income, net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><B><FONT face="Times New Roman" size=2>(7</FONT></B></TD>
    <TD noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>)</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(10</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Income taxes on continuing
    operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    335</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>315</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>305</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Interest expense
</FONT></I></B><FONT face="Times New Roman" size=2>decreased $12 in fiscal year
2016, primarily due to a lower weighted-average interest rate on total
debt.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Interest
expense</FONT><B><I><FONT face="Times New Roman" size=2> </FONT></I></B><FONT face="Times New Roman" size=2>decreased $3 in fiscal year 2015, primarily due to
a lower weighted-average interest rate on long-term debt resulting from the
issuance of senior notes in December 2014 and the maturities of senior notes in
January 2015, combined with less interest expense on a lower balance of
commercial paper throughout fiscal year 2015. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Other (income) expense,
net</FONT></I></B><FONT face="Times New Roman" size=2>, of $(7) in fiscal year
2016 included $(15) of income from equity investees, $(11) gain on the sale of
the Los Angeles bleach manufacturing facility, partially offset by $9 of noncash
asset impairment charges and $8 of amortization of trademarks and other
intangible assets. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Other (income) expense, net,
of $(13) in fiscal year 2015 included $(14) of income from equity investees,
$(13) gain on the sale of real estate assets by a low-income housing partnership
and $(4) of interest income, partially offset by $9 of foreign currency exchange
losses, $8 of amortization of trademarks and other intangible assets and $3 of
noncash asset impairment charges. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Other (income) expense, net,
of $(10) in fiscal year 2014 included $(13) of income from equity investees,
$(5) of insurance and litigation settlements and other smaller items, partially
offset by $8 of amortization of trademarks and other intangible assets and $3 of
noncash asset impairment charges. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>The effective tax rate
on earnings </FONT></I></B><FONT face="Times New Roman" size=2>was 34.1%, 34.2%
and 34.6% in fiscal years 2016, 2015 and 2014, respectively. The effective tax
rate in fiscal year 2016 compared to fiscal year 2015 was essentially flat. The
lower effective tax rate in fiscal year 2015 compared to fiscal year 2014 was
primarily due to higher uncertain tax position releases, partially offset by
higher tax on foreign earnings, in fiscal year 2015.</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Diluted net earnings per
share</FONT></I></B><FONT face="Times New Roman"> </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=5><STRONG><FONT face="Times New Roman" size=1>%
      Change</FONT></STRONG></TD></TR>
  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="85%">&nbsp;</TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016<BR>to<BR>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015<BR>to<BR>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Diluted net EPS from continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      <STRONG>4.92</STRONG></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
4.57</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
4.39</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      <STRONG>8</STRONG></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Diluted net earnings per share
(EPS) from continuing operations increased $0.35, driven by the benefits of
higher sales and gross margin expansion, partially offset by increased
advertising investments. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Diluted net EPS from
continuing operations increased $0.18 in fiscal year 2015, driven by the
benefits of higher sales and gross margin expansion, partially offset by
increased selling and administrative expenses, primarily from higher
performance-based incentive costs as a result of fiscal year financial
performance exceeding financial targets. Expenses in the prior year reflected
lower performance-based incentive costs when the Company&#146;s results fell below
financial targets. Increased investments in total demand-building programs also
reduced fiscal year diluted EPS.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>6</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Discontinued Operations
</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>On September 22, 2014, Clorox
Venezuela announced that it was discontinuing its operations, effective
immediately, and seeking to sell its assets. Since fiscal year 2012, Clorox
Venezuela was required to sell more than two thirds of its products at prices
frozen by the Venezuelan government. During this same period, Clorox Venezuela
experienced successive years of hyperinflation resulting in significant
sustained increases in its input costs, including packaging, raw materials,
transportation and wages. As a result, Clorox Venezuela had been selling its
products at a loss, resulting in ongoing operating losses. Clorox Venezuela
repeatedly met with government authorities in an effort to help them understand
the rapidly declining state of the business, including the need for immediate,
significant and ongoing price increases and other critical remedial actions to
address these adverse impacts. Based on the Venezuelan government&#146;s
representations, Clorox Venezuela had expected significant price increases would
be forthcoming much earlier; however, the price increases subsequently approved
were insufficient and would have caused Clorox Venezuela to continue operating
at a significant loss into the foreseeable future. As such, Clorox Venezuela was
no longer financially viable and was forced to discontinue its
operations.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>On September 26, 2014, the
Company reported that Venezuelan Vice President Jorge Arreaza announced, with
endorsement by President Nicol&#225;s Maduro, that the Venezuelan government had
occupied the Santa Luc&#237;a and Guacara production facilities of Clorox Venezuela.
On November 6, 2014, the Company reported that the Venezuelan government had
published a resolution granting a government-sponsored Special Administrative
Board full authority to restart and operate the business of Clorox Venezuela,
thereby reaffirming the government's expropriation of Clorox Venezuela&#146;s assets.
Further, President Nicol&#225;s Maduro announced the government's intention to
facilitate the resumed production of bleach and other cleaning products at
Clorox Venezuela plants. He also announced his approval of a financial credit to
invest in raw materials and production at the plants. These actions by the
Venezuelan government were taken without the consent or involvement of Clorox
Venezuela, its parent Clorox Spain S.L. (Clorox Spain) or any of their
affiliates. Clorox Venezuela, Clorox Spain and their affiliates reserved their
rights under all applicable laws and treaties. Since the exit of Clorox
Venezuela in the first quarter of fiscal year 2015, the Company has recognized
$49 in after-tax exit costs and other related expenses within discontinued
operations related to the exit of Clorox Venezuela. The Company believes it is
reasonably possible that it will recognize $1 to $11 in after-tax exit costs and
other related expenses in discontinued operations for Clorox Venezuela during
fiscal years 2017 through 2019, for a total of $50 to $60 over the entire
five-year period.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>See Notes to Consolidated
Financial Statements for more information regarding discontinued operations of
Clorox Venezuela. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Unrelated to Clorox Venezuela,
in the fiscal year ended June 30, 2015, the Company recognized $32 of previously
unrecognized tax benefits relating to other discontinued operations upon the
expiration of the applicable statute of limitations. Recognition of these
previously disclosed tax benefits had no impact on the Company&#146;s cash flows or
earnings from continuing operations for the fiscal year ended June 30,
2015.</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>SEGMENT RESULTS FROM
CONTINUING OPERATIONS</FONT></I></B><I><FONT face="Times New Roman" size=2>
</FONT></I></P>
<P align=left><FONT face="Times New Roman" size=2>The following presents the
results from continuing operations of the Company&#146;s reportable segments and
certain unallocated costs reflected in Corporate (see Notes to Consolidated
Financial Statements for a reconciliation of segment results to consolidated
results): </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Cleaning </FONT></B></P>
<TABLE style="LINE-HEIGHT: 12pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="75%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>% Change</FONT></B></TD></TR>
  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="75%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016<BR>to<BR>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015<BR>to<BR>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="75%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net sales</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>1,912</FONT></B></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>$&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG></FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,824</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>$&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG></FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,776</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>5</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>%</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="75%"><FONT face="Times New Roman" size=2>Earnings from continuing operations before income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><B><FONT face="Times New Roman" size=2>511</FONT></B></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>445</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>428</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><B><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp; 15</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp; </STRONG>4</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>7</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal year 2016 versus
fiscal year 2015: </FONT></B><FONT face="Times New Roman" size=2>Volume, net
sales and earnings from continuing operations before income taxes increased by
6%, 5% and 15%, respectively, during fiscal year 2016. Both volume and net sales
growth were driven primarily by higher shipments across several Home Care
brands, including Clorox<SUP>&#174;</SUP> disinfecting wipes resulting from increased
merchandising support and expanded warehouse club distribution, and in
Professional Products mainly in cleaning products. These increases were
partially offset by lower shipments in Laundry, primarily due to the impact of
the February 2015 price increase on Clorox<SUP>&#174;</SUP> liquid bleach. Volume
outpaced net sales due to unfavorable product mix. The increase in earnings from
continuing operations before income taxes was mainly due to net sales growth,
the benefit of favorable commodity costs, strong cost savings, and the gain on
the sale of the Company&#146;s Los Angeles bleach manufacturing facility, partially
offset by higher manufacturing and logistics costs and increased advertising
investments. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal year 2015 versus
fiscal year 2014: </FONT></B><FONT face="Times New Roman" size=2>Volume, net
sales and earnings from continuing operations before income taxes increased by
2%, 3% and 4%, respectively, during fiscal year 2015. Both volume and net sales
grew primarily due to higher shipments of Clorox<SUP>&#174;</SUP> toilet bowl cleaner
and Clorox<SUP>&#174;</SUP> disinfecting wipes in Home Care, behind increased
merchandising activities. The Professional Products Division also grew volume,
which was driven primarily by distribution gains across a number of brands.
These increases were partially offset by lower shipments of Clorox<SUP>&#174;</SUP>
liquid bleach in Laundry, primarily due to the February 2015 price increase. Net
sales growth outpaced volume growth primarily due to the benefit of price
increase. The increase in earnings from continuing operations before income
taxes was driven by the benefit of sales growth and cost savings, partially
offset by an increase in demand-building investments. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Household </FONT></B></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=5><STRONG><FONT face="Times New Roman" size=1>%
      Change</FONT></STRONG></TD></TR>
  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="85%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016<BR>to<BR>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015<BR>to<BR>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net sales</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><STRONG><FONT face="Times New Roman" size=2>1,862</FONT></STRONG></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG>1,794</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG>1,709</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>4</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>%</FONT></B></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"><FONT face="Times New Roman" size=2>Earnings from continuing operations before income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 428</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>375</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>326</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </STRONG>15</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal year 2016 versus
fiscal year 2015: </FONT></B><FONT face="Times New Roman" size=2>Volume, net
sales and earnings from continuing operations before income taxes increased by
3%, 4% and 14%, respectively, during fiscal year 2016. Both volume growth and
net sales growth were driven by the acquisition of the Renew Life business,
higher shipments of Charcoal resulting from increased merchandising support and
increased shipments across several Glad<SUP>&#174;</SUP> products, including
continued strength in premium trash bags. These increases were partially offset
by lower shipments of Cat Litter, largely due to continuing competitive
activity. Net sales growth outpaced volume growth, primarily due to favorable
product mix and the benefit of price increases, partially offset by higher trade
promotion spending, mainly in Bags and Wraps. The increase in earnings from
continuing operations before income taxes was mainly due to net sales growth,
the benefit of favorable commodity costs and strong cost savings, partially
offset by higher manufacturing and logistics costs and increased advertising
investments. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal year 2015 versus
fiscal year 2014: </FONT></B><FONT face="Times New Roman" size=2>Volume, net
sales and earnings from continuing operations before income taxes increased by
2%, 5% and 15%, respectively, during fiscal year 2015. Both volume growth and
net sales growth were driven by higher shipments of Kingsford<SUP>&#174;
</SUP></FONT><FONT face="Times New Roman" size=2>charcoal products behind
increased merchandising activities. Net sales growth outpaced volume growth
primarily due to the benefits of price increases on Glad<SUP>&#174;</SUP> bags and
wraps. The increase in earnings from continuing operations before income taxes
was driven by strong sales growth and the benefit of cost savings, partially
offset by an increase in demand building investments and manufacturing and
logistics costs.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>8</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Lifestyle </FONT></B></P>
<P align=left>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="75%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>% Change</FONT></B></TD></TR>
  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="75%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016<BR>to<BR>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015<BR>to<BR>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="75%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net sales</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>990</FONT></B></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>$&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG></FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>950</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>$&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG></FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>936</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>4</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>%</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="75%"><FONT face="Times New Roman" size=2>Earnings from continuing operations before income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><B><FONT face="Times New Roman" size=2>251</FONT></B></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>257</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>258</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><B><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp; (2</FONT></B></TD>
    <TD noWrap align=left width="1%"><STRONG><FONT face="Times New Roman" size=2>)</FONT></STRONG></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp; </STRONG>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR></TABLE></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal year 2016 versus
fiscal year 2015:</FONT></B><FONT face="Times New Roman" size=2> Volume and net
sales increase by 5% and 4%, respectively, while earnings from continuing
operations before income taxes decreased 2% during fiscal year 2016. Both volume
growth and net sales growth were primarily driven by higher shipments of Burt&#146;s
Bees<SUP>&#174;</SUP> Natural Personal Care largely due to innovation in lip and face
care and higher shipments of Hidden Valley<SUP>&#174; </SUP></FONT><FONT face="Times New Roman" size=2>bottled salad dressings due to innovation. Volume
growth outpaced net sales growth primarily due to increased trade promotion
spending. The decrease in earnings from continuing operations before income
taxes was primarily due to increased advertising investments to support new
products and increased selling and administrative expenses to support innovation
and growth, partially offset by net sales growth and cost savings. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal year 2015 versus
fiscal year 2014:</FONT></B><FONT face="Times New Roman" size=2> Net sales and
volume both increased by 1%, while earnings from continuing operations before
income taxes remained flat during fiscal year 2015. Both net sales growth and
volume growth were driven by higher shipments of Burt&#146;s Bees<SUP>&#174;</SUP> natural
personal care products, largely due to innovation in lip and face care products
combined with distribution gains. The increase was partially offset by lower
shipments of Brita<SUP>&#174;</SUP> </FONT><FONT face="Times New Roman" size=2>water-filtration products, primarily due to continuing category softness
and increased competition. Flat earnings from continuing operations before
income taxes reflected lower commodity costs, cost savings and favorable product
mix. These increases were offset by higher manufacturing and logistics costs and
demand building investments. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>International
</FONT></B></P>
<P align=left>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="75%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>% Change</FONT></B></TD></TR>
  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="75%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016<BR>to<BR>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015<BR>to<BR>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="75%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net sales</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>997</FONT></B></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>$&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG></FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,087</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>$&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG></FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,093</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>(8</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>)%</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="75%"><FONT face="Times New Roman" size=2>Earnings from continuing operations before income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><B><FONT face="Times New Roman" size=2>66</FONT></B></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>79</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>99</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><B><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp; (16</FONT></B></TD>
    <TD noWrap align=left width="1%"><STRONG><FONT face="Times New Roman" size=2>)</FONT></STRONG></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp; </STRONG>(20</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal year 2016 versus
fiscal year 2015:</FONT></B><FONT face="Times New Roman" size=2> Volume
increased 1%, while net sales and earnings from continuing operations before
income taxes decreased by 8% and 16%, respectively, during fiscal year 2016.
Volume grew primarily due to higher shipments, mainly in Canada, which included
the benefit of Renew Life acquisition, Mexico, and Europe, partially offset by
lower shipments in certain other Latin American countries largely due to the
impact of price increases taken to offset inflationary pressures. The decline in
net sales was primarily due to unfavorable foreign currency exchange rates
across multiple countries, including the impact of the significant devaluation
of the Argentine peso, partially offset by the benefit of price increases. The
decrease in earnings from continuing operations before income taxes was
primarily due to lower net sales, unfavorable foreign currency exchange rates,
inflationary pressure on manufacturing and logistics costs and higher
advertising costs, offset by the benefits of price increases and cost savings.
</FONT><B><FONT face="Times New Roman" size=2></FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal year 2015 versus
fiscal year 2014:</FONT></B><FONT face="Times New Roman" size=2> Volume
increased 3%, while net sales and earnings from continuing operations before
income taxes decreased 1% and 20%, respectively, during fiscal year 2015. Volume
grew primarily due to higher shipments in Latin America, Canada, Europe and
Asia. Volume growth outpaced net sales growth primarily due to unfavorable
foreign currency exchange rates, partially offset by the benefit of price
increases and favorable product mix. The decrease in earnings from continuing
operations before income taxes was primarily driven by unfavorable foreign
currency exchange rates and inflation across multiple countries, primarily in
Argentina (see &#147;Argentina&#148; below), which resulted in higher selling and
administrative expenses, higher manufacturing and logistics costs and higher
commodity costs. These decreases in earnings were partially offset by the
benefit of price increases, favorable product mix and cost savings.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>9</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Argentina
</FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company operates in
Argentina through certain wholly owned subsidiaries (collectively, &#147;Clorox
Argentina&#148;). Net sales from Clorox Argentina represented approximately 3% and 4%
for the fiscal years ended June 30, 2016 and 2015, respectively, of the
Company&#146;s consolidated net sales for those periods. The operating environment in
Argentina and the Latin America region continues to present business challenges,
including significant devaluing currency and inflation.</FONT><FONT face="Times New Roman"> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Clorox Argentina manufactures
products at three plants that it owns and operates across Argentina and markets
those products to consumers throughout the country. Products are advertised
nationally and sold to consumers through wholesalers and retail outlets located
throughout Argentina. Sales are made primarily through the use of Clorox
Argentina&#146;s sales force. Small amounts of products produced in Argentina are
exported each year, including sales to the Company&#146;s subsidiaries located
primarily in Latin America. Clorox Argentina obtains its raw materials almost
entirely from local sources. The Company also conducts research and development
activities at its owned facility in Buenos Aires, Argentina. Additionally,
Clorox Argentina performs marketing, legal, and various other shared service
activities to support the Company&#146;s Latin American operations. Clorox Argentina
in turn benefits from shared service activities performed within other
geographic locations, such as information technology support and manufacturing
technical assistance. </FONT><FONT face="Times New Roman"></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>For the fiscal year ended June
30, 2016 and 2015, the value of the Argentine peso (ARS) declined 39% and 10%,
respectively. As of June 30, 2016, using the exchange rate of 15 ARS per U.S.
dollar (USD), Clorox Argentina had total assets of $77, including cash and cash
equivalents of $22, net receivables of $13, inventories of $19, net property,
plant and equipment of $15 and intangible assets excluding goodwill of $3.
Goodwill for Argentina is aggregated and assessed for impairment at the Latin
America reporting unit level, which is part of the Company&#146;s International
reportable segment. Based on the results of the annual impairment test performed
in the fourth quarter of fiscal year 2016, the fair value of the Latin America
reporting unit exceeded its carrying value by more than 20% and reflected
unfavorable foreign currency exchange rates across several countries and the
Company&#146;s expectations of continued challenges from the Latin America region.
Although Argentina is not currently designated as a highly inflationary economy
for accounting purposes, further volatility and declines in the exchange rate
are expected in the future, which would have an additional adverse impact on
Clorox Argentina&#146;s net sales, net earnings, and net monetary asset
position.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is closely
monitoring developments in Argentina and is taking steps intended to mitigate
the adverse conditions, but there can be no assurances that these actions will
be able to mitigate these conditions.</FONT><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Corporate </FONT></B></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="73%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><STRONG><FONT face="Times New Roman" size=1>% Change<FONT face="Times New Roman"></FONT></FONT></STRONG></TD></TR>
  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="73%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"><STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </STRONG></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016<BR>to<BR>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015<BR>to<BR>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Losses from continuing operations before
      income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT></B></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>(273</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>)</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$<STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG></FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(235</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$<STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </STRONG></FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(227</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>%</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG></STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Corporate includes certain
non-allocated administrative costs, interest income, interest expense and other
non-operating income and expenses. Corporate assets include cash and cash
equivalents, property and equipment, other investments and deferred taxes.
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal year 2016 versus
fiscal year 2015: </FONT></B><FONT face="Times New Roman" size=2>The increase in
losses from continuing operations before income was primarily due to higher
current year benefits and performance-based employee incentive costs including
the prior year change in the Company&#146;s long-term disability plan to bring it
more in line with the marketplace, absence of the prior year&#146;s gain on the sale
of real estate assets by a low-income housing partnership and increased current
year information technology spending to support the Company&#146;s initiatives. This
was partially offset by lower current year interest expense primarily due to a
lower weighted-average interest rate on total debt. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fiscal year 2015 versus
fiscal year 2014: </FONT></B><FONT face="Times New Roman" size=2>The increase in
losses from continuing operations before income taxes was primarily due to
higher performance-based incentive costs as a result of fiscal year financial
performance exceeding financial targets, compared to the prior year which
reflected lower performance-based incentive costs when the Company&#146;s results
fell below financial targets. This factor was partially offset by cost savings,
a gain on the sale of real estate assets by a low-income housing partnership and
benefits from a change in the Company&#146;s long-term disability plan to bring it
more in line with the marketplace.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>10</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>FINANCIAL POSITION AND
LIQUIDITY</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Management&#146;s discussion and
analysis of the Company&#146;s financial position and liquidity describes its
consolidated operating, investing and financing activities from continuing
operations, contractual obligations and off-balance sheet arrangements.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The following table summarizes
cash activities from continuing operations for the years ended June 30:
</FONT></P>
<TABLE style="LINE-HEIGHT: 12pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net cash provided by continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>768</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>858</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>786</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Net
      cash used for investing activities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      <STRONG>(430</STRONG></FONT></TD>
    <TD noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>)</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (106</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (137</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net cash used for financing
    activities</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>(316</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>)</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(696</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(592</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s cash position
includes amounts held by foreign subsidiaries and, as a result, the repatriation
of certain cash balances from some of the Company&#146;s foreign subsidiaries could
result in additional tax costs in excess of tax benefits. However, these cash
balances held by foreign subsidiaries are generally available without legal
restriction to fund local business operations.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In addition, a portion of the
Company&#146;s cash balance is held in U.S. dollars by foreign subsidiaries, whose
functional currency is their local currency. Such U.S. dollar balances are
reported on the foreign subsidiaries&#146; books, in their functional currency, with
the impact from foreign currency exchange rate differences recorded in Other
(income) expense, net. The Company&#146;s cash holdings at June 30 were as follows:
</FONT></P>
<TABLE style="LINE-HEIGHT: 12pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>U.S. dollar balances held by U.S. dollar
      functional currency subsidiaries and at parent</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>249</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      221</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>180</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>Non-U.S. dollar balances held by non-U.S. dollar functional
      currency subsidiaries</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><B><FONT face="Times New Roman" size=2>133</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>142</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>132</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>U.S. dollar balances held by non-U.S. dollar
      functional currency subsidiaries</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>19</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>19</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>12</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>Non-U.S. dollar balances held by U.S. dollar functional currency
      subsidiaries</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: right" noWrap align=left width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>5</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 401</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG></STRONG>382</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><STRONG>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </STRONG>329</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s total cash
balance was $401 as of June 30, 2016, as compared to $382 as of June 30, 2015.
The increase of $19 was primarily attributable to $768 of net cash provided by
continuing operations, largely offset by cash used in investing activities of
$430, which included the $290 acquisition of Renew Life and $172 in capital
expenditures, and cash used in financing activities of $316, which included cash
dividends of $398 and share repurchases of $254, partially offset by proceeds
from the issuance of common stock for employee stock plans of $210 and
incremental borrowings of $126.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s total cash
balance was $382 as of June 30, 2015, as compared to $329 as of June 30, 2014.
The increase of $53 was primarily attributable to $858 of net cash provided by
continuing operations, $495 of net proceeds from the December 2014 long-term
debt issuance and $251 of proceeds from the issuance of common stock for
employee stock plans. These increases were partially offset by $575 of
repayments of long-term debt, $434 of share repurchases, $385 of dividend
payments, $125 of capital expenditures and $48 of repayments of commercial paper
borrowings. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Operating
Activities</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Net cash provided by
continuing operations decreased to $768 in fiscal year 2016 from $858 in fiscal
year 2015. The decrease reflected higher payments in the current year for both
taxes and performance-based employee incentive compensation related to the
Company&#146;s strong 2015 fiscal year results. These factors were partially offset
by higher earnings from continuing operations in fiscal year 2016 and $25 in
prior year payments to settle interest-rate hedges related to the Company&#146;s
issuance of long-term debt.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Net cash provided by
continuing operations increased to $858 in fiscal year 2015 from $786 in fiscal
year 2014. The increase was primarily due to the company&#146;s fiscal year
performance, including solid net sales growth and margin expansion. Other
contributing factors include lower performance-based incentive payments related
to the company's fiscal year 2014 performance and lower tax payments in the
current period, as well as the initial funding of the company's non-qualified
deferred compensation plan in the year-ago period. These benefits were partially
offset by $25 in payments to settle interest-rate hedges related to the
company's issuance of long-term debt in December 2014. </FONT><B><FONT face="Times New Roman" size=2></FONT></B></P>
<P align=center><FONT face="Times New Roman" size=2>11</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Investing
Activities</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Capital expenditures were
$172, $125 and $137, respectively, in fiscal years 2016, 2015 and 2014. Capital
spending as a percentage of net sales was 3.0%, 2.2% and 2.5% for fiscal years
2016, 2015 and 2014, respectively. The increase in fiscal year 2016 was due to
additional capital spending to drive cost savings and to support innovation and
growth. The relatively flat fiscal year 2015 capital spending as a percentage of
net sales was due to prudent management of capital spending against
manufacturing, technology and facility projects which meet growth, efficiency,
replacement or compliance requirements.</FONT><BR></P>
<P align=left><FONT face="Times New Roman" size=2>In April 2016, the Company
sold its Los Angeles bleach manufacturing facility, resulting in $20 in cash
proceeds from investing activities and a gain of $(11) recorded in Other
(income) expense, net, on the consolidated statement of earnings for the year
ended June 30, 2016. In September 2015, the Company sold its corporate jet to an
unrelated party for cash proceeds of $11. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In April 2015, a low-income
housing partnership, in which the Company was a limited partner, sold its real
estate holdings. The real property sale resulted in $15 in cash proceeds from
investing activities and a gain of $(14) recorded in Other (income) expense,
net, on the consolidated statement of earnings for the year ended June 30,
2015.</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Acquisition</FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>On May 2, 2016, the Company
acquired Renew Life, a leading brand in digestive health. The amount paid was
$290 funded through commercial paper. </FONT><B><I><FONT face="Times New Roman" size=2></FONT></I></B></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Free cash
flow</FONT></I></B></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net cash provided by continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>768</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>858</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>786</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>Less: capital expenditures</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<STRONG>(172</STRONG></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>)</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(125</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(137</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Free cash flow</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>596</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>733</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>649</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>Free
      cash flow as a percentage of net sales</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><B><FONT face="Times New Roman" size=2>10.3</FONT></B></TD>
    <TD noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>%</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>13.0</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>11.8</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>%</FONT></TD></TR></TABLE><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Financing
Activities</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Capital Resources and
Liquidity</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Net cash used for financing
activities was $316 in fiscal year 2016, as compared to $696 in fiscal year
2015. Net cash used for financing activities was lower in fiscal year 2016,
mainly driven by the increase in net borrowings to fund the Renew Life
acquisition. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Net cash used for financing
activities was $696 in fiscal year 2015, as compared to $592 in fiscal year
2014. Net cash used for financing activities was higher in fiscal year 2015 due
to a net reduction in long-term debt and an increase in share repurchases and
dividends paid. These factors were partially offset by an increase in proceeds
from the issuance of common stock for employee stock plans.</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Credit
Arrangements</FONT></I></B><B><FONT face="Times New Roman" size=2>
</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016, the
Company had a $1,100 revolving credit agreement (the Credit Agreement), which
expires in October 2019. There were no borrowings under the Credit Agreement as
of June 30, 2016 or 2015, and the Company believes that borrowings under the
Credit Agreement are and will continue to be available for general corporate
purposes. The agreement includes certain restrictive covenants and limitations.
The primary restrictive covenant is a maximum ratio of total debt to earnings
before interest, taxes, depreciation and amortization and intangible asset
impairment (Consolidated EBITDA) for the trailing four quarters (Consolidated
Leverage ratio), as defined and described in the Credit Agreement, of
3.50.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>12</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>The following table sets forth
the calculation of the Consolidated Leverage ratio as of June 30, using
Consolidated EBITDA for the trailing four quarters, as contractually defined:
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Earnings from continuing
operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>648</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>Add
      back:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="2%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest
expense</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>88</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax
    expense</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>335</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and
      amortization</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>165</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncash intangible asset
      impairment charges</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>9</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Deduct:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>5</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Consolidated EBITDA</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,240</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>Total debt</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>2,320</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Consolidated Leverage ratio</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>1.87</FONT></B></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The Company was in compliance
with all restrictive covenants and limitations in the credit agreement as of
June 30, 2016, and anticipates being in compliance with all restrictive
covenants for the foreseeable future. The Company continues to monitor the
financial markets and assess its ability to fully draw on its revolving credit
agreement, and currently expects that any drawing on the agreement will be fully
funded. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Of the $28 of foreign and
other credit lines as of June 30, 2016, $5 was outstanding and the remainder of
$23 was available for borrowing. Of the $29 of foreign and other credit lines as
of June 30, 2015, $4 was outstanding and the remainder of $25 was available for
borrowing.</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Short-term Borrowings
</FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s notes and loans
payable include U.S. commercial paper issued by the parent company and a
short-term loan held by a non-U.S. subsidiary. These short-term borrowings have
stated maturities less than one year and provide supplemental funding for
supporting operations. The level of U.S. commercial paper borrowings generally
fluctuate depending upon the amount and timing of operating cash flows and
payments for items such as dividends, income taxes, share repurchases and
pension contributions. The average balance of U.S. commercial paper borrowings
outstanding was $371 and $104 for the fiscal year ended June 30, 2016 and 2015,
respectively. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Long-term Borrowings
</FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>In November 2015, $300 of the
Company&#146;s senior notes with an annual fixed interest rate of 3.55% became due
and were repaid using commercial paper borrowings and cash on hand. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In January 2015, $575 of the
Company&#146;s senior notes with an annual fixed interest rate of 5.00% became due
and were repaid using the net proceeds from the December 2014 debt issuance and
commercial paper borrowings. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In December 2014, under a
shelf registration statement filed with the SEC that will expire in December
2017, the Company issued $500 of senior notes with an annual fixed interest rate
of 3.50%. Interest on the notes is payable semi-annually in June and December
and the notes have a maturity date of December 15, 2024. The notes carry an
effective interest rate of 4.10%, which includes the impact from the settlement
of interest rate forward contracts in December 2014 (see Notes to Consolidated
Financial Statements). The notes rank equally with all of the Company&#146;s existing
senior indebtedness. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>13</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>Based on the Company&#146;s working
capital requirements, anticipated ability to generate positive cash flows from
operations in the future, investment-grade credit ratings, demonstrated access
to long- and short-term credit markets and current borrowing availability under
credit agreements, the Company believes it will have the funds necessary to meet
its financing requirements and other fixed obligations as they become due. The
Company may consider other transactions which may require the issuance of
additional long- and/or short-term debt or other securities to finance
acquisitions, repurchase shares, refinance debt or fund other activities for
general business purposes. Such transactions could require funds in excess of
the Company&#146;s current cash levels and available credit lines, and the Company&#146;s
access to or cost of such additional funds could be adversely affected by any
decrease in credit ratings, which were the following as of June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=3><STRONG><FONT face="Times New Roman" size=1>2016</FONT></STRONG></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=3><STRONG><FONT face="Times New Roman" size=1>2015</FONT></STRONG></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%"><B><FONT face="Times New Roman" size=1>Short-term</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%"><B><FONT face="Times New Roman" size=1>Long-term</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%"><FONT face="Times New Roman" size=1>Short-term</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%"><FONT face="Times New Roman" size=1>Long-term</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Standard and Poor&#146;s</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>A-2</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>BBB+</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>A-2</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>BBB+</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"><FONT face="Times New Roman" size=2>Moody&#146;s</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><B><FONT face="Times New Roman" size=2>P-2</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;</TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><B><FONT face="Times New Roman" size=2>Baal</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>P-2</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>Baa1</FONT></TD></TR></TABLE><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Share Repurchases and
Dividend Payments</FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company has two share
repurchase programs: an open-market purchase program with an authorized
aggregate purchase amount of up to $750, all of which was available for share
repurchases as of both June 30, 2016 and 2015, and a program to offset the
anticipated impact of share dilution related to share-based awards (the
Evergreen Program), which has no authorization limit as to amount or timing of
repurchases. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Share repurchases under
authorized programs were as follows during the fiscal years ended June 30:
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="73%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="8%" colSpan=4><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="8%" colSpan=4><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="8%" colSpan=4><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 73%; PADDING-TOP: 2pt; TEXT-ALIGN: left" noWrap width="73%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%"><B><FONT face="Times New Roman" size=1>Shares<BR>(000)</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%"><B><FONT face="Times New Roman" size=1>Shares<BR>(000)</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%"><B><FONT face="Times New Roman" size=1>Shares<BR>(000)</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Open-market purchase programs</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%"><FONT face="Times New Roman" size=2>Evergreen Program</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>254</FONT></TD>
    <TD noWrap align=right width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2,151</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>434</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>4,016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>260</FONT></TD>
    <TD noWrap align=right width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3,046</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;254</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,151</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;434</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,016</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;260</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3,046</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Dividends per share and total
dividends amount paid were as follows during the fiscal years ended June 30:
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Dividends per share declared</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.11</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.99</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.87</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Total dividends paid</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>398</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>385</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>368</FONT></TD></TR></TABLE><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Contractual
Obligations</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company had contractual
obligations as of June 30, 2016, payable or maturing in the following fiscal
years: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="73%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><FONT size=+0><B><FONT face="Times New Roman" size=1>2017</FONT></B></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><FONT size=+0><B><FONT face="Times New Roman" size=1>2018</FONT></B></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><FONT size=+0><B><FONT face="Times New Roman" size=1>2019</FONT></B></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><FONT size=+0><B><FONT face="Times New Roman" size=1>2020</FONT></B></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><FONT size=+0><B><FONT face="Times New Roman" size=1>2021</FONT></B></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><FONT size=+0><B><FONT face="Times New Roman" size=1>Thereafter</FONT></B></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><STRONG><FONT face="Times New Roman" size=1>Total</FONT></STRONG></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Long-term debt maturities including
      interest</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;payments</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>72</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>460</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>48</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>47</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>47</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,495</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,169</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%"><FONT face="Times New Roman" size=2>Notes and loans payable</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>523</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%">&nbsp;</TD>
    <TD noWrap align=right width="1%">&nbsp;</TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%">&nbsp;</TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>523</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Purchase obligations </FONT><FONT face="Times New Roman" size=2><SUP>(1)</SUP></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>150</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>54</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>37</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>12</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>256</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%"><FONT face="Times New Roman" size=2>Capital leases</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%">&nbsp;</TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%">&nbsp;</TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>6</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Operating leases</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>49</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>45</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>38</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>29</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>135</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>328</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="74%" colSpan=2><FONT face="Times New Roman" size=2>Payments related to nonqualified postretirement plans </FONT><FONT face="Times New Roman" size=2><SUP>(2)</SUP></FONT></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>17</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>18</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>16</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>16</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>15</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>70</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>152</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Venture <FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">agreement</FONT> terminal obligation
      </FONT><FONT face="Times New Roman" size=2><SUP>(3)</SUP></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>448</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>448</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="73%"><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;814</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;579</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;140</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;107</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;93</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,149</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,882</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>14</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" noWrap><FONT face="Times New Roman" size=2>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="100%"><FONT face="Times New Roman" size=2>Purchase obligations are defined as purchase
      agreements that are enforceable and legally binding and that contain
      specified or determinable significant terms, including quantity, price and
      the approximate timing of the transaction. For purchase obligations
      subject to variable price and/or quantity provisions, an estimate of the
      price and/or quantity has been made. Examples of the Company&#146;s purchase
      obligations include contracts to purchase raw materials, commitments to
      contract manufacturers, commitments for information technology and related
      services, advertising contracts, capital expenditure agreements, software
      acquisition and license commitments and service contracts. The raw
      material contracts included above are entered into during the regular
      course of business based on expectations of future purchases. Many of
      these raw material contracts are flexible to allow for changes in the
      Company&#146;s business and related requirements. If such changes were to
      occur, the Company believes its exposure could differ from the amounts
      listed above. Any amounts reflected in the consolidated balance sheets as
      Accounts payable and accrued liabilities are excluded from the table
      above.</FONT></TD></TR>
  <TR>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" noWrap><FONT face="Times New Roman" size=2>(2)</FONT></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="100%"><FONT face="Times New Roman" size=2>This amount represents expected payments
      through 2026. Based on the accounting rules for retirement and
      postretirement benefit plans, the liabilities reflected in the Company&#146;s
      consolidated balance sheets differ from these expected future payments
      (see Notes to Consolidated Financial Statements).</FONT></TD></TR>
  <TR>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" noWrap><FONT face="Times New Roman" size=2>(3)</FONT></TD>
    <TD style="VERTICAL-ALIGN: top; TEXT-ALIGN: left" width="100%"><FONT face="Times New Roman" size=2>The Company has a venture agreement with The
      Procter &amp; Gamble Company (P&amp;G) for the Company&#146;s Glad<SUP>&#174;
      </SUP>bags, wraps and containers business. As of June 30, 2016 and 2015,
      P&amp;G had a 20% interest in the venture. The agreement with P&amp;G will
      expire in January 2023, unless the parties decide on or prior to January
      2018, to extend the term of the agreement for another 10 years. Upon
      termination of the agreement, the Company is required to purchase
      P&amp;G&#146;s interest for cash at fair value as established by predetermined
      valuation procedures. As of June 30, 2016, the estimated fair value of
      P&amp;G&#146;s interest was $448, of which $302 has been recognized and is
      reflected in Other liabilities in the Company&#146;s June 30, 2016 Consolidated
      Balance Sheet. The difference between the estimated fair value and the
      amount recognized, and any future changes in the fair value of P&amp;G&#146;s
      interest, is charged to Cost of products sold on a straight-line basis
      over the remaining life of the agreement. The estimated fair value of
      P&amp;G&#146;s interest increased significantly in 2016 and may increase or
      decrease up until any such purchase by the Company of P&amp;G&#146;s interest.
      These changes will affect the amount of future charges to Cost of products
      sold. Refer to Notes to Consolidated Financial Statements for further
      details.</FONT></TD></TR></TABLE>
<P align=left><B><I><FONT face="Times New Roman" size=2>Off-Balance Sheet
Arrangements</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In conjunction with
divestitures and other transactions, the Company may provide typical
indemnifications (e.g., indemnifications for representations and warranties and
retention of previously existing environmental, tax and employee liabilities)
that have terms that vary in duration and in the potential amount of the total
obligation and, in many circumstances, are not explicitly defined. The Company
has not made, nor does it believe that it is probable that it will make, any
payments relating to its indemnifications, and believes that any reasonably
possible payments would not have a material adverse effect, individually or in
the aggregate, on the Company&#146;s consolidated financial statements taken as a
whole. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company had not recorded
any liabilities on the aforementioned indemnifications as of June 30, 2016 and
2015. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016 and 2015,
the Company was a party to letters of credit of $10 and $11, respectively, both
primarily related to one of its insurance carriers, of which $0 had been drawn
upon. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>CONTINGENCIES</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>A summary of contingencies is
contained in Note 12 of Notes to Consolidated Financial
Statements.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>QUANTITATIVE AND
QUALITATIVE DISCLOSURES ABOUT MARKET RISK</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As a multinational company,
the Company is exposed to the impact of foreign currency fluctuations, changes
in commodity prices, interest-rate risk and other types of market risk.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In the normal course of
business, where available at a reasonable cost, the Company manages its exposure
to market risk using contractual agreements and a variety of derivative
instruments. The Company&#146;s objective in managing its exposure to market risk is
to limit the impact of fluctuations on earnings and cash flow through the use of
swaps, forward purchases and futures contracts. Derivative contracts are entered
into for non-trading purposes with major credit-worthy institutions, thereby
decreasing the risk of credit loss. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>15</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>The Company uses different
methodologies, when necessary, to estimate the fair value of its derivative
contracts. The estimated fair values of the majority of the Company&#146;s contracts
are based on quoted market prices, traded exchange market prices or broker price
quotations, and represent the estimated amounts that the Company would pay or
receive to terminate the contracts.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Sensitivity Analysis for
Derivative Contracts</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>For fiscal years 2016 and
2015, the Company&#146;s exposure to market risk was estimated using sensitivity
analyses, which illustrate the change in the fair value of a derivative
financial instrument assuming hypothetical changes in foreign exchange rates,
commodity prices or interest rates. The results of the sensitivity analyses for
foreign currency derivative contracts, commodity derivative contracts and
interest rate contracts are summarized below. Actual changes in foreign exchange
rates, commodity prices or interest rates may differ from the hypothetical
changes, and any changes in the fair value of the contracts, real or
hypothetical, would be partly to fully offset by an inverse change in the value
of the underlying hedged items. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The changes in the fair value
of derivatives are recorded as either assets or liabilities in the consolidated
balance sheets with an offset to net earnings or Other comprehensive income
(loss), depending on whether or not, for accounting purposes, the derivative is
designated and qualified as a cash flow hedge. During the fiscal years ended
June 30, 2016, 2015 and 2014, the Company had no hedging instruments designated
as fair value hedges. In the event the Company has contracts not designated as
hedges for accounting purposes, the Company recognizes the changes in the fair
value of these contracts in the consolidated statement of earnings.</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Foreign Currency
Risk</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company seeks to minimize
the impact of certain foreign currency fluctuations by hedging transactional
exposures with foreign currency forward contracts. Based on a hypothetical
decrease of 10% in the value of the U.S. dollar as of June 30, 2016 and June 30,
2015, the estimated fair value of the Company&#146;s then-existing foreign currency
derivative contracts would decrease by $9 and $12, respectively, with the
corresponding impact included in Accumulated other comprehensive income (loss).
Based on a hypothetical increase of 10% in the value of the U.S. dollar as of
June 30, 2016 and June 30, 2015, the estimated fair value of the Company&#146;s
then-existing foreign currency derivative contracts would increase by $7 and
$10, respectively, with the corresponding impact included in Accumulated other
comprehensive income (loss).</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Commodity Price
Risk</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is exposed to
changes in the price of commodities used as raw materials in the manufacturing
of its products. The Company uses various strategies to manage cost exposures on
certain raw material purchases with the objective of obtaining more predictable
costs for these commodities, including long-term commodity purchase contracts
and commodity derivative contracts, where available at a reasonable cost. During
fiscal years 2016 and 2015, the Company&#146;s raw materials exposures pertaining to
derivative contracts existed with jet fuel and soybean oil. Based on a
hypothetical decrease or increase of 10% in these commodity prices as of June
30, 2016, and June 30, 2015, the estimated fair value of the Company&#146;s
then-existing commodity derivative contracts would decrease or increase by $3
and $4, respectively, with the corresponding impact included in Accumulated
other comprehensive income (loss). </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Interest Rate
Risk</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is exposed to
interest rate volatility with regard to existing short-term borrowings,
primarily commercial paper, and anticipated future issuances of long-term debt.
Weighted average interest rates for commercial paper borrowings have been less
than 1% during fiscal years 2016 and 2015. Assuming average variable rate debt
levels during fiscal years 2016 and 2015, a 100 basis point increase in interest
rates would increase interest expense from commercial paper by approximately $4
and $1, respectively. Assuming average variable rate debt levels in fiscal years
2016 and 2015, a decrease in interest rates to zero percent would decrease
interest expense from commercial paper by $3 and $1, respectively. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is also exposed to
interest rate volatility with regard to anticipated future issuances of debt.
Primary exposures include movements in U.S. Treasury rates. The Company used
interest rate forward contracts to reduce interest rate volatility on fixed rate
long-term debt during fiscal year 2015, but had no interest rate forward
contract positions during fiscal year 2016, and no outstanding contracts as of
June 30, 2016.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>16</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>RECENTLY ISSUED ACCOUNTING
STANDARDS</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company plans to adopt
Accounting Standards Update (ASU) No. 2016-09, &#147;Compensation-Stock Compensation
(Topic 718): Improvements to Employee Share-Based Payment Accounting,&#148; in the
first quarter of fiscal year 2017. While the actual benefit realized may vary
significantly given the inherent uncertainty in predicting future share-based
transactions, the Company currently estimates that the adoption will result in
approximately a 4 percentage point benefit to the Company&#146;s historical effective
tax rate of 34% to 35% for fiscal year 2017. A summary of all recently issued
accounting standards, including ASU 2016-09, is contained in Note 1 of Notes to
Consolidated Financial Statements.</FONT><B><FONT face="Times New Roman" size=2>
</FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>CRITICAL ACCOUNTING
POLICIES AND ESTIMATES</FONT></B><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The methods, estimates, and
judgments the Company uses in applying its most critical accounting policies
have a significant impact on the results the Company reports in its consolidated
financial statements. Specific areas requiring the application of management&#146;s
estimates and judgment include, among others, assumptions pertaining to accruals
for consumer and trade-promotion programs, stock-based compensation costs,
pension and post-employment benefit costs, future cash flows associated with
impairment testing of goodwill and other long-lived assets, credit worthiness of
customers, uncertain tax positions, tax valuation allowances and legal,
environmental and insurance matters. Accordingly, a different financial
presentation could result depending on the judgments, estimates or assumptions
that are used. The most critical accounting policies and estimates are those
that are most important to the portrayal of the Company&#146;s financial condition
and results, and require the Company to make the most difficult and subjective
judgments, often estimating the outcome of future events that are inherently
uncertain. The Company&#146;s most critical accounting policies and estimates are
related to: revenue recognition; valuation of goodwill and intangible assets;
employee benefits, including estimates related to stock-based compensation and
retirement income plans; and income taxes. The Company&#146;s critical accounting
policies and estimates have been reviewed with the Audit Committee of the Board
of Directors. A summary of the Company&#146;s significant accounting policies and
estimates is contained in Note 1 of Notes to Consolidated Financial
Statements.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Revenue
Recognition</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Sales are recognized as
revenue when the risk of loss and title pass to the customer and when all of the
following have occurred: a firm sales arrangement exists, pricing is fixed or
determinable and collection is reasonably assured. Sales are recorded net of
allowances for trade promotions, coupons, returns and other discounts. The
Company routinely commits to one-time or ongoing trade-promotion programs with
customers. Programs include shelf-price reductions, end-of-aisle or in-store
displays of the Company&#146;s products and graphics and other trade-promotion
activities conducted by the customer. Costs related to these programs are
recorded as a reduction of sales. The Company&#146;s trade promotion accruals are
primarily based on estimated volume and incorporate historical sales and
spending trends by customer and category. The determination of these estimated
accruals requires judgment and may change in the future as a result of changes
in customer promotion participation, particularly for new programs and for
programs related to the introduction of new products. Final determination of the
total cost of a promotion is dependent upon customers providing information
about proof of performance and other information related to the promotional
event. This process of analyzing and settling trade-promotion programs with
customers could impact the Company&#146;s results of operations and trade promotion
accruals depending on how actual results of the programs compare to original
estimates. If the Company&#146;s trade promotion accrual estimates as of June 30,
2016 were to differ by 10%, the impact on net sales would be approximately $11.
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Goodwill and Other
Intangible Assets</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company tests its goodwill
and other indefinite-lived intangible assets for impairment annually in the
fiscal fourth quarter unless there are indications during a different interim
period that these assets may have become impaired. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Goodwill
</FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>Consistent with fiscal year
2015, the Company&#146;s reporting units for goodwill impairment testing purposes are
its domestic Strategic Business Units (SBUs), Canada, Latin America and AMEA
(Asia, Middle East, Europe and Australia, New Zealand, and South Africa). These
reporting units are components of the Company&#146;s business that are either
operating segments or one level below an operating segment and for which
discrete financial information is available that is reviewed by the managers of
the respective operating segments. No instances of impairment were identified
during the fiscal year 2016 annual impairment review. All of the Company&#146;s
reporting units had fair values that exceeded recorded values. However, future
changes in the judgments, assumptions and estimates that are used in the
impairment testing for goodwill and indefinite-lived intangible assets as
described below could result in significantly different estimates of the fair
values.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>17</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>In its evaluation of goodwill
impairment, the Company has the option to first assess qualitative factors such
as maturity and stability of the reporting unit, magnitude of excess fair value
over carrying value from the prior year&#146;s impairment testing, other reporting
unit operating results as well as new events and circumstances impacting the
operations at the reporting unit level. If the result of a qualitative test
indicates a potential for impairment, a quantitative test is performed. The
quantitative test is a two-step process. In the first step, the Company compares
the estimated fair value of each reporting unit to its carrying value. In all
instances, the estimated fair value exceeded the carrying value of the reporting
unit. Had the estimated fair value of any reporting unit been less than its
carrying value, the Company would have performed a second step to determine the
implied fair value of the reporting unit&#146;s goodwill. If the carrying amount of a
reporting unit&#146;s goodwill had exceeded its implied fair value, an impairment
charge would have been recorded for the difference between the carrying amount
and the implied fair value of the reporting unit&#146;s goodwill. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>To determine the fair value of
a reporting unit as part of its quantitative test, the Company uses a discounted
cash flow (DCF) approach, as it believes that this approach is the most reliable
indicator of the fair value of its businesses and the fair value of their future
earnings and cash flows. Under this approach, the Company estimates the future
cash flows of each reporting unit and discounts these cash flows at a rate of
return that reflects their relative risk. The cash flows used in the DCF are
consistent with those the Company uses in its internal planning, which gives
consideration to actual business trends experienced, and the broader business
strategy for the long term. The other key estimates and factors used in the DCF
include, but are not limited to, future sales volumes, revenue and expense
growth rates, changes in working capital, foreign exchange rates, currency
devaluation, inflation and a perpetuity growth rate. Changes in such estimates
or the application of alternative assumptions could produce different results.
</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Trademarks and Other
Indefinite-Lived Intangible Assets </FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>For trademarks and other
intangible assets with indefinite lives, the Company performs a quantitative
analysis to test for impairment. When a quantitative test is performed, the
estimated fair value of an asset is compared to its carrying amount. If the
carrying amount of such asset exceeds its estimated fair value, an impairment
charge is recorded for the difference between the carrying amount and the
estimated fair value. The Company uses the income approach to estimate the fair
value of its trademarks and other intangible assets with indefinite lives. This
approach requires significant judgments in determining both the assets&#146;
estimated cash flows as well as the appropriate discount and foreign exchange
rates applied to those cash flows to determine fair value. Changes in such
estimates or the use of alternative assumptions could produce different
results.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>During fiscal year 2016, the
Company recognized $9 of intangible asset impairment charges, of which $6
related to the Aplicare<SUP>&#174;</SUP> trademark within the Cleaning segment. The
Aplicare<SUP>&#174;</SUP> trademark impairment was recognized based on the
anticipated impact on future results from a competitive market entrant. No
instances of impairment were identified as a result of the Company&#146;s fourth
quarter annual impairment review.</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Finite-Lived Intangible
Assets </FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>Finite-lived intangible assets
are reviewed for possible impairment whenever events or changes in circumstances
occur that indicate that the carrying amount of an asset (or asset group) may
not be recoverable. The Company&#146;s impairment review requires significant
management judgment, including estimating the future success of product lines,
future sales volumes, revenue and expense growth rates, alternative uses for the
assets and estimated proceeds from the disposal of the assets. The Company
reviews business plans for possible impairment indicators. Impairment occurs
when the carrying amount of the asset (or asset group) exceeds its estimated
future undiscounted cash flows and the impairment is viewed as other than
temporary. When impairment is indicated, an impairment charge is recorded for
the difference between the asset&#146;s carrying value and its estimated fair value.
Depending on the asset, estimated fair value may be determined either by use of
a DCF model or by reference to estimated selling values of assets in similar
condition. The use of different assumptions would increase or decrease the
estimated fair value of assets and would increase or decrease any impairment
measurement.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Employee
Benefits</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s critical
accounting policies and estimates in this area relate to its stock-based
compensation and retirement income programs. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>18</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Stock-based
Compensation</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company grants various
nonqualified stock-based compensation awards to eligible employees, including
stock options, performance units and restricted stock. The stock-based
compensation expense and related income tax benefit recognized in the
consolidated statement of earnings in fiscal year 2016 were $45 and $17,
respectively. As of June 30, 2016, there was $53 of unrecognized compensation
costs related to non-vested stock options, restricted stock and performance unit
awards, which are expected to be recognized over a weighted average remaining
vesting period of one year. The Company estimates the fair value of each stock
option award on the date of grant using the Black-Scholes valuation model, which
requires management to make estimates regarding expected option life, stock
price volatility and other assumptions. Groups of employees that have similar
historical exercise behavior are considered separately for valuation purposes.
The total number of stock options expected to vest is adjusted by actual and
estimated forfeitures. Changes to the actual and estimated forfeitures will
result in a cumulative catch-up adjustment in the period of change. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The use of different
assumptions in the Black-Scholes valuation model could lead to a different
estimate of the fair value of each stock option. The expected volatility is
based on implied volatility from publicly traded options on the Company&#146;s stock
at the date of grant, historical implied volatility of the Company&#146;s publicly
traded options and other factors. If the Company&#146;s assumption for the volatility
rate is increased by one percentage point, the fair value of options granted in
fiscal year 2016 would have increased by $1. The expected life of the stock
options is based on observed historical exercise patterns. If the Company&#146;s
assumption for the expected life is increased by one year, the fair value of
options granted in fiscal year 2016 would have increased by less than $1.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s performance unit
grants provide for the issuance of common stock to certain managerial staff and
executive management if the Company achieves specified performance targets. The
performance period is three years and the payout determination is made at the
end of the three-year performance period. The fair value of each grant issued is
estimated on the date of grant based on the current market price of the stock.
The total amount of compensation expense recognized reflects estimated
forfeiture rates and the initial assumption that performance goals will be
achieved. Compensation expense is adjusted based on management&#146;s assessment of
the probability that performance goals will be achieved. If such goals are not
met or it is determined that achievement of performance goals is not probable,
previously recognized compensation expense is trued up in the current period to
reflect the expected payout level. Actual results could materially differ from
previous estimates. If it is determined that the performance goals will be
exceeded, additional compensation expense is recognized, subject to a cap of
150% of target.</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Retirement Income
Plans</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The determination of net
periodic pension cost is based on actuarial assumptions including a discount
rate to reflect the time value of money, the long-term rate of return on plan
assets, employee compensation rates and demographic assumptions to determine the
probability and timing of benefit payments. The selection of assumptions is
based on historical trends and known economic and market conditions at the time
of valuation. The expected long-term rate of return assumption is based on an
analysis of historical experience of the portfolio and the summation of
prospective returns for each asset class in proportion to the fund&#146;s current
asset allocation. The actual net periodic pension cost could differ from the
expected results because actuarial assumptions and estimates are used. In the
calculation of pension expense related to domestic plans for 2016, the Company
used a beginning-of-year discount rate assumption of 4.2% and a long-term rate
of return on plan assets assumption of 4.3%. The use of a different discount
rate or long-term rate of return on domestic plan assets can significantly
impact pension expense. For example, as of June 30, 2016, a decrease of 100
basis points in the discount rate would increase the domestic retirement income
plans&#146; pension liability by approximately $63, and decrease fiscal year 2016
domestic retirement income plans&#146; pension expense by $2. A 100 basis point
decrease in the long-term rate of return on plan assets would increase fiscal
year 2016 domestic retirement income plans&#146; pension expense by $4. At the end of
fiscal year 2016, the long-term rate of return is assumed to be 4.7% for the
domestic plan assets. This change is a result of the change in the plan&#146;s target
investment allocation. The Company also has defined benefit pension plans for
eligible international employees, including Canadian employees, and different
assumptions are used in the determination of pension expense for those plans, as
appropriate. See Notes to Consolidated Financial Statements for further
discussion of pension and other retirement plan obligations.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Income
Taxes</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s effective tax
rate is based on income by tax jurisdiction, statutory tax rates and tax
planning opportunities available to the Company in the various jurisdictions in
which the Company operates. Significant judgment is required in determining the
Company&#146;s effective tax rate and in evaluating its tax positions.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>19</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>The Company maintains
valuation allowances when it is likely that all or a portion of a deferred tax
asset will not be realized. Changes in valuation allowances from period to
period are included in the Company&#146;s income tax provision in the period of
change. In determining whether a valuation allowance is warranted, the Company
takes into account such factors as prior earnings history, expected future
earnings, unsettled circumstances that, if unfavorably resolved, would adversely
affect the utilization of a deferred tax asset, statutory carry-back and
carry-forward periods and tax strategies that could potentially enhance the
likelihood of realization of a deferred tax asset. Valuation allowances
maintained by the Company relate mostly to deferred tax assets arising from the
Company&#146;s currently anticipated inability to use net operating losses in certain
foreign countries. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In addition to valuation
allowances, the Company provides for uncertain tax positions when such tax
positions do not meet certain recognition thresholds or measurement standards.
Amounts for uncertain tax positions are adjusted in quarters when new
information becomes available or when positions are effectively settled.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016, the
liability recorded for uncertain tax positions, excluding associated interest
and penalties, was approximately $37. Since audit outcomes and the timing of
audit settlements are subject to significant uncertainty, liabilities for
uncertain tax positions are excluded from the contractual obligations table (see
Notes to Consolidated Financial Statements).</FONT><B><I><FONT face="Times New Roman" size=2> </FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>United States income taxes and
foreign withholding taxes are not provided when foreign earnings are
indefinitely reinvested. The Company determines whether its foreign subsidiaries
will invest their undistributed earnings indefinitely and reassesses this
determination on a periodic basis. A change to the Company&#146;s determination may
be warranted based on the Company&#146;s experience as well as plans regarding future
international operations and expected remittances. Changes in the Company&#146;s
determination would likely require an adjustment to the income tax provision in
the quarter in which the determination is made. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>SUMMARY OF NON-GAAP
FINANCIAL MEASURES </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The non-GAAP financial
measures included in this MD&amp;A and Exhibit 99.3 and the reasons management
believes they are useful to investors are described below. These measures should
be considered supplemental in nature and are not intended to be a substitute for
the related financial information prepared in accordance with U.S. GAAP. In
addition, these measures may not be the same as similarly named measures
presented by other companies. </FONT></P>
<P align=left><I><FONT face="Times New Roman" size=2>Free cash flow
</FONT></I><FONT face="Times New Roman" size=2>is calculated as net cash
provided by continuing operations less capital expenditures related to
continuing operations. The Company&#146;s management uses this measure and
</FONT><I><FONT face="Times New Roman" size=2>free cash flow as a percentage of
net sales</FONT></I><FONT face="Times New Roman" size=2> to help assess the cash
generation ability of the business and funds available for investing activities,
such as acquisitions, investing in the business to drive growth and financing
activities, including debt payments, dividend payments and share repurchases.
Free cash flow does not represent cash available only for discretionary
expenditures, since the Company has mandatory debt service requirements and
other contractual and non-discretionary expenditures. Refer to &#147;Free cash flow&#148;
and &#147;Free cash flow as a percentage of net sales&#148; above for a reconciliation of
these non-GAAP measures. </FONT></P>
<P align=left><I><FONT face="Times New Roman" size=2>EBIT </FONT></I><FONT face="Times New Roman" size=2>represents earnings from continuing operations
before income taxes, interest income and interest expense. </FONT><I><FONT face="Times New Roman" size=2>EBIT margin</FONT></I><FONT face="Times New Roman" size=2> is the ratio of EBIT to net sales. The company's management believes
these measures provide useful additional information to investors about trends
in the company's operations and are useful for period-over-period comparisons.
</FONT></P>
<P align=left><I><FONT face="Times New Roman" size=2>Currency-neutral net sales
growth</FONT></I><FONT face="Times New Roman" size=2> represents U.S. GAAP net
sales growth excluding the impact of the change in foreign currency exchange
rates. The Company&#146;s management believes these measures provide useful
additional information to investors about changes in the Company&#146;s core business
operations without the unpredictability and volatility of currency fluctuations.
The following table presents the </FONT><I><FONT face="Times New Roman" size=2>currency-neutral net sales growth </FONT></I><FONT face="Times New Roman" size=2>reconciliation for fiscal year 2016: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net sales growth &#150; GAAP</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>Less: foreign exchange impact</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Currency-neutral net sales growth &#150;
      non-GAAP</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>20</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><I><FONT face="Times New Roman" size=2>Economic profit
(EP)</FONT></I><FONT face="Times New Roman" size=2> is defined by the Company as
earnings from continuing operations before income taxes, excluding noncash U.S.
GAAP restructuring and intangible asset impairment costs, and interest expense;
less an amount of tax based on the effective tax rate and less a charge equal to
average capital employed multiplied by a cost of capital rate. EP is a key
financial metric the Company&#146;s management uses to evaluate business performance
and allocate resources, and is a component in determining employee incentive
compensation. The Company&#146;s management believes EP provides additional
perspective to investors about financial returns generated by the business and
represents profit generated over and above the cost of capital used by the
business to generate that profit. Refer to Exhibit 99.3 for a reconciliation of
EP to earnings from continuing operations before income taxes. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>CAUTIONARY
STATEMENT</FONT></B><FONT face="Times New Roman" size=4> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>This Annual Report on Form
10-K (this Report), including the exhibits hereto and the information
incorporated by reference herein, contains &#147;forward-looking statements&#148; within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, and such
forward-looking statements involve risks and uncertainties. Except for
historical information, statements about future volume, sales, foreign
currencies, costs, cost savings, margin, earnings, earnings per share, diluted
earnings per share, foreign currency exchange rates, cash flows, plans,
objectives, expectations, growth or profitability, are forward-looking
statements based on management&#146;s estimates, assumptions and projections. Words
such as &#147;could,&#148; &#147;may,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;targets,&#148; &#147;goals,&#148;
&#147;projects,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;seeks,&#148; &#147;estimates,&#148; &#147;predicts&#148; and
variations on such words, and similar expressions that reflect our current views
with respect to future events and operational and financial performance, are
intended to identify such forward-looking statements. These forward-looking
statements are only predictions, subject to risks and uncertainties, and actual
results could differ materially from those discussed. Important factors that
could affect performance and cause results to differ materially from
management&#146;s expectations are described in the sections entitled &#147;Risk Factors&#148;
and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations&#148; in this Report, as updated from time to time in the Company&#146;s
Securities and Exchange Commission filings. These factors include, but are not
limited to:</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>intense competition in
      the Company&#146;s markets;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>worldwide, regional and
      local economic conditions and financial market
volatility;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the ability of the
      Company to drive sales growth, increase price and market share, grow its
      product categories and achieve favorable product and geographic
      mix;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>volatility and increases
      in commodity costs such as resin, sodium hypochlorite and agricultural
      commodities, and increases in energy, transportation or other
      costs;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>dependence on key
      customers and risks related to customer consolidation and ordering
      patterns;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>risks related to
      reliance on information technology systems, including potential security
      breaches, cyber-attacks, privacy breaches or data breaches that result in
      the unauthorized disclosure of consumer, customer, employee or Company
      information, or service interruptions;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>costs resulting from
      government regulations;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the ability of the
      Company to successfully manage global political, legal, tax and regulatory
      risks, including changes in regulatory or administrative
      activity;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>risks related to
      international operations, including political instability;
      government-imposed price controls or other regulations; foreign currency
      exchange rate controls, including periodic changes in such controls,
      fluctuations and devaluations; labor claims, labor unrest and inflationary
      pressures, particularly in Argentina; and potential harm and liabilities
      from the use, storage and transportation of chlorine in certain
      international markets where chlorine is used in the production of bleach;
      and the possibility of nationalization, expropriation of assets or other
      government action;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>risks relating to
      acquisitions, new ventures and divestitures, and associated costs,
      including the potential for asset impairment charges related to, among
      others, intangible assets and goodwill;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the ability of the
      Company to develop and introduce commercially successful
      products;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>supply disruptions and
      other risks inherent in reliance on a limited base of
    suppliers;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the impact of product
      liability claims, labor claims and other legal proceedings, including in
      foreign jurisdictions</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the success of the
      Company&#146;s business strategies;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the ability of the
      Company to implement and generate anticipated cost savings and
      efficiencies;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the Company&#146;s ability to
      attract and retain key personnel;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the Company&#146;s ability to
      maintain its business reputation and the reputation of its
      brands;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>environmental matters,
      including costs associated with the remediation of past contamination and
      the handling and/or transportation of hazardous
  substances;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the impact of natural
      disasters, terrorism and other events beyond the Company&#146;s
      control;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the Company&#146;s ability to
      maximize, assert and defend its intellectual property
  rights;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>any infringement or
      claimed infringement by the Company of third-party intellectual property
      rights;</FONT></P></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>21</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>risks related to the
      potential increase in the Company&#146;s purchase price for P&amp;G&#146;s interest
      in the Glad<SUP>&#174;</SUP> business and the impact from the decision on
      whether or not to extend the term of the related agreement with
      P&amp;G;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the effect of the
      Company&#146;s indebtedness and credit rating on its business operations and
      financial results;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>risks related to the
      Company&#146;s discontinuation of operations in Venezuela;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the Company&#146;s ability to
      pay and declare dividends or repurchase its stock in the
    future;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the Company&#146;s ability to
      maintain an effective system of internal controls, including after
      completing acquisitions;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>uncertainties relating
      to tax positions, tax disputes and changes in the Company&#146;s tax
      rate;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the accuracy of the
      Company&#146;s estimates and assumptions on which its earnings guidance is
      based; and</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the impacts of potential
      stockholder activism.</FONT></P></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s forward-looking
statements in this Report are based on management&#146;s current views and
assumptions regarding future events and speak only as of their dates. The
Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise, except as required by the federal securities
laws.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>22</FONT></P>
<HR align=center width="100%" noShade SIZE=2>
<!--PART 3-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>MANAGEMENT&#146;S REPORT ON
INTERNAL CONTROL OVER FINANCIAL REPORTING </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s management is
responsible for establishing and maintaining adequate internal control over
financial reporting. The Company&#146;s internal control over financial reporting is
a process designed under the supervision of its Chief Executive Officer and
Chief Financial Officer to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of the Company&#146;s
financial statements for external reporting in accordance with accounting
principles generally accepted in the United States of America. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Because of its inherent
limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become inadequate because of
changes in conditions or that the degree of compliance with the policies or
procedures may deteriorate.</FONT><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Management evaluated the
effectiveness of the Company&#146;s internal control over financial reporting using
the criteria set forth by the Committee of Sponsoring Organizations of the
Treadway Commission (COSO) in</FONT><I><FONT face="Times New Roman" size=2>
Internal Control-Integrated Framework</FONT></I><FONT face="Times New Roman" size=2> published in 2013. Management, under the supervision and with the
participation of the Company&#146;s Chief Executive Officer and Chief Financial
Officer, assessed the effectiveness of the Company&#146;s internal control over
financial reporting at June 30, 2015, and concluded that it is effective.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Management has excluded Renew
Life from its assessment of internal control over financial reporting as of June
30, 2016 because Renew Life was acquired by the Company on May 2, 2016. The
acquired business&#146; internal control over financial reporting and related
processes have not been integrated into the Company&#146;s existing systems and
internal control over financial reporting, and have been excluded from
management&#146;s assessment of the effectiveness of internal control over financial
reporting as of June 30, 2016. Renew Life, which is included in the June 30,
2016 consolidated financial statements, constitutes $344 and $284 of total and
net assets, respectively, as of June 30, 2016 and $21 and $(6) of <FONT STYLE="BACKGROUND-COLOR: Transparent">net sales</FONT> and
net <FONT STYLE="BACKGROUND-COLOR: Transparent">earnings</FONT>, respectively, for the year then ended.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s independent
registered public accounting firm, Ernst &amp; Young LLP, has audited the
effectiveness of the Company&#146;s internal control over financial reporting as of
June 30, 2016.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>23</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Board of Directors and
Stockholders of The Clorox Company </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>We have audited the
accompanying consolidated balance sheets of The Clorox Company as of June 30,
2016 and 2015, and the related consolidated statements of earnings,
comprehensive income, stockholders&#146; equity and cash flows for each of the three
years in the period ended June 30, 2016. Our audits also included the financial
statement schedule in Exhibit 99.2. These financial statements and schedule are
the responsibility of the Company&#146;s management. Our responsibility is to express
an opinion on these financial statements and schedule based on our audits.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>We conducted our audits in
accordance with the standards of the Public Company Accounting Oversight Board
(United States). Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our
opinion. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In our opinion, the financial
statements referred to above present fairly, in all material respects, the
consolidated financial position of The Clorox Company at June 30, 2016 and 2015,
and the consolidated results of its operations and its cash flows for each of
the three years in the period ended June 30, 2016, in conformity with U.S.
generally accepted accounting principles. Also, in our opinion, the related
financial statement schedule, when considered in relation to the basic financial
statements taken as a whole, presents fairly in all material respects the
information set forth therein. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>We also have audited, in
accordance with the standards of the Public Company Accounting Oversight Board
(United States), The Clorox Company&#146;s internal control over financial reporting
as of June 30, 2016, based on criteria established in Internal
Control-Integrated Framework issued by the Committee of Sponsoring Organizations
of the Treadway Commission (2013 framework) and our report dated August 16, 2016
expressed an unqualified opinion thereon. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>/s/ Ernst &amp; Young LLP
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>San Francisco, CA<BR>August
16, 2016 </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>24</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Board of Directors and
Stockholders of The Clorox Company </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>We have audited The Clorox
Company&#146;s internal control over financial reporting as of June 30, 2016, based
on criteria established in Internal Control - Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission (2013
framework) (the COSO criteria). The Clorox Company&#146;s management is responsible
for maintaining effective internal control over financial reporting, and for its
assessment of the effectiveness of internal control over financial reporting
included in the accompanying Management&#146;s Report on Internal Control Over
Financial Reporting. Our responsibility is to express an opinion on the
company&#146;s internal control over financial reporting based on our audit.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>We conducted our audit in
accordance with the standards of the Public Company Accounting Oversight Board
(United States). Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether effective internal control over
financial reporting was maintained in all material respects. Our audit included
obtaining an understanding of internal control over financial reporting,
assessing the risk that a material weakness exists, testing and evaluating the
design and operating effectiveness of internal control based on the assessed
risk, and performing such other procedures as we considered necessary in the
circumstances. We believe that our audit provides a reasonable basis for our
opinion. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>A company&#146;s internal control
over financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted
accounting principles. A company&#146;s internal control over financial reporting
includes those policies and procedures that (1) pertain to the maintenance of
records that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company; (2) provide
reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the company are
being made only in accordance with authorizations of management and directors of
the company; and (3) provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use, or disposition of the company&#146;s
assets that could have a material effect on the financial statements.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Because of its inherent
limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become inadequate because of
changes in conditions, or that the degree of compliance with the policies or
procedures may deteriorate. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As indicated in the
accompanying Management&#146;s Report on Internal Control Over Financial Reporting,
management&#146;s assessment of and conclusion on the effectiveness of internal
control over financial reporting did not include the internal controls of Renew
Life, which is included in the June 30, 2016 consolidated financial statements
of The Clorox Company and constituted $344 and $284 of total and net assets,
respectively, as of June 30, 2016 and $21 and $(6) of net sales and net
earnings, respectively, for the year then ended. Our audit of internal control
over financial reporting of The Clorox Company also did not include an
evaluation of the internal control over financial reporting of Renew Life.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In our opinion, The Clorox
Company maintained, in all material respects, effective internal control over
financial reporting as of June 30, 2016, based on the COSO criteria. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>We also have audited, in
accordance with the standards of the Public Company Accounting Oversight Board
(United States), the consolidated balance sheets as of June 30, 2016 and 2015,
and the related consolidated statements of earnings, comprehensive income,
stockholders&#146; equity, and cash flows for each of the three years in the period
ended June 30, 2016 of The Clorox Company and our report dated August 16, 2016
expressed an unqualified opinion thereon. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>/s/ Ernst &amp; Young LLP
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>San Francisco, CA<BR>August
16, 2016 </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>25</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>CONSOLIDATED STATEMENTS OF
EARNINGS</FONT></B><FONT face="Times New Roman" size=2> <BR></FONT><I><FONT face="Times New Roman" size=2>The Clorox Company </FONT></I></P>
<P align=left><B><FONT face="Times New Roman" size=1>Years ended June
30</FONT></B></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%"><B><FONT face="Times New Roman" size=1>Dollars in millions,
      except share and per share data</FONT></B></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD style="TEXT-ALIGN: center" noWrap width="86%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Net sales</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5,761</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5,655</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5,514</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>Cost of products sold</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3,163</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3,190</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3,158</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Gross profit</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,598</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,465</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,356</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=14>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>Selling and administrative expenses</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>806</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>798</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>751</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Advertising costs</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>587</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>523</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>503</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>Research and development costs</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>141</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>136</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>125</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Interest expense</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>88</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>100</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>103</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>Other (income) expense, net</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(7</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(10</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Earnings from continuing operations before
      income taxes</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>983</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>921</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>884</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>Income taxes on continuing operations</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>335</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>315</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>305</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Earnings from continuing
operations</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>648</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>606</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>579</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>Losses from discontinued operations, net of tax</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(26</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(21</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Net earnings</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>648</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>580</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>558</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=14>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>Net earnings (losses) per share</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing
      operations</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>5.01</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4.65</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4.47</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued
      operations</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(0.20</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(0.16</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic net earnings per
      share</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>5.01</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>4.45</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>4.31</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"></TD></TR>
  <TR>
    <TD width="100%" colSpan=14>&nbsp; </TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing
      operations</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4.92</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4.57</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4.39</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued
      operations</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(0.20</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(0.16</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted net earnings per
      share</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>4.92</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>4.37</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>4.23</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; TEXT-ALIGN: left" noWrap width="1%"></TD></TR>
  <TR>
    <TD width="100%" colSpan=14>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Weighted average shares outstanding (in
      thousands)</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic</FONT></TD>
    <TD noWrap align=left width="86%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>129,472</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>130,310</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>129,558</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted</FONT></TD>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>131,717</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>132,776</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>131,742</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>See Notes to Consolidated
Financial Statements </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>26</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME</FONT></B><FONT face="Times New Roman" size=2>
<BR></FONT><I><FONT face="Times New Roman" size=2>The Clorox Company
</FONT></I></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" colSpan=2><B><FONT face="Times New Roman" size=1>Years ended June 30</FONT></B> &nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD noWrap align=left width="88%" colSpan=2>&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><B><FONT face="Times New Roman" size=1>Dollars in
      millions</FONT></B></TD>
    <TD noWrap align=left width="87%">&nbsp;</TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Earnings from continuing
operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>648</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>606</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>579</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" colSpan=2><FONT face="Times New Roman" size=2>Losses from discontinued operations, net of tax</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(26</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(21</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Net earnings</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>648</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>580</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>558</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" colSpan=2><FONT face="Times New Roman" size=2>Other comprehensive (losses) income:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign
      currency adjustments, net of tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(53</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(54</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(37</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains (losses)
      on derivatives, net of tax</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>9</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(14</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(9</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension
      and postretirement benefit adjustments, net of tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(24</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(17</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" colSpan=2><FONT face="Times New Roman" size=2>Total other comprehensive (losses) income, net of tax</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(68</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(85</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(50</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Comprehensive income</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>580</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>495</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>508</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>See Notes to Consolidated
Financial Statements </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>27</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P style="MARGIN-BOTTOM: 8pt" align=left><B><FONT face="Times New Roman" size=2>CONSOLIDATED BALANCE SHEETS <BR></FONT></B><I><FONT face="Times New Roman" size=2>The Clorox Company </FONT></I></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><B><FONT face="Times New Roman" size=1>As of June 30</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR style="LINE-HEIGHT: 8pt">
    <TD noWrap align=left width="92%" colSpan=2>&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="29%"><B><FONT face="Times New Roman" size=1>Dollars in millions,
      except share and per share data</FONT></B></TD>
    <TD noWrap align=left width="63%">&nbsp;</TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><B><FONT face="Times New Roman" size=2>ASSETS</FONT></B> &nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>Current assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and
      cash equivalents</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>401</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>382</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables, net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>569</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>519</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>443</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>385</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>72</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>143</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
      current assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,485</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,429</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>Property, plant and equipment, net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>906</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>918</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Goodwill</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,197</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,067</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>Trademarks, net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>657</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>535</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Other intangible assets, net</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>78</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>50</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>Other assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>195</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>165</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Total assets</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,518</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,164</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR style="LINE-HEIGHT: 8pt">
    <TD align=left width="100%" bgColor=#c0c0c0 colSpan=10>&nbsp; </TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><B><FONT face="Times New Roman" size=2>LIABILITIES AND STOCKHOLDERS&#146;
      EQUITY</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Current liabilities</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes and loans
    payable</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>523</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>95</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current
      maturities of long-term debt</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>300</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued
      liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1,035</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>979</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income
      taxes payable</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>31</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt solid; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
      current liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1,558</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1,405</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Long-term debt</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,797</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,796</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>Other liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>784</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>750</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Deferred income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>82</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>95</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
      liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4,221</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4,046</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR style="LINE-HEIGHT: 4pt">
    <TD align=left width="100%" colSpan=10>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Commitments and contingencies</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR style="LINE-HEIGHT: 4pt">
    <TD align=left width="100%" bgColor=#c0c0c0 colSpan=10>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>Stockholders&#146; equity</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Preferred stock: $1.00 par value; 5,000,000
      shares authorized; none</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;issued
      or outstanding</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="1%" bgColor=#c0c0c0>-</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="1%" bgColor=#c0c0c0>-</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>Common stock: $1.00 par value; 750,000,000 shares authorized;
      158,741,461</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued as of June 30,
      2016 and 2015; and 129,355,263 and 128,614,310</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares outstanding as of June
      30, 2016 and 2015, respectively</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>159</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>159</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Additional paid-in capital</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>868</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>775</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>Retained earnings</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2,163</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1,923</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Treasury shares, at cost: 29,386,198 and
      30,127,151 shares</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as of
      June 30, 2016 and 2015, respectively</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(2,323</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(2,237</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>Accumulated other comprehensive net (losses) income</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(570</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(502</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Stockholders&#146; equity</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>297</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>118</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" colSpan=2><FONT face="Times New Roman" size=2>Total liabilities and stockholders&#146; equity</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4,518</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4,164</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>See Notes to Consolidated
Financial Statements</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>28</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>CONSOLIDATED STATEMENTS OF
STOCKHOLDERS&#146; EQUITY<BR></FONT></B><I><FONT face="Times New Roman" size=2>The
Clorox Company</FONT></I><I><FONT face="Times New Roman" size=2></FONT></I></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 71%; PADDING-TOP: 2pt; TEXT-ALIGN: left" noWrap width="67%" colSpan=2></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=4><FONT face="Times New Roman" size=1><STRONG>Common Stock</STRONG></FONT></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2 rowSpan=2><FONT face="Times New Roman" size=1><STRONG>Additional</STRONG></FONT><BR><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Paid-in<BR>Capital</FONT></B></FONT></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="2%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 6%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="6%" colSpan=6><FONT face="Times New Roman" size=1><STRONG>Treasury<BR>Shares</STRONG></FONT></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 5%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="6%" colSpan=3 rowSpan=2><FONT face="Times New Roman" size=1><STRONG>Accumulated<BR>Other</STRONG></FONT><BR><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Comprehensive<BR>Net (Losses) Income</FONT></B></FONT></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="2%"></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: left" noWrap width="1%"><STRONG><FONT size=1>Dollars in
    millions</FONT></STRONG></TD>
    <TD noWrap width="66%">&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="1%"><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Shares<BR>(000)</FONT></B></FONT></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Amount</FONT></B></FONT></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%" colSpan=3><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Retained<BR>Earnings</FONT></B></FONT></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="2%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Shares<BR>(000)</FONT></B></FONT></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%" colSpan=3><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Amount</FONT></B></FONT></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="6%" colSpan=3><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Total</FONT></B></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Balance as of June 30, 2013</FONT></B></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>158,741</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>159</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>661</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>1,561</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(28,375</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(1,868</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="4%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(367</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>146</FONT></FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Net earnings</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>558</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="4%"></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>558</FONT></FONT></TD>
    <TD noWrap align=left width="2%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Other
      comprehensive loss</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="4%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(50</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(50</FONT></FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Accrued
    dividends</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(374</FONT></FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="4%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(374</FONT></FONT></TD>
    <TD noWrap align=left width="2%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Stock-based compensation</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>36</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="4%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>36</FONT></FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Other employee stock plan
      activities</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>12</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(6</FONT></FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>1,476</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>92</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="4%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>98</FONT></FONT></TD>
    <TD noWrap align=left width="2%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Treasury
      stock purchased</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(3,046</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(260</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="4%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(260</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Balance as of June 30,
      2014</FONT></B></FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>158,741</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>159</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>709</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>1,739</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(29,945</FONT></FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(2,036</FONT></FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="4%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(417</FONT></FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>154</FONT></FONT></TD>
    <TD noWrap align=left width="2%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Net
      earnings</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>580</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="4%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>580</FONT></FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Other comprehensive
      loss</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="4%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(85</FONT></FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(85</FONT></FONT></TD>
    <TD noWrap align=left width="2%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Accrued
      dividends</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(391</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="4%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(391</FONT></FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Stock-based
      compensation</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>32</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="4%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>32</FONT></FONT></TD>
    <TD noWrap align=left width="2%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Other
      employee stock plan activities</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>34</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(5</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(4,198</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>233</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="4%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>262</FONT></FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Treasury stock
      purchased</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>4,016</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(434</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="4%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(434</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Balance as of June 30, 2015</FONT></B></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>158,741</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>159</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>775</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>1,923</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(30,127</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(2,237</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="4%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(502</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>118</FONT></FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Net earnings</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>648</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="4%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>648</FONT></FONT></TD>
    <TD noWrap align=left width="2%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Other
      comprehensive loss</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="4%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(68</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(68</FONT></FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Accrued
    dividends</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(406</FONT></FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="4%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(406</FONT></FONT></TD>
    <TD noWrap align=left width="2%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Stock-based compensation</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>45</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="4%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>45</FONT></FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Other employee stock plan
      activities</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>48</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(2</FONT></FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>2,892</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>168</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="4%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>214</FONT></FONT></TD>
    <TD noWrap align=left width="2%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>Treasury
      stock purchased</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(2,151</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(254</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="4%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(254</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" colSpan=2><FONT face="Times New Roman" size=1><B><FONT face="Times New Roman" size=1>Balance as of June 30,
      2016</FONT></B></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>158,741</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>159</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>868</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>2,163</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(29,386</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(2,323</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="4%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>(570</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>)</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=1><FONT face="Times New Roman" size=1>297</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="2%"></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>See Notes to</FONT><FONT face="Times New Roman" size=2> Consolidated </FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>Financial</FONT><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>
Statements</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>29</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P style="MARGIN-BOTTOM: 3pt" align=left><B><FONT face="Times New Roman" size=2>CONSOLIDATED STATEMENTS OF CASH FLOWS <BR></FONT></B><I><FONT face="Times New Roman" size=2>The Clorox Company </FONT></I></P>
<TABLE style="LINE-HEIGHT: 12pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><B><FONT face="Times New Roman" size=1>Years ended June 30</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR style="LINE-HEIGHT: 4pt">
    <TD noWrap align=left width="89%" colSpan=2>&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left" noWrap><B><FONT face="Times New Roman" size=1>Dollars in
      millions</FONT></B></TD>
    <TD noWrap align=left width="89%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Operating activities:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net earnings</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>648</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>580</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>558</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deduct: Losses from
      discontinued operations, net of tax</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(26</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(21</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings from continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>648</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>606</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>579</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile
      earnings from continuing operations to net cash</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provided
      by continuing operations:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation
      and amortization</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>165</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>169</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>177</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based
      compensation</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>45</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>36</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred
      income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>5</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(16</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(21</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Settlement
      of interest rate forward contracts</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(25</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(17</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes
      in:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables,
      net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(52</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>20</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories,
      net</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(45</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(25</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
      current assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>5</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts
      payable and accrued liabilities</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>57</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>93</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(12</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income
      taxes payable</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(62</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>29</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Net cash provided by continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>768</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>858</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>786</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>Net cash provided by (used for) discontinued operations</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>10</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>16</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(19</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Net cash provided by operations</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>778</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>874</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>767</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR style="LINE-HEIGHT: 8pt">
    <TD width="100%" bgColor=#c0c0c0 colSpan=13>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>Investing activities:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital
      expenditures</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(172</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(125</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(137</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business acquired, net of
      cash acquired</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(290</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>19</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>Net cash used for investing activities from continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(430</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(106</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(137</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Net cash used for investing activities by
      discontinued operations</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>Net cash used for investing activities</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(430</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(106</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(138</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR style="LINE-HEIGHT: 8pt">
    <TD width="100%" colSpan=13>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Financing activities:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes and loans payable,
      net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>426</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(48</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(60</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term debt
      borrowings, net of issuance costs</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>495</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term debt
      repayments</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(300</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(575</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock
      purchased</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(254</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(434</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(260</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash dividends
    paid</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(398</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(385</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(368</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock
      for employee stock plans and other</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>210</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>251</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>96</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>Net cash used for financing activities</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(316</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(696</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(592</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Effect of exchange rate changes on cash and
      cash equivalents</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(19</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(7</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>Net increase in cash and cash equivalents</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>19</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>53</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>30</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Cash and cash equivalents:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning of
    year</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>382</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>329</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>299</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;End of year</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>401</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>382</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>329</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR style="LINE-HEIGHT: 8pt">
    <TD width="100%" bgColor=#c0c0c0 colSpan=13>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>Supplemental cash flow information:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest paid</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>79</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>104</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>76</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#ffffff colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes paid, net of
      refunds</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff><FONT face="Times New Roman" size=2>323</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff><FONT face="Times New Roman" size=2>236</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff><FONT face="Times New Roman" size=2>312</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0 colSpan=2><FONT face="Times New Roman" size=2>Noncash financing activities:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash dividends declared
      and accrued, but not paid</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>104</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>99</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>95</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>See Notes to Consolidated
Financial Statements </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>30</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS</FONT></B><FONT face="Times New Roman" size=2>
<BR></FONT><B><FONT face="Times New Roman" size=2>The Clorox
Company<BR></FONT></B><B><FONT face="Times New Roman" size=2>(Dollars in
millions, except share and per share data)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 1. SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES</FONT></B><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Nature of Operations and
Basis of Presentation</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is principally
engaged in the production, marketing and sales of consumer products through mass
retail outlets and grocery, e-commerce channels, wholesale distributors and
medical supply distributors. The consolidated financial statements include the
statements of the Company and its wholly owned and controlled subsidiaries. All
significant intercompany transactions and accounts were eliminated in
consolidation. Certain prior year reclassifications were made in the
consolidated financial statements and related notes to the consolidated
financial statements to conform to the current year presentation. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Effective September 22, 2014,
the Company&#146;s Venezuela affiliate, Corporaci&#243;n Clorox de Venezuela S.A. (Clorox
Venezuela), discontinued its operations. Consequently, the Company presents the
financial results of Clorox Venezuela as a discontinued operation in the
consolidated financial statements for all periods presented herein. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Use of
Estimates</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The preparation of these
consolidated financial statements in conformity with generally accepted
accounting principles in the United States of America (U.S. GAAP) requires
management to reach opinions as to estimates and assumptions that affect
reported amounts and related disclosures. Specific areas requiring management&#146;s
opinion on estimates and judgments include assumptions pertaining to accruals
for consumer and trade-promotion programs, stock-based compensation costs,
pension and post-employment benefit costs, future cash flows associated with
impairment testing of goodwill and other long-lived assets, the credit
worthiness of customers, uncertain tax positions, tax valuation allowances and
legal, environmental and insurance matters. Actual results could materially
differ from estimates and assumptions made. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Cash and Cash
Equivalents</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Cash equivalents consist of
highly liquid instruments, time deposits and money market funds with an initial
maturity at purchase of three months or less. The fair value of cash and cash
equivalents approximates the carrying amount. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s cash position
includes amounts held by foreign subsidiaries and, as a result, the repatriation
of certain cash balances from some of the Company&#146;s foreign subsidiaries could
result in additional tax costs in the United States and in certain foreign
jurisdictions. However, these cash balances are generally available without
legal restriction to fund local business operations. In addition, a portion of
the Company&#146;s cash balance is held in U.S. dollars by foreign subsidiaries,
whose functional currency is their local currency. Such U.S. dollar balances are
reported on the foreign subsidiaries&#146; books, in their functional currency, with
the impact from foreign currency exchange rate differences recorded in Other
(income) expense, net. The Company&#146;s cash holdings were as follows as of June
30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>U.S. dollar balances held by U.S. dollar
      functional currency subsidiaries and at parent</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>249</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>221</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Non-U.S. dollar balances held by non-U.S. dollar functional
      currency subsidiaries</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>133</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>142</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>U.S. dollar balances held by non-U.S. dollar
      functional currency subsidiaries</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>19</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>19</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Non-U.S. dollar balances held by U.S. dollar functional currency
      subsidiaries</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>401</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 2pt double; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="1%"><FONT face="Times New Roman" size=2>382</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016 and 2015,
the Company had $4 and $3 of restricted cash, respectively, which is primarily
related to fiscal year 2012 acquisitions. Restricted cash was included in Other
assets as of June 30, 2016 and in Other current assets as of June 30,
2015.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>31</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 1. SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (Continued) </FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Inventories</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Inventories are stated at the
lower of cost or market. When necessary, the Company provides allowances to
adjust the carrying value of its inventory to the lower of cost or market,
including any costs to sell or dispose. Appropriate consideration is given to
obsolescence, excessive inventory levels, product deterioration and other
factors in evaluating net realizable value for the purposes of determining the
lower of cost or market.</FONT><B><FONT face="Times New Roman" size=2>
</FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Property, Plant and
Equipment and Finite-Lived Intangible Assets</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Property, plant and equipment
and finite-lived intangible assets are stated at cost. Depreciation and
amortization expense are calculated by the straight-line method using the
estimated useful lives or lives determined by lease contracts for the related
assets. The table below provides estimated useful lives of property, plant and
equipment by asset classification. </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="99%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="1%"><B><FONT face="Times New Roman" size=1>Estimated<BR>Useful
      Lives</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="99%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Buildings and leasehold
    improvements</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>10 - 40 years</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="99%"><FONT face="Times New Roman" size=2>Land
      improvements</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>10 -
      30 years</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="99%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Machinery and equipment</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3 - 15 years</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="99%"><FONT face="Times New Roman" size=2>Computer equipment</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3 -
      5 years</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="99%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Capitalized software costs</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3 - 7 years</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Property, plant and equipment
and finite-lived intangible assets are reviewed for impairment whenever events
or changes in circumstances occur that indicate that the carrying amount of an
asset (or asset group) may not be fully recoverable. The risk of impairment is
initially assessed based on an estimate of the undiscounted cash flows at the
lowest level for which identifiable cash flows exist. Impairment occurs when the
carrying value of the asset exceeds the estimated future undiscounted cash flows
generated by the asset. When impairment is indicated, an impairment charge is
recorded for the difference between the carrying value of the asset and its
estimated fair market value. Depending on the asset, estimated fair market value
may be determined either by use of a discounted cash flow model or by reference
to estimated selling values of assets in similar condition. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Capitalization of Software
Costs </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company capitalizes
certain qualifying costs incurred in the acquisition and development of software
for internal use, including the costs of the software, materials, consultants,
interest and payroll and payroll-related costs for employees during the
application development stage. Internal and external costs incurred during the
preliminary project stage and post implementation-operation stage, mainly
training and maintenance costs, are expensed as incurred. Once the application
is substantially complete and ready for its intended use, qualifying costs are
amortized on a straight-line basis over the software&#146;s estimated useful
life.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Impairment Review of
Goodwill and Indefinite-Lived Intangible Assets</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company tests its
goodwill, trademarks with indefinite lives and other indefinite-lived intangible
assets annually for impairment in the fiscal fourth quarter unless there are
indications during a different interim period that these assets may have become
impaired.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>With respect to goodwill, the
Company has the option to first assess qualitative factors such as maturity and
stability of the reporting unit, magnitude of excess fair value over carrying
value from the prior year&#146;s impairment testing, other reporting unit specific
operating results as well as new events and circumstances impacting the
operations at the reporting unit level. If the result of a qualitative test
indicates a potential for impairment of a reporting unit, a quantitative test is
performed. The quantitative test is a two-step process. In the first step, the
Company compares the estimated fair value of the reporting unit to its carrying
value. In all instances, the estimated fair value exceeded the carrying value of
the reporting unit. Had the estimated fair value of any reporting unit been less
than its carrying value, the Company would have performed a second step to
determine the implied fair value of the reporting unit&#146;s goodwill. If the
carrying amount of a reporting unit&#146;s goodwill had exceeded its implied fair
value, an impairment charge would have been recorded for the difference between
the carrying amount and the implied fair value of the reporting unit&#146;s
goodwill.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>32</FONT></P>
<HR align=center width="100%" noShade SIZE=2>
<!--PART 4-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 1. SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (Continued) </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>To determine the fair value of
a reporting unit as part of its quantitative test, the Company uses a discounted
cash flow (DCF) approach, as it believes that this approach is the most reliable
indicator of the fair value of its businesses and the fair value of their future
earnings and cash flows. Under this approach, the Company estimates the future
cash flows of each reporting unit and discounts these cash flows at a rate of
return that reflects their relative risk. The cash flows used in the DCF are
consistent with those the Company uses in its internal planning, which gives
consideration to actual business trends experienced, and the broader business
strategy for the long term. The other key estimates and factors used in the DCF
include, but are not limited to, future sales volumes, revenue and expense
growth rates, changes in working capital, foreign exchange rates, currency
devaluation, inflation and a perpetuity growth rate. Changes in such estimates
or the application of alternative assumptions could produce different results.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>For trademarks and other
intangible assets with indefinite lives, the Company performs a quantitative
analysis to test for impairment. When a quantitative test is performed, the
estimated fair value of an asset is compared to its carrying amount. If the
carrying amount of such asset exceeds its estimated fair value, an impairment
charge is recorded for the difference between the carrying amount and the
estimated fair value. The Company uses the income approach to estimate the fair
value of its trademarks and other intangible assets with indefinite lives. This
approach requires significant judgments in determining both the assets&#146;
estimated cash flows as well as the appropriate discount and foreign exchange
rates applied to those cash flows to determine fair value. Changes in such
estimates or the use of alternative assumptions could produce different
results.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Stock-based
Compensation</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company grants various
nonqualified stock-based compensation awards to eligible employees, including
stock options and performance units. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>For stock options, the Company
estimates the fair value of each award on the date of grant using the
Black-Scholes valuation model, which requires management to make estimates
regarding expected option life, stock price volatility and other assumptions.
Groups of employees that have similar historical exercise behavior are
considered separately for valuation purposes. The Company estimates stock option
forfeitures based on historical data for each employee grouping. The total
number of stock options expected to vest is adjusted by actual and estimated
forfeitures. Changes to the actual and estimated forfeitures will result in a
cumulative catch-up adjustment in the period of change. Compensation expense is
recorded by amortizing the grant date fair values on a straight-line basis over
the vesting period, adjusted for estimated forfeitures. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s performance unit
grants provide for the issuance of common stock to certain managerial staff and
executive management if the Company achieves specified performance targets. The
number of shares issued are dependent upon vesting and the achievement of
specified performance targets. The performance period is three years and the
payout determination is made at the end of the three-year performance period.
Performance unit grants receive dividends earned during the vesting period upon
vesting. The fair value of each grant issued is estimated on the date of grant
based on the current market price of the stock. The total amount of compensation
expense recognized reflects estimated forfeiture rates and the initial
assumption that performance goals will be achieved. Compensation expense is
adjusted based on management&#146;s assessment of the probability that performance
goals will be achieved. If such goals are not met or it is determined that
achievement of performance goals is not probable, previously recognized
compensation expense is trued up in the current period to reflect the expected
payout level. If it is determined that the performance goals will be exceeded,
additional compensation expense is recognized, subject to a cap of 150%.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Cash flows resulting from tax
deductions in excess of the cumulative compensation cost recognized for
stock-based payment arrangements (excess tax benefits) are primarily classified
as financing cash inflows. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>33</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 1. SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (Continued) </FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Employee
Benefits</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company accounts for its
defined benefit retirement income and retirement health care plans using
actuarial methods</FONT><I><FONT face="Times New Roman" size=2>.</FONT></I><FONT face="Times New Roman" size=2> These methods use an attribution approach that
generally spreads &#147;plan events&#148; over the service lives or expected lifetime (for
frozen plans) of plan participants. Examples of plan events are plan amendments
and changes in actuarial assumptions such as the expected return on plan assets,
discount rate, rate of compensation increase and certain employee-related
factors, such as retirement age and mortality. The principle underlying the
attribution approach is that employees render service over their employment
period on a relatively &#147;smooth&#148; basis and, therefore, the statement of earnings
effects of retirement income and retirement health care plans are recognized in
the same pattern. One of the principal assumptions used in the net periodic
benefit cost calculation is the expected return on plan assets. The required use
of an expected return on plan assets may result in recognized pension expense or
income that differs from the actual returns of those plan assets in any given
year. Over time, however, the goal is for the expected long-term returns to
approximate the actual returns and, therefore, the expectation is that the
pattern of income and expense recognition should closely match the pattern of
the services provided by the participants. The Company uses a market-related
value method for calculating plan assets for purposes of determining the
amortization of actuarial gains and losses. The differences between actual and
expected returns are recognized in the net periodic benefit cost calculation
over the average remaining service period or expected lifetime (for frozen
plans) of the plan participants using the corridor approach. Under this
approach, only actuarial gains (losses) that exceed 5% of the greater of the
projected benefit obligation or the market-related value of assets are amortized
to pension expense by the Company. In developing its expected return on plan
assets, the Company considers the long-term actual returns relative to the mix
of investments that comprise its plan assets and also develops estimates of
future investment returns by considering external sources. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company recognizes an
actuarial-based obligation at the onset of disability for certain benefits
provided to individuals after employment, but before retirement, that include
medical, dental, vision, life and other benefits. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Environmental
Costs</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is involved in
certain environmental remediation and ongoing compliance activities. Accruals
for environmental matters are recorded on a site-by-site basis when it is
probable that a liability has been incurred and based upon a reasonable estimate
of the liability. The Company&#146;s accruals reflect the anticipated participation
of other potentially responsible parties in those instances where it is probable
that such parties are legally responsible and financially capable of paying
their respective shares of the relevant costs. These accruals are adjusted
periodically as assessment and remediation efforts progress or as additional
technical or legal information become available. Actual costs to be incurred at
identified sites in future periods may vary from the estimates, given the
inherent uncertainties in evaluating environmental exposures. The accrual for
environmental matters is included in Accounts payable and accrued liabilities
and Other liabilities in the Company&#146;s consolidated balance sheets on an
undiscounted basis due to uncertainty regarding the timing of future payments.
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Revenue
Recognition</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Sales are recognized as
revenue when the risk of loss and title pass to the customer and when all of the
following have occurred: a firm sales arrangement exists, pricing is fixed or
determinable and collection is reasonably assured. Sales are recorded net of
allowances for trade promotions, coupons, returns and other discounts. The
Company routinely commits to one-time or ongoing trade-promotion programs with
customers and consumer coupon programs that require the Company to estimate and
accrue the expected costs of such programs. Programs include shelf price
reductions, end-of-aisle or in-store displays of the Company&#146;s products and
graphics and other trade-promotion activities conducted by the customer. Coupons
are recognized as a liability when distributed based upon expected consumer
redemptions. The Company maintains liabilities related to these programs for the
estimated expenses incurred, but not paid, at the end of each period.
Trade-promotion and coupon redemption costs are recorded as a reduction of
sales.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company provides an
allowance for doubtful accounts based on its historical experience and ongoing
assessment of its customers&#146; credit risk. Receivables were presented net of an
allowance for doubtful accounts of $5 and $4 as of June 30, 2016 and 2015,
respectively. Receivables, net, included non-customer receivables of $9 and $12
as of June 30, 2016 and 2015, respectively.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>34</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 1. SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (Continued) </FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Cost of Products
Sold</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Cost of products sold
represents the costs directly related to the manufacture and distribution of the
Company&#146;s products and primarily includes raw materials, packaging, contract
manufacturing fees, shipping and handling, warehousing, package design,
depreciation, amortization, direct and indirect labor and operating costs for
the Company&#146;s manufacturing and distribution facilities including salary,
benefit costs and incentive compensation, and royalties and other charges
related to the Company&#146;s Glad<SUP>&#174;</SUP> Venture Agreement (see Note 10).
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Costs associated with
developing and designing new packaging are expensed as incurred and include
design, artwork, films and labeling. Expenses for fiscal years ended June 30,
2016, 2015 and 2014 were $11, $11 and $12, respectively, all of which were
reflected in Cost of products sold or discontinued operations, as appropriate,
in the consolidated statements of earnings.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Selling and Administrative
Expenses</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Selling and administrative
expenses represent costs incurred by the Company in generating revenues and
managing the business and include market research, commissions and certain
administrative expenses. Administrative expenses include salary, benefits,
incentive compensation, professional fees and services, software and licensing
fees and other operating costs associated with the Company&#146;s non-manufacturing,
non-research and development staff, facilities and equipment. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Advertising and Research
and Development Costs</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company expenses
advertising and research and development costs in the period incurred.
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Income Taxes</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company uses the asset and
liability method to account for income taxes. Deferred tax assets and
liabilities are recognized for the anticipated future tax consequences
attributable to differences between financial statement amounts and their
respective tax basis. Management reviews the Company&#146;s deferred tax assets to
determine whether their value can be realized based upon available evidence. A
valuation allowance is established when management believes that it is more
likely than not that some portion of its deferred tax assets will not be
realized. Changes in valuation allowances from period to period are included in
the Company&#146;s tax provision in the period of change. In addition to valuation
allowances, the Company provides for uncertain tax positions when such tax
positions do not meet certain recognition thresholds or measurement standards.
Amounts for uncertain tax positions are adjusted in quarters when new
information becomes available or when positions are effectively
settled.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>U.S. income tax expense and
foreign withholding taxes are provided on unremitted foreign earnings that are
not indefinitely reinvested at the time the earnings are generated. Where
foreign earnings are indefinitely reinvested, no provision for U.S. income or
foreign withholding taxes is made. When circumstances change and the Company
determines that some or all of the undistributed earnings will be remitted in
the foreseeable future, the Company accrues an expense in the current period for
U.S. income taxes and foreign withholding taxes attributable to the anticipated
remittance. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Foreign Currency
Transactions and Translation</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Local currencies are the
functional currencies for substantially all of the Company&#146;s foreign operations.
When the transactional currency is different than the functional currency,
transaction gains and losses are included as a component of Other (income)
expense, net. In addition, certain assets and liabilities denominated in
currencies different than a foreign subsidiary&#146;s functional currency are
reported on the subsidiary&#146;s books in its functional currency, with the impact
from exchange rate differences recorded in Other (income) expense, net. Assets
and liabilities of foreign operations are translated into U.S. dollars using the
exchange rates in effect at the balance sheet date, while income and expenses
are translated at the average monthly exchange rates during the year.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>35</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 1. SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (Continued) </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Gains and losses on foreign
currency translations are reported as a component of Other comprehensive income
(loss). Deferred taxes are not provided on cumulative translation adjustments
where the Company expects earnings of a foreign subsidiary to be indefinitely
reinvested. The income tax effect of currency translation adjustments related to
foreign subsidiaries and joint ventures for which earnings are not considered
indefinitely reinvested is recorded as a component of deferred taxes with an
offset to Other comprehensive income (loss). </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Derivative
Instruments</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s use of
derivative instruments, principally swaps, futures and forward contracts, is
limited to non-trading purposes and is designed to partially manage exposure to
changes in commodity prices, interest rates and foreign currencies. The
Company&#146;s contracts are hedges for transactions with notional amounts and
periods consistent with the related exposures and do not constitute investments
independent of these exposures. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The changes in the fair value
(i.e., gains or losses) of a derivative instrument are recorded as either assets
or liabilities in the consolidated balance sheets with an offset to net earnings
or Other comprehensive income (loss) depending on whether, for accounting
purposes, it has been designated and qualifies as an accounting hedge and, if
so, on the type of hedging relationship. The criteria used to determine if hedge
accounting treatment is appropriate are: (a) formal designation and
documentation of the hedging relationship, the risk management objective and
hedging strategy at hedge inception; (b) eligibility of hedged items,
transactions and corresponding hedging instrument; and (c) effectiveness of the
hedging relationship both at inception of the hedge and on an ongoing basis in
achieving the hedging objectives. For those derivative instruments designated
and qualifying as hedging instruments, the Company must designate the hedging
instrument either as a fair value hedge or as a cash flow hedge. The Company
designates its commodity forward and future contracts for forecasted purchases
of raw materials, interest rate forward contracts for forecasted interest
payments, and foreign currency forward contracts for forecasted purchases of
inventory as cash flow hedges. During the fiscal years ended June 30, 2016, 2015
and 2014, the Company had no hedging instruments designated as fair value
hedges.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>For derivative instruments
designated and qualifying as cash flow hedges, the effective portion of gains or
losses is reported as a component of Other comprehensive income (loss) and
reclassified into earnings in the same period or periods during which the hedged
transaction affects earnings. From time to time, the Company may have contracts
not designated as hedges for accounting purposes, for which it recognizes
changes in the fair value in the consolidated statement of earnings in the
current period. Cash flows from hedging activities are classified as operating
activities in the consolidated statements of cash flows. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Recently Issued Accounting
Standards</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>In March 2016, the Financial
Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No.
2016-09, &#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee
Share-Based Payment Accounting,&#148; which simplifies several aspects of the
accounting for share-based payment transactions, including requiring excess tax
benefits and deficiencies to be recognized as income tax benefit or expense in
the consolidated statement of earnings and excess tax benefits and deficiencies
to be classified as an operating activity in the consolidated statement of cash
flows. The new guidance is effective for the Company beginning in the first
quarter of fiscal year 2018, with early adoption permitted. The Company is
planning to adopt the standard in the first quarter of fiscal year 2017. While
the actual benefit realized may vary significantly given the inherent
uncertainty in predicting future share-based transactions, the Company currently
estimates that the adoption will result in approximately a 4 percentage point
benefit to the Company&#146;s historical effective tax rate of 34% to 35% for fiscal
year 2017.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In February 2016, the FASB
issued ASU No. 2016-02, &#147;Leases (Topic 842),&#148; which requires lessees to
recognize a right-of-use asset and lease liability for all leases with terms of
more than 12 months. Recognition, measurement and presentation will depend on
classification as a finance or operating lease. ASU 2016-02 also requires
expanded disclosures about leasing arrangements. The new guidance is effective
for the Company beginning in the first quarter of fiscal year 2020, with early
adoption permitted. The Company is currently evaluating the impact that adoption
of this guidance will have on its consolidated financial statements.
</FONT><FONT face="Times New Roman"></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In November 2015, the FASB
issued ASU No. 2015-17, &#147;Income Taxes (Topic 740): Balance Sheet Classification
of Deferred Taxes,&#148; which requires all deferred tax liabilities and assets to be
classified as noncurrent. The Company adopted the standard in the fourth quarter
of fiscal year 2016 on a prospective basis as permitted. Prior period balances
have not been retrospectively adjusted.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>36</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 1. SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (Continued) </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>In April 2015, the Financial
Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No.
2015-03, &#147;Simplifying the Presentation of Debt Issuance Cost,&#148; which requires
that debt issuance costs related to a recognized debt liability be presented in
the balance sheet as a direct deduction from the carrying amount of that debt
liability, consistent with debt discounts. The new guidance is effective for the
Company beginning in the first quarter of fiscal year 2017, with early adoption
permitted. The Company does not expect the adoption of this guidance will have a
significant impact on its consolidated financial statements.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In February 2015, the FASB
issued ASU No. 2015-02,</FONT><FONT face="Times New Roman"> &#147;</FONT><FONT face="Times New Roman" size=2>Amendments to the Consolidation Analysis,&#148; which
changes the guidance for evaluating whether to consolidate certain legal
entities. The amendments modify the evaluation of whether limited partnerships
and similar legal entities are variable interest entities ("VIEs") or voting
interest entities. The new guidance is effective for the Company beginning in
the first quarter of fiscal year 2017, with early adoption permitted. The
Company does not expect the adoption of this guidance will have a significant
impact on its consolidated financial statements. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In May 2014, the FASB issued
ASU No. 2014-09, &#147;Revenue from Contracts with Customers (Topic 606),&#148; which
replaces most existing U.S. GAAP revenue recognition guidance and is intended to
improve and converge with international standards the financial reporting
requirements for revenue from contracts with customers. The core principle of
ASU 2014-09 is that an entity should recognize revenue for the transfer of goods
or services equal to the amount that it expects to be entitled to receive for
those goods or services. ASU 2014-09 also requires additional disclosures about
the nature, timing and uncertainty of revenue and cash flows arising from
contracts with customers, including information about significant judgments and
changes in judgments. The new guidance is effective for the Company beginning in
the first quarter of fiscal year 2019, with the option to early adopt in the
first quarter of fiscal year 2018. The Company is currently evaluating the
impact that adoption of this guidance will have on its consolidated financial
statements. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 2. DISCONTINUED
OPERATIONS </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>On September 22, 2014, Clorox
Venezuela announced that it was discontinuing its operations, effective
immediately, and seeking to sell its assets. Since fiscal year 2012, Clorox
Venezuela was required to sell more than two thirds of its products at prices
frozen by the Venezuelan government. During this same period, Clorox Venezuela
experienced successive years of hyperinflation resulting in significant
sustained increases in its input costs, including packaging, raw materials,
transportation and wages. As a result, Clorox Venezuela had been selling its
products at a loss, resulting in ongoing operating losses. Clorox Venezuela
repeatedly met with government authorities in an effort to help them understand
the rapidly declining state of the business, including the need for immediate,
significant and ongoing price increases and other critical remedial actions to
address these adverse impacts. Based on the Venezuelan government&#146;s
representations, Clorox Venezuela had expected significant price increases would
be forthcoming much earlier; however, the price increases subsequently approved
were insufficient and would have caused Clorox Venezuela to continue operating
at a significant loss into the foreseeable future. As such, Clorox Venezuela was
no longer financially viable and was forced to discontinue its
operations.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>On September 26, 2014, the
Company reported that Venezuelan Vice President Jorge Arreaza announced, with
endorsement by President Nicol&#225;s Maduro, that the Venezuelan government had
occupied the Santa Luc&#237;a and Guacara production facilities of Clorox Venezuela.
On November 6, 2014, the Company reported that the Venezuelan government had
published a resolution granting a government-sponsored Special Administrative
Board full authority to restart and operate the business of Clorox Venezuela,
thereby reaffirming the government's expropriation of Clorox Venezuela&#146;s assets.
Further, President Nicol&#225;s Maduro announced the government's intention to
facilitate the resumed production of bleach and other cleaning products at
Clorox Venezuela plants. He also announced his approval of a financial credit to
invest in raw materials and production at the plants. These actions by the
Venezuelan government were taken without the consent or involvement of Clorox
Venezuela, its parent Clorox Spain S.L. (Clorox Spain) or any of their
affiliates. Clorox Venezuela, Clorox Spain and their affiliates reserved their
rights under all applicable laws and treaties. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>With this exit, the financial
results of Clorox Venezuela are reflected as discontinued operations in the
Company&#146;s consolidated financial statements. The results of Clorox Venezuela
have historically been part of the International reportable segment. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Net sales for Clorox Venezuela
were $0, $11 and $77 for the fiscal years ended June 30, 2016, 2015 and 2014,
respectively. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>37</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 2. DISCONTINUED
OPERATIONS (Continued)</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The following table provides a
summary of gains (losses) from discontinued operations for Clorox Venezuela and
gains (losses) from discontinued operations other than Clorox Venezuela for the
years ended June 30:</FONT><B><FONT face="Times New Roman" size=2>
</FONT></B></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Operating losses from Clorox Venezuela
      before income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>-</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(23</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Exit
      costs and other related expenses for Clorox Venezuela</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>(2</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>)</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(78</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total losses from Clorox Venezuela before
      income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>(2</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>)</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(84</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(23</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Income tax benefit attributable to Clorox Venezuela</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>2</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>29</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total losses from Clorox Venezuela, net of
      tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>-</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(55</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(17</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=13>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Gains (losses) from discontinued operations other than</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clorox Venezuela, net of
      tax</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>-</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>29</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Losses from discontinued operations, net of
      tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>-</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(26</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(21</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Unrelated to Clorox Venezuela,
in the fiscal year ended June 30, 2015, $32 of gross unrecognized tax benefits
relating to other discontinued operations for periods prior to fiscal year 2015
were recognized upon the expiration of the applicable statute of limitations.
Recognition of these previously disclosed tax benefits had no impact on the
Company&#146;s cash flow or earnings from continuing operations for the fiscal years
ended June 30, 2015 and 2014. (See Note 18) </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Summary of Operating
Losses, Asset Charges and Other Costs</FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>The following provides a
breakdown of (losses) gains from discontinued operations for Clorox Venezuela
and gains from discontinued operations other than Clorox Venezuela for the
fiscal years ended June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: center" noWrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Operating losses from Clorox Venezuela
      before income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">$</FONT>
      &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>Net
      asset charges:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(11</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property, plant and
      equipment</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: right" noWrap></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(16</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trademark and other
      intangible assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: right" noWrap></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Other exit and business termination
      costs:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severance</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: right" noWrap></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recognition of deferred
      foreign currency translation loss</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(30</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: right" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(10</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total losses from Clorox Venezuela before
      income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(84</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>Income tax benefit attributable to Clorox Venezuela</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: right" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>29</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total losses from Clorox Venezuela, net of
      tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(55</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=8>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>Gains from discontinued operations other than</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clorox Venezuela, net of
      tax</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: right" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>29</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Losses from discontinued operations, net of
      tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">$</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(26</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>38</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 2. DISCONTINUED
OPERATIONS (Continued)</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Prior to Clorox Venezuela
being consolidated under the rules governing the preparation of financial
statements in a highly inflationary economy, cumulative translation gains
(losses) were included as a component of Accumulated other comprehensive net
(losses) income. The charge of $30 to discontinued operations in September 2014
represents the recognition of these losses as a result of Clorox Venezuela
discontinuing its operations effective September 22, 2014. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Financial Reporting:
Hyperinflation and the Selection of Exchange Rates </FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>Due to a sustained
inflationary environment, the financial statements of Clorox Venezuela are
consolidated under the rules governing the preparation of financial statements
in a highly inflationary economy. As such, Clorox Venezuela&#146;s non-U.S. dollar
(non-USD) monetary assets and liabilities were remeasured into U.S. dollars
(USD) each reporting period with the resulting gains and losses now reflected in
discontinued operations. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Subsequent to Clorox Venezuela
discontinuing operations in September 2014, the Venezuelan government has
continued to evolve its currency exchange mechanisms; however, these changes
have not had a material impact on the Company&#146;s financial results because the
balance of net bolivar assets and liabilities on the local books of Clorox
Venezuela was $0 as of both June 30, 2016 and 2015. As of June 30, 2016 and
2015, the local books of Clorox Venezuela carried a net asset position of $0. In
addition, as of June 30, 2016 and 2015, the Company held $0 and $13,
respectively, of tax asset balances related to Clorox Venezuela in Corporate in
the reconciliation of the results of the Company&#146;s reportable segments to
consolidated results.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 3. BUSINESSES ACQUIRED
</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>On May 2, 2016, the Company
acquired 100 percent of ReNew Life Holdings Corporation (Renew Life), a leading
brand in digestive health. The amount paid was $290 funded through commercial
paper. The amount paid of $290 represents the aggregate purchase price less cash
acquired. The purchase of the Renew Life business reflects the Company&#146;s
strategy to acquire leading brands with attractive margins in growth categories.
Results for Renew Life&#146;s U.S. business are reflected in the Household reportable
segment and results for Renew Life&#146;s international business are reflected in the
International reportable segment. Included in the Company&#146;s results for fiscal
year 2016 was $21 of Renew Life&#146;s global net sales. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The assets and liabilities of
Renew Life were recorded at their respective estimated fair values as of the
date of the acquisition using generally accepted accounting principles for
business combinations. The excess of the purchase price over the fair value of
the net identifiable assets acquired has been allocated to goodwill. Goodwill
recorded primarily reflects the value of expanding the Company&#146;s portfolio
further into the health and wellness arena.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>39</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 3. BUSINESSES ACQUIRED
(Continued)</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The following table summarizes
the estimated fair values of Renew Life&#146;s assets acquired and liabilities
assumed and related deferred income taxes as of the acquisition date. Due to the
timing of the acquisition, the fair value of the assets acquired and liabilities
assumed are based on a preliminary valuation and the Company&#146;s estimates and
assumptions are subject to change within the measurement period. The primary
areas of the purchase price that are not yet finalized are related to goodwill
and income taxes. The weighted-average estimated useful life of intangible
assets subject to amortization is 15 years. </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>Renew
  Life</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Goodwill</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>137</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>Trademarks</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>134</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Customer relationships</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>36</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>Property, plant and equipment</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Working capital, net</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>41</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>Deferred income taxes</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(61</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Purchase Price</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>290</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Pro forma results reflecting
the acquisition were not presented because the acquisition did not meet the
threshold requirements for additional disclosure. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 4.
INVENTORIES</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Inventories consisted of the
following as of June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="93%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Finished goods</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>361</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>316</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>Raw
      materials and packaging</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>111</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>101</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Work in process</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>LIFO
      allowances</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(32</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(35</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>443</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>385</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>The last-in, first-out (LIFO)
method was used to value approximately 38% of inventories as of June 30, 2016
and 2015, respectively. The carrying values for all other inventories are
determined on the first-in, first-out (FIFO) method. The effect on earnings of
the liquidation of LIFO layers was a benefit of $0, $0 and $2 for the fiscal
years ended June 30, 2016, 2015 and 2014, respectively. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>40</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 5. OTHER CURRENT
ASSETS</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Other current assets consisted
of the following as of June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Deferred tax assets<SUP>(a)</SUP></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>99</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"><FONT face="Times New Roman" size=2>Prepaid expenses</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>70</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>39</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Other</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>72</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>143</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=1><SUP>(a) </SUP></FONT><FONT face="Times New Roman" size=1>The Company prospectively adopted ASU No. 2015-17,
"Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes,"
requiring all deferred tax assets and liabilities to be classified as
noncurrent. See Note 1 and 18 for further details.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 6. PROPERTY, PLANT AND
EQUIPMENT, NET</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The components of property,
plant and equipment, net, consisted of the following as of June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Machinery and equipment</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,607</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,608</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>Buildings</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>524</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>515</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Capitalized software costs</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>368</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>371</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>Land
      and improvements</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>118</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>122</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Construction in progress</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>112</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>65</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>Computer equipment</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>88</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>76</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,817</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,757</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>Less: Accumulated depreciation and amortization</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(1,911</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(1,839</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>906</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>918</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Included in Machinery and
equipment above are $12 of capital leases as of June 30, 2016 and 2015,
respectively. Accumulated depreciation for assets under capital leases was $3
and $2 as of June 30, 2016 and 2015, respectively.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Included in Land and
improvements above are $3 and $2 of asset retirement obligations as of June 30,
2016 and 2015, respectively, for two leased properties. The liability of $1 and
$2 incurred in fiscal year 2016 and 2015, respectively, was recorded in Other
liabilities. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Depreciation and amortization
expense related to property, plant and equipment, net, was $157, $157 and $161
in fiscal years 2016, 2015 and 2014, respectively, which includes depreciation
of assets under capital leases. This also includes amortization of capitalized
software of $16, $19 and $22 in fiscal years 2016, 2015 and 2014, respectively.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Non-cash capital expenditures
were $10, $18 and $0 in fiscal years 2016, 2015 and 2014, respectively.
</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>41</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 7. GOODWILL,
TRADEMARKS AND OTHER INTANGIBLE ASSETS </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The changes in the carrying
amount of goodwill by reportable segment for the fiscal years ended June 30,
2016 and 2015 were as follows: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD noWrap align=left width="83%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="16%" colSpan=16><STRONG><FONT face="Times New Roman" size=1>Goodwill</FONT></STRONG></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Cleaning</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Lifestyle</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Household</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>International</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>Total</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Balance June 30, 2014</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>323</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>244</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>85</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>449</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,101</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Effect of foreign currency translation</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(34</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(34</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Balance June 30, 2015</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>323</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>244</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>85</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>415</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,067</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Acquisition</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>122</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>15</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>137</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Effect of foreign currency
    translation</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(7</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(7</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Balance June 30, 2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>323</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>244</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>207</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>423</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1,197</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>The changes in the carrying
amount of trademarks and other intangible assets for the fiscal years ended June
30 were as follows: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=8><B><FONT face="Times New Roman" size=1>As of June 30,
      2016</FONT></B></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: center" noWrap>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="8%" colSpan=8><B><FONT face="Times New Roman" size=1>As of June 30,
      2015</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 84%; PADDING-TOP: 2pt; TEXT-ALIGN: left" noWrap width="90%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Gross<BR>carrying<BR>amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: center" noWrap>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap colSpan=2><B><FONT face="Times New Roman" size=1>Accumulated<BR>amortization</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: center" noWrap>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap colSpan=2><B><FONT face="Times New Roman" size=1>Net
      carrying<BR>amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: center" noWrap></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap colSpan=2><B><FONT face="Times New Roman" size=1>Gross<BR>carrying<BR>amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: center" noWrap>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap colSpan=2><B><FONT face="Times New Roman" size=1>Accumulated<BR>amortization</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: center" noWrap>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap colSpan=2><B><FONT face="Times New Roman" size=1>Net
      carrying<BR>amount</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Trademarks not subject to
    amortization</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>647</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT> <FONT face="Times New Roman" size=2></FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>647</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>524</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>524</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2>Trademarks subject to amortization</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>22</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>10</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>33</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>22</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>11</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Other intangible assets:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Technology and product
      formulae</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>137</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>134</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>137</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>133</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>221</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>146</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>75</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>188</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>142</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>46</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1,037</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>302</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>735</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>882</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>297</FONT></TD>
    <TD style="WIDTH: 1%; BORDER-BOTTOM: black 1pt; TEXT-ALIGN: left" noWrap></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>585</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Finite-lived intangible assets
are amortized over their estimated useful lives, generally ranging from 2 to 30
years. Amortization expense relating to the Company&#146;s intangible assets was $8,
$12 and $15 for the years ended June 30, 2016, 2015 and 2014, respectively.
Estimated amortization expense for these intangible assets is $10, $9, $9, $9
and $8 for fiscal years 2017, 2018, 2019, 2020 and 2021,
respectively.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>During fiscal year 2016, the
Company recognized $9 of intangible asset impairment charges, of which $6
related to the Aplicare<SUP>&#174;</SUP> trademark within the Cleaning segment. The
Aplicare<SUP>&#174;</SUP> trademark impairment was recognized based on the
anticipated impact on future results from a competitive market entrant.
</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 8. ACCOUNTS PAYABLE
AND ACCRUED LIABILITIES</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Accounts payable and accrued
liabilities consisted of the following as of June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR>
    <TD noWrap align=left width="95%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2>
      <P><B><FONT face="Times New Roman" size=1>2016</FONT></B></P></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2>
      <P><B><FONT face="Times New Roman" size=1>2015</FONT></B></P></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Accounts payable</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>490</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>431</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Compensation and employee benefit costs</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>192</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>189</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Trade and sales promotion</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>127</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>115</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Dividends</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>108</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>103</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Other</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>118</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>141</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Total </FONT><FONT face="Times New Roman" size=2><SUP>(a)</SUP></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1,035</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>979</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=1><SUP>(a) </SUP></FONT><FONT face="Times New Roman" size=1>Accounts payable and accrued liabilities were
combined into one financial statement line as of June 30, 2016. The change has
been retrospectively applied to all periods presented.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>42</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 9. DEBT
</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Notes and loans payable, which
mature in less than one year, included the following as of June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Commercial paper</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>522</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>93</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Foreign borrowings</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>523</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>95</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>The weighted average interest
rates incurred on average outstanding notes and loans payable during the fiscal
years ended June 30, 2016, 2015 and 2014, including fees associated with the
Company&#146;s undrawn revolving credit facility, were 1.10%, 2.05% and 0.97%,
respectively. The weighted average effective interest rates on commercial paper
balances as of June 30, 2016 and 2015 were 0.82% and 0.39%,
respectively.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Long-term debt, carried at
face value net of unamortized discounts or premiums, included the following as
of June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Senior unsecured notes and
    debentures:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.55%, $300 due November
      2015</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>300</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.95%, $400 due October
      2017</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>400</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>399</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.80%, $300 due November
      2021</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>298</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>298</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.05%, $600 due September
      2022</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>599</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>599</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.50%, $500 due December
      2024</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>500</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>500</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,797</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,096</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%"><FONT face="Times New Roman" size=2>Less: Current maturities of long-term debt</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(300</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="97%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Long-term debt</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,797</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,796</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>The weighted average interest
rates incurred on average outstanding long-term debt during the fiscal years
ended June 30, 2016, 2015 and 2014, were 4.37%, 4.44% and 4.56%, respectively.
The weighted average effective interest rates on long-term debt balances as of
June 30, 2016 and 2015, were 4.41% and 4.31%, respectively.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Long-term debt maturities as
of June 30, 2016, are $0, $400, $0, $0, $0 and $1,400 in fiscal years 2017,
2018, 2019, 2020, 2021 and thereafter, respectively. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In November 2015, $300 of the
Company&#146;s senior notes with an annual fixed interest rate of 3.55% became due
and were repaid using commercial paper borrowings and cash on hand.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>43</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 9. DEBT
(continued)</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>In December 2014, under a
shelf registration statement filed with the SEC that will expire in December
2017, the Company issued $500 of senior notes with an annual fixed interest rate
of 3.50%. Interest on the notes is payable semi-annually in June and December
and the notes have a maturity date of December 15, 2024. The notes carry an
effective interest rate of 4.10%, which includes the impact from the settlement
of interest rate forward contracts in December 2014 (see Note 11). The notes
rank equally with all of the Company&#146;s existing senior indebtedness. In January
2015, $575 of the Company&#146;s senior notes with an annual fixed interest rate of
5.00% became due and were repaid using the net proceeds from the December 2014
debt issuance and commercial paper borrowings. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s borrowing
capacity under other financing arrangements as of June 30 was as follows:
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Revolving credit facility</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,100</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,100</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Foreign credit lines</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>10</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>11</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Other credit lines</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>18</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>18</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1,128</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1,129</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016, the
Company had a $1,100 revolving credit agreement (the Credit Agreement), which
expires in October 2019. There were no borrowings under the Credit Agreement as
of June 30, 2016 or 2015. The agreement includes certain restrictive covenants
and limitations, with which the Company was in compliance as of June 30,
2016.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Of the $28 of foreign and
other credit lines as of June 30, 2016, $5 was outstanding and the remainder of
$23 was available for borrowing. Of the $29 of foreign and other credit lines as
of June 30, 2015, $4 was outstanding and the remainder of $25 was available for
borrowing.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 10. OTHER
LIABILITIES</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Other liabilities consisted of
the following as of June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Employee benefit obligations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>335</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>299</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Venture agreement terminal obligation, net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>302</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>294</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>40</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>38</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Other</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>107</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>119</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>784</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>750</FONT></TD></TR></TABLE>
<P align=left><B><FONT face="Times New Roman" size=2>Venture
Agreement</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company has an agreement
with The Procter &amp; Gamble Company (P&amp;G) for the Company&#146;s
Glad<SUP>&#174;</SUP> bags, wraps and containers business. As of June 30, 2016 and
2015, P&amp;G had a 20% interest in the venture. The Company pays a royalty to
P&amp;G for its interest in the profits, losses and cash flows, as contractually
defined, of the Glad<SUP>&#174;</SUP> business, which is included in Cost of products
sold. The agreement with P&amp;G will expire in January 2023 unless the parties
decide, on or prior to January 2018, to extend the term of the agreement for
another 10 years. The agreement can be terminated under certain circumstances,
including at P&amp;G&#146;s option upon a change in control of the Company or, at
either party&#146;s option, upon the sale of the Glad<SUP>&#174;</SUP> business by the
Company. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Upon termination of the
agreement, the Company is required to purchase P&amp;G&#146;s interest for cash at
fair value as established by predetermined valuation procedures. As of June 30,
2016, the estimated fair value of P&amp;G&#146;s interest was $448, of which $302 has
been recognized and is reflected in Other liabilities as noted in the table
above. The difference between the estimated fair value and the amount
recognized, and any future changes in the fair value of P&amp;G&#146;s interest, is
charged to Cost of products sold on a straight-line basis over the remaining
life of the agreement. Following termination, the Glad<SUP>&#174;</SUP> business will
retain the exclusive core intellectual property licenses contributed by P&amp;G
on a royalty-free basis for the licensed products marketed.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>44</FONT></P>
<HR align=center width="100%" noShade SIZE=2>
<!--PART 5-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 10. OTHER LIABILITIES
(continued)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Deferred Gain on
Sale-leaseback Transaction</FONT></B><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In December 2012, the Company
completed a sale-leaseback transaction under which it sold its general office
building in Oakland, CA to an unrelated third party for net proceeds of $108 and
entered into a 15-year operating lease agreement with renewal options with the
buyer for a portion of the building. The Company deferred recognition of the
portion of the total gain on the sale that was equivalent to the present value
of the lease payments and will continue to amortize such amount to earnings
ratably over the lease term. As of June 30, 2016 and 2015, the long-term portion
of the deferred gain of $36 and $40, respectively, was included in Other in the
table above. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 11. FINANCIAL
INSTRUMENTS AND FAIR VALUE MEASUREMENTS</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Financial assets and
liabilities measured at fair value on a recurring basis in the consolidated
balance sheets are required to be classified and disclosed in one of the
following three categories of the fair value hierarchy: </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Level 1: Quoted market prices
in active markets for identical assets or liabilities. <BR></FONT><FONT face="Times New Roman" size=2>Level 2: Observable market-based inputs or
unobservable inputs that are corroborated by market data.<BR>Level 3:
Unobservable inputs reflecting the reporting entity&#146;s own assumptions.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016 and 2015,
the Company&#146;s financial assets and liabilities that were measured at fair value
on a recurring basis during the period included derivative financial
instruments, which were classified as either Level 1 or Level 2, and trust
assets to fund certain of the Company&#146;s nonqualified deferred compensation
plans, which were classified as Level 1. </FONT><B><FONT face="Times New Roman" size=2></FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Financial Risk Management
and Derivative Instruments</FONT></B><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is exposed to
certain commodity, foreign currency and interest rate risks related to its
ongoing business operations and uses derivative instruments to mitigate its
exposure to these risks.</FONT><B><I><FONT face="Times New Roman" size=2>
</FONT></I></B></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Commodity Price Risk
Management</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company may use commodity
exchange traded futures and over-the-counter swap contracts, which are generally
no longer than 2 years, to fix the price of a portion of its forecasted raw
material requirements. Commodity purchase contracts are measured at fair value
using market quotations obtained from commodity derivative dealers. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016, the
notional amount of commodity derivatives was $30, of which $16 related to jet
fuel swaps and $14 related to soybean oil futures. As of June 30, 2015, the
notional amount of commodity derivatives was $47, of which $27 related to jet
fuel swaps and $20 related to soybean oil futures. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Foreign Currency Risk
Management</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company may also enter
into certain over-the-counter derivative contracts to manage a portion of the
Company&#146;s forecasted foreign currency exposure associated with the purchase of
inventory. These foreign currency contracts generally have durations of no
longer than 2 years. The foreign exchange contracts are measured at fair value
using information quoted by foreign exchange dealers.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The notional amounts of
outstanding foreign currency forward contracts used by the Company&#146;s
subsidiaries to hedge forecasted purchases of inventory were $84 and $105,
respectively, as of June 30, 2016 and 2015.</FONT><B><I><FONT face="Times New Roman" size=2> </FONT></I></B></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Interest Rate Risk
Management</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company may enter into
over-the-counter interest rate forward contracts to fix a portion of the
benchmark interest rate prior to the anticipated issuance of fixed rate debt or
to manage the Company&#146;s level of fixed and floating rate debt. The interest rate
contracts are measured at fair value using information quoted by U.S. government
bond dealers.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>45</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 11. FINANCIAL
INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued) </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>During fiscal year 2015, the
Company paid $25 to settle interest rate forward contracts related to the
December 2014 issuance of $500 in senior notes. The settlement payments are
reflected as operating cash flows in the consolidated statements of cash flows
for the fiscal year ended June 30, 2015. The loss is reflected in Accumulated
other comprehensive net loss on the consolidated balance sheets as of June 30,
2016 and 2015, and is being amortized into <FONT STYLE="BACKGROUND-COLOR: Transparent">Interest</FONT> expense on the consolidated
statements of earnings over the 10-year term of the notes. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company had no outstanding
interest rate forward contracts as of June 30, 2016 and 2015.</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Counterparty Risk
Management and Derivative Contract Requirements</FONT></I></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company utilizes a variety
of financial institutions as counterparties for over-the counter derivative
instruments. The Company enters into agreements governing the use of
over-the-counter derivative instruments and sets internal limits on the
aggregate over-the-counter derivative instrument positions held with each
counterparty. Certain terms of these agreements require the Company or the
counterparty to post collateral when the fair value of the derivative
instruments exceeds contractually defined counterparty liability position
limits. Of the derivative instruments of $5 and $8 reflected in Accounts payable
and accrued liabilities and Other liabilities as of June 30, 2016 and 2015,
respectively, $4 and $8, respectively, contained such terms. As of both June 30,
2016 and 2015, neither the Company nor any counterparty was required to post any
collateral as no counterparty liability position limits were
exceeded.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Certain terms of the
agreements governing the Company&#146;s over-the-counter derivative instruments
require the credit ratings, as assigned by Standard &amp; Poor&#146;s and Moody&#146;s to
the Company and its counterparties, to remain at a level equal to or better than
the minimum of an investment grade credit rating. If the Company&#146;s credit
ratings were to fall below investment grade, the counterparties to the
derivative instruments could request full collateralization on derivative
instruments in net liability positions. As of both June 30, 2016 and 2015, the
Company and each of its counterparties had been assigned investment grade
ratings by both Standard &amp; Poor&#146;s and Moody&#146;s. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Certain of the Company&#146;s
exchange-traded futures contracts used for commodity price risk management
include requirements for the Company to post collateral in the form of a cash
margin account held by the Company&#146;s broker for trades conducted on that
exchange. As of June 30, 2016 and 2015, the Company maintained cash margin
balances related to exchange-traded futures contracts of $1 and $2,
respectively, which are classified as Other current assets on the consolidated
balance sheets. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Trust Assets
</FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company has held interests
in mutual funds and cash equivalents as part of trust assets related to certain
of its nonqualified deferred compensation plans. The participants, who are the
Company&#146;s current and former employees, in the deferred compensation plans may
select among certain mutual funds in which their compensation deferrals are
invested in accordance with the terms of the plan and within the confines of the
trusts which hold the marketable securities. The trusts represent variable
interest entities for which the Company is considered the primary beneficiary,
and therefore, trust assets are consolidated and included in Other assets in the
consolidated balance sheets. The interests in mutual funds are measured at fair
value using quoted market prices. The Company has designated these
marketable</FONT><B><FONT face="Times New Roman" size=2> </FONT></B><FONT face="Times New Roman" size=2>securities as trading investments.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The value of the trust assets
related to certain of the Company&#146;s nonqualified deferred compensation plans
increased by $14 as compared to June 30, 2015, primarily due to current year
employees&#146; contributions to these plans.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>46</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 11. FINANCIAL
INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued) </FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fair Value of Financial
Instruments</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The following table summarizes
the fair value of Company&#146;s assets and liabilities for which disclosure of fair
value is required as of June 30:</FONT></P>
<TABLE style="FONT-SIZE: 10pt; LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="71%"></TD>
    <TD noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 72%; PADDING-TOP: 2pt; TEXT-ALIGN: left" noWrap width="71%"><STRONG><FONT face="Times New Roman" size=2>Assets</FONT></STRONG></TD>
    <TD noWrap width="1%">&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%"><B><FONT face="Times New Roman" size=1>Balance sheet
      classification</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%"><B><FONT face="Times New Roman" size=1>Fair
      value<BR>hierarchy<BR>level</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Carrying<BR>Amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Estimated<BR>Fair<BR>Value</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Carrying<BR>Amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp; </TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Estimated<BR>Fair<BR>Value</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Investments including money market
      funds</FONT></TD>
    <TD noWrap width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Cash and cash equivalents
      <SUP>(a)</SUP></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;</TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>234</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>234</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>212</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>212</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%"><FONT face="Times New Roman" size=2>Time
      deposits</FONT></TD>
    <TD noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>Cash and cash equivalents
      <SUP>(a)</SUP></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>79</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>79</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>84</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>84</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Commodity purchase derivative
      contracts</FONT></TD>
    <TD noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Other current assets</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%"><FONT face="Times New Roman" size=2>Foreign exchange derivative contracts</FONT></TD>
    <TD noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>Other current assets</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Commodity purchase derivative
      contracts</FONT></TD>
    <TD noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Other assets</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%"><FONT face="Times New Roman" size=2>Trust assets for nonqualified deferred<BR>compensation
    plans</FONT></TD>
    <TD noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>Other assets</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>52</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>52</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>38</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>38</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0></TD>
    <TD noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>368</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>368</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>335</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>335</FONT></TD></TR>
  <TR>
    <TD width="99%" bgColor=#c0c0c0 colSpan=17>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%"><B><FONT face="Times New Roman" size=2>Liabilities</FONT></B></TD>
    <TD noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Notes and loans payable</FONT></TD>
    <TD noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Notes and loans payable </FONT><FONT face="Times New Roman" size=2><SUP>(b)</SUP></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>523</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>523</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>95</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>95</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD style="WIDTH: 72%; TEXT-ALIGN: left" vAlign=middle noWrap width="71%"><FONT face="Times New Roman" size=2>Commodity purchase
      derivative contracts</FONT></TD>
    <TD noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>Accounts payable and</FONT><BR><FONT face="Times New Roman" size=2>accrued liabilities</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>8</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>8</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD style="WIDTH: 72%; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" vAlign=middle noWrap width="71%"><FONT face="Times New Roman" size=2>Foreign exchange derivative contracts</FONT></TD>
    <TD noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Accounts payable and</FONT><BR><FONT face="Times New Roman" size=2>accrued liabilities</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD style="WIDTH: 72%; TEXT-ALIGN: left" vAlign=middle noWrap width="71%"><FONT face="Times New Roman" size=2>Current maturities of
      long-term debt and<BR>Long-term debt</FONT></TD>
    <TD noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>Current maturities of long-<BR>term debt and
      Long-term<BR>debt <FONT face="Times New Roman" size=2><SUP>(c)</SUP></FONT></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1,797</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1,922</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2,096</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2,137</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="71%" bgColor=#c0c0c0></TD>
    <TD noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,325</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,450</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,199</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,240</FONT></TD></TR></TABLE><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=1>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=1>Cash and cash
      equivalents are composed of time deposits and other interest bearing
      investments including money market funds with original maturity dates of
      90 days or less. Cash and cash equivalents are recorded at cost, which
      approximates fair value.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=1>(b)</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=1>Notes and loan
      payable is composed of U.S. commercial paper and/or other similar
      short-term debts issued by non-U.S. subsidiaries, all of which are
      recorded at cost, which approximates fair value.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=1>(c)</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=1>Current maturities of
      long-term debt and Long-term debt are recorded at cost. The fair value of
      Long-term debt, including current maturities, was determined using
      secondary market prices quoted by corporate bond dealers, and is
      classified as Level 2.</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>47</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 11. FINANCIAL
INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued) </FONT></B></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Derivatives
</FONT></I></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company designates its
commodity forward and future contracts for forecasted purchases of raw
materials, interest rate forward contracts for forecasted interest payments, and
foreign currency forward contracts for forecasted purchases of inventory as cash
flow hedges. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The effects of derivative
instruments designated as hedging instruments on Other comprehensive income
(loss) and net earnings were as follows during the fiscal years ended June 30:
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 83%; TEXT-ALIGN: left" noWrap width="83%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 17%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="17%" colSpan=11><B><FONT face="Times New Roman" size=1>Gains
      (losses)<BR>recognized in other comprehensive net loss</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Commodity purchase derivative
      contracts</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Interest rate derivative contracts</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(12</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Foreign exchange derivative
    contracts</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>7</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(18</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(14</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=12>&nbsp;</TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 83%; TEXT-ALIGN: left" noWrap width="83%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 17%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="17%" colSpan=11><B><FONT face="Times New Roman" size=1>Gains
      (losses) reclassified from accumulated<BR>other comprehensive net loss and
      recognized<BR>in net earnings</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Commodity purchase derivative
      contracts</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Interest rate derivative contracts</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(6</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Foreign exchange derivative
    contracts</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(18</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(7</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The gains (losses)
reclassified from Accumulated other comprehensive net (losses) income and
recognized in earnings during the fiscal years ended June 30, 2016, 2015 and
2014, for commodity purchase and foreign exchange contracts were included in
Cost of products sold, and for interest rate contracts were included in Interest
expense.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The estimated amount of the
existing net gain (loss) in Accumulated other comprehensive net (losses) income
as of June 30, 2016, which is expected to be reclassified into earnings within
the next twelve months, is $(11). Gains and losses on derivative instruments
representing either hedge ineffectiveness or hedge components excluded from the
assessment of effectiveness are recognized in the consolidated statement of
earnings. During each of the fiscal years ended June 30, 2016, 2015 and 2014,
hedge ineffectiveness was not significant.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>48</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 12. OTHER
CONTINGENCIES AND GUARANTEES </FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Contingencies</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is involved in
certain environmental matters, including response actions at various locations.
The Company had a recorded liability of $14 and $12 as of June 30, 2016 and
2015, respectively, for its share of aggregate future remediation costs related
to these matters. One matter in Dickinson County, Michigan, for which the
Company is jointly and severally liable, accounted for a substantial majority of
the recorded liability as of both June 30, 2016 and 2015. The Company has agreed
to be liable for 24.3% of the aggregate remediation and associated costs for
this matter pursuant to a cost-sharing arrangement with a third party. With the
assistance of environmental consultants, the Company maintains an undiscounted
liability representing its current best estimate of its share of the capital
expenditures, maintenance and other costs that may be incurred over an estimated
30-year remediation period. Currently, the Company cannot accurately predict the
timing of future payments that may be made under this obligation. In addition,
the Company&#146;s estimated loss exposure is sensitive to a variety of uncertain
factors, including the efficacy of remediation efforts, changes in remediation
requirements and the future availability of alternative clean-up technologies.
Although it is reasonably possible that the Company&#146;s exposure may exceed the
amount recorded, any amount of such additional exposures, or range of exposures,
is not estimable at this time.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is subject to
various legal proceedings, claims and other loss contingencies, including,
without limitation, loss contingencies relating to contractual arrangements,
product liability, patents and trademarks, advertising, labor and employment,
environmental, health and safety and other matters. With respect to these
proceedings, claims and other loss contingencies, while considerable uncertainty
exists, in the opinion of management at this time, the ultimate disposition of
these matters, to the extent not previously provided for, will not have a
material adverse effect, either individually or in the aggregate, on the
Company&#146;s consolidated financial statements taken as a whole.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Guarantees</FONT></B><FONT face="Times New Roman"> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In conjunction with
divestitures and other transactions, the Company may provide typical
indemnifications (e.g., indemnifications for representations and warranties and
retention of previously existing environmental, tax and employee liabilities)
that have terms that vary in duration and in the potential amount of the total
obligation and, in many circumstances, are not explicitly defined. The Company
has not made, nor does it believe that it is probable that it will make, any
material payments relating to its indemnifications, and believes that any
reasonably possible payments would not have a material adverse effect, either
individually or in the aggregate, on the Company&#146;s consolidated financial
statements taken as a whole. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company had not recorded
any liabilities on the aforementioned indemnifications as of June 30, 2016 and
2015. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company was a party to
letters of credit of $10 and $11 as of June 30, 2016 and 2015, respectively,
primarily related to one of its insurance carriers, of which $0 had been drawn
upon. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 13. LEASES AND OTHER
COMMITMENTS</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company leases various
property, plant, and equipment including office, warehousing, and manufacturing
facilities, in addition to certain manufacturing and information technology
equipment. The Company expects that, in the normal course of business, existing
contracts will be renewed or replaced by other leases. Rental expense for all
operating leases was $77, $76 and $71 in fiscal years 2016, 2015 and 2014,
respectively.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>49</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 13. LEASES AND OTHER
COMMITMENTS (Continued)</FONT></B><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The future minimum annual
lease commitments required under the Company&#146;s existing non-cancelable operating
and capital lease agreements as of June 30, 2016, were as follows:</FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 89%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: left" noWrap width="89%"><B><FONT face="Times New Roman" size=1>Year</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: left" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Operating<BR>leases</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Capital<BR>leases</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2017</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>49</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>2018</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>45</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2019</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>38</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>2020</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2021</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>29</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>Thereafter</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>135</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;328</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>The Company is also a party to
certain purchase obligations, which are defined as purchase agreements that are
enforceable and legally binding and that contain specified or determinable
significant terms, including quantity, price and the approximate timing of the
transaction. Examples of the Company&#146;s purchase obligations include contracts to
purchase raw materials, commitments to contract manufacturers, commitments for
information technology and related services, advertising contracts, capital
expenditure agreements, software acquisition and license commitments and service
contracts. The Company enters into purchase obligations based on expectations of
future business needs. For purchase obligations subject to variable price and/or
quantity provisions, an estimate of the price and/or quantity has been made.
Many of these purchase obligations are short term in nature and are flexible to
allow for changes in the Company&#146;s business and related requirements. As of June
30, 2016, the Company&#146;s purchase obligations were as follows: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 95%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: left" noWrap width="95%"><B><FONT face="Times New Roman" size=1>Year</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: left" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Purchase<BR>Obligations</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2017</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>150</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>2018</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>54</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2019</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>37</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>2020</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>12</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2021</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Thereafter</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>256</FONT></TD></TR></TABLE><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 14. STOCKHOLDERS&#146;
EQUITY</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company has two share
repurchase programs: an open-market purchase program with an authorized
aggregate purchase amount of up to $750, all of which was available for share
repurchases as of both June 30, 2016 and 2015, and a program to offset the
anticipated impact of share dilution related to share-based awards (the
Evergreen Program), which has no authorization limit as to amount or timing of
repurchases. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Share repurchases under
authorized programs were as follows during the fiscal years ended June 30:
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=4><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=4><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=4><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 86%; PADDING-TOP: 2pt; TEXT-ALIGN: left" noWrap width="86%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="1%"><B><FONT face="Times New Roman" size=1>Shares<BR>(in
      000's)</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="1%"><B><FONT face="Times New Roman" size=1>Shares<BR>(in
      000's)</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Amount</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="1%"><B><FONT face="Times New Roman" size=1>Shares<BR>(in
      000's)</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Open-market purchase programs</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP ALIGN="LEFT" WIDTH="1%" BGCOLOR="#c0c0c0" STYLE="text-align: right"><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">-</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>Evergreen Program</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>254</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2,151</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>434</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4,016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>260</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3,046</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=+0><FONT face="Times New Roman" size=2>$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=+0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;254</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=+0><FONT face="Times New Roman" size=2>2,151</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=+0><FONT face="Times New Roman" size=2>$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=+0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;434</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=+0><FONT face="Times New Roman" size=2>4,016</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=+0><FONT face="Times New Roman" size=2>$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=+0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;260</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=+0><FONT face="Times New Roman" size=2>3,046</FONT></FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>50</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 14. STOCKHOLDERS&#146;
EQUITY (Continued) </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Dividends per share declared
and paid, respectively, during the fiscal years ended June 30 were as follows:
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Dividends per share declared</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.11</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.99</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.87</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2>Dividends per share paid</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>3.08</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>2.96</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2.84</FONT></TD></TR></TABLE><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Accumulated Other
Comprehensive Net (Losses) Income </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Changes in Accumulated other
comprehensive net (losses) income by component were as follows for the fiscal
years ended June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 88%; TEXT-ALIGN: left" noWrap width="83%"></TD>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: center; width: 5%; border-bottom: Black 1pt solid"><B><FONT face="Times New Roman" size=1>Foreign
currency<BR>adjustments</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: center" noWrap align=center width="1%"></TD>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: center; width: 3%; border-bottom: Black 1pt solid"><B><FONT face="Times New Roman" size=1>Net<BR>unrealized<BR>gains<BR>(losses)
      on<BR>derivatives</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: center" noWrap align=center width="1%"></TD>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: center; width: 3%; border-bottom: Black 1pt solid"><B><FONT face="Times New Roman" size=1>Pension
      and<BR>postretirement<BR>benefit<BR>adjustments</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: center" noWrap align=center width="1%"></TD>
    <TD NOWRAP COLSPAN="3" STYLE="text-align: center; width: 3%; border-bottom: Black 1pt solid">
      <P><B><FONT face="Times New Roman" size=1>Accumulated<BR>Other<BR>Comprehensive<BR></FONT></B><B><FONT face="Times New Roman" size=1>Income</FONT></B></P></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>Balance June 30, 2013</FONT></B></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">$</FONT></FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(209</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">$</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(30</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">$</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(128</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">$</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(367</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive
      (loss) income before</FONT></TD>
    <TD noWrap align=left width="2%" ></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reclassifications</FONT></TD>
    <TD noWrap align=left width="2%" ></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(26</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(15</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(16</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(57</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from
      accumulated other</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;comprehensive net
      losses</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit
      (expense)</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(11</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net current period other comprehensive
      income (loss)</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(37</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(9</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(50</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><B><FONT face="Times New Roman" size=2>Balance June 30, 2014</FONT></B></TD>
    <TD noWrap align=left width="2%" ></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(246</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(39</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(132</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(417</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive
      (loss) income before</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reclassifications</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(92</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(18</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(29</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(139</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from
      accumulated other</FONT></TD>
    <TD noWrap align=left width="2%" ></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;comprehensive net
      losses</FONT></TD>
    <TD noWrap align=left width="2%" ></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>7</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>7</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recognition of deferred
      foreign currency translation</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;loss</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>30</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>30</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit
      (expense)</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>8</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>12</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>17</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net current period other comprehensive
      income (loss)</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(54</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(14</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(17</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(85</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><B><FONT face="Times New Roman" size=2>Balance June 30, 2015</FONT></B></TD>
    <TD noWrap align=left width="2%" ></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(300</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(53</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(149</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(502</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive
      (loss) income before</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reclassifications</FONT></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(43</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(7</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(38</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(88</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from
      accumulated other</FONT></TD>
    <TD noWrap align=left width="2%" ></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;comprehensive net
      losses</FONT></TD>
    <TD noWrap align=left width="2%" ></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>18</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%" ></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>18</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit
      (expense)</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(10</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>14</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%"><FONT face="Times New Roman" size=2>Net
      current period other comprehensive income (loss)</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="2%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(53</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>9</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(24</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" ></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(68</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="83%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>Balance June 30, 2016</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(353</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(44</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(173</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">$</FONT></FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(570</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Included in foreign currency
adjustments are re-measurement losses on long-term intercompany loans where
settlement is not planned or anticipated in the foreseeable future. For the
fiscal years ended June 30, 2016, 2015 and 2014, Other comprehensive losses on
these loans totaled $14, $9 and $12, respectively, and there were no amounts
reclassified from Accumulated other comprehensive net (losses)
income.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Pension and postretirement
benefit reclassification adjustments are reflected in Cost of products sold,
Selling and administrative expenses and Research and development
costs.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>51</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 15. NET EARNINGS PER
SHARE (EPS)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P style="MARGIN-BOTTOM: 6pt" align=left><FONT face="Times New Roman" size=2>The
following is the reconciliation of the weighted average number of shares
outstanding (in thousands) used to calculate basic net EPS to those used to
calculate diluted net EPS for the fiscal years ended June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%"><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="1%"><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="1%"><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Basic</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>129,472</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>130,310</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>129,558</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"><FONT face="Times New Roman" size=2>Dilutive effect of stock options and other</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>2,245</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2,466</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2,184</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Diluted</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>131,717</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>132,776</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>131,742</FONT></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=6>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"><FONT face="Times New Roman" size=2>Antidilutive stock options and other</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>42</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>23</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD></TR></TABLE><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 16. STOCK-BASED
COMPENSATION PLANS</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In November 2012, the
Company&#146;s stockholders voted to approve the amended and restated 2005 Stock
Incentive Plan (the Plan). The Plan permits the Company to grant various
nonqualified stock-based compensation awards, including stock options,
restricted stock, performance units, deferred stock units, stock appreciation
rights and other stock-based awards. The primary amendment reflected in the Plan
was an increase of approximately 3 million common shares that may be issued for
stock-based compensation purposes. As of June 30, 2016, the Company is
authorized to grant up to approximately 8 million common shares under the Plan,
and, as of June 30, 2016, approximately 8 million common shares were available
for grant. </FONT></P>
<P style="MARGIN-BOTTOM: 6pt" align=left><FONT face="Times New Roman" size=2>Compensation cost and the related income tax benefit recognized for
stock-based compensation plans were classified as indicated below for the fiscal
years ended June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Cost of products sold</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>Selling and administrative expenses</FONT></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>35</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>25</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>29</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Research and development costs</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>Total compensation cost</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;45</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Related income tax benefit</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>17</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>12</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>13</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Cash received during fiscal
years 2016, 2015 and 2014 from stock options exercised under all stock-based
payment arrangements was $180, $230 and $86, respectively. The Company issues
shares for stock-based compensation plans from treasury stock. The Company may
repurchase shares under its Evergreen Program to offset the estimated impact of
share dilution related to stock-based awards (see Note 14). </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Details regarding the
valuation and accounting for stock options, restricted stock awards, performance
units and deferred stock units for non-employee directors follow. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Stock Options
</FONT></B></P>
<P style="MARGIN-BOTTOM: 6pt" align=left><FONT face="Times New Roman" size=2>The
fair value of each stock option award granted during fiscal years 2016, 2015 and
2014 was estimated on the date of grant using the Black-Scholes valuation model
and assumptions noted in the following table: </FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%"><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="1%"><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="1%"><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Expected life</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5.6 years</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5.6 to 5.8 years</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5.7 years</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"><FONT face="Times New Roman" size=2>Weighted-average expected life</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%"><FONT face="Times New Roman" size=2>5.6 years</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"><FONT face="Times New Roman" size=2>5.7 years</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"><FONT face="Times New Roman" size=2>5.7 years</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Expected volatility</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>16.43% to 17.3%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>16.3% to 18.6%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>18.4% to 18.5%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"><FONT face="Times New Roman" size=2>Weighted-average volatility</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%"><FONT face="Times New Roman" size=2>17.2%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"><FONT face="Times New Roman" size=2>16.6%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"><FONT face="Times New Roman" size=2>18.5%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Risk-free interest rate</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1.3% to 1.7%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1.4% to 2.0%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1.8% to 1.9%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"><FONT face="Times New Roman" size=2>Weighted-average risk-free interest rate</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%"><FONT face="Times New Roman" size=2>1.7%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"><FONT face="Times New Roman" size=2>1.9%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"><FONT face="Times New Roman" size=2>1.8%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Dividend yield</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2.5% to 2.8%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2.8% to 3.4%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3.4%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="94%"><FONT face="Times New Roman" size=2>Weighted-average dividend yield</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="2%"><FONT face="Times New Roman" size=2>2.8%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"><FONT face="Times New Roman" size=2>3.3%</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"><FONT face="Times New Roman" size=2>3.4%</FONT></TD></TR></TABLE>
<P style="MARGIN-TOP: 6pt; MARGIN-BOTTOM: 6pt" align=center><FONT face="Times New Roman" size=2>52</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 16. STOCK-BASED
COMPENSATION PLANS (Continued)</FONT></B><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The expected life of the stock
options is based on observed historical exercise patterns. The expected
volatility is based on implied volatility from publicly traded options on the
Company&#146;s stock at the date of grant, historical implied volatility of the
Company&#146;s publicly traded options and other factors. The risk-free interest rate
is based on the implied yield on a U.S. Treasury zero-coupon issue with a
remaining term equal to the expected term of the option. The dividend yield is
based on the projected annual dividend payment per share, divided by the stock
price at the date of grant.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Details of the Company&#146;s stock
option activities are summarized below: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 88%; TEXT-ALIGN: left" noWrap width="88%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Number
      of<BR>Shares<BR>(In thousands)</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Weighted-<BR>Average<BR>Exercise<BR>Price<BR>per
Share</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="1%"><B><FONT face="Times New Roman" size=1>Average<BR>Remaining<BR>Contractual<BR>Life</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Aggregate<BR>Intrinsic<BR>Value</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Options outstanding as of June 30,
      2015</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8,357</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>76</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>7 years</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>236</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Granted</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1,317</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;112</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Exercised</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2,633</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>69</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Cancelled</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(214</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>95</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Options outstanding as of June 30,
      2016</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>6,827</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>85</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>7 years</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;366</FONT></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=11>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Options vested as of June 30, 2016</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3,555</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>74</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"><FONT face="Times New Roman" size=2>5 years</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>228</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The weighted-average fair
value per share of each option granted during fiscal years 2016, 2015 and 2014,
estimated at the grant date using the Black-Scholes option pricing model was
$13.21, $9.65 and $9.69, respectively. The total intrinsic value of options
exercised in fiscal years 2016, 2015 and 2014 was $142, $140 and $42,
respectively. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Stock option awards
outstanding as of June 30, 2016, have been granted at prices that are equal to
the market value of the stock on the date of grant. Stock option grants
generally vest over four years and expire no later than ten years after the
grant date. The Company recognizes compensation expense ratably over the vesting
period. As of June 30, 2016, there was $16 of total unrecognized compensation
cost related to non-vested options, which is expected to be recognized over a
remaining weighted-average vesting period of one year, subject to forfeiture
changes. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Restricted Stock
Awards</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The fair value of restricted
stock awards is estimated on the date of grant based on the market price of the
stock and is amortized to compensation expense on a straight-line basis over the
related vesting periods, which are generally three to four years. The total
number of restricted stock awards expected to vest is adjusted by actual and
estimated forfeitures. Restricted stock grants receive dividend distributions
earned during the vesting period upon vesting. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016, there was
$1 of total unrecognized compensation cost related to non-vested restricted
stock awards, which is expected to be recognized over a remaining
weighted-average vesting period of one year. The total fair value of the shares
that vested in each of the fiscal years 2016, 2015 and 2014 was $1,
respectively. The weighted-average grant-date fair value of awards granted was
$128.91, $95.67 and $89.25 per share for fiscal years 2016, 2015 and 2014,
respectively.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>53</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 16. STOCK-BASED
COMPENSATION PLANS (Continued)</FONT></B><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>A summary of the status of the
Company&#146;s restricted stock awards is presented below: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 93%; TEXT-ALIGN: left" noWrap width="93%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 4%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Number
      of<BR>Shares<BR>(In thousands)</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Weighted-Average<BR>Grant Date<BR>Fair Value<BR>per
    Share</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Restricted stock awards as of June 30,
      2015</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>18</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>91</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>Granted</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>5</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>129</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Vested</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(9</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>88</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%"><FONT face="Times New Roman" size=2>Forfeited</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>106</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="93%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Restricted stock awards as of June 30,
      2016</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>13</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>108</FONT></TD></TR></TABLE>
<P align=left><B><FONT face="Times New Roman" size=2>Performance
Units</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016, there was
$37 in unrecognized compensation cost related to non-vested performance unit
grants that is expected to be recognized over a remaining weighted-average
performance period of one year. The weighted-average grant-date fair value of
awards granted was $92.35, $89.75 and $84.45 per share for fiscal years 2016,
2015 and 2014, respectively. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>A summary of the status of the
Company&#146;s performance unit awards is presented below: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 97%; TEXT-ALIGN: left" noWrap width="95%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2>
      <P><B><FONT face="Times New Roman" size=1>Number of<BR></FONT></B><B><FONT face="Times New Roman" size=1>Shares<BR></FONT></B><B><FONT face="Times New Roman" size=1>(In thousands)</FONT></B></P></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Weighted-Average<BR>Grant Date<BR>Fair Value<BR>per
    Share</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Performance unit awards as of June 30,
      2015</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,123</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>79</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Granted</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>286</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>92</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Distributed</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(377</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>70</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Forfeited</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(80</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>87</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Performance unit awards as of June 30,
      2016</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>952</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>90</FONT></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=6>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="95%"><FONT face="Times New Roman" size=2>Performance units vested and deferred as of June 30, 2016</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>157</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>58</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>The non-vested performance
units outstanding as of June 30, 2016 and 2015 were 794,000 and 944,000,
respectively, and the weighted average grant date fair value was $95.18 and
$81.92 per share, respectively. Total shares vested during fiscal year 2016 were
354,000, which had a weighted average grant date fair value per share of $72.11.
During fiscal year 2016, $25 of the vested awards was paid by the issuance of
shares and $1 of the vested awards was deferred. Deferred shares continue to
earn dividends, which are also deferred. The total fair value of shares vested
was $26, $24 and $0 during fiscal years 2016, 2015 and 2014, respectively. Upon
vesting, the recipients of the grants receive the distribution as shares or, if
previously elected by eligible recipients, as deferred stock.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Deferred Stock Units for
Nonemployee Directors</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Nonemployee directors receive
annual grants of deferred stock units under the Company&#146;s director compensation
program and can elect to receive all or a portion of their annual retainers and
fees in the form of deferred stock units. The deferred stock units receive
dividend distributions, which are reinvested as deferred stock units, and are
recognized at their fair value on the date of grant. Each deferred stock unit
represents the right to receive one share of the Company&#146;s common stock
following the completion of a director&#146;s service. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>During fiscal year 2016, the
Company granted 13,000 deferred stock units, reinvested dividends of 6,000 units
and distributed 16,000 shares, which had a weighted-average fair value on grant
date of $126.65, $124.03 and $62.70 per share, respectively. As of June 30,
2016, 244,000 units were outstanding, which had a weighted-average fair value on
the grant date of $71.13 per share. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>54</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 17. OTHER (INCOME)
EXPENSE, NET</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The major components of Other
(income) expense, net, for the fiscal years ended June 30 were: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Income from equity investees</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(15</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(14</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>Interest <FONT STYLE="BACKGROUND-COLOR: Transparent">income</FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Low income housing partnership gains,
      net</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>Foreign exchange transaction losses, net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>9</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Amortization of trademarks and other
      intangible assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>Intangible asset impairment charges</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>9</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Other</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(6</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(7</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(10</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>In April 2016, the Company
sold its Los Angeles bleach manufacturing facility, previously reported in the
Cleaning segment, which resulted in $20 in cash proceeds from investing
activities and a gain of $(11) included in Other in the table above for the year
ended June 30, 2016. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>During fiscal year 2016, the
Company recognized $9 of intangible asset impairment charges, of which $6
related to the Aplicare<SUP>&#174;</SUP> trademark within the Cleaning segment. The
Aplicare<SUP>&#174;</SUP> trademark impairment was recognized based on the
anticipated impact on future results from a competitive market
entrant.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Investment in Low-Income
Housing Partnerships </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company owns, directly or
indirectly, limited partnership interests in low-income housing partnerships,
which are accounted for using the equity method of accounting. These
partnerships are considered to be variable interest entities; however, the
Company does not consolidate them because it does not have the power to direct
the partnerships&#146; activities that significantly impact their economic
performance. The purpose of the partnerships is to develop and operate
low-income housing rental properties. The general partners, who typically hold
1% of the partnership interests, are third parties unrelated to the Company and
its affiliates, and are responsible for controlling and managing the business
and financial operations of the partnerships. As a limited partner, the Company
is not responsible for any of the liabilities and obligations of the
partnerships nor do the partnerships or their creditors have any recourse to the
Company other than for the capital requirements. All available tax benefits from
low-income housing tax credits provided by the partnerships were claimed as of
fiscal year 2012. The risk that previously claimed low-income housing tax
credits might be recaptured or otherwise retroactively invalidated is considered
remote. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In April 2015, a low-income
housing partnership, in which the Company was a limited partner, sold its real
estate holdings. The real property sale resulted in $15 in cash proceeds from
investing activities and a gain of $(14) recorded to Other (income) expense,
net, on the consolidated statement of earnings for the year ended June 30,
2015.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B></P>
<P align=center><FONT face="Times New Roman" size=2>55</FONT></P>
<HR align=center width="100%" noShade SIZE=2>
<!--PART 6-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 18. INCOME
TAXES</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The provision for income taxes
on continuing operations, by tax jurisdiction, consisted of the following for
the fiscal years ended June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Current</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Federal</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>254</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>265</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>247</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      State</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>31</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>28</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>34</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>45</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>38</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>45</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total current</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>330</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>331</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>326</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR style="VERTICAL-ALIGN: bottom">
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="82%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="3%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="3%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="3%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Deferred</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Federal</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>11</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(19</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; State</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Foreign</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(7</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Total deferred</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>5</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(16</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(21</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>335</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>315</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>305</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The components of earnings
from continuing operations before income taxes, by tax jurisdiction, consisted
of the following for the fiscal years ended June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>United States</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>900</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>829</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>754</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Foreign</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>83</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>92</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>130</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>983</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>921</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>884</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>A reconciliation of the
statutory federal income tax rate to the Company&#146;s effective tax rate on
continuing operations follows for the fiscal years ended June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Statutory federal tax rate</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>35.0</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>35.0</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>35.0</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"><FONT face="Times New Roman" size=2>State taxes (net of federal tax benefits)</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2.1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2.1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2.6</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Tax differential on foreign
    earnings</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>0.5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(0.3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(0.3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"><FONT face="Times New Roman" size=2>Domestic manufacturing deduction</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(2.4</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(2.1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(2.3</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Change in valuation allowance</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>0.5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>0.6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>0.6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"><FONT face="Times New Roman" size=2>Other differences</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(1.6</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(1.1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(1.0</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Effective tax rate</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>34.1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>34.2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>34.6</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Applicable U.S. income taxes
and foreign withholding taxes have not been provided on approximately $216 of
undistributed earnings of certain foreign subsidiaries as of June 30, 2016,
because these earnings are considered indefinitely reinvested. The estimated net
federal income tax liability that could arise if these earnings were not
indefinitely reinvested is approximately $56. Applicable U.S. income and foreign
withholding taxes are provided on these earnings in the periods in which they
are no longer considered indefinitely reinvested.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Tax benefits resulting from
stock-based payment arrangements that are in excess of the tax benefits recorded
in net earnings over the vesting period of those arrangements (excess tax
benefits) are recorded as increases to Additional paid-in capital. Excess tax
benefits of approximately $51, $42, and $11 were realized and recorded to
Additional paid-in capital for fiscal years 2016, 2015 and 2014,
respectively.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>56</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 18. INCOME TAXES
(Continued)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The components of net deferred
tax assets (liabilities) as of June 30 are shown below: </FONT></P>
<TABLE style="LINE-HEIGHT: 12pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Deferred tax assets </FONT><FONT face="Times New Roman" size=2><SUP>(a)</SUP></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Compensation and benefit
      programs</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>193</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>191</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Basis
      difference related to Venture Agreement</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>30</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>30</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accruals and
reserves</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>34</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>43</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Inventory costs</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>21</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>19</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net operating loss and tax
      credit carryforwards</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>48</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>41</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Other</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>54</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>61</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Subtotal</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>380</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>385</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Valuation allowance</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(37</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(34</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total deferred tax
      assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>343</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>351</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD width="100%" colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Deferred tax liabilities </FONT><FONT face="Times New Roman" size=2><SUP>(a)</SUP></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fixed and intangible
      assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(325</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(277</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Low-income housing partnerships</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(23</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(22</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unremitted foreign
      earnings</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(16</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(7</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Other</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(25</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(24</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total deferred tax
      liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (389</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (330</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net
      deferred tax assets (liabilities)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(46</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>21</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=1><SUP>(a) </SUP></FONT><FONT face="Times New Roman" size=1>The Company prospectively adopted ASU No. 2015-17,
"Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes,"
requiring all deferred tax assets and liabilities to be classified as
noncurrent. See Note 1 for further details.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company periodically
reviews its deferred tax assets for recoverability. A valuation allowance is
established when the Company believes that it is more likely than not that some
portion of its deferred tax assets will not be realized. Valuation allowances
have been provided to reduce deferred tax assets to amounts considered
recoverable. Details of the valuation allowance were as follows as of June 30:
</FONT></P>
<TABLE style="LINE-HEIGHT: 12pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD noWrap align=center width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Valuation allowance at beginning of
      year</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(34</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(51</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Net
      decrease/(increase) for other foreign deferred tax assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>15</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net decrease/(increase) for foreign net
      operating loss carryforwards and tax credits</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(6</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Valuation allowance at end of year</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (37</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (34</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>As of June 30, 2016, the
Company had foreign tax credit carryforwards of $15 for U.S. income tax purposes
with expiration dates between fiscal years 2024 and 2025. Tax credit
carryforwards in foreign jurisdictions of $19 have expiration dates in fiscal
year 2031. Tax credit carryforwards in foreign jurisdictions of $1 can be
carried forward indefinitely. Tax benefits from foreign net operating loss
carryforwards of $16 have expiration dates between fiscal years 2017 and 2036.
Tax benefits from foreign net operating loss carryforwards of $12 can be carried
forward indefinitely.</FONT><B><FONT face="Times New Roman" size=2>
</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company files income tax
returns in the U.S. federal and various state, local and foreign jurisdictions.
The federal statute of limitations has expired for all tax years through June
30, 2012. Various income tax returns in state and foreign jurisdictions are
currently in the process of examination. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company recognizes
interest and penalties related to uncertain tax positions as a component of
income tax expense. As of June 30, 2016 and 2015, the total balance of accrued
interest and penalties related to uncertain tax positions was $3 and $10,
respectively. Interest and penalties related to uncertain tax positions included
in income tax expense resulted in a net benefit of $1, a net benefit of $1, and
a net expense of $3 in fiscal years 2016, 2015 and 2014,
respectively.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>57</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 18. INCOME TAXES
(Continued)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The following is a
reconciliation of the beginning and ending amounts of the Company&#146;s gross
unrecognized tax benefits: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Unrecognized tax benefits at beginning of
      year</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>38</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>71</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>69</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Gross increases - tax positions in prior periods</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Gross decreases - tax positions in prior
      periods</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(8</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Gross increases - current period tax positions</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>8</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>7</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Gross decreases - current period tax
      positions</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Lapse of applicable statute of limitations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(34</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Settlements</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: right" noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Unrecognized tax benefits at end of year</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>37</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>38</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>71</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Included in the balance of
unrecognized tax benefits as of June 30, 2016, 2015 and 2014, are potential
benefits of $27, $27 and $58, respectively, which if recognized, would affect
net earnings. During the fiscal year ended June 30, 2015, $32 of gross
unrecognized tax benefits relating to other discontinued operations for periods
prior to fiscal year 2015 were recognized upon the expiration of the applicable
statute of limitations. Recognition of these previously disclosed tax benefits
had no impact on the Company&#146;s cash flow or earnings from continuing operations
for the fiscal years ended June 30, 2016, 2015 and 2014. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 19. EMPLOYEE BENEFIT
PLANS</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Retirement Income
Plans</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Effective July 1, 2011, and as
part of a set of long-term, cost-neutral enhancements to the Company&#146;s overall
employee benefit plans, the domestic qualified retirement income pension plan
was frozen for service accrual and eligibility purposes for most participants,
however, interest credits have continued to accrue on participant balances. As
of June 30, 2016 and 2015, the benefits of the domestic pension plan are based
on either employee years of service and compensation or a stated dollar amount
per year of service. The Company is the sole contributor to the plan in amounts
deemed necessary to provide benefits and to the extent deductible for federal
income tax purposes. Assets of the plan consist primarily of investments in cash
equivalents and common collective trusts.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company contributed $15 to
its domestic qualified pension plan during fiscal year 2016. No contributions
were made in fiscal year 2015 and 2014. The Company&#146;s funding policy for its
qualified plans is to contribute amounts sufficient to meet minimum funding
requirements as set forth in employee benefit tax laws plus additional amounts
as the Company may determine to be appropriate. Subsequent to June 30, 2016, the
Company made a $15 discretionary contribution to the pension plan.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Contributions made to the
domestic non-qualified pension plans were $16, $13 and $13 in fiscal years 2016,
2015 and 2014, respectively.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Retirement Health Care
Plans</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company provides certain
health care benefits for employees who meet age, participation and length of
service requirements at retirement. The plans pay stated percentages of covered
expenses after annual deductibles have been met or stated reimbursements up to a
specified dollar subsidy amount. Benefits paid take into consideration payments
by Medicare for the domestic plan. The plans are funded as claims are paid, and
the Company has the right to modify or terminate certain plans. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The assumed domestic health
care cost trend rate used in measuring the accumulated benefit obligation (ABO)
was 6.75% for both medical and prescription drugs for fiscal year 2016. These
rates have been assumed to gradually decrease each year until an assumed
ultimate trend of 4.5% is reached in 2037. The health care cost trend rate
assumption has a minimal effect on the amounts reported due primarily to the
existence of benefit cap provisions in the Company&#146;s domestic plan. As such, the
effect of a hypothetical 100 basis point increase or decrease in the assumed
domestic health care cost trend rate on the total service and interest cost
components as well as the postretirement benefit obligation would have been
immaterial for each of the fiscal years ended June 30, 2016, 2015 and
2014.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>58</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 19. EMPLOYEE BENEFIT
PLANS (Continued) </FONT></B></P>
<P align=left><B><FONT face="Times New Roman" size=2>Financial Information
Related to Retirement Income and Retirement Health Care </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Summarized information for the
Company&#146;s retirement income and retirement health care plans as of and for the
fiscal years ended June 30 is as follows: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="76%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="11%" colSpan=7><B><FONT face="Times New Roman" size=1>Retirement<BR>Income</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="11%" colSpan=7><B><FONT face="Times New Roman" size=1>Retirement<BR>Health
      Care</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Change in benefit obligations:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"><FONT face="Times New Roman" size=2>Projected benefit obligation as of beginning of year</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>639</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="TEXT-ALIGN: left" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>641</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>45</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>49</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Service
      cost</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest cost</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>26</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>25</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Actuarial loss (gain)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>51</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>14</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Plan amendments</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Translation and other adjustments</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benefits paid</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(42</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(38</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Projected benefit obligation as of end of year</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>673</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>639</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>47</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>45</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR style="VERTICAL-ALIGN: bottom">
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="76%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="3%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="3%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="3%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: right" noWrap width="3%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: black 1pt; BACKGROUND-COLOR: #c0c0c0; TEXT-ALIGN: left" noWrap width="1%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"><FONT face="Times New Roman" size=2>Change in plan assets:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fair
      value of assets as of beginning of year</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>409</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="TEXT-ALIGN: left" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>432</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Actual return on plan
      assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>26</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Employer contributions</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>31</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>13</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benefits paid</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(42</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(38</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Translation and other adjustments</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"><FONT face="Times New Roman" size=2>Fair
      value of plan assets as of end of year</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>423</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>409</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Accrued benefit cost, net funded
      status</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(250</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(230</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(47</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(45</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=17>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Amount recognized in the balance sheets
      consists of:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pension benefit
    assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="TEXT-ALIGN: left" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current
      accrued benefit liability</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(14</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(16</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-current accrued benefit
      liability</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(237</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(216</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(44</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(42</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="76%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued
      benefit cost, net</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(250</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double; TEXT-ALIGN: left" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(230</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(47</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(45</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>59</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 19. EMPLOYEE BENEFIT
PLANS (Continued)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Retirement income plans with
ABO in excess of plan assets as of June 30 were as follows: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="80%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>Pension
    Plans</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>Other<BR>Retirement
      Plans</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Projected benefit obligation</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>575</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>538</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      76</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      80</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"><FONT face="Times New Roman" size=2>Accumulated benefit obligation</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>574</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>538</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>76</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>80</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Fair value of plan assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>399</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>385</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The ABO for all pension plans
was $596, $559 and $563 as of June 30, 2016, 2015 and 2014, respectively.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The net costs of the
retirement income and health care plans for the fiscal years ended June 30
included the following components: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="67%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="16%" colSpan=11><B><FONT face="Times New Roman" size=1>Retirement
      Income</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="16%" colSpan=10><B><FONT face="Times New Roman" size=1>Retirement Health
      Care</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Service cost</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%"><FONT face="Times New Roman" size=2>Interest cost</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>26</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>25</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>27</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Expected return on plan assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      (17</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      (20</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (25</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%"><FONT face="Times New Roman" size=2>Amortization of unrecognized
      items&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>10</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>12</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>11</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="67%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>20</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>19</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>16</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>) </FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>60</FONT></P>

<HR align=center width="100%" noShade SIZE=2>


<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 19. EMPLOYEE BENEFIT
PLANS (Continued) </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Items not yet recognized as a
component of postretirement expense as of June 30, 2016, consisted of:
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="89%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>Retirement<BR>Income</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>Retirement<BR>Health
      Care</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net actuarial loss (gain)</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>296</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(13</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>Prior service benefit</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(6</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net deferred income tax (assets)
      liabilities</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (111</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>7</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>Accumulated other comprehensive loss (income)</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>185</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(12</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Net actuarial loss (gain)
recorded in Accumulated other comprehensive net (losses) income for the fiscal
year ended June 30, 2016, included the following: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>Retirement<BR>Income</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=1>Retirement<BR>Health
      Care</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net actuarial loss (gain) as of beginning of
      year</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
264</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(17</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Amortization during the year</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(10</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Loss (gain) during the year</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>42</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Net
      actuarial loss (gain) as of end of year</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>296</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>(13</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The Company uses the
straight-line amortization method for unrecognized prior service costs and
benefits. In fiscal year 2017, the Company expects to recognize, on a pre-tax
basis, $11 of the net actuarial loss as a component of net periodic benefit cost
for the Pension Plans. In addition, in fiscal year 2017, the Company expects to
recognize, on a pre-tax basis, $1 of the net actuarial gain as a component of
net periodic benefit cost for the retirement health care plans. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Weighted-average assumptions
used to estimate the actuarial present value of benefit obligations as of June
30 were as follows: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="80%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>Retirement
      Income</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>Retirement Health
      Care</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Discount rate</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3.42</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.20</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3.42</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.16</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"><FONT face="Times New Roman" size=2>Rate
      of compensation increase</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2.92</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3.37</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>n/a</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>n/a</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Weighted-average assumptions
used to estimate the net periodic pension and other postretirement benefit costs
as of June 30 were as follows: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="14%" colSpan=8><B><FONT face="Times New Roman" size=1>Retirement
      Income</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Discount rate</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.20</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.05</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.39</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"><FONT face="Times New Roman" size=2>Rate
      of compensation increase</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3.37</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>4.46</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3.44</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Expected return on plan assets</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.34</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5.28</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>6.61</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=10>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="14%" colSpan=8><B><FONT face="Times New Roman" size=1>Retirement Health
      Care</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="85%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Discount rate</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.16</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.00</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.33</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The expected long-term rate of
return assumption is based on an analysis of historical experience of the
portfolio and the summation of prospective returns for each asset class in
proportion to the fund&#146;s current asset allocation.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>61</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 19. EMPLOYEE BENEFIT
PLANS (Continued) </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>Expected benefit payments for
the Company&#146;s pension and other postretirement plans as of June 30, 2016, were
as follows: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR style="PADDING-BOTTOM: 2pt; LINE-HEIGHT: normal; PADDING-TOP: 2pt" vAlign=bottom>
    <TD noWrap align=left width="91%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Retirement<BR>Income</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Retirement<BR>Health
      Care</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2017</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>39</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%"><FONT face="Times New Roman" size=2>2018</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>52</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2019</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>39</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%"><FONT face="Times New Roman" size=2>2020</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>39</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2021</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>39</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%"><FONT face="Times New Roman" size=2>Fiscal years 2022 through 2026</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>193</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>12</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Expected benefit payments are
based on the same assumptions used to measure the benefit obligations and
include estimated future employee service. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The target allocations and
weighted average asset allocations by asset category of the investment portfolio
for the Company&#146;s domestic retirement income plans as of June 30 were:
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="81%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>% Target
      Allocation</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=5><B><FONT face="Times New Roman" size=1>% of Plan
      Assets</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="81%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="81%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>U.S. equity</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>11</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>11</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>11</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>11</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="81%"><FONT face="Times New Roman" size=2>International equity</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>12</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>12</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>11</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>12</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="81%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Fixed income</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>74</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>74</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>74</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>74</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="81%"><FONT face="Times New Roman" size=2>Other</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="81%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>100</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>100</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>100</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>100</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The target asset allocation is
determined based on the optimal balance between risk and return and, at times,
may be adjusted to achieve the plan&#146;s overall investment objective to generate
sufficient resources to pay current and projected plan obligations over the life
of the domestic qualified retirement income plan. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>62</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 19. EMPLOYEE BENEFIT
PLANS (Continued)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The following table sets forth
by level within the fair value hierarchy, the retirement income plans&#146; assets
carried at fair value as of June 30: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR>
    <TD noWrap align=left width="86%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="13%" colSpan=8><STRONG><FONT face="Times New Roman" size=1>2016</FONT></STRONG></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Level 1</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Level 2</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>Total</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Cash equivalents</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: right" noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: left" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>Common collective trusts</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="TEXT-ALIGN: right" noWrap align=left width="2%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bond
      funds</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>307</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>307</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; International equity
      funds</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>56</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>56</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Domestic equity funds</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>44</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>44</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Real estate fund</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>14</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>14</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total common collective trusts</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>421</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>421</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>Total assets at fair value</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>421</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double; TEXT-ALIGN: left" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>423</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=10>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="13%" colSpan=8><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Level 1</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=1>Level 2</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>Total</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Cash equivalents</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: left" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: right" noWrap align=left width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: left" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>Common collective trusts</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="2%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bond
      funds</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>295</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>295</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; International equity
      funds</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>59</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>59</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      Domestic equity funds</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>41</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>41</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Real estate fund</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>11</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>11</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total common collective trusts</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>406</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>406</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="86%"><FONT face="Times New Roman" size=2>Total assets at fair value</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double; TEXT-ALIGN: left" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>406</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>409</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The carrying value of cash
equivalents approximates its fair value as of June 30, 2016 and 2015.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>63</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 19. EMPLOYEE BENEFIT
PLANS (Continued)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Common collective trust funds
are not publicly traded and, therefore, are classified as Level 2. They are
valued at a net asset value unit price determined by the portfolio&#146;s sponsor
based on the fair value of underlying assets held by the common collective trust
fund on June 30, 2016 and 2015. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The common collective trusts
are invested in various trusts that attempt to achieve their investment
objectives by investing primarily in other collective investment funds which
have characteristics consistent with each trust&#146;s overall investment objective
and strategy. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Defined Contribution
Plans</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company has defined
contribution plans for most of its domestic employees. The plans include The
Clorox Company 401(k) Plan, The Clorox Company 2011 Nonqualified Defined
Contribution Plan and the Executive Retirement Plan. The aggregate cost of the
domestic defined contribution plans was $45, $45 and $43 in fiscal years 2016,
2015 and 2014, respectively. Included in the aggregate cost was the cost of The
Clorox Company 401(k) Plan of $41, $42 and $38 in fiscal years 2016, 2015 and
2014, respectively. The Company also has defined contribution plans for certain
international employees. The aggregate cost of these foreign plans was $3 for
the fiscal years ended June 30, 2016, 2015 and 2014. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 20. SEGMENT
REPORTING</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company operates through
strategic business units that are aggregated into the following four reportable
segments based on the economics and nature of the products sold: </FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: left" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%"><EM>Cleaning</EM><FONT face="Times New Roman" size=2> consists of laundry, home care and professional products marketed
      and sold in the United States. Products within this segment include
      laundry additives, including bleach products under the Clorox<SUP>&#174;</SUP>
      brand and Clorox 2<SUP>&#174;</SUP> stain fighter and color booster; home care
      products, primarily under the Clorox<SUP>&#174;</SUP>, Formula 409<SUP>&#174;</SUP>,
      Liquid-Plumr<SUP>&#174;</SUP>, Pine-Sol<SUP>&#174;</SUP>, S.O.S<SUP>&#174;</SUP> and
      Tilex<SUP>&#174;</SUP> brands; naturally derived products under the Green
      Works<SUP>&#174;</SUP> brand; and professional cleaning and disinfecting
      products under the Clorox<SUP>&#174;</SUP>, Dispatch<SUP>&#174;</SUP>,
      Aplicare<SUP>&#174;</SUP>, HealthLink<SUP>&#174;</SUP> and Clorox
      Healthcare<SUP>&#174;</SUP> brands.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%"><EM>Household</EM><FONT face="Times New Roman" size=2> consists of charcoal, cat litter, digestive health products and
      bags, wraps and container products marketed and sold in the United States.
      Products within this segment include charcoal products under the
      Kingsford<SUP>&#174;</SUP> and Match Light<SUP>&#174;</SUP> brands; cat litter
      products under the Fresh Step<SUP>&#174;</SUP>, Scoop Away<SUP>&#174;</SUP> and Ever
      Clean<SUP>&#174;</SUP> brands; digestive health products under the Renew
      Life<SUP>&#174;</SUP> brand; and bags, wraps and containers under the
      Glad<SUP>&#174;</SUP> brand.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%"><EM>Lifestyle</EM><FONT face="Times New Roman">
      consists of food products, water-filtration systems and filters and
      natural personal care products marketed and sold in the United States.
      Products within this segment include dressings and sauces, primarily under
      the Hidden Valley<SUP>&#174;</SUP>, KC Masterpiece<SUP>&#174;</SUP> and Soy
      Vay<SUP>&#174;</SUP> brands; water-filtration systems and filters under the
      Brita<SUP>&#174;</SUP> brand; and natural personal care products under the
      Burt&#146;s Bees<SUP>&#174;</SUP> brand.</FONT></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%"><EM>International</EM><FONT face="Times New Roman"> consists of products sold outside the United
      States. Products within this segment include laundry, home care,
      water-filtration, digestive health products, charcoal and cat litter
      products, dressings and sauces, bags, wraps and containers and natural
      personal care products, primarily under the Clorox<SUP>&#174;</SUP>,
      Glad<SUP>&#174;</SUP>, PinoLuz<SUP>&#174;</SUP>, Ayudin<SUP>&#174;</SUP>,
      Limpido<SUP>&#174;</SUP>, Clorinda<SUP>&#174;</SUP>, Poett<SUP>&#174;</SUP>,
      Mistolin<SUP>&#174;</SUP>, Lestoil<SUP>&#174;</SUP>, Bon Bril<SUP>&#174;</SUP>,
      Brita<SUP>&#174;</SUP>, Green Works<SUP>&#174;</SUP>, Pine-Sol<SUP>&#174;</SUP>, Agua
      Jane<SUP>&#174;</SUP>, Chux<SUP>&#174;</SUP>, Renew Life<SUP>&#174;</SUP>,
      Kingsford<SUP>&#174;</SUP>, Fresh Step<SUP>&#174;</SUP>, Scoop Away<SUP>&#174;</SUP>,
      Ever Clean<SUP>&#174;</SUP>, KC Masterpiece<SUP>&#174;</SUP>, Hidden
      Valley<SUP>&#174;</SUP> and Burt&#146;s Bees<SUP>&#174;</SUP>
brands.</FONT></TD></TR></TABLE>
<P align=left><FONT face="Times New Roman" size=2>Certain non-allocated
administrative costs, interest income, interest expense and various other
non-operating income and expenses are reflected in Corporate. Corporate assets
include cash and cash equivalents, property and equipment, other investments and
deferred taxes.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>64</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 20. SEGMENT REPORTING
(Continued)</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 72%; PADDING-TOP: 2pt; TEXT-ALIGN: left" noWrap width="72%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: left" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%"><B><FONT face="Times New Roman" size=1>Fiscal<BR>Year</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>Cleaning</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>Household</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>Lifestyle</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>International</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>Corporate</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 3%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>Total<BR>Company</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>Net
    sales</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>2016</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>1,912</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>1,862</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>990</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>997</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>5,761</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>2015</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>1,824</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>1,794</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>950</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>1,087</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>5,655</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>2014</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>1,776</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>1,709</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>936</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>1,093</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>5,514</FONT></FONT></TD></TR>
  <TR>
    <TD align=left width="100%" bgColor=#c0c0c0 colSpan=22><FONT color=#000000>&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%"><FONT face="Times New Roman" size=2>Earnings (losses) from continuing</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;operations before income
      taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>511</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>428</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>251</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>66</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(273</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>983</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>445</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>375</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>257</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>79</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(235</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>921</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2014</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>428</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>326</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>258</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>99</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(227</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>884</FONT></TD></TR>
  <TR>
    <TD align=left width="100%" colSpan=22></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>Income from equity
      investees</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>2016</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>-</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>15</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>15</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>2015</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>-</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>14</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>14</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>2014</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>-</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>13</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>13</FONT></FONT></TD></TR>
  <TR>
    <TD align=left width="100%" bgColor=#c0c0c0 colSpan=22></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%"><FONT face="Times New Roman" size=2>Total assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>883</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1,092</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>880</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1,057</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>606</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>4,518</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>876</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>725</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>860</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1,057</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>646</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>4,164</FONT></TD></TR>
  <TR>
    <TD align=left width="100%" colSpan=22></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>Capital
      expenditures</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>2016</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>44</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>83</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>18</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>24</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>3</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>172</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>2015</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>35</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>50</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>11</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>25</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>4</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>125</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>2014</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>37</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>53</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>11</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>31</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>5</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>137</FONT></FONT></TD></TR>
  <TR>
    <TD align=left width="100%" bgColor=#c0c0c0 colSpan=22></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%"><FONT face="Times New Roman" size=2>Depreciation and amortization</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>61</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>60</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>19</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>21</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>165</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>52</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>67</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>19</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>24</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>7</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>169</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2014</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>49</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>67</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>19</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>25</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>17</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>177</FONT></TD></TR>
  <TR>
    <TD align=left width="100%" colSpan=22></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>Significant noncash
      charges included</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in earnings (losses) from
      continuing</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#c0c0c0><FONT color=#000000><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;operations before income
      taxes:</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based
      compensation</FONT></FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="3%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>2016</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>10</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>8</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>5</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>1</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>21</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>45</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="3%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>2015</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>8</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>7</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>4</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>1</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>12</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>32</FONT></FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="72%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="3%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>2014</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>11</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>9</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>5</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>1</FONT></FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="1%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>10</FONT></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=left width="1%" bgColor=#ffffff></TD>
    <TD noWrap align=right width="2%" bgColor=#ffffff><FONT color=#000000><FONT face="Times New Roman" size=2>36</FONT></FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman"><FONT face="Times New Roman" size=2>65</FONT></FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 20. SEGMENT
REPORTING</FONT></B><FONT face="Times New Roman" size=2></FONT> <B><FONT face="Times New Roman" size=2>(Continued)</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>All intersegment sales are
eliminated and are not included in the Company&#146;s reportable segments&#146; net
sales.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Net sales to the Company&#146;s
largest customer, Walmart Stores, Inc. and its affiliates, were 27%, 26% and 27%
of consolidated net sales for each of the fiscal years ended June 30, 2016, 2015
and 2014, respectively, and occurred in each of the Company&#146;s reportable
segments. No other customers accounted for more than 10% of consolidated net
sales in any of these fiscal years. During fiscal years 2016, 2015 and 2014, the
Company&#146;s five largest customers accounted for 46%, 45%, and 45% of its
consolidated net sales for each of the three fiscal years,
respectively.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Three of the Company&#146;s product
lines have accounted for 10% or more of consolidated net sales during each of
the past three fiscal years. In fiscal years 2016, 2015 and 2014, sales of
liquid bleach represented approximately 13%, 14% and 13% of the Company&#146;s
consolidated net sales, respectively, approximately 25%, 26%, and 26% of net
sales in the Cleaning segment for each such years, respectively, and
approximately 27%, 27% and 28% of net sales in the International segment,
respectively. Sales of trash bags represented approximately 13%, 14% and 13% of
the Company&#146;s consolidated net sales in each of the fiscal years 2016, 2015 and
2014, respectively, and approximately 37%, 38% and 36% of net sales in the
Household segment, respectively, for each such years. Sales of charcoal
represented approximately 11% of the Company&#146;s consolidated net sales and
approximately 34% of net sales in the Household segment in fiscal years 2016,
2015 and 2014.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Net sales and property, plant
and equipment, net, by geographic area as of and for the fiscal years ended June
30 were as follows:</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR style="LINE-HEIGHT: normal" vAlign=bottom>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 100%; PADDING-TOP: 2pt; TEXT-ALIGN: left" noWrap width="90%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="1%"><B><FONT face="Times New Roman" size=1>Fiscal<BR>Year</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>United<BR>States</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Foreign</FONT></B></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 1%; PADDING-TOP: 2pt; TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="PADDING-BOTTOM: 2pt; WIDTH: 2%; PADDING-TOP: 2pt; BORDER-BOTTOM: #000000 1pt solid; TEXT-ALIGN: center" noWrap width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>Total<BR>Company</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net sales</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,805</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>956</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5,761</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,609</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,046</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5,655</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2014</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,466</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,048</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5,514</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2>Property, plant and equipment, net</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>799</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>107</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>906</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>2015</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>801</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>117</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>918</FONT></TD></TR></TABLE><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 21. RELATED PARTY
TRANSACTIONS</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The Company holds various
equity investments with ownership percentages of up to 50% in a number of
consumer products businesses, most of which operate outside the United States.
The equity investments, presented in Other assets accounted for under the equity
method, were $59 as of the fiscal years ended June 30, 2016 and 2015. The
Company has no ongoing capital commitments, loan requirements, guarantees or any
other types of arrangements under the terms of its agreements that would require
any future cash contributions or disbursements arising out of an equity
investment.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Transactions with the
Company&#146;s equity investees typically represent payments for contract
manufacturing and purchases of raw materials. Payments to related parties,
including equity investees, for such transactions during the fiscal years ended
June 30, 2016, 2015 and 2014 were $57, $55 and $57, respectively. Receipts from
and ending accounts receivable and payable balances related to the Company&#146;s
related parties were not significant during or as of the end of each of the
fiscal years presented.</FONT></P>
<P align=center><FONT face="Times New Roman"><FONT face="Times New Roman" size=2>66</FONT></FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 22. UNAUDITED
QUARTERLY DATA</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>Dollars in millions, except market price and per share
    data</FONT></TD>
    <TD noWrap align=center width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="17%" colSpan=17><B><FONT face="Times New Roman" size=1>Quarters
    Ended</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD noWrap align=center width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>September
30</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>December 31</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>March 31</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>June 30</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>Total
  Year</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=1>Fiscal year ended June 30,
2016</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>Net
      sales</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>1,390</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>1,345</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>1,426</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>1,600</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>5,761</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>Cost of products sold</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>765</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>745</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>780</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>873</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>3,163</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>Earnings from continuing operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>173</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>151</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>159</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>165</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>648</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>(Losses) earnings from discontinued
      operations,</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;net of tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>(2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>Net
      earnings</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>172</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>149</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>162</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>165</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>648</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>Per common share:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.34</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.16</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.23</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.28</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>5.01</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued
      operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>(0.01</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>(0.01</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.02</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic
      net earnings per share</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.33</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.15</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.25</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.28</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>5.01</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.32</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.14</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.21</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.26</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>4.92</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued
      operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>(0.01</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>(0.01</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.02</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted
      net earnings per share</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.31</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.13</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.23</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.26</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>4.92</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>Dividends declared per common share</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.77</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.77</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.77</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.80</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>3.11</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>Market price (NYSE)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;High</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>119.75</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>131.78</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>132.19</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>138.41</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>138.41</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Low</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>104.26</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>114.06</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>122.40</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>119.23</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>104.26</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year-end</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>138.39</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=1>Fiscal year ended June 30,
2015</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>Net
      sales</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>1,352</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>1,345</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>1,401</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>1,557</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>5,655</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>Cost of products sold</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>774</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>773</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>796</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>847</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>3,190</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>Earnings from continuing operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>145</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>128</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>144</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>189</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>606</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>Losses from discontinued
    operations,</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;net of tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>(55</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>(3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>30</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>(26</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>Net
      earnings</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>90</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>125</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>174</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>191</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>580</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>Per common share:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.12</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>0.98</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.09</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.46</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>4.65</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued
      operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>(0.42</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>(0.02</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.22</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.02</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>(0.20</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic
      net earnings per share</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>0.70</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>0.96</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.31</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.48</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>4.45</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.10</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>0.97</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.08</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.44</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>4.57</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued
      operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>(0.42</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>(0.02</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.22</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.02</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=1>(0.20</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=1>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted
      net earnings per share</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>0.68</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>0.95</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.30</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>1.46</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>4.37</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>Dividends declared per common share</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.74</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.74</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.74</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>0.77</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>2.99</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD align=left width="100%" colSpan=19>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>Market price (NYSE)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;High</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>112.70</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>112.65</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>106.36</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>98.31</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=1>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>112.70</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Low</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>103.77</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>102.95</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>95.19</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>86.03</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=1>86.03</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year-end</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=1>104.02</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman"><FONT face="Times New Roman" size=2>67</FONT></FONT></P>
<HR align=center width="100%" noShade SIZE=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>FIVE-YEAR FINANCIAL SUMMARY
<BR></FONT></B><I><FONT face="Times New Roman" size=2>The Clorox
Company</FONT></I><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD noWrap align=center width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="17%" colSpan=17><B><FONT face="Times New Roman" size=1>Years ended June
      30</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><B><FONT face="Times New Roman" size=1>Dollars in millions, except per share data</FONT></B></TD>
    <TD noWrap align=center width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2013</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2012</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>OPERATIONS</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Net
      sales</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>5,761</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>5,655</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>5,514</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>5,533</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>5,379</FONT></TD></TR>
  <TR>
    <TD align=left width="100%" colSpan=19>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Gross profit</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,598</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,465</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,356</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,391</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,272</FONT></TD></TR>
  <TR>
    <TD align=left width="100%" bgColor=#c0c0c0 colSpan=19>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Earnings from continuing operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>648</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>606</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>579</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>573</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>535</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(Losses) earnings from discontinued
      operations,</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;net of
      tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(26</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(21</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>6</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Net
      earnings</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>648</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>580</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>558</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>572</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>541</FONT></TD></TR>
  <TR>
    <TD align=left width="100%" bgColor=#c0c0c0 colSpan=19>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>COMMON STOCK</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Earnings per share</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>5.01</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4.65</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4.47</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4.37</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4.09</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.92</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.57</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.39</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.31</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4.05</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Dividends declared per share</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3.11</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2.99</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2.87</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2.63</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2.44</FONT></TD></TR>
  <TR>
    <TD align=left width="100%" colSpan=19>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD noWrap align=center width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="17%" colSpan=17><B><FONT face="Times New Roman" size=1>As of June
    30</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><B><FONT face="Times New Roman" size=1>Dollars in millions</FONT></B></TD>
    <TD noWrap align=center width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2014</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=1>2013</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>2012</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>OTHER DATA</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Total assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4,518</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4,164</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4,258</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4,311</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>4,355</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Long-term debt</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,797</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,796</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,595</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,170</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,571</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman"><FONT face="Times New Roman" size=2>68</FONT></FONT></P>
<HR align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>13
<FILENAME>clorox3118951_1-ex992.htm
<DESCRIPTION>VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit 99.2
</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>VALUATION AND QUALIFYING
ACCOUNTS AND RESERVES (Dollars in millions) </FONT></B></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="89%"><B><FONT face="Times New Roman" size=1>Column
A</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=1>Column
B</FONT></B></TD>
    <TD style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=1>Column
C</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=5><B><FONT face="Times New Roman" size=1>Column
      D</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=1>Column
  E</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="2%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=1>Additions</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=5><B><FONT face="Times New Roman" size=1>Deductions</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="2%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD></TR>
  <TR vAlign=bottom style="line-height: normal">
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: left; width: 89%; padding-top: 2pt; padding-bottom: 2pt"><STRONG><FONT size=1 face="Times New Roman">Description</FONT></STRONG></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt"></TD>
    <TD NOWRAP COLSPAN="3" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 4%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Balance
      at<BR>beginning<BR>of period</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt"></TD>
    <TD NOWRAP COLSPAN="3" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 4%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Charged to<BR>costs
      and<BR>expenses</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt"></TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 2%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Credited
      to<BR>costs and<BR>expenses</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 2%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Credited<BR>to
      other<BR>accounts</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; padding-top: 2pt; padding-bottom: 2pt"></TD>
    <TD NOWRAP COLSPAN="3" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 4%; padding-top: 2pt; padding-bottom: 2pt"><B><FONT face="Times New Roman" size=1>Balance
      at<BR>end<BR>of period</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Allowance for doubtful accounts</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year ended June 30,
      2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman">-<FONT face="Times New Roman"></FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year ended June 30,
      2015</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year ended June 30,
      2014</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(3</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>LIFO
      allowance</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year ended June 30,
      2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(34</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman">-<FONT face="Times New Roman"></FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(32</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year ended June 30,
      2015</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(36</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(34</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year ended June 30,
      2014</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(40</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(36</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Valuation allowance on deferred tax assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year ended June 30,
      2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(34</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman">-<FONT face="Times New Roman"></FONT></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(37</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year ended June 30,
      2015</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(51</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>21</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(34</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Year ended June 30,
      2014</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(36</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(25</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>10</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(51</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>1</FONT></P>
<HR align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>14
<FILENAME>clorox3118951_1-ex993.htm
<DESCRIPTION>RECONCILIATION OF ECONOMIC PROFIT (UNAUDITED)
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit
99.3</FONT></B></P>
<P align=center style="margin-bottom: 10pt"><B><FONT face="Times New Roman" size=2>THE CLOROX COMPANY
<BR></FONT></B><B><FONT face="Times New Roman" size=2>RECONCILIATION OF ECONOMIC
PROFIT (UNAUDITED) </FONT></B><B><FONT face="Times New Roman" size=2><SUP>(1)
</SUP></FONT></B></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="88%"><B><FONT face="Times New Roman" size=1>Dollars in
      millions</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>FY16</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=1>FY15</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=1>FY14</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>Earnings from
      continuing operations before income taxes</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>983</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>921</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>884</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Noncash U.S. GAAP restructuring and intangible asset
      impairment costs</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>9</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Interest expense</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>88</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>100</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>103</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Earnings from continuing operations before income
      taxes,</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;noncash U.S. GAAP
      restructuring and intangible asset impairment</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;costs, and interest
      expense</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1,080</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1,022</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>990</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Income taxes on earnings from continuing operations
      before</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;income taxes,
      noncash U.S. GAAP restructuring and intangible asset</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;impairment costs
      and interest expense<SUP>(2)</SUP></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>368</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>350</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>342</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><B><FONT face="Times New Roman" size=2>Adjusted after tax profit</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><B><FONT face="Times New Roman" size=2>712</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><B><FONT face="Times New Roman" size=2>672</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>648</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Average capital employed<SUP>(3)</SUP></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,472</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,393</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2,494</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><B><FONT face="Times New Roman" size=2>Capital charge</FONT></B><FONT face="Times New Roman" size=2><SUP>(4)</SUP></FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><B><FONT face="Times New Roman" size=2>222</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><B><FONT face="Times New Roman" size=2>214</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>225</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>Economic
      profit</FONT></B><FONT face="Times New Roman" size=2><SUP>(1) </SUP></FONT><FONT face="Times New Roman" size=2>(Adjusted after tax profit less capital charge)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>490</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>458</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>423</FONT></B></TD></TR></TABLE></DIV><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Economic profit (EP)
      is defined by the Company as earnings from continuing operations before
      income taxes, excluding noncash U.S. GAAP restructuring and intangible
      asset impairment costs, and interest expense; less an amount of tax based
      on the effective tax rate, and less a charge equal to average capital
      employed multiplied by a cost of capital rate. EP is a key financial
      metric that the Company&#146;s management uses to evaluate business performance
      and allocate resources, and is a component in determining employee
      incentive compensation. The Company&#146;s management believes EP provides
      additional perspective to investors about financial returns generated by
      the business and represents profit generated over and above the cost of
      capital used by the business to generate that profit.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(2)</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>The tax rate applied
      is the effective tax rate on earnings from continuing operations, which
      was 34.1%, 34.2% and 34.6% in fiscal years 2016, 2015 and 2014,
      respectively.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(3)</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Total capital
      employed represents total assets less non-interest bearing liabilities.
      Adjusted capital employed represents total capital employed adjusted to
      add back current year after tax noncash U.S. GAAP restructuring and
      intangible asset impairment costs. Average capital employed is the average
      of adjusted capital employed for the current year and total capital
      employed for the prior year, based on year-end balances. See below for
      details of the average capital employed
calculation:</FONT></TD></TR></TABLE><BR>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="91%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,518</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,164</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4,258</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%"><FONT face="Times New Roman" size=2>Less:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable
      and accrued liabilities </FONT><FONT face="Times New Roman" size=2><SUP>(5)</SUP></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,032</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>976</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>912</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes
      payable</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>31</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>8</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities
      </FONT><FONT face="Times New Roman" size=2><SUP>(5)</SUP></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>784</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>745</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>768</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income
      taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>82</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>95</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>103</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-interest
      bearing liabilities</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,898</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,847</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,791</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%"><B><FONT face="Times New Roman" size=2>Total capital employed</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>2,620</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>2,317</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>2,467</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>After tax noncash U.S. GAAP restructuring</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and intangible
      asset impairment costs</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%"><B><FONT face="Times New Roman" size=2>Adjusted capital employed</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>2,626</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>2,318</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><B><FONT face="Times New Roman" size=2>2,469</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="91%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>Average capital
      employed</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>2,472</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>2,393</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>$</FONT></B></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>2,494</FONT></B></TD></TR></TABLE></DIV><BR>
<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="line-height: normal; border-collapse: collapse">

  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Capital charge
      represents average capital employed multiplied by a cost of capital, which
      was 9% for all fiscal years presented. The calculation of capital charge
      includes the impact of rounding numbers.</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>(5)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>Accounts payable and
      accrued liabilities were combined into one financial statement line as of
      June 30, 2016. The change has been retrospectively applied to all periods
      presented. Accounts payable and accrued liabilities and Other Liabilities
      are adjusted to exclude interest-bearing
liabilities.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>1 </FONT></P>
<HR align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>clorox3118951_1-ex9911x4x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 clorox3118951_1-ex9911x4x1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !Y 9@# 2(  A$! Q$!_\0
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MU'_:?[_@HW_[QNOW^H _ '_AP7_UFH_X+_?^+&__ ,3='_#@O_K-1_P7^_\
M%C?_ .)NOW^HH _ '_AP7_UFH_X+_?\ BQO_ /$W1_PX+_ZS4?\ !?[_ ,6-
M_P#XFZ_?ZB@#\ ?^'!?_ %FH_P""_P!_XL;_ /Q-T?\ #@O_ *S4?\%_O_%C
M?_XFZ_?ZB@#\ ?\ AP7_ -9J/^"_W_BQO_\ $W1_PX+_ .LU'_!?[_Q8W_\
MB;K]_J* /P!_X<%_]9J/^"_W_BQO_P#$W1_PX+_ZS4?\%_O_ !8W_P#B;K]_
MJ* /P!_X<%_]9J/^"_W_ (L;_P#Q-T?\."_^LU'_  7^_P#%C?\ ^)NOW^HH
M _ '_AP7_P!9J/\ @O\ ?^+&_P#\3='_  X+_P"LU'_!?[_Q8W_^)NOW^HH
M_ '_ (<%_P#6:C_@O]_XL;__ !-T?\."_P#K-1_P7^_\6-__ (FZ_?ZB@#\
M?^'!?_6:C_@O]_XL;_\ Q-T?\."_^LU'_!?[_P 6-_\ XFZ_?ZB@#\ ?^'!?
M_6:C_@O]_P"+&_\ \3='_#@O_K-1_P %_O\ Q8W_ /B;K]_J* /P!_X<%_\
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MPEXJ\=1>&=/EU3Q'<^%- UW5K'5-<LM!L8O.UB^T^UGL]-,UI#=SPSWMG%.
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M+QEJ'C_]GOQ#HWA?P!I>J?LU7-EX#TJ&X_>:B@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /P!_P""^G_.%?\ [3_?\$Y/
M_>R44?\ !?3_ )PK_P#:?[_@G)_[V2B@ _X(%_\ .:C_ +3_ '_!1O\ ]XW7
M[O>++;Q5>>%O$UIX%UGP_P"'/&UUX?UFV\'>(?%GAG4?&GA;0O%4^G7,7A[6
M?$W@[1_%G@'5_%GA_2]7>SOM9\-:7XZ\%ZCKVG07.E6/BSPY<W46L6?X0_\
M! O_ )S4?]I_O^"C?_O&Z_=[Q9X9T[QIX6\2^#M8N?$%GI'BSP_K/AK5;SPG
MXL\5> O%5KIVNZ=<Z7>W/AKQUX%UGPYXV\%^((+:[EET;Q9X.\0Z#XJ\.:DE
MMK'A[6=,U:SM+Z  _G!_8^_;R_X*R_MQ?L]ZO\4O@7XJ_8Q;XEZ!\ M#^+^I
M?#'XE_\ !.O]M7X/:#K'C/QEJGC;3?A]\+?A5\3?B-^VWH/ACXR^'_%0^&_C
M@ZM\=_"/D?#GPCK%GX0T"SA\:?\ "6>*]5^%/U[I/[8_[7OQ4_9*_:2_;P^#
MGB[]GO2OV>?#_P"S%XA^*/[,?ASXH?LK_&6P^*'BKQU\,? FD>)_B5XA^*4)
M_:R\-?8?AW?^*O"OQ4^'OA'P?8^%O#/BA)+[P]XZ7QMXG\)^%K*3XQ_HG\#?
MV3_@G^S;\ [7]F3X,:9X^\(_!O3M(UW0-$T.X^-WQO\ %?B;PQH_B*&X@O;#
MP?\ $_QG\1?$/Q3\&PV*W4TGAG_A%O&FD/X-N2EYX1?1+N*&=.%\*_L#_LR>
M"?V4_$/[$WAKP[\3+']FWQ1I6M^']5\%7'[1_P"TGJOB)/#?B2>.?7O"^C?%
MC5_BY?\ QA\->%-6"SVM]X7\-^/M)T"?3-2US27TXZ7K^MV>H 'YZ_&+_@LM
M\/\ X;?M#?L'?L[Q?$7]E_1_%?QH^(7PA\+?M7V'Q!^*6B^&/&7PTL?C;^S3
M\0/C)X 'PV^'=[XSL/$8M-3\4:%X%T;5/B!XQ%WX+TF7XF_#/P#H">.O'?CS
M4'^'?ZQ?M.:MJN@?LV_M":[H6IZAHNMZ+\#_ (L:MHVL:3>W.G:KI.JZ;X"U
M^]T[4],U"SEAN[#4+"[AAN[*]M9HKFUN88IX)4EC1ADK^RM\#F\,_LX>$KSP
MOKFM:1^R5XMT+QU\ I?$OQ&^)OBC7O!OBWPU\-?''P@T77-4\6>(O&.J>*OB
M#=VGPZ^)'C/PZZ_$K6?%\%X-8&K7T-SKFFZ1J=AZE\2/!&G_ !,^'?CWX<:M
M=WEAI7Q \%^*?!&I7VG>2-0LM/\ %>AWV@WEW8FYBGMQ>6UO?R36QN()H!,B
M&6*2/<A /\3K_A[%_P %3?\ I)9^W_\ ^)D?M%?_ #QJ/^'L7_!4W_I)9^W_
M /\ B9'[17_SQJ_N\_X@E_V!?^CKOVO_ /P(^#'_ ,ZZC_B"7_8%_P"CKOVO
M_P#P(^#'_P ZZ@#^$/\ X>Q?\%3?^DEG[?\ _P")D?M%?_/&H_X>Q?\ !4W_
M *26?M__ /B9'[17_P \:O[O/^()?]@7_HZ[]K__ ,"/@Q_\ZZC_ (@E_P!@
M7_HZ[]K_ /\  CX,?_.NH _A#_X>Q?\ !4W_ *26?M__ /B9'[17_P \:C_A
M[%_P5-_Z26?M_P#_ (F1^T5_\\:O[O/^()?]@7_HZ[]K_P#\"/@Q_P#.NH_X
M@E_V!?\ HZ[]K_\ \"/@Q_\ .NH _A#_ .'L7_!4W_I)9^W_ /\ B9'[17_S
MQJ/^'L7_  5-_P"DEG[?_P#XF1^T5_\ /&K^[S_B"7_8%_Z.N_:__P# CX,?
M_.NH_P"()?\ 8%_Z.N_:_P#_  (^#'_SKJ /X0_^'L7_  5-_P"DEG[?_P#X
MF1^T5_\ /&H_X>Q?\%3?^DEG[?\ _P")D?M%?_/&K^[S_B"7_8%_Z.N_:_\
M_ CX,?\ SKJ/^()?]@7_ *.N_:__ / CX,?_ #KJ /X0_P#A[%_P5-_Z26?M
M_P#_ (F1^T5_\\:C_A[%_P %3?\ I)9^W_\ ^)D?M%?_ #QJ_N\_X@E_V!?^
MCKOVO_\ P(^#'_SKJ/\ B"7_ &!?^CKOVO\ _P "/@Q_\ZZ@#^$/_A[%_P %
M3?\ I)9^W_\ ^)D?M%?_ #QJ/^'L7_!4W_I)9^W_ /\ B9'[17_SQJ_N\_X@
ME_V!?^CKOVO_ /P(^#'_ ,ZZC_B"7_8%_P"CKOVO_P#P(^#'_P ZZ@#^$/\
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M_P %3?\ I)9^W_\ ^)D?M%?_ #QJ_N\_X@E_V!?^CKOVO_\ P(^#'_SKJ/\
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M /**C_A_O_P62_Z2$_M ?^#C0_\ Y14 ?[/5%?XPO_#_ '_X+)?])"?V@/\
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M/^'^_P#P62_Z2$_M ?\ @XT/_P"45 '^SU17^,+_ ,/]_P#@LE_TD)_: _\
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M _E!_P"(-O\ X)(?]#+^V!_X>3P/_P#.?H_X@V_^"2'_ $,O[8'_ (>3P/\
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M_P"'D\#_ /SGZ_J^HH _E!_X@V_^"2'_ $,O[8'_ (>3P/\ _.?H_P"(-O\
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MF1^T5_\ /&H_X>Q?\%3?^DEG[?\ _P")D?M%?_/&K^[S_B"7_8%_Z.N_:_\
M_ CX,?\ SKJ/^()?]@7_ *.N_:__ / CX,?_ #KJ /X0_P#A[%_P5-_Z26?M
M_P#_ (F1^T5_\\:C_A[%_P %3?\ I)9^W_\ ^)D?M%?_ #QJ_N\_X@E_V!?^
MCKOVO_\ P(^#'_SKJ/\ B"7_ &!?^CKOVO\ _P "/@Q_\ZZ@#^$/_A[%_P %
M3?\ I)9^W_\ ^)D?M%?_ #QJ/^'L7_!4W_I)9^W_ /\ B9'[17_SQJ_N\_X@
ME_V!?^CKOVO_ /P(^#'_ ,ZZC_B"7_8%_P"CKOVO_P#P(^#'_P ZZ@#^$/\
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M_P %3?\ I)9^W_\ ^)D?M%?_ #QJ_N\_X@E_V!?^CKOVO_\ P(^#'_SKJ/\
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M_P#M/]_P3D_][)11_P %]/\ G"O_ -I_O^"<G_O9** #_@@7_P YJ/\ M/\
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M'_1\W_FLW[8?_P!#[1_Q%'?\$*/^CYO_ #6;]L/_ .A]K]_J* /P!_XBCO\
M@A1_T?-_YK-^V'_]#[1_Q%'?\$*/^CYO_-9OVP__ *'VOW^HH _ '_B*._X(
M4?\ 1\W_ )K-^V'_ /0^T?\ $4=_P0H_Z/F_\UF_;#_^A]K]_J* /P!_XBCO
M^"%'_1\W_FLW[8?_ -#[1_Q%'?\ !"C_ */F_P#-9OVP_P#Z'VOW^HH _ '_
M (BCO^"%'_1\W_FLW[8?_P!#[1_Q%'?\$*/^CYO_ #6;]L/_ .A]K]_J* /P
M!_XBCO\ @A1_T?-_YK-^V'_]#[1_Q%'?\$*/^CYO_-9OVP__ *'VOW^HH _
M'_B*._X(4?\ 1\W_ )K-^V'_ /0^T?\ $4=_P0H_Z/F_\UF_;#_^A]K]_J*
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MP0H_Z/F_\UF_;#_^A]K]_J* /P!_XBCO^"%'_1\W_FLW[8?_ -#[1_Q%'?\
M!"C_ */F_P#-9OVP_P#Z'VOW^HH _CB_;Y_X*V?L!?\ !4;XR_\ !'_]GS]@
MGXU>(/VC/C'X+_X+/?L2_'[Q1X%\-? ;]HOPYJ.C_!KX3P?%*^^)OQ"N;OQ[
M\)?">DOX?\!:3JD'B'Q9-!J$T^A>%;76?%>H00>&_#VO:KII7]CAZ?BO\Q10
#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>clorox3118951_1-ex9911x4x2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 clorox3118951_1-ex9911x4x2.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "A 8H# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]//V6M/\
M^"QO_!0;XF?\%$O%'PG_ ."Q<O[*WP[_ &:?^"F7[7W['O@GX;W/_!/O]E;X
MY2Q>#?@SXNTO4/"4@\8:O'X#U^X6S\/^--/TZ2?7)=<O[V\M[N:2:W*&XU/[
M _X=X?\ !=+_ *6(U_\ %2G[)/\ \\"G_P#! _[G_!:'_M/S_P %'?\ T?\
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M2_%FEZ+XL\<_#_0]:L/",GBOPOI\NCZ#XCU7QAXAU37;6P\&^&?$DUKJHTX
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M!O\ @@?]S_@M#_VGY_X*._\ H_X0U^_- !1110 4444 %%%% !1110 4444
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MVOV?AW]A6\?]H[2?&.FK8ZM\1==\)Z+J6M6_[87@CX[?#7XB>-HO!_[!<GQ
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M[/U?ONW4_4_SK\"/^#HW_E!5^W'_ +W[,O\ ZV'^S]7[[MU/U/\ .@#\#?\
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M23_OS+_\11YJ^DG_ 'YE_P#B*_QD/^'^G_!8W_I(/\>__!MI7_RBH_X?Z?\
M!8W_ *2#_'O_ ,&VE?\ RBH _P!F_P U?23_ +\R_P#Q%'FKZ2?]^9?_ (BO
M\9#_ (?Z?\%C?^D@_P >_P#P;:5_\HJ/^'^G_!8W_I(/\>__  ;:5_\ **@#
M_9O\U?23_OS+_P#$4>:OI)_WYE_^(K_&0_X?Z?\ !8W_ *2#_'O_ ,&VE?\
MRBH_X?Z?\%C?^D@_Q[_\&VE?_**@#_9O\U?23_OS+_\ $4>:OI)_WYE_^(K_
M !D/^'^G_!8W_I(/\>__  ;:5_\ **C_ (?Z?\%C?^D@_P >_P#P;:5_\HJ
M/]F_S5])/^_,O_Q%'FKZ2?\ ?F7_ .(K_&0_X?Z?\%C?^D@_Q[_\&VE?_**C
M_A_I_P %C?\ I(/\>_\ P;:5_P#**@#_ &;_ #5])/\ OS+_ /$4>:OI)_WY
ME_\ B*_QD/\ A_I_P6-_Z2#_ ![_ /!MI7_RBH_X?Z?\%C?^D@_Q[_\ !MI7
M_P HJ /]F_S5])/^_,O_ ,11YJ^DG_?F7_XBO\9#_A_I_P %C?\ I(/\>_\
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MFKZ2?]^9?_B*_P 9#_A_I_P6-_Z2#_'O_P &VE?_ "BH_P"'^G_!8W_I(/\
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MU?P!XRT7Q#X1UF/X@6WA#Q'-K&DZ@+_P#X2EB-@WV10 4444 %%%% 'X _\
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MBWH_X@96_P"DH$?_ (A3)_\ 1;U_?Y10!_ '_P 0,K?])0(__$*9/_HMZ/\
MB!E;_I*!'_XA3)_]%O7]_E% '\ ?_$#*W_24"/\ \0ID_P#HMZ/^(&5O^DH$
M?_B%,G_T6]?W^44 ?P!_\0,K?])0(_\ Q"F3_P"BWH_X@96_Z2@1_P#B%,G_
M -%O7]_E% '\ ?\ Q RM_P!)0(__ !"F3_Z+>C_B!E;_ *2@1_\ B%,G_P!%
MO7]_E% '\ ?_ ! RM_TE C_\0ID_^BWH_P"(&5O^DH$?_B%,G_T6]?W^44 ?
MP!_\0,K?])0(_P#Q"F3_ .BWH_X@96_Z2@1_^(4R?_1;U_?Y10!_ '_Q RM_
MTE C_P#$*9/_ *+>C_B!E;_I*!'_ .(4R?\ T6]?W^44 ?P!_P#$#*W_ $E
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M_P %C?\ I(/\>_\ P;:5_P#**@#_ &;_ #5])/\ OS+_ /$4>:OI)_WYE_\
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MM_TE C_\0ID_^BWK^_RB@#^ /_B!E;_I*!'_ .(4R?\ T6]'_$#*W_24"/\
M\0ID_P#HMZ_O\HH _@#_ .(&5O\ I*!'_P"(4R?_ $6]'_$#*W_24"/_ ,0I
MD_\ HMZ_O\HH _@#_P"(&5O^DH$?_B%,G_T6]'_$#*W_ $E C_\ $*9/_HMZ
M_O\ ** /X _^(&5O^DH$?_B%,G_T6]'_ ! RM_TE C_\0ID_^BWK^_RB@#^
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MNI^I_G7X$?\ !T;_ ,H*OVX_][]F7_UL/]GZOWW;J?J?YT ?@;_P0/\ N?\
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M37S!H/C"UUKPS?P:GHWBBZM0FLZ;.(R&<VGG1QQR '["B9-B.<H)%#*),1L
M0#AE<@JP!&5(RIX8 \4>=%_?3_ON/_XJO\A%_P#@Y\_X+D6V'@_;<,33JKSS
M#]FK]CY1<W"(D<S>=:?L\(MP5E63$CS7)$31J9!)YHIG_$4/_P %T/\ H^1O
M_$;OV2O_ *'Z@#_7Q\Z+^^G_ 'W'_P#%4>=%_?3_ +[C_P#BJ_R#O^(H?_@N
MA_T?(W_B-W[)7_T/U'_$4/\ \%T/^CY&_P#$;OV2O_H?J /]?'SHO[Z?]]Q_
M_%4>=%_?3_ON/_XJO\@[_B*'_P""Z'_1\C?^(W?LE?\ T/U'_$4/_P %T/\
MH^1O_$;OV2O_ *'Z@#_7Q\Z+^^G_ 'W'_P#%4>=%_?3_ +[C_P#BJ_R#O^(H
M?_@NA_T?(W_B-W[)7_T/U'_$4/\ \%T/^CY&_P#$;OV2O_H?J /]?'SHO[Z?
M]]Q__%4>=%_?3_ON/_XJO\@[_B*'_P""Z'_1\C?^(W?LE?\ T/U'_$4/_P %
MT/\ H^1O_$;OV2O_ *'Z@#_7Q\Z+^^G_ 'W'_P#%4>=%_?3_ +[C_P#BJ_R#
MO^(H?_@NA_T?(W_B-W[)7_T/U'_$4/\ \%T/^CY&_P#$;OV2O_H?J /]?'SH
MO[Z?]]Q__%4>=%_?3_ON/_XJO\@[_B*'_P""Z'_1\C?^(W?LE?\ T/U'_$4/
M_P %T/\ H^1O_$;OV2O_ *'Z@#_7Q\Z+^^G_ 'W'_P#%4>=%_?3_ +[C_P#B
MJ_R#O^(H?_@NA_T?(W_B-W[)7_T/U'_$4/\ \%T/^CY&_P#$;OV2O_H?J /]
M?'SHO[Z?]]Q__%4>=%_?3_ON/_XJO\@[_B*'_P""Z'_1\C?^(W?LE?\ T/U'
M_$4/_P %T/\ H^1O_$;OV2O_ *'Z@#_7Q\Z+^^G_ 'W'_P#%4>=%_?3_ +[C
M_P#BJ_R#O^(H?_@NA_T?(W_B-W[)7_T/U'_$4/\ \%T/^CY&_P#$;OV2O_H?
MJ /]?'SHO[Z?]]Q__%4>=%_?3_ON/_XJO\@[_B*'_P""Z'_1\C?^(W?LE?\
MT/U'_$4/_P %T/\ H^1O_$;OV2O_ *'Z@#_7Q\Z+^^G_ 'W'_P#%4>=%_?3_
M +[C_P#BJ_R#O^(H?_@NA_T?(W_B-W[)7_T/U'_$4/\ \%T/^CY&_P#$;OV2
MO_H?J /]?'SHO[Z?]]Q__%4>=%_?3_ON/_XJO\@[_B*'_P""Z'_1\C?^(W?L
ME?\ T/U'_$4/_P %T/\ H^1O_$;OV2O_ *'Z@#_7Q\Z+^^G_ 'W'_P#%4>=%
M_?3_ +[C_P#BJ_R#O^(H?_@NA_T?(W_B-W[)7_T/U'_$4/\ \%T/^CY&_P#$
M;OV2O_H?J /]?'SHO[Z?]]Q__%4>=%_?3_ON/_XJO\@[_B*'_P""Z'_1\C?^
M(W?LE?\ T/U'_$4/_P %T/\ H^1O_$;OV2O_ *'Z@#_7Q\Z+^^G_ 'W'_P#%
M4>=%_?3_ +[C_P#BJ_R#O^(H?_@NA_T?(W_B-W[)7_T/U'_$4/\ \%T/^CY&
M_P#$;OV2O_H?J /]?'SHO[Z?]]Q__%4&9-CN,N(U+,(\2,0 3A50DLQ .% R
MQX4$\5_D'?\ $4/_ ,%T/^CY&_\ $;OV2O\ Z'ZI8_\ @YZ_X+D72RR3?MNF
M9[2)IX7/[-/[(#M!(V+>.5)+K]G:18 )YH#+(LUJ1") )#)Y0 !_KTV]RMSY
MC)%.D:.$62:,Q"4[07V1N1.HC8F)_.BB(D1U4,%W4VZO+>R1'N'V!W6-  69
MG=ECB15')::=X;:%0"9;F>WMT!EFC5OR&_X(,_M.?&S]LW_@EG^S5^TU^T9X
M[@^)GQG^)DWQIC\8>-8/#?ACPBFIIX*_:&^+G@30;;_A'O!VFZ-X?T\6&A^'
M+&.-=.TFPAGADBN/)5Y71,7_ (+'?MF_M+_L:>%_V:_$OP;E\*?#KX/^,?C7
MX3T7]I#]IKQK\(O$_P ;/"/P/\(V7Q)^%$EKIGCGPSX9\4>%&\'?#SXH>%+[
MXE:/XO\ BK>7.IW>AQ:'I_P_\%6&B_$SXH^"/B#X& /V#BU_3Y8H)P9TAN?L
MWD2R0E89S>&X2V6TN,FWU%YI;61(DTV6\>2*2UOHU;3;VSO9[LM_##<);.EU
MOD\G:R6=U+%_I#O''NFBA>-0&C<7#E@EF#"UXUNMW9FX_*W0OCE^UY8_M/?L
MP^"/&B?LW>._@M^U=X0^)^K:IIWP2\/^//$?BOX.>%OA-\/=-\8VWQ-N_CWX
MB\3:KX/^.WPN\>>)_$_AOX>W-E#\#_A7;> [SXM>"M%TKQU\0=9637/$WS7^
MVG_P4$_:1_91^+WQ:TB\^%]CX8^$G@SX8^(?%/P"\-ZM^SMXB\::?^TIJ/@C
MX9V_B3QM>^'OVD_A-\?/$.F? 75_@\]S/\0]8^'_ ,4OV49?$C_ 3X.^,O&G
MAO5]6&IZI<_#T _=Z#6+6X@-P$GC5#$L\<BQF>VFEMHIQ:W$,4LLD=\KS1VK
M:?@WWVET"V[0R1S/<@NX;AG2-L2)'!,T,F([A8;E&:"66U<BYMA(R31*MU#!
M)YMO.FS]V37\HWQ-_P""V_Q^\&>'/$T.B?$[]AGQO8^ /BEKOPYOOV[/ OPT
M^*'Q!_9C^(D/B+]F#P]^T/\ L]>#=/\ @MX0_:<_X3;X?ZO\3M>N?B%X%\7?
M%2_^/OB7X;?!^3X6KXZ\1JOAKQZMIX5_IO\ @UJGBGQ#\./!/B;QSI6BZ!XV
MUSP3X/O?%V@>%]>F\2>$]&\37&B6^H>(K#P]K:7-QIFMV%MX@U#58(==L9+J
M;5+:&U:]U*^,%N+< ]3HHHH _ '_ (.C?^4%7[<?^]^S+_ZV'^S]7[[MU/U/
M\Z_ C_@Z-_Y05?MQ_P"]^S+_ .MA_L_5^^[=3]3_ #H _G\_X(.IE_\ @LHZ
MLL<H_P""_P#_ ,%((D?*J\BR/\(GEMB=HD,!6'[=,D5Q;M(^GP(QE0M$WR-^
MT5^S#^S%^UY_P6S^+7PBTS2O^"<OBCQ)8_LG?L8:E\>OAI\?_P!GOPG\:?B_
MXPN;;X]_'K6?C_%X"\4Z1\3?"'BGX0_&V'X WOPV36_&,FA_%'5;RPUCX5VL
MKZ+I1U'7;+ZZ_P""#UE]M3_@LZ"598O^"_'_  4C(B? C>25_A# 6+I']JC<
M6TEU"KV]S"-EQ(DT=PC[4_>RST981="=;24W1!N'BMR'O'\N& W-W)=27ES<
M3/96]EI\R7EU?)+;Z99%7AC MH@#^8W7OV8_V#? ?_!2B^_X)=:5X,_9'\._
ML]?M,_#CPK^VW\0OV8KOP#\,9+S4OC9^S3/X:\%>%OAUX>\&[8-;L_ 7Q.\)
M:[H7QKA\-6\AN?"FC_LW_'LQV4WPL^+WQ0N%^BM#UKX&?#/_ (+"?M6^ _V<
M8/@5I/QK7_@EY\ VMOA)X:/@FP\3Z[X_^'?Q$^.C^$M#\2>!]*UW3/%6L2^$
M?A7!\$8M*TM;.Q7PU\(6^&D_A_4X_"6K^#=)N_WMN-+6X-N#':*ENT&T".59
M&%G,);7]Y;RVJ!(1YCP6SPRQ6=ZT&H0,9K*-)(7TR[DD,C2V\88R9CMVNT93
M/*A-PCS3W%H9K6(%HEDTV19KU9[U'L)-1G6  _F._P"""WB_4-6\<?$2ZU[Q
M;\&?VFOBA\1?V>_A1\?/VCOVK?"VC_$"P^/_ ,,_V@/&<^NVGC_]CW]I?4_'
M_C[XD_;M=^$-[8B+X?\ PZT6;X8Z=\+]!;Q(J_"#P6WB>.\\1?I=_P %H?V7
MYOVQ_P#@F_\ '_\ 9AM/&R?#EOB_XL_9VT"X\93Z!<>,8_#;Q?M._ O7I;B#
MPXNO^&!J\31:8T*6DFL:8H>=MLD<193^HEKIVHGS%U2]MKI)$TU7BM;:2UMF
M>TML7?V>UDGN!9V5W>GSXK*6;4;V!!)'<:W?V\MI::;YO\<_AWK/Q/\ AU>^
M$-#GTFSU*Z\7?"[Q$+G5KB[@L_L_@KXG^#?&>KPL]G87TXGET?PU/;:;BW9+
MC4)+:*ZDLK=I;N, _A7U'_@R#TZRW-=_\%1H;9%34;V5I/V*@GD65EYAN[MX
ME_:\XL[5TAA>6&#"37ME$XW7$:I^:/C?_@W2_98\$:1^TYJL_P#P4\\9:@?V
M7?C=X _9Y\0PWG[&'PQ^'&E_$/XI?$/PSH7BK3=&^'?CSXU_\%"/A?\ "ZTL
M-*TW5[]M:USXJ>.OAAI M_#6JZYHUWK/A;5?!>O^*_\ 3I^+7PXO/BEX \8_
M#^U\:^*/AVOC7PGXI\*2^-_ DNB0>.O"+^(K"XM+;Q3X.N/%6@>+?"UOXDT*
M2;[7I%QK/A755L[_ ,B^A=%M9[+4_P @OA7_ ,$YOVFOV=?$G[8R:%X@^$G[
M9?PS_:2U_P"#VC^&OAK^UEXC^%GPP\':1\//AW^SGI/PEGU#QQX._9Z_X)\0
M>'-7UC2=0TC2?!.A_#WPQ#X<\*Z[\+_#6AZUJOBG1?&MYXAM]5 /X_?CG_P:
M=Z3^SW^REJO[6?CW]L;XZW'AWPMX>T7Q5X[^&/A;]BCX)>(OBAX'T'4TT^XU
M74]2GM/^"DZ_";Q-8^$M/U.UU/Q!?_#CXJ^.-/N+4RQ>&+KQ)?Q/9#S^U_X-
MH/V<V_:K^(G[)^L_\%,/B#X2U[X9^%?B1XG\0?%7Q7^PGX7TCX1LWP>^&/P,
M^,_Q1T5;D_MVS_$G1[KP5\+/VCOA%XRU'Q%XM^&?AKX?ZC9>)7TWP]XSUG7]
M,U+2+;^UWXU_L#_M/>(/^"7GCW_@G5\/8?@=XJO%^!?PL^!_@/XF_$7XX?%?
MPA:^);&V$-[\0]=\1Z)I'P(^)>L?#B/P-J%C96'PD\-Z?XE^+NG^(=#6.UUN
MZ\ 06L^GZK].>,_V*(_B=\2=&^,&K_#[X ?"_P")^L>#](UWXJ?$7P%X9\/^
M)/B7XO\ BEX;L=&D^'WPZU?XD:A\)_!?B?QK\!/A5XRTG3_B!83Z]-I?B7XA
M:WX4^'^CZ[X;\-^%_#FH:1KX!_'+\.O^#)R#XD>"O#GCJQ_X*1Z]X=TSQ3I<
M&MZ3IWBK]A^RL-=&DWS22:7=ZAING_MEZK_9<NI:?]EU1-+U":WUK3(+Z&PU
M_3=(UVWU/2+#MO\ B!E;_I*!'_XA3)_]%O7]9G_!+;]F7]KK]EGX&>*? G[8
M?QS?XX>.-3\9>'M6\/:@_P :/C5^T&VBZ9IGP?\ ACX/\7WS?%']H&PT_P")
M4G_"R?BMX8^('Q9A^'\D=UX5^%5GXWM? OA75=;L])GUK4/TPH _@#_X@96_
MZ2@1_P#B%,G_ -%O1_Q RM_TE C_ /$*9/\ Z+>O[_** /X _P#B!E;_ *2@
M1_\ B%,G_P!%O1_Q RM_TE C_P#$*9/_ *+>O[_** /X _\ B!E;_I*!'_XA
M3)_]%O1_Q RM_P!)0(__ !"F3_Z+>O[_ "B@#^ /_B!E;_I*!'_XA3)_]%O1
M_P 0,K?])0(__$*9/_HMZ_O\HH _@#_X@96_Z2@1_P#B%,G_ -%O1_Q RM_T
ME C_ /$*9/\ Z+>O[_** /X _P#B!E;_ *2@1_\ B%,G_P!%O1_Q RM_TE C
M_P#$*9/_ *+>O[_** /X _\ B!E;_I*!'_XA3)_]%O1_Q RM_P!)0(__ !"F
M3_Z+>O[_ "B@#^ /_B!E;_I*!'_XA3)_]%O1_P 0,K?])0(__$*9/_HMZ_O\
MHH _@#_X@96_Z2@1_P#B%,G_ -%O1_Q RM_TE C_ /$*9/\ Z+>O[_** /X
M_P#B!E;_ *2@1_\ B%,G_P!%O1_Q RM_TE C_P#$*9/_ *+>O[_** /X _\
MB!E;_I*!'_XA3)_]%O1_Q RM_P!)0(__ !"F3_Z+>O[_ "B@#^ /_B!E;_I*
M!'_XA3)_]%O1_P 0,K?])0(__$*9/_HMZ_O\HH _@#_X@96_Z2@1_P#B%,G_
M -%O1_Q RM_TE C_ /$*9/\ Z+>O[_** /X _P#B!E;_ *2@1_\ B%,G_P!%
MO4D7_!C2\4@/_#SR"6-UGCD5_P!BN0!!+:SQQSHO_#6K"26"=XI(T8QKD%RY
M*"*3^_BB@#\^O^"7/[#=W_P3?_8C^#O[&UU\4G^- ^$3_$(P_$F3PS-X(;Q
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MH7=KX9T'1]*GN;^\N3=)I<-\4BU"\U*:Z];HH **** /P!_X.C?^4%7[<?\
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M##_H]^;_ ,1A_;'_ /H>Z/\ B*%_X(8?]'OS?^(P_MC_ /T/= '[\45^ _\
MQ%"_\$,/^CWYO_$8?VQ__H>Z/^(H7_@AA_T>_-_XC#^V/_\ 0]T ?OQ17X#_
M /$4+_P0P_Z/?F_\1A_;'_\ H>Z/^(H7_@AA_P!'OS?^(P_MC_\ T/= '[\4
M5^ __$4+_P $,/\ H]^;_P 1A_;'_P#H>Z/^(H7_ ((8?]'OS?\ B,/[8_\
M]#W0!^_%%?@/_P 10O\ P0P_Z/?F_P#$8?VQ_P#Z'NC_ (BA?^"&'_1[\W_B
M,/[8_P#]#W0!^_%%?@/_ ,10O_!##_H]^;_Q&']L?_Z'NC_B*%_X(8?]'OS?
M^(P_MC__ $/= '[\45^ _P#Q%"_\$,/^CWYO_$8?VQ__ *'NC_B*%_X(8?\
M1[\W_B,/[8__ -#W0!^_%%?@/_Q%"_\ !##_ */?F_\ $8?VQ_\ Z'NC_B*%
M_P""&'_1[\W_ (C#^V/_ /0]T ?OQ17X#_\ $4+_ ,$,/^CWYO\ Q&']L?\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>17
<FILENAME>clx-20160630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: Clorox 0616 10K Final to Update.xfr; Date: 2016%2D08%2D12T16:24:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80AE0001 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:country="http://xbrl.sec.gov/country/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:clx="http://thecloroxcompany.com/20160630">
    <link:schemaRef xlink:href="clx-20160630.xsd" xlink:type="simple" />
    <xbrli:context id="C849211">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849195">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849220">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849221">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851165">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851166">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851167">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851168">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851169">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849284">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851170">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851171">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851172">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851173">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851174">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851175">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851176">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851177">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851178">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851179">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851180">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851181">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851182">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851183">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851237">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851235">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851238">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851236">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_BuildingAndBuildingImprovementsMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_BuildingAndBuildingImprovementsMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_LandImprovementsMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_LandImprovementsMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_MachineryAndEquipmentMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_MachineryAndEquipmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_ComputerEquipmentMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_ComputerEquipmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_CapitalizedSoftwareCostsMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">clx:CapitalizedSoftwareCostsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_CapitalizedSoftwareCostsMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">clx:CapitalizedSoftwareCostsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:VenezuelanSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849207">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:VenezuelanSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849209">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:DiscontinuedOperationsOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:VenezuelanSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_DiscontinuedOperationsOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:DiscontinuedOperationsOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_custom_DiscontinuedOperationsOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:DiscontinuedOperationsOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849199">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:VenezuelanSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849198">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:VenezuelanSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C896429">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">clx:CapitalizedSoftwareCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_CapitalizedSoftwareCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">clx:CapitalizedSoftwareCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850660">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850662">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">clx:CapitalizedSoftwareCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_CapitalizedSoftwareCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">clx:CapitalizedSoftwareCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_LandAndLandImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_LandAndLandImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850665">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_AssetsHeldUnderCapitalLeasesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AssetsHeldUnderCapitalLeasesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C896428">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C896432">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">clx:CapitalizedSoftwareCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850673">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850674">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850675">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850668">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850669">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850670">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850671">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C850672">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_TrademarkMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_TechnologyAndProductFormulaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:OtherIntangibleAssetsAxis">clx:TechnologyAndProductFormulaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_OtherIntangibleAssetsOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:OtherIntangibleAssetsAxis">clx:OtherIntangibleAssetsOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_CleaningMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_LifestyleMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_HouseholdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_InternationalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851366">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_TechnologyAndProductFormulaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:OtherIntangibleAssetsAxis">clx:TechnologyAndProductFormulaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_OtherIntangibleAssetsOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:OtherIntangibleAssetsAxis">clx:OtherIntangibleAssetsOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851367">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851092">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2014-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_InternationalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849251">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_CleaningMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_LifestyleMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_HouseholdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849248">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849250">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849249">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-30_custom_SeniorNotes3.55PercentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">clx:SeniorNotes3.55PercentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_SeniorNotes3.50PercentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">clx:SeniorNotes3.50PercentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-01to2015-11-30_custom_SeniorNotes3.55PercentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">clx:SeniorNotes3.55PercentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-01</xbrli:startDate>
        <xbrli:endDate>2015-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851125">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">clx:RevolvingLineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_RevolvingLineOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">clx:RevolvingLineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommercialPaperMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ForeignAndOtherCreditLinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">clx:ForeignAndOtherCreditLinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ForeignBorrowingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:ForeignBorrowingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">clx:SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">clx:SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">clx:SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">clx:SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">clx:SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">clx:SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">clx:SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">clx:SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">clx:SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">clx:SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_RevolvingCreditFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ForeignCreditLinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">clx:ForeignCreditLinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_OtherCreditLinesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">clx:OtherCreditLinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_RevolvingLineOfCreditMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">clx:RevolvingLineOfCreditMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851107">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851130">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:ForeignBorrowingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851151">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851152">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">clx:ForeignCreditLinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851153">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">clx:OtherCreditLinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851116">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">clx:ForeignAndOtherCreditLinesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851154">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-12-01</xbrli:startDate>
        <xbrli:endDate>2012-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849240">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_JetFuelMember_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:DerivativeNatureAxis">clx:JetFuelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849235">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_SoybeanOilMember_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:DerivativeNatureAxis">clx:SoybeanOilMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849237">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_ForeignExchangeContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849262">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849277">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_us-gaap_InterestRateContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_InterestRateContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849279">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_ForeignExchangeContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849230">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_JetFuelMember_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:DerivativeNatureAxis">clx:JetFuelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_SoybeanOilMember_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:DerivativeNatureAxis">clx:SoybeanOilMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C896301">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_BankTimeDepositsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C896306">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C896309">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C896310">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C896313">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C896314">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C896331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_LongTermDebtMember_us-gaap_OtherLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_LongTermDebtMember_us-gaap_OtherLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_EvergreenProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851232">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermIntercompanyLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851225">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:OpenMarketProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_OpenMarketProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:OpenMarketProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851230">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:OpenMarketProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_custom_OpenMarketProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:OpenMarketProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851193">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851233">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermIntercompanyLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_LongTermIntercompanyLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermIntercompanyLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851295">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851309">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851294">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851311">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851376">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851377">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851378">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851302">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_PerformanceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_NotSubjectToExpirationMember_custom_ForeignMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:ExpirationPeriodAxis">clx:NotSubjectToExpirationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">clx:ForeignMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_ForeignTaxCreditCarryforwardMember_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">clx:ForeignTaxCreditCarryforwardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_SubjectToExpirationMember_us-gaap_LatestTaxYearMember_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:ExpirationPeriodAxis">clx:SubjectToExpirationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_SubjectToExpirationMember_us-gaap_EarliestTaxYearMember_custom_ForeignMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:ExpirationPeriodAxis">clx:SubjectToExpirationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">clx:ForeignMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignCountryMember_custom_ForeignTaxCreditCarryforwardMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">clx:ForeignTaxCreditCarryforwardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_SubjectToExpirationMember_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:ExpirationPeriodAxis">clx:SubjectToExpirationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_DomesticCountryMember_us-gaap_LatestTaxYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_DomesticCountryMember_us-gaap_EarliestTaxYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ForeignTaxCreditCarryforwardMember_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">clx:ForeignTaxCreditCarryforwardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_MedicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:MedicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_PrescriptionDrugsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:PrescriptionDrugsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_RetirementHealthCarePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCarePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_DomesticNonQualifiedRetirementIncomePlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:DomesticNonQualifiedRetirementIncomePlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851264">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:DomesticNonQualifiedRetirementIncomePlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_custom_DomesticNonQualifiedRetirementIncomePlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:DomesticNonQualifiedRetirementIncomePlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_RetirementHealthCarePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCarePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912132">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_RetirementIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912134">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_RetirementHealthCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912136">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912137">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912138">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912139">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912140">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912141">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_PensionPlansDefinedBenefitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_PensionPlansDefinedBenefitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_OtherPensionPlansDefinedBenefitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_OtherPensionPlansDefinedBenefitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:OtherPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851274">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:DomesticQualifiedRetirementIncomePlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851273">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:DomesticQualifiedRetirementIncomePlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_custom_CompanyFourZeroOneKPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedContributionPlanNameAxis">clx:CompanyFourZeroOneKPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_custom_CompanyFourZeroOneKPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedContributionPlanNameAxis">clx:CompanyFourZeroOneKPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_CompanyFourZeroOneKPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedContributionPlanNameAxis">clx:CompanyFourZeroOneKPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_custom_InternationalDefinedContributionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedContributionPlanNameAxis">clx:InternationalDefinedContributionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_custom_InternationalDefinedContributionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedContributionPlanNameAxis">clx:InternationalDefinedContributionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_InternationalDefinedContributionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedContributionPlanNameAxis">clx:InternationalDefinedContributionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_custom_UnitedStatesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:UnitedStatesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_UnitedStatesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:UnitedStatesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851226">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:UnitedStatesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_UnitedStatesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:UnitedStatesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_custom_ForeignEquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:ForeignEquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_ForeignEquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:ForeignEquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851227">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:ForeignEquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ForeignEquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:ForeignEquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_FixedIncomeFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_FixedIncomeFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851228">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_FixedIncomeFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_OtherCreditDerivativesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:OtherCreditDerivativesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_OtherCreditDerivativesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:OtherCreditDerivativesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851229">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:OtherCreditDerivativesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_OtherCreditDerivativesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:OtherCreditDerivativesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_BondFundMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:BondFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912160">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:BondFundMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_ForeignEquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:ForeignEquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851197">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:ForeignEquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851198">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:DomesticEquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912162">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:DomesticEquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_RealEstateFundMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:RealEstateFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912164">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:RealEstateFundMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_DomesticEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:DomesticEquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912167">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:RealEstateFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_custom_ForeignEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:ForeignEquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C912169">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:BondFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849233">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_custom_CleaningMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_custom_HouseholdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_custom_LifestyleMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_custom_InternationalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_CorporateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_WalmartStoresIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C849252">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851325">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851326">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">clx:ForeignMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_ForeignMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">clx:ForeignMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ForeignMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">clx:ForeignMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TopFiveLargestCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">clx:TopFiveLargestCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TopFiveLargestCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">clx:TopFiveLargestCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TopFiveLargestCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">clx:TopFiveLargestCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851341">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:LiquidBleachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember_custom_LiquidBleachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:LiquidBleachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_custom_LiquidBleachMember_custom_CleaningMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:LiquidBleachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851344">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:LiquidBleachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851349">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:LiquidBleachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_custom_LiquidBleachMember_custom_InternationalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:LiquidBleachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember_custom_TrashBagsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:TrashBagsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851360">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:TrashBagsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_custom_TrashBagsMember_custom_HouseholdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:TrashBagsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851364">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:CharcoalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember_custom_CharcoalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:CharcoalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851370">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:CharcoalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_custom_CharcoalMember_custom_HouseholdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:CharcoalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851308">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851541">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851542">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember_custom_LiquidBleachMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:LiquidBleachMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851347">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:LiquidBleachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851352">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:LiquidBleachMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851353">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:TrashBagsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851359">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:TrashBagsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851372">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:TrashBagsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851375">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:CharcoalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851373">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">clx:CharcoalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851332">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">clx:ForeignMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851333">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851334">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">clx:ForeignMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851093">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851094">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851114">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_AllowanceForDoubtfulAccountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851102">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851108">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">clx:LifoAllowanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851109">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">clx:LifoAllowanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851110">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">clx:LifoAllowanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851111">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">clx:LifoAllowanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_LifoAllowanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">clx:LifoAllowanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_LifoAllowanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">clx:LifoAllowanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_custom_LifoAllowanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">clx:LifoAllowanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851120">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C911937">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851100">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851101">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AllowanceForDoubtfulAccountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_AllowanceForDoubtfulAccountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForDoubtfulAccountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851121">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851122">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C851123">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-07-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-07-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_OpenMarketProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:OpenMarketProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-10-01to2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-10-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CorporateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_RetirementIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_DomesticQualifiedRetirementIncomePlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:DomesticQualifiedRetirementIncomePlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-07-07_custom_DomesticQualifiedRetirementIncomePlansMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:DomesticQualifiedRetirementIncomePlansMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-07-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_RenewLifeHoldingsCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:RenewLifeHoldingsCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:RenewLifeHoldingsCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:RenewLifeHoldingsCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:RenewLifeHoldingsCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_PerformanceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_BankTimeDepositsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_BankTimeDepositsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_LongTermDebtMember_us-gaap_OtherLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_LongTermDebtMember_us-gaap_OtherLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-01-31_custom_SeniorNotes5.00PercentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">clx:SeniorNotes5.00PercentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-31_custom_SeniorNotes5.00PercentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">clx:SeniorNotes5.00PercentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CorporateMember_custom_VenezuelanSubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:VenezuelanSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_VenezuelanSubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:VenezuelanSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_RetirementIncomePlanMember_us-gaap_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementIncomePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_RetirementHealthCarePlanMember_us-gaap_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCarePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-05-03to2016-06-30_custom_RenewLifeHoldingsCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:RenewLifeHoldingsCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-05-03</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-12-01to2014-12-31_custom_SeniorNotes3.50PercentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">clx:SeniorNotes3.50PercentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-12-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_LandAndLandImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndLandImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ForeignTaxCreditCarryforwardMember_us-gaap_ForeignCountryMember_custom_NotSubjectToExpirationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">clx:ForeignTaxCreditCarryforwardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="clx:ExpirationPeriodAxis">clx:NotSubjectToExpirationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_DomesticEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:DomesticEquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_DomesticEquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:DomesticEquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ForeignEquitySecuritiesMember174410593">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:ForeignEquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_BondFundMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:BondFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_BondFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:BondFundMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ForeignEquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:ForeignEquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_DomesticEquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:DomesticEquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_RealEstateFundMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:RealEstateFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_RealEstateFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:RealEstateFundMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_RealEstateFundMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:RealEstateFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ForeignEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:ForeignEquitySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_BondFundMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">clx:BondFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-06-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-06-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-11-01to2012-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-11-01</xbrli:startDate>
        <xbrli:endDate>2012-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2014-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_DeferredStockUnitsForNonemployeeDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">clx:DeferredStockUnitsForNonemployeeDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_custom_DeferredStockUnitsForNonemployeeDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">clx:DeferredStockUnitsForNonemployeeDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPerShare">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Item">
      <xbrli:measure>clx:item</xbrli:measure>
    </xbrli:unit>
    <us-gaap:SalesRevenueNet contextRef="C849211" unitRef="USD" decimals="-6">5514000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="C849195" unitRef="USD" decimals="-6">5655000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">997000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="C849251" unitRef="USD" decimals="-6">1087000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">1912000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">990000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">1862000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="C849248" unitRef="USD" decimals="-6">1824000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="C849250" unitRef="USD" decimals="-6">950000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="C849249" unitRef="USD" decimals="-6">1794000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="C849233" unitRef="USD" decimals="-6">0</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2013-07-01to2014-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">1776000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2013-07-01to2014-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">1709000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2013-07-01to2014-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">936000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2013-07-01to2014-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">1093000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-06-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">0</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="C849252" unitRef="USD" decimals="-6">0</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="C851325" unitRef="USD" decimals="-6">4466000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="C851326" unitRef="USD" decimals="-6">1048000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-06-30_country_US" unitRef="USD" decimals="-6">4805000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-06-30_custom_ForeignMember" unitRef="USD" decimals="-6">956000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2014-07-01to2015-06-30_country_US" unitRef="USD" decimals="-6">4609000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="C851332" unitRef="USD" decimals="-6">1046000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">5761000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-05-03to2016-06-30_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">21000000</us-gaap:SalesRevenueNet>
    <us-gaap:CostOfGoodsSold contextRef="C849211" unitRef="USD" decimals="-6">3158000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="C849195" unitRef="USD" decimals="-6">3190000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="C851092" unitRef="USD" decimals="-6">774000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="C851093" unitRef="USD" decimals="-6">773000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="C851094" unitRef="USD" decimals="-6">796000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="C851114" unitRef="USD" decimals="-6">847000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">3163000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">765000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2015-10-01to2015-12-31" unitRef="USD" decimals="-6">745000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-6">780000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="-6">873000000</us-gaap:CostOfGoodsSold>
    <us-gaap:GrossProfit contextRef="C849211" unitRef="USD" decimals="-6">2356000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="C849195" unitRef="USD" decimals="-6">2465000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">2598000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="C849211" unitRef="USD" decimals="-6">751000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="C849195" unitRef="USD" decimals="-6">798000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">806000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AdvertisingExpense contextRef="C849211" unitRef="USD" decimals="-6">503000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="C849195" unitRef="USD" decimals="-6">523000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">587000000</us-gaap:AdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="C849211" unitRef="USD" decimals="-6">125000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="C849195" unitRef="USD" decimals="-6">136000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">141000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:InterestExpense contextRef="C849211" unitRef="USD" decimals="-6">103000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="C849195" unitRef="USD" decimals="-6">100000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">88000000</us-gaap:InterestExpense>
    <clx:OtherIncomeExpenseNet contextRef="C849211" unitRef="USD" decimals="-6">-10000000</clx:OtherIncomeExpenseNet>
    <clx:OtherIncomeExpenseNet contextRef="C849195" unitRef="USD" decimals="-6">-13000000</clx:OtherIncomeExpenseNet>
    <clx:OtherIncomeExpenseNet contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-7000000</clx:OtherIncomeExpenseNet>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="C849211" unitRef="USD" decimals="-6">305000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="C849195" unitRef="USD" decimals="-6">315000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">335000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="C849211" unitRef="USD" decimals="-6">579000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="C849195" unitRef="USD" decimals="-6">606000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="C851092" unitRef="USD" decimals="-6">145000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="C851093" unitRef="USD" decimals="-6">128000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="C851094" unitRef="USD" decimals="-6">144000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="C851114" unitRef="USD" decimals="-6">189000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">648000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">173000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-10-01to2015-12-31" unitRef="USD" decimals="-6">151000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-6">159000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="-6">165000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="C849211" unitRef="USD" decimals="-6">-21000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="C849195" unitRef="USD" decimals="-6">-26000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">-55000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="C849207" unitRef="USD" decimals="-6">-17000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="C849209" unitRef="USD" decimals="-6">-4000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2015-07-01to2016-06-30_custom_DiscontinuedOperationsOtherMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2014-07-01to2015-06-30_custom_DiscontinuedOperationsOtherMember" unitRef="USD" decimals="-6">29000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="C851092" unitRef="USD" decimals="-6">-55000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="C851093" unitRef="USD" decimals="-6">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="C851094" unitRef="USD" decimals="-6">30000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="C851114" unitRef="USD" decimals="-6">2000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2015-10-01to2015-12-31" unitRef="USD" decimals="-6">-2000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-6">3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="C849211" unitRef="USD" decimals="-6">558000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="C849195" unitRef="USD" decimals="-6">580000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="C851170" unitRef="USD" decimals="-6">558000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="C851171" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="C851172" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="C851173" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="C851237" unitRef="USD" decimals="-6">580000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="C851235" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="C851238" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="C851236" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="C851092" unitRef="USD" decimals="-6">90000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="C851093" unitRef="USD" decimals="-6">125000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="C851094" unitRef="USD" decimals="-6">174000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="C851114" unitRef="USD" decimals="-6">191000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">648000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-6">648000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-06-30_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2013-07-01to2014-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2014-07-01to2015-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">172000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-10-01to2015-12-31" unitRef="USD" decimals="-6">149000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-6">162000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="-6">165000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="C849211" unitRef="USDPerShare" decimals="2">4.47</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="C849195" unitRef="USDPerShare" decimals="2">4.65</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="C851092" unitRef="USDPerShare" decimals="2">1.12</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="C851093" unitRef="USDPerShare" decimals="2">0.98</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="C851094" unitRef="USDPerShare" decimals="2">1.09</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="C851114" unitRef="USDPerShare" decimals="2">1.46</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">5.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="From2015-07-01to2015-09-30" unitRef="USDPerShare" decimals="INF">1.34</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="From2015-10-01to2015-12-31" unitRef="USDPerShare" decimals="INF">1.16</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="From2016-01-01to2016-03-31" unitRef="USDPerShare" decimals="INF">1.23</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">1.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="C849211" unitRef="USDPerShare" decimals="2">-0.16</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="C849195" unitRef="USDPerShare" decimals="2">-0.20</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="C851092" unitRef="USDPerShare" decimals="2">-0.42</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="C851093" unitRef="USDPerShare" decimals="2">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="C851094" unitRef="USDPerShare" decimals="2">0.22</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="C851114" unitRef="USDPerShare" decimals="2">0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="From2015-07-01to2015-09-30" unitRef="USDPerShare" decimals="INF">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="From2015-10-01to2015-12-31" unitRef="USDPerShare" decimals="INF">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="From2016-01-01to2016-03-31" unitRef="USDPerShare" decimals="INF">0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic contextRef="C849211" unitRef="USDPerShare" decimals="2">4.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="C849195" unitRef="USDPerShare" decimals="2">4.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="C851092" unitRef="USDPerShare" decimals="2">0.70</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="C851093" unitRef="USDPerShare" decimals="2">0.96</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="C851094" unitRef="USDPerShare" decimals="2">1.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="C851114" unitRef="USDPerShare" decimals="2">1.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">5.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2015-09-30" unitRef="USDPerShare" decimals="INF">1.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-10-01to2015-12-31" unitRef="USDPerShare" decimals="INF">1.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-01-01to2016-03-31" unitRef="USDPerShare" decimals="INF">1.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">1.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="C849211" unitRef="USDPerShare" decimals="2">4.39</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="C849195" unitRef="USDPerShare" decimals="2">4.57</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="C851092" unitRef="USDPerShare" decimals="2">1.10</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="C851093" unitRef="USDPerShare" decimals="2">0.97</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="C851094" unitRef="USDPerShare" decimals="2">1.08</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="C851114" unitRef="USDPerShare" decimals="2">1.44</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">4.92</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2015-07-01to2015-09-30" unitRef="USDPerShare" decimals="INF">1.32</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2015-10-01to2015-12-31" unitRef="USDPerShare" decimals="INF">1.14</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2016-01-01to2016-03-31" unitRef="USDPerShare" decimals="INF">1.21</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">1.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="C849211" unitRef="USDPerShare" decimals="2">-0.16</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="C849195" unitRef="USDPerShare" decimals="2">-0.20</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="C851092" unitRef="USDPerShare" decimals="2">-0.42</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="C851093" unitRef="USDPerShare" decimals="2">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="C851094" unitRef="USDPerShare" decimals="2">0.22</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="C851114" unitRef="USDPerShare" decimals="2">0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="From2015-07-01to2015-09-30" unitRef="USDPerShare" decimals="INF">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="From2015-10-01to2015-12-31" unitRef="USDPerShare" decimals="INF">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="From2016-01-01to2016-03-31" unitRef="USDPerShare" decimals="INF">0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted contextRef="C849211" unitRef="USDPerShare" decimals="2">4.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="C849195" unitRef="USDPerShare" decimals="2">4.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="C851092" unitRef="USDPerShare" decimals="2">0.68</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="C851093" unitRef="USDPerShare" decimals="2">0.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="C851094" unitRef="USDPerShare" decimals="2">1.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="C851114" unitRef="USDPerShare" decimals="2">1.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">4.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-07-01to2015-09-30" unitRef="USDPerShare" decimals="INF">1.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-10-01to2015-12-31" unitRef="USDPerShare" decimals="INF">1.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-01-01to2016-03-31" unitRef="USDPerShare" decimals="INF">1.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">1.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="C849211" unitRef="Shares" decimals="-3">129558000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="C849195" unitRef="Shares" decimals="-3">130310000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-07-01to2016-06-30" unitRef="Shares" decimals="-3">129472000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="C849211" unitRef="Shares" decimals="-3">131742000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="C849195" unitRef="Shares" decimals="-3">132776000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-07-01to2016-06-30" unitRef="Shares" decimals="-3">131717000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="C849211" unitRef="USD" decimals="-6">-37000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="C849195" unitRef="USD" decimals="-6">-54000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-53000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent contextRef="C849211" unitRef="USD" decimals="-6">-9000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent contextRef="C849195" unitRef="USD" decimals="-6">-14000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">9000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="C849211" unitRef="USD" decimals="-6">4000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="C849195" unitRef="USD" decimals="-6">17000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">24000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="C849211" unitRef="USD" decimals="-6">-50000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="C849195" unitRef="USD" decimals="-6">-85000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="C851170" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="C851171" unitRef="USD" decimals="-6">-50000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="C851172" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="C851173" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="C851237" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="C851235" unitRef="USD" decimals="-6">-85000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="C851238" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="C851236" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-68000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2016-06-30_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="-6">-68000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2013-07-01to2014-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2014-07-01to2015-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="C849211" unitRef="USD" decimals="-6">508000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="C849195" unitRef="USD" decimals="-6">495000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">580000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="C849220" unitRef="USD" decimals="-6">329000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="C849221" unitRef="USD" decimals="-6">382000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="C849284" unitRef="USD" decimals="-6">299000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">401000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent contextRef="C849221" unitRef="USD" decimals="-6">519000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">569000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet contextRef="C849221" unitRef="USD" decimals="-6">385000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">443000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent contextRef="C849221" unitRef="USD" decimals="-6">143000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">72000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="C849221" unitRef="USD" decimals="-6">1429000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1485000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="C849221" unitRef="USD" decimals="-6">918000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-06-30_country_US" unitRef="USD" decimals="-6">799000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-06-30_custom_ForeignMember" unitRef="USD" decimals="-6">107000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="C851333" unitRef="USD" decimals="-6">801000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="C851334" unitRef="USD" decimals="-6">117000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">906000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="C849220" unitRef="USD" decimals="-6">1101000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="C849221" unitRef="USD" decimals="-6">1067000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="C850673" unitRef="USD" decimals="-6">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="C850674" unitRef="USD" decimals="-6">85000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="C850675" unitRef="USD" decimals="-6">415000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="C850668" unitRef="USD" decimals="-6">323000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="C850669" unitRef="USD" decimals="-6">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="C850670" unitRef="USD" decimals="-6">85000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="C850671" unitRef="USD" decimals="-6">449000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="C850672" unitRef="USD" decimals="-6">323000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2016-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">323000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2016-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">244000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2016-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">207000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2016-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">423000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1197000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">137000000</us-gaap:Goodwill>
    <clx:TrademarksNet contextRef="C849221" unitRef="USD" decimals="-6">535000000</clx:TrademarksNet>
    <clx:TrademarksNet contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">657000000</clx:TrademarksNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="C849221" unitRef="USD" decimals="-6">50000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">78000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="C849221" unitRef="USD" decimals="-6">165000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">195000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="C849221" unitRef="USD" decimals="-6">4164000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="C850673" unitRef="USD" decimals="-6">860000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="C850674" unitRef="USD" decimals="-6">725000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="C850675" unitRef="USD" decimals="-6">1057000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="C850672" unitRef="USD" decimals="-6">876000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">883000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">880000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">1092000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">1057000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="C851308" unitRef="USD" decimals="-6">646000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">4518000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-06-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">606000000</us-gaap:Assets>
    <us-gaap:CommercialPaper contextRef="C849221" unitRef="USD" decimals="-6">95000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="AsOf2016-06-30_us-gaap_CommercialPaperMember" unitRef="USD" decimals="-6">522000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="AsOf2016-06-30_custom_ForeignBorrowingsMember" unitRef="USD" decimals="-6">1000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="C851107" unitRef="USD" decimals="-6">93000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="C851130" unitRef="USD" decimals="-6">2000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">523000000</us-gaap:CommercialPaper>
    <us-gaap:LongTermDebtCurrent contextRef="C849221" unitRef="USD" decimals="-6">300000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="C849221" unitRef="USD" decimals="-6">31000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="C849221" unitRef="USD" decimals="-6">1405000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1558000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="C849221" unitRef="USD" decimals="-6">1796000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1797000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="C849221" unitRef="USD" decimals="-6">95000000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">82000000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="C849221" unitRef="USD" decimals="-6">4046000000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">4221000000</us-gaap:Liabilities>
    <us-gaap:CommonStockValue contextRef="C849221" unitRef="USD" decimals="-6">159000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">159000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="C849221" unitRef="USD" decimals="-6">775000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">868000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="C849221" unitRef="USD" decimals="-6">1923000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">2163000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue contextRef="C849221" unitRef="USD" decimals="-6">2237000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">2323000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="C849220" unitRef="USD" decimals="-6">-417000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="C849221" unitRef="USD" decimals="-6">-502000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="C849284" unitRef="USD" decimals="-6">-367000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">-570000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2013-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-209000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2014-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-246000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-300000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-353000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2013-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-30000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2014-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-39000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-53000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-44000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2013-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-128000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2014-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-132000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-149000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-173000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="C849220" unitRef="USD" decimals="-6">154000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C849221" unitRef="USD" decimals="-6">118000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851165" unitRef="USD" decimals="-6">159000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851166" unitRef="USD" decimals="-6">661000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851167" unitRef="USD" decimals="-6">1561000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851168" unitRef="USD" decimals="-6">-1868000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851169" unitRef="USD" decimals="-6">-367000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C849284" unitRef="USD" decimals="-6">146000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851174" unitRef="USD" decimals="-6">159000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851175" unitRef="USD" decimals="-6">709000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851176" unitRef="USD" decimals="-6">1739000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851177" unitRef="USD" decimals="-6">-2036000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851178" unitRef="USD" decimals="-6">-417000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851179" unitRef="USD" decimals="-6">159000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851180" unitRef="USD" decimals="-6">775000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851181" unitRef="USD" decimals="-6">1923000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851182" unitRef="USD" decimals="-6">-2237000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="C851183" unitRef="USD" decimals="-6">-502000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">297000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="-6">159000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-6">868000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-6">2163000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30_us-gaap_TreasuryStockMember" unitRef="USD" decimals="-6">-2323000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="-6">-570000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="C849221" unitRef="USD" decimals="-6">4164000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">4518000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="C849221" unitRef="USDPerShare" decimals="INF">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-06-30" unitRef="USDPerShare" decimals="INF">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="C849221" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="C849221" unitRef="USDPerShare" decimals="INF">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-06-30" unitRef="USDPerShare" decimals="INF">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="C849221" unitRef="Shares" decimals="INF">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="C849221" unitRef="Shares" decimals="INF">158741461</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">158741461</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="C849221" unitRef="Shares" decimals="INF">128614310</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">129355263</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TreasuryStockShares contextRef="C849221" unitRef="Shares" decimals="INF">30127151</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">29386198</us-gaap:TreasuryStockShares>
    <us-gaap:PreferredStockSharesIssued contextRef="C849221" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="C849221" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="C849221" unitRef="USD" decimals="-6">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:PreferredStockValue>
    <us-gaap:CommitmentsAndContingencies contextRef="C849221" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="C851165" unitRef="Shares" decimals="-3">158741000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="C851168" unitRef="Shares" decimals="-3">-28375000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="C851174" unitRef="Shares" decimals="-3">158741000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="C851177" unitRef="Shares" decimals="-3">-29945000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="C851179" unitRef="Shares" decimals="-3">158741000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="C851182" unitRef="Shares" decimals="-3">-30127000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2016-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="-3">158741000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2016-06-30_us-gaap_TreasuryStockMember" unitRef="Shares" decimals="-3">-29386000</us-gaap:SharesOutstanding>
    <us-gaap:DividendsCash contextRef="C849211" unitRef="USD" decimals="-6">374000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash contextRef="C849195" unitRef="USD" decimals="-6">391000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash contextRef="C851170" unitRef="USD" decimals="-6">374000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash contextRef="C851171" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="C851172" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="C851173" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="C851237" unitRef="USD" decimals="-6">391000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash contextRef="C851235" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="C851238" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="C851236" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">406000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash contextRef="From2015-07-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="From2015-07-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="From2015-07-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-6">406000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash contextRef="From2015-07-01to2016-06-30_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="From2013-07-01to2014-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCash contextRef="From2014-07-01to2015-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="C849211" unitRef="USD" decimals="-6">36000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="C849195" unitRef="USD" decimals="-6">32000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="C851172" unitRef="USD" decimals="-6">36000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="C851237" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="C851235" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="C851238" unitRef="USD" decimals="-6">32000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="C851236" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">45000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="From2015-07-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="From2015-07-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-6">45000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="From2015-07-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="From2015-07-01to2016-06-30_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="From2013-07-01to2014-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition contextRef="From2014-07-01to2015-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="C849211" unitRef="USD" decimals="-6">98000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="C849195" unitRef="USD" decimals="-6">262000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="C851170" unitRef="USD" decimals="-6">-6000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="C851171" unitRef="USD" xsi:nil="true" />
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="C851172" unitRef="USD" decimals="-6">12000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="C851173" unitRef="USD" decimals="-6">92000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="C851237" unitRef="USD" decimals="-6">-5000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="C851235" unitRef="USD" xsi:nil="true" />
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="C851238" unitRef="USD" decimals="-6">34000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="C851236" unitRef="USD" decimals="-6">233000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">214000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="From2015-07-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="From2015-07-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-6">48000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="From2015-07-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-6">-2000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="From2015-07-01to2016-06-30_us-gaap_TreasuryStockMember" unitRef="USD" decimals="-6">168000000</clx:OtherEmployeeStockPlanActivitiesValue>
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="From2013-07-01to2014-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <clx:OtherEmployeeStockPlanActivitiesValue contextRef="From2014-07-01to2015-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <clx:OtherEmployeeStockPlanActivitiesShares contextRef="C851173" unitRef="Shares" decimals="-3">1476000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesShares contextRef="C851236" unitRef="Shares" decimals="-3">-4198000</clx:OtherEmployeeStockPlanActivitiesShares>
    <clx:OtherEmployeeStockPlanActivitiesShares contextRef="From2015-07-01to2016-06-30_us-gaap_TreasuryStockMember" unitRef="Shares" decimals="-3">2892000</clx:OtherEmployeeStockPlanActivitiesShares>
    <us-gaap:TreasuryStockSharesAcquired contextRef="C851173" unitRef="Shares" decimals="-3">3046000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired contextRef="C851236" unitRef="Shares" decimals="-3">-4016000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired contextRef="From2015-07-01to2016-06-30_us-gaap_TreasuryStockMember" unitRef="Shares" decimals="-3">2151000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="C849211" unitRef="USD" decimals="-6">260000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="C849195" unitRef="USD" decimals="-6">434000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="C851170" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="C851171" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="C851172" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="C851173" unitRef="USD" decimals="-6">260000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="C851237" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="C851235" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="C851238" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="C851236" unitRef="USD" decimals="-6">434000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">254000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="From2015-07-01to2016-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="From2015-07-01to2016-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="From2015-07-01to2016-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="From2015-07-01to2016-06-30_us-gaap_TreasuryStockMember" unitRef="USD" decimals="-6">254000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="From2013-07-01to2014-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="From2014-07-01to2015-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DepreciationAndAmortization contextRef="C849211" unitRef="USD" decimals="-6">177000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="C849195" unitRef="USD" decimals="-6">169000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2015-07-01to2016-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">21000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="C849251" unitRef="USD" decimals="-6">24000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2015-07-01to2016-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">61000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2015-07-01to2016-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">19000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2015-07-01to2016-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">60000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="C849248" unitRef="USD" decimals="-6">52000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="C849250" unitRef="USD" decimals="-6">19000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="C849249" unitRef="USD" decimals="-6">67000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="C849233" unitRef="USD" decimals="-6">17000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2013-07-01to2014-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">49000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2013-07-01to2014-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">67000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2013-07-01to2014-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">19000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2013-07-01to2014-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">25000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2015-07-01to2016-06-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">4000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="C849252" unitRef="USD" decimals="-6">7000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">165000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="C849211" unitRef="USD" decimals="-6">36000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="C849195" unitRef="USD" decimals="-6">32000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2016-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">1000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="C849251" unitRef="USD" decimals="-6">1000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2016-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">10000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2016-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">5000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2016-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">8000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="C849248" unitRef="USD" decimals="-6">8000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="C849250" unitRef="USD" decimals="-6">4000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="C849249" unitRef="USD" decimals="-6">7000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="C851376" unitRef="USD" decimals="-6">4000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2016-06-30_us-gaap_CostOfSalesMember" unitRef="USD" decimals="-6">6000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="C851377" unitRef="USD" decimals="-6">29000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2016-06-30_us-gaap_SellingAndMarketingExpenseMember" unitRef="USD" decimals="-6">35000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="C851378" unitRef="USD" decimals="-6">3000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2016-06-30_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-6">4000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2014-07-01to2015-06-30_us-gaap_CostOfSalesMember" unitRef="USD" decimals="-6">4000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2014-07-01to2015-06-30_us-gaap_SellingAndMarketingExpenseMember" unitRef="USD" decimals="-6">25000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2014-07-01to2015-06-30_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-6">3000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="C849233" unitRef="USD" decimals="-6">10000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2013-07-01to2014-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">11000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2013-07-01to2014-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">9000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2013-07-01to2014-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">5000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2013-07-01to2014-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">1000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2016-06-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">21000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="C849252" unitRef="USD" decimals="-6">12000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">45000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="C849211" unitRef="USD" decimals="-6">-21000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="C849195" unitRef="USD" decimals="-6">-16000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">5000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="C849211" unitRef="USD" decimals="-6">-20000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="C849195" unitRef="USD" decimals="-6">-6000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">52000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories contextRef="C849211" unitRef="USD" decimals="-6">-1000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="C849195" unitRef="USD" decimals="-6">25000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">45000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="C849211" unitRef="USD" decimals="-6">-5000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="C849195" unitRef="USD" decimals="-6">-6000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-6000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="C849211" unitRef="USD" decimals="-6">-12000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="C849195" unitRef="USD" decimals="-6">93000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">57000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="C849211" unitRef="USD" decimals="-6">-5000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="C849195" unitRef="USD" decimals="-6">29000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-62000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="C849211" unitRef="USD" decimals="-6">786000000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="C849195" unitRef="USD" decimals="-6">858000000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">768000000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="C849211" unitRef="USD" decimals="-6">-19000000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="C849195" unitRef="USD" decimals="-6">16000000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">10000000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="C849211" unitRef="USD" decimals="-6">767000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="C849195" unitRef="USD" decimals="-6">874000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">778000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="C849211" unitRef="USD" decimals="-6">137000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="C849195" unitRef="USD" decimals="-6">125000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-07-01to2016-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">24000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="C849251" unitRef="USD" decimals="-6">25000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-07-01to2016-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">44000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-07-01to2016-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">18000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-07-01to2016-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">83000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="C849248" unitRef="USD" decimals="-6">35000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="C849250" unitRef="USD" decimals="-6">11000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="C849249" unitRef="USD" decimals="-6">50000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="C849233" unitRef="USD" decimals="-6">5000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2013-07-01to2014-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">37000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2013-07-01to2014-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">53000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2013-07-01to2014-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">11000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2013-07-01to2014-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">31000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-07-01to2016-06-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">3000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="C849252" unitRef="USD" decimals="-6">4000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">172000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="C849211" unitRef="USD" decimals="-6">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="C849195" unitRef="USD" decimals="-6">-19000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-32000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="C849211" unitRef="USD" decimals="-6">-137000000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="C849195" unitRef="USD" decimals="-6">-106000000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-430000000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="C849211" unitRef="USD" decimals="-6">-1000000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="C849195" unitRef="USD" decimals="-6">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="C849211" unitRef="USD" decimals="-6">-138000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="C849195" unitRef="USD" decimals="-6">-106000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-430000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="C849211" unitRef="USD" decimals="-6">-60000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="C849195" unitRef="USD" decimals="-6">-48000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">426000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="C849211" unitRef="USD" decimals="-6">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="C849195" unitRef="USD" decimals="-6">495000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="C849211" unitRef="USD" decimals="-6">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="C849195" unitRef="USD" decimals="-6">575000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="From2015-11-01to2015-11-30_custom_SeniorNotes3.55PercentMember" unitRef="USD" decimals="-6">300000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">300000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="From2015-01-01to2015-01-31_custom_SeniorNotes5.00PercentMember" unitRef="USD" decimals="-6">575000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="C849211" unitRef="USD" decimals="-6">260000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="C849195" unitRef="USD" decimals="-6">434000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">254000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="C849211" unitRef="USD" decimals="-6">368000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="C849195" unitRef="USD" decimals="-6">385000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">398000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="C849211" unitRef="USD" decimals="-6">96000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="C849195" unitRef="USD" decimals="-6">251000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">210000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="C849211" unitRef="USD" decimals="-6">-592000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="C849195" unitRef="USD" decimals="-6">-696000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-316000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="C849211" unitRef="USD" decimals="-6">-7000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="C849195" unitRef="USD" decimals="-6">-19000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-13000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="C849211" unitRef="USD" decimals="-6">30000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="C849195" unitRef="USD" decimals="-6">53000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">19000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:OtherNoncashIncomeExpense contextRef="C849211" unitRef="USD" decimals="-6">-6000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="C849195" unitRef="USD" decimals="-6">17000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-1000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:SaleLeasebackTransactionNetProceedsInvestingActivities contextRef="C851154" unitRef="USD" decimals="-6">108000000</us-gaap:SaleLeasebackTransactionNetProceedsInvestingActivities>
    <us-gaap:InterestPaid contextRef="C849211" unitRef="USD" decimals="-6">76000000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="C849195" unitRef="USD" decimals="-6">104000000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">79000000</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaidNet contextRef="C849211" unitRef="USD" decimals="-6">312000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="C849195" unitRef="USD" decimals="-6">236000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">323000000</us-gaap:IncomeTaxesPaidNet>
    <clx:InterestRateForwardContractsSettlement contextRef="C849211" unitRef="USD" decimals="-6">0</clx:InterestRateForwardContractsSettlement>
    <clx:InterestRateForwardContractsSettlement contextRef="C849195" unitRef="USD" decimals="-6">25000000</clx:InterestRateForwardContractsSettlement>
    <clx:InterestRateForwardContractsSettlement contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">0</clx:InterestRateForwardContractsSettlement>
    <clx:UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries contextRef="C849221" unitRef="USD" decimals="-6">19000000</clx:UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries>
    <clx:UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">19000000</clx:UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries>
    <clx:UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent contextRef="C849221" unitRef="USD" decimals="-6">221000000</clx:UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent>
    <clx:UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">249000000</clx:UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent>
    <clx:NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries contextRef="C849221" unitRef="USD" decimals="-6">142000000</clx:NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries>
    <clx:NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">133000000</clx:NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries>
    <clx:NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries contextRef="C849221" unitRef="USD" decimals="-6">0</clx:NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries>
    <clx:NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</clx:NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2015-07-01to2016-06-30_us-gaap_BuildingAndBuildingImprovementsMember_us-gaap_MinimumMember">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2015-07-01to2016-06-30_us-gaap_BuildingAndBuildingImprovementsMember_us-gaap_MaximumMember">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2015-07-01to2016-06-30_us-gaap_LandImprovementsMember_us-gaap_MinimumMember">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2015-07-01to2016-06-30_us-gaap_LandImprovementsMember_us-gaap_MaximumMember">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2015-07-01to2016-06-30_us-gaap_MachineryAndEquipmentMember_us-gaap_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2015-07-01to2016-06-30_us-gaap_MachineryAndEquipmentMember_us-gaap_MaximumMember">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2015-07-01to2016-06-30_us-gaap_ComputerEquipmentMember_us-gaap_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2015-07-01to2016-06-30_us-gaap_ComputerEquipmentMember_us-gaap_MaximumMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2015-07-01to2016-06-30_custom_CapitalizedSoftwareCostsMember_us-gaap_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2015-07-01to2016-06-30_custom_CapitalizedSoftwareCostsMember_us-gaap_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <clx:DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges contextRef="C849211" unitRef="Item" decimals="0">0</clx:DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges>
    <clx:DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges contextRef="C849195" unitRef="Item" decimals="0">0</clx:DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges>
    <clx:DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges contextRef="From2015-07-01to2016-06-30" unitRef="Item" decimals="0">0</clx:DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="C849195" unitRef="USD" decimals="-6">4000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">5000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:NontradeReceivablesCurrent contextRef="C849221" unitRef="USD" decimals="-6">12000000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">9000000</us-gaap:NontradeReceivablesCurrent>
    <clx:DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">6000000</clx:DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets>
    <clx:DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</clx:DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets>
    <clx:DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">2000000</clx:DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets>
    <clx:DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</clx:DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets>
    <clx:DisposalGroupIncludingDiscontinuedOperationSeverance contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">3000000</clx:DisposalGroupIncludingDiscontinuedOperationSeverance>
    <clx:DisposalGroupIncludingDiscontinuedOperationSeverance contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</clx:DisposalGroupIncludingDiscontinuedOperationSeverance>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">-30000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses>
    <clx:DisposalGroupIncludingDiscontinuedOperationOther contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">10000000</clx:DisposalGroupIncludingDiscontinuedOperationOther>
    <clx:DisposalGroupIncludingDiscontinuedOperationOther contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">2000000</clx:DisposalGroupIncludingDiscontinuedOperationOther>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">-84000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="C849207" unitRef="USD" decimals="-6">-23000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">-2000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">-29000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="C849207" unitRef="USD" decimals="-6">-6000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">-2000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">-6000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="C849207" unitRef="USD" decimals="-6">-23000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <clx:DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">11000000</clx:DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet>
    <clx:DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</clx:DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet>
    <clx:DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">16000000</clx:DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet>
    <clx:DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</clx:DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">11000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="C849207" unitRef="USD" decimals="-6">77000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense contextRef="From2014-07-01to2015-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">78000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense contextRef="C849207" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense contextRef="From2015-07-01to2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">2000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense>
    <us-gaap:DepreciationNonproduction contextRef="C849211" unitRef="USD" decimals="-6">161000000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction contextRef="C849195" unitRef="USD" decimals="-6">157000000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">157000000</us-gaap:DepreciationNonproduction>
    <clx:DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet contextRef="C849198" unitRef="USD" decimals="-6">0</clx:DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet>
    <clx:DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet contextRef="AsOf2016-06-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</clx:DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets contextRef="C849199" unitRef="USD" decimals="-6">13000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets contextRef="AsOf2016-06-30_us-gaap_CorporateMember_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets>
    <us-gaap:InventoryFinishedGoods contextRef="C849221" unitRef="USD" decimals="-6">316000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">361000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterials contextRef="C849221" unitRef="USD" decimals="-6">101000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">111000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess contextRef="C849221" unitRef="USD" decimals="-6">3000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">3000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryLIFOReserve contextRef="C849221" unitRef="USD" decimals="-6">35000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">32000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:AdjustmentForAmortization contextRef="C896429" unitRef="USD" decimals="-6">22000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="From2015-07-01to2016-06-30_custom_CapitalizedSoftwareCostsMember" unitRef="USD" decimals="-6">16000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="C896432" unitRef="USD" decimals="-6">19000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:PercentageOfLIFOInventory contextRef="C849221" unitRef="Pure" decimals="2">0.38</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:PercentageOfLIFOInventory contextRef="AsOf2016-06-30" unitRef="Pure" decimals="2">0.38</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:EffectOfLIFOInventoryLiquidationOnIncome contextRef="C849211" unitRef="USD" decimals="-6">2000000</us-gaap:EffectOfLIFOInventoryLiquidationOnIncome>
    <us-gaap:EffectOfLIFOInventoryLiquidationOnIncome contextRef="C849195" unitRef="USD" decimals="-6">0</us-gaap:EffectOfLIFOInventoryLiquidationOnIncome>
    <us-gaap:EffectOfLIFOInventoryLiquidationOnIncome contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:EffectOfLIFOInventoryLiquidationOnIncome>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="C849221" unitRef="USD" decimals="-6">2757000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="C850660" unitRef="USD" decimals="-6">1608000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-06-30_us-gaap_BuildingMember" unitRef="USD" decimals="-6">515000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="C850662" unitRef="USD" decimals="-6">371000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_MachineryAndEquipmentMember" unitRef="USD" decimals="-6">1607000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_BuildingMember" unitRef="USD" decimals="-6">524000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_custom_CapitalizedSoftwareCostsMember" unitRef="USD" decimals="-6">368000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_LandAndLandImprovementsMember" unitRef="USD" decimals="-6">118000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_ConstructionInProgressMember" unitRef="USD" decimals="-6">112000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="-6">88000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-06-30_us-gaap_LandAndLandImprovementsMember" unitRef="USD" decimals="-6">122000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-06-30_us-gaap_ConstructionInProgressMember" unitRef="USD" decimals="-6">65000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="C850665" unitRef="USD" decimals="-6">76000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-06-30_us-gaap_AssetsHeldUnderCapitalLeasesMember" unitRef="USD" decimals="-6">12000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_AssetsHeldUnderCapitalLeasesMember" unitRef="USD" decimals="-6">12000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">2817000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:DeferredTaxAssetsNetCurrent contextRef="C849221" unitRef="USD" id="Foot-00-0" decimals="-6">99000000</us-gaap:DeferredTaxAssetsNetCurrent>
    <us-gaap:DeferredTaxAssetsNetCurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-1" decimals="-6">0</us-gaap:DeferredTaxAssetsNetCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="C849221" unitRef="USD" decimals="-6">39000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">70000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent contextRef="C849221" unitRef="USD" decimals="-6">5000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">2000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="C849221" unitRef="USD" decimals="-6">1839000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2015-06-30_us-gaap_AssetsHeldUnderCapitalLeasesMember" unitRef="USD" decimals="-6">2000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2016-06-30_us-gaap_AssetsHeldUnderCapitalLeasesMember" unitRef="USD" decimals="-6">3000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1911000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AssetRetirementObligation contextRef="AsOf2016-06-30_us-gaap_LandAndLandImprovementsMember" unitRef="USD" decimals="-6">3000000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation contextRef="AsOf2015-06-30_us-gaap_LandAndLandImprovementsMember" unitRef="USD" decimals="-6">2000000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligationLiabilitiesIncurred contextRef="C896428" unitRef="USD" decimals="-6">2000000</us-gaap:AssetRetirementObligationLiabilitiesIncurred>
    <us-gaap:AssetRetirementObligationLiabilitiesIncurred contextRef="From2015-07-01to2016-06-30_us-gaap_LandAndLandImprovementsMember" unitRef="USD" decimals="-6">1000000</us-gaap:AssetRetirementObligationLiabilitiesIncurred>
    <clx:NonCashCapitalExpenditures contextRef="C849211" unitRef="USD" decimals="-6">0</clx:NonCashCapitalExpenditures>
    <clx:NonCashCapitalExpenditures contextRef="C849195" unitRef="USD" decimals="-6">18000000</clx:NonCashCapitalExpenditures>
    <clx:NonCashCapitalExpenditures contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">10000000</clx:NonCashCapitalExpenditures>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="C849211" unitRef="USD" decimals="-6">15000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="C849195" unitRef="USD" decimals="-6">12000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">8000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="C849221" unitRef="USD" decimals="-6">882000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-06-30_us-gaap_TrademarksMember" unitRef="USD" decimals="-6">32000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-06-30_custom_TechnologyAndProductFormulaeMember" unitRef="USD" decimals="-6">137000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-06-30_custom_OtherIntangibleAssetsOtherMember" unitRef="USD" decimals="-6">221000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2015-06-30_custom_TechnologyAndProductFormulaeMember" unitRef="USD" decimals="-6">137000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2015-06-30_custom_OtherIntangibleAssetsOtherMember" unitRef="USD" decimals="-6">188000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="C851367" unitRef="USD" decimals="-6">33000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1037000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2015-07-01to2016-06-30_us-gaap_MinimumMember">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2015-07-01to2016-06-30_us-gaap_MaximumMember">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2016-06-30_us-gaap_TrademarkMember" unitRef="USD" decimals="-6">647000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="C851366" unitRef="USD" decimals="-6">524000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="C849221" unitRef="USD" decimals="-6">297000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2016-06-30_us-gaap_TrademarksMember" unitRef="USD" decimals="-6">22000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2016-06-30_custom_TechnologyAndProductFormulaeMember" unitRef="USD" decimals="-6">134000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2016-06-30_custom_OtherIntangibleAssetsOtherMember" unitRef="USD" decimals="-6">146000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2015-06-30_custom_TechnologyAndProductFormulaeMember" unitRef="USD" decimals="-6">133000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2015-06-30_custom_OtherIntangibleAssetsOtherMember" unitRef="USD" decimals="-6">142000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="C851367" unitRef="USD" decimals="-6">22000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">302000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="C849221" unitRef="USD" decimals="-6">585000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2016-06-30_us-gaap_TrademarksMember" unitRef="USD" decimals="-6">10000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2016-06-30_custom_TechnologyAndProductFormulaeMember" unitRef="USD" decimals="-6">3000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2016-06-30_custom_OtherIntangibleAssetsOtherMember" unitRef="USD" decimals="-6">75000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2015-06-30_custom_TechnologyAndProductFormulaeMember" unitRef="USD" decimals="-6">4000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2015-06-30_custom_OtherIntangibleAssetsOtherMember" unitRef="USD" decimals="-6">46000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="C851367" unitRef="USD" decimals="-6">11000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">735000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="C849195" unitRef="USD" decimals="-6">-34000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="From2015-07-01to2016-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">-7000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="C849251" unitRef="USD" decimals="-6">-34000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="From2015-07-01to2016-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="From2015-07-01to2016-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="From2015-07-01to2016-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="C849248" unitRef="USD" decimals="-6">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="C849250" unitRef="USD" decimals="-6">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="C849249" unitRef="USD" decimals="-6">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-7000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="C849221" unitRef="USD" decimals="-6">189000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">192000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <clx:AccruedTradeAndSalesPromotionCostsCurrent contextRef="C849221" unitRef="USD" decimals="-6">115000000</clx:AccruedTradeAndSalesPromotionCostsCurrent>
    <clx:AccruedTradeAndSalesPromotionCostsCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">127000000</clx:AccruedTradeAndSalesPromotionCostsCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="C849221" unitRef="USD" decimals="-6">103000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">108000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="C849221" unitRef="USD" decimals="-6">8000000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">5000000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="C849221" unitRef="USD" decimals="-6">141000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">118000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2015-11-30_custom_SeniorNotes3.55PercentMember" unitRef="Pure" decimals="4">0.0355</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2014-12-31_custom_SeniorNotes3.50PercentMember" unitRef="Pure" decimals="4">0.0350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2015-01-31_custom_SeniorNotes5.00PercentMember" unitRef="Pure" decimals="4">.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2014-12-31_custom_SeniorNotes3.50PercentMember" unitRef="USD" decimals="-6">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" unitRef="USD" decimals="-6">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" unitRef="USD" decimals="-6">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" unitRef="USD" decimals="-6">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" unitRef="USD" decimals="-6">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" unitRef="USD" decimals="-6">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" unitRef="USD" decimals="-6">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" unitRef="USD" decimals="-6">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" unitRef="USD" decimals="-6">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" unitRef="USD" decimals="-6">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" unitRef="USD" decimals="-6">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="C849221" unitRef="USD" decimals="-6">1129000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="C851125" unitRef="USD" decimals="-6">1100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-06-30_custom_RevolvingLineOfCreditMember" unitRef="USD" decimals="-6">1100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-06-30_custom_ForeignAndOtherCreditLinesMember" unitRef="USD" decimals="-6">28000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-06-30_us-gaap_RevolvingCreditFacilityMember" unitRef="USD" decimals="-6">1100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-06-30_custom_ForeignCreditLinesMember" unitRef="USD" decimals="-6">10000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-06-30_custom_OtherCreditLinesMember" unitRef="USD" decimals="-6">18000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="C851151" unitRef="USD" decimals="-6">1100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="C851152" unitRef="USD" decimals="-6">11000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="C851153" unitRef="USD" decimals="-6">18000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="C851116" unitRef="USD" decimals="-6">29000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1128000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="C851125" unitRef="USD" decimals="-6">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2016-06-30_custom_RevolvingLineOfCreditMember" unitRef="USD" decimals="-6">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2016-06-30_custom_ForeignAndOtherCreditLinesMember" unitRef="USD" decimals="-6">5000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="C851116" unitRef="USD" decimals="-6">4000000</us-gaap:LineOfCredit>
    <clx:ShortTermDebtWeightedAverageInterestRateDuringPeriod contextRef="C849211" unitRef="Pure" decimals="4">0.0097</clx:ShortTermDebtWeightedAverageInterestRateDuringPeriod>
    <clx:ShortTermDebtWeightedAverageInterestRateDuringPeriod contextRef="C849195" unitRef="Pure" decimals="4">0.0205</clx:ShortTermDebtWeightedAverageInterestRateDuringPeriod>
    <clx:ShortTermDebtWeightedAverageInterestRateDuringPeriod contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="4">0.0110</clx:ShortTermDebtWeightedAverageInterestRateDuringPeriod>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate contextRef="AsOf2016-06-30_us-gaap_CommercialPaperMember" unitRef="Pure" decimals="4">.0082</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate contextRef="C851107" unitRef="Pure" decimals="4">0.0039</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <clx:WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps contextRef="C849211" unitRef="Pure" decimals="4">0.0456</clx:WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps>
    <clx:WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps contextRef="C849195" unitRef="Pure" decimals="4">0.0444</clx:WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps>
    <clx:WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="4">.0437</clx:WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="C849221" unitRef="Pure" decimals="4">0.0431</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" unitRef="Pure" decimals="4">0.0355</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" unitRef="Pure" decimals="4">0.0595</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" unitRef="Pure" decimals="4">0.0380</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" unitRef="Pure" decimals="4">0.0305</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" unitRef="Pure" decimals="4">0.0355</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" unitRef="Pure" decimals="4">0.0595</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" unitRef="Pure" decimals="4">0.0380</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" unitRef="Pure" decimals="4">0.0305</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" unitRef="Pure" decimals="4">0.0350</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" unitRef="Pure" decimals="4">0.0350</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="AsOf2016-06-30" unitRef="Pure" decimals="4">.0441</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="AsOf2016-06-30_custom_ForeignAndOtherCreditLinesMember" unitRef="USD" decimals="-6">23000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="C851116" unitRef="USD" decimals="-6">25000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">400000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1400000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LongTermDebt contextRef="C849221" unitRef="USD" decimals="-6">2096000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" unitRef="USD" decimals="-6">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" unitRef="USD" decimals="-6">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" unitRef="USD" decimals="-6">298000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" unitRef="USD" decimals="-6">599000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" unitRef="USD" decimals="-6">300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" unitRef="USD" decimals="-6">399000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" unitRef="USD" decimals="-6">298000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" unitRef="USD" decimals="-6">599000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2016-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" unitRef="USD" decimals="-6">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2015-06-30_custom_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" unitRef="USD" decimals="-6">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1797000000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2015-07-01to2016-06-30_custom_RevolvingLineOfCreditMember">2019-10-01</us-gaap:LineOfCreditFacilityExpirationDate1>
    <clx:EmployeeBenefitObligationsNoncurrent contextRef="C849221" unitRef="USD" decimals="-6">299000000</clx:EmployeeBenefitObligationsNoncurrent>
    <clx:EmployeeBenefitObligationsNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">335000000</clx:EmployeeBenefitObligationsNoncurrent>
    <clx:VentureAgreementNetTerminalObligation contextRef="C849221" unitRef="USD" decimals="-6">294000000</clx:VentureAgreementNetTerminalObligation>
    <clx:VentureAgreementNetTerminalObligation contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">302000000</clx:VentureAgreementNetTerminalObligation>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="C849221" unitRef="USD" decimals="-6">38000000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">40000000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <clx:MaximumPercentageOfNoncontrollingInterestInVentureAgreement contextRef="C849221" unitRef="Pure" decimals="2">0.20</clx:MaximumPercentageOfNoncontrollingInterestInVentureAgreement>
    <clx:MaximumPercentageOfNoncontrollingInterestInVentureAgreement contextRef="AsOf2016-06-30" unitRef="Pure" decimals="2">0.20</clx:MaximumPercentageOfNoncontrollingInterestInVentureAgreement>
    <clx:SaleLeasebackTransactionLeaseTerm contextRef="C851154">P15Y</clx:SaleLeasebackTransactionLeaseTerm>
    <clx:SaleLeasebackTransactionNoncurrentPortionOfDeferredGain contextRef="C849221" unitRef="USD" decimals="-6">40000000</clx:SaleLeasebackTransactionNoncurrentPortionOfDeferredGain>
    <clx:SaleLeasebackTransactionNoncurrentPortionOfDeferredGain contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">36000000</clx:SaleLeasebackTransactionNoncurrentPortionOfDeferredGain>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember" unitRef="USD" decimals="-6">84000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">30000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-06-30_custom_JetFuelMember_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">16000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-06-30_custom_SoybeanOilMember_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">14000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="C849237" unitRef="USD" decimals="-6">0</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2015-06-30_us-gaap_ForeignExchangeContractMember" unitRef="USD" decimals="-6">105000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="C849230" unitRef="USD" decimals="-6">47000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2015-06-30_custom_JetFuelMember_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">27000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2015-06-30_custom_SoybeanOilMember_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">20000000</invest:DerivativeNotionalAmount>
    <clx:DerivativeIntrumentsMaximumContractDuration contextRef="From2015-07-01to2016-06-30_us-gaap_CommodityContractMember">P2Y</clx:DerivativeIntrumentsMaximumContractDuration>
    <clx:DerivativeIntrumentsMaximumContractDuration contextRef="From2015-07-01to2016-06-30_us-gaap_ForeignExchangeContractMember">P2Y</clx:DerivativeIntrumentsMaximumContractDuration>
    <clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits contextRef="C849221" unitRef="USD" decimals="-6">8000000</clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits>
    <clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">4000000</clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits>
    <us-gaap:MarginDepositAssets contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">1000000</us-gaap:MarginDepositAssets>
    <us-gaap:MarginDepositAssets contextRef="C849230" unitRef="USD" decimals="-6">2000000</us-gaap:MarginDepositAssets>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">8000000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">8000000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2015-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">0</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2015-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">0</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">4000000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">4000000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="C896313" unitRef="USD" decimals="-6">2199000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="C896314" unitRef="USD" decimals="-6">2240000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="AsOf2015-06-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" id="Foot-01-0" decimals="-6">95000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="C896331" unitRef="USD" id="Foot-01-1" decimals="-6">95000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="AsOf2015-06-30_us-gaap_LongTermDebtMember_us-gaap_OtherLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" id="Foot-02-0" decimals="-6">2096000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="AsOf2015-06-30_us-gaap_LongTermDebtMember_us-gaap_OtherLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" id="Foot-02-1" decimals="-6">2137000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" id="Foot-01-2" decimals="-6">523000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" id="Foot-01-3" decimals="-6">523000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_LongTermDebtMember_us-gaap_OtherLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" id="Foot-02-2" decimals="-6">1797000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_LongTermDebtMember_us-gaap_OtherLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" id="Foot-02-3" decimals="-6">1922000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">2325000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:LiabilitiesFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">2450000000</us-gaap:LiabilitiesFairValueDisclosureRecurring>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="C849211" unitRef="USD" decimals="-6">-14000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="C849195" unitRef="USD" decimals="-6">-18000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="C849240" unitRef="USD" decimals="-6">-12000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="C849235" unitRef="USD" decimals="-6">-13000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="C849262" unitRef="USD" decimals="-6">7000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="C849277" unitRef="USD" decimals="-6">2000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2015-07-01to2016-06-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">-4000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2013-07-01to2014-06-30_us-gaap_InterestRateContractMember" unitRef="USD" decimals="-6">-13000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2015-07-01to2016-06-30_us-gaap_InterestRateContractMember" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="C849279" unitRef="USD" decimals="-6">-3000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2015-07-01to2016-06-30_us-gaap_ForeignExchangeContractMember" unitRef="USD" decimals="-6">-3000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-7000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="C849211" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="C849195" unitRef="USD" decimals="-6">-7000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="C849240" unitRef="USD" decimals="-6">-5000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="C849235" unitRef="USD" decimals="-6">-5000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="C849262" unitRef="USD" decimals="-6">3000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="C849277" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2015-07-01to2016-06-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">-13000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2013-07-01to2014-06-30_us-gaap_InterestRateContractMember" unitRef="USD" decimals="-6">-4000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2015-07-01to2016-06-30_us-gaap_InterestRateContractMember" unitRef="USD" decimals="-6">-6000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="C849279" unitRef="USD" decimals="-6">4000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2015-07-01to2016-06-30_us-gaap_ForeignExchangeContractMember" unitRef="USD" decimals="-6">1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-18000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-11000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="AsOf2015-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember" unitRef="USD" id="Foot-03-0" decimals="-6">212000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="AsOf2015-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember" unitRef="USD" id="Foot-03-1" decimals="-6">212000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="C896301" unitRef="USD" id="Foot-03-2" decimals="-6">84000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="AsOf2015-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_BankTimeDepositsMember" unitRef="USD" id="Foot-03-3" decimals="-6">84000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="C896313" unitRef="USD" decimals="-6">335000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="C896314" unitRef="USD" decimals="-6">335000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember" unitRef="USD" id="Foot-03-4" decimals="-6">234000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember" unitRef="USD" id="Foot-03-5" decimals="-6">234000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_BankTimeDepositsMember" unitRef="USD" id="Foot-03-6" decimals="-6">79000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_BankTimeDepositsMember" unitRef="USD" id="Foot-03-7" decimals="-6">79000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">368000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:AssetsFairValueDisclosureRecurring contextRef="AsOf2016-06-30_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">368000000</us-gaap:AssetsFairValueDisclosureRecurring>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2015-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="C896306" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2015-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DeferredCompensationPlanAssets contextRef="C896309" unitRef="USD" decimals="-6">38000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="C896310" unitRef="USD" decimals="-6">38000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="AsOf2016-06-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">52000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="AsOf2016-06-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">52000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">14000000</us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss>
    <us-gaap:AccrualForEnvironmentalLossContingencies contextRef="C849221" unitRef="USD" decimals="-6">12000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">14000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:LeaseAndRentalExpense contextRef="C849211" unitRef="USD" decimals="-6">71000000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense contextRef="C849195" unitRef="USD" decimals="-6">76000000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">77000000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">29000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">135000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">2000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1000000</us-gaap:UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">49000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">3000000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">45000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">2000000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">38000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1000000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears>
    <clx:LetterOfCreditBorrowingCapacity contextRef="C849221" unitRef="USD" decimals="-6">11000000</clx:LetterOfCreditBorrowingCapacity>
    <clx:LetterOfCreditBorrowingCapacity contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">10000000</clx:LetterOfCreditBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="C849221" unitRef="USD" decimals="-6">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">32000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">54000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">37000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">328000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDue contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">6000000</us-gaap:CapitalLeasesFutureMinimumPaymentsDue>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueThereafter contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:CapitalLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="C849211" unitRef="USD" decimals="-6">260000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="C849195" unitRef="USD" decimals="-6">434000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="C851231" unitRef="USD" decimals="-6">260000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2015-07-01to2016-06-30_custom_EvergreenProgramMember" unitRef="USD" decimals="-6">254000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2015-07-01to2016-06-30_custom_OpenMarketProgramMember" unitRef="USD" decimals="-6">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="C851230" unitRef="USD" decimals="-6">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2014-07-01to2015-06-30_custom_OpenMarketProgramMember" unitRef="USD" decimals="-6">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="C851193" unitRef="USD" decimals="-6">434000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">254000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="C849211" unitRef="Shares" decimals="-3">3046000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="C849195" unitRef="Shares" decimals="-3">4016000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="C851231" unitRef="Shares" decimals="-3">3046000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2015-07-01to2016-06-30_custom_EvergreenProgramMember" unitRef="Shares" decimals="-3">2151000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2015-07-01to2016-06-30_custom_OpenMarketProgramMember" unitRef="Shares" decimals="-3">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="C851230" unitRef="Shares" decimals="-3">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2014-07-01to2015-06-30_custom_OpenMarketProgramMember" unitRef="Shares" decimals="-3">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="C851193" unitRef="Shares" decimals="-3">4016000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2015-07-01to2016-06-30" unitRef="Shares" decimals="-3">2151000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="C849211" unitRef="USDPerShare" decimals="INF">2.87</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="C849195" unitRef="USDPerShare" decimals="INF">2.99</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="C851092" unitRef="USDPerShare" decimals="INF">0.74</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="C851093" unitRef="USDPerShare" decimals="INF">0.74</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="C851094" unitRef="USDPerShare" decimals="INF">0.74</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="C851114" unitRef="USDPerShare" decimals="INF">0.77</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">3.11</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="From2015-07-01to2015-09-30" unitRef="USDPerShare" decimals="INF">0.77</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="From2015-10-01to2015-12-31" unitRef="USDPerShare" decimals="INF">0.77</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="From2016-01-01to2016-03-31" unitRef="USDPerShare" decimals="INF">0.77</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">0.80</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareCashPaid contextRef="C849211" unitRef="USDPerShare" decimals="INF">2.84</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid contextRef="C849195" unitRef="USDPerShare" decimals="INF">2.96</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">3.08</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="C851225" unitRef="USD" decimals="-6">750000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="AsOf2016-06-30_custom_OpenMarketProgramMember" unitRef="USD" decimals="-6">750000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="C851225" unitRef="USD" decimals="-6">750000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="AsOf2016-06-30_custom_OpenMarketProgramMember" unitRef="USD" decimals="-6">750000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax contextRef="C851232" unitRef="USD" decimals="-6">9000000</us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax>
    <us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax contextRef="C851233" unitRef="USD" decimals="-6">12000000</us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax>
    <us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax contextRef="From2015-07-01to2016-06-30_custom_LongTermIntercompanyLoansMember" unitRef="USD" decimals="-6">14000000</us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="C849211" unitRef="Shares" decimals="-3">2184000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="C849195" unitRef="Shares" decimals="-3">2466000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="From2015-07-01to2016-06-30" unitRef="Shares" decimals="-3">2245000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="C849211" unitRef="Shares" decimals="-3">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="C849195" unitRef="Shares" decimals="-3">23000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2015-07-01to2016-06-30" unitRef="Shares" decimals="-3">42000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember_us-gaap_MinimumMember">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember_us-gaap_MaximumMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="C851295" unitRef="USDPerShare" decimals="2">95.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="C851309" unitRef="USDPerShare" decimals="2">89.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember" unitRef="USDPerShare" decimals="2">128.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="C851294" unitRef="USDPerShare" decimals="2">89.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="C851311" unitRef="USDPerShare" decimals="2">84.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USDPerShare" decimals="2">92.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="C849211" unitRef="USD" decimals="-6">86000000</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="C849195" unitRef="USD" decimals="-6">230000000</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">180000000</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="C851295" unitRef="USD" decimals="-6">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="C851309" unitRef="USD" decimals="-6">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember" unitRef="USD" decimals="-6">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="C851294" unitRef="USD" decimals="-6">24000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="C851311" unitRef="USD" decimals="-6">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USD" decimals="-6">26000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="C849211" unitRef="USD" decimals="-6">13000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="C849195" unitRef="USD" decimals="-6">12000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">17000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <clx:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm contextRef="C849211">P5Y8M12D</clx:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm>
    <clx:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm contextRef="From2015-07-01to2016-06-30">P5Y7M6D</clx:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="C849211">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="C849195">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2015-07-01to2016-06-30">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="C849211" unitRef="Pure" decimals="3">0.184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="C849195" unitRef="Pure" decimals="3">0.163</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="4">.1643</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="C849211" unitRef="Pure" decimals="3">0.185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="C849195" unitRef="Pure" decimals="3">0.186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.173</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="C849211" unitRef="Pure" decimals="3">0.185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="C849195" unitRef="Pure" decimals="3">0.166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.172</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="C849211" unitRef="Pure" decimals="3">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="C849195" unitRef="Pure" decimals="3">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="C849211" unitRef="Pure" decimals="3">0.019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="C849195" unitRef="Pure" decimals="3">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="C849211" unitRef="Pure" decimals="3">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="C849195" unitRef="Pure" decimals="3">0.019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum contextRef="C849195" unitRef="Pure" decimals="3">0.028</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.025</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="C849211" unitRef="Pure" decimals="3">0.034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum contextRef="C849195" unitRef="Pure" decimals="3">0.034</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.028</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate contextRef="C849211" unitRef="Pure" decimals="3">0.034</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate contextRef="C849195" unitRef="Pure" decimals="3">0.033</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.028</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="C849221" unitRef="Shares" decimals="-3">8357000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-06-30" unitRef="Shares" decimals="-3">6827000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C849195">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2015-07-01to2016-06-30">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="C849221" unitRef="USD" decimals="-6">236000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">366000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2015-06-30_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="-3">1123000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2016-06-30_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="-3">952000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare contextRef="AsOf2015-06-30_us-gaap_PerformanceSharesMember" unitRef="USDPerShare" decimals="INF">79</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare contextRef="AsOf2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USDPerShare" decimals="INF">90</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare>
    <clx:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum contextRef="C849195">P5Y7M6D</clx:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum>
    <clx:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum contextRef="C849195">P5Y9M18D</clx:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2016-06-30_us-gaap_RestrictedStockMember" unitRef="USD" decimals="-6">1000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USD" decimals="-6">37000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2016-06-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="-6">16000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USDPerShare" decimals="2">72.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue>
    <clx:VestedAwardsWerePaidByIssuanceOfShares contextRef="AsOf2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USD" decimals="-6">25000000</clx:VestedAwardsWerePaidByIssuanceOfShares>
    <clx:VestedStockAwardsDeferred contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USD" decimals="-6">1000000</clx:VestedStockAwardsDeferred>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="C849211" unitRef="USD" decimals="-6">10000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="C849195" unitRef="USD" decimals="-6">13000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">7000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="C849211" unitRef="USD" decimals="-6">3000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="C849195" unitRef="USD" decimals="-6">3000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">9000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <clx:LowIncomeHousingPartnershipGainsLosses contextRef="C849211" unitRef="USD" decimals="-6">0</clx:LowIncomeHousingPartnershipGainsLosses>
    <clx:LowIncomeHousingPartnershipGainsLosses contextRef="C849195" unitRef="USD" decimals="-6">13000000</clx:LowIncomeHousingPartnershipGainsLosses>
    <clx:LowIncomeHousingPartnershipGainsLosses contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">0</clx:LowIncomeHousingPartnershipGainsLosses>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="C849195" unitRef="USD" decimals="-6">15000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">20000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="C849211" unitRef="USD" decimals="-6">13000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="C849195" unitRef="USD" decimals="-6">14000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2015-07-01to2016-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">15000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="C849251" unitRef="USD" decimals="-6">14000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2015-07-01to2016-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2015-07-01to2016-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2015-07-01to2016-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="C849248" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="C849250" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="C849249" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="C849233" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2013-07-01to2014-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2013-07-01to2014-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2013-07-01to2014-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2013-07-01to2014-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">13000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2015-07-01to2016-06-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="C849252" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">15000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <clx:MiscellaneousOtherIncomeExpense contextRef="C849211" unitRef="USD" decimals="-6">6000000</clx:MiscellaneousOtherIncomeExpense>
    <clx:MiscellaneousOtherIncomeExpense contextRef="C849195" unitRef="USD" decimals="-6">2000000</clx:MiscellaneousOtherIncomeExpense>
    <clx:MiscellaneousOtherIncomeExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">5000000</clx:MiscellaneousOtherIncomeExpense>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="C849195" unitRef="USD" decimals="-6">14000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">11000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="C849211" unitRef="USD" decimals="-6">-1000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="C849195" unitRef="USD" decimals="-6">-9000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-1000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2016-06-30_custom_NotSubjectToExpirationMember_custom_ForeignMember" unitRef="USD" decimals="-6">12000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2016-06-30_custom_SubjectToExpirationMember_us-gaap_ForeignCountryMember" unitRef="USD" decimals="-6">16000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardExpirationDate contextRef="From2015-07-01to2016-06-30_custom_ForeignTaxCreditCarryforwardMember_us-gaap_ForeignCountryMember">2031-06-30</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate contextRef="From2015-07-01to2016-06-30_us-gaap_DomesticCountryMember_us-gaap_LatestTaxYearMember">2025-06-30</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:TaxCreditCarryforwardExpirationDate contextRef="From2015-07-01to2016-06-30_us-gaap_DomesticCountryMember_us-gaap_EarliestTaxYearMember">2024-06-30</us-gaap:TaxCreditCarryforwardExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="From2015-07-01to2016-06-30_custom_SubjectToExpirationMember_us-gaap_LatestTaxYearMember_us-gaap_ForeignCountryMember">2036-06-30</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="From2015-07-01to2016-06-30_custom_SubjectToExpirationMember_us-gaap_EarliestTaxYearMember_custom_ForeignMember">2017-06-30</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="C849211" unitRef="USD" decimals="-6">247000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="C849195" unitRef="USD" decimals="-6">265000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">254000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="C849221" unitRef="USD" decimals="-6">10000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">3000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="C849211" unitRef="USD" decimals="-6">3000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="C849195" unitRef="USD" decimals="-6">-1000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-1000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="C849220" unitRef="USD" decimals="-6">58000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="C849221" unitRef="USD" decimals="-6">27000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">27000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="C849211" unitRef="USD" decimals="-6">1000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="C849195" unitRef="USD" decimals="-6">34000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="From2014-07-01to2015-06-30_custom_DiscontinuedOperationsOtherMember" unitRef="USD" decimals="-6">32000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">4000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="C849211" unitRef="USD" decimals="-6">34000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="C849195" unitRef="USD" decimals="-6">28000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">31000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="C849211" unitRef="USD" decimals="-6">45000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="C849195" unitRef="USD" decimals="-6">38000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">45000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <clx:DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">56000000</clx:DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions contextRef="C849211" unitRef="USD" decimals="-6">11000000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions contextRef="C849195" unitRef="USD" decimals="-6">42000000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">51000000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="AsOf2016-06-30_us-gaap_ForeignCountryMember_custom_ForeignTaxCreditCarryforwardMember" unitRef="USD" decimals="-6">19000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="AsOf2016-06-30_custom_ForeignTaxCreditCarryforwardMember_us-gaap_DomesticCountryMember" unitRef="USD" decimals="-6">15000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="AsOf2016-06-30_custom_ForeignTaxCreditCarryforwardMember_us-gaap_ForeignCountryMember_custom_NotSubjectToExpirationMember" unitRef="USD" decimals="-6">1000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="C849211" unitRef="USD" decimals="-6">326000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="C849195" unitRef="USD" decimals="-6">331000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">330000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="C849211" unitRef="USD" decimals="-6">-19000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="C849195" unitRef="USD" decimals="-6">-13000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">11000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="C849211" unitRef="USD" decimals="-6">2000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="C849195" unitRef="USD" decimals="-6">-1000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">1000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="C849211" unitRef="USD" decimals="-6">-4000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="C849195" unitRef="USD" decimals="-6">-2000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-7000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="C849211" unitRef="USD" decimals="-6">754000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="C849195" unitRef="USD" decimals="-6">829000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">900000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="C849211" unitRef="USD" decimals="-6">130000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="C849195" unitRef="USD" decimals="-6">92000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">83000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="C849211" unitRef="Pure" decimals="3">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="C849195" unitRef="Pure" decimals="3">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="C849211" unitRef="Pure" decimals="3">0.026</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="C849195" unitRef="Pure" decimals="3">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="C849211" unitRef="Pure" decimals="3">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="C849195" unitRef="Pure" decimals="3">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities contextRef="C849211" unitRef="Pure" decimals="3">-0.023</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities contextRef="C849195" unitRef="Pure" decimals="3">-0.021</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">-0.024</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="C849211" unitRef="Pure" decimals="3">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="C849195" unitRef="Pure" decimals="3">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="C849211" unitRef="Pure" decimals="3">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="C849195" unitRef="Pure" decimals="3">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">-0.016</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="C849211" unitRef="Pure" decimals="3">0.346</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="C849195" unitRef="Pure" decimals="3">0.342</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.341</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2015-07-01to2016-06-30_us-gaap_MinimumMember" unitRef="Pure" decimals="2">0.34</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2015-07-01to2016-06-30_us-gaap_MaximumMember" unitRef="Pure" decimals="2">0.35</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="C849221" unitRef="USD" id="Foot-04-0" decimals="-6">191000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-1" decimals="-6">193000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <clx:DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement contextRef="C849221" unitRef="USD" id="Foot-04-2" decimals="-6">30000000</clx:DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement>
    <clx:DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-3" decimals="-6">30000000</clx:DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="C849221" unitRef="USD" id="Foot-04-4" decimals="-6">43000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-5" decimals="-6">34000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsInventory contextRef="C849221" unitRef="USD" id="Foot-04-6" decimals="-6">19000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-7" decimals="-6">21000000</us-gaap:DeferredTaxAssetsInventory>
    <clx:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign contextRef="C849221" unitRef="USD" id="Foot-04-8" decimals="-6">41000000</clx:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign>
    <clx:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-9" decimals="-6">48000000</clx:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOther contextRef="C849221" unitRef="USD" id="Foot-04-10" decimals="-6">61000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-11" decimals="-6">54000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="C849221" unitRef="USD" id="Foot-04-12" decimals="-6">385000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-13" decimals="-6">380000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="C849220" unitRef="USD" decimals="-6">51000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="C849221" unitRef="USD" id="Foot-04-14" decimals="-6">34000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-15" decimals="-6">37000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="C849221" unitRef="USD" id="Foot-04-16" decimals="-6">351000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-17" decimals="-6">343000000</us-gaap:DeferredTaxAssetsNet>
    <clx:DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets contextRef="C849221" unitRef="USD" id="Foot-04-18" decimals="-6">277000000</clx:DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets>
    <clx:DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-19" decimals="-6">325000000</clx:DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets>
    <clx:DeferredTaxLiabilitiesLowIncomeHousingPartnerships contextRef="C849221" unitRef="USD" id="Foot-04-20" decimals="-6">22000000</clx:DeferredTaxLiabilitiesLowIncomeHousingPartnerships>
    <clx:DeferredTaxLiabilitiesLowIncomeHousingPartnerships contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-21" decimals="-6">23000000</clx:DeferredTaxLiabilitiesLowIncomeHousingPartnerships>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="C849221" unitRef="USD" id="Foot-04-22" decimals="-6">7000000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-23" decimals="-6">16000000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="C849221" unitRef="USD" id="Foot-04-24" decimals="-6">24000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-25" decimals="-6">25000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilities contextRef="C849221" unitRef="USD" id="Foot-04-26" decimals="-6">330000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-27" decimals="-6">389000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="C849221" unitRef="USD" id="Foot-04-28" decimals="-6">21000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-04-29" decimals="-6">-46000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:UnrecognizedTaxBenefits contextRef="C849220" unitRef="USD" decimals="-6">71000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="C849221" unitRef="USD" decimals="-6">38000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="C849284" unitRef="USD" decimals="-6">69000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">37000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="C849211" unitRef="USD" decimals="-6">3000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="C849195" unitRef="USD" decimals="-6">3000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">3000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="C849211" unitRef="USD" decimals="-6">5000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="C849195" unitRef="USD" decimals="-6">8000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">3000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="C849211" unitRef="USD" decimals="-6">7000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="C849195" unitRef="USD" decimals="-6">6000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">8000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <clx:UnrecognizedTaxBenefitsSettlements contextRef="C849211" unitRef="USD" decimals="-6">-2000000</clx:UnrecognizedTaxBenefitsSettlements>
    <clx:UnrecognizedTaxBenefitsSettlements contextRef="C849195" unitRef="USD" decimals="-6">0</clx:UnrecognizedTaxBenefitsSettlements>
    <clx:UnrecognizedTaxBenefitsSettlements contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-5000000</clx:UnrecognizedTaxBenefitsSettlements>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions contextRef="C849211" unitRef="USD" decimals="-6">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions contextRef="C849195" unitRef="USD" decimals="-6">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">216000000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate contextRef="From2015-07-01to2016-06-30_custom_MedicalMember" unitRef="Pure" decimals="4">.0675</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate contextRef="From2015-07-01to2016-06-30_custom_PrescriptionDrugsMember" unitRef="Pure" decimals="4">.0675</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCarePlanMember" unitRef="Pure" decimals="3">.045</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate>
    <us-gaap:DefinedBenefitPlanYearThatRateReachesUltimateTrendRate contextRef="AsOf2016-06-30_custom_RetirementHealthCarePlanMember">2037</us-gaap:DefinedBenefitPlanYearThatRateReachesUltimateTrendRate>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="From2015-07-01to2016-06-30_custom_DomesticNonQualifiedRetirementIncomePlansMember" unitRef="USD" decimals="-6">16000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="C851264" unitRef="USD" decimals="-6">13000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="From2013-07-01to2014-06-30_custom_DomesticNonQualifiedRetirementIncomePlansMember" unitRef="USD" decimals="-6">13000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="C912136" unitRef="USD" decimals="-6">13000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="C912139" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="C851274" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="C851273" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">31000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">2000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="From2015-07-01to2016-06-30_custom_DomesticQualifiedRetirementIncomePlansMember" unitRef="USD" decimals="-6">15000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="From2016-07-01to2016-07-07_custom_DomesticQualifiedRetirementIncomePlansMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="-6">15000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <clx:BasisPointIncreaseDecrease contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCarePlanMember" unitRef="Item" decimals="0">100</clx:BasisPointIncreaseDecrease>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="C912132" unitRef="USD" decimals="-6">641000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">673000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="C912134" unitRef="USD" decimals="-6">49000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">47000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="C912140" unitRef="USD" decimals="-6">639000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="C912141" unitRef="USD" decimals="-6">45000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="C912136" unitRef="USD" decimals="-6">2000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="C912137" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="C912138" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="C912139" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="C912136" unitRef="USD" decimals="-6">25000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="C912137" unitRef="USD" decimals="-6">27000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="C912138" unitRef="USD" decimals="-6">2000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="C912139" unitRef="USD" decimals="-6">2000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">26000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">2000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="C912136" unitRef="USD" decimals="-6">-14000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="C912139" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">-51000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">-2000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAmendments contextRef="C912136" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments contextRef="C912139" unitRef="USD" decimals="-6">-1000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">-1000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="C912136" unitRef="USD" decimals="-6">-5000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="C912139" unitRef="USD" decimals="-6">-2000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">-1000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitsPaid contextRef="C912136" unitRef="USD" decimals="-6">38000000</us-gaap:DefinedBenefitPlanBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitsPaid contextRef="C912139" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedBenefitPlanBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitsPaid contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">42000000</us-gaap:DefinedBenefitPlanBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitsPaid contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">2000000</us-gaap:DefinedBenefitPlanBenefitsPaid>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="C849221" unitRef="USD" decimals="-6">409000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="C912132" unitRef="USD" decimals="-6">432000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">423000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="C912134" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="C912140" unitRef="USD" decimals="-6">409000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="C912141" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="AsOf2015-06-30_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="AsOf2015-06-30_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">406000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">421000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">423000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="C912136" unitRef="USD" decimals="-6">6000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="C912139" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">26000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets contextRef="C912136" unitRef="USD" decimals="-6">4000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets contextRef="C912139" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">-250000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">-47000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="C912140" unitRef="USD" decimals="-6">-230000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="C912141" unitRef="USD" decimals="-6">-45000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent contextRef="C912140" unitRef="USD" decimals="-6">2000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent contextRef="C912141" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">14000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">3000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities contextRef="C912140" unitRef="USD" decimals="-6">16000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities contextRef="C912141" unitRef="USD" decimals="-6">3000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">237000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">44000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="C912140" unitRef="USD" decimals="-6">216000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent contextRef="C912141" unitRef="USD" decimals="-6">42000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">-250000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">-47000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet contextRef="C912140" unitRef="USD" decimals="-6">-230000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet contextRef="C912141" unitRef="USD" decimals="-6">-45000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation contextRef="AsOf2015-06-30_us-gaap_PensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">538000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation contextRef="AsOf2016-06-30_us-gaap_PensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">575000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation contextRef="AsOf2015-06-30_us-gaap_OtherPensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">80000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation contextRef="AsOf2016-06-30_us-gaap_OtherPensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">76000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="C849220" unitRef="USD" decimals="-6">563000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="C849221" unitRef="USD" decimals="-6">559000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="AsOf2015-06-30_us-gaap_PensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">538000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="AsOf2016-06-30_us-gaap_PensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">574000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="AsOf2015-06-30_us-gaap_OtherPensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">80000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="AsOf2016-06-30_us-gaap_OtherPensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">76000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">596000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets contextRef="AsOf2015-06-30_us-gaap_PensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">385000000</us-gaap:DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets contextRef="AsOf2016-06-30_us-gaap_PensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">399000000</us-gaap:DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets contextRef="AsOf2015-06-30_us-gaap_OtherPensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets contextRef="AsOf2016-06-30_us-gaap_OtherPensionPlansDefinedBenefitMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="C912136" unitRef="USD" decimals="-6">20000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="C912137" unitRef="USD" decimals="-6">25000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="C912138" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="C912139" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">17000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="C912136" unitRef="USD" decimals="-6">-12000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="C912137" unitRef="USD" decimals="-6">-11000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="C912138" unitRef="USD" decimals="-6">4000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="C912139" unitRef="USD" decimals="-6">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">-10000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="C912136" unitRef="USD" decimals="-6">19000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="C912137" unitRef="USD" decimals="-6">16000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="C912138" unitRef="USD" decimals="-6">-1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="C912139" unitRef="USD" decimals="-6">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">20000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">-1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">-296000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">13000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="C912140" unitRef="USD" decimals="-6">-264000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax contextRef="C912141" unitRef="USD" decimals="-6">17000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">-6000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">111000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">-7000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">185000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">-12000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <clx:OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">-10000000</clx:OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost>
    <clx:OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">2000000</clx:OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost>
    <clx:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">42000000</clx:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod>
    <clx:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">2000000</clx:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod>
    <us-gaap:DefinedBenefitPlanFutureAmortizationOfGainLoss contextRef="From2016-07-01to2017-06-30_custom_RetirementIncomePlanMember_us-gaap_ScenarioForecastMember" unitRef="USD" decimals="-6">-11000000</us-gaap:DefinedBenefitPlanFutureAmortizationOfGainLoss>
    <us-gaap:DefinedBenefitPlanFutureAmortizationOfGainLoss contextRef="From2016-07-01to2017-06-30_custom_RetirementHealthCarePlanMember_us-gaap_ScenarioForecastMember" unitRef="USD" decimals="-6">1000000</us-gaap:DefinedBenefitPlanFutureAmortizationOfGainLoss>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="C849211" unitRef="USD" decimals="-6">43000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="C849195" unitRef="USD" decimals="-6">45000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="From2014-07-01to2015-06-30_custom_CompanyFourZeroOneKPlanMember" unitRef="USD" decimals="-6">42000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="From2013-07-01to2014-06-30_custom_CompanyFourZeroOneKPlanMember" unitRef="USD" decimals="-6">38000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="From2015-07-01to2016-06-30_custom_CompanyFourZeroOneKPlanMember" unitRef="USD" decimals="-6">41000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="From2014-07-01to2015-06-30_custom_InternationalDefinedContributionPlanMember" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="From2013-07-01to2014-06-30_custom_InternationalDefinedContributionPlanMember" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="From2015-07-01to2016-06-30_custom_InternationalDefinedContributionPlanMember" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">45000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="Pure" decimals="4">.0342</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="Pure" decimals="4">.0342</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate contextRef="C912140" unitRef="Pure" decimals="4">0.0420</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate contextRef="C912141" unitRef="Pure" decimals="4">0.0416</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="Pure" decimals="4">.0292</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease contextRef="C912140" unitRef="Pure" decimals="4">0.0337</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate contextRef="C912136" unitRef="Pure" decimals="4">0.0405</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate contextRef="C912137" unitRef="Pure" decimals="4">0.0439</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate contextRef="C912138" unitRef="Pure" decimals="4">0.0433</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate contextRef="C912139" unitRef="Pure" decimals="4">0.0400</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="Pure" decimals="4">.0420</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate contextRef="From2015-07-01to2016-06-30_custom_RetirementHealthCareMember" unitRef="Pure" decimals="4">.0416</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease contextRef="C912136" unitRef="Pure" decimals="4">0.0446</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease contextRef="C912137" unitRef="Pure" decimals="4">0.0344</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="Pure" decimals="4">.0337</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets contextRef="C912136" unitRef="Pure" decimals="4">0.0528</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets contextRef="C912137" unitRef="Pure" decimals="4">0.0661</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets contextRef="From2015-07-01to2016-06-30_custom_RetirementIncomeMember" unitRef="Pure" decimals="4">.0434</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">39000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">52000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">39000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">39000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">2000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">39000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">2000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter contextRef="AsOf2016-06-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">193000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter contextRef="AsOf2016-06-30_custom_RetirementHealthCareMember" unitRef="USD" decimals="-6">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations contextRef="C849195" unitRef="Pure" decimals="2">1.00</us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations>
    <us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations contextRef="From2014-07-01to2015-06-30_custom_UnitedStatesEquityMember" unitRef="Pure" decimals="2">0.11</us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations>
    <us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations contextRef="From2015-07-01to2016-06-30_custom_UnitedStatesEquityMember" unitRef="Pure" decimals="2">.11</us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations>
    <us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations contextRef="From2014-07-01to2015-06-30_custom_ForeignEquitySecuritiesMember" unitRef="Pure" decimals="2">0.12</us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations>
    <us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations contextRef="From2015-07-01to2016-06-30_custom_ForeignEquitySecuritiesMember" unitRef="Pure" decimals="2">.12</us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations>
    <us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations contextRef="From2014-07-01to2015-06-30_us-gaap_FixedIncomeFundsMember" unitRef="Pure" decimals="2">0.74</us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations>
    <us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations contextRef="From2015-07-01to2016-06-30_us-gaap_FixedIncomeFundsMember" unitRef="Pure" decimals="2">.74</us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations>
    <us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations contextRef="From2014-07-01to2015-06-30_us-gaap_OtherCreditDerivativesMember" unitRef="Pure" decimals="2">0.03</us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations>
    <us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations contextRef="From2015-07-01to2016-06-30_us-gaap_OtherCreditDerivativesMember" unitRef="Pure" decimals="2">.03</us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations>
    <us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="2">1.00</us-gaap:DefinedBenefitPlanTargetPlanAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="C849221" unitRef="Pure" decimals="2">1.00</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="C851226" unitRef="Pure" decimals="2">0.11</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="AsOf2016-06-30_custom_UnitedStatesEquityMember" unitRef="Pure" decimals="2">.11</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="C851227" unitRef="Pure" decimals="2">0.12</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="AsOf2016-06-30_custom_ForeignEquitySecuritiesMember" unitRef="Pure" decimals="2">.11</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="C851228" unitRef="Pure" decimals="2">0.74</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="AsOf2016-06-30_us-gaap_FixedIncomeFundsMember" unitRef="Pure" decimals="2">.74</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="C851229" unitRef="Pure" decimals="2">0.03</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="AsOf2016-06-30_us-gaap_OtherCreditDerivativesMember" unitRef="Pure" decimals="2">.04</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="AsOf2016-06-30" unitRef="Pure" decimals="2">1.00</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <clx:CashEquivalents contextRef="C849221" unitRef="USD" decimals="-6">3000000</clx:CashEquivalents>
    <clx:CashEquivalents contextRef="AsOf2015-06-30_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">3000000</clx:CashEquivalents>
    <clx:CashEquivalents contextRef="AsOf2015-06-30_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">0</clx:CashEquivalents>
    <clx:CashEquivalents contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">2000000</clx:CashEquivalents>
    <clx:CashEquivalents contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">0</clx:CashEquivalents>
    <clx:CashEquivalents contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">2000000</clx:CashEquivalents>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_WalmartStoresIncMember" unitRef="Pure" decimals="2">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TopFiveLargestCustomersMember" unitRef="Pure" decimals="2">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2014-07-01to2015-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TopFiveLargestCustomersMember" unitRef="Pure" decimals="2">0.45</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2013-07-01to2014-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TopFiveLargestCustomersMember" unitRef="Pure" decimals="2">0.45</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851341" unitRef="Pure" decimals="2">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember_custom_LiquidBleachMember" unitRef="Pure" decimals="2">.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_custom_LiquidBleachMember_custom_CleaningMember" unitRef="Pure" decimals="2">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851344" unitRef="Pure" decimals="2">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851349" unitRef="Pure" decimals="2">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_custom_LiquidBleachMember_custom_InternationalMember" unitRef="Pure" decimals="2">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember_custom_TrashBagsMember" unitRef="Pure" decimals="2">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851360" unitRef="Pure" decimals="2">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_custom_TrashBagsMember_custom_HouseholdMember" unitRef="Pure" decimals="2">.37</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851364" unitRef="Pure" decimals="2">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember_custom_CharcoalMember" unitRef="Pure" decimals="2">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851370" unitRef="Pure" decimals="2">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-07-01to2016-06-30_us-gaap_SalesRevenueNetMember_custom_CharcoalMember_custom_HouseholdMember" unitRef="Pure" decimals="2">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851541" unitRef="Pure" decimals="2">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851542" unitRef="Pure" decimals="2">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2014-07-01to2015-06-30_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember_custom_LiquidBleachMember" unitRef="Pure" decimals="2">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851347" unitRef="Pure" decimals="2">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851352" unitRef="Pure" decimals="2">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851353" unitRef="Pure" decimals="2">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851359" unitRef="Pure" decimals="2">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851372" unitRef="Pure" decimals="2">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851375" unitRef="Pure" decimals="2">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="C851373" unitRef="Pure" decimals="2">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="C849211" unitRef="USD" decimals="-6">57000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="C849195" unitRef="USD" decimals="-6">55000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">57000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:SalesRevenueGoodsNet contextRef="C849195" unitRef="USD" decimals="-6">5655000000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="C851092" unitRef="USD" decimals="-6">1352000000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="C851093" unitRef="USD" decimals="-6">1345000000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="C851094" unitRef="USD" decimals="-6">1401000000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="C851114" unitRef="USD" decimals="-6">1557000000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">5761000000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">1390000000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2015-10-01to2015-12-31" unitRef="USD" decimals="-6">1345000000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-6">1426000000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="-6">1600000000</us-gaap:SalesRevenueGoodsNet>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh contextRef="C849195" unitRef="USDPerShare" decimals="INF">112.70</clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh contextRef="C851092" unitRef="USDPerShare" decimals="INF">112.70</clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh contextRef="C851093" unitRef="USDPerShare" decimals="INF">112.65</clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh contextRef="C851094" unitRef="USDPerShare" decimals="INF">106.36</clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh contextRef="C851114" unitRef="USDPerShare" decimals="INF">98.31</clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">138.41</clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh contextRef="From2015-07-01to2015-09-30" unitRef="USDPerShare" decimals="INF">119.75</clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh contextRef="From2015-10-01to2015-12-31" unitRef="USDPerShare" decimals="INF">131.78</clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh contextRef="From2016-01-01to2016-03-31" unitRef="USDPerShare" decimals="INF">132.19</clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">138.41</clx:RangeOfNyseMarketPriceOfEntityCommonStockHigh>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockLow contextRef="C849195" unitRef="USDPerShare" decimals="INF">86.03</clx:RangeOfNyseMarketPriceOfEntityCommonStockLow>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockLow contextRef="C851092" unitRef="USDPerShare" decimals="INF">103.77</clx:RangeOfNyseMarketPriceOfEntityCommonStockLow>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockLow contextRef="C851093" unitRef="USDPerShare" decimals="INF">102.95</clx:RangeOfNyseMarketPriceOfEntityCommonStockLow>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockLow contextRef="C851094" unitRef="USDPerShare" decimals="INF">95.19</clx:RangeOfNyseMarketPriceOfEntityCommonStockLow>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockLow contextRef="C851114" unitRef="USDPerShare" decimals="INF">86.03</clx:RangeOfNyseMarketPriceOfEntityCommonStockLow>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockLow contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">104.26</clx:RangeOfNyseMarketPriceOfEntityCommonStockLow>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockLow contextRef="From2015-07-01to2015-09-30" unitRef="USDPerShare" decimals="INF">104.26</clx:RangeOfNyseMarketPriceOfEntityCommonStockLow>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockLow contextRef="From2015-10-01to2015-12-31" unitRef="USDPerShare" decimals="INF">114.06</clx:RangeOfNyseMarketPriceOfEntityCommonStockLow>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockLow contextRef="From2016-01-01to2016-03-31" unitRef="USDPerShare" decimals="INF">122.40</clx:RangeOfNyseMarketPriceOfEntityCommonStockLow>
    <clx:RangeOfNyseMarketPriceOfEntityCommonStockLow contextRef="From2016-04-01to2016-06-30" unitRef="USDPerShare" decimals="INF">119.23</clx:RangeOfNyseMarketPriceOfEntityCommonStockLow>
    <clx:NyseMarketPriceOfEntityCommonStockPeriodEnd contextRef="C849221" unitRef="USDPerShare" decimals="INF">104.02</clx:NyseMarketPriceOfEntityCommonStockPeriodEnd>
    <clx:NyseMarketPriceOfEntityCommonStockPeriodEnd contextRef="AsOf2016-06-30" unitRef="USDPerShare" decimals="INF">138.39</clx:NyseMarketPriceOfEntityCommonStockPeriodEnd>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="From2015-07-01to2016-06-30_us-gaap_AllowanceForDoubtfulAccountsMember" unitRef="USD" decimals="-6">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="C851102" unitRef="USD" decimals="-6">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="C851111" unitRef="USD" decimals="-6">1000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="From2015-07-01to2016-06-30_custom_LifoAllowanceMember" unitRef="USD" decimals="-6">3000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="From2014-07-01to2015-06-30_custom_LifoAllowanceMember" unitRef="USD" decimals="-6">2000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="From2014-07-01to2015-06-30_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" unitRef="USD" decimals="-6">21000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="From2015-07-01to2016-06-30_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" unitRef="USD" decimals="-6">2000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="C851120" unitRef="USD" decimals="-6">10000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="From2014-07-01to2015-06-30_us-gaap_AllowanceForDoubtfulAccountsMember" unitRef="USD" decimals="-6">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="From2015-07-01to2016-06-30_us-gaap_AllowanceForDoubtfulAccountsMember" unitRef="USD" decimals="-6">1000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="C851102" unitRef="USD" decimals="-6">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="C851111" unitRef="USD" decimals="-6">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="From2015-07-01to2016-06-30_custom_LifoAllowanceMember" unitRef="USD" decimals="-6">1000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="From2014-07-01to2015-06-30_custom_LifoAllowanceMember" unitRef="USD" decimals="-6">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="From2014-07-01to2015-06-30_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" unitRef="USD" decimals="-6">4000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="From2015-07-01to2016-06-30_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" unitRef="USD" decimals="-6">5000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="C851120" unitRef="USD" decimals="-6">25000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="From2014-07-01to2015-06-30_us-gaap_AllowanceForDoubtfulAccountsMember" unitRef="USD" decimals="-6">1000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses contextRef="From2015-07-01to2016-06-30_us-gaap_AllowanceForDoubtfulAccountsMember" unitRef="USD" decimals="-6">0</clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses>
    <clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses contextRef="C851102" unitRef="USD" decimals="-6">2000000</clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses>
    <clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses contextRef="C851111" unitRef="USD" decimals="-6">3000000</clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses>
    <clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses contextRef="From2015-07-01to2016-06-30_custom_LifoAllowanceMember" unitRef="USD" decimals="-6">0</clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses>
    <clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses contextRef="From2014-07-01to2015-06-30_custom_LifoAllowanceMember" unitRef="USD" decimals="-6">0</clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses>
    <clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses contextRef="From2014-07-01to2015-06-30_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" unitRef="USD" decimals="-6">0</clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses>
    <clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses contextRef="From2015-07-01to2016-06-30_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" unitRef="USD" decimals="-6">0</clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses>
    <clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses contextRef="C851120" unitRef="USD" decimals="-6">0</clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses>
    <clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses contextRef="From2014-07-01to2015-06-30_us-gaap_AllowanceForDoubtfulAccountsMember" unitRef="USD" decimals="-6">0</clx:ValuationAllowancesAndReservesCreditedToCostsAndExpenses>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2016-07-29" unitRef="Shares" decimals="INF">129469454</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentType contextRef="From2015-07-01to2016-06-30">10-K</dei:DocumentType>
    <dei:AmendmentFlag contextRef="From2015-07-01to2016-06-30">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="From2015-07-01to2016-06-30">2016-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2015-07-01to2016-06-30">2016</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2015-07-01to2016-06-30">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityRegistrantName contextRef="From2015-07-01to2016-06-30">CLOROX CO /DE/</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2015-07-01to2016-06-30">0000021076</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="From2015-07-01to2016-06-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityFilerCategory contextRef="From2015-07-01to2016-06-30">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2015-07-01to2016-06-30">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2015-07-01to2016-06-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2015-07-01to2016-06-30">Yes</dei:EntityCurrentReportingStatus>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="C849220" unitRef="USD" decimals="-6">95000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="C849221" unitRef="USD" decimals="-6">99000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">104000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">10000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">9000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">9000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">9000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">8000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="From2015-07-01to2016-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">15000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="From2015-07-01to2016-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="From2015-07-01to2016-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="From2015-07-01to2016-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">122000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">137000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <clx:VentureAgreementRenewalOption contextRef="From2015-07-01to2016-06-30">P10Y</clx:VentureAgreementRenewalOption>
    <clx:SiteContingencyAgreedPercentageOfCostSharing contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="3">0.243</clx:SiteContingencyAgreedPercentageOfCostSharing>
    <clx:RemediationPeriod contextRef="From2015-07-01to2016-06-30">P30Y</clx:RemediationPeriod>
    <us-gaap:EquityMethodInvestments contextRef="C849221" unitRef="USD" decimals="-6">59000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">59000000</us-gaap:EquityMethodInvestments>
    <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1 contextRef="From2015-07-01to2016-06-30_custom_RenewLifeHoldingsCorporationMember">2016-05-02</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2015-07-01to2016-06-30_custom_RenewLifeHoldingsCorporationMember">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2016-06-30" unitRef="Shares" decimals="-3">3555000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="C849221" unitRef="USDPerShare" decimals="INF">76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2016-06-30" unitRef="USDPerShare" decimals="INF">85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">112</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">69</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2015-07-01to2016-06-30" unitRef="USDPerShare" decimals="INF">95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">228000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="C851302" unitRef="Shares" decimals="-3">18000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2015-06-30_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="-3">944000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2016-06-30_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="-3">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2016-06-30_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="-3">794000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="-3">5000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="-3">286000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="-3">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="INF">354000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="-3">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="-3">80000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="C851302" unitRef="USDPerShare" decimals="INF">91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2015-06-30_us-gaap_PerformanceSharesMember" unitRef="USDPerShare" decimals="INF">81.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2016-06-30_us-gaap_RestrictedStockMember" unitRef="USDPerShare" decimals="INF">108</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USDPerShare" decimals="INF">95.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember" unitRef="USDPerShare" decimals="INF">88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockMember" unitRef="USDPerShare" decimals="INF">106</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USDPerShare" decimals="INF">87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USDPerShare" decimals="INF">70</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="USDPerShare" decimals="INF">58</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue>
    <clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="-3">157000</clx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="From2015-07-01to2016-06-30_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="-3">377000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <clx:DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod contextRef="From2015-07-01to2016-06-30_us-gaap_InterestRateContractMember">P10Y</clx:DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod>
    <us-gaap:OpenTaxYear contextRef="From2015-07-01to2016-06-30">2012</us-gaap:OpenTaxYear>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="C851108" unitRef="USD" decimals="-6">36000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="C851109" unitRef="USD" decimals="-6">34000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="C851110" unitRef="USD" decimals="-6">40000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="AsOf2016-06-30_custom_LifoAllowanceMember" unitRef="USD" decimals="-6">32000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="C911937" unitRef="USD" decimals="-6">3000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="C851100" unitRef="USD" decimals="-6">4000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="C851101" unitRef="USD" decimals="-6">5000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="AsOf2016-06-30_us-gaap_AllowanceForDoubtfulAccountsMember" unitRef="USD" decimals="-6">5000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="C851121" unitRef="USD" decimals="-6">51000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="C851122" unitRef="USD" decimals="-6">34000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="C851123" unitRef="USD" decimals="-6">36000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="AsOf2016-06-30_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" unitRef="USD" decimals="-6">37000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2015-07-01to2016-06-30" unitRef="Shares" decimals="-3">1317000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2015-07-01to2016-06-30" unitRef="Shares" decimals="-3">2633000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="From2015-07-01to2016-06-30" unitRef="Shares" decimals="-3">214000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2016-06-30" unitRef="Shares" decimals="-6">8000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2016-06-30" unitRef="Shares" decimals="-6">8000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="C849211" unitRef="USD" decimals="-6">884000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="C849195" unitRef="USD" decimals="-6">921000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2016-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">66000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="C849251" unitRef="USD" decimals="-6">79000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2016-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">511000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2016-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">251000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2016-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">428000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="C849248" unitRef="USD" decimals="-6">445000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="C849250" unitRef="USD" decimals="-6">257000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="C849249" unitRef="USD" decimals="-6">375000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="C849233" unitRef="USD" decimals="-6">-227000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2013-07-01to2014-06-30_custom_CleaningMember" unitRef="USD" decimals="-6">428000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2013-07-01to2014-06-30_custom_HouseholdMember" unitRef="USD" decimals="-6">326000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2013-07-01to2014-06-30_custom_LifestyleMember" unitRef="USD" decimals="-6">258000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2013-07-01to2014-06-30_custom_InternationalMember" unitRef="USD" decimals="-6">99000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2016-06-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">-273000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="C849252" unitRef="USD" decimals="-6">-235000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">983000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="C849221" unitRef="USD" decimals="-6">119000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">107000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent contextRef="C849221" unitRef="USD" decimals="-6">750000000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">784000000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <clx:CompensationExpensePerformanceGoalsExceededTargetPercentageCap contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="2">1.50</clx:CompensationExpensePerformanceGoalsExceededTargetPercentageCap>
    <clx:MaximumOwnershipPercentageOfEquityInvestments contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="2">0.50</clx:MaximumOwnershipPercentageOfEquityInvestments>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">61000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">290000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <clx:ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets contextRef="C849195" unitRef="USD" decimals="-6">-15000000</clx:ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets>
    <clx:ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-3000000</clx:ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets>
    <clx:ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits contextRef="C849195" unitRef="USD" decimals="-6">-2000000</clx:ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits>
    <clx:ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">6000000</clx:ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="Pure" decimals="2">1.00</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <clx:ImpairmentOfTrademarks contextRef="From2015-07-01to2016-06-30_us-gaap_TrademarksMember" unitRef="USD" decimals="-6">6000000</clx:ImpairmentOfTrademarks>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">41000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="C849211" unitRef="USD" decimals="-6">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="C849195" unitRef="USD" decimals="-6">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">290000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="From2015-07-01to2016-06-30_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">290000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2014-12-31_custom_SeniorNotes3.50PercentMember" unitRef="Pure" decimals="4">0.0410</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2014-12-01to2014-12-31_custom_SeniorNotes3.50PercentMember">2024-12-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentPaymentTerms contextRef="From2014-12-01to2014-12-31_custom_SeniorNotes3.50PercentMember">Interest on the notes is payable semi-annually in June and December</us-gaap:DebtInstrumentPaymentTerms>
    <dei:EntityPublicFloat contextRef="AsOf2015-12-31" unitRef="USD" decimals="-8">16400000000</dei:EntityPublicFloat>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="C849221" unitRef="USD" id="Foot-05-0" decimals="-6">979000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-05-1" decimals="-6">1035000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">4000000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember_us-gaap_TrademarksMember" unitRef="USD" decimals="-6">134000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-6">36000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">3000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <clx:NumberOfLeasedProperties contextRef="C896428" unitRef="Item" decimals="INF">2</clx:NumberOfLeasedProperties>
    <clx:NumberOfLeasedProperties contextRef="From2015-07-01to2016-06-30_us-gaap_LandAndLandImprovementsMember" unitRef="Item" decimals="INF">2</clx:NumberOfLeasedProperties>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">9000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <clx:SettlementOfInterestRateForwardContract contextRef="C849195" unitRef="USD" decimals="-6">25000000</clx:SettlementOfInterestRateForwardContract>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="C849211" unitRef="USD" decimals="-6">3000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="C849195" unitRef="USD" decimals="-6">4000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">5000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <clx:AmortizationOfTrademarksAndOtherIntangibleAssets contextRef="C849211" unitRef="USD" decimals="-6">8000000</clx:AmortizationOfTrademarksAndOtherIntangibleAssets>
    <clx:AmortizationOfTrademarksAndOtherIntangibleAssets contextRef="C849195" unitRef="USD" decimals="-6">8000000</clx:AmortizationOfTrademarksAndOtherIntangibleAssets>
    <clx:AmortizationOfTrademarksAndOtherIntangibleAssets contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">8000000</clx:AmortizationOfTrademarksAndOtherIntangibleAssets>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2016-06-30" unitRef="USDPerShare" decimals="INF">74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2015-07-01to2016-06-30">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <clx:CommonOrCollectiveTrusts contextRef="C849221" unitRef="USD" decimals="-6">406000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2015-06-30_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">0</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2015-06-30_custom_BondFundMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">295000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="C912160" unitRef="USD" decimals="-6">295000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2015-06-30_custom_ForeignEquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">59000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="C851197" unitRef="USD" decimals="-6">59000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="C851198" unitRef="USD" decimals="-6">41000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="C912162" unitRef="USD" decimals="-6">41000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2015-06-30_custom_RealEstateFundMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">11000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="C912164" unitRef="USD" decimals="-6">11000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2015-06-30_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">406000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2015-06-30_custom_DomesticEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">0</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="C912167" unitRef="USD" decimals="-6">0</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2015-06-30_custom_ForeignEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">0</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="C912169" unitRef="USD" decimals="-6">0</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">0</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">421000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">421000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_DomesticEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">0</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_DomesticEquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">44000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_ForeignEquitySecuritiesMember174410593" unitRef="USD" decimals="-6">56000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_BondFundMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">307000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_BondFundMember" unitRef="USD" decimals="-6">307000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_ForeignEquitySecuritiesMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">56000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_DomesticEquitySecuritiesMember" unitRef="USD" decimals="-6">44000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_RealEstateFundMember_us-gaap_FairValueInputsLevel2Member" unitRef="USD" decimals="-6">14000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_RealEstateFundMember" unitRef="USD" decimals="-6">14000000</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_RealEstateFundMember_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">0</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_ForeignEquitySecuritiesMember_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">0</clx:CommonOrCollectiveTrusts>
    <clx:CommonOrCollectiveTrusts contextRef="AsOf2016-06-30_custom_BondFundMember_us-gaap_FairValueInputsLevel1Member" unitRef="USD" decimals="-6">0</clx:CommonOrCollectiveTrusts>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="C849211" unitRef="USD" decimals="-6">-57000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="C849195" unitRef="USD" decimals="-6">-139000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-88000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-43000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-92000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-26000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-7000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-18000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-15000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-38000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-29000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-16000000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="C849211" unitRef="USD" decimals="-6">8000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="C849195" unitRef="USD" decimals="-6">7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">18000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">18000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">8000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="C849211" unitRef="USD" decimals="-6">1000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="C849195" unitRef="USD" decimals="-6">-17000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-2000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">10000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-8000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">11000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">2000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">3000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-6000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-14000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-12000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-4000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="C849211" unitRef="USD" decimals="-6">-50000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="C849195" unitRef="USD" decimals="-6">-85000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">-68000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-53000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-54000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-37000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-14000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2015-07-01to2016-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-17000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2013-07-01to2014-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax contextRef="C849195" unitRef="USD" decimals="-6">-30000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-30000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax contextRef="From2014-07-01to2015-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax>
    <us-gaap:AccountsPayableCurrent contextRef="C849221" unitRef="USD" decimals="-6">431000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">490000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">256000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">12000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary>
    <clx:PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement contextRef="From2016-07-01to2017-06-30_us-gaap_ScenarioForecastMember" unitRef="Pure" decimals="2">.04</clx:PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement>
    <clx:TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">448000000</clx:TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement>
    <clx:PackagingDevelopmentAndDesignCosts contextRef="C849211" unitRef="USD" decimals="-6">12000000</clx:PackagingDevelopmentAndDesignCosts>
    <clx:PackagingDevelopmentAndDesignCosts contextRef="C849195" unitRef="USD" decimals="-6">11000000</clx:PackagingDevelopmentAndDesignCosts>
    <clx:PackagingDevelopmentAndDesignCosts contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-6">11000000</clx:PackagingDevelopmentAndDesignCosts>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">150000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="C849221" unitRef="USD" decimals="-6">3000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Nature of Operations and Basis of Presentation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is principally engaged in the production, marketing&#13;and sales of consumer products through mass retail outlets and grocery, e-commerce channels, wholesale distributors and medical&#13;supply distributors. The consolidated financial statements include the statements of the Company and its wholly owned and controlled&#13;subsidiaries. All significant intercompany transactions and accounts were eliminated in consolidation. Certain prior year reclassifications&#13;were made in the consolidated financial statements and related notes to the consolidated financial statements to conform to the&#13;current year presentation.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Effective September 22, 2014, the Company&amp;#146;s Venezuela&#13;affiliate, Corporaci&amp;#243;n Clorox de Venezuela S.A. (Clorox Venezuela), discontinued its operations. Consequently, the Company&#13;presents the financial results of Clorox Venezuela as a discontinued operation in the consolidated financial statements for all&#13;periods presented herein.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The preparation of these consolidated financial statements&#13;in conformity with generally accepted accounting principles in the United States of America (U.S. GAAP) requires management to&#13;reach opinions as to estimates and assumptions that affect reported amounts and related disclosures. Specific areas requiring management&amp;#146;s&#13;opinion on estimates and judgments include assumptions pertaining to accruals for consumer and trade-promotion programs, stock-based&#13;compensation costs, pension and post-employment benefit costs, future cash flows associated with impairment testing of goodwill&#13;and other long-lived assets, the credit worthiness of customers, uncertain tax positions, tax valuation allowances and legal, environmental&#13;and insurance matters. Actual results could materially differ from estimates and assumptions made.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Cash equivalents consist of highly liquid instruments, time&#13;deposits and money market funds with an initial maturity at purchase of three months or less. The fair value of cash and cash equivalents&#13;approximates the carrying amount.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company&amp;#146;s cash position includes amounts held by&#13;foreign subsidiaries and, as a result, the repatriation of certain cash balances from some of the Company&amp;#146;s foreign subsidiaries&#13;could result in additional tax costs in the United States and in certain foreign jurisdictions. However, these cash balances are&#13;generally available without legal restriction to fund local business operations. In addition, a portion of the Company&amp;#146;s cash&#13;balance is held in U.S. dollars by foreign subsidiaries, whose functional currency is their local currency. Such U.S. dollar balances&#13;are reported on the foreign subsidiaries&amp;#146; books, in their functional currency, with the impact from foreign currency exchange&#13;rate differences recorded in Other (income) expense, net. The Company&amp;#146;s cash holdings were as follows as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;249&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;221&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;142&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;401&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;382&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of June 30, 2016 and 2015, the Company had $4 and $3 of&#13;restricted cash, respectively, which is primarily related to fiscal year 2012 acquisitions. Restricted cash was included in Other&#13;assets as of June 30, 2016 and in Other current assets as of June 30, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Inventories&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Inventories are stated at the lower of cost or market. When&#13;necessary, the Company provides allowances to adjust the carrying value of its inventory to the lower of cost or market, including&#13;any costs to sell or dispose. Appropriate consideration is given to obsolescence, excessive inventory levels, product deterioration&#13;and other factors in evaluating net realizable value for the purposes of determining the lower of cost or market.&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Property, Plant and Equipment and Finite-Lived Intangible&#13;Assets&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Property, plant and equipment and finite-lived intangible&#13;assets are stated at cost. Depreciation and amortization expense are calculated by the straight-line method using the estimated&#13;useful lives or lives determined by lease contracts for the related assets. The table below provides estimated useful lives of&#13;property, plant and equipment by asset classification.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 99%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Useful Lives&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Buildings and leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10 - 40 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Land improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10 - 30 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Machinery and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 - 15 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 - 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Capitalized software costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 - 7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Property, plant and equipment and finite-lived intangible&#13;assets are reviewed for impairment whenever events or changes in circumstances occur that indicate that the carrying amount of&#13;an asset (or asset group) may not be fully recoverable. The risk of impairment is initially assessed based on an estimate of the&#13;undiscounted cash flows at the lowest level for which identifiable cash flows exist. Impairment occurs when the carrying value&#13;of the asset exceeds the estimated future undiscounted cash flows generated by the asset. When impairment is indicated, an impairment&#13;charge is recorded for the difference between the carrying value of the asset and its estimated fair market value. Depending on&#13;the asset, estimated fair market value may be determined either by use of a discounted cash flow model or by reference to estimated&#13;selling values of assets in similar condition.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Capitalization of Software Costs &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company capitalizes certain qualifying costs incurred&#13;in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest&#13;and payroll and payroll-related costs for employees during the application development stage. Internal and external costs incurred&#13;during the preliminary project stage and post implementation-operation stage, mainly training and maintenance costs, are expensed&#13;as incurred. Once the application is substantially complete and ready for its intended use, qualifying costs are amortized on a&#13;straight-line basis over the software&amp;#146;s estimated useful life.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Impairment Review of Goodwill and Indefinite-Lived Intangible&#13;Assets&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company tests its goodwill, trademarks with indefinite&#13;lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications&#13;during a different interim period that these assets may have become impaired.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;With respect to goodwill, the Company has the option to first&#13;assess qualitative factors such as maturity and stability of the reporting unit, magnitude of excess fair value over carrying value&#13;from the prior year&amp;#146;s impairment testing, other reporting unit specific operating results as well as new events and circumstances&#13;impacting the operations at the reporting unit level. If the result of a qualitative test indicates a potential for impairment&#13;of a reporting unit, a quantitative test is performed. The quantitative test is a two-step process. In the first step, the Company&#13;compares the estimated fair value of the reporting unit to its carrying value. In all instances, the estimated fair value exceeded&#13;the carrying value of the reporting unit. Had the estimated fair value of any reporting unit been less than its carrying value,&#13;the Company would have performed a second step to determine the implied fair value of the reporting unit&amp;#146;s goodwill. If the&#13;carrying amount of a reporting unit&amp;#146;s goodwill had exceeded its implied fair value, an impairment charge would have been recorded&#13;for the difference between the carrying amount and the implied fair value of the reporting unit&amp;#146;s goodwill.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;To determine the fair value of a reporting unit as part of&#13;its quantitative test, the Company uses a discounted cash flow (DCF) approach, as it believes that this approach is the most reliable&#13;indicator of the fair value of its businesses and the fair value of their future earnings and cash flows. Under this approach,&#13;the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects&#13;their relative risk. The cash flows used in the DCF are consistent with those the Company uses in its internal planning, which&#13;gives consideration to actual business trends experienced, and the broader business strategy for the long term. The other key estimates&#13;and factors used in the DCF include, but are not limited to, future sales volumes, revenue and expense growth rates, changes in&#13;working capital, foreign exchange rates, currency devaluation, inflation and a perpetuity growth rate. Changes in such estimates&#13;or the application of alternative assumptions could produce different results.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;For trademarks and other intangible assets with indefinite&#13;lives, the Company performs a quantitative analysis to test for impairment. When a quantitative test is performed, the estimated&#13;fair value of an asset is compared to its carrying amount. If the carrying amount of such asset exceeds its estimated fair value,&#13;an impairment charge is recorded for the difference between the carrying amount and the estimated fair value. The Company uses&#13;the income approach to estimate the fair value of its trademarks and other intangible assets with indefinite lives. This approach&#13;requires significant judgments in determining both the assets&amp;#146; estimated cash flows as well as the appropriate discount and&#13;foreign exchange rates applied to those cash flows to determine fair value. Changes in such estimates or the use of alternative&#13;assumptions could produce different results.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Stock-based Compensation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company grants various nonqualified stock-based compensation&#13;awards to eligible employees, including stock options and performance units.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;For stock options, the Company estimates the fair value of&#13;each award on the date of grant using the Black-Scholes valuation model, which requires management to make estimates regarding&#13;expected option life, stock price volatility and other assumptions. Groups of employees that have similar historical exercise behavior&#13;are considered separately for valuation purposes. The Company estimates stock option forfeitures based on historical data for each&#13;employee grouping. The total number of stock options expected to vest is adjusted by actual and estimated forfeitures. Changes&#13;to the actual and estimated forfeitures will result in a cumulative catch-up adjustment in the period of change. Compensation expense&#13;is recorded by amortizing the grant date fair values on a straight-line basis over the vesting period, adjusted for estimated forfeitures.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company&amp;#146;s performance unit grants provide for the&#13;issuance of common stock to certain managerial staff and executive management if the Company achieves specified performance targets.&#13;The number of shares issued are dependent upon vesting and the achievement of specified performance targets. The performance period&#13;is three years and the payout determination is made at the end of the three-year performance period. Performance unit grants receive&#13;dividends earned during the vesting period upon vesting. The fair value of each grant issued is estimated on the date of grant&#13;based on the current market price of the stock. The total amount of compensation expense recognized reflects estimated forfeiture&#13;rates and the initial assumption that performance goals will be achieved. Compensation expense is adjusted based on management&amp;#146;s&#13;assessment of the probability that performance goals will be achieved. If such goals are not met or it is determined that achievement&#13;of performance goals is not probable, previously recognized compensation expense is trued up in the current period to reflect the&#13;expected payout level. If it is determined that the performance goals will be exceeded, additional compensation expense is recognized,&#13;subject to a cap of 150%.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Cash flows resulting from tax deductions in excess of the&#13;cumulative compensation cost recognized for stock-based payment arrangements (excess tax benefits) are primarily classified as&#13;financing cash inflows.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Employee Benefits&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company accounts for its defined benefit retirement income&#13;and retirement health care plans using actuarial methods&lt;i&gt;.&lt;/i&gt; These methods use an attribution approach that generally spreads&#13;&amp;#147;plan events&amp;#148; over the service lives or expected lifetime (for frozen plans) of plan participants. Examples of plan events&#13;are plan amendments and changes in actuarial assumptions such as the expected return on plan assets, discount rate, rate of compensation&#13;increase and certain employee-related factors, such as retirement age and mortality. The principle underlying the attribution approach&#13;is that employees render service over their employment period on a relatively &amp;#147;smooth&amp;#148; basis and, therefore, the statement&#13;of earnings effects of retirement income and retirement health care plans are recognized in the same pattern. One of the principal&#13;assumptions used in the net periodic benefit cost calculation is the expected return on plan assets. The required use of an expected&#13;return on plan assets may result in recognized pension expense or income that differs from the actual returns of those plan assets&#13;in any given year. Over time, however, the goal is for the expected long-term returns to approximate the actual returns and, therefore,&#13;the expectation is that the pattern of income and expense recognition should closely match the pattern of the services provided&#13;by the participants. The Company uses a market-related value method for calculating plan assets for purposes of determining the&#13;amortization of actuarial gains and losses. The differences between actual and expected returns are recognized in the net periodic&#13;benefit cost calculation over the average remaining service period or expected lifetime (for frozen plans) of the plan participants&#13;using the corridor approach. Under this approach, only actuarial gains (losses) that exceed 5% of the greater of the projected&#13;benefit obligation or the market-related value of assets are amortized to pension expense by the Company. In developing its expected&#13;return on plan assets, the Company considers the long-term actual returns relative to the mix of investments that comprise its&#13;plan assets and also develops estimates of future investment returns by considering external sources.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company recognizes an actuarial-based obligation at the&#13;onset of disability for certain benefits provided to individuals after employment, but before retirement, that include medical,&#13;dental, vision, life and other benefits.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Environmental Costs&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is involved in certain environmental remediation&#13;and ongoing compliance activities. Accruals for environmental matters are recorded on a site-by-site basis when it is probable&#13;that a liability has been incurred and based upon a reasonable estimate of the liability. The Company&amp;#146;s accruals reflect the&#13;anticipated participation of other potentially responsible parties in those instances where it is probable that such parties are&#13;legally responsible and financially capable of paying their respective shares of the relevant costs. These accruals are adjusted&#13;periodically as assessment and remediation efforts progress or as additional technical or legal information become available. Actual&#13;costs to be incurred at identified sites in future periods may vary from the estimates, given the inherent uncertainties in evaluating&#13;environmental exposures. The accrual for environmental matters is included in Accounts payable and accrued liabilities and Other&#13;liabilities in the Company&amp;#146;s consolidated balance sheets on an undiscounted basis due to uncertainty regarding the timing&#13;of future payments.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Sales are recognized as revenue when the risk of loss and&#13;title pass to the customer and when all of the following have occurred: a firm sales arrangement exists, pricing is fixed or determinable&#13;and collection is reasonably assured. Sales are recorded net of allowances for trade promotions, coupons, returns and other discounts.&#13;The Company routinely commits to one-time or ongoing trade-promotion programs with customers and consumer coupon programs that&#13;require the Company to estimate and accrue the expected costs of such programs. Programs include shelf price reductions, end-of-aisle&#13;or in-store displays of the Company&amp;#146;s products and graphics and other trade-promotion activities conducted by the customer.&#13;Coupons are recognized as a liability when distributed based upon expected consumer redemptions. The Company maintains liabilities&#13;related to these programs for the estimated expenses incurred, but not paid, at the end of each period. Trade-promotion and coupon&#13;redemption costs are recorded as a reduction of sales.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company provides an allowance for doubtful accounts based&#13;on its historical experience and ongoing assessment of its customers&amp;#146; credit risk. Receivables were presented net of an allowance&#13;for doubtful accounts of $5 and $4 as of June 30, 2016 and 2015, respectively. Receivables, net, included non-customer receivables&#13;of $9 and $12 as of June 30, 2016 and 2015, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Cost of Products Sold&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Cost of products sold represents the costs directly related&#13;to the manufacture and distribution of the Company&amp;#146;s products and primarily includes raw materials, packaging, contract manufacturing&#13;fees, shipping and handling, warehousing, package design, depreciation, amortization, direct and indirect labor and operating costs&#13;for the Company&amp;#146;s manufacturing and distribution facilities including salary, benefit costs and incentive compensation, and&#13;royalties and other charges related to the Company&amp;#146;s Glad&lt;sup&gt;&amp;#174;&lt;/sup&gt; Venture Agreement (see Note 10).&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Costs associated with developing and designing new packaging&#13;are expensed as incurred and include design, artwork, films and labeling. Expenses for fiscal years ended June 30, 2016, 2015 and&#13;2014 were $11, $11 and $12, respectively, all of which were reflected in Cost of products sold or discontinued operations, as appropriate,&#13;in the consolidated statements of earnings.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Selling and Administrative Expenses&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Selling and administrative expenses represent costs incurred&#13;by the Company in generating revenues and managing the business and include market research, commissions and certain administrative&#13;expenses. Administrative expenses include salary, benefits, incentive compensation, professional fees and services, software and&#13;licensing fees and other operating costs associated with the Company&amp;#146;s non-manufacturing, non-research and development staff,&#13;facilities and equipment.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Advertising and Research and Development Costs&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company expenses advertising and research and development&#13;costs in the period incurred.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company uses the asset and liability method to account&#13;for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to&#13;differences between financial statement amounts and their respective tax basis. Management reviews the Company&amp;#146;s deferred&#13;tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established&#13;when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes&#13;in valuation allowances from period to period are included in the Company&amp;#146;s tax provision in the period of change. In addition&#13;to valuation allowances, the Company provides for uncertain tax positions when such tax positions do not meet certain recognition&#13;thresholds or measurement standards. Amounts for uncertain tax positions are adjusted in quarters when new information becomes&#13;available or when positions are effectively settled.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;U.S. income tax expense and foreign withholding taxes are&#13;provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign&#13;earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change&#13;and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company&#13;accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign Currency Transactions and Translation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Local currencies are the functional currencies for substantially&#13;all of the Company&amp;#146;s foreign operations. When the transactional currency is different than the functional currency, transaction&#13;gains and losses are included as a component of Other (income) expense, net. In addition, certain assets and liabilities denominated&#13;in currencies different than a foreign subsidiary&amp;#146;s functional currency are reported on the subsidiary&amp;#146;s books in its&#13;functional currency, with the impact from exchange rate differences recorded in Other (income) expense, net. Assets and liabilities&#13;of foreign operations are translated into U.S. dollars using the exchange rates in effect at the balance sheet date, while income&#13;and expenses are translated at the average monthly exchange rates during the year.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Gains and losses on foreign currency translations are reported&#13;as a component of Other comprehensive income (loss). Deferred taxes are not provided on cumulative translation adjustments where&#13;the Company expects earnings of a foreign subsidiary to be indefinitely reinvested. The income tax effect of currency translation&#13;adjustments related to foreign subsidiaries and joint ventures for which earnings are not considered indefinitely reinvested is&#13;recorded as a component of deferred taxes with an offset to Other comprehensive income (loss).&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Derivative Instruments&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company&amp;#146;s use of derivative instruments, principally&#13;swaps, futures and forward contracts, is limited to non-trading purposes and is designed to partially manage exposure to changes&#13;in commodity prices, interest rates and foreign currencies. The Company&amp;#146;s contracts are hedges for transactions with notional&#13;amounts and periods consistent with the related exposures and do not constitute investments independent of these exposures.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The changes in the fair value (i.e., gains or losses) of&#13;a derivative instrument are recorded as either assets or liabilities in the consolidated balance sheets with an offset to net earnings&#13;or Other comprehensive income (loss) depending on whether, for accounting purposes, it has been designated and qualifies as an&#13;accounting hedge and, if so, on the type of hedging relationship. The criteria used to determine if hedge accounting treatment&#13;is appropriate are: (a) formal designation and documentation of the hedging relationship, the risk management objective and hedging&#13;strategy at hedge inception; (b) eligibility of hedged items, transactions and corresponding hedging instrument; and (c) effectiveness&#13;of the hedging relationship both at inception of the hedge and on an ongoing basis in achieving the hedging objectives. For those&#13;derivative instruments designated and qualifying as hedging instruments, the Company must designate the hedging instrument either&#13;as a fair value hedge or as a cash flow hedge. The Company designates its commodity forward and future contracts for forecasted&#13;purchases of raw materials, interest rate forward contracts for forecasted interest payments, and foreign currency forward contracts&#13;for forecasted purchases of inventory as cash flow hedges. During the fiscal years ended June 30, 2016, 2015 and 2014, the Company&#13;had no hedging instruments designated as fair value hedges.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;For derivative instruments designated and qualifying as cash&#13;flow hedges, the effective portion of gains or losses is reported as a component of Other comprehensive income (loss) and reclassified&#13;into earnings in the same period or periods during which the hedged transaction affects earnings. From time to time, the Company&#13;may have contracts not designated as hedges for accounting purposes, for which it recognizes changes in the fair value in the consolidated&#13;statement of earnings in the current period. Cash flows from hedging activities are classified as operating activities in the consolidated&#13;statements of cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In March 2016, the Financial Accounting Standards Board (FASB)&#13;issued Accounting Standards Update (ASU) No. 2016-09, &amp;#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee&#13;Share-Based Payment Accounting,&amp;#148; which simplifies several aspects of the accounting for share-based payment transactions,&#13;including requiring excess tax benefits and deficiencies to be recognized as income tax benefit or expense in the consolidated&#13;statement of earnings and excess tax benefits and deficiencies to be classified as an operating activity in the consolidated statement&#13;of cash flows. The new guidance is effective for the Company beginning in the first quarter of fiscal year 2018, with early adoption&#13;permitted. The Company is planning to adopt the standard in the first quarter of fiscal year 2017. While the actual benefit realized&#13;may vary significantly given the inherent uncertainty in predicting future share-based transactions, the Company currently estimates&#13;that the adoption will result in approximately a 4 percentage point benefit to the Company&amp;#146;s historical effective tax rate&#13;of 34% to 35% for fiscal year 2017.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In February 2016, the FASB issued ASU No. 2016-02, &amp;#147;Leases&#13;(Topic 842),&amp;#148; which requires lessees to recognize a right-of-use asset and lease liability for all leases with terms of more&#13;than 12 months. Recognition, measurement and presentation will depend on classification as a finance or operating lease. ASU 2016-02&#13;also requires expanded disclosures about leasing arrangements. The new guidance is effective for the Company beginning in the first&#13;quarter of fiscal year 2020, with early adoption permitted. The Company is currently evaluating the impact that adoption of this&#13;guidance will have on its consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In November 2015, the FASB issued ASU No. 2015-17, &amp;#147;Income&#13;Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes,&amp;#148; which requires all deferred tax liabilities and assets&#13;to be classified as noncurrent. The Company adopted the standard in the fourth quarter of fiscal year 2016 on a prospective basis&#13;as permitted. Prior period balances have not been retrospectively adjusted.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In April 2015, the Financial Accounting Standards Board (FASB)&#13;issued Accounting Standards Update (ASU) No. 2015-03, &amp;#147;Simplifying the Presentation of Debt Issuance Cost,&amp;#148; which requires&#13;that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the&#13;carrying amount of that debt liability, consistent with debt discounts. The new guidance is effective for the Company beginning&#13;in the first quarter of fiscal year 2017, with early adoption permitted. The Company does not expect the adoption of this guidance&#13;will have a significant impact on its consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;In February 2015, the FASB&#13;issued ASU No. 2015-02,&lt;/font&gt; &amp;#147;&lt;font style="font-size: 10pt"&gt;Amendments to the Consolidation Analysis,&amp;#148; which changes&#13;the guidance for evaluating whether to consolidate certain legal entities. The amendments modify the evaluation of whether limited&#13;partnerships and similar legal entities are variable interest entities ("VIEs") or voting interest entities. The new guidance is&#13;effective for the Company beginning in the first quarter of fiscal year 2017, with early adoption permitted. The Company does not&#13;expect the adoption of this guidance will have a significant impact on its consolidated financial statements. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In May 2014, the FASB issued ASU No. 2014-09, &amp;#147;Revenue&#13;from Contracts with Customers (Topic 606),&amp;#148; which replaces most existing U.S. GAAP revenue recognition guidance and is intended&#13;to improve and converge with international standards the financial reporting requirements for revenue from contracts with customers.&#13;The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services equal to the&#13;amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional disclosures&#13;about the nature, timing and uncertainty of revenue and cash flows arising from contracts with customers, including information&#13;about significant judgments and changes in judgments. The new guidance is effective for the Company beginning in the first quarter&#13;of fiscal year 2019, with the option to early adopt in the first quarter of fiscal year 2018. The Company is currently evaluating&#13;the impact that adoption of this guidance will have on its consolidated financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 3. BUSINESSES ACQUIRED &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;On May 2, 2016, the Company acquired 100 percent of ReNew&#13;Life Holdings Corporation (Renew Life), a leading brand in digestive health. The amount paid was $290 funded through commercial&#13;paper. The amount paid of $290 represents the aggregate purchase price less cash acquired. The purchase of the Renew Life business&#13;reflects the Company&amp;#146;s strategy to acquire leading brands with attractive margins in growth categories. Results for Renew&#13;Life&amp;#146;s U.S. business are reflected in the Household reportable segment and results for Renew Life&amp;#146;s international business&#13;are reflected in the International reportable segment. Included in the Company&amp;#146;s results for fiscal year 2016 was $21 of Renew&#13;Life&amp;#146;s global net sales.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The assets and liabilities of Renew Life were recorded at&#13;their respective estimated fair values as of the date of the acquisition using generally accepted accounting principles for business&#13;combinations. The excess of the purchase price over the fair value of the net identifiable assets acquired has been allocated to&#13;goodwill. Goodwill recorded primarily reflects the value of expanding the Company&amp;#146;s portfolio further into the health and&#13;wellness arena.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the estimated fair values&#13;of Renew Life&amp;#146;s assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date. Due&#13;to the timing of the acquisition, the fair value of the assets acquired and liabilities assumed are based on a preliminary valuation&#13;and the Company&amp;#146;s estimates and assumptions are subject to change within the measurement period. The primary areas of the&#13;purchase price that are not yet finalized are related to goodwill and income taxes. The weighted-average estimated useful life&#13;of intangible assets subject to amortization is 15 years.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Renew Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 97%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trademarks&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;134&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Customer relationships&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Property, plant and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Working capital, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Purchase Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;290&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Pro forma results reflecting the acquisition were not presented&#13;because the acquisition did not meet the threshold requirements for additional disclosure.&lt;/p&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 4. INVENTORIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Inventories consisted of the following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 93%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Finished goods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;361&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;316&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Raw materials and packaging&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;111&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;101&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Work in process&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;LIFO allowances&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;443&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;385&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The last-in, first-out (LIFO) method was used to value approximately&#13;38% of inventories as of June 30, 2016 and 2015, respectively. The carrying values for all other inventories are determined on&#13;the first-in, first-out (FIFO) method. The effect on earnings of the liquidation of LIFO layers was a benefit of $0, $0 and $2&#13;for the fiscal years ended June 30, 2016, 2015 and 2014, respectively.&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 5. OTHER CURRENT ASSETS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Other current assets consisted of the following as of June&#13;30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 94%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred tax assets&lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;99&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Prepaid expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;39&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;143&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;(a) &lt;/sup&gt;The Company prospectively adopted ASU No.&#13;2015-17, "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes," requiring all deferred tax assets and liabilities&#13;to be classified as noncurrent. See Note 1 and 18 for further details.&lt;/p&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 6. PROPERTY, PLANT AND EQUIPMENT, NET&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The components of property, plant and equipment, net, consisted&#13;of the following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 93%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Machinery and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,607&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,608&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Buildings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;524&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;515&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Capitalized software costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;371&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Land and improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;118&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;122&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Construction in progress&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,817&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,757&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Less: Accumulated depreciation and amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,911&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,839&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;906&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;918&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Included in Machinery and equipment above are $12 of capital&#13;leases as of June 30, 2016 and 2015, respectively. Accumulated depreciation for assets under capital leases was $3 and $2 as of&#13;June 30, 2016 and 2015, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Included in Land and improvements above are $3 and $2 of&#13;asset retirement obligations as of June 30, 2016 and 2015, respectively, for two leased properties. The liability of $1 and $2&#13;incurred in fiscal year 2016 and 2015, respectively, was recorded in Other liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Depreciation and amortization expense related to property,&#13;plant and equipment, net, was $157, $157 and $161 in fiscal years 2016, 2015 and 2014, respectively, which includes depreciation&#13;of assets under capital leases. This also includes amortization of capitalized software of $16, $19 and $22 in fiscal years 2016,&#13;2015 and 2014, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Non-cash capital expenditures were $10, $18 and $0 in fiscal&#13;years 2016, 2015 and 2014, respectively.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 7. GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS&#13;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The changes in the carrying amount of goodwill by reportable&#13;segment for the fiscal years ended June 30, 2016 and 2015 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="16" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Cleaning&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Lifestyle&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Household&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;International&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 83%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance June 30, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;449&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,101&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effect of foreign currency translation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;415&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,067&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Acquisition&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;122&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effect of foreign currency translation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;207&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;423&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,197&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The changes in the carrying amount of trademarks and other&#13;intangible assets for the fiscal years ended June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of June 30, 2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of June 30, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amortization&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Net carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amortization&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Net carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 82%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trademarks not subject to amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;647&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt; &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;647&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;524&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;524&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trademarks subject to amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;22&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;22&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other intangible assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Technology and product formulae&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;134&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;221&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;146&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;188&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;142&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;46&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,037&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;302&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;735&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;882&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;297&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;585&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Finite-lived intangible assets are amortized over their estimated&#13;useful lives, generally ranging from 2 to 30 years. Amortization expense relating to the Company&amp;#146;s intangible assets was $8,&#13;$12 and $15 for the years ended June 30, 2016, 2015 and 2014, respectively. Estimated amortization expense for these intangible&#13;assets is $10, $9, $9, $9 and $8 for fiscal years 2017, 2018, 2019, 2020 and 2021, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;During fiscal year 2016, the Company recognized $9 of intangible&#13;asset impairment charges, of which $6 related to the Aplicare&lt;sup&gt;&amp;#174;&lt;/sup&gt; trademark within the Cleaning segment. The Aplicare&lt;sup&gt;&amp;#174;&lt;/sup&gt;&#13;trademark impairment was recognized based on the anticipated impact on future results from a competitive market entrant.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable and accrued liabilities consisted of the&#13;following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;490&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;431&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Compensation and employee benefit costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;192&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;189&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trade and sales promotion&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;127&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;115&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividends&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;108&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;103&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;118&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;141&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,035&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;979&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;(a) &lt;/sup&gt;Accounts payable and accrued liabilities&#13;were combined into one financial statement line as of June 30, 2016. The change has been retrospectively applied to all periods&#13;presented.&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 9. DEBT &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable, which mature in less than one year,&#13;included the following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commercial paper&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;522&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;93&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign borrowings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;523&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;95&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The weighted average interest rates incurred on average outstanding&#13;notes and loans payable during the fiscal years ended June 30, 2016, 2015 and 2014, including fees associated with the Company&amp;#146;s&#13;undrawn revolving credit facility, were 1.10%, 2.05% and 0.97%, respectively. The weighted average effective interest rates on&#13;commercial paper balances as of June 30, 2016 and 2015 were 0.82% and 0.39%, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Long-term debt, carried at face value net of unamortized&#13;discounts or premiums, included the following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 94%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Senior unsecured notes and debentures:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3.55%, $300 due November 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;300&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;5.95%, $400 due October 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;399&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3.80%, $300 due November 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;298&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;298&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3.05%, $600 due September 2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;599&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;599&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3.50%, $500 due December 2024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,797&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,096&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Less: Current maturities of long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(300&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,797&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,796&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The weighted average interest rates incurred on average outstanding&#13;long-term debt during the fiscal years ended June 30, 2016, 2015 and 2014, were 4.37%, 4.44% and 4.56%, respectively. The weighted&#13;average effective interest rates on long-term debt balances as of June 30, 2016 and 2015, were 4.41% and 4.31%, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Long-term debt maturities as of June 30, 2016, are $0, $400,&#13;$0, $0, $0 and $1,400 in fiscal years 2017, 2018, 2019, 2020, 2021 and thereafter, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In November 2015, $300 of the Company&amp;#146;s senior notes&#13;with an annual fixed interest rate of 3.55% became due and were repaid using commercial paper borrowings and cash on hand.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In December 2014, under a shelf registration statement filed&#13;with the SEC that will expire in December 2017, the Company issued $500 of senior notes with an annual fixed interest rate of 3.50%.&#13;Interest on the notes is payable semi-annually in June and December and the notes have a maturity date of December 15, 2024. The&#13;notes carry an effective interest rate of 4.10%, which includes the impact from the settlement of interest rate forward contracts&#13;in December 2014 (see Note 11). The notes rank equally with all of the Company&amp;#146;s existing senior indebtedness. In January&#13;2015, $575 of the Company&amp;#146;s senior notes with an annual fixed interest rate of 5.00% became due and were repaid using the&#13;net proceeds from the December 2014 debt issuance and commercial paper borrowings.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company&amp;#146;s borrowing capacity under other financing&#13;arrangements as of June 30 was as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Revolving credit facility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,100&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign credit lines&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other credit lines&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,128&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,129&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of June 30, 2016, the Company had a $1,100 revolving credit&#13;agreement (the Credit Agreement), which expires in October 2019. There were no borrowings under the Credit Agreement as of June&#13;30, 2016 or 2015. The agreement includes certain restrictive covenants and limitations, with which the Company was in compliance&#13;as of June 30, 2016.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Of the $28 of foreign and other credit lines as of June 30,&#13;2016, $5 was outstanding and the remainder of $23 was available for borrowing. Of the $29 of foreign and other credit lines as&#13;of June 30, 2015, $4 was outstanding and the remainder of $25 was available for borrowing.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 10. OTHER LIABILITIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Other liabilities consisted of the following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Employee benefit obligations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;335&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;299&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Venture agreement terminal obligation, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;302&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;294&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;107&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;119&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;784&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;750&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Venture Agreement&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company has an agreement with The Procter &amp;#38; Gamble&#13;Company (P&amp;#38;G) for the Company&amp;#146;s Glad&lt;sup&gt;&amp;#174;&lt;/sup&gt; bags, wraps and containers business. As of June 30, 2016 and 2015,&#13;P&amp;#38;G had a 20% interest in the venture. The Company pays a royalty to P&amp;#38;G for its interest in the profits, losses and cash&#13;flows, as contractually defined, of the Glad&lt;sup&gt;&amp;#174;&lt;/sup&gt; business, which is included in Cost of products sold. The agreement&#13;with P&amp;#38;G will expire in January 2023 unless the parties decide, on or prior to January 2018, to extend the term of the agreement&#13;for another 10 years. The agreement can be terminated under certain circumstances, including at P&amp;#38;G&amp;#146;s option upon a change&#13;in control of the Company or, at either party&amp;#146;s option, upon the sale of the Glad&lt;sup&gt;&amp;#174;&lt;/sup&gt; business by the Company.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Upon termination of the agreement, the Company is required&#13;to purchase P&amp;#38;G&amp;#146;s interest for cash at fair value as established by predetermined valuation procedures. As of June 30,&#13;2016, the estimated fair value of P&amp;#38;G&amp;#146;s interest was $448, of which $302 has been recognized and is reflected in Other&#13;liabilities as noted in the table above. The difference between the estimated fair value and the amount recognized, and any future&#13;changes in the fair value of P&amp;#38;G&amp;#146;s interest, is charged to Cost of products sold on a straight-line basis over the remaining&#13;life of the agreement. Following termination, the Glad&lt;sup&gt;&amp;#174;&lt;/sup&gt; business will retain the exclusive core intellectual property&#13;licenses contributed by P&amp;#38;G on a royalty-free basis for the licensed products marketed.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Deferred Gain on Sale-leaseback Transaction&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In December 2012, the Company completed a sale-leaseback&#13;transaction under which it sold its general office building in Oakland, CA to an unrelated third party for net proceeds of $108&#13;and entered into a 15-year operating lease agreement with renewal options with the buyer for a portion of the building. The Company&#13;deferred recognition of the portion of the total gain on the sale that was equivalent to the present value of the lease payments&#13;and will continue to amortize such amount to earnings ratably over the lease term. As of June 30, 2016 and 2015, the long-term&#13;portion of the deferred gain of $36 and $40, respectively, was included in Other in the table above.&lt;/p&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <clx:FinancialInstrumentsAndFairValueMeasurementsTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 11. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Financial assets and liabilities measured at fair value on&#13;a recurring basis in the consolidated balance sheets are required to be classified and disclosed in one of the following three&#13;categories of the fair value hierarchy:&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Level 1: Quoted market prices in active markets for identical&#13;assets or liabilities.&lt;br /&gt;&#13;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;br /&gt;&#13;Level 3: Unobservable inputs reflecting the reporting entity&amp;#146;s own assumptions.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of June 30, 2016 and 2015, the Company&amp;#146;s financial&#13;assets and liabilities that were measured at fair value on a recurring basis during the period included derivative financial instruments,&#13;which were classified as either Level 1 or Level 2, and trust assets to fund certain of the Company&amp;#146;s nonqualified deferred&#13;compensation plans, which were classified as Level 1.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial Risk Management and Derivative Instruments&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is exposed to certain commodity, foreign currency&#13;and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to&#13;these risks.&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Commodity Price Risk Management&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company may use commodity exchange traded futures and&#13;over-the-counter swap contracts, which are generally no longer than 2 years, to fix the price of a portion of its forecasted raw&#13;material requirements. Commodity purchase contracts are measured at fair value using market quotations obtained from commodity&#13;derivative dealers.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of June 30, 2016, the notional amount of commodity derivatives&#13;was $30, of which $16 related to jet fuel swaps and $14 related to soybean oil futures. As of June 30, 2015, the notional amount&#13;of commodity derivatives was $47, of which $27 related to jet fuel swaps and $20 related to soybean oil futures.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Foreign Currency Risk Management&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company may also enter into certain over-the-counter&#13;derivative contracts to manage a portion of the Company&amp;#146;s forecasted foreign currency exposure associated with the purchase&#13;of inventory. These foreign currency contracts generally have durations of no longer than 2 years. The foreign exchange contracts&#13;are measured at fair value using information quoted by foreign exchange dealers.&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The notional amounts of outstanding foreign currency forward&#13;contracts used by the Company&amp;#146;s subsidiaries to hedge forecasted purchases of inventory were $84 and $105, respectively, as&#13;of June 30, 2016 and 2015.&lt;b&gt;&lt;i&gt; &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Interest Rate Risk Management&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company may enter into over-the-counter interest rate&#13;forward contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt or to manage&#13;the Company&amp;#146;s level of fixed and floating rate debt. The interest rate contracts are measured at fair value using information&#13;quoted by U.S. government bond dealers.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;During fiscal year 2015, the Company paid $25 to settle interest&#13;rate forward contracts related to the December 2014 issuance of $500 in senior notes. The settlement payments are reflected as&#13;operating cash flows in the consolidated statements of cash flows for the fiscal year ended June 30, 2015. The loss is reflected&#13;in Accumulated other comprehensive net loss on the consolidated balance sheets as of June 30, 2016 and 2015, and is being amortized&#13;into Interest expense on the consolidated statements of earnings over the 10-year term of the notes.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company had no outstanding interest rate forward contracts&#13;as of June 30, 2016 and 2015.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Counterparty Risk Management and Derivative Contract&#13;Requirements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company utilizes a variety of financial institutions&#13;as counterparties for over-the counter derivative instruments. The Company enters into agreements governing the use of over-the-counter&#13;derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each&#13;counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value&#13;of the derivative instruments exceeds contractually defined counterparty liability position limits. Of the derivative instruments&#13;of $5 and $8 reflected in Accounts payable and accrued liabilities and Other liabilities as of June 30, 2016 and 2015, respectively,&#13;$4 and $8, respectively, contained such terms. As of both June 30, 2016 and 2015, neither the Company nor any counterparty was&#13;required to post any collateral as no counterparty liability position limits were exceeded.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Certain terms of the agreements governing the Company&amp;#146;s&#13;over-the-counter derivative instruments require the credit ratings, as assigned by Standard &amp;#38; Poor&amp;#146;s and Moody&amp;#146;s&#13;to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating.&#13;If the Company&amp;#146;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could&#13;request full collateralization on derivative instruments in net liability positions. As of both June 30, 2016 and 2015, the Company&#13;and each of its counterparties had been assigned investment grade ratings by both Standard &amp;#38; Poor&amp;#146;s and Moody&amp;#146;s.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Certain of the Company&amp;#146;s exchange-traded futures contracts&#13;used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account&#13;held by the Company&amp;#146;s broker for trades conducted on that exchange. As of June 30, 2016 and 2015, the Company maintained cash&#13;margin balances related to exchange-traded futures contracts of $1 and $2, respectively, which are classified as Other current&#13;assets on the consolidated balance sheets.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Trust Assets &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company has held interests in mutual funds and cash equivalents&#13;as part of trust assets related to certain of its nonqualified deferred compensation plans. The participants, who are the Company&amp;#146;s&#13;current and former employees, in the deferred compensation plans may select among certain mutual funds in which their compensation&#13;deferrals are invested in accordance with the terms of the plan and within the confines of the trusts which hold the marketable&#13;securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and therefore,&#13;trust assets are consolidated and included in Other assets in the consolidated balance sheets. The interests in mutual funds are&#13;measured at fair value using quoted market prices. The Company has designated these marketable&lt;b&gt; &lt;/b&gt;securities as trading investments.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The value of the trust assets related to certain of the Company&amp;#146;s&#13;nonqualified deferred compensation plans increased by $14 as compared to June 30, 2015, primarily due to current year employees&amp;#146;&#13;contributions to these plans.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the fair value of Company&amp;#146;s&#13;assets and liabilities for which disclosure of fair value is required as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance sheet classification&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;hierarchy&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;level&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Investments including money market funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash and cash equivalents &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;234&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;234&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;212&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;212&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Time deposits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash and cash equivalents &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;84&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;84&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trust assets for nonqualified deferred&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;compensation plans&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;335&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;335&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="17"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable &lt;sup&gt;(b)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;523&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;523&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;95&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;95&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; vertical-align: middle"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable and&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;accrued liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; vertical-align: middle"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable and&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;accrued liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; vertical-align: middle"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current maturities of long-term debt and&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current maturities of long-&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;term debt and Long-term&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;debt &lt;sup&gt;(c)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,797&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,922&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,096&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,137&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2,325&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2,450&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2,199&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2,240&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;table cellspacing="0" cellpadding="0" border="0"&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(a)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 100%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(b)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Notes and loan payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(c)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Derivatives &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company designates its commodity forward and future contracts&#13;for forecasted purchases of raw materials, interest rate forward contracts for forecasted interest payments, and foreign currency&#13;forward contracts for forecasted purchases of inventory as cash flow hedges.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The effects of derivative instruments designated as hedging&#13;instruments on Other comprehensive income (loss) and net earnings were as follows during the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gains (losses)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;recognized in other comprehensive net loss&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 86%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest rate derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="12"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gains (losses) reclassified from accumulated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;other comprehensive net loss and recognized&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;in net earnings&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest rate derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The gains (losses) reclassified from Accumulated other comprehensive&#13;net (losses) income and recognized in earnings during the fiscal years ended June 30, 2016, 2015 and 2014, for commodity purchase&#13;and foreign exchange contracts were included in Cost of products sold, and for interest rate contracts were included in Interest&#13;expense.&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The estimated amount of the existing net gain (loss) in Accumulated&#13;other comprehensive net (losses) income as of June 30, 2016, which is expected to be reclassified into earnings within the next&#13;twelve months, is $(11). Gains and losses on derivative instruments representing either hedge ineffectiveness or hedge components&#13;excluded from the assessment of effectiveness are recognized in the consolidated statement of earnings. During each of the fiscal&#13;years ended June 30, 2016, 2015 and 2014, hedge ineffectiveness was not significant.&lt;/p&gt;</clx:FinancialInstrumentsAndFairValueMeasurementsTextBlock>
    <clx:ContingenciesAndGuaranteesDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 12. OTHER CONTINGENCIES AND GUARANTEES &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Contingencies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is involved in certain environmental matters,&#13;including response actions at various locations. The Company had a recorded liability of $14 and $12 as of June 30, 2016 and 2015,&#13;respectively, for its share of aggregate future remediation costs related to these matters. One matter in Dickinson County, Michigan,&#13;for which the Company is jointly and severally liable, accounted for a substantial majority of the recorded liability as of both&#13;June 30, 2016 and 2015. The Company has agreed to be liable for 24.3% of the aggregate remediation and associated costs for this&#13;matter pursuant to a cost-sharing arrangement with a third party. With the assistance of environmental consultants, the Company&#13;maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance&#13;and other costs that may be incurred over an estimated 30-year remediation period. Currently, the Company cannot accurately predict&#13;the timing of future payments that may be made under this obligation. In addition, the Company&amp;#146;s estimated loss exposure is&#13;sensitive to a variety of uncertain factors, including the efficacy of remediation efforts, changes in remediation requirements&#13;and the future availability of alternative clean-up technologies. Although it is reasonably possible that the Company&amp;#146;s exposure&#13;may exceed the amount recorded, any amount of such additional exposures, or range of exposures, is not estimable at this time.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is subject to various legal proceedings, claims&#13;and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements, product liability,&#13;patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to&#13;these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at&#13;this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse&#13;effect, either individually or in the aggregate, on the Company&amp;#146;s consolidated financial statements taken as a whole.&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Guarantees&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In conjunction with divestitures and other transactions,&#13;the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously&#13;existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the&#13;total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it&#13;is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible&#13;payments would not have a material adverse effect, either individually or in the aggregate, on the Company&amp;#146;s consolidated&#13;financial statements taken as a whole.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company had not recorded any liabilities on the aforementioned&#13;indemnifications as of June 30, 2016 and 2015.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company was a party to letters of credit of $10 and $11&#13;as of June 30, 2016 and 2015, respectively, primarily related to one of its insurance carriers, of which $0 had been drawn upon.&lt;/p&gt;</clx:ContingenciesAndGuaranteesDisclosureTextBlock>
    <us-gaap:CommitmentsDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 13. LEASES AND OTHER COMMITMENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company leases various property, plant, and equipment&#13;including office, warehousing, and manufacturing facilities, in addition to certain manufacturing and information technology equipment.&#13;The Company expects that, in the normal course of business, existing contracts will be renewed or replaced by other leases. Rental&#13;expense for all operating leases was $77, $76 and $71 in fiscal years 2016, 2015 and 2014, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The future minimum annual lease commitments required under&#13;the Company&amp;#146;s existing non-cancelable operating and capital lease agreements as of June 30, 2016, were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Operating&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;leases&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Capital&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;leases&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 90%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;328&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;6&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is also a party to certain purchase obligations,&#13;which are defined as purchase agreements that are enforceable and legally binding and that contain specified or determinable significant&#13;terms, including quantity, price and the approximate timing of the transaction. Examples of the Company&amp;#146;s purchase obligations&#13;include contracts to purchase raw materials, commitments to contract manufacturers, commitments for information technology and&#13;related services, advertising contracts, capital expenditure agreements, software acquisition and license commitments and service&#13;contracts. The Company enters into purchase obligations based on expectations of future business needs. For purchase obligations&#13;subject to variable price and/or quantity provisions, an estimate of the price and/or quantity has been made. Many of these purchase&#13;obligations are short term in nature and are flexible to allow for changes in the Company&amp;#146;s business and related requirements.&#13;As of June 30, 2016, the Company&amp;#146;s purchase obligations were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Purchase&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Obligations&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 96%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;150&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;37&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;256 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 15. NET EARNINGS PER SHARE (EPS)&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif"&gt;The following is the reconciliation of&#13;the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted&#13;net EPS for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;129,472&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;130,310&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;129,558&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dilutive effect of stock options and other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,245&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,466&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,184&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;131,717&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;132,776&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;131,742&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="6"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Antidilutive stock options and other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 16. STOCK-BASED COMPENSATION PLANS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In November 2012, the Company&amp;#146;s stockholders voted to&#13;approve the amended and restated 2005 Stock Incentive Plan (the Plan). The Plan permits the Company to grant various nonqualified&#13;stock-based compensation awards, including stock options, restricted stock, performance units, deferred stock units, stock appreciation&#13;rights and other stock-based awards. The primary amendment reflected in the Plan was an increase of approximately 3 million common&#13;shares that may be issued for stock-based compensation purposes. As of June 30, 2016, the Company is authorized to grant up to&#13;approximately 8 million common shares under the Plan, and, as of June 30, 2016, approximately 8 million common shares were available&#13;for grant.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif"&gt;Compensation cost and the related income&#13;tax benefit recognized for stock-based compensation plans were classified as indicated below for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cost of products sold&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Selling and administrative expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Research and development costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total compensation cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;36&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="9"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Related income tax benefit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;13&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Cash received during fiscal years 2016, 2015 and 2014 from&#13;stock options exercised under all stock-based payment arrangements was $180, $230 and $86, respectively. The Company issues shares&#13;for stock-based compensation plans from treasury stock. The Company may repurchase shares under its Evergreen Program to offset&#13;the estimated impact of share dilution related to stock-based awards (see Note 14).&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Details regarding the valuation and accounting for stock&#13;options, restricted stock awards, performance units and deferred stock units for non-employee directors follow.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Stock Options &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif"&gt;The fair value of each stock option award&#13;granted during fiscal years 2016, 2015 and 2014 was estimated on the date of grant using the Black-Scholes valuation model and&#13;assumptions noted in the following table:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected life&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.6 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.6 to 5.8 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average expected life&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.6 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;16.43% to 17.3%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;16.3% to 18.6%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18.4% to 18.5%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17.2%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;16.6%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18.5%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.3% to 1.7%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.4% to 2.0%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.8% to 1.9%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.7%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.9%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.8%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.5% to 2.8%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.8% to 3.4%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.4%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.8%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.3%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.4%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The expected life of the stock options is based on observed&#13;historical exercise patterns. The expected volatility is based on implied volatility from publicly traded options on the Company&amp;#146;s&#13;stock at the date of grant, historical implied volatility of the Company&amp;#146;s publicly traded options and other factors. The&#13;risk-free interest rate is based on the implied yield on a U.S. Treasury zero-coupon issue with a remaining term equal to the expected&#13;term of the option. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price&#13;at the date of grant.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Details of the Company&amp;#146;s stock option activities are&#13;summarized below:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 89%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options outstanding as of June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8,357&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;236&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,317&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(2,633&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cancelled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(214&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;95&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options outstanding as of June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,827&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;366&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="11"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options vested as of June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,555&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;228&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The weighted-average fair value per share of each option&#13;granted during fiscal years 2016, 2015 and 2014, estimated at the grant date using the Black-Scholes option pricing model was $13.21,&#13;$9.65 and $9.69, respectively. The total intrinsic value of options exercised in fiscal years 2016, 2015 and 2014 was $142, $140&#13;and $42, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Stock option awards outstanding as of June 30, 2016, have&#13;been granted at prices that are equal to the market value of the stock on the date of grant. Stock option grants generally vest&#13;over four years and expire no later than ten years after the grant date. The Company recognizes compensation expense ratably over&#13;the vesting period. As of June 30, 2016, there was $16 of total unrecognized compensation cost related to non-vested options, which&#13;is expected to be recognized over a remaining weighted-average vesting period of one year, subject to forfeiture changes.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Restricted Stock Awards&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The fair value of restricted stock awards is estimated on&#13;the date of grant based on the market price of the stock and is amortized to compensation expense on a straight-line basis over&#13;the related vesting periods, which are generally three to four years. The total number of restricted stock awards expected to vest&#13;is adjusted by actual and estimated forfeitures. Restricted stock grants receive dividend distributions earned during the vesting&#13;period upon vesting.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of June 30, 2016, there was $1 of total unrecognized compensation&#13;cost related to non-vested restricted stock awards, which is expected to be recognized over a remaining weighted-average vesting&#13;period of one year. The total fair value of the shares that vested in each of the fiscal years 2016, 2015 and 2014 was $1, respectively.&#13;The weighted-average grant-date fair value of awards granted was $128.91, $95.67 and $89.25 per share for fiscal years 2016, 2015&#13;and 2014, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;A summary of the status of the Company&amp;#146;s restricted&#13;stock awards is presented below:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted-Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Grant Date&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 94%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Restricted stock awards as of June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;91&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;129&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;106&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Restricted stock awards as of June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;108&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Performance Units&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of June 30, 2016, there was $37 in unrecognized compensation&#13;cost related to non-vested performance unit grants that is expected to be recognized over a remaining weighted-average performance&#13;period of one year. The weighted-average grant-date fair value of awards granted was $92.35, $89.75 and $84.45 per share for fiscal&#13;years 2016, 2015 and 2014, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;A summary of the status of the Company&amp;#146;s performance&#13;unit awards is presented below:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted-Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Grant Date&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Performance unit awards as of June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,123&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;92&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Distributed&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(377&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;70&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;87&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Performance unit awards as of June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;952&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;90&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="6"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Performance units vested and deferred as of June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;157&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;58&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The non-vested performance units outstanding as of June 30,&#13;2016 and 2015 were 794,000 and 944,000, respectively, and the weighted average grant date fair value was $95.18 and $81.92 per&#13;share, respectively. Total shares vested during fiscal year 2016 were 354,000, which had a weighted average grant date fair value&#13;per share of $72.11. During fiscal year 2016, $25 of the vested awards was paid by the issuance of shares and $1 of the vested&#13;awards was deferred. Deferred shares continue to earn dividends, which are also deferred. The total fair value of shares vested&#13;was $26, $24 and $0 during fiscal years 2016, 2015 and 2014, respectively. Upon vesting, the recipients of the grants receive the&#13;distribution as shares or, if previously elected by eligible recipients, as deferred stock.&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Deferred Stock Units for Nonemployee Directors&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Nonemployee directors receive annual grants of deferred stock&#13;units under the Company&amp;#146;s director compensation program and can elect to receive all or a portion of their annual retainers&#13;and fees in the form of deferred stock units. The deferred stock units receive dividend distributions, which are reinvested as&#13;deferred stock units, and are recognized at their fair value on the date of grant. Each deferred stock unit represents the right&#13;to receive one share of the Company&amp;#146;s common stock following the completion of a director&amp;#146;s service.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;During fiscal year 2016, the Company granted 13,000 deferred&#13;stock units, reinvested dividends of 6,000 units and distributed 16,000 shares, which had a weighted-average fair value on grant&#13;date of $126.65, $124.03 and $62.70 per share, respectively. As of June 30, 2016, 244,000 units were outstanding, which had a weighted-average&#13;fair value on the grant date of $71.13 per share.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <clx:OtherIncomeExpenseNetDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 17. OTHER (INCOME) EXPENSE, NET&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The major components of Other (income) expense, net, for&#13;the fiscal years ended June 30 were:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 89%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income from equity investees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Low income housing partnership gains, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange transaction losses, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization of trademarks and other intangible assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible asset impairment charges&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In April 2016, the Company sold its Los Angeles bleach manufacturing&#13;facility, previously reported in the Cleaning segment, which resulted in $20 in cash proceeds from investing activities and a gain&#13;of $(11) included in Other in the table above for the year ended June 30, 2016.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;During fiscal year 2016, the Company recognized $9 of intangible&#13;asset impairment charges, of which $6 related to the Aplicare&lt;sup&gt;&amp;#174;&lt;/sup&gt; trademark within the Cleaning segment. The Aplicare&lt;sup&gt;&amp;#174;&lt;/sup&gt;&#13;trademark impairment was recognized based on the anticipated impact on future results from a competitive market entrant.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Investment in Low-Income Housing Partnerships &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company owns, directly or indirectly, limited partnership&#13;interests in low-income housing partnerships, which are accounted for using the equity method of accounting. These partnerships&#13;are considered to be variable interest entities; however, the Company does not consolidate them because it does not have the power&#13;to direct the partnerships&amp;#146; activities that significantly impact their economic performance. The purpose of the partnerships&#13;is to develop and operate low-income housing rental properties. The general partners, who typically hold 1% of the partnership&#13;interests, are third parties unrelated to the Company and its affiliates, and are responsible for controlling and managing the&#13;business and financial operations of the partnerships. As a limited partner, the Company is not responsible for any of the liabilities&#13;and obligations of the partnerships nor do the partnerships or their creditors have any recourse to the Company other than for&#13;the capital requirements. All available tax benefits from low-income housing tax credits provided by the partnerships were claimed&#13;as of fiscal year 2012. The risk that previously claimed low-income housing tax credits might be recaptured or otherwise retroactively&#13;invalidated is considered remote.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In April 2015, a low-income housing partnership, in which&#13;the Company was a limited partner, sold its real estate holdings. The real property sale resulted in $15 in cash proceeds from&#13;investing activities and a gain of $(14) recorded to Other (income) expense, net, on the consolidated statement of earnings for&#13;the year ended June 30, 2015.&lt;/p&gt;</clx:OtherIncomeExpenseNetDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 18. INCOME TAXES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The provision for income taxes on continuing operations,&#13;by tax jurisdiction, consisted of the following for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 85%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Federal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;254&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;265&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;247&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; State&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Foreign&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total current&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;330&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;331&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Federal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; State&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Foreign&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total deferred&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;335&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;315&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;305&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The components of earnings from continuing operations before&#13;income taxes, by tax jurisdiction, consisted of the following for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;United States&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;829&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;754&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;130&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;921&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;884&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;A reconciliation of the statutory federal income tax rate&#13;to the Company&amp;#146;s effective tax rate on continuing operations follows for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 88%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Statutory federal tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;35.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;35.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;35.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;State taxes (net of federal tax benefits)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Tax differential on foreign earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(0.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(0.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Domestic manufacturing deduction&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2.4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Change in valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effective tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Applicable U.S. income taxes and foreign withholding taxes&#13;have not been provided on approximately $216 of undistributed earnings of certain foreign subsidiaries as of June 30, 2016, because&#13;these earnings are considered indefinitely reinvested. The estimated net federal income tax liability that could arise if these&#13;earnings were not indefinitely reinvested is approximately $56. Applicable U.S. income and foreign withholding taxes are provided&#13;on these earnings in the periods in which they are no longer considered indefinitely reinvested.&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Tax benefits resulting from stock-based payment arrangements&#13;that are in excess of the tax benefits recorded in net earnings over the vesting period of those arrangements (excess tax benefits)&#13;are recorded as increases to Additional paid-in capital. Excess tax benefits of approximately $51, $42, and $11 were realized and&#13;recorded to Additional paid-in capital for fiscal years 2016, 2015 and 2014, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The components of net deferred tax assets (liabilities) as&#13;of June 30 are shown below:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 12pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 90%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred tax assets &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Compensation and benefit programs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;191&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Basis difference related to Venture Agreement&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Accruals and reserves&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;43&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Inventory costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Net operating loss and tax credit carryforwards&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;48&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Subtotal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;380&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;385&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;343&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;351&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="9"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred tax liabilities &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Fixed and intangible assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(325&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(277&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Low-income housing partnerships&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(22&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Unremitted foreign earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total deferred tax liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (389&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (330&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Net deferred tax assets (liabilities)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;(a) &lt;/sup&gt;The Company prospectively adopted ASU No.&#13;2015-17, "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes," requiring all deferred tax assets and liabilities&#13;to be classified as noncurrent. See Note 1 for further details.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company periodically reviews its deferred tax assets&#13;for recoverability. A valuation allowance is established when the Company believes that it is more likely than not that some portion&#13;of its deferred tax assets will not be realized. Valuation allowances have been provided to reduce deferred tax assets to amounts&#13;considered recoverable. Details of the valuation allowance were as follows as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 12pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Valuation allowance at beginning of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(51&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net decrease/(increase) for other foreign deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net decrease/(increase) for foreign net operating loss carryforwards and tax credits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Valuation allowance at end of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of June 30, 2016, the Company had foreign tax credit carryforwards&#13;of $15 for U.S. income tax purposes with expiration dates between fiscal years 2024 and 2025. Tax credit carryforwards in foreign&#13;jurisdictions of $19 have expiration dates in fiscal year 2031. Tax credit carryforwards in foreign jurisdictions of $1 can be&#13;carried forward indefinitely. Tax benefits from foreign net operating loss carryforwards of $16 have expiration dates between fiscal&#13;years 2017 and 2036. Tax benefits from foreign net operating loss carryforwards of $12 can be carried forward indefinitely.&lt;b&gt;&#13;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company files income tax returns in the U.S. federal&#13;and various state, local and foreign jurisdictions. The federal statute of limitations has expired for all tax years through June&#13;30, 2012. Various income tax returns in state and foreign jurisdictions are currently in the process of examination.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company recognizes interest and penalties related to&#13;uncertain tax positions as a component of income tax expense. As of June 30, 2016 and 2015, the total balance of accrued interest&#13;and penalties related to uncertain tax positions was $3 and $10, respectively. Interest and penalties related to uncertain tax&#13;positions included in income tax expense resulted in a net benefit of $1, a net benefit of $1, and a net expense of $3 in fiscal&#13;years 2016, 2015 and 2014, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following is a reconciliation of the beginning and ending&#13;amounts of the Company&amp;#146;s gross unrecognized tax benefits:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 85%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Unrecognized tax benefits at beginning of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;71&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gross increases - tax positions in prior periods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gross decreases - tax positions in prior periods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gross increases - current period tax positions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gross decreases - current period tax positions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Lapse of applicable statute of limitations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Settlements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Unrecognized tax benefits at end of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;71&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Included in the balance of unrecognized tax benefits as of&#13;June 30, 2016, 2015 and 2014, are potential benefits of $27, $27 and $58, respectively, which if recognized, would affect net earnings.&#13;During the fiscal year ended June 30, 2015, $32 of gross unrecognized tax benefits relating to other discontinued operations for&#13;periods prior to fiscal year 2015 were recognized upon the expiration of the applicable statute of limitations. Recognition of&#13;these previously disclosed tax benefits had no impact on the Company&amp;#146;s cash flow or earnings from continuing operations for&#13;the fiscal years ended June 30, 2016, 2015 and 2014.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 19. EMPLOYEE BENEFIT PLANS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Income Plans&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Effective July 1, 2011, and as part of a set of long-term,&#13;cost-neutral enhancements to the Company&amp;#146;s overall employee benefit plans, the domestic qualified retirement income pension&#13;plan was frozen for service accrual and eligibility purposes for most participants, however, interest credits have continued to&#13;accrue on participant balances. As of June 30, 2016 and 2015, the benefits of the domestic pension plan are based on either employee&#13;years of service and compensation or a stated dollar amount per year of service. The Company is the sole contributor to the plan&#13;in amounts deemed necessary to provide benefits and to the extent deductible for federal income tax purposes. Assets of the plan&#13;consist primarily of investments in cash equivalents and common collective trusts.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company contributed $15 to its domestic qualified pension&#13;plan during fiscal year 2016. No contributions were made in fiscal year 2015 and 2014. The Company&amp;#146;s funding policy for its&#13;qualified plans is to contribute amounts sufficient to meet minimum funding requirements as set forth in employee benefit tax laws&#13;plus additional amounts as the Company may determine to be appropriate. Subsequent to June 30, 2016, the Company made a $15 discretionary&#13;contribution to the pension plan.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Contributions made to the domestic non-qualified pension&#13;plans were $16, $13 and $13 in fiscal years 2016, 2015 and 2014, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Health Care Plans&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company provides certain health care benefits for employees&#13;who meet age, participation and length of service requirements at retirement. The plans pay stated percentages of covered expenses&#13;after annual deductibles have been met or stated reimbursements up to a specified dollar subsidy amount. Benefits paid take into&#13;consideration payments by Medicare for the domestic plan. The plans are funded as claims are paid, and the Company has the right&#13;to modify or terminate certain plans.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The assumed domestic health care cost trend rate used in&#13;measuring the accumulated benefit obligation (ABO) was 6.75% for both medical and prescription drugs for fiscal year 2016. These&#13;rates have been assumed to gradually decrease each year until an assumed ultimate trend of 4.5% is reached in 2037. The health&#13;care cost trend rate assumption has a minimal effect on the amounts reported due primarily to the existence of benefit cap provisions&#13;in the Company&amp;#146;s domestic plan. As such, the effect of a hypothetical 100 basis point increase or decrease in the assumed&#13;domestic health care cost trend rate on the total service and interest cost components as well as the postretirement benefit obligation&#13;would have been immaterial for each of the fiscal years ended June 30, 2016, 2015 and 2014.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial Information Related to Retirement Income and&#13;Retirement Health Care &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Summarized information for the Company&amp;#146;s retirement&#13;income and retirement health care plans as of and for the fiscal years ended June 30 is as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 80%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Change in benefit obligations:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Projected benefit obligation as of beginning of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;639&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;641&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Service cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Interest cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Actuarial loss (gain)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;51&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Plan amendments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Translation and other adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Benefits paid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Projected benefit obligation as of end of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;673&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;639&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;47&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Change in plan assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Fair value of assets as of beginning of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;409&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;432&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Actual return on plan assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Employer contributions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Benefits paid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Translation and other adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fair value of plan assets as of end of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;423&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;409&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued benefit cost, net funded status&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(230&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(47&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="17"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amount recognized in the balance sheets consists of:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Pension benefit assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Current accrued benefit liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Non-current accrued benefit liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(237&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(216&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Accrued benefit cost, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(230&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(47&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Retirement income plans with ABO in excess of plan assets&#13;as of June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Pension Plans&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Plans&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 84%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Projected benefit obligation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;575&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;538&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 80&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accumulated benefit obligation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;574&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;538&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;80&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fair value of plan assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;399&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;385&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The ABO for all pension plans was $596, $559 and $563 as&#13;of June 30, 2016, 2015 and 2014, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The net costs of the retirement income and health care plans&#13;for the fiscal years ended June 30 included the following components:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="10" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 72%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Service cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;27&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected return on plan assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization of unrecognized items&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Items not yet recognized as a component of postretirement&#13;expense as of June 30, 2016, consisted of:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 91%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net actuarial loss (gain)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;296&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Prior service benefit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net deferred income tax (assets) liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (111&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accumulated other comprehensive loss (income)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Net actuarial loss (gain) recorded in Accumulated other comprehensive&#13;net (losses) income for the fiscal year ended June 30, 2016, included the following:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 90%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net actuarial loss (gain) as of beginning of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 264&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization during the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Loss (gain) during the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net actuarial loss (gain) as of end of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;296&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company uses the straight-line amortization method for&#13;unrecognized prior service costs and benefits. In fiscal year 2017, the Company expects to recognize, on a pre-tax basis, $11 of&#13;the net actuarial loss as a component of net periodic benefit cost for the Pension Plans. In addition, in fiscal year 2017, the&#13;Company expects to recognize, on a pre-tax basis, $1 of the net actuarial gain as a component of net periodic benefit cost for&#13;the retirement health care plans.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average assumptions used to estimate the actuarial&#13;present value of benefit obligations as of June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 84%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Discount rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Rate of compensation increase&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;n/a&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;n/a&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average assumptions used to estimate the net periodic&#13;pension and other postretirement benefit costs as of June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 88%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Discount rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Rate of compensation increase&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected return on plan assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="10"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Discount rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The expected long-term rate of return assumption is based&#13;on an analysis of historical experience of the portfolio and the summation of prospective returns for each asset class in proportion&#13;to the fund&amp;#146;s current asset allocation.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Expected benefit payments for the Company&amp;#146;s pension&#13;and other postretirement plans as of June 30, 2016, were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 93%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fiscal years 2022 through 2026&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Expected benefit payments are based on the same assumptions&#13;used to measure the benefit obligations and include estimated future employee service.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The target allocations and weighted average asset allocations&#13;by asset category of the investment portfolio for the Company&amp;#146;s domestic retirement income plans as of June 30 were:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;% Target Allocation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;% of Plan Assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 85%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. equity&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;International equity&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fixed income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The target asset allocation is determined based on the optimal&#13;balance between risk and return and, at times, may be adjusted to achieve the plan&amp;#146;s overall investment objective to generate&#13;sufficient resources to pay current and projected plan obligations over the life of the domestic qualified retirement income plan.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table sets forth by level within the fair value&#13;hierarchy, the retirement income plans&amp;#146; assets carried at fair value as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 89%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 2%; border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Common collective trusts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Bond funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;307&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;307&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; International equity funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;56&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;56&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Domestic equity funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;44&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Real estate fund&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total common collective trusts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;421&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;421&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total assets at fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;421&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;423&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="10"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Common collective trusts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Bond funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;295&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;295&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; International equity funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;59&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;59&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Domestic equity funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Real estate fund&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total common collective trusts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;406&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;406&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total assets at fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;406&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;409&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The carrying value of cash equivalents approximates its fair&#13;value as of June 30, 2016 and 2015.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Common collective trust funds are not publicly traded and,&#13;therefore, are classified as Level 2. They are valued at a net asset value unit price determined by the portfolio&amp;#146;s sponsor&#13;based on the fair value of underlying assets held by the common collective trust fund on June 30, 2016 and 2015.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The common collective trusts are invested in various trusts&#13;that attempt to achieve their investment objectives by investing primarily in other collective investment funds which have characteristics&#13;consistent with each trust&amp;#146;s overall investment objective and strategy.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Defined Contribution Plans&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company has defined contribution plans for most of its&#13;domestic employees. The plans include The Clorox Company 401(k) Plan, The Clorox Company 2011 Nonqualified Defined Contribution&#13;Plan and the Executive Retirement Plan. The aggregate cost of the domestic defined contribution plans was $45, $45 and $43 in fiscal&#13;years 2016, 2015 and 2014, respectively. Included in the aggregate cost was the cost of The Clorox Company 401(k) Plan of $41,&#13;$42 and $38 in fiscal years 2016, 2015 and 2014, respectively. The Company also has defined contribution plans for certain international&#13;employees. The aggregate cost of these foreign plans was $3 for the fiscal years ended June 30, 2016, 2015 and 2014.&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 20. SEGMENT REPORTING&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company operates through strategic business units that&#13;are aggregated into the following four reportable segments based on the economics and nature of the products sold:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 8pt; padding-left: 15pt; width: 1%"&gt;&lt;font style="font-size: 9.5pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 99%"&gt;&lt;i&gt;Cleaning&lt;/i&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt; consists of laundry, home care and professional products marketed and sold in the United States. Products within this segment include laundry additives, including bleach products under the Clorox&lt;sup&gt;&amp;#174;&lt;/sup&gt; brand and Clorox 2&lt;sup&gt;&amp;#174;&lt;/sup&gt; stain fighter and color booster; home care products, primarily under the Clorox&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Formula 409&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Liquid-Plumr&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Pine-Sol&lt;sup&gt;&amp;#174;&lt;/sup&gt;, S.O.S&lt;sup&gt;&amp;#174;&lt;/sup&gt; and Tilex&lt;sup&gt;&amp;#174;&lt;/sup&gt; brands; naturally derived products under the Green Works&lt;sup&gt;&amp;#174;&lt;/sup&gt; brand; and professional cleaning and disinfecting products under the Clorox&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Dispatch&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Aplicare&lt;sup&gt;&amp;#174;&lt;/sup&gt;, HealthLink&lt;sup&gt;&amp;#174;&lt;/sup&gt; and Clorox Healthcare&lt;sup&gt;&amp;#174;&lt;/sup&gt; brands.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 8pt; padding-left: 15pt"&gt;&lt;font style="font-size: 9.5pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;i&gt;Household&lt;/i&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt; consists of charcoal, cat litter, digestive health products and bags, wraps and container products marketed and sold in the United States. Products within this segment include charcoal products under the Kingsford&lt;sup&gt;&amp;#174;&lt;/sup&gt; and Match Light&lt;sup&gt;&amp;#174;&lt;/sup&gt; brands; cat litter products under the Fresh Step&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Scoop Away&lt;sup&gt;&amp;#174;&lt;/sup&gt; and Ever Clean&lt;sup&gt;&amp;#174;&lt;/sup&gt; brands; digestive health products under the Renew Life&lt;sup&gt;&amp;#174;&lt;/sup&gt; brand; and bags, wraps and containers under the Glad&lt;sup&gt;&amp;#174;&lt;/sup&gt; brand.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 8pt; padding-left: 15pt"&gt;&lt;font style="font-size: 9.5pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;i&gt;Lifestyle&lt;/i&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt; consists of food products, water-filtration systems and filters and natural personal care products marketed and sold in the United States. Products within this segment include dressings and sauces, primarily under the Hidden Valley&lt;sup&gt;&amp;#174;&lt;/sup&gt;, KC Masterpiece&lt;sup&gt;&amp;#174;&lt;/sup&gt; and Soy Vay&lt;sup&gt;&amp;#174;&lt;/sup&gt; brands; water-filtration systems and filters under the Brita&lt;sup&gt;&amp;#174;&lt;/sup&gt; brand; and natural personal care products under the Burt&amp;#146;s Bees&lt;sup&gt;&amp;#174;&lt;/sup&gt; brand.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 8pt; padding-left: 15pt"&gt;&lt;font style="font-size: 9.5pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;i&gt;International&lt;/i&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt; consists of products sold outside the United States. Products within this segment include laundry, home care, water-filtration, digestive health products, charcoal and cat litter products, dressings and sauces, bags, wraps and containers and natural personal care products, primarily under the Clorox&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Glad&lt;sup&gt;&amp;#174;&lt;/sup&gt;, PinoLuz&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Ayudin&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Limpido&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Clorinda&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Poett&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Mistolin&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Lestoil&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Bon Bril&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Brita&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Green Works&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Pine-Sol&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Agua Jane&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Chux&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Renew Life&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Kingsford&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Fresh Step&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Scoop Away&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Ever Clean&lt;sup&gt;&amp;#174;&lt;/sup&gt;, KC Masterpiece&lt;sup&gt;&amp;#174;&lt;/sup&gt;, Hidden Valley&lt;sup&gt;&amp;#174;&lt;/sup&gt; and Burt&amp;#146;s Bees&lt;sup&gt;&amp;#174;&lt;/sup&gt; brands.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Certain non-allocated administrative costs, interest income,&#13;interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash&#13;and cash equivalents, property and equipment, other investments and deferred taxes.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Cleaning&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Household&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Lifestyle&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;International&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Corporate&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Company&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 77%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;Net sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,912&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,862&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;990&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;997&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5,761&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,824&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,794&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;950&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,087&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5,655&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,776&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;936&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,093&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5,514&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Earnings (losses) from continuing&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;operations before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;511&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;66&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(273&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;983&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;445&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;375&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;257&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(235&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;921&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;258&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;99&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(227&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;884&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;Income from equity investees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;15&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;14&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;13&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,092&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;880&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,057&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;606&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,518&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;876&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;725&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;860&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,057&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;646&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,164&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;Capital expenditures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;172&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;125&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;53&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;137&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation and amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;60&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;165&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;67&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;169&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;67&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;177&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;Significant noncash charges included&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;in earnings (losses) from continuing&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;operations before income taxes:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #ffffff"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Share-based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;45&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #ffffff"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;32&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #ffffff"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;36&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;All intersegment sales are eliminated and are not included&#13;in the Company&amp;#146;s reportable segments&amp;#146; net sales.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Net sales to the Company&amp;#146;s largest customer, Walmart&#13;Stores, Inc. and its affiliates, were 27%, 26% and 27% of consolidated net sales for each of the fiscal years ended June 30, 2016,&#13;2015 and 2014, respectively, and occurred in each of the Company&amp;#146;s reportable segments. No other customers accounted for more&#13;than 10% of consolidated net sales in any of these fiscal years. During fiscal years 2016, 2015 and 2014, the Company&amp;#146;s five&#13;largest customers accounted for 46%, 45%, and 45% of its consolidated net sales for each of the three fiscal years, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Three of the Company&amp;#146;s product lines have accounted&#13;for 10% or more of consolidated net sales during each of the past three fiscal years. In fiscal years 2016, 2015 and 2014, sales&#13;of liquid bleach represented approximately 13%, 14% and 13% of the Company&amp;#146;s consolidated net sales, respectively, approximately&#13;25%, 26%, and 26% of net sales in the Cleaning segment for each such years, respectively, and approximately 27%, 27% and 28% of&#13;net sales in the International segment, respectively. Sales of trash bags represented approximately 13%, 14% and 13% of the Company&amp;#146;s&#13;consolidated net sales in each of the fiscal years 2016, 2015 and 2014, respectively, and approximately 37%, 38% and 36% of net&#13;sales in the Household segment, respectively, for each such years. Sales of charcoal represented approximately 11% of the Company&amp;#146;s&#13;consolidated net sales and approximately 34% of net sales in the Household segment in fiscal years 2016, 2015 and 2014.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Net sales and property, plant and equipment, net, by geographic&#13;area as of and for the fiscal years ended June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;United&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;States&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Company&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 90%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,805&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;956&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,761&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,609&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,046&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,655&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,466&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,048&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,514&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Property, plant and equipment, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;799&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;107&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;906&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;801&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;117&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;918&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 21. RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company holds various equity investments with ownership&#13;percentages of up to 50% in a number of consumer products businesses, most of which operate outside the United States. The equity&#13;investments, presented in Other assets accounted for under the equity method, were $59 as of the fiscal years ended June 30, 2016&#13;and 2015. The Company has no ongoing capital commitments, loan requirements, guarantees or any other types of arrangements under&#13;the terms of its agreements that would require any future cash contributions or disbursements arising out of an equity investment.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Transactions with the Company&amp;#146;s equity investees typically&#13;represent payments for contract manufacturing and purchases of raw materials. Payments to related parties, including equity investees,&#13;for such transactions during the fiscal years ended June 30, 2016, 2015 and 2014 were $57, $55 and $57, respectively. Receipts&#13;from and ending accounts receivable and payable balances related to the Company&amp;#146;s related parties were not significant during&#13;or as of the end of each of the fiscal years presented.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 22. UNAUDITED QUARTERLY DATA&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Dollars in millions, except market price and per share data&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="17" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Quarters Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September 30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;March 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;June 30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total Year&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 82%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal year ended June 30, 2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Net sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,390&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,345&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,426&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;5,761&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Cost of products sold&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;765&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;745&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;780&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;873&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;3,163&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Earnings from continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;173&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;151&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;165&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;648&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(Losses) earnings from discontinued operations,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Net earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;172&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;162&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;165&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;648&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Per common share:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;5.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Discontinued operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic net earnings per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;5.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Discontinued operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Diluted net earnings per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Dividends declared per common share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;3.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Market price (NYSE)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;High&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;119.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;131.78&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;132.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;138.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;138.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Low&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;104.26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;114.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;122.40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;119.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;104.26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year-end&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;138.39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal year ended June 30, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Net sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,352&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,345&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,401&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,557&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;5,655&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Cost of products sold&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;774&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;773&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;796&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;847&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;3,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Earnings from continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;145&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;128&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;144&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;189&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;606&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Losses from discontinued operations,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Net earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;90&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;125&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;174&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;191&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;580&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Per common share:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.98&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Discontinued operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.22&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic net earnings per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.48&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.97&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.57&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Discontinued operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.22&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Diluted net earnings per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.68&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.95&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Dividends declared per common share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;2.99&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="19" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Market price (NYSE)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;High&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;112.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;112.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;106.36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;98.31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;112.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Low&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;103.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;102.95&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;95.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;86.03&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;86.03&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year-end&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;104.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Dollars&#13;in millions) &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Column A&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Column B&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Column C&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Column D&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Column E&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Deductions&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal"&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;beginning&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;of period&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Charged to&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;costs and&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;expenses&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Credited to&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;costs and&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;expenses&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Credited&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;to other&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;accounts&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;end&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;of period&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 82%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Allowance for doubtful accounts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year ended June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year ended June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year ended June 30, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;LIFO allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year ended June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year ended June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year ended June 30, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Valuation allowance on deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year ended June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year ended June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(51&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year ended June 30, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(51&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Nature of Operations and Basis of Presentation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is principally engaged in the production, marketing&#13;and sales of consumer products through mass retail outlets and grocery, e-commerce channels, wholesale distributors and medical&#13;supply distributors. The consolidated financial statements include the statements of the Company and its wholly owned and controlled&#13;subsidiaries. All significant intercompany transactions and accounts were eliminated in consolidation. Certain prior year reclassifications&#13;were made in the consolidated financial statements and related notes to the consolidated financial statements to conform to the&#13;current year presentation.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Effective September 22, 2014, the Company&amp;#146;s Venezuela&#13;affiliate, Corporaci&amp;#243;n Clorox de Venezuela S.A. (Clorox Venezuela), discontinued its operations. Consequently, the Company&#13;presents the financial results of Clorox Venezuela as a discontinued operation in the consolidated financial statements for all&#13;periods presented herein.&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The preparation of these consolidated financial statements&#13;in conformity with generally accepted accounting principles in the United States of America (U.S. GAAP) requires management to&#13;reach opinions as to estimates and assumptions that affect reported amounts and related disclosures. Specific areas requiring management&amp;#146;s&#13;opinion on estimates and judgments include assumptions pertaining to accruals for consumer and trade-promotion programs, stock-based&#13;compensation costs, pension and post-employment benefit costs, future cash flows associated with impairment testing of goodwill&#13;and other long-lived assets, the credit worthiness of customers, uncertain tax positions, tax valuation allowances and legal, environmental&#13;and insurance matters. Actual results could materially differ from estimates and assumptions made.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Cash equivalents consist of highly liquid instruments, time&#13;deposits and money market funds with an initial maturity at purchase of three months or less. The fair value of cash and cash equivalents&#13;approximates the carrying amount.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company&amp;#146;s cash position includes amounts held by&#13;foreign subsidiaries and, as a result, the repatriation of certain cash balances from some of the Company&amp;#146;s foreign subsidiaries&#13;could result in additional tax costs in the United States and in certain foreign jurisdictions. However, these cash balances are&#13;generally available without legal restriction to fund local business operations. In addition, a portion of the Company&amp;#146;s cash&#13;balance is held in U.S. dollars by foreign subsidiaries, whose functional currency is their local currency. Such U.S. dollar balances&#13;are reported on the foreign subsidiaries&amp;#146; books, in their functional currency, with the impact from foreign currency exchange&#13;rate differences recorded in Other (income) expense, net. The Company&amp;#146;s cash holdings were as follows as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;249&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;221&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;142&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;401&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;382&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of June 30, 2016 and 2015, the Company had $4 and $3 of&#13;restricted cash, respectively, which is primarily related to fiscal year 2012 acquisitions. Restricted cash was included in Other&#13;assets as of June 30, 2016 and in Other current assets as of June 30, 2015.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Inventories&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Inventories are stated at the lower of cost or market. When&#13;necessary, the Company provides allowances to adjust the carrying value of its inventory to the lower of cost or market, including&#13;any costs to sell or dispose. Appropriate consideration is given to obsolescence, excessive inventory levels, product deterioration&#13;and other factors in evaluating net realizable value for the purposes of determining the lower of cost or market.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Property, Plant and Equipment and Finite-Lived Intangible&#13;Assets&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Property, plant and equipment and finite-lived intangible&#13;assets are stated at cost. Depreciation and amortization expense are calculated by the straight-line method using the estimated&#13;useful lives or lives determined by lease contracts for the related assets. The table below provides estimated useful lives of&#13;property, plant and equipment by asset classification.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 99%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Useful Lives&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Buildings and leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10 - 40 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Land improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10 - 30 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Machinery and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 - 15 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 - 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Capitalized software costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 - 7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Property, plant and equipment and finite-lived intangible&#13;assets are reviewed for impairment whenever events or changes in circumstances occur that indicate that the carrying amount of&#13;an asset (or asset group) may not be fully recoverable. The risk of impairment is initially assessed based on an estimate of the&#13;undiscounted cash flows at the lowest level for which identifiable cash flows exist. Impairment occurs when the carrying value&#13;of the asset exceeds the estimated future undiscounted cash flows generated by the asset. When impairment is indicated, an impairment&#13;charge is recorded for the difference between the carrying value of the asset and its estimated fair market value. Depending on&#13;the asset, estimated fair market value may be determined either by use of a discounted cash flow model or by reference to estimated&#13;selling values of assets in similar condition.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:InternalUseSoftwarePolicy contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Capitalization of Software Costs &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company capitalizes certain qualifying costs incurred&#13;in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest&#13;and payroll and payroll-related costs for employees during the application development stage. Internal and external costs incurred&#13;during the preliminary project stage and post implementation-operation stage, mainly training and maintenance costs, are expensed&#13;as incurred. Once the application is substantially complete and ready for its intended use, qualifying costs are amortized on a&#13;straight-line basis over the software&amp;#146;s estimated useful life.&lt;/p&gt;</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Impairment Review of Goodwill and Indefinite-Lived Intangible&#13;Assets&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company tests its goodwill, trademarks with indefinite&#13;lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications&#13;during a different interim period that these assets may have become impaired.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;With respect to goodwill, the Company has the option to first&#13;assess qualitative factors such as maturity and stability of the reporting unit, magnitude of excess fair value over carrying value&#13;from the prior year&amp;#146;s impairment testing, other reporting unit specific operating results as well as new events and circumstances&#13;impacting the operations at the reporting unit level. If the result of a qualitative test indicates a potential for impairment&#13;of a reporting unit, a quantitative test is performed. The quantitative test is a two-step process. In the first step, the Company&#13;compares the estimated fair value of the reporting unit to its carrying value. In all instances, the estimated fair value exceeded&#13;the carrying value of the reporting unit. Had the estimated fair value of any reporting unit been less than its carrying value,&#13;the Company would have performed a second step to determine the implied fair value of the reporting unit&amp;#146;s goodwill. If the&#13;carrying amount of a reporting unit&amp;#146;s goodwill had exceeded its implied fair value, an impairment charge would have been recorded&#13;for the difference between the carrying amount and the implied fair value of the reporting unit&amp;#146;s goodwill.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;To determine the fair value of a reporting unit as part of&#13;its quantitative test, the Company uses a discounted cash flow (DCF) approach, as it believes that this approach is the most reliable&#13;indicator of the fair value of its businesses and the fair value of their future earnings and cash flows. Under this approach,&#13;the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects&#13;their relative risk. The cash flows used in the DCF are consistent with those the Company uses in its internal planning, which&#13;gives consideration to actual business trends experienced, and the broader business strategy for the long term. The other key estimates&#13;and factors used in the DCF include, but are not limited to, future sales volumes, revenue and expense growth rates, changes in&#13;working capital, foreign exchange rates, currency devaluation, inflation and a perpetuity growth rate. Changes in such estimates&#13;or the application of alternative assumptions could produce different results.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;For trademarks and other intangible assets with indefinite&#13;lives, the Company performs a quantitative analysis to test for impairment. When a quantitative test is performed, the estimated&#13;fair value of an asset is compared to its carrying amount. If the carrying amount of such asset exceeds its estimated fair value,&#13;an impairment charge is recorded for the difference between the carrying amount and the estimated fair value. The Company uses&#13;the income approach to estimate the fair value of its trademarks and other intangible assets with indefinite lives. This approach&#13;requires significant judgments in determining both the assets&amp;#146; estimated cash flows as well as the appropriate discount and&#13;foreign exchange rates applied to those cash flows to determine fair value. Changes in such estimates or the use of alternative&#13;assumptions could produce different results.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Stock-based Compensation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company grants various nonqualified stock-based compensation&#13;awards to eligible employees, including stock options and performance units.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;For stock options, the Company estimates the fair value of&#13;each award on the date of grant using the Black-Scholes valuation model, which requires management to make estimates regarding&#13;expected option life, stock price volatility and other assumptions. Groups of employees that have similar historical exercise behavior&#13;are considered separately for valuation purposes. The Company estimates stock option forfeitures based on historical data for each&#13;employee grouping. The total number of stock options expected to vest is adjusted by actual and estimated forfeitures. Changes&#13;to the actual and estimated forfeitures will result in a cumulative catch-up adjustment in the period of change. Compensation expense&#13;is recorded by amortizing the grant date fair values on a straight-line basis over the vesting period, adjusted for estimated forfeitures.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company&amp;#146;s performance unit grants provide for the&#13;issuance of common stock to certain managerial staff and executive management if the Company achieves specified performance targets.&#13;The number of shares issued are dependent upon vesting and the achievement of specified performance targets. The performance period&#13;is three years and the payout determination is made at the end of the three-year performance period. Performance unit grants receive&#13;dividends earned during the vesting period upon vesting. The fair value of each grant issued is estimated on the date of grant&#13;based on the current market price of the stock. The total amount of compensation expense recognized reflects estimated forfeiture&#13;rates and the initial assumption that performance goals will be achieved. Compensation expense is adjusted based on management&amp;#146;s&#13;assessment of the probability that performance goals will be achieved. If such goals are not met or it is determined that achievement&#13;of performance goals is not probable, previously recognized compensation expense is trued up in the current period to reflect the&#13;expected payout level. If it is determined that the performance goals will be exceeded, additional compensation expense is recognized,&#13;subject to a cap of 150%.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Cash flows resulting from tax deductions in excess of the&#13;cumulative compensation cost recognized for stock-based payment arrangements (excess tax benefits) are primarily classified as&#13;financing cash inflows.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <clx:EmployeeBenefitsPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Employee Benefits&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company accounts for its defined benefit retirement income&#13;and retirement health care plans using actuarial methods&lt;i&gt;.&lt;/i&gt; These methods use an attribution approach that generally spreads&#13;&amp;#147;plan events&amp;#148; over the service lives or expected lifetime (for frozen plans) of plan participants. Examples of plan events&#13;are plan amendments and changes in actuarial assumptions such as the expected return on plan assets, discount rate, rate of compensation&#13;increase and certain employee-related factors, such as retirement age and mortality. The principle underlying the attribution approach&#13;is that employees render service over their employment period on a relatively &amp;#147;smooth&amp;#148; basis and, therefore, the statement&#13;of earnings effects of retirement income and retirement health care plans are recognized in the same pattern. One of the principal&#13;assumptions used in the net periodic benefit cost calculation is the expected return on plan assets. The required use of an expected&#13;return on plan assets may result in recognized pension expense or income that differs from the actual returns of those plan assets&#13;in any given year. Over time, however, the goal is for the expected long-term returns to approximate the actual returns and, therefore,&#13;the expectation is that the pattern of income and expense recognition should closely match the pattern of the services provided&#13;by the participants. The Company uses a market-related value method for calculating plan assets for purposes of determining the&#13;amortization of actuarial gains and losses. The differences between actual and expected returns are recognized in the net periodic&#13;benefit cost calculation over the average remaining service period or expected lifetime (for frozen plans) of the plan participants&#13;using the corridor approach. Under this approach, only actuarial gains (losses) that exceed 5% of the greater of the projected&#13;benefit obligation or the market-related value of assets are amortized to pension expense by the Company. In developing its expected&#13;return on plan assets, the Company considers the long-term actual returns relative to the mix of investments that comprise its&#13;plan assets and also develops estimates of future investment returns by considering external sources.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company recognizes an actuarial-based obligation at the&#13;onset of disability for certain benefits provided to individuals after employment, but before retirement, that include medical,&#13;dental, vision, life and other benefits.&lt;/p&gt;</clx:EmployeeBenefitsPolicyTextBlock>
    <us-gaap:EnvironmentalCostsPolicy contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Environmental Costs&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is involved in certain environmental remediation&#13;and ongoing compliance activities. Accruals for environmental matters are recorded on a site-by-site basis when it is probable&#13;that a liability has been incurred and based upon a reasonable estimate of the liability. The Company&amp;#146;s accruals reflect the&#13;anticipated participation of other potentially responsible parties in those instances where it is probable that such parties are&#13;legally responsible and financially capable of paying their respective shares of the relevant costs. These accruals are adjusted&#13;periodically as assessment and remediation efforts progress or as additional technical or legal information become available. Actual&#13;costs to be incurred at identified sites in future periods may vary from the estimates, given the inherent uncertainties in evaluating&#13;environmental exposures. The accrual for environmental matters is included in Accounts payable and accrued liabilities and Other&#13;liabilities in the Company&amp;#146;s consolidated balance sheets on an undiscounted basis due to uncertainty regarding the timing&#13;of future payments.&lt;/p&gt;</us-gaap:EnvironmentalCostsPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Sales are recognized as revenue when the risk of loss and&#13;title pass to the customer and when all of the following have occurred: a firm sales arrangement exists, pricing is fixed or determinable&#13;and collection is reasonably assured. Sales are recorded net of allowances for trade promotions, coupons, returns and other discounts.&#13;The Company routinely commits to one-time or ongoing trade-promotion programs with customers and consumer coupon programs that&#13;require the Company to estimate and accrue the expected costs of such programs. Programs include shelf price reductions, end-of-aisle&#13;or in-store displays of the Company&amp;#146;s products and graphics and other trade-promotion activities conducted by the customer.&#13;Coupons are recognized as a liability when distributed based upon expected consumer redemptions. The Company maintains liabilities&#13;related to these programs for the estimated expenses incurred, but not paid, at the end of each period. Trade-promotion and coupon&#13;redemption costs are recorded as a reduction of sales.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company provides an allowance for doubtful accounts based&#13;on its historical experience and ongoing assessment of its customers&amp;#146; credit risk. Receivables were presented net of an allowance&#13;for doubtful accounts of $5 and $4 as of June 30, 2016 and 2015, respectively. Receivables, net, included non-customer receivables&#13;of $9 and $12 as of June 30, 2016 and 2015, respectively.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Cost of Products Sold&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Cost of products sold represents the costs directly related&#13;to the manufacture and distribution of the Company&amp;#146;s products and primarily includes raw materials, packaging, contract manufacturing&#13;fees, shipping and handling, warehousing, package design, depreciation, amortization, direct and indirect labor and operating costs&#13;for the Company&amp;#146;s manufacturing and distribution facilities including salary, benefit costs and incentive compensation, and&#13;royalties and other charges related to the Company&amp;#146;s Glad&lt;sup&gt;&amp;#174;&lt;/sup&gt; Venture Agreement (see Note 10).&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Costs associated with developing and designing new packaging&#13;are expensed as incurred and include design, artwork, films and labeling. Expenses for fiscal years ended June 30, 2016, 2015 and&#13;2014 were $11, $11 and $12, respectively, all of which were reflected in Cost of products sold or discontinued operations, as appropriate,&#13;in the consolidated statements of earnings.&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Selling and Administrative Expenses&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Selling and administrative expenses represent costs incurred&#13;by the Company in generating revenues and managing the business and include market research, commissions and certain administrative&#13;expenses. Administrative expenses include salary, benefits, incentive compensation, professional fees and services, software and&#13;licensing fees and other operating costs associated with the Company&amp;#146;s non-manufacturing, non-research and development staff,&#13;facilities and equipment.&lt;/p&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <clx:AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Advertising and Research and Development Costs&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company expenses advertising and research and development&#13;costs in the period incurred.&lt;/p&gt;</clx:AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company uses the asset and liability method to account&#13;for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to&#13;differences between financial statement amounts and their respective tax basis. Management reviews the Company&amp;#146;s deferred&#13;tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established&#13;when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes&#13;in valuation allowances from period to period are included in the Company&amp;#146;s tax provision in the period of change. In addition&#13;to valuation allowances, the Company provides for uncertain tax positions when such tax positions do not meet certain recognition&#13;thresholds or measurement standards. Amounts for uncertain tax positions are adjusted in quarters when new information becomes&#13;available or when positions are effectively settled.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;U.S. income tax expense and foreign withholding taxes are&#13;provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign&#13;earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change&#13;and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company&#13;accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign Currency Transactions and Translation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Local currencies are the functional currencies for substantially&#13;all of the Company&amp;#146;s foreign operations. When the transactional currency is different than the functional currency, transaction&#13;gains and losses are included as a component of Other (income) expense, net. In addition, certain assets and liabilities denominated&#13;in currencies different than a foreign subsidiary&amp;#146;s functional currency are reported on the subsidiary&amp;#146;s books in its&#13;functional currency, with the impact from exchange rate differences recorded in Other (income) expense, net. Assets and liabilities&#13;of foreign operations are translated into U.S. dollars using the exchange rates in effect at the balance sheet date, while income&#13;and expenses are translated at the average monthly exchange rates during the year.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Gains and losses on foreign currency translations are reported&#13;as a component of Other comprehensive income (loss). Deferred taxes are not provided on cumulative translation adjustments where&#13;the Company expects earnings of a foreign subsidiary to be indefinitely reinvested. The income tax effect of currency translation&#13;adjustments related to foreign subsidiaries and joint ventures for which earnings are not considered indefinitely reinvested is&#13;recorded as a component of deferred taxes with an offset to Other comprehensive income (loss).&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Derivative Instruments&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company&amp;#146;s use of derivative instruments, principally&#13;swaps, futures and forward contracts, is limited to non-trading purposes and is designed to partially manage exposure to changes&#13;in commodity prices, interest rates and foreign currencies. The Company&amp;#146;s contracts are hedges for transactions with notional&#13;amounts and periods consistent with the related exposures and do not constitute investments independent of these exposures.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The changes in the fair value (i.e., gains or losses) of&#13;a derivative instrument are recorded as either assets or liabilities in the consolidated balance sheets with an offset to net earnings&#13;or Other comprehensive income (loss) depending on whether, for accounting purposes, it has been designated and qualifies as an&#13;accounting hedge and, if so, on the type of hedging relationship. The criteria used to determine if hedge accounting treatment&#13;is appropriate are: (a) formal designation and documentation of the hedging relationship, the risk management objective and hedging&#13;strategy at hedge inception; (b) eligibility of hedged items, transactions and corresponding hedging instrument; and (c) effectiveness&#13;of the hedging relationship both at inception of the hedge and on an ongoing basis in achieving the hedging objectives. For those&#13;derivative instruments designated and qualifying as hedging instruments, the Company must designate the hedging instrument either&#13;as a fair value hedge or as a cash flow hedge. The Company designates its commodity forward and future contracts for forecasted&#13;purchases of raw materials, interest rate forward contracts for forecasted interest payments, and foreign currency forward contracts&#13;for forecasted purchases of inventory as cash flow hedges. During the fiscal years ended June 30, 2016, 2015 and 2014, the Company&#13;had no hedging instruments designated as fair value hedges.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;For derivative instruments designated and qualifying as cash&#13;flow hedges, the effective portion of gains or losses is reported as a component of Other comprehensive income (loss) and reclassified&#13;into earnings in the same period or periods during which the hedged transaction affects earnings. From time to time, the Company&#13;may have contracts not designated as hedges for accounting purposes, for which it recognizes changes in the fair value in the consolidated&#13;statement of earnings in the current period. Cash flows from hedging activities are classified as operating activities in the consolidated&#13;statements of cash flows.&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Recently Issued Accounting Standards&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In March 2016, the Financial Accounting Standards Board (FASB)&#13;issued Accounting Standards Update (ASU) No. 2016-09, &amp;#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee&#13;Share-Based Payment Accounting,&amp;#148; which simplifies several aspects of the accounting for share-based payment transactions,&#13;including requiring excess tax benefits and deficiencies to be recognized as income tax benefit or expense in the consolidated&#13;statement of earnings and excess tax benefits and deficiencies to be classified as an operating activity in the consolidated statement&#13;of cash flows. The new guidance is effective for the Company beginning in the first quarter of fiscal year 2018, with early adoption&#13;permitted. The Company is planning to adopt the standard in the first quarter of fiscal year 2017. While the actual benefit realized&#13;may vary significantly given the inherent uncertainty in predicting future share-based transactions, the Company currently estimates&#13;that the adoption will result in approximately a 4 percentage point benefit to the Company&amp;#146;s historical effective tax rate&#13;of 34% to 35% for fiscal year 2017.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In February 2016, the FASB issued ASU No. 2016-02, &amp;#147;Leases&#13;(Topic 842),&amp;#148; which requires lessees to recognize a right-of-use asset and lease liability for all leases with terms of more&#13;than 12 months. Recognition, measurement and presentation will depend on classification as a finance or operating lease. ASU 2016-02&#13;also requires expanded disclosures about leasing arrangements. The new guidance is effective for the Company beginning in the first&#13;quarter of fiscal year 2020, with early adoption permitted. The Company is currently evaluating the impact that adoption of this&#13;guidance will have on its consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In November 2015, the FASB issued ASU No. 2015-17, &amp;#147;Income&#13;Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes,&amp;#148; which requires all deferred tax liabilities and assets&#13;to be classified as noncurrent. The Company adopted the standard in the fourth quarter of fiscal year 2016 on a prospective basis&#13;as permitted. Prior period balances have not been retrospectively adjusted.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In April 2015, the Financial Accounting Standards Board (FASB)&#13;issued Accounting Standards Update (ASU) No. 2015-03, &amp;#147;Simplifying the Presentation of Debt Issuance Cost,&amp;#148; which requires&#13;that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the&#13;carrying amount of that debt liability, consistent with debt discounts. The new guidance is effective for the Company beginning&#13;in the first quarter of fiscal year 2017, with early adoption permitted. The Company does not expect the adoption of this guidance&#13;will have a significant impact on its consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;In February 2015, the FASB&#13;issued ASU No. 2015-02,&lt;/font&gt; &amp;#147;&lt;font style="font-size: 10pt"&gt;Amendments to the Consolidation Analysis,&amp;#148; which changes&#13;the guidance for evaluating whether to consolidate certain legal entities. The amendments modify the evaluation of whether limited&#13;partnerships and similar legal entities are variable interest entities ("VIEs") or voting interest entities. The new guidance is&#13;effective for the Company beginning in the first quarter of fiscal year 2017, with early adoption permitted. The Company does not&#13;expect the adoption of this guidance will have a significant impact on its consolidated financial statements. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In May 2014, the FASB issued ASU No. 2014-09, &amp;#147;Revenue&#13;from Contracts with Customers (Topic 606),&amp;#148; which replaces most existing U.S. GAAP revenue recognition guidance and is intended&#13;to improve and converge with international standards the financial reporting requirements for revenue from contracts with customers.&#13;The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services equal to the&#13;amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional disclosures&#13;about the nature, timing and uncertainty of revenue and cash flows arising from contracts with customers, including information&#13;about significant judgments and changes in judgments. The new guidance is effective for the Company beginning in the first quarter&#13;of fiscal year 2019, with the option to early adopt in the first quarter of fiscal year 2018. The Company is currently evaluating&#13;the impact that adoption of this guidance will have on its consolidated financial statements.&lt;/p&gt;</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company&amp;#146;s cash holdings were as follows as of June&#13;30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;249&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;221&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;142&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;401&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;382&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <clx:UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The table below provides estimated useful lives of property,&#13;plant and equipment by asset classification.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 99%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Useful Lives&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Buildings and leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10 - 40 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Land improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10 - 30 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Machinery and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 - 15 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 - 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Capitalized software costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 - 7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</clx:UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock>
    <clx:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table provides a summary of gains (losses)&#13;from discontinued operations for Clorox Venezuela and gains (losses) from discontinued operations other than Clorox Venezuela for&#13;the years ended June 30:&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 88%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Operating losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exit costs and other related expenses for Clorox Venezuela&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(78&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(84&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income tax benefit attributable to Clorox Venezuela&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="13"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gains (losses) from discontinued operations other than&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Losses from discontinued operations, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</clx:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the estimated fair values&#13;of Renew Life&amp;#146;s assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date. Due&#13;to the timing of the acquisition, the fair value of the assets acquired and liabilities assumed are based on a preliminary valuation&#13;and the Company&amp;#146;s estimates and assumptions are subject to change within the measurement period. The primary areas of the&#13;purchase price that are not yet finalized are related to goodwill and income taxes. The weighted-average estimated useful life&#13;of intangible assets subject to amortization is 15 years.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Renew Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 97%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trademarks&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;134&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Customer relationships&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Property, plant and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Working capital, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Purchase Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;290 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Inventories consisted of the following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 93%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Finished goods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;361&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;316&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Raw materials and packaging&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;111&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;101&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Work in process&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;LIFO allowances&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;443&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;385 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Other current assets consisted of the following as of June&#13;30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 94%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred tax assets&lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;99&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Prepaid expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;39&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;143&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;(a) &lt;/sup&gt;The Company prospectively adopted ASU No.&#13;2015-17, "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes," requiring all deferred tax assets and liabilities&#13;to be classified as noncurrent. See Note 1 and 18 for further details.&lt;/p&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The components of property, plant and equipment, net, consisted&#13;of the following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 93%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Machinery and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,607&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,608&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Buildings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;524&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;515&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Capitalized software costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;371&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Land and improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;118&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;122&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Construction in progress&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,817&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,757&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Less: Accumulated depreciation and amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,911&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,839&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;906&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;918 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The changes in the carrying amount of goodwill by reportable&#13;segment for the fiscal years ended June 30, 2016 and 2015 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="16" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Cleaning&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Lifestyle&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Household&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;International&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 83%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance June 30, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;449&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,101&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effect of foreign currency translation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;415&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,067&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Acquisition&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;122&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effect of foreign currency translation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;244&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;207&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;423&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,197 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The changes in the carrying amount of trademarks and other&#13;intangible assets for the fiscal years ended June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of June 30, 2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As of June 30, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amortization&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Net carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amortization&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Net carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 82%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trademarks not subject to amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;647&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt; &lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;647&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;524&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;524&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trademarks subject to amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;22&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;22&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other intangible assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Technology and product formulae&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;134&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;221&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;146&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;188&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;142&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;46&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,037&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;302&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;735&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;882&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;297&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;585 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable and accrued liabilities consisted of the&#13;following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;490&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;431&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Compensation and employee benefit costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;192&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;189&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trade and sales promotion&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;127&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;115&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividends&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;108&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;103&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;118&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;141&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,035&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;979&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;(a) &lt;/sup&gt;Accounts payable and accrued liabilities&#13;were combined into one financial statement line as of June 30, 2016. The change has been retrospectively applied to all periods&#13;presented.&lt;/p&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfShortTermDebtTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable, which mature in less than one year,&#13;included the following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commercial paper&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;522&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;93&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign borrowings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;523&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;95 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Long-term debt, carried at face value net of unamortized&#13;discounts or premiums, included the following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 94%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Senior unsecured notes and debentures:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3.55%, $300 due November 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;300&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;5.95%, $400 due October 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;399&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3.80%, $300 due November 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;298&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;298&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3.05%, $600 due September 2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;599&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;599&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3.50%, $500 due December 2024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,797&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,096&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Less: Current maturities of long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(300&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,797&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,796 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company&amp;#146;s borrowing capacity under other financing&#13;arrangements as of June 30 was as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Revolving credit facility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,100&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign credit lines&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other credit lines&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,128&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,129 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Other liabilities consisted of the following as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Employee benefit obligations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;335&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;299&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Venture agreement terminal obligation, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;302&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;294&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;107&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;119&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;784&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;750 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the fair value of Company&amp;#146;s&#13;assets and liabilities for which disclosure of fair value is required as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance sheet classification&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;hierarchy&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;level&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Investments including money market funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash and cash equivalents &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;234&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;234&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;212&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;212&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Time deposits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash and cash equivalents &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;84&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;84&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trust assets for nonqualified deferred&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;compensation plans&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;335&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;335&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="17"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable &lt;sup&gt;(b)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;523&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;523&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;95&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;95&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; vertical-align: middle"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable and&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;accrued liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; vertical-align: middle"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable and&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;accrued liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; vertical-align: middle"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current maturities of long-term debt and&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current maturities of long-&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;term debt and Long-term&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;debt &lt;sup&gt;(c)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,797&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,922&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,096&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,137&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2,325&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2,450&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2,199&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2,240&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;table cellspacing="0" cellpadding="0" border="0"&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(a)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 100%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(b)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Notes and loan payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(c)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2. &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gains (losses)&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;recognized in other comprehensive net loss&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 86%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest rate derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gains (losses) reclassified from accumulated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;other comprehensive net loss and recognized&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;in net earnings&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 86%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest rate derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;- &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <clx:ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The future minimum annual lease commitments required under&#13;the Company&amp;#146;s existing non-cancelable operating and capital lease agreements as of June 30, 2016, were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Operating&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;leases&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Capital&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;leases&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 90%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 3%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;328&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;6 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</clx:ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of June 30, 2016, the Company&amp;#146;s purchase obligations&#13;were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Purchase&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Obligations&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 96%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;150&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;37&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;256 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock>
    <us-gaap:DividendsDeclaredTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Dividends per share declared and paid, respectively, during&#13;the fiscal years ended June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividends per share declared&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2.99&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2.87&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividends per share paid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.84 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:DividendsDeclaredTableTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif"&gt;The following is the reconciliation of&#13;the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted&#13;net EPS for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;129,472&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;130,310&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;129,558&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dilutive effect of stock options and other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,245&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,466&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,184&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;131,717&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;132,776&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;131,742&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="6"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Antidilutive stock options and other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;- &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif"&gt;Compensation cost and the related income&#13;tax benefit recognized for stock-based compensation plans were classified as indicated below for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cost of products sold&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Selling and administrative expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Research and development costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total compensation cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;36&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="9"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Related income tax benefit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;13 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif"&gt;The fair value of each stock option award&#13;granted during fiscal years 2016, 2015 and 2014 was estimated on the date of grant using the Black-Scholes valuation model and&#13;assumptions noted in the following table:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected life&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.6 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.6 to 5.8 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average expected life&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.6 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;16.43% to 17.3%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;16.3% to 18.6%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18.4% to 18.5%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17.2%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;16.6%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18.5%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.3% to 1.7%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.4% to 2.0%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.8% to 1.9%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.7%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.9%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.8%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.5% to 2.8%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.8% to 3.4%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.4%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.8%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.3%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.4% &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Details of the Company&amp;#146;s stock option activities are&#13;summarized below:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 89%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options outstanding as of June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8,357&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;236&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,317&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(2,633&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cancelled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(214&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;95&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options outstanding as of June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,827&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;366&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="11"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options vested as of June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,555&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;228 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;A summary of the status of the Company&amp;#146;s restricted&#13;stock awards is presented below:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted-Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Grant Date&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 94%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Restricted stock awards as of June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;91&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;129&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;106&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Restricted stock awards as of June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;108 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;A summary of the status of the Company&amp;#146;s performance&#13;unit awards is presented below:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(In thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted-Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Grant Date&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 95%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Performance unit awards as of June 30, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,123&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;92&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Distributed&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(377&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;70&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;87&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Performance unit awards as of June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;952&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;90&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="6"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Performance units vested and deferred as of June 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;157&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;58 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock>
    <clx:OtherIncomeAndOtherExpenseDisclosureTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The major components of Other (income) expense, net, for&#13;the fiscal years ended June 30 were:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 89%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income from equity investees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Low income housing partnership gains, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange transaction losses, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization of trademarks and other intangible assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible asset impairment charges&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</clx:OtherIncomeAndOtherExpenseDisclosureTableTextBlock>
    <clx:ProvisionForIncomeTaxesByTaxJurisdictionTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The provision for income taxes on continuing operations,&#13;by tax jurisdiction, consisted of the following for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 85%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Federal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;254&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;265&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;247&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; State&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Foreign&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total current&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;330&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;331&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Federal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; State&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Foreign&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total deferred&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;335&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;315&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;305 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</clx:ProvisionForIncomeTaxesByTaxJurisdictionTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The components of earnings from continuing operations before&#13;income taxes, by tax jurisdiction, consisted of the following for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;United States&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;829&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;754&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;130&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;921&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;884 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;A reconciliation of the statutory federal income tax rate&#13;to the Company&amp;#146;s effective tax rate on continuing operations follows for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 88%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Statutory federal tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;35.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;35.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;35.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;State taxes (net of federal tax benefits)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Tax differential on foreign earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(0.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(0.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Domestic manufacturing deduction&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2.4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Change in valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effective tax rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;% &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The components of net deferred tax assets (liabilities) as&#13;of June 30 are shown below:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 12pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 90%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred tax assets &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Compensation and benefit programs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;191&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Basis difference related to Venture Agreement&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Accruals and reserves&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;43&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Inventory costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Net operating loss and tax credit carryforwards&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;48&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Subtotal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;380&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;385&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;343&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;351&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="9"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred tax liabilities &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Fixed and intangible assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(325&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(277&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Low-income housing partnerships&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(22&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Unremitted foreign earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total deferred tax liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (389&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (330&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Net deferred tax assets (liabilities)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;sup&gt;(a) &lt;/sup&gt;The Company prospectively adopted ASU No.&#13;2015-17, "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes," requiring all deferred tax assets and liabilities&#13;to be classified as noncurrent. See Note 1 for further details.&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Details of the valuation allowance were as follows as of&#13;June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 12pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Valuation allowance at beginning of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(51&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net decrease/(increase) for other foreign deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net decrease/(increase) for foreign net operating loss carryforwards and tax credits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Valuation allowance at end of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following is a reconciliation of the beginning and ending&#13;amounts of the Company&amp;#146;s gross unrecognized tax benefits:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 85%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Unrecognized tax benefits at beginning of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;71&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gross increases - tax positions in prior periods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gross decreases - tax positions in prior periods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gross increases - current period tax positions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gross decreases - current period tax positions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Lapse of applicable statute of limitations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Settlements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Unrecognized tax benefits at end of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;71&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Summarized information for the Company&amp;#146;s retirement&#13;income and retirement health care plans as of and for the fiscal years ended June 30 is as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 80%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Change in benefit obligations:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Projected benefit obligation as of beginning of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;639&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;641&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Service cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Interest cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Actuarial loss (gain)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;51&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Plan amendments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Translation and other adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Benefits paid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Projected benefit obligation as of end of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;673&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;639&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;47&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Change in plan assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Fair value of assets as of beginning of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;409&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;432&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Actual return on plan assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Employer contributions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Benefits paid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Translation and other adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fair value of plan assets as of end of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;423&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;409&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued benefit cost, net funded status&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(230&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(47&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="17"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 80%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amount recognized in the balance sheets consists of:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Pension benefit assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Current accrued benefit liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Non-current accrued benefit liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(237&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(216&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Accrued benefit cost, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(230&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(47&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Retirement income plans with ABO in excess of plan assets&#13;as of June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Pension Plans&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Plans&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 84%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Projected benefit obligation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;575&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;538&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 80&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accumulated benefit obligation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;574&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;538&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;80&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fair value of plan assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;399&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;385&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The net costs of the retirement income and health care plans&#13;for the fiscal years ended June 30 included the following components:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="10" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 72%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Service cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;27&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected return on plan assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization of unrecognized items&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Items not yet recognized as a component of postretirement&#13;expense as of June 30, 2016, consisted of:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 91%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net actuarial loss (gain)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;296&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Prior service benefit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net deferred income tax (assets) liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (111&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accumulated other comprehensive loss (income)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Net actuarial loss (gain) recorded in Accumulated other comprehensive&#13;net (losses) income for the fiscal year ended June 30, 2016, included the following:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 90%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net actuarial loss (gain) as of beginning of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 264&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; (17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization during the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Loss (gain) during the year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net actuarial loss (gain) as of end of year&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;296&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average assumptions used to estimate the actuarial&#13;present value of benefit obligations as of June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 84%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Discount rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Rate of compensation increase&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;n/a&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;n/a&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average assumptions used to estimate the net periodic&#13;pension and other postretirement benefit costs as of June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 88%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Discount rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Rate of compensation increase&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected return on plan assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="10"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Discount rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Expected benefit payments for the Company&amp;#146;s pension&#13;and other postretirement plans as of June 30, 2016, were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Retirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Health Care&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 93%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fiscal years 2022 through 2026&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The target allocations and weighted average asset allocations&#13;by asset category of the investment portfolio for the Company&amp;#146;s domestic retirement income plans as of June 30 were:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;% Target Allocation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;% of Plan Assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 85%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. equity&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;International equity&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fixed income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table sets forth by level within the fair value&#13;hierarchy, the retirement income plans&amp;#146; assets carried at fair value as of June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 89%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 2%; border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Common collective trusts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Bond funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;307&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;307&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; International equity funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;56&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;56&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Domestic equity funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;44&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Real estate fund&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total common collective trusts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;421&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;421&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total assets at fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;421&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;423&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="10"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Common collective trusts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Bond funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;295&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;295&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; International equity funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;59&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;59&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Domestic equity funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Real estate fund&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total common collective trusts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;406&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;406&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total assets at fair value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;406&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;409&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2015-07-01to2016-06-30">&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Cleaning&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Household&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Lifestyle&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;International&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Corporate&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Company&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;Net sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,912&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,862&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;990&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;997&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5,761&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,824&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,794&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;950&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,087&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5,655&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,776&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;936&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1,093&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5,514&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Earnings (losses) from continuing&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;operations before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;511&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;66&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(273&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;983&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;445&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;375&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;257&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(235&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;921&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;258&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;99&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(227&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;884&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;Income from equity investees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;15&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;14&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;13&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,092&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;880&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,057&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;606&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,518&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;876&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;725&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;860&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,057&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;646&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,164&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;Capital expenditures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;172&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;125&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;53&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;137&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation and amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;60&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;165&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;67&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;169&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;67&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;177&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="22" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;Significant noncash charges included&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;in earnings (losses) from continuing&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;operations before income taxes:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #ffffff"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Share-based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;45&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #ffffff"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;32&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #ffffff"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; color: #000000"&gt;36&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Net sales and property, plant and equipment, net, by geographic&#13;area as of and for the fiscal years ended June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;United&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;States&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Company&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 90%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,805&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;956&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,761&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,609&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,046&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,655&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,466&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,048&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,514&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Property, plant and equipment, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;799&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;107&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;906&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;801&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;117&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;918&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Dollars in millions, except market price and per share data&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="17" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Quarters Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September 30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;March 31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;June 30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total Year&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 82%"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal year ended June 30, 2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Net sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,390&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,345&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,426&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;5,761&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Cost of products sold&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;765&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;745&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;780&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;873&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;3,163&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Earnings from continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;173&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;151&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;165&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;648&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(Losses) earnings from discontinued operations,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Net earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;172&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;162&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;165&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;648&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Per common share:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;5.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Discontinued operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic net earnings per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;5.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Discontinued operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Diluted net earnings per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Dividends declared per common share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;3.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Market price (NYSE)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;High&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;119.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;131.78&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;132.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;138.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;138.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Low&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;104.26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;114.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;122.40&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;119.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;104.26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year-end&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;138.39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal year ended June 30, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Net sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,352&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,345&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,401&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1,557&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;5,655&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Cost of products sold&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;774&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;773&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;796&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;847&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;3,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Earnings from continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;145&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;128&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;144&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;189&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;606&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Losses from discontinued operations,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Net earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;90&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;125&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;174&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;191&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;580&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Per common share:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.98&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Discontinued operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.22&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Basic net earnings per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.48&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.97&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.57&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Discontinued operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.42&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.22&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;(0.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Diluted net earnings per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.68&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.95&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;1.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;4.37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Dividends declared per common share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;0.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;2.99&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="19" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;Market price (NYSE)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;High&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;112.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;112.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;106.36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;98.31&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;112.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Low&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;103.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;102.95&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;95.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;86.03&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;86.03&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Year-end&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;104.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <clx:MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="2">0.05</clx:MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="From2012-11-01to2012-11-30" unitRef="Shares" decimals="0">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2014-07-01to2015-06-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPerShare" decimals="INF">9.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPerShare" decimals="INF">13.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2013-07-01to2014-06-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPerShare" decimals="INF">9.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="From2014-07-01to2015-06-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="-6">140000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="-6">142000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="From2013-07-01to2014-06-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="-6">42000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <clx:DeferredStockUnitsForNonemployeeDirectorsGranted contextRef="From2015-07-01to2016-06-30_custom_DeferredStockUnitsForNonemployeeDirectorsMember" unitRef="Shares" decimals="0">13000</clx:DeferredStockUnitsForNonemployeeDirectorsGranted>
    <clx:DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends contextRef="From2015-07-01to2016-06-30_custom_DeferredStockUnitsForNonemployeeDirectorsMember" unitRef="Shares" decimals="0">6000</clx:DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends>
    <clx:DeferredStockUnitsForNonemployeeDirectorsDistributed contextRef="From2015-07-01to2016-06-30_custom_DeferredStockUnitsForNonemployeeDirectorsMember" unitRef="Shares" decimals="0">16000</clx:DeferredStockUnitsForNonemployeeDirectorsDistributed>
    <clx:DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate contextRef="From2015-07-01to2016-06-30_custom_DeferredStockUnitsForNonemployeeDirectorsMember" unitRef="USDPerShare" decimals="INF">126.65</clx:DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate>
    <clx:DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate contextRef="From2015-07-01to2016-06-30_custom_DeferredStockUnitsForNonemployeeDirectorsMember" unitRef="USDPerShare" decimals="INF">124.03</clx:DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate>
    <clx:DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate contextRef="From2015-07-01to2016-06-30_custom_DeferredStockUnitsForNonemployeeDirectorsMember" unitRef="USDPerShare" decimals="INF">62.70</clx:DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate>
    <clx:DeferredStockUnitsForNonemployeeDirectorsOutstanding contextRef="AsOf2016-06-30_custom_DeferredStockUnitsForNonemployeeDirectorsMember" unitRef="Shares" decimals="0">244000</clx:DeferredStockUnitsForNonemployeeDirectorsOutstanding>
    <clx:DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate contextRef="AsOf2016-06-30_custom_DeferredStockUnitsForNonemployeeDirectorsMember" unitRef="USDPerShare" decimals="INF">71.13</clx:DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 2. DISCONTINUED OPERATIONS &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;On September 22, 2014, Clorox Venezuela announced that it&#13;was discontinuing its operations, effective immediately, and seeking to sell its assets. Since fiscal year 2012, Clorox Venezuela&#13;was required to sell more than two thirds of its products at prices frozen by the Venezuelan government. During this same period,&#13;Clorox Venezuela experienced successive years of hyperinflation resulting in significant sustained increases in its input costs,&#13;including packaging, raw materials, transportation and wages. As a result, Clorox Venezuela had been selling its products at a&#13;loss, resulting in ongoing operating losses. Clorox Venezuela repeatedly met with government authorities in an effort to help them&#13;understand the rapidly declining state of the business, including the need for immediate, significant and ongoing price increases&#13;and other critical remedial actions to address these adverse impacts. Based on the Venezuelan government&amp;#146;s representations,&#13;Clorox Venezuela had expected significant price increases would be forthcoming much earlier; however, the price increases subsequently&#13;approved were insufficient and would have caused Clorox Venezuela to continue operating at a significant loss into the foreseeable&#13;future. As such, Clorox Venezuela was no longer financially viable and was forced to discontinue its operations.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;On September 26, 2014, the Company reported that Venezuelan&#13;Vice President Jorge Arreaza announced, with endorsement by President Nicol&amp;#225;s Maduro, that the Venezuelan government had occupied&#13;the Santa Luc&amp;#237;a and Guacara production facilities of Clorox Venezuela. On November 6, 2014, the Company reported that the&#13;Venezuelan government had published a resolution granting a government-sponsored Special Administrative Board full authority to&#13;restart and operate the business of Clorox Venezuela, thereby reaffirming the government's expropriation of Clorox Venezuela&amp;#146;s&#13;assets. Further, President Nicol&amp;#225;s Maduro announced the government's intention to facilitate the resumed production of bleach&#13;and other cleaning products at Clorox Venezuela plants. He also announced his approval of a financial credit to invest in raw materials&#13;and production at the plants. These actions by the Venezuelan government were taken without the consent or involvement of Clorox&#13;Venezuela, its parent Clorox Spain S.L. (Clorox Spain) or any of their affiliates. Clorox Venezuela, Clorox Spain and their affiliates&#13;reserved their rights under all applicable laws and treaties.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;With this exit, the financial results of Clorox Venezuela&#13;are reflected as discontinued operations in the Company&amp;#146;s consolidated financial statements. The results of Clorox Venezuela&#13;have historically been part of the International reportable segment.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Net sales for Clorox Venezuela were $0, $11 and $77 for the&#13;fiscal years ended June 30, 2016, 2015 and 2014, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table provides a summary of gains (losses)&#13;from discontinued operations for Clorox Venezuela and gains (losses) from discontinued operations other than Clorox Venezuela for&#13;the years ended June 30:&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 88%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Operating losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exit costs and other related expenses for Clorox Venezuela&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(78&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(84&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income tax benefit attributable to Clorox Venezuela&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="13"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gains (losses) from discontinued operations other than&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Losses from discontinued operations, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Unrelated to Clorox Venezuela, in the fiscal year ended June&#13;30, 2015, $32 of gross unrecognized tax benefits relating to other discontinued operations for periods prior to fiscal year 2015&#13;were recognized upon the expiration of the applicable statute of limitations. Recognition of these previously disclosed tax benefits&#13;had no impact on the Company&amp;#146;s cash flow or earnings from continuing operations for the fiscal years ended June 30, 2015 and&#13;2014. (See Note 18)&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Summary of Operating Losses, Asset Charges and Other&#13;Costs&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following provides a breakdown of (losses) gains from&#13;discontinued operations for Clorox Venezuela and gains from discontinued operations other than Clorox Venezuela for the fiscal&#13;years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 93%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Operating losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net asset charges:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Inventories&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Property, plant and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Trademark and other intangible assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other exit and business termination costs:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Severance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Recognition of deferred foreign currency translation loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(84&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income tax benefit attributable to Clorox Venezuela&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="8"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gains from discontinued operations other than&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Losses from discontinued operations, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Prior to Clorox Venezuela being consolidated under the rules&#13;governing the preparation of financial statements in a highly inflationary economy, cumulative translation gains (losses) were&#13;included as a component of Accumulated other comprehensive net (losses) income. The charge of $30 to discontinued operations in&#13;September 2014 represents the recognition of these losses as a result of Clorox Venezuela discontinuing its operations effective&#13;September 22, 2014.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Financial Reporting: Hyperinflation and the Selection&#13;of Exchange Rates &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Due to a sustained inflationary environment, the financial&#13;statements of Clorox Venezuela are consolidated under the rules governing the preparation of financial statements in a highly inflationary&#13;economy. As such, Clorox Venezuela&amp;#146;s non-U.S. dollar (non-USD) monetary assets and liabilities were remeasured into U.S. dollars&#13;(USD) each reporting period with the resulting gains and losses now reflected in discontinued operations.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Subsequent to Clorox Venezuela discontinuing operations in&#13;September 2014, the Venezuelan government has continued to evolve its currency exchange mechanisms; however, these changes have&#13;not had a material impact on the Company&amp;#146;s financial results because the balance of net bolivar assets and liabilities on&#13;the local books of Clorox Venezuela was $0 as of both June 30, 2016 and 2015. As of June 30, 2016 and 2015, the local books of&#13;Clorox Venezuela carried a net asset position of $0. In addition, as of June 30, 2016 and 2015, the Company held $0 and $13, respectively,&#13;of tax asset balances related to Clorox Venezuela in Corporate in the reconciliation of the results of the Company&amp;#146;s reportable&#13;segments to consolidated results.&lt;/p&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <clx:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following provides a breakdown of (losses) gains from&#13;discontinued operations for Clorox Venezuela and gains from discontinued operations other than Clorox Venezuela for the fiscal&#13;years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 93%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Operating losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net asset charges:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Inventories&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Property, plant and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Trademark and other intangible assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other exit and business termination costs:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Severance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Recognition of deferred foreign currency translation loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(84&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income tax benefit attributable to Clorox Venezuela&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="8"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gains from discontinued operations other than&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Losses from discontinued operations, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(26 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</clx:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 14. STOCKHOLDERS&amp;#146; EQUITY&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company has two share repurchase programs: an open-market&#13;purchase program with an authorized aggregate purchase amount of up to $750, all of which was available for share repurchases as&#13;of both June 30, 2016 and 2015, and a program to offset the anticipated impact of share dilution related to share-based awards&#13;(the Evergreen Program), which has no authorization limit as to amount or timing of repurchases.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Share repurchases under authorized programs were as follows&#13;during the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in 000's)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in 000's)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in 000's)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 86%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Open-market purchase programs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Evergreen Program&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;254&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,151&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;434&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;260&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,046&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;254&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,151&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;434&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;260&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,046&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Dividends per share declared and paid, respectively, during&#13;the fiscal years ended June 30 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividends per share declared&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2.99&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2.87&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividends per share paid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.84&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated Other Comprehensive Net (Losses) Income &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Changes in Accumulated other comprehensive net (losses) income&#13;by component were as follows for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign currency&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;adjustments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Net&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;unrealized&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;gains&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(losses) on&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;derivatives&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Pension and&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;postretirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;benefit&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;adjustments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Comprehensive&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance June 30, 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(209&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(128&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(367&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other comprehensive (loss) income before&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;reclassifications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(57&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amounts reclassified from accumulated other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;comprehensive net losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance June 30, 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(246&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(132&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(417&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other comprehensive (loss) income before&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;reclassifications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(139&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amounts reclassified from accumulated other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;comprehensive net losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Recognition of deferred foreign currency translation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance June 30, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(300&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(53&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(502&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other comprehensive (loss) income before&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;reclassifications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(43&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amounts reclassified from accumulated other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;comprehensive net losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(53&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(68&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance June 30, 2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(353&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(173&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(570&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Included in foreign currency adjustments are re-measurement&#13;losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. For the fiscal&#13;years ended June 30, 2016, 2015 and 2014, Other comprehensive losses on these loans totaled $14, $9 and $12, respectively, and&#13;there were no amounts reclassified from Accumulated other comprehensive net (losses) income.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Pension and postretirement benefit reclassification adjustments&#13;are reflected in Cost of products sold, Selling and administrative expenses and Research and development costs.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <clx:ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Share repurchases under authorized programs were as follows&#13;during the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in 000's)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in 000's)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in 000's)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 86%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Open-market purchase programs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Evergreen Program&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;254&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,151&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;434&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;260&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,046&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;254&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,151&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;434&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;260&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,046 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</clx:ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="From2015-07-01to2016-06-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Changes in Accumulated other comprehensive net (losses) income&#13;by component were as follows for the fiscal years ended June 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign currency&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;adjustments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Net&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;unrealized&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;gains&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(losses) on&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;derivatives&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Pension and&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;postretirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;benefit&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;adjustments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Comprehensive&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 7.5pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance June 30, 2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(209&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(128&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(367&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other comprehensive (loss) income before&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;reclassifications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(57&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amounts reclassified from accumulated other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;comprehensive net losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(37&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance June 30, 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(246&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(132&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(417&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other comprehensive (loss) income before&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;reclassifications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(139&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amounts reclassified from accumulated other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;comprehensive net losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Recognition of deferred foreign currency translation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(17&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance June 30, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(300&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(53&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(502&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other comprehensive (loss) income before&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;reclassifications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(43&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(88&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amounts reclassified from accumulated other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;comprehensive net losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(53&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(68&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance June 30, 2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(353&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(173&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(570&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-04" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-1" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-2" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-3" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-02" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-0" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-1" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-2" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-3" xlink:label="Foot-02_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-02_loc" xlink:to="Footnote-03" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-0" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-1" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-2" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-3" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-4" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-5" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-6" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-7" xlink:label="Foot-03_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-03_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-0" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-1" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-2" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-3" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-4" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-5" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-6" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-7" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-8" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-9" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-10" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-11" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-12" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-13" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-14" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-15" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-16" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-17" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-18" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-19" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-20" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-21" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-22" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-23" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-24" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-25" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-26" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-27" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-28" xlink:label="Foot-04_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-04-29" xlink:label="Foot-04_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-04_loc" xlink:to="Footnote-05" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-05-0" xlink:label="Foot-05_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-05-1" xlink:label="Foot-05_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-05_loc" xlink:to="Footnote-06" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">Notes and loan payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-04" xml:lang="en-US">The Company prospectively adopted ASU No. 2015-17 "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes" requiring all deferred tax assets and liabilities to be classified as noncurrent.  See Note 1 and 18 for further details.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-05" xml:lang="en-US">The Company prospectively adopted ASU No. 2015-17 "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes" requiring all deferred tax assets and liabilities to be classified as noncurrent.  See Note 1 for further details.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-06" xml:lang="en-US">Accounts payable and accrued liabilities were combined into one financial statement line as of June 30, 2016. The change has been retrospectively applied to all periods presented.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>18
<FILENAME>clx-20160630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: Clorox 0616 10K Final to Update.xfr; Date: 2016%2D08%2D12T16:24:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80AE0001 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +a45o7xRiXhun8uHZnVMWaCG+bPtx5R66ekxs2RzHUlKHywsnsNO1CPYR1hWQXEH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:clx="http://thecloroxcompany.com/20160630" elementFormDefault="qualified" targetNamespace="http://thecloroxcompany.com/20160630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-daei" id="clx-daei">
	  <link:definition>00000001 - Document - DOCUMENT AND ENTITY INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-csoe" id="clx-csoe">
	  <link:definition>00000002 - Statement - CONSOLIDATED STATEMENT OF EARNINGS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-csoci" id="clx-csoci">
	  <link:definition>00000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-cbs" id="clx-cbs">
	  <link:definition>00000004 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-cbsp" id="clx-cbsp">
	  <link:definition>00000005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-csose" id="clx-csose">
	  <link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-csocf" id="clx-csocf">
	  <link:definition>00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-sosap" id="clx-sosap">
	  <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-do" id="clx-do">
	  <link:definition>00000009 - Disclosure - DISCONTINUED OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/BusinessesAcquired" id="BusinessesAcquired">
	  <link:definition>00000010 - Disclosure - BUSINESSES ACQUIRED</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-in1" id="clx-in1">
	  <link:definition>00000011 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-oca" id="clx-oca">
	  <link:definition>00000012 - Disclosure - OTHER CURRENT ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ppaen" id="clx-ppaen">
	  <link:definition>00000013 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-gtaoia" id="clx-gtaoia">
	  <link:definition>00000014 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
	  <link:definition>00000015 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-d1" id="clx-d1">
	  <link:definition>00000016 - Disclosure - DEBT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ol1" id="clx-ol1">
	  <link:definition>00000017 - Disclosure - OTHER LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-fiafvm1" id="clx-fiafvm1">
	  <link:definition>00000018 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ocag" id="clx-ocag">
	  <link:definition>00000019 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-laoc" id="clx-laoc">
	  <link:definition>00000020 - Disclosure - LEASES AND OTHER COMMITMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-se" id="clx-se">
	  <link:definition>00000021 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-nepse1" id="clx-nepse1">
	  <link:definition>00000022 - Disclosure - NET EARNINGS PER SHARE (EPS)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-scp" id="clx-scp">
	  <link:definition>00000023 - Disclosure - STOCK-BASED COMPENSATION PLANS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-oein" id="clx-oein">
	  <link:definition>00000024 - Disclosure - OTHER (INCOME) EXPENSE, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-it1" id="clx-it1">
	  <link:definition>00000025 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebp" id="clx-ebp">
	  <link:definition>00000026 - Disclosure - EMPLOYEE BENEFIT PLANS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-sr1" id="clx-sr1">
	  <link:definition>00000027 - Disclosure - SEGMENT REPORTING</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-rpt" id="clx-rpt">
	  <link:definition>00000028 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-uqd" id="clx-uqd">
	  <link:definition>00000029 - Disclosure - UNAUDITED QUARTERLY DATA</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/ValuationAndQualifyingAccountsAndReserves" id="ValuationAndQualifyingAccountsAndReserves">
	  <link:definition>00000030 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-sosapp" id="clx-sosapp">
	  <link:definition>00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-sosapt" id="clx-sosapt">
	  <link:definition>00000032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-dot" id="clx-dot">
	  <link:definition>00000033 - Disclosure - DISCONTINUED OPERATIONS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredTables" id="BusinessesAcquiredTables">
	  <link:definition>00000034 - Disclosure - BUSINESSES ACQUIRED (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-int1" id="clx-int1">
	  <link:definition>00000035 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ocat" id="clx-ocat">
	  <link:definition>00000036 - Disclosure - OTHER CURRENT ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ppaent" id="clx-ppaent">
	  <link:definition>00000037 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-gtaoiat" id="clx-gtaoiat">
	  <link:definition>00000038 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-alt" id="clx-alt">
	  <link:definition>00000039 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-dt" id="clx-dt">
	  <link:definition>00000040 - Disclosure - DEBT (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-olt1" id="clx-olt1">
	  <link:definition>00000041 - Disclosure - OTHER LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-fiafvmt1" id="clx-fiafvmt1">
	  <link:definition>00000042 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-laoct" id="clx-laoct">
	  <link:definition>00000043 - Disclosure - LEASES AND OTHER COMMITMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-set" id="clx-set">
	  <link:definition>00000044 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-nepset1" id="clx-nepset1">
	  <link:definition>00000045 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-scpt" id="clx-scpt">
	  <link:definition>00000046 - Disclosure - STOCK-BASED COMPENSATION PLANS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-oeint" id="clx-oeint">
	  <link:definition>00000047 - Disclosure - OTHER (INCOME) EXPENSE, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-itt" id="clx-itt">
	  <link:definition>00000048 - Disclosure - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebpt" id="clx-ebpt">
	  <link:definition>00000049 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-srt1" id="clx-srt1">
	  <link:definition>00000050 - Disclosure - SEGMENT REPORTING (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-uqdt" id="clx-uqdt">
	  <link:definition>00000051 - Disclosure - UNAUDITED QUARTERLY DATA (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-sosapsochd" id="clx-sosapsochd">
	  <link:definition>00000052 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Cash Holdings) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-sosapsoeuloppaed" id="clx-sosapsoeuloppaed">
	  <link:definition>00000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Estimated Useful Lives of Property, Plant and Equipment) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-sosapaid" id="clx-sosapaid">
	  <link:definition>00000054 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Additional Information) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-dosolgfdod" id="clx-dosolgfdod">
	  <link:definition>00000055 - Disclosure - DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-dosoolacaoc" id="clx-dosoolacaoc">
	  <link:definition>00000056 - Disclosure - DISCONTINUED OPERATIONS (Summary of Operating Losses, Asset Charges and Other Costs) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-dond" id="clx-dond">
	  <link:definition>00000057 - Disclosure - DISCONTINUED OPERATIONS (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" id="BusinessesAcquiredDetails">
	  <link:definition>00000058 - Disclosure - BUSINESSES ACQUIRED (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ind1" id="clx-ind1">
	  <link:definition>00000059 - Disclosure - INVENTORIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ocad" id="clx-ocad">
	  <link:definition>00000060 - Disclosure - OTHER CURRENT ASSETS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ppaend" id="clx-ppaend">
	  <link:definition>00000061 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-gtaoiand" id="clx-gtaoiand">
	  <link:definition>00000062 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-gtaoiasogd" id="clx-gtaoiasogd">
	  <link:definition>00000064 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-gtaoiasoiaegd" id="clx-gtaoiasoiaegd">
	  <link:definition>00000065 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilitiesDetails" id="AccountsPayableAndAccruedLiabilitiesDetails">
	  <link:definition>00000067 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-dnd" id="clx-dnd">
	  <link:definition>00000068 - Disclosure - DEBT (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-dnalpd" id="clx-dnalpd">
	  <link:definition>00000069 - Disclosure - DEBT (Notes and Loans Payable) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-dldnoudopd" id="clx-dldnoudopd">
	  <link:definition>00000070 - Disclosure - DEBT (Long-term Debt, Net of Unamortized Discounts or Premiums) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-dbcuofad" id="clx-dbcuofad">
	  <link:definition>00000071 - Disclosure - DEBT (Borrowing Capacity Under Other Financing Arrangements) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-old1" id="clx-old1">
	  <link:definition>00000072 - Disclosure - OTHER LIABILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-fiafvmnd1" id="clx-fiafvmnd1">
	  <link:definition>00000073 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-fiafvmsofimafvd1" id="clx-fiafvmsofimafvd1">
	  <link:definition>00000074 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Financial Instruments Measured at Fair Value) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-fiafvmsoeodidahid1" id="clx-fiafvmsoeodidahid1">
	  <link:definition>00000075 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ocagd" id="clx-ocagd">
	  <link:definition>00000076 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/LeasesAndOtherCommitmentsDetails" id="LeasesAndOtherCommitmentsDetails">
	  <link:definition>00000077 - Disclosure - LEASES AND OTHER COMMITMENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-sesrpd" id="clx-sesrpd">
	  <link:definition>00000078 - Disclosure - STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-secsdd" id="clx-secsdd">
	  <link:definition>00000079 - Disclosure - STOCKHOLDERS' EQUITY (Common Stock Dividends) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" id="StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails">
	  <link:definition>00000080 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/StockholdersEquityNarrativeDetails" id="StockholdersEquityNarrativeDetails">
	  <link:definition>00000081 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-nepsed" id="clx-nepsed">
	  <link:definition>00000082 - Disclosure - NET EARNINGS PER SHARE (EPS) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-scpnd" id="clx-scpnd">
	  <link:definition>00000083 - Disclosure - STOCK-BASED COMPENSATION PLANS (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-scpccaritbd" id="clx-scpccaritbd">
	  <link:definition>00000084 - Disclosure - STOCK-BASED COMPENSATION PLANS (Compensation Cost and Related Income Tax Benefit) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-scpauiviccefsogd" id="clx-scpauiviccefsogd">
	  <link:definition>00000085 - Disclosure - STOCK-BASED COMPENSATION PLANS (Assumptions Utilized in the Valuation in Calculating the Compensation Expense for Stock Options Granted) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-scpsosoad" id="clx-scpsosoad">
	  <link:definition>00000086 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Stock Option Activity) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-scpsorsaad" id="clx-scpsorsaad">
	  <link:definition>00000087 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Restricted Stock Award Activity) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-scpsopsaad" id="clx-scpsopsaad">
	  <link:definition>00000088 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Performance Stock Award Activity) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails" id="OtherIncomeExpenseNetDetails">
	  <link:definition>00000089 - Disclosure - OTHER (INCOME) EXPENSE, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-itnd" id="clx-itnd">
	  <link:definition>00000091 - Disclosure - INCOME TAXES (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-itpfitbtjadafebtd" id="clx-itpfitbtjadafebtd">
	  <link:definition>00000092 - Disclosure - INCOME TAXES (Provision for Income Taxes by Tax Jurisdiction and Domestic and Foreign Earnings before Taxes) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-iteitrrd" id="clx-iteitrrd">
	  <link:definition>00000093 - Disclosure - INCOME TAXES (Effective Income Tax Rate Reconciliation) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-itcondtad" id="clx-itcondtad">
	  <link:definition>00000094 - Disclosure - INCOME TAXES (Components of Net Deferred Tax Assets) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-itvad" id="clx-itvad">
	  <link:definition>00000095 - Disclosure - INCOME TAXES (Valuation Allowance) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-itutbd" id="clx-itutbd">
	  <link:definition>00000096 - Disclosure - INCOME TAXES (Unrecognized Tax Benefits) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebpnd" id="clx-ebpnd">
	  <link:definition>00000097 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebpsifdbriahpd" id="clx-ebpsifdbriahpd">
	  <link:definition>00000099 - Disclosure - EMPLOYEE BENEFIT PLANS (Summarized Information for Defined Benefit Retirement Income and Healthcare Plans) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebpifripwaboieopad" id="clx-ebpifripwaboieopad">
	  <link:definition>00000100 - Disclosure - EMPLOYEE BENEFIT PLANS (Information for Retirement Income Plans with Accumulated Benefit Obligation in Excess of Plan Assets) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebpconcoriahcpd" id="clx-ebpconcoriahcpd">
	  <link:definition>00000101 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income and Health Care Plans) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebpinyracoped" id="clx-ebpinyracoped">
	  <link:definition>00000102 - Disclosure - EMPLOYEE BENEFIT PLANS (Items Not Yet Recognized as a Component of Postretirement Expense) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebpnalgapscbariaoclid" id="clx-ebpnalgapscbariaoclid">
	  <link:definition>00000103 - Disclosure - EMPLOYEE BENEFIT PLANS (Net Actuarial Loss (Gain) and Prior Service Cost (Benefit) Activity Recorded in Accumulated Other Comprehensive Loss (Income)) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebpwautenppaopbcd" id="clx-ebpwautenppaopbcd">
	  <link:definition>00000104 - Disclosure - EMPLOYEE BENEFIT PLANS (Weighted-Average Assumptions Used to Estimate the Net Periodic Pension and Other Postretirement Benefit Costs) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebpebpd" id="clx-ebpebpd">
	  <link:definition>00000105 - Disclosure - EMPLOYEE BENEFIT PLANS (Expected Benefit Payments) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-ebptaawaaad" id="clx-ebptaawaaad">
	  <link:definition>00000106 - Disclosure - EMPLOYEE BENEFIT PLANS (Target Allocations and Weighted Average Asset Allocations) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansAssetsCarriedAtFairValueDetails" id="EmployeeBenefitPlansAssetsCarriedAtFairValueDetails">
	  <link:definition>00000107 - Disclosure - EMPLOYEE BENEFIT PLANS (Retirement Income Plan's Assets Carried at Fair Value) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails" id="SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails">
	  <link:definition>00000108 - Disclosure - SEGMENT REPORTING (Selected Financial Information Relating To Company's Segments ) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-srnsalabgad" id="clx-srnsalabgad">
	  <link:definition>00000109 - Disclosure - SEGMENT REPORTING (Net Sales and Long-Lived Assets by Geographic Area) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-srcpd" id="clx-srcpd">
	  <link:definition>00000110 - Disclosure - SEGMENT REPORTING (Concentration Percentages) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-rptd" id="clx-rptd">
	  <link:definition>00000111 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-uqdd" id="clx-uqdd">
	  <link:definition>00000112 - Disclosure - UNAUDITED QUARTERLY DATA (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-vaqaard" id="clx-vaqaard">
	  <link:definition>00000113 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="clx-20160630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="clx-20160630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="clx-20160630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="clx-20160630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
    <element id="clx_OtherIncomeExpenseNet" name="OtherIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_TrademarksNet" name="TrademarksNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherEmployeeStockPlanActivitiesValue" name="OtherEmployeeStockPlanActivitiesValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherEmployeeStockPlanActivitiesShares" name="OtherEmployeeStockPlanActivitiesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="clx_InterestRateForwardContractsSettlement" name="InterestRateForwardContractsSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" name="UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" name="UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" name="NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" name="NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges" name="DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" name="DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" name="DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DisposalGroupIncludingDiscontinuedOperationSeverance" name="DisposalGroupIncludingDiscontinuedOperationSeverance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DisposalGroupIncludingDiscontinuedOperationOther" name="DisposalGroupIncludingDiscontinuedOperationOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" name="DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" name="DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet" name="DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_NonCashCapitalExpenditures" name="NonCashCapitalExpenditures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_AccruedTradeAndSalesPromotionCostsCurrent" name="AccruedTradeAndSalesPromotionCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod" name="ShortTermDebtWeightedAverageInterestRateDuringPeriod" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps" name="WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_EmployeeBenefitObligationsNoncurrent" name="EmployeeBenefitObligationsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_VentureAgreementNetTerminalObligation" name="VentureAgreementNetTerminalObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement" name="MaximumPercentageOfNoncontrollingInterestInVentureAgreement" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SaleLeasebackTransactionLeaseTerm" name="SaleLeasebackTransactionLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain" name="SaleLeasebackTransactionNoncurrentPortionOfDeferredGain" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DerivativeIntrumentsMaximumContractDuration" name="DerivativeIntrumentsMaximumContractDuration" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" name="DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LetterOfCreditBorrowingCapacity" name="LetterOfCreditBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_VestedAwardsWerePaidByIssuanceOfShares" name="VestedAwardsWerePaidByIssuanceOfShares" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_VestedStockAwardsDeferred" name="VestedStockAwardsDeferred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LowIncomeHousingPartnershipGainsLosses" name="LowIncomeHousingPartnershipGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_MiscellaneousOtherIncomeExpense" name="MiscellaneousOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability" name="DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" name="DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" name="DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" name="DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships" name="DeferredTaxLiabilitiesLowIncomeHousingPartnerships" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_UnrecognizedTaxBenefitsSettlements" name="UnrecognizedTaxBenefitsSettlements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_BasisPointIncreaseDecrease" name="BasisPointIncreaseDecrease" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost" name="OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod" name="OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CashEquivalents" name="CashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh" name="RangeOfNyseMarketPriceOfEntityCommonStockHigh" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RangeOfNyseMarketPriceOfEntityCommonStockLow" name="RangeOfNyseMarketPriceOfEntityCommonStockLow" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="clx_NyseMarketPriceOfEntityCommonStockPeriodEnd" name="NyseMarketPriceOfEntityCommonStockPeriodEnd" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses" name="ValuationAllowancesAndReservesCreditedToCostsAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_VentureAgreementRenewalOption" name="VentureAgreementRenewalOption" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SiteContingencyAgreedPercentageOfCostSharing" name="SiteContingencyAgreedPercentageOfCostSharing" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RemediationPeriod" name="RemediationPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" name="DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap" name="CompensationExpensePerformanceGoalsExceededTargetPercentageCap" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_MaximumOwnershipPercentageOfEquityInvestments" name="MaximumOwnershipPercentageOfEquityInvestments" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets" name="ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits" name="ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ImpairmentOfTrademarks" name="ImpairmentOfTrademarks" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_NumberOfLeasedProperties" name="NumberOfLeasedProperties" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SettlementOfInterestRateForwardContract" name="SettlementOfInterestRateForwardContract" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_AmortizationOfTrademarksAndOtherIntangibleAssets" name="AmortizationOfTrademarksAndOtherIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CommonOrCollectiveTrusts" name="CommonOrCollectiveTrusts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement" name="PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement" name="TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_PackagingDevelopmentAndDesignCosts" name="PackagingDevelopmentAndDesignCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" name="FinancialInstrumentsAndFairValueMeasurementsTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ContingenciesAndGuaranteesDisclosureTextBlock" name="ContingenciesAndGuaranteesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherIncomeExpenseNetDisclosureTextBlock" name="OtherIncomeExpenseNetDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_EmployeeBenefitsPolicyTextBlock" name="EmployeeBenefitsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock" name="AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" name="UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" name="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock" name="ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock" name="OtherIncomeAndOtherExpenseDisclosureTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock" name="ProvisionForIncomeTaxesByTaxJurisdictionTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach" name="MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredStockUnitsForNonemployeeDirectorsGranted" name="DeferredStockUnitsForNonemployeeDirectorsGranted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends" name="DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredStockUnitsForNonemployeeDirectorsDistributed" name="DeferredStockUnitsForNonemployeeDirectorsDistributed" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate" name="DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate" name="DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate" name="DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding" name="DeferredStockUnitsForNonemployeeDirectorsOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate" name="DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock" name="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock" name="ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CapitalizedSoftwareCostsMember" name="CapitalizedSoftwareCostsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_VenezuelanSubsidiaryMember" name="VenezuelanSubsidiaryMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherDiscontinuedOperationMember" name="OtherDiscontinuedOperationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DiscontinuedOperationsOtherMember" name="DiscontinuedOperationsOtherMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ForeignSubsidiaryRestrictedCashMember" name="ForeignSubsidiaryRestrictedCashMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_EscrowRestrictedCashMember" name="EscrowRestrictedCashMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LifestyleMember" name="LifestyleMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_HouseholdMember" name="HouseholdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_InternationalMember" name="InternationalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CleaningMember" name="CleaningMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_TechnologyAndProductFormulaeMember" name="TechnologyAndProductFormulaeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherIntangibleAssetsOtherMember" name="OtherIntangibleAssetsOtherMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SeniorNotes3.55PercentMember" name="SeniorNotes3.55PercentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SeniorNotes3.50PercentMember" name="SeniorNotes3.50PercentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RepaidSeniorNotesMember" name="RepaidSeniorNotesMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_NewSeniorNotesMember" name="NewSeniorNotesMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RevolvingLineOfCreditMember" name="RevolvingLineOfCreditMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ForeignAndOtherCreditLinesMember" name="ForeignAndOtherCreditLinesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ForeignBorrowingsMember" name="ForeignBorrowingsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember" name="SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" name="SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" name="SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" name="SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" name="SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" name="SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ForeignCreditLinesMember" name="ForeignCreditLinesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherCreditLinesMember" name="OtherCreditLinesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_JetFuelMember" name="JetFuelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SoybeanOilMember" name="SoybeanOilMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember" name="CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_EvergreenProgramMember" name="EvergreenProgramMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LongTermIntercompanyLoansMember" name="LongTermIntercompanyLoansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OpenMarketProgramMember" name="OpenMarketProgramMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_NotSubjectToExpirationMember" name="NotSubjectToExpirationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ForeignMember" name="ForeignMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ForeignTaxCreditCarryforwardMember" name="ForeignTaxCreditCarryforwardMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SubjectToExpirationMember" name="SubjectToExpirationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherForeignDeferredTaxAssetsMember" name="OtherForeignDeferredTaxAssetsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ForeignNetOperatingLossCarryforwardAndTaxCreditsMember" name="ForeignNetOperatingLossCarryforwardAndTaxCreditsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_MedicalMember" name="MedicalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_PrescriptionDrugsMember" name="PrescriptionDrugsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RetirementHealthCarePlanMember" name="RetirementHealthCarePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DomesticNonQualifiedRetirementIncomePlansMember" name="DomesticNonQualifiedRetirementIncomePlansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ForeignRetirementIncomePlansMember" name="ForeignRetirementIncomePlansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RetirementIncomeMember" name="RetirementIncomeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RetirementHealthCareMember" name="RetirementHealthCareMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DomesticQualifiedRetirementIncomePlansMember" name="DomesticQualifiedRetirementIncomePlansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RetirementIncomePlanMember" name="RetirementIncomePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CompanyFourZeroOneKPlanMember" name="CompanyFourZeroOneKPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_InternationalDefinedContributionPlanMember" name="InternationalDefinedContributionPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_UnitedStatesEquityMember" name="UnitedStatesEquityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ForeignEquitySecuritiesMember" name="ForeignEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_BondFundMember" name="BondFundMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DomesticEquitySecuritiesMember" name="DomesticEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RealEstateFundMember" name="RealEstateFundMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_WalmartStoresIncMember" name="WalmartStoresIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_TopFiveLargestCustomersMember" name="TopFiveLargestCustomersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LiquidBleachMember" name="LiquidBleachMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_TrashBagsMember" name="TrashBagsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CharcoalMember" name="CharcoalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LifoAllowanceMember" name="LifoAllowanceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RenewLifeHoldingsCorporationMember" name="RenewLifeHoldingsCorporationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_VentureAgreementNetTerminalObligationNetMember" name="VentureAgreementNetTerminalObligationNetMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SeniorNotes5.00PercentMember" name="SeniorNotes5.00PercentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredStockUnitsForNonemployeeDirectorsMember" name="DeferredStockUnitsForNonemployeeDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherCurrentAssetsAbstract" name="OtherCurrentAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" name="GoodwillTrademarksAndOtherIntangibleAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" name="FinancialInstrumentsAndFairValueMeasurementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherContingenciesAndGuaranteesAbstract" name="OtherContingenciesAndGuaranteesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LeasesAndOtherCommitmentsAbstract" name="LeasesAndOtherCommitmentsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor" name="CompensationExpensePerformanceGoalsExceededTargetPercentageFloor" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" name="DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear" name="DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter" name="DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal" name="FiniteLivedIntangibleAssetsUsefulLifeRenewal" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherIntangibleAssetsAxis" name="OtherIntangibleAssetsAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="clx_OtherIntangibleAssetsDomain" name="OtherIntangibleAssetsDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LongTermAndShortTermDebtLineItems" name="LongTermAndShortTermDebtLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_VentureAgreementTerm" name="VentureAgreementTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DerivativeNatureAxis" name="DerivativeNatureAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="clx_DerivativeNatureDomain" name="DerivativeNatureDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_FairValueMeasurementsRecurringTable" name="FairValueMeasurementsRecurringTable" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" />
    <element id="clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" name="FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShareRepurchaseProgramsTable" name="ShareRepurchaseProgramsTable" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" />
    <element id="clx_ShareRepurchaseProgramsLineItems" name="ShareRepurchaseProgramsLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_IncomeTaxesTable" name="IncomeTaxesTable" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" />
    <element id="clx_TaxCreditAndOperatingLossCarryforwardsLineItems" name="TaxCreditAndOperatingLossCarryforwardsLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ExpirationPeriodAxis" name="ExpirationPeriodAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="clx_ExpirationPeriodDomain" name="ExpirationPeriodDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DiscretionaryCompanyContributions" name="DiscretionaryCompanyContributions" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod" name="NondiscretionaryDomesticProfitSharingContributionsDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_MutualFunds" name="MutualFunds" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>clx-20160630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: Clorox 0616 10K Final to Update.xfr; Date: 2016%2D08%2D12T16:24:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80AE0001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-daei" xlink:href="clx-20160630.xsd#clx-daei" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csoe" xlink:href="clx-20160630.xsd#clx-csoe" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csoci" xlink:href="clx-20160630.xsd#clx-csoci" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-cbs" xlink:href="clx-20160630.xsd#clx-cbs" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-cbsp" xlink:href="clx-20160630.xsd#clx-cbsp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csose" xlink:href="clx-20160630.xsd#clx-csose" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csocf" xlink:href="clx-20160630.xsd#clx-csocf" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosap" xlink:href="clx-20160630.xsd#clx-sosap" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-do" xlink:href="clx-20160630.xsd#clx-do" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:href="clx-20160630.xsd#BusinessesAcquired" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-in1" xlink:href="clx-20160630.xsd#clx-in1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-oca" xlink:href="clx-20160630.xsd#clx-oca" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ppaen" xlink:href="clx-20160630.xsd#clx-ppaen" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoia" xlink:href="clx-20160630.xsd#clx-gtaoia" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="clx-20160630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-d1" xlink:href="clx-20160630.xsd#clx-d1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ol1" xlink:href="clx-20160630.xsd#clx-ol1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:href="clx-20160630.xsd#clx-fiafvm1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocag" xlink:href="clx-20160630.xsd#clx-ocag" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-laoc" xlink:href="clx-20160630.xsd#clx-laoc" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-se" xlink:href="clx-20160630.xsd#clx-se" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-nepse1" xlink:href="clx-20160630.xsd#clx-nepse1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scp" xlink:href="clx-20160630.xsd#clx-scp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-oein" xlink:href="clx-20160630.xsd#clx-oein" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-it1" xlink:href="clx-20160630.xsd#clx-it1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebp" xlink:href="clx-20160630.xsd#clx-ebp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sr1" xlink:href="clx-20160630.xsd#clx-sr1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-rpt" xlink:href="clx-20160630.xsd#clx-rpt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-uqd" xlink:href="clx-20160630.xsd#clx-uqd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ValuationAndQualifyingAccountsAndReserves" xlink:href="clx-20160630.xsd#ValuationAndQualifyingAccountsAndReserves" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapp" xlink:href="clx-20160630.xsd#clx-sosapp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapt" xlink:href="clx-20160630.xsd#clx-sosapt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dot" xlink:href="clx-20160630.xsd#clx-dot" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:href="clx-20160630.xsd#BusinessesAcquiredTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-int1" xlink:href="clx-20160630.xsd#clx-int1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocat" xlink:href="clx-20160630.xsd#clx-ocat" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ppaent" xlink:href="clx-20160630.xsd#clx-ppaent" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiat" xlink:href="clx-20160630.xsd#clx-gtaoiat" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-alt" xlink:href="clx-20160630.xsd#clx-alt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dt" xlink:href="clx-20160630.xsd#clx-dt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-olt1" xlink:href="clx-20160630.xsd#clx-olt1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmt1" xlink:href="clx-20160630.xsd#clx-fiafvmt1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-laoct" xlink:href="clx-20160630.xsd#clx-laoct" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-set" xlink:href="clx-20160630.xsd#clx-set" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-nepset1" xlink:href="clx-20160630.xsd#clx-nepset1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpt" xlink:href="clx-20160630.xsd#clx-scpt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-oeint" xlink:href="clx-20160630.xsd#clx-oeint" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itt" xlink:href="clx-20160630.xsd#clx-itt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpt" xlink:href="clx-20160630.xsd#clx-ebpt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-srt1" xlink:href="clx-20160630.xsd#clx-srt1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-uqdt" xlink:href="clx-20160630.xsd#clx-uqdt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapsochd" xlink:href="clx-20160630.xsd#clx-sosapsochd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapsoeuloppaed" xlink:href="clx-20160630.xsd#clx-sosapsoeuloppaed" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapaid" xlink:href="clx-20160630.xsd#clx-sosapaid" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dosolgfdod" xlink:href="clx-20160630.xsd#clx-dosolgfdod" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dosoolacaoc" xlink:href="clx-20160630.xsd#clx-dosoolacaoc" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dond" xlink:href="clx-20160630.xsd#clx-dond" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:href="clx-20160630.xsd#BusinessesAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ind1" xlink:href="clx-20160630.xsd#clx-ind1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocad" xlink:href="clx-20160630.xsd#clx-ocad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ppaend" xlink:href="clx-20160630.xsd#clx-ppaend" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiand" xlink:href="clx-20160630.xsd#clx-gtaoiand" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiasogd" xlink:href="clx-20160630.xsd#clx-gtaoiasogd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiasoiaegd" xlink:href="clx-20160630.xsd#clx-gtaoiasoiaegd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="clx-20160630.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dnd" xlink:href="clx-20160630.xsd#clx-dnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dnalpd" xlink:href="clx-20160630.xsd#clx-dnalpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dldnoudopd" xlink:href="clx-20160630.xsd#clx-dldnoudopd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dbcuofad" xlink:href="clx-20160630.xsd#clx-dbcuofad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-old1" xlink:href="clx-20160630.xsd#clx-old1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmnd1" xlink:href="clx-20160630.xsd#clx-fiafvmnd1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmsofimafvd1" xlink:href="clx-20160630.xsd#clx-fiafvmsofimafvd1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmsoeodidahid1" xlink:href="clx-20160630.xsd#clx-fiafvmsoeodidahid1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocagd" xlink:href="clx-20160630.xsd#clx-ocagd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/LeasesAndOtherCommitmentsDetails" xlink:href="clx-20160630.xsd#LeasesAndOtherCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sesrpd" xlink:href="clx-20160630.xsd#clx-sesrpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-secsdd" xlink:href="clx-20160630.xsd#clx-secsdd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:href="clx-20160630.xsd#StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StockholdersEquityNarrativeDetails" xlink:href="clx-20160630.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-nepsed" xlink:href="clx-20160630.xsd#clx-nepsed" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpnd" xlink:href="clx-20160630.xsd#clx-scpnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpccaritbd" xlink:href="clx-20160630.xsd#clx-scpccaritbd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpauiviccefsogd" xlink:href="clx-20160630.xsd#clx-scpauiviccefsogd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpsosoad" xlink:href="clx-20160630.xsd#clx-scpsosoad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpsorsaad" xlink:href="clx-20160630.xsd#clx-scpsorsaad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpsopsaad" xlink:href="clx-20160630.xsd#clx-scpsopsaad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails" xlink:href="clx-20160630.xsd#OtherIncomeExpenseNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itnd" xlink:href="clx-20160630.xsd#clx-itnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itpfitbtjadafebtd" xlink:href="clx-20160630.xsd#clx-itpfitbtjadafebtd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-iteitrrd" xlink:href="clx-20160630.xsd#clx-iteitrrd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itcondtad" xlink:href="clx-20160630.xsd#clx-itcondtad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itvad" xlink:href="clx-20160630.xsd#clx-itvad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itutbd" xlink:href="clx-20160630.xsd#clx-itutbd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpnd" xlink:href="clx-20160630.xsd#clx-ebpnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpsifdbriahpd" xlink:href="clx-20160630.xsd#clx-ebpsifdbriahpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpifripwaboieopad" xlink:href="clx-20160630.xsd#clx-ebpifripwaboieopad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpconcoriahcpd" xlink:href="clx-20160630.xsd#clx-ebpconcoriahcpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpinyracoped" xlink:href="clx-20160630.xsd#clx-ebpinyracoped" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpnalgapscbariaoclid" xlink:href="clx-20160630.xsd#clx-ebpnalgapscbariaoclid" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpwautenppaopbcd" xlink:href="clx-20160630.xsd#clx-ebpwautenppaopbcd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpebpd" xlink:href="clx-20160630.xsd#clx-ebpebpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebptaawaaad" xlink:href="clx-20160630.xsd#clx-ebptaawaaad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansAssetsCarriedAtFairValueDetails" xlink:href="clx-20160630.xsd#EmployeeBenefitPlansAssetsCarriedAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:href="clx-20160630.xsd#SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-srnsalabgad" xlink:href="clx-20160630.xsd#clx-srnsalabgad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-srcpd" xlink:href="clx-20160630.xsd#clx-srcpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-rptd" xlink:href="clx-20160630.xsd#clx-rptd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-uqdd" xlink:href="clx-20160630.xsd#clx-uqdd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-vaqaard" xlink:href="clx-20160630.xsd#clx-vaqaard" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-daei" xlink:title="00000001 - Document - DOCUMENT AND ENTITY INFORMATION">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DocumentAndEntityInformationAbstract" xlink:label="loc_clxDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csoe" xlink:title="00000002 - Statement - CONSOLIDATED STATEMENT OF EARNINGS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIncomeExpenseNet" xlink:label="loc_clxOtherIncomeExpenseNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_clxOtherIncomeExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareDilutedAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csoci" xlink:title="00000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-cbs" xlink:title="00000004 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaapReceivablesNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TrademarksNet" xlink:label="loc_clxTrademarksNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_clxTrademarksNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaper" xlink:label="loc_us-gaapCommercialPaper" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapCommercialPaper" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredTaxLiabilitiesNoncurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-cbsp" xlink:title="00000005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapTreasuryStockShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csose" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsCash" xlink:label="loc_us-gaapDividendsCash" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherEmployeeStockPlanActivitiesValue" xlink:label="loc_clxOtherEmployeeStockPlanActivitiesValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxOtherEmployeeStockPlanActivitiesValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherEmployeeStockPlanActivitiesShares" xlink:label="loc_clxOtherEmployeeStockPlanActivitiesShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxOtherEmployeeStockPlanActivitiesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaapTreasuryStockValueAcquiredCostMethod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValueAcquiredCostMethod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaapTreasuryStockSharesAcquired" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockSharesAcquired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csocf" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InterestRateForwardContractsSettlement" xlink:label="loc_clxInterestRateForwardContractsSettlement" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_clxInterestRateForwardContractsSettlement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaapOtherNoncashIncomeExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherNoncashIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfShortTermDebt" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaapPaymentsOfDividendsCommonStock" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapDividendsPayableCurrentAndNoncurrent" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDividendsPayableCurrentAndNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosap" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-do" xlink:title="00000009 - Disclosure - DISCONTINUED OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:title="00000010 - Disclosure - BUSINESSES ACQUIRED">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-in1" xlink:title="00000011 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-oca" xlink:title="00000012 - Disclosure - OTHER CURRENT ASSETS">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherCurrentAssetsAbstract" xlink:label="loc_clxOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="loc_us-gaapOtherCurrentAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapOtherCurrentAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ppaen" xlink:title="00000013 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNetAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoia" xlink:title="00000014 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:label="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000015 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-d1" xlink:title="00000016 - Disclosure - DEBT">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ol1" xlink:title="00000017 - Disclosure - OTHER LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapOtherLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:title="00000018 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_clxFinancialInstrumentsAndFairValueMeasurementsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocag" xlink:title="00000019 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherContingenciesAndGuaranteesAbstract" xlink:label="loc_clxOtherContingenciesAndGuaranteesAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ContingenciesAndGuaranteesDisclosureTextBlock" xlink:label="loc_clxContingenciesAndGuaranteesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_clxContingenciesAndGuaranteesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-laoc" xlink:title="00000020 - Disclosure - LEASES AND OTHER COMMITMENTS">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LeasesAndOtherCommitmentsAbstract" xlink:label="loc_clxLeasesAndOtherCommitmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLeasesAndOtherCommitmentsAbstract" xlink:to="loc_us-gaapCommitmentsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-se" xlink:title="00000021 - Disclosure - STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-nepse1" xlink:title="00000022 - Disclosure - NET EARNINGS PER SHARE (EPS)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scp" xlink:title="00000023 - Disclosure - STOCK-BASED COMPENSATION PLANS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaapShareBasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-oein" xlink:title="00000024 - Disclosure - OTHER (INCOME) EXPENSE, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIncomeExpenseNetDisclosureTextBlock" xlink:label="loc_clxOtherIncomeExpenseNetDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_clxOtherIncomeExpenseNetDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-it1" xlink:title="00000025 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebp" xlink:title="00000026 - Disclosure - EMPLOYEE BENEFIT PLANS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaapPensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapPensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sr1" xlink:title="00000027 - Disclosure - SEGMENT REPORTING">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-rpt" xlink:title="00000028 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-uqd" xlink:title="00000029 - Disclosure - UNAUDITED QUARTERLY DATA">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract" xlink:label="loc_us-gaapQuarterlyFinancialDataAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaapQuarterlyFinancialInformationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_us-gaapQuarterlyFinancialInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ValuationAndQualifyingAccountsAndReserves" xlink:title="00000030 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_us-gaapValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_us-gaapScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAndQualifyingAccountsAbstract" xlink:to="loc_us-gaapScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapp" xlink:title="00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="loc_us-gaapInternalUseSoftwarePolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInternalUseSoftwarePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EmployeeBenefitsPolicyTextBlock" xlink:label="loc_clxEmployeeBenefitsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_clxEmployeeBenefitsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EnvironmentalCostsPolicy" xlink:label="loc_us-gaapEnvironmentalCostsPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEnvironmentalCostsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaapCostOfSalesPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCostOfSalesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock" xlink:label="loc_clxAdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_clxAdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="loc_us-gaapDescriptionOfNewAccountingPronouncementsNotYetAdopted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapt" xlink:title="00000032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfCashAndCashEquivalentsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="loc_clxUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_clxUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dot" xlink:title="00000033 - Disclosure - DISCONTINUED OPERATIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" xlink:label="loc_clxScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_clxScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock" xlink:label="loc_clxScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_clxScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:title="00000034 - Disclosure - BUSINESSES ACQUIRED (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-int1" xlink:title="00000035 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocat" xlink:title="00000036 - Disclosure - OTHER CURRENT ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherCurrentAssetsAbstract" xlink:label="loc_clxOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherCurrentAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ppaent" xlink:title="00000037 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNetAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiat" xlink:title="00000038 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:label="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaapScheduleOfGoodwillTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:to="loc_us-gaapScheduleOfGoodwillTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-alt" xlink:title="00000039 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dt" xlink:title="00000040 - Disclosure - DEBT (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:label="loc_us-gaapScheduleOfShortTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="loc_us-gaapScheduleOfLineOfCreditFacilitiesTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-olt1" xlink:title="00000041 - Disclosure - OTHER LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:label="loc_us-gaapOtherNoncurrentLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapOtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmt1" xlink:title="00000042 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-laoct" xlink:title="00000043 - Disclosure - LEASES AND OTHER COMMITMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LeasesAndOtherCommitmentsAbstract" xlink:label="loc_clxLeasesAndOtherCommitmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock" xlink:label="loc_clxScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLeasesAndOtherCommitmentsAbstract" xlink:to="loc_clxScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLeasesAndOtherCommitmentsAbstract" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-set" xlink:title="00000044 - Disclosure - STOCKHOLDERS' EQUITY (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock" xlink:label="loc_clxScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_clxScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsDeclaredTableTextBlock" xlink:label="loc_us-gaapDividendsDeclaredTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapDividendsDeclaredTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-nepset1" xlink:title="00000045 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaapScheduleOfWeightedAverageNumberOfSharesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpt" xlink:title="00000046 - Disclosure - STOCK-BASED COMPENSATION PLANS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaapShareBasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:label="loc_us-gaapShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-oeint" xlink:title="00000047 - Disclosure - OTHER (INCOME) EXPENSE, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock" xlink:label="loc_clxOtherIncomeAndOtherExpenseDisclosureTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_clxOtherIncomeAndOtherExpenseDisclosureTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itt" xlink:title="00000048 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock" xlink:label="loc_clxProvisionForIncomeTaxesByTaxJurisdictionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_clxProvisionForIncomeTaxesByTaxJurisdictionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaapSummaryOfValuationAllowanceTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfValuationAllowanceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:label="loc_us-gaapSummaryOfIncomeTaxContingenciesTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpt" xlink:title="00000049 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:label="loc_us-gaapChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:label="loc_us-gaapScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:label="loc_us-gaapScheduleOfNetBenefitCostsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:label="loc_us-gaapScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaapScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="loc_us-gaapScheduleOfAssumptionsUsedTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfExpectedBenefitPaymentsTableTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfAllocationOfPlanAssetsTableTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-srt1" xlink:title="00000050 - Disclosure - SEGMENT REPORTING (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-uqdt" xlink:title="00000051 - Disclosure - UNAUDITED QUARTERLY DATA (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract" xlink:label="loc_us-gaapQuarterlyFinancialDataAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapsochd" xlink:title="00000052 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Cash Holdings) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" xlink:label="loc_clxUsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_clxUsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:label="loc_clxNonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_clxNonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:label="loc_clxUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_clxUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" xlink:label="loc_clxNonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_clxNonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapsoeuloppaed" xlink:title="00000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Estimated Useful Lives of Property, Plant and Equipment) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaapBuildingAndBuildingImprovementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingAndBuildingImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandImprovementsMember" xlink:label="loc_us-gaapLandImprovementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CapitalizedSoftwareCostsMember" xlink:label="loc_clxCapitalizedSoftwareCostsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_clxCapitalizedSoftwareCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapaid" xlink:title="00000054 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Additional Information) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaapScenarioForecastMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_us-gaapScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap" xlink:label="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageCap" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageCap" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor" xlink:label="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageFloor" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageFloor" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach" xlink:label="loc_clxMinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxMinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NontradeReceivablesCurrent" xlink:label="loc_us-gaapNontradeReceivablesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNontradeReceivablesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_PackagingDevelopmentAndDesignCosts" xlink:label="loc_clxPackagingDevelopmentAndDesignCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxPackagingDevelopmentAndDesignCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges" xlink:label="loc_clxDerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxDerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement" xlink:label="loc_clxPercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxPercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dosolgfdod" xlink:title="00000055 - Disclosure - DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VenezuelanSubsidiaryMember" xlink:label="loc_clxVenezuelanSubsidiaryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxVenezuelanSubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationsOtherMember" xlink:label="loc_clxDiscontinuedOperationsOtherMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxDiscontinuedOperationsOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dosoolacaoc" xlink:title="00000056 - Disclosure - DISCONTINUED OPERATIONS (Summary of Operating Losses, Asset Charges and Other Costs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VenezuelanSubsidiaryMember" xlink:label="loc_clxVenezuelanSubsidiaryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxVenezuelanSubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationsOtherMember" xlink:label="loc_clxDiscontinuedOperationsOtherMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxDiscontinuedOperationsOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" xlink:label="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" xlink:label="loc_clxDisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_clxDisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:label="loc_clxDisposalGroupIncludingDiscontinuedOperationSeverance" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" xlink:to="loc_clxDisposalGroupIncludingDiscontinuedOperationSeverance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationOther" xlink:label="loc_clxDisposalGroupIncludingDiscontinuedOperationOther" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" xlink:to="loc_clxDisposalGroupIncludingDiscontinuedOperationOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaapReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear" xlink:label="loc_clxDisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_clxDisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter" xlink:label="loc_clxDisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_clxDisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dond" xlink:title="00000057 - Disclosure - DISCONTINUED OPERATIONS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VenezuelanSubsidiaryMember" xlink:label="loc_clxVenezuelanSubsidiaryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxVenezuelanSubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="loc_us-gaapCorporateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_us-gaapCorporateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet" xlink:label="loc_clxDisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract" xlink:to="loc_clxDisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:title="00000058 - Disclosure - BUSINESSES ACQUIRED (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RenewLifeHoldingsCorporationMember" xlink:label="loc_clxRenewLifeHoldingsCorporationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_clxRenewLifeHoldingsCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="loc_us-gaapBusinessAcquisitionEffectiveDateOfAcquisition1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEffectiveDateOfAcquisition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ind1" xlink:title="00000059 - Disclosure - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryLIFOReserve" xlink:label="loc_us-gaapInventoryLIFOReserve" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryLIFOReserve" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PercentageOfLIFOInventory" xlink:label="loc_us-gaapPercentageOfLIFOInventory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapPercentageOfLIFOInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfLIFOInventoryLiquidationOnIncome" xlink:label="loc_us-gaapEffectOfLIFOInventoryLiquidationOnIncome" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapEffectOfLIFOInventoryLiquidationOnIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:label="loc_us-gaapOtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocad" xlink:title="00000060 - Disclosure - OTHER CURRENT ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherCurrentAssetsAbstract" xlink:label="loc_clxOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:label="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EscrowRestrictedCashMember" xlink:label="loc_clxEscrowRestrictedCashMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_clxEscrowRestrictedCashMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignSubsidiaryRestrictedCashMember" xlink:label="loc_clxForeignSubsidiaryRestrictedCashMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_clxForeignSubsidiaryRestrictedCashMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="loc_us-gaapDeferredTaxAssetsNetCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent" xlink:label="loc_us-gaapOtherAssetsMiscellaneousCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="loc_us-gaapOtherAssetsMiscellaneousCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ppaend" xlink:title="00000061 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNetAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CapitalizedSoftwareCostsMember" xlink:label="loc_clxCapitalizedSoftwareCostsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_clxCapitalizedSoftwareCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandAndLandImprovementsMember" xlink:label="loc_us-gaapLandAndLandImprovementsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandAndLandImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaapConstructionInProgressMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapConstructionInProgressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:label="loc_us-gaapAssetsHeldUnderCapitalLeasesMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapAssetsHeldUnderCapitalLeasesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligation" xlink:label="loc_us-gaapAssetRetirementObligation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAssetRetirementObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NumberOfLeasedProperties" xlink:label="loc_clxNumberOfLeasedProperties" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_clxNumberOfLeasedProperties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:label="loc_us-gaapAssetRetirementObligationLiabilitiesIncurred" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAssetRetirementObligationLiabilitiesIncurred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationNonproduction" xlink:label="loc_us-gaapDepreciationNonproduction" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciationNonproduction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NonCashCapitalExpenditures" xlink:label="loc_clxNonCashCapitalExpenditures" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_clxNonCashCapitalExpenditures" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiand" xlink:title="00000062 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:label="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal" xlink:label="loc_clxFiniteLivedIntangibleAssetsUsefulLifeRenewal" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_clxFiniteLivedIntangibleAssetsUsefulLifeRenewal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiand" xlink:title="00000063 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:label="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:to="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" order="110" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ImpairmentOfTrademarks" xlink:label="loc_clxImpairmentOfTrademarks" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_clxImpairmentOfTrademarks" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiasogd" xlink:title="00000064 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:label="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaapScheduleOfGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:to="loc_us-gaapScheduleOfGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaapGoodwillLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfGoodwillTable" xlink:to="loc_us-gaapGoodwillLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfGoodwillTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CleaningMember" xlink:label="loc_clxCleaningMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxCleaningMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LifestyleMember" xlink:label="loc_clxLifestyleMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxLifestyleMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_HouseholdMember" xlink:label="loc_clxHouseholdMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxHouseholdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InternationalMember" xlink:label="loc_clxInternationalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxInternationalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillLineItems" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:label="loc_us-gaapGoodwillTranslationAndPurchaseAccountingAdjustments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillLineItems" xlink:to="loc_us-gaapGoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillLineItems" xlink:to="loc_us-gaapGoodwill_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiasoiaegd" xlink:title="00000065 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:label="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIntangibleAssetsAxis" xlink:label="loc_clxOtherIntangibleAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_clxOtherIntangibleAssetsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIntangibleAssetsDomain" xlink:label="loc_clxOtherIntangibleAssetsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherIntangibleAssetsAxis" xlink:to="loc_clxOtherIntangibleAssetsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TechnologyAndProductFormulaeMember" xlink:label="loc_clxTechnologyAndProductFormulaeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherIntangibleAssetsDomain" xlink:to="loc_clxTechnologyAndProductFormulaeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIntangibleAssetsOtherMember" xlink:label="loc_clxOtherIntangibleAssetsOtherMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherIntangibleAssetsDomain" xlink:to="loc_clxOtherIntangibleAssetsOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiasoiaegd" xlink:title="00000066 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:label="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxGoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:to="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" order="110" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000067 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_AccruedTradeAndSalesPromotionCostsCurrent" xlink:label="loc_clxAccruedTradeAndSalesPromotionCostsCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="loc_clxAccruedTradeAndSalesPromotionCostsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDividendsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dnd" xlink:title="00000068 - Disclosure - DEBT (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LongTermAndShortTermDebtLineItems" xlink:label="loc_clxLongTermAndShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_clxLongTermAndShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes3.55PercentMember" xlink:label="loc_clxSeniorNotes3.55PercentMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_clxSeniorNotes3.55PercentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes3.50PercentMember" xlink:label="loc_clxSeniorNotes3.50PercentMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_clxSeniorNotes3.50PercentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes5.00PercentMember" xlink:label="loc_clxSeniorNotes5.00PercentMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_clxSeniorNotes5.00PercentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RevolvingLineOfCreditMember" xlink:label="loc_clxRevolvingLineOfCreditMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_clxRevolvingLineOfCreditMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignAndOtherCreditLinesMember" xlink:label="loc_clxForeignAndOtherCreditLinesMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_clxForeignAndOtherCreditLinesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaapCommercialPaperMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapCommercialPaperMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="loc_us-gaapDebtInstrumentPaymentTerms" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPaymentTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod" xlink:label="loc_clxShortTermDebtWeightedAverageInterestRateDuringPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_clxShortTermDebtWeightedAverageInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaapShortTermDebtWeightedAverageInterestRate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapShortTermDebtWeightedAverageInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps" xlink:label="loc_clxWeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_clxWeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaapLongtermDebtWeightedAverageInterestRate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLongtermDebtWeightedAverageInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityRemainingBorrowingCapacity" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaapLongTermDebtByMaturityAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLongTermDebtByMaturityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dnalpd" xlink:title="00000069 - Disclosure - DEBT (Notes and Loans Payable) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaapCommercialPaperMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapCommercialPaperMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignBorrowingsMember" xlink:label="loc_clxForeignBorrowingsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_clxForeignBorrowingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaper" xlink:label="loc_us-gaapCommercialPaper" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapCommercialPaper" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dldnoudopd" xlink:title="00000070 - Disclosure - DEBT (Long-term Debt, Net of Unamortized Discounts or Premiums) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" xlink:label="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" xlink:label="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" xlink:label="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" xlink:label="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" xlink:label="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaapLongtermDebtWeightedAverageInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongtermDebtWeightedAverageInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dbcuofad" xlink:title="00000071 - Disclosure - DEBT (Borrowing Capacity Under Other Financing Arrangements) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaapRevolvingCreditFacilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_us-gaapRevolvingCreditFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignCreditLinesMember" xlink:label="loc_clxForeignCreditLinesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_clxForeignCreditLinesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherCreditLinesMember" xlink:label="loc_clxOtherCreditLinesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_clxOtherCreditLinesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-old1" xlink:title="00000072 - Disclosure - OTHER LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EmployeeBenefitObligationsNoncurrent" xlink:label="loc_clxEmployeeBenefitObligationsNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_clxEmployeeBenefitObligationsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VentureAgreementNetTerminalObligation" xlink:label="loc_clxVentureAgreementNetTerminalObligation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_clxVentureAgreementNetTerminalObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="loc_us-gaapLiabilityForUncertainTaxPositionsNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapLiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement" xlink:label="loc_clxMaximumPercentageOfNoncontrollingInterestInVentureAgreement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_clxMaximumPercentageOfNoncontrollingInterestInVentureAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VentureAgreementTerm" xlink:label="loc_clxVentureAgreementTerm" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_clxVentureAgreementTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VentureAgreementRenewalOption" xlink:label="loc_clxVentureAgreementRenewalOption" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_clxVentureAgreementRenewalOption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement" xlink:label="loc_clxTotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_clxTotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities" xlink:label="loc_us-gaapSaleLeasebackTransactionNetProceedsInvestingActivities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapSaleLeasebackTransactionNetProceedsInvestingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SaleLeasebackTransactionLeaseTerm" xlink:label="loc_clxSaleLeasebackTransactionLeaseTerm" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_clxSaleLeasebackTransactionLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain" xlink:label="loc_clxSaleLeasebackTransactionNoncurrentPortionOfDeferredGain" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_clxSaleLeasebackTransactionNoncurrentPortionOfDeferredGain" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmnd1" xlink:title="00000073 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaapDerivativeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapDerivativeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaapDerivativeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapDerivativeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateContractMember" xlink:label="loc_us-gaapInterestRateContractMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapInterestRateContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeNatureAxis" xlink:label="loc_clxDerivativeNatureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_clxDerivativeNatureAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeNatureDomain" xlink:label="loc_clxDerivativeNatureDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDerivativeNatureAxis" xlink:to="loc_clxDerivativeNatureDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_JetFuelMember" xlink:label="loc_clxJetFuelMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDerivativeNatureDomain" xlink:to="loc_clxJetFuelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SoybeanOilMember" xlink:label="loc_clxSoybeanOilMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDerivativeNatureDomain" xlink:to="loc_clxSoybeanOilMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes3.50PercentMember" xlink:label="loc_clxSeniorNotes3.50PercentMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_clxSeniorNotes3.50PercentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeIntrumentsMaximumContractDuration" xlink:label="loc_clxDerivativeIntrumentsMaximumContractDuration" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDerivativeIntrumentsMaximumContractDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_investDerivativeNotionalAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_investDerivativeNotionalAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InterestRateForwardContractsSettlement" xlink:label="loc_clxInterestRateForwardContractsSettlement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxInterestRateForwardContractsSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SettlementOfInterestRateForwardContract" xlink:label="loc_clxSettlementOfInterestRateForwardContract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxSettlementOfInterestRateForwardContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:label="loc_clxDeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers" xlink:label="loc_us-gaapGoodFaithAndMarginDepositsWithBrokerDealers" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapGoodFaithAndMarginDepositsWithBrokerDealers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:label="loc_clxDerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MarginDepositAssets" xlink:label="loc_us-gaapMarginDepositAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapMarginDepositAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="loc_us-gaapCashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapCashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmsofimafvd1" xlink:title="00000074 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Financial Instruments Measured at Fair Value) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FairValueMeasurementsRecurringTable" xlink:label="loc_clxFairValueMeasurementsRecurringTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_clxFairValueMeasurementsRecurringTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:label="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="loc_us-gaapCashAndCashEquivalentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapCashAndCashEquivalentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="loc_us-gaapOtherCurrentAssetsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherCurrentAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaapOtherAssetsMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaapNotesPayableOtherPayablesMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapNotesPayableOtherPayablesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="loc_us-gaapOtherLiabilitiesMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaapFairValueByMeasurementBasisAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapFairValueByMeasurementBasisAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaapFairValueDisclosureItemAmountsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementBasisAxis" xlink:to="loc_us-gaapFairValueDisclosureItemAmountsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosureItemAmountsDomain" xlink:to="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosureItemAmountsDomain" xlink:to="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaapCashAndCashEquivalentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapCashAndCashEquivalentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaapMoneyMarketFundsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapMoneyMarketFundsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BankTimeDepositsMember" xlink:label="loc_us-gaapBankTimeDepositsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapBankTimeDepositsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMember" xlink:label="loc_us-gaapLongTermDebtMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapLongTermDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:label="loc_us-gaapCashFlowHedgeDerivativeInstrumentAssetsAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_us-gaapCashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="loc_us-gaapDeferredCompensationPlanAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_us-gaapDeferredCompensationPlanAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosureRecurring" xlink:label="loc_us-gaapAssetsFairValueDisclosureRecurring" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosureRecurring" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:label="loc_us-gaapCashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_us-gaapCashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureRecurring" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosureRecurring" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosureRecurring" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmsoeodidahid1" xlink:title="00000075 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateContractMember" xlink:label="loc_us-gaapInterestRateContractMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapInterestRateContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocagd" xlink:title="00000076 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherContingenciesAndGuaranteesAbstract" xlink:label="loc_clxOtherContingenciesAndGuaranteesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies" xlink:label="loc_us-gaapAccrualForEnvironmentalLossContingencies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_us-gaapAccrualForEnvironmentalLossContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:label="loc_clxSiteContingencyAgreedPercentageOfCostSharing" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_clxSiteContingencyAgreedPercentageOfCostSharing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RemediationPeriod" xlink:label="loc_clxRemediationPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_clxRemediationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LetterOfCreditBorrowingCapacity" xlink:label="loc_clxLetterOfCreditBorrowingCapacity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_clxLetterOfCreditBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaapLettersOfCreditOutstandingAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_us-gaapLettersOfCreditOutstandingAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/LeasesAndOtherCommitmentsDetails" xlink:title="00000077 - Disclosure - LEASES AND OTHER COMMITMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LeasesAndOtherCommitmentsAbstract" xlink:label="loc_clxLeasesAndOtherCommitmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLeasesAndOtherCommitmentsAbstract" xlink:to="loc_us-gaapLeaseAndRentalExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLeasesAndOtherCommitmentsAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLeasesAndOtherCommitmentsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueThereafter" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationAbstract" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxLeasesAndOtherCommitmentsAbstract" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationAbstract" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationAbstract" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationAbstract" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationAbstract" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationAbstract" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationAbstract" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationAbstract" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sesrpd" xlink:title="00000078 - Disclosure - STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareRepurchaseProgramsTable" xlink:label="loc_clxShareRepurchaseProgramsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_clxShareRepurchaseProgramsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareRepurchaseProgramsLineItems" xlink:label="loc_clxShareRepurchaseProgramsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsTable" xlink:to="loc_clxShareRepurchaseProgramsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaapShareRepurchaseProgramAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsTable" xlink:to="loc_us-gaapShareRepurchaseProgramAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OpenMarketProgramMember" xlink:label="loc_clxOpenMarketProgramMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_clxOpenMarketProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EvergreenProgramMember" xlink:label="loc_clxEvergreenProgramMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_clxEvergreenProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-secsdd" xlink:title="00000079 - Disclosure - STOCKHOLDERS' EQUITY (Common Stock Dividends) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaapCommonStockDividendsPerShareDeclared" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapCommonStockDividendsPerShareDeclared" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid" xlink:label="loc_us-gaapCommonStockDividendsPerShareCashPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapCommonStockDividendsPerShareCashPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:title="00000080 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaapAccumulatedTranslationAdjustmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedTranslationAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaapAccumulatedDefinedBenefitPlansAdjustmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StockholdersEquityNarrativeDetails" xlink:title="00000081 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:label="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceLineItems" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LongTermIntercompanyLoansMember" xlink:label="loc_clxLongTermIntercompanyLoansMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" xlink:to="loc_clxLongTermIntercompanyLoansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:label="loc_us-gaapAdjustmentForLongTermIntercompanyTransactionsNetOfTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" xlink:to="loc_us-gaapAdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-nepsed" xlink:title="00000082 - Disclosure - NET EARNINGS PER SHARE (EPS) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpnd" xlink:title="00000083 - Disclosure - STOCK-BASED COMPENSATION PLANS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaapShareBasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsMember" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaapPerformanceSharesMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapPerformanceSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap" xlink:label="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageCap" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageCap" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VestedAwardsWerePaidByIssuanceOfShares" xlink:label="loc_clxVestedAwardsWerePaidByIssuanceOfShares" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxVestedAwardsWerePaidByIssuanceOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VestedStockAwardsDeferred" xlink:label="loc_clxVestedStockAwardsDeferred" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxVestedStockAwardsDeferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsGranted" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsGranted" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsReinvestedDividends" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsReinvestedDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsDistributed" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsDistributed" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsDistributed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsOutstanding" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpccaritbd" xlink:title="00000084 - Disclosure - STOCK-BASED COMPENSATION PLANS (Compensation Cost and Related Income Tax Benefit) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaapShareBasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaapSellingAndMarketingExpenseMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingAndMarketingExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpauiviccefsogd" xlink:title="00000085 - Disclosure - STOCK-BASED COMPENSATION PLANS (Assumptions Utilized in the Valuation in Calculating the Compensation Expense for Stock Options Granted) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaapShareBasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum" xlink:label="loc_clxSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_clxSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum" xlink:label="loc_clxSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_clxSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm" xlink:label="loc_clxSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_clxSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpsosoad" xlink:title="00000086 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Stock Option Activity) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaapShareBasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpsorsaad" xlink:title="00000087 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Restricted Stock Award Activity) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaapShareBasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpsopsaad" xlink:title="00000088 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Performance Stock Award Activity) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaapShareBasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaapPerformanceSharesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapPerformanceSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails" xlink:title="00000089 - Disclosure - OTHER (INCOME) EXPENSE, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LowIncomeHousingPartnershipGainsLosses" xlink:label="loc_clxLowIncomeHousingPartnershipGainsLosses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_clxLowIncomeHousingPartnershipGainsLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_AmortizationOfTrademarksAndOtherIntangibleAssets" xlink:label="loc_clxAmortizationOfTrademarksAndOtherIntangibleAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_clxAmortizationOfTrademarksAndOtherIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MiscellaneousOtherIncomeExpense" xlink:label="loc_clxMiscellaneousOtherIncomeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_clxMiscellaneousOtherIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails" xlink:title="00000090 - Disclosure - OTHER (INCOME) EXPENSE, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" order="110" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ImpairmentOfTrademarks" xlink:label="loc_clxImpairmentOfTrademarks" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_clxImpairmentOfTrademarks" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itnd" xlink:title="00000091 - Disclosure - INCOME TAXES (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_IncomeTaxesTable" xlink:label="loc_clxIncomeTaxesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_clxIncomeTaxesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TaxCreditAndOperatingLossCarryforwardsLineItems" xlink:label="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaapTaxCreditCarryforwardAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_us-gaapTaxCreditCarryforwardAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaapTaxCreditCarryforwardNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxCreditCarryforwardAxis" xlink:to="loc_us-gaapTaxCreditCarryforwardNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignTaxCreditCarryforwardMember" xlink:label="loc_clxForeignTaxCreditCarryforwardMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxCreditCarryforwardNameDomain" xlink:to="loc_clxForeignTaxCreditCarryforwardMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignMember" xlink:label="loc_clxForeignMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_clxForeignMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaapTaxPeriodAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_us-gaapTaxPeriodAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaapTaxPeriodDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodAxis" xlink:to="loc_us-gaapTaxPeriodDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="loc_us-gaapEarliestTaxYearMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_us-gaapEarliestTaxYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="loc_us-gaapLatestTaxYearMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_us-gaapLatestTaxYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ExpirationPeriodAxis" xlink:label="loc_clxExpirationPeriodAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_clxExpirationPeriodAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ExpirationPeriodDomain" xlink:label="loc_clxExpirationPeriodDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxExpirationPeriodAxis" xlink:to="loc_clxExpirationPeriodDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NotSubjectToExpirationMember" xlink:label="loc_clxNotSubjectToExpirationMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxExpirationPeriodDomain" xlink:to="loc_clxNotSubjectToExpirationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SubjectToExpirationMember" xlink:label="loc_clxSubjectToExpirationMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxExpirationPeriodDomain" xlink:to="loc_clxSubjectToExpirationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationsOtherMember" xlink:label="loc_clxDiscontinuedOperationsOtherMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxDiscontinuedOperationsOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:label="loc_us-gaapUndistributedEarningsOfForeignSubsidiaries" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapUndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability" xlink:label="loc_clxDeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_clxDeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions" xlink:label="loc_us-gaapIncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaapOpenTaxYear" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOpenTaxYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaapTaxCreditCarryforwardAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapTaxCreditCarryforwardAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate" xlink:label="loc_us-gaapTaxCreditCarryforwardExpirationDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapTaxCreditCarryforwardExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaapOperatingLossCarryforwardsExpirationDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itpfitbtjadafebtd" xlink:title="00000092 - Disclosure - INCOME TAXES (Provision for Income Taxes by Tax Jurisdiction and Domestic and Foreign Earnings before Taxes) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-iteitrrd" xlink:title="00000093 - Disclosure - INCOME TAXES (Effective Income Tax Rate Reconciliation) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itcondtad" xlink:title="00000094 - Disclosure - INCOME TAXES (Components of Net Deferred Tax Assets) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" xlink:label="loc_clxDeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_clxDeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" xlink:label="loc_clxDeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_clxDeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" xlink:label="loc_clxDeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_clxDeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships" xlink:label="loc_clxDeferredTaxLiabilitiesLowIncomeHousingPartnerships" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_clxDeferredTaxLiabilitiesLowIncomeHousingPartnerships" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:label="loc_us-gaapDeferredTaxLiabilitiesUndistributedForeignEarnings" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itvad" xlink:title="00000095 - Disclosure - INCOME TAXES (Valuation Allowance) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets" xlink:label="loc_clxValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_clxValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits" xlink:label="loc_clxValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_clxValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itutbd" xlink:title="00000096 - Disclosure - INCOME TAXES (Unrecognized Tax Benefits) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapUnrecognizedTaxBenefits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UnrecognizedTaxBenefitsSettlements" xlink:label="loc_clxUnrecognizedTaxBenefitsSettlements" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_clxUnrecognizedTaxBenefitsSettlements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapUnrecognizedTaxBenefits_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpnd" xlink:title="00000097 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DomesticQualifiedRetirementIncomePlansMember" xlink:label="loc_clxDomesticQualifiedRetirementIncomePlansMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxDomesticQualifiedRetirementIncomePlansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DomesticNonQualifiedRetirementIncomePlansMember" xlink:label="loc_clxDomesticNonQualifiedRetirementIncomePlansMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxDomesticNonQualifiedRetirementIncomePlansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MedicalMember" xlink:label="loc_clxMedicalMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxMedicalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_PrescriptionDrugsMember" xlink:label="loc_clxPrescriptionDrugsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxPrescriptionDrugsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCarePlanMember" xlink:label="loc_clxRetirementHealthCarePlanMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCarePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomePlanMember" xlink:label="loc_clxRetirementIncomePlanMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapStatementScenarioAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaapScenarioForecastMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_us-gaapScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="loc_us-gaapDefinedBenefitPlanContributionsByEmployer" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanContributionsByEmployer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate" xlink:label="loc_us-gaapDefinedBenefitPlanUltimateHealthCareCostTrendRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanUltimateHealthCareCostTrendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanYearThatRateReachesUltimateTrendRate" xlink:label="loc_us-gaapDefinedBenefitPlanYearThatRateReachesUltimateTrendRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanYearThatRateReachesUltimateTrendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_BasisPointIncreaseDecrease" xlink:label="loc_clxBasisPointIncreaseDecrease" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxBasisPointIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscretionaryCompanyContributions" xlink:label="loc_clxDiscretionaryCompanyContributions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxDiscretionaryCompanyContributions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit" xlink:label="loc_us-gaapDefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss" xlink:label="loc_us-gaapDefinedBenefitPlanFutureAmortizationOfGainLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanFutureAmortizationOfGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod" xlink:label="loc_clxNondiscretionaryDomesticProfitSharingContributionsDuringPeriod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxNondiscretionaryDomesticProfitSharingContributionsDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanOtherChanges" xlink:label="loc_us-gaapDefinedBenefitPlanOtherChanges" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanOtherChanges" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpnd" xlink:title="00000098 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="loc_us-gaapDefinedContributionPlanTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapDefinedContributionPlanTable" order="110" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedContributionPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedContributionPlanTable" xlink:to="loc_us-gaapDefinedContributionPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanNameAxis" xlink:label="loc_us-gaapDefinedContributionPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedContributionPlanTable" xlink:to="loc_us-gaapDefinedContributionPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanNameDomain" xlink:label="loc_us-gaapDefinedContributionPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedContributionPlanNameAxis" xlink:to="loc_us-gaapDefinedContributionPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompanyFourZeroOneKPlanMember" xlink:label="loc_clxCompanyFourZeroOneKPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedContributionPlanNameDomain" xlink:to="loc_clxCompanyFourZeroOneKPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InternationalDefinedContributionPlanMember" xlink:label="loc_clxInternationalDefinedContributionPlanMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedContributionPlanNameDomain" xlink:to="loc_clxInternationalDefinedContributionPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaapDefinedContributionPlanCostRecognized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedContributionPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedContributionPlanCostRecognized" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpsifdbriahpd" xlink:title="00000099 - Disclosure - EMPLOYEE BENEFIT PLANS (Summarized Information for Defined Benefit Retirement Income and Healthcare Plans) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanBenefitObligation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanBenefitObligation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaapDefinedBenefitPlanServiceCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanServiceCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaapDefinedBenefitPlanInterestCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanInterestCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:label="loc_us-gaapDefinedBenefitPlanActuarialGainLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanActuarialGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments" xlink:label="loc_us-gaapDefinedBenefitPlanPlanAmendments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanPlanAmendments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitsPaid" xlink:label="loc_us-gaapDefinedBenefitPlanBenefitsPaid" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanBenefitsPaid" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanBenefitObligation_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanBenefitObligation_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanFairValueOfPlanAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanActualReturnOnPlanAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="loc_us-gaapDefinedBenefitPlanContributionsByEmployer" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanContributionsByEmployer" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitsPaid" xlink:label="loc_us-gaapDefinedBenefitPlanBenefitsPaid_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanBenefitsPaid_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanFairValueOfPlanAssets_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="loc_us-gaapDefinedBenefitPlanFairValueOfPlanAssets_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:label="loc_us-gaapDefinedBenefitPlanFundedStatusOfPlan" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:label="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent" xlink:label="loc_us-gaapDefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:label="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:label="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheet" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpifripwaboieopad" xlink:title="00000100 - Disclosure - EMPLOYEE BENEFIT PLANS (Information for Retirement Income Plans with Accumulated Benefit Obligation in Excess of Plan Assets) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember" xlink:label="loc_us-gaapPensionPlansDefinedBenefitMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_us-gaapPensionPlansDefinedBenefitMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:label="loc_us-gaapOtherPensionPlansDefinedBenefitMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_us-gaapOtherPensionPlansDefinedBenefitMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpconcoriahcpd" xlink:title="00000101 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income and Health Care Plans) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaapDefinedBenefitPlanServiceCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanServiceCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaapDefinedBenefitPlanInterestCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanInterestCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpinyracoped" xlink:title="00000102 - Disclosure - EMPLOYEE BENEFIT PLANS (Items Not Yet Recognized as a Component of Postretirement Expense) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpnalgapscbariaoclid" xlink:title="00000103 - Disclosure - EMPLOYEE BENEFIT PLANS (Net Actuarial Loss (Gain) and Prior Service Cost (Benefit) Activity Recorded in Accumulated Other Comprehensive Loss (Income)) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost" xlink:label="loc_clxOtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxOtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod" xlink:label="loc_clxOtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxOtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpwautenppaopbcd" xlink:title="00000104 - Disclosure - EMPLOYEE BENEFIT PLANS (Weighted-Average Assumptions Used to Estimate the Net Periodic Pension and Other Postretirement Benefit Costs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:label="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:label="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:label="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:label="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:label="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:label="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:label="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpebpd" xlink:title="00000105 - Disclosure - EMPLOYEE BENEFIT PLANS (Expected Benefit Payments) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebptaawaaad" xlink:title="00000106 - Disclosure - EMPLOYEE BENEFIT PLANS (Target Allocations and Weighted Average Asset Allocations) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UnitedStatesEquityMember" xlink:label="loc_clxUnitedStatesEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxUnitedStatesEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignEquitySecuritiesMember" xlink:label="loc_clxForeignEquitySecuritiesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxForeignEquitySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FixedIncomeFundsMember" xlink:label="loc_us-gaapFixedIncomeFundsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_us-gaapFixedIncomeFundsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCreditDerivativesMember" xlink:label="loc_us-gaapOtherCreditDerivativesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_us-gaapOtherCreditDerivativesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations" xlink:label="loc_us-gaapDefinedBenefitPlanTargetPlanAssetAllocations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanTargetPlanAssetAllocations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:label="loc_us-gaapDefinedBenefitPlanWeightedAverageAssetAllocations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlansAssetsCarriedAtFairValueDetails" xlink:title="00000107 - Disclosure - EMPLOYEE BENEFIT PLANS (Retirement Income Plan's Assets Carried at Fair Value) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="loc_us-gaapDefinedBenefitPlanByPlanAssetCategoriesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanByPlanAssetCategoriesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="loc_us-gaapPlanAssetCategoriesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="loc_us-gaapPlanAssetCategoriesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_BondFundMember" xlink:label="loc_clxBondFundMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanAssetCategoriesDomain" xlink:to="loc_clxBondFundMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignEquitySecuritiesMember" xlink:label="loc_clxForeignEquitySecuritiesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanAssetCategoriesDomain" xlink:to="loc_clxForeignEquitySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DomesticEquitySecuritiesMember" xlink:label="loc_clxDomesticEquitySecuritiesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanAssetCategoriesDomain" xlink:to="loc_clxDomesticEquitySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RealEstateFundMember" xlink:label="loc_clxRealEstateFundMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanAssetCategoriesDomain" xlink:to="loc_clxRealEstateFundMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CashEquivalents" xlink:label="loc_clxCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MutualFunds" xlink:label="loc_clxMutualFunds" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxMutualFunds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CommonOrCollectiveTrusts" xlink:label="loc_clxCommonOrCollectiveTrusts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxCommonOrCollectiveTrusts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanFairValueOfPlanAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:title="00000108 - Disclosure - SEGMENT REPORTING (Selected Financial Information Relating To Company's Segments ) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapSegmentReportingInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CleaningMember" xlink:label="loc_clxCleaningMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxCleaningMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_HouseholdMember" xlink:label="loc_clxHouseholdMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxHouseholdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LifestyleMember" xlink:label="loc_clxLifestyleMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxLifestyleMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InternationalMember" xlink:label="loc_clxInternationalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxInternationalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="loc_us-gaapCorporateMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_us-gaapCorporateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-srnsalabgad" xlink:title="00000109 - Disclosure - SEGMENT REPORTING (Net Sales and Long-Lived Assets by Geographic Area) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignMember" xlink:label="loc_clxForeignMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_clxForeignMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-srcpd" xlink:title="00000110 - Disclosure - SEGMENT REPORTING (Concentration Percentages) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaapProductConcentrationRiskMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapProductConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaapMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_WalmartStoresIncMember" xlink:label="loc_clxWalmartStoresIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_clxWalmartStoresIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TopFiveLargestCustomersMember" xlink:label="loc_clxTopFiveLargestCustomersMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_clxTopFiveLargestCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaapProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapProductOrServiceAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaapProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductOrServiceAxis" xlink:to="loc_us-gaapProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LiquidBleachMember" xlink:label="loc_clxLiquidBleachMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductsAndServicesDomain" xlink:to="loc_clxLiquidBleachMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TrashBagsMember" xlink:label="loc_clxTrashBagsMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductsAndServicesDomain" xlink:to="loc_clxTrashBagsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CharcoalMember" xlink:label="loc_clxCharcoalMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductsAndServicesDomain" xlink:to="loc_clxCharcoalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CleaningMember" xlink:label="loc_clxCleaningMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxCleaningMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InternationalMember" xlink:label="loc_clxInternationalMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxInternationalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_HouseholdMember" xlink:label="loc_clxHouseholdMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxHouseholdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-rptd" xlink:title="00000111 - Disclosure - RELATED PARTY TRANSACTIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MaximumOwnershipPercentageOfEquityInvestments" xlink:label="loc_clxMaximumOwnershipPercentageOfEquityInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_clxMaximumOwnershipPercentageOfEquityInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-uqdd" xlink:title="00000112 - Disclosure - UNAUDITED QUARTERLY DATA (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract" xlink:label="loc_us-gaapQuarterlyFinancialDataAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_us-gaapSalesRevenueGoodsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareDilutedAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaapCommonStockDividendsPerShareDeclared" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_us-gaapCommonStockDividendsPerShareDeclared" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh" xlink:label="loc_clxRangeOfNyseMarketPriceOfEntityCommonStockHigh" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_clxRangeOfNyseMarketPriceOfEntityCommonStockHigh" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RangeOfNyseMarketPriceOfEntityCommonStockLow" xlink:label="loc_clxRangeOfNyseMarketPriceOfEntityCommonStockLow" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_clxRangeOfNyseMarketPriceOfEntityCommonStockLow" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NyseMarketPriceOfEntityCommonStockPeriodEnd" xlink:label="loc_clxNyseMarketPriceOfEntityCommonStockPeriodEnd" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialDataAbstract" xlink:to="loc_clxNyseMarketPriceOfEntityCommonStockPeriodEnd" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-vaqaard" xlink:title="00000113 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_us-gaapValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_us-gaapValuationAndQualifyingAccountsDisclosureTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAndQualifyingAccountsAbstract" xlink:to="loc_us-gaapValuationAndQualifyingAccountsDisclosureTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureTable" xlink:to="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaapValuationAllowancesAndReservesTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureTable" xlink:to="loc_us-gaapValuationAllowancesAndReservesTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaapValuationAllowancesAndReservesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAllowancesAndReservesTypeAxis" xlink:to="loc_us-gaapValuationAllowancesAndReservesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsMember" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LifoAllowanceMember" xlink:label="loc_clxLifoAllowanceMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_clxLifoAllowanceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="loc_us-gaapValuationAllowanceOfDeferredTaxAssetsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_us-gaapValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaapValuationAllowancesAndReservesBalance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesBalance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaapValuationAllowancesAndReservesChargedToCostAndExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses" xlink:label="loc_clxValuationAllowancesAndReservesCreditedToCostsAndExpenses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_clxValuationAllowancesAndReservesCreditedToCostsAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaapValuationAllowancesAndReservesDeductions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesDeductions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaapValuationAllowancesAndReservesBalance_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesBalance_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>20
<FILENAME>clx-20160630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: Clorox 0616 10K Final to Update.xfr; Date: 2016%2D08%2D12T16:24:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80AE0001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated Other Comprehensive Net (Losses) Income [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_lbl" xml:lang="en-US">Building and leasehold improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandImprovementsMember" xlink:label="us-gaap_LandImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandImprovementsMember" xlink:to="us-gaap_LandImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandImprovementsMember_lbl" xml:lang="en-US">Land Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CapitalizedSoftwareCostsMember" xlink:label="clx_CapitalizedSoftwareCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CapitalizedSoftwareCostsMember" xlink:to="clx_CapitalizedSoftwareCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CapitalizedSoftwareCostsMember_lbl" xml:lang="en-US">Capitalized software costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VenezuelanSubsidiaryMember" xlink:label="clx_VenezuelanSubsidiaryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VenezuelanSubsidiaryMember" xlink:to="clx_VenezuelanSubsidiaryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_VenezuelanSubsidiaryMember_lbl" xml:lang="en-US">Clorox Venezuela [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationsOtherMember" xlink:label="clx_DiscontinuedOperationsOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationsOtherMember" xlink:to="clx_DiscontinuedOperationsOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DiscontinuedOperationsOtherMember_lbl" xml:lang="en-US">Other Discontinued Operations [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="us-gaap_CorporateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateMember" xlink:to="us-gaap_CorporateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CorporateMember_lbl" xml:lang="en-US">Corporate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segment Reporting Information, by Segment [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Buildings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandAndLandImprovementsMember" xlink:label="us-gaap_LandAndLandImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandAndLandImprovementsMember" xlink:to="us-gaap_LandAndLandImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandAndLandImprovementsMember_lbl" xml:lang="en-US">Land improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US">Construction in progress [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:label="us-gaap_AssetsHeldUnderCapitalLeasesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:to="us-gaap_AssetsHeldUnderCapitalLeasesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldUnderCapitalLeasesMember_lbl" xml:lang="en-US">Equipment held under capital leases [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LifestyleMember" xlink:label="clx_LifestyleMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LifestyleMember" xlink:to="clx_LifestyleMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LifestyleMember_lbl" xml:lang="en-US">Lifestyle [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_HouseholdMember" xlink:label="clx_HouseholdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_HouseholdMember" xlink:to="clx_HouseholdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_HouseholdMember_lbl" xml:lang="en-US">Household [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InternationalMember" xlink:label="clx_InternationalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InternationalMember" xlink:to="clx_InternationalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_InternationalMember_lbl" xml:lang="en-US">International [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CleaningMember" xlink:label="clx_CleaningMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CleaningMember" xlink:to="clx_CleaningMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CleaningMember_lbl" xml:lang="en-US">Cleaning [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademarks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TechnologyAndProductFormulaeMember" xlink:label="clx_TechnologyAndProductFormulaeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TechnologyAndProductFormulaeMember" xlink:to="clx_TechnologyAndProductFormulaeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_TechnologyAndProductFormulaeMember_lbl" xml:lang="en-US">Technology And product formulae [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIntangibleAssetsAxis" xlink:label="clx_OtherIntangibleAssetsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIntangibleAssetsAxis" xlink:to="clx_OtherIntangibleAssetsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherIntangibleAssetsAxis_lbl" xml:lang="en-US">Other Intangible Assets [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIntangibleAssetsOtherMember" xlink:label="clx_OtherIntangibleAssetsOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIntangibleAssetsOtherMember" xlink:to="clx_OtherIntangibleAssetsOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherIntangibleAssetsOtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes3.55PercentMember" xlink:label="clx_SeniorNotes3.55PercentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorNotes3.55PercentMember" xlink:to="clx_SeniorNotes3.55PercentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SeniorNotes3.55PercentMember_lbl" xml:lang="en-US">Senior notes with an annual fixed interest rate of 3.55% [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes3.50PercentMember" xlink:label="clx_SeniorNotes3.50PercentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorNotes3.50PercentMember" xlink:to="clx_SeniorNotes3.50PercentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SeniorNotes3.50PercentMember_lbl" xml:lang="en-US">Senior notes with an annual fixed interest rate of 3.50% [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RevolvingLineOfCreditMember" xlink:label="clx_RevolvingLineOfCreditMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RevolvingLineOfCreditMember" xlink:to="clx_RevolvingLineOfCreditMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RevolvingLineOfCreditMember_lbl" xml:lang="en-US">Revolving Line of Credit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US">Line of Credit Facility [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommercialPaperMember_lbl" xml:lang="en-US">Commercial Paper [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignAndOtherCreditLinesMember" xlink:label="clx_ForeignAndOtherCreditLinesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignAndOtherCreditLinesMember" xlink:to="clx_ForeignAndOtherCreditLinesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ForeignAndOtherCreditLinesMember_lbl" xml:lang="en-US">Foreign and Other Credit Lines [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignBorrowingsMember" xlink:label="clx_ForeignBorrowingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignBorrowingsMember" xlink:to="clx_ForeignBorrowingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ForeignBorrowingsMember_lbl" xml:lang="en-US">Foreign Borrowings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember_lbl" xml:lang="en-US">Senior Unsecured Long-Term Notes and Debentures; 3.55%, $300 Due November 2015 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember_lbl" xml:lang="en-US">Senior Unsecured Long-Term Notes and Debentures; 5.95%, $400 Due October 2017 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember_lbl" xml:lang="en-US">Senior Unsecured Long-Term Notes and Debentures; 3.80%, $300 Due November 2021 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember_lbl" xml:lang="en-US">Senior Unsecured Long-Term Notes and Debentures; 3.05%, $600 Due November 2022 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember_lbl" xml:lang="en-US">Senior Unsecured Long-Term Notes and Debentures; 3.50%, $500 Due December 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignCreditLinesMember" xlink:label="clx_ForeignCreditLinesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignCreditLinesMember" xlink:to="clx_ForeignCreditLinesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ForeignCreditLinesMember_lbl" xml:lang="en-US">Foreign Credit Lines [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherCreditLinesMember" xlink:label="clx_OtherCreditLinesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherCreditLinesMember" xlink:to="clx_OtherCreditLinesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherCreditLinesMember_lbl" xml:lang="en-US">Other Credit Lines [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateContractMember" xlink:label="us-gaap_InterestRateContractMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestRateContractMember" xlink:to="us-gaap_InterestRateContractMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestRateContractMember_lbl" xml:lang="en-US">Interest rate derivative contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Derivative Instrument Risk [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="us-gaap_ForeignExchangeContractMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignExchangeContractMember" xlink:to="us-gaap_ForeignExchangeContractMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignExchangeContractMember_lbl" xml:lang="en-US">Foreign exchange derivative contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="us-gaap_CommodityContractMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommodityContractMember" xlink:to="us-gaap_CommodityContractMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommodityContractMember_lbl" xml:lang="en-US">Commodity purchase derivative contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_JetFuelMember" xlink:label="clx_JetFuelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_JetFuelMember" xlink:to="clx_JetFuelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_JetFuelMember_lbl" xml:lang="en-US">Jet Fuel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeNatureAxis" xlink:label="clx_DerivativeNatureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeNatureAxis" xlink:to="clx_DerivativeNatureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DerivativeNatureAxis_lbl" xml:lang="en-US">Derivative Nature [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SoybeanOilMember" xlink:label="clx_SoybeanOilMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SoybeanOilMember" xlink:to="clx_SoybeanOilMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SoybeanOilMember_lbl" xml:lang="en-US">Soybean Oil [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsMember" xlink:to="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Defined Benefit Plan, Fair Value of Plan Assets by Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" xml:lang="en-US">Carrying Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_lbl" xml:lang="en-US">Measurement Basis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Investments including money market funds [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xml:lang="en-US">Estimated Fair Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BankTimeDepositsMember" xlink:label="us-gaap_BankTimeDepositsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BankTimeDepositsMember" xlink:to="us-gaap_BankTimeDepositsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BankTimeDepositsMember_lbl" xml:lang="en-US">Time Deposits [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="us-gaap_OtherCurrentAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsMember" xlink:to="us-gaap_OtherCurrentAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsMember_lbl" xml:lang="en-US">Other Current Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsMember_lbl" xml:lang="en-US">Other assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="us-gaap_NotesPayableOtherPayablesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableOtherPayablesMember" xlink:to="us-gaap_NotesPayableOtherPayablesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableOtherPayablesMember_lbl" xml:lang="en-US">Notes and loans payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMember" xlink:label="us-gaap_LongTermDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMember" xlink:to="us-gaap_LongTermDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMember_lbl" xml:lang="en-US">Current maturities of long-term debt and Long-term debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesMember" xlink:to="us-gaap_OtherLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesMember_lbl" xml:lang="en-US">Other Liabilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EvergreenProgramMember" xlink:label="clx_EvergreenProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_EvergreenProgramMember" xlink:to="clx_EvergreenProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_EvergreenProgramMember_lbl" xml:lang="en-US">Evergreen Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="us-gaap_ShareRepurchaseProgramAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareRepurchaseProgramAxis" xlink:to="us-gaap_ShareRepurchaseProgramAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareRepurchaseProgramAxis_lbl" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LongTermIntercompanyLoansMember" xlink:label="clx_LongTermIntercompanyLoansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LongTermIntercompanyLoansMember" xlink:to="clx_LongTermIntercompanyLoansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LongTermIntercompanyLoansMember_lbl" xml:lang="en-US">Long term intercompany loans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:label="us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_lbl" xml:lang="en-US">Intercompany Foreign Currency Balance by Description [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OpenMarketProgramMember" xlink:label="clx_OpenMarketProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OpenMarketProgramMember" xlink:to="clx_OpenMarketProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OpenMarketProgramMember_lbl" xml:lang="en-US">Open-market program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Award Type and Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PerformanceSharesMember" xlink:to="us-gaap_PerformanceSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PerformanceSharesMember_lbl" xml:lang="en-US">Performance Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of products sold [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Selling and administrative expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and development costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NotSubjectToExpirationMember" xlink:label="clx_NotSubjectToExpirationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NotSubjectToExpirationMember" xlink:to="clx_NotSubjectToExpirationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_NotSubjectToExpirationMember_lbl" xml:lang="en-US">Not Subject to Expiration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ExpirationPeriodAxis" xlink:label="clx_ExpirationPeriodAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ExpirationPeriodAxis" xlink:to="clx_ExpirationPeriodAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ExpirationPeriodAxis_lbl" xml:lang="en-US">Expiration Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignMember" xlink:label="clx_ForeignMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignMember" xlink:to="clx_ForeignMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ForeignMember_lbl" xml:lang="en-US">Foreign [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignTaxCreditCarryforwardMember" xlink:label="clx_ForeignTaxCreditCarryforwardMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignTaxCreditCarryforwardMember" xlink:to="clx_ForeignTaxCreditCarryforwardMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ForeignTaxCreditCarryforwardMember_lbl" xml:lang="en-US">Foreign Tax Credit Carryforward [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SubjectToExpirationMember" xlink:label="clx_SubjectToExpirationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SubjectToExpirationMember" xlink:to="clx_SubjectToExpirationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SubjectToExpirationMember_lbl" xml:lang="en-US">Subject to Expiration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LatestTaxYearMember" xlink:to="us-gaap_LatestTaxYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LatestTaxYearMember_lbl" xml:lang="en-US">Latest tax year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxPeriodAxis_lbl" xml:lang="en-US">Tax Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarliestTaxYearMember" xlink:to="us-gaap_EarliestTaxYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarliestTaxYearMember_lbl" xml:lang="en-US">Earliest tax year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">U.S. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MedicalMember" xlink:label="clx_MedicalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MedicalMember" xlink:to="clx_MedicalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_MedicalMember_lbl" xml:lang="en-US">Medical [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_lbl" xml:lang="en-US">Defined Benefit Plans Disclosures, Defined Benefit Plans [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_PrescriptionDrugsMember" xlink:label="clx_PrescriptionDrugsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_PrescriptionDrugsMember" xlink:to="clx_PrescriptionDrugsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_PrescriptionDrugsMember_lbl" xml:lang="en-US">Prescription Drugs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCarePlanMember" xlink:label="clx_RetirementHealthCarePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementHealthCarePlanMember" xlink:to="clx_RetirementHealthCarePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RetirementHealthCarePlanMember_lbl" xml:lang="en-US">Retirement Health Care Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DomesticNonQualifiedRetirementIncomePlansMember" xlink:label="clx_DomesticNonQualifiedRetirementIncomePlansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DomesticNonQualifiedRetirementIncomePlansMember" xlink:to="clx_DomesticNonQualifiedRetirementIncomePlansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DomesticNonQualifiedRetirementIncomePlansMember_lbl" xml:lang="en-US">Domestic Non-Qualified Retirement Income Plans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="clx_RetirementIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementIncomeMember" xlink:to="clx_RetirementIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RetirementIncomeMember_lbl" xml:lang="en-US">Retirement Income [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="clx_RetirementHealthCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementHealthCareMember" xlink:to="clx_RetirementHealthCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RetirementHealthCareMember_lbl" xml:lang="en-US">Retirement Health Care [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember" xlink:label="us-gaap_PensionPlansDefinedBenefitMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionPlansDefinedBenefitMember" xlink:to="us-gaap_PensionPlansDefinedBenefitMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionPlansDefinedBenefitMember_lbl" xml:lang="en-US">Pension Plans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:label="us-gaap_OtherPensionPlansDefinedBenefitMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:to="us-gaap_OtherPensionPlansDefinedBenefitMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPensionPlansDefinedBenefitMember_lbl" xml:lang="en-US">Other Retirement Plans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DomesticQualifiedRetirementIncomePlansMember" xlink:label="clx_DomesticQualifiedRetirementIncomePlansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DomesticQualifiedRetirementIncomePlansMember" xlink:to="clx_DomesticQualifiedRetirementIncomePlansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DomesticQualifiedRetirementIncomePlansMember_lbl" xml:lang="en-US">Domestic Qualified Retirement Income Plans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompanyFourZeroOneKPlanMember" xlink:label="clx_CompanyFourZeroOneKPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CompanyFourZeroOneKPlanMember" xlink:to="clx_CompanyFourZeroOneKPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CompanyFourZeroOneKPlanMember_lbl" xml:lang="en-US">Company 401(k) plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanNameAxis" xlink:label="us-gaap_DefinedContributionPlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanNameAxis" xlink:to="us-gaap_DefinedContributionPlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedContributionPlanNameAxis_lbl" xml:lang="en-US">Defined Benefit Plans Disclosures, Defined Benefit Plans [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InternationalDefinedContributionPlanMember" xlink:label="clx_InternationalDefinedContributionPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InternationalDefinedContributionPlanMember" xlink:to="clx_InternationalDefinedContributionPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_InternationalDefinedContributionPlanMember_lbl" xml:lang="en-US">International Defined Contribution Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UnitedStatesEquityMember" xlink:label="clx_UnitedStatesEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_UnitedStatesEquityMember" xlink:to="clx_UnitedStatesEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_UnitedStatesEquityMember_lbl" xml:lang="en-US">U.S. Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignEquitySecuritiesMember" xlink:label="clx_ForeignEquitySecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignEquitySecuritiesMember" xlink:to="clx_ForeignEquitySecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ForeignEquitySecuritiesMember_lbl" xml:lang="en-US">International Equity Funds [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FixedIncomeFundsMember" xlink:label="us-gaap_FixedIncomeFundsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FixedIncomeFundsMember" xlink:to="us-gaap_FixedIncomeFundsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FixedIncomeFundsMember_lbl" xml:lang="en-US">Fixed Income [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCreditDerivativesMember" xlink:label="us-gaap_OtherCreditDerivativesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCreditDerivativesMember" xlink:to="us-gaap_OtherCreditDerivativesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCreditDerivativesMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_BondFundMember" xlink:label="clx_BondFundMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_BondFundMember" xlink:to="clx_BondFundMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_BondFundMember_lbl" xml:lang="en-US">Bond Fund [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_lbl" xml:lang="en-US">Defined Benefit Plan by Plan Asset Categories [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DomesticEquitySecuritiesMember" xlink:label="clx_DomesticEquitySecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DomesticEquitySecuritiesMember" xlink:to="clx_DomesticEquitySecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DomesticEquitySecuritiesMember_lbl" xml:lang="en-US">Domestic Equity Funds [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RealEstateFundMember" xlink:label="clx_RealEstateFundMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RealEstateFundMember" xlink:to="clx_RealEstateFundMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RealEstateFundMember_lbl" xml:lang="en-US">Real Estate Fund [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Net sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_WalmartStoresIncMember" xlink:label="clx_WalmartStoresIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_WalmartStoresIncMember" xlink:to="clx_WalmartStoresIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_WalmartStoresIncMember_lbl" xml:lang="en-US">Walmart Stores, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">United States [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TopFiveLargestCustomersMember" xlink:label="clx_TopFiveLargestCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TopFiveLargestCustomersMember" xlink:to="clx_TopFiveLargestCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_TopFiveLargestCustomersMember_lbl" xml:lang="en-US">Top Five Largest Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="us-gaap_ProductConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductConcentrationRiskMember" xlink:to="us-gaap_ProductConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductConcentrationRiskMember_lbl" xml:lang="en-US">Product Concentration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LiquidBleachMember" xlink:label="clx_LiquidBleachMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LiquidBleachMember" xlink:to="clx_LiquidBleachMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LiquidBleachMember_lbl" xml:lang="en-US">Liquid Bleach [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductOrServiceAxis_lbl" xml:lang="en-US">Products and Services [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TrashBagsMember" xlink:label="clx_TrashBagsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TrashBagsMember" xlink:to="clx_TrashBagsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_TrashBagsMember_lbl" xml:lang="en-US">Trash Bags [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CharcoalMember" xlink:label="clx_CharcoalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CharcoalMember" xlink:to="clx_CharcoalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CharcoalMember_lbl" xml:lang="en-US">Charcoal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsMember" xlink:label="us-gaap_AllowanceForDoubtfulAccountsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsMember" xlink:to="us-gaap_AllowanceForDoubtfulAccountsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsMember_lbl" xml:lang="en-US">Allowance for Doubtful Accounts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xml:lang="en-US">Valuation Allowances and Reserves Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LifoAllowanceMember" xlink:label="clx_LifoAllowanceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LifoAllowanceMember" xlink:to="clx_LifoAllowanceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LifoAllowanceMember_lbl" xml:lang="en-US">LIFO Allowance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_lbl" xml:lang="en-US">Valuation Allowance on Deferred Tax Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RenewLifeHoldingsCorporationMember" xlink:label="clx_RenewLifeHoldingsCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RenewLifeHoldingsCorporationMember" xlink:to="clx_RenewLifeHoldingsCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RenewLifeHoldingsCorporationMember_lbl" xml:lang="en-US">Renew Life [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes5.00PercentMember" xlink:label="clx_SeniorNotes5.00PercentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorNotes5.00PercentMember" xlink:to="clx_SeniorNotes5.00PercentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SeniorNotes5.00PercentMember_lbl" xml:lang="en-US">Senior notes with an annual fixed interest rate of 5.00% [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomePlanMember" xlink:label="clx_RetirementIncomePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementIncomePlanMember" xlink:to="clx_RetirementIncomePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RetirementIncomePlanMember_lbl" xml:lang="en-US">Retirement Income Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="us-gaap_ScenarioForecastMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioForecastMember" xlink:to="us-gaap_ScenarioForecastMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScenarioForecastMember_lbl" xml:lang="en-US">Scenario, Forecast [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xml:lang="en-US">Foreign currency adjustments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_lbl" xml:lang="en-US">Net unrealized gain (losses) on derivatives [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_lbl" xml:lang="en-US">Pension and postretirement benefit adjustments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsMember" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsMember" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsMember_lbl" xml:lang="en-US">Deferred Stock Units for Nonemployee Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DocumentAndEntityInformationAbstract" xlink:label="clx_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DocumentAndEntityInformationAbstract" xlink:to="clx_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US">Net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="us-gaap_CostOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsSold" xlink:to="us-gaap_CostOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsSold_lbl" xml:lang="en-US">Cost of products sold</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIncomeExpenseNet" xlink:label="clx_OtherIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIncomeExpenseNet" xlink:to="clx_OtherIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherIncomeExpenseNet_lbl" xml:lang="en-US">Other (income) expense, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Earnings from continuing operations before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income taxes on continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Earnings from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xml:lang="en-US">Losses from discontinued operations, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="us-gaap_EarningsPerShareBasicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAbstract_lbl" xml:lang="en-US">Net earnings (losses) per share, Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xml:lang="en-US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="us-gaap_EarningsPerShareDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedAbstract" xlink:to="us-gaap_EarningsPerShareDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDilutedAbstract_lbl" xml:lang="en-US">Net earnings (losses) per share, Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xml:lang="en-US">Continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xml:lang="en-US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average shares outstanding (in thousands)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xml:lang="en-US">Earnings from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other comprehensive (losses) income:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Foreign currency adjustments, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Net unrealized gains (losses) on derivatives, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Pension and postretirement benefit adjustments, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Total other comprehensive (losses) income, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="us-gaap_ReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesNetCurrent_lbl" xml:lang="en-US">Receivables, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property, plant and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TrademarksNet" xlink:label="clx_TrademarksNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TrademarksNet" xlink:to="clx_TrademarksNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_TrademarksNet_lbl" xml:lang="en-US">Trademarks, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="us-gaap_OtherIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Other intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaper" xlink:label="us-gaap_CommercialPaper" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaper" xlink:to="us-gaap_CommercialPaper_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommercialPaper_lbl" xml:lang="en-US">Notes and loans payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current maturities of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock: $1.00 par value; 750,000,000 shares authorized; 158,741,461 shares issued as of June 30, 2016 and 2015; and 129,355,263 and 128,614,310 shares outstanding as of June 30, 2016 and 2015, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury shares, at cost: 29,386,198 and 30,127,151 shares as of June 30, 2016 and 2015, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive net (losses) income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance, amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsCash" xlink:label="us-gaap_DividendsCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCash" xlink:to="us-gaap_DividendsCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsCash_lbl" xml:lang="en-US">Accrued dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherEmployeeStockPlanActivitiesValue" xlink:label="clx_OtherEmployeeStockPlanActivitiesValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherEmployeeStockPlanActivitiesValue" xlink:to="clx_OtherEmployeeStockPlanActivitiesValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherEmployeeStockPlanActivitiesValue_lbl" xml:lang="en-US">Other employee stock plan activities, amount</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherEmployeeStockPlanActivitiesShares" xlink:label="clx_OtherEmployeeStockPlanActivitiesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherEmployeeStockPlanActivitiesShares" xlink:to="clx_OtherEmployeeStockPlanActivitiesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherEmployeeStockPlanActivitiesShares_lbl" xml:lang="en-US">Other employee stock plan activities, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod_lbl" xml:lang="en-US">Treasury stock purchased, amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xml:lang="en-US">Treasury stock purchased, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance, amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xml:lang="en-US">Deduct: Losses from discontinued operations, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile earnings from continuing operations to net cash provided by continuing operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InterestRateForwardContractsSettlement" xlink:label="clx_InterestRateForwardContractsSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InterestRateForwardContractsSettlement" xlink:to="clx_InterestRateForwardContractsSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_InterestRateForwardContractsSettlement_lbl" xml:lang="en-US">Settlement of interest rate forward contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Receivables, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided by continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Net cash provided by (used for) discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US">Business acquired, net of cash acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used for investing activities from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Net cash used for investing activities by discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used for investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfShortTermDebt_lbl" xml:lang="en-US">Notes and loans payable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US">Long-term debt borrowings, net of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Long-term debt repayments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US">Treasury stock purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xml:lang="en-US">Cash dividends paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock for employee stock plans and other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used for financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Cash and cash equivalents:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">End of year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes paid, net of refunds</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Noncash financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Cash dividends declared and accrued, but not paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xml:lang="en-US">DISCONTINUED OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US">Business Combinations [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">BUSINESSES ACQUIRED</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherCurrentAssetsAbstract" xlink:label="clx_OtherCurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherCurrentAssetsAbstract" xlink:to="clx_OtherCurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherCurrentAssetsAbstract_lbl" xml:lang="en-US">OTHER CURRENT ASSETS [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">OTHER CURRENT ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:label="clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:to="clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract_lbl" xml:lang="en-US">GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">DEBT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_lbl" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" xlink:to="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock_lbl" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherContingenciesAndGuaranteesAbstract" xlink:label="clx_OtherContingenciesAndGuaranteesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherContingenciesAndGuaranteesAbstract" xlink:to="clx_OtherContingenciesAndGuaranteesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherContingenciesAndGuaranteesAbstract_lbl" xml:lang="en-US">OTHER CONTINGENCIES AND GUARANTEES [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ContingenciesAndGuaranteesDisclosureTextBlock" xlink:label="clx_ContingenciesAndGuaranteesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ContingenciesAndGuaranteesDisclosureTextBlock" xlink:to="clx_ContingenciesAndGuaranteesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ContingenciesAndGuaranteesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER CONTINGENCIES AND GUARANTEES</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LeasesAndOtherCommitmentsAbstract" xlink:label="clx_LeasesAndOtherCommitmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LeasesAndOtherCommitmentsAbstract" xlink:to="clx_LeasesAndOtherCommitmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LeasesAndOtherCommitmentsAbstract_lbl" xml:lang="en-US">LEASES AND OTHER COMMITMENTS [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xml:lang="en-US">LEASES AND OTHER COMMITMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">NET EARNINGS PER SHARE (EPS)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="us-gaap_ShareBasedCompensationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAbstract_lbl" xml:lang="en-US">Share-based Compensation [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">STOCK-BASED COMPENSATION PLANS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIncomeExpenseNetDisclosureTextBlock" xlink:label="clx_OtherIncomeExpenseNetDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIncomeExpenseNetDisclosureTextBlock" xlink:to="clx_OtherIncomeExpenseNetDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherIncomeExpenseNetDisclosureTextBlock_lbl" xml:lang="en-US">OTHER (INCOME) EXPENSE, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_lbl" xml:lang="en-US">Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xml:lang="en-US">EMPLOYEE BENEFIT PLANS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT REPORTING</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract" xlink:label="us-gaap_QuarterlyFinancialDataAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialDataAbstract" xlink:to="us-gaap_QuarterlyFinancialDataAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialDataAbstract_lbl" xml:lang="en-US">Quarterly Financial Data [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US">UNAUDITED QUARTERLY DATA</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:label="us-gaap_ValuationAndQualifyingAccountsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:to="us-gaap_ValuationAndQualifyingAccountsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAndQualifyingAccountsAbstract_lbl" xml:lang="en-US">Valuation and Qualifying Accounts [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US">VALUATION AND QUALIFYING ACCOUNTS AND RESERVES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Nature of Operations and Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment and Finite-Lived Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalUseSoftwarePolicy" xlink:to="us-gaap_InternalUseSoftwarePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InternalUseSoftwarePolicy_lbl" xml:lang="en-US">Capitalization of Software Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Impairment Review of Goodwill and Indefinite-Lived Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EmployeeBenefitsPolicyTextBlock" xlink:label="clx_EmployeeBenefitsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_EmployeeBenefitsPolicyTextBlock" xlink:to="clx_EmployeeBenefitsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_EmployeeBenefitsPolicyTextBlock_lbl" xml:lang="en-US">Employee Benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EnvironmentalCostsPolicy" xlink:label="us-gaap_EnvironmentalCostsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EnvironmentalCostsPolicy" xlink:to="us-gaap_EnvironmentalCostsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EnvironmentalCostsPolicy_lbl" xml:lang="en-US">Environmental Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of Products Sold</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xml:lang="en-US">Selling and Administrative Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock" xlink:label="clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock" xlink:to="clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising and Research and Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Transactions and Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:to="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_lbl" xml:lang="en-US">Recently Issued Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xml:lang="en-US">Components of Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:to="clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_lbl" xml:lang="en-US">Useful Lives of Property, Plant and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" xlink:label="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" xlink:to="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock_lbl" xml:lang="en-US">Summary of (losses) gains from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock" xlink:label="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock" xlink:to="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock_lbl" xml:lang="en-US">Summary of operating losses, asset charges and other costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed as of Acquisition Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property, Plant and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US">Schedule of Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets, Excluding Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl" xml:lang="en-US">Short-term Notes and Loans Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US">Long-Term Debt, Net of Unamortized Discounts or Premiums</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xml:lang="en-US">Borrowing Capacity Under Other Financing Arrangements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:label="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US">Effects of Derivative Instruments Designated as Hedging Instruments on OCI</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl" xml:lang="en-US">Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock" xlink:label="clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock" xlink:to="clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock_lbl" xml:lang="en-US">Schedule of future minimum annual lease commitments required under existing non-cancelable operating and capital lease agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Purchase Obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock" xlink:label="clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock" xlink:to="clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share Repurchases under Authorized Programs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsDeclaredTableTextBlock" xlink:label="us-gaap_DividendsDeclaredTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsDeclaredTableTextBlock" xlink:to="us-gaap_DividendsDeclaredTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsDeclaredTableTextBlock_lbl" xml:lang="en-US">Schedule of Dividends Declared and Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Valuation Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Restricted Stock Award Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Performance Units Award Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock" xlink:label="clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock" xlink:to="clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock_lbl" xml:lang="en-US">Major Components of Other (Income) Expense, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock" xlink:label="clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock" xlink:to="clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock_lbl" xml:lang="en-US">Provision for Income Taxes on Continuing Operations by Tax Jurisdiction</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Earnings from Continuing Operations before Income Taxes, by Tax Jurisdiction</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Components of Net Deferred Tax Assets (Liabilities)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xml:lang="en-US">Summary of Changes in Deferred Tax Asset Valuation Allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:label="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_lbl" xml:lang="en-US">Reconciliation of Gross Unrecognized Tax Benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:label="us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:to="us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_lbl" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:label="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_lbl" xml:lang="en-US">Schedule of Amounts Recognized in the Balance Sheets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Accumulated Benefit Obligations in Excess of Plan Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:label="us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:label="us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:to="us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_lbl" xml:lang="en-US">Schedule of Items Not Yet Recognized as a Component of Postretirement Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US">Summary of Amounts Recognized in Accumulated Other Comprehensive Net Losses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Assumptions Used</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:label="us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_lbl" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Target Allocation and Weighted Average Allocation of Plan Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of Plan Assets Carried at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Selected Financial Information Relating to the Company's Segments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xml:lang="en-US">Net Sales and Long-Lived Assets By Geographic Area</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US">Unaudited Quarterly Data</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" xlink:label="clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" xlink:to="clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent_lbl" xml:lang="en-US">U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:label="clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:to="clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries_lbl" xml:lang="en-US">Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:label="clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:to="clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries_lbl" xml:lang="en-US">U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" xlink:label="clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" xlink:to="clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries_lbl" xml:lang="en-US">Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_4_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xml:lang="en-US">Noncurrent restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Current restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated Useful Lives</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod_lbl" xml:lang="en-US">Performance period for performance awards</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap" xlink:label="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap" xlink:to="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap_lbl" xml:lang="en-US">Additional compensation expense, target cap</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor" xlink:label="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor" xlink:to="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor_lbl" xml:lang="en-US">Additional compensation expense, target floor</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach" xlink:label="clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach" xlink:to="clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach_lbl" xml:lang="en-US">Minimum percentage for calculating the amortization of actuarial gains and losses under the corridor approach</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NontradeReceivablesCurrent" xlink:label="us-gaap_NontradeReceivablesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NontradeReceivablesCurrent" xlink:to="us-gaap_NontradeReceivablesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NontradeReceivablesCurrent_lbl" xml:lang="en-US">Non-customer receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_PackagingDevelopmentAndDesignCosts" xlink:label="clx_PackagingDevelopmentAndDesignCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_PackagingDevelopmentAndDesignCosts" xlink:to="clx_PackagingDevelopmentAndDesignCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_PackagingDevelopmentAndDesignCosts_lbl" xml:lang="en-US">Packaging development and design costs</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges" xlink:label="clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges" xlink:to="clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges_lbl" xml:lang="en-US">Number of hedging instruments designated as fair value hedges</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement" xlink:label="clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement" xlink:to="clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement_lbl" xml:lang="en-US">Percentage point benefit from adoption of ASU 2016-09</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xml:lang="en-US">Net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_lbl" xml:lang="en-US">Operating losses from discontinued operations before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_lbl" xml:lang="en-US">Exit costs and other related expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_lbl" xml:lang="en-US">Total losses from discontinued operations before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_lbl" xml:lang="en-US">Income tax benefit attributable to discontinued operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3_lbl" xml:lang="en-US">Total gain (losses) from discontinued operations, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xml:lang="en-US">Unrecognized tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl" xml:lang="en-US">Gross unrecognized tax benefits recognized upon the expiration of the applicable statute of limitations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating losses before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" xlink:label="us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" xlink:to="us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract_lbl" xml:lang="en-US">Net asset charges:</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property, plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets_lbl" xml:lang="en-US">Trademark and other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" xlink:to="clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract_lbl" xml:lang="en-US">Other exit and business termination costs:</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationSeverance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:to="clx_DisposalGroupIncludingDiscontinuedOperationSeverance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationSeverance_lbl" xml:lang="en-US">Severance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_lbl" xml:lang="en-US">Recognition of deferred foreign currency translation loss</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationOther" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupIncludingDiscontinuedOperationOther" xlink:to="clx_DisposalGroupIncludingDiscontinuedOperationOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:to="us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_lbl" xml:lang="en-US">Percentage of fair value of the reporting unit in excess of recorded value</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear" xlink:label="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear" xlink:to="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear_lbl" xml:lang="en-US">Additional exit cost expected to be incurred for the remainder of fiscal year 2015</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter" xlink:label="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter" xlink:to="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter_lbl" xml:lang="en-US">Additional exit cost expected to be incurred thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">Noncash goodwill impairment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StatementBusinessSegmentsAxis_2_lbl" xml:lang="en-US">Segments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract_lbl" xml:lang="en-US">Major Classes of Remaining Assets and Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet" xlink:to="clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net asset position</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_lbl" xml:lang="en-US">Tax asset balances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xml:lang="en-US">Business acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Percentage of business acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2_lbl" xml:lang="en-US">Amount paid for acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">The weighted-average estimated useful life of intangible assets subject to amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_lbl" xml:lang="en-US">Estimated fair values of assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property, plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xml:lang="en-US">Working capital, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials and packaging</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work in process</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryLIFOReserve" xlink:label="us-gaap_InventoryLIFOReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReserve" xlink:to="us-gaap_InventoryLIFOReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryLIFOReserve_lbl" xml:lang="en-US">LIFO allowances</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PercentageOfLIFOInventory" xlink:label="us-gaap_PercentageOfLIFOInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PercentageOfLIFOInventory" xlink:to="us-gaap_PercentageOfLIFOInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PercentageOfLIFOInventory_lbl" xml:lang="en-US">Percentage of inventory valued with the LIFO method</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfLIFOInventoryLiquidationOnIncome" xlink:label="us-gaap_EffectOfLIFOInventoryLiquidationOnIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfLIFOInventoryLiquidationOnIncome" xlink:to="us-gaap_EffectOfLIFOInventoryLiquidationOnIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfLIFOInventoryLiquidationOnIncome_lbl" xml:lang="en-US">Effect on earnings of the liquidation of LIFO layers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:label="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:to="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_lbl" xml:lang="en-US">Inventory consigned to others</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_lbl" xml:lang="en-US">Schedule of Restricted Cash and Cash Equivalents [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_lbl" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EscrowRestrictedCashMember" xlink:label="clx_EscrowRestrictedCashMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_EscrowRestrictedCashMember" xlink:to="clx_EscrowRestrictedCashMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_EscrowRestrictedCashMember_lbl" xml:lang="en-US">Escrow [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignSubsidiaryRestrictedCashMember" xlink:label="clx_ForeignSubsidiaryRestrictedCashMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignSubsidiaryRestrictedCashMember" xlink:to="clx_ForeignSubsidiaryRestrictedCashMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ForeignSubsidiaryRestrictedCashMember_lbl" xml:lang="en-US">Foreign subsidiary, prepayment for intercompany services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="us-gaap_DeferredTaxAssetsNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetCurrent" xlink:to="us-gaap_DeferredTaxAssetsNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetCurrent_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent" xlink:label="us-gaap_OtherAssetsMiscellaneousCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="us-gaap_OtherAssetsMiscellaneousCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsMiscellaneousCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property, plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligation" xlink:label="us-gaap_AssetRetirementObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligation" xlink:to="us-gaap_AssetRetirementObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligation_lbl" xml:lang="en-US">Asset retirement obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NumberOfLeasedProperties" xlink:label="clx_NumberOfLeasedProperties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NumberOfLeasedProperties" xlink:to="clx_NumberOfLeasedProperties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_NumberOfLeasedProperties_lbl" xml:lang="en-US">Number of leased properties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:label="us-gaap_AssetRetirementObligationLiabilitiesIncurred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:to="us-gaap_AssetRetirementObligationLiabilitiesIncurred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationLiabilitiesIncurred_lbl" xml:lang="en-US">Asset retirement obligation liabilities incurred</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationNonproduction" xlink:label="us-gaap_DepreciationNonproduction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationNonproduction" xlink:to="us-gaap_DepreciationNonproduction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationNonproduction_lbl" xml:lang="en-US">Depreciation and amortization expense related to property, plant and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NonCashCapitalExpenditures" xlink:label="clx_NonCashCapitalExpenditures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NonCashCapitalExpenditures" xlink:to="clx_NonCashCapitalExpenditures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_NonCashCapitalExpenditures_lbl" xml:lang="en-US">Non-cash capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal" xlink:label="clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal" xlink:to="clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal_lbl" xml:lang="en-US">Renewal period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl" xml:lang="en-US">Future amortization expense:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_lbl" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ImpairmentOfTrademarks" xlink:label="clx_ImpairmentOfTrademarks" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ImpairmentOfTrademarks" xlink:to="clx_ImpairmentOfTrademarks_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ImpairmentOfTrademarks_lbl" xml:lang="en-US">Trademark impairment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets impairment charge</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="us-gaap_ScheduleOfGoodwillTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_ScheduleOfGoodwillTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTable_lbl" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="us-gaap_GoodwillLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillLineItems_lbl" xml:lang="en-US">Goodwill [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Goodwill_2_lbl" xml:lang="en-US">Goodwill, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xml:lang="en-US">Acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:label="us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_lbl" xml:lang="en-US">Effect of foreign currency translation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Goodwill_3_lbl" xml:lang="en-US">Goodwill, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Net carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Trademarks not subject to amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Compensation and employee benefit costs</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_AccruedTradeAndSalesPromotionCostsCurrent" xlink:label="clx_AccruedTradeAndSalesPromotionCostsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_AccruedTradeAndSalesPromotionCostsCurrent" xlink:to="clx_AccruedTradeAndSalesPromotionCostsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_AccruedTradeAndSalesPromotionCostsCurrent_lbl" xml:lang="en-US">Trade and sales promotion</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrent" xlink:to="us-gaap_DividendsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableCurrent_lbl" xml:lang="en-US">Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LongTermAndShortTermDebtLineItems" xlink:label="clx_LongTermAndShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LongTermAndShortTermDebtLineItems" xlink:to="clx_LongTermAndShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LongTermAndShortTermDebtLineItems_lbl" xml:lang="en-US">Long-term and Short-term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_2_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LineOfCreditFacilityAxis_2_lbl" xml:lang="en-US">Lender Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Long-term debt issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Long-term debt maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPaymentTerms" xlink:to="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xml:lang="en-US">Long-term debt payment terms</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xml:lang="en-US">Long-term debt repayments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Fixed interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Effective interest rate (as a percent)</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod" xlink:label="clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod" xlink:to="clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod_lbl" xml:lang="en-US">Weighted average interest rate on notes and loans payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:label="us-gaap_ShortTermDebtWeightedAverageInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="us-gaap_ShortTermDebtWeightedAverageInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtWeightedAverageInterestRate_lbl" xml:lang="en-US">Weighted average effective interest rate on short-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps" xlink:label="clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps" xlink:to="clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps_lbl" xml:lang="en-US">Weighted average interest rates on long-term debt, including the effect of interest rate swaps</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:label="us-gaap_LongtermDebtWeightedAverageInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="us-gaap_LongtermDebtWeightedAverageInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtWeightedAverageInterestRate_lbl" xml:lang="en-US">Weighted average effective interest rates on long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US">Line of credit facility, expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Line of credit facility, borrowing capacity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Line of credit facility, amount outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xml:lang="en-US">Line of credit facility, remaining borrowing capacity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xml:lang="en-US">Long-term debt maturities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="us-gaap_LongtermDebtWeightedAverageInterestRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongtermDebtWeightedAverageInterestRate_2_lbl" xml:lang="en-US">Weighted average interest rate on long-term debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Face value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Long-term debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LongTermDebtCurrent_2_lbl" xml:lang="en-US">Less: Current maturities of long-term debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtNoncurrent_2_lbl" xml:lang="en-US">Long-term debt, noncurrent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EmployeeBenefitObligationsNoncurrent" xlink:label="clx_EmployeeBenefitObligationsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_EmployeeBenefitObligationsNoncurrent" xlink:to="clx_EmployeeBenefitObligationsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_EmployeeBenefitObligationsNoncurrent_lbl" xml:lang="en-US">Employee benefit obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VentureAgreementNetTerminalObligation" xlink:label="clx_VentureAgreementNetTerminalObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VentureAgreementNetTerminalObligation" xlink:to="clx_VentureAgreementNetTerminalObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_VentureAgreementNetTerminalObligation_lbl" xml:lang="en-US">Venture agreement terminal obligation, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_lbl" xml:lang="en-US">Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement" xlink:label="clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement" xlink:to="clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement_lbl" xml:lang="en-US">Interest in the joint venture by venture partner</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VentureAgreementTerm" xlink:label="clx_VentureAgreementTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VentureAgreementTerm" xlink:to="clx_VentureAgreementTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_VentureAgreementTerm_lbl" xml:lang="en-US">Agreement term</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VentureAgreementRenewalOption" xlink:label="clx_VentureAgreementRenewalOption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VentureAgreementRenewalOption" xlink:to="clx_VentureAgreementRenewalOption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_VentureAgreementRenewalOption_lbl" xml:lang="en-US">Venture agreement renewal option</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement" xlink:label="clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement" xlink:to="clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement_lbl" xml:lang="en-US">Venture agreement terminal obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities" xlink:label="us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities" xlink:to="us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities_lbl" xml:lang="en-US">Proceeds from sale-leasebacks, net of transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SaleLeasebackTransactionLeaseTerm" xlink:label="clx_SaleLeasebackTransactionLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SaleLeasebackTransactionLeaseTerm" xlink:to="clx_SaleLeasebackTransactionLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SaleLeasebackTransactionLeaseTerm_lbl" xml:lang="en-US">Lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain" xlink:label="clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain" xlink:to="clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain_lbl" xml:lang="en-US">Deferred gain on sale-lease back, noncurrent portion</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_DerivativeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeTable_lbl" xml:lang="en-US">Derivative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLineItems_lbl" xml:lang="en-US">Derivative [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeNatureAxis" xlink:to="clx_DerivativeNatureAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="clx_DerivativeNatureAxis_2_lbl" xml:lang="en-US">DerivativeNatureAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:to="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_lbl" xml:lang="en-US">Non-qualified deferred compensation plan assets, changes in fair value of trust assets</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeIntrumentsMaximumContractDuration" xlink:label="clx_DerivativeIntrumentsMaximumContractDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeIntrumentsMaximumContractDuration" xlink:to="clx_DerivativeIntrumentsMaximumContractDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DerivativeIntrumentsMaximumContractDuration_lbl" xml:lang="en-US">Maximum contract duration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="invest_DerivativeNotionalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_DerivativeNotionalAmount" xlink:to="invest_DerivativeNotionalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="invest_DerivativeNotionalAmount_lbl" xml:lang="en-US">Notional amounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InterestRateForwardContractsSettlement" xlink:to="clx_InterestRateForwardContractsSettlement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_InterestRateForwardContractsSettlement_2_lbl" xml:lang="en-US">Settlement of interest rate forward contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SettlementOfInterestRateForwardContract" xlink:label="clx_SettlementOfInterestRateForwardContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SettlementOfInterestRateForwardContract" xlink:to="clx_SettlementOfInterestRateForwardContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SettlementOfInterestRateForwardContract_lbl" xml:lang="en-US">Payment to settle interest rate forward contracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_3_lbl" xml:lang="en-US">Debt issued</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:label="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:to="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_lbl" xml:lang="en-US">Amortization period of settlement payment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Term of notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers" xlink:label="us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers" xlink:to="us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers_lbl" xml:lang="en-US">Cash margin balances related to exchange-traded futures contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xml:lang="en-US">Derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:label="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:to="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_lbl" xml:lang="en-US">Derivative instruments subject to contractually defined counterparty liability position limits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MarginDepositAssets" xlink:label="us-gaap_MarginDepositAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarginDepositAssets" xlink:to="us-gaap_MarginDepositAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarginDepositAssets_lbl" xml:lang="en-US">Cash margin balances amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_lbl" xml:lang="en-US">Estimated amount of the existing net loss to be reclassified into earnings in the next 12 months</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FairValueMeasurementsRecurringTable" xlink:label="clx_FairValueMeasurementsRecurringTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FairValueMeasurementsRecurringTable" xlink:to="clx_FairValueMeasurementsRecurringTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_FairValueMeasurementsRecurringTable_lbl" xml:lang="en-US">Fair Value Measurements, Recurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:label="clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_2_lbl" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:label="us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:to="us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_lbl" xml:lang="en-US">Derivative assets designated as hedging instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="us-gaap_DeferredCompensationPlanAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationPlanAssets" xlink:to="us-gaap_DeferredCompensationPlanAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationPlanAssets_lbl" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosureRecurring" xlink:label="us-gaap_AssetsFairValueDisclosureRecurring" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureRecurring" xlink:to="us-gaap_AssetsFairValueDisclosureRecurring_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsFairValueDisclosureRecurring_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:label="us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:to="us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_lbl" xml:lang="en-US">Derivative liabilities designated as hedging instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureRecurring" xlink:label="us-gaap_LiabilitiesFairValueDisclosureRecurring" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosureRecurring" xlink:to="us-gaap_LiabilitiesFairValueDisclosureRecurring_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesFairValueDisclosureRecurring_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:to="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_lbl" xml:lang="en-US">Gains (losses) recognized in other comprehensive net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_lbl" xml:lang="en-US">Gains (losses) reclassified from accumulated other comprehensive net loss and recognized in net earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies" xlink:label="us-gaap_AccrualForEnvironmentalLossContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="us-gaap_AccrualForEnvironmentalLossContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccrualForEnvironmentalLossContingencies_lbl" xml:lang="en-US">Liability for aggregate future remediation costs</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:label="clx_SiteContingencyAgreedPercentageOfCostSharing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:to="clx_SiteContingencyAgreedPercentageOfCostSharing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SiteContingencyAgreedPercentageOfCostSharing_lbl" xml:lang="en-US">Percentage of liability for aggregate remediation and associated costs, other than legal fees</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RemediationPeriod" xlink:label="clx_RemediationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RemediationPeriod" xlink:to="clx_RemediationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RemediationPeriod_lbl" xml:lang="en-US">Remediation period</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LetterOfCreditBorrowingCapacity" xlink:label="clx_LetterOfCreditBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LetterOfCreditBorrowingCapacity" xlink:to="clx_LetterOfCreditBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LetterOfCreditBorrowingCapacity_lbl" xml:lang="en-US">Letter of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="us-gaap_LettersOfCreditOutstandingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LettersOfCreditOutstandingAmount" xlink:to="us-gaap_LettersOfCreditOutstandingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LettersOfCreditOutstandingAmount_lbl" xml:lang="en-US">Letter of credit, amount outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Rent expense for all operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_lbl" xml:lang="en-US">Operating leases:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueAbstract_lbl" xml:lang="en-US">Capital leases:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationAbstract" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationAbstract" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationAbstract_lbl" xml:lang="en-US">Future purchase obligation:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareRepurchaseProgramsTable" xlink:label="clx_ShareRepurchaseProgramsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareRepurchaseProgramsTable" xlink:to="clx_ShareRepurchaseProgramsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareRepurchaseProgramsTable_lbl" xml:lang="en-US">Share Repurchase Programs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareRepurchaseProgramsLineItems" xlink:label="clx_ShareRepurchaseProgramsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareRepurchaseProgramsLineItems" xlink:to="clx_ShareRepurchaseProgramsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareRepurchaseProgramsLineItems_lbl" xml:lang="en-US">Share Repurchase Programs [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US">Authorized repurchase amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Remaining authorized repurchase amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Value of shares repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Shares repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US">Dividends declared per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid" xlink:label="us-gaap_CommonStockDividendsPerShareCashPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="us-gaap_CommonStockDividendsPerShareCashPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsPerShareCashPaid_lbl" xml:lang="en-US">Dividends paid per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2_lbl" xml:lang="en-US">Balance, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_lbl" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_lbl" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive net losses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_lbl" xml:lang="en-US">Recognition of deferred foreign currency translation loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_lbl" xml:lang="en-US">Income tax benefit (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Net current period other comprehensive income (loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3_lbl" xml:lang="en-US">Balance, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:label="us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:to="us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable_lbl" xml:lang="en-US">Schedule of Intercompany Foreign Currency Balance [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceLineItems" xlink:label="us-gaap_IntercompanyForeignCurrencyBalanceLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntercompanyForeignCurrencyBalanceLineItems" xlink:to="us-gaap_IntercompanyForeignCurrencyBalanceLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntercompanyForeignCurrencyBalanceLineItems_lbl" xml:lang="en-US">Intercompany Foreign Currency Balance [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:label="us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:to="us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax_lbl" xml:lang="en-US">Other comprehensive loss before reclassifications</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted Average Shares Outstanding - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xml:lang="en-US">Dilutive effect of stock options and other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted Average Shares Outstanding - Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive shares excluded from calculation of diluted net EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AwardTypeAxis_2_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Stock-based compensation plans, shares authorized to issue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Common shares available for grant</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xml:lang="en-US">Stock option plan, additional shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions_lbl" xml:lang="en-US">Cash received from stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average fair value per share of options or awards granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value of options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Expiration period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized compensation cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Unrecognized compensation cost, weighted-average period for recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant date fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Nonvested awards outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant date fair value per share of nonvested awards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Awards vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant date fair value per share of vested awards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Nonvested awards outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant date fair value per share of nonvested awards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Awards vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_lbl" xml:lang="en-US">Weighted-average grant date fair value per share of vested awards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xml:lang="en-US">Fair value of shares vested</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VestedAwardsWerePaidByIssuanceOfShares" xlink:label="clx_VestedAwardsWerePaidByIssuanceOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VestedAwardsWerePaidByIssuanceOfShares" xlink:to="clx_VestedAwardsWerePaidByIssuanceOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_VestedAwardsWerePaidByIssuanceOfShares_lbl" xml:lang="en-US">Vested awards paid by the issuance of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VestedStockAwardsDeferred" xlink:label="clx_VestedStockAwardsDeferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VestedStockAwardsDeferred" xlink:to="clx_VestedStockAwardsDeferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_VestedStockAwardsDeferred_lbl" xml:lang="en-US">Vested stock awards deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsGranted" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsGranted" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsGranted_lbl" xml:lang="en-US">Deferred stock units for nonemployee directors granted</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends_lbl" xml:lang="en-US">Deferred stock units for nonemployee directors reinvested dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsDistributed" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsDistributed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsDistributed" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsDistributed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsDistributed_lbl" xml:lang="en-US">Deferred stock units for nonemployee directors distributed</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate_lbl" xml:lang="en-US">Deferred stock units for nonemployee directors granted weighted average fair value on grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate_lbl" xml:lang="en-US">Deferred stock units for nonemployee directors reinvested weighted average fair value on grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate_lbl" xml:lang="en-US">Deferred stock units for nonemployee directors distributed weighted average fair value on grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding_lbl" xml:lang="en-US">Deferred stock units for nonemployee directors outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate_lbl" xml:lang="en-US">Deferred stock units for nonemployee directors outstanding weighted average fair value on grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_lbl" xml:lang="en-US">Related income tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum" xlink:label="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum" xlink:to="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum_lbl" xml:lang="en-US">Expected life, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum" xlink:label="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum" xlink:to="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum_lbl" xml:lang="en-US">Expected life, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm" xlink:label="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm" xlink:to="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Weighted average expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Expected volatility, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Expected volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US">Weighted-average volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Weighted-average risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum_lbl" xml:lang="en-US">Dividend yield, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum_lbl" xml:lang="en-US">Dividend yield, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate_lbl" xml:lang="en-US">Weighted-average dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Number of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US">Weighted-Average Exercise Price per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Average remaining contractual life of options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Average remaining contractual life of options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_lbl" xml:lang="en-US">Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xml:lang="en-US">Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Outstanding, beginning balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Distributed</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred_lbl" xml:lang="en-US">Vested and deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_lbl" xml:lang="en-US">Outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Distributed</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_2_lbl" xml:lang="en-US">Outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Vested and deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Income from equity investees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xml:lang="en-US">Interest Income</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LowIncomeHousingPartnershipGainsLosses" xlink:label="clx_LowIncomeHousingPartnershipGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LowIncomeHousingPartnershipGainsLosses" xlink:to="clx_LowIncomeHousingPartnershipGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_LowIncomeHousingPartnershipGainsLosses_lbl" xml:lang="en-US">Low income housing partnership gains, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign exchange transaction losses, net</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_AmortizationOfTrademarksAndOtherIntangibleAssets" xlink:label="clx_AmortizationOfTrademarksAndOtherIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_AmortizationOfTrademarksAndOtherIntangibleAssets" xlink:to="clx_AmortizationOfTrademarksAndOtherIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_AmortizationOfTrademarksAndOtherIntangibleAssets_lbl" xml:lang="en-US">Amortization of trademarks and other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Intangible asset impairment charges</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MiscellaneousOtherIncomeExpense" xlink:label="clx_MiscellaneousOtherIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MiscellaneousOtherIncomeExpense" xlink:to="clx_MiscellaneousOtherIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_MiscellaneousOtherIncomeExpense_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Cash proceeds from sale of property</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">Gain on sale of property</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_IncomeTaxesTable" xlink:label="clx_IncomeTaxesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_IncomeTaxesTable" xlink:to="clx_IncomeTaxesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_IncomeTaxesTable_lbl" xml:lang="en-US">Income Taxes [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TaxCreditAndOperatingLossCarryforwardsLineItems" xlink:label="clx_TaxCreditAndOperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="clx_TaxCreditAndOperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_TaxCreditAndOperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Tax Credit and Operating Loss Carryforwards [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ExpirationPeriodAxis" xlink:to="clx_ExpirationPeriodAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="clx_ExpirationPeriodAxis_2_lbl" xml:lang="en-US">ExpirationPeriodAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:label="us-gaap_UndistributedEarningsOfForeignSubsidiaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="us-gaap_UndistributedEarningsOfForeignSubsidiaries_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UndistributedEarningsOfForeignSubsidiaries_lbl" xml:lang="en-US">Undistributed earning of certain foreign subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability" xlink:label="clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability" xlink:to="clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability_lbl" xml:lang="en-US">Federal income tax liability on unremitted earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions" xlink:to="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions_lbl" xml:lang="en-US">Realized and recorded excess tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OpenTaxYear" xlink:to="us-gaap_OpenTaxYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OpenTaxYear_lbl" xml:lang="en-US">Open tax year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Accrued interest and penalties related to uncertain tax positions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Interest and penalties of income tax expense (benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xml:lang="en-US">Potential benefits which, if recognized, would affect the effective tax rate on earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xml:lang="en-US">Tax credit carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate" xlink:label="us-gaap_TaxCreditCarryforwardExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardExpirationDate" xlink:to="us-gaap_TaxCreditCarryforwardExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxCreditCarryforwardExpirationDate_lbl" xml:lang="en-US">Tax credit carryforwards, expiration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:to="us-gaap_OperatingLossCarryforwardsExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate_lbl" xml:lang="en-US">Net operating loss carryforwards, expiration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Total deferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xml:lang="en-US">Earnings from continuing operations before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">United States</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory federal tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State taxes (net of federal tax benefits)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Tax differential on foreign earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_lbl" xml:lang="en-US">Domestic manufacturing deduction</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other differences</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xml:lang="en-US">Compensation and benefit programs</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" xlink:label="clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" xlink:to="clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement_lbl" xml:lang="en-US">Basis difference related to Venture Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xml:lang="en-US">Accruals and reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Inventory costs</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" xlink:label="clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" xlink:to="clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign_lbl" xml:lang="en-US">Net operating loss and tax credit carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" xlink:label="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" xlink:to="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets_lbl" xml:lang="en-US">Fixed and intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships" xlink:label="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships" xlink:to="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships_lbl" xml:lang="en-US">Low-income housing partnerships</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_lbl" xml:lang="en-US">Unremitted foreign earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets (liabilities)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Valuation allowance at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets" xlink:label="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets" xlink:to="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets_lbl" xml:lang="en-US">Net decrease/(increase) for other foreign deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits" xlink:label="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits" xlink:to="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits_lbl" xml:lang="en-US">Net decrease/(increase) for foreign net operating loss carryforwards and tax credits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_3_lbl" xml:lang="en-US">Valuation allowance at end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized tax benefits at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US">Gross increases - tax positions in prior periods</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US">Gross decreases - tax positions in prior periods</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xml:lang="en-US">Gross increases - current period tax positions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_lbl" xml:lang="en-US">Gross decreases - current period tax positions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2_lbl" xml:lang="en-US">Lapse of applicable statute of limitations</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UnrecognizedTaxBenefitsSettlements" xlink:label="clx_UnrecognizedTaxBenefitsSettlements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_UnrecognizedTaxBenefitsSettlements" xlink:to="clx_UnrecognizedTaxBenefitsSettlements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_UnrecognizedTaxBenefitsSettlements_lbl" xml:lang="en-US">Settlements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_2_lbl" xml:lang="en-US">Unrecognized tax benefits at end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_2_lbl" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" xml:lang="en-US">Discretionary contributions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate" xlink:label="us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate" xlink:to="us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate_lbl" xml:lang="en-US">Assumed ultimate trend</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanYearThatRateReachesUltimateTrendRate" xlink:label="us-gaap_DefinedBenefitPlanYearThatRateReachesUltimateTrendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanYearThatRateReachesUltimateTrendRate" xlink:to="us-gaap_DefinedBenefitPlanYearThatRateReachesUltimateTrendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanYearThatRateReachesUltimateTrendRate_lbl" xml:lang="en-US">Ultimate trend, year reached</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_BasisPointIncreaseDecrease" xlink:label="clx_BasisPointIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_BasisPointIncreaseDecrease" xlink:to="clx_BasisPointIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_BasisPointIncreaseDecrease_lbl" xml:lang="en-US">Basis point increase</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:label="us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:to="us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_lbl" xml:lang="en-US">Hypothetical effect of basis point change on benefit obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscretionaryCompanyContributions" xlink:label="clx_DiscretionaryCompanyContributions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscretionaryCompanyContributions" xlink:to="clx_DiscretionaryCompanyContributions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="clx_DiscretionaryCompanyContributions_lbl" xml:lang="en-US">Discretionary contributions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit" xlink:label="us-gaap_DefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit" xlink:to="us-gaap_DefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit_lbl" xml:lang="en-US">Recognized prior service (cost) benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss" xlink:label="us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss" xlink:to="us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss_lbl" xml:lang="en-US">Net actuarial gains (losses) as a component of net periodic benefit cost</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod" xlink:label="clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod" xlink:to="clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod_lbl" xml:lang="en-US">Profit sharing contributions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:label="us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_lbl" xml:lang="en-US">Accumulated benefit obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanOtherChanges" xlink:label="us-gaap_DefinedBenefitPlanOtherChanges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanOtherChanges" xlink:to="us-gaap_DefinedBenefitPlanOtherChanges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanOtherChanges_lbl" xml:lang="en-US">Change in accumulated benefit obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xml:lang="en-US">Defined Contribution Plan [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Contribution Plan Disclosure [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanNameAxis" xlink:to="us-gaap_DefinedContributionPlanNameAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanNameAxis_2_lbl" xml:lang="en-US">Defined Contribution Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="us-gaap_DefinedContributionPlanCostRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xml:lang="en-US">Aggregate cost of the defined contribution plans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_lbl" xml:lang="en-US">Change in benefit obligations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="us-gaap_DefinedBenefitPlanBenefitObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="us-gaap_DefinedBenefitPlanBenefitObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_DefinedBenefitPlanBenefitObligation_lbl" xml:lang="en-US">Projected benefit obligation as of beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="us-gaap_DefinedBenefitPlanServiceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanServiceCost" xlink:to="us-gaap_DefinedBenefitPlanServiceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanServiceCost_lbl" xml:lang="en-US">Service cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="us-gaap_DefinedBenefitPlanInterestCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanInterestCost" xlink:to="us-gaap_DefinedBenefitPlanInterestCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanInterestCost_lbl" xml:lang="en-US">Interest cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:label="us-gaap_DefinedBenefitPlanActuarialGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="us-gaap_DefinedBenefitPlanActuarialGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DefinedBenefitPlanActuarialGainLoss_lbl" xml:lang="en-US">Actuarial loss (gain)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments" xlink:label="us-gaap_DefinedBenefitPlanPlanAmendments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="us-gaap_DefinedBenefitPlanPlanAmendments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanPlanAmendments_lbl" xml:lang="en-US">Plan amendments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:label="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_lbl" xml:lang="en-US">Translation and other adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitsPaid" xlink:label="us-gaap_DefinedBenefitPlanBenefitsPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanBenefitsPaid" xlink:to="us-gaap_DefinedBenefitPlanBenefitsPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DefinedBenefitPlanBenefitsPaid_lbl" xml:lang="en-US">Benefits paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="us-gaap_DefinedBenefitPlanBenefitObligation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DefinedBenefitPlanBenefitObligation_2_lbl" xml:lang="en-US">Projected benefit obligation as of end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_lbl" xml:lang="en-US">Change in plan assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_lbl" xml:lang="en-US">Fair value of assets as of beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:label="us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_lbl" xml:lang="en-US">Actual return on plan assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="us-gaap_DefinedBenefitPlanContributionsByEmployer_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer_2_lbl" xml:lang="en-US">Employer contributions nonqualified plans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets" xlink:label="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets_lbl" xml:lang="en-US">Translation and other adjustment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_2_lbl" xml:lang="en-US">Fair value of plan assets as of end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:label="us-gaap_DefinedBenefitPlanFundedStatusOfPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="us-gaap_DefinedBenefitPlanFundedStatusOfPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanFundedStatusOfPlan_lbl" xml:lang="en-US">Accrued benefit cost, net funded status</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:label="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_lbl" xml:lang="en-US">Amounts recognized in the balance sheet consist of:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent" xlink:label="us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent" xlink:to="us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent_lbl" xml:lang="en-US">Pension benefit assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:label="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_lbl" xml:lang="en-US">Current accrued benefit liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_lbl" xml:lang="en-US">Non-current accrued benefit liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:label="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_lbl" xml:lang="en-US">Accrued benefit cost, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:label="us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:to="us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_lbl" xml:lang="en-US">Projected benefit obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:label="us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_lbl" xml:lang="en-US">Fair value of plan assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_lbl" xml:lang="en-US">Expected return on plan assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_lbl" xml:lang="en-US">Amortization of unrecognized items</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:label="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_lbl" xml:lang="en-US">Net actuarial loss (gain)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:label="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_lbl" xml:lang="en-US">Prior service benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" xlink:label="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" xlink:to="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax_lbl" xml:lang="en-US">Net deferred income tax (assets) liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss (income)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2_lbl" xml:lang="en-US">Net actuarial loss (gain)</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost" xlink:label="clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost" xlink:to="clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost_lbl" xml:lang="en-US">Amortization during the year</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod" xlink:label="clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod" xlink:to="clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod_lbl" xml:lang="en-US">Loss (gain) during the year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_3_lbl" xml:lang="en-US">Net actuarial loss (gain)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:label="us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_lbl" xml:lang="en-US">Weighted-average assumptions used to estimate the actuarial present value of benefit obligations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_lbl" xml:lang="en-US">Discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_lbl" xml:lang="en-US">Rate of compensation increase</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:label="us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_lbl" xml:lang="en-US">Weighted-average assumptions used to estimate the net periodic pension and other postretirement benefit costs:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_lbl" xml:lang="en-US">Discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_lbl" xml:lang="en-US">Rate of compensation increase</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_lbl" xml:lang="en-US">Expected return on plan assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_lbl" xml:lang="en-US">Fiscal years 2022 - 2026</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations" xlink:label="us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations" xlink:to="us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations_lbl" xml:lang="en-US">% Target Allocation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:label="us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_lbl" xml:lang="en-US">% of Plan Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2_lbl" xml:lang="en-US">Defined Benefit Plan, Asset Categories [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CashEquivalents" xlink:label="clx_CashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CashEquivalents" xlink:to="clx_CashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CashEquivalents_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MutualFunds" xlink:label="clx_MutualFunds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MutualFunds" xlink:to="clx_MutualFunds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_MutualFunds_lbl" xml:lang="en-US">Mutual funds</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CommonOrCollectiveTrusts" xlink:label="clx_CommonOrCollectiveTrusts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CommonOrCollectiveTrusts" xlink:to="clx_CommonOrCollectiveTrusts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CommonOrCollectiveTrusts_lbl" xml:lang="en-US">Common/Collective trusts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3_lbl" xml:lang="en-US">Total assets at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Earnings (losses) from continuing operations before income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Income from equity investees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Total assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_3_lbl" xml:lang="en-US">Net property, plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MaximumOwnershipPercentageOfEquityInvestments" xlink:label="clx_MaximumOwnershipPercentageOfEquityInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MaximumOwnershipPercentageOfEquityInvestments" xlink:to="clx_MaximumOwnershipPercentageOfEquityInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_MaximumOwnershipPercentageOfEquityInvestments_lbl" xml:lang="en-US">Percentage ownership of equity investments, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US">Equity method investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xml:lang="en-US">Payments to related parties during the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="us-gaap_SalesRevenueGoodsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueGoodsNet" xlink:to="us-gaap_SalesRevenueGoodsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SalesRevenueGoodsNet_lbl" xml:lang="en-US">Net sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_4_lbl" xml:lang="en-US">Earnings (losses) from discontinued operations, net of tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic net earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted net earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh" xlink:label="clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh" xlink:to="clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh_lbl" xml:lang="en-US">Market price (NYSE), high</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RangeOfNyseMarketPriceOfEntityCommonStockLow" xlink:label="clx_RangeOfNyseMarketPriceOfEntityCommonStockLow" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RangeOfNyseMarketPriceOfEntityCommonStockLow" xlink:to="clx_RangeOfNyseMarketPriceOfEntityCommonStockLow_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RangeOfNyseMarketPriceOfEntityCommonStockLow_lbl" xml:lang="en-US">Market price (NYSE), low</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NyseMarketPriceOfEntityCommonStockPeriodEnd" xlink:label="clx_NyseMarketPriceOfEntityCommonStockPeriodEnd" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NyseMarketPriceOfEntityCommonStockPeriodEnd" xlink:to="clx_NyseMarketPriceOfEntityCommonStockPeriodEnd_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_NyseMarketPriceOfEntityCommonStockPeriodEnd_lbl" xml:lang="en-US">Market price (NYSE), year-end</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="us-gaap_ValuationAndQualifyingAccountsDisclosureTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="us-gaap_ValuationAndQualifyingAccountsDisclosureTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAndQualifyingAccountsDisclosureTable_lbl" xml:lang="en-US">Valuation and Qualifying Accounts Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xml:lang="en-US">Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xml:lang="en-US">Balance at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xml:lang="en-US">Charged to costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses" xlink:label="clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses" xlink:to="clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses_lbl" xml:lang="en-US">Credited to costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xml:lang="en-US">Credited to other accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_2_lbl" xml:lang="en-US">Balance at end of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_AccruedTradeAndSalesPromotionCostsCurrent" xlink:to="clx_AccruedTradeAndSalesPromotionCostsCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_AccruedTradeAndSalesPromotionCostsCurrent_doc" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for trade and sales promotion costs of the entity. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock" xlink:to="clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock_doc" xml:lang="en-US">Disclosure of accounting policy for recognition of (1) advertising costs and (2) research and development costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_BasisPointIncreaseDecrease" xlink:to="clx_BasisPointIncreaseDecrease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_BasisPointIncreaseDecrease_doc" xml:lang="en-US">Increase or decrease in the basis point for the assumed health care cost trend rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_BondFundMember" xlink:to="clx_BondFundMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_BondFundMember_doc" xml:lang="en-US">Bond Fund [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CapitalizedSoftwareCostsMember" xlink:to="clx_CapitalizedSoftwareCostsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CapitalizedSoftwareCostsMember_doc" xml:lang="en-US">Capitalized Software Costs [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CashEquivalents" xlink:to="clx_CashEquivalents_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CashEquivalents_doc" xml:lang="en-US">Type of cash or cash equivalent. Cash includes currency on hand as well as demand deposits with banks or financial institutions. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CharcoalMember" xlink:to="clx_CharcoalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CharcoalMember_doc" xml:lang="en-US">Charcoal [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CleaningMember" xlink:to="clx_CleaningMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CleaningMember_doc" xml:lang="en-US">Cleaning [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap" xlink:to="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap_doc" xml:lang="en-US">Cap percentage of target recognized as additional compensation expense if performance goals are exceeded.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ContingenciesAndGuaranteesDisclosureTextBlock" xlink:to="clx_ContingenciesAndGuaranteesDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ContingenciesAndGuaranteesDisclosureTextBlock_doc" xml:lang="en-US">This item represents the complete disclosure regarding the entity's exposure to loss pertaining to environmental matters, litigation and potential losses not disclosed in other notes and guarantees.</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember" xlink:label="clx_CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember" xlink:to="clx_CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember_doc" xml:lang="en-US">Information related to the Company's corporate headquarters and primary research and development facility.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:to="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_doc" xml:lang="en-US">Amortization period of settlement payment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsDistributed" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsDistributed_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsDistributed_doc" xml:lang="en-US">Deferred stock units for nonemployee directors distributed.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate_doc" xml:lang="en-US">The weighted-average grant date fair value of the deferred stock units for nonemployee directors dividends distributed during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsGranted" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsGranted_doc" xml:lang="en-US">Deferred stock units for nonemployee directors granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate_doc" xml:lang="en-US">The weighted-average grant date fair value of the deferred stock units for nonemployee directors granted during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding_doc" xml:lang="en-US">The number of shares of deferred stock units for nonemployee directors outstanding as of the end of the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate_doc" xml:lang="en-US">The weighted-average grant date fair value of the deferred stock units for nonemployee directors outstanding as of the end of the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends_doc" xml:lang="en-US">Deferred stock units for nonemployee directors reinvested dividends.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate_doc" xml:lang="en-US">The weighted-average grant date fair value of the deferred stock units for nonemployee directors dividends reinvested during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" xlink:to="clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement_doc" xml:lang="en-US">The tax effect as of the balance sheet date of the amount of the estimated future tax reductions attributable to the difference between the tax basis and the generally accepted accounting principles basis of a company's venture investment which will decrease future taxable income when such basis difference reverses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" xlink:to="clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign_doc" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards and foreign tax credit carryforwards.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships" xlink:to="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships_doc" xml:lang="en-US">Carrying amount as of the balance sheet date for deferred tax consequences attributable to taxable temporary differences between tax and GAAP reporting for the entity's low income housing partnerships.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" xlink:to="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets_doc" xml:lang="en-US">The amount as of the balance sheet date of the estimated future tax effects attributable to the difference between the tax basis of capital assets and intangible assets and the basis of capital assets and intangible assets computed in accordance with generally accepted accounting principles. The difference in basis, attributable to different capitalization of costs, depreciation, or amortization methodologies, impairment charges, or other reasons will increase future taxable income when such basis difference is realized. Capital assets include but are not limited to assets such as land, real estate, leasehold improvements, machinery and equipment and furniture and fixtures.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability" xlink:to="clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability_doc" xml:lang="en-US">The amount of the deferred tax liability which was not recognized because of the exceptions to comprehensive recognition of deferred taxes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:to="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_doc" xml:lang="en-US">Derivative instruments subject to contractually defined counterparty liability position limits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeIntrumentsMaximumContractDuration" xlink:to="clx_DerivativeIntrumentsMaximumContractDuration_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DerivativeIntrumentsMaximumContractDuration_doc" xml:lang="en-US">Maximum contract duration for a derivative instrument.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges" xlink:to="clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges_doc" xml:lang="en-US">The number of hedging instruments designated as fair value hedges held by the entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets_doc" xml:lang="en-US">Amount, before tax, of loss recognized for the write-down to fair value of intangible assets, less cost to sell, of a disposal group.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet_doc" xml:lang="en-US">Amount, before tax, of loss recognized for the write-down to fair value of Inventories, less cost to sell, of a disposal group.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets_doc" xml:lang="en-US">Amount, before tax, of loss recognized for the write-down to fair value of other assets, less cost to sell, of a disposal group.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet_doc" xml:lang="en-US">Amount, before tax, of loss recognized for the write-down to fair value of property, plant and equipment, less cost to sell, of a disposal group.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationsOtherMember" xlink:to="clx_DiscontinuedOperationsOtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DiscontinuedOperationsOtherMember_doc" xml:lang="en-US">Discontinued operations not otherwise disclosed.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscretionaryCompanyContributions" xlink:to="clx_DiscretionaryCompanyContributions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DiscretionaryCompanyContributions_doc" xml:lang="en-US">Company contributions to the profit sharing component above specified percent of employee eligible earnings are discretionary and are based on certain Company performance targets for eligible employees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet" xlink:to="clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet_doc" xml:lang="en-US">Amount of assets net of liabilities attributable to disposal group held for sale or disposed of.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupIncludingDiscontinuedOperationOther" xlink:to="clx_DisposalGroupIncludingDiscontinuedOperationOther_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationOther_doc" xml:lang="en-US">Amount of other miscellaneous expense attributable to disposal group.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:to="clx_DisposalGroupIncludingDiscontinuedOperationSeverance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationSeverance_doc" xml:lang="en-US">Amount of severance expense attributable to disposal group.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear" xlink:to="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear_doc" xml:lang="en-US">Represents the amount of additional exit cost consisting of employee-related and other costs expected to be incurred for the remainder of fiscal year following the latest fiscal year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter" xlink:to="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter_doc" xml:lang="en-US">Represents the amount of additional exit cost consisting of employee-related and other costs expected to be incurred thereafter.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DocumentAndEntityInformationAbstract" xlink:to="clx_DocumentAndEntityInformationAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DocumentAndEntityInformationAbstract_doc" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DomesticEquitySecuritiesMember" xlink:to="clx_DomesticEquitySecuritiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DomesticEquitySecuritiesMember_doc" xml:lang="en-US">Domestic Equity Securities [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DomesticNonQualifiedRetirementIncomePlansMember" xlink:to="clx_DomesticNonQualifiedRetirementIncomePlansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DomesticNonQualifiedRetirementIncomePlansMember_doc" xml:lang="en-US">Domestic Non-Qualified Retirement Income Plans [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DomesticQualifiedRetirementIncomePlansMember" xlink:to="clx_DomesticQualifiedRetirementIncomePlansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DomesticQualifiedRetirementIncomePlansMember_doc" xml:lang="en-US">The company's defined benefit pension plans, all combined, in the United States, which is deemed to be its country of domicile.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_EmployeeBenefitObligationsNoncurrent" xlink:to="clx_EmployeeBenefitObligationsNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_EmployeeBenefitObligationsNoncurrent_doc" xml:lang="en-US">The sum of the carrying amounts as of the balance sheet date of the portions of obligations to employees under pension, postretirement, and health benefit plans that are due beyond one year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_EmployeeBenefitsPolicyTextBlock" xlink:to="clx_EmployeeBenefitsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_EmployeeBenefitsPolicyTextBlock_doc" xml:lang="en-US">Disclosure of accounting policy for the entity's various types of employee benefit plans, including retirement, postretirement and postemployment plans.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_EscrowRestrictedCashMember" xlink:to="clx_EscrowRestrictedCashMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_EscrowRestrictedCashMember_doc" xml:lang="en-US">Restricted cash held in escrow related to acquisition [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_EvergreenProgramMember" xlink:to="clx_EvergreenProgramMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_EvergreenProgramMember_doc" xml:lang="en-US">A share repurchase program to offset the impact of share dilution related to share-based awards.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_doc" xml:lang="en-US">Fair Value Assets and Liabilities Measured on Recurring Basis [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FairValueMeasurementsRecurringTable" xlink:to="clx_FairValueMeasurementsRecurringTable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_FairValueMeasurementsRecurringTable_doc" xml:lang="en-US">Disclosure about financial instruments measured at fair value on a recurring basis.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_doc" xml:lang="en-US">Financial Instruments and Fair Value Measurements [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" xlink:to="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock_doc" xml:lang="en-US">The entire disclosure for financial instruments and fair value measurements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal" xlink:to="clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal_doc" xml:lang="en-US">Useful life renewal period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignAndOtherCreditLinesMember" xlink:to="clx_ForeignAndOtherCreditLinesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ForeignAndOtherCreditLinesMember_doc" xml:lang="en-US">Foreign and Other Credit Lines [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignBorrowingsMember" xlink:to="clx_ForeignBorrowingsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ForeignBorrowingsMember_doc" xml:lang="en-US">Foreign Borrowings [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignCreditLinesMember" xlink:to="clx_ForeignCreditLinesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ForeignCreditLinesMember_doc" xml:lang="en-US">Foreign Credit Lines [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignEquitySecuritiesMember" xlink:to="clx_ForeignEquitySecuritiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ForeignEquitySecuritiesMember_doc" xml:lang="en-US">Foreign Equity Securities [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignMember" xlink:to="clx_ForeignMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ForeignMember_doc" xml:lang="en-US">Foreign [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignNetOperatingLossCarryforwardAndTaxCreditsMember" xlink:label="clx_ForeignNetOperatingLossCarryforwardAndTaxCreditsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignNetOperatingLossCarryforwardAndTaxCreditsMember" xlink:to="clx_ForeignNetOperatingLossCarryforwardAndTaxCreditsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ForeignNetOperatingLossCarryforwardAndTaxCreditsMember_doc" xml:lang="en-US">Net (increase) decrease in foreign net operating loss carryforward and tax credits deductible items.</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignRetirementIncomePlansMember" xlink:label="clx_ForeignRetirementIncomePlansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignRetirementIncomePlansMember" xlink:to="clx_ForeignRetirementIncomePlansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ForeignRetirementIncomePlansMember_doc" xml:lang="en-US">Foreign Retirement Income Plans [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignSubsidiaryRestrictedCashMember" xlink:to="clx_ForeignSubsidiaryRestrictedCashMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ForeignSubsidiaryRestrictedCashMember_doc" xml:lang="en-US">Restricted cash held by a foreign subsidiary as a prepayment received for intercompany services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignTaxCreditCarryforwardMember" xlink:to="clx_ForeignTaxCreditCarryforwardMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ForeignTaxCreditCarryforwardMember_doc" xml:lang="en-US">Foreign tax credits that have been carried forward to reduce taxable income or taxes payable in a future year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract" xlink:to="clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract_doc" xml:lang="en-US">Goodwill, Trademarks And Other Intangible Assets [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_HouseholdMember" xlink:to="clx_HouseholdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_HouseholdMember_doc" xml:lang="en-US">Household [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ImpairmentOfTrademarks" xlink:to="clx_ImpairmentOfTrademarks_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ImpairmentOfTrademarks_doc" xml:lang="en-US">The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of trademarks to fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_IncomeTaxesTable" xlink:to="clx_IncomeTaxesTable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_IncomeTaxesTable_doc" xml:lang="en-US">Income Taxes [Table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InterestRateForwardContractsSettlement" xlink:to="clx_InterestRateForwardContractsSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_InterestRateForwardContractsSettlement_doc" xml:lang="en-US">Cash payment to counterparties to settle an interest rate cash flow hedge in connection with the issuance of long-term debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InternationalMember" xlink:to="clx_InternationalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_InternationalMember_doc" xml:lang="en-US">International [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_JetFuelMember" xlink:to="clx_JetFuelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_JetFuelMember_doc" xml:lang="en-US">Jet Fuel [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LeasesAndOtherCommitmentsAbstract" xlink:to="clx_LeasesAndOtherCommitmentsAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LeasesAndOtherCommitmentsAbstract_doc" xml:lang="en-US">Leases And Other Commitments [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LetterOfCreditBorrowingCapacity" xlink:to="clx_LetterOfCreditBorrowingCapacity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LetterOfCreditBorrowingCapacity_doc" xml:lang="en-US">Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LifestyleMember" xlink:to="clx_LifestyleMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LifestyleMember_doc" xml:lang="en-US">Lifestyle [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LifoAllowanceMember" xlink:to="clx_LifoAllowanceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LifoAllowanceMember_doc" xml:lang="en-US">Lifo Allowance [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LiquidBleachMember" xlink:to="clx_LiquidBleachMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LiquidBleachMember_doc" xml:lang="en-US">Liquid Bleach [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LongTermAndShortTermDebtLineItems" xlink:to="clx_LongTermAndShortTermDebtLineItems_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LongTermAndShortTermDebtLineItems_doc" xml:lang="en-US">Long-Term And Short-Term Debt [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LongTermIntercompanyLoansMember" xlink:to="clx_LongTermIntercompanyLoansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LongTermIntercompanyLoansMember_doc" xml:lang="en-US">Long term intercompany loans included in foreign currency adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LowIncomeHousingPartnershipGainsLosses" xlink:to="clx_LowIncomeHousingPartnershipGainsLosses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LowIncomeHousingPartnershipGainsLosses_doc" xml:lang="en-US">Low-income housing partnership (gains) losses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement" xlink:to="clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement_doc" xml:lang="en-US">The percentage of ownership interest by the venture partner.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MedicalMember" xlink:to="clx_MedicalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_MedicalMember_doc" xml:lang="en-US">Medical [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MiscellaneousOtherIncomeExpense" xlink:to="clx_MiscellaneousOtherIncomeExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_MiscellaneousOtherIncomeExpense_doc" xml:lang="en-US">Represents the sum of miscellaneous other nonoperating income and expense recognized by the entity in the period that is not otherwise specified.</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NewSeniorNotesMember" xlink:label="clx_NewSeniorNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NewSeniorNotesMember" xlink:to="clx_NewSeniorNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_NewSeniorNotesMember_doc" xml:lang="en-US">New Senior Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NonCashCapitalExpenditures" xlink:to="clx_NonCashCapitalExpenditures_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_NonCashCapitalExpenditures_doc" xml:lang="en-US">Amount of non-cash capital expenditures incurred during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:to="clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries_doc" xml:lang="en-US">Non US dollar cash balances held by non US dollar functional currency subsidiaries.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" xlink:to="clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries_doc" xml:lang="en-US">Non US dollar cash balances held by US dollar functional currency subsidiaries.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod" xlink:to="clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod_doc" xml:lang="en-US">The amount of nondiscretionary payments the company made during the period pertaining to the profit-sharing component of its U.S. defined contribution plans</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NotSubjectToExpirationMember" xlink:to="clx_NotSubjectToExpirationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_NotSubjectToExpirationMember_doc" xml:lang="en-US">Foreign benefits not subject to expiration.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NumberOfLeasedProperties" xlink:to="clx_NumberOfLeasedProperties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_NumberOfLeasedProperties_doc" xml:lang="en-US">Represents information pertaining to number of leased properties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NyseMarketPriceOfEntityCommonStockPeriodEnd" xlink:to="clx_NyseMarketPriceOfEntityCommonStockPeriodEnd_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_NyseMarketPriceOfEntityCommonStockPeriodEnd_doc" xml:lang="en-US">The closing market price of the entity's common stock on the New York Stock Exchange on the last day of the reporting period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OpenMarketProgramMember" xlink:to="clx_OpenMarketProgramMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OpenMarketProgramMember_doc" xml:lang="en-US">A program to repurchase issued and outstanding common shares of the entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod" xlink:to="clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod_doc" xml:lang="en-US">The accumulated change in the value of either the projected benefit obligation or the plans assets resulting from experience different from that assumed or from a change in an actuarial assumption that has not been recognized in net periodic benefit cost pursuant to FAS 87 and 106.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost" xlink:to="clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost_doc" xml:lang="en-US">The adjustment out of other comprehensive income for actuarial gains (losses) recognized as a component of net periodic benefit cost during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherCreditLinesMember" xlink:to="clx_OtherCreditLinesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherCreditLinesMember_doc" xml:lang="en-US">Other Credit Lines [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherCurrentAssetsAbstract" xlink:to="clx_OtherCurrentAssetsAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherCurrentAssetsAbstract_doc" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherDiscontinuedOperationMember" xlink:label="clx_OtherDiscontinuedOperationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherDiscontinuedOperationMember" xlink:to="clx_OtherDiscontinuedOperationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherDiscontinuedOperationMember_doc" xml:lang="en-US">Represents information pertaining to other discontinued operations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherEmployeeStockPlanActivitiesShares" xlink:to="clx_OtherEmployeeStockPlanActivitiesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherEmployeeStockPlanActivitiesShares_doc" xml:lang="en-US">Number of shares issued during the period as a result of the vesting of share-based awards.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherEmployeeStockPlanActivitiesValue" xlink:to="clx_OtherEmployeeStockPlanActivitiesValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherEmployeeStockPlanActivitiesValue_doc" xml:lang="en-US">Amount includes the value of stock granted during the period as a result of the vesting of share-based awards and other items, net of the amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit. This element is not the recognition of equity-based compensation expense in pursuant to FAS 123R.</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherForeignDeferredTaxAssetsMember" xlink:label="clx_OtherForeignDeferredTaxAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherForeignDeferredTaxAssetsMember" xlink:to="clx_OtherForeignDeferredTaxAssetsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherForeignDeferredTaxAssetsMember_doc" xml:lang="en-US">Net increase (decrease) in realizability of other foreign deferred tax assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIncomeExpenseNet" xlink:to="clx_OtherIncomeExpenseNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherIncomeExpenseNet_doc" xml:lang="en-US">The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIntangibleAssetsAxis" xlink:to="clx_OtherIntangibleAssetsAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherIntangibleAssetsAxis_doc" xml:lang="en-US">Other Intangible Assets [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIntangibleAssetsDomain" xlink:label="clx_OtherIntangibleAssetsDomain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIntangibleAssetsDomain" xlink:to="clx_OtherIntangibleAssetsDomain_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherIntangibleAssetsDomain_doc" xml:lang="en-US">Other Intangible Assets [Domain]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIntangibleAssetsOtherMember" xlink:to="clx_OtherIntangibleAssetsOtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherIntangibleAssetsOtherMember_doc" xml:lang="en-US">Other Intangible Assets, Other [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_PrescriptionDrugsMember" xlink:to="clx_PrescriptionDrugsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_PrescriptionDrugsMember_doc" xml:lang="en-US">Prescription Drugs [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock" xlink:to="clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock_doc" xml:lang="en-US">A schedule that reflects the provision for income taxes on continuing operations, by tax jurisdiction.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh" xlink:to="clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh_doc" xml:lang="en-US">The highest daily closing market price for the entity's common stock on the New York Stock Exchange for a given period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RangeOfNyseMarketPriceOfEntityCommonStockLow" xlink:to="clx_RangeOfNyseMarketPriceOfEntityCommonStockLow_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RangeOfNyseMarketPriceOfEntityCommonStockLow_doc" xml:lang="en-US">The lowest daily closing market price for the entity's common stock on the New York Stock Exchange for a given period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RealEstateFundMember" xlink:to="clx_RealEstateFundMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RealEstateFundMember_doc" xml:lang="en-US">Real Estate Fund [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RemediationPeriod" xlink:to="clx_RemediationPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RemediationPeriod_doc" xml:lang="en-US">Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RepaidSeniorNotesMember" xlink:label="clx_RepaidSeniorNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RepaidSeniorNotesMember" xlink:to="clx_RepaidSeniorNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RepaidSeniorNotesMember_doc" xml:lang="en-US">Repaid Senior Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementHealthCareMember" xlink:to="clx_RetirementHealthCareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RetirementHealthCareMember_doc" xml:lang="en-US">A plan that defines postretirement benefits in terms of monetary amounts (for example, $100,000 of life insurance) or benefit coverage to be provided (for example, up to $200 per day for hospitalization, 80 percent of the cost of specified surgical procedures, and so forth). Any postretirement benefit plan that is not a defined contribution postretirement plan is a defined benefit postretirement plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementHealthCarePlanMember" xlink:to="clx_RetirementHealthCarePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RetirementHealthCarePlanMember_doc" xml:lang="en-US">Retirement Health Care Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementIncomeMember" xlink:to="clx_RetirementIncomeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RetirementIncomeMember_doc" xml:lang="en-US">Retirement Income [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementIncomePlanMember" xlink:to="clx_RetirementIncomePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RetirementIncomePlanMember_doc" xml:lang="en-US">Retirement Income Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RevolvingLineOfCreditMember" xlink:to="clx_RevolvingLineOfCreditMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RevolvingLineOfCreditMember_doc" xml:lang="en-US">Revolving Line Of Credit [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SaleLeasebackTransactionLeaseTerm" xlink:to="clx_SaleLeasebackTransactionLeaseTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SaleLeasebackTransactionLeaseTerm_doc" xml:lang="en-US">The term of the lease related to the assets being leased-back in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain" xlink:to="clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain_doc" xml:lang="en-US">The noncurrent portion of the deferred gain recorded in connection with the sale-leaseback transaction.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" xlink:to="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock_doc" xml:lang="en-US">Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and profit or loss reported in discontinued operations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock" xlink:to="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock_doc" xml:lang="en-US">Tabular disclosure of disposal groups, which provides a breakdown of charges and costs included in losses from discontinued operations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock" xlink:to="clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock_doc" xml:lang="en-US">Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases and capital leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock" xlink:to="clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock_doc" xml:lang="en-US">Tabular disclosure of shares repurchases under authorized programs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorNotes3.50PercentMember" xlink:to="clx_SeniorNotes3.50PercentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SeniorNotes3.50PercentMember_doc" xml:lang="en-US">Represents information pertaining to senior notes with an annual fixed interest rate of 3.50%.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorNotes5.00PercentMember" xlink:to="clx_SeniorNotes5.00PercentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SeniorNotes5.00PercentMember_doc" xml:lang="en-US">Senior Notes 5.00% [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember_doc" xml:lang="en-US">Represents information pertaining to senior unsecured long term notes and debtentures 3.50%, due December 2024.</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember_doc" xml:lang="en-US">Senior Unsecured Long Term Notes And Debentures Instrument Due January Two Thousand Fifteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember_doc" xml:lang="en-US">Senior Unsecured Long Term Notes And Debentures Instrument Due November Two Thousand Fifteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember_doc" xml:lang="en-US">Senior Unsecured Long Term Notes And Debentures Instrument Due November Two Thousand Twenty One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember_doc" xml:lang="en-US">Senior Unsecured Long Term Notes And Debentures Instrument Due October Two Thousand Seventeen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember_doc" xml:lang="en-US">Senior Unsecured Long-term Notes and Debentures Instrument Due September 2022 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SettlementOfInterestRateForwardContract" xlink:to="clx_SettlementOfInterestRateForwardContract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SettlementOfInterestRateForwardContract_doc" xml:lang="en-US">Payment for the settlement of interest rate forward contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue_doc" xml:lang="en-US">The weighted average fair value at grant date for distributed equity-based awards issued during the period on other than stock (or unit) option plans.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred_doc" xml:lang="en-US">The number of shares under a share-based award plan other than a stock option plan that were vested and deferred during the reporting period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award equity instruments other than options vested and deferred in period weighted average grant date fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_doc" xml:lang="en-US">The weighted average fair value of vested and nonvested awards on equity-based plans excluding option plans outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award fair value assumptions expected dividend rate in one year maximum.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award fair value assumptions expected dividend rate in one year minimum.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award fair value assumptions weighted average expected dividend.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod_doc" xml:lang="en-US">Period over which performance is measured for performance-based awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareRepurchaseProgramsLineItems" xlink:to="clx_ShareRepurchaseProgramsLineItems_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareRepurchaseProgramsLineItems_doc" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareRepurchaseProgramsTable" xlink:to="clx_ShareRepurchaseProgramsTable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareRepurchaseProgramsTable_doc" xml:lang="en-US">Disclosure of information about share repurchase programs and shares repurchased.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm" xlink:to="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm_doc" xml:lang="en-US">Represents the expected term of share-based compensation awards, in ''PnYnMnDTnHnMnS'' format, for example, ''P1Y5M13D'' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum" xlink:to="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum_doc" xml:lang="en-US">Maximum expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum" xlink:to="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum_doc" xml:lang="en-US">Minimum expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod" xlink:to="clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod_doc" xml:lang="en-US">Reflects the calculation as of the balance sheet date of average interest rate incurred during the reporting period weighted by the amount of short-term debt outstanding by type or by instrument during that time.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:to="clx_SiteContingencyAgreedPercentageOfCostSharing_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SiteContingencyAgreedPercentageOfCostSharing_doc" xml:lang="en-US">The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SoybeanOilMember" xlink:to="clx_SoybeanOilMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SoybeanOilMember_doc" xml:lang="en-US">Soybean Oil [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SubjectToExpirationMember" xlink:to="clx_SubjectToExpirationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SubjectToExpirationMember_doc" xml:lang="en-US">Foreign benefits subject to expiration.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="clx_TaxCreditAndOperatingLossCarryforwardsLineItems_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_TaxCreditAndOperatingLossCarryforwardsLineItems_doc" xml:lang="en-US">Tax Credit and Operating Loss Carryforwards [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TechnologyAndProductFormulaeMember" xlink:to="clx_TechnologyAndProductFormulaeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_TechnologyAndProductFormulaeMember_doc" xml:lang="en-US">Technology and Product Formulae [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TrademarksNet" xlink:to="clx_TrademarksNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_TrademarksNet_doc" xml:lang="en-US">Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TrashBagsMember" xlink:to="clx_TrashBagsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_TrashBagsMember_doc" xml:lang="en-US">Trash Bags [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_UnitedStatesEquityMember" xlink:to="clx_UnitedStatesEquityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_UnitedStatesEquityMember_doc" xml:lang="en-US">U.S. Equity [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_UnrecognizedTaxBenefitsSettlements" xlink:to="clx_UnrecognizedTaxBenefitsSettlements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_UnrecognizedTaxBenefitsSettlements_doc" xml:lang="en-US">The net amount of increases or decreases in unrecognized tax benefits resulting from settlements with taxing authorities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:to="clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries_doc" xml:lang="en-US">US dollar cash balances held by non US dollar functional currency subsidiaries.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" xlink:to="clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent_doc" xml:lang="en-US">US dollar cash balances held by US dollar functional currency subsidiaries and by parent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:to="clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_doc" xml:lang="en-US">Useful Lives Of Property, Plant and Equipment [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses" xlink:to="clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses_doc" xml:lang="en-US">Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs, credited to costs and expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VenezuelanSubsidiaryMember" xlink:to="clx_VenezuelanSubsidiaryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_VenezuelanSubsidiaryMember_doc" xml:lang="en-US">Subsidiary in Venezuela [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VentureAgreementNetTerminalObligation" xlink:to="clx_VentureAgreementNetTerminalObligation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_VentureAgreementNetTerminalObligation_doc" xml:lang="en-US">Aggregate carrying amount, as of the balance sheet date, of the contractual obligation to purchase the venture partners interest upon termination of the venture arrangement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VentureAgreementRenewalOption" xlink:to="clx_VentureAgreementRenewalOption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_VentureAgreementRenewalOption_doc" xml:lang="en-US">The venture agreement renewal option between the Company and the venture partner.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VentureAgreementTerm" xlink:to="clx_VentureAgreementTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_VentureAgreementTerm_doc" xml:lang="en-US">The agreement term between the Company and The Procter &amp;amp; Gamble Company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VestedAwardsWerePaidByIssuanceOfShares" xlink:to="clx_VestedAwardsWerePaidByIssuanceOfShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_VestedAwardsWerePaidByIssuanceOfShares_doc" xml:lang="en-US">The total grant date fair value of the vested shares that were paid by issuance of stocks during the year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VestedStockAwardsDeferred" xlink:to="clx_VestedStockAwardsDeferred_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_VestedStockAwardsDeferred_doc" xml:lang="en-US">The total grant date fair value of the vested shares that were deferred during the year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_WalmartStoresIncMember" xlink:to="clx_WalmartStoresIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_WalmartStoresIncMember_doc" xml:lang="en-US">Walmart Stores, Inc. and its affiliates [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps" xlink:to="clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps_doc" xml:lang="en-US">Reflects the calculation as of the balance sheet date of the average interest rate weighted by the amount of long-term debt outstanding by type or by instrument at that time, including the effect of interest rate swaps.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RenewLifeHoldingsCorporationMember" xlink:to="clx_RenewLifeHoldingsCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RenewLifeHoldingsCorporationMember_doc" xml:lang="en-US">Renew Life Holdings Corporation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorNotes3.55PercentMember" xlink:to="clx_SeniorNotes3.55PercentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SeniorNotes3.55PercentMember_doc" xml:lang="en-US">Senior Notes 3.55% [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeNatureAxis" xlink:to="clx_DerivativeNatureAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DerivativeNatureAxis_doc" xml:lang="en-US">Derivative Nature [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor" xlink:to="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor_doc" xml:lang="en-US">Floor percentage of target recognized as additional compensation expense if performance goals are exceeded.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CompanyFourZeroOneKPlanMember" xlink:to="clx_CompanyFourZeroOneKPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CompanyFourZeroOneKPlanMember_doc" xml:lang="en-US">Company 401(k) plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InternationalDefinedContributionPlanMember" xlink:to="clx_InternationalDefinedContributionPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_InternationalDefinedContributionPlanMember_doc" xml:lang="en-US">International Defined Contribution Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TopFiveLargestCustomersMember" xlink:to="clx_TopFiveLargestCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_TopFiveLargestCustomersMember_doc" xml:lang="en-US">Top Five Largest Customers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MaximumOwnershipPercentageOfEquityInvestments" xlink:to="clx_MaximumOwnershipPercentageOfEquityInvestments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_MaximumOwnershipPercentageOfEquityInvestments_doc" xml:lang="en-US">Maximum ownership percentage in equity investments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets" xlink:to="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets_doc" xml:lang="en-US">Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized resulting from other foreign deferred tax assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits" xlink:to="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits_doc" xml:lang="en-US">Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized resulting from foreign net operating loss carryforwards and tax credits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIncomeExpenseNetDisclosureTextBlock" xlink:to="clx_OtherIncomeExpenseNetDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherIncomeExpenseNetDisclosureTextBlock_doc" xml:lang="en-US">The entire disclosure for the net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VentureAgreementNetTerminalObligationNetMember" xlink:label="clx_VentureAgreementNetTerminalObligationNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VentureAgreementNetTerminalObligationNetMember" xlink:to="clx_VentureAgreementNetTerminalObligationNetMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_VentureAgreementNetTerminalObligationNetMember_doc" xml:lang="en-US">Venture Agreement Net Terminal Obligation Net [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_AmortizationOfTrademarksAndOtherIntangibleAssets" xlink:to="clx_AmortizationOfTrademarksAndOtherIntangibleAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_AmortizationOfTrademarksAndOtherIntangibleAssets_doc" xml:lang="en-US">Amortization of trademarks and other intangible assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MutualFunds" xlink:to="clx_MutualFunds_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_MutualFunds_doc" xml:lang="en-US">An investment fund formed from the pooling of investments by institutional investors, which are traded on the exchange and hold a quoted market price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CommonOrCollectiveTrusts" xlink:to="clx_CommonOrCollectiveTrusts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CommonOrCollectiveTrusts_doc" xml:lang="en-US">A professionally managed type of collective investment scheme that pools money from many investors and invests typically in investment securities (stocks, bonds, short-term money market instruments, other mutual funds, other securities and/or commodities).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement" xlink:to="clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement_doc" xml:lang="en-US">Percentage point benefit to historical effective tax rate from adoption of Accounting Standards Update (ASU) No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting".</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement" xlink:to="clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement_doc" xml:lang="en-US">Estimated fair value of the venture partner's 20% interest required to be purchased by the Company at termination of venture agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_PackagingDevelopmentAndDesignCosts" xlink:to="clx_PackagingDevelopmentAndDesignCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_PackagingDevelopmentAndDesignCosts_doc" xml:lang="en-US">Aggregate costs expensed during the period for developing and designing packaging, including design, artwork, films, and labeling.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ExpirationPeriodAxis" xlink:to="clx_ExpirationPeriodAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ExpirationPeriodAxis_doc" xml:lang="en-US">Expiration Period [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock" xlink:to="clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock_doc" xml:lang="en-US">Tabular disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach" xlink:to="clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach_doc" xml:lang="en-US">Represents the minimum percentage of the greater of the projected benefit obligation or the market-related asset value that actuarial gains and losses must exceed in order to be amortized to pension expense under the corridor approach for purposes of determining the amortization of actuarial gains and losses related to the entity's employee benefits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredStockUnitsForNonemployeeDirectorsMember" xlink:to="clx_DeferredStockUnitsForNonemployeeDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredStockUnitsForNonemployeeDirectorsMember_doc" xml:lang="en-US">Deferred Stock Units for Nonemployee Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_2_lbl" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCreditDerivativesMember" xlink:to="us-gaap_OtherCreditDerivativesMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCreditDerivativesMember_2_lbl" xml:lang="en-US">Other Credit Derivatives [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2_lbl" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCash" xlink:to="us-gaap_DividendsCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsCash_2_lbl" xml:lang="en-US">Dividends, Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="us-gaap_TreasuryStockValueAcquiredCostMethod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValueAcquiredCostMethod_2_lbl" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockSharesAcquired_2_lbl" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashIncomeExpense_2_lbl" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2_lbl" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_2_lbl" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet_3_lbl" xml:lang="en-US">DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet_3_lbl" xml:lang="en-US">DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets_3_lbl" xml:lang="en-US">DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" xlink:to="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets_3_lbl" xml:lang="en-US">DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:to="clx_DisposalGroupIncludingDiscontinuedOperationSeverance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationSeverance_3_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationSeverance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DisposalGroupIncludingDiscontinuedOperationOther" xlink:to="clx_DisposalGroupIncludingDiscontinuedOperationOther_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DisposalGroupIncludingDiscontinuedOperationOther_3_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationOther</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReserve" xlink:to="us-gaap_InventoryLIFOReserve_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLIFOReserve_2_lbl" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2_lbl" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2_lbl" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_2_lbl" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Long-term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureRecurring" xlink:to="us-gaap_AssetsFairValueDisclosureRecurring_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosureRecurring_2_lbl" xml:lang="en-US">Assets, Fair Value Disclosure, Recurring</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosureRecurring" xlink:to="us-gaap_LiabilitiesFairValueDisclosureRecurring_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosureRecurring_2_lbl" xml:lang="en-US">Liabilities, Fair Value Disclosure, Recurring</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Two Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Three Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Four Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Five Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDue_2_lbl" xml:lang="en-US">Capital Leases, Future Minimum Payments Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_2_lbl" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due in Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_2_lbl" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due within Two Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_2_lbl" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due within Three Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary_2_lbl" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due within Four Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary_2_lbl" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due within Five Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears_2_lbl" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due after Five Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_2_lbl" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value, Amount Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" xlink:to="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_2_lbl" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LowIncomeHousingPartnershipGainsLosses" xlink:to="clx_LowIncomeHousingPartnershipGainsLosses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LowIncomeHousingPartnershipGainsLosses_3_lbl" xml:lang="en-US">LowIncomeHousingPartnershipGainsLosses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_MiscellaneousOtherIncomeExpense" xlink:to="clx_MiscellaneousOtherIncomeExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_MiscellaneousOtherIncomeExpense_3_lbl" xml:lang="en-US">MiscellaneousOtherIncomeExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_2_lbl" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_2_lbl" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_4_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" xlink:to="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets_3_lbl" xml:lang="en-US">DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships" xlink:to="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships_3_lbl" xml:lang="en-US">DeferredTaxLiabilitiesLowIncomeHousingPartnerships</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets" xlink:to="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets_3_lbl" xml:lang="en-US">ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits" xlink:to="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits_3_lbl" xml:lang="en-US">ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_3_lbl" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_2_lbl" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_2_lbl" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscretionaryCompanyContributions" xlink:to="clx_DiscretionaryCompanyContributions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DiscretionaryCompanyContributions_3_lbl" xml:lang="en-US">DiscretionaryCompanyContributions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="us-gaap_DefinedBenefitPlanBenefitObligation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanBenefitObligation_3_lbl" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="us-gaap_DefinedBenefitPlanActuarialGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanActuarialGainLoss_2_lbl" xml:lang="en-US">Defined Benefit Plan, Actuarial Gain (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanBenefitsPaid" xlink:to="us-gaap_DefinedBenefitPlanBenefitsPaid_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanBenefitsPaid_2_lbl" xml:lang="en-US">Defined Benefit Plan, Benefits Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets_2_lbl" xml:lang="en-US">Defined Benefit Plan, Foreign Currency Exchange Rate Changes, Plan Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_2_lbl" xml:lang="en-US">Pension and Other Postretirement Defined Benefit Plans, Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_2_lbl" xml:lang="en-US">Defined Benefit Plan, Amounts Recognized in Balance Sheet</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2_lbl" xml:lang="en-US">Defined Benefit Plan, Expected Return on Plan Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_2_lbl" xml:lang="en-US">Defined Benefit Plan, Amortization of Gains (Losses)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2_lbl" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4_lbl" xml:lang="en-US">Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Net Gains (Losses), before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" xlink:to="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax_2_lbl" xml:lang="en-US">Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Net Transition Assets (Obligations), before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_2_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_2_lbl" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_2_lbl" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_2_lbl" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments, Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2_lbl" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_2_lbl" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_2_lbl" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_2_lbl" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payments, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueGoodsNet" xlink:to="us-gaap_SalesRevenueGoodsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueGoodsNet_2_lbl" xml:lang="en-US">Sales Revenue, Goods, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_3_lbl" xml:lang="en-US">Valuation Allowances and Reserves, Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2_lbl" xml:lang="en-US">Valuation Allowances and Reserves, Additions for Charges to Cost and Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember" xlink:to="clx_CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember_2_lbl" xml:lang="en-US">CorporateHeadquartersAndPrimaryResearchAndDevelopmentFacilityMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignNetOperatingLossCarryforwardAndTaxCreditsMember" xlink:to="clx_ForeignNetOperatingLossCarryforwardAndTaxCreditsMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ForeignNetOperatingLossCarryforwardAndTaxCreditsMember_2_lbl" xml:lang="en-US">ForeignNetOperatingLossCarryforwardAndTaxCreditsMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ForeignRetirementIncomePlansMember" xlink:to="clx_ForeignRetirementIncomePlansMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ForeignRetirementIncomePlansMember_2_lbl" xml:lang="en-US">ForeignRetirementIncomePlansMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NewSeniorNotesMember" xlink:to="clx_NewSeniorNotesMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_NewSeniorNotesMember_2_lbl" xml:lang="en-US">NewSeniorNotesMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherDiscontinuedOperationMember" xlink:to="clx_OtherDiscontinuedOperationMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherDiscontinuedOperationMember_2_lbl" xml:lang="en-US">OtherDiscontinuedOperationMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherForeignDeferredTaxAssetsMember" xlink:to="clx_OtherForeignDeferredTaxAssetsMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherForeignDeferredTaxAssetsMember_2_lbl" xml:lang="en-US">OtherForeignDeferredTaxAssetsMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIntangibleAssetsDomain" xlink:to="clx_OtherIntangibleAssetsDomain_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherIntangibleAssetsDomain_2_lbl" xml:lang="en-US">OtherIntangibleAssetsDomain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RepaidSeniorNotesMember" xlink:to="clx_RepaidSeniorNotesMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RepaidSeniorNotesMember_2_lbl" xml:lang="en-US">RepaidSeniorNotesMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember" xlink:to="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember_2_lbl" xml:lang="en-US">SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueJanuaryTwoThousandFifteenMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VentureAgreementNetTerminalObligationNetMember" xlink:to="clx_VentureAgreementNetTerminalObligationNetMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_VentureAgreementNetTerminalObligationNetMember_2_lbl" xml:lang="en-US">VentureAgreementNetTerminalObligationNetMember</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>21
<FILENAME>clx-20160630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: Clorox 0616 10K Final to Update.xfr; Date: 2016%2D08%2D12T16:24:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80AE0001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-daei" xlink:href="clx-20160630.xsd#clx-daei" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csoe" xlink:href="clx-20160630.xsd#clx-csoe" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csoci" xlink:href="clx-20160630.xsd#clx-csoci" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-cbs" xlink:href="clx-20160630.xsd#clx-cbs" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-cbsp" xlink:href="clx-20160630.xsd#clx-cbsp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csose" xlink:href="clx-20160630.xsd#clx-csose" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csocf" xlink:href="clx-20160630.xsd#clx-csocf" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosap" xlink:href="clx-20160630.xsd#clx-sosap" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-do" xlink:href="clx-20160630.xsd#clx-do" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:href="clx-20160630.xsd#BusinessesAcquired" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-in1" xlink:href="clx-20160630.xsd#clx-in1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-oca" xlink:href="clx-20160630.xsd#clx-oca" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ppaen" xlink:href="clx-20160630.xsd#clx-ppaen" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoia" xlink:href="clx-20160630.xsd#clx-gtaoia" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="clx-20160630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-d1" xlink:href="clx-20160630.xsd#clx-d1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ol1" xlink:href="clx-20160630.xsd#clx-ol1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:href="clx-20160630.xsd#clx-fiafvm1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocag" xlink:href="clx-20160630.xsd#clx-ocag" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-laoc" xlink:href="clx-20160630.xsd#clx-laoc" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-se" xlink:href="clx-20160630.xsd#clx-se" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-nepse1" xlink:href="clx-20160630.xsd#clx-nepse1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scp" xlink:href="clx-20160630.xsd#clx-scp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-oein" xlink:href="clx-20160630.xsd#clx-oein" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-it1" xlink:href="clx-20160630.xsd#clx-it1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebp" xlink:href="clx-20160630.xsd#clx-ebp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sr1" xlink:href="clx-20160630.xsd#clx-sr1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-rpt" xlink:href="clx-20160630.xsd#clx-rpt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-uqd" xlink:href="clx-20160630.xsd#clx-uqd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ValuationAndQualifyingAccountsAndReserves" xlink:href="clx-20160630.xsd#ValuationAndQualifyingAccountsAndReserves" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapp" xlink:href="clx-20160630.xsd#clx-sosapp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapt" xlink:href="clx-20160630.xsd#clx-sosapt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dot" xlink:href="clx-20160630.xsd#clx-dot" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:href="clx-20160630.xsd#BusinessesAcquiredTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-int1" xlink:href="clx-20160630.xsd#clx-int1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocat" xlink:href="clx-20160630.xsd#clx-ocat" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ppaent" xlink:href="clx-20160630.xsd#clx-ppaent" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiat" xlink:href="clx-20160630.xsd#clx-gtaoiat" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-alt" xlink:href="clx-20160630.xsd#clx-alt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dt" xlink:href="clx-20160630.xsd#clx-dt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-olt1" xlink:href="clx-20160630.xsd#clx-olt1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmt1" xlink:href="clx-20160630.xsd#clx-fiafvmt1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-laoct" xlink:href="clx-20160630.xsd#clx-laoct" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-set" xlink:href="clx-20160630.xsd#clx-set" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-nepset1" xlink:href="clx-20160630.xsd#clx-nepset1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpt" xlink:href="clx-20160630.xsd#clx-scpt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-oeint" xlink:href="clx-20160630.xsd#clx-oeint" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itt" xlink:href="clx-20160630.xsd#clx-itt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpt" xlink:href="clx-20160630.xsd#clx-ebpt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-srt1" xlink:href="clx-20160630.xsd#clx-srt1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-uqdt" xlink:href="clx-20160630.xsd#clx-uqdt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapsochd" xlink:href="clx-20160630.xsd#clx-sosapsochd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapsoeuloppaed" xlink:href="clx-20160630.xsd#clx-sosapsoeuloppaed" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapaid" xlink:href="clx-20160630.xsd#clx-sosapaid" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dosolgfdod" xlink:href="clx-20160630.xsd#clx-dosolgfdod" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dosoolacaoc" xlink:href="clx-20160630.xsd#clx-dosoolacaoc" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dond" xlink:href="clx-20160630.xsd#clx-dond" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:href="clx-20160630.xsd#BusinessesAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ind1" xlink:href="clx-20160630.xsd#clx-ind1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocad" xlink:href="clx-20160630.xsd#clx-ocad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ppaend" xlink:href="clx-20160630.xsd#clx-ppaend" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiand" xlink:href="clx-20160630.xsd#clx-gtaoiand" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiasogd" xlink:href="clx-20160630.xsd#clx-gtaoiasogd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiasoiaegd" xlink:href="clx-20160630.xsd#clx-gtaoiasoiaegd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="clx-20160630.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dnd" xlink:href="clx-20160630.xsd#clx-dnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dnalpd" xlink:href="clx-20160630.xsd#clx-dnalpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dldnoudopd" xlink:href="clx-20160630.xsd#clx-dldnoudopd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dbcuofad" xlink:href="clx-20160630.xsd#clx-dbcuofad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-old1" xlink:href="clx-20160630.xsd#clx-old1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmnd1" xlink:href="clx-20160630.xsd#clx-fiafvmnd1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmsofimafvd1" xlink:href="clx-20160630.xsd#clx-fiafvmsofimafvd1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmsoeodidahid1" xlink:href="clx-20160630.xsd#clx-fiafvmsoeodidahid1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocagd" xlink:href="clx-20160630.xsd#clx-ocagd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/LeasesAndOtherCommitmentsDetails" xlink:href="clx-20160630.xsd#LeasesAndOtherCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sesrpd" xlink:href="clx-20160630.xsd#clx-sesrpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-secsdd" xlink:href="clx-20160630.xsd#clx-secsdd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:href="clx-20160630.xsd#StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StockholdersEquityNarrativeDetails" xlink:href="clx-20160630.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-nepsed" xlink:href="clx-20160630.xsd#clx-nepsed" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpnd" xlink:href="clx-20160630.xsd#clx-scpnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpccaritbd" xlink:href="clx-20160630.xsd#clx-scpccaritbd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpauiviccefsogd" xlink:href="clx-20160630.xsd#clx-scpauiviccefsogd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpsosoad" xlink:href="clx-20160630.xsd#clx-scpsosoad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpsorsaad" xlink:href="clx-20160630.xsd#clx-scpsorsaad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpsopsaad" xlink:href="clx-20160630.xsd#clx-scpsopsaad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails" xlink:href="clx-20160630.xsd#OtherIncomeExpenseNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itnd" xlink:href="clx-20160630.xsd#clx-itnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itpfitbtjadafebtd" xlink:href="clx-20160630.xsd#clx-itpfitbtjadafebtd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-iteitrrd" xlink:href="clx-20160630.xsd#clx-iteitrrd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itcondtad" xlink:href="clx-20160630.xsd#clx-itcondtad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itvad" xlink:href="clx-20160630.xsd#clx-itvad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itutbd" xlink:href="clx-20160630.xsd#clx-itutbd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpnd" xlink:href="clx-20160630.xsd#clx-ebpnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpsifdbriahpd" xlink:href="clx-20160630.xsd#clx-ebpsifdbriahpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpifripwaboieopad" xlink:href="clx-20160630.xsd#clx-ebpifripwaboieopad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpconcoriahcpd" xlink:href="clx-20160630.xsd#clx-ebpconcoriahcpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpinyracoped" xlink:href="clx-20160630.xsd#clx-ebpinyracoped" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpnalgapscbariaoclid" xlink:href="clx-20160630.xsd#clx-ebpnalgapscbariaoclid" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpwautenppaopbcd" xlink:href="clx-20160630.xsd#clx-ebpwautenppaopbcd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpebpd" xlink:href="clx-20160630.xsd#clx-ebpebpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebptaawaaad" xlink:href="clx-20160630.xsd#clx-ebptaawaaad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansAssetsCarriedAtFairValueDetails" xlink:href="clx-20160630.xsd#EmployeeBenefitPlansAssetsCarriedAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:href="clx-20160630.xsd#SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-srnsalabgad" xlink:href="clx-20160630.xsd#clx-srnsalabgad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-srcpd" xlink:href="clx-20160630.xsd#clx-srcpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-rptd" xlink:href="clx-20160630.xsd#clx-rptd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-uqdd" xlink:href="clx-20160630.xsd#clx-uqdd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-vaqaard" xlink:href="clx-20160630.xsd#clx-vaqaard" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-daei" xlink:title="00000001 - Document - DOCUMENT AND ENTITY INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csoe" xlink:title="00000002 - Statement - CONSOLIDATED STATEMENT OF EARNINGS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIncomeExpenseNet" xlink:label="loc_clxOtherIncomeExpenseNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_clxOtherIncomeExpenseNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEarningsPerShareBasic" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEarningsPerShareBasic" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEarningsPerShareDiluted" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEarningsPerShareDiluted" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csoci" xlink:title="00000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-cbs" xlink:title="00000004 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaapReceivablesNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TrademarksNet" xlink:label="loc_clxTrademarksNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_clxTrademarksNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaper" xlink:label="loc_us-gaapCommercialPaper" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapCommercialPaper" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredTaxLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-cbsp" xlink:title="00000005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csose" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csocf" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaapOtherNoncashIncomeExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapOtherNoncashIncomeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InterestRateForwardContractsSettlement" xlink:label="loc_clxInterestRateForwardContractsSettlement" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_clxInterestRateForwardContractsSettlement" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapCashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfShortTermDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaapPaymentsOfDividendsCommonStock" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosap" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-do" xlink:title="00000009 - Disclosure - DISCONTINUED OPERATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:title="00000010 - Disclosure - BUSINESSES ACQUIRED" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-in1" xlink:title="00000011 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-oca" xlink:title="00000012 - Disclosure - OTHER CURRENT ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ppaen" xlink:title="00000013 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoia" xlink:title="00000014 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000015 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-d1" xlink:title="00000016 - Disclosure - DEBT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ol1" xlink:title="00000017 - Disclosure - OTHER LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:title="00000018 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocag" xlink:title="00000019 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-laoc" xlink:title="00000020 - Disclosure - LEASES AND OTHER COMMITMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-se" xlink:title="00000021 - Disclosure - STOCKHOLDERS' EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-nepse1" xlink:title="00000022 - Disclosure - NET EARNINGS PER SHARE (EPS)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scp" xlink:title="00000023 - Disclosure - STOCK-BASED COMPENSATION PLANS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-oein" xlink:title="00000024 - Disclosure - OTHER (INCOME) EXPENSE, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-it1" xlink:title="00000025 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebp" xlink:title="00000026 - Disclosure - EMPLOYEE BENEFIT PLANS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sr1" xlink:title="00000027 - Disclosure - SEGMENT REPORTING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-rpt" xlink:title="00000028 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-uqd" xlink:title="00000029 - Disclosure - UNAUDITED QUARTERLY DATA" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ValuationAndQualifyingAccountsAndReserves" xlink:title="00000030 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapp" xlink:title="00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapt" xlink:title="00000032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dot" xlink:title="00000033 - Disclosure - DISCONTINUED OPERATIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:title="00000034 - Disclosure - BUSINESSES ACQUIRED (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-int1" xlink:title="00000035 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocat" xlink:title="00000036 - Disclosure - OTHER CURRENT ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ppaent" xlink:title="00000037 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiat" xlink:title="00000038 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-alt" xlink:title="00000039 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dt" xlink:title="00000040 - Disclosure - DEBT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-olt1" xlink:title="00000041 - Disclosure - OTHER LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmt1" xlink:title="00000042 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-laoct" xlink:title="00000043 - Disclosure - LEASES AND OTHER COMMITMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-set" xlink:title="00000044 - Disclosure - STOCKHOLDERS' EQUITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-nepset1" xlink:title="00000045 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpt" xlink:title="00000046 - Disclosure - STOCK-BASED COMPENSATION PLANS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-oeint" xlink:title="00000047 - Disclosure - OTHER (INCOME) EXPENSE, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itt" xlink:title="00000048 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpt" xlink:title="00000049 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-srt1" xlink:title="00000050 - Disclosure - SEGMENT REPORTING (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-uqdt" xlink:title="00000051 - Disclosure - UNAUDITED QUARTERLY DATA (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapsochd" xlink:title="00000052 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Cash Holdings) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" xlink:label="loc_clxUsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:to="loc_clxUsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:label="loc_clxUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:to="loc_clxUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:label="loc_clxNonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:to="loc_clxNonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" xlink:label="loc_clxNonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:to="loc_clxNonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapsoeuloppaed" xlink:title="00000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Estimated Useful Lives of Property, Plant and Equipment) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapaid" xlink:title="00000054 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Additional Information) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dosolgfdod" xlink:title="00000055 - Disclosure - DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" weight="-1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dosoolacaoc" xlink:title="00000056 - Disclosure - DISCONTINUED OPERATIONS (Summary of Operating Losses, Asset Charges and Other Costs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:label="loc_clxDisposalGroupIncludingDiscontinuedOperationSeverance" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_clxDisposalGroupIncludingDiscontinuedOperationSeverance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationOther" xlink:label="loc_clxDisposalGroupIncludingDiscontinuedOperationOther" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_clxDisposalGroupIncludingDiscontinuedOperationOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dond" xlink:title="00000057 - Disclosure - DISCONTINUED OPERATIONS (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:title="00000058 - Disclosure - BUSINESSES ACQUIRED (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ind1" xlink:title="00000059 - Disclosure - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryLIFOReserve" xlink:label="loc_us-gaapInventoryLIFOReserve" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryLIFOReserve" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocad" xlink:title="00000060 - Disclosure - OTHER CURRENT ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent" xlink:label="loc_us-gaapOtherAssetsMiscellaneousCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsMiscellaneousCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="loc_us-gaapDeferredTaxAssetsNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsCurrent" xlink:to="loc_us-gaapDeferredTaxAssetsNetCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ppaend" xlink:title="00000061 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiand" xlink:title="00000062 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiand" xlink:title="00000063 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiasogd" xlink:title="00000064 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiasoiaegd" xlink:title="00000065 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiasoiaegd" xlink:title="00000066 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000067 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_AccruedTradeAndSalesPromotionCostsCurrent" xlink:label="loc_clxAccruedTradeAndSalesPromotionCostsCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_clxAccruedTradeAndSalesPromotionCostsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapDividendsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dnd" xlink:title="00000068 - Disclosure - DEBT (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dnalpd" xlink:title="00000069 - Disclosure - DEBT (Notes and Loans Payable) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dldnoudopd" xlink:title="00000070 - Disclosure - DEBT (Long-term Debt, Net of Unamortized Discounts or Premiums) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dbcuofad" xlink:title="00000071 - Disclosure - DEBT (Borrowing Capacity Under Other Financing Arrangements) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-old1" xlink:title="00000072 - Disclosure - OTHER LIABILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EmployeeBenefitObligationsNoncurrent" xlink:label="loc_clxEmployeeBenefitObligationsNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="loc_clxEmployeeBenefitObligationsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VentureAgreementNetTerminalObligation" xlink:label="loc_clxVentureAgreementNetTerminalObligation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="loc_clxVentureAgreementNetTerminalObligation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="loc_us-gaapLiabilityForUncertainTaxPositionsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="loc_us-gaapLiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmnd1" xlink:title="00000073 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmsofimafvd1" xlink:title="00000074 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Financial Instruments Measured at Fair Value) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmsoeodidahid1" xlink:title="00000075 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocagd" xlink:title="00000076 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/LeasesAndOtherCommitmentsDetails" xlink:title="00000077 - Disclosure - LEASES AND OTHER COMMITMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueThereafter" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sesrpd" xlink:title="00000078 - Disclosure - STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-secsdd" xlink:title="00000079 - Disclosure - STOCKHOLDERS' EQUITY (Common Stock Dividends) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:title="00000080 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StockholdersEquityNarrativeDetails" xlink:title="00000081 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-nepsed" xlink:title="00000082 - Disclosure - NET EARNINGS PER SHARE (EPS) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpnd" xlink:title="00000083 - Disclosure - STOCK-BASED COMPENSATION PLANS (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpccaritbd" xlink:title="00000084 - Disclosure - STOCK-BASED COMPENSATION PLANS (Compensation Cost and Related Income Tax Benefit) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpauiviccefsogd" xlink:title="00000085 - Disclosure - STOCK-BASED COMPENSATION PLANS (Assumptions Utilized in the Valuation in Calculating the Compensation Expense for Stock Options Granted) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpsosoad" xlink:title="00000086 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Stock Option Activity) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpsorsaad" xlink:title="00000087 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Restricted Stock Award Activity) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpsopsaad" xlink:title="00000088 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Performance Stock Award Activity) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails" xlink:title="00000089 - Disclosure - OTHER (INCOME) EXPENSE, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MiscellaneousOtherIncomeExpense" xlink:label="loc_clxMiscellaneousOtherIncomeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_clxMiscellaneousOtherIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="loc_us-gaapInvestmentIncomeInterestAndDividend" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterestAndDividend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LowIncomeHousingPartnershipGainsLosses" xlink:label="loc_clxLowIncomeHousingPartnershipGainsLosses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_clxLowIncomeHousingPartnershipGainsLosses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_AmortizationOfTrademarksAndOtherIntangibleAssets" xlink:label="loc_clxAmortizationOfTrademarksAndOtherIntangibleAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_clxAmortizationOfTrademarksAndOtherIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails" xlink:title="00000090 - Disclosure - OTHER (INCOME) EXPENSE, NET (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itnd" xlink:title="00000091 - Disclosure - INCOME TAXES (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itpfitbtjadafebtd" xlink:title="00000092 - Disclosure - INCOME TAXES (Provision for Income Taxes by Tax Jurisdiction and Domestic and Foreign Earnings before Taxes) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-iteitrrd" xlink:title="00000093 - Disclosure - INCOME TAXES (Effective Income Tax Rate Reconciliation) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itcondtad" xlink:title="00000094 - Disclosure - INCOME TAXES (Components of Net Deferred Tax Assets) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" xlink:label="loc_clxDeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_clxDeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" xlink:label="loc_clxDeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_clxDeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:label="loc_us-gaapDeferredTaxLiabilitiesUndistributedForeignEarnings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships" xlink:label="loc_clxDeferredTaxLiabilitiesLowIncomeHousingPartnerships" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_clxDeferredTaxLiabilitiesLowIncomeHousingPartnerships" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" xlink:label="loc_clxDeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_clxDeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itvad" xlink:title="00000095 - Disclosure - INCOME TAXES (Valuation Allowance) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itutbd" xlink:title="00000096 - Disclosure - INCOME TAXES (Unrecognized Tax Benefits) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpnd" xlink:title="00000097 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpnd" xlink:title="00000098 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpsifdbriahpd" xlink:title="00000099 - Disclosure - EMPLOYEE BENEFIT PLANS (Summarized Information for Defined Benefit Retirement Income and Healthcare Plans) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:label="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent" xlink:label="loc_us-gaapDefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="loc_us-gaapDefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:label="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpifripwaboieopad" xlink:title="00000100 - Disclosure - EMPLOYEE BENEFIT PLANS (Information for Retirement Income Plans with Accumulated Benefit Obligation in Excess of Plan Assets) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpconcoriahcpd" xlink:title="00000101 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income and Health Care Plans) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaapDefinedBenefitPlanServiceCost" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_us-gaapDefinedBenefitPlanServiceCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaapDefinedBenefitPlanInterestCost" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_us-gaapDefinedBenefitPlanInterestCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpinyracoped" xlink:title="00000102 - Disclosure - EMPLOYEE BENEFIT PLANS (Items Not Yet Recognized as a Component of Postretirement Expense) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpnalgapscbariaoclid" xlink:title="00000103 - Disclosure - EMPLOYEE BENEFIT PLANS (Net Actuarial Loss (Gain) and Prior Service Cost (Benefit) Activity Recorded in Accumulated Other Comprehensive Loss (Income)) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpwautenppaopbcd" xlink:title="00000104 - Disclosure - EMPLOYEE BENEFIT PLANS (Weighted-Average Assumptions Used to Estimate the Net Periodic Pension and Other Postretirement Benefit Costs) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpebpd" xlink:title="00000105 - Disclosure - EMPLOYEE BENEFIT PLANS (Expected Benefit Payments) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebptaawaaad" xlink:title="00000106 - Disclosure - EMPLOYEE BENEFIT PLANS (Target Allocations and Weighted Average Asset Allocations) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlansAssetsCarriedAtFairValueDetails" xlink:title="00000107 - Disclosure - EMPLOYEE BENEFIT PLANS (Retirement Income Plan's Assets Carried at Fair Value) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:title="00000108 - Disclosure - SEGMENT REPORTING (Selected Financial Information Relating To Company's Segments ) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-srnsalabgad" xlink:title="00000109 - Disclosure - SEGMENT REPORTING (Net Sales and Long-Lived Assets by Geographic Area) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-srcpd" xlink:title="00000110 - Disclosure - SEGMENT REPORTING (Concentration Percentages) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-rptd" xlink:title="00000111 - Disclosure - RELATED PARTY TRANSACTIONS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-uqdd" xlink:title="00000112 - Disclosure - UNAUDITED QUARTERLY DATA (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-vaqaard" xlink:title="00000113 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>22
<FILENAME>clx-20160630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: Clorox 0616 10K Final to Update.xfr; Date: 2016%2D08%2D12T16:24:44Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80AE0001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-daei" xlink:href="clx-20160630.xsd#clx-daei" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csoe" xlink:href="clx-20160630.xsd#clx-csoe" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csoci" xlink:href="clx-20160630.xsd#clx-csoci" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-cbs" xlink:href="clx-20160630.xsd#clx-cbs" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-cbsp" xlink:href="clx-20160630.xsd#clx-cbsp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csose" xlink:href="clx-20160630.xsd#clx-csose" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-csocf" xlink:href="clx-20160630.xsd#clx-csocf" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosap" xlink:href="clx-20160630.xsd#clx-sosap" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-do" xlink:href="clx-20160630.xsd#clx-do" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:href="clx-20160630.xsd#BusinessesAcquired" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-in1" xlink:href="clx-20160630.xsd#clx-in1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-oca" xlink:href="clx-20160630.xsd#clx-oca" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ppaen" xlink:href="clx-20160630.xsd#clx-ppaen" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoia" xlink:href="clx-20160630.xsd#clx-gtaoia" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="clx-20160630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-d1" xlink:href="clx-20160630.xsd#clx-d1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ol1" xlink:href="clx-20160630.xsd#clx-ol1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:href="clx-20160630.xsd#clx-fiafvm1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocag" xlink:href="clx-20160630.xsd#clx-ocag" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-laoc" xlink:href="clx-20160630.xsd#clx-laoc" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-se" xlink:href="clx-20160630.xsd#clx-se" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-nepse1" xlink:href="clx-20160630.xsd#clx-nepse1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scp" xlink:href="clx-20160630.xsd#clx-scp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-oein" xlink:href="clx-20160630.xsd#clx-oein" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-it1" xlink:href="clx-20160630.xsd#clx-it1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebp" xlink:href="clx-20160630.xsd#clx-ebp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sr1" xlink:href="clx-20160630.xsd#clx-sr1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-rpt" xlink:href="clx-20160630.xsd#clx-rpt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-uqd" xlink:href="clx-20160630.xsd#clx-uqd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ValuationAndQualifyingAccountsAndReserves" xlink:href="clx-20160630.xsd#ValuationAndQualifyingAccountsAndReserves" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapp" xlink:href="clx-20160630.xsd#clx-sosapp" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapt" xlink:href="clx-20160630.xsd#clx-sosapt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dot" xlink:href="clx-20160630.xsd#clx-dot" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:href="clx-20160630.xsd#BusinessesAcquiredTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-int1" xlink:href="clx-20160630.xsd#clx-int1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocat" xlink:href="clx-20160630.xsd#clx-ocat" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ppaent" xlink:href="clx-20160630.xsd#clx-ppaent" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiat" xlink:href="clx-20160630.xsd#clx-gtaoiat" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-alt" xlink:href="clx-20160630.xsd#clx-alt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dt" xlink:href="clx-20160630.xsd#clx-dt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-olt1" xlink:href="clx-20160630.xsd#clx-olt1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmt1" xlink:href="clx-20160630.xsd#clx-fiafvmt1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-laoct" xlink:href="clx-20160630.xsd#clx-laoct" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-set" xlink:href="clx-20160630.xsd#clx-set" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-nepset1" xlink:href="clx-20160630.xsd#clx-nepset1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpt" xlink:href="clx-20160630.xsd#clx-scpt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-oeint" xlink:href="clx-20160630.xsd#clx-oeint" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itt" xlink:href="clx-20160630.xsd#clx-itt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpt" xlink:href="clx-20160630.xsd#clx-ebpt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-srt1" xlink:href="clx-20160630.xsd#clx-srt1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-uqdt" xlink:href="clx-20160630.xsd#clx-uqdt" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapsochd" xlink:href="clx-20160630.xsd#clx-sosapsochd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapsoeuloppaed" xlink:href="clx-20160630.xsd#clx-sosapsoeuloppaed" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sosapaid" xlink:href="clx-20160630.xsd#clx-sosapaid" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dosolgfdod" xlink:href="clx-20160630.xsd#clx-dosolgfdod" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dosoolacaoc" xlink:href="clx-20160630.xsd#clx-dosoolacaoc" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dond" xlink:href="clx-20160630.xsd#clx-dond" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:href="clx-20160630.xsd#BusinessesAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ind1" xlink:href="clx-20160630.xsd#clx-ind1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocad" xlink:href="clx-20160630.xsd#clx-ocad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ppaend" xlink:href="clx-20160630.xsd#clx-ppaend" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiand" xlink:href="clx-20160630.xsd#clx-gtaoiand" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiasogd" xlink:href="clx-20160630.xsd#clx-gtaoiasogd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-gtaoiasoiaegd" xlink:href="clx-20160630.xsd#clx-gtaoiasoiaegd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="clx-20160630.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dnd" xlink:href="clx-20160630.xsd#clx-dnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dnalpd" xlink:href="clx-20160630.xsd#clx-dnalpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dldnoudopd" xlink:href="clx-20160630.xsd#clx-dldnoudopd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-dbcuofad" xlink:href="clx-20160630.xsd#clx-dbcuofad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-old1" xlink:href="clx-20160630.xsd#clx-old1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmnd1" xlink:href="clx-20160630.xsd#clx-fiafvmnd1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmsofimafvd1" xlink:href="clx-20160630.xsd#clx-fiafvmsofimafvd1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvmsoeodidahid1" xlink:href="clx-20160630.xsd#clx-fiafvmsoeodidahid1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ocagd" xlink:href="clx-20160630.xsd#clx-ocagd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/LeasesAndOtherCommitmentsDetails" xlink:href="clx-20160630.xsd#LeasesAndOtherCommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-sesrpd" xlink:href="clx-20160630.xsd#clx-sesrpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-secsdd" xlink:href="clx-20160630.xsd#clx-secsdd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:href="clx-20160630.xsd#StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StockholdersEquityNarrativeDetails" xlink:href="clx-20160630.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-nepsed" xlink:href="clx-20160630.xsd#clx-nepsed" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpnd" xlink:href="clx-20160630.xsd#clx-scpnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpccaritbd" xlink:href="clx-20160630.xsd#clx-scpccaritbd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpauiviccefsogd" xlink:href="clx-20160630.xsd#clx-scpauiviccefsogd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpsosoad" xlink:href="clx-20160630.xsd#clx-scpsosoad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpsorsaad" xlink:href="clx-20160630.xsd#clx-scpsorsaad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-scpsopsaad" xlink:href="clx-20160630.xsd#clx-scpsopsaad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails" xlink:href="clx-20160630.xsd#OtherIncomeExpenseNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itnd" xlink:href="clx-20160630.xsd#clx-itnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itpfitbtjadafebtd" xlink:href="clx-20160630.xsd#clx-itpfitbtjadafebtd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-iteitrrd" xlink:href="clx-20160630.xsd#clx-iteitrrd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itcondtad" xlink:href="clx-20160630.xsd#clx-itcondtad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itvad" xlink:href="clx-20160630.xsd#clx-itvad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-itutbd" xlink:href="clx-20160630.xsd#clx-itutbd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpnd" xlink:href="clx-20160630.xsd#clx-ebpnd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpsifdbriahpd" xlink:href="clx-20160630.xsd#clx-ebpsifdbriahpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpifripwaboieopad" xlink:href="clx-20160630.xsd#clx-ebpifripwaboieopad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpconcoriahcpd" xlink:href="clx-20160630.xsd#clx-ebpconcoriahcpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpinyracoped" xlink:href="clx-20160630.xsd#clx-ebpinyracoped" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpnalgapscbariaoclid" xlink:href="clx-20160630.xsd#clx-ebpnalgapscbariaoclid" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpwautenppaopbcd" xlink:href="clx-20160630.xsd#clx-ebpwautenppaopbcd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebpebpd" xlink:href="clx-20160630.xsd#clx-ebpebpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-ebptaawaaad" xlink:href="clx-20160630.xsd#clx-ebptaawaaad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansAssetsCarriedAtFairValueDetails" xlink:href="clx-20160630.xsd#EmployeeBenefitPlansAssetsCarriedAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:href="clx-20160630.xsd#SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-srnsalabgad" xlink:href="clx-20160630.xsd#clx-srnsalabgad" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-srcpd" xlink:href="clx-20160630.xsd#clx-srcpd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-rptd" xlink:href="clx-20160630.xsd#clx-rptd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-uqdd" xlink:href="clx-20160630.xsd#clx-uqdd" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-vaqaard" xlink:href="clx-20160630.xsd#clx-vaqaard" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-daei" xlink:title="00000001 - Document - DOCUMENT AND ENTITY INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csoe" xlink:title="00000002 - Statement - CONSOLIDATED STATEMENT OF EARNINGS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csoci" xlink:title="00000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-cbs" xlink:title="00000004 - Statement - CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-cbsp" xlink:title="00000005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csose" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsCash" xlink:label="loc_us-gaapDividendsCash_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCash_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherEmployeeStockPlanActivitiesValue" xlink:label="loc_clxOtherEmployeeStockPlanActivitiesValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxOtherEmployeeStockPlanActivitiesValue_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherEmployeeStockPlanActivitiesShares" xlink:label="loc_clxOtherEmployeeStockPlanActivitiesShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxOtherEmployeeStockPlanActivitiesShares_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaapTreasuryStockValueAcquiredCostMethod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValueAcquiredCostMethod_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaapTreasuryStockSharesAcquired_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockSharesAcquired_70" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-csocf" xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosap" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-do" xlink:title="00000009 - Disclosure - DISCONTINUED OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:title="00000010 - Disclosure - BUSINESSES ACQUIRED" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-in1" xlink:title="00000011 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-oca" xlink:title="00000012 - Disclosure - OTHER CURRENT ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ppaen" xlink:title="00000013 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoia" xlink:title="00000014 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000015 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-d1" xlink:title="00000016 - Disclosure - DEBT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ol1" xlink:title="00000017 - Disclosure - OTHER LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:title="00000018 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocag" xlink:title="00000019 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-laoc" xlink:title="00000020 - Disclosure - LEASES AND OTHER COMMITMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-se" xlink:title="00000021 - Disclosure - STOCKHOLDERS' EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-nepse1" xlink:title="00000022 - Disclosure - NET EARNINGS PER SHARE (EPS)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scp" xlink:title="00000023 - Disclosure - STOCK-BASED COMPENSATION PLANS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-oein" xlink:title="00000024 - Disclosure - OTHER (INCOME) EXPENSE, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-it1" xlink:title="00000025 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebp" xlink:title="00000026 - Disclosure - EMPLOYEE BENEFIT PLANS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sr1" xlink:title="00000027 - Disclosure - SEGMENT REPORTING" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-rpt" xlink:title="00000028 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-uqd" xlink:title="00000029 - Disclosure - UNAUDITED QUARTERLY DATA" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ValuationAndQualifyingAccountsAndReserves" xlink:title="00000030 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapp" xlink:title="00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapt" xlink:title="00000032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dot" xlink:title="00000033 - Disclosure - DISCONTINUED OPERATIONS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:title="00000034 - Disclosure - BUSINESSES ACQUIRED (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-int1" xlink:title="00000035 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocat" xlink:title="00000036 - Disclosure - OTHER CURRENT ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ppaent" xlink:title="00000037 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiat" xlink:title="00000038 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-alt" xlink:title="00000039 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dt" xlink:title="00000040 - Disclosure - DEBT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-olt1" xlink:title="00000041 - Disclosure - OTHER LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmt1" xlink:title="00000042 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-laoct" xlink:title="00000043 - Disclosure - LEASES AND OTHER COMMITMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-set" xlink:title="00000044 - Disclosure - STOCKHOLDERS' EQUITY (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-nepset1" xlink:title="00000045 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpt" xlink:title="00000046 - Disclosure - STOCK-BASED COMPENSATION PLANS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-oeint" xlink:title="00000047 - Disclosure - OTHER (INCOME) EXPENSE, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itt" xlink:title="00000048 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpt" xlink:title="00000049 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-srt1" xlink:title="00000050 - Disclosure - SEGMENT REPORTING (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-uqdt" xlink:title="00000051 - Disclosure - UNAUDITED QUARTERLY DATA (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapsochd" xlink:title="00000052 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Cash Holdings) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapsoeuloppaed" xlink:title="00000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Estimated Useful Lives of Property, Plant and Equipment) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaapBuildingAndBuildingImprovementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingAndBuildingImprovementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandImprovementsMember" xlink:label="loc_us-gaapLandImprovementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandImprovementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CapitalizedSoftwareCostsMember" xlink:label="loc_clxCapitalizedSoftwareCostsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_clxCapitalizedSoftwareCostsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sosapaid" xlink:title="00000054 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Additional Information) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaapScenarioForecastMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_us-gaapScenarioForecastMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap" xlink:label="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageCap_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageCap_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompensationExpensePerformanceGoalsExceededTargetPercentageFloor" xlink:label="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageFloor_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageFloor_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach" xlink:label="loc_clxMinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxMinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NontradeReceivablesCurrent" xlink:label="loc_us-gaapNontradeReceivablesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNontradeReceivablesCurrent_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_PackagingDevelopmentAndDesignCosts" xlink:label="loc_clxPackagingDevelopmentAndDesignCosts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxPackagingDevelopmentAndDesignCosts_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges" xlink:label="loc_clxDerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxDerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement" xlink:label="loc_clxPercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_clxPercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_90" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dosolgfdod" xlink:title="00000055 - Disclosure - DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VenezuelanSubsidiaryMember" xlink:label="loc_clxVenezuelanSubsidiaryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxVenezuelanSubsidiaryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationsOtherMember" xlink:label="loc_clxDiscontinuedOperationsOtherMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxDiscontinuedOperationsOtherMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_100" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_100" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dosoolacaoc" xlink:title="00000056 - Disclosure - DISCONTINUED OPERATIONS (Summary of Operating Losses, Asset Charges and Other Costs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VenezuelanSubsidiaryMember" xlink:label="loc_clxVenezuelanSubsidiaryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxVenezuelanSubsidiaryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationsOtherMember" xlink:label="loc_clxDiscontinuedOperationsOtherMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxDiscontinuedOperationsOtherMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract" xlink:label="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract_60" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract_60" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract_60" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets" xlink:label="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract_60" xlink:to="loc_clxDiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract" xlink:label="loc_clxDisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_clxDisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:label="loc_clxDisposalGroupIncludingDiscontinuedOperationSeverance_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxDisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract_60" xlink:to="loc_clxDisposalGroupIncludingDiscontinuedOperationSeverance_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxDisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract_60" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationOther" xlink:label="loc_clxDisposalGroupIncludingDiscontinuedOperationOther_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxDisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract_60" xlink:to="loc_clxDisposalGroupIncludingDiscontinuedOperationOther_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaapReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear" xlink:label="loc_clxDisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_clxDisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredInRemainderOfFiscalYear_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter" xlink:label="loc_clxDisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_clxDisposalGroupsIncludingDiscontinuedOperationsAdditionalExitCostExpectedToBeIncurredThereafter_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss_60" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dond" xlink:title="00000057 - Disclosure - DISCONTINUED OPERATIONS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VenezuelanSubsidiaryMember" xlink:label="loc_clxVenezuelanSubsidiaryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxVenezuelanSubsidiaryMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="loc_us-gaapCorporateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_us-gaapCorporateMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet" xlink:label="loc_clxDisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract_50" xlink:to="loc_clxDisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract_50" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:title="00000058 - Disclosure - BUSINESSES ACQUIRED (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RenewLifeHoldingsCorporationMember" xlink:label="loc_clxRenewLifeHoldingsCorporationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_clxRenewLifeHoldingsCorporationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="loc_us-gaapBusinessAcquisitionEffectiveDateOfAcquisition1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEffectiveDateOfAcquisition1_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSalesRevenueNet_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_60" xlink:to="loc_us-gaapGoodwill_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_60" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_60" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_60" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_60" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_60" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_60" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ind1" xlink:title="00000059 - Disclosure - INVENTORIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocad" xlink:title="00000060 - Disclosure - OTHER CURRENT ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:label="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EscrowRestrictedCashMember" xlink:label="loc_clxEscrowRestrictedCashMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_clxEscrowRestrictedCashMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignSubsidiaryRestrictedCashMember" xlink:label="loc_clxForeignSubsidiaryRestrictedCashMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_clxForeignSubsidiaryRestrictedCashMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="loc_us-gaapDeferredTaxAssetsNetCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsNetCurrent_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="loc_us-gaapPrepaidExpenseCurrent_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent" xlink:label="loc_us-gaapOtherAssetsMiscellaneousCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="loc_us-gaapOtherAssetsMiscellaneousCurrent_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="loc_us-gaapOtherAssetsCurrent_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ppaend" xlink:title="00000061 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CapitalizedSoftwareCostsMember" xlink:label="loc_clxCapitalizedSoftwareCostsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_clxCapitalizedSoftwareCostsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LandAndLandImprovementsMember" xlink:label="loc_us-gaapLandAndLandImprovementsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandAndLandImprovementsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaapConstructionInProgressMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapConstructionInProgressMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:label="loc_us-gaapAssetsHeldUnderCapitalLeasesMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapAssetsHeldUnderCapitalLeasesMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_250" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligation" xlink:label="loc_us-gaapAssetRetirementObligation_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAssetRetirementObligation_250" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NumberOfLeasedProperties" xlink:label="loc_clxNumberOfLeasedProperties_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_clxNumberOfLeasedProperties_250" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:label="loc_us-gaapAssetRetirementObligationLiabilitiesIncurred_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAssetRetirementObligationLiabilitiesIncurred_250" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationNonproduction" xlink:label="loc_us-gaapDepreciationNonproduction_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciationNonproduction_250" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAdjustmentForAmortization_250" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NonCashCapitalExpenditures" xlink:label="loc_clxNonCashCapitalExpenditures_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_clxNonCashCapitalExpenditures_250" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiand" xlink:title="00000062 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FiniteLivedIntangibleAssetsUsefulLifeRenewal" xlink:label="loc_clxFiniteLivedIntangibleAssetsUsefulLifeRenewal_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_clxFiniteLivedIntangibleAssetsUsefulLifeRenewal_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_80" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_80" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_80" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_80" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_80" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_80" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiand" xlink:title="00000063 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="20" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ImpairmentOfTrademarks" xlink:label="loc_clxImpairmentOfTrademarks_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_clxImpairmentOfTrademarks_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiasogd" xlink:title="00000064 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaapGoodwillLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaapScheduleOfGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapGoodwillLineItems" xlink:to="loc_us-gaapScheduleOfGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfGoodwillTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CleaningMember" xlink:label="loc_clxCleaningMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxCleaningMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LifestyleMember" xlink:label="loc_clxLifestyleMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxLifestyleMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_HouseholdMember" xlink:label="loc_clxHouseholdMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxHouseholdMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InternationalMember" xlink:label="loc_clxInternationalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxInternationalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapGoodwillLineItems" xlink:to="loc_us-gaapGoodwill_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapGoodwillLineItems" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:label="loc_us-gaapGoodwillTranslationAndPurchaseAccountingAdjustments_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapGoodwillLineItems" xlink:to="loc_us-gaapGoodwillTranslationAndPurchaseAccountingAdjustments_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiasoiaegd" xlink:title="00000065 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIntangibleAssetsAxis" xlink:label="loc_clxOtherIntangibleAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_clxOtherIntangibleAssetsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIntangibleAssetsDomain" xlink:label="loc_clxOtherIntangibleAssetsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_clxOtherIntangibleAssetsAxis" xlink:to="loc_clxOtherIntangibleAssetsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIntangibleAssetsDomain" xlink:label="loc_clxOtherIntangibleAssetsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_clxOtherIntangibleAssetsAxis" xlink:to="loc_clxOtherIntangibleAssetsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TechnologyAndProductFormulaeMember" xlink:label="loc_clxTechnologyAndProductFormulaeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxOtherIntangibleAssetsDomain" xlink:to="loc_clxTechnologyAndProductFormulaeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherIntangibleAssetsOtherMember" xlink:label="loc_clxOtherIntangibleAssetsOtherMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxOtherIntangibleAssetsDomain" xlink:to="loc_clxOtherIntangibleAssetsOtherMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-gtaoiasoiaegd" xlink:title="00000066 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="20" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000067 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dnd" xlink:title="00000068 - Disclosure - DEBT (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LongTermAndShortTermDebtLineItems" xlink:label="loc_clxLongTermAndShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes3.55PercentMember" xlink:label="loc_clxSeniorNotes3.55PercentMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_clxSeniorNotes3.55PercentMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes3.50PercentMember" xlink:label="loc_clxSeniorNotes3.50PercentMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_clxSeniorNotes3.50PercentMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes5.00PercentMember" xlink:label="loc_clxSeniorNotes5.00PercentMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_clxSeniorNotes5.00PercentMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RevolvingLineOfCreditMember" xlink:label="loc_clxRevolvingLineOfCreditMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_clxRevolvingLineOfCreditMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignAndOtherCreditLinesMember" xlink:label="loc_clxForeignAndOtherCreditLinesMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_clxForeignAndOtherCreditLinesMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaapCommercialPaperMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapCommercialPaperMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="loc_us-gaapDebtInstrumentPaymentTerms_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPaymentTerms_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod" xlink:label="loc_clxShortTermDebtWeightedAverageInterestRateDuringPeriod_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_clxShortTermDebtWeightedAverageInterestRateDuringPeriod_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaapShortTermDebtWeightedAverageInterestRate_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapShortTermDebtWeightedAverageInterestRate_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps" xlink:label="loc_clxWeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_clxWeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaapLongtermDebtWeightedAverageInterestRate_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLongtermDebtWeightedAverageInterestRate_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_190" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCredit_190" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityRemainingBorrowingCapacity_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityRemainingBorrowingCapacity_190" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaapLongTermDebtByMaturityAbstract_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxLongTermAndShortTermDebtLineItems" xlink:to="loc_us-gaapLongTermDebtByMaturityAbstract_190" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract_190" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_190" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract_190" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_190" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract_190" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_190" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract_190" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_190" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract_190" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_190" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermDebtByMaturityAbstract_190" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_190" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dnalpd" xlink:title="00000069 - Disclosure - DEBT (Notes and Loans Payable) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaapCommercialPaperMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapCommercialPaperMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignBorrowingsMember" xlink:label="loc_clxForeignBorrowingsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_clxForeignBorrowingsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaper" xlink:label="loc_us-gaapCommercialPaper_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapCommercialPaper_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dldnoudopd" xlink:title="00000070 - Disclosure - DEBT (Long-term Debt, Net of Unamortized Discounts or Premiums) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember" xlink:label="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember" xlink:label="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember" xlink:label="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember" xlink:label="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember" xlink:label="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_clxSeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:label="loc_us-gaapLongtermDebtWeightedAverageInterestRate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongtermDebtWeightedAverageInterestRate_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebt_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent_130" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-dbcuofad" xlink:title="00000071 - Disclosure - DEBT (Borrowing Capacity Under Other Financing Arrangements) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaapRevolvingCreditFacilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_us-gaapRevolvingCreditFacilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignCreditLinesMember" xlink:label="loc_clxForeignCreditLinesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_clxForeignCreditLinesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherCreditLinesMember" xlink:label="loc_clxOtherCreditLinesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_clxOtherCreditLinesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-old1" xlink:title="00000072 - Disclosure - OTHER LIABILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmnd1" xlink:title="00000073 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaapDerivativeLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaapDerivativeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDerivativeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateContractMember" xlink:label="loc_us-gaapInterestRateContractMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapInterestRateContractMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeNatureAxis" xlink:label="loc_clxDerivativeNatureAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_clxDerivativeNatureAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeNatureDomain" xlink:label="loc_clxDerivativeNatureDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_clxDerivativeNatureAxis" xlink:to="loc_clxDerivativeNatureDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeNatureDomain" xlink:label="loc_clxDerivativeNatureDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_clxDerivativeNatureAxis" xlink:to="loc_clxDerivativeNatureDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_JetFuelMember" xlink:label="loc_clxJetFuelMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxDerivativeNatureDomain" xlink:to="loc_clxJetFuelMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SoybeanOilMember" xlink:label="loc_clxSoybeanOilMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxDerivativeNatureDomain" xlink:to="loc_clxSoybeanOilMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SeniorNotes3.50PercentMember" xlink:label="loc_clxSeniorNotes3.50PercentMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_clxSeniorNotes3.50PercentMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeIntrumentsMaximumContractDuration" xlink:label="loc_clxDerivativeIntrumentsMaximumContractDuration_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDerivativeIntrumentsMaximumContractDuration_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_investDerivativeNotionalAmount_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_investDerivativeNotionalAmount_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InterestRateForwardContractsSettlement" xlink:label="loc_clxInterestRateForwardContractsSettlement_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxInterestRateForwardContractsSettlement_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SettlementOfInterestRateForwardContract" xlink:label="loc_clxSettlementOfInterestRateForwardContract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxSettlementOfInterestRateForwardContract_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:label="loc_clxDeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers" xlink:label="loc_us-gaapGoodFaithAndMarginDepositsWithBrokerDealers_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapGoodFaithAndMarginDepositsWithBrokerDealers_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:label="loc_clxDerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MarginDepositAssets" xlink:label="loc_us-gaapMarginDepositAssets_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapMarginDepositAssets_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="loc_us-gaapCashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapCashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_170" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmsofimafvd1" xlink:title="00000074 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Financial Instruments Measured at Fair Value) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:label="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_FairValueMeasurementsRecurringTable" xlink:label="loc_clxFairValueMeasurementsRecurringTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_clxFairValueMeasurementsRecurringTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="loc_us-gaapCashAndCashEquivalentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapCashAndCashEquivalentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="loc_us-gaapOtherCurrentAssetsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherCurrentAssetsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaapOtherAssetsMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherAssetsMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaapNotesPayableOtherPayablesMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapNotesPayableOtherPayablesMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember_280" xlink:type="arc" order="282" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="loc_us-gaapOtherLiabilitiesMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherLiabilitiesMember_360" xlink:type="arc" order="362" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaapFairValueByMeasurementBasisAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapFairValueByMeasurementBasisAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaapFairValueDisclosureItemAmountsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementBasisAxis" xlink:to="loc_us-gaapFairValueDisclosureItemAmountsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaapFairValueDisclosureItemAmountsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementBasisAxis" xlink:to="loc_us-gaapFairValueDisclosureItemAmountsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueDisclosureItemAmountsDomain" xlink:to="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueDisclosureItemAmountsDomain" xlink:to="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaapCashAndCashEquivalentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapCashAndCashEquivalentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaapMoneyMarketFundsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapMoneyMarketFundsMember_0" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BankTimeDepositsMember" xlink:label="loc_us-gaapBankTimeDepositsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapBankTimeDepositsMember_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxFairValueMeasurementsRecurringTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMember" xlink:label="loc_us-gaapLongTermDebtMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapLongTermDebtMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:label="loc_us-gaapCashFlowHedgeDerivativeInstrumentAssetsAtFairValue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_us-gaapCashFlowHedgeDerivativeInstrumentAssetsAtFairValue_450" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="loc_us-gaapDeferredCompensationPlanAssets_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_us-gaapDeferredCompensationPlanAssets_450" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosureRecurring" xlink:label="loc_us-gaapAssetsFairValueDisclosureRecurring_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosureRecurring_450" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:label="loc_us-gaapCashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_us-gaapCashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_450" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureRecurring" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosureRecurring_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosureRecurring_450" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvmsoeodidahid1" xlink:title="00000075 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateContractMember" xlink:label="loc_us-gaapInterestRateContractMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapInterestRateContractMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_130" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ocagd" xlink:title="00000076 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/LeasesAndOtherCommitmentsDetails" xlink:title="00000077 - Disclosure - LEASES AND OTHER COMMITMENTS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-sesrpd" xlink:title="00000078 - Disclosure - STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareRepurchaseProgramsLineItems" xlink:label="loc_clxShareRepurchaseProgramsLineItems" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareRepurchaseProgramsTable" xlink:label="loc_clxShareRepurchaseProgramsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_clxShareRepurchaseProgramsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaapShareRepurchaseProgramAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxShareRepurchaseProgramsTable" xlink:to="loc_us-gaapShareRepurchaseProgramAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OpenMarketProgramMember" xlink:label="loc_clxOpenMarketProgramMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_clxOpenMarketProgramMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_EvergreenProgramMember" xlink:label="loc_clxEvergreenProgramMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_clxEvergreenProgramMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_120" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-secsdd" xlink:title="00000079 - Disclosure - STOCKHOLDERS' EQUITY (Common Stock Dividends) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:title="00000080 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaapAccumulatedTranslationAdjustmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedTranslationAdjustmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaapAccumulatedDefinedBenefitPlansAdjustmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedDefinedBenefitPlansAdjustmentMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_130" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StockholdersEquityNarrativeDetails" xlink:title="00000081 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceLineItems" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:label="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" xlink:to="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LongTermIntercompanyLoansMember" xlink:label="loc_clxLongTermIntercompanyLoansMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" xlink:to="loc_clxLongTermIntercompanyLoansMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:label="loc_us-gaapAdjustmentForLongTermIntercompanyTransactionsNetOfTax_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" xlink:to="loc_us-gaapAdjustmentForLongTermIntercompanyTransactionsNetOfTax_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-nepsed" xlink:title="00000082 - Disclosure - NET EARNINGS PER SHARE (EPS) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpnd" xlink:title="00000083 - Disclosure - STOCK-BASED COMPENSATION PLANS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsMember" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaapPerformanceSharesMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapPerformanceSharesMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_250" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions_250" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_250" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_250" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedAwardPeriod_250" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap" xlink:label="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageCap_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxCompensationExpensePerformanceGoalsExceededTargetPercentageCap_250" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_250" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_250" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_250" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_250" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_250" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_250" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_250" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_250" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_250" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_250" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_250" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_250" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue_250" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_250" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VestedAwardsWerePaidByIssuanceOfShares" xlink:label="loc_clxVestedAwardsWerePaidByIssuanceOfShares_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxVestedAwardsWerePaidByIssuanceOfShares_250" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_VestedStockAwardsDeferred" xlink:label="loc_clxVestedStockAwardsDeferred_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxVestedStockAwardsDeferred_250" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsGranted" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsGranted_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsGranted_250" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsReinvestedDividends_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsReinvestedDividends_250" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsDistributed" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsDistributed_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsDistributed_250" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate_250" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate_250" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate_250" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsOutstanding_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsOutstanding_250" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate" xlink:label="loc_clxDeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_clxDeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate_250" xlink:type="arc" order="31" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpccaritbd" xlink:title="00000084 - Disclosure - STOCK-BASED COMPENSATION PLANS (Compensation Cost and Related Income Tax Benefit) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaapSellingAndMarketingExpenseMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingAndMarketingExpenseMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapShareBasedCompensation_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_130" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpauiviccefsogd" xlink:title="00000085 - Disclosure - STOCK-BASED COMPENSATION PLANS (Assumptions Utilized in the Valuation in Calculating the Compensation Expense for Stock Options Granted) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpsosoad" xlink:title="00000086 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Stock Option Activity) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpsorsaad" xlink:title="00000087 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Restricted Stock Award Activity) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-scpsopsaad" xlink:title="00000088 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Performance Stock Award Activity) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaapPerformanceSharesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapPerformanceSharesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_50" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_50" xlink:to="loc_clxShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails" xlink:title="00000089 - Disclosure - OTHER (INCOME) EXPENSE, NET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails" xlink:title="00000090 - Disclosure - OTHER (INCOME) EXPENSE, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="20" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ImpairmentOfTrademarks" xlink:label="loc_clxImpairmentOfTrademarks_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="loc_clxImpairmentOfTrademarks_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itnd" xlink:title="00000091 - Disclosure - INCOME TAXES (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TaxCreditAndOperatingLossCarryforwardsLineItems" xlink:label="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_IncomeTaxesTable" xlink:label="loc_clxIncomeTaxesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_clxIncomeTaxesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaapTaxCreditCarryforwardAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_us-gaapTaxCreditCarryforwardAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaapTaxCreditCarryforwardNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTaxCreditCarryforwardAxis" xlink:to="loc_us-gaapTaxCreditCarryforwardNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaapTaxCreditCarryforwardNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTaxCreditCarryforwardAxis" xlink:to="loc_us-gaapTaxCreditCarryforwardNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignTaxCreditCarryforwardMember" xlink:label="loc_clxForeignTaxCreditCarryforwardMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTaxCreditCarryforwardNameDomain" xlink:to="loc_clxForeignTaxCreditCarryforwardMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignMember" xlink:label="loc_clxForeignMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_clxForeignMember_130" xlink:type="arc" order="133" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaapTaxPeriodAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_us-gaapTaxPeriodAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaapTaxPeriodDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTaxPeriodAxis" xlink:to="loc_us-gaapTaxPeriodDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaapTaxPeriodDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTaxPeriodAxis" xlink:to="loc_us-gaapTaxPeriodDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="loc_us-gaapEarliestTaxYearMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_us-gaapEarliestTaxYearMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="loc_us-gaapLatestTaxYearMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_us-gaapLatestTaxYearMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ExpirationPeriodAxis" xlink:label="loc_clxExpirationPeriodAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_clxExpirationPeriodAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ExpirationPeriodDomain" xlink:label="loc_clxExpirationPeriodDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_clxExpirationPeriodAxis" xlink:to="loc_clxExpirationPeriodDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ExpirationPeriodDomain" xlink:label="loc_clxExpirationPeriodDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_clxExpirationPeriodAxis" xlink:to="loc_clxExpirationPeriodDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NotSubjectToExpirationMember" xlink:label="loc_clxNotSubjectToExpirationMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxExpirationPeriodDomain" xlink:to="loc_clxNotSubjectToExpirationMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_SubjectToExpirationMember" xlink:label="loc_clxSubjectToExpirationMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxExpirationPeriodDomain" xlink:to="loc_clxSubjectToExpirationMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxIncomeTaxesTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscontinuedOperationsOtherMember" xlink:label="loc_clxDiscontinuedOperationsOtherMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxDiscontinuedOperationsOtherMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:label="loc_us-gaapUndistributedEarningsOfForeignSubsidiaries_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapUndistributedEarningsOfForeignSubsidiaries_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability" xlink:label="loc_clxDeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_clxDeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions" xlink:label="loc_us-gaapIncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapIncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaapOpenTaxYear_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOpenTaxYear_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_180" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_180" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaapTaxCreditCarryforwardAmount_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapTaxCreditCarryforwardAmount_180" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TaxCreditCarryforwardExpirationDate" xlink:label="loc_us-gaapTaxCreditCarryforwardExpirationDate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapTaxCreditCarryforwardExpirationDate_180" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_180" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaapOperatingLossCarryforwardsExpirationDate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsExpirationDate_180" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxTaxCreditAndOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_180" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_180" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_180" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itpfitbtjadafebtd" xlink:title="00000092 - Disclosure - INCOME TAXES (Provision for Income Taxes by Tax Jurisdiction and Domestic and Foreign Earnings before Taxes) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-iteitrrd" xlink:title="00000093 - Disclosure - INCOME TAXES (Effective Income Tax Rate Reconciliation) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itcondtad" xlink:title="00000094 - Disclosure - INCOME TAXES (Components of Net Deferred Tax Assets) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itvad" xlink:title="00000095 - Disclosure - INCOME TAXES (Valuation Allowance) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-itutbd" xlink:title="00000096 - Disclosure - INCOME TAXES (Unrecognized Tax Benefits) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpnd" xlink:title="00000097 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DomesticQualifiedRetirementIncomePlansMember" xlink:label="loc_clxDomesticQualifiedRetirementIncomePlansMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxDomesticQualifiedRetirementIncomePlansMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DomesticNonQualifiedRetirementIncomePlansMember" xlink:label="loc_clxDomesticNonQualifiedRetirementIncomePlansMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxDomesticNonQualifiedRetirementIncomePlansMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MedicalMember" xlink:label="loc_clxMedicalMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxMedicalMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_PrescriptionDrugsMember" xlink:label="loc_clxPrescriptionDrugsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxPrescriptionDrugsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCarePlanMember" xlink:label="loc_clxRetirementHealthCarePlanMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCarePlanMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomePlanMember" xlink:label="loc_clxRetirementIncomePlanMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomePlanMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapStatementScenarioAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaapScenarioForecastMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_us-gaapScenarioForecastMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="loc_us-gaapDefinedBenefitPlanContributionsByEmployer_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanContributionsByEmployer_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate" xlink:label="loc_us-gaapDefinedBenefitPlanUltimateHealthCareCostTrendRate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanUltimateHealthCareCostTrendRate_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanYearThatRateReachesUltimateTrendRate" xlink:label="loc_us-gaapDefinedBenefitPlanYearThatRateReachesUltimateTrendRate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanYearThatRateReachesUltimateTrendRate_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_BasisPointIncreaseDecrease" xlink:label="loc_clxBasisPointIncreaseDecrease_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxBasisPointIncreaseDecrease_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DiscretionaryCompanyContributions" xlink:label="loc_clxDiscretionaryCompanyContributions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxDiscretionaryCompanyContributions_180" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit" xlink:label="loc_us-gaapDefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit_180" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss" xlink:label="loc_us-gaapDefinedBenefitPlanFutureAmortizationOfGainLoss_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanFutureAmortizationOfGainLoss_180" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_NondiscretionaryDomesticProfitSharingContributionsDuringPeriod" xlink:label="loc_clxNondiscretionaryDomesticProfitSharingContributionsDuringPeriod_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxNondiscretionaryDomesticProfitSharingContributionsDuringPeriod_180" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_180" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanOtherChanges" xlink:label="loc_us-gaapDefinedBenefitPlanOtherChanges_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanOtherChanges_180" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpnd" xlink:title="00000098 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedContributionPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="loc_us-gaapDefinedContributionPlanTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedContributionPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedContributionPlanTable" xlink:type="arc" order="20" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanNameAxis" xlink:label="loc_us-gaapDefinedContributionPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDefinedContributionPlanTable" xlink:to="loc_us-gaapDefinedContributionPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanNameDomain" xlink:label="loc_us-gaapDefinedContributionPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedContributionPlanNameAxis" xlink:to="loc_us-gaapDefinedContributionPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanNameDomain" xlink:label="loc_us-gaapDefinedContributionPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedContributionPlanNameAxis" xlink:to="loc_us-gaapDefinedContributionPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CompanyFourZeroOneKPlanMember" xlink:label="loc_clxCompanyFourZeroOneKPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedContributionPlanNameDomain" xlink:to="loc_clxCompanyFourZeroOneKPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InternationalDefinedContributionPlanMember" xlink:label="loc_clxInternationalDefinedContributionPlanMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedContributionPlanNameDomain" xlink:to="loc_clxInternationalDefinedContributionPlanMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaapDefinedContributionPlanCostRecognized_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedContributionPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedContributionPlanCostRecognized_100" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpsifdbriahpd" xlink:title="00000099 - Disclosure - EMPLOYEE BENEFIT PLANS (Summarized Information for Defined Benefit Retirement Income and Healthcare Plans) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanBenefitObligation_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanBenefitObligation_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaapDefinedBenefitPlanServiceCost_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanServiceCost_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaapDefinedBenefitPlanInterestCost_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanInterestCost_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:label="loc_us-gaapDefinedBenefitPlanActuarialGainLoss_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanActuarialGainLoss_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAmendments" xlink:label="loc_us-gaapDefinedBenefitPlanPlanAmendments_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanPlanAmendments_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitsPaid" xlink:label="loc_us-gaapDefinedBenefitPlanBenefitsPaid_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInBenefitObligationRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanBenefitsPaid_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanFairValueOfPlanAssets_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanFairValueOfPlanAssets_110" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanActualReturnOnPlanAssets_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanActualReturnOnPlanAssets_110" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="loc_us-gaapDefinedBenefitPlanContributionsByEmployer_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanContributionsByEmployer_110" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_110" xlink:to="loc_us-gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets_110" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:label="loc_us-gaapDefinedBenefitPlanFundedStatusOfPlan_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanFundedStatusOfPlan_110" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:label="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_110" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent" xlink:label="loc_us-gaapDefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_110" xlink:to="loc_us-gaapDefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent_110" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:label="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_110" xlink:to="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_110" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_110" xlink:to="loc_us-gaapPensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_110" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:label="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_110" xlink:to="loc_us-gaapDefinedBenefitPlanAmountsRecognizedInBalanceSheet_110" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpifripwaboieopad" xlink:title="00000100 - Disclosure - EMPLOYEE BENEFIT PLANS (Information for Retirement Income Plans with Accumulated Benefit Obligation in Excess of Plan Assets) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember" xlink:label="loc_us-gaapPensionPlansDefinedBenefitMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_us-gaapPensionPlansDefinedBenefitMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherPensionPlansDefinedBenefitMember" xlink:label="loc_us-gaapOtherPensionPlansDefinedBenefitMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_us-gaapOtherPensionPlansDefinedBenefitMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:label="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_80" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpconcoriahcpd" xlink:title="00000101 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income and Health Care Plans) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaapDefinedBenefitPlanServiceCost_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanServiceCost_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaapDefinedBenefitPlanInterestCost_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanInterestCost_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpinyracoped" xlink:title="00000102 - Disclosure - EMPLOYEE BENEFIT PLANS (Items Not Yet Recognized as a Component of Postretirement Expense) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpnalgapscbariaoclid" xlink:title="00000103 - Disclosure - EMPLOYEE BENEFIT PLANS (Net Actuarial Loss (Gain) and Prior Service Cost (Benefit) Activity Recorded in Accumulated Other Comprehensive Loss (Income)) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:label="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost" xlink:label="loc_clxOtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxOtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod" xlink:label="loc_clxOtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxOtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpwautenppaopbcd" xlink:title="00000104 - Disclosure - EMPLOYEE BENEFIT PLANS (Weighted-Average Assumptions Used to Estimate the Net Periodic Pension and Other Postretirement Benefit Costs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:label="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:label="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_110" xlink:to="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:label="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_110" xlink:to="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:label="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:label="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_110" xlink:to="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:label="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_110" xlink:to="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:label="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_110" xlink:to="loc_us-gaapDefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_110" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebpebpd" xlink:title="00000105 - Disclosure - EMPLOYEE BENEFIT PLANS (Expected Benefit Payments) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RetirementHealthCareMember" xlink:label="loc_clxRetirementHealthCareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_30" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-ebptaawaaad" xlink:title="00000106 - Disclosure - EMPLOYEE BENEFIT PLANS (Target Allocations and Weighted Average Asset Allocations) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_UnitedStatesEquityMember" xlink:label="loc_clxUnitedStatesEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxUnitedStatesEquityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignEquitySecuritiesMember" xlink:label="loc_clxForeignEquitySecuritiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxForeignEquitySecuritiesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FixedIncomeFundsMember" xlink:label="loc_us-gaapFixedIncomeFundsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_us-gaapFixedIncomeFundsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCreditDerivativesMember" xlink:label="loc_us-gaapOtherCreditDerivativesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_us-gaapOtherCreditDerivativesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations" xlink:label="loc_us-gaapDefinedBenefitPlanTargetPlanAssetAllocations_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanTargetPlanAssetAllocations_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:label="loc_us-gaapDefinedBenefitPlanWeightedAverageAssetAllocations_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanWeightedAverageAssetAllocations_210" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlansAssetsCarriedAtFairValueDetails" xlink:title="00000107 - Disclosure - EMPLOYEE BENEFIT PLANS (Retirement Income Plan's Assets Carried at Fair Value) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:label="loc_us-gaapDefinedBenefitPlanByPlanAssetCategoriesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="loc_us-gaapPlanAssetCategoriesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="loc_us-gaapPlanAssetCategoriesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanAssetCategoriesDomain" xlink:label="loc_us-gaapPlanAssetCategoriesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="loc_us-gaapPlanAssetCategoriesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_BondFundMember" xlink:label="loc_clxBondFundMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanAssetCategoriesDomain" xlink:to="loc_clxBondFundMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignEquitySecuritiesMember" xlink:label="loc_clxForeignEquitySecuritiesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanAssetCategoriesDomain" xlink:to="loc_clxForeignEquitySecuritiesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_DomesticEquitySecuritiesMember" xlink:label="loc_clxDomesticEquitySecuritiesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanAssetCategoriesDomain" xlink:to="loc_clxDomesticEquitySecuritiesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_RealEstateFundMember" xlink:label="loc_clxRealEstateFundMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanAssetCategoriesDomain" xlink:to="loc_clxRealEstateFundMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CashEquivalents" xlink:label="loc_clxCashEquivalents_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxCashEquivalents_310" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_MutualFunds" xlink:label="loc_clxMutualFunds_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxMutualFunds_310" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CommonOrCollectiveTrusts" xlink:label="loc_clxCommonOrCollectiveTrusts_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_clxCommonOrCollectiveTrusts_310" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanFairValueOfPlanAssets_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanFairValueOfPlanAssets_310" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:title="00000108 - Disclosure - SEGMENT REPORTING (Selected Financial Information Relating To Company's Segments ) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CleaningMember" xlink:label="loc_clxCleaningMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxCleaningMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_HouseholdMember" xlink:label="loc_clxHouseholdMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxHouseholdMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LifestyleMember" xlink:label="loc_clxLifestyleMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxLifestyleMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InternationalMember" xlink:label="loc_clxInternationalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxInternationalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="loc_us-gaapCorporateMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_us-gaapCorporateMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapSalesRevenueNet_310" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_310" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments_310" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapAssets_310" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_310" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization_310" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensation_310" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-srnsalabgad" xlink:title="00000109 - Disclosure - SEGMENT REPORTING (Net Sales and Long-Lived Assets by Geographic Area) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd#country_US" xlink:label="loc_countryUS_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_countryUS_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ForeignMember" xlink:label="loc_clxForeignMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_clxForeignMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapSalesRevenueNet_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_160" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-srcpd" xlink:title="00000110 - Disclosure - SEGMENT REPORTING (Concentration Percentages) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaapProductConcentrationRiskMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapProductConcentrationRiskMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaapMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_WalmartStoresIncMember" xlink:label="loc_clxWalmartStoresIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_clxWalmartStoresIncMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TopFiveLargestCustomersMember" xlink:label="loc_clxTopFiveLargestCustomersMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_clxTopFiveLargestCustomersMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaapProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapProductOrServiceAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaapProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapProductOrServiceAxis" xlink:to="loc_us-gaapProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaapProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductOrServiceAxis" xlink:to="loc_us-gaapProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LiquidBleachMember" xlink:label="loc_clxLiquidBleachMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductsAndServicesDomain" xlink:to="loc_clxLiquidBleachMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_TrashBagsMember" xlink:label="loc_clxTrashBagsMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductsAndServicesDomain" xlink:to="loc_clxTrashBagsMember_150" xlink:type="arc" order="153" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CharcoalMember" xlink:label="loc_clxCharcoalMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductsAndServicesDomain" xlink:to="loc_clxCharcoalMember_240" xlink:type="arc" order="243" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_CleaningMember" xlink:label="loc_clxCleaningMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxCleaningMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_InternationalMember" xlink:label="loc_clxInternationalMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxInternationalMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_HouseholdMember" xlink:label="loc_clxHouseholdMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxHouseholdMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_310" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-rptd" xlink:title="00000111 - Disclosure - RELATED PARTY TRANSACTIONS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-uqdd" xlink:title="00000112 - Disclosure - UNAUDITED QUARTERLY DATA (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-vaqaard" xlink:title="00000113 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_us-gaapValuationAndQualifyingAccountsDisclosureTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaapValuationAllowancesAndReservesTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureTable" xlink:to="loc_us-gaapValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaapValuationAllowancesAndReservesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationAllowancesAndReservesTypeAxis" xlink:to="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaapValuationAllowancesAndReservesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationAllowancesAndReservesTypeAxis" xlink:to="loc_us-gaapValuationAllowancesAndReservesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsMember" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_LifoAllowanceMember" xlink:label="loc_clxLifoAllowanceMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_clxLifoAllowanceMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="loc_us-gaapValuationAllowanceOfDeferredTaxAssetsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationAllowancesAndReservesDomain" xlink:to="loc_us-gaapValuationAllowanceOfDeferredTaxAssetsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaapValuationAllowancesAndReservesBalance_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesBalance_220" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaapValuationAllowancesAndReservesChargedToCostAndExpense_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesChargedToCostAndExpense_220" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160630.xsd#clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses" xlink:label="loc_clxValuationAllowancesAndReservesCreditedToCostsAndExpenses_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_clxValuationAllowancesAndReservesCreditedToCostsAndExpenses_220" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaapValuationAllowancesAndReservesDeductions_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="loc_us-gaapValuationAllowancesAndReservesDeductions_220" xlink:type="arc" order="3" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6822708768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DOCUMENT AND ENTITY INFORMATION - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jul. 29, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CLOROX CO /DE/<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000021076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,469,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823055168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF EARNINGS - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">$ 5,761<span></span>
</td>
<td class="nump">$ 5,655<span></span>
</td>
<td class="nump">$ 5,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of products sold</a></td>
<td class="nump">3,163<span></span>
</td>
<td class="nump">3,190<span></span>
</td>
<td class="nump">3,158<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,598<span></span>
</td>
<td class="nump">2,465<span></span>
</td>
<td class="nump">2,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expenses</a></td>
<td class="nump">806<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="nump">751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">587<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherIncomeExpenseNet', window );">Other (income) expense, net</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings from continuing operations before income taxes</a></td>
<td class="nump">983<span></span>
</td>
<td class="nump">921<span></span>
</td>
<td class="nump">884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes on continuing operations</a></td>
<td class="nump">335<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Earnings from continuing operations</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Losses from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 648<span></span>
</td>
<td class="nump">$ 580<span></span>
</td>
<td class="nump">$ 558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Net earnings (losses) per share, Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations</a></td>
<td class="nump">$ 5.01<span></span>
</td>
<td class="nump">$ 4.65<span></span>
</td>
<td class="nump">$ 4.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.20)<span></span>
</td>
<td class="num">(0.16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share</a></td>
<td class="nump">5.01<span></span>
</td>
<td class="nump">4.45<span></span>
</td>
<td class="nump">4.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Net earnings (losses) per share, Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations</a></td>
<td class="nump">4.92<span></span>
</td>
<td class="nump">4.57<span></span>
</td>
<td class="nump">4.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.20)<span></span>
</td>
<td class="num">(0.16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share</a></td>
<td class="nump">$ 4.92<span></span>
</td>
<td class="nump">$ 4.37<span></span>
</td>
<td class="nump">$ 4.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">129,472<span></span>
</td>
<td class="nump">130,310<span></span>
</td>
<td class="nump">129,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">131,717<span></span>
</td>
<td class="nump">132,776<span></span>
</td>
<td class="nump">131,742<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4613673-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20187-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20187-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355146-122828<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823100112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Earnings from continuing operations</a></td>
<td class="nump">$ 648<span></span>
</td>
<td class="nump">$ 606<span></span>
</td>
<td class="nump">$ 579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Losses from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">580<span></span>
</td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (losses) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency adjustments, net of tax</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent', window );">Net unrealized gains (losses) on derivatives, net of tax</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Pension and postretirement benefit adjustments, net of tax</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive (losses) income, net of tax</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 580<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831223<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4613673-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of (increase) decrease in accumulated other comprehensive (income) loss related to pension and other postretirement defined benefit plans, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569643-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569643-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6822908656">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 401<span></span>
</td>
<td class="nump">$ 382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">569<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">443<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,485<span></span>
</td>
<td class="nump">1,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">906<span></span>
</td>
<td class="nump">918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,197<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TrademarksNet', window );">Trademarks, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">657<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">78<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">195<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,518<span></span>
</td>
<td class="nump">4,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">523<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,035<span></span>
</td>
<td class="nump">979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,558<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,797<span></span>
</td>
<td class="nump">1,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">784<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">82<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,221<span></span>
</td>
<td class="nump">4,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $1.00 par value; 750,000,000 shares authorized; 158,741,461 shares issued as of June 30, 2016 and 2015; and 129,355,263 and 128,614,310 shares outstanding as of June 30, 2016 and 2015, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">159<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">868<span></span>
</td>
<td class="nump">775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,163<span></span>
</td>
<td class="nump">1,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost: 29,386,198 and 30,127,151 shares as of June 30, 2016 and 2015, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,323)<span></span>
</td>
<td class="num">(2,237)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive net (losses) income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(570)<span></span>
</td>
<td class="num">(502)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">297<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,518<span></span>
</td>
<td class="nump">$ 4,164<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Accounts payable and accrued liabilities were combined into one financial statement line as of June 30, 2016. The change has been retrospectively applied to all periods presented.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_TrademarksNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_TrademarksNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6805034960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">158,741,461<span></span>
</td>
<td class="nump">158,741,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">129,355,263<span></span>
</td>
<td class="nump">128,614,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">29,386,198<span></span>
</td>
<td class="nump">30,127,151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823187344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Shares [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Net (Losses) Income [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Jun. 30, 2013</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
<td class="nump">$ 1,561<span></span>
</td>
<td class="num">$ (1,868)<span></span>
</td>
<td class="num">$ (367)<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2013</a></td>
<td class="nump">158,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,375)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">558<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Accrued dividends</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(374)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesValue', window );">Other employee stock plan activities, amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesShares', window );">Other employee stock plan activities, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock purchased, amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (260)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(260)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock purchased, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,046)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Jun. 30, 2014</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">709<span></span>
</td>
<td class="nump">1,739<span></span>
</td>
<td class="num">$ (2,036)<span></span>
</td>
<td class="num">(417)<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2014</a></td>
<td class="nump">158,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,945)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">580<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Accrued dividends</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(391)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(391)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesValue', window );">Other employee stock plan activities, amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">$ 233<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesShares', window );">Other employee stock plan activities, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,198)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock purchased, amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (434)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(434)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock purchased, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Jun. 30, 2015</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">775<span></span>
</td>
<td class="nump">1,923<span></span>
</td>
<td class="num">$ (2,237)<span></span>
</td>
<td class="num">(502)<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2015</a></td>
<td class="nump">158,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">648<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Accrued dividends</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(406)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(406)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesValue', window );">Other employee stock plan activities, amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherEmployeeStockPlanActivitiesShares', window );">Other employee stock plan activities, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock purchased, amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (254)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock purchased, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,151)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Jun. 30, 2016</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 868<span></span>
</td>
<td class="nump">$ 2,163<span></span>
</td>
<td class="num">$ (2,323)<span></span>
</td>
<td class="num">$ (570)<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2016</a></td>
<td class="nump">158,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherEmployeeStockPlanActivitiesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the vesting of share-based awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherEmployeeStockPlanActivitiesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherEmployeeStockPlanActivitiesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount includes the value of stock granted during the period as a result of the vesting of share-based awards and other items, net of the amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit. This element is not the recognition of equity-based compensation expense in pursuant to FAS 123R.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherEmployeeStockPlanActivitiesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of recognized equity-based compensation related to employee stock purchase programs during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6805263776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 648<span></span>
</td>
<td class="nump">$ 580<span></span>
</td>
<td class="nump">$ 558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Deduct: Losses from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Earnings from continuing operations</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile earnings from continuing operations to net cash provided by continuing operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_InterestRateForwardContractsSettlement', window );">Settlement of interest rate forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables, net</a></td>
<td class="num">(52)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other current assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="num">(62)<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash provided by continuing operations</a></td>
<td class="nump">768<span></span>
</td>
<td class="nump">858<span></span>
</td>
<td class="nump">786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash provided by (used for) discontinued operations</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operations</a></td>
<td class="nump">778<span></span>
</td>
<td class="nump">874<span></span>
</td>
<td class="nump">767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(172)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquired, net of cash acquired</a></td>
<td class="num">(290)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash used for investing activities from continuing operations</a></td>
<td class="num">(430)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash used for investing activities by discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
<td class="num">(430)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Notes and loans payable, net</a></td>
<td class="nump">426<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Long-term debt borrowings, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repayments</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(575)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Treasury stock purchased</a></td>
<td class="num">(254)<span></span>
</td>
<td class="num">(434)<span></span>
</td>
<td class="num">(260)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid</a></td>
<td class="num">(398)<span></span>
</td>
<td class="num">(385)<span></span>
</td>
<td class="num">(368)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Issuance of common stock for employee stock plans and other</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used for financing activities</a></td>
<td class="num">(316)<span></span>
</td>
<td class="num">(696)<span></span>
</td>
<td class="num">(592)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Beginning of year</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">End of year</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net of refunds</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Noncash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Cash dividends declared and accrued, but not paid</a></td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_InterestRateForwardContractsSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payment to counterparties to settle an interest rate cash flow hedge in connection with the issuance of long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_InterestRateForwardContractsSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4613673-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3095-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3098-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813473856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Nature of Operations and Basis of Presentation</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is principally engaged in the production, marketing
and sales of consumer products through mass retail outlets and grocery, e-commerce channels, wholesale distributors and medical
supply distributors. The consolidated financial statements include the statements of the Company and its wholly owned and controlled
subsidiaries. All significant intercompany transactions and accounts were eliminated in consolidation. Certain prior year reclassifications
were made in the consolidated financial statements and related notes to the consolidated financial statements to conform to the
current year presentation.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Effective September 22, 2014, the Company&#146;s Venezuela
affiliate, Corporaci&#243;n Clorox de Venezuela S.A. (Clorox Venezuela), discontinued its operations. Consequently, the Company
presents the financial results of Clorox Venezuela as a discontinued operation in the consolidated financial statements for all
periods presented herein.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Use of Estimates</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The preparation of these consolidated financial statements
in conformity with generally accepted accounting principles in the United States of America (U.S. GAAP) requires management to
reach opinions as to estimates and assumptions that affect reported amounts and related disclosures. Specific areas requiring management&#146;s
opinion on estimates and judgments include assumptions pertaining to accruals for consumer and trade-promotion programs, stock-based
compensation costs, pension and post-employment benefit costs, future cash flows associated with impairment testing of goodwill
and other long-lived assets, the credit worthiness of customers, uncertain tax positions, tax valuation allowances and legal, environmental
and insurance matters. Actual results could materially differ from estimates and assumptions made.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Cash and Cash Equivalents</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Cash equivalents consist of highly liquid instruments, time
deposits and money market funds with an initial maturity at purchase of three months or less. The fair value of cash and cash equivalents
approximates the carrying amount.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company&#146;s cash position includes amounts held by
foreign subsidiaries and, as a result, the repatriation of certain cash balances from some of the Company&#146;s foreign subsidiaries
could result in additional tax costs in the United States and in certain foreign jurisdictions. However, these cash balances are
generally available without legal restriction to fund local business operations. In addition, a portion of the Company&#146;s cash
balance is held in U.S. dollars by foreign subsidiaries, whose functional currency is their local currency. Such U.S. dollar balances
are reported on the foreign subsidiaries&#146; books, in their functional currency, with the impact from foreign currency exchange
rate differences recorded in Other (income) expense, net. The Company&#146;s cash holdings were as follows as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">249</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">221</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">133</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">142</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">401</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">382</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of June 30, 2016 and 2015, the Company had $4 and $3 of
restricted cash, respectively, which is primarily related to fiscal year 2012 acquisitions. Restricted cash was included in Other
assets as of June 30, 2016 and in Other current assets as of June 30, 2015.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Inventories</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Inventories are stated at the lower of cost or market. When
necessary, the Company provides allowances to adjust the carrying value of its inventory to the lower of cost or market, including
any costs to sell or dispose. Appropriate consideration is given to obsolescence, excessive inventory levels, product deterioration
and other factors in evaluating net realizable value for the purposes of determining the lower of cost or market.<b> </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Property, Plant and Equipment and Finite-Lived Intangible
Assets</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Property, plant and equipment and finite-lived intangible
assets are stated at cost. Depreciation and amortization expense are calculated by the straight-line method using the estimated
useful lives or lives determined by lease contracts for the related assets. The table below provides estimated useful lives of
property, plant and equipment by asset classification.</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; width: 99%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Estimated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Useful Lives</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Buildings and leasehold improvements</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10 - 40 years</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Land improvements</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10 - 30 years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Machinery and equipment</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3 - 15 years</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Computer equipment</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3 - 5 years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Capitalized software costs</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3 - 7 years</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Property, plant and equipment and finite-lived intangible
assets are reviewed for impairment whenever events or changes in circumstances occur that indicate that the carrying amount of
an asset (or asset group) may not be fully recoverable. The risk of impairment is initially assessed based on an estimate of the
undiscounted cash flows at the lowest level for which identifiable cash flows exist. Impairment occurs when the carrying value
of the asset exceeds the estimated future undiscounted cash flows generated by the asset. When impairment is indicated, an impairment
charge is recorded for the difference between the carrying value of the asset and its estimated fair market value. Depending on
the asset, estimated fair market value may be determined either by use of a discounted cash flow model or by reference to estimated
selling values of assets in similar condition.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Capitalization of Software Costs </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company capitalizes certain qualifying costs incurred
in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest
and payroll and payroll-related costs for employees during the application development stage. Internal and external costs incurred
during the preliminary project stage and post implementation-operation stage, mainly training and maintenance costs, are expensed
as incurred. Once the application is substantially complete and ready for its intended use, qualifying costs are amortized on a
straight-line basis over the software&#146;s estimated useful life.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Impairment Review of Goodwill and Indefinite-Lived Intangible
Assets</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company tests its goodwill, trademarks with indefinite
lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications
during a different interim period that these assets may have become impaired.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">With respect to goodwill, the Company has the option to first
assess qualitative factors such as maturity and stability of the reporting unit, magnitude of excess fair value over carrying value
from the prior year&#146;s impairment testing, other reporting unit specific operating results as well as new events and circumstances
impacting the operations at the reporting unit level. If the result of a qualitative test indicates a potential for impairment
of a reporting unit, a quantitative test is performed. The quantitative test is a two-step process. In the first step, the Company
compares the estimated fair value of the reporting unit to its carrying value. In all instances, the estimated fair value exceeded
the carrying value of the reporting unit. Had the estimated fair value of any reporting unit been less than its carrying value,
the Company would have performed a second step to determine the implied fair value of the reporting unit&#146;s goodwill. If the
carrying amount of a reporting unit&#146;s goodwill had exceeded its implied fair value, an impairment charge would have been recorded
for the difference between the carrying amount and the implied fair value of the reporting unit&#146;s goodwill.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">To determine the fair value of a reporting unit as part of
its quantitative test, the Company uses a discounted cash flow (DCF) approach, as it believes that this approach is the most reliable
indicator of the fair value of its businesses and the fair value of their future earnings and cash flows. Under this approach,
the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects
their relative risk. The cash flows used in the DCF are consistent with those the Company uses in its internal planning, which
gives consideration to actual business trends experienced, and the broader business strategy for the long term. The other key estimates
and factors used in the DCF include, but are not limited to, future sales volumes, revenue and expense growth rates, changes in
working capital, foreign exchange rates, currency devaluation, inflation and a perpetuity growth rate. Changes in such estimates
or the application of alternative assumptions could produce different results.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">For trademarks and other intangible assets with indefinite
lives, the Company performs a quantitative analysis to test for impairment. When a quantitative test is performed, the estimated
fair value of an asset is compared to its carrying amount. If the carrying amount of such asset exceeds its estimated fair value,
an impairment charge is recorded for the difference between the carrying amount and the estimated fair value. The Company uses
the income approach to estimate the fair value of its trademarks and other intangible assets with indefinite lives. This approach
requires significant judgments in determining both the assets&#146; estimated cash flows as well as the appropriate discount and
foreign exchange rates applied to those cash flows to determine fair value. Changes in such estimates or the use of alternative
assumptions could produce different results.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Stock-based Compensation</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company grants various nonqualified stock-based compensation
awards to eligible employees, including stock options and performance units.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">For stock options, the Company estimates the fair value of
each award on the date of grant using the Black-Scholes valuation model, which requires management to make estimates regarding
expected option life, stock price volatility and other assumptions. Groups of employees that have similar historical exercise behavior
are considered separately for valuation purposes. The Company estimates stock option forfeitures based on historical data for each
employee grouping. The total number of stock options expected to vest is adjusted by actual and estimated forfeitures. Changes
to the actual and estimated forfeitures will result in a cumulative catch-up adjustment in the period of change. Compensation expense
is recorded by amortizing the grant date fair values on a straight-line basis over the vesting period, adjusted for estimated forfeitures.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company&#146;s performance unit grants provide for the
issuance of common stock to certain managerial staff and executive management if the Company achieves specified performance targets.
The number of shares issued are dependent upon vesting and the achievement of specified performance targets. The performance period
is three years and the payout determination is made at the end of the three-year performance period. Performance unit grants receive
dividends earned during the vesting period upon vesting. The fair value of each grant issued is estimated on the date of grant
based on the current market price of the stock. The total amount of compensation expense recognized reflects estimated forfeiture
rates and the initial assumption that performance goals will be achieved. Compensation expense is adjusted based on management&#146;s
assessment of the probability that performance goals will be achieved. If such goals are not met or it is determined that achievement
of performance goals is not probable, previously recognized compensation expense is trued up in the current period to reflect the
expected payout level. If it is determined that the performance goals will be exceeded, additional compensation expense is recognized,
subject to a cap of 150%.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Cash flows resulting from tax deductions in excess of the
cumulative compensation cost recognized for stock-based payment arrangements (excess tax benefits) are primarily classified as
financing cash inflows.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Employee Benefits</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company accounts for its defined benefit retirement income
and retirement health care plans using actuarial methods<i>.</i> These methods use an attribution approach that generally spreads
&#147;plan events&#148; over the service lives or expected lifetime (for frozen plans) of plan participants. Examples of plan events
are plan amendments and changes in actuarial assumptions such as the expected return on plan assets, discount rate, rate of compensation
increase and certain employee-related factors, such as retirement age and mortality. The principle underlying the attribution approach
is that employees render service over their employment period on a relatively &#147;smooth&#148; basis and, therefore, the statement
of earnings effects of retirement income and retirement health care plans are recognized in the same pattern. One of the principal
assumptions used in the net periodic benefit cost calculation is the expected return on plan assets. The required use of an expected
return on plan assets may result in recognized pension expense or income that differs from the actual returns of those plan assets
in any given year. Over time, however, the goal is for the expected long-term returns to approximate the actual returns and, therefore,
the expectation is that the pattern of income and expense recognition should closely match the pattern of the services provided
by the participants. The Company uses a market-related value method for calculating plan assets for purposes of determining the
amortization of actuarial gains and losses. The differences between actual and expected returns are recognized in the net periodic
benefit cost calculation over the average remaining service period or expected lifetime (for frozen plans) of the plan participants
using the corridor approach. Under this approach, only actuarial gains (losses) that exceed 5% of the greater of the projected
benefit obligation or the market-related value of assets are amortized to pension expense by the Company. In developing its expected
return on plan assets, the Company considers the long-term actual returns relative to the mix of investments that comprise its
plan assets and also develops estimates of future investment returns by considering external sources.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company recognizes an actuarial-based obligation at the
onset of disability for certain benefits provided to individuals after employment, but before retirement, that include medical,
dental, vision, life and other benefits.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Environmental Costs</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is involved in certain environmental remediation
and ongoing compliance activities. Accruals for environmental matters are recorded on a site-by-site basis when it is probable
that a liability has been incurred and based upon a reasonable estimate of the liability. The Company&#146;s accruals reflect the
anticipated participation of other potentially responsible parties in those instances where it is probable that such parties are
legally responsible and financially capable of paying their respective shares of the relevant costs. These accruals are adjusted
periodically as assessment and remediation efforts progress or as additional technical or legal information become available. Actual
costs to be incurred at identified sites in future periods may vary from the estimates, given the inherent uncertainties in evaluating
environmental exposures. The accrual for environmental matters is included in Accounts payable and accrued liabilities and Other
liabilities in the Company&#146;s consolidated balance sheets on an undiscounted basis due to uncertainty regarding the timing
of future payments.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Revenue Recognition</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Sales are recognized as revenue when the risk of loss and
title pass to the customer and when all of the following have occurred: a firm sales arrangement exists, pricing is fixed or determinable
and collection is reasonably assured. Sales are recorded net of allowances for trade promotions, coupons, returns and other discounts.
The Company routinely commits to one-time or ongoing trade-promotion programs with customers and consumer coupon programs that
require the Company to estimate and accrue the expected costs of such programs. Programs include shelf price reductions, end-of-aisle
or in-store displays of the Company&#146;s products and graphics and other trade-promotion activities conducted by the customer.
Coupons are recognized as a liability when distributed based upon expected consumer redemptions. The Company maintains liabilities
related to these programs for the estimated expenses incurred, but not paid, at the end of each period. Trade-promotion and coupon
redemption costs are recorded as a reduction of sales.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company provides an allowance for doubtful accounts based
on its historical experience and ongoing assessment of its customers&#146; credit risk. Receivables were presented net of an allowance
for doubtful accounts of $5 and $4 as of June 30, 2016 and 2015, respectively. Receivables, net, included non-customer receivables
of $9 and $12 as of June 30, 2016 and 2015, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Cost of Products Sold</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Cost of products sold represents the costs directly related
to the manufacture and distribution of the Company&#146;s products and primarily includes raw materials, packaging, contract manufacturing
fees, shipping and handling, warehousing, package design, depreciation, amortization, direct and indirect labor and operating costs
for the Company&#146;s manufacturing and distribution facilities including salary, benefit costs and incentive compensation, and
royalties and other charges related to the Company&#146;s Glad<sup>&#174;</sup> Venture Agreement (see Note 10).</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Costs associated with developing and designing new packaging
are expensed as incurred and include design, artwork, films and labeling. Expenses for fiscal years ended June 30, 2016, 2015 and
2014 were $11, $11 and $12, respectively, all of which were reflected in Cost of products sold or discontinued operations, as appropriate,
in the consolidated statements of earnings.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Selling and Administrative Expenses</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Selling and administrative expenses represent costs incurred
by the Company in generating revenues and managing the business and include market research, commissions and certain administrative
expenses. Administrative expenses include salary, benefits, incentive compensation, professional fees and services, software and
licensing fees and other operating costs associated with the Company&#146;s non-manufacturing, non-research and development staff,
facilities and equipment.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Advertising and Research and Development Costs</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company expenses advertising and research and development
costs in the period incurred.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Income Taxes</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company uses the asset and liability method to account
for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to
differences between financial statement amounts and their respective tax basis. Management reviews the Company&#146;s deferred
tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established
when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes
in valuation allowances from period to period are included in the Company&#146;s tax provision in the period of change. In addition
to valuation allowances, the Company provides for uncertain tax positions when such tax positions do not meet certain recognition
thresholds or measurement standards. Amounts for uncertain tax positions are adjusted in quarters when new information becomes
available or when positions are effectively settled.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">U.S. income tax expense and foreign withholding taxes are
provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign
earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change
and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company
accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Foreign Currency Transactions and Translation</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Local currencies are the functional currencies for substantially
all of the Company&#146;s foreign operations. When the transactional currency is different than the functional currency, transaction
gains and losses are included as a component of Other (income) expense, net. In addition, certain assets and liabilities denominated
in currencies different than a foreign subsidiary&#146;s functional currency are reported on the subsidiary&#146;s books in its
functional currency, with the impact from exchange rate differences recorded in Other (income) expense, net. Assets and liabilities
of foreign operations are translated into U.S. dollars using the exchange rates in effect at the balance sheet date, while income
and expenses are translated at the average monthly exchange rates during the year.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Gains and losses on foreign currency translations are reported
as a component of Other comprehensive income (loss). Deferred taxes are not provided on cumulative translation adjustments where
the Company expects earnings of a foreign subsidiary to be indefinitely reinvested. The income tax effect of currency translation
adjustments related to foreign subsidiaries and joint ventures for which earnings are not considered indefinitely reinvested is
recorded as a component of deferred taxes with an offset to Other comprehensive income (loss).</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Derivative Instruments</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company&#146;s use of derivative instruments, principally
swaps, futures and forward contracts, is limited to non-trading purposes and is designed to partially manage exposure to changes
in commodity prices, interest rates and foreign currencies. The Company&#146;s contracts are hedges for transactions with notional
amounts and periods consistent with the related exposures and do not constitute investments independent of these exposures.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The changes in the fair value (i.e., gains or losses) of
a derivative instrument are recorded as either assets or liabilities in the consolidated balance sheets with an offset to net earnings
or Other comprehensive income (loss) depending on whether, for accounting purposes, it has been designated and qualifies as an
accounting hedge and, if so, on the type of hedging relationship. The criteria used to determine if hedge accounting treatment
is appropriate are: (a) formal designation and documentation of the hedging relationship, the risk management objective and hedging
strategy at hedge inception; (b) eligibility of hedged items, transactions and corresponding hedging instrument; and (c) effectiveness
of the hedging relationship both at inception of the hedge and on an ongoing basis in achieving the hedging objectives. For those
derivative instruments designated and qualifying as hedging instruments, the Company must designate the hedging instrument either
as a fair value hedge or as a cash flow hedge. The Company designates its commodity forward and future contracts for forecasted
purchases of raw materials, interest rate forward contracts for forecasted interest payments, and foreign currency forward contracts
for forecasted purchases of inventory as cash flow hedges. During the fiscal years ended June 30, 2016, 2015 and 2014, the Company
had no hedging instruments designated as fair value hedges.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">For derivative instruments designated and qualifying as cash
flow hedges, the effective portion of gains or losses is reported as a component of Other comprehensive income (loss) and reclassified
into earnings in the same period or periods during which the hedged transaction affects earnings. From time to time, the Company
may have contracts not designated as hedges for accounting purposes, for which it recognizes changes in the fair value in the consolidated
statement of earnings in the current period. Cash flows from hedging activities are classified as operating activities in the consolidated
statements of cash flows.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Recently Issued Accounting Standards</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In March 2016, the Financial Accounting Standards Board (FASB)
issued Accounting Standards Update (ASU) No. 2016-09, &#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee
Share-Based Payment Accounting,&#148; which simplifies several aspects of the accounting for share-based payment transactions,
including requiring excess tax benefits and deficiencies to be recognized as income tax benefit or expense in the consolidated
statement of earnings and excess tax benefits and deficiencies to be classified as an operating activity in the consolidated statement
of cash flows. The new guidance is effective for the Company beginning in the first quarter of fiscal year 2018, with early adoption
permitted. The Company is planning to adopt the standard in the first quarter of fiscal year 2017. While the actual benefit realized
may vary significantly given the inherent uncertainty in predicting future share-based transactions, the Company currently estimates
that the adoption will result in approximately a 4 percentage point benefit to the Company&#146;s historical effective tax rate
of 34% to 35% for fiscal year 2017.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In February 2016, the FASB issued ASU No. 2016-02, &#147;Leases
(Topic 842),&#148; which requires lessees to recognize a right-of-use asset and lease liability for all leases with terms of more
than 12 months. Recognition, measurement and presentation will depend on classification as a finance or operating lease. ASU 2016-02
also requires expanded disclosures about leasing arrangements. The new guidance is effective for the Company beginning in the first
quarter of fiscal year 2020, with early adoption permitted. The Company is currently evaluating the impact that adoption of this
guidance will have on its consolidated financial statements.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In November 2015, the FASB issued ASU No. 2015-17, &#147;Income
Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes,&#148; which requires all deferred tax liabilities and assets
to be classified as noncurrent. The Company adopted the standard in the fourth quarter of fiscal year 2016 on a prospective basis
as permitted. Prior period balances have not been retrospectively adjusted.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In April 2015, the Financial Accounting Standards Board (FASB)
issued Accounting Standards Update (ASU) No. 2015-03, &#147;Simplifying the Presentation of Debt Issuance Cost,&#148; which requires
that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the
carrying amount of that debt liability, consistent with debt discounts. The new guidance is effective for the Company beginning
in the first quarter of fiscal year 2017, with early adoption permitted. The Company does not expect the adoption of this guidance
will have a significant impact on its consolidated financial statements.</p>

<p style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">In February 2015, the FASB
issued ASU No. 2015-02,</font> &#147;<font style="font-size: 10pt">Amendments to the Consolidation Analysis,&#148; which changes
the guidance for evaluating whether to consolidate certain legal entities. The amendments modify the evaluation of whether limited
partnerships and similar legal entities are variable interest entities ("VIEs") or voting interest entities. The new guidance is
effective for the Company beginning in the first quarter of fiscal year 2017, with early adoption permitted. The Company does not
expect the adoption of this guidance will have a significant impact on its consolidated financial statements. </font></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In May 2014, the FASB issued ASU No. 2014-09, &#147;Revenue
from Contracts with Customers (Topic 606),&#148; which replaces most existing U.S. GAAP revenue recognition guidance and is intended
to improve and converge with international standards the financial reporting requirements for revenue from contracts with customers.
The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services equal to the
amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional disclosures
about the nature, timing and uncertainty of revenue and cash flows arising from contracts with customers, including information
about significant judgments and changes in judgments. The new guidance is effective for the Company beginning in the first quarter
of fiscal year 2019, with the option to early adopt in the first quarter of fiscal year 2018. The Company is currently evaluating
the impact that adoption of this guidance will have on its consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801612544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DISCONTINUED OPERATIONS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 2. DISCONTINUED OPERATIONS </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">On September 22, 2014, Clorox Venezuela announced that it
was discontinuing its operations, effective immediately, and seeking to sell its assets. Since fiscal year 2012, Clorox Venezuela
was required to sell more than two thirds of its products at prices frozen by the Venezuelan government. During this same period,
Clorox Venezuela experienced successive years of hyperinflation resulting in significant sustained increases in its input costs,
including packaging, raw materials, transportation and wages. As a result, Clorox Venezuela had been selling its products at a
loss, resulting in ongoing operating losses. Clorox Venezuela repeatedly met with government authorities in an effort to help them
understand the rapidly declining state of the business, including the need for immediate, significant and ongoing price increases
and other critical remedial actions to address these adverse impacts. Based on the Venezuelan government&#146;s representations,
Clorox Venezuela had expected significant price increases would be forthcoming much earlier; however, the price increases subsequently
approved were insufficient and would have caused Clorox Venezuela to continue operating at a significant loss into the foreseeable
future. As such, Clorox Venezuela was no longer financially viable and was forced to discontinue its operations.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">On September 26, 2014, the Company reported that Venezuelan
Vice President Jorge Arreaza announced, with endorsement by President Nicol&#225;s Maduro, that the Venezuelan government had occupied
the Santa Luc&#237;a and Guacara production facilities of Clorox Venezuela. On November 6, 2014, the Company reported that the
Venezuelan government had published a resolution granting a government-sponsored Special Administrative Board full authority to
restart and operate the business of Clorox Venezuela, thereby reaffirming the government's expropriation of Clorox Venezuela&#146;s
assets. Further, President Nicol&#225;s Maduro announced the government's intention to facilitate the resumed production of bleach
and other cleaning products at Clorox Venezuela plants. He also announced his approval of a financial credit to invest in raw materials
and production at the plants. These actions by the Venezuelan government were taken without the consent or involvement of Clorox
Venezuela, its parent Clorox Spain S.L. (Clorox Spain) or any of their affiliates. Clorox Venezuela, Clorox Spain and their affiliates
reserved their rights under all applicable laws and treaties.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">With this exit, the financial results of Clorox Venezuela
are reflected as discontinued operations in the Company&#146;s consolidated financial statements. The results of Clorox Venezuela
have historically been part of the International reportable segment.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Net sales for Clorox Venezuela were $0, $11 and $77 for the
fiscal years ended June 30, 2016, 2015 and 2014, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table provides a summary of gains (losses)
from discontinued operations for Clorox Venezuela and gains (losses) from discontinued operations other than Clorox Venezuela for
the years ended June 30:<b> </b></p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 88%"><font style="font: 10pt Times New Roman, Times, Serif">Operating losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif"><b>-</b></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(23</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exit costs and other related expenses for Clorox Venezuela</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>(2</b></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>)</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(78</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>(2</b></font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>)</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(84</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(23</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Income tax benefit attributable to Clorox Venezuela</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>2</b></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>-</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(55</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(17</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="13">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gains (losses) from discontinued operations other than</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>-</b></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Losses from discontinued operations, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>-</b></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(26</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(21</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Unrelated to Clorox Venezuela, in the fiscal year ended June
30, 2015, $32 of gross unrecognized tax benefits relating to other discontinued operations for periods prior to fiscal year 2015
were recognized upon the expiration of the applicable statute of limitations. Recognition of these previously disclosed tax benefits
had no impact on the Company&#146;s cash flow or earnings from continuing operations for the fiscal years ended June 30, 2015 and
2014. (See Note 18)</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Summary of Operating Losses, Asset Charges and Other
Costs</i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following provides a breakdown of (losses) gains from
discontinued operations for Clorox Venezuela and gains from discontinued operations other than Clorox Venezuela for the fiscal
years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 93%"><font style="font: 10pt Times New Roman, Times, Serif">Operating losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="width: 1%; border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font><font style="font: 10pt Times New Roman, Times, Serif"> &#160;&#160;&#160;&#160;&#160;&#160;(6</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net asset charges:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Inventories</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(11</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property, plant and equipment</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trademark and other intangible assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other exit and business termination costs:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Severance</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Recognition of deferred foreign currency translation loss</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(30</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(10</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(84</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Income tax benefit attributable to Clorox Venezuela</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(55</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="8">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gains from discontinued operations other than</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Losses from discontinued operations, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;(26</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Prior to Clorox Venezuela being consolidated under the rules
governing the preparation of financial statements in a highly inflationary economy, cumulative translation gains (losses) were
included as a component of Accumulated other comprehensive net (losses) income. The charge of $30 to discontinued operations in
September 2014 represents the recognition of these losses as a result of Clorox Venezuela discontinuing its operations effective
September 22, 2014.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Financial Reporting: Hyperinflation and the Selection
of Exchange Rates </i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Due to a sustained inflationary environment, the financial
statements of Clorox Venezuela are consolidated under the rules governing the preparation of financial statements in a highly inflationary
economy. As such, Clorox Venezuela&#146;s non-U.S. dollar (non-USD) monetary assets and liabilities were remeasured into U.S. dollars
(USD) each reporting period with the resulting gains and losses now reflected in discontinued operations.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Subsequent to Clorox Venezuela discontinuing operations in
September 2014, the Venezuelan government has continued to evolve its currency exchange mechanisms; however, these changes have
not had a material impact on the Company&#146;s financial results because the balance of net bolivar assets and liabilities on
the local books of Clorox Venezuela was $0 as of both June 30, 2016 and 2015. As of June 30, 2016 and 2015, the local books of
Clorox Venezuela carried a net asset position of $0. In addition, as of June 30, 2016 and 2015, the Company held $0 and $13, respectively,
of tax asset balances related to Clorox Venezuela in Corporate in the reconciliation of the results of the Company&#146;s reportable
segments to consolidated results.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721533-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721665-107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=SL51724579-110230<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721663-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721659-107760<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721671-107760<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721677-107760<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1474-107760<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813478752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESSES ACQUIRED<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESSES ACQUIRED</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 3. BUSINESSES ACQUIRED </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">On May 2, 2016, the Company acquired 100 percent of ReNew
Life Holdings Corporation (Renew Life), a leading brand in digestive health. The amount paid was $290 funded through commercial
paper. The amount paid of $290 represents the aggregate purchase price less cash acquired. The purchase of the Renew Life business
reflects the Company&#146;s strategy to acquire leading brands with attractive margins in growth categories. Results for Renew
Life&#146;s U.S. business are reflected in the Household reportable segment and results for Renew Life&#146;s international business
are reflected in the International reportable segment. Included in the Company&#146;s results for fiscal year 2016 was $21 of Renew
Life&#146;s global net sales.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The assets and liabilities of Renew Life were recorded at
their respective estimated fair values as of the date of the acquisition using generally accepted accounting principles for business
combinations. The excess of the purchase price over the fair value of the net identifiable assets acquired has been allocated to
goodwill. Goodwill recorded primarily reflects the value of expanding the Company&#146;s portfolio further into the health and
wellness arena.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table summarizes the estimated fair values
of Renew Life&#146;s assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date. Due
to the timing of the acquisition, the fair value of the assets acquired and liabilities assumed are based on a preliminary valuation
and the Company&#146;s estimates and assumptions are subject to change within the measurement period. The primary areas of the
purchase price that are not yet finalized are related to goodwill and income taxes. The weighted-average estimated useful life
of intangible assets subject to amortization is 15 years.</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Renew Life</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 97%"><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">137</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trademarks</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Customer relationships</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">36</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Property, plant and equipment</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Working capital, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Deferred income taxes</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(61</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Purchase Price</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">290</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Pro forma results reflecting the acquisition were not presented
because the acquisition did not meet the threshold requirements for additional disclosure.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1497-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1490-128463<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1486-128463<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1524-128463<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7000-128479<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4922-128472<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4934-128472<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4926-128472<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=SL65897772-128472<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1383-128463<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6996-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801714256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 4. INVENTORIES</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Inventories consisted of the following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 93%"><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">361</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">316</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Raw materials and packaging</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">111</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">101</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Work in process</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">LIFO allowances</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(32</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(35</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">443</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">385</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The last-in, first-out (LIFO) method was used to value approximately
38% of inventories as of June 30, 2016 and 2015, respectively. The carrying values for all other inventories are determined on
the first-in, first-out (FIFO) method. The effect on earnings of the liquidation of LIFO layers was a benefit of $0, $0 and $2
for the fiscal years ended June 30, 2016, 2015 and 2014, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813500528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherCurrentAssetsAbstract', window );"><strong>OTHER CURRENT ASSETS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">OTHER CURRENT ASSETS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 5. OTHER CURRENT ASSETS</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Other current assets consisted of the following as of June
30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 94%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax assets<sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="width: 1%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">99</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">70</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">39</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">72</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">143</font></td></tr>
</table>
<p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"><sup>(a) </sup>The Company prospectively adopted ASU No.
2015-17, "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes," requiring all deferred tax assets and liabilities
to be classified as noncurrent. See Note 1 and 18 for further details.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801714256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY, PLANT AND EQUIPMENT, NET</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 6. PROPERTY, PLANT AND EQUIPMENT, NET</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The components of property, plant and equipment, net, consisted
of the following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 93%"><font style="font: 10pt Times New Roman, Times, Serif">Machinery and equipment</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">1,607</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">1,608</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Buildings</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">524</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">515</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Capitalized software costs</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">371</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Land and improvements</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">118</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">122</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Construction in progress</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">112</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">65</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Computer equipment</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">88</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,817</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,757</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Less: Accumulated depreciation and amortization</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,911</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,839</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">906</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">918</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Included in Machinery and equipment above are $12 of capital
leases as of June 30, 2016 and 2015, respectively. Accumulated depreciation for assets under capital leases was $3 and $2 as of
June 30, 2016 and 2015, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Included in Land and improvements above are $3 and $2 of
asset retirement obligations as of June 30, 2016 and 2015, respectively, for two leased properties. The liability of $1 and $2
incurred in fiscal year 2016 and 2015, respectively, was recorded in Other liabilities.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Depreciation and amortization expense related to property,
plant and equipment, net, was $157, $157 and $161 in fiscal years 2016, 2015 and 2014, respectively, which includes depreciation
of assets under capital leases. This also includes amortization of capitalized software of $16, $19 and $22 in fiscal years 2016,
2015 and 2014, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Non-cash capital expenditures were $10, $18 and $0 in fiscal
years 2016, 2015 and 2014, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2921-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801748064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract', window );"><strong>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 7. GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS
</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The changes in the carrying amount of goodwill by reportable
segment for the fiscal years ended June 30, 2016 and 2015 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="16" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Goodwill</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Cleaning</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Lifestyle</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Household</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>International</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 83%"><font style="font: 10pt Times New Roman, Times, Serif">Balance June 30, 2014</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">323</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">244</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">85</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">449</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">1,101</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Effect of foreign currency translation</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Balance June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">323</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">244</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">85</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">415</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,067</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Acquisition</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">122</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">15</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">137</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Effect of foreign currency translation</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Balance June 30, 2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">323</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">244</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">207</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">423</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,197</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The changes in the carrying amount of trademarks and other
intangible assets for the fiscal years ended June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>As of June 30, 2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>As of June 30, 2015</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Gross</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Accumulated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amortization</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Net carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Gross</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Accumulated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amortization</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Net carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amount</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 82%"><font style="font: 10pt Times New Roman, Times, Serif">Trademarks not subject to amortization</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">647</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font> </td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">647</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">524</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">524</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trademarks subject to amortization</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">32</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">33</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other intangible assets:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Technology and product formulae</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">137</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">137</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">133</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">221</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">146</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">75</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">188</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">142</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">46</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,037</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">302</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">735</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">882</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">297</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">585</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Finite-lived intangible assets are amortized over their estimated
useful lives, generally ranging from 2 to 30 years. Amortization expense relating to the Company&#146;s intangible assets was $8,
$12 and $15 for the years ended June 30, 2016, 2015 and 2014, respectively. Estimated amortization expense for these intangible
assets is $10, $9, $9, $9 and $8 for fiscal years 2017, 2018, 2019, 2020 and 2021, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">During fiscal year 2016, the Company recognized $9 of intangible
asset impairment charges, of which $6 related to the Aplicare<sup>&#174;</sup> trademark within the Cleaning segment. The Aplicare<sup>&#174;</sup>
trademark impairment was recognized based on the anticipated impact on future results from a competitive market entrant.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Trademarks And Other Intangible Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801714256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 8. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Accounts payable and accrued liabilities consisted of the
following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 80%">
<tr>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">490</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">431</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Compensation and employee benefit costs</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">192</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">189</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trade and sales promotion</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">127</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">115</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dividends</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">108</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">103</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">118</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">141</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,035</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">979</font></td></tr>
</table>
<p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"><sup>(a) </sup>Accounts payable and accrued liabilities
were combined into one financial statement line as of June 30, 2016. The change has been retrospectively applied to all periods
presented.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801641536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 9. DEBT </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Notes and loans payable, which mature in less than one year,
included the following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">Commercial paper</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">522</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">93</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign borrowings</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">523</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">95</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The weighted average interest rates incurred on average outstanding
notes and loans payable during the fiscal years ended June 30, 2016, 2015 and 2014, including fees associated with the Company&#146;s
undrawn revolving credit facility, were 1.10%, 2.05% and 0.97%, respectively. The weighted average effective interest rates on
commercial paper balances as of June 30, 2016 and 2015 were 0.82% and 0.39%, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Long-term debt, carried at face value net of unamortized
discounts or premiums, included the following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 94%"><font style="font: 10pt Times New Roman, Times, Serif">Senior unsecured notes and debentures:</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3.55%, $300 due November 2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">300</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.95%, $400 due October 2017</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">400</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">399</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3.80%, $300 due November 2021</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">298</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">298</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3.05%, $600 due September 2022</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">599</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">599</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3.50%, $500 due December 2024</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">500</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">500</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,797</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,096</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Less: Current maturities of long-term debt</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(300</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Long-term debt</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,797</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,796</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The weighted average interest rates incurred on average outstanding
long-term debt during the fiscal years ended June 30, 2016, 2015 and 2014, were 4.37%, 4.44% and 4.56%, respectively. The weighted
average effective interest rates on long-term debt balances as of June 30, 2016 and 2015, were 4.41% and 4.31%, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Long-term debt maturities as of June 30, 2016, are $0, $400,
$0, $0, $0 and $1,400 in fiscal years 2017, 2018, 2019, 2020, 2021 and thereafter, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In November 2015, $300 of the Company&#146;s senior notes
with an annual fixed interest rate of 3.55% became due and were repaid using commercial paper borrowings and cash on hand.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In December 2014, under a shelf registration statement filed
with the SEC that will expire in December 2017, the Company issued $500 of senior notes with an annual fixed interest rate of 3.50%.
Interest on the notes is payable semi-annually in June and December and the notes have a maturity date of December 15, 2024. The
notes carry an effective interest rate of 4.10%, which includes the impact from the settlement of interest rate forward contracts
in December 2014 (see Note 11). The notes rank equally with all of the Company&#146;s existing senior indebtedness. In January
2015, $575 of the Company&#146;s senior notes with an annual fixed interest rate of 5.00% became due and were repaid using the
net proceeds from the December 2014 debt issuance and commercial paper borrowings.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company&#146;s borrowing capacity under other financing
arrangements as of June 30 was as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">Revolving credit facility</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">1,100</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">1,100</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign credit lines</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other credit lines</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">18</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">18</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,128</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,129</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of June 30, 2016, the Company had a $1,100 revolving credit
agreement (the Credit Agreement), which expires in October 2019. There were no borrowings under the Credit Agreement as of June
30, 2016 or 2015. The agreement includes certain restrictive covenants and limitations, with which the Company was in compliance
as of June 30, 2016.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Of the $28 of foreign and other credit lines as of June 30,
2016, $5 was outstanding and the remainder of $23 was available for borrowing. Of the $29 of foreign and other credit lines as
of June 30, 2015, $4 was outstanding and the remainder of $25 was available for borrowing.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801769296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">OTHER LIABILITIES</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 10. OTHER LIABILITIES</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Other liabilities consisted of the following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">Employee benefit obligations</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">335</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">299</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Venture agreement terminal obligation, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">302</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">294</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">40</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">107</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">119</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">784</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">750</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Venture Agreement</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company has an agreement with The Procter &#38; Gamble
Company (P&#38;G) for the Company&#146;s Glad<sup>&#174;</sup> bags, wraps and containers business. As of June 30, 2016 and 2015,
P&#38;G had a 20% interest in the venture. The Company pays a royalty to P&#38;G for its interest in the profits, losses and cash
flows, as contractually defined, of the Glad<sup>&#174;</sup> business, which is included in Cost of products sold. The agreement
with P&#38;G will expire in January 2023 unless the parties decide, on or prior to January 2018, to extend the term of the agreement
for another 10 years. The agreement can be terminated under certain circumstances, including at P&#38;G&#146;s option upon a change
in control of the Company or, at either party&#146;s option, upon the sale of the Glad<sup>&#174;</sup> business by the Company.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Upon termination of the agreement, the Company is required
to purchase P&#38;G&#146;s interest for cash at fair value as established by predetermined valuation procedures. As of June 30,
2016, the estimated fair value of P&#38;G&#146;s interest was $448, of which $302 has been recognized and is reflected in Other
liabilities as noted in the table above. The difference between the estimated fair value and the amount recognized, and any future
changes in the fair value of P&#38;G&#146;s interest, is charged to Cost of products sold on a straight-line basis over the remaining
life of the agreement. Following termination, the Glad<sup>&#174;</sup> business will retain the exclusive core intellectual property
licenses contributed by P&#38;G on a royalty-free basis for the licensed products marketed.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Deferred Gain on Sale-leaseback Transaction</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In December 2012, the Company completed a sale-leaseback
transaction under which it sold its general office building in Oakland, CA to an unrelated third party for net proceeds of $108
and entered into a 15-year operating lease agreement with renewal options with the buyer for a portion of the building. The Company
deferred recognition of the portion of the total gain on the sale that was equivalent to the present value of the lease payments
and will continue to amortize such amount to earnings ratably over the lease term. As of June 30, 2016 and 2015, the long-term
portion of the deferred gain of $36 and $40, respectively, was included in Other in the table above.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801809248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock', window );">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 11. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Financial assets and liabilities measured at fair value on
a recurring basis in the consolidated balance sheets are required to be classified and disclosed in one of the following three
categories of the fair value hierarchy:</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Level 1: Quoted market prices in active markets for identical
assets or liabilities.<br />
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.<br />
Level 3: Unobservable inputs reflecting the reporting entity&#146;s own assumptions.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of June 30, 2016 and 2015, the Company&#146;s financial
assets and liabilities that were measured at fair value on a recurring basis during the period included derivative financial instruments,
which were classified as either Level 1 or Level 2, and trust assets to fund certain of the Company&#146;s nonqualified deferred
compensation plans, which were classified as Level 1.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Financial Risk Management and Derivative Instruments</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is exposed to certain commodity, foreign currency
and interest rate risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to
these risks.<b><i> </i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Commodity Price Risk Management</i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company may use commodity exchange traded futures and
over-the-counter swap contracts, which are generally no longer than 2 years, to fix the price of a portion of its forecasted raw
material requirements. Commodity purchase contracts are measured at fair value using market quotations obtained from commodity
derivative dealers.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of June 30, 2016, the notional amount of commodity derivatives
was $30, of which $16 related to jet fuel swaps and $14 related to soybean oil futures. As of June 30, 2015, the notional amount
of commodity derivatives was $47, of which $27 related to jet fuel swaps and $20 related to soybean oil futures.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Foreign Currency Risk Management</i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company may also enter into certain over-the-counter
derivative contracts to manage a portion of the Company&#146;s forecasted foreign currency exposure associated with the purchase
of inventory. These foreign currency contracts generally have durations of no longer than 2 years. The foreign exchange contracts
are measured at fair value using information quoted by foreign exchange dealers.<b> </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The notional amounts of outstanding foreign currency forward
contracts used by the Company&#146;s subsidiaries to hedge forecasted purchases of inventory were $84 and $105, respectively, as
of June 30, 2016 and 2015.<b><i> </i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Interest Rate Risk Management</i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company may enter into over-the-counter interest rate
forward contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt or to manage
the Company&#146;s level of fixed and floating rate debt. The interest rate contracts are measured at fair value using information
quoted by U.S. government bond dealers.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">During fiscal year 2015, the Company paid $25 to settle interest
rate forward contracts related to the December 2014 issuance of $500 in senior notes. The settlement payments are reflected as
operating cash flows in the consolidated statements of cash flows for the fiscal year ended June 30, 2015. The loss is reflected
in Accumulated other comprehensive net loss on the consolidated balance sheets as of June 30, 2016 and 2015, and is being amortized
into Interest expense on the consolidated statements of earnings over the 10-year term of the notes.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company had no outstanding interest rate forward contracts
as of June 30, 2016 and 2015.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Counterparty Risk Management and Derivative Contract
Requirements</i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company utilizes a variety of financial institutions
as counterparties for over-the counter derivative instruments. The Company enters into agreements governing the use of over-the-counter
derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each
counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value
of the derivative instruments exceeds contractually defined counterparty liability position limits. Of the derivative instruments
of $5 and $8 reflected in Accounts payable and accrued liabilities and Other liabilities as of June 30, 2016 and 2015, respectively,
$4 and $8, respectively, contained such terms. As of both June 30, 2016 and 2015, neither the Company nor any counterparty was
required to post any collateral as no counterparty liability position limits were exceeded.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Certain terms of the agreements governing the Company&#146;s
over-the-counter derivative instruments require the credit ratings, as assigned by Standard &#38; Poor&#146;s and Moody&#146;s
to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating.
If the Company&#146;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could
request full collateralization on derivative instruments in net liability positions. As of both June 30, 2016 and 2015, the Company
and each of its counterparties had been assigned investment grade ratings by both Standard &#38; Poor&#146;s and Moody&#146;s.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Certain of the Company&#146;s exchange-traded futures contracts
used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account
held by the Company&#146;s broker for trades conducted on that exchange. As of June 30, 2016 and 2015, the Company maintained cash
margin balances related to exchange-traded futures contracts of $1 and $2, respectively, which are classified as Other current
assets on the consolidated balance sheets.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Trust Assets </i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company has held interests in mutual funds and cash equivalents
as part of trust assets related to certain of its nonqualified deferred compensation plans. The participants, who are the Company&#146;s
current and former employees, in the deferred compensation plans may select among certain mutual funds in which their compensation
deferrals are invested in accordance with the terms of the plan and within the confines of the trusts which hold the marketable
securities. The trusts represent variable interest entities for which the Company is considered the primary beneficiary, and therefore,
trust assets are consolidated and included in Other assets in the consolidated balance sheets. The interests in mutual funds are
measured at fair value using quoted market prices. The Company has designated these marketable<b> </b>securities as trading investments.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The value of the trust assets related to certain of the Company&#146;s
nonqualified deferred compensation plans increased by $14 as compared to June 30, 2015, primarily due to current year employees&#146;
contributions to these plans.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table summarizes the fair value of Company&#146;s
assets and liabilities for which disclosure of fair value is required as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Assets</b></font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Balance sheet classification</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fair value</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>hierarchy</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>level</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Estimated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fair</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Value</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Estimated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fair</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Value</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Investments including money market funds</font></td>
    <td nowrap="nowrap" style="width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: center; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: center; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">234</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">234</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">212</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">212</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Time deposits</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">84</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">84</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other current assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other current assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trust assets for nonqualified deferred</font><br /><font style="font: 10pt Times New Roman, Times, Serif">compensation plans</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">335</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">335</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="17">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Liabilities</b></font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Notes and loans payable</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Notes and loans payable <sup>(b)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">523</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">523</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">95</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">95</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; vertical-align: middle"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable and</font><br /><font style="font: 10pt Times New Roman, Times, Serif">accrued liabilities</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; vertical-align: middle"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable and</font><br /><font style="font: 10pt Times New Roman, Times, Serif">accrued liabilities</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; vertical-align: middle"><font style="font: 10pt Times New Roman, Times, Serif">Current maturities of long-term debt and</font><br /><font style="font: 10pt Times New Roman, Times, Serif">Long-term debt</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Current maturities of long-</font><br /><font style="font: 10pt Times New Roman, Times, Serif">term debt and Long-term</font><br /><font style="font: 10pt Times New Roman, Times, Serif">debt <sup>(c)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,797</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,922</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,096</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,137</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,325</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,450</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,199</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,240</font></td></tr>
</table>
<table cellspacing="0" cellpadding="0" border="0">
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 7.5pt Times New Roman, Times, Serif">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td style="width: 100%"><font style="font: 7.5pt Times New Roman, Times, Serif">Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</font></td></tr>
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 7.5pt Times New Roman, Times, Serif">(b)</font></td>
    <td><font style="font: 7.5pt Times New Roman, Times, Serif">Notes and loan payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.</font></td></tr>
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 7.5pt Times New Roman, Times, Serif">(c)</font></td>
    <td><font style="font: 7.5pt Times New Roman, Times, Serif">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Derivatives </i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company designates its commodity forward and future contracts
for forecasted purchases of raw materials, interest rate forward contracts for forecasted interest payments, and foreign currency
forward contracts for forecasted purchases of inventory as cash flow hedges.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The effects of derivative instruments designated as hedging
instruments on Other comprehensive income (loss) and net earnings were as follows during the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Gains (losses)</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>recognized in other comprehensive net loss</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 86%"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest rate derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(12</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(18</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(14</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr>
    <td colspan="12">&#160;</td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Gains (losses) reclassified from accumulated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>other comprehensive net loss and recognized</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>in net earnings</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest rate derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(18</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The gains (losses) reclassified from Accumulated other comprehensive
net (losses) income and recognized in earnings during the fiscal years ended June 30, 2016, 2015 and 2014, for commodity purchase
and foreign exchange contracts were included in Cost of products sold, and for interest rate contracts were included in Interest
expense.<b> </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The estimated amount of the existing net gain (loss) in Accumulated
other comprehensive net (losses) income as of June 30, 2016, which is expected to be reclassified into earnings within the next
twelve months, is $(11). Gains and losses on derivative instruments representing either hedge ineffectiveness or hedge components
excluded from the assessment of effectiveness are recognized in the consolidated statement of earnings. During each of the fiscal
years ended June 30, 2016, 2015 and 2014, hedge ineffectiveness was not significant.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments and Fair Value Measurements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801780528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONTINGENCIES AND GUARANTEES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherContingenciesAndGuaranteesAbstract', window );"><strong>OTHER CONTINGENCIES AND GUARANTEES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ContingenciesAndGuaranteesDisclosureTextBlock', window );">OTHER CONTINGENCIES AND GUARANTEES</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 12. OTHER CONTINGENCIES AND GUARANTEES </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Contingencies</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is involved in certain environmental matters,
including response actions at various locations. The Company had a recorded liability of $14 and $12 as of June 30, 2016 and 2015,
respectively, for its share of aggregate future remediation costs related to these matters. One matter in Dickinson County, Michigan,
for which the Company is jointly and severally liable, accounted for a substantial majority of the recorded liability as of both
June 30, 2016 and 2015. The Company has agreed to be liable for 24.3% of the aggregate remediation and associated costs for this
matter pursuant to a cost-sharing arrangement with a third party. With the assistance of environmental consultants, the Company
maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance
and other costs that may be incurred over an estimated 30-year remediation period. Currently, the Company cannot accurately predict
the timing of future payments that may be made under this obligation. In addition, the Company&#146;s estimated loss exposure is
sensitive to a variety of uncertain factors, including the efficacy of remediation efforts, changes in remediation requirements
and the future availability of alternative clean-up technologies. Although it is reasonably possible that the Company&#146;s exposure
may exceed the amount recorded, any amount of such additional exposures, or range of exposures, is not estimable at this time.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is subject to various legal proceedings, claims
and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements, product liability,
patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to
these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at
this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse
effect, either individually or in the aggregate, on the Company&#146;s consolidated financial statements taken as a whole.<b> </b></p>

<p style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Guarantees</b></font></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In conjunction with divestitures and other transactions,
the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously
existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the
total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it
is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible
payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#146;s consolidated
financial statements taken as a whole.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company had not recorded any liabilities on the aforementioned
indemnifications as of June 30, 2016 and 2015.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company was a party to letters of credit of $10 and $11
as of June 30, 2016 and 2015, respectively, primarily related to one of its insurance carriers, of which $0 had been drawn upon.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ContingenciesAndGuaranteesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the complete disclosure regarding the entity's exposure to loss pertaining to environmental matters, litigation and potential losses not disclosed in other notes and guarantees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ContingenciesAndGuaranteesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherContingenciesAndGuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherContingenciesAndGuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801690752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND OTHER COMMITMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LeasesAndOtherCommitmentsAbstract', window );"><strong>LEASES AND OTHER COMMITMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">LEASES AND OTHER COMMITMENTS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 13. LEASES AND OTHER COMMITMENTS</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company leases various property, plant, and equipment
including office, warehousing, and manufacturing facilities, in addition to certain manufacturing and information technology equipment.
The Company expects that, in the normal course of business, existing contracts will be renewed or replaced by other leases. Rental
expense for all operating leases was $77, $76 and $71 in fiscal years 2016, 2015 and 2014, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The future minimum annual lease commitments required under
the Company&#146;s existing non-cancelable operating and capital lease agreements as of June 30, 2016, were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 60%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Year</b></font></td>
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Operating</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>leases</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Capital</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>leases</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 90%"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">49</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">32</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Thereafter</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">135</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;328</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is also a party to certain purchase obligations,
which are defined as purchase agreements that are enforceable and legally binding and that contain specified or determinable significant
terms, including quantity, price and the approximate timing of the transaction. Examples of the Company&#146;s purchase obligations
include contracts to purchase raw materials, commitments to contract manufacturers, commitments for information technology and
related services, advertising contracts, capital expenditure agreements, software acquisition and license commitments and service
contracts. The Company enters into purchase obligations based on expectations of future business needs. For purchase obligations
subject to variable price and/or quantity provisions, an estimate of the price and/or quantity has been made. Many of these purchase
obligations are short term in nature and are flexible to allow for changes in the Company&#146;s business and related requirements.
As of June 30, 2016, the Company&#146;s purchase obligations were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Year</b></font></td>
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Purchase</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Obligations</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 96%"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">150</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">37</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Thereafter</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">256 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_LeasesAndOtherCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases And Other Commitments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_LeasesAndOtherCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813496720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 14. STOCKHOLDERS&#146; EQUITY</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company has two share repurchase programs: an open-market
purchase program with an authorized aggregate purchase amount of up to $750, all of which was available for share repurchases as
of both June 30, 2016 and 2015, and a program to offset the anticipated impact of share dilution related to share-based awards
(the Evergreen Program), which has no authorization limit as to amount or timing of repurchases.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Share repurchases under authorized programs were as follows
during the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(in 000's)</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(in 000's)</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(in 000's)</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 86%"><font style="font: 10pt Times New Roman, Times, Serif">Open-market purchase programs</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="width: 1%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Evergreen Program</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">254</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,151</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">434</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">260</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,046</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;254</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,151</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;434</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;260</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,046</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Dividends per share declared and paid, respectively, during
the fiscal years ended June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Dividends per share declared</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;3.11</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;2.99</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;2.87</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dividends per share paid</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.08</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.96</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.84</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Accumulated Other Comprehensive Net (Losses) Income </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Changes in Accumulated other comprehensive net (losses) income
by component were as follows for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="padding-bottom: 2pt; text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Foreign currency</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>adjustments</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Net</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>unrealized</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>gains</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(losses) on</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>derivatives</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Pension and</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>postretirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>benefit</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>adjustments</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Accumulated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Other</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Comprehensive</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Income</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance June 30, 2013</b></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">(209</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(30</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(128</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(367</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive (loss) income before</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassifications</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(26</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(15</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(57</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;comprehensive net losses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income tax benefit (expense)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(11</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net current period other comprehensive income (loss)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(37</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(9</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(50</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance June 30, 2014</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(246</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(39</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(132</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(417</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive (loss) income before</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassifications</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(92</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(18</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(29</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(139</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;comprehensive net losses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Recognition of deferred foreign currency translation</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;loss</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income tax benefit (expense)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net current period other comprehensive income (loss)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(54</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(14</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(17</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(85</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance June 30, 2015</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(300</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(53</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(149</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(502</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive (loss) income before</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassifications</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(43</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(38</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(88</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;comprehensive net losses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">18</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">18</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income tax benefit (expense)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(10</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net current period other comprehensive income (loss)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(53</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(24</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(68</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance June 30, 2016</b></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(353</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(44</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(173</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(570</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Included in foreign currency adjustments are re-measurement
losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. For the fiscal
years ended June 30, 2016, 2015 and 2014, Other comprehensive losses on these loans totaled $14, $9 and $12, respectively, and
there were no amounts reclassified from Accumulated other comprehensive net (losses) income.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Pension and postretirement benefit reclassification adjustments
are reflected in Cost of products sold, Selling and administrative expenses and Research and development costs.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813443760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS PER SHARE (EPS)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET EARNINGS PER SHARE (EPS)</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 15. NET EARNINGS PER SHARE (EPS)</b></p>

<p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif">The following is the reconciliation of
the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted
net EPS for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; width: 95%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129,472</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">130,310</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129,558</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dilutive effect of stock options and other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,245</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,466</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,184</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,717</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">132,776</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,742</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="6">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Antidilutive stock options and other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">42</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813553152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION PLANS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 16. STOCK-BASED COMPENSATION PLANS</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In November 2012, the Company&#146;s stockholders voted to
approve the amended and restated 2005 Stock Incentive Plan (the Plan). The Plan permits the Company to grant various nonqualified
stock-based compensation awards, including stock options, restricted stock, performance units, deferred stock units, stock appreciation
rights and other stock-based awards. The primary amendment reflected in the Plan was an increase of approximately 3 million common
shares that may be issued for stock-based compensation purposes. As of June 30, 2016, the Company is authorized to grant up to
approximately 8 million common shares under the Plan, and, as of June 30, 2016, approximately 8 million common shares were available
for grant.</p>

<p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif">Compensation cost and the related income
tax benefit recognized for stock-based compensation plans were classified as indicated below for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Cost of products sold</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Selling and administrative expenses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">35</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Research and development costs</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total compensation cost</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;45</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;32</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;36</font></td></tr>
<tr>
    <td colspan="9">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Related income tax benefit</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Cash received during fiscal years 2016, 2015 and 2014 from
stock options exercised under all stock-based payment arrangements was $180, $230 and $86, respectively. The Company issues shares
for stock-based compensation plans from treasury stock. The Company may repurchase shares under its Evergreen Program to offset
the estimated impact of share dilution related to stock-based awards (see Note 14).</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Details regarding the valuation and accounting for stock
options, restricted stock awards, performance units and deferred stock units for non-employee directors follow.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Stock Options </b></p>

<p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif">The fair value of each stock option award
granted during fiscal years 2016, 2015 and 2014 was estimated on the date of grant using the Black-Scholes valuation model and
assumptions noted in the following table:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; width: 95%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected life</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.6 years</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.6 to 5.8 years</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.7 years</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average expected life</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.6 years</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.7 years</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.7 years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">16.43% to 17.3%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">16.3% to 18.6%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">18.4% to 18.5%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average volatility</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">17.2%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">16.6%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">18.5%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.3% to 1.7%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.4% to 2.0%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.8% to 1.9%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average risk-free interest rate</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.7%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.9%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.8%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dividend yield</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.5% to 2.8%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.8% to 3.4%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3.4%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average dividend yield</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.8%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3.3%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3.4%</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The expected life of the stock options is based on observed
historical exercise patterns. The expected volatility is based on implied volatility from publicly traded options on the Company&#146;s
stock at the date of grant, historical implied volatility of the Company&#146;s publicly traded options and other factors. The
risk-free interest rate is based on the implied yield on a U.S. Treasury zero-coupon issue with a remaining term equal to the expected
term of the option. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price
at the date of grant.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Details of the Company&#146;s stock option activities are
summarized below:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Number of</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(In thousands)</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Weighted-</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Average</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Exercise</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Price</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>per Share</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Average</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Remaining</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Contractual</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Life</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Aggregate</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Intrinsic</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Value</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 89%"><font style="font: 10pt Times New Roman, Times, Serif">Options outstanding as of June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">8,357</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">76</font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: center; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">7 years</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">236</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,317</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;112</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,633</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">69</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Cancelled</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(214</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">95</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Options outstanding as of June 30, 2016</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,827</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">85</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">7 years</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;366</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="11">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Options vested as of June 30, 2016</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,555</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">228</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The weighted-average fair value per share of each option
granted during fiscal years 2016, 2015 and 2014, estimated at the grant date using the Black-Scholes option pricing model was $13.21,
$9.65 and $9.69, respectively. The total intrinsic value of options exercised in fiscal years 2016, 2015 and 2014 was $142, $140
and $42, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Stock option awards outstanding as of June 30, 2016, have
been granted at prices that are equal to the market value of the stock on the date of grant. Stock option grants generally vest
over four years and expire no later than ten years after the grant date. The Company recognizes compensation expense ratably over
the vesting period. As of June 30, 2016, there was $16 of total unrecognized compensation cost related to non-vested options, which
is expected to be recognized over a remaining weighted-average vesting period of one year, subject to forfeiture changes.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Restricted Stock Awards</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The fair value of restricted stock awards is estimated on
the date of grant based on the market price of the stock and is amortized to compensation expense on a straight-line basis over
the related vesting periods, which are generally three to four years. The total number of restricted stock awards expected to vest
is adjusted by actual and estimated forfeitures. Restricted stock grants receive dividend distributions earned during the vesting
period upon vesting.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of June 30, 2016, there was $1 of total unrecognized compensation
cost related to non-vested restricted stock awards, which is expected to be recognized over a remaining weighted-average vesting
period of one year. The total fair value of the shares that vested in each of the fiscal years 2016, 2015 and 2014 was $1, respectively.
The weighted-average grant-date fair value of awards granted was $128.91, $95.67 and $89.25 per share for fiscal years 2016, 2015
and 2014, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">A summary of the status of the Company&#146;s restricted
stock awards is presented below:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Number of</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(In thousands)</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Weighted-Average</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Grant Date</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fair Value</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>per Share</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 94%"><font style="font: 10pt Times New Roman, Times, Serif">Restricted stock awards as of June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">18</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">91</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(9</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">88</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">106</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Restricted stock awards as of June 30, 2016</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">108</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Performance Units</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of June 30, 2016, there was $37 in unrecognized compensation
cost related to non-vested performance unit grants that is expected to be recognized over a remaining weighted-average performance
period of one year. The weighted-average grant-date fair value of awards granted was $92.35, $89.75 and $84.45 per share for fiscal
years 2016, 2015 and 2014, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">A summary of the status of the Company&#146;s performance
unit awards is presented below:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Number of</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(In thousands)</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Weighted-Average</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Grant Date</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fair Value</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>per Share</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">Performance unit awards as of June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,123</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">286</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">92</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Distributed</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(377</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">70</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(80</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">87</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Performance unit awards as of June 30, 2016</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">952</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">90</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="6">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Performance units vested and deferred as of June 30, 2016</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">157</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">58</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The non-vested performance units outstanding as of June 30,
2016 and 2015 were 794,000 and 944,000, respectively, and the weighted average grant date fair value was $95.18 and $81.92 per
share, respectively. Total shares vested during fiscal year 2016 were 354,000, which had a weighted average grant date fair value
per share of $72.11. During fiscal year 2016, $25 of the vested awards was paid by the issuance of shares and $1 of the vested
awards was deferred. Deferred shares continue to earn dividends, which are also deferred. The total fair value of shares vested
was $26, $24 and $0 during fiscal years 2016, 2015 and 2014, respectively. Upon vesting, the recipients of the grants receive the
distribution as shares or, if previously elected by eligible recipients, as deferred stock.<b> </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Deferred Stock Units for Nonemployee Directors</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Nonemployee directors receive annual grants of deferred stock
units under the Company&#146;s director compensation program and can elect to receive all or a portion of their annual retainers
and fees in the form of deferred stock units. The deferred stock units receive dividend distributions, which are reinvested as
deferred stock units, and are recognized at their fair value on the date of grant. Each deferred stock unit represents the right
to receive one share of the Company&#146;s common stock following the completion of a director&#146;s service.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">During fiscal year 2016, the Company granted 13,000 deferred
stock units, reinvested dividends of 6,000 units and distributed 16,000 shares, which had a weighted-average fair value on grant
date of $126.65, $124.03 and $62.70 per share, respectively. As of June 30, 2016, 244,000 units were outstanding, which had a weighted-average
fair value on the grant date of $71.13 per share.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65895303&amp;loc=d3e17540-113929<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813501616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME) EXPENSE, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherIncomeExpenseNetDisclosureTextBlock', window );">OTHER (INCOME) EXPENSE, NET</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 17. OTHER (INCOME) EXPENSE, NET</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The major components of Other (income) expense, net, for
the fiscal years ended June 30 were:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 89%"><font style="font: 10pt Times New Roman, Times, Serif">Income from equity investees</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(15</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(14</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest income</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Low income housing partnership gains, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange transaction losses, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Amortization of trademarks and other intangible assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Intangible asset impairment charges</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(10</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In April 2016, the Company sold its Los Angeles bleach manufacturing
facility, previously reported in the Cleaning segment, which resulted in $20 in cash proceeds from investing activities and a gain
of $(11) included in Other in the table above for the year ended June 30, 2016.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">During fiscal year 2016, the Company recognized $9 of intangible
asset impairment charges, of which $6 related to the Aplicare<sup>&#174;</sup> trademark within the Cleaning segment. The Aplicare<sup>&#174;</sup>
trademark impairment was recognized based on the anticipated impact on future results from a competitive market entrant.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Investment in Low-Income Housing Partnerships </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company owns, directly or indirectly, limited partnership
interests in low-income housing partnerships, which are accounted for using the equity method of accounting. These partnerships
are considered to be variable interest entities; however, the Company does not consolidate them because it does not have the power
to direct the partnerships&#146; activities that significantly impact their economic performance. The purpose of the partnerships
is to develop and operate low-income housing rental properties. The general partners, who typically hold 1% of the partnership
interests, are third parties unrelated to the Company and its affiliates, and are responsible for controlling and managing the
business and financial operations of the partnerships. As a limited partner, the Company is not responsible for any of the liabilities
and obligations of the partnerships nor do the partnerships or their creditors have any recourse to the Company other than for
the capital requirements. All available tax benefits from low-income housing tax credits provided by the partnerships were claimed
as of fiscal year 2012. The risk that previously claimed low-income housing tax credits might be recaptured or otherwise retroactively
invalidated is considered remote.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In April 2015, a low-income housing partnership, in which
the Company was a limited partner, sold its real estate holdings. The real property sale resulted in $15 in cash proceeds from
investing activities and a gain of $(14) recorded to Other (income) expense, net, on the consolidated statement of earnings for
the year ended June 30, 2015.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherIncomeExpenseNetDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherIncomeExpenseNetDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813553152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 18. INCOME TAXES</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The provision for income taxes on continuing operations,
by tax jurisdiction, consisted of the following for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 85%"><font style="font: 10pt Times New Roman, Times, Serif">Current</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Federal</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">254</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">265</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">247</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; State</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">31</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Foreign</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total current</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">330</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">331</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">326</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Deferred</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Federal</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(19</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; State</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Foreign</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total deferred</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(21</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">335</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">315</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">305</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The components of earnings from continuing operations before
income taxes, by tax jurisdiction, consisted of the following for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">United States</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">900</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">829</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">754</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">92</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">130</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">983</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">921</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">884</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">A reconciliation of the statutory federal income tax rate
to the Company&#146;s effective tax rate on continuing operations follows for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 88%"><font style="font: 10pt Times New Roman, Times, Serif">Statutory federal tax rate</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">35.0</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">35.0</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">35.0</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">State taxes (net of federal tax benefits)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Tax differential on foreign earnings</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.5</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Domestic manufacturing deduction</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2.4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2.1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2.3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Change in valuation allowance</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.5</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other differences</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1.6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1.1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1.0</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Effective tax rate</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34.1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34.2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34.6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Applicable U.S. income taxes and foreign withholding taxes
have not been provided on approximately $216 of undistributed earnings of certain foreign subsidiaries as of June 30, 2016, because
these earnings are considered indefinitely reinvested. The estimated net federal income tax liability that could arise if these
earnings were not indefinitely reinvested is approximately $56. Applicable U.S. income and foreign withholding taxes are provided
on these earnings in the periods in which they are no longer considered indefinitely reinvested.<b> </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Tax benefits resulting from stock-based payment arrangements
that are in excess of the tax benefits recorded in net earnings over the vesting period of those arrangements (excess tax benefits)
are recorded as increases to Additional paid-in capital. Excess tax benefits of approximately $51, $42, and $11 were realized and
recorded to Additional paid-in capital for fiscal years 2016, 2015 and 2014, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The components of net deferred tax assets (liabilities) as
of June 30 are shown below:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 12pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 90%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax assets <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Compensation and benefit programs</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">193</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">191</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Basis difference related to Venture Agreement</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Accruals and reserves</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">43</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Inventory costs</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Net operating loss and tax credit carryforwards</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">48</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">61</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subtotal</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">380</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">385</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Valuation allowance</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(37</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Total deferred tax assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">343</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">351</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr>
    <td colspan="9">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax liabilities <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Fixed and intangible assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(325</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(277</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Low-income housing partnerships</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(23</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(22</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Unremitted foreign earnings</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(25</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(24</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Total deferred tax liabilities</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160; (389</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160; (330</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Net deferred tax assets (liabilities)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(46</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"><sup>(a) </sup>The Company prospectively adopted ASU No.
2015-17, "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes," requiring all deferred tax assets and liabilities
to be classified as noncurrent. See Note 1 for further details.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company periodically reviews its deferred tax assets
for recoverability. A valuation allowance is established when the Company believes that it is more likely than not that some portion
of its deferred tax assets will not be realized. Valuation allowances have been provided to reduce deferred tax assets to amounts
considered recoverable. Details of the valuation allowance were as follows as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 12pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Valuation allowance at beginning of year</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(51</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net decrease/(increase) for other foreign deferred tax assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">15</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net decrease/(increase) for foreign net operating loss carryforwards and tax credits</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Valuation allowance at end of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160; (37</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160; (34</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of June 30, 2016, the Company had foreign tax credit carryforwards
of $15 for U.S. income tax purposes with expiration dates between fiscal years 2024 and 2025. Tax credit carryforwards in foreign
jurisdictions of $19 have expiration dates in fiscal year 2031. Tax credit carryforwards in foreign jurisdictions of $1 can be
carried forward indefinitely. Tax benefits from foreign net operating loss carryforwards of $16 have expiration dates between fiscal
years 2017 and 2036. Tax benefits from foreign net operating loss carryforwards of $12 can be carried forward indefinitely.<b>
</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company files income tax returns in the U.S. federal
and various state, local and foreign jurisdictions. The federal statute of limitations has expired for all tax years through June
30, 2012. Various income tax returns in state and foreign jurisdictions are currently in the process of examination.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company recognizes interest and penalties related to
uncertain tax positions as a component of income tax expense. As of June 30, 2016 and 2015, the total balance of accrued interest
and penalties related to uncertain tax positions was $3 and $10, respectively. Interest and penalties related to uncertain tax
positions included in income tax expense resulted in a net benefit of $1, a net benefit of $1, and a net expense of $3 in fiscal
years 2016, 2015 and 2014, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following is a reconciliation of the beginning and ending
amounts of the Company&#146;s gross unrecognized tax benefits:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 85%"><font style="font: 10pt Times New Roman, Times, Serif">Unrecognized tax benefits at beginning of year</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">71</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">69</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gross increases - tax positions in prior periods</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gross decreases - tax positions in prior periods</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(8</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gross increases - current period tax positions</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gross decreases - current period tax positions</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Lapse of applicable statute of limitations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Settlements</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Unrecognized tax benefits at end of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">37</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">71</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Included in the balance of unrecognized tax benefits as of
June 30, 2016, 2015 and 2014, are potential benefits of $27, $27 and $58, respectively, which if recognized, would affect net earnings.
During the fiscal year ended June 30, 2015, $32 of gross unrecognized tax benefits relating to other discontinued operations for
periods prior to fiscal year 2015 were recognized upon the expiration of the applicable statute of limitations. Recognition of
these previously disclosed tax benefits had no impact on the Company&#146;s cash flow or earnings from continuing operations for
the fiscal years ended June 30, 2016, 2015 and 2014.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813465056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract', window );"><strong>Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">EMPLOYEE BENEFIT PLANS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 19. EMPLOYEE BENEFIT PLANS</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Retirement Income Plans</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Effective July 1, 2011, and as part of a set of long-term,
cost-neutral enhancements to the Company&#146;s overall employee benefit plans, the domestic qualified retirement income pension
plan was frozen for service accrual and eligibility purposes for most participants, however, interest credits have continued to
accrue on participant balances. As of June 30, 2016 and 2015, the benefits of the domestic pension plan are based on either employee
years of service and compensation or a stated dollar amount per year of service. The Company is the sole contributor to the plan
in amounts deemed necessary to provide benefits and to the extent deductible for federal income tax purposes. Assets of the plan
consist primarily of investments in cash equivalents and common collective trusts.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company contributed $15 to its domestic qualified pension
plan during fiscal year 2016. No contributions were made in fiscal year 2015 and 2014. The Company&#146;s funding policy for its
qualified plans is to contribute amounts sufficient to meet minimum funding requirements as set forth in employee benefit tax laws
plus additional amounts as the Company may determine to be appropriate. Subsequent to June 30, 2016, the Company made a $15 discretionary
contribution to the pension plan.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Contributions made to the domestic non-qualified pension
plans were $16, $13 and $13 in fiscal years 2016, 2015 and 2014, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Retirement Health Care Plans</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company provides certain health care benefits for employees
who meet age, participation and length of service requirements at retirement. The plans pay stated percentages of covered expenses
after annual deductibles have been met or stated reimbursements up to a specified dollar subsidy amount. Benefits paid take into
consideration payments by Medicare for the domestic plan. The plans are funded as claims are paid, and the Company has the right
to modify or terminate certain plans.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The assumed domestic health care cost trend rate used in
measuring the accumulated benefit obligation (ABO) was 6.75% for both medical and prescription drugs for fiscal year 2016. These
rates have been assumed to gradually decrease each year until an assumed ultimate trend of 4.5% is reached in 2037. The health
care cost trend rate assumption has a minimal effect on the amounts reported due primarily to the existence of benefit cap provisions
in the Company&#146;s domestic plan. As such, the effect of a hypothetical 100 basis point increase or decrease in the assumed
domestic health care cost trend rate on the total service and interest cost components as well as the postretirement benefit obligation
would have been immaterial for each of the fiscal years ended June 30, 2016, 2015 and 2014.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Financial Information Related to Retirement Income and
Retirement Health Care </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Summarized information for the Company&#146;s retirement
income and retirement health care plans as of and for the fiscal years ended June 30 is as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Health Care</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 80%"><font style="font: 10pt Times New Roman, Times, Serif">Change in benefit obligations:</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Projected benefit obligation as of beginning of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">639</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">641</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Service cost</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Interest cost</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Actuarial loss (gain)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">51</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Plan amendments</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Translation and other adjustments</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Benefits paid</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(42</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(38</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Projected benefit obligation as of end of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">673</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">639</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">47</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Change in plan assets:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Fair value of assets as of beginning of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">409</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">432</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Actual return on plan assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Employer contributions</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">31</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Benefits paid</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(42</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(38</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Translation and other adjustments</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Fair value of plan assets as of end of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">423</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">409</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Accrued benefit cost, net funded status</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(250</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(230</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(47</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr>
    <td colspan="17">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Amount recognized in the balance sheets consists of:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Pension benefit assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Current accrued benefit liability</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(14</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Non-current accrued benefit liability</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(237</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(216</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(44</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(42</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Accrued benefit cost, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(250</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(230</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(47</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Retirement income plans with ABO in excess of plan assets
as of June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Pension Plans</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Other</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Plans</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 84%"><font style="font: 10pt Times New Roman, Times, Serif">Projected benefit obligation</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">575</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">538</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; 76</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; 80</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Accumulated benefit obligation</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">574</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">538</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">80</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Fair value of plan assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">399</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">385</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The ABO for all pension plans was $596, $559 and $563 as
of June 30, 2016, 2015 and 2014, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The net costs of the retirement income and health care plans
for the fiscal years ended June 30 included the following components:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="10" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Health Care</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 72%"><font style="font: 10pt Times New Roman, Times, Serif">Service cost</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest cost</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">27</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected return on plan assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160; (17</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160; (20</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160; (25</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Amortization of unrecognized items&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160; (3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160; (4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">20</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">) </font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Items not yet recognized as a component of postretirement
expense as of June 30, 2016, consisted of:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Health Care</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 91%"><font style="font: 10pt Times New Roman, Times, Serif">Net actuarial loss (gain)</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">296</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (13</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Prior service benefit</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net deferred income tax (assets) liabilities</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (111</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Accumulated other comprehensive loss (income)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">185</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(12</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Net actuarial loss (gain) recorded in Accumulated other comprehensive
net (losses) income for the fiscal year ended June 30, 2016, included the following:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Health Care</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 90%"><font style="font: 10pt Times New Roman, Times, Serif">Net actuarial loss (gain) as of beginning of year</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 264</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (17</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Amortization during the year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(10</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Loss (gain) during the year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">42</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net actuarial loss (gain) as of end of year</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">296</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company uses the straight-line amortization method for
unrecognized prior service costs and benefits. In fiscal year 2017, the Company expects to recognize, on a pre-tax basis, $11 of
the net actuarial loss as a component of net periodic benefit cost for the Pension Plans. In addition, in fiscal year 2017, the
Company expects to recognize, on a pre-tax basis, $1 of the net actuarial gain as a component of net periodic benefit cost for
the retirement health care plans.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Weighted-average assumptions used to estimate the actuarial
present value of benefit obligations as of June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Health Care</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 84%"><font style="font: 10pt Times New Roman, Times, Serif">Discount rate</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">3.42</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">4.20</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">3.42</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">4.16</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Rate of compensation increase</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.92</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.37</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">n/a</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">n/a</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Weighted-average assumptions used to estimate the net periodic
pension and other postretirement benefit costs as of June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Income</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 88%"><font style="font: 10pt Times New Roman, Times, Serif">Discount rate</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">4.20</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">4.05</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">4.39</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Rate of compensation increase</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.37</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.46</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.44</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected return on plan assets</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.34</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5.28</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6.61</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr>
    <td colspan="10">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Health Care</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Discount rate</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.16</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.00</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.33</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The expected long-term rate of return assumption is based
on an analysis of historical experience of the portfolio and the summation of prospective returns for each asset class in proportion
to the fund&#146;s current asset allocation.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Expected benefit payments for the Company&#146;s pension
and other postretirement plans as of June 30, 2016, were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Health Care</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 93%"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">39</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">39</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">39</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">39</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Fiscal years 2022 through 2026</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">193</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Expected benefit payments are based on the same assumptions
used to measure the benefit obligations and include estimated future employee service.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The target allocations and weighted average asset allocations
by asset category of the investment portfolio for the Company&#146;s domestic retirement income plans as of June 30 were:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>% Target Allocation</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>% of Plan Assets</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 85%"><font style="font: 10pt Times New Roman, Times, Serif">U.S. equity</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">International equity</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Fixed income</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The target asset allocation is determined based on the optimal
balance between risk and return and, at times, may be adjusted to achieve the plan&#146;s overall investment objective to generate
sufficient resources to pay current and projected plan obligations over the life of the domestic qualified retirement income plan.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table sets forth by level within the fair value
hierarchy, the retirement income plans&#146; assets carried at fair value as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Level 1</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Level 2</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 89%"><font style="font: 10pt Times New Roman, Times, Serif">Cash equivalents</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="width: 2%; border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="width: 1%; border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Common collective trusts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Bond funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">307</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">307</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; International equity funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">56</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">56</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Domestic equity funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">44</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">44</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Real estate fund</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total common collective trusts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">421</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">421</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total assets at fair value</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">421</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">423</font></td></tr>
<tr>
    <td colspan="10">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Level 1</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Level 2</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Cash equivalents</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Common collective trusts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Bond funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">295</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">295</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; International equity funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">59</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">59</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Domestic equity funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Real estate fund</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total common collective trusts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">406</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">406</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total assets at fair value</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">406</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">409</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The carrying value of cash equivalents approximates its fair
value as of June 30, 2016 and 2015.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Common collective trust funds are not publicly traded and,
therefore, are classified as Level 2. They are valued at a net asset value unit price determined by the portfolio&#146;s sponsor
based on the fair value of underlying assets held by the common collective trust fund on June 30, 2016 and 2015.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The common collective trusts are invested in various trusts
that attempt to achieve their investment objectives by investing primarily in other collective investment funds which have characteristics
consistent with each trust&#146;s overall investment objective and strategy.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Defined Contribution Plans</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company has defined contribution plans for most of its
domestic employees. The plans include The Clorox Company 401(k) Plan, The Clorox Company 2011 Nonqualified Defined Contribution
Plan and the Executive Retirement Plan. The aggregate cost of the domestic defined contribution plans was $45, $45 and $43 in fiscal
years 2016, 2015 and 2014, respectively. Included in the aggregate cost was the cost of The Clorox Company 401(k) Plan of $41,
$42 and $38 in fiscal years 2016, 2015 and 2014, respectively. The Company also has defined contribution plans for certain international
employees. The aggregate cost of these foreign plans was $3 for the fiscal years ended June 30, 2016, 2015 and 2014.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450702-114947<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2410-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39675-114964<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813422752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 20. SEGMENT REPORTING</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company operates through strategic business units that
are aggregated into the following four reportable segments based on the economics and nature of the products sold:</p>

<table cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
    <td style="padding-right: 8pt; padding-left: 15pt; width: 1%"><font style="font-size: 9.5pt">&#9679;</font></td>
    <td style="width: 99%"><i>Cleaning</i><font style="font: 10pt Times New Roman, Times, Serif"> consists of laundry, home care and professional products marketed and sold in the United States. Products within this segment include laundry additives, including bleach products under the Clorox<sup>&#174;</sup> brand and Clorox 2<sup>&#174;</sup> stain fighter and color booster; home care products, primarily under the Clorox<sup>&#174;</sup>, Formula 409<sup>&#174;</sup>, Liquid-Plumr<sup>&#174;</sup>, Pine-Sol<sup>&#174;</sup>, S.O.S<sup>&#174;</sup> and Tilex<sup>&#174;</sup> brands; naturally derived products under the Green Works<sup>&#174;</sup> brand; and professional cleaning and disinfecting products under the Clorox<sup>&#174;</sup>, Dispatch<sup>&#174;</sup>, Aplicare<sup>&#174;</sup>, HealthLink<sup>&#174;</sup> and Clorox Healthcare<sup>&#174;</sup> brands.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 8pt; padding-left: 15pt"><font style="font-size: 9.5pt">&#9679;</font></td>
    <td><i>Household</i><font style="font: 10pt Times New Roman, Times, Serif"> consists of charcoal, cat litter, digestive health products and bags, wraps and container products marketed and sold in the United States. Products within this segment include charcoal products under the Kingsford<sup>&#174;</sup> and Match Light<sup>&#174;</sup> brands; cat litter products under the Fresh Step<sup>&#174;</sup>, Scoop Away<sup>&#174;</sup> and Ever Clean<sup>&#174;</sup> brands; digestive health products under the Renew Life<sup>&#174;</sup> brand; and bags, wraps and containers under the Glad<sup>&#174;</sup> brand.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 8pt; padding-left: 15pt"><font style="font-size: 9.5pt">&#9679;</font></td>
    <td><i>Lifestyle</i><font style="font-family: Times New Roman, Times, Serif"> consists of food products, water-filtration systems and filters and natural personal care products marketed and sold in the United States. Products within this segment include dressings and sauces, primarily under the Hidden Valley<sup>&#174;</sup>, KC Masterpiece<sup>&#174;</sup> and Soy Vay<sup>&#174;</sup> brands; water-filtration systems and filters under the Brita<sup>&#174;</sup> brand; and natural personal care products under the Burt&#146;s Bees<sup>&#174;</sup> brand.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 8pt; padding-left: 15pt"><font style="font-size: 9.5pt">&#9679;</font></td>
    <td><i>International</i><font style="font-family: Times New Roman, Times, Serif"> consists of products sold outside the United States. Products within this segment include laundry, home care, water-filtration, digestive health products, charcoal and cat litter products, dressings and sauces, bags, wraps and containers and natural personal care products, primarily under the Clorox<sup>&#174;</sup>, Glad<sup>&#174;</sup>, PinoLuz<sup>&#174;</sup>, Ayudin<sup>&#174;</sup>, Limpido<sup>&#174;</sup>, Clorinda<sup>&#174;</sup>, Poett<sup>&#174;</sup>, Mistolin<sup>&#174;</sup>, Lestoil<sup>&#174;</sup>, Bon Bril<sup>&#174;</sup>, Brita<sup>&#174;</sup>, Green Works<sup>&#174;</sup>, Pine-Sol<sup>&#174;</sup>, Agua Jane<sup>&#174;</sup>, Chux<sup>&#174;</sup>, Renew Life<sup>&#174;</sup>, Kingsford<sup>&#174;</sup>, Fresh Step<sup>&#174;</sup>, Scoop Away<sup>&#174;</sup>, Ever Clean<sup>&#174;</sup>, KC Masterpiece<sup>&#174;</sup>, Hidden Valley<sup>&#174;</sup> and Burt&#146;s Bees<sup>&#174;</sup> brands.</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Certain non-allocated administrative costs, interest income,
interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash
and cash equivalents, property and equipment, other investments and deferred taxes.</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; line-height: normal">
    <td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fiscal</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Year</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Cleaning</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Household</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Lifestyle</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>International</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Corporate</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Company</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 77%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">Net sales</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2016</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,912</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,862</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">990</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">997</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5,761</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,824</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,794</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">950</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,087</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5,655</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,776</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,709</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">936</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,093</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5,514</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Earnings (losses) from continuing</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;operations before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">511</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">428</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">251</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">66</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(273</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">983</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">445</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">375</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">257</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(235</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">921</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">428</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">326</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">258</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">99</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(227</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">884</font></td></tr>
<tr>
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">Income from equity investees</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">15</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">15</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">14</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">14</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">13</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">13</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">883</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,092</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">880</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,057</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">606</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,518</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">876</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">725</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">860</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,057</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">646</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,164</font></td></tr>
<tr>
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">Capital expenditures</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">44</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">83</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">18</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">24</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">172</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">35</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">50</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">11</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">25</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">125</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">37</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">53</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">11</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">31</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">137</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Depreciation and amortization</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">61</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">60</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">165</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">67</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">24</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">169</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">67</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">177</font></td></tr>
<tr>
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">Significant noncash charges included</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">&#160;&#160;&#160;&#160;&#160;&#160;&#160;in earnings (losses) from continuing</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">&#160;&#160;&#160;&#160;&#160;&#160;&#160;operations before income taxes:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #ffffff">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share-based compensation</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">10</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">8</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">21</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">45</font></td></tr>
<tr style="vertical-align: bottom; background-color: #ffffff">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">8</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">7</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">4</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">32</font></td></tr>
<tr style="vertical-align: bottom; background-color: #ffffff">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">11</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">9</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">10</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">36</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">All intersegment sales are eliminated and are not included
in the Company&#146;s reportable segments&#146; net sales.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Net sales to the Company&#146;s largest customer, Walmart
Stores, Inc. and its affiliates, were 27%, 26% and 27% of consolidated net sales for each of the fiscal years ended June 30, 2016,
2015 and 2014, respectively, and occurred in each of the Company&#146;s reportable segments. No other customers accounted for more
than 10% of consolidated net sales in any of these fiscal years. During fiscal years 2016, 2015 and 2014, the Company&#146;s five
largest customers accounted for 46%, 45%, and 45% of its consolidated net sales for each of the three fiscal years, respectively.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Three of the Company&#146;s product lines have accounted
for 10% or more of consolidated net sales during each of the past three fiscal years. In fiscal years 2016, 2015 and 2014, sales
of liquid bleach represented approximately 13%, 14% and 13% of the Company&#146;s consolidated net sales, respectively, approximately
25%, 26%, and 26% of net sales in the Cleaning segment for each such years, respectively, and approximately 27%, 27% and 28% of
net sales in the International segment, respectively. Sales of trash bags represented approximately 13%, 14% and 13% of the Company&#146;s
consolidated net sales in each of the fiscal years 2016, 2015 and 2014, respectively, and approximately 37%, 38% and 36% of net
sales in the Household segment, respectively, for each such years. Sales of charcoal represented approximately 11% of the Company&#146;s
consolidated net sales and approximately 34% of net sales in the Household segment in fiscal years 2016, 2015 and 2014.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Net sales and property, plant and equipment, net, by geographic
area as of and for the fiscal years ended June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom; line-height: normal">
    <td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fiscal</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Year</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>United</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>States</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Foreign</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Company</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 90%"><font style="font: 10pt Times New Roman, Times, Serif">Net sales</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">4,805</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">956</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">5,761</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,609</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,046</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,655</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,466</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,048</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,514</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Property, plant and equipment, net</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">799</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">107</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">906</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">801</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">117</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">918</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8981-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9038-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 33<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8971-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8595-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8380-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8984-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9031-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8538-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8864-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813465056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 21. RELATED PARTY TRANSACTIONS</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company holds various equity investments with ownership
percentages of up to 50% in a number of consumer products businesses, most of which operate outside the United States. The equity
investments, presented in Other assets accounted for under the equity method, were $59 as of the fiscal years ended June 30, 2016
and 2015. The Company has no ongoing capital commitments, loan requirements, guarantees or any other types of arrangements under
the terms of its agreements that would require any future cash contributions or disbursements arising out of an equity investment.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Transactions with the Company&#146;s equity investees typically
represent payments for contract manufacturing and purchases of raw materials. Payments to related parties, including equity investees,
for such transactions during the fiscal years ended June 30, 2016, 2015 and 2014 were $57, $55 and $57, respectively. Receipts
from and ending accounts receivable and payable balances related to the Company&#146;s related parties were not significant during
or as of the end of each of the fiscal years presented.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801546080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED QUARTERLY DATA<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">UNAUDITED QUARTERLY DATA</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 22. UNAUDITED QUARTERLY DATA</b></p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Dollars in millions, except market price and per share data</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="17" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Quarters Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>September 30</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>December 31</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>March 31</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>June 30</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total Year</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 82%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fiscal year ended June 30, 2016</b></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Net sales</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,390</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,345</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,426</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,600</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">5,761</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Cost of products sold</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">765</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">745</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">780</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">873</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">3,163</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Earnings from continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">173</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">151</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">159</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">165</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">648</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">(Losses) earnings from discontinued operations,</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Net earnings</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">172</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">149</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">162</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">165</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">648</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Per common share:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.34</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.16</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.23</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.28</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">5.01</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.01</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.01</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.02</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic net earnings per share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.33</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.15</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.25</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.28</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">5.01</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.32</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.14</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.21</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.92</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.01</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.01</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.02</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted net earnings per share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.31</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.13</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.23</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.92</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Dividends declared per common share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.77</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.77</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.77</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.80</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">3.11</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Market price (NYSE)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;High</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">119.75</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">131.78</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">132.19</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">138.41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">138.41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Low</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">104.26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">114.06</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">122.40</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">119.23</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">104.26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year-end</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">138.39</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fiscal year ended June 30, 2015</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Net sales</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,352</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,345</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,401</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,557</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">5,655</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Cost of products sold</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">774</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">773</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">796</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">847</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">3,190</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Earnings from continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">145</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">128</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">144</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">189</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">606</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Losses from discontinued operations,</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(55</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(26</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Net earnings</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">90</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">125</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">174</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">191</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">580</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Per common share:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.98</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.09</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.46</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.65</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.42</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.02</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.22</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.02</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.20</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic net earnings per share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.70</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.96</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.31</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.48</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.10</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.97</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.08</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.44</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.57</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.42</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.02</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.22</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.02</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.20</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted net earnings per share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.68</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.95</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.46</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.37</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Dividends declared per common share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.77</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">2.99</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr>
    <td colspan="19" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Market price (NYSE)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;High</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">112.70</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">112.65</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">106.36</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">98.31</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">112.70</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Low</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">103.77</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">102.95</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">95.19</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">86.03</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">86.03</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year-end</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">104.02</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68076893&amp;loc=d3e1570-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=68064558&amp;loc=d3e765-108305<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=68064558&amp;loc=d3e725-108305<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813419232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>VALUATION AND QUALIFYING ACCOUNTS AND RESERVES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAndQualifyingAccountsAbstract', window );"><strong>Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">VALUATION AND QUALIFYING ACCOUNTS AND RESERVES</a></td>
<td class="text"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif"><b>VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Dollars
in millions) </b></p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Column A</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Column B</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Column C</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Column D</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Column E</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Additions</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Deductions</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; line-height: normal">
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Description</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Balance at</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>beginning</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>of period</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Charged to</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>costs and</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>expenses</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Credited to</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>costs and</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>expenses</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Credited</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>to other</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>accounts</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Balance at</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>end</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>of period</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 82%"><font style="font: 10pt Times New Roman, Times, Serif">Allowance for doubtful accounts</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year ended June 30, 2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year ended June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year ended June 30, 2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">LIFO allowance</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year ended June 30, 2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(32</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year ended June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(36</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year ended June 30, 2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(40</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(36</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Valuation allowance on deferred tax assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year ended June 30, 2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(37</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year ended June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(51</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year ended June 30, 2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(36</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(25</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(51</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">) </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any allowance and reserve accounts (their beginning and ending balances, as well as a reconciliation by type of activity during the period). Alternatively, disclosure of the required information may be within the footnotes to the financial statements or a supplemental schedule to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6804863088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Nature of Operations and Basis of Presentation</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Nature of Operations and Basis of Presentation</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is principally engaged in the production, marketing
and sales of consumer products through mass retail outlets and grocery, e-commerce channels, wholesale distributors and medical
supply distributors. The consolidated financial statements include the statements of the Company and its wholly owned and controlled
subsidiaries. All significant intercompany transactions and accounts were eliminated in consolidation. Certain prior year reclassifications
were made in the consolidated financial statements and related notes to the consolidated financial statements to conform to the
current year presentation.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Effective September 22, 2014, the Company&#146;s Venezuela
affiliate, Corporaci&#243;n Clorox de Venezuela S.A. (Clorox Venezuela), discontinued its operations. Consequently, the Company
presents the financial results of Clorox Venezuela as a discontinued operation in the consolidated financial statements for all
periods presented herein.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Use of Estimates</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The preparation of these consolidated financial statements
in conformity with generally accepted accounting principles in the United States of America (U.S. GAAP) requires management to
reach opinions as to estimates and assumptions that affect reported amounts and related disclosures. Specific areas requiring management&#146;s
opinion on estimates and judgments include assumptions pertaining to accruals for consumer and trade-promotion programs, stock-based
compensation costs, pension and post-employment benefit costs, future cash flows associated with impairment testing of goodwill
and other long-lived assets, the credit worthiness of customers, uncertain tax positions, tax valuation allowances and legal, environmental
and insurance matters. Actual results could materially differ from estimates and assumptions made.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Cash and Cash Equivalents</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Cash equivalents consist of highly liquid instruments, time
deposits and money market funds with an initial maturity at purchase of three months or less. The fair value of cash and cash equivalents
approximates the carrying amount.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company&#146;s cash position includes amounts held by
foreign subsidiaries and, as a result, the repatriation of certain cash balances from some of the Company&#146;s foreign subsidiaries
could result in additional tax costs in the United States and in certain foreign jurisdictions. However, these cash balances are
generally available without legal restriction to fund local business operations. In addition, a portion of the Company&#146;s cash
balance is held in U.S. dollars by foreign subsidiaries, whose functional currency is their local currency. Such U.S. dollar balances
are reported on the foreign subsidiaries&#146; books, in their functional currency, with the impact from foreign currency exchange
rate differences recorded in Other (income) expense, net. The Company&#146;s cash holdings were as follows as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">249</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">221</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">133</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">142</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">401</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">382</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of June 30, 2016 and 2015, the Company had $4 and $3 of
restricted cash, respectively, which is primarily related to fiscal year 2012 acquisitions. Restricted cash was included in Other
assets as of June 30, 2016 and in Other current assets as of June 30, 2015.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Inventories</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Inventories are stated at the lower of cost or market. When
necessary, the Company provides allowances to adjust the carrying value of its inventory to the lower of cost or market, including
any costs to sell or dispose. Appropriate consideration is given to obsolescence, excessive inventory levels, product deterioration
and other factors in evaluating net realizable value for the purposes of determining the lower of cost or market.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment and Finite-Lived Intangible Assets</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Property, Plant and Equipment and Finite-Lived Intangible
Assets</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Property, plant and equipment and finite-lived intangible
assets are stated at cost. Depreciation and amortization expense are calculated by the straight-line method using the estimated
useful lives or lives determined by lease contracts for the related assets. The table below provides estimated useful lives of
property, plant and equipment by asset classification.</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; width: 99%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Estimated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Useful Lives</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Buildings and leasehold improvements</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10 - 40 years</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Land improvements</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10 - 30 years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Machinery and equipment</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3 - 15 years</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Computer equipment</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3 - 5 years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Capitalized software costs</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3 - 7 years</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Property, plant and equipment and finite-lived intangible
assets are reviewed for impairment whenever events or changes in circumstances occur that indicate that the carrying amount of
an asset (or asset group) may not be fully recoverable. The risk of impairment is initially assessed based on an estimate of the
undiscounted cash flows at the lowest level for which identifiable cash flows exist. Impairment occurs when the carrying value
of the asset exceeds the estimated future undiscounted cash flows generated by the asset. When impairment is indicated, an impairment
charge is recorded for the difference between the carrying value of the asset and its estimated fair market value. Depending on
the asset, estimated fair market value may be determined either by use of a discounted cash flow model or by reference to estimated
selling values of assets in similar condition.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Capitalization of Software Costs</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Capitalization of Software Costs </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company capitalizes certain qualifying costs incurred
in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest
and payroll and payroll-related costs for employees during the application development stage. Internal and external costs incurred
during the preliminary project stage and post implementation-operation stage, mainly training and maintenance costs, are expensed
as incurred. Once the application is substantially complete and ready for its intended use, qualifying costs are amortized on a
straight-line basis over the software&#146;s estimated useful life.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment Review of Goodwill and Indefinite-Lived Intangible Assets</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Impairment Review of Goodwill and Indefinite-Lived Intangible
Assets</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company tests its goodwill, trademarks with indefinite
lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications
during a different interim period that these assets may have become impaired.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">With respect to goodwill, the Company has the option to first
assess qualitative factors such as maturity and stability of the reporting unit, magnitude of excess fair value over carrying value
from the prior year&#146;s impairment testing, other reporting unit specific operating results as well as new events and circumstances
impacting the operations at the reporting unit level. If the result of a qualitative test indicates a potential for impairment
of a reporting unit, a quantitative test is performed. The quantitative test is a two-step process. In the first step, the Company
compares the estimated fair value of the reporting unit to its carrying value. In all instances, the estimated fair value exceeded
the carrying value of the reporting unit. Had the estimated fair value of any reporting unit been less than its carrying value,
the Company would have performed a second step to determine the implied fair value of the reporting unit&#146;s goodwill. If the
carrying amount of a reporting unit&#146;s goodwill had exceeded its implied fair value, an impairment charge would have been recorded
for the difference between the carrying amount and the implied fair value of the reporting unit&#146;s goodwill.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">To determine the fair value of a reporting unit as part of
its quantitative test, the Company uses a discounted cash flow (DCF) approach, as it believes that this approach is the most reliable
indicator of the fair value of its businesses and the fair value of their future earnings and cash flows. Under this approach,
the Company estimates the future cash flows of each reporting unit and discounts these cash flows at a rate of return that reflects
their relative risk. The cash flows used in the DCF are consistent with those the Company uses in its internal planning, which
gives consideration to actual business trends experienced, and the broader business strategy for the long term. The other key estimates
and factors used in the DCF include, but are not limited to, future sales volumes, revenue and expense growth rates, changes in
working capital, foreign exchange rates, currency devaluation, inflation and a perpetuity growth rate. Changes in such estimates
or the application of alternative assumptions could produce different results.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">For trademarks and other intangible assets with indefinite
lives, the Company performs a quantitative analysis to test for impairment. When a quantitative test is performed, the estimated
fair value of an asset is compared to its carrying amount. If the carrying amount of such asset exceeds its estimated fair value,
an impairment charge is recorded for the difference between the carrying amount and the estimated fair value. The Company uses
the income approach to estimate the fair value of its trademarks and other intangible assets with indefinite lives. This approach
requires significant judgments in determining both the assets&#146; estimated cash flows as well as the appropriate discount and
foreign exchange rates applied to those cash flows to determine fair value. Changes in such estimates or the use of alternative
assumptions could produce different results.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Stock-based Compensation</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company grants various nonqualified stock-based compensation
awards to eligible employees, including stock options and performance units.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">For stock options, the Company estimates the fair value of
each award on the date of grant using the Black-Scholes valuation model, which requires management to make estimates regarding
expected option life, stock price volatility and other assumptions. Groups of employees that have similar historical exercise behavior
are considered separately for valuation purposes. The Company estimates stock option forfeitures based on historical data for each
employee grouping. The total number of stock options expected to vest is adjusted by actual and estimated forfeitures. Changes
to the actual and estimated forfeitures will result in a cumulative catch-up adjustment in the period of change. Compensation expense
is recorded by amortizing the grant date fair values on a straight-line basis over the vesting period, adjusted for estimated forfeitures.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company&#146;s performance unit grants provide for the
issuance of common stock to certain managerial staff and executive management if the Company achieves specified performance targets.
The number of shares issued are dependent upon vesting and the achievement of specified performance targets. The performance period
is three years and the payout determination is made at the end of the three-year performance period. Performance unit grants receive
dividends earned during the vesting period upon vesting. The fair value of each grant issued is estimated on the date of grant
based on the current market price of the stock. The total amount of compensation expense recognized reflects estimated forfeiture
rates and the initial assumption that performance goals will be achieved. Compensation expense is adjusted based on management&#146;s
assessment of the probability that performance goals will be achieved. If such goals are not met or it is determined that achievement
of performance goals is not probable, previously recognized compensation expense is trued up in the current period to reflect the
expected payout level. If it is determined that the performance goals will be exceeded, additional compensation expense is recognized,
subject to a cap of 150%.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Cash flows resulting from tax deductions in excess of the
cumulative compensation cost recognized for stock-based payment arrangements (excess tax benefits) are primarily classified as
financing cash inflows.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_EmployeeBenefitsPolicyTextBlock', window );">Employee Benefits</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Employee Benefits</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company accounts for its defined benefit retirement income
and retirement health care plans using actuarial methods<i>.</i> These methods use an attribution approach that generally spreads
&#147;plan events&#148; over the service lives or expected lifetime (for frozen plans) of plan participants. Examples of plan events
are plan amendments and changes in actuarial assumptions such as the expected return on plan assets, discount rate, rate of compensation
increase and certain employee-related factors, such as retirement age and mortality. The principle underlying the attribution approach
is that employees render service over their employment period on a relatively &#147;smooth&#148; basis and, therefore, the statement
of earnings effects of retirement income and retirement health care plans are recognized in the same pattern. One of the principal
assumptions used in the net periodic benefit cost calculation is the expected return on plan assets. The required use of an expected
return on plan assets may result in recognized pension expense or income that differs from the actual returns of those plan assets
in any given year. Over time, however, the goal is for the expected long-term returns to approximate the actual returns and, therefore,
the expectation is that the pattern of income and expense recognition should closely match the pattern of the services provided
by the participants. The Company uses a market-related value method for calculating plan assets for purposes of determining the
amortization of actuarial gains and losses. The differences between actual and expected returns are recognized in the net periodic
benefit cost calculation over the average remaining service period or expected lifetime (for frozen plans) of the plan participants
using the corridor approach. Under this approach, only actuarial gains (losses) that exceed 5% of the greater of the projected
benefit obligation or the market-related value of assets are amortized to pension expense by the Company. In developing its expected
return on plan assets, the Company considers the long-term actual returns relative to the mix of investments that comprise its
plan assets and also develops estimates of future investment returns by considering external sources.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company recognizes an actuarial-based obligation at the
onset of disability for certain benefits provided to individuals after employment, but before retirement, that include medical,
dental, vision, life and other benefits.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EnvironmentalCostsPolicy', window );">Environmental Costs</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Environmental Costs</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is involved in certain environmental remediation
and ongoing compliance activities. Accruals for environmental matters are recorded on a site-by-site basis when it is probable
that a liability has been incurred and based upon a reasonable estimate of the liability. The Company&#146;s accruals reflect the
anticipated participation of other potentially responsible parties in those instances where it is probable that such parties are
legally responsible and financially capable of paying their respective shares of the relevant costs. These accruals are adjusted
periodically as assessment and remediation efforts progress or as additional technical or legal information become available. Actual
costs to be incurred at identified sites in future periods may vary from the estimates, given the inherent uncertainties in evaluating
environmental exposures. The accrual for environmental matters is included in Accounts payable and accrued liabilities and Other
liabilities in the Company&#146;s consolidated balance sheets on an undiscounted basis due to uncertainty regarding the timing
of future payments.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Revenue Recognition</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Sales are recognized as revenue when the risk of loss and
title pass to the customer and when all of the following have occurred: a firm sales arrangement exists, pricing is fixed or determinable
and collection is reasonably assured. Sales are recorded net of allowances for trade promotions, coupons, returns and other discounts.
The Company routinely commits to one-time or ongoing trade-promotion programs with customers and consumer coupon programs that
require the Company to estimate and accrue the expected costs of such programs. Programs include shelf price reductions, end-of-aisle
or in-store displays of the Company&#146;s products and graphics and other trade-promotion activities conducted by the customer.
Coupons are recognized as a liability when distributed based upon expected consumer redemptions. The Company maintains liabilities
related to these programs for the estimated expenses incurred, but not paid, at the end of each period. Trade-promotion and coupon
redemption costs are recorded as a reduction of sales.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company provides an allowance for doubtful accounts based
on its historical experience and ongoing assessment of its customers&#146; credit risk. Receivables were presented net of an allowance
for doubtful accounts of $5 and $4 as of June 30, 2016 and 2015, respectively. Receivables, net, included non-customer receivables
of $9 and $12 as of June 30, 2016 and 2015, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Products Sold</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Cost of Products Sold</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Cost of products sold represents the costs directly related
to the manufacture and distribution of the Company&#146;s products and primarily includes raw materials, packaging, contract manufacturing
fees, shipping and handling, warehousing, package design, depreciation, amortization, direct and indirect labor and operating costs
for the Company&#146;s manufacturing and distribution facilities including salary, benefit costs and incentive compensation, and
royalties and other charges related to the Company&#146;s Glad<sup>&#174;</sup> Venture Agreement (see Note 10).</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Costs associated with developing and designing new packaging
are expensed as incurred and include design, artwork, films and labeling. Expenses for fiscal years ended June 30, 2016, 2015 and
2014 were $11, $11 and $12, respectively, all of which were reflected in Cost of products sold or discontinued operations, as appropriate,
in the consolidated statements of earnings.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Selling and Administrative Expenses</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Selling and Administrative Expenses</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Selling and administrative expenses represent costs incurred
by the Company in generating revenues and managing the business and include market research, commissions and certain administrative
expenses. Administrative expenses include salary, benefits, incentive compensation, professional fees and services, software and
licensing fees and other operating costs associated with the Company&#146;s non-manufacturing, non-research and development staff,
facilities and equipment.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock', window );">Advertising and Research and Development Costs</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Advertising and Research and Development Costs</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company expenses advertising and research and development
costs in the period incurred.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Income Taxes</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company uses the asset and liability method to account
for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to
differences between financial statement amounts and their respective tax basis. Management reviews the Company&#146;s deferred
tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established
when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes
in valuation allowances from period to period are included in the Company&#146;s tax provision in the period of change. In addition
to valuation allowances, the Company provides for uncertain tax positions when such tax positions do not meet certain recognition
thresholds or measurement standards. Amounts for uncertain tax positions are adjusted in quarters when new information becomes
available or when positions are effectively settled.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">U.S. income tax expense and foreign withholding taxes are
provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign
earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change
and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company
accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions and Translation</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Foreign Currency Transactions and Translation</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Local currencies are the functional currencies for substantially
all of the Company&#146;s foreign operations. When the transactional currency is different than the functional currency, transaction
gains and losses are included as a component of Other (income) expense, net. In addition, certain assets and liabilities denominated
in currencies different than a foreign subsidiary&#146;s functional currency are reported on the subsidiary&#146;s books in its
functional currency, with the impact from exchange rate differences recorded in Other (income) expense, net. Assets and liabilities
of foreign operations are translated into U.S. dollars using the exchange rates in effect at the balance sheet date, while income
and expenses are translated at the average monthly exchange rates during the year.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Gains and losses on foreign currency translations are reported
as a component of Other comprehensive income (loss). Deferred taxes are not provided on cumulative translation adjustments where
the Company expects earnings of a foreign subsidiary to be indefinitely reinvested. The income tax effect of currency translation
adjustments related to foreign subsidiaries and joint ventures for which earnings are not considered indefinitely reinvested is
recorded as a component of deferred taxes with an offset to Other comprehensive income (loss).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Derivative Instruments</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company&#146;s use of derivative instruments, principally
swaps, futures and forward contracts, is limited to non-trading purposes and is designed to partially manage exposure to changes
in commodity prices, interest rates and foreign currencies. The Company&#146;s contracts are hedges for transactions with notional
amounts and periods consistent with the related exposures and do not constitute investments independent of these exposures.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The changes in the fair value (i.e., gains or losses) of
a derivative instrument are recorded as either assets or liabilities in the consolidated balance sheets with an offset to net earnings
or Other comprehensive income (loss) depending on whether, for accounting purposes, it has been designated and qualifies as an
accounting hedge and, if so, on the type of hedging relationship. The criteria used to determine if hedge accounting treatment
is appropriate are: (a) formal designation and documentation of the hedging relationship, the risk management objective and hedging
strategy at hedge inception; (b) eligibility of hedged items, transactions and corresponding hedging instrument; and (c) effectiveness
of the hedging relationship both at inception of the hedge and on an ongoing basis in achieving the hedging objectives. For those
derivative instruments designated and qualifying as hedging instruments, the Company must designate the hedging instrument either
as a fair value hedge or as a cash flow hedge. The Company designates its commodity forward and future contracts for forecasted
purchases of raw materials, interest rate forward contracts for forecasted interest payments, and foreign currency forward contracts
for forecasted purchases of inventory as cash flow hedges. During the fiscal years ended June 30, 2016, 2015 and 2014, the Company
had no hedging instruments designated as fair value hedges.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">For derivative instruments designated and qualifying as cash
flow hedges, the effective portion of gains or losses is reported as a component of Other comprehensive income (loss) and reclassified
into earnings in the same period or periods during which the hedged transaction affects earnings. From time to time, the Company
may have contracts not designated as hedges for accounting purposes, for which it recognizes changes in the fair value in the consolidated
statement of earnings in the current period. Cash flows from hedging activities are classified as operating activities in the consolidated
statements of cash flows.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Recently Issued Accounting Standards</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In March 2016, the Financial Accounting Standards Board (FASB)
issued Accounting Standards Update (ASU) No. 2016-09, &#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee
Share-Based Payment Accounting,&#148; which simplifies several aspects of the accounting for share-based payment transactions,
including requiring excess tax benefits and deficiencies to be recognized as income tax benefit or expense in the consolidated
statement of earnings and excess tax benefits and deficiencies to be classified as an operating activity in the consolidated statement
of cash flows. The new guidance is effective for the Company beginning in the first quarter of fiscal year 2018, with early adoption
permitted. The Company is planning to adopt the standard in the first quarter of fiscal year 2017. While the actual benefit realized
may vary significantly given the inherent uncertainty in predicting future share-based transactions, the Company currently estimates
that the adoption will result in approximately a 4 percentage point benefit to the Company&#146;s historical effective tax rate
of 34% to 35% for fiscal year 2017.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In February 2016, the FASB issued ASU No. 2016-02, &#147;Leases
(Topic 842),&#148; which requires lessees to recognize a right-of-use asset and lease liability for all leases with terms of more
than 12 months. Recognition, measurement and presentation will depend on classification as a finance or operating lease. ASU 2016-02
also requires expanded disclosures about leasing arrangements. The new guidance is effective for the Company beginning in the first
quarter of fiscal year 2020, with early adoption permitted. The Company is currently evaluating the impact that adoption of this
guidance will have on its consolidated financial statements.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In November 2015, the FASB issued ASU No. 2015-17, &#147;Income
Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes,&#148; which requires all deferred tax liabilities and assets
to be classified as noncurrent. The Company adopted the standard in the fourth quarter of fiscal year 2016 on a prospective basis
as permitted. Prior period balances have not been retrospectively adjusted.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In April 2015, the Financial Accounting Standards Board (FASB)
issued Accounting Standards Update (ASU) No. 2015-03, &#147;Simplifying the Presentation of Debt Issuance Cost,&#148; which requires
that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the
carrying amount of that debt liability, consistent with debt discounts. The new guidance is effective for the Company beginning
in the first quarter of fiscal year 2017, with early adoption permitted. The Company does not expect the adoption of this guidance
will have a significant impact on its consolidated financial statements.</p>

<p style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">In February 2015, the FASB
issued ASU No. 2015-02,</font> &#147;<font style="font-size: 10pt">Amendments to the Consolidation Analysis,&#148; which changes
the guidance for evaluating whether to consolidate certain legal entities. The amendments modify the evaluation of whether limited
partnerships and similar legal entities are variable interest entities ("VIEs") or voting interest entities. The new guidance is
effective for the Company beginning in the first quarter of fiscal year 2017, with early adoption permitted. The Company does not
expect the adoption of this guidance will have a significant impact on its consolidated financial statements. </font></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In May 2014, the FASB issued ASU No. 2014-09, &#147;Revenue
from Contracts with Customers (Topic 606),&#148; which replaces most existing U.S. GAAP revenue recognition guidance and is intended
to improve and converge with international standards the financial reporting requirements for revenue from contracts with customers.
The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services equal to the
amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional disclosures
about the nature, timing and uncertainty of revenue and cash flows arising from contracts with customers, including information
about significant judgments and changes in judgments. The new guidance is effective for the Company beginning in the first quarter
of fiscal year 2019, with the option to early adopt in the first quarter of fiscal year 2018. The Company is currently evaluating
the impact that adoption of this guidance will have on its consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of (1) advertising costs and (2) research and development costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_AdvertisingAndResearchAndDevelopmentCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_EmployeeBenefitsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the entity's various types of employee benefit plans, including retirement, postretirement and postemployment plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_EmployeeBenefitsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of costs in the period which correspond to the sales and revenue categories presented in the statement of operations. The accounting policy may include the amount and nature of costs incurred, provisions associated with inventories, purchase discounts, freight and other costs included in cost of sales incurred and recorded in the period. This disclosure also includes the nature of costs of sales incurred and recorded in the statement of operations for the period relating to transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 50<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68069731&amp;loc=d3e63676-111659<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41620-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5579240-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5579245-113959<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41675-113959<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=d3e41638-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M)<br> -URI http://asc.fasb.org/extlink&amp;oid=26874127&amp;loc=d3e31137-122693<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13669-110860<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2175709<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13231-110859<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13185-110859<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19379-109286<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6389767&amp;loc=d3e17916-109280<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4492-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4556-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801789376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Components of Cash and Cash Equivalents</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company&#146;s cash holdings were as follows as of June
30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">249</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">221</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">133</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">142</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">401</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; border-bottom: Black 2pt double"><font style="font: 10pt Times New Roman, Times, Serif">382</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock', window );">Useful Lives of Property, Plant and Equipment</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The table below provides estimated useful lives of property,
plant and equipment by asset classification.</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; width: 99%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Estimated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Useful Lives</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Buildings and leasehold improvements</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10 - 40 years</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Land improvements</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10 - 30 years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Machinery and equipment</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3 - 15 years</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Computer equipment</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3 - 5 years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Capitalized software costs</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3 - 7 years</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful Lives Of Property, Plant and Equipment [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_UsefulLivesOfPropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808237680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock', window );">Summary of (losses) gains from discontinued operations</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table provides a summary of gains (losses)
from discontinued operations for Clorox Venezuela and gains (losses) from discontinued operations other than Clorox Venezuela for
the years ended June 30:<b> </b></p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 88%"><font style="font: 10pt Times New Roman, Times, Serif">Operating losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif"><b>-</b></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(23</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exit costs and other related expenses for Clorox Venezuela</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>(2</b></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>)</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(78</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>(2</b></font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>)</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(84</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(23</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Income tax benefit attributable to Clorox Venezuela</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>2</b></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>-</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(55</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(17</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="13">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gains (losses) from discontinued operations other than</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>-</b></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Losses from discontinued operations, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>-</b></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(26</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(21</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">) </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock', window );">Summary of operating losses, asset charges and other costs</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following provides a breakdown of (losses) gains from
discontinued operations for Clorox Venezuela and gains from discontinued operations other than Clorox Venezuela for the fiscal
years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 93%"><font style="font: 10pt Times New Roman, Times, Serif">Operating losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="width: 1%; border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font><font style="font: 10pt Times New Roman, Times, Serif"> &#160;&#160;&#160;&#160;&#160;&#160;(6</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net asset charges:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Inventories</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(11</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property, plant and equipment</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trademark and other intangible assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other exit and business termination costs:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Severance</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Recognition of deferred foreign currency translation loss</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(30</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(10</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(84</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Income tax benefit attributable to Clorox Venezuela</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(55</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="8">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gains from discontinued operations other than</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Losses from discontinued operations, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom-color: black; border-bottom-width: 1pt; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;(26 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and profit or loss reported in discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disposal groups, which provides a breakdown of charges and costs included in losses from discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncurredExitChargesAndCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823171568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESSES ACQUIRED (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed as of Acquisition Date</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table summarizes the estimated fair values
of Renew Life&#146;s assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date. Due
to the timing of the acquisition, the fair value of the assets acquired and liabilities assumed are based on a preliminary valuation
and the Company&#146;s estimates and assumptions are subject to change within the measurement period. The primary areas of the
purchase price that are not yet finalized are related to goodwill and income taxes. The weighted-average estimated useful life
of intangible assets subject to amortization is 15 years.</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Renew Life</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 97%"><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">137</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trademarks</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Customer relationships</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">36</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Property, plant and equipment</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Working capital, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Deferred income taxes</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(61</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Purchase Price</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">290 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6804552400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Inventories consisted of the following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 93%"><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">361</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">316</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Raw materials and packaging</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">111</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">101</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Work in process</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">LIFO allowances</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(32</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(35</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">443</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">385 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813438352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherCurrentAssetsAbstract', window );"><strong>OTHER CURRENT ASSETS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Other Current Assets</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Other current assets consisted of the following as of June
30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 94%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax assets<sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="width: 1%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">99</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">70</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">39</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">72</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">143</font></td></tr>
</table>
<p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"><sup>(a) </sup>The Company prospectively adopted ASU No.
2015-17, "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes," requiring all deferred tax assets and liabilities
to be classified as noncurrent. See Note 1 and 18 for further details.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6646276272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, Plant and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment, Net</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The components of property, plant and equipment, net, consisted
of the following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 93%"><font style="font: 10pt Times New Roman, Times, Serif">Machinery and equipment</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">1,607</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">1,608</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Buildings</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">524</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">515</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Capitalized software costs</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">371</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Land and improvements</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">118</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">122</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Construction in progress</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">112</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">65</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Computer equipment</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">88</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,817</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,757</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Less: Accumulated depreciation and amortization</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,911</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,839</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">906</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">918 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6646325792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract', window );"><strong>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The changes in the carrying amount of goodwill by reportable
segment for the fiscal years ended June 30, 2016 and 2015 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="16" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Goodwill</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Cleaning</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Lifestyle</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Household</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>International</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 83%"><font style="font: 10pt Times New Roman, Times, Serif">Balance June 30, 2014</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">323</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">244</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">85</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">449</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">1,101</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Effect of foreign currency translation</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Balance June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">323</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">244</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">85</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">415</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,067</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Acquisition</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">122</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">15</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">137</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Effect of foreign currency translation</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Balance June 30, 2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">323</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">244</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">207</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">423</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,197 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Schedule of Intangible Assets, Excluding Goodwill</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The changes in the carrying amount of trademarks and other
intangible assets for the fiscal years ended June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>As of June 30, 2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>As of June 30, 2015</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Gross</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Accumulated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amortization</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Net carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Gross</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Accumulated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amortization</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Net carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>amount</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 82%"><font style="font: 10pt Times New Roman, Times, Serif">Trademarks not subject to amortization</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">647</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font> </td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">647</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">524</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">524</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trademarks subject to amortization</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">32</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">33</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other intangible assets:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Technology and product formulae</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">137</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">137</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">133</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">221</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">146</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">75</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">188</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">142</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">46</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,037</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">302</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">735</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">882</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">297</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">585 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Trademarks And Other Intangible Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_GoodwillTrademarksAndOtherIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801791616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Accounts payable and accrued liabilities consisted of the
following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 80%">
<tr>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">490</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">431</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Compensation and employee benefit costs</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">192</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">189</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trade and sales promotion</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">127</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">115</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dividends</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">108</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">103</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">118</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">141</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,035</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">979</font></td></tr>
</table>
<p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"><sup>(a) </sup>Accounts payable and accrued liabilities
were combined into one financial statement line as of June 30, 2016. The change has been retrospectively applied to all periods
presented.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6807633120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Short-term Notes and Loans Payable</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Notes and loans payable, which mature in less than one year,
included the following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">Commercial paper</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">522</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">93</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign borrowings</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">523</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">95 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Long-Term Debt, Net of Unamortized Discounts or Premiums</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Long-term debt, carried at face value net of unamortized
discounts or premiums, included the following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 94%"><font style="font: 10pt Times New Roman, Times, Serif">Senior unsecured notes and debentures:</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3.55%, $300 due November 2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">300</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.95%, $400 due October 2017</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">400</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">399</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3.80%, $300 due November 2021</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">298</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">298</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3.05%, $600 due September 2022</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">599</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">599</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3.50%, $500 due December 2024</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">500</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">500</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,797</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,096</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Less: Current maturities of long-term debt</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(300</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Long-term debt</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,797</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,796 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Borrowing Capacity Under Other Financing Arrangements</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company&#146;s borrowing capacity under other financing
arrangements as of June 30 was as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">Revolving credit facility</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">1,100</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">1,100</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign credit lines</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other credit lines</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">18</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">18</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,128</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,129 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801676768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Schedule of Other Liabilities</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Other liabilities consisted of the following as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">Employee benefit obligations</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">335</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">299</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Venture agreement terminal obligation, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">302</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">294</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">40</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">107</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">119</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">784</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">750 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813025664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table summarizes the fair value of Company&#146;s
assets and liabilities for which disclosure of fair value is required as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="font-size: 10pt; line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Assets</b></font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Balance sheet classification</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fair value</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>hierarchy</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>level</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Estimated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fair</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Value</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Carrying</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Estimated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fair</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Value</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Investments including money market funds</font></td>
    <td nowrap="nowrap" style="width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: center; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: center; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">234</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">234</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">212</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">212</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Time deposits</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">84</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">84</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other current assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other current assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trust assets for nonqualified deferred</font><br /><font style="font: 10pt Times New Roman, Times, Serif">compensation plans</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">335</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">335</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="17">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Liabilities</b></font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Notes and loans payable</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Notes and loans payable <sup>(b)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">523</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">523</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">95</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">95</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; vertical-align: middle"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable and</font><br /><font style="font: 10pt Times New Roman, Times, Serif">accrued liabilities</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; vertical-align: middle"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable and</font><br /><font style="font: 10pt Times New Roman, Times, Serif">accrued liabilities</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; vertical-align: middle"><font style="font: 10pt Times New Roman, Times, Serif">Current maturities of long-term debt and</font><br /><font style="font: 10pt Times New Roman, Times, Serif">Long-term debt</font></td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Current maturities of long-</font><br /><font style="font: 10pt Times New Roman, Times, Serif">term debt and Long-term</font><br /><font style="font: 10pt Times New Roman, Times, Serif">debt <sup>(c)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,797</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,922</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,096</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,137</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,325</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,450</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,199</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,240</font></td></tr>
</table>
<table cellspacing="0" cellpadding="0" border="0">
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 7.5pt Times New Roman, Times, Serif">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td style="width: 100%"><font style="font: 7.5pt Times New Roman, Times, Serif">Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</font></td></tr>
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 7.5pt Times New Roman, Times, Serif">(b)</font></td>
    <td><font style="font: 7.5pt Times New Roman, Times, Serif">Notes and loan payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.</font></td></tr>
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 7.5pt Times New Roman, Times, Serif">(c)</font></td>
    <td><font style="font: 7.5pt Times New Roman, Times, Serif">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2. </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock', window );">Effects of Derivative Instruments Designated as Hedging Instruments on OCI</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Gains (losses)</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>recognized in other comprehensive net loss</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 86%"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest rate derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(12</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(18</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(14</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">) </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Gains (losses) reclassified from accumulated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>other comprehensive net loss and recognized</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>in net earnings</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 86%"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest rate derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(18</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">- </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments and Fair Value Measurements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6648512992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND OTHER COMMITMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LeasesAndOtherCommitmentsAbstract', window );"><strong>LEASES AND OTHER COMMITMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock', window );">Schedule of future minimum annual lease commitments required under existing non-cancelable operating and capital lease agreements</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The future minimum annual lease commitments required under
the Company&#146;s existing non-cancelable operating and capital lease agreements as of June 30, 2016, were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 60%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Year</b></font></td>
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Operating</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>leases</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Capital</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>leases</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 90%"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">49</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">32</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Thereafter</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">135</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;328</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock', window );">Schedule of Purchase Obligations</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of June 30, 2016, the Company&#146;s purchase obligations
were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Year</b></font></td>
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Purchase</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Obligations</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 96%"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">150</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">37</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Thereafter</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">256 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_LeasesAndOtherCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases And Other Commitments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_LeasesAndOtherCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases and capital leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ScheduleOfFutureMinimumRentalPaymentsForOperatingAndCapitalLeaseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unconditional purchase obligations that are not recognized as a liability on the balance sheet, including the nature and significant terms of an unconditional purchase obligation; the amount of the fixed and determinable portion of the obligation as of the date of the latest balance sheet presented in the aggregate and, if determinable, for each of the five succeeding fiscal years; the nature of any variable components of the obligation; the amount purchased under the obligation (for example, the take-or-pay or throughput contract) for the reporting period; and may include the amount of imputed interest necessary to reduce the obligation to present value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6646427344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock', window );">Schedule of Share Repurchases under Authorized Programs</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Share repurchases under authorized programs were as follows
during the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(in 000's)</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(in 000's)</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; padding-top: 2pt; border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(in 000's)</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 86%"><font style="font: 10pt Times New Roman, Times, Serif">Open-market purchase programs</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="width: 1%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Evergreen Program</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">254</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,151</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">434</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">260</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,046</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;254</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,151</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;434</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;260</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,046 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsDeclaredTableTextBlock', window );">Schedule of Dividends Declared and Paid</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Dividends per share declared and paid, respectively, during
the fiscal years ended June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Dividends per share declared</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;3.11</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;2.99</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;2.87</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dividends per share paid</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.08</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.96</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.84 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Changes in Accumulated other comprehensive net (losses) income
by component were as follows for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="padding-bottom: 2pt; text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Foreign currency</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>adjustments</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Net</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>unrealized</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>gains</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(losses) on</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>derivatives</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Pension and</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>postretirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>benefit</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>adjustments</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 2pt; text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="text-align: center; border-bottom: Black 1pt solid"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Accumulated</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Other</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Comprehensive</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Income</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance June 30, 2013</b></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">(209</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(30</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(128</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(367</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive (loss) income before</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassifications</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(26</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(15</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(57</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;comprehensive net losses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income tax benefit (expense)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(11</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net current period other comprehensive income (loss)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(37</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(9</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(50</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance June 30, 2014</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(246</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(39</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(132</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(417</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive (loss) income before</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassifications</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(92</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(18</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(29</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(139</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;comprehensive net losses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Recognition of deferred foreign currency translation</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;loss</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income tax benefit (expense)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net current period other comprehensive income (loss)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(54</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(14</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(17</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(85</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance June 30, 2015</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(300</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(53</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(149</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(502</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive (loss) income before</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassifications</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(43</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(38</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(88</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;comprehensive net losses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">18</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">18</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income tax benefit (expense)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(10</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net current period other comprehensive income (loss)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(53</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(24</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(68</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance June 30, 2016</b></font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(353</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(44</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(173</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(570</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">) </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of shares repurchases under authorized programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ScheduleOfShareRepurchasesUnderAuthorizedProgramsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsDeclaredTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsDeclaredTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813493312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS PER SHARE (EPS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares</a></td>
<td class="text"><p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif">The following is the reconciliation of
the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted
net EPS for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; width: 95%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129,472</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">130,310</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129,558</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dilutive effect of stock options and other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,245</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,466</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,184</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,717</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">132,776</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,742</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="6">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Antidilutive stock options and other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">42</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">- </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808367904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-based Compensation</a></td>
<td class="text"><p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif">Compensation cost and the related income
tax benefit recognized for stock-based compensation plans were classified as indicated below for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Cost of products sold</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Selling and administrative expenses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">35</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Research and development costs</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total compensation cost</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;45</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;32</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;36</font></td></tr>
<tr>
    <td colspan="9">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Related income tax benefit</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Stock Option Valuation Assumptions</a></td>
<td class="text"><p style="text-align: left; margin-bottom: 6pt; font: 10pt Times New Roman, Times, Serif">The fair value of each stock option award
granted during fiscal years 2016, 2015 and 2014 was estimated on the date of grant using the Black-Scholes valuation model and
assumptions noted in the following table:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; width: 95%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 1%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected life</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.6 years</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.6 to 5.8 years</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.7 years</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average expected life</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.6 years</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.7 years</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5.7 years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">16.43% to 17.3%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">16.3% to 18.6%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">18.4% to 18.5%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average volatility</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">17.2%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">16.6%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">18.5%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.3% to 1.7%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.4% to 2.0%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.8% to 1.9%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average risk-free interest rate</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.7%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.9%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1.8%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dividend yield</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.5% to 2.8%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.8% to 3.4%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3.4%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average dividend yield</font></td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.8%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3.3%</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">3.4% </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Details of the Company&#146;s stock option activities are
summarized below:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Number of</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(In thousands)</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Weighted-</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Average</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Exercise</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Price</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>per Share</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Average</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Remaining</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Contractual</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Life</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Aggregate</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Intrinsic</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Value</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 89%"><font style="font: 10pt Times New Roman, Times, Serif">Options outstanding as of June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">8,357</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">76</font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: center; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">7 years</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">236</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,317</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;112</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2,633</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">69</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Cancelled</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(214</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">95</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Options outstanding as of June 30, 2016</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,827</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">85</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">7 years</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;366</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="11">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Options vested as of June 30, 2016</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,555</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">228 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Stock Award Activity</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">A summary of the status of the Company&#146;s restricted
stock awards is presented below:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Number of</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(In thousands)</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Weighted-Average</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Grant Date</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fair Value</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>per Share</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 94%"><font style="font: 10pt Times New Roman, Times, Serif">Restricted stock awards as of June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">18</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">91</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(9</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">88</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">106</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Restricted stock awards as of June 30, 2016</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">108 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock', window );">Summary of Performance Units Award Activity</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">A summary of the status of the Company&#146;s performance
unit awards is presented below:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Number of</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>(In thousands)</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Weighted-Average</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Grant Date</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fair Value</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>per Share</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 95%"><font style="font: 10pt Times New Roman, Times, Serif">Performance unit awards as of June 30, 2015</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,123</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">286</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">92</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Distributed</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(377</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">70</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(80</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">87</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Performance unit awards as of June 30, 2016</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">952</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">90</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="6">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Performance units vested and deferred as of June 30, 2016</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">157</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">58 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813455680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME) EXPENSE, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock', window );">Major Components of Other (Income) Expense, Net</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The major components of Other (income) expense, net, for
the fiscal years ended June 30 were:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 89%"><font style="font: 10pt Times New Roman, Times, Serif">Income from equity investees</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(15</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(14</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest income</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Low income housing partnership gains, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange transaction losses, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Amortization of trademarks and other intangible assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Intangible asset impairment charges</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(10</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">) </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherIncomeAndOtherExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6804878160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock', window );">Provision for Income Taxes on Continuing Operations by Tax Jurisdiction</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The provision for income taxes on continuing operations,
by tax jurisdiction, consisted of the following for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 85%"><font style="font: 10pt Times New Roman, Times, Serif">Current</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Federal</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">254</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">265</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">247</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; State</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">31</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">28</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Foreign</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total current</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">330</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">331</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">326</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Deferred</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Federal</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(19</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; State</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Foreign</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total deferred</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(21</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">335</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">315</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">305 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Earnings from Continuing Operations before Income Taxes, by Tax Jurisdiction</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The components of earnings from continuing operations before
income taxes, by tax jurisdiction, consisted of the following for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">United States</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">900</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">829</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">754</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">92</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">130</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">983</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">921</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">884 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">A reconciliation of the statutory federal income tax rate
to the Company&#146;s effective tax rate on continuing operations follows for the fiscal years ended June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 88%"><font style="font: 10pt Times New Roman, Times, Serif">Statutory federal tax rate</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">35.0</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">35.0</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">35.0</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">State taxes (net of federal tax benefits)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Tax differential on foreign earnings</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.5</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Domestic manufacturing deduction</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2.4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2.1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2.3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Change in valuation allowance</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.5</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other differences</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1.6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1.1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1.0</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Effective tax rate</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34.1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34.2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34.6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">% </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of Net Deferred Tax Assets (Liabilities)</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The components of net deferred tax assets (liabilities) as
of June 30 are shown below:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 12pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 90%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax assets <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Compensation and benefit programs</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">193</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">191</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Basis difference related to Venture Agreement</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Accruals and reserves</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">43</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Inventory costs</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Net operating loss and tax credit carryforwards</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">48</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">61</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subtotal</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">380</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">385</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Valuation allowance</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(37</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Total deferred tax assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">343</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">351</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr>
    <td colspan="9">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax liabilities <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Fixed and intangible assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(325</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(277</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Low-income housing partnerships</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(23</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(22</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Unremitted foreign earnings</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(25</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(24</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Total deferred tax liabilities</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160; (389</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160; (330</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Net deferred tax assets (liabilities)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(46</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 7.5pt Times New Roman, Times, Serif"><sup>(a) </sup>The Company prospectively adopted ASU No.
2015-17, "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes," requiring all deferred tax assets and liabilities
to be classified as noncurrent. See Note 1 for further details.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Changes in Deferred Tax Asset Valuation Allowance</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Details of the valuation allowance were as follows as of
June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 12pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Valuation allowance at beginning of year</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(51</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net decrease/(increase) for other foreign deferred tax assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">15</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net decrease/(increase) for foreign net operating loss carryforwards and tax credits</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Valuation allowance at end of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160; (37</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160; (34</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Reconciliation of Gross Unrecognized Tax Benefits</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following is a reconciliation of the beginning and ending
amounts of the Company&#146;s gross unrecognized tax benefits:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 85%"><font style="font: 10pt Times New Roman, Times, Serif">Unrecognized tax benefits at beginning of year</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">71</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">69</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gross increases - tax positions in prior periods</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gross decreases - tax positions in prior periods</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(8</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gross increases - current period tax positions</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gross decreases - current period tax positions</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Lapse of applicable statute of limitations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Settlements</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Unrecognized tax benefits at end of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">37</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">71</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A schedule that reflects the provision for income taxes on continuing operations, by tax jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ProvisionForIncomeTaxesByTaxJurisdictionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Valuation Allowance<br> -URI http://asc.fasb.org/extlink&amp;oid=6528051<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6822650560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract', window );"><strong>Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock', window );">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Summarized information for the Company&#146;s retirement
income and retirement health care plans as of and for the fiscal years ended June 30 is as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Health Care</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 80%"><font style="font: 10pt Times New Roman, Times, Serif">Change in benefit obligations:</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Projected benefit obligation as of beginning of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">639</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">641</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Service cost</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Interest cost</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Actuarial loss (gain)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">51</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Plan amendments</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Translation and other adjustments</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Benefits paid</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(42</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(38</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Projected benefit obligation as of end of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">673</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">639</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">47</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Change in plan assets:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Fair value of assets as of beginning of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">409</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">432</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Actual return on plan assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Employer contributions</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">31</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Benefits paid</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(42</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(38</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Translation and other adjustments</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Fair value of plan assets as of end of year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">423</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">409</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Accrued benefit cost, net funded status</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(250</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(230</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(47</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr>
    <td colspan="17">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of Amounts Recognized in the Balance Sheets</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 80%"><font style="font: 10pt Times New Roman, Times, Serif">Amount recognized in the balance sheets consists of:</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 2%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Pension benefit assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Current accrued benefit liability</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(14</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Non-current accrued benefit liability</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(237</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(216</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(44</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(42</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Accrued benefit cost, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(250</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(230</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(47</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Accumulated Benefit Obligations in Excess of Plan Assets</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Retirement income plans with ABO in excess of plan assets
as of June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Pension Plans</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Other</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Plans</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 84%"><font style="font: 10pt Times New Roman, Times, Serif">Projected benefit obligation</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">575</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">538</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; 76</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; 80</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Accumulated benefit obligation</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">574</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">538</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">80</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Fair value of plan assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">399</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">385</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The net costs of the retirement income and health care plans
for the fiscal years ended June 30 included the following components:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="11" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="10" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Health Care</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 72%"><font style="font: 10pt Times New Roman, Times, Serif">Service cost</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest cost</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">27</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected return on plan assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160; (17</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160; (20</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160; (25</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Amortization of unrecognized items&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160; (3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160; (4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">20</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">) </font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock', window );">Schedule of Items Not Yet Recognized as a Component of Postretirement Expense</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Items not yet recognized as a component of postretirement
expense as of June 30, 2016, consisted of:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Health Care</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 91%"><font style="font: 10pt Times New Roman, Times, Serif">Net actuarial loss (gain)</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">296</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (13</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Prior service benefit</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net deferred income tax (assets) liabilities</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (111</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Accumulated other comprehensive loss (income)</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">185</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(12</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Summary of Amounts Recognized in Accumulated Other Comprehensive Net Losses</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Net actuarial loss (gain) recorded in Accumulated other comprehensive
net (losses) income for the fiscal year ended June 30, 2016, included the following:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Health Care</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 90%"><font style="font: 10pt Times New Roman, Times, Serif">Net actuarial loss (gain) as of beginning of year</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 264</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (17</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Amortization during the year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(10</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Loss (gain) during the year</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">42</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net actuarial loss (gain) as of end of year</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">296</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(13</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Weighted Average Assumptions Used</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Weighted-average assumptions used to estimate the actuarial
present value of benefit obligations as of June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Health Care</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 84%"><font style="font: 10pt Times New Roman, Times, Serif">Discount rate</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">3.42</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">4.20</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">3.42</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">4.16</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Rate of compensation increase</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.92</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.37</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">n/a</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">n/a</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Weighted-average assumptions used to estimate the net periodic
pension and other postretirement benefit costs as of June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Income</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 88%"><font style="font: 10pt Times New Roman, Times, Serif">Discount rate</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">4.20</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">4.05</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">4.39</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Rate of compensation increase</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.37</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.46</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.44</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected return on plan assets</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.34</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5.28</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6.61</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr>
    <td colspan="10">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement Health Care</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2014</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Discount rate</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.16</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.00</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.33</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Expected benefit payments for the Company&#146;s pension
and other postretirement plans as of June 30, 2016, were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom; line-height: normal; padding-top: 2pt; padding-bottom: 2pt">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Income</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Retirement</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Health Care</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 93%"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">39</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">39</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">39</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">39</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Fiscal years 2022 through 2026</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">193</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Target Allocation and Weighted Average Allocation of Plan Assets</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The target allocations and weighted average asset allocations
by asset category of the investment portfolio for the Company&#146;s domestic retirement income plans as of June 30 were:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>% Target Allocation</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>% of Plan Assets</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 85%"><font style="font: 10pt Times New Roman, Times, Serif">U.S. equity</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">International equity</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Fixed income</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Plan Assets Carried at Fair Value</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table sets forth by level within the fair value
hierarchy, the retirement income plans&#146; assets carried at fair value as of June 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2016</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Level 1</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Level 2</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 89%"><font style="font: 10pt Times New Roman, Times, Serif">Cash equivalents</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="width: 2%; border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="width: 1%; border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Common collective trusts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Bond funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">307</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">307</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; International equity funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">56</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">56</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Domestic equity funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">44</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">44</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Real estate fund</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total common collective trusts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">421</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">421</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total assets at fair value</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">421</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">423</font></td></tr>
<tr>
    <td colspan="10">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="8" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>2015</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Level 1</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Level 2</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Cash equivalents</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Common collective trusts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Bond funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">295</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">295</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; International equity funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">59</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">59</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Domestic equity funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160; Real estate fund</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total common collective trusts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">406</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">406</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total assets at fair value</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">406</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160; </font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">409</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(b)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of accumulated benefit obligations and fair values of plan assets of pension plans and/or other employee benefit plans where the accumulated benefit obligation exceeds the fair value of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the assumptions used to determine for pension plans and/or other employee benefit plans the benefit obligation and net benefit cost, including assumed discount rates, rate increase in compensation increase, and expected long-term rates of return on plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6646289856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Selected Financial Information Relating to the Company's Segments</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; line-height: normal">
    <td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fiscal</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Year</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Cleaning</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Household</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Lifestyle</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>International</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Corporate</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Company</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">Net sales</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2016</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,912</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,862</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">990</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">997</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">$&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5,761</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,824</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,794</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">950</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,087</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5,655</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,776</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,709</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">936</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1,093</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5,514</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Earnings (losses) from continuing</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;operations before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">511</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">428</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">251</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">66</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(273</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">983</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">445</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">375</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">257</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(235</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">921</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">428</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">326</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">258</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">99</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(227</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">884</font></td></tr>
<tr>
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">Income from equity investees</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">15</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">15</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">14</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">14</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">13</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">13</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">883</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,092</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">880</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,057</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">606</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,518</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">876</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">725</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">860</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,057</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">646</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,164</font></td></tr>
<tr>
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">Capital expenditures</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">44</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">83</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">18</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">24</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">172</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">35</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">50</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">11</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">25</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">125</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">37</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">53</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">11</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">31</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">137</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Depreciation and amortization</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">61</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">60</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">165</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">67</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">24</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">169</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">67</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">25</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">177</font></td></tr>
<tr>
    <td colspan="22" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">Significant noncash charges included</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">&#160;&#160;&#160;&#160;&#160;&#160;&#160;in earnings (losses) from continuing</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">&#160;&#160;&#160;&#160;&#160;&#160;&#160;operations before income taxes:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #ffffff">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share-based compensation</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">10</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">8</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">21</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">45</font></td></tr>
<tr style="vertical-align: bottom; background-color: #ffffff">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">8</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">7</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">4</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">32</font></td></tr>
<tr style="vertical-align: bottom; background-color: #ffffff">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">11</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">9</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">5</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">10</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif; color: #000000">36</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Net Sales and Long-Lived Assets By Geographic Area</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Net sales and property, plant and equipment, net, by geographic
area as of and for the fiscal years ended June 30 were as follows:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom; line-height: normal">
    <td nowrap="nowrap" style="text-align: left; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fiscal</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Year</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>United</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>States</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Foreign</b></font></td>
    <td nowrap="nowrap" style="text-align: center; padding-top: 2pt; padding-bottom: 2pt">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center; padding-top: 2pt; padding-bottom: 2pt"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total</b></font><br /><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Company</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 90%"><font style="font: 10pt Times New Roman, Times, Serif">Net sales</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">4,805</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">956</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">5,761</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,609</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,046</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,655</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,466</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,048</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,514</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Property, plant and equipment, net</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">799</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">107</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">906</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">801</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">117</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">918</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8813-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813384176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED QUARTERLY DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Unaudited Quarterly Data</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Dollars in millions, except market price and per share data</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="17" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Quarters Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>September 30</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>December 31</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>March 31</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>June 30</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Total Year</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 82%"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fiscal year ended June 30, 2016</b></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Net sales</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,390</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,345</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,426</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,600</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">5,761</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Cost of products sold</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">765</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">745</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">780</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">873</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">3,163</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Earnings from continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">173</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">151</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">159</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">165</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">648</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">(Losses) earnings from discontinued operations,</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Net earnings</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">172</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">149</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">162</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">165</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">648</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Per common share:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.34</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.16</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.23</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.28</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">5.01</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.01</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.01</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.02</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic net earnings per share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.33</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.15</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.25</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.28</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">5.01</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.32</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.14</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.21</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.92</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.01</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.01</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.02</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted net earnings per share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.31</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.13</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.23</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.92</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Dividends declared per common share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.77</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.77</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.77</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.80</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">3.11</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Market price (NYSE)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;High</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">119.75</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">131.78</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">132.19</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">138.41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">138.41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Low</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">104.26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">114.06</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">122.40</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">119.23</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">104.26</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year-end</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">138.39</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif"><b>Fiscal year ended June 30, 2015</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Net sales</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,352</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,345</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,401</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1,557</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">5,655</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Cost of products sold</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">774</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">773</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">796</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">847</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">3,190</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Earnings from continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">145</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">128</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">144</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">189</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">606</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Losses from discontinued operations,</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(55</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(26</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Net earnings</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">90</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">125</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">174</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">191</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">580</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Per common share:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.12</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.98</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.09</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.46</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.65</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.42</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.02</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.22</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.02</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.20</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basic net earnings per share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.70</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.96</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.31</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.48</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.45</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.10</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.97</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.08</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.44</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.57</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Discontinued operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.42</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.02</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.22</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.02</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">(0.20</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Diluted net earnings per share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.68</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.95</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.30</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">1.46</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">4.37</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Dividends declared per common share</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.74</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">0.77</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">2.99</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr>
    <td colspan="19" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">Market price (NYSE)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;High</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">112.70</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">112.65</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">106.36</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">98.31</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">112.70</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Low</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">103.77</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">102.95</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">95.19</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">86.03</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">86.03</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 7.5pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Year-end</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 7.5pt Times New Roman, Times, Serif">104.02</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)-(j)<br> -URI http://asc.fasb.org/extlink&amp;oid=68076893&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808324048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Cash Holdings) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent', window );">U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent</a></td>
<td class="nump">$ 249<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries', window );">Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries', window );">U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries', window );">Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Total</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="nump">$ 329<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Noncurrent restricted cash</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Current restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non US dollar cash balances held by non US dollar functional currency subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_NonUsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non US dollar cash balances held by US dollar functional currency subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_NonUsDollarBalancesHeldByUsDollarFunctionalCurrencySubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>US dollar cash balances held by non US dollar functional currency subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_UsDollarBalancesHeldByNonUsDollarFunctionalCurrencySubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>US dollar cash balances held by US dollar functional currency subsidiaries and by parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_UsDollarBalancesIncludingThoseBalancesHeldByUsDollarFunctionalCurrencySubsidiariesAndParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash and equivalents whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6805258448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Estimated Useful Lives of Property, Plant and Equipment) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and leasehold improvements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and leasehold improvements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember', window );">Land Improvements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember', window );">Land Improvements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=clx_CapitalizedSoftwareCostsMember', window );">Capitalized software costs [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=clx_CapitalizedSoftwareCostsMember', window );">Capitalized software costs [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=clx_CapitalizedSoftwareCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=clx_CapitalizedSoftwareCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6804744000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Additional Information) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($) </div>
<div>item</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap', window );">Additional compensation expense, target cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach', window );">Minimum percentage for calculating the amortization of actuarial gains and losses under the corridor approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NontradeReceivablesCurrent', window );">Non-customer receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_PackagingDevelopmentAndDesignCosts', window );">Packaging development and design costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges', window );">Number of hedging instruments designated as fair value hedges | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.10%<span></span>
</td>
<td class="nump">34.20%<span></span>
</td>
<td class="nump">34.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember', window );">Scenario, Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement', window );">Percentage point benefit from adoption of ASU 2016-09</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cap percentage of target recognized as additional compensation expense if performance goals are exceeded.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of hedging instruments designated as fair value hedges held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeNumberOfInstrumentsHeldDesignatedAsFairValueHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum percentage of the greater of the projected benefit obligation or the market-related asset value that actuarial gains and losses must exceed in order to be amortized to pension expense under the corridor approach for purposes of determining the amortization of actuarial gains and losses related to the entity's employee benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_MinimumPercentageForCalculatingAmortizationOfActuarialGainsAndLossesUnderCorridorApproach</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_PackagingDevelopmentAndDesignCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate costs expensed during the period for developing and designing packaging, including design, artwork, films, and labeling.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_PackagingDevelopmentAndDesignCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage point benefit to historical effective tax rate from adoption of Accounting Standards Update (ASU) No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_PercentagePointBenefitToHistoricalEffectiveTaxRateFromAdoptionOfNewAccountingPronouncement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823280512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Total gain (losses) from discontinued operations, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (55)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized tax benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Gross unrecognized tax benefits recognized upon the expiration of the applicable statute of limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember', window );">Clorox Venezuela [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Operating losses from discontinued operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense', window );">Exit costs and other related expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Total losses from discontinued operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit attributable to discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Total gain (losses) from discontinued operations, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember', window );">Other Discontinued Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Total gain (losses) from discontinued operations, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized tax benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Gross unrecognized tax benefits recognized upon the expiration of the applicable statute of limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65896914&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6804934720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Summary of Operating Losses, Asset Charges and Other Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Total gain (losses) from discontinued operations, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (55)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember', window );">Clorox Venezuela [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Operating losses before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Total losses from discontinued operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit attributable to discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Total gain (losses) from discontinued operations, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract', window );"><strong>Net asset charges:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets', window );">Trademark and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract', window );"><strong>Other exit and business termination costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DisposalGroupIncludingDiscontinuedOperationSeverance', window );">Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses', window );">Recognition of deferred foreign currency translation loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DisposalGroupIncludingDiscontinuedOperationOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember', window );">Other Discontinued Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Total gain (losses) from discontinued operations, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of loss recognized for the write-down to fair value of intangible assets, less cost to sell, of a disposal group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DiscontinuedOperationProvisionForLossGainOnDisposalIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of loss recognized for the write-down to fair value of Inventories, less cost to sell, of a disposal group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DiscontinuedOperationProvisionForLossGainOnDisposalInventoriesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of loss recognized for the write-down to fair value of other assets, less cost to sell, of a disposal group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DiscontinuedOperationProvisionForLossGainOnDisposalOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of loss recognized for the write-down to fair value of property, plant and equipment, less cost to sell, of a disposal group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DiscontinuedOperationProvisionForLossGainOnDisposalPropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DisposalGroupIncludingDiscontinuedOperationOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous expense attributable to disposal group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DisposalGroupIncludingDiscontinuedOperationOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DisposalGroupIncludingDiscontinuedOperationOtherTerminationCostsAndOperatingResultsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DisposalGroupIncludingDiscontinuedOperationSeverance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of severance expense attributable to disposal group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DisposalGroupIncludingDiscontinuedOperationSeverance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65896914&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6646516640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Narrative) (Details) - Clorox Venezuela [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract', window );"><strong>Major Classes of Remaining Assets and Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet', window );">Net asset position</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember', window );">Corporate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract', window );"><strong>Major Classes of Remaining Assets and Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets', window );">Tax asset balances</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets net of liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DisposalGroupIncludingDiscontinuedOperationAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationBalanceSheetDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721533-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6804897040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESSES ACQUIRED (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>May 02, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Amount paid for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,761<span></span>
</td>
<td class="nump">5,655<span></span>
</td>
<td class="nump">5,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Estimated fair values of assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 1,197<span></span>
</td>
<td class="nump">$ 1,197<span></span>
</td>
<td class="nump">$ 1,067<span></span>
</td>
<td class="nump">$ 1,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=clx_RenewLifeHoldingsCorporationMember', window );">Renew Life [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1', window );">Business acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  02,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of business acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Amount paid for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">The weighted-average estimated useful life of intangible assets subject to amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Estimated fair values of assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Working capital, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=clx_RenewLifeHoldingsCorporationMember', window );">Renew Life [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Estimated fair values of assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=clx_RenewLifeHoldingsCorporationMember', window );">Renew Life [Member] | Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Estimated fair values of assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e845-128460<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Acquisition Date<br> -URI http://asc.fasb.org/extlink&amp;oid=6919109<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e848-128460<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=clx_RenewLifeHoldingsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=clx_RenewLifeHoldingsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808072848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 361<span></span>
</td>
<td class="nump">$ 316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials and packaging</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">LIFO allowances</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 443<span></span>
</td>
<td class="nump">$ 385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfLIFOInventory', window );">Percentage of inventory valued with the LIFO method</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfLIFOInventoryLiquidationOnIncome', window );">Effect on earnings of the liquidation of LIFO layers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfLIFOInventoryLiquidationOnIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of liquidating LIFO (last in first out) inventory layers on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SAB Topic 11.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100079-122729<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100079-122729<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6386917&amp;loc=d3e99609-122727<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfLIFOInventoryLiquidationOnIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfLIFOInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfLIFOInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6804825840">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT ASSETS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetCurrent', window );">Deferred tax assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company prospectively adopted ASU No. 2015-17 "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes" requiring all deferred tax assets and liabilities to be classified as noncurrent.  See Note 1 and 18 for further details.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31928-109318<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31958-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823748096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT, NET (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 2,817<span></span>
</td>
<td class="nump">$ 2,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(1,911)<span></span>
</td>
<td class="num">(1,839)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">906<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationNonproduction', window );">Depreciation and amortization expense related to property, plant and equipment, net</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_NonCashCapitalExpenditures', window );">Non-cash capital expenditures</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">1,607<span></span>
</td>
<td class="nump">1,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=clx_CapitalizedSoftwareCostsMember', window );">Capitalized software costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember', window );">Land improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Asset retirement obligations</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_NumberOfLeasedProperties', window );">Number of leased properties | item</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationLiabilitiesIncurred', window );">Asset retirement obligation liabilities incurred</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember', window );">Equipment held under capital leases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_NonCashCapitalExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of non-cash capital expenditures incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_NonCashCapitalExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_NumberOfLeasedProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information pertaining to number of leased properties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_NumberOfLeasedProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Asset Retirement Obligation<br> -URI http://asc.fasb.org/extlink&amp;oid=6505190<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset retirement obligations incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationNonproduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationNonproduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=clx_CapitalizedSoftwareCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=clx_CapitalizedSoftwareCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndLandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6805046368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible assets</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future amortization expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2017</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2018</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2019</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2020</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2021</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible assets impairment charge</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ImpairmentOfTrademarks', window );">Trademark impairment</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ImpairmentOfTrademarks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of trademarks to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ImpairmentOfTrademarks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6804759376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 1,067<span></span>
</td>
<td class="nump">$ 1,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition</a></td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Effect of foreign currency translation</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">1,197<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember', window );">Cleaning [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Effect of foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember', window );">Lifestyle [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Effect of foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember', window );">Household [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition</a></td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Effect of foreign currency translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember', window );">International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">415<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Effect of foreign currency translation</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 423<span></span>
</td>
<td class="nump">$ 415<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e961-128460<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6802056976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 1,037<span></span>
</td>
<td class="nump">$ 882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">302<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">585<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherIntangibleAssetsAxis=clx_TechnologyAndProductFormulaeMember', window );">Technology And product formulae [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherIntangibleAssetsAxis=clx_OtherIntangibleAssetsOtherMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Trademarks not subject to amortization</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherIntangibleAssetsAxis=clx_TechnologyAndProductFormulaeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherIntangibleAssetsAxis=clx_TechnologyAndProductFormulaeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherIntangibleAssetsAxis=clx_OtherIntangibleAssetsOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherIntangibleAssetsAxis=clx_OtherIntangibleAssetsOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6646516640">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 490<span></span>
</td>
<td class="nump">$ 431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation and employee benefit costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">192<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_AccruedTradeAndSalesPromotionCostsCurrent', window );">Trade and sales promotion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">127<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">108<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">118<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,035<span></span>
</td>
<td class="nump">$ 979<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Accounts payable and accrued liabilities were combined into one financial statement line as of June 30, 2016. The change has been retrospectively applied to all periods presented.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_AccruedTradeAndSalesPromotionCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for trade and sales promotion costs of the entity. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_AccruedTradeAndSalesPromotionCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808784960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2015</div></th>
<th class="th"><div>Jan. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LongTermAndShortTermDebtLineItems', window );"><strong>Long-term and Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repayments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod', window );">Weighted average interest rate on notes and loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">2.05%<span></span>
</td>
<td class="nump">0.97%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps', window );">Weighted average interest rates on long-term debt, including the effect of interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.37%<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
<td class="nump">4.56%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average effective interest rates on long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.41%<span></span>
</td>
<td class="nump">4.31%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,128<span></span>
</td>
<td class="nump">$ 1,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term debt maturities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LongTermAndShortTermDebtLineItems', window );"><strong>Long-term and Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtWeightedAverageInterestRate', window );">Weighted average effective interest rate on short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.82%<span></span>
</td>
<td class="nump">0.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=clx_RevolvingLineOfCreditMember', window );">Revolving Line of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LongTermAndShortTermDebtLineItems', window );"><strong>Long-term and Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of credit facility, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct.  01,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility, amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=clx_ForeignAndOtherCreditLinesMember', window );">Foreign and Other Credit Lines [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LongTermAndShortTermDebtLineItems', window );"><strong>Long-term and Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility, amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit facility, remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes3.55PercentMember', window );">Senior notes with an annual fixed interest rate of 3.55% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LongTermAndShortTermDebtLineItems', window );"><strong>Long-term and Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repayments</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate</a></td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes3.50PercentMember', window );">Senior notes with an annual fixed interest rate of 3.50% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LongTermAndShortTermDebtLineItems', window );"><strong>Long-term and Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Long-term debt issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Long-term debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 15,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Long-term debt payment terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Interest on the notes is payable semi-annually in June and December<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes5.00PercentMember', window );">Senior notes with an annual fixed interest rate of 5.00% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LongTermAndShortTermDebtLineItems', window );"><strong>Long-term and Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repayments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_LongTermAndShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term And Short-Term Debt [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_LongTermAndShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the calculation as of the balance sheet date of average interest rate incurred during the reporting period weighted by the amount of short-term debt outstanding by type or by instrument during that time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShortTermDebtWeightedAverageInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the calculation as of the balance sheet date of the average interest rate weighted by the amount of long-term debt outstanding by type or by instrument at that time, including the effect of interest rate swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_WeightedAverageInterestRatesOnLongTermDebtIncludingEffectOfInterestRateSwaps</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of short-term debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=clx_RevolvingLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=clx_RevolvingLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=clx_ForeignAndOtherCreditLinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=clx_ForeignAndOtherCreditLinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes3.55PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes3.55PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes3.50PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes3.50PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes5.00PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes5.00PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6802049904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Notes and Loans Payable) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="nump">$ 523<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=clx_ForeignBorrowingsMember', window );">Foreign Borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=clx_ForeignBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=clx_ForeignBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808503360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Long-term Debt, Net of Unamortized Discounts or Premiums) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate on long-term debt</a></td>
<td class="nump">4.41%<span></span>
</td>
<td class="nump">4.31%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,797<span></span>
</td>
<td class="nump">$ 2,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current maturities of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, noncurrent</a></td>
<td class="nump">$ 1,797<span></span>
</td>
<td class="nump">$ 1,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember', window );">Senior Unsecured Long-Term Notes and Debentures; 3.55%, $300 Due November 2015 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate on long-term debt</a></td>
<td class="nump">3.55%<span></span>
</td>
<td class="nump">3.55%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember', window );">Senior Unsecured Long-Term Notes and Debentures; 5.95%, $400 Due October 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate on long-term debt</a></td>
<td class="nump">5.95%<span></span>
</td>
<td class="nump">5.95%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember', window );">Senior Unsecured Long-Term Notes and Debentures; 3.80%, $300 Due November 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate on long-term debt</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember', window );">Senior Unsecured Long-Term Notes and Debentures; 3.05%, $600 Due November 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate on long-term debt</a></td>
<td class="nump">3.05%<span></span>
</td>
<td class="nump">3.05%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 599<span></span>
</td>
<td class="nump">$ 599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember', window );">Senior Unsecured Long-Term Notes and Debentures; 3.50%, $500 Due December 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate on long-term debt</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueOctoberTwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueNovemberTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueSeptemberTwoThousandTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=clx_SeniorUnsecuredLongTermNotesAndDebenturesInstrumentDueDecemberTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6809556064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Borrowing Capacity Under Other Financing Arrangements) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td>
<td class="nump">$ 1,128<span></span>
</td>
<td class="nump">$ 1,129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=clx_ForeignCreditLinesMember', window );">Foreign Credit Lines [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=clx_OtherCreditLinesMember', window );">Other Credit Lines [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=clx_ForeignCreditLinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=clx_ForeignCreditLinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=clx_OtherCreditLinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=clx_OtherCreditLinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6822783408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2012</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_EmployeeBenefitObligationsNoncurrent', window );">Employee benefit obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 335<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_VentureAgreementNetTerminalObligation', window );">Venture agreement terminal obligation, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 784<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement', window );">Interest in the joint venture by venture partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_VentureAgreementRenewalOption', window );">Venture agreement renewal option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement', window );">Venture agreement terminal obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities', window );">Proceeds from sale-leasebacks, net of transaction costs</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_SaleLeasebackTransactionLeaseTerm', window );">Lease term</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain', window );">Deferred gain on sale-lease back, noncurrent portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_EmployeeBenefitObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the carrying amounts as of the balance sheet date of the portions of obligations to employees under pension, postretirement, and health benefit plans that are due beyond one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_EmployeeBenefitObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership interest by the venture partner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_MaximumPercentageOfNoncontrollingInterestInVentureAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SaleLeasebackTransactionLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of the lease related to the assets being leased-back in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SaleLeasebackTransactionLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of the deferred gain recorded in connection with the sale-leaseback transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SaleLeasebackTransactionNoncurrentPortionOfDeferredGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated fair value of the venture partner's 20% interest required to be purchased by the Company at termination of venture agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_TotalEstimatedLiabilityForRepurchaseOfInterestForCashAtFairValuePerTerminationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_VentureAgreementNetTerminalObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of the contractual obligation to purchase the venture partners interest upon termination of the venture arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_VentureAgreementNetTerminalObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_VentureAgreementRenewalOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The venture agreement renewal option between the Company and the venture partner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_VentureAgreementRenewalOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow after closing and debt issuance costs received by a seller-lessee in a sale-leaseback recognized in investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=28365400&amp;loc=d3e51843-112757<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 55<br> -Paragraph 50<br> -URI http://asc.fasb.org/extlink&amp;oid=28365400&amp;loc=d3e51831-112757<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=28365400&amp;loc=d3e51840-112757<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808967904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss', window );">Non-qualified deferred compensation plan assets, changes in fair value of trust assets</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_InterestRateForwardContractsSettlement', window );">Settlement of interest rate forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_SettlementOfInterestRateForwardContract', window );">Payment to settle interest rate forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivatives</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits', window );">Derivative instruments subject to contractually defined counterparty liability position limits</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Estimated amount of the existing net loss to be reclassified into earnings in the next 12 months</a></td>
<td class="num">$ (11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes3.50PercentMember', window );">Senior notes with an annual fixed interest rate of 3.50% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DerivativeIntrumentsMaximumContractDuration', window );">Maximum contract duration</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amounts</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarginDepositAssets', window );">Cash margin balances amount</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts [Member] | Jet Fuel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amounts</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts [Member] | Soybean Oil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amounts</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DerivativeIntrumentsMaximumContractDuration', window );">Maximum contract duration</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amounts</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod', window );">Amortization period of settlement payment</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period of settlement payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative instruments subject to contractually defined counterparty liability position limits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeIntrumentsMaximumContractDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum contract duration for a derivative instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeIntrumentsMaximumContractDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_InterestRateForwardContractsSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payment to counterparties to settle an interest rate cash flow hedge in connection with the issuance of long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_InterestRateForwardContractsSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SettlementOfInterestRateForwardContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment for the settlement of interest rate forward contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SettlementOfInterestRateForwardContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 12<br> -Section 13<br> -Sentence Column B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=35736893&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13495-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarginDepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarginDepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized holding gain (loss) recognized in the income statement for investments in debt and equity securities and other forms of securities that provide ownership interests classified as trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Trading Securities<br> -URI http://asc.fasb.org/extlink&amp;oid=6526789<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=27723805&amp;loc=d3e24584-111560<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes3.50PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=clx_SeniorNotes3.50PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeNatureAxis=clx_JetFuelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeNatureAxis=clx_JetFuelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeNatureAxis=clx_SoybeanOilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeNatureAxis=clx_SoybeanOilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808776320">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Financial Instruments Measured at Fair Value) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 368<span></span>
</td>
<td class="nump">$ 335<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureRecurring', window );">Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,325<span></span>
</td>
<td class="nump">2,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">368<span></span>
</td>
<td class="nump">335<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureRecurring', window );">Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,450<span></span>
</td>
<td class="nump">2,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents [Member] | Level 1 [Member] | Carrying Value [Member] | Investments including money market funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">234<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents [Member] | Level 1 [Member] | Estimated Fair Value [Member] | Investments including money market funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">234<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents [Member] | Level 2 [Member] | Carrying Value [Member] | Time Deposits [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">79<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Time Deposits [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">79<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets [Member] | Level 1 [Member] | Carrying Value [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Derivative assets designated as hedging instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets [Member] | Level 1 [Member] | Estimated Fair Value [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Derivative assets designated as hedging instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets [Member] | Level 2 [Member] | Carrying Value [Member] | Foreign exchange derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Derivative assets designated as hedging instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Foreign exchange derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Derivative assets designated as hedging instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets [Member] | Level 1 [Member] | Carrying Value [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Trust assets for nonqualified deferred compensation plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">52<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets [Member] | Level 1 [Member] | Estimated Fair Value [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Trust assets for nonqualified deferred compensation plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">52<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets [Member] | Level 2 [Member] | Carrying Value [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Derivative assets designated as hedging instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Derivative assets designated as hedging instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes and loans payable [Member] | Level 2 [Member] | Carrying Value [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureRecurring', window );">Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">523<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes and loans payable [Member] | Level 2 [Member] | Estimated Fair Value [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureRecurring', window );">Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">523<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities [Member] | Level 2 [Member] | Carrying Value [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue', window );">Derivative liabilities designated as hedging instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities [Member] | Level 2 [Member] | Carrying Value [Member] | Foreign exchange derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue', window );">Derivative liabilities designated as hedging instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue', window );">Derivative liabilities designated as hedging instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Foreign exchange derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue', window );">Derivative liabilities designated as hedging instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member] | Level 2 [Member] | Carrying Value [Member] | Current maturities of long-term debt and Long-term debt [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureRecurring', window );">Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">1,797<span></span>
</td>
<td class="nump">2,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Current maturities of long-term debt and Long-term debt [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureRecurring', window );">Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 1,922<span></span>
</td>
<td class="nump">$ 2,137<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Notes and loan payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Assets and Liabilities Measured on Recurring Basis [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureRecurring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value on a recurring basis by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureRecurring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all liability derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureRecurring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregation of the liabilities reported on the balance sheet measured at fair value on a recurring basis by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureRecurring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823189408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gains (losses) recognized in other comprehensive net loss</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (18)<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gains (losses) reclassified from accumulated other comprehensive net loss and recognized in net earnings</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gains (losses) recognized in other comprehensive net loss</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gains (losses) reclassified from accumulated other comprehensive net loss and recognized in net earnings</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gains (losses) recognized in other comprehensive net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gains (losses) reclassified from accumulated other comprehensive net loss and recognized in net earnings</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gains (losses) recognized in other comprehensive net loss</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gains (losses) reclassified from accumulated other comprehensive net loss and recognized in net earnings</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624177-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6798858624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONTINGENCIES AND GUARANTEES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherContingenciesAndGuaranteesAbstract', window );"><strong>OTHER CONTINGENCIES AND GUARANTEES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_SiteContingencyAgreedPercentageOfCostSharing', window );">Percentage of liability for aggregate remediation and associated costs, other than legal fees</a></td>
<td class="nump">24.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_RemediationPeriod', window );">Remediation period</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LetterOfCreditBorrowingCapacity', window );">Letter of credit</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit, amount outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_LetterOfCreditBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_LetterOfCreditBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherContingenciesAndGuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherContingenciesAndGuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_RemediationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_RemediationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SiteContingencyAgreedPercentageOfCostSharing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SiteContingencyAgreedPercentageOfCostSharing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6395460&amp;loc=d3e13647-108346<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6805190400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES AND OTHER COMMITMENTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LeasesAndOtherCommitmentsAbstract', window );"><strong>LEASES AND OTHER COMMITMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent expense for all operating leases</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2017</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2018</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2019</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2020</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2021</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Capital leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent', window );">2017</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears', window );">2018</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears', window );">2019</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationAbstract', window );"><strong>Future purchase obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary', window );">2017</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary', window );">2018</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary', window );">2019</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary', window );">2020</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary', window );">2021</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears', window );">Thereafter</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount', window );">Total</a></td>
<td class="nump">$ 256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_LeasesAndOtherCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases And Other Commitments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_LeasesAndOtherCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fixed and determinable portion of the unrecorded unconditional purchase obligation maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fixed and determinable portion of the unrecorded unconditional purchase obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fixed and determinable portion of the unrecorded unconditional purchase obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fixed and determinable portion of the unrecorded unconditional purchase obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fixed and determinable portion of the unrecorded unconditional purchase obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fixed and determinable portion of the unrecorded unconditional purchase obligation maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808159952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareRepurchaseProgramsLineItems', window );"><strong>Share Repurchase Programs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased</a></td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">4,016<span></span>
</td>
<td class="nump">3,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=clx_OpenMarketProgramMember', window );">Open-market program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareRepurchaseProgramsLineItems', window );"><strong>Share Repurchase Programs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized repurchase amount</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount</a></td>
<td class="nump">750<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember', window );">Evergreen Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareRepurchaseProgramsLineItems', window );"><strong>Share Repurchase Programs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased</a></td>
<td class="nump">2,151<span></span>
</td>
<td class="nump">4,016<span></span>
</td>
<td class="nump">3,046<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShareRepurchaseProgramsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShareRepurchaseProgramsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=clx_OpenMarketProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=clx_OpenMarketProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801710416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Common Stock Dividends) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share</a></td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 0.77<span></span>
</td>
<td class="nump">$ 0.77<span></span>
</td>
<td class="nump">$ 0.77<span></span>
</td>
<td class="nump">$ 0.77<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 3.11<span></span>
</td>
<td class="nump">$ 2.99<span></span>
</td>
<td class="nump">$ 2.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.08<span></span>
</td>
<td class="nump">$ 2.96<span></span>
</td>
<td class="nump">$ 2.84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6822711056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">$ (502)<span></span>
</td>
<td class="num">$ (417)<span></span>
</td>
<td class="num">$ (367)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(88)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax', window );">Amounts reclassified from accumulated other comprehensive net losses</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax', window );">Recognition of deferred foreign currency translation loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income (loss)</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">(570)<span></span>
</td>
<td class="num">(502)<span></span>
</td>
<td class="num">(417)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(246)<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax', window );">Amounts reclassified from accumulated other comprehensive net losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax', window );">Recognition of deferred foreign currency translation loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Income tax benefit (expense)</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income (loss)</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">(353)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="num">(246)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Net unrealized gain (losses) on derivatives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax', window );">Amounts reclassified from accumulated other comprehensive net losses</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax', window );">Recognition of deferred foreign currency translation loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Income tax benefit (expense)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income (loss)</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension and postretirement benefit adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">(149)<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax', window );">Amounts reclassified from accumulated other comprehensive net losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax', window );">Recognition of deferred foreign currency translation loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Income tax benefit (expense)</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income (loss)</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">$ (173)<span></span>
</td>
<td class="num">$ (149)<span></span>
</td>
<td class="num">$ (132)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e709-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004921&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive (income) loss related to net period benefit cost (credit) for pension and other postretirement defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6441202&amp;loc=d3e80720-113993<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6693689936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermIntercompanyLoansMember', window );">Long term intercompany loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntercompanyForeignCurrencyBalanceLineItems', window );"><strong>Intercompany Foreign Currency Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax', window );">Other comprehensive loss before reclassifications</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current period adjustment resulting from gains and losses on intercompany foreign currency transactions that are of a long-term-investment nature because settlement is not planned or anticipated in the foreseeable future.  Resulting from the entities to the transaction being consolidated, combined, or accounted for by the equity method in the reporting entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6939497&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32157-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntercompanyForeignCurrencyBalanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntercompanyForeignCurrencyBalanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermIntercompanyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermIntercompanyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801843232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS PER SHARE (EPS) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Shares Outstanding - Basic</a></td>
<td class="nump">129,472<span></span>
</td>
<td class="nump">130,310<span></span>
</td>
<td class="nump">129,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of stock options and other</a></td>
<td class="nump">2,245<span></span>
</td>
<td class="nump">2,466<span></span>
</td>
<td class="nump">2,184<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Shares Outstanding - Diluted</a></td>
<td class="nump">131,717<span></span>
</td>
<td class="nump">132,776<span></span>
</td>
<td class="nump">131,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares excluded from calculation of diluted net EPS</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1500-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6804705088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2012</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock-based compensation plans, shares authorized to issue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Stock option plan, additional shares authorized</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions', window );">Cash received from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap', window );">Additional compensation expense, target cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=clx_DeferredStockUnitsForNonemployeeDirectorsMember', window );">Deferred Stock Units for Nonemployee Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredStockUnitsForNonemployeeDirectorsGranted', window );">Deferred stock units for nonemployee directors granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends', window );">Deferred stock units for nonemployee directors reinvested dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredStockUnitsForNonemployeeDirectorsDistributed', window );">Deferred stock units for nonemployee directors distributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate', window );">Deferred stock units for nonemployee directors granted weighted average fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate', window );">Deferred stock units for nonemployee directors reinvested weighted average fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate', window );">Deferred stock units for nonemployee directors distributed weighted average fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding', window );">Deferred stock units for nonemployee directors outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate', window );">Deferred stock units for nonemployee directors outstanding weighted average fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value per share of options or awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.21<span></span>
</td>
<td class="nump">$ 9.65<span></span>
</td>
<td class="nump">$ 9.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, weighted-average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, weighted-average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128.91<span></span>
</td>
<td class="nump">$ 95.67<span></span>
</td>
<td class="nump">$ 89.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested awards outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per share of nonvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Awards vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, weighted-average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92.35<span></span>
</td>
<td class="nump">$ 89.75<span></span>
</td>
<td class="nump">$ 84.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested awards outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">794,000<span></span>
</td>
<td class="nump">944,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per share of nonvested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95.18<span></span>
</td>
<td class="nump">$ 81.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Awards vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue', window );">Weighted-average grant date fair value per share of vested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_VestedAwardsWerePaidByIssuanceOfShares', window );">Vested awards paid by the issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_VestedStockAwardsDeferred', window );">Vested stock awards deferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cap percentage of target recognized as additional compensation expense if performance goals are exceeded.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_CompensationExpensePerformanceGoalsExceededTargetPercentageCap</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredStockUnitsForNonemployeeDirectorsDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred stock units for nonemployee directors distributed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredStockUnitsForNonemployeeDirectorsDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average grant date fair value of the deferred stock units for nonemployee directors dividends distributed during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredStockUnitsForNonemployeeDirectorsDistributedWeightedAverageFairValueOnGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredStockUnitsForNonemployeeDirectorsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred stock units for nonemployee directors granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredStockUnitsForNonemployeeDirectorsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average grant date fair value of the deferred stock units for nonemployee directors granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredStockUnitsForNonemployeeDirectorsGrantedWeightedAverageFairValueOnGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares of deferred stock units for nonemployee directors outstanding as of the end of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredStockUnitsForNonemployeeDirectorsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average grant date fair value of the deferred stock units for nonemployee directors outstanding as of the end of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredStockUnitsForNonemployeeDirectorsOutstandingWeightedAverageFairValueOnGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred stock units for nonemployee directors reinvested dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average grant date fair value of the deferred stock units for nonemployee directors dividends reinvested during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredStockUnitsForNonemployeeDirectorsReinvestedWeightedAverageFairValueOnGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_VestedAwardsWerePaidByIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total grant date fair value of the vested shares that were paid by issuance of stocks during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_VestedAwardsWerePaidByIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_VestedStockAwardsDeferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total grant date fair value of the vested shares that were deferred during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_VestedStockAwardsDeferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received by the entity during the annual period from exercises of stock or unit options and conversion of similar instruments granted under equity-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share weighted average intrinsic value of equity-based compensation awards vested. Excludes stock and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under an established share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=clx_DeferredStockUnitsForNonemployeeDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=clx_DeferredStockUnitsForNonemployeeDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6816376944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Compensation Cost and Related Income Tax Benefit) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Related income tax benefit</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and administrative expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total recognized tax benefit related to compensation cost for equity-based payment arrangements recognized in income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823221696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Assumptions Utilized in the Valuation in Calculating the Compensation Expense for Stock Options Granted) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum', window );">Expected life, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum', window );">Expected life, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm', window );">Expected life</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted average expected life</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">16.43%<span></span>
</td>
<td class="nump">16.30%<span></span>
</td>
<td class="nump">18.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">17.30%<span></span>
</td>
<td class="nump">18.60%<span></span>
</td>
<td class="nump">18.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted-average volatility</a></td>
<td class="nump">17.20%<span></span>
</td>
<td class="nump">16.60%<span></span>
</td>
<td class="nump">18.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted-average risk-free interest rate</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum', window );">Dividend yield, minimum</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum', window );">Dividend yield, maximum</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate', window );">Weighted-average dividend yield</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award fair value assumptions expected dividend rate in one year maximum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award fair value assumptions expected dividend rate in one year minimum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateInOneYearMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award fair value assumptions weighted average expected dividend.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expected term of share-based compensation awards, in ''PnYnMnDTnHnMnS'' format, for example, ''P1Y5M13D'' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedLifeTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTermMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average expected volatility rate of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6798871872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Summary of Stock Option Activity) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance</a></td>
<td class="nump">8,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(2,633)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancelled</a></td>
<td class="num">(214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance</a></td>
<td class="nump">6,827<span></span>
</td>
<td class="nump">8,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options vested</a></td>
<td class="nump">3,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options vested</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Average remaining contractual life of options outstanding</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual life of options vested</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding</a></td>
<td class="nump">$ 366<span></span>
</td>
<td class="nump">$ 236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options vested</a></td>
<td class="nump">$ 228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6651968544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Summary of Restricted Stock Award Activity) (Details) - Restricted Stock [Member] - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning balance</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending balance</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted</a></td>
<td class="nump">128.91<span></span>
</td>
<td class="nump">$ 95.67<span></span>
</td>
<td class="nump">$ 89.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, ending balance</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6810748480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Summary of Performance Stock Award Activity) (Details) - Performance Units [Member] - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, beginning balance</a></td>
<td class="nump">1,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Distributed</a></td>
<td class="num">(377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, ending balance</a></td>
<td class="nump">952<span></span>
</td>
<td class="nump">1,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred', window );">Vested and deferred</a></td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted</a></td>
<td class="nump">92.35<span></span>
</td>
<td class="nump">$ 89.75<span></span>
</td>
<td class="nump">$ 84.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue', window );">Distributed</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare', window );">Outstanding, ending balance</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue', window );">Vested and deferred</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for distributed equity-based awards issued during the period on other than stock (or unit) option plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsDistributedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under a share-based award plan other than a stock option plan that were vested and deferred during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodVestedAndDeferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options vested and deferred in period weighted average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferredInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of vested and nonvested awards on equity-based plans excluding option plans outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823146656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER (INCOME) EXPENSE, NET (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income from equity investees</a></td>
<td class="num">$ (15)<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest Income</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LowIncomeHousingPartnershipGainsLosses', window );">Low income housing partnership gains, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange transaction losses, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_AmortizationOfTrademarksAndOtherIntangibleAssets', window );">Amortization of trademarks and other intangible assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_MiscellaneousOtherIncomeExpense', window );">Other</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Cash proceeds from sale of property</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on sale of property</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ImpairmentOfTrademarks', window );">Trademark impairment</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_AmortizationOfTrademarksAndOtherIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of trademarks and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_AmortizationOfTrademarksAndOtherIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ImpairmentOfTrademarks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of trademarks to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ImpairmentOfTrademarks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_LowIncomeHousingPartnershipGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Low-income housing partnership (gains) losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_LowIncomeHousingPartnershipGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_MiscellaneousOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the sum of miscellaneous other nonoperating income and expense recognized by the entity in the period that is not otherwise specified.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_MiscellaneousOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30700-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66022249&amp;loc=d3e33749-111570<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808422384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems', window );"><strong>Tax Credit and Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earning of certain foreign subsidiaries</a></td>
<td class="nump">$ 216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability', window );">Federal income tax liability on unremitted earnings</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions', window );">Realized and recorded excess tax benefits</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open tax year</a></td>
<td class="text">2012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties related to uncertain tax positions</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalties of income tax expense (benefit)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Potential benefits which, if recognized, would affect the effective tax rate on earnings</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized tax benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Gross unrecognized tax benefits recognized upon the expiration of the applicable statute of limitations</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember', window );">Other Discontinued Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized tax benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Gross unrecognized tax benefits recognized upon the expiration of the applicable statute of limitations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">U.S. [Member] | Earliest tax year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems', window );"><strong>Tax Credit and Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax credit carryforwards, expiration</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">U.S. [Member] | Latest tax year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems', window );"><strong>Tax Credit and Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax credit carryforwards, expiration</a></td>
<td class="text">Jun. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign [Member] | Subject to Expiration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems', window );"><strong>Tax Credit and Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign [Member] | Latest tax year [Member] | Subject to Expiration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems', window );"><strong>Tax Credit and Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Net operating loss carryforwards, expiration</a></td>
<td class="text">Jun. 30,  2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=clx_ForeignMember', window );">Foreign [Member] | Not Subject to Expiration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems', window );"><strong>Tax Credit and Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=clx_ForeignMember', window );">Foreign [Member] | Earliest tax year [Member] | Subject to Expiration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems', window );"><strong>Tax Credit and Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Net operating loss carryforwards, expiration</a></td>
<td class="text">Jun. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=clx_ForeignTaxCreditCarryforwardMember', window );">Foreign Tax Credit Carryforward [Member] | U.S. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems', window );"><strong>Tax Credit and Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=clx_ForeignTaxCreditCarryforwardMember', window );">Foreign Tax Credit Carryforward [Member] | Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems', window );"><strong>Tax Credit and Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardExpirationDate', window );">Tax credit carryforwards, expiration</a></td>
<td class="text">Jun. 30,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=clx_ForeignTaxCreditCarryforwardMember', window );">Foreign Tax Credit Carryforward [Member] | Foreign [Member] | Not Subject to Expiration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems', window );"><strong>Tax Credit and Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the deferred tax liability which was not recognized because of the exceptions to comprehensive recognition of deferred taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredTaxLiabilityNotRecordedAmountOfUnrecognizedDeferredTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_TaxCreditAndOperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Credit and Operating Loss Carryforwards [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_TaxCreditAndOperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax effects of employee stock option transactions that are recognized differently for financial reporting and tax purposes, occurring during the period and charged or credited directly to shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=65880886&amp;loc=d3e23586-113945<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65880886&amp;loc=d3e23594-113945<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=65896914&amp;loc=d3e39076-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Carryforwards<br> -URI http://asc.fasb.org/extlink&amp;oid=6506874<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the tax credit carryforward, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 995<br> -SubTopic 740<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6503627&amp;loc=d3e59836-110443<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28200-109314<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ExpirationPeriodAxis=clx_SubjectToExpirationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ExpirationPeriodAxis=clx_SubjectToExpirationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=clx_ForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=clx_ForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ExpirationPeriodAxis=clx_NotSubjectToExpirationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ExpirationPeriodAxis=clx_NotSubjectToExpirationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=clx_ForeignTaxCreditCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=clx_ForeignTaxCreditCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6810970272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Provision for Income Taxes by Tax Jurisdiction and Domestic and Foreign Earnings before Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 265<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">335<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Earnings from continuing operations before income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">829<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings from continuing operations before income taxes</a></td>
<td class="nump">$ 983<span></span>
</td>
<td class="nump">$ 921<span></span>
</td>
<td class="nump">$ 884<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6802112752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Effective Income Tax Rate Reconciliation) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal tax rate</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes (net of federal tax benefits)</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Tax differential on foreign earnings</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities', window );">Domestic manufacturing deduction</a></td>
<td class="num">(2.40%)<span></span>
</td>
<td class="num">(2.10%)<span></span>
</td>
<td class="num">(2.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other differences</a></td>
<td class="num">(1.60%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">34.10%<span></span>
</td>
<td class="nump">34.20%<span></span>
</td>
<td class="nump">34.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for qualified production activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6802200656">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Components of Net Deferred Tax Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2"><div>Jun. 30, 2016</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Compensation and benefit programs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 191<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement', window );">Basis difference related to Venture Agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals and reserves</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">43<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign', window );">Net operating loss and tax credit carryforwards</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">48<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">41<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">54<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">61<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Subtotal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">380<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">385<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(37)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(34)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (51)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">343<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">351<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets', window );">Fixed and intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(325)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(277)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships', window );">Low-income housing partnerships</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(23)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Unremitted foreign earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(16)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(25)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(389)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(330)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets (liabilities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (46)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company prospectively adopted ASU No. 2015-17 "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes" requiring all deferred tax assets and liabilities to be classified as noncurrent.  See Note 1 for further details.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax effect as of the balance sheet date of the amount of the estimated future tax reductions attributable to the difference between the tax basis and the generally accepted accounting principles basis of a company's venture investment which will decrease future taxable income when such basis difference reverses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredTaxAssetsBasisDifferenceRelatedToVentureAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards and foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date for deferred tax consequences attributable to taxable temporary differences between tax and GAAP reporting for the entity's low income housing partnerships.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredTaxLiabilitiesLowIncomeHousingPartnerships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount as of the balance sheet date of the estimated future tax effects attributable to the difference between the tax basis of capital assets and intangible assets and the basis of capital assets and intangible assets computed in accordance with generally accepted accounting principles. The difference in basis, attributable to different capitalization of costs, depreciation, or amortization methodologies, impairment charges, or other reasons will increase future taxable income when such basis difference is realized. Capital assets include but are not limited to assets such as land, real estate, leasehold improvements, machinery and equipment and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DeferredTaxLiabilitiesPlantAndEquipmentAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiaries and other recognized entities not within the country of domicile of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801680864">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Valuation Allowance) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance at beginning of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (34)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets', window );">Net decrease/(increase) for other foreign deferred tax assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits', window );">Net decrease/(increase) for foreign net operating loss carryforwards and tax credits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance at end of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (37)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (34)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company prospectively adopted ASU No. 2015-17 "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes" requiring all deferred tax assets and liabilities to be classified as noncurrent.  See Note 1 for further details.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized resulting from foreign net operating loss carryforwards and tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForForeignNetOperatingLossCarryforwardsAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized resulting from other foreign deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ValuationAllowanceDeferredTaxAssetNetIncreaseDecreaseForOtherForeignDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6644725984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Unrecognized Tax Benefits) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at beginning of year</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases - tax positions in prior periods</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Gross decreases - tax positions in prior periods</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross increases - current period tax positions</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions', window );">Gross decreases - current period tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapse of applicable statute of limitations</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_UnrecognizedTaxBenefitsSettlements', window );">Settlements</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at end of year</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_UnrecognizedTaxBenefitsSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of increases or decreases in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_UnrecognizedTaxBenefitsSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Unrecognized Tax Benefit<br> -URI http://asc.fasb.org/extlink&amp;oid=6527854<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6822570976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 07, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 596<span></span>
</td>
<td class="nump">$ 559<span></span>
</td>
<td class="nump">$ 563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Aggregate cost of the defined contribution plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanNameAxis=clx_CompanyFourZeroOneKPlanMember', window );">Company 401(k) plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Aggregate cost of the defined contribution plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanNameAxis=clx_InternationalDefinedContributionPlanMember', window );">International Defined Contribution Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Aggregate cost of the defined contribution plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_DomesticQualifiedRetirementIncomePlansMember', window );">Domestic Qualified Retirement Income Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Discretionary contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_DomesticQualifiedRetirementIncomePlansMember', window );">Domestic Qualified Retirement Income Plans [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Discretionary contributions</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_DomesticNonQualifiedRetirementIncomePlansMember', window );">Domestic Non-Qualified Retirement Income Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Discretionary contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_MedicalMember', window );">Medical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate', window );">Assumed ultimate trend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_PrescriptionDrugsMember', window );">Prescription Drugs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate', window );">Assumed ultimate trend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCarePlanMember', window );">Retirement Health Care Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate', window );">Assumed ultimate trend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanYearThatRateReachesUltimateTrendRate', window );">Ultimate trend, year reached</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_BasisPointIncreaseDecrease', window );">Basis point increase | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCarePlanMember', window );">Retirement Health Care Plan [Member] | Scenario, Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss', window );">Net actuarial gains (losses) as a component of net periodic benefit cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomePlanMember', window );">Retirement Income Plan [Member] | Scenario, Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss', window );">Net actuarial gains (losses) as a component of net periodic benefit cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_BasisPointIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase or decrease in the basis point for the assumed health care cost trend rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_BasisPointIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by the employer to defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 35<br> -Paragraph 123<br> -Subparagraph B<br> -URI http://asc.fasb.org/extlink&amp;oid=64937487&amp;loc=d3e36068-114959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 35<br> -Paragraph 63<br> -Subparagraph B<br> -URI http://asc.fasb.org/extlink&amp;oid=64937038&amp;loc=d3e12551-114930<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount included in accumulated other comprehensive income (AOCI) related to gain (loss) expected to be recognized as components of net periodic benefit cost for the fiscal year that follows the most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If aggregate disclosures are presented, the aggregate pension accumulated benefit obligation for pension plans with accumulated benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=73719040&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ultimate trend rate for health care costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanYearThatRateReachesUltimateTrendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Year the ultimate health care cost trend rate is expected to be reached, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanYearThatRateReachesUltimateTrendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the cost recognized during the period for defined contribution plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanNameAxis=clx_CompanyFourZeroOneKPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanNameAxis=clx_CompanyFourZeroOneKPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanNameAxis=clx_InternationalDefinedContributionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanNameAxis=clx_InternationalDefinedContributionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_DomesticQualifiedRetirementIncomePlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_DomesticQualifiedRetirementIncomePlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_DomesticNonQualifiedRetirementIncomePlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_DomesticNonQualifiedRetirementIncomePlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_PrescriptionDrugsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_PrescriptionDrugsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCarePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCarePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811086912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Summarized Information for Defined Benefit Retirement Income and Healthcare Plans) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of assets as of beginning of year</a></td>
<td class="nump">$ 409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets as of end of year</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">$ 409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember', window );">Retirement Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation as of beginning of year</a></td>
<td class="nump">639<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss (gain)</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Plan amendments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Translation and other adjustments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation as of end of year</a></td>
<td class="nump">673<span></span>
</td>
<td class="nump">639<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of assets as of beginning of year</a></td>
<td class="nump">409<span></span>
</td>
<td class="nump">432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions nonqualified plans</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets', window );">Translation and other adjustment</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets as of end of year</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">409<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Accrued benefit cost, net funded status</a></td>
<td class="num">(250)<span></span>
</td>
<td class="num">(230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Amounts recognized in the balance sheet consist of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent', window );">Pension benefit assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current accrued benefit liability</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Non-current accrued benefit liability</a></td>
<td class="num">(237)<span></span>
</td>
<td class="num">(216)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Accrued benefit cost, net</a></td>
<td class="num">(250)<span></span>
</td>
<td class="num">(230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember', window );">Retirement Health Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation as of beginning of year</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss (gain)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Plan amendments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Translation and other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation as of end of year</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of assets as of beginning of year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions nonqualified plans</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets', window );">Translation and other adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets as of end of year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Accrued benefit cost, net funded status</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Amounts recognized in the balance sheet consist of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent', window );">Pension benefit assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current accrued benefit liability</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Non-current accrued benefit liability</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Accrued benefit cost, net</a></td>
<td class="num">$ (47)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between fair value of plan assets at the end of the period and the fair value at the beginning of the period, adjusted for contributions and payments of benefits during the period, and after adjusting for taxes and other expenses, as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Actual Return on Plan Assets (Component of Net Periodic Postretirement Benefit Cost)<br> -URI http://asc.fasb.org/extlink&amp;oid=6504192<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Actual Return on Plan Assets (Component of Net Periodic Pension Cost)<br> -URI http://asc.fasb.org/extlink&amp;oid=6504226<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) related to change in benefit obligation resulting from changes in actuarial assumptions, for example, but not limited to, interest, mortality, employee turnover, salary, and temporary deviation from the substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Gain or Loss<br> -URI http://asc.fasb.org/extlink&amp;oid=49168827<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount recognized in the balance sheet associated with the defined benefit plan(s). Will normally be the same as the Defined Benefit Plan, Funded Status of Plan, Total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64852052&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents the entire assets recognized in the balance sheet that are associated with the defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64852052&amp;loc=d3e1703-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>1) For defined benefit pension plans, the benefit obligation is the projected benefit obligation, which is the actuarial present value as of a date of all benefits attributed by the pension benefit formula to employee service rendered prior to that date.  2) For other postretirement defined benefit plans, the benefit obligation is the accumulated postretirement benefit obligation, which is the actuarial present value of benefits attributed to employee service rendered to a particular date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Projected Benefit Obligation<br> -URI http://asc.fasb.org/extlink&amp;oid=6522206<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Accumulated Postretirement Benefit Obligation<br> -URI http://asc.fasb.org/extlink&amp;oid=6503904<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payments made for which participants are entitled under a pension plan, including pension benefits, death benefits, and benefits due on termination of employment. Also includes payments made under a postretirement benefit plan, including prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services. This item represents a periodic decrease to the plan obligations and a decrease to plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Benefits<br> -URI http://asc.fasb.org/extlink&amp;oid=49170737<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Postretirement Benefits<br> -URI http://asc.fasb.org/extlink&amp;oid=6521376<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by the employer to defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 35<br> -Paragraph 123<br> -Subparagraph B<br> -URI http://asc.fasb.org/extlink&amp;oid=64937487&amp;loc=d3e36068-114959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 35<br> -Paragraph 63<br> -Subparagraph B<br> -URI http://asc.fasb.org/extlink&amp;oid=64937038&amp;loc=d3e12551-114930<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of assets that have been segregated and restricted to provide pension or postretirement benefits. Assets include, but are not limited to, stocks, bonds, other investments, earnings from investments, and contributions by the employer and employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 35<br> -Paragraph 50<br> -URI http://asc.fasb.org/extlink&amp;oid=64937038&amp;loc=d3e12355-114930<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Plan Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6749337<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Plan Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6520858<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from foreign currency exchange rate changes for benefit obligation for plans of a foreign operation whose functional currency is not the reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of increase or decrease in plan assets attributed to foreign currency changes. The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation whose functional currency is not the reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The funded status is measured as the difference between the fair value of plan assets and the benefit obligation. Will normally be the same as the net Defined Benefit Plan, Amounts Recognized in Balance Sheet, Total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64852052&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of increase or decrease due to a change in the terms of an existing plan or the initiation of a new plan. A plan amendment may increase or decrease benefits, including those attributed to years of service already rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Plan Amendment<br> -URI http://asc.fasb.org/extlink&amp;oid=49173939<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Service Cost (Component of Net Periodic Pension Cost)<br> -URI http://asc.fasb.org/extlink&amp;oid=6525008<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the amount recognized in balance sheet as a current liability associated with an underfunded defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64852052&amp;loc=d3e1703-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64852052&amp;loc=d3e1703-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2410-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811503360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Information for Retirement Income Plans with Accumulated Benefit Obligation in Excess of Plan Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">$ 596<span></span>
</td>
<td class="nump">$ 559<span></span>
</td>
<td class="nump">$ 563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherPensionPlansDefinedBenefitMember', window );">Other Retirement Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If aggregate disclosures are presented, the aggregate pension accumulated benefit obligation for pension plans with accumulated benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=73719040&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If aggregate disclosures are presented, the aggregate projected benefit obligation for pension plans with accumulated benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=73719040&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If aggregate disclosures are presented, the aggregate fair value of plan assets for plans with benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherPensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherPensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808719168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income and Health Care Plans) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember', window );">Retirement Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of unrecognized items</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember', window );">Retirement Health Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of unrecognized items</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of gains or losses recognized in net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An amount calculated as a basis for determining the extent of delayed recognition of the effects of changes in the fair value of assets. The expected return on plan assets is determined based on the expected long-term rate of return on plan assets and the market-related value of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Expected Return on Plan Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6512171<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of net periodic benefit cost for defined benefit plans for the period. Periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Service Cost (Component of Net Periodic Pension Cost)<br> -URI http://asc.fasb.org/extlink&amp;oid=6525008<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823252128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Items Not Yet Recognized as a Component of Postretirement Expense) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember', window );">Retirement Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">$ 296<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax', window );">Net deferred income tax (assets) liabilities</a></td>
<td class="num">(111)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated other comprehensive loss (income)</a></td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember', window );">Retirement Health Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service benefit</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax', window );">Net deferred income tax (assets) liabilities</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated other comprehensive loss (income)</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of net gain (loss), prior service cost (credit), and transition assets (obligations), as well as minimum pension liability if still remaining, included in accumulated other comprehensive income associated with a defined benefit pension or other postretirement plan(s) because they have yet to be recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pretax net amount of gains and losses that are not yet recognized as a component of net periodic benefit cost, and that are recognized as increases or decreases in other comprehensive income as they arise. Gains and losses are due to changes in the value of either the benefit obligation or the plan assets resulting from experience different from that assumed or from a change in an actuarial assumption, or the consequence of a decision to temporarily deviate from the substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount related to the pretax cost of benefit changes attributable to plan participants' prior service pursuant to a plan amendment or a plan initiation, which has not yet been recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Prior Service Cost<br> -URI http://asc.fasb.org/extlink&amp;oid=49177896<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Before tax amount of net transition assets (obligations) which has yet to be recognized as a component of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)-(j)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Transition Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6749452<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Transition Obligation<br> -URI http://asc.fasb.org/extlink&amp;oid=6749492<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6802065424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Net Actuarial Loss (Gain) and Prior Service Cost (Benefit) Activity Recorded in Accumulated Other Comprehensive Loss (Income)) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember', window );">Retirement Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">$ 264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost', window );">Amortization during the year</a></td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod', window );">Loss (gain) during the year</a></td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember', window );">Retirement Health Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost', window );">Amortization during the year</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod', window );">Loss (gain) during the year</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss (gain)</a></td>
<td class="num">$ (13)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The accumulated change in the value of either the projected benefit obligation or the plans assets resulting from experience different from that assumed or from a change in an actuarial assumption that has not been recognized in net periodic benefit cost pursuant to FAS 87 and 106.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The adjustment out of other comprehensive income for actuarial gains (losses) recognized as a component of net periodic benefit cost during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pretax net amount of gains and losses that are not yet recognized as a component of net periodic benefit cost, and that are recognized as increases or decreases in other comprehensive income as they arise. Gains and losses are due to changes in the value of either the benefit obligation or the plan assets resulting from experience different from that assumed or from a change in an actuarial assumption, or the consequence of a decision to temporarily deviate from the substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6802086608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Weighted-Average Assumptions Used to Estimate the Net Periodic Pension and Other Postretirement Benefit Costs) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember', window );">Retirement Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Weighted-average assumptions used to estimate the actuarial present value of benefit obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">3.42%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">2.92%<span></span>
</td>
<td class="nump">3.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Weighted-average assumptions used to estimate the net periodic pension and other postretirement benefit costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.05%<span></span>
</td>
<td class="nump">4.39%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.37%<span></span>
</td>
<td class="nump">4.46%<span></span>
</td>
<td class="nump">3.44%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">4.34%<span></span>
</td>
<td class="nump">5.28%<span></span>
</td>
<td class="nump">6.61%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember', window );">Retirement Health Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Weighted-average assumptions used to estimate the actuarial present value of benefit obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">3.42%<span></span>
</td>
<td class="nump">4.16%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Weighted-average assumptions used to estimate the net periodic pension and other postretirement benefit costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.16%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.33%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate used to adjust for the time value of money for the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected rate of compensation increases (for pay-related plans).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate used to adjust for the time value of money.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested to provide for the benefits included in the benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Expected Long-Term Rate of Return on Plan Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6512046<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected rate of compensation increases (for pay-related plans).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6804853840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Expected Benefit Payments) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember', window );">Retirement Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2017</a></td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2018</a></td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2019</a></td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2020</a></td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2021</a></td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Fiscal years 2022 - 2026</a></td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember', window );">Retirement Health Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2017</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2018</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2019</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2020</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2021</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Fiscal years 2022 - 2026</a></td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits from a defined benefit plan expected to be paid in the five fiscal years after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits from a defined benefit plan expected to be paid in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits from a defined benefit plan expected to be paid in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits from a defined benefit plan expected to be paid in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits from a defined benefit plan expected to be paid in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefits from a defined benefit plan expected to be paid in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6801948464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Target Allocations and Weighted Average Asset Allocations) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations', window );">% Target Allocation</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">% of Plan Assets</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_UnitedStatesEquityMember', window );">U.S. Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations', window );">% Target Allocation</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">% of Plan Assets</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_ForeignEquitySecuritiesMember', window );">International Equity Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations', window );">% Target Allocation</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">% of Plan Assets</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_FixedIncomeFundsMember', window );">Fixed Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations', window );">% Target Allocation</a></td>
<td class="nump">74.00%<span></span>
</td>
<td class="nump">74.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">% of Plan Assets</a></td>
<td class="nump">74.00%<span></span>
</td>
<td class="nump">74.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherCreditDerivativesMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations', window );">% Target Allocation</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">% of Plan Assets</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Target allocation of investments of this type to total plan assets presented on a weighted average basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2446-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair value of investments (categorized by debt securities, equity securities, real estate and other plan assets) to the fair value of plan assets held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2446-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_UnitedStatesEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_UnitedStatesEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_ForeignEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_ForeignEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_FixedIncomeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_FixedIncomeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherCreditDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherCreditDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6802216688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Retirement Income Plan's Assets Carried at Fair Value) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Total assets at fair value</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Total assets at fair value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Total assets at fair value</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_BondFundMember', window );">Bond Fund [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_BondFundMember', window );">Bond Fund [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_BondFundMember', window );">Bond Fund [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_ForeignEquitySecuritiesMember', window );">International Equity Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_ForeignEquitySecuritiesMember', window );">International Equity Funds [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_ForeignEquitySecuritiesMember', window );">International Equity Funds [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_DomesticEquitySecuritiesMember', window );">Domestic Equity Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_DomesticEquitySecuritiesMember', window );">Domestic Equity Funds [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_DomesticEquitySecuritiesMember', window );">Domestic Equity Funds [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_RealEstateFundMember', window );">Real Estate Fund [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_RealEstateFundMember', window );">Real Estate Fund [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_RealEstateFundMember', window );">Real Estate Fund [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_CommonOrCollectiveTrusts', window );">Common/Collective trusts</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Type of cash or cash equivalent. Cash includes currency on hand as well as demand deposits with banks or financial institutions. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_CommonOrCollectiveTrusts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A professionally managed type of collective investment scheme that pools money from many investors and invests typically in investment securities (stocks, bonds, short-term money market instruments, other mutual funds, other securities and/or commodities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_CommonOrCollectiveTrusts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of assets that have been segregated and restricted to provide pension or postretirement benefits. Assets include, but are not limited to, stocks, bonds, other investments, earnings from investments, and contributions by the employer and employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 35<br> -Paragraph 50<br> -URI http://asc.fasb.org/extlink&amp;oid=64937038&amp;loc=d3e12355-114930<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Plan Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6749337<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Plan Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6520858<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_BondFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_BondFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_ForeignEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_ForeignEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_DomesticEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_DomesticEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_RealEstateFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=clx_RealEstateFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811600064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Selected Financial Information Relating To Company's Segments ) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">$ 5,761<span></span>
</td>
<td class="nump">$ 5,655<span></span>
</td>
<td class="nump">$ 5,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="nump">983<span></span>
</td>
<td class="nump">921<span></span>
</td>
<td class="nump">884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income from equity investees</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">4,518<span></span>
</td>
<td class="nump">4,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember', window );">Cleaning [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">1,912<span></span>
</td>
<td class="nump">1,824<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="nump">511<span></span>
</td>
<td class="nump">445<span></span>
</td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income from equity investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">883<span></span>
</td>
<td class="nump">876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember', window );">Household [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">1,862<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
<td class="nump">1,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="nump">428<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income from equity investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,092<span></span>
</td>
<td class="nump">725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember', window );">Lifestyle [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">990<span></span>
</td>
<td class="nump">950<span></span>
</td>
<td class="nump">936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income from equity investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">880<span></span>
</td>
<td class="nump">860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember', window );">International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">997<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income from equity investees</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,057<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="num">(273)<span></span>
</td>
<td class="num">(235)<span></span>
</td>
<td class="num">(227)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income from equity investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">606<span></span>
</td>
<td class="nump">646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66022249&amp;loc=d3e33749-111570<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6820927200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Net Sales and Long-Lived Assets by Geographic Area) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">$ 5,761<span></span>
</td>
<td class="nump">$ 5,655<span></span>
</td>
<td class="nump">$ 5,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net property, plant and equipment</a></td>
<td class="nump">906<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">4,805<span></span>
</td>
<td class="nump">4,609<span></span>
</td>
<td class="nump">4,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net property, plant and equipment</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=clx_ForeignMember', window );">Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">956<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">$ 1,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net property, plant and equipment</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=clx_ForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=clx_ForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6808387184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Concentration Percentages) (Details) - Net sales [Member]<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Liquid Bleach [Member] | Cleaning [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Liquid Bleach [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Trash Bags [Member] | Household [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Charcoal [Member] | Household [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Customer Concentration [Member] | Walmart Stores, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Customer Concentration [Member] | Top Five Largest Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">46.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Product Concentration [Member] | Liquid Bleach [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Product Concentration [Member] | Trash Bags [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Product Concentration [Member] | Charcoal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=clx_LiquidBleachMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=clx_LiquidBleachMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=clx_TrashBagsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=clx_TrashBagsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=clx_CharcoalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=clx_CharcoalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=clx_WalmartStoresIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=clx_WalmartStoresIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=clx_TopFiveLargestCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=clx_TopFiveLargestCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6800756656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_MaximumOwnershipPercentageOfEquityInvestments', window );">Percentage ownership of equity investments, maximum</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Payments to related parties during the period</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_MaximumOwnershipPercentageOfEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum ownership percentage in equity investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_MaximumOwnershipPercentageOfEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66022249&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823746272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED QUARTERLY DATA (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Net sales</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 1,426<span></span>
</td>
<td class="nump">$ 1,345<span></span>
</td>
<td class="nump">$ 1,390<span></span>
</td>
<td class="nump">$ 1,557<span></span>
</td>
<td class="nump">$ 1,401<span></span>
</td>
<td class="nump">$ 1,345<span></span>
</td>
<td class="nump">$ 1,352<span></span>
</td>
<td class="nump">$ 5,761<span></span>
</td>
<td class="nump">$ 5,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of products sold</a></td>
<td class="nump">873<span></span>
</td>
<td class="nump">780<span></span>
</td>
<td class="nump">745<span></span>
</td>
<td class="nump">765<span></span>
</td>
<td class="nump">847<span></span>
</td>
<td class="nump">796<span></span>
</td>
<td class="nump">773<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">3,163<span></span>
</td>
<td class="nump">3,190<span></span>
</td>
<td class="nump">$ 3,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Earnings from continuing operations</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="nump">648<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Earnings (losses) from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 648<span></span>
</td>
<td class="nump">$ 580<span></span>
</td>
<td class="nump">$ 558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Net earnings (losses) per share, Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations</a></td>
<td class="nump">$ 1.28<span></span>
</td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 1.46<span></span>
</td>
<td class="nump">$ 1.09<span></span>
</td>
<td class="nump">$ 0.98<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
<td class="nump">$ 5.01<span></span>
</td>
<td class="nump">$ 4.65<span></span>
</td>
<td class="nump">$ 4.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="nump">0.22<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.42)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.20)<span></span>
</td>
<td class="num">(0.16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share</a></td>
<td class="nump">1.28<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="nump">1.15<span></span>
</td>
<td class="nump">1.33<span></span>
</td>
<td class="nump">1.48<span></span>
</td>
<td class="nump">1.31<span></span>
</td>
<td class="nump">0.96<span></span>
</td>
<td class="nump">0.70<span></span>
</td>
<td class="nump">5.01<span></span>
</td>
<td class="nump">4.45<span></span>
</td>
<td class="nump">4.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Net earnings (losses) per share, Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations</a></td>
<td class="nump">1.26<span></span>
</td>
<td class="nump">1.21<span></span>
</td>
<td class="nump">1.14<span></span>
</td>
<td class="nump">1.32<span></span>
</td>
<td class="nump">1.44<span></span>
</td>
<td class="nump">1.08<span></span>
</td>
<td class="nump">0.97<span></span>
</td>
<td class="nump">1.10<span></span>
</td>
<td class="nump">4.92<span></span>
</td>
<td class="nump">4.57<span></span>
</td>
<td class="nump">4.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="nump">0.22<span></span>
</td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.42)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.20)<span></span>
</td>
<td class="num">(0.16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share</a></td>
<td class="nump">1.26<span></span>
</td>
<td class="nump">1.23<span></span>
</td>
<td class="nump">1.13<span></span>
</td>
<td class="nump">1.31<span></span>
</td>
<td class="nump">1.46<span></span>
</td>
<td class="nump">1.30<span></span>
</td>
<td class="nump">0.95<span></span>
</td>
<td class="nump">0.68<span></span>
</td>
<td class="nump">4.92<span></span>
</td>
<td class="nump">4.37<span></span>
</td>
<td class="nump">4.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share</a></td>
<td class="nump">0.80<span></span>
</td>
<td class="nump">0.77<span></span>
</td>
<td class="nump">0.77<span></span>
</td>
<td class="nump">0.77<span></span>
</td>
<td class="nump">0.77<span></span>
</td>
<td class="nump">0.74<span></span>
</td>
<td class="nump">0.74<span></span>
</td>
<td class="nump">0.74<span></span>
</td>
<td class="nump">3.11<span></span>
</td>
<td class="nump">2.99<span></span>
</td>
<td class="nump">$ 2.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh', window );">Market price (NYSE), high</a></td>
<td class="nump">138.41<span></span>
</td>
<td class="nump">132.19<span></span>
</td>
<td class="nump">131.78<span></span>
</td>
<td class="nump">119.75<span></span>
</td>
<td class="nump">98.31<span></span>
</td>
<td class="nump">106.36<span></span>
</td>
<td class="nump">112.65<span></span>
</td>
<td class="nump">112.70<span></span>
</td>
<td class="nump">138.41<span></span>
</td>
<td class="nump">112.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_RangeOfNyseMarketPriceOfEntityCommonStockLow', window );">Market price (NYSE), low</a></td>
<td class="nump">119.23<span></span>
</td>
<td class="nump">$ 122.40<span></span>
</td>
<td class="nump">$ 114.06<span></span>
</td>
<td class="nump">$ 104.26<span></span>
</td>
<td class="nump">86.03<span></span>
</td>
<td class="nump">$ 95.19<span></span>
</td>
<td class="nump">$ 102.95<span></span>
</td>
<td class="nump">$ 103.77<span></span>
</td>
<td class="nump">104.26<span></span>
</td>
<td class="nump">86.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_NyseMarketPriceOfEntityCommonStockPeriodEnd', window );">Market price (NYSE), year-end</a></td>
<td class="nump">$ 138.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138.39<span></span>
</td>
<td class="nump">$ 104.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_NyseMarketPriceOfEntityCommonStockPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The closing market price of the entity's common stock on the New York Stock Exchange on the last day of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_NyseMarketPriceOfEntityCommonStockPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest daily closing market price for the entity's common stock on the New York Stock Exchange for a given period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_RangeOfNyseMarketPriceOfEntityCommonStockHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_RangeOfNyseMarketPriceOfEntityCommonStockLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The lowest daily closing market price for the entity's common stock on the New York Stock Exchange for a given period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_RangeOfNyseMarketPriceOfEntityCommonStockLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4613673-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20187-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20187-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355146-122828<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6823145728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForDoubtfulAccountsMember', window );">Allowance for Doubtful Accounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses', window );">Credited to costs and expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Credited to other accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=clx_LifoAllowanceMember', window );">LIFO Allowance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses', window );">Credited to costs and expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Credited to other accounts</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Valuation Allowance on Deferred Tax Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses', window );">Credited to costs and expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Credited to other accounts</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="num">$ (37)<span></span>
</td>
<td class="num">$ (34)<span></span>
</td>
<td class="num">$ (51)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs, credited to costs and expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ValuationAllowancesAndReservesCreditedToCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the allowances and reserves, which consist of the valuation and qualifying accounts that are either netted against the cost of an asset or that reflect a liability established to represent expected future costs, from charges to costs and expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the deductions in a given period to allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs, representing receivables written off as uncollectible and portions of the reserves utilized, respectively.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForDoubtfulAccountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForDoubtfulAccountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=clx_LifoAllowanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=clx_LifoAllowanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>132
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M5JV[OG[XK\EUU9])NK_^E^#I!U!+ P04    " !,A1!)!KGF*T\%  "*&
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MFG9Q,*$AE [% 70"2Y.LS:[V.\&T(\PU;R9=5P30I$5<93@!>JR8@&!&M@F
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
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M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( $R%$$FT1S%71@(  '8*   -
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MO<2?AZH,\F)_W3ZXNLSDF\I?#P]-A:#I/(SG@3_S$CYC<2)?6NS\AG$O"GT
MF0 R?Q84*])T?K\ T A H_\!77N!%TXYB^\X3V* 6 "QSH*P#XL40&, C<^J
M5IS,IP"R 62?USY>? <@!T#.*2A>WM][T6-; O\V]&_\J:=$F$[G2RD"@%P
MN:>@F1_+0B5^N)0EFB]XU*J#C3P!P.04<+V,_9#',8_ET_]<^A&?H7@&FF><
MWNZ'#[(%YI'/\9E#35C"V'ERQR,V7491Z[]\O";&$#T=$J(N(E77Y/$36P3>
MVPB2I5^H_OC$$(6F#@E5;^?SV1<_"#ZQ)/)F7';+Y[CE'<J(*/1U2 A[[+Z8
M+;Q'[SK@+49^&:G.";!7AVCLD%!VQJ\3O![%'!)F'@H;^-ZU'_C)N]Y &8>$
MC3=^*,>6[P5R^HF3:'F06A7^QO/U)D =AX2/QXYME;SE$LH/H-NE%\F.0A2*
M.23,#+@7<^P*.07=^TE;.)S24%&34%0-\<]W\V#&H_B7UI+D$>]'5TW"U9 G
MAWDTO)4]*\L1WWD19Q_X(OZ('&UN)9QMR_'KM:S4K)U->1BW@[556*L1*FL2
MRAZ:XX,?2@S_R/A?BL4_,5E2Q*"N)J'KX7Z6>']INICHIDFXR>\7P?R1<W;-
M0W[C)Z<50%M-PM:8W[81*N*+>:1,P9O15I.P->)!._\N/#D!J$$KVW'Z?M8S
M4523$'49>LN9KSA_2C43'@6/3,[K'C+04),P],$+EH<N5))*3N#?/,K:'.=Q
M#)<HZ8B2M"\@C(:(0E]'A*_]*!-1J.R(4+8CNK /,DW*18TH+2$@G"7BS!L&
M1]$(I1V1TOX(..3]*.^(D)>*/"0('1X1#O>&H)&#*#1Z1!C=&X)&+J)0ZQ&A
M=6\(&DT0A7:/"+M5"*):QD*7+<+EDUA$4E!CB]"X-RA9J+&%&EN$QGV11)8-
M4:BQ16A,!1.R>EIN2WC<%U7>E0F5M@BE^P,+AF\+I;8ZTP@RLJA:(@JEM@BI
M,;J0+80J6X3*=)@A4:BR1:A\$F\HRAB]'A->=X6,(PQ1*/?XW#EZC'*/4>XQ
ME5;THD:(0KG'E-R]* M1J/>8T+LS<L3[[3:M$*4MWJA4N \UMA&%>H\)O3M1
M85I5:8,HU'M,Z$W&LYEHTBS7K4+-QX3F6D"C "CWF)";CF@$R4;!;4+PWI!F
M8Q)BH^ V(7AO2+-1<!L%MPG!^U$HN(V"V^>N]6P4W$;![7/7>O8842BXW;'6
M>U,P^RH^TIVG;4U0;A\H92-JEA9K%I1I4;-%^EW-31\Q"MCHMDVX?4 %9?'\
M:R.J+9N)IT;& /E[N6'+ E%HMTWM3[2HZ[*JRM>L>&;3=)>NLN:[Q*Q%I94*
M/;<[/=?2"J*=')3<(23OS2L<E-Q!R9US4Q0')7=0<H>0O!^%DCLHN=.Y.NQ8
M@CLHN8.2.X3D_8D3;A0Y*+G3E:2<)$[Q2UH)%HD=HM!TAUH]DJAIN=V6!8MQ
M%G>T;3AJ'XXNU>I%K/>Y0#T=--TA3*=1/T8UHM!TAS"]/S?$9G?1=K=K\Z,K
M-W31=A=M=ZF<I1>%MKMHNWON5HB+MKMHN]N5D'>BT'87;7<)V_M1.*6[:+M[
M;DKN8L[BHNWNN2GY#+URT7;W?U/RDX"#*&W;F<Q:$+6H2G7Z(8??IJR87ZP0
MA;:[A.TZBF\VHCWK49ARJXW!"=H^(7>C$25GA%U9B**I5=R2X0M1:/N$L%U'
M/:3YOCV 8UZ>EZ\IQL )VCXA;-=1RZ(2J_*Y4(=2+$F_:15$VR>$[5UKHF-?
M(@IMGQ"V=Z$.";J&0MLG/[TA*)TMVI-(1*'M$\+V+M2Q+Q&%MD\(VSM+U8AM
MS7!W;H*V3\Y8BJJ4R%MI7FG'+83M7:@O(GM^:;""0T,_?"%\[X+Q;SLYB'28
M=B1C$,9WK[>K9WF1!M/.9PS"^2Y8))JL$EL-IIW0&-0<?[I\CT6N:KAF-UFA
MP;0S&H.:Y4]AJAOC-&\39PVFG=(8U#Q_"IN6Q4K..6HXEAI,.\(Q"/>[-[;;
M"5J#:4<Z!F%_]V;%^[E^:&B'.@;A?]]&]]"8:##M6,>8'(_#VPO:$_"UV&2%
M6*O_!]3M@U9IOE)_&I O+<&TQNIL2'V^+]?RZ>JT?\ V^SR?RN_FA5S9J.N.
MY+>_"?SQ+U!+ P04    " !,A1!)$@BW;X,"  !["0  &    'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;'U6R8ZC,!3\%<0'!&RV)")(632:.8S4ZL/,V4F<
M!#5@VG9"S]^/;0A-VX^^X(6J5UY>V<X[QM_$C5+I?=15(S;^3<IV'03B=*,U
M$0O6TD;]N3!>$ZF:_!J(EE-R-J2Z"G 8ID%-RL8O<M/WPHN<W655-O2%>^)>
MUX3_V]&*=1L?^<^.U_)ZD[HC*/)@Y)W+FC:B9(W'Z67C;]'Z@#(-,8@_)>W$
MI.[IP1\9>].-7^>-'^HQT(J>I Y!5/&@>UI5.I)2?A^"?FIJXK3^C/[#3%<-
M_T@$W;/J;WF6-S7:T/?.]$+NE7QEW4\ZS"'1 4^L$N;KG>Y"LOI)\;V:?/1E
MV9BRZ_\DZ4"#"7@@X)& XV\)T4"(1@+ZGA /A-@B!/U4S$(<B"1%SEGG\7[W
M6J*3!*UCM=0GW6E6UOQ32R%4[Z,(\^"APPR(78_ $P0:$8&*/0I@2&"''3K^
M*K!W$=%7Q,%%Q/ 0(G".D:%'$WH"TV.0'AMZ/*&GUA*YB P62$"!Q*$O+0$7
ML8(%4E @=>C(WF4 ,K/-&2B1N7QKGW<])#60IL^$$*6PR!(46;HB5JKL ,A,
MKJQ B97+3RP) #(S"WWB0)X+W0B9[;K072T49G-",^9&KI"=6A!F)KD0Z/ M
MPDX$[!PB &8FOQ!L8A2Y$>P,@S#1C KL=>1:&<>V"H"9.5 0;'CD^AG;9PJ$
MF9L+['KD>AI;:788,-DDS5"ZF'$,@JV/7.]C*\OVR#4_PJLX7<6)+19,KJZ:
M\JMY PCOQ.Z->7),>L=WQA:;J^\37N0MN=+?A%_+1GA')M4%:JZY"V.2JA&%
M"[6^-_42&AL5O4A=S52=]V^#OB%9^WSJC.^MXC]02P,$%     @ 3(4022^3
MC/ "!   9Q,  !@   !X;"]W;W)K<VAE971S+W-H965T,BYX;6R%F-MNVS@0
MAE]%\'TMSHC4(7 ,Q#:*[L4"12]VKQ6;/J"2Z$I*W'W[U2F.,C-,;VQ)_H;\
M.1K/+W%U<_7/YFQM&_PNBZIY7)S;]OH0ALW^;,N\6;JKK;I?CJXN\[8[K4]A
M<ZUM?AB"RB)$I>*PS"_58KT:KGVOUROWTA:7RGZO@^:E+//ZOXTMW.UQ 8NW
M"S\NIW/;7PC7J_ >=[B4MFHNK@IJ>WQ</,'##I,>&8A_+O;6S(Z#7ORS<S_[
MD[\.CPO5:["%W;?]$'GW]6JWMBCZD;J9?TV#OL_9!\Z/WT;_.BRWD_^<-W;K
MBG\OA_;<J56+X&"/^4O1_G"W;W9:@^D'W+NB&3Z#_4O3NO(M9!&4^>_Q^U(-
MW[?QEU1-87( 3@%X#X#XTX!H"HC> _2G 7H*T"0@')<R)&*7M_EZ5;M;4(]W
M[YKW10(/NDOUOK\X9';XK4M%TUU]76.V"E_[<29D,R(X0^!.A-W@]QE0FF&#
M+!P_3K#E1*0^(CL!\8B(Q&5&0WPTCT<Y7HOQ>HC7\_B(I&E$T@&I!L0D,9"E
M"E!L#%FL !G0LEPCRC5<KB9R1R2>31)!3-:TE:",WAL),JDL-Q;EQEPNR<DF
M9I.@R5(B5X!T3+,K0)&)9;F)*#?A<F,B-V&3I(HP6\XD=$4[@3&>PD]%K2G7
MFA"M*9O#I(39"@R28MD)C(IDK9FH->-:23XV&9L#-/V/"0R]/SN!02-K[6U#
M:IR*JV6=4_$RH#4K,*#H7TR$/+D%3Z,'IE<KJA?8-%]H)4@,T%(0(>71*]K&
M$R#7"U0OLFFRE/8P"4*@@CF4IIZ6"[+%0,0%(Q4<\5Y)6]U6@H!V,0E2O@J6
M/0VXJ6EJ:A,SGR;6K(0%B':[G0"9)/,(EET-N*UI:FO W4A1N1SY@DRN!'DZ
M+\BN!MS6-+6UB4D_SR^'3,I:A #Y7!AD7X.$/25ICS&"[#; [493NYF8;"YT
MJ6@3%RB]9%XN4K,9/VJ670>X[= [L 'N%ZRJ1J3OU.\5HY9(%<L8>/*,LOD@
M-Q]-S6=B/LPD)%K"NAS23,N8[R$<90]"8 5F/*Z LBN@X JTP":&2,W86X>(
MF80N7,0B3^="V1M0\ 9:8\@[.JVQ"?E3C7DP;XW)]H#<'@PUX(G)_I!IB:*/
MH3N10L]##LH.@887F.<]#^6FC;QI&VJ*R%\A #.=L'4+7*0B8"^WXGC>[HUR
M]T;^6F*H.R)_GX ($J />2*'24)=TC.>ICD/9]L1I:U/P[Y.$^S=2]7VK_6S
MJ_>]HR?LMS/(]0T\[,8=H/=AUJMK?K)_Y_7I4C7!LVM;5PY;&D?G6MO)5,NN
M+,XV/]Q/"GML^\.D.Z['?:#QI'77MVVM^][:^G]02P,$%     @ 3(4025N,
M1=J8 @  M D  !@   !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q]EDUOHS 0
MAO\*XMX"YC,506J(5KN'E:H>=L]NXB2H@%/;:;K_?FU#*!T/O03;O._,,\:Q
M75ZY>)4GQI3WT;6]7/LGI<X/02!W)]91><_/K-=O#EQT5.FN. ;R+!C=6U/7
M!B0,LZ"C3>]7I1U[$E7)+ZIM>O8D/'GI.BK^;5C+KVL_\F\#S\WQI,Q 4)7!
MY-LW'>MEPWM/L,/:?XP>MA$Q$JOXT["KG+4] __"^:OI_-JO_= PL);ME E!
M]>.=U:QM322=^6T,^IG3&.?M6_0?MER-_T(EJWG[M]FKDZ8-?6_/#O32JF=^
M_<G&&E(3<,=;:7^]W44JWMTLOM?1C^'9]/9Y'=[D9+3A!C(:R&2(LF\-\6B(
M/PW)MX9D-"3 $ REV(G84D6K4O"K)X:O=Z9FD40/B9[JG1FT,VO?Z:F0>O2]
M2M,R>#=Q1LEFD)"9))H4@0X^92!8A@UQ[.1K@MI5Q.%7R1:1+$#$:)FQ]<?S
M,C/<GZ#^Q/J3F3^)P30-DL)*>BO)D@)4BFC"#)3J:M)\A;.F*&OJLB: =9!D
MLQQ@PFM7<4<@*:99^"H92IJYI'#Q94X.=U9=35K !81HT@)GS5'6W%U!.>XO
M4'_AU)J".C:%.Y\I6&4UI@%?=XMHX@76%<JZ<EE7@'7EY "*VE7<19 4T2PL
M=;-Y8]M7Z*!F(=R_0F2= I(:$T4YP,5$R0+OPG8;N;P1Y(W<+!E<\YBH2"$O
M(DK#!6!T]WZ,B M,(#!QMRSX!ZP14;)R@)%((?R;!K.SK6/B:"\)TMOQ2Z_,
M&3$;G2XBC_:X!N,;<T&Q9^9GF*H\TR/[3<6QZ:7WPI4^>>WY>.!<,<T8WNMM
M[Z2O4%.G90=EFKENB^%2,704/]_N2--%K?H/4$L#!!0    ( $R%$$E ['?=
M*P0  ,P4   8    >&PO=V]R:W-H965T<R]S:&5E=#0N>&ULC9C!DJ,V$(9?
MA?)]%ZDE0)KRN"H#E4H.J=K:0W)F;-FF%I #>+QY^P#V>'%W:W8O-HB_I1_1
M?+2TOOCN6W]T;HB^-W7;/Z^.PW!ZBN-^>W1-V7_V)]>.5_:^:\IA/.T.<7_J
M7+F;@YHZ!B'2N"FK=K59SVU?NLW:GX>Z:MV7+NK/35-V_[VXVE^>5W+UWO"U
M.AR'J2'>K.-[W*YJ7-M7OHTZMW]>_2:?"I5,DEGQ=^4N_>(XFLR_>O]M.OES
M][P2DP=7N^TP=5&.?V\N=W4]]32._.^MTQ]C3H'+X_?>?Y]O=[3_6O8N]_4_
MU6XXCF[%*MJY?7FNAZ_^\H>[W</L<.OK?OZ-MN=^\,U[R"IJRN_7_ZJ=_R_7
M*T;<PO@ N 7 KP:H6X"Z!TC]88"^!6@4$%]O99Z(HAS*S;KSEZB[/KU3.26)
M?-+C5&^GQGEFYVOC5/1CZ]LF5>OX;>KG)LFO$EA(X%%14(42=TD\CG\W :P)
MF./5TH3FXQ4;K^9XO8Q/T$U<)6:6M+-$"XEN@VJ4 =Z'9GUHZB-%/JZ2=#%&
MDEKD@]%(R_M(6!\)]9$A'PD90VOTX NJ42;A?:2LCY3Z,,A'2L;(<'91B5Q8
M?;"1L38R:@-->9XQ8QB40P4G@L"#,:P30YQD CDQ9! K4!(5C$8:WH=E?5CJ
M [T,N:4W*RW*HH(1B46J/3B9\,L!2% O@ DDR#AI@KTPHD0%TE4&8"BI%T)#
M23/68"M4DP2 *'DB2J!.-'8"=/8MSEE.E(9FA:>KI'C-,%YOF@>>))+,"Z.2
M(=1+GK%2DX]%E@9ZX.DH*1XSC$=)V9< YB,CLJ&IY0$I*2%Q,N62\D]@(U2B
M1"CA>$9*"LD,0?*%T1B,+\E 4BB2E51ELP!))8]225EJ,,,D!269.BI1,F"$
M9ZFD,#4$8 PHDX2\'HQ*BT!& 8]3H#@U&&% 22DSPG9>%7C5@ <J4* :C#'@
M@*JQ&4840BH$BDR*5/R%SX'2$C_+@M&$WGK@@0H4J ;7B<"@$@!7K)Q*Z- S
MXH$*M&HU&(><!F?OQYI')SR8(2%H-P$H ,]3H#RUF%#P<YY^*'GTP=,4*"DM
MAA,PI$SP4N GHD<O/"B!@M)B/@&EH,&E>L&(LBR4^3PK@;+2$CI1"H+$B]*"
M44D+@66!XEFI*"LMII.B%/P$BI0"K Q4H!16/"T5I26NYW)%0?@IP8N(@E6)
MP%I6\;Q4#"_QLDE1%@+YD# B&5JNJ, "GQ+38F(J9HE/2U!.%2Q!%4],I>_1
M-(1'FZ(U)RZ=7AB-Q0D4+_9U&M<=Y@VR/MKZ<SM,Y%RTWC?A7N8M,]RN]%.N
M-'-E]#%>F7?%XA]#;-:G\N#^*KM#U?;1JQ\&W\S[1GOO!S?:%Y]'^T=7[NXG
MM=L/TV$V'G?7S;;KR>!/[WN']PW,S?]02P,$%     @ 3(402;W',AE, @
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M$V.2JJCP2?W)ENK*GB8U/4D]3-28#Y?8,)&LN]W)TS\&Q3]02P,$%     @
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M&G2:5^\98E8D]B6($A414KYE(6''(>DXRO B3L!R*!6Y)2F^O?@0N9>++8?
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M<VAE970X+GAM;'U3P6[<(!#]%<0'!"_K9-N5UU(V5=4>*D4YM&?6'MLHP+B
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M..[]V8PC-1H.N^L'F7]I\0Y02P,$%     @ 384026]]UJ2A 0  L0,  !D
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M&7UXV=3_&M%#D)+=W%+2AO\S&PIJ'X_WX6S'D1H-C]WU@\R_M/@-4$L#!!0
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M['^-Z,!+26YVE+3^_\R&A-J%XP]_-N-(C8;#[OI!YE]:_ -02P,$%     @
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MW=Q2TH7_LQ@*&A^/]^%LIY&:#(_]]8,LO[3\ U!+ P04    " !-A1!)S-%
M4Z$!  "Q P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q]4\%NW" 0
M_17D#PB8W:3-RFLIFZAJ#Y6B'-HS:X]M%& <P.OT[PO8ZUB-U0LPP[PW;X:A
M&-&^N@[ DW>MC#MFG??]@5)7=:"%N\$>3+AIT&KA@VE;ZGH+HDX@K2AG[(YJ
M(4U6%LGW;,L"!Z^D@6=+W*"UL'].H' \9GEV=;S(MO/10<N"+KA::C!.HB$6
MFF/VD!].^QB1 GY)&-WJ3*+V,^)K-'[4QXQ%":"@\I%!A.T"CZ!4) J)WV;.
MCY01N#Y?V;^E:H/ZLW#PB.JWK'T7Q+*,U-"(0?D7'+_#7,)M)*Q0N;22:G >
M]162$2W>IUV:M(_3S5T^P[8!? ;P!?"5)>%3HB3S27A1%A9'8J?6]B*^8'[@
MH1%5=*:ZTUT0ZH+W4N;W]P6]1*(YYC3%\'7,$D$#^Y*";Z4X\4]PO@W?;2K<
M)?AN#6=LFV"_2;!/!/O_EO@YAK-_BZ2KGFJP;1H=1RH<3!K4E7>9S@>>WN0C
MO"QZT<)/85MI'#FC#R^;^M\@>@A2V,UM1KKP?Q9#0>/C\4LXVVFD)L-C?_T@
MRR\M_P)02P,$%     @ 384022S-FDR@ 0  L0,  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL?5/!;MP@$/T5Q <$+^NDU<IK*9LJ2@Z1HAS:,VN/
M;11@7,#K].\+V.NXK=4+,,.\-V^&H1C1OKL.P),/K8P[TL[[_L"8JSK0PMU@
M#R;<-&BU\,&T+7.]!5$GD%:,9]D=TT(:6A;)]VK+ @>OI(%72]R@M;"_3J!P
M/-(=O3K>9-OYZ&!EP19<+348)]$0"\V1WN\.ISQ&I(#O$D:W.I.H_8SX'HWG
M^DBS* $45#XRB+!=X &4BD0A\<^9\S-E!*[/5_;'5&U0?Q8.'E#]D+7O@MB,
MDAH:,2C_AN,3S"7<1L(*E4LKJ0;G45\AE&CQ,>W2I'V<;O*[&;8-X#. +X"O
M61(^)4HROPDORL+B2.S4VE[$%]P=>&A$%9VI[G07A+K@O90\XP6[1*(YYC3%
M\%7,;HE@@7U)P;=2G/@_<+X-WV\JW"?X_@^%^VV"?),@3P3Y?TO<BLG_2L)6
M/=5@VS0ZCE0XF#2H*^\RG?<\O<EG>%GTHH4785MI'#FC#R^;^M\@>@A2LIM;
M2KKP?Q9#0>/C\4LXVVFD)L-C?_T@RR\M?P-02P,$%     @ 38402?(\CVF@
M 0  L0,  !D   !X;"]W;W)K<VAE971S+W-H965T,C N>&UL?5/!;MP@$/T5
MQ <$+^M-JI774C95U1XJ13FT9]8>VRC N(#7Z=\7L-=Q6JL78(9Y;]X,0S&B
M?74=@"=O6AEWHIWW_9$Q5W6@A;O#'DRX:=!JX8-I6^9Z"Z).(*T8S[)[IH4T
MM"R2[]F6!0Y>20//EKA!:V%_GT'A>*([>G.\R+;ST<'*@BVX6FHP3J(A%IH3
M?=P=SWF,2 $_)(QN=291^P7Q-1K?ZA/-H@104/G((,)VA2=0*A*%Q+]FSO>4
M$;@^W]B_I&J#^HMP\(3JIZQ]%\1FE-30B$'Y%QR_PES"(1)6J%Q:234XC_H&
MH42+MVF7)NWC=)-G,VP;P&< 7P"?$H!-B9+,S\*+LK X$CNUMA?Q!7=''AI1
M16>J.]T%H2YXKR7/#@6[1J(YYCS%\%7,;HE@@7U)P;=2G/D_<+X-WV\JW"?X
M_H/"^VV"?),@3P3Y?TO<BGGX*PE;]52#;=/H.%+A8-*@KKS+=#[R]";OX671
MBQ:^"]M*X\@%?7C9U/\&T4.0DMT=*.G"_UD,!8V/QX=PMM-(38;'_O9!EE]:
M_@%02P,$%     @ 384022@*9=:A 0  L0,  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C$N>&UL?5/!;MP@$/T5Q <$F]TTZ<IK*9NH:@^5HAS:,VN/;11@
M',#K].\+V.NXK=4+,,.\-V^&H1C1OKH.P)-WK8P[TL[[_L"8JSK0PMU@#R;<
M-&BU\,&T+7.]!5$GD%:,9]DGIH4TM"R2[]F6!0Y>20//EKA!:V%_G4#A>*0Y
MO3I>9-OYZ&!EP19<+348)]$0"\V1/N2'TSY&I( ?$D:W.I.H_8SX&HUO]9%F
M40(HJ'QD$&&[P",H%8E"XK>9\R-E!*[/5_8OJ=J@_BP</*+Z*6O?!;$9)34T
M8E#^!<>O,)=P&PDK5"ZMI!J<1WV%4*+%^[1+D_9QNMG=S;!M )\!? '<9TGX
ME"C)?!)>E(7%D=BIM;V(+Y@?>&A$%9VI[G07A+K@O90\NR_8)1+-,:<IAJ]B
M\B6"!?8E!=]*<>+_P/DV?+>I<)?@NS\4?MXFV&\2[!/!_K\E;L3DV5])V*JG
M&FR;1L>1"@>3!G7E7:;S@:<W^0@OBUZT\%W85AI'SNC#RZ;^-X@>@I3LYI:2
M+OR?Q5#0^'B\"V<[C=1D>.RO'V3YI>5O4$L#!!0    ( $V%$$G, S=?GP$
M +$#   9    >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;'U3VV[<(!#]%<0'
M!!MOTFKEM91-5"4/D:(\M,^L/;XHP#B U^G?%[#7Z[9N7X 9YIPY,PSYB.;=
MM@".?"JI[8&VSO5[QFS9@A+V!GO0_J9&HX3SIFF8[0V(*H*49#Q)[I@2G:9%
M'GVOILAQ<++3\&J('902YN<1)(X'FM*+XZUK6A<<K,C9@JLZ!=IVJ(F!^D#O
MT_UQ%R)BP/<.1KLZDZ#]A/@>C.?J0),@ 224+C (OYWA :0,1#[QQ\QY31F
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M3;2="PY:%G3!U4*!M@(U,="<DOOL>,Y#1 SX+F"TJS,)VB^([\%XKD])&B2
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MD-"X</SBSV8:J<EPV-\^R/)+R]]02P,$%     @ 38402649MMVA 0  L0,
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M^"F<[312D^&QOWZ0Y9>6OP%02P,$%     @ 38402?OKXV.= 0  L0,  !D
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M3?UO$#T$*=G=@9(N_)_%4-#X>/P<SG8:J<GPV-\^R/)+RS]02P,$%     @
M384025T/,P&A 0  L0,  !D   !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M?5/;;MP@$/T5Q <$+[NY=.6UE$U5)0^5HCRTSZP]ME& <0&OT[\O8*_C)%9?
M@!GFG#DS#/F ]M6U )Z\:67<@;;>=WO&7-F"%NX*.S#AID:KA0^F;9CK+(@J
M@;1B/,MNF!;2T")/OF=;Y-A[)0T\6^)ZK87]>P2%PX%NZ,7Q(IO61P<K<C;C
M*JG!.(F&6*@/]'ZS/^YB1 KX)6%PBS.)VD^(K]%XJ@XTBQ) 0>DC@PC;&1Y
MJ4@4$O^9.-]31N#R?&'_D:H-ZD_"P0.JW[+R;1";45)!+7KE7W!XA*F$ZTA8
MHG)I)67O/.H+A!(MWL9=FK0/XPW_-L'6 7P"\!EPER7A8Z(D\[OPHL@M#L2.
MK>U$?,'-GH=&E-&9ZDYW0:@+WG/!^4W.SI%HBCF.,7P1LYDC6&"?4_"U%$?^
M!<[7X=M5A=L$WWY0>+M.L%LEV"6"W7]+7(NY^Y2$+7JJP39I=!PIL3=I4!?>
M>3KO>7J3]_ B[T0#/X5MI''DA#Z\;.I_C>@A2,FNKBEIP_^9#06UC\?;<+;C
M2(V&Q^[R0>9?6OP#4$L#!!0    ( $V%$$F.H%HKH $  +$#   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(X+GAM;'U3P6[<(!#]%<0'!"_>I.G*:RF;JDH/
ME:(<TC-KCVT48%S Z_3O ]CK6*W5"S##O#=OAJ$8T;ZY#L"3=ZV,.]+.^_[
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M:&5E=#,S+GAM;'54W6[;(!1^%>0'*#9.UBYR+#6=INUB4M6+[9K8QS8J^'B
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MT(>73?VO$3T$*=G=/25M^#^SH:#V\?@0SG8<J='PV-T^R/Q+BW]02P,$%
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M/X:SG49J,CSVUP^R_-+R#U!+ P04    " !-A1!)RB\U*Z,!  "Q P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6QM4\%NXR 0_17$!Q2'.&TW<BPU
MK:KVL%+5P^Z9V&,;%3PNX+C[]PO8<=W6%V"&>6_>#$,VH'FS#8 C'UJU]D ;
MY[H]8[9H0 M[A1VT_J9"HX7SIJF9[0R(,H*T8CQ)KID6LJ5Y%GTO)L^P=TJV
M\&*([;46YM\1% X'NJ$7QZNL&Q<<+,_8C"NEAM9*;(F!ZD#O-OMC&B)BP!\)
M@UV<2=!^0GP+QG-YH$F0  H*%QB$W\YP#TH%(I_X?>+\3!F R_.%_3%6Z]6?
MA(5[5']EZ1HO-J&DA$KTRKWB\ 13";M 6*"R<25%;QWJ"X02+3[&7;9Q'\:;
M]&:"K0/X!. SX#:)PL=$4>:#<"+/# [$C*WM1'C!S9[[1A3!&>N.=UZH]=YS
MSG^E&3L'HBGF.,;P1<QFCF">?4[!UU(<^0\X7X=O5Q5N(WR[S'Z[6R=(5PG2
M2)!^*7'WK<2UF.MO2=BBIQI,'4?'D@+[-@[JPCM/YQV/;_(9GF>=J.&W,+5L
M+3FA\R\;^U\A.O!2DJL=)8W_/[.AH'+A>.//9ARIT7#873[(_$OS_U!+ P04
M    " !-A1!)UV^HGK$!   6!   &0   'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6QM5,UNXR 0?A7D!R@.2=HT<BPU7:UV#RM5/;1G8H]_5&"\@./V[0O8
M<=V4BX%AOI\!QMF ^LTT ):\2Z',(6FL[?:4FJ(!R<T-=J#<3H5:<NN6NJ:F
MT\#+ )*"LC2]I9*W*LFS$'O2>8:]%:V")TU,+R77'T<0.!R257()/+=U8WV
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M9*_AR1 [*B7,WQ-(G(XTI5?'<]]V+CA86; 55_<*M.U1$P/-D=ZGAU,>(F+
M[QXFNSF3H/V,^!*,G_61)D$"2*A<8!!^N\ #2!F(?.+7A?,]90!NSU?VQUBM
M5W\6%AY0_NEKUWFQ"24U-&*4[AFG'["4<!L(*Y0VKJ0:K4-UA5"BQ-N\]SKN
MTWR3)PML'\ 7 %\!7R. S8FBS._"B;(P.!$SMW80X073 _>-J((SUAWOO%#K
MO9<R2WG!+H%HB3G-,7P3DZX1S+.O*?A>BA/_#\[WX=FNPBS"LVWV;W?[!/DN
M01X)\@\E9I]*W(O)/R5AFYXJ,&T<'4LJ''4<U(UWG<Y['M_D/;PL!M'"+V':
M7EMR1N=?-O:_073@I20WMY1T_O^LAH3&A>.=/YMYI&;#X7#](.LO+?\!4$L#
M!!0    ( $V%$$F$ E8"NP$  'L$   9    >&PO=V]R:W-H965T<R]S:&5E
M=#0R+GAM;&U4W6ZD(!1^%>(#%&5F;'?BF'2Z:78O-FEZL7O-Z%%)^;& 8_?M
M%]"QKN5&X/#]G(,<BE'I-],!6/0AN#2GI+.V/V)LJ@X$-7>J!^EV&J4%M6ZI
M6VQZ#;0.),$Q2=,<"\ID4A8A]J++0@V6,PDO&IE!"*K_GH&K\91DR2WPRMK.
M^@ N"[SP:B9 &J8DTM"<DL?L>,X](@!^,QC-:HY\[A>EWOSB9WU*4I\"<*BL
M5Z!NN,(3<.Z%G/'[K/EIZ8GK^4W].53KLK]0 T^*_V&U[5RR:8)J:.C [:L:
M?\!<PL$+5HJ;\$758*P2-TJ"!/V81B;#.$X[#^E,BQ/(3" ; IZ,0IK?J:5E
MH=6(]'2T/?5_,#L2=Q"5#X:ZPYY+U+CHM=QEAP)?O=",.4\8LL)D"P([]<6"
MQ"S.Y N=Q.F[:(:[0-^MZ6D:%]A'!?9!8/]?B?FFQ!CF/FYRB)H<(@(/&Y,8
MYEO<)(^:Y%\%2+HQB6&VOPNO;H< W88F,*A2@PPMMXHN??9(PNWZA)=%3UOX
M177+I$$79=T=#3>I4<J"2R6]<P5W[B58%AP:ZZ?W;JZGYI@65O6W5E_>F_(?
M4$L#!!0    ( $V%$$E5ZWDBK $  !8$   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0S+GAM;&U4P8[;(!#]%>0/6!R<;*O(L;39JFH/E59[:,_$'MMH@7$!
MQ]N_+V#'ZZ9<# SOO7D#C,L)S9OM 1QY5U+;4]8[-QPIM74/BML''$#[G1:-
MXLXO34?M8( WD:0D97G^2!47.JO*&'LQ58FCDT+#BR%V5(J;/V>0.)VR778+
MO(JN=R% JY*NO$8HT%:@)@;:4_:T.YX/ 1$!/P5,=C,GP?L%\2TLOC>G+ \6
M0$+M@@+WPQ6>0<H@Y!/_7C0_4@;B=GY3_QJK]>XOW,(SRE^B<;TWFV>D@9:/
MTKWB] V6$J+#&J6-7U*/UJ&Z43*B^/L\"AW':=[YG"^T-($M!'9'H'.B:/,+
M=[PJ#4[$S$<[\'"#NR/S!U&'8*P[[GFCUD>O5<%82:]!:,&<9PS;8'8K@GKU
M-05+I3BS_^@L32^2#HM(+[;T_#$ML$\*[*/ _I\2B[L24YA].LDAF>20$#C<
M)4EA[BNAFXM38+KX/BVI<=2Q&S;1M06>6+SX#WA5#KR#']QT0EMR0>>?3[SD
M%M&!MY(_>"^];])U(:%U8?K)S\W\;N>%P^'6A>NOH/H+4$L#!!0    ( $V%
M$$DG5=<UO@$  'L$   9    >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;'54
MS7+;(!!^%48/$&1D.ZE'UDR<3J<]=":30WO&TNIG JP*R$K?OH L177(Q<#R
M_>SB7>4CZE?3 ECR)H4RQZ2UMC]0:LH6)#=WV(-R-S5JR:T[ZH::7@.O DD*
MRM)T3R7O5%+D(?:LBQP'*SH%SYJ804JN_YY X'A,-LD<>.F:UOH +7*Z\*I.
M@C(=*J*A/B:/F\-I[Q$!\*N#T:SVQ.=^1GSUAQ_5,4E]"B"@M%Z!N^4"3R"$
M%W+&?ZZ:[Y:>N-[/ZM]"M2[[,S?PA.)W5]G6)9LFI(*:#\*^X/@=KB7LO&")
MPH1?4@[&HIPI"9'\;5H[%=9QNKF?:7$"NQ+80GA(0^*344CS*[>\R#6.1$]/
MVW/_#VX.S#U$Z8.A[G#G$C4N>BDR=I_3BQ>Z8DX3AJTPFP5!G?IBP6(6)_:!
MSN+T+)IA%NC9FIY^B0MLHP+;(+#]K\2'FQ)CF$],=E&3W4>!++TQB6$^><E]
MU&0?$6 W)C%,=F-"5]TA03=A" PI<5!AY%;19<X>6>BN=WB1][R!GUPWG3+D
MC-;U:.BD&M&"2R6]<P6W[DNP' 34UF]=:Q,]#<=TL-C/H[Y\;XI_4$L#!!0
M   ( $V%$$E9A?-OH0$  +$#   9    >&PO=V]R:W-H965T<R]S:&5E=#0U
M+GAM;'53VV[<(!#]%<0'!!M[TVCEM91-%*4/E:(\M,^L/;91N#B U^G?![#7
M<;;N"S##G#-GAJ$8M7FS'8!#'U(H>\"=<_V>$%MU()F]T3TH?]-H(YGSIFF)
M[0VP.H*D(#1);HED7.&RB+X74Q9Z<((K>#'(#E(R\_<(0H\'G.*+XY6WG0L.
M4A9DP=5<@K)<*V2@.>#[='_,0T0,^,UAM*LS"MI/6K\%XV=]P$F0  (J%QB8
MW\[P $($(I_X?>;\2AF Z_.%_2E6Z]6?F(4'+?[PVG5>;()1#0T;A'O5XS/,
M)>P"8:6%C2NJ!NNTO$ PDNQCVKF*^SC=W"4S;!M 9P"] I I493YR!PK"Z-'
M9*;6]BR\8+JGOA%5<,:ZXYT7:KWW7&997I!S()ICCE,,7<6D2P3Q[$L*NI7B
M2/^!TVUXMJDPB_!L#4__0Y!O$N21(/]6XNZJQ*V8VZLD9-53"::-HV-1I0<5
M!W7E7:;SGL8W^0HOBYZU\(N9EBN+3MKYEXW];[1VX*4D-SN,.O]_%D- X\+Q
MAS^;::0FP^G^\D&67UI^ E!+ P04    " !-A1!)+7(J@]@!  !%!0  &0
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M(=]5 Z"]#\XZ=?0;K?M#$*BB 4[5@^BA,SN5D)QJLY1UH'H)M'0DS@(2ADG
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M;'_<A8@8\$? :%=G$K2?$%^#\50?DC1(  F5"PS<;V>X RD#D4_\-G-^I S
M]?G"_A"K]>I/W,(=RK^B=IT7FR:DAH8/TKW@^ AS"=>!L$)IXTJJP3I4%TA"
M%'^?=J'C/DXW^<T,VP:P&< 6P,\T"I\219GWW/&R,#@2,[6VY^$%LSWSC:B"
M,]8=[[Q0Z[WG,O^5%O0<B.:8XQ3#5C'9$D$]^Y*";:4XLF]PM@W/-Q7F$9ZO
MX7F^3;#;)-A%@MVG$K,O)6[%?%5)5SU58-HX.I94..@XJ"OO,IVW++[)1WA9
M]+R%W]RT0EMR0N=?-O:_073@I:17UPGI_/]9# F-"\<?_FRFD9H,A_WE@RR_
MM/P/4$L#!!0    ( $V%$$GM?"H5. (  (0'   9    >&PO=V]R:W-H965T
M<R]S:&5E=#4R+GAM;(U5VXZ;,!3\%<0'K,&8VXH@-215^U!IM0_MLY,X 2U@
M:CMA^_>U#6'!>*-]P;>9.7..C9WUE+WQDA#AO#=URS=N*43W#  _EJ3!_(EV
MI)4K9\H:+.2070#O&,$G36IJ #TO @VN6C?/]-P+RS-Z%775DA?F\&O38/9O
M2VK:;US?O4^\5I=2J F09V#BG:J&M+RBK</(>>-^\Y_WJ4)HP.^*]'S6=Y3W
M Z5O:O#SM'$]98'4Y"B4 I;-C12DKI60#/QWU/P(J8CS_EW]N\Y6NC]@3@I:
M_ZE.HI1F/=<YD3.^UN*5]C_(F$*H!(^TYOKK'*]<T.9.<9T&OP]MU>JV'U82
M;Z39"7 DP(G@HX>$8"0$7R6@D8"^2@A'0F@0P)"[KMP."YQGC/8.&W:[P^I0
M^<^AW)NCFM1;H==D[;B<O>5!&F3@IH1&S'; P!D&+A'%&A%X2\C. O&7D+T%
MDJ() V0>4S+0F@S4 L%,P(\]NT!@%0BT %HX"(UJ#)A$8]JA&B@UZF'!0-]N
M!%F-((N1R# R8*)9$#\PMJZP8!"T&PFM1D*+D=@P$JZ#F 5Y"%G8B*PV(HN-
MQ+ 1K6(89[!XA%B8B*TFXI4)WS=/1[P*@3SCG!=K3) 8?]0N7IV@ !I%W:\Q
M,/VDJHDUH<1252/(-ED%^>273*TATE4(Y)G;DJYS-4* V776X0OYA=FE:KES
MH$+>C/K^.E,JB%3SGN19*^63. UJ<A:J&\L^&UZ)82!H=W_SIH<W_P]02P,$
M%     @ 384021X,&8RD @  2 P  !D   !X;"]W;W)K<VAE971S+W-H965T
M-3,N>&ULE5==;Z,P$/PKB!]0V(5\502IZ>ET]W!2U8>[9S=Q$E3 .>PTO7]_
MMDG2M!E+Y"48,SN[@SUF4QQ4]ZJW4IKHO:E;/8^WQNSNDT0OM[(1^D[M9&N?
MK%77"&-ONTVB=YT4*Q_4U FGZ3AI1-7&9>'GGKJR4'M35ZU\ZB*];QK1_5O(
M6AWF,<6GB>=JLS5N(BF+Y!RWJAK9ZDJU42?7\_B![A<9.XA'_*[D05^,(U?\
MBU*O[N;G:AZGK@99RZ5Q%,)>WN2CK&O'9#/_/9)^Y'2!E^,3^W<OUY;_(K1\
M5/6?:F6VMMHTCE9R+?:U>5:''_*H8>0(EZK6_C=:[K51S2DDCAKQWE^KUE\/
M_9-I>@S# 7P,X', C7WA?2)?YC=A1%ETZA!U_;O=";>$=,_V12S=I-?MG]E"
MM9U]*_.4BN3-$1TQBQ[#%Y@/1&+9SRD8I5CP53CC\ Q6F/GP_%.% 8(<$N2>
M(/M$D&&"$208@0KR+^\(848XR1@F&0.",2:80(+)<)E32# =(!-A)CC)#":9
M 8(I)G!N0CLV'2Z4 IN>!DB%H,"2$MSY#\2 8A:@P+N?LAO4XOU/^1"U $1I
M( ^V"0$/4."D(&P"&M^@%MN )D/4 A %#A7";B%@!0J5BKU L^%J&9N!TP%J
M$8CR0![L& 9FH( 9&)N!^0:UV R,O@57:@$HM+:,'</(#('#F+$9>'2#6FP&
M1I^$*[4 1($3F;%C&)DA<"8S-@-/;U"+S<#HRW"E%H!":YMAQV3(#($S.<-F
MR&BXV@R;(4-?AJ]J$8B_GLG)1:?7R&[C&UH=+=6^]?WSQ>RY:7[P/7/R 2^+
MG=C(7Z+;5*V.7I2Q_:;O"M=*&6EK2>_L?M[:MOY\4\NU<<.)'7=]H]O?&+4[
M]>WG/P_E?U!+ P04    " !-A1!)PP@JWY "  #Y"0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970U-"YX;6R-5MN2HC 0_16*#QA(#(H64J7HUN[#5DW-P^YS
MU*C4 &&2J+-_OTE U- X\T*2YISNDUNGDPL7[_+(F/(^RZ*2<_^H5#T+ KD]
MLI+*%UZS2O_9<U%2I8?B$,A:,+JSI+((<!B.@Y+FE9\FUO8JTH2?5)%7[%5X
M\E265/Q;LH)?YC[RKX:W_'!4QA"D2=#Q=GG)*IGSRA-L/_<7:+9&D8%8Q)^<
M7>1=WS/B-YR_F\&OW=P/C096L*TR+JANSBQC16$\Z<@?K=-;3$.\[U^]_[#3
MU?(W5+*,%W_SG3IJM:'O[=B>G@KUQB\_63L'JW#+"VF_WO8D%2^O%-\KZ6?3
MYI5M+\V?.&QI, &W!-P1T/@I8=021AT!1T\)I"60[Q*BEA YA*"9NUVY%54T
M302_>*+9[IJ:4X5FD=Z;K3':K;#_]-I);3VG!*,D.!M'+6;98/ =YH8(M/<N
M!(9"+'&/3C!^#)%!F-$C9@5AR"-F#6$B6.P(7(^1=4 >'(P=L1!F @<A8! "
M.(B=(!!F"@>)P"!1W\$H=((TF-AB*HN)G$7O(P@L8@R*& ,BG..5-9CQ78BI
M(Z*/0!A6,0%53  5[@F<]":*'*&KKR%K #*@- :5QH!2YQYD<6\UG&U=?8E8
M/T,\R)R",J> 3.<J9A#&/5T0QKEM:P@S<-O,DP#EN!!P$0^X&$B3Z!LS!D$#
M=Q:!N7*!<-\%&=@:!&<P!*2GOE0 1 :R.H*3& (R%!DX[ A.40C(4<0Y[DL0
MY":AX.Z]*YDXV$I#>EM^JI1Y#^ZL736SP.:]=.Q+4^78=_3F)DUJ>F"_J3CD
ME?0V7.G7V+Z9>\X5TQK#%ZWQJ.NP;E"PO3+=B>Z+IC)I!HK7UT*KJ_;2_U!+
M P04    " !-A1!)C^I]8V8#   C$   &0   'AL+W=O<FMS:&5E=',O<VAE
M970U-2YX;6R-6%USHC 4_2N,[RV$;QQUIMHOK3O3Z</N,]6H3(&X$&OWWV\2
M(DIRH[P(A'-.3I*;>XFC(ZF^ZAW&U/HI\K(>#W:4[H>V7:]VN$CK>[+')7NS
M(5614O98;>UZ7^%T+4A%;KN.$]I%FI6#R4BTO5>3$3G0/"OQ>V75AZ)(JW]3
MG)/C>( &IX:/;+NCO,&>C.R6M\X*7-89*:T*;\:#!S1<HH1#!.)WAH_UQ;W%
MS7\2\L4?YNOQP.$><(Y7E$ND[/*-9SC/N1+K^:\4/??)B9?W)_5G,5QF_S.M
M\8SD?[(UW3&WSL!:XTUZR.D'.;YB.8: "ZY(7HM?:W6H*2E.E(%5I#_--2O%
M]=B\B1U)@PFN)+@MH>T')GB2X)T)_E6"+PE^7T(@"4%?0B@)85]") E17T(L
M"7%?0B()25\"7_-FY9PS);Q.:1<;]>[EM-S(52AV$U@B+!]3FDY&%3E:5;.7
M]BG?LFC(6$R<MXI %R]99-:L]7OB^\'(_N9*$C-M,&X'$W8Q"QV#6H3-++0^
M7-#'U-7X;K>'F8[P_:B+>00P7<03I!)W,<\ZQG.ZD!=()NEB7@%,H.C,(0Q2
MIO;FU+S=-KP$((8%\N! \82 UW'JP@H^K. +!;^CX"FAUF!B@2D%1AG(3$<H
M&H\ZXDZ9L"< HLSZLPY11%X )XK95Z ?Q>T<@ 3*!ES<G)4W:,S*%EU"&$,,
M!/ *!D ,^+!"""N$0 RHHVTPX85/91._Z0A/@2QUB&&H$6PT HR&L$(,*\3]
M-TP"*R2:!T^)GD6B#5.-#!V!E%!?ZI H@HWRH@96$0>8+B4Y+R3HFED <J>&
M,81Q/8-?4]5#@-]8]8N CE3# ":*5<<ZR#'XA:OC W(!OXGJU^WA%\#$ZMX!
MA4PS;"@7R-,=AX[JV-,ZT@P#D$3UJV,,6Q492A/J49L6$G0U?G6(ELV7$ B9
M-IPA$Z, F%Y#AD.&7(S"_AD*&=(D@O*D-G'1S?HE(=>769>Y,U0?9,C)"$K*
M)@U#5D9Z6M9JV)L$=3X.U*FU+S[2"UQMQ=FSME;D4%+N\:*U/=\^N/PC7VF?
MHN$< >T+?AX6AX*S_&2T3[?X5UIML[*V/@EEAPOQ_;\AA&)FW;EGH;5C)_;V
M(<<;RF\C=E\U9]CF@9+]Z4C>_B\P^0]02P,$%     @ 384026/O7;*5 P
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M#O^'ZC"L.FRJ#D@6DIW>(+R[0VM%FX.Z7[3.EIUK+H]D=[/#'>89RT.O-K]
MDU5W$[F9F66G_$!_YLVAJ%MGP[@X4JN#[YXQ3D6,_I.HQ5'<OH9!2?=<OL;B
MO>GN(]V L]/U>C7<\6;_ %!+ P04    " !-A1!)3"8N!U,"  #K!P  &0
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MV>Z9X@XB!B%B "(R(.)%BF^^^0E"FA &24"09 &"D%F-9/'N@\"LQU+C)P]
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M 0[?=_@!SJ$<*?O@+4+"^R2XYUN_%6+8 ,#K%A'(G^B >CESHHQ (8?L#/C
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M=15'819<3:)6LVXTI*,A?<5FJ*"?20(-\* @* 6Q\;1+00!/0-$$U":(>LL
M9QF-)K6:RFH@I#-G)4-1FA*<)$))(H3$V:YUHTDZD]#0W=*AALQG.$B,@L0(
M"'5 XL$D,QH[($--G,8X2(*") A(A">8H0EFTT]'BB9()YR.=+!,&!R.YYH>
MR!P%F4\X''-DDL@!P304!S$FAM5]..%XM*+>074K?R@9^;8P8D" @(R<+\#=
M _[#/@#W#YAB(*VH5Y,$W T9BB!-1V!P"X$I'@)#@X H<6$PT8B= 6XC,,5'
M #$2UT<038>WCX(;"2!.0L:V%K<2P+QD[,#B9@*8FR3NA@RM(HE<.T%$XS"X
MH0#B*&-;0G G(.'TZB%X#1.LAMWJ:44],W%_]##-B*^1D9L$F5 [K:A?R"[*
M4TT?!?<4@GF*6SD$NY6X*(C&_4!!Y\)W9D?^D]7'O)+>5BA]=[0WO(,0BNM\
MX8NNQ).^TS\Z!3\HTYSI=MW<<IN.$N?[I?WQG\/J'U!+ P04    " !-A1!)
M\XQ =U0"  "V!P  &0   'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6R%E=V.
MFS 0A5\%\0!K?@-$!*D!5>U%I=5>M-<.,0$M8&H[8?OVM0UA63/9O0EX.&?\
MS4 \Z4C9*Z\)$=9;U_;\8-="#'N$>%F3#O,G.I!>/JDHZ["02W9!?& $G[6I
M:Y'G.#O4X::WLU3'GEF6TJMHFYX\,XM?NPZS?T?2TO%@N_8]\-)<:J$"*$O1
MXCLW'>EY0WN+D>I@?W/WA>LHB5;\;LC(5_>6@C]1^JH6/\\'VU$,I"6E4"FP
MO-Q(3MI699([_YV3ON^IC.O[>_;ONER)?\*<Y+3]TYQ%+6D=VSJ3"E];\4+'
M'V2N(50)2]IR_6N55RYH=[?85H??IFO3Z^LX/8GN-MC@S09O,<3.IP9_-OB+
MP0T^-02S(3 ,:"I%-Z+  F<IHZ/%IK<W8/61N/M MKI40=U9_4RV@LOH+0N#
M*$4WE6C6Y)/&6VF\CXIBJ_"=18(DP$+A@12>]OLKOYNX< (?3.#K!,&',F*C
MC$D3:TVO-4'B&(4 &O\!2 ""! !(8H!,FMUJ$S<Q.PIHX@0&"4&0< L2&M7F
MX783SWCY!:!Q0QAD!X+L !#7 -EM-W&,UU= &A\&B4"0: /B!F9'(J!:$P30
M! ^^D1@$B;<@JY9JS7&KB4W6>/.MRH88>8JM*(D>?$<)")LLUHU!':C0D>)\
MR7X$-$ED8*'5&=81=M'#@%LEO?9"G0.KZ#)PCGH\F/%DGR= 7%+L\VE"H?<-
MLG3 %_(+LTO3<^M$A3Q[]0E942J(A'>>Y'^BED-T6;2D$NI6#@6+36-E6@@Z
MW*?D,JJS_U!+ P04    " !-A1!)-*K1R!($  "(%0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970V-BYX;6R56-N2FD 4_!7*#PC,#=!RK5IW79.'5*7RD#RS
M.BH58 S@FOQ]N"VK9WHV[HO V.><GDOWP,S/IOQ5';2NO3]Y5E1WDT-='V>^
M7VT..D^J3^:HB^:?G2GSI&X>R[U?'4N=;+N@//-Y$(1^GJ3%9#'OVKZ5B[DY
MU5E:Z&^E5YWR/"G_+G5FSG<3-GEM^)[N#W7;X"_F_ABW37-=5*DIO%+O[B;W
M;+:6HH5TB!^I/E<7]UY+_MF87^W#E^W=)&@YZ$QOZC9%TEQ>](/.LC934_GW
MD/2M9AMX>?^:_:GK;D/_.:GT@\E^IMOZT+ -)MY6[Y)35G\WY\]ZZ(-J$VY,
M5G6_WN94U29_#9EX>?*GOZ9%=SWW_\3!$(8#^!# QX"Q#@X00X!X"Y#O!L@A
M0(X!8?QN@!H"U%N%\-V < @(;Z44#0$1"?#[T>WFYC&ID\6\-&>O[!?4,6G7
M+9M%S>QOVL9NLKO_FMFIFM:7A5)\[K^TB0;,LL?P*XRXQJQL#!L1?L-@I,$1
MC24')>1UB0>$4=>81QLC54"HVAC2X2<;(4B2-8 X.BS@N(LN7EQU)L0))$P@
MNP3R<L#IB*UZ3-QABJ$?I"-/-D9%9%37-B; 5!6DJBRJ2D6$*L+$A"K"3 E5
M@ D=9$-(-@0)&"&+,'0-(0P1S1IA)"8;0;(12$ F;X4P(2&+,!$F$D,B,4A
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M(=.[NKV-FONR/RCL'VIS?#WW' ]?%_\ 4$L#!!0    ( $V%$$F WS/TX0$
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M"-1"+5.Y9N9W,1M!A^FOG#_LX@]02P,$%     @ 38402=!]_E,@ P  'Q
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M&^_G$+<)=Z)H]-]@=VFD*&\A85"R]^Z85_IX[>ZDJ ^# T@?0.X!>#$90/L
M:@5$G3,]KR],LNVZ%M>@[A;CS-HUQX]456[7#NI"Z7MJ9HT:?=O&J^4Z>FL3
M]9JG3D,&&F(J,E=!T5T2*0-W%P1T070\-5RD< (*)J ZP<)(L+*F 6B2Q)H(
MI%G"1A:@D863(*66CTZ2:DFE)7AIUSQS102M$MA)##J)'2<)0I:53I,,GF(I
M,E?QB:*1M4U 'PG@ UL^$I^2@**1DBQ!*TO "H$3I&""U+]/5V""E4>? AJ[
MA[)IC6&DI1CTXB.@&':K]J)AS:G=1-F,R#0S0B$\_]KTFG2B60')N!.81)@
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MMJ=+=5YW^]?N0HKS;3M^_Y_ ]A]02P,$%     @ 38402?7%4Y & @  V08
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ML;^O<QV%!0+M-O2I8=MHGB6*\ .)#_8JW!X&M&\TB#;$,8(6FV"]3S['#%;
M[!#J\)G\POQ<M\(Y,:G.,W/JE(Q)HO2\!_775^J>F0:4E%)W=ZK/AY-W&$C6
MW2Z2Z39+_P%02P,$%     @ 38402;H!Y ^5 @  >0D  !D   !X;"]W;W)K
M<VAE971S+W-H965T-S N>&UL?5;;;N,@%/P5RQ]0&XQOE6.I3;3:?5BIZL/N
M,TU(8M4V*9"F^_<+V'$<..Y+N'CFS' @!ZH+%^_RR)@*OKJVEZOPJ-3I,8KD
M]L@Z*A_XB?7ZRYZ+CBH]%(=(G@2C.TOJV@C'<19UM.G#NK)S+Z*N^%FU3<]>
M1"#/74?%OV?6\LLJ1.%UXK4Y')69B.HJFGB[IF.];'@?"+9?A4_H<8.(@5C$
MGX9=Y*P?&/-OG+^;P:_=*HR-!]:RK3(AJ&X^V9JUK8FDE3_&H#=-0YSWK]%_
MV.5J^V]4LC5O_S8[==1NXS#8L3T]M^J57WZR<0VI";CEK;2_P?8L%>^NE##H
MZ-?0-KUM+\.7-!MI, &/!#P1)AV8D(R$Y$;X7H&,!'(CV%Q'PU)L(C94T;H2
M_!*(8?=.U!P2]$ATJK=FTF;6?M.ID'KVL\Y05D6?)M"(>1XP>(9)T^0>L_8Q
M:$)$VL%D T,VGK%'SU#N2/@8?(_8^(@DAETD8#(2RT_FBRAS.  ! Q ;@-PM
MHW"6,6 *B^D'DTGJ+,3'X+*$C:2@D10P4CI&!DPV-Q*[&?4QN"2PD0PTDOE&
M<.P8R3P1XD V/B0I8!LY:"/W;"!78YU[&BAVSN &P*"%C2E (X5O!#F[ORZ\
MW<\+XA@!,.G"62]!(R6P,<@Q F'<$_(]YLZ(*<!0"8J!$%Y]\4$D3A=T%DH=
M G2(JX.\Q!*R<-006,N>$ 9T4K>F8D\'Q4LZ<+5"":#CU6X?1-#"/QC!10T!
M50V[Q1D!9<WQL@$PQ#VST>SBZI@XV!> #+;\W-L'QVQV>F4\87OQW>!U=:('
M]IN*0]/+X(TK?7W:2V[/N6+:2OR@"]M1OX.F0<OVRG1SW1?#RV 8*'ZZ/G2F
MUU;]'U!+ P04    " !-A1!),1#4VTH#   A#P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970W,2YX;6R55\&2HC 0_16*^PZD X@66C4RL[5[V*JI.>R>&8U*
M#1 7XCC[]YL$5$PZ4WH1B*^[7U[R&I(=>?O>[1@3WF==-=W<WPFQGP5!M]JQ
MNN@>^)XU\I\-;^M"R,=V&W3[EA5K'517 81A$M1%V?B+3(^]M(N,'T15-NRE
M];I#71?MOR6K^''N$_\T\%IN=T(-!(LL.,>MRYHU7<D;KV6;N?](9L]40S3B
M=\F.W>C>4^3?.']7#S_7<S]4'%C%5D*E*.3E@^6LJE0F6?GOD/124P6.[T_9
MO^OI2OIO1<=R7OTIUV(GV8:^MV:;XE")5W[\P88YQ"KABE>=_O56AT[P^A3B
M>W7QV5_+1E^/_3]I.(3A 3 $P#F )%\&T"& 7@*B+P.B(2"Z-2 > F(C(.CG
MKI5[*D2QR%I^]-I^N?>%VE5D%LNU6:E!O13Z/ZE=)T<_%@FD6?"A$@V898^!
M$8:<$8',?BX!6(DE6.%P72"W$32\ACPA$'(->;8A41SB1"FJ!=4)Z)464SQ!
MA":(=()HG,"<R++'I!K3]&)&>(T8K1%;-0B=&C5Z3#*J8;#(8XL%Q(;B-L0A
M9H+R3! MC!7+$XOGB,55C0E:8X+4,/;6<F+5,"::VX@4)Y&B)%*$!#5(I%:)
MR"!A(QPDIBB)*4+"*+&<6@OZC3B,K'HKUBQ"JTR<.G8O<?0;<KO)"-I/'@D@
MDS46]7D C6<;AXX-3/!V0"A2)W&DP!L"B>Z8+>YW8AL^H1.S0]N@&":..KA?
M"698ZTV06*J:#2XGMJLC%Q7<U@3SM=GCB&U;L[T@$' 0P:U-$&]'KDV$&Y-,
M;]\!@+L.;-?9*S. KN1(##T0C&N3 .Y>((@@KH\!W+T =PB"&Q,P8UJ"T*]>
MM(,@U!;$L;R &QR05W[DV&2 &QSB.P3!O0N8=\T>@8"</0)P8P)F3$OXB25\
M:@F/F#=TO/H!]R9@WJ2.%+@WX0YO4MR;] 9OY@/HAD\IBMN.8K8S7^\(*+(T
M#4;G@IJU6WTBZ[P5/S1"?3N/1L^GOD=0YPIC?$EF3_W9[9)FD>V++?M5M-NR
MZ;PW+N2I19\M-IP+)CF&#W*O[^1Y]?Q0L8U0MQ-YW_8GN/Y!\/WI0'H^%2_^
M U!+ P04    " !-A1!)*XMMB 4%  #"'@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6R56=MNXD@0_17$!XS==QP1I"71:/9AI=$\[#X[T 0TOK"V
M$V;_?GTA#'2="O8+8/M4N?JT3_7!O3R5U<]Z[WTS^Y5G1?TXWS?-\2&*ZLW>
MYVG]I3SZHKVR*ZL\;=K#ZC6JCY5/MWU0GD4RCFV4IX=BOEKVY[Y7JV7YUF2'
MPG^O9O5;GJ?5?VN?E:?'N9A_G/AQ>-TWW8EHM8PN<=M#[HOZ4!:SRN\>YW^(
MAV>G.DB/^/O@3_75[UE7_$M9_NP._MP^SN.N!I_Y3=.E2-NO=__DLZS+U-[Y
MWW/2W_?L J]_?V3_V@^W+?\EK?U3F?USV#;[MMIX/MOZ7?J6-3_*TS=_'H/I
M$F[*K.X_9YNWNBGSCY#Y+$]_#=^'HO\^#5<6\3D,!\AS@!P;H,X!ZA(@]*<!
M^AR@@X!H&$I/Q'/:I*ME59YFU3![Q[1[2,2#;JG>="=[9OMK+15U>_9]9;59
M1N]=HC/F:<#(*XR\13Q3A(HOD*@MX%*%A%7(/E[?5&%Q @43J#Z!NDG@< (-
M$VA0P2+@8< L>DPQC-(&F&> 40878F A!A22!(4,&'MU$ZED,&O/ "22!)=B
M82F6EF*8:74P@1L_*PN88#%B5A9DG'16 (:;E006DHR8E802KJ_X&BH!(*D9
M4KN&A20;@WD13 I&]6+\S @L68$T&_"^!J!%''87"9YF'388 !*2*1BW"*$
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M'1@"JHU9VPG=OU]?"*'@]B6VAW/FG!G'DP^,OXL&0'H?E'1B[S=2]CN$1-D
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M]>C-TZP9DZ",! _J\ALUBZ<#@5KJ[5;MN1U/]B!9?QNVT\0O_@-02P,$%
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MJENH<"'WN!!FG.(;F" 7<<\?&6'"B0$B4D\*#"^Y7 (B@(IEOA'!]%)R"Q-
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MDKE7#&S!B<U)*#AM;2@4F+>" Y?#4'#B/M"Z;8$HID5!>2Q$%)C= L&;,E$
M\ 9LTB&13QT#D;*M;0QQ@2C.L CPJ[AEI*($2)!J2H#YCA*S7"*6!Y84F*Q2
MW(]%B<DJY1U8'$4?#S82L4T6%%F6D\0@EPCDE(D2P#>BAH&&[L82*+*-$H:X
M!!!G2)0<O6QG"#1T.P0DMNIB?DO.;\Y$>3=Y)2:O1'MEBD3)R?O OKJ 1M&:
M<(UMI6* 2P1P"D3)P<O*AMA,<8A$EDV#Q/R6B-^4AA)0U_>IX3L@GR"1LCG&
M_):(WY8Q4IBFRKL?A0K35(%]*D/A*")C2$<:JA3=;D&5M'S+*<QOA?A-::@0
M=2E=D$A2?B.1=:0LIQB WPR'BF.7;H;^+4F Q%9=C&[%T<UIJ.YFKL+,56C/
M3&FH.',I.[9(PR8=UUB^Q11FMT+LIC14B-W,+A"Q#WPDLAG&^%8(WY2'HRB>
M>Z%['*BBJS^!JLGJ'TR[D^/-0E?'_IRX=G;F4C;=*>'D[>TL^EEVQZ/D_48\
M)L.)\GN:]>J<'O77M#IF9>V\F*8Q17]$>C"FT:U)[U,[#TXZW=\><GUHNMNH
MO:^&<^7AH3'GMV/RVUG]^B]02P,$%     @ 384021MAR3C? 0  ]@0  !D
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M%"R^?$;$V8Y0&=3\TBGS 2VB\Y1^@69R./%*3^]QV-YERJ+'9_(+BW/;R>#
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M:MNJ'([(7ZJJ-5T-HZ#CW,'D^^M-85[:_C+IKNOQ1<1XTU;G]_<JUY<[Z_\
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M]Y = 'E@P@?S]#7?O\LS@ 4"4"#0 L&T")YA,NLQL<8T&A,LC%3G$-^HQ@Z
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MQ !+9K'$#@LB:($E 5D2@"6W6!*'Y1M."(%I4I F=6E0:-&D  V*8)8,9,D
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M7-1L+_5KJMZ[?L3K%Y*?KA/K.#:7_P%02P,$%     @ 38402=1PKD*" @
MX @  !D   !X;"]W;W)K<VAE971S+W-H965T.#4N>&ULC59-CYLP$/TKB'L#
M-A\Q$4'*AZKV4&FUA_;L$">@!4QM)]G^^]K&(03,*I=@F_?FC6<F,Z0WRCYX
M08AP/NNJX6NW$*)=>1[/"U)COJ M:>2;$V4U%G++SAYO&<%'3:HK#_I^[-6X
M;-PLU6=O+$OI151E0]Z8PR]UC=F_+:GH;>T"]W[P7IX+H0Z\+/5ZWK&L2<-+
MVCB,G-;N!JSV(%00C?A=DAL?K!WE_('2#[7Y>5R[OO*!5"07R@26CRO9D:I2
MEJ3R7V/TH:F(P_7=^G=]7>G^ 7.RH]6?\B@*Z:WO.D=RPI=*O-/;#V+N$"F#
M.:VX_G7R"Q>TOE-<I\:?W;-L]//6O4&^H=D)T!!@3P#QEX3 $(('(?R2$!I"
M.")XW55T(/98X"QE].:P+GLM5D4"5J$,=:X.=63U.QD*+D^O&0(H]:[*D,%L
M.PP<8$"/\*3U7@+:)+9P0H?/ KLI(O"?(7L+9,:)P'K/0/.#X3W]V&X@M!H(
MM8'PR<!R%*@.$VM,TP4*V34BJT9DT1@G(YIH1':)V"H13R5 ,I*()Q+?$KO&
MTJJQG&K 43ZWRZG&3#Z150-9[@%&&FB:CF!4>1;(3,82JQO)M*S@S#U4^[']
M ?T7"LN T,#/9$YFYG\.7J@M U)JCWA M$A&D=T98#+T)UK$([?W%AA*%G"F
M8(&U?6P ?*%D#6B82#232&!O$"!XH6H-Z*E>YMH(L/<18&DDD\HU(/2D@\9)
MF((F1>$-YD!-V%D/5.[D]-((U4X'I_W0WD U1T;G6S7,]7QYF,G2%I_)+\S.
M9<.= Q5R2NE9<J)4$.FBOY#=JI"?&_VF(B>AEDNY9MT [C:"MO?OB?ZC)OL/
M4$L#!!0    ( $V%$$G*3XAGJ0(  ,$)   9    >&PO=V]R:W-H965T<R]S
M:&5E=#@V+GAM;(U638_;(!#]*Y;OC0W^7CF6-HFJ]E!IM8?V3!*26&N;%,AF
M^^\+V'&\,%XEAQCC]^;-#,Q >67\39PHE=Y'VW1BZ9^D/#\%@=B=:$O$@IUI
MI[X<&&^)5*_\&(@SIV1O2&T3X#!,@Y;4G5^59NZ%5R6[R*;NZ OWQ*5M"?^W
MH@V[+GWDWR9>Z^-)ZHF@*H.1MZ];VHF:=1ZGAZ7_C)XV*-40@_A=TZN8C#WM
M_):Q-_WR<[_T0^T#;>A.:A-$/=[IFC:-MJ24_PY&[YJ:.!W?K'\WX2KWMT30
M-6O^U'MY4MZ&OK>G!W)IY"N[_J!##(DVN&.-,/_>[B(D:V\4WVO)1_^L._.\
M]E_R<*#!!#P0\$CH,S%+B 9"="?$7Q+B@1!;A* /Q21B0R2I2LZN'N]7[TST
M)D%/L4KU3D^:S)IO*A5"S;Y7.<9E\*X-#9A5C\$3#!H1@;(^2F!(8H4=NB6P
M=A%1^!FR 2 S3D1@G)'A1],XPQ0V$(,&8F,@_F0@LQ+58U*#Z?I$(1S!*@FH
MD@ JN:62."HXGPDE!4525V3B92^2.B+?HBR#53)0)0-4K%5=9:Y*'L(B.2B2
MNR((62*Y(U(D]@YT,?,K5X">%$"XL>5)X:HD,SG5S0HJU]#=QWBF$-!,Q:,'
M=O( RB>N9L6,#%CUSP@_L)4'D([JOCAX$<7%Y&<MU< I)I2\6&2)U3 @6+R(
MDYD@X*Z!H@=*90!-ES6;V<0([BT(:"Y.K2"WN^1SFP=N+@CH+DZU(+>]%*&]
M!,GCNP-N00CJ07:Y#*"I3));,L'DH&LI/YH;@_!V[-))?5Y,9L=;R3/6!Z4U
MO]*W%7. WLU4Y9D<Z2_"CW4GO"V3ZA@VA^6!,4F5B^%"9>*D[E/C2T,/4@\S
M->;]#:-_D>Q\NS"-M[;J/U!+ P04    " !-A1!)8F348=,"  !D"P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6R%EDUSFS 0AO\*P[T!B0_C#&8F
MX.FTA\YD<FC/BBW;3 "YDARG_[Z2P 2DQ;D8)-[=?;265IM?&7\3)TJE]]$V
MG=CX)RG/CT$@=B?:$O' SK137PZ,MT2J(3\&XLPIV1NCM@EP&*9!2^K.+W(S
M]\R+G%UD4W?TF7OBTK:$_RMIPZX;'_FWB9?Z>))Z(BCR8+3;URWM1,TZC]/#
MQG]"CUN4:HE1_*[I54S>/0W_RMB;'OS<;_Q0,]"&[J1V0=3CG5:T:;0G%?GO
MX/0SIC:<OM^\?S?+5?BO1-"*-7_JO3PIVM#W]O1 +HU\8=<?=%A#HAWN6"/,
MK[>[",G:FXGOM>2C?]:=>5[[+RD>S& #/!C@T:#/Q*)!-!A$GP;Q78-X,(@M
M@Z!?BDG$EDA2Y)Q=/=[_>V>B-PEZC%6J=WK29-9\4ZD0:O:]R'"2!^_:T: I
M>PV>:-"H")3W,02&0I38,<?S )6KB,*Y9 M(%B B<)V1L8^F$"B#'<2@@]@X
MB&>)2JU$]9K,:#JC^8:L9%:0)K86"VDB&#8!81, =F7!]IIT&L1F!20V*B!9
M($U!TA0@S2S2U(EA[8[*54P3UI/>\S(#78&@*P!T;8&NG!#( G45EH_M/1\S
MS S$S%Q,^RR5F1/"RGCUI6)[3S'#7(.8:P#3RE6Y_BI7E:NP__1[BAFFOAR@
M\A@ZH"BV\SF([AXE2&.5P2VD21=P%ZHY<G'M"E0.HEF8E8T+:)P3-8CF=6KA
M4"'P;GA"&-@(V ;&#@RV*P"@F2Q\C@+?$"@"4"(;)7+#V&=\T$S3,JGP<Q3X
MKD'N99/@A?.%X!L )<Z%E^ E"K@T([<V)T[)&T33Q=I;-ICT(BWE1]/4"6_'
M+IW45_ID=FP<GTQ[9<V7NJ$T/<ZGFR(_DR/]1?BQ[H3WRJ3JE$P_<V!,4D48
M/JA,G%3+.PX:>I#Z=:7>>=\$]@/)SK>>=FRLB_]02P,$%     @ 384024T+
M*&>B P  81(  !D   !X;"]W;W)K<VAE971S+W-H965T.#@N>&ULE5A-DYI
M$/TK%/<L3,^ :*E5JU8J.:1J*X?DS.JHU )C8%PW_SY\K:LS;S9Z$1A?]^ON
MX74#TY.J7NJ]E-I[*_*RGOE[K0^3(*C7>UFD]8,ZR++Y9ZNJ(M7-9;4+ZD,E
MTTUG5.0!A6$<%&E6^O-IM_94S:?JJ/.LE$^55Q^+(JW^+F2N3C.?^>\+/[/=
M7K<+P7P:G.TV62'+.E.E5\GMS']DDY7@+:1#_,KDJ;XX]]K@GY5Z:2^^;V9^
MV,8@<[G6K8NT.;S*I<SSUE/#_&=P^L'9&EZ>OWO_VJ7;A/^<UG*I\M_91N^;
M:$/?V\AM>LSU3W7Z)H<<HM;A6N5U]^NMC[56Q;N)[Q7I6W_,RNYXZO])PL$,
M&]!@0&<#%G]JP <#_F$@/C40@X$P#((^E:X0JU2G\VFE3E[5[]XA;6\2-A%-
MJ=?M8E?9[K^F%'6S^CI/N)@&KZVC ;/H,72!86=$T'@_4Q"B6)!E3M<$2QO!
MPVO("D <07"8)^_L^56>$78@H /1.1!7#F*C4#TFZ3!EGRF+,4D$22) ,C)(
M>DQ\01(Y.&+($0..Q."(K40B9NR9#1'&MJYL"'/LV0A&.@*1CHU(1U8U*&2$
M61+(DM@LPKC[%HF5"3?*D5AQL!!',891C$$41LD78XOCB[DK_X>L; C'@;;]
M$G6,$(1*9LL([7TQ;N3E#9@5P$2)(UQ'@V.6\D4D'"Y@ WMD9&4LHLC,F&Q!
MF F377IA)FR[<6B&X4;'N!UL['*!6QT3=Y0,-S)F=S*K9,L!="4KAW09[F4,
M-#/ANIUQDV&CVR<#PQV$H19B#5$$<O'@'L%0DW#T?L+BI?#V; D+BM@-V4+0
MR,&#54>VZA+AT#YA+= =4Y^P%@C,?6$.(;('OVON$]8+@<D?.08(82U0?$>R
M6 L$)JXY^!<0Y) M8<$0T$+DD"UA+=#X]FPYU@)'@\S<V@%TM;6.9#G6"P=2
M<'53CJ7 Z8YD'<^_]EBPMQ:"7#Q8+QSHQ?5\RK$6>'1'ME@+',R%R'R0YN#Y
MU$6#]<*1%!PMBF,I\.2.9+$4.!@+=K)C.]DQIA%8+@+)Q>S["!2Y>+!>!-!+
M[&B% NM%W*$7@?4BD!3,H@Z@SQ[6@HL7\4)6N^Z+1NVMU;'4[?OLQ>KYJ\DC
MM2_RQOJ"35;]MX\/-_/I(=W)'VFUR\K:>U9:JZ)[F=\JI6438?C0:&DOT\WY
M(I=;W9Z.FO.J_P+27VAU>/^@<_ZJ-/\'4$L#!!0    ( $V%$$E=$]F^ 0,
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MD]PL$H$7OW0E- .HB)<8)TU0T@0A!=NQ2)PU8B!9NI((DG[K942:HJ0I0IH
MTM3%@)F\Q#1@XU>(AB8X;(;"9DBZ3V10CCK([TCWW*$D,(-<R0,!;E:8)L=9
M30G'BEAX1[X/HA$NH$4D#_#5()J).D(F*BZY(^4'T8@DA;2(AD):1#-Q/@E:
MO9\)17 SB$N=9> )120/)(&XB(A.U'F"%WH2.;R$.-L;(8?0(49$T-,*$X43
M=87@_RPD=@YK/!4S7NX)5N]S&+-;JO,0%B=$E-$<QNR*TME45N%EG]Q3]XE;
MLK,( KN:W#D$KH;<E.4Q+U[\B5O]8Z=-2IV_[=SE1434J3&N*,O@!@<W+5[#
MNYWME:6W%L=6F4[I9O;2CS]3TR*"^87ITVWK>'53%@>VX[]9MZM:Z;T)I1M0
MVR9NA5!<,X:/.@GV^DOB,JCY5IG;5-]W?6_=#Y0XG#\5+M\KY7]02P,$%
M  @ 384020A+=C-6 @  S0@  !D   !X;"]W;W)K<VAE971S+W-H965T.3 N
M>&ULC9;=CJ,@&(9OQ7@!@S_4_L2:3&LVNP>;3.9@]YA:6LV@.$#K[-TOH+66
M?FWF9 1\WI<7AO*9=EQ\R))2Y7W5K)%KOU2J72$DBY+61+[PEC;ZS8&+FBC=
M%4<D6T')WHIJAJ(@2%!-JL;/4COV)K*4GQ2K&OHF/'FJ:R+^;2CCW=H/_<O
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MUVW15]N^HWA[^7@8OV"R_U!+ P04    " !-A1!)%X@Q3'$#   %$   &0
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MD.@4Q *)W7^_@,88I=U]$;B<<^ZYX%RRCK)W7B$DK$^"&[ZV*R':% !>5HA
M_DA;U,B=(V4$"KED)\!;AN!!DP@&GN-$@,"ZL?-,QUY8GM&SP'6#7IC%SX1
M]F>#,.W6MFM? Z_UJ1(J /(,C+Q#35##:]I8#!W7]I.;[A*%T(#?->KX9&XI
M[WM*W]7BYV%M.\H"PJ@42@'*X8(*A+$2DHD_!LU;2D6<SJ_JS[I:Z7X/.2HH
M?JL/HI)F'=LZH",\8_%*NQ]H*"%4@B7%7'^M\LP%)5>*;1'XV8]UH\>NWXF=
M@68F> /!^U^"/Q#\D>!&WQ*"@1",A.!;?#C@PUL"30!]Z?K@ME# /&.TLUA_
MV2U4_Y2;AO)J2A74-Z'WY-%Q&;WDB1-DX**$!DS18[P)QAT10*J/*3Q3BL);
MT+W[!+LEPG?,&7QC$;[F^],,WA<6 Z- H 6"NU,(9Z?08V*-:33FP9^=U':I
M$SNS6@TRX1=>0Z/7T. UFGGM,=$DB3^SL42XH=E%9'01&5RL9BZB18Z'F='=
M$N*97:R,+E8&%_%]BLT2,[^38F6XVEDQ.Q,F,'N-C5YOU 4A,1*2?QK?+"&)
MX\],@4DK((B== _F5DG/C5#_V"0ZMOF-IUK)+%[(]N^:XEZZ->&?XG0;&^*;
M)-WJ9P3<[.19"T_H%V2GNN'6G@K9\'1;.E(JD"S5>91_;"4?NG&!T5&HZ4K.
M6=_[^X6@[?4E&Y_3_"]02P,$%     @ 384029O 5(Y_ @  7@D  !D   !X
M;"]W;W)K<VAE971S+W-H965T.3,N>&ULA99-CYLP$(;_"N+>Y3.01 1I":K:
M0Z75'MJS0YR %C"UG;#]][5-0L@PR5X"-N\[\W@@'B<]XQ^BI%1:GTW=BHU=
M2MFM'4<4)6V(>&$=;=63 ^,-D6K(CX[H."5[8VIJQW?=R&E(U=II8N;>>)JP
MDZRKEKYQ2YR:AO!_&:U9O[$]^SKQ7AU+J2><-'%&W[YJ:"LJUEJ<'C;VJ[?.
M/2,QBM\5[<7DWM+P.\8^].#G?F.[FH'6M) Z!%&7,]W2NM:15.:_EZ"WG-HX
MO;]&_VZ6J_!W1- MJ_]4>UDJ6M>V]O1 3K5\9_T/>EG#0@<L6"W,KU6<A&3-
MU6);#?D<KE5KKOWP)+[:<(-_,?BCP8N>&H*+(;@9PJ>&\&((@<$9EF(*D1-)
MTH2SWN+#V^N(_DB\=:A*7>A)4UGS3)5"J-ESNG)7B7/6@2Z:;-#X$XTW*AP5
M?4SA8RDR?V;W[Q-LYXK O9?DB.0!1("N,S#^8 KA/P@0H@%"$R"<%LH#D-F@
M61I-.T NP5+GDM@#2YU+HA5.ND!)%P@IR)$-FFA*"D"_5.3/%'>8$8H9(9C@
MP\BB68IOD!.1@)KGB&2!D\8H:8R0 HPLGN6 ;WZNB #G7!'CF$L4<XE@A@!S
M.4L!ON'MEXK\F>(.<X5BKA#,!<!<S=\86,D6D01 DR.:!_]YW1NPW=%%8".X
M/;K/OJ^!%M' LF)A_ >T#_9R#Z&-(:TWWZ1B2(MHX)\*T<2PN,ZD"S64'TT[
M%U;!3JW4F_ED=CPRO/JZBX'Y3!\E3'>[A4F3CASI+\*/52NL'9.J1YI.=F!,
M4H7HOJ@=JE2'G7%0TX/4MZIY6WQH_\- LNYZFAF/5.E_4$L#!!0    ( $V%
M$$G-P^-92P,  .<0   9    >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;)58
M77.:0!3]*PSO#>Q>0,RH,XVITSYT)M.']GFCJS(!UL(:TW]?OF)D.6OP16 Y
M]^P]5\Z]XNRDBI=R+Z5VWK(T+^?N7NO#O>>5Z[W,1'FG#C*O[FQ5D0E=718[
MKSP44FR:H"SUN.]'7B:2W%W,FK6G8C%31YTFN7PJG/*89:+X]R!3=9J[S'U?
M^)7L]KI>\!8S[QRW23*9EXG*G4)NY^Y7=K^B20UI$+\3>2HOSITZ^6>E7NJ+
M'YNYZ]<YR%2N=4TAJL.K7,HTK9FJG?]VI!][UH&7Y^_LJT9NE?ZS*.52I7^2
MC=Y7V?JNLY%;<4SU+W7Z+CL-84VX5FG9?#KK8ZE5]A[B.IEX:X])WAQ/[9W8
M[\)P .\"^#F LZL!U 70V("@"P@^ L*K 6$7$([=(>H"(B/ :XO5E/I1:+&8
M%>KD%.WS<1#U8\CNH^K+7->+S7?7W*N*75:KKXLIBV?>:TW481Y:#.]AIGW,
M$F"XW\<\#C$!IS[FVQ##R,"L$"8X8[Q*[UDTAZ)Y0T"]9!DF($A #4'0(^"&
MVA83-YB\P833R% +,*%1V17 1(23#6"R 5!K(0@A00C4!H;:%A-=9!F$AMC/
M(2L L60:P4PCD&F("2:08#*^5C$DB$?4*AZJ9$:M ,1XOE9#",4XTRG,= HR
MC3!!W9M1[_#'5XM9V@\;4:\.U)-JMHU/(:NKD'ZNN&LP#G*=6"APWV TOO,P
M[&86@"QBLV+!0"LS[0@POEFR:Y!^LKAS,-0ZIA8*;&D6W5 R;&HV^;QD#QTH
MQB7K;X.MSX#WR58O[$DV'2^68U-R?\3ST8%Z8LW9A#"FIZYC^NGB!L!! R";
M8LLTOV&<<^Q+#@8ZF0,=@FQJL7DY,*_UIPNV% ]O4(LMQ<&8'*I%()M:[#L.
M?$<63W'L*1[?H!9[BH-!-U2+0)9I2-AX!(Q'$V.?#G394;E/EB%"V#*$+&,Z
MG(;3COF69D385P3F'5F:-UE^)]\P[PA;AH!E F-0+3M0KP]9=L&N(C"H AL%
M=A7=,*@(&X: 889:AX/J"S/W\2[>_PYB)W^*8I?DI?.L=/4JV;SP;972LB+T
M[RKM>RDVYXM4;G5].JG.B_8]O+W0ZO#^M\+YOXW%?U!+ P04    " !-A1!)
MI37K)O $  #,'   &0   'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6R-F5MO
MXD@0A?^*Q7O&[HL-1 0I8*UV'U8:S</NLP/-1>,+8YLP^^_7-@[!5:<<7@(X
MIZJ/N]M?5[L7EZ+\61V<J[W?69I7+Y-#79^>?;_:'%R65-^*D\N;_^R*,DOJ
MYF>Y]ZM3Z9)M%Y2EO@Z"R,^28SY9+KIKW\OEHCC7Z3%WWTNO.F=94OZW<FEQ
M>9FHR<>%'\?]H6XO^,N%?XO;'C.75\<B]TJW>YF\JN<X["2=XI^CNU1WW[W6
M_%M1_&Q__+5]F02M!Y>Z3=VF2)J/=[=V:=IF:EK^U2?];+,-O/_^D?V/[G8;
M^V])Y=9%^N]Q6Q\:M\'$V[I=<D[K'\7E3]??0]@FW!1IU?WU-N>J+K*/D(F7
M);^OG\>\^[Q<_S,+^C <H/L ?0M0T6B Z0/,9X =#;!]@"4!_O56NHZ(DSI9
M+LKBXI77T3LE[211S[;IZDU[L>O9[G]-5U3-U??EW.J%_]XFZC6KJT;?:=1-
MX3?9;TUHU,1*LW#2P)HK3#"4Q$ BF##P/DT7;P;W:7 ""Q/8+H$=)+"DHZZ:
M6:?).XT-YKB1$#82@D9"TLA5$]TWH@WIT/!Q(Q$T$@$C$4XPA0FFH+^G.,$,
M)I@!!S/2%3/6%9&9DZX &BO,G#DT,@=&2".K.6M$$1M<01Z">,[&3)B?+<?0
MDQQPHV% '^6 ^XB(5:0ADS!&&F%XE0 >!>PJ:E>Q9JAF#33*"E8@H%Z5!E88
M!#5KYHE9X9I <((II0QP8J@3\X 3H D%*YAW"@ OI,#K18-FZ/*Q1B(S$\Q@
M+BH QI""47$R1E-*1B2BS(B12(*&P@!5T>,+CL((5=,'EIQ>% FH[V\:B(P6
MS& <*\#C,*)F.&PY70"0!2>8QPH .9Q2)YRWACTC@-K""&F,7(V02T=(<U3R
M9P2)I&=$8Z!J!%2Z8FH.2\8.I!& JC%0-0 JJV,TAR4O9)"(3N\8B:3IK3%X
M-0(O7>4U@*JF2^P:JHRP#F@,7VTY/2(I!4:F!LB,Z/JJ.>C8;. 2J6LQ"36H
M)2.ZNO:BX;RTU H2"?#0F*D:,#6B"ZSFN&Q&<$K=()5H!U-5 ZI&#""<F&C:
M(94X[3!:-4!K))0-!B/1!(\7_@:#S "0L=+?<$A1PJR11M@%&0PR@T!&L6#&
MJK[>R9>2&$BD#:ZPPT4(H_6_X7"B2]'7DGA4,O2*^690<4GA9'C=R+QRB3#C
M#::D084EA9/A"&0#S"5/TO!A3!J 25;Z&TY Y@1 4AH<S$@#&,FJ&H/H1ZT
MC5!@&<Q'@ZI.6D@83CY+88TT=$^+-!(N,#_-_/&BWV)^6E!2\O=,O%JDTV!4
M,C2"*6Q1.4D+?LL)RXR,289&,(,MVIW3>M]R>M+9""32T&# 6@18-C2H^J-.
M@$:R(KR,1/RD2Z0=@V/OY&%^6LQ/^\@;2_LU/[^6Q):_U)2\8L):1%BZF%N
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MW3MB]9&@>213O5&#.K/ZG4P%EZ/G;):@U#NK0!V3MTS08^Z$)Z/?I@B@*?+
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M971S+W-H965T.3@N>&ULC55-CYLP%/PKB/NN,1 @$4%JLJK:0Z75'MJS0YR
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MZN,2 ;3$)IC0K06V4T3H?X7L ,B,B1#,,S1\_)@GCF !# I@(Q!^*50("RQ
M@<7408*M2D.8A54L"#.3200:B0"!V#("81++"(1)82,Q:"2>EC3U88$$%$B>
M*"F$B:Q, $R*K T(80+8; J:39\H.X1)+;, )@TMLQ &PV9U5X3Z@C^5B">-
M 0"E]GX%0=8_L -!\8SCF4Z&IA+18D8"[%1K%#S_D2.XSR"@T4SV) B:U T
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M@FQ%+D@&0K)-ZND$7T.R#01E$4PQ-0[54;A-\21V6#A*$3V?Y BN,X2?27-
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M'5Q;1P>*6E .UV$B.&8A( N!6 B-10<*;^XA;M;:\0 8/\1, L@D0$P"C4D
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MH%)F^JSG8FPDXT+Q[M(6Y]Y<_ -02P,$%     @ 384023DD*7#U!0  :B(
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M9];^IZ>BUJUO"Q9.PEGP9C(Y:-E _!JZ$(%.?^F#HSZ6O!/.VQVLND1$-"0
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M3F0 $!1/RV$JDBXA$PNV4."6OJQ2?(;,5P27,[C,@)31\9?V;3OZ<';V^03
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M)CA\$J',@$2'VOYVY8B^*%V>ZA8;ICH$%^$O<Y@-D(HP5KV5_)+B];OT*R*
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MRI-AW/4K9K/E9C_;BW&+@9FU16C1XZ:3_OB0YW#W9QL?"6ZM4Z );=&/A*Q
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M$$]T+R$,'A89*QMN!-LF4J_D%?13U]/U.$4)C2HY^SXC-Z+@57WP1RDGF.S
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M:!J:MZ7"%E5*/J'MH.;O;,NE?.[#,FC>E-L3J/ _%!]W6-G+W2,.Y2)'U+@
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M?.WAE/'7'.AV+7D")9*+)@8U$JY@I]/Y(RAQK_X NUQ;3(DJN$1.O%/]U50
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M( C U <!4!/X4PI_JVEF?BRJR GWB0<Y>  _25]YZSZ0JA5U"!)&@1SWJ>O
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MK@N$_8K.RXO[5K!$T4?L0_%Z0T74;<779W1@@B2?9[$(6X".(!9)19"P5CR
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M /[Y4OZUJ\'W@=+!__*@-4D%(.%]#2CA;= CBCD\'"96"^X?")/>%!L5#/?
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MI-]+S><8/X4%PSRWJ-N ^#Q$U+WX)9EQQZ62F56<PJXB^4QV$/"E';LF8^<
MPP@'4N5Q\$UANN6@R]**GL5#:)>W&VP44CG LMR@'M*B^I-OB9O0IT\U[@Y
M >MR3S5Q-B4<J(5WD;B8=@7;_@$NOL-B"F\O/GRZN+J+;BX^7]_<75Y]J#S
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MX4/)1JO[X^>-XS0C7#CC.A.(</Y<58A3)>NL(KFI@/JV[>#!EN-7X. /JRH
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MQ-8B" [)X//8*"%2';F6T#:0A17%(OV'04NH'V-UT5_\6!TP\H_]T/)#&^Q
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M/5_:42W'=(#DL^(/ 1<U$)P6K!&M_,_1#3F&4)"3>K]V?K@=W%47KL=YX=A
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M83.P,_%ZQ,MOO^[[I,Y7=-XK336EHY73)S#78=_73YT[JU2@J!6/_U#&^'_
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MJ_JR%W'/G/V]UZN.)T.57KV7@\.8-7R<?@"'L<V\-EZ%.4>?@,F1\.$ O1S
MD$Z4<9:QC*LE4-5'JR)^R0R)X#20[6*SC/)?ZR(*\J::R"ASV"T0YFK'9I4C
MW]IX"F3%CB )TP6^.=,H11O+6@=\HGA1Z>0,D/*CAU0[[W_RP-)FM+J=/Z*\
M2]S[Q_>[BR#->A<Y4\0$Y2\\<'.\EOM;UZ;X(MT<@D"6P0^8SRY"OG96S8;4
M<$^][@8X8"B[J/,C!C1YQ;;S?4)&Y*,X&Y""FPB3%3NIT=#VXLGU[3;<!C]F
M3S8:Q#_Z>%R$G5&'D:;<^'^F/ZB_O998NSO%YLGI(@(*;DL-_ZN6WV*T=B#0
MWMSV'S[1UW&7'S2\?_0)^"<-\T=PZA^R>1L8I0UXE?FH\HQGKQ[LSA7^P4/6
M,M^T#&7(D8>/(+457!T0I;B9DN*<?!36Y4!G7/,I;2C_DH=GM9X_D '+\8O1
MK(8=^/N%?!V+8K-IQ_6#U6C8$U7GX/O7^?0K9[7^052UDS^],%>7'6MN/-\X
M9"!PAJGQ5S^1OQK>^DG7D-K,'^>(W5!R0&_$4N%@2-A8#BT*](4^9-P_8$Z'
M;I=0W^WXUD$@I5CPRK")J=<SC'V"G)U-EI2]@ ]NL)+4#+.Z;!"P3?RWY]66
MB375"39W*\H#AD5?2X$?7!TGWEG.E$>)5ZK_:(MB3^>&8[4UP[+- :?.M?6+
M7%O6$Z\S55H-M2@YEE-EW]4' U(2K4[7=,N;A%#OE8UN=T.&\)P7O -.7QO_
M.*/''H>-ZQ/V*G#:V,?Q!:$&X+I]_#RZ'EW<C@]Q,YQKBR9E+^F"]_<<[HI1
MRK/YI-H8[F9A+"I:LYNA</7-9H7AZR3U;W 1F4Q;N 6!Q3V@F[OP#2UIWLY\
MW\&UU3C;P7R+_7;+<=H<P+'K^R:1).=P0L9V=.3)Y:=/9[=R8O;/](#>5#@R
MT0X9H,F[I.AK;S^4OO?BC$Z<X&WO:PEIUA*2\9SX"9&WER?__LOE^>GX^N;/
ME/-P^P7X H%%71>ZA2NIJQD^W1NN[0YDN%6EW5N[P@PJ.J@]Z+H*FG2XUN][
M.^-FYQ- Y.6Q9LC4>[74^+R%FXZ.LFFQPL1MTB\G>[PU_E:LT>6U5)2H'$MX
MQ02*^6:[FOX>ZQ!,=[G>Q#\)Y3P.O!LZK/H5RB_:]7C%/K-ANXQCJ4DE$0VA
M<$B ;&WKDM_4X.*1?"<K"#TL'+N7!-TOND*)I%R;NV8:]O:JFBN'7TJ-LN"/
MA%=YX4P47^U6: QU)K/B.5;2JZB-X=-!^'9YMDJ3!HP+D1,DI<A%;L H1.,Y
MK $#,54U*NII-!E*>(^_QHF+PB<YI%D'F4JB'AM3:EU/ZE$="*%HJG+TZO9U
M:->26--TLV+"W'AT?0'BS$U\!7?HS2^CZW%\-+ZZ<:D@C#QP@50&::D:$L+A
M+\U-#NT1 *3/JA;/)%V:(.<-\<G5DRDG09OYL$X%NM$[L<LMZ#W2M<RP^$/*
M##&2I\(V$M !"P(2*!7<7L?O03HY19GD:GQQ0]@"JM+HSHWVDT5G1'K>=4G;
M ?5^U0\+7MM)*;#B@U"UL9]380 C<O;7[4"ZQT+@W60^;JF)6#?L=L7*9] [
MO-0O? .RD-*+LAC<LX%(.VMK4'<@-!KT&:_CH+F!T9_4,KN;K?@#]>J 0**#
M3'@$M$(TS(O54N=HG )CFFY7ZSI[HS3#W3[K9I96,S/=#-&@9C#-6@$FPU#Y
MH+Q6YG_LU^1LOF% EE</3J;H5XRQ-?TE/U81LWPH,?Y975K$^J?U6:-#'=[2
MX:/G4W/Y5 ^\X]7?LIHW:+O C-5Q196-2YI7G)0S+$J[1-QA;3/:>=1_+3A8
M**S5YN'$SK%)K0B_Y^!-.5QS&JB76?]TRP?E$*D/EW%MT'+*S28T>%\ITH '
MO$Z-U\<LN+54@2@V.7"R5C5[LUD/[F98EMKWKGKNE9\)1K1\*ZFNX4<KR=0
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M2P$"% ,4    " !,A1!)(Y:UDYX"  "X/@  $P              @ $
M6T-O;G1E;G1?5'EP97-=+GAM;%!+ 0(4 Q0    ( $R%$$E(=07NQ0   "L"
M   +              "  <\"  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( $R%
M$$EUCR"-)@,  *M    :              "  ;T#  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $R%$$D&N>8K3P4  (H8   0
M          "  1L'  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 3(40
M26E+N5T^ 0  :0,  !$              ( !F P  &1O8U!R;W!S+V-O<F4N
M>&UL4$L! A0#%     @ 3(4029E<G",0!@  G"<  !,              ( !
M!0X  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !,A1!)M$<Q5T8"
M  !V"@  #0              @ %&%   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( $R%$$G^*8>7Y@<  &\A   /              "  ;<6  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " !,A1!)$@BW;X,"  !["0  &
M    @ '*'@  >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M3(4022^3C/ "!   9Q,  !@              ( !@R$  'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+ 0(4 Q0    ( $R%$$E;C$7:F (  +0)   8
M          "  ;LE  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M    " !,A1!)0.QWW2L$  #,%   &               @ &)*   >&PO=V]R
M:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ 3(402;W',AE, @  ) @
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M965T.2YX;6Q02P$"% ,4    " !-A1!)&Q]5RJ !  "Q P  &0
M    @ $V/@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (
M $V%$$EO?=:DH0$  +$#   9              "  0U   !X;"]W;W)K<VAE
M971S+W-H965T,3$N>&UL4$L! A0#%     @ 384028OL&T.? 0  L0,  !D
M             ( !Y4$  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"
M% ,4    " !-A1!)I(,&K* !  "Q P  &0              @ &[0P  >&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( $V%$$F>"SVUH $
M +$#   9              "  9)%  !X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L! A0#%     @ 384024/^JHF? 0  L0,  !D              ( !
M:4<  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " !-A1!)
M?.'2K: !  "Q P  &0              @ $_20  >&PO=V]R:W-H965T<R]S
M:&5E=#$V+GAM;%!+ 0(4 Q0    ( $V%$$G0ZNNOH $  +$#   9
M      "  19+  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%
M  @ 38402<S10%.A 0  L0,  !D              ( ![4P  'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " !-A1!)+,V:3* !  "Q P
M&0              @ '%3@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+
M 0(4 Q0    ( $V%$$GR/(]IH $  +$#   9              "  9Q0  !X
M;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ 384022@*9=:A
M 0  L0,  !D              ( !<U(  'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q02P$"% ,4    " !-A1!)S ,W7Y\!  "Q P  &0
M@ %+5   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( $V%
M$$D**H>/H $  +$#   9              "  2%6  !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&UL4$L! A0#%     @ 38402649MMVA 0  L0,  !D
M         ( !^%<  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
M    " !-A1!)L+9_^)\!  "Q P  &0              @ '060  >&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( $V%$$G[Z^-CG0$  +$#
M   9              "  :9;  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL
M4$L! A0#%     @ 384025T/,P&A 0  L0,  !D              ( !>ET
M 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !-A1!)CJ!:
M*Z !  "Q P  &0              @ %27P  >&PO=V]R:W-H965T<R]S:&5E
M=#(X+GAM;%!+ 0(4 Q0    ( $V%$$G8</ 8H $  +$#   9
M  "  2EA  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @
M38402;?E3A.A 0  L0,  !D              ( ! &,  'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6Q02P$"% ,4    " !-A1!)Y-V'D(,"  "+"@  &0
M            @ '89   >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4
M Q0    ( $V%$$D Y!ZJKP$  !8$   9              "  9)G  !X;"]W
M;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ 384029<R*">O 0
M%@0  !D              ( !>&D  'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6Q02P$"% ,4    " !-A1!)2Q9_TZ$!  "Q P  &0              @ %>
M:P  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( $V%$$EZ
MW!D&I $  +$#   9              "  39M  !X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L! A0#%     @ 38402;070>RB 0  L0,  !D
M     ( !$6\  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
M" !-A1!)RB\U*Z,!  "Q P  &0              @ 'J<   >&PO=V]R:W-H
M965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( $V%$$G7;ZB>L0$  !8$   9
M              "  <1R  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L!
M A0#%     @ 38402:OPG"JC 0  L0,  !D              ( !K'0  'AL
M+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " !-A1!)@%T"A+X!
M  ![!   &0              @ &&=@  >&PO=V]R:W-H965T<R]S:&5E=#0P
M+GAM;%!+ 0(4 Q0    ( $V%$$EI^48HHP$  +$#   9              "
M 7MX  !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ 3840
M280"5@*[ 0  >P0  !D              ( !57H  'AL+W=O<FMS:&5E=',O
M<VAE970T,BYX;6Q02P$"% ,4    " !-A1!)5>MY(JP!   6!   &0
M        @ %'?   >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0
M   ( $V%$$DG5=<UO@$  'L$   9              "  2I^  !X;"]W;W)K
M<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ 384025F%\V^A 0  L0,
M !D              ( !'X   'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q0
M2P$"% ,4    " !-A1!)+7(J@]@!  !%!0  &0              @ 'W@0
M>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( $V%$$D(@A.\
MI $  +$#   9              "  0:$  !X;"]W;W)K<VAE971S+W-H965T
M-#<N>&UL4$L! A0#%     @ 38402?R^3A7C 0  J@4  !D
M ( !X84  'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " !-
MA1!)5QCD@1H"  !+!P  &0              @ '[AP  >&PO=V]R:W-H965T
M<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( $V%$$G$BKCSKP$  !8$   9
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M970U-"YX;6Q02P$"% ,4    " !-A1!)C^I]8V8#   C$   &0
M    @ $<E@  >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    (
M $V%$$EC[UVRE0,  'T1   9              "  ;F9  !X;"]W;W)K<VAE
M971S+W-H965T-38N>&UL4$L! A0#%     @ 384023(EI)V[ 0  LP0  !D
M             ( !A9T  'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"
M% ,4    " !-A1!)=?.2_2@#  #O#0  &0              @ %WGP  >&PO
M=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( $V%$$E,)BX'4P(
M .L'   9              "  =:B  !X;"]W;W)K<VAE971S+W-H965T-3DN
M>&UL4$L! A0#%     @ 384026W7?#P@ @  E 8  !D              ( !
M8*4  'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " !-A1!)
M7ZLU:XX#  !=$0  &0              @ &WIP  >&PO=V]R:W-H965T<R]S
M:&5E=#8Q+GAM;%!+ 0(4 Q0    ( $V%$$E+!D)NG0(  & *   9
M      "  7RK  !X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%
M  @ 3840263;BX=1 P  ]P\  !D              ( !4*X  'AL+W=O<FMS
M:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " !-A1!)LP;Z",0"  !%#
M&0              @ '8L0  >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+
M 0(4 Q0    ( $V%$$GSC$!W5 (  +8'   9              "  =.T  !X
M;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ 3840232JT<@2
M!   B!4  !D              ( !7K<  'AL+W=O<FMS:&5E=',O<VAE970V
M-BYX;6Q02P$"% ,4    " !-A1!)@-\S].$!  "\!0  &0
M@ &GNP  >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( $V%
M$$G0??Y3( ,  !\0   9              "  ;^]  !X;"]W;W)K<VAE971S
M+W-H965T-C@N>&UL4$L! A0#%     @ 38402?7%4Y & @  V08  !D
M         ( !%L$  'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4
M    " !-A1!)N@'D#Y4"  !Y"0  &0              @ %3PP  >&PO=V]R
M:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( $V%$$DQ$-3;2@,  "$/
M   9              "  1_&  !X;"]W;W)K<VAE971S+W-H965T-S$N>&UL
M4$L! A0#%     @ 384022N+;8@%!0  PAX  !D              ( !H,D
M 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " !-A1!)IJFP
M&*H"  #^"@  &0              @ '<S@  >&PO=V]R:W-H965T<R]S:&5E
M=#<S+GAM;%!+ 0(4 Q0    ( $V%$$F-%/7H P(  /T%   9
M  "  ;W1  !X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @
M384023N,J:T( P  [PT  !D              ( !]],  'AL+W=O<FMS:&5E
M=',O<VAE970W-2YX;6Q02P$"% ,4    " !-A1!)TGQAPI("  !#"@  &0
M            @ $VUP  >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4
M Q0    ( $V%$$G4*-7PA (  'T)   9              "  ?_9  !X;"]W
M;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ 38402>Y@;RA-!
MMQ<  !D              ( !NMP  'AL+W=O<FMS:&5E=',O<VAE970W."YX
M;6Q02P$"% ,4    " !-A1!)&V').-\!  #V!   &0              @ $^
MX0  >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( $V%$$D9
M"*B%+P(  -$&   9              "  53C  !X;"]W;W)K<VAE971S+W-H
M965T.# N>&UL4$L! A0#%     @ 384025UF'^CG!   Z!D  !D
M     ( !NN4  'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $V%$$G*3XAGJ0(  ,$)   9              "
M 47V  !X;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ 3840
M26)DU&'3 @  9 L  !D              ( !)?D  'AL+W=O<FMS:&5E=',O
M<VAE970X-RYX;6Q02P$"% ,4    " !-A1!)30LH9Z(#  !A$@  &0
M        @ $O_   >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0
M   ( $V%$$E=$]F^ 0,  +L,   9              "  0@  0!X;"]W;W)K
M<VAE971S+W-H965T.#DN>&UL4$L! A0#%     @ 384020A+=C-6 @  S0@
M !D              ( !0 ,! 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q0
M2P$"% ,4    " !-A1!)%X@Q3'$#   %$   &0              @ '-!0$
M>&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( $V%$$FLO4PU
M1@(  %H'   9              "  74) 0!X;"]W;W)K<VAE971S+W-H965T
M.3(N>&UL4$L! A0#%     @ 384029O 5(Y_ @  7@D  !D
M ( !\@L! 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    " !-
MA1!)S</C64L#  #G$   &0              @ &H#@$ >&PO=V]R:W-H965T
M<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    ( $V%$$FE->LF\ 0  ,P<   9
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M970Y.2YX;6Q02P$"% ,4    " !-A1!))(L-_GH"  "U"0  &@
M    @ &1(0$ >&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4
M" !-A1!)RJ"[+3<"  !G"   &@              @ %#) $ >&PO=V]R:W-H
M965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4    " !-A1!)YC>*'I<"  !<"P
M&@              @ &R)@$ >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q0
M2P$"% ,4    " !-A1!)PTH)D+H#  #H%0  &@              @ &!*0$
M>&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6Q02P$"% ,4    " !-A1!)\]AP
M6:X%  "8(@  &@              @ %S+0$ >&PO=V]R:W-H965T<R]S:&5E
M=#$P-"YX;6Q02P$"% ,4    " !-A1!)P4WPQG<"  #."   &@
M    @ %9,P$ >&PO=V]R:W-H965T<R]S:&5E=#$P-2YX;6Q02P$"% ,4
M" !-A1!);]>]7/\"  #C#@  &@              @ $(-@$ >&PO=V]R:W-H
M965T<R]S:&5E=#$P-BYX;6Q02P$"% ,4    " !-A1!)>C3J!O<!  "G!0
M&@              @ $_.0$ >&PO=V]R:W-H965T<R]S:&5E=#$P-RYX;6Q0
M2P$"% ,4    " !-A1!).20I</4%  !J(@  &@              @ %N.P$
M>&PO=V]R:W-H965T<R]S:&5E=#$P."YX;6Q02P$"% ,4    " !-A1!)-H8L
MH34#  "2#P  &@              @ &;00$ >&PO=V]R:W-H965T<R]S:&5E
M=#$P.2YX;6Q02P$"% ,4    " !-A1!)",+!O&[3   "+@, %
M    @ $(10$ >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P4&     '8 =@!V(
&J!@"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.5.0.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>438</ContextCount>
  <ElementCount>552</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>118</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - DOCUMENT AND ENTITY INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-daei</Role>
      <ShortName>DOCUMENT AND ENTITY INFORMATION</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED STATEMENT OF EARNINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-csoe</Role>
      <ShortName>CONSOLIDATED STATEMENT OF EARNINGS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-csoci</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-cbs</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-cbsp</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-csose</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-csocf</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-sosap</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - DISCONTINUED OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-do</Role>
      <ShortName>DISCONTINUED OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - BUSINESSES ACQUIRED</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/BusinessesAcquired</Role>
      <ShortName>BUSINESSES ACQUIRED</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-in1</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - OTHER CURRENT ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-oca</Role>
      <ShortName>OTHER CURRENT ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ppaen</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-gtaoia</Role>
      <ShortName>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-d1</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - OTHER LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ol1</Role>
      <ShortName>OTHER LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-fiafvm1</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ocag</Role>
      <ShortName>OTHER CONTINGENCIES AND GUARANTEES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - LEASES AND OTHER COMMITMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-laoc</Role>
      <ShortName>LEASES AND OTHER COMMITMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-se</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - NET EARNINGS PER SHARE (EPS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-nepse1</Role>
      <ShortName>NET EARNINGS PER SHARE (EPS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - STOCK-BASED COMPENSATION PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-scp</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - OTHER (INCOME) EXPENSE, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-oein</Role>
      <ShortName>OTHER (INCOME) EXPENSE, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-it1</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - EMPLOYEE BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebp</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - SEGMENT REPORTING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-sr1</Role>
      <ShortName>SEGMENT REPORTING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-rpt</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - UNAUDITED QUARTERLY DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-uqd</Role>
      <ShortName>UNAUDITED QUARTERLY DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/ValuationAndQualifyingAccountsAndReserves</Role>
      <ShortName>VALUATION AND QUALIFYING ACCOUNTS AND RESERVES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-sosapp</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-sosapt</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-sosap</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - DISCONTINUED OPERATIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-dot</Role>
      <ShortName>DISCONTINUED OPERATIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-do</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - BUSINESSES ACQUIRED (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/BusinessesAcquiredTables</Role>
      <ShortName>BUSINESSES ACQUIRED (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/BusinessesAcquired</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-int1</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-in1</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - OTHER CURRENT ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ocat</Role>
      <ShortName>OTHER CURRENT ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-oca</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ppaent</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ppaen</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-gtaoiat</Role>
      <ShortName>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-gtaoia</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-alt</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-dt</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-d1</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - OTHER LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-olt1</Role>
      <ShortName>OTHER LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ol1</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-fiafvmt1</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-fiafvm1</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - LEASES AND OTHER COMMITMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-laoct</Role>
      <ShortName>LEASES AND OTHER COMMITMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-laoc</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-set</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-se</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-nepset1</Role>
      <ShortName>NET EARNINGS PER SHARE (EPS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-nepse1</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - STOCK-BASED COMPENSATION PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-scpt</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-scp</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - OTHER (INCOME) EXPENSE, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-oeint</Role>
      <ShortName>OTHER (INCOME) EXPENSE, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-oca</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-itt</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-it1</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebpt</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebp</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - SEGMENT REPORTING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-srt1</Role>
      <ShortName>SEGMENT REPORTING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-sr1</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - UNAUDITED QUARTERLY DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-uqdt</Role>
      <ShortName>UNAUDITED QUARTERLY DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-uqd</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Cash Holdings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-sosapsochd</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Cash Holdings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-sosapt</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Estimated Useful Lives of Property, Plant and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-sosapsoeuloppaed</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Estimated Useful Lives of Property, Plant and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-sosapt</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-sosapaid</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-sosapt</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-dosolgfdod</Role>
      <ShortName>DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-dot</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - DISCONTINUED OPERATIONS (Summary of Operating Losses, Asset Charges and Other Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-dosoolacaoc</Role>
      <ShortName>DISCONTINUED OPERATIONS (Summary of Operating Losses, Asset Charges and Other Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-dot</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - DISCONTINUED OPERATIONS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-dond</Role>
      <ShortName>DISCONTINUED OPERATIONS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-dot</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - BUSINESSES ACQUIRED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/BusinessesAcquiredDetails</Role>
      <ShortName>BUSINESSES ACQUIRED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/BusinessesAcquiredTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ind1</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-int1</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - OTHER CURRENT ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ocad</Role>
      <ShortName>OTHER CURRENT ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ocat</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ppaend</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ppaent</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-gtaoiand</Role>
      <ShortName>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-gtaoiat</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-gtaoiasogd</Role>
      <ShortName>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-gtaoiat</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-gtaoiasoiaegd</Role>
      <ShortName>GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-gtaoiat</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/AccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-alt</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - DEBT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-dnd</Role>
      <ShortName>DEBT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-dt</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - DEBT (Notes and Loans Payable) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-dnalpd</Role>
      <ShortName>DEBT (Notes and Loans Payable) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-dt</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - DEBT (Long-term Debt, Net of Unamortized Discounts or Premiums) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-dldnoudopd</Role>
      <ShortName>DEBT (Long-term Debt, Net of Unamortized Discounts or Premiums) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-dt</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - DEBT (Borrowing Capacity Under Other Financing Arrangements) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-dbcuofad</Role>
      <ShortName>DEBT (Borrowing Capacity Under Other Financing Arrangements) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-dt</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - OTHER LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-old1</Role>
      <ShortName>OTHER LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-olt1</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-fiafvmnd1</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-fiafvmt1</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Financial Instruments Measured at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-fiafvmsofimafvd1</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Financial Instruments Measured at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-fiafvmt1</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-fiafvmsoeodidahid1</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-fiafvmt1</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ocagd</Role>
      <ShortName>OTHER CONTINGENCIES AND GUARANTEES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ocag</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - LEASES AND OTHER COMMITMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/LeasesAndOtherCommitmentsDetails</Role>
      <ShortName>LEASES AND OTHER COMMITMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-laoct</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-sesrpd</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-set</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - STOCKHOLDERS' EQUITY (Common Stock Dividends) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-secsdd</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Common Stock Dividends) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-set</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-set</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-set</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - NET EARNINGS PER SHARE (EPS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-nepsed</Role>
      <ShortName>NET EARNINGS PER SHARE (EPS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-nepset1</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - STOCK-BASED COMPENSATION PLANS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-scpnd</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-scpt</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - STOCK-BASED COMPENSATION PLANS (Compensation Cost and Related Income Tax Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-scpccaritbd</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Compensation Cost and Related Income Tax Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-scpt</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000085 - Disclosure - STOCK-BASED COMPENSATION PLANS (Assumptions Utilized in the Valuation in Calculating the Compensation Expense for Stock Options Granted) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-scpauiviccefsogd</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Assumptions Utilized in the Valuation in Calculating the Compensation Expense for Stock Options Granted) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-scpt</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000086 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-scpsosoad</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Summary of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-scpt</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>00000087 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Restricted Stock Award Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-scpsorsaad</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Summary of Restricted Stock Award Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-scpt</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>00000088 - Disclosure - STOCK-BASED COMPENSATION PLANS (Summary of Performance Stock Award Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-scpsopsaad</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Summary of Performance Stock Award Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-scpt</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>00000089 - Disclosure - OTHER (INCOME) EXPENSE, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/OtherIncomeExpenseNetDetails</Role>
      <ShortName>OTHER (INCOME) EXPENSE, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ocat</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>00000091 - Disclosure - INCOME TAXES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-itnd</Role>
      <ShortName>INCOME TAXES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-itt</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>00000092 - Disclosure - INCOME TAXES (Provision for Income Taxes by Tax Jurisdiction and Domestic and Foreign Earnings before Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-itpfitbtjadafebtd</Role>
      <ShortName>INCOME TAXES (Provision for Income Taxes by Tax Jurisdiction and Domestic and Foreign Earnings before Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-itt</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>00000093 - Disclosure - INCOME TAXES (Effective Income Tax Rate Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-iteitrrd</Role>
      <ShortName>INCOME TAXES (Effective Income Tax Rate Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-itt</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>00000094 - Disclosure - INCOME TAXES (Components of Net Deferred Tax Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-itcondtad</Role>
      <ShortName>INCOME TAXES (Components of Net Deferred Tax Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-itt</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>00000095 - Disclosure - INCOME TAXES (Valuation Allowance) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-itvad</Role>
      <ShortName>INCOME TAXES (Valuation Allowance) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-itt</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>00000096 - Disclosure - INCOME TAXES (Unrecognized Tax Benefits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-itutbd</Role>
      <ShortName>INCOME TAXES (Unrecognized Tax Benefits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-itt</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>00000097 - Disclosure - EMPLOYEE BENEFIT PLANS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebpnd</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebpt</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>00000099 - Disclosure - EMPLOYEE BENEFIT PLANS (Summarized Information for Defined Benefit Retirement Income and Healthcare Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebpsifdbriahpd</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Summarized Information for Defined Benefit Retirement Income and Healthcare Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebpt</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>00000100 - Disclosure - EMPLOYEE BENEFIT PLANS (Information for Retirement Income Plans with Accumulated Benefit Obligation in Excess of Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebpifripwaboieopad</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Information for Retirement Income Plans with Accumulated Benefit Obligation in Excess of Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebpt</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>00000101 - Disclosure - EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income and Health Care Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebpconcoriahcpd</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income and Health Care Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebpt</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>00000102 - Disclosure - EMPLOYEE BENEFIT PLANS (Items Not Yet Recognized as a Component of Postretirement Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebpinyracoped</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Items Not Yet Recognized as a Component of Postretirement Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebpt</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>00000103 - Disclosure - EMPLOYEE BENEFIT PLANS (Net Actuarial Loss (Gain) and Prior Service Cost (Benefit) Activity Recorded in Accumulated Other Comprehensive Loss (Income)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebpnalgapscbariaoclid</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Net Actuarial Loss (Gain) and Prior Service Cost (Benefit) Activity Recorded in Accumulated Other Comprehensive Loss (Income)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebpt</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>00000104 - Disclosure - EMPLOYEE BENEFIT PLANS (Weighted-Average Assumptions Used to Estimate the Net Periodic Pension and Other Postretirement Benefit Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebpwautenppaopbcd</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Weighted-Average Assumptions Used to Estimate the Net Periodic Pension and Other Postretirement Benefit Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebpt</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>00000105 - Disclosure - EMPLOYEE BENEFIT PLANS (Expected Benefit Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebpebpd</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Expected Benefit Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebpt</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>00000106 - Disclosure - EMPLOYEE BENEFIT PLANS (Target Allocations and Weighted Average Asset Allocations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-ebptaawaaad</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Target Allocations and Weighted Average Asset Allocations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebpt</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>00000107 - Disclosure - EMPLOYEE BENEFIT PLANS (Retirement Income Plan's Assets Carried at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/EmployeeBenefitPlansAssetsCarriedAtFairValueDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Retirement Income Plan's Assets Carried at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-ebpt</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>00000108 - Disclosure - SEGMENT REPORTING (Selected Financial Information Relating To Company's Segments ) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/SegmentReportingSelectedFinancialInformationRelatingToCompanysSegmentsDetails</Role>
      <ShortName>SEGMENT REPORTING (Selected Financial Information Relating To Company's Segments ) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-srt1</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>00000109 - Disclosure - SEGMENT REPORTING (Net Sales and Long-Lived Assets by Geographic Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-srnsalabgad</Role>
      <ShortName>SEGMENT REPORTING (Net Sales and Long-Lived Assets by Geographic Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-srt1</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>00000110 - Disclosure - SEGMENT REPORTING (Concentration Percentages) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-srcpd</Role>
      <ShortName>SEGMENT REPORTING (Concentration Percentages) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-srt1</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>00000111 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-rptd</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-rpt</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>00000112 - Disclosure - UNAUDITED QUARTERLY DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-uqdd</Role>
      <ShortName>UNAUDITED QUARTERLY DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-uqdt</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="clx-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>00000113 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-vaqaard</Role>
      <ShortName>VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/ValuationAndQualifyingAccountsAndReserves</ParentRole>
      <Position>109</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>clx-20160630.xml</File>
    <File>clx-20160630.xsd</File>
    <File>clx-20160630_cal.xml</File>
    <File>clx-20160630_def.xml</File>
    <File>clx-20160630_lab.xml</File>
    <File>clx-20160630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>138
<FILENAME>0001206774-16-006893-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001206774-16-006893-xbrl.zip
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M^\MG6^45-WLSO3]I[$\:E1#$_EBI/U9201RW8F<&;W//QO^Y_"M";',1_.!
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M8\7WQ>D^_/:6?@J8_OF7X>EPPG.ZL3>K;-!$)) +>CQ2!'2&+Y8#6CO5=(5
M&TR@!Z>SJ4*@AXR<'LR4 4VXE[F@AV,E0+,ZJ5ET7-]>H>CN%+<_49.23(N9
M2XEV:@S5HH1B>0LHT922+JH%+Z!$-Q2CI-@3***D*MU:G V4XSF<# IDB@-
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MU_Q(G[LJ(1U23C9&&:_-5+1=J&^*UL832K,TLOU@54@,2G!&MHNK3K:S;+>
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M.KBK66Y?OJR&WFME^QOPP-\10'IR&^.LN%X9D 2[!BX4F!Q1+BA#?WS>5:L
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M8'K:=&L=*#@DPL55=S[R(E8\0(U!?4#7+M+_ ^%5!-;-Y<JAU\:UHW_T5\_
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M]\RO2>RKXGSJ4QG('O Q.KY'?1!$S,:&1FF:H6L9U0MLD\G#.*1@U/./NFK
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M4ZE3/LJX(-,F9LC;0V4Y\01-&ZW*(\YBQ7=#OWD0F"ZNO_[BN_A/FQ-Z*>4
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M?1&G$AR3UHPD@Z 31-' X*.(AJ(6RJABV$K*2LCE8-0\K1?;0^A_1Z;KO#C
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M^U.38E'!PQ^^-F4!ST3 <)<,RPR83I"9CAF*R&B("5F/495B1#5L2+_4A8?
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MK%;<263:+X*,12BW&W!GJZ-=B'TGB6\U)+@RA5JJED7A9$#MS@[.,2NU+-I
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MHHW-I6=", ?MHWTP$E;MY'9QODU*H12I+Y[3\7PO\62\3F_:5FM&5,Q??D5
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M_"N]?C"3F/#R^,U!VOFW-*@VN^U5K9"#9X975001:FWXH[*%@CZ:25=.%$U
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MWSC3KAE.BFP2.+E4#H6^U_5D_ "@??3#[H^E.RS_'S_Y;23B9.++O[_!)P[
MIND''X0O>\EOH@?+?!"MPU$B'KRAC 6(/W$7#IV@P1\TQ+V,O-Z;_]-/?L.U
M.OC#[=>':]%JBOOO?_QQ>?<_XNMG<7_S^^W-YYNKR]L'<7EU]?7[[</-[>_B
MV]<O-U<WU_?XZ*\=O<BO(_KIOUI'ZC^E (FCJ:0(>R*=;4Y3GSXZL1?CY]]
M^*&JP#]M#L"'@11HNCK!A*9415[0]48TFTH&?=!;+LZH @,7_A2Z8[)<&P+;
MHTLD!8('MQ$#.=$V@!1PG$>DOQ_#PU$X[@_@H3@6D4P<SQ?A./&QESL^VH_"
MKHPF#2$/P&H>HL84P&!!('T ]6D0PLJPNG ]).7.&!0G/SB4+FI0@B$>CT8
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M^),L< B'PEM,?TB1#Y^.?2;7Z?<)!\XR^TKSNN6I 0Y3@#Q@&*A6.=9G"(_
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M#P#K*O1UE0,>EX*W>I$"6'\.BFL,RM%:W2"&23V2J1)4LWUSC]%L0W3"\ >
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M+3A")6+ &).ZE,KWEL"=3?B:HS5Q\9G,7']F2"5O#8I::ZRR,IV!:,J(%\J
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M2K&P&&"[2C' BL=+*X6K78V7'A<0\LF9/XCKJ;G [QR^>^GAP<5>V_<F:F=
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MMF745Z!OT')-&I+(<>70B7[P?,Z0!I(C*)[IE:$[GSS?K&%WNC.4?1.J6@>
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M4)^F+;O$DY<,5&NO*U\Z 8(>RSZ^LRD>7K(HP9TN;,&.%&9MN./$R W\4B>
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MU'0%DHCD7V.@%JYF@J,>C2/ 82SGH=MP#1XWU6I1SWXO4CW[@4/@KR!ZO7@
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M/J;,X'649(/J6("%W?0*JI=EVP?I&JS2K@^O]WJ>,@=<I@6F*IP@/9-WDPQ
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M^#+ :$<WH;8P06S!Y0GOZR/?06.,A#9<"D:(V2E?1HBW#(GM_2,)!B7;=/@
MO':,-Q/VV\%/BK-(#&N+G,Q*=8W)/L""OH<5C_Q%?:&8I* T"19[)^Q19<%H
MK#,NFX33'Z.<P\L_@BEC ,6H*LMYC3*:O+&!?,+;)NE#W^GR/ )E,A+&FN*.
M5)OMUF:G!$ZU !RR+%?H1>Y\>W;6@/\PB[T]:R&(&0=_KL_2YL*-"!1UTX/[
MKS<<#P&2 &U^V@>%%A2/Z:NBRQ?@:4,D>X73SO4P..BBC/!),Z98XH$O["3@
M-Y'+A5^4[T?/MK0ON5G]456;U;\\Y:7TLMK_ 5I>9$6OV1^SG%KE=K5+E;]J
M3EF V()+?EEPE7*0SR+M-1_E%8NY"A[D"AEO93=<OU@X &W9'KV'K:(GI=?=
MD\51 = =%SUFLCZ70LYE?M+U"C)BNUFQP/SKYFE6/T&\C%SLRDV#W@6LS6\M
M71WE6@A/56X^\"Y0QU$MB0JM]MI!9=2NW'CU72"!HW):]K]RK,W/W7Y=RJB]
M;CWH7E)'NU;AV^:I+=<+#F0DG5XBHZH1PK[4N[:.*G?)VA?4[X=N+*(DN*Z^
MVU[U73$]F(_:E;MWUC2PM8[<Z4_S6W/ER,"2ZRRMM&?'CT,[DTFGB)@&GFEF
MG\I_Y!PCS.13J7N8&&"^;F42<,H<?$]B<DE7<HHWULIA7K4_$1W,?%/Y"/1E
M3 W!EV,.!M?F8>:?Q"Q%+Z#'K:HQSH' !$8['?\OK.KP$DZAZDJA,^J=T2@*
M?W(Z<%IN0,4':89G4US_A /S9:S_F)-?D8<9*U/'KLX$?)IO1\Z3R03$U&@K
MM\-*^+92<RBGR_X:UX'FYNG +E7%$2>+Q3)Z]#CC,DT 3P%KY-6(6$?7 %N@
MEV">D7"Z?XT]E3I-9P?+!E.Y*5P\1&\D*,Q[LDF=%/&-N=PR#XF@UV,\\D#E
M%JE/TZH0G4PD BE=6/QS&,T_C:E\?J(>0Q*_PI.:4CB!-]8YGYG:&DI^S7T(
M,U0IP0Y35)OB#]R@22W/5 +;.T2,QH,P2BCS%E.2 H=QCX5+\&_/ES^Y2"/$
MU*;PB6N,T_*1.41I4,,9PTP%=GD))W!=YB7WO(#.-YP(=%PG M6)0%O,'OFF
M^7@^7@M.'_EJ2;'G#[,ZMZ<TA^2TSB'9JMT\/U>AB G<K9/Y(96=\\G5V0JK
MX>UD?NNXZDBD.O"^M?CA?-F]@R*BCB&OI"?V)3>G#H=N/7.K#NSM=W2IT)2E
MRHJ:.KJTVY&%]LFI6"T$\+=?ERNZG2[1O58=W;[)Z![[ U6J.O>D*6ZO'\3U
MY=WMS>WO]^+;]9VX_^?EW;5X=_WM_OV4\^-E19A#)^I[@3G@T]%*A9GDX:3N
M2[%I<!5@::VCFC&8(LPG\B]B( 0;:/6E",;#CHRH*0XB/A;A.,$>"!2A>$=>
MW' <P^_Q>S&.N;@;)%&7VAZB&]SK4H]#P 1W)PECF?-%U_/'NNY??YV;72WJ
M95F-XLW6X7RG;1E#5[5[ZF1]]\]JKLIE7$15FUU9I-.L6E@K<XKEZ\7:OLVS
M_(B2N$#Z*.QR?=$X/BLR2[OX:8R%)>T=-HY:1;I@JKM5.-63D_D.Z9V[&7]"
M\P1;%7*_(S*'$C0_PU':[(J:?)1CT)=[ZVPWVH56[94ZWJ%L5!R?%CEY<*=1
MT3K?C^C()W7YV,6[>.NHU3@K-,2\E>$LA6&CW3@[VQD&W@1M'*_HH'X9KYHT
MF-,%N-HYM7\9))ZK5?\K4O@+:*)B'%*RBBMG,/VNH>%%-2UYSMRY[MEI/V[J
MZOW:PSQ-&<3D@KSC-$^<'!/3"A\Q?_:;ZD-:*6_O:5/</WR]^G\''R_OKS]A
M&\9OU[?WEP\W7V_%MR^7MQOLQG@3B-OP49*#%G;?GIO_2J)K$/HN)BT_AMR#
MD\"A7'+J08M-T=FYRGFWU',5>PD>GHA[$GTW 3IE4!1^\YU O,-G\*?WG!M-
M'XXPOSV),TWSDU#TL1NG:149A,%?8]@VIL5S@C.N?\ YTUV++(3SY$1N)BD^
M(X6IR6$2>5T> 0-_:2 $E%>.#47'@8<9X*[L29H!P ^K3_D71(#LLB.<\\Z1
MI^RVR39P# _OE_N:3AAMU+H[DCV?1_.H[&9""?57#7 +$34HQ.;W:0:_/Q%'
M8NCY/D_*& X5&,K;GAEE$,=C-;]B+L)&XV@44I/)Y_*CJ6)BG S"B(;JF$/"
M-OP6;1@HSZ>@U/$ /<6 =]O@GLFYG1>76X_3LGE:@.I'C#LFX%9I8[EV!,66
M4S1@PA1BZ.1T'MO$,13G)QQ5('M>8H\L6GQF@#>U;VN4DT-]G+%=L*3>S2I_
MO@Z(%*=S"\K=WJ$HR&O#59FQC]>&J]V*>*1ASB)RO7-'$A9L^^](ZGP1T!7I
M8*DK&@J#;MTQZ/6Q;/A8=LXA=@\&HRYS=ESL] [7+X<C8]S)/JZ:1Z6,JH#*
M=5_9!:RU:ZRM@K7Y=3O5,=;6W^:=C.$VV^5A;:Y\A/LN#>O@B8X;];'OKA^W
M:/V_82SL+N)W/(SP&A&_<Z85%45D'8,H^\H1?7550XZO9(V.2-5K>EX?_$8.
MOGH-ANN#W\S!OZ@)FO5K7M+,1;%),Q6V\NV F;""9:5P4:5<2@6D<Q7=2*:D
M"_1K0WOE1/Q^H/U%MGV)72:OG!@'Q'>E]PBBRU6329\9OREZ43A,<UM,VJ#\
M*:.N%^OAES3STTX,4*.7!<W-[JONDS0#M'5^V!!OVT=J$._YZ=2$3Y'MAAF/
M85N<4F%R*)[)0$"018))*N-HPE_.KHIY*)$TS?0R"2"8]',-Z@@;+P;B6Q3V
M(V=(DWY[O5CJF?;2M"0$)0"+JE** ;7@I$1+@,8:$SR;>R/>Q5**VS"1HG7\
MOO2YII]DXG@^SBSMP]MIQC9LXM'QQX[I(^ETNSA)G,A"8YD F9NE9/*:9I*5
ME/]K-E^)EL8QJ&8.NNL!429AI#L8EHX+7(O"QYP.]E61-+UVU7RW8NJ;'2^B
M,Z'D*NET!YDT,<8V04-91"_@8N2\E&+5=&]7==14^5*QIHJ//EA=!_=='$L>
M6S0R#%WIF[ZF#K#F4*$N"*UDL;1*FV19-5)YSNO2YLHG];S>(MVZM/GU)_JL
M;RE>4XMEB0V=>[)P.ED?OI/F*:N8DF KZ"91Y';!=#MIGN_7KL^>V>X*++==
MOOJWZ@5SH'O!R)K1=HOD]FR[KU*I/89P&_9\+YE4D.-:I\WCHU]0W+?.FD>_
M[ <APJ;5GL^;I_NRY_/FL=[SR?P][[Z.JS:[G37;^T)PI_O$6\6R5&65VIT7
M_SCH15+BY!R)7E$1.4D53<F6%O'-LWVA0B7@V\W#O=GQN3KCB]>LT:(=8KK]
M8;8%)/?*=GJ^'[KMD_?HN3)PQ<23A=86%G42;; R6, O.)%717MM)>"/0+7M
MQXX7[G3W59E;?1[;%]XZVAMWSTMYJN2!MQDGO![LF4TR\JSYHV$'QYFJ/CL#
M#[X8(9N;1"0Q<A) 4Z":VLA9MV-F.6\X\KWLGREM:#3N^%[7G^ (6NQ'HD$)
MYXWYM'*CG&0VK:(A+%AS7KIHIFT^)&E#'YQ)&T:\80)CCH6<V3B^3<-!T@<_
M=,3WYCVLHW.F_B.C$(R2\0@QA2E8XLE+!O"U2 X=+Z#<#AR6*K']$;?#3U'.
M*5+X9[4YAIS/)2OY9B ;1>&??&Y.$.#:YOLZH6R$G8PPSZJA_N:*SL2B'1H-
MRPDJ.<>QL3RK^>>:S>C!K#<O\23-H65:&@^'#O<RHFXYU9CGNB!_IJ1YKK,'
ML9?S3F_UW K:6WXR1,$#3^\YVW)C[WMW8T_?6/#>]5-E]I*$C/FYN2.]9$-W
M<R^\5F; YM[XC13-QEZ'>H\8<W?XH\H\L7$"O=.6T^9>>06/16!AC-60LHV\
M](M.J=D)$MT5$7[9[V/F?K)!@KT!XO$"/6QE(Z_\%Z:^+T$\*SB RN[N=GY1
M0(,E78E@CR:;[4!:^(2+0J>1GS>.3G9Z4'S=&VP5Z J=55!\8ONJ:>O+[K[P
M_,6:- N#KOW2$O<JAQ)^Y\*OHA%>0'RT<;0K==U57; "W2#2GUJ[4BY>+U@U
MHWA]$M;>G K*N6*X:]F?WK4;IT?E=&5;!PGO]THT%$0YI_,[8%9@D_6".S_E
MZPK;+_A^60, R^V ^*[=6K?MYZK-(FM)N&%)>%&Y+H/U@OMB6B[G8UW7F[6=
M/H"GC?/VNG?PE=LN5I^V*^7B*L#37J04K7#>8CG.U9K&-G?;/5HPBGRA;EEQ
M=F^K]9K,>JVQ'F6<\#R]@I55"71SU#@YV5<C[Y6)@+,BIS%46,V<U&IF:S36
M;I^_1$&47)GP-%VN8_5E-.GGID,C9W(3("_LROC_V7O3YK:1)&'X^T3,?ZAP
MN"/D"(K-2Y?=/1&R+4][GQ[;:ZEGW_D( D6RVB" P2&9_>O?S*S"19$R10)D
M@:B-63?%HY"5F969E6>GT))1):O+5HR4LKZN'Z/*',<\=_R";,HH.ZL.NX-^
MAR!Y>=4]EP_"5U>K6JS&-*=!I%D^>=_)QRU>A;=9A\F7_=&@@__V9 (^/A[?
M*3V<"%AC!O[MHXZ9/[SL==@,2$V0C+'K:TI'( J5$ZCQQ4CU4L7#W J_\3C'
M7*&"946'S2XK@4;O16S*/6 RUUV0?B<8_'LL[O"34*$;\<B_!P(>[_D,>\KB
M^%P+'@&PJJ],8C6\..>@<L_;;(AO5&Z9J\:=8:$('*H%PX?+"@[L#XL,"C@#
MKA>^LWX6,T FZ7].:"#.2KS"W.!'XT"*S7&Q&ZPR;K).LP\S8<\(#A'EQ3SP
MY3$OSB,F5!7+4AZ=W?(6B+\!>L1:AT7)&*M-<-F)'TZXB!.<73S#CL71_MK0
M?LV[ZDH.N2:NI>?GB7 U0O*X]^R:1K]8KU-L(YLQ2KF5;*FD1QT2.DCE0X)\
MC<.[YSX8W6IV]TK>I HE'-"'M#W%>A-\!/RTQ*PI1Y4IGO(2G=[\L,4S+),B
MPJ?GK"@6O;3J8BTFBCR9G5S<C?-G0JP\7C"9>RO/;X:UG-/@B5^75U=20;7I
MSLN?'!Q0*,:)$LU6Z.5ZIG!2"0K%ZE2]I=ZOG9E_*!DV$ P$U!/"86WW:4G@
M:@1%$8,%85%DCO)1(7XN#+E7P(+.E.;!Y/&H\_7Z<UE7(C K31+BDU,Z=F5P
M%'NF*DPN.[CL7L':+Z_.NN<7JN_Z57=P5C!GL"WW&B S92Z-EKUJ\VLFZ^$6
MN>BPXN2I^KJ<2XJEF9GX"N!S[L6FNLY4UTU-=9TIS:BNNF[O)464"\K>[[4J
MY ,JFQ_5:1RP]&T+[V[=I2%7HPJ2F!\9BDJC-:T\I+_>T:-7DOSJ/'23@;]5
MOD>_RO-ZV&B,M@GX;0VWZ)7:U&_)G/-_TRU7OU-P4D^2[2X@F13!;9);GA40
MTEME?) >OV;FY>ZWWJ&BJHGU]H;))-9CP:K4;:_2VDYMU>WFU[]F9JX^,22U
M&6FK!3QHENSQ?#FJG5'7[^F2'I+YI+X4!I[^@7--EWQ3!PRU#2\P^+1UE&UY
ME&L:DJ3@UHXQML+:3\;9=@MW70VZP[,.A;@N5!+,Y:@[6AWM(CB>2-'1/-JU
MC%&BF(EVF6B7B7:9:)>)=IEHU]ZC76<5! R^+-L@!XAV51'X.)0#I-_I#ZKN
M&F&:L$UUC[-=5!I[,'&VU;4*EU766^GOJ=/5]7>UOC^5/FIQ]VV^3Q-_=3P+
M)\.+>GJ^[0*4<:1OHSIZQZ,Z&AUO.[E<3PD3O-)CP:IBW.MEYS%IL,TO<\V,
M75V=[=HI\]#!*U.HO#&MMU236S:R.'^"*HU3R\MR(.]H@?5M?,+#L"GM+?J5
MM[AOQWD^@ECTF2ZA:(R3/A&V?:KHG6#!DY7&.<_8 X:/+ZY&'50\^.[5B%Z7
M Z =^B@N1&A9*4++EB.T,AY[UNU?JCALOWLU0%AE;9Z<X[?4FX!J+%5%I=K<
MXX8*)!@DU,,S!:DL YU9 -2&\*5!Z+REP\N+0;??[[+WJY_882\'9VDX-A5?
MTIS!K0:6R,81XMQ$H@9\6^V&4- O_UP65^9+I((00$A%HOJU#=PAO(2JEK$
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M4!18-"LD M*)"9P5#Y&N>%EV/0#>]_RYL(M=:^3I"I(P\*.L7\$CA(@(D>#
M'ET_D)%W6 /WLX)"(> %1 Y(V #OKURU?9AR6!+?5XLC\4!@+ *\X0*H,U0*
M_9]6P%#FBPZ1&\1%*)D'=XYC5THR**4!@DI=!283T"'PC5)CB"A (B--)U3$
M#:?8=UU2 _ =P(\U56Q$((QQ?SR2FF$B/,"?@ U)5&";BE7XHP8"UC*[ESE%
M2!98!H@.D5P18!^C$H3-2@Y%$HSAF*Y_,"P9 GL]?E]J)N '&YA;4.<18KY4
M(21AQ)?Q*!,M@,&\4@&[;04BII8@<,I"3NT%8,.NRZQ[2[AT7&+K.S"\QR<B
M%:$K> :_),'!Z2D^]H;(6OJ4@*=6"[9K@>!137QH\TMJ;B!9+A31-WDJ"I:#
M^O&/H)BC$:E&[5@!Z@$',4>(>! 1O@_<8JDV$8I%[RUYS!TD:4&" &K\N/YN
M'463ZZR#7/>D_.R@B"4)FA$TI3?JRA5,FQEN(0=L<YR3P^G@PLKJF-,GZNR#
MI6>YO&R#]<]6VV I!I^RPYBTP4:OB$]#1Y[W)]LM*/U>$,'8S@7^0[H3UL.>
M3@A]B:_76&UGI2X<SVF;D;;:2#MWR)_<6=\U;;%QV66RMP:[N_[_;F[W:T"0
M (@PXVM"1@/Q+YQ-[$CEI0VYD$ERR2N;JZ' @"/\)YB^D2,HY;8CCR'UG%%"
M,N^VDQKIZ_MPF!8<NWDYCK/[@NGJ8;IZF*X>N7BJ8OC0NR3$BT/%'M;&C\\9
M-!3NIJYM\-T2?#<N\+[+9#+V@3OH?-$M?J5%<(I5B)6JIEV=U=/]0-?45D/[
M NW/Z^E@8FC? -J/]CCA0)^;Q(&5XVV<CK=MRYFKJI3 5'CK0(:!*4/4@0S#
M/=IL+;N]R)X:NG%Y6U+N1X<JY]%)8+2%V,-=E8DA=G.(K=?)/J8+B9RG9=<2
MU##LO:DL&QYJJJ\19H>@]J[744/M!E%[<*A"T$;H+IU8<E^7=UU!U']!@\0F
M(K%Q3J!T'*=N]K!9T"QH%CR\=-+V-M^>W!N]0BI]$V#4@0RF<?^A%ZR,D/5T
MPJR'D(VS;TT6RD&41*N0IBL53NHA@U$1^TXFVA_2S W!Y+?H$$JHJV.>:4!Z
ME-QBVM4:;MG?&%.]N*5Q5S*9A^-H&GAHRRG0*LW,T+I>B=<_K@[=AEUJ-J<.
ME;6EC8;4]E);1:_W?7%IW3V/:^'1FCL8#X<U*=X?([L!FM=PS*J*3L,QAF.>
MQ3$]O3AFA?ZML<GY'?66G >^AZU/R_TDL=7IRF:%;,PG?BA[RA:[&W:8:6!X
MT :&65>XP9;&91N[#6J%*\V[#6J%JX9V&[P:5-!M\ ^/&AM3SD75 W ?]1_;
MS2@X?%^;2C=TU=NU)N_'\%5H2AIB/CEY>U!E/IDAYB'W<_%$S[DMU,!A/5?5
M9%2TQ0=[665Z;S5E4&U!_565^58M07TU(J+_1', ?<Q>/9SXQA^V^8%NCC U
MY%LECZO,8S;DVR_0EY?/LF%K= Q?TX@BSZ:I8SC*1OEN<?90$OOA@DUD66!A
MO@W#B6H$27GZEN*=T?F;B/')A-/,J>P':V?B*#]Q9+S$M<2(CM]!:!S/QO%L
M',^Y>+JLP,MR^TC^9X*_(8ZT\N)5...'9]TJ?<*5>\9^JALX0QE#F=909@O)
M?E@'"@4)U?S)$X_3U-"B\$Z'VU:90EQ]+ZFJRD.[[2JW-F@[+-IVK25H:3GR
M'<@E1TPF'-L/TY!R&J:+,;$L0ZT-XJK7;=<PI:J*,GI=T_''(/[XRD'?^W,<
M,&\S^#B96':<A.@T=;B34+9M&V3BR:!;SZ0:<[A_B'C3).= B#]RJ:JM(?IN
M9GE3SH3'[BTWD:$P"\-2EF=7[O+4D?>,!;HEVO9X\]-@P2:BK7'6W^=XQL/L
M7FQ7FOE_B-R[RCHV[,PU>M7@ZU4U6COQCJN!0LN(=Z@)5<9T_=$N;QZE6C5%
M7=1=\CVJ2^34FQU8=;2XN>2KJ86A(=]^R%>3M78H\JU0&G5FY@:!"UH(\UK_
MZ-YV6;$# [,\)XN3/8AX-O-=S'*5GQ(H,PL4@N?';,RYQX+0OQ>82(MNC0#^
M^B[FH"C<!7LYZ)]CI@!H-1'%H1@G6'"<=8> 3VQ0AY;(XW)1,HZ$(ZQ0("#T
M%96>VV&8C=F!1]I6$JD4X1F/>+Z>%7+9* (("\\1GL,G HN< 118WKOGV$&B
MR[!A!7K $4K@#QZORD-VA346KH@7+)Y9,:R;N X\0< #!:4Q*QBRIS_ 0PDI
M:Y[+1+2,GK/S+EM#BB>)0#M-T4Y0 .J7D"'H'18 S7V'_GR8"7N&;R[H]Y[/
M7-^;PF5P YPA\U&RHBS?S/,65^1+5]97I)!7 K!$B1M3OP_L*1+%OOWM=&Q%
M '-@+>8<#J05ANAGP]>18@\KIJW"YOEWN.I&:09Z7%[:1EF FR=FR/D3C#7Z
M.B(!'RV1*1?Q =G%)[(3]8AR.@S"@2!D#[&0%G;( 73XKL^N'4>@1Q"X+["$
M<PI V%8@8LOMLIO'*^+#E[FHWV$O1X,.\<S+?E]R(CS!%7_A SW)(AD$3SZ4
M$N5+2?+RV&%Z+ST <U<[2(Y &H;NHEL[(SQJ,(-D2ON9$GJL*.)(@_34@OAX
M!6_*LY')$&*&:.8_>(!/UW^H.>5_8%+^-TS-'NJ4FJUYRK]6N-HDY5^?^W#>
M/Z5707KG^Q4""!>,$I(H)Y9T$:@_*S;<]]HBHHZU!PV%NZEK'PS?C8N0[#3&
M!,L5N1>I("_82\IP0W-]&EKSJALMU131VP5_NU;-UN OZ%_5D_MPY)%4+2FY
MQR1R?2R7 TNUMU8DHD+0&.Y_+CE/X"[Y;[ K$[A774]#3E=A<]*V<&A67<BD
M-]8,&=IF%UW;=IA8KO0NASSBX7WE32?;P:+UY"WKBC5=R3#:HT%IS! E1#YZ
M]V!?8., VX]B(SZVP'^EK9WTQYJN9*AI!KDQ-&#A..W_Y$V9ZT?2Y$ ?K1UR
M1\3,ML)P,?'#!RMTC S91O==M@IKVI+!>$+V+UXH?5XW]M>^6VU5(S0/-4A6
M)TG2%F*?'RJEWQA1U;QBM\DXUG%Z8A.4^_#2>(3UH,,>2U>-E:4DQ[]KK9,V
M:O@YY5G#BP/IX5V@;GAI79/9Y5 V>CWLTBJ[C]&<C%69U>8X'>8X#7>.,YDK
M;X.H?:;_G7<5,%EN^E5+C-M2ZG>AYF1_^=_Z'5*S8+,7;)>E\T%\E[5Q3'BQ
MY4T%%GSI:>LTP4UR,AS4XR<YJDM@(R@YN-CUPJ_Y_4Q;JV(G@?:[_W"J:L=G
M?A)1N;(5QAX/HYD(C%#;ZB@TJ6.F!GC7EY!53IC54*0U6&[]X85\+F(L)JFQ
M.7][6+U?3_-+([/V34ACA350FIGTL$/&GG:^@^H5>S+L4C.[F%!E<R7MBE!E
MP1%OSM1ASM06A#P97NY:#*/7.30LIA^+[5S8K1>+&7M;4?;3)HT &W)2ZVT]
MNVLOE\,T^CT9-;+/;]-93I/^08>!>N<2Z:U9;M.X_#:=H9_3W3'/8*&=IBDL
MV(<5^YM9W@+;F>4=8)GE^ %Z<*]O_V"?_"Y!A=TA3_L7'?;BHPQ+W<GIT7=^
M(&QV,>J]>LW>6B[F=K/;&0=!_LX%Z2TFH+LH]=N?L"S/AG[;><%"_M]$T+A"
MRUV9J$@A_>)% $&)?3;FS%;+RR:\GN_928BC8;NP>PY@QYSU9?O;))1#<GAL
M"3?:2W_;#*_48AC5-S5@OA?\(6+8]W=54B8"@@!C:U_0^JIA=9==KQHTAOVG
M>82<(Z(9K/,PX[)%=/KH,7<%O\>NQ-@W6<3X@[D?<D#G-R0RO.TQ;'!-GT=(
MTL /:6(D @+D6@,G>Q! +-DO/.M+W%V5Y!\Q:BU>;BL.U MQ-B5?N39\:LW!
MJ%'H*/2RSK#B\BYP$M$R;0"]"C_4-ADX8^+C6TOMQ_5H%=SOF5[!6O6_-;V"
MC[]7\*""7L$K9!VS4!Y.A8>Q3I0TV&Z]8KMQKUUK#VDI/C(#*X5N]Z*66I%7
M]6W#<$TU7+-S-O^!N*9Q@03I!9)#-7X^2<=KO")CWB=3/DTM:4!I4Q.2$]K5
M35E7*O1-:7KEXB(5%-[C-F*EOF%+3<6TDR)MB0:=F*F]AELV=^T>B%F.H^!J
MS266>TY-UU<3:=M?U&.KL'I-K4%,<,YP:85<6E.:WZ&X=(7>J'-4[*HAK,6P
MT<S**S?6=ME5 :*7_3.RLI>&SK(@"0,?!V+BJ%/&OP<BE(K&L6)X=\SC!PP)
M+<VE'(S41,K!61<CA"L?S?+IL@3%GTDH(D?8N#QM[67_2D:='CU6E)X(SQGV
M-WH.6_$,^#(.G90Q*OB=D/4N^-/2T%7Y@&S:)PT[W?A.0D\Z7[.;,A()D&S
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M<$ZZ[#891P"%@O*);DZ$3(LHAC8!"BYX<+A(.3)#?G9F"J>[=@9[5Z(^P:K
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M9--9MADN^\%YU2D])@349GZJOK6."0%M4!/O)"'*<32U*Q;D>MZF:[EUFB9
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MA$1_ \(9=&7H&AAT;8:N_"+>O/S%JPH25MY9T8R2.T!'8EU-U:9ZE8E%6[C
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M&7>SE=?<JP@!N-Z!Z'*W'C1)%CDMA28=PU9#X2=1>B.4A$$DQS&?P^/* U@
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MJ[0+NS'(*C7(JM1^K<4CF!$7^C72:2@FG^A/8S#Y#(-L:#BR(H/LJLJN:*W
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M_3IPMP3UH^X^)^JUU5=ADNN.-/AODNL,RYCD.L,R)KGN6)%ODNM,<IU)KFN
M;4S10)->=WP1]U[WO.D3V4QZW2'2Z_3*TS"B1G^FZ7>/J(E].PFH7YFV(>"S
M_-'#7?W1;4^O>R_NA<,])V(.MUVP?ATRA(NM574[(AKR?TV%(EK'N4SL_XB(
M:0[F,=+R&%'?D!2:HT/]H'NUQW92*PVI58^R?3<*+._7%_VKUF>1_LL*O_&8
M!:&P.3OY])_;&^T"<69!LZ!9T"QH%C3I<!N^^@T,F&:HL:.S^?K]P>[=*HP3
M0B=R[K,[IE8+'A\U>^?=H7;QBY8@_^I2P]X:+<']OK724?D(JK')?O<?FL'\
MU9L9.\KL86,\F+HN6!TM!KMG_30+==K2XNJLVV_(L +-,'=YWNT-#>;TQUQ;
MW3?_X59XRCW3>LDL:!8T"YH%]=6(_=YHKQ5L*U3BS[$U=CF^]<O/270ZM:S@
M]?\F5ACST%U\$)[EV<)R/WH3/YQ30?L=/.ZMZ]O?_O'WOR%POZ2_NK5GW$E<
M_GGR;\M-Z+O7G@-KN6*R$-[TVK;A=AY'6"?O^E$2\FPIAH7S\,=7/OGUQ8?0
MGP]Z_;/3WL5IKQ_[\/K\M'=^.NR]^ ="'*S:N,UA@? -D_CO]S;3M[#:&%_\
M^_KW/Z[O/G[^Q*X_O6?_^\?U[Q\__.?CIW^RZW?O/O_QZ>Z6WO]Z<WOS]=\W
MM^SDO>^Z5A@1$H7'YL)UL=3_%5'JYW&&ZR!'=6:"(+H!7!>S*&Q RZ\O>B_H
M[\!RG/1OF21++]5F7>'QTQE'QH/]C8+XC?H2>CM<*XCX:Y:^>L,>A!//$ ^]
MGUZ4R%VE!720XKV,9N]\-YE[['H)Y=6<(\E.V\N,+$EFN"6VB@!4BJ^WS\=7
M!?C1%Q_O].:?,]WP]5YO?&G'7S<;X.L@-]6*3*%=*=>:)8]3BEZ#S9*W.=)6
M+.@C1M^#C6SKB['C77(+(?N&E:QN#Z] ;KT6\ANFK@&GL1^\QJJX_)UT&7BS
M6HZ,[% $R),ULN2S-G9 $^  !'AKN7#+YLR*G\#_.&0_5_C,,9\*#]MP[.^1
M_@0+'87O&"X[!)>]FUGAE#LL]O='<MN/XHA9WE,DK_B1_'O O8C7J5WWQV2#
MQC%9R,$>-%QFN&P?7+8_>L<^\^,9#_?W1$MYRX^"PQJG+ ]ADO%]"K#G&&-;
MW9QJ2<?, AN7@Y^>(/>&X9]KU_4?B,P3/Z3F(_$D<5GIY%47ELN#,C]5'MPT
M:YNUS=IF;;-V/6M3OL?A =]"$>\>)]I%PU:7T,C .H)KY?\D'F?#7H=A4DC%
M"KIRHNZ.OWT6 VT(TDD]G7AV :DA/3>.C1'JJ<8SC- T1C@U6#=8;PG63^HI
M7ZM'Z.GCM]'<DFQ736)51Z&>4JX6Z'_-Z&CLN*.@8T,, H.TQB.M42X XS,K
M6CH-::.L&;\WR>C7 .VZTK%=PEY7*F@WL+$)2&L7Z[;QAGI,SIK?/W[XS*PT
MNZ:MK*LKB/HO:)!HD&CVK.N>S8W:9*$<WK1KD@_*<(()7QA&,%?D(\1Z0SJA
M'AG63X;U>-&,:\/DH33/RU>/"=X""T O0C9$@>NZH*&"B6DU"FG-NL,;KY?)
M(]F5X4?US% REHK1D4U:L%VN![V0UI 1>GHAK5E7S&-RMV23!/)T$@9_.'S"
MPQ#;C%G?F15%O/)N+8WA:UU!U']!@T2#1+-G7?=L[MNMRS*I!($5(JJ5?B[#
M3]KSDRE',NS4.F>6H5USXTZ&=BO-@GK&TANGDLGA:9R#]<QD\1X'(<U5YRCH
MV!"C4"^D#4QP[>C=(\8M:=* =F;X)D63-<"[MH0<&$_<41#26#O;9!+5D\QX
MY%C3\J;+GF/N_!Q;8Y?C6[_\G$2G4\L*7M_:,^XD+O\\R1)VKCWG?Q, <[(0
MWO1:C51Z+R+;]:,DY'>PB[>N;W_[Q]__AGO^)5WJ;1()CT=182HM+/76BD3T
M>?(EY!'W8GI M@*S 7#XXRN?_/KB0^C/T0MSVKLX[?5C'V.GI[WSTV'OQ3\0
M^F =&M^PYYE5KAJD]<F*83O,G[#/ 0\),II%R AD?+\(-"%PG*$VR#&;HK<J
M .]FG+WSYX'E+1C $83"LT5@N>X"[+BIA9- A<=B^%80^FHD=8?-K? ;CW$L
M+,*#VX@LE],V ,M1,N=A^OT(?ASZR70&/XHB%O+8$B[SD]CE<AHCFX:^S<-%
MA_%3VY_#3VW.[)GE>=P%4!]F/JP,JS-'1'$HQDGLA_*'<^Z@&4TP1$D0 ,S%
M[W09;@[AP8EQ%HZ;G C/@OU9+F /WI@#OB/8G^TF#J=-%MZ&O<0%Y. #!;R-
M\,"#_ </UL,WD:U">(\["I!Q)!QAA8(#!-<N/ IH(R8 *9P[@8/J;+5D'%I>
M9-DY+Z0CQ=@#!U[AKI@#O+$D0;X/^'J7O8,[A 5O \'\D"W0[@ZY[0**Z5%R
M<CC"0TO-+=B?HN./$8*@A-RE+WA^#'2-_0U_"E^$+TW\<*Y^0S#821C"QQ+,
MH,#GW;K9^V8RX8#@>P[O!0#D&!AS,)"7DDZ1ODK^C\[?1.S?W.-_)8  R=V3
MB7 %[+ #WPT#/[1L(;\]& W?>.R=ZX?^=P8(SG[';KO777:B/LG>?M5!_D1^
M$5[")3OYF30 FL*__+\)(,==E(%#.!3>(OH@1SZ\F[B279>?QRR@9?F1V>,V
MYP8<>@?R0,) LP"CE(;PDQFPERC2,9?VSQ?1RT+^CPA4Q4T4B[F%7'A0 0ZP
M((XS:/8KH@'A@:4H)P53M 'M"!0I._!(BGC!'D0\8U/@D)!D/$@</!>9Z &1
MGNH E.>*2?[P:%CO;4QD@.=?@Y0&*<-._NC>=MD_KZ^_O )&_&\B@*H@;#S0
M&P@ CO=%$$)NV3/@/>%)44=R@F=T)=$7@=8(I"B,9U;,+#JYL"J<. )P+D5C
M43@YF9T I^<VX#;*/F;!XR(%#NXGAZ=PR DN!1&F"I>A^3-QIF7E4(0OD+(7
MUX9] .9"L&#D0<FT'ZX"\MWAIZ 'YSX1#EY-0VL.Q(UBX/;3L14II8$:@8,N
MH*_1G.(.PS<HHQE6"N"M4SX/7']!>!T# 2<B3K\Z2<BXL*UHQB:N_X HCGQ;
M$)*(X@+DB @E37"K #J0<>K[SH-09QN?0\-KF>M[TU,7A*:CDJ:E,+)IG"Y[
M 'K,Z&"3ND]@+[!A^$[BV4HI8;HU@"P(71WZ\_YQAK9$M<NGE@NZW[L7H>\A
MA%8.CP!LAI3-#;0!S8D:U8Z3@M@#KG4=_!08DCC:$< X(9L UI]@,52(*X56
M6>0L"Z1W@&&08?B?&V OV!0RR1<XA/9"$T,38:/MTHL"E/L36/1DGC^93@48
M9L@O,[@? 95< 1\3?>,PH9,&; +K$"P.)^911I[O\84R.('1/= ^Q-$6JC#@
M,."%.=K6*-Q ; 1)"+:CE-5@>'*."\0SX%7@:^!9:11.X# 02]+W[!1E]A+@
MD@\#.+??%1_1.;#"$&\K2B35;L/<K;92"-CTE*5R*LKDY(S#N1A+TP$D$X>G
MLZ)MBAON2 M!GB5YR%'/@ 6=:9KT2-/3QG+<<21/5P3G?LE*+L*WZJ%*V.&1
ME0]%#8,CFO%Q0$F4%'),^TK-(T5"!E/ZA#^!^A%<!909]9O_P.]YV$FU9 ER
M4 X$1$$%WL.%!.^JQ%=P,9$B"0$$1-"B*.:1]4 RPGV#C95A4S+>/N8; ;0R
MU%JYLEY'/P)%P8;7+R(:[(S4J@.7"@NN.N/%2ES2U0CV!X#9"GW2SK;I)@=/
M%:$".'T?E&0"BKBP>H88R>HASQ6N+RFPDHS9-MC8][\!*))<\, 5T'3D@<7%
M4 V!4B?V21?.@.;?\=8WE?0!O'(ERSD1#FXW.!.<T/.9U-0)\#RPX"OX(>I*
ML,\]'LOSO>ZXP-T-QX&K"Y:%3.HJ?8F44C&+U^M.-+DT@/U<G%=NPT*_ONB]
MH+_5G''Z6\XNIY=* +C +J> GND,3_T(!Y.K ><V4B&(^&N6OLI'?/9Z/[TH
MN53JCR!MXP3+IK</LL6WF=[^A'_JV5/+LTSX7-U5XT@K@GH\N#K; %=;!#3K
M'NY^=5;!</=5LC#5G25!N4K,+NM3,D L='54[+Q]-/=WERUOGBI9W2963T;>
M*8MB=%4WDBN,,1R(@ TAY1,9,8U+I/CD>Z=/"A5OZ0L_$BPZA\^JBA$.V]6D
MH1I.ZX_6Y_7KHZYK5M'F-#WFBZH5H]Z'J7ZL'9\.VN.)>=[]IA+N>-XC-4P.
MJJ:*?FLT' _JCTD-WOD8&:GZRK-$L+<N;)X- "#'3\8NK^*R4OG5HW:81[TJ
MLZ_JZ8EA2+>ZV]OELXSB/$NM\K#-==&E++MSD(\('6ZE[ XVLQSV<D0?OAS"
MCU3,7(8?N Q+=3 >$<A<%LP.>9@)>Z8RMN:@I]U%%A7'8(6(T.]/^3;PO &S
M[/\F0@5DN^QK>6WV8&6![MR_+B,"%/\MN\<+>\E\\6F&S]KOGZV,MFX43UT.
MPG[T[N%;?KC0*NZ:0B7VF1I2>"A&MF3J![DAD;]<_P%(0SEY&'P-512UR_YO
MQCV"Q>-@%4966$XWPD2%>T'!Q#Q6CYD.SI])%)=CH%D055#03E$F31A; T%'
M<5N>0+A083_X7<1=%[_JB"CP(]YEUQB #3 F*5-> +(TAREB4S@/%)_SQQ$F
M"MH8+>I@+ DVAGE?.4PNOZ>,0I68R!R.20.^7&LI!6)BV91F" S.5>H";-;C
MF) "Y/J+ D%R[YCV0?F128CP$N?3TG.5(O($)5:=B77LO7P,OH08?HP77\"V
MC^$0X0$*,)2NU;%(H>PP@I.D1@8I_?4!P_C\]'?*-_GHQ98W%2B3D2#7><^^
MO9RG'-H@@Y:7H)U(:&5VC"A#FPJ_TD%$BG?9>QZ$W%9A=8H4S#% _)=\0P4P
MZ9<@M^U$"G*XJ,F<U-!"[7F*840VY_',=QB&H"5OI4DN,I,HB?@D<1G")W,>
MZ$7*CW)1EULR>PP6ME6&GXS]R^?*?<A(J@QYCCEP<"X6LD>R\N,F*E'Q*23"
M\VE]5DY679M%L=>8Z^4^0ZYY(.MJ]X##-F'$S9SXSXXHWF0,63ZW19-L'+*?
M*WSD'Y(-488L2XMCOQ:^383*:9#9='"T,<L!4RW@N*H\T%HN,SMYVWKLE(UZ
M9*&N!Z]QCK??R2C6'_/#&C"O[0GYEV5COFJX*&LB_4@S!,KTSX[M3."E(@%M
MHSOF:T"\MD?BG16(&.\Q8,)%_B1^(,L3;V!ZTN;B^;2IT;-3V2TAY/>"/V#Q
M!EC@A13]![B?8PHKW#UE*5K(9&HD74AM$=K)'&X8="_W;3L)9<F$\+ >+N;R
MKQ6IRJF%;GG*!C_!VAYZA4P:O()[*894L<" @4%%3B4;=%F(N)07@E!$W^B^
MGX,KHC05VY7&/?P/+AI8W<#HNI-=&%0ZK+RI>%29E'B9&TJ5+N3.BRB6EW;"
MC_)X.?!$N#7(6T'^*_Y=X#WK8PX5(28B7*YP6<CZ#YF<*S& +@/N1.4[55I:
ML0Y8F49<N*S16M+#\@A%DCJ8=5W\3.9$SZQP2BG 69YK>BO+DV"!*O$#7[D=
M5MI*6JM8V 8FO*LD>OH!74FYYU EB/1^9+_O//5#8A%@C\*5D@ORF0 &$IEX
MKXK.EK#%YK[#R;4S1KY*-U4H!5(5E'"WRS9&[A1U9(#W(S$7&+2$RZO,M5[I
M0MG4-?+8LPA[\BP7KA.W2BK*7QRZI$-)ZRPK/X6.O2.OV?X<),5R83M3(E&6
MDO_?K)8[R^,GU["3EJ(1D^7.:&)5!\^X+Z4G;"Y32"05%4F0M0IN0U6[&.5U
MNNFO.EDQ$ !.Y5@N2,J8<M3A?6"US-476 LLW&6%UZ>I#T2NC1#(LBN.7I0D
M3!]M!8&K/!<E\$$J3SD6 RBH235\5W^LP$AAR2!4!;\A.6#_Q.HW6BZK $.A
MX=*]@AY\FA=STO=PY\)SJ:Y8NAZI?L;"?7M48:#*Q1"WRN7D*)640=5EG^E0
M+NT1!!/F!" FI9C'BC471("JQ[.<A207;3"6+8"(9(\X I^NO%]*/\A37_)R
MC655/.K (G&+"?TKG%"3U35=:X_UH_.?">7/X7MR/UONY\GOOC<E[Z3T1GY,
M>3#W5<H/Y)I:>5\+ZO KV1IX6OZIJOZ(=!^!4A.-/+!% 8.5BA&Q5%JHV)$U
ME:B/5!F8R. G4*0C,O?CYQ\_,L:R6)7G)<322T:8$E8JE#;QDQ >!]P<XETF
M\;"8#+\02K>MTNY9V;TZV%:FOE7MOY@S642=&6E1!@EJUIEUCWH>"UL4,' F
MZT;Z_R$F57P1]7$!W:4PI32._""KB1)A*D[)ZI.'':73/<]"*!&6'%E1H4H/
MVT6 =2Y<_$N);UEVA"A+@%HHRJ;P7ZR\A2_(:$ZI:@\EPPJ+CBJ+I#1-^R(4
M9<;C,MB.8I3R\UF4%A,K&0OOIQ6G%E8/X>F)F <X528ZE0\6#7.I\*C>*97P
M?J'S1[QBU]+8!>V1HH0JY,B>*B(6(<^LR8AJS6).<GF)A5,;UWJ$75H0?E):
MD0J;L4X<M0">PY7?L5C\X)]&,0]02]E44ODQ/2K #@P_>MR]@'I>A/R1>5TJ
MQ%R!$N R% !E4LMJ.Z !UH\2MCOKUY5VO=)TZRWG\G.[[#?+>1)6/!%+L([1
M-E=R 4W\1W!W,AC2,_5 M9!TZ#/D XHCC@8NH1(QD-G::1&=*S; 79'QTQ.=
M,I>DR:/;X2-66;4&Y2ND6)4:_Q%$2W<<INXWA>T2LM++3EJENM&%1T%+%?:[
MHJ-V=;9,O"4F6F8A$"IP3+*+.B+WT2DL2^4DXM&Z"]?)^W<?7C$J8+;L&57[
M$IL"ONYYE&H@/-3J*ZIP%&YJ$4:Z7;IF*].=Y(T?IL@M;P0!3<MBE0)^_*6T
M0I1NU""9O2QLD=^HN^P/4-EA&:S'YR:O[*?'/.I_@$H#][.,7L_),!45ZX,S
MUP-01/DI0@Z+>A))<%MU03=&*1PBE,%2) DZ1%2KH7RE),H;)P$19&175L&3
M@T<6Q&+Y[B-:"B^SHNG6@#XFCS05>4!D]3*9.>5D"&I%0;T1LOKD&$Z1$Y&M
M'PH\4.1[D*09 V81T=F7T0"/^721.1ZP#01#WI6[DWKR&R\@/[M)I;I^>=LJ
MJ:@#3XD)!^A;PEN.S%/*.E?([E'WOIO0^0E1J29<W9YD;'P:^@]HI>!S.P5W
M&,'PX(??Z(8AKZ2=K+@XK2G.?I=F.#L\ZTB!-\.)6PC-HR@.@/IHGA0>VV7O
M<B<<635E1"BT%:]->,1=HB.QBE7H0"&KX&4N"B]8B<K,J%TR?4!P<V.Z:#(O
M6\AK#>VEK"&IP*)EZ\("+E[@=0Z3@M"**%LIREGV(Y-D2<-+C;&DD97[2T1,
MF1O.(_M!]6Q(;:P5*E#9JT67X I?6D&?K]1TVWCREA3;JB>6RMM)7F2B45;#
MYZ*\X%=;(["W([],]D! "A):I2RJ#D#%CF?%5CJEO*BQKYH"R,<4>@KD&R]U
MM,G,;G7*LJ2P5*+C+E)+8L7IER=3\H24O87E2U96$=]KSSQ35$U]GODY3V]$
M6YSU@M.B>E_$LKOC%EB5OT4W_;M"_Z'/::<N6!RO%?<<W:B1#H[0V[QM$BN"
M?!CWQ#1$OR+P"5PUDP@KT:2O"UFLT.")%9L[2=9XL$)']L "0.BH94[&HH^3
M%E'7;7E$E30D9QX:-/M1$R4XRC)_R0XKBA@"A8PPVF_:3\11YA5AKY#&1JG@
MI[<VM7LLM(NBH$&:[[RZQQC\]8T70 GY%!Z8)I>B 4&ISLIO@6Y"U8$+O02
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MOJ\7E7%2&V#GLW/RV77RTH7D,.4/=,%30)[,YI*5^UFGF X<D#E\C_3H06:
M3$1/$\^E6Y0G@8,D,1D2XF3B67P/S5*M9-WP\AU1EA7;X%Z060X%W%:2EW8^
MT4'.DU+Y)XE329L;V"SB4GR7IYKDAI 4=L^/SZHT43[S#*3Y9\\1G/*F.5GV
M6.S4\K-]&3JAL*27DI]ACZ;UR;$!PUDA_>P0 E.H80J7*X"/G"[K=I+$=DCO
M2U+;4^SPU1+U+)$A 85.C!;9B>A9GMNFI+;GZ@>"_:GF2W-<7E1)225X#'.=
M^ETD/E3JM"H*;P?\(5FR:BS"\?$L>)JB>T@L&NJE-YMT#"E:<>V) R#&G=16
M"A\7<B?"%^+00J+O9LXB 0X+'!GQC:N&ECQ%SC0=.']2".4$F;\TK4Y(P' $
M']Z2(_J:R N_FRTB UOVK2B#$$[-YU53Z^0I: 7OD2^+9F-8)SO]7:Q 4OPP
M@,604X;@A,QU>4>.)J\3L),,]5-^!_ #V9QWEG=CG#03Q/FR=DI<F8N6"=P[
M^:TCZW7NHX"H3&KNK5M5##L4I[W'DRO2(,U5D8*79*S$J92RU@\JJE/[*QT\
M(XA001)3"W*%DQSZ59IWM53%^$]\Q3J?.*7FT($O&V)I)H7-&&^^W/XJ;.]X
MF4E&;P$K4+Z_G$V5/29&P,HU<WHP2%6<8.\M=1,#_2R&SG*/HT#HFZ0JZ4F&
MPY)V?W[D/!DN_WJ:I=I9=2 \/A\H\TT7!EN:5]XHD/*G= $G=FYZ;Q_AAA>C
MY_X0 -#T_%7,7I(._HQOA\'[V4=P@6 QB7.B)9!MZ?8LNI&?G"YQWFARQ=SC
MQI!$E?)2]<2:@-S+U%9>JN7,2LC2HSVY6<7V=:8.[*)>(C0I+<TR ,@GF8<N
MO8-^4M;XE-<9J',NTF 9+/.Y8):L/)4*_2\*1?Y\PRF^XH1-M'0:^B@6S:[T
MQG5) :E 7M)3@2UD?TI(HR)"0"%@7/C:B].16[   [KJ)K'^ O#\JL#%F2K5
M^_54B/M%1M2O@>_YX$>7#_WBA_]AX87M+Y+\TCHSTB&2+TSDJQAS)9\RN4FC
M 8>[4UQYY'<9H8WU&?#N4Q8^6S4U\MX'=7OTZ>+F_>O$+EF[#O+'0L+''%W<
M_/&:?/&[)";O>:=0#5X$C#B6R&_+B"Q'M_["L<AI_^SU6^C[DO5<@[V8UJ')
MF4@0BF.)0D&^)C 8^;0ZA8+S>(]Q"2DL+3T.)<JRNG^15I6'LR5C3+HFY0.6
M<3:*!DV:6I0FML5IXG%QXC/\C20H/G4L)_'AQ8Z(Y>3I@N<A*R -GGG7M]O]
ML5]JZXDL;W?J/=_QCRL-_&<U^T74WUM9)?Q [B+Q[322F9T<3Q(+Q2R$'O+B
MLS,YD@%Z/$7G!W??<@?LL\3M*/Z$N@0[1C5+"Z/BB,:R\0.E70GR;MS[6/PD
MA1Z04KSMHT_![>RX2Y7J.31''"G-3@I9W52 SW0?-]<U24HO(%LZAIE/\70+
M KDDB,O5O+&Z=Y\B^F:%\2F=GL&PY?7W0$TR@A,#U!?<[1?2:Y6N<'V693%7
M/&,TR!\8@JF(#$<_PQ##\<]/<PMCTAY #WYBDR "MA14H5!R*3:64&$%#38H
M:K#/@-<1DS115F>CP>OG^B9#-03L>!;OLVRW0T6 1)GSI\<17TK$D' @>3K&
M-(GCR?>3"S1<(Z76@@A_RER/] >QAUGV@L^"TIVE&'2<H"RSYV@N!/%U6CI@
ME_KWQE9;G&(1%]AD2D'.IRL)E1 IB=YP/U^ZT%Q46M*0K>FFGI1)C!%%X\RA
M G*1&H4AY[%VYPYZ*Y4&6:\P"ALJ;QI>B'3$,>=T''F6)&[9;!4)P#Y4:B4=
M!(HJ=$4*2_57 K$'OL#9"F![<:W"ACTP/NZ?%O? 51[^D&E,V;$]ZHEC^WWB
M\[F189/+98D2],GB /*W&W8.E:)92$MY6F])<UB25:>8YWL)\Y:92A/3<*7B
M7VX)\USSG\2%TT)79BE%TIF0WLL+@O15MBM)KB6))XS'<A GU<AF"6$^DA3(
M../C$ )PL0@<M\C]BHU!87</BV)T$YMD&3;1UZ)BDH(R":7E+,4),O[6"TM^
MQMGPJPS3,DX\+ 1F:-'FDM_-E>VD6(:4",1R$)#&;1EDV40&ZI95+L>ICL_1
MQ_-Y9<_J//,[R\_SZL=]=6$QX?U%*V8G76C[++[FQL&V96,BT7O9;.,LM4SO
MT27X\$1S5JT,CZ=T[KB/;[>\L3UM9GK,A8S$^VF5V5!0F4N[H:@VA>FPU-ZT
M(/S;//$BARC+3*Z45D#TBP2$__FV*,9?X'>9$,G"]_P<RW(6_2(;LNR$& 4
MDM'#+!Q3P$T#S^$T3KC/.R_$Y1SQL$E8*3;)A11Z+ !_;9*XGB L+S]$.A\
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M;T=6R('HF/*U]^Q4A\$QNT?)[%1W^T2V5,P6X^[6-\)@3+O&4!L:U? 0,&;
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M-6-VY++K:?SS]VSJ!RP;ZH/XAXM#]\*S$S?K,D1B;2B'8GX+WV->R &8D-'
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M]N;(\>)7KZ4![$OS-TW',* <R(2 ?KL0B'7E0A_+N96KBU11>,^AMY:PMIX
M<6FG1=H203G";I<H+=N[0VL2EF84*:VYQ#*A":NYOF)TZG"1@KU"T17!:6!
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MJ]IKV7OM9M^.W4M6K2A+E>WW-O"NEM-&MU1UK0H,*L+];![7]$D!QP(#+##
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MD7:=7MI$_3/M"L%:1/V3TE4$M=MO^KKC/ON<L\2PLU=W^.CH)OLX( Z( ^*
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MB9,KU7'B*/+E',3H(0T292,%BBTIK54+EFL+V 361<7^"N:I2LMG]7\X:(#
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M6UUF(MSR\EQF(GK7MGO2G9E5^E?ULA/TM$KQM(J_, ^EY@BDQK)%NV91;(Y
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MV.E5=X7_C<%B;X#E:\@[RX?JAS0@$7WDYPO$2U8@^7YZ>\H?S%CL>,#"B$8
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M@2_PEZLN9Y1WR?^%K_\/4$L#!!0    ( $V%$$D5=KD'C2$  .QF 0 0
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MKCI9$;(-BRR)6NBJ_1=8Y%VFB!0V5;EE])N<0EQP[F[RT;$<>>KLMO04,IU
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MG3\UL.B4JQO7X=;/VI%QQ_@J,#]"XA1HEG>!7;)Z]D+FO,YH;VAW\&0S5."
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MZWKJ#QJ4_DFE&'/Z4Y:"LDQU$Y'P# DO%^2>^S4D9BDZJ$3=Y*'S,/H1XSW
M7ABI)#$%[^MNNK\V>*V:H?%3!XW/74#V9JJ;B O!K4N7IQ2K3&K=S0PFSF*P
M2W/53<:4ZE ?&/TD@_F>=W4W^1=B;XAT9H[0%GPSV>B];^MN]EQL+]D='6HG
M>:?K*@?ZADSUE[),=1,Q9-"1K0N;$C/E.9K[IN[FSB51ZPN2UMNRR74W%,].
MF"*M#F=2ZV[FD"U%& $OXX6;\ZKN!NLHV^@@?"UL/,6B@AV#C,VK4LZZR:ET
MGSTD9@Y '%:J;C)C;G-O7YZ5>CCFY:F;A,KGT5+RPL'%:B=4F'H#'>.OZ%L+
M!ER'G<5Z.KZ'520-5<G[>+\L+P>>8>"KI]JVQF-NT')M.T[3592C:=1<"6'=
M0QO*HR&FJ3RF9-.H/R2,69K^X\HV#0'_2J!]T<WRNW:%[$VC4X?D"7LHQL=D
M3BY;*V1L&FU'QY.?1#'!];L@,19<_9GJ_I+CK%_:0B2L<X^LI^:H-_'SW<7'
MN[W;!J)0GL&=/.%6XY0JU\X.J6?]1-,&XT'GY3N6Q3PSJ#XQ#\2&%UB+"QJ<
MIA_P*47IS,( U)=0$;$_42)SX7WN+S8TF.DS8#"'GDC)TJ'/"73B(PW%%@0=
MR(%!%C,WK0;Q%Y?4O[\J)AP=4J;VY2!?;GU@*B'XY&?X@V<@R_E@L0U>W^@1
M?BA5/:WI%=(59&G<D9C >1!6A-E:2&VWZ-&%]A#&VF,WL)=F;-K"D3;+8)/W
MF6S\=[4/FQY\ZXY@S/01T0V,C9C\=\T=+.GV)L?)OK>-&R*Y^N<4=YH0,!UY
M)IRDJV3]XQFVWJ%PZRYH"</"YON3,;=B-V/[)%EC'A*D;UO.S!2/K:5ITT@J
M!%$BY%!"J=N;I[D<W]/N#$_+\S6-:[$(LPE.9=.;RYW0JS2NKV6N-\HPZ^!B
M3>-=Y!7MF3?BBV#^N^8N@NGV)A?!?6\;MPBB2B:I5K_DSG>@BGL8J9A*5YJQ
M7OO,2' KWLC A00FM24++M---+F7<_/[HVMIJ&YZXSHNL=$?);H',)%4^W5'
MWY\J<TTW!'[^/U!+ P04    " !-A1!)Y7O3P?4I  !=+0( %    &-L>"TR
M,#$V,#8S,%]C86PN>&UL[3UMD]HXFM^OZOZ#+U=7FZF:GG0GF;S=SFVYP=WA
ME@ #='9R7[:$+4 [1F(DTR_[ZT^2#6VP9<M@6R*U6UN3=.>1_+SI>9/TZ,]_
M>5R%SCVD#!'\RXNKGRY?.!#[)$!X\<N+N\F%.^GT>B\<%@$<@)!@^,L+3%[\
MY7_^_=\<_K\__\?%A7.#8!A\<KK$O^CA.?EO9P!6\)-S"S&D("+TOYVO(-R(
MWY#?KL=]_F/\N4_.VY^NW@+GXD)CMJ\0!X3>C7N[V991M/[TZM7#P\-/F-R#
M!T)_9S_Y1&^Z"=E0'^[FZH2$DD?G\MW5.^?J\J]\% :A$Q'G;AV "/[T..=4
M=/G?/CFO+Z_>_=?K[N4'_I^KU].K=Y]>O_WT]NW_:7XW M&&[;Y[^?CATO4N
M+R^OXN%_#A'^_9/XSPPPZ'#98/;ID:%?7J2H?7CS$Z&+5Z_YJ%>_?>E/_"5<
M@0N$A8Q\^&([2LR2-^[JX\>/K^2_;D$SD(\S&FZ_\>;5%IW=S/Q?40%\"A.&
M/C&)7I_X()(J5OH91PDA?KK8@EV(7UU<O;YX<_73(PM>;)DO.4A)",=P[H@_
MN<[LOAHMH2]%[9/5&N GKB^K5P+HE1\^7@0 (HZTG&%)X?R7%^*W0N"7[]Y<
MBJ_\YR%8]+3F*X*AU3KD]+ZJ 0F?$:B!1!JL$21\'5;LP36 QHSI(/$,U0@*
M:ST<UHV*@VDJ!6M8*^::6C%O#@U.)-"1R1Y<_6@$1,=6D&80N-XPA"%CD+G^
M'QM$85""C'I _9Q!^$J#-2FH^E'@[D8#A114_2BLUP!B#23VX.I'8Q$!@G28
ML0]8+R*N[Y,-CM@(/(%9"%T<\-_0#0SZ",Q0B"($RRQ]E2D:6.PZ&ATTJ="A
M#@8IJ/I1F",POU_IH'$ V<CR7NBM[T5S2(2 ^!I(I,$:<(8Z<4&300&&:P9U
ME&(?L %.^%I!@=]@2$ @TK'X:; &O&^DY7VC!D4!9SJB2$$UH U4APLIJ/I1
MH.M( X445/TH;/XHBPL/H.I%050Y9-K/O?6O&Q"B^1/"BZTGY[\<0P;I?:GO
MKSQ/0TF'=M;1I&*+^744:Q^PB?Q'!XL45-,9T%3$A66J5#:LB6Q(SR#C)BVR
M*+_I!4P-:HS,='30V =L*B?2P>0 LGY40*B#1@JJ@86LM8X;1("$6BLD#=94
M=J.%R"%H,ZF%CE3VX)I(+K0<#6P0!9DU:$GE +*1!$.+'7Z37E?D#EJ6/ W7
M1)*A@T0*JI$D0P>'-%@3:8:6;J;!&HGR=3B1!FLH+F7$7^ID'%G@QA""FY"(
M>*("6IDA#2$'D#92*= F(GE&PL4\(#KH9(&;08B$P-<KL.5 -X$2UN,.;H@O
MV<2E"R. PNH)S\&X)C(>K7)Y&JR1C$='8&FPAC(>'33V 9O*>+10.01M"AE&
M%OKHI(&;0P@!6 FG/?CV=\ST#, 1,S5@/O6L9Y-:%V 0KO6P2 ,V@$@88+()
MB!XR&> &$)KY&S+7,I>'H$T4 [2<1QJLJ6* GAO+P#:%#B-SM.)_J8!5=DAS
MR$$2H  L427TLH.:V2S6# 6:LN9]"$0 AH,AAZ$=LEJA: 6Y4=8SX;K#FZ@
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M]5C1 "HV96N8UG39O5%EJ(?G-FJ'LAMWG;I2_!'3/:6LTAP=>=BH1ST< ;Q
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MFA,J>AT4;#7F+8**<YK.;XY?[4<QS_XES_.1"HM90MN$?I7*3HW5FA;C_I2
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M3](#:PD;26VHU+A:P/#LI?6(;? DI6#G3Z@%,'N)[<UW\(ALB#92PL.>5 N
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M]NF\U]'_71FO:*N/@%ZK],=)__YN,%X8O?&-0?X[7'PSAN/;R>RNMQA.QLU
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MM$MF;@9-IC:J&5OW;TP5Y6MRWB4S-HLG4_W4C+,]TP\ MH%3)M,U,_F2><Q
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MT"+,3?Z?$=Q^+QO<WA/A$(6>@AUUDG6!Z&80[ +172"Z"T1W@>@N$-T%HKM
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M[XWN>Y2T1F\<0CX:WGZCN?V]?G]R/U[,P]_/!O/![/?!7(NL?MK4?=_AXK<
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MJ&)[D=(BF1P]:KWX14E!!0P;M>_=IV09GJ8+O-Z:YKZ*>2;)?56I+\Q]%3&
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M1&@E @S*^^G-QXVYE +<8%UP8XR=>VF@K ZJXYK(Z:I,D'A;$0L8 )KIR36
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M.,WN5A_BV$\7<>A+3..HW/9D$:K8[L/2(@$#";%>?+^5-*.7&7=E*=&4T,*
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M.WFD_AX,)@1*\;6U<I( %!38#DEK8E9MI70(G6]U"17E=J]:5& @(E5-DO
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M,T<?L*E9)H65)E13T<,%F#Y($Z(,7(36.CS,33,Y9BPI)SNO;:LJ/;#-R<#
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MW6JQB9/L$2?;2_PDW1LTXW7;-M/"G';S3 -&,,BTT9;SM7%6=$L/8R^JLD\
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MG_Z'9@D]>R&=3"3ORTZ$2_SV,:Z)8!M^,&ZXA])= .<BJ#_&A9"\_LRRJ,I
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M]+3/4!1#FOF+FFUD_-S'8; T:+JD8'#:.DFK>*L!DI0:#/:T*DK*[5'75W*
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MG:%;?/1NU="^L[Q!9>XL!1S3>$>IZF)WR)&#@9Y>1Q7F2AX8R.I>\;-IFV/
MZ?BZLZDIG8O/.C8PR#/751T:=NY9GJ&KUV(;!!@\ZZ%6UC^[]PXTQ*!9M\ME
MLL?-5:%E&-E'Y#2NL[_Q8M]J+P_,$!C "-78J*I%%E+SO.Q<;G-# -KP6&SB
MA(0^R?82/VF#53W;-#!7&R&&LI@'(%R5BO)]G GQFXQ0H]LX*W:'YS%MO50
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M8T<-O-NNOX>XI=.I<RZM;*Z!O+T8EZ#O:V03]K8RP "_I^+*,H(UBM&%1V1
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MBCN7#84^Q%Z8TOOXV*<W>&B^-_EV28SUUOC"VPG>W+$"70V/80PO!\)QTD!
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M(S]\DHG!R0L53BFC/GGRT3J)N8H*QKB\P,-NZ["^6EF,GE@^Q[X,P8KA7CR
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M1#B+'T]NLK@L-OYI5K4H.6<8D4 G!*GQ/:< 3M[DV!_0""[[S'LMP/^43Q-
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M\[#Z/@FB9;#SPIO(L.';D3*G FMO\V58MA8(+HER &/@]GRSLD[=\JV?*+!
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M(4UDZKE@U? QUI<[;1\D@]G1;-\(1@>8\F720,W[:I.M)G^Q*#!>]CC]%6%
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M=LDJF>A/\R^)HCA:RDLDFK,[W3^V-*JUBVS("V9X6"HLV[4XL ,/;[U.6.O
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M3@K$Q[T5D( ] J:P;I#8*<T!DHJ'@<4+;Q=06X_9R;64X?8.7P_SVC?W+ 2
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MQ!G"RKA78/@:Z<.22Y*0FP_*N@8-V8<Q5B>W9*7L,S'--WXG0;1=31KN"D\
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M3(8BF_<9D#T<2:R2TWQ('YJ1UT'EI',?^OY'D8;)/#[0"-C,(9L="&Z)WS2
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MV\.Z>\@7G&60BLE6\?U"9?5UYLI?.SVCKNL^K^ V$]4LM?J^MCL"&K&NA/(
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M^6L",:\:M!/7+.KU_2T6YU:DRR+[3T1T(5E36Z6U&I#03V1;X=@6RM)#>%N
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MWG+SRC]XW*P1E@_?J_CVM(5=AQMI+]2'1#-\M=N)?6@?QHRS#4P=ON0%O\<
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M/R>:'M^1VQ(H>"'A!'%EB"/,5&8ODVWH>RH(/</O._*1CTM?G=W>IRLQZX[
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MZ="L$HQ!2"D+$  E")5<9,_*<H")@@P7N"EL@L"-RXR/+2H21XPG3G%\A,N
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M;/B(U)/O6#%4'3+<B,<18"VB&T8\8PCRCU+Q@,XW.O#+\$,ZC@UAC5&N4:P
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M)<Q+FCVKE"=*WACW!Y$0#XZ/<ZQW7^.KT/>=Z+W81>*?J.^]/WX) _7AXR'
M5-J.?XFYNMTC/R#$S&/\I$RK(G(:.+OD9Q!:*MK_0#SL35Q8B.7N'9,MAPZN
MJ(!OR5F;33H$<>48<+Y*![%!9-+\P8_;,*;%V3*;*K!H'4A&VB9. PYEM:@-
M3V=7,307031->8\]#C>/0-+-P;_A!FI\N[F3!22@/ R<?F&CW</<-R=Z[0/#
M,A'J34!%-A 405A0TD5!6V'-'>$+2"&27Q$F : $H<YAS,!EF;A<\_WP!469
MDWU/8QIQ(H0/@UL!(:8MAPEYA<NOZO[5%XY5HG B$15S"'-&P[$O!8<B$$F
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M*0K0]!%W^5G(N$;)3-I;Q!@C-,L,PDXJ1VVNV]P\^A3Q!?P.K2\=2W*?+>*
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M2"_(RQ 3_I4W3([P(!32 8+9O9<O50<0FB;PRQ4A(ZH&$*BF<98A7FV9\P<
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M<3.6-X&:?SW.(?HU\!BW?MGZD*3GZ0].%'"<V\P>0RAVKN5=D6]<Z7/ 5J0
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M)$<BS/#@D U%OF*VW&RP>M-S1=20Z,=>K,P!\K>;?(9%%>XVC@36CW=6\FA
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MO#\VFLGBXV#6NWV<S0;\K,?6ID4SZQ%7UMP>E[,$9A);V!:@%+2WG?/V@"R
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M.$H39(JSJK>_2O1*<6V0!;!\&(QY4%AF?1\>^[/^>#%HN/))+A&R8($5#;(
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MR*8 MWX&^*&2YHA7(L9@W1=0DGBO1O/G,&*[[6C-J=2R0U%/VS>G.D6*H7+
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M8E3;+FO3N!X(SPBRQ?I<^F08W1+?X>ER>7C/FJ>9^'>1(*KO)"D['!#_ SM
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M_2K?EO^QEVW3>UR\V2"Y6*C;VXL%1X!'F;@];7P=]N)-&+/S1A2F&T#4A_9
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MBEP.728];^F1'5=;QON!6XH487]+U]1EVM[HRKF;#]K>F;=8O T)'X>&;9\
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MC2=!>7D?!L5SY'SFR.JM[M>+SV0C"-KM]@O6[G<;FK$)^>(P[_(=8"/K!@\
MQ/QG%)CK,H<*TAHG_.!UXT69J/FI^9W>#5NEL[U@@398PL6"%\<'\NJMT_5-
M&$7A9S;+W)(-^TORI@>H>!0HLJC<0TT$A0]B&(0VPT8Z@@@O!%OEF5'NV&=:
MT]+.9.- 843E-&HF+"1 EW9I/+]/[D16OWE4];,7^-!R8Z,6!C[@"DH]&I?]
MEU-V>':\#?&'P9B^)HO/U'^A#V&0/"MBL%L,"X7=V"-_((1BW!O+\OR?^VN)
MX1,ET>)SV)$F[4:#*I"Q^VSS"G0DN2]1;]C7%8?G)N/9#_0ZC>Z4I?<%:L]]
MF$K"9!H.!]4=HX\KS.M.679?HNIX+UW.._EP4-7IWH=W6M4IR>Z+4IW^,J%1
MI]IS-"(XH.5<%:A6@H@RO>8YBXB_$:0M^EF0MH@__>F1P.V-0A+$O2+5TS6)
MT36)T1DE,3)P(5[QLRBNOTOM<>#3]A% B2$DU2>N3S0D3S0L5X>X/M&X/M$P
MF00<T1,-V<._W4T)Y+U?M;'M]-Q *<M8P'2_<*0&8*6W7L1"Z\9'P"6VLXGO
M!F'JAH+SR9^_JS^?\!/:USQ0I\=%\:?>F":\_M]C0/)ZF-3->F5I:ADJO6E$
MUUZZCJ\'&".QW(IS2VUC' NZUG&EE@\DIY1#V@#'%&$'/, (%$R*"K[SB3BE
MX#GEK6R*!Z;3R"%EUW25AM.#/08Q=5+N/R_\J9E7L1^XC!A&!/M+O"?I+J7C
M\"7;+2X^AXOG,(U)X-Y[RX320)USJ?MOV3[:J)2UDJ[)E+@-YM;2)7GB).$A
MQ7/ZPOYD1$4 '[-],#.N(V"!(U*2&KU>?&9_>IL$]"032>5KMHLUV9A*!")'
MI"=SNDGJJ6:_Z%Y10)^S70_*N*9H"!V1JMQ1IYYH'G32O:J /F>[YI1Q5=$0
M.@Z_(KJG=:>!7N6(;/ZF[DP#< [%<Y(T2R<ZA:B@5G%^_MC",L<TRA9SHE,"
MQ%PEN6':EV^SC)JRJE]M8UQ;>!T,6U?B^SF',J"KK*(N*C#'8>#HX%ENCVNO
MK0-IE>N.)U:K-X)/3AHNB> ^\%W]?>#NPKFW?8O8>^19:'M9CMG>O1>0P.%_
M[D<1"58T"^.\7@8:?%*KN!*4=,'C60=?#$JX07(]6$=A9<H!YE_'=E6H5#](
M]G5TUX9U5)YW98,N<,)TG5BK1]>R!@;+&G25";2H G"40401 JGH9OND#M7&
M2EI0@#!,QD;J%4-H7@3!7%6=QC40C-4^J)6W3NF)E@4GC!V#&\CZ'*I,U+&%
M)//329$\3=XGFZ?;T'?W6<<.3K;OCT^VD\7'P:PW&O9OAJ/A8CB8HSBN9N8T
M\L@3E[Y'8YVC*Z1O=_/=8+WQPS=*;VA EUXR>?*]589G+/4:L:ZPGI8-" Y$
M:3+4D8F11>C7_*:OOXIHYH09TRR@W0N(OR>F'A5@5]O[L$:X:(D%RYJ5L_AV
MSZ]V'1JQJ2E8D-=I&'MJ*]O-Z!J#V-[HZ2/;A$M,&!]S#(%4UL?V]K$Q@FI!
M7,#5YIZ]C-W%,PG*=_<Z]@P9P_;]2VMSA@O*WOUI[2)<[)GW)00F2TXS+[4>
M^JSS:AN7,0R.%Z;ZI;G5@+8#F1HMV!V(\"3[*[Z+@&VG\I:V:ZYULGLJ,WT2
M*<_8=OHSVZIMX+O7HR[6*B%T*?=:,1@!8,'GQ4&<>.LL)J&TOYK131HYSR2F
M^U3\[->W)'[N)_?$BWXE?LJKIQ3[ZTS \MG-V,>L545H [IAT>/8^,Z)3T>4
M<?)$G-\7$0EB)@Q&+CN73:/0H=2-A\$+XX_-]'U>CR>3GWA?U'0\:S44VNZ1
MV@G03.BW@*3L=^)U$M#-7GF$-H8,EL=)T=AOGJ?\)7\83)9WQ8[Y0_V=JH05
MY6#VRA^80 XH.V0N\:5'EB_K0.07__[8+WX_'/?'M\/^J#<<SQ>SQX?!>#'O
M]<=WO?O^<-;[M3]Z'/0>!OWYXVR0_^VK,8EXU8^7U@GLZB\R\^@RGDUR&\W'
MGS7L5KP'!A4C/?^]V$G.[P4;C60UU#WR7C+)*E- '#6T'.#06-BUJUV%.R11
M7WNZ1I"$$#6-<<2A"-1,B,((7337GK:]MLV\^'=5.@A9K_/$IHX3'/%<>QIO
MN1^'F3LD8YV\%S:,Q-HG!*R.+11Q7#S#5>BRL^>60D@2N]H.MEV0$,VK2>\E
M81[',;J(<QJ\.L\\ZAZ*DZ*;O8)8S>$"20(':.5'F5#$9'WL%;YJ#I=:!D8.
MQ7M*QR3SK-;O#EC3^I;85IO:'8&0^M+]O3F1"I?S&K*0+.)"@2GE:C+'TW_3
MY#ZEOBR*]*B)M3L.B60J(JQERXP'+'Q[HB28>%(95EM9NS70$:.(.1Q+7/FV
M7ITQO+[U6<RU4@Y*T3:(L%"^G1&TQX&'3+,4H)A/R)<E7/G^FQ^_*\(6U)EK
M1#U0U+(3:TTE]XR<<QR3TB(BO([\G"?)R>X"'H.($I\G,_X8^OQ/W(D_"F/)
M5*4SAO4D,D+?Y)&AZ O&\.:<G0X*?W$1!K0](MRED22 66L VV', 'AT6>K>
MV&+J?+,*7[[ULJMD;FK?%S]S^+XO&5G^V_)I(.1$$5^8FB?O(>Y@.QH9 )"*
M!8/&4CY WX?19Q*Y6X6(YS1)?$F\#;2O[6ABF(GH2<)0TKOM9_:!.37DB#8"
MP,ZVXWEA<&C* L?6P$)&L1/XNE7KOK%L8@SU=@'W@OW!/M2";T8F@4C7>$3<
MO1]^_DC=%>>)5ZS(Y,]VIU[HBG8/G0UO.\@7NK?H6)X8;5D0=U9K 5K!9L8B
MA9O:;Y<19=T@\2$,>;1'\MP/W <2K;S@CF[XDZSX-_;+FRC\G49W[*#!9@LQ
M1%J#V [XA6/70#8X0"VSN(NJ4^;\D_>R'86K8W)J[HT?CG?15//TZ9_421;A
M=E>5$M]_8_,ZXX+MM%(^A3,!\(?_113Y]D7DR%LS55,?HSO\E/4@7OT3=^>"
MQF'"!_--/XYIK284K6L;6P_KA5NLA%D<:!QLKK9[L45X0V?4\4D<>TN/NGQ1
M\(+%9^J_T >F@\\2Q!H/B"CN0X5J2Z&AC-".PZ6W9C^( K5_Z"!0>UO_EA?S
MV\7G]DHS7:^(RG5[).GQ4-U>%JM[C>N6<U+WH1GWIT=>L!*%;G/"(1WMAT=T
M$<H-Y;9U:+<<H7P)8,27-G!;G9\$.V)N2.S%E5E( %[#,1'@"M?;.A@;\HTD
M9/R&^$RIZ?R9TF3$/\/%+@U4$/<X2RB57.$(&Z^C3Q7$(.N#(Y!!I7T D' %
MB_-7R('+_S/X5\JV<7YV5ZF*&)?VLGU'J]:\FFVI2@@X3AUYUL;<<9%/XRJH
MQ#ULNV^T85(QCP@B#6P:@?+.F!^[&2IXX<A"G*;DC:^D&:G%STIPE!VAD0[&
MK@RUH0+* @=P?2>O4U_0R.9G]ILHI8>[5CF&.F- X<0S'^I+" >RQX_[0=-D
M<\2^1S97(D=G=R*Y>=O]^-&C$:/K^6U$7Z@O/VU!^Y_SV0O*8]NG.QTC6N:S
M2K?J<*8Y#([SFIXVBV"&<8SB0+<C;QALTB3.6'RG?%DJZV3[.-=(?45(BJ6"
M;/8M$?J^"7SO->$SMDLU!=][U/#=O)78S3RIX%6SON.%+)?US.%X<K4C<W]=
MQUW?>71E#%X>I;W1K8HR-17!*.40Q2IX2Z+HC6GEC&["B!=6SFBL84#MZ=0<
M",UJ"5#BBANTD=!PS+S;U)N3Y8[@!G#KC6+[K4L+K)N("P?0]<YZ^>HJZW/.
M"ZN,K]*[$JM%Y>(D\APVF]33VNS^J=VH.-9@M1Y72M*U81K%LOP0!O3M@42_
M\VP2@:O$6=3>]B+;A58?!SQ*18-CZKTAP>\+;TVW,>\J^$3M;1])#< G%PT.
M^"XPV6*KU1.4?/'':_)%,T9X3;Z8;P-:)E\\P>N::_)%TEGR14S9_,XH^>(%
M9*9JM51),U7]=,U4=4F9JKI#95$0IYK;ZMI:#ZZ I;*2<(!I_CIX^%2W\REB
M\O?>5KDS2W<L6TFM.GAV('1\-9,G#GW8)G%@.Z8-#>(\*X-/ M6S3E4_:XX1
M4T##!(4#U)RF&C?ZCF5)I"*@K[7K!E/@P@76/*=-VTJA)YK_2]+L9A$0#6@M
M.YBUI4 N6AQ31XG&9O,'> !KZ<A,X:\INDYG$@ROSVGH>BYY]D3OSW_L^/TY
MHZHW6"ZID\3\GWN+.WB/?D=C;Q7P4I@]$O>X;3(,RBVN3]/-._?C;8J%F[<"
M@1GU,T6,G[W-S=LP8!I%YTPW,T:V(>PW;R+?++B:F7D:$'AS3!1*,R\X=#78
M:EBNS/F:NC9"\UK? L#Z&C9"]\C_ J\J,6O"M>3<]=;SK&X]3Y"A[+)N/2U5
M+\-4:\Y\\;(+N*"^WD]WOYN=42=<!;PNQS#(<UBP\WQ$GVD09QWXXIZ?J-D_
MBQ+E8PI*R]KEU] 4/H$<"'2VMRWE?QX:MDN?>,\$VW><=)WZW/TRN1VRB2\T
MH&7-OXAGD3>@:FV!0);DDFGT:I\J_L"S^-.Q9W&R^#B8]6XGX\5P_&$POAT.
M<K_BA\?^K#]>#-@_#3C]"I,.$G9NHH'#W?R!^R$E$6$+/E7X^<"=[69"B5+B
ML^5P$+QX41APE2,^U[<#RB6WB^ 1+ 8*:.)838:B)20CZ;[G7KZUS+_VUE]%
ME+I%;36RHI/E;1@G\V<BN,OA=5BT1K!YW=\0+FT>#<(UHVOJ>D158J2FF<VK
M^.:"%_)K1+HCFK #%T,S8A]-;L(H"C\SDF_)ACCLM%PO:V4GF_?7S24/E 6.
MK69.;+RE=I(F<4("7E!055Y)W=/F]7.[!08J%43[MQ$E<<;D]M2S]I)LNUIL
MPNJW=7\^WM:-!OUYL9/;[O >'H:+XFZX^PV=D&SY5@[0S:I1,>H8<;-L6S)X
MY=%LDJM407.+VS,P*A6[D3".8\*;;"@OQAFL<A[O4U[#^\$+>+W.*7G+32:E
M$O4K1M(>R.8&KBF@#:5U5E K*R/ICF/;7]X4M$;0BRLKZ85<O=#H*6Q7DO"D
M6C,,%I_#3Y3("J,U&,JVZ_ZDNE.5X9>D/NRKM#,%*@UFNPCMJ56H(L<O2(GN
MPS3J2H=*8]E.VG!B%:I(\4O2(.^ELUFH-);M^KJGUJ!C*7XQ&K1@YPE*EHDT
MJ;?^4+9+_)Y4?ZHR_&+4I[72V*\H?%)5::T@:![);3Q.2$LGC.8PUO*LM'#!
M-)(4#@<,B'2E^T5O%.LUC)OAU0#SB_.\@+B&^%VT![)>+/ED2G.)+A<HXP"'
M2X.AK)=D/J7N7*"O!<@ZP-.B/Y+U3&(GU)T+=+) .5>[6/1'@JJ.,3?O*57G
M\KPK(,XAOA7M@:"*8\RY>S+%N42W"HCQEMH"UQ%C[MN3Z<BE^%,>@X@Z'!;W
M,7#"P/4X5,2?II'SS/B?//G>*H=/Z5-I,)2]2K8M'"N-18;#N0(FOZA<.6'+
M:!0G_2!@JVD4DZ@N*E=7-)*QH3IAS"_;'-^&>J(4]/DO/_JRF%/>SI#6U0P.
M53MCN;3MJ9U0U%^BWBV>O<B4VE7'!H?\79[6B03])2H=]W$DSZ:6V.K@4+4S
MYK>VN,:*1/U%ZIVW-*=VE;&A6F?,XVUS9U<OZ"](Z?C!F_M4 %[--F-"E<R8
M:_SD2B84[!>D7(6AS9\I350/$%L-"E4O8^YS6W-8C6@O)DUN3.-H(TA@\9?C
MEX[SQ>3V;Q\GH[O!;/X?O<$OC\/%I]Y7_"DZ[<WHII!?;QJ%JXBL6^>P[<:0
MYDGH_/X<^DPY8UZN+GD;APD@3DK5K\.T"%R >_EMQ2?*)LM3!$A[X$CE!Y-[
M.>^!E*G6>5EU1#^2)%@54SI"DU95*4VH\$?H4I_6$RI/?"KK<UY( 1C"D:*T
MGD)5BE)Y+R3SFE(!06!UE*"T/N73A@9YK=SB8\+DB#SM@ZBQ[31D$!4JS6 *
MIHWD<!FPXP)/SQ, Y"QJ:_OILZ:8Y2SCN.?+MAY5$TV3YS#B>0[SO?P[R3P$
M'<!BP@GHUN5X-M*3#69 9Y3K*,\PLZ-^WZ8AQK Q;>:EZ!1W'1&B5 7W+N5Y
MT/)\78JB4("N-A.7=0.L6"#X\<LD(-O' _K:3(!F ,%#D2!*GI4[CYS8%3B/
M?H8YC[+L\$$O$P%K_^*YC)BKY\AH)8(@(W G;*9HF9;=\>2\T5X1!&4)E+TM
M)\K6\SMI<89I'I51S&O^38G7$,E];^LGP*ZA/!8,HOFTRNNVJMQD>9LE^(^'
M03E?=B53^Y@F/)TOE:8O_,MW0*=^J:1=\?F>%_1*!/0R"GH')/08#;VO<BJN
M<[BY?-=B)<CSIW,$%,7H]$9!XGIK,A_H,8JD_!N0Z,K.LC'.(S1W%XU@:X/\
M"-\=Q[:46:[DG.XPR,+SY=<<\FX7@ZN"3QP7($>TJ6X^!,UQ8 ;2QR.0! RA
MJ,=6TL%%1((X+R;8=_^9QMDS&%4M*6A_V_MGJ0Z*)TN 3'"<@4HTLXWGML@,
M+RRSKZ\\B7Y)B>\MW[)\\J5:Z+$&RBU&MYU:LJ$.M)8G.@VYHTNVT+LW-& _
M)%.?Z7@CBP>-8SL76T/4-62$#E_9;H)I\V2Y(*^MM\G[@2Q[N9H>$)IMD8_E
MUSC\<9,[M1,2)?9#;$4<\_A0-L7]F[K;*7 2[,N:Q?W(B]GD5_;2W]!E&%&I
M@AGYF.T-1D=::! ('-.43#C[FGC.T98KJY WN1U.>1?VA^*Y]C2,DX@F7I1M
MR<MS=0LU-$>)[?@6PSIJ&D+\"ES4H<USZSEOV>F!.$G.;NDLH9;2K+#V1[9K
MF1.?3J*1QS8R;AZ,WTZY3T^E[;H$)U!\6]#K[S]^SO<? 5UQ>>#=>W"IEI:X
M_5FK'^>GK,8&H![5]E'U! H+%>UE*YCZ.-3I&<A86JP3*$QG)Q\D28]L'9C_
M\=Y^@0,[9V;.>2>GYD%P/*W@B548DRC*IE5I[,$[6.S!;K!K"($IEG:A)<,@
MH5$!\-%NKGC]JH@C:# 4EDNM!L$$#;A%$E&@IK<R[U7!UAH$"<Q-5?T(>2W6
MD<01J&F^>;NCL1-YFPP4:71!H\&^-!VH$0&.< 0UZ6.RIJHH!;U1<(#?P@BT
MX2]S;^)AYR@,5@L:K<N4C$(2B.^R>;)/52?;MPA-=+-</!XF%!R.U)+G*XSJ
M*"_YT""GL&;#6;Z\;+ 7.3Z#M1$CHJAO;N4!W<2T_A7-7]X?GYC&@T5OT)^-
MA^,/\]YT,.O-/_9G@]Y7@^D<QVEI0"+^GG 7<J\^)XE[6+33WYA2/K,3?O^%
M1F1%QRF?2B;+_#G6)$WBA 0NH_J&Q)XCYDUS&,MVJ<+NR @;R>C\,W,- R>_
MMR-^\=8D8[B?))'WE"9\_[@(L]_=\-=\1>;T?A3Q5Q19EFW9!JO]V+:7<TTM
MZDZ<.%9X@57<>7[*?ELQ#NVY0SR0[9OV;J8/E:#.W@,?))[+>?1>Z)PZ:>0E
M'HT'KXZ?LOT#OP_E#N4TAVVRK A5D>*OH^%M7UYKZE*G0D6V/XR=32#8'GY?
MZU#_^J8_']SU;B</T\%XWE\,)^/>=-0?S_&YUG?3.H>'LAU[7?I&09XH23\4
MKG4!D:6%Z^:MNJY])I$+=KFW_@0.%PU,#82N^-920.*B5_(A8@/@N>]B;"3*
MTK6!U:5K:RDI)/[_G%?V%;EG_ZC9EP'S$=,XO/3-6=VS$[@\D!3BS3?S-1SJ
M4ZOZNI;>B'\3?O^[XIR3W5D_!E["(R_'84#7&S]\H_3.BZC#AI+> V@/8CN\
MRZ0UE.X/&@H7A[=A4!"9$3_);K!4;]DD78"(&RL$=0K$U5+ A.^,LDVPYR2%
M>JJP%32W7OGVA,!*)88#U"F-EF&TSFL+<#>7"E9A!^L5 T\(K$)J.*"=<;[E
MV^U2$QQ[)=-;[1+#)1>T;9"44VFY$0Z@*LI5)^@MR2@R;135@U6R/FIFO9!1
MC8(<B;J6,1Q3T -Y!<G\L)GUZCX F=<QAD/FC9U&AY?F^RS,!CQYXD_9SMC9
MF=^S*U>>"I7+4KH7XOE\^6;'W@^LK_Z]2P=?M!VT@%X'12!=B"KVW6T9MA/.
MA+*/V@ZFP*N0:JAPZ.3.PT.C%Z\X,U;XYBFL9M2AWDL>)C!XI9'CQ?PLM'<,
M20YSG7[$=M"%,9TS  4.'6LLL8*;;"J/AT&>O>8H(BK[XQU)Z#WQ(E5MBU,3
M8CM9 +[YL1VDEZ'/6YO=\;_@07?#((F\(/8<PTH,^SKZ:RU;FJL#GI%R:HT9
M*+F&L[]M?\EXJ+\+-?,EVPD.NM<L8Z(RJ$5E,@>O_$=:(N5#2'P>&$JI2]T%
MB58T87]U.$PK>DLV]?K2=DS;^4"-:$8W@C[SA2_[GU]IG.QR$,IJSG7Z%:!2
MV;O[._E")@$#D9H]J3E[.N:,V9<798V%RUI9>-U\ GTX2"L%ZQ(&'-H%.F:/
MP^"%64BQ'L?9'N_@&![&R3A,/M&$'<;#52#WP1G\)-@E?';J9QRG"U?'W/;N
MPZCX%6\G675/30=4<<_O,L,.HCBTN;%0\^12PR!.HC2+H<FRQBV>28#&"=@]
MB5 ;^(+N3TSI 2+S:+*E*IC?S1J']YX&]KFJ#T)5]_RN80QC=&&*V'8B/A$-
M^&.[K:OK%S:5_GK2>;3^:U"M/--;%D/H7)+^69P^P01 M?2,;FQ.+4)TBFMD
M:WZT\[%Q!*N0 %7>,[I4.KT0*^I[IDG)3B RE(X)$SOE+^C"S #Z5UL22S-?
M58>P.[R34 "UB3.]XSLABE>]ATK,>#A@2WK H?]7F]!"^&HA4/EE=V96]U5R
M>J 6<GXWG'81-A(/^6OI,O8W&M$I\=R;MV$<ISQ,3^(@9)VA?:$*<4;7?1K<
M&P<O>P"3T['-5B3#J[:Y]4?U!B&2R,<(*N"44=DQ2026_BC6'^D;P;"I-.U"
M.Z-><32^\UX\EP:N8 YM-R(4\C.Z2&DM$PSPWWEQGJ"^M74?C 2%^XQN)!K+
M @/,Q91SY/W:;=PFP<X1ULT<#_H05$G.R/-O2E08=&@_AYE7(\UO037IC%SB
M!J6%09E*,Z1Y;=+]&%2=SLB;;%)<&/1)7HI&A_LFM6B^/R,?:F-9((/9_+2A
M^S&HLIR1.]&DN(3Z9+E*C>.0R$N>!+5J?M"M55.&HL<?C?28C'HSZC,AN+UA
MP#Y/>PORVKNA 5UZR;6DC?&2-J#W/WT_H\7CA9:.7_AP&&-P>9M./X<CA2M,
M/82E;CJ5")*R-]WP5)F)&[X#U/D0$I4R:9Y-'@#JB!!)I9Q\-9DSZ++E?E30
M+T_D+>WTY>F&5!PXZNL(2%27O9=VPP$U0(5A@'54R*8;Q+C6399SXJN+)-0T
MM9U5%J1O1Z@(.4828T]]-N:J'[@/)/J=\DPK1>X?%3[JGK9SKC:!"RH/'.C-
MF$ 9#<^,W#OZ0OUPPQD% @CJ;#N':1,,-:2" \;ZU5OW<&D]\;NAG3\HI.MR
M@A)!4ER0U\)-LBV&?)2YK>6Q"3"^[<7X--K6+1KXG'PD]1A?#EW&X4K@Z?M1
MU]/7C^-TG4=)]AX3S^<B[WE!CQ'3X^[/W 7(?G%+?"?U"5]DLS\>N @+T?66
M8=3+?*Z](O*R5UP87QV$&FE8F[P=W;FK2X!R5'@QM@6-UD71G/K;!?-?Q5GF
M1.#Z.XE$#-Y,F2,^KP)T:B7:?M7V*H9(BPZ!.!\M&GE+RADXH0KM/VG[C(M#
M?XXA0'2L,F$JJI3 AKYI^RS>[+++. B(E*U)S(&,SU]#OCOVO>1M1A(JWF^U
MC7MH0 /2@B$ 93PI2%^.<@KW<2>4O>:N[M2/+.PK9[=[/(3*>11Q=<C^B913
M00/2LB(G5$X02!>HG#,O_OT^HG08))2!GIQ^49=2@+2JR0D5$P#0EZ*6)UW.
MI10@K8MB6RTO?BFOX]JB/J*MGV)9$<T[#+O>$V^?'G/JA\$DH)\HB=27&:<E
M VNY%(5GT096YZYYRAN0TY*!M=X)"LV[^%6WCOT3.W4./XVU](@%9TX=)O@G
MOZ/3/E#!NC9K$!58:X6<:.K30 I?)%,<QB$1A##]I!O"-$_7:Q*]]<+E0>Q1
MK^\D3!C)VS7V"-M:5@2'E1[?SD+?OP\C_D<#"YCB>V<5G&18%A>Q5ZKR:*QV
M@/A32*.5NM(08^K847F 318W/$](E-B/$V\KGL/R=.;4^/@[2".F<.IP/4A(
MIE*^,>+94]D.,8UV);HS?N+LCY/M\85&CA?+Z@XW&0MI.)0A16HL;/W9[N=\
MM@OHBJ?F./^9CDEV2;V$[?SC?E"J^7V"R0_P::2!5#CG0S"45ZVWN5/]QWNT
M,5@X];I6@IWL5@?!!>ARL:CQ;!6F=;GF4T@#MG!JLA J))O6[F19\9;F&Z]I
MY#F4RWEY0M\3F)8O*\:K-6A?E-):UU2TL5ZGT#0K*O^%N<1B+7>+(5OID@BD
M(6D([:5[Z,\_U4AKH6WE8MMD-.G &EMWAF;32 ,N8U>E]$79V6NU) MK]!]"
MVSB%?ER&J9S+ 43#;WGR>,/S,P -H5]=G37^,SNF B8 :[#D^1F*)N87<O!X
M4@OL21NY&>6)0=GO;\,@<RFFQ.?90MXK#.;4Q$"-!V'^##NX(=H(M1" V-)%
M C"1:Z@-,5#%19A;PPYNB!2WQ1+5=UV/_T#\?1Q]W#C2O*O/0I7Q0G)IZ&!Q
M&6I76C"&S+R\(/:<[-7*28Z*QY^$JAN^0JU:FF/L%%@/(2)-[6:%.&3S- MX
MY9M0745[E=I85XV"V/'9R_J;N2@FHD=S?V[Q:&Y&>>E4_GBP>#^72?GZ?.YT
MM?V:W^R Z_FU_@2.2DO-]G#=20%)W;[&\_5(7:JOB[&1*$O7!M;5;FN$K@A?
MSBO[BKSLWE&S+P/F(Z9QE--KSNJ>G<"=^B08DS555>$S\S4<ZE.K^IV%7LCX
M1U'E;[_[RS9_@$)D=<W1/W9N80[5BF5B@2$Z'S=9F,9AD)^N!O]*V=9_&#!6
MTTQ\)\O5H$\"SO0-+0K8GUZ$%W57V41D54FQ\WBT>":%)&,FTQ=F^-0U]J9)
MGP3TDV[G"MJ1@31%^PN)O&\L-N-I*K0I.-L$%NA-1)GMXKJ$'$GLUVQ&L6D=
MQQ2<;58.]-91C_47G.A *;$B MNN@=00<;8I/]#;B!#QJYF<TSGDK/.'H#>2
M&F%?X^\UQ'84 9CM6N_8)+%+J6O6FV6*T+--<V+,Z656)<[<K]NA<' ;"=JD
M*=85&)^97;UJ33PM* U4F\2SS1US(5;:4*>N[CVHRP>EF6J3>+8I:R[$3!OJ
MU*7O5DO9&E#:F1Y]YYOAYD*LK(DZ7;J)7<J!4"=+"+Y B0LQ,#VX#/DWK3_?
MV8B?[_REQ?,=MC=8AM&:! Z]OM^YOM^YOM^YOM^YOM^I-[#K^YWK^YWK^YWK
M^YU+>K]3VOYE',2J%SS"#NC#R;M[PZ,0VID?[J^O>"XAH.'ZBL>,R(P%SFE]
M'?UDBS5BK@'&UP"#Z[.=+\0ZKL]VND,,4@K7Z%>OSW/,8WI]:W!]DO/%V,7U
M2<XE'RJN#W%.)V<,;W#XQ3)7]N]^^OZ[3-79+TZY&N3!:?W O2M8KU%_1I)=
MBL[VH4Q;@[ N^8MPI5X?FIWK<QIC?EG<#\U.O"CL[![.-)LPLH^=>K5H1>KU
MO8HT@A O<%</\/6)V?7MBGU/\UD\,3OQXGGG\4RB3VG#*'NCDZX>;=<G+!;7
MQR9J=.G'LB_SA1B^:($+6<MLO!"[GN0,D'K>1:,O8+%JB=T7Z'>ON%;;'--.
M@VT#2L^W0/4E&65C%;N04FN98(8!^S<=O'(1TS%-BM>3]2\W?SY^N3E9?!S,
M>E\-Q[>3A\$?>X._\[>;@S_UQH,%BH>8)189X 67@.JPJGX6CQ$Y5:,PCN^9
M5>?:_D"3YY#I,;>\3.?%G &[6PY0A^%VM"/6DLSYQWCLF<H9'P8)92@E?&;S
M7CR730DR-0!TMAVVW5 +P&*QJ0.U^ZI1^#DG^F.8QEZPFI(H"6@4/WN;#\0+
M8J[;M,ZX66=H7]O1QGJ@:C!F']-N[)KMB=A&)+A-&>F!\[9@VY"828;!P]GE
MW-[0)6NS(*]B^]8:Q';H;2,[;R F=/;>7X=1XOT[$_1DR5APZ9I$O\=,"H5,
M$K;=]9Y\VF<Z7KNLLV'T1[$=4ZH]!S05% [/[Y!MO+V(+TF3Y3&E@U?'3WET
MTX<P=#][OB]9L_6&L1T=V6SU;B(J(\['!W;.H;Y/ LJ6G>I1J=X4E9UL1^AI
M6QY0#.>_[&:\C<,@W+#3?\*T3 5W6:*2?K9CRAJ9(4P8;4%?A GQ[2,_C4*'
M4C<[-<X)3\W!?L,83][X\WI^<.!GR0V?E,1JH#6([0"K1CK10$PXEM_M?G 2
MU) -@!;:WW8,3B-4]813 ^C9>"]__N[JO;3NO=RG/QHRS)=>X"5TY+UP)_SA
M9@^<*PXV#H[L/8TL5)?5<GR$5?>DE-B;MP?RSS"Z]4D<C]1YWIJ-A@/U9CI?
M<6LV$0"2A&T:Q,M3NFD/]&5J *;<;PJR]T1#4KLU&@R'#C2T 3TEJ!< BM1M
M>Z>=*F=;M:7MBZ@6.GR$GT@*1EQ896?:_L/UGBM16\L7P6UV$24OEEP2B$XU
M'$<O*5U1'IQ@WAV?8/*C2V_1__M@WOMJ3"+NK7FA.+)@YQO=!7G=DZP^NT@[
M=6@:V\]0X4F#JTVE%9:U1"G9LO)7N&B=&+I6INP+MQ%U/>X*FFP=A]RW<,OT
M\FV9AWI)-_ML%.U!+"-2*]\*!-I<(=FX[^@NTRG?HDNZX(=*S0..374M@9 -
MM+(CC@E.J7<0P#K< M?.=T4$0NVWA7M<UA'2S_:M$5#!2E,<7!HX;@5V4T$_
M39[#R$O>5*Z'^O9G,ZF)&"@%?*&"0^T+$/7 ,8?)%4P)#JK#.R.&QHGGW(9I
MD$1OJA.\H+GM24VE8T>82)G&,8EM@^!@L-2WMOZ<61,6&<_HWM,7Q *V [IP
M& O.@\)1)1V393#Z\U<]RM-*N=G9+.9'=)<B=#'('' *.6R(8\6NU1F1X%&M
MSP,2^1Y;K!AUGRB)5 N!H+GML"2!_APA(.45Q^0S(@D<C-K&MF.)8%!(^#1R
MH3%XW7A1)@/IW,Z:UK?$/[T+22^%Y)N3IW#>KB$+R=0M%)A2KB9=0^,PF:=/
M_Z1.L@CWWY7M N4][&5QD BN(F$(UV82A>C)N@-!=_\62D?0QJ7<I4]GSJ27
MO]@G?EZ#C%)^#])W78]33OS]+59\\\;^L0ECXG^(PG03LR'R-Q^\31@D7I#2
M[0U*&"BCA4[S??M3H)8+T+Q 2D^+;#JM= B'7)XT'A#'\>:TYGCL3&LJ.Q/+
M<_U7L^A<V;H!Z 9=/XSY.%LJ?6F1 0L)QV+S&+C[U(#LC!@PKN/)LG!1L14S
M]ER/1%[M^_EB$)TQ; 5&-8DFJ+5(?8$9V;MML_ PID8>>?)\+WEC&\D9=;@$
MW?Z:^WDGR\<@8K]9!=Z_J5O716"Q70UN+0*Q/=Q=B@&3P>_V/(/EDFV&X[Z?
M?8R1[C$V$O^-;8^S'#"#]<8/WRA;^4+G]R()%.!:L=FPUM)K=#8O=")7'"K"
MA! 4WBDQX >-K*7"Z R^&IYQ@%&>71B!-S2@2X_GS"[4;4K9WC-ARPUC?Y>T
MQW&B5%:3L-6@UM)@=+B&MY;I^2J'\FE^JT&MI<^PJASB%_[XE&/Q3)+?PM1W
M>72_D^3+E??"69NQ]4I;+Y3C64O>85HE@)+$H0WUL:'9%E9ZXRSN9"TNJ3-<
M 3)!#-[>BWTGM5M09VN7V&;!K)<1#E#%K$IWW<(^UBZ_N]R$*R2"'3FH3<)'
ML!=G> )8,9LG=_,$CN=[1?H\P29@EUXM7S?B*8T2XG&O(+]G)&LF&]Y\1I,T
M"N*:[-U5Y3#_97O%0CI3JE/!@T,9!=S-J)MFR3O93W'J<T'R/%,CLHGI9-G?
M;'S/X1>;_/8J3=BO1M[:RV&6^O,-?,QZ18V3*0SH[- %<N@>8&\89T_)/XE+
MEO0I$;S&?B]_C3V-PA<O9J3UV$S0RT_=O>R*OO?TQG_H_7<:>;'K9=+KD<#M
M;5\<9/\H+F)ZVZN9WE.6SS8?XOK"NW-F\DS"R=[]G;M""CV_S:]"&1"EZVXE
MKVW&M)YY ?S&O -F,2U1!1_WE,F7^!5&E&B+.]K.8](!0K60JT2%"M<L (;M
MV$;L2PW0576WG5_?%,8PL:%">O\D6=>"A1UMI\HW9L$*4:'"5<!]TV78?CY\
M4Z@J!-7XM62"(W'SOH!7AUNV5H/:SKFOOVGK0(8XYH8M(\5>1'N.@/:WG<&_
M"\#J50 F.9M/K+O5E(,=36-]@8UB._6!.:W1D>+EZ$ZQ7VH^RRCZVWZ*:W"6
M 4GN<C2EL8JTU0UC;X/-Z<:%[U>U5:&M"IP@9PMXH_E%8+LM/EIG WDYNM)+
MO0<OR-*KE"I4@DJ80EWL)R;&WE5L2YVT AJ.0U,# 6SOJ#K5OOV@UF]7;>I$
M:^T\!N=LM:S8)7:J9+LQ[3WROP0=.X+F_'?J#60P>&5"96KB!21ZRX)[QF'
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M8 >K(/;Y;:Z[Q(9[_QJQW[MXLL0X,HYQ-^E2%_P+J7ICJ$JP%I%,96P^S&_
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M              "  4*% @!C;'@M,C Q-C V,S!?;&%B+GAM;%!+ 0(4 Q0
M   ( $V%$$G\G5>GL8D  +JF"0 4              "  7UL P!C;'@M,C Q
C-C V,S!?<')E+GAM;%!+!08     !@ & (0!  !@]@,    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
